<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2017-04-05T16:29:10Z</responseDate><request verb="ListRecords" resumptionToken="oai%3Apubmedcentral.nih.gov%3A5359529!2017-04-04!2017-04-05!pmc!">https://www.ncbi.nlm.nih.gov/oai/oai.cgi</request><ListRecords><record><header><identifier>oai:pubmedcentral.nih.gov:5359529</identifier><datestamp>2017-04-04</datestamp><setSpec>frontbehavneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Behav Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Behav Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Behav. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Behavioral Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5153</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359529</article-id>
      <article-id pub-id-type="pmcid">PMC5359529</article-id>
      <article-id pub-id-type="pmc-uid">5359529</article-id>
      <article-id pub-id-type="doi">10.3389/fnbeh.2017.00039</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Brain Acetaldehyde Exposure Impacts upon Neonatal Respiratory Plasticity and Ethanol-Related Learning in Rodents</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Acevedo</surname>
            <given-names>María B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/377149/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Aloisio</surname>
            <given-names>Génesis</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/401303/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haymal</surname>
            <given-names>Olga B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/401310/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Molina</surname>
            <given-names>Juan C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn002">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/400617/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Laboratorio de Alcohol, Ontogenia y Aprendizaje, Instituto de Investigación Médica Mercedes y Martín Ferreyra, Consejo Nacional de Investigaciones Científicas y Técnicas (INIMEC-CONICET), Universidad Nacional de Córdoba</institution>
        <country>Córdoba, Argentina</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Experimental Psychobiology Chair, Department of Psychology, Universidad Nacional de Córdoba</institution>
        <country>Córdoba, Argentina</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Merce Correa, Jaume I University, Spain</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: M. Yanina Pepino, Washington University School of Medicine, USA; Inmaculada Cubero, University of Almería, Spain</p>
        </fn>
        <corresp id="fn001">*Correspondence: María B. Acevedo <email xlink:type="simple">sallycabooh@gmail.com</email></corresp>
        <corresp id="fn002">Juan C. Molina <email xlink:type="simple">juancmolina2003@hotmail.com.ar</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>39</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Acevedo, D'Aloisio, Haymal and Molina.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Acevedo, D'Aloisio, Haymal and Molina</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Prior studies indicate that neonates are very sensitive to ethanol's positive reinforcing effects and to its depressant effects upon breathing. Acetaldehyde (ACD) appears to play a major role in terms of modulating early reinforcing effects of the drug. Yet, there is no pre-existing literature relative to the incidence of this metabolite upon respiratory plasticity. The present study analyzed physiological and behavioral effects of early central administrations of ethanol, acetaldehyde or vehicle. Respiration rates (breaths/min) were registered at post-natal days (PDs) 2 and 4 (post-administration time: 5, 60, or 120 min). At PD5, all pups were placed in a context (plethysmograph) where they had previously experienced the effects of central administrations and breathing patterns were recorded. Following this test, pups were evaluated using and operant conditioning procedure where ethanol or saccharin served as positive reinforcers. Body temperatures were also registered prior to drug administrations as well as at the beginning and the end of each specific evaluation. Across days, breathing responses were high at the beginning of the evaluation session and progressively declined as a function of the passage of time. At PDs 2 and 4, shortly after central administration (5 min), ACD exerted a significant depression upon respiration frequencies. At PD5, non-intoxicated pups with a prior history of ACD central administrations, exhibited a marked increase in respiratory frequencies; a result that probably indicates a conditioned compensatory response. When operant testing procedures were conducted, prior ethanol or ACD central administrations were found to reduce the reinforcing effects of ethanol. This was not the case when saccharin was employed as a reinforcer. As a whole, the results indicate a significant role of central ACD upon respiratory plasticity of the neonate and upon ethanol's reinforcing effects; phenomena that affect the physiological integrity of the immature organism and its subsequent affinity for ethanol operationalized through self-administration procedures.</p>
      </abstract>
      <kwd-group>
        <kwd>neonates</kwd>
        <kwd>ethanol</kwd>
        <kwd>acetaldehyde</kwd>
        <kwd>breathing</kwd>
        <kwd>operant learning</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">Consejo Nacional de Investigaciones Científicas y Técnicas<named-content content-type="fundref-id">10.13039/501100002923</named-content></funding-source>
          <award-id rid="cn001">PIP 11220110100763</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn002">Agencia Nacional de Promoción Científica y Tecnológica<named-content content-type="fundref-id">10.13039/501100003074</named-content></funding-source>
          <award-id rid="cn002">PICT 2011-0999</award-id>
          <award-id rid="cn002">PICT 2014-1606</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="80"/>
        <page-count count="12"/>
        <word-count count="10341"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Low doses of ethanol (0.11 g/kg/h), combined or not with a tocolytic agent (ritodrine), have been employed to reduce the incidence of human preterm births. Under these clinical conditions, in approximately 80% of the patients, uterine contractions were suppressed and a significant number of preterm births were prevented (Schrock et al., <xref rid="B70" ref-type="bibr">1989</xref>). According to this study no adverse effects of ethanol were observed. Yet, the obstetric use of ethanol, depending upon factors such as dose, frequency of exposure and fetal stage of development has been questioned due to a variety of disruptive physiological effects of the drug upon the fetus. Hypothermia, acidosis, hypercapnia, bradycardia, hypoglycemia, apneas and hypoxia are likely to occur in the developing organism exposed to ethanol (Abel, <xref rid="B4" ref-type="bibr">1981</xref>; Duxbury, <xref rid="B31" ref-type="bibr">2001</xref>; Abate et al., <xref rid="B1" ref-type="bibr">2004</xref>). When considering the central nervous system, there are also numerous studies confirming disruptions caused by relatively infrequent and small doses of the drug upon a variety of parameters. Rat fetuses exposed to low ethanol doses (blood ethanol concentration ≤ 30 mg%) show impairments in spatial learning accompanied by alterations in hippocampal glutamate-dependent synaptic neurotransmission (Savage et al., <xref rid="B69" ref-type="bibr">2002</xref>). In rhesus monkeys, moderate maternal ethanol consumption (0.6 g/kg ethanol daily) during midgestation to late gestation, induces heightened dopaminergic function (Wise, <xref rid="B76" ref-type="bibr">2002</xref>). During a stage in the development of the mouse characterized by a brain growth spurt, similar to the one observed during the third gestational trimester in humans (Dobbing and Sands, <xref rid="B24" ref-type="bibr">1973</xref>, <xref rid="B25" ref-type="bibr">1979</xref>), a single ethanol dose (0.63 g/kg) yielding relatively low peak blood ethanol levels (57 mg%) is sufficient to trigger a significant neuroapoptosis response (Young and Olney, <xref rid="B79" ref-type="bibr">2006</xref>).</p>
      <p>Preclinical and clinical studies have indicated that relatively low ethanol doses during pregnancy are sufficient to trigger fetal sensory and learning capabilities with an impact upon later patterns of chemosensory recognition of the drug, ethanol odor and taste preference (Faas et al., <xref rid="B34" ref-type="bibr">2000</xref>, <xref rid="B33" ref-type="bibr">2015</xref>; Abate et al., <xref rid="B2" ref-type="bibr">2008</xref>) and sensitivity to the drug's positive reinforcing effects (Nizhnikov et al., <xref rid="B59" ref-type="bibr">2006</xref>). Fetal experience with ethanol generates conditioned responses derived from the association between the drug's odor and taste and its motivational properties (Abate et al., <xref rid="B3" ref-type="bibr">2001</xref>; Spear and Molina, <xref rid="B71" ref-type="bibr">2005</xref>; Molina et al., <xref rid="B55" ref-type="bibr">2007</xref>; Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>). These phenomena predispose the organism to heightened seeking and intake patterns of the drug during infancy and adolescence (Dominguez et al., <xref rid="B27" ref-type="bibr">1998</xref>; Foltran et al., <xref rid="B36" ref-type="bibr">2011</xref>; Fabio et al., <xref rid="B35" ref-type="bibr">2013</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>). Epidemiological studies have validated the significant association existing between fetal ethanol exposure and subsequent predisposition to seek and consume the drug (Baer et al., <xref rid="B10" ref-type="bibr">1998</xref>, <xref rid="B11" ref-type="bibr">2003</xref>; Griesler and Kandel, <xref rid="B38" ref-type="bibr">1998</xref>; Yates et al., <xref rid="B78" ref-type="bibr">1998</xref>; Alati et al., <xref rid="B6" ref-type="bibr">2006</xref>).</p>
      <p>Acetaldehyde (ACD), ethanol's principal metabolite, mainly and rapidly forms in the perinatal brain via the oxidative process of the catalase system. The activity of this enzymatic system is significantly higher during early ontogeny relative to adolescence and adulthood (Del Maestro and McDonald, <xref rid="B22" ref-type="bibr">1987</xref>; Gill et al., <xref rid="B37" ref-type="bibr">1992</xref>; Hamby-Mason et al., <xref rid="B41" ref-type="bibr">1997</xref>). When considering ethanol's reinforcing effects, ACD formation in the brain plays a critical role (Wall et al., <xref rid="B74" ref-type="bibr">1992</xref>; Hahn et al., <xref rid="B39" ref-type="bibr">2006</xref>). In newborn rats, intracisternal administration of relatively low doses of ethanol (100 mg%) or of ACD (0.35 μmol) promote appetitive conditioning (Nizhnikov et al., <xref rid="B58" ref-type="bibr">2007</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>). Furthermore, when considering either peripheral or central administration of ethanol, the establishment of early appetitive memories are blocked when sequestering brain ACD via the use of d-penicilamine (Pautassi et al., <xref rid="B61" ref-type="bibr">2011</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>) or when inhibiting the catalase system through sodium azide (Nizhnikov et al., <xref rid="B58" ref-type="bibr">2007</xref>).</p>
      <p>Ethanol consumption during pregnancy has also been found to endanger the wellbeing of the fetus and the neonate due to its detrimental effects upon the respiratory system and its plasticity; a phenomenon that has stimulated research efforts based on the fact that fetal alcohol exposure is a risk factor for Sudden Infant Death Syndrome (Burd et al., <xref rid="B15" ref-type="bibr">2004</xref>; O'Leary et al., <xref rid="B60" ref-type="bibr">2013</xref>). In human and ewes, the depressant effects of the drug upon fetal breathing movements (FBMs) have been well documented (Vojcek et al., <xref rid="B73" ref-type="bibr">1988</xref>; Brien and Smith, <xref rid="B13" ref-type="bibr">1991</xref>) and there is evidence that maternal human consumption of only two glasses of wine during late gestation significantly suppresses fetal breathing activity (Brien and Smith, <xref rid="B13" ref-type="bibr">1991</xref>; Dillner et al., <xref rid="B23" ref-type="bibr">1996</xref>). In rats, chronic ethanol exposure during pregnancy, reduces brainstem-dependent respiratory rhythmic activity in the progeny and sensitizes juveniles to the depressant effects of acute ethanol upon phrenic and hypoglossal nerve activity (Dubois et al., <xref rid="B29" ref-type="bibr">2006</xref>). Analogous effects in rats have been recently reported utilizing moderate levels of ethanol exposure during the last days of pregnancy or during the first days of post-natal life (Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>; Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>). These stages in development, in terms of brain developmental patterns, are equivalent to the 2nd and 3rd human gestational trimester; respectively (Dobbing and Sands, <xref rid="B24" ref-type="bibr">1973</xref>, <xref rid="B25" ref-type="bibr">1979</xref>). Indeed, we have reported that maternal intragastric (i.g.) administration of ethanol (2.0 g/kg) during gestational days (GDs) 17–20 is sufficient to sensitize the progeny to the drug's depressant effects upon respiratory rates and exacerbate the presence of apneic episodes; disruptions that occur without affecting different pulmonary morphometric parameters (Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>). This sensitization process has also been observed when neonates [post-natal days (PDs) 3, 5, and 7] were peripherically administered with ethanol (i.g.: 2.0 g/kg). Furthermore, in both studies, it was observed that the explicit association between ethanol's sensory attributes and the depressant consequences of the drug resulted in conditioned isodirectional breathing responses (Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>).</p>
      <p>After systematically reviewing the pre-existing literature concerning ethanol's central effects upon breathing patterns of the perinate, we were unable to find specific literature related with possible contributions of ACD. Despite this observation, it should be noted that respiratory plasticity is linked with thermoregulatory disruptions. Indeed, prenatal or neonatal hypothermia can cause respiratory arrests (Duxbury, <xref rid="B31" ref-type="bibr">2001</xref>). Among the multiple physiological consequences of ACD is the modulation of the thermoregulatory system. In mice, peripheral administration of ACD causes hypothermia (Closon et al., <xref rid="B17" ref-type="bibr">2009</xref>). Nevertheless, there is certain degree of contradiction relative to the prior statement. It has been observed that in rats the inhibition of the central catalase system following ethanol administration seems not to play a significant role in the induction of hypothermia (Aragon et al., <xref rid="B7" ref-type="bibr">1991</xref>).</p>
      <p>The first goal of the present study was based on the preceding observations: (i) the absence of specific literature related with the central role of ethanol or its first metabolite (ACD) in terms of disruptive effects upon early respiratory plasticity and (ii) a possible association existing between ethanol and/or ACD central effects leading to thermoregulatory alterations that may impact upon breathing responsiveness. To address these phenomena in perinatal rats, it was decided to employ similar central ethanol (100 mg%) and ACD (0.35 μmol) doses that have been observed to exert analogous motivational effects (Nizhnikov et al., <xref rid="B58" ref-type="bibr">2007</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>). A second goal was to further analyze if central pre-exposure to the drug or its metabolite modulate subsequent seeking behavior of ethanol as a reinforcer in an operant task specifically developed for perinatal or infant rats (Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>; Miranda-Morales et al., <xref rid="B52" ref-type="bibr">2014</xref>). These goals were sequentially examined. As a first step, during PDs 2 and 4, pups were intracisternally administered with either ethanol, ACD or a phosphate buffer as a control solution and respiration rates were recorded at different post-administration times. At PD5, all pups were re-exposed to the respiratory testing chamber without receiving any specific drug. This particular strategy obeys to the fact that prior experiments have indicated that early respiratory plasticity is also dependent upon exteroceptive ambient cues originally associated with breathing pattern changes. Following this testing procedure, pups were evaluated in terms of operant responding regulated by either an ethanol solution or a sweet reinforcer (saccharin). The inclusion of this last reinforcer obeyed to the need to control for unspecific learning alterations derived from the preceding central drug administration experiences. Body temperatures, before and after each specific drug treatment or evaluation procedure, were recorded.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and methods</title>
      <sec>
        <title>Subjects</title>
        <p>A total of 146 Wistar neonate rats, representative of 17 litters, were employed. Rats were born and reared at the vivarium of the Instituto de Investigación Médica Mercedes y Martin Ferreyra (INIMEC-CONICET-UNC, Argentina). The colony room was illuminated on a 12 h light/dark cycle (lights on: 08:00–20:00) at an ambient temperature and humidity of 22 ± 1°C and 45%, respectively. Births were daily examined and the day of parturition was considered post-natal day 0 (PD0). At PD1 each litter was randomly culled to 10 pups (5 males and 5 females, whenever possible). Throughout days pups were kept with their dams in standard cages that contained water and food <italic>ad libitum</italic> (ACA Nutrición, Buenos Aires, Argentina).</p>
        <p>All experimental treatments were in accordance with the Guide for Care and Use of Laboratory Animals (National Research Council, <xref rid="B57" ref-type="bibr">1996</xref>) and were approved by the Institutional Animal Care and Use Committee of our institution (CICUAL-INIMEC-CONICET-UNC). To reduce confounds between litter and treatment effects (Holson and Pearce, <xref rid="B44" ref-type="bibr">1992</xref>) no more than one male and one female per litter were assigned to a given experimental condition.</p>
      </sec>
      <sec>
        <title>General experimental procedures</title>
        <p>During PDs 2 and 4, pups were removed from their maternal cages and placed in similar cages partially filled with clean corncob. Ambient temperature was kept at 31–33°C via heating pads placed beneath the cages. Pups were centrally administered with a buffer solution, ethanol or ACD (see below) and tested in a plethysmograph at post-administration time 5, 60, or 120 min. Respiratory frequencies were assessed during 5 consecutive minutes. At PD5 pups representative of each prior treatment were removed from their maternal cages and kept in pairs under the same holding conditions as in the previous experimental days. Fifteen minutes later, respiratory evaluations were performed. Following these physiological recordings, pups were subjected to a minor surgical procedure in order to implant an intraoral cannula that served to conduct operant conditioning procedures defined by saccharin or ethanol reinforcement. Body temperatures were recorded before and after each specific physiological or behavioral evaluation.</p>
      </sec>
      <sec>
        <title>Central drug administration procedures</title>
        <p>Ethanol (100 mg%), acetaldehyde (0.35 μmol) and phosphate buffer (PB 0.1M) were administered with a 30 gauge hypodermic needle attached to a 20-cm length of polyethylene-10 tubing (PE-10 Clay Adams, Parsippany, New Yersey, USA) connected to a 50 μl gastight syringe (Hamilton, Reno Nevada, USA). Fluids (1 μl) were slowly injected (5–8 s) into the foramen magnum between the occipital bone and the first cervical vertebra, with the needle tip placed 1.5 mm depth in the cisterna magna (IC). PB 0.1M served as vehicle for ethanol and acetaldehyde solutions. The needle was kept in position for 10 s. The appearance of a small quantity of cerebrospinal fluid served to indicate the successful placement of the administrations. Similar procedures have been previously utilized in different studies (Varlinskaya et al., <xref rid="B72" ref-type="bibr">1996</xref>; Petrov et al., <xref rid="B65" ref-type="bibr">1998</xref>; Nizhnikov et al., <xref rid="B59" ref-type="bibr">2006</xref>, <xref rid="B58" ref-type="bibr">2007</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>).</p>
      </sec>
      <sec>
        <title>Determination of breathing frequencies</title>
        <p>Breathing frequencies were determinated through a whole body plethysmograph (Model 10G equipped with the software “Breath Medidor de Respiración,” Itcom, Argentina). The apparatus was built to record breathing patterns of small organisms weighing between 6 and 28 g. It consists of two identical transparent and hermetic Plexiglas chambers (5 × 10 × 5 cm), that are interconnected via a polyurethane hose system. The hose system allows injection and extraction of equivalent amounts of air in both chambers in order to maintain constant and equivalent pressures. One of the chambers is used as a testing device while the other serves as a reference box in terms of flow/air pressure. The plethysmograph records air pressure/flow rate differences between the testing and reference chambers. These differences activate a pressure sensor (AWM2100 Honeywell) with the capability of recording one complete breathing event every 1 × 10<sup>−7</sup> s. The plethysmograph records the breathing response every 1.5 s. These scores are transformed to mean breaths per minute.</p>
        <p>For each session, unrestrained awake pups were introduced into the chambers and the lids were closed. One minute after that pups were individually placed inside the chamber, respiratory responses were measured during 10 consecutive minutes. The minute of delay at the beginning of the test was used to allow air pressure stabilization in the chamber.</p>
        <p>An air conditioner kept the room temperature at 22 ± 1°C during experimental sessions. The temperature was kept at 31–33°C (similar to their maternal nest thermal condition) inside the plethysmograph chamber through heating pads placed beneath the apparatus (Julien et al., <xref rid="B45" ref-type="bibr">2010</xref>). The overall procedure has been previously used to evaluate breathing disruptions as a function of pre- and post-natal ethanol exposure (Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>; Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>).</p>
      </sec>
      <sec>
        <title>Body temperature measurements</title>
        <p>Body temperatures were non-invasively registered through a thermal infrared imaging camera (“Flir Exx Series,” Boston FLIR System, Inc.). The temperature corresponding to the nape of the neck of each subject served as the dependent variable. Thermal measurements were taken before and after each plethysmograph recording (PDs 2, 4, and 5) as well as prior and following each operant conditioning test (PD 5).</p>
      </sec>
      <sec>
        <title>Apparatus and operant conditioning test</title>
        <p>At PD5, and following breathing evaluations, pups were removed from their maternal cages and were intraorally implanted with a cannula (PE-10) that allowed liquid infusions (Hall, <xref rid="B40" ref-type="bibr">1979</xref>; Dominguez et al., <xref rid="B26" ref-type="bibr">1996</xref>; Abate et al., <xref rid="B3" ref-type="bibr">2001</xref>; Cheslock et al., <xref rid="B16" ref-type="bibr">2001</xref>; Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; Miranda-Morales et al., <xref rid="B52" ref-type="bibr">2014</xref>). They remained pair-housed in holding cages for 3 h until operant procedures took place. Before commencement of the evaluation, animals were anogenitally stimulated with a cotton swab to promote urination and defecation, weighed to the nearest 0.01 g. They were then fastened inside a disposable respirator mask (3M dust, fume and mist respirator 8801 P2) through a restrictor vest, expandable enough, to allow free movements of the head and limbs. The respiration mask was tilted at 40 degrees from the floor surface supported with a cardboard box (see Arias et al., <xref rid="B8" ref-type="bibr">2007</xref> for further procedural details).</p>
        <p>All procedures took place at a constant temperature (31–33°C) via the use of heating pads. A 40–50-cm section of polyethylene-50 tubing (PE-50 Clay Adams, Parsippany, New Yersey, USA) was connected to the end of oral cannula (PE-10) and to a 5 ml syringe (Becton Dickinson, Rutherford, NJ) with a 23-gauge needle that was filled with a specific solution and mounted in an infusion pump (KD Scientific, Model 200, Holliston, MA). The pump was set to deliver 1 μl of fluid in 1 s directly into the intraoral cavity of a given “Paired” pup and its corresponding “Yoked” control (see description below). Once evaluations begun, pups were able to gain access to intraoral infusions of 0.1% w/v saccharin or 3% v/v ethanol solution (Porta Hnos, Córdoba, Argentina; vehicle: tap water).</p>
        <p>To this end, two same-sex and same drug-treatment pups from a single litter with similar body weights were placed in front of a touch-sensitive copper sensor (5 cm length × 1 cm width × 45 cm 1 mm thickness). The sensor was 1 cm away from their mouths and perpendicular to the floor while they remained hold inside the mask. Each time the animal touched the sensor a red light bulb lit signaling a physical contact, which resulted in an infusion pump pulse.</p>
        <p>The apparatus was set to work with two subjects at a time: a Paired animal receiving infusions in a fixed ratio (FR) 1 schedule and a Yoked control receiving infusions in accordance to its corresponding paired pup. Each evaluation lasted 15 min. During these sessions pups received a given solution (ethanol or saccharin reinforcers) contingent upon their operant behavior (i.e., sensor contact). All pups received 4 priming pulses at the beginning of the training session, 60, 120, and 180 s. These pulses were administered independently of motor activity patterns in order to introduce the pup with the reinforcer and to minimally stimulate head and body movements. The number of sensor contacts of each Paired subject and its corresponding Yoked control were recorded. Similar procedures have been employed when analyzing early operant leaning regulated by positive reinforcers such as milk, sucrose and ethanol (Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>; Miranda-Morales et al., <xref rid="B52" ref-type="bibr">2014</xref>).</p>
      </sec>
      <sec>
        <title>Experimental design and data analysis</title>
        <p>Body weights were analyzed using a four-way mixed analysis of variance (ANOVA). Drug treatment at PDs 2 and 4 (PB 0.1 M, ACD 0.35 μmol or ethanol 100 mg%), sex (male or female) and post-administration time (5, 60, or 120 min) served as between-group factors. Days of assessment (PDs 2, 4, and 5) served as the within-measure factor. A five-way mixed ANOVA was performed to analyze mean respiration rates at PDs 2-4 where drug treatment, sex and post-administration time served as the independent factors, while days of assessment and minutes corresponding to each specific evaluations (minutes: 1–5) represented repeated measures. At PD5 breathing patterns were analyzed through a between-within ANOVA defined by the same independent factors and repeated measures.</p>
        <p>Thermoregulatory processes were analyzed using a five- or four-way mixed ANOVA (PDs 2, 4, and 5; respectively) where drug treatment, sex, post-administration time served as between factors while post-natal days and time of temperature recordings (before and after plethysmograph assessments) were considered as within-group variables.</p>
        <p>Relative to the operant task, the total number of sensor contacts was considered the dependent variable. Separate ANOVAs were conducted to analyze operant performance when either saccharin or ethanol served as reinforcers. More specifically, a two-way mixed ANOVA was utilized. This inferential analysis was defined by prior drug treatments the between-group factor and conditioning status (Paired or Yoked) as the within-group factor.</p>
        <p>Preliminary analysis relative to operant performance indicated no significant main or interaction effects when considering sex as a factor. Therefore, data were collapsed across sex for all the remaining analyses. The absence of sex effects has also been observed in prior studies when employing a variety of reinforcers in operant conditioning tasks during early ontogeny (Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>; Miranda-Morales et al., <xref rid="B50" ref-type="bibr">2010</xref>, <xref rid="B51" ref-type="bibr">2012a</xref>,<xref rid="B53" ref-type="bibr">b</xref>, <xref rid="B52" ref-type="bibr">2014</xref>).</p>
        <p>The loci of significant main effects were further analyzed with Ducan's <italic>post-hoc</italic> tests. A rejection criterion of <italic>p</italic> &lt; 0.05 was adopted for all statistical analyses in the present study. According to the nature of the dependent variables under consideration, tests were performed using between or within error terms. Since there is no unambiguous choice of appropriate error term for <italic>post-hoc</italic> comparisons involving between- and within-group significant interactions (Winer, <xref rid="B75" ref-type="bibr">1991</xref>), orthogonal planned comparisons were conducted when such interactions were obtained. All the statistical analyses were performed using the STATISTICA 8.0 software.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec>
        <title>Body weights across days (PDs 2, 4, and 5)</title>
        <p>Data corresponding to body weights across days was analyzed via a between-within ANOVA (drug treatment at PDs 2 and 4 × post-administration time × post-natal days × sex). As expected body weights progressively increased as a function of age; <italic>F</italic><sub>(2, 250)</sub> = 3,897.01, <italic>p</italic> &lt; 0.0001. Duncan's <italic>post-hoc</italic> tests showed that pups at PD4 exhibited significantly greater body weights than those previously recorded during PD2. At PD5, weight values were significantly higher than those observed at PD4 (means ± standard errors of the means for each day were as follows: PD2, 7.25 ± 0.06 g; PD4, 10.08 ± 0.07 g and PD5, 11.41 ± 0.09 g. Body weights did not differ as a function of the other factors under consideration.</p>
      </sec>
      <sec>
        <title>Breathing frequencies during drug pretreatment (PDs 2 and 4) and test (PD5)</title>
        <p>Figure <xref ref-type="fig" rid="F1">1</xref> illustrates average breathing responses corresponding to PDs 2 and 4 as a function of post-administration time (5, 60, or 120 min) and across minutes of evaluation. Respiration rates were not significantly different across days. The between-within ANOVA [drug treatment (PB 0.1 M, ACD 0.35 μmol or ethanol 100 mg%) × sex (female or male) × post-administration time (5, 60, or 120 min) × days of assessment (PDs 2 and 4) × minutes of evaluation (1–5)] indicated significant main effects of sex <italic>F</italic><sub>(1, 125)</sub> = 5.90, <italic>p</italic> = 0.0158; post-administration time <italic>F</italic><sub>(2, 125)</sub> = 12.27, <italic>p</italic> &lt; 0.0001; minutes of evaluation <italic>F</italic><sub>(4, 500)</sub> = 118.49, <italic>p</italic> &lt; 0.0001 as well as significant interactions between post-administration time and minutes of evaluation <italic>F</italic><sub>(8, 500)</sub> = 7.48, <italic>p</italic> &lt; 0.0001. Drug treatment was also found to significantly interact with post-administration time and minutes of evaluation; <italic>F</italic><sub>(16, 500)</sub> = 2.13, <italic>p</italic> = 0.0063.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Breathing rates (breaths/min) as a function of post-administration time (5, 60, or 120 min) and minutes of evaluation</bold>. Data have been collapsed across sex, postnatal days and drug treatment. <sup>###</sup> Indicates significant differences between breathing scores at post-administration time 5 min relative to scores attained at post-administration time 60 and 120 min. <sup>***</sup> Indicates significant differences between respiratory rates at minute 1 relative to the remaining minutes of evaluation; <italic>p</italic> &lt; 0.0001. <sup>&amp;<italic>&amp;&amp;</italic></sup> Indicates significant differences between minute 2 and minute 5; <italic>p</italic> &lt; 0.0001. Vertical lines indicate standard errors of the means (SEMs).</p>
          </caption>
          <graphic xlink:href="fnbeh-11-00039-g0001"/>
        </fig>
        <p>According to Duncan's <italic>post-hoc</italic> tests, breathing frequencies were significantly higher in male than female pups (181.30 ± 2.99 and 170.91 ± 3.01 breaths/min; respectively). Relative to the significant main effects of post-administration time, minutes of evaluation, and its significant interaction at PDs 2 and 4; <italic>post-hoc</italic> tests showed that breathing responses were significantly lower at post-administration time 5 min relative to the scores attained at 60 and 120 min. It is likely that the stress related with the intracisternal administration of the drugs, affected breathing rates shortly after performing these procedures. At 60 and 120 min, respiratory frequencies were similar to those reported in previous experiments where a given vehicle (e.g., water) was intragastrically administered 30 min prior to the evaluation (Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>).</p>
        <p>Within each test, respiration rates decreased as a function of the progression of the test; a phenomenon probably indicative of habituation to the context. This progressive depression was particularly observed in the group of animals evaluated at 60 and 120 min. When the evaluation was conducted 5 min after drug administration pups exhibited heightened respiratory rates during the initial minute of the test relative to the remaining minutes. This interaction has been depicted in Figure <xref ref-type="fig" rid="F1">1</xref>.</p>
        <p>With regard to the triple interaction involving drug treatment, post-administration time and minutes of evaluation, planned comparisons indicated significant differences in respiration rates between PB-treated and ACD-treated pups during the first minute of evaluation (Figure <xref ref-type="fig" rid="F2">2</xref>). This effect was only observed 5 min after administering the drug. At this point in time, ethanol-treated animals showed intermediate respiratory frequencies relative to PB- and ACD-treated pups.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Respiration frequencies (breaths/min) at PDs 2 and 4 as a function of drug treatment (PB, ACD or Ethanol), post-administration time (5, 60, or 120 min) and minutes of evaluation (1–5)</bold>. Data have been collapsed across sex and postnatal days. <sup>*</sup> Indicates a significant difference between PB-treated and ACD-treated pups (post-administration time: 5 min.; minute of evaluation: 1 min); <italic>p</italic> &lt; 0.05. Vertical lines indicate standard errors of the means (SEMs).</p>
          </caption>
          <graphic xlink:href="fnbeh-11-00039-g0002"/>
        </fig>
        <p>At PD 5, the corresponding between-within ANOVA (drug treatment at PDs 2 and 4 × sex × post-administration time × minutes of evaluation) showed that breaths per minute significantly varied as a function of drug treatment [<italic>F</italic><sub>(2, 128)</sub> = 4.37, <italic>p</italic> = 0.0146], minutes of evaluation [<italic>F</italic><sub>(4, 512)</sub> = 110.95, <italic>p</italic> &lt; 0.0001] and the following two-way interaction: drug treatment × minutes of evaluation [<italic>F</italic><sub>(8, 512)</sub> = 1.99, <italic>p</italic> = 0.0447].</p>
        <p>Once, again breathing responses progressively decreased as a function of the passage of time. Moreover, the group of animals previously treated with acetaldehyde during PDs 2 and 4 exhibited significantly higher breathing frequencies relative to the control group (PB). This significant difference was observed at minutes 2, 3, 4, and 5. Breathing scores of ethanol-treated pups did not significantly differ from PB- or ACD-treated subjects throughout the evaluation. This interaction has been depicted in Figure <xref ref-type="fig" rid="F3">3</xref>. As can be observed ACD-treated pups exhibited during PD5 breathing patterns which were opposite to those recorded at PDs 2 and 4 at the earliest post-administration time (5 min). When tested without being administered with acetaldehyde (PD5) breathing frequencies were significantly higher than in controls while under the effects of the drug (PDs 2 and 4), respiration rates were significantly lower.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Breathing rates (breaths/min) as a function of drug treatment (PB, ACD, or Ethanol) and minutes of evaluation at PD 5</bold>. <sup>*</sup> Indicates significant differences between ACD pups and pups pre-exposed to PB administrations. Vertical lines indicate standard errors of the means (SEMs).</p>
          </caption>
          <graphic xlink:href="fnbeh-11-00039-g0003"/>
        </fig>
      </sec>
      <sec>
        <title>Thermal responsiveness during drug treatment (PDs 2 and 4) and test (PD 5)</title>
        <p>As stated, body temperatures of pups treated with PB 0.1M, ACD 0.35 μmol or ethanol 100 mg% were recorded immediately before and after being exposed to the plethysmograph at PDs 2 and 4 as well as at PD5 (see Table <xref ref-type="table" rid="T1">1</xref>). The corresponding between-within ANOVA (drug treatment × sex × post-administration time × days of assessment x moment of recording) during PDs 2 and 4 only indicated a significant main effect of post-administration time; <italic>F</italic><sub>(2, 117)</sub> = 92.26, <italic>p</italic> &lt; 0.0001. Thermal temperatures soon after drug treatment (5 min) were significantly lower (33.91 ± 0.12°C) than those observed at post-administration times 60 and 120 min (35.96 ± 0.11 and 35.62 ± 0.12°C; respectively) Apparently, a stress-related factor derived form intracerebral administrations was responsible for the significant decrease in body temperature in pups tested 5 mins after the injection. At PD 5 (drug treatment × sex × post-administration time × moment of recording) no significant differences emerged when considering the main factors and the interactions between them. Notice that at this age pups were not IC administered. A similar lack of main significant effects or interactions was observed when processing body temperatures before and after the operant task.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Pup's body temperatures across days as a function of drug treatment and post-administration time</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Drug treatment at PDs 2 and 4</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Post-administration Time (min)</bold>
                </th>
                <th valign="top" align="center" colspan="6" style="border-bottom: thin solid #000000;" rowspan="1">
                  <bold>Body temperature (°C)</bold>
                </th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1"/>
                <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                  <bold>PD2</bold>
                </th>
                <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                  <bold>PD4</bold>
                </th>
                <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                  <bold>PD5</bold>
                </th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1"/>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Before</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>After</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Before</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>After</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Before</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>After</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Phosphate buffer (PB 0.1M)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.23 ± 0.31</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.12 ± 0.29</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.96 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.05 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.99 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.77 ± 0.28</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.73 ± 0.30</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.01 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.81 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.66 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.91 ± 0.24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.06 ± 0.25</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">120</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.67 ± 0.31</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.86 ± 0.29</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.56 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.40 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.66 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.58 ± 0.27</td>
              </tr>
              <tr style="border-top: thin solid #000000;">
                <td valign="top" align="left" rowspan="1" colspan="1">Acetaldehyde (0.35 μmol)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.83 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.12 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.71 ± 0.25</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.83 ± 0.25</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.72 ± 0.24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.57 ± 0.24</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.23 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.35 ± 0.25</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.98 ± 0.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.83 ± 0.24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.12 ± 0.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.38 ± 0.24</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">120</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.68 ± 0.29</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.36 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.04 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.49 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.64 ± 0.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.96 ± 0.24</td>
              </tr>
              <tr style="border-top: thin solid #000000;">
                <td valign="top" align="left" rowspan="1" colspan="1">Ethanol (100 mg%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.83 ± 0.30</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.12 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.42 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">33.63 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.43 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.17 ± 0.26</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.21 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.07 ± 0.25</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.70 ± 0.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.87 ± 0.24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.18 ± 0.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.65 ± 0.24</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">120</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.76 ± 0.30</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.53 ± 0.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.78 ± 0.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35.28 ± 0.27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.57 ± 0.25</td>
                <td valign="top" align="center" rowspan="1" colspan="1">34.39 ± 0.25</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Values are expressed as means ± SEMs. Body temperatures at PDs 2 and 4, recorded immediately after intracisternal administrations (5 min), were significantly lower than those registered at 60 or 120 min</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Operant conditioning at PD5</title>
        <p>Figure <xref ref-type="fig" rid="F4">4</xref> depicts the total number of sensor contacts in Paired and Yoked groups reinforced with either intraorally administered saccharin or ethanol. Separate ANOVAs were conducted to analyze learning patterns dependent upon either saccharin (0.1%) or ethanol (3%) reinforcement. In each case, tree-way mixed ANOVAs were used. This analyses were defined by drug treatment as the between factor and conditioning (Paired or Yoked) as well as minutes of evaluation as within factors.</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Sensor contacts at PD5 when pups were reinforced with saccharin or ethanol</bold>. When saccharin was employed a main significant effect of conditioning (Paired vs. Yoked) was observed. <sup>###</sup> Indicates the significantly higher level of responding of Paired pups when compared to Yoked controls; <italic>p</italic> &lt; 0.0001. When ethanol served as a reinforcer, only Paired pups pre-exposed to PB exhibited significantly higher levels of sensor contacts when compared with the corresponding Yoked controls (<sup>*</sup>); <italic>p</italic> &lt; 0.05. Vertical lines indicate standard errors of the means (SEMs).</p>
          </caption>
          <graphic xlink:href="fnbeh-11-00039-g0004"/>
        </fig>
        <p>When saccharin was employed as a reinforcer, the ANOVA indicated that conditioning exerted a significant main effect [<italic>F</italic><sub>(1, 28)</sub> = 34.82, <italic>p</italic> &lt; 0.0001]. As can be observed in Figure <xref ref-type="fig" rid="F4">4</xref>, all Paired groups, independently from prior drug experience, showed higher operant responsiveness relative to the corresponding Yoked controls. This result is analogous to those reported when employing saccharin in older infants (Miranda-Morales et al., <xref rid="B52" ref-type="bibr">2014</xref>) or when neonates are reinforced with milk (Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>). It is interesting to note that prior drug exposure appears not to affect the learning capability of the organisms nor its overall activity. Relative to the activity rate, Yoked controls pretreated with buffer, ethanol or acetaldehyde showed similar levels of spontaneous sensor contacts.</p>
        <p>When ethanol was employed as a reinforcer not all Paired groups differed from the corresponding Yoked controls. The ANOVA revealed a significant main effect of conditioning and a significant interaction between this factor and drug treatment [<italic>F</italic><sub>(1, 32)</sub> = 21.75, <italic>p</italic> &lt; 0.0001 and <italic>F</italic><sub>(2, 32)</sub> = 3.51, <italic>p</italic> = 0.0419; respectively]. Planned comparisons indicated that only Paired pups treated with a PB control solution had higher sensor contacts that their corresponding Yoked controls. Pretreatment with ethanol or its metabolite appeared to decrease the reinforcement capability of ethanol. Once again, this effect cannot be attributed to motor activity differences across drug pretreatments that can contribute to the probability of sensor contacts. Relative to this issue, all Yoked groups has similar levels of activity.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>As stated (see Introduction section) the present study pursued two main goals: (i) the analysis of central ethanol and ACD effects in terms of disruptive effects upon early respiratory plasticity and possible association existing between ethanol and/or ACD central effects leading to thermoregulatory alterations in neonatal rats, and (ii) the analysis of central pre-exposure to the ethanol or its metabolite effect on subsequent seeking behavior of ethanol as a reinforcer in an operant task in neonate rats (Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>; Miranda-Morales et al., <xref rid="B52" ref-type="bibr">2014</xref>).</p>
      <p>Ethanol and ACD doses were chosen according to previous literature indicating analogous effects at least when considering the motivational properties of these drugs (Nizhnikov et al., <xref rid="B59" ref-type="bibr">2006</xref>, <xref rid="B58" ref-type="bibr">2007</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>). When doing so, during PDs 2 and 4, neonates exhibited a respiratory depression when administered with ACD and tested only 5 min after drug administration. This effect was clear at the beginning of the testing procedure (minute 1) relative to control pups administered with PB. Pups treated with ethanol exhibited intermediate values relative to the above mentioned groups. These effects were observed despite the fact that at this post-administration time, respiration rates were very low across groups (see Figure <xref ref-type="fig" rid="F2">2</xref>). Preliminary pilot studies performed with untreated animals confirmed that the mere handling of the neonates is enough to alter respiratory frequencies when evaluations are temporally close to this manipulation. The values obtained in these untreated pups were found to be almost identical to the PB controls here utilized.</p>
      <p>It was also observed that respiratory frequencies increased at 60 and 120 min post-administration time (Figure <xref ref-type="fig" rid="F1">1</xref>) and neither ethanol nor ACD exerted depressant effects relative to controls. Relative to ACD, these null results may indicate that further pharmacokinetic processes (e.g., ACD conversion into acetate) partially or completely reduce brain concentrations of the metabolite (Quertemont and Didone, <xref rid="B67" ref-type="bibr">2006</xref>; Zimatkin et al., <xref rid="B80" ref-type="bibr">2006</xref>; Hipolito et al., <xref rid="B42" ref-type="bibr">2007</xref>). The fact that ethanol was never found to produce significant respiratory decrements may be related with the dose here employed. Under the present experimental circumstances, it is not possible to determine whether the 100 mg% dose is sufficient to negatively act upon respiratory plasticity or generate, via oxidative processes, ACD levels capable of disrupting breathing patterns. Relative to this dose-related problem, and as previously stated, it is interesting to note that pups tested shortly after receiving brain ethanol administration, exhibited a trend toward a reduction in breathing frequencies relative to controls but not as profound as the group treated with ACD (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
      <p>At PD5, pups were re-exposed to the testing chamber without receiving any explicit drug treatment. ACD pretreated neonates were found to show heightened respiratory frequencies relative to the remaining groups (Figure <xref ref-type="fig" rid="F3">3</xref>). We cannot discard the possibility that prior administrations of the metabolite disrupted the respiratory system causing hyperventilation. Nevertheless, a second hypothesis seems plausible. The effect at PD5 (high respiration rates) was opposite relative to the one observed at PDs 2 and 4 (low respiration rates). This apparent contradiction is in agreement with the establishment of learned tolerance to drugs of abuse where conditioned stimuli elicit neurally-mediated homeostatic responses that serve to reduce a specific perturbation (Woods and Ramsay, <xref rid="B77" ref-type="bibr">2000</xref>). Some studies have shown that ambient cues associated with the depressant effects of ethanol appear to modulate the effects of the drug upon respiratory plasticity (Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>; Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>). This modulation is related with classical conditioning learning where ambient cues such as the testing environment or a specific odorant (e.g., ethanol odor perceived in the amniotic fluid or as an ambient odor) are associated with the unconditioned effect of the drug. Similar learning processes have been observed in 2-day-old mice when olfactory cues associated with maternal care resulted in heightened conditioned respiratory responses (Durand et al., <xref rid="B30" ref-type="bibr">2003</xref>). When utilizing peripheral ethanol in developing rats, conditioned responses are <italic>isodirectional</italic> relative to the depressant effects upon respiration. In accordance with the systematic review of Eikelboom and Stewart (<xref rid="B32" ref-type="bibr">1982</xref>), physiological disruptions mediated by the central nervous system are associated with conditioned stimuli which later elicit <italic>compensatory</italic> conditioned reactivity. If the drug acts on afferent pathways of the brain, the associative process results in isodirectional conditioned responses. In agreement with their analysis and predictions based on specific feedback mechanisms, cues associated with respiratory depressions caused by peripheral (i.g.) ethanol administrations, latter elicit isodirectional learned responses (Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>). As observed in the present experiment, contextual cues associated with central-nervous-system-mediated respiratory depressions caused by ACD, cause the opposite (probably compensatory) effect.</p>
      <p>As previously stated (see Introduction), thermoregulatory disruptions can determine or modulate respiratory depressions. When considering neonatal thermal responsiveness at PDs 2 and 4, it was clear that soon after intracisternal administrations (5 min), body temperatures were low when compared to those recorded at post-administrations time 60 or 120 min (Table <xref ref-type="table" rid="T1">1</xref>). Stress-related effects of the administration procedure or even the temperature of the solutions injected into the cisterna magna are factors which can account for this phenomenon. As mentioned, at the earlier post-administration time (5 min) we also observed very low breathing frequencies; a result which argues in favor of the modulatory effects of thermoregulation upon breathing. Yet, drug treatment affected breathing but not thermal responsiveness; a result that argues in favor of early breathing disruptions caused by ACD independently from thermal alterations. At PD5, when tests were performed without any prior administration procedure, temperatures were similar across all groups but as stated, ACD pre-exposed neonates exhibited heightened respiratory rates. Once again, this phenomenon favors the hypothesis that ACD respiratory effects across the experiment were not related with temperature variations. Nevertheless, when taken into account that the administration procedure does affect thermoregulation and that all breathing tests were performed in chambers maintained at 31–32°C, a possible association between thermal and breathing disruptions should not be completely overruled.</p>
      <p>The second major goal of the study attempted to elucidate whether prior exposure to central ethanol or ACD impacts upon operant conditioning processes where ethanol or saccharin serve as positive intraoral reinforcers. The results obtained with saccharin confirmed the rapid learning capability of neonates that has been reported when utilizing alternative sweet reinforcer or milk (Arias et al., <xref rid="B8" ref-type="bibr">2007</xref>; Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>). Independently of prior drug condition, pups exposed to the explicit contingency between sensor contacts and saccharin intraoral administration (Paired groups), exhibited relative to Yoked controls, a significantly higher number of responses. This pattern of results was not observed when ethanol served as a reinforcer. Once again, Paired pups pre-exposed to the buffer control solution significantly differed from the corresponding Yoked control group. As in previous studies, neonates without any specific prior drug experience rapidly learn to self-administer an ethanol solution (Bordner et al., <xref rid="B12" ref-type="bibr">2008</xref>; March et al., <xref rid="B48" ref-type="bibr">2009</xref>). This was not the case when neonates were centrally administered with ethanol or ACD (PDs 2 and 4) prior to the assessment of response-stimulus learning associations (PD5). When using these drugs Paired pups did not differ from Yoked controls. Furthermore, Paired pups with a prior history of ACD administrations differed from Paired pups pretreated with the buffer solution. As in the case of respiratory frequencies, Paired subjects pre-exposed to central ethanol, exhibited intermediate levels of responding relative to the two remaining drug-related Paired conditions (ACD or PB).</p>
      <p>The results obtained with saccharin indicate that neither ethanol nor ACD pre-exposure altered learning capabilities of the neonates. Therefore, the absence of operant conditioning observed in Paired pups reinforced with ethanol that were previously treated with ethanol or ACD, argues against deleterious effects of these drugs upon the learning process itself. Two hypotheses appear pertinent when addressing the lack of significant learning in Paired subjects pre-exposed to ethanol or ACD and subsequently reinforced with ethanol. Both of them are based on the direct action of ACD in the central nervous system and the biotransformation of ethanol into its principal metabolite via the central catalase system. Favoring the possibility of rapid ethanol metabolism in the neonatal brain is the fact that catalase concentrations in the brain of the newborn rat are approximately eight times higher than in adult animals (Del Maestro and McDonald, <xref rid="B22" ref-type="bibr">1987</xref>). The first hypothesis is related with prior findings concerning altered motor neonatal activity induced by central ACD administration. March et al. (<xref rid="B47" ref-type="bibr">2013a</xref>) reported that a single neonatal central administration of ACD (0.52 μmol) exerts a sedative effect upon motor activity. Hence, it is difficult to discard the possibility that sequential administrations of lower ACD doses (0.35 μmol) or of ethanol (100 mg%) into the brain, sensitizes the organism to later sedative of effects of ethanol administered during the operant conditioning task. Nevertheless, this hypothesis is not supported by the following observations. When focusing on the motor activity of Yoked controls (i.e., number of spontaneous sensor contacts) that also received ethanol as a function of the activity of the corresponding Paired neonates, no specific effects of prior drug treatment were detected. The second observation arguing against the motor-related hypothesis is that March et al. (<xref rid="B47" ref-type="bibr">2013a</xref>) also found that late prenatal exposure to ethanol generates tolerance rather than sensitization to the depressant of ACD. As stated, this metabolite is likely to be formed due to brain metabolic processes when neonates were exposed to ethanol during the operant task. Yet, when considering both ethanol and ACD pre-exposure effects upon operant performance, we cannot completely discard an alternative possibility of sensitization effects related with anxiogenic or antianxiety effects of both drugs. The arousal state involved in the acquisition of the operant response could be affected by either of these effects. Infants are sensitive to ethanol's antianxiety effects (Pautassi et al., <xref rid="B63" ref-type="bibr">2007</xref>) but there is still no empirical evidence supporting a sensitization effect as a function of prior ethanol treatment during early development. On the contrary, in neonates, exposure to moderate or high ethanol doses seem to potentiate later states of anxiety (Brolese et al., <xref rid="B14" ref-type="bibr">2014</xref>; Baculis et al., <xref rid="B9" ref-type="bibr">2015</xref>). In adults, when considering centrally administered ACD, inhibition of the catalase system or when sequestering this metabolite, the results argue in favor of anxiogenic rather than antianxiety effects (Correa et al., <xref rid="B18" ref-type="bibr">2008</xref>). Taken these considerations into account, sensitization to ethanol's or ACD's anti-anxiety effects does not seem to adequately account for the described disruptions in operant learning processes. The possibility of sensitization to anxiogenic effects of early ethanol or ACD central administration should not be discarded. The second hypothesis is related with the consequences of drug pre-exposure upon subsequent ethanol's motivational properties. Only one conditioning trial has been utilized when central ethanol or ACD are observed to exert positive reinforcing effects in neonates (Nizhnikov et al., <xref rid="B58" ref-type="bibr">2007</xref>; March et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B49" ref-type="bibr">b</xref>). So far we ignore if increasing the number of doses results in the recruitment of aversive properties of these psychopharmacological agents or maximizes the possibility of an unconditioned stimulus pre-exposure effect that later competes with the contingency existing between operant responses and ethanol reinforcement. In either case, subsequent ethanol positive reinforcing effects are likely to be devalued. Most importantly, it is necessary to consider that during PDs 2 and 4, these drugs were intracisternally administered. This procedure, the additional handling of the neonate and the isolation from the mother can be viewed as significant aversive stressors (Molina et al., <xref rid="B56" ref-type="bibr">2000</xref>; Hofer et al., <xref rid="B43" ref-type="bibr">2002</xref>; Pautassi et al., <xref rid="B63" ref-type="bibr">2007</xref>). Hence, during these days the effects of the drugs were contingent with aversive events; an association that may compete with subsequent reinforcing effects of ethanol or its metabolite. Notice that whenever pre-exposure to ethanol has resulted in early sensitization to the reinforcing effects of the drug (Nizhnikov et al., <xref rid="B59" ref-type="bibr">2006</xref>; Pautassi et al., <xref rid="B62" ref-type="bibr">2012</xref>), the initial drug experience occurred during late prenatal life via maternal ethanol administration and without any explicit manipulation of the fetus or its natural environment. In support of the present hypothesis, studies have demonstrated that early in ontogeny, the rat is capable of associating different motivational effects of ethanol (positive reinforcing, aversive or anxiolytic) with aversive and appetitive stimuli such as citric acid and sucrose; respectively. As a result of the nature of the associations, the effects of the drug or of the alternative stimuli are reduced or potentiated (Molina et al., <xref rid="B54" ref-type="bibr">1996</xref>; Pautassi et al., <xref rid="B64" ref-type="bibr">2006</xref>; Cullere et al., <xref rid="B20" ref-type="bibr">2014</xref>). The proposed hypothesis may also apply when considering the heightened respiratory rates (PD5) observed in neonates pre-exposed to acetaldehyde. The interoceptive effects of the metabolite (PDs 2 and 4) were experienced in a distinct context (plethysmograph chamber) immediately following intracisternal administration of the drug and while pups were isolated from the mother. At test (PD5), these pups were again placed in the context and as stated, they exhibited a significant increase in breathing frequencies. This physiological reaction, under the framework of the present hypothesis, may represent an anticipatory physiological response linked with prior experiences involving the context, the interoceptive effects of acetaldehyde and different stressors. Obviously, this hypothesis requires further investigation.</p>
      <p>Beyond these considerations, the results of this study argue in favor of centrally mediated respiratory and motivational effects of acetaldehyde during a stage in development comparable to the 3rd human gestational trimester. To our knowledge this is the first study indicating a significant role of the metabolite upon early respiratory plasticity. This phenomenon logically requires further investigation particularly when considering the negative effects of ethanol upon the developing respiratory network (Abel, <xref rid="B4" ref-type="bibr">1981</xref>; Dubois et al., <xref rid="B28" ref-type="bibr">2013</xref>). In conjunction with recently conducted studies in rat fetuses and neonates (Cullere et al., <xref rid="B21" ref-type="bibr">2015</xref>; Macchione et al., <xref rid="B46" ref-type="bibr">2016</xref>; Acevedo et al., <xref rid="B5" ref-type="bibr">2017</xref>), the present results confirm that disruptions of the developing respiratory network are attained even when employing moderate levels of exposure to ethanol, or in the present case, to acetaldehyde. Breathing depressions associated with hypoxemia and bradycardia represent a risk factor in terms of hypoxic ischemic effects upon the developing human brain (Pillekamp et al., <xref rid="B66" ref-type="bibr">2007</xref>). As mentioned, fetal alcohol exposure also represents a risk factor for Sudden Infant Death Syndrome (Burd et al., <xref rid="B15" ref-type="bibr">2004</xref>; O'Leary et al., <xref rid="B60" ref-type="bibr">2013</xref>), a phenomenon that has driven scientific attention toward the effects of the drug upon respiratory plasticity. Hence, when considering breathing disruptions involved in hypoxic ischemic consequences upon the brain and the need to better understand factors that can potentially predispose to a devastating pathology such as the Sudden Infant Death Syndrome, the role of acetaldehyde, following ethanol exposure, deserves further scientific attention. Finally, the present study also indicates that centrally administered acetaldehyde impacts upon later ethanol self-administration patterns operationalized through operant conditioning procedures. From a general perspective, these results validate the notions that the metabolite is a neuroactive agent capable of mediating ethanol's motivational properties (Quertemont et al., <xref rid="B68" ref-type="bibr">2005</xref>; Correa et al., <xref rid="B19" ref-type="bibr">2012</xref>) and that it plays a significant role during early ontogeny in terms of structuring ethanol affinity (March et al., <xref rid="B47" ref-type="bibr">2013a</xref>).</p>
    </sec>
    <sec id="s5">
      <title>Author contributions</title>
      <p>All authors (MA, GD, OH and JM) meet the following criteria: -contributed to the conception or design of the work, -contributed to the analysis and interpretation of data, -participated in the writing and revision of the draft, and -agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
    </sec>
    <sec id="s6">
      <title>Funding</title>
      <p>This work was supported by grants from Agencia Nacional de Promoción Científica y Tecnológica (FONCyT, PICT 2011-0999 and PICT 2014-1606), SECyT and CONICET PIP 11220110100763 awarded to JM;.</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Pepino</surname><given-names>M. Y.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Fetal learning with ethanol: correlations between maternal hypothermia during pregnancy and neonatal responsiveness to chemosensory cues of the drug</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>28</volume>, <fpage>805</fpage>–<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1097/01.ALC.0000125354.15808.24</pub-id><?supplied-pmid 15166658?><pub-id pub-id-type="pmid">15166658</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Pueta</surname><given-names>M.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Fetal learning about ethanol and later ethanol responsiveness: evidence against “safe” amounts of prenatal exposure</article-title>. <source>Exp. Biol. Med.</source>
<volume>233</volume>, <fpage>139</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.3181/0703-MR-69</pub-id><?supplied-pmid 18222969?><pub-id pub-id-type="pmid">18222969</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Fetal and infantile alcohol-mediated associative learning in the rat</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>25</volume>, <fpage>989</fpage>–<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2001.tb02307.x</pub-id><?supplied-pmid 11505023?><pub-id pub-id-type="pmid">11505023</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>E. L.</given-names></name></person-group> (<year>1981</year>). <article-title>A critical evaluation of the obstetric use of alcohol in preterm labor</article-title>. <source>Drug Alcohol Depend.</source>
<volume>7</volume>, <fpage>367</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/0376-8716(81)90051-X</pub-id><?supplied-pmid 7274006?><pub-id pub-id-type="pmid">7274006</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acevedo</surname><given-names>M. B.</given-names></name><name><surname>Macchione</surname><given-names>A. F.</given-names></name><name><surname>Anunziata</surname><given-names>F.</given-names></name><name><surname>Haymal</surname><given-names>O. B.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Neonatal experiences with ethanol intoxication modify respiratory and thermoregulatory plasticity and affect subsequent ethanol intake in rats</article-title>. <source>Dev. Psychobiol.</source>
<volume>59</volume>, <fpage>48</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1002/dev.21466</pub-id><?supplied-pmid 27540704?><pub-id pub-id-type="pmid">27540704</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alati</surname><given-names>R.</given-names></name><name><surname>Al Mamun</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>G. M.</given-names></name><name><surname>O'Callaghan</surname><given-names>M.</given-names></name><name><surname>Najman</surname><given-names>J. M.</given-names></name><name><surname>Bor</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>). <article-title><italic>In utero</italic> alcohol exposure and prediction of alcohol disorders in early adulthood: a birth cohort study</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>63</volume>, <fpage>1009</fpage>–<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.9.1009</pub-id><?supplied-pmid 16953003?><pub-id pub-id-type="pmid">16953003</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragon</surname><given-names>C. M.</given-names></name><name><surname>Stotland</surname><given-names>L. M.</given-names></name><name><surname>Amit</surname><given-names>Z.</given-names></name></person-group> (<year>1991</year>). <article-title>Studies on ethanol-brain catalase interaction: evidence for central ethanol oxidation</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>15</volume>, <fpage>165</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.1991.tb01848.x</pub-id><?supplied-pmid 2058789?><pub-id pub-id-type="pmid">2058789</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Molina</surname><given-names>A.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Rapid acquisition of operant conditioning in 5-day-old rat pups: a new technique articulating suckling-related motor activity and milk reinforcement</article-title>. <source>Dev. Psychobiol.</source>
<volume>49</volume>, <fpage>576</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1002/dev.20236</pub-id><?supplied-pmid 17680606?><pub-id pub-id-type="pmid">17680606</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baculis</surname><given-names>B. C.</given-names></name><name><surname>Diaz</surname><given-names>M. R.</given-names></name><name><surname>Valenzuela</surname><given-names>C. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Third trimester-equivalent ethanol exposure increases anxiety-like behavior and glutamatergic transmission in the basolateral amygdala</article-title>. <source>Pharmacol. Biochem. Behav.</source>
<volume>137</volume>, <fpage>78</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2015.08.009</pub-id><?supplied-pmid 26284742?><pub-id pub-id-type="pmid">26284742</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baer</surname><given-names>J. S.</given-names></name><name><surname>Barr</surname><given-names>H. M.</given-names></name><name><surname>Bookstein</surname><given-names>F. L.</given-names></name><name><surname>Sampson</surname><given-names>P. D.</given-names></name><name><surname>Streissguth</surname><given-names>A. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Prenatal alcohol exposure and family history of alcoholism in the etiology of adolescent alcohol problems</article-title>. <source>J. Stud. Alcohol</source>
<volume>59</volume>, <fpage>533</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.15288/jsa.1998.59.533</pub-id><?supplied-pmid 9718105?><pub-id pub-id-type="pmid">9718105</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baer</surname><given-names>J. S.</given-names></name><name><surname>Sampson</surname><given-names>P. D.</given-names></name><name><surname>Barr</surname><given-names>H. M.</given-names></name><name><surname>Connor</surname><given-names>P. D.</given-names></name><name><surname>Streissguth</surname><given-names>A. P.</given-names></name></person-group> (<year>2003</year>). <article-title>A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>60</volume>, <fpage>377</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.4.377</pub-id><?supplied-pmid 12695315?><pub-id pub-id-type="pmid">12695315</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordner</surname><given-names>K. A.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Analysis of ethanol reinforcement in 1-day-old rats: assessment through a brief and novel operant procedure</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>32</volume>, <fpage>580</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2007.00609.x</pub-id><?supplied-pmid 18366451?><pub-id pub-id-type="pmid">18366451</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brien</surname><given-names>J. F.</given-names></name><name><surname>Smith</surname><given-names>G. N.</given-names></name></person-group> (<year>1991</year>). <article-title>Effects of alcohol (ethanol) on the fetus</article-title>. <source>J. Dev. Physiol.</source>
<volume>15</volume>, <fpage>21</fpage>–<lpage>32</lpage>. <?supplied-pmid 1875037?><pub-id pub-id-type="pmid">1875037</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brolese</surname><given-names>G.</given-names></name><name><surname>Lunardi</surname><given-names>P.</given-names></name><name><surname>Broetto</surname><given-names>N.</given-names></name><name><surname>Engelke</surname><given-names>D. S.</given-names></name><name><surname>Lirio</surname><given-names>F.</given-names></name><name><surname>Batassini</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Moderate prenatal alcohol exposure alters behavior and neuroglial parameters in adolescent rats</article-title>. <source>Behav. Brain Res.</source>
<volume>269</volume>, <fpage>175</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.04.023</pub-id><?supplied-pmid 24786333?><pub-id pub-id-type="pmid">24786333</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burd</surname><given-names>L.</given-names></name><name><surname>Klug</surname><given-names>M.</given-names></name><name><surname>Martsolf</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Increased sibling mortality in children with fetal alcohol syndrome</article-title>. <source>Addict. Biol.</source>
<volume>9</volume>, <fpage>179</fpage>–<lpage>186</lpage>. discussion: 187–178. <pub-id pub-id-type="doi">10.1080/13556210410001717088</pub-id><?supplied-pmid 15223547?><pub-id pub-id-type="pmid">15223547</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheslock</surname><given-names>S. J.</given-names></name><name><surname>Varlinskaya</surname><given-names>E. I.</given-names></name><name><surname>Petrov</surname><given-names>E. S.</given-names></name><name><surname>Silveri</surname><given-names>M. M.</given-names></name><name><surname>Spear</surname><given-names>L. P.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Ethanol as a reinforcer in the newborn's first suckling experience</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>25</volume>, <fpage>391</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2001.tb02226.x</pub-id><?supplied-pmid 11290850?><pub-id pub-id-type="pmid">11290850</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Closon</surname><given-names>C.</given-names></name><name><surname>Didone</surname><given-names>V.</given-names></name><name><surname>Tirelli</surname><given-names>E.</given-names></name><name><surname>Quertemont</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Acetaldehyde and the hypothermic effects of ethanol in mice</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>33</volume>, <fpage>2005</fpage>–<lpage>2014</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2009.01039.x</pub-id><?supplied-pmid 19719790?><pub-id pub-id-type="pmid">19719790</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>M.</given-names></name><name><surname>Manrique</surname><given-names>H. M.</given-names></name><name><surname>Font</surname><given-names>L.</given-names></name><name><surname>Escrig</surname><given-names>M. A.</given-names></name><name><surname>Aragon</surname><given-names>C. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Reduction in the anxiolytic effects of ethanol by centrally formed acetaldehyde: the role of catalase inhibitors and acetaldehyde-sequestering agents</article-title>. <source>Psychopharmacology</source>
<volume>200</volume>, <fpage>455</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-008-1219-3</pub-id><?supplied-pmid 18587667?><pub-id pub-id-type="pmid">18587667</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>M.</given-names></name><name><surname>Salamone</surname><given-names>J. D.</given-names></name><name><surname>Segovia</surname><given-names>K. N.</given-names></name><name><surname>Pardo</surname><given-names>M.</given-names></name><name><surname>Longoni</surname><given-names>R.</given-names></name><name><surname>Spina</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Piecing together the puzzle of acetaldehyde as a neuroactive agent</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>36</volume>, <fpage>404</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2011.07.009</pub-id><?supplied-pmid 21824493?><pub-id pub-id-type="pmid">21824493</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullere</surname><given-names>M. E.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal ethanol increases sucrose reinforcement, an effect strengthened by postnatal association of ethanol and sucrose</article-title>. <source>Alcohol</source>
<volume>48</volume>, <fpage>25</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2013.11.003</pub-id><?supplied-pmid 24398347?><pub-id pub-id-type="pmid">24398347</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullere</surname><given-names>M.</given-names></name><name><surname>Macchione</surname><given-names>A. F.</given-names></name><name><surname>Haymal</surname><given-names>B.</given-names></name><name><surname>Paradelo</surname><given-names>M.</given-names></name><name><surname>Langer</surname><given-names>M. D.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Neonatal sensitization to ethanol-induced breathing disruptions as a function of late prenatal exposure to the drug in the rat: modulatory effects of ethanol's chemosensory cues</article-title>. <source>Physiol. Behav.</source>
<volume>139</volume>, <fpage>412</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.10.017</pub-id><?supplied-pmid 25447327?><pub-id pub-id-type="pmid">25447327</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Maestro</surname><given-names>R.</given-names></name><name><surname>McDonald</surname><given-names>W.</given-names></name></person-group> (<year>1987</year>). <article-title>Distribution of superoxide dismutase, glutathione peroxidase and catalase in developing rat brain</article-title>. <source>Mech. Ageing Dev.</source>
<volume>41</volume>, <fpage>29</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/0047-6374(87)90051-0</pub-id><?supplied-pmid 3431167?><pub-id pub-id-type="pmid">3431167</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillner</surname><given-names>L.</given-names></name><name><surname>Josefson</surname><given-names>D.</given-names></name><name><surname>Karcher</surname><given-names>H.</given-names></name><name><surname>Sheldon</surname><given-names>T.</given-names></name><name><surname>Dorozynski</surname><given-names>A.</given-names></name><name><surname>Zinn</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>). <article-title>Alcohol–pushing the limits</article-title>. <source>BMJ</source>
<volume>312</volume>, <fpage>7</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.312.7022.7</pub-id><?supplied-pmid 8555891?><pub-id pub-id-type="pmid">8555891</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbing</surname><given-names>J.</given-names></name><name><surname>Sands</surname><given-names>J.</given-names></name></person-group> (<year>1973</year>). <article-title>Quantitative growth and development of human brain</article-title>. <source>Arch. Dis. Child.</source>
<volume>48</volume>, <fpage>757</fpage>–<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1136/adc.48.10.757</pub-id><?supplied-pmid 4796010?><pub-id pub-id-type="pmid">4796010</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbing</surname><given-names>J.</given-names></name><name><surname>Sands</surname><given-names>J.</given-names></name></person-group> (<year>1979</year>). <article-title>Comparative aspects of the brain growth spurt</article-title>. <source>Early Hum. Dev.</source>
<volume>3</volume>, <fpage>79</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/0378-3782(79)90022-7</pub-id><?supplied-pmid 118862?><pub-id pub-id-type="pmid">118862</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>H. D.</given-names></name><name><surname>Lopez</surname><given-names>M. F.</given-names></name><name><surname>Chotro</surname><given-names>M. G.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>1996</year>). <article-title>Perinatal responsiveness to alcohol's chemosensory cues as a function of prenatal alcohol administration during gestational days 17-20 in the rat</article-title>. <source>Neurobiol. Learn. Mem.</source>
<volume>65</volume>, <fpage>103</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1006/nlme.1996.0012</pub-id><?supplied-pmid 8833099?><pub-id pub-id-type="pmid">8833099</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>H. D.</given-names></name><name><surname>Lopez</surname><given-names>M. F.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Neonatal responsiveness to alcohol odor and infant alcohol intake as a function of alcohol experience during late gestation</article-title>. <source>Alcohol</source>
<volume>16</volume>, <fpage>109</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/S0741-8329(97)00169-9</pub-id><?supplied-pmid 9665312?><pub-id pub-id-type="pmid">9665312</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>C. J.</given-names></name><name><surname>Kervern</surname><given-names>M.</given-names></name><name><surname>Naassila</surname><given-names>M.</given-names></name><name><surname>Pierrefiche</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>Chronic ethanol exposure during development: disturbances of breathing and adaptation</article-title>. <source>Respir. Physiol. Neurobiol.</source>
<volume>189</volume>, <fpage>250</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2013.06.015</pub-id><?supplied-pmid 23811193?><pub-id pub-id-type="pmid">23811193</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>C. J.</given-names></name><name><surname>Naassila</surname><given-names>M.</given-names></name><name><surname>Daoust</surname><given-names>M.</given-names></name><name><surname>Pierrefiche</surname><given-names>O.</given-names></name></person-group> (<year>2006</year>). <article-title>Early chronic ethanol exposure in rats disturbs respiratory network activity and increases sensitivity to ethanol</article-title>. <source>J. Physiol.</source>
<volume>576</volume>(<issue>Pt 1</issue>), <fpage>297</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.111138</pub-id><?supplied-pmid 16857714?><pub-id pub-id-type="pmid">16857714</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>E.</given-names></name><name><surname>Dauger</surname><given-names>S.</given-names></name><name><surname>Vardon</surname><given-names>G.</given-names></name><name><surname>Gressens</surname><given-names>P.</given-names></name><name><surname>Gaultier</surname><given-names>C.</given-names></name><name><surname>De Schonen</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Classical conditioning of breathing pattern after two acquisition trials in 2-day-old mice</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>94</volume>, <fpage>812</fpage>–<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00488.2002</pub-id><?supplied-pmid 12391118?><pub-id pub-id-type="pmid">12391118</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Duxbury</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>El papel de la enfermera en neonatología</article-title>, in <source>Neonatología: Fisiopatología y Manejo del Recién Nacido</source>, eds <person-group person-group-type="editor"><name><surname>Avery</surname><given-names>G.</given-names></name><name><surname>Flechter Hardcover</surname><given-names>M. A.</given-names></name></person-group> (<publisher-loc>Buenos Aires</publisher-loc>: <publisher-name>Editorial Médica Panamericana S.A</publisher-name>), <fpage>75</fpage>–<lpage>115</lpage>.</mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eikelboom</surname><given-names>R.</given-names></name><name><surname>Stewart</surname><given-names>J.</given-names></name></person-group> (<year>1982</year>). <article-title>Conditioning of drug-induced physiological responses</article-title>. <source>Psychol. Rev.</source>
<volume>89</volume>, <fpage>507</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1037/0033-295X.89.5.507</pub-id><?supplied-pmid 7178331?><pub-id pub-id-type="pmid">7178331</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faas</surname><given-names>A. E.</given-names></name><name><surname>March</surname><given-names>S. M.</given-names></name><name><surname>Moya</surname><given-names>P. R.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Alcohol odor elicits appetitive facial expressions in human neonates prenatally exposed to the drug</article-title>. <source>Physiol. Behav.</source>
<volume>148</volume>, <fpage>78</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2015.02.031</pub-id><?supplied-pmid 25707382?><pub-id pub-id-type="pmid">25707382</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faas</surname><given-names>A. E.</given-names></name><name><surname>Sponton</surname><given-names>E. D.</given-names></name><name><surname>Moya</surname><given-names>P. R.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Differential responsiveness to alcohol odor in human neonates: effects of maternal consumption during gestation</article-title>. <source>Alcohol</source>
<volume>22</volume>, <fpage>7</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/S0741-8329(00)00103-8</pub-id><?supplied-pmid 11109023?><pub-id pub-id-type="pmid">11109023</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabio</surname><given-names>M. C.</given-names></name><name><surname>March</surname><given-names>S. M.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Pautassi</surname><given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Prenatal ethanol exposure increases ethanol intake and reduces c-Fos expression in infralimbic cortex of adolescent rats</article-title>. <source>Pharmacol. Biochem. Behav.</source>
<volume>103</volume>, <fpage>842</fpage>–<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2012.12.009</pub-id><?supplied-pmid 23266368?><pub-id pub-id-type="pmid">23266368</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foltran</surname><given-names>F.</given-names></name><name><surname>Gregori</surname><given-names>D.</given-names></name><name><surname>Franchin</surname><given-names>L.</given-names></name><name><surname>Verduci</surname><given-names>E.</given-names></name><name><surname>Giovannini</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Effect of alcohol consumption in prenatal life, childhood, and adolescence on child development</article-title>. <source>Nutr. Rev.</source>
<volume>69</volume>, <fpage>642</fpage>–<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1111/j.1753-4887.2011.00417.x</pub-id><?supplied-pmid 22029831?><pub-id pub-id-type="pmid">22029831</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>K.</given-names></name><name><surname>Menez</surname><given-names>J. F.</given-names></name><name><surname>Lucas</surname><given-names>D.</given-names></name><name><surname>Deitrich</surname><given-names>R. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Enzymatic production of acetaldehyde from ethanol in rat brain tissue</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>16</volume>, <fpage>910</fpage>–<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.1992.tb01892.x</pub-id><?supplied-pmid 1443429?><pub-id pub-id-type="pmid">1443429</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesler</surname><given-names>P. C.</given-names></name><name><surname>Kandel</surname><given-names>D. B.</given-names></name></person-group> (<year>1998</year>). <article-title>The impact of maternal drinking during and after pregnancy on the drinking of adolescent offspring</article-title>. <source>J. Stud. Alcohol</source>
<volume>59</volume>, <fpage>292</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.15288/jsa.1998.59.292</pub-id><?supplied-pmid 9598710?><pub-id pub-id-type="pmid">9598710</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>C. Y.</given-names></name><name><surname>Huang</surname><given-names>S. Y.</given-names></name><name><surname>Ko</surname><given-names>H. C.</given-names></name><name><surname>Hsieh</surname><given-names>C. H.</given-names></name><name><surname>Lee</surname><given-names>I. H.</given-names></name><name><surname>Yeh</surname><given-names>T. L.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Acetaldehyde involvement in positive and negative alcohol expectancies in han Chinese persons with alcoholism</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>63</volume>, <fpage>817</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.7.817</pub-id><?supplied-pmid 16818871?><pub-id pub-id-type="pmid">16818871</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>W. G.</given-names></name></person-group> (<year>1979</year>). <article-title>Feeding and behavioral activation in infant rats</article-title>. <source>Science</source>
<volume>205</volume>, <fpage>206</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1126/science.451591</pub-id><?supplied-pmid 451591?><pub-id pub-id-type="pmid">451591</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamby-Mason</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J. J.</given-names></name><name><surname>Schenker</surname><given-names>S.</given-names></name><name><surname>Perez</surname><given-names>A.</given-names></name><name><surname>Henderson</surname><given-names>G. I.</given-names></name></person-group> (<year>1997</year>). <article-title>Catalase mediates acetaldehyde formation from ethanol in fetal and neonatal rat brain</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>21</volume>, <fpage>1063</fpage>–<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.1997.tb04255.x</pub-id><?supplied-pmid 9309319?><pub-id pub-id-type="pmid">9309319</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hipolito</surname><given-names>L.</given-names></name><name><surname>Sanchez</surname><given-names>M. J.</given-names></name><name><surname>Polache</surname><given-names>A.</given-names></name><name><surname>Granero</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain metabolism of ethanol and alcoholism: an update</article-title>. <source>Curr. Drug Metab.</source>
<volume>8</volume>, <fpage>716</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="doi">10.2174/138920007782109797</pub-id><?supplied-pmid 17979660?><pub-id pub-id-type="pmid">17979660</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>M. A.</given-names></name><name><surname>Shair</surname><given-names>H. N.</given-names></name><name><surname>Brunelli</surname><given-names>S. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Ultrasonic vocalizations in rat and mouse pups</article-title>. <source>Curr. Protoc. Neurosci.</source> Chapter 8:Unit 8.14. <pub-id pub-id-type="doi">10.1002/0471142301.ns0814s17</pub-id><?supplied-pmid 18428567?><pub-id pub-id-type="pmid">18428567</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holson</surname><given-names>R. R.</given-names></name><name><surname>Pearce</surname><given-names>B.</given-names></name></person-group> (<year>1992</year>). <article-title>Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species</article-title>. <source>Neurotoxicol. Teratol.</source>
<volume>14</volume>, <fpage>221</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/0892-0362(92)90020-B</pub-id><?supplied-pmid 1635542?><pub-id pub-id-type="pmid">1635542</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julien</surname><given-names>C. A.</given-names></name><name><surname>Joseph</surname><given-names>V.</given-names></name><name><surname>Bairam</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Caffeine reduces apnea frequency and enhances ventilatory long-term facilitation in rat pups raised in chronic intermittent hypoxia</article-title>. <source>Pediatr. Res.</source>
<volume>68</volume>, <fpage>105</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e3181e5bc78</pub-id><?supplied-pmid 20453714?><pub-id pub-id-type="pmid">20453714</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macchione</surname><given-names>A. F.</given-names></name><name><surname>Anunziata</surname><given-names>F.</given-names></name><name><surname>Cullere</surname><given-names>M. E.</given-names></name><name><surname>Haymal</surname><given-names>B. O.</given-names></name><name><surname>Spear</surname><given-names>N.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Conditioned breathing depression during neonatal life as a function of associating ethanol odor and the drug's intoxicating effects</article-title>. <source>Dev. Psychobiol.</source>
<volume>58</volume>, <fpage>670</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1002/dev.21398</pub-id><?supplied-pmid 27255447?><pub-id pub-id-type="pmid">27255447</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March</surname><given-names>S. M.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2013a</year>). <article-title>Acetaldehyde involvement in ethanol's postabsortive effects during early ontogeny</article-title>. <source>Front. Behav. Neurosci.</source>
<volume>7</volume>:<fpage>70</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2013.00070</pub-id><?supplied-pmid 23801947?><pub-id pub-id-type="pmid">23801947</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March</surname><given-names>S. M.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Fetal exposure to moderate ethanol doses: heightened operant responsiveness elicited by ethanol-related reinforcers</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>33</volume>, <fpage>1981</fpage>–<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2009.01037.x</pub-id><?supplied-pmid 19719792?><pub-id pub-id-type="pmid">19719792</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March</surname><given-names>S. M.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2013b</year>). <article-title>The role of acetaldehyde in ethanol reinforcement assessed by Pavlovian conditioning in newborn rats</article-title>. <source>Psychopharmacology</source>
<volume>226</volume>, <fpage>491</fpage>–<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-012-2920-9</pub-id><?supplied-pmid 23196716?><pub-id pub-id-type="pmid">23196716</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Morales</surname><given-names>R. S.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Participation of the endogenous opioid system in the acquisition of a prenatal ethanol-related memory: effects on neonatal and preweanling responsiveness to ethanol</article-title>. <source>Physiol. Behav.</source>
<volume>101</volume>, <fpage>153</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2010.04.033</pub-id><?supplied-pmid 20451537?><pub-id pub-id-type="pmid">20451537</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Morales</surname><given-names>R. S.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name></person-group> (<year>2012a</year>). <article-title>Naloxone attenuation of ethanol-reinforced operant responding in infant rats in a re-exposure paradigm</article-title>. <source>Psychopharmacology</source>
<volume>219</volume>, <fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-011-2402-5</pub-id><?supplied-pmid 21750896?><pub-id pub-id-type="pmid">21750896</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Morales</surname><given-names>R. S.</given-names></name><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal exposure to ethanol during late gestation facilitates operant self-administration of the drug in 5-day-old rats</article-title>. <source>Alcohol</source>
<volume>48</volume>, <fpage>19</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2013.11.001</pub-id><?supplied-pmid 24355072?><pub-id pub-id-type="pmid">24355072</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-Morales</surname><given-names>R. S.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Abate</surname><given-names>P.</given-names></name></person-group> (<year>2012b</year>). <article-title>Role of mu, delta and kappa opioid receptors in ethanol-reinforced operant responding in infant rats</article-title>. <source>Behav. Brain Res.</source>
<volume>234</volume>, <fpage>267</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2012.07.002</pub-id><?supplied-pmid 22789403?><pub-id pub-id-type="pmid">22789403</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Bannoura</surname><given-names>M. D.</given-names></name><name><surname>Chotro</surname><given-names>M. G.</given-names></name><name><surname>McKinzie</surname><given-names>D. L.</given-names></name><name><surname>Arnold</surname><given-names>H. M.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Alcohol-mediated tactile conditioned aversions in infant rats: devaluation of conditioning through alcohol-sucrose associations</article-title>. <source>Neurobiol. Learn. Mem.</source>
<volume>66</volume>, <fpage>121</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1006/nlme.1996.0053</pub-id><?supplied-pmid 8946405?><pub-id pub-id-type="pmid">8946405</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Pautassi</surname><given-names>R. M.</given-names></name><name><surname>Truxell</surname><given-names>E.</given-names></name><name><surname>Spear</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>Differential motivational properties of ethanol during early ontogeny as a function of dose and postadministration time</article-title>. <source>Alcohol</source>
<volume>41</volume>, <fpage>41</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2007.01.005</pub-id><?supplied-pmid 17452298?><pub-id pub-id-type="pmid">17452298</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Pepino</surname><given-names>M. Y.</given-names></name><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2000</year>). <article-title>The infant rat learns about alcohol through interaction with an intoxicated mother</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>24</volume>, <fpage>428</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2000.tb02009.x</pub-id><?supplied-pmid 10798578?><pub-id pub-id-type="pmid">10798578</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Research Council</collab></person-group> (<year>1996</year>). <source>Guide for the Care and Use of Laboratory Animals</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Central reinforcing effects of ethanol are blocked by catalase inhibition</article-title>. <source>Alcohol</source>
<volume>41</volume>, <fpage>525</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2007.08.006</pub-id><?supplied-pmid 17980789?><pub-id pub-id-type="pmid">17980789</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Varlinskaya</surname><given-names>E. I.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Reinforcing effects of central ethanol injections in newborn rat pups</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>30</volume>, <fpage>2089</fpage>–<lpage>2096</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2006.00253.x</pub-id><?supplied-pmid 17117974?><pub-id pub-id-type="pmid">17117974</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Leary</surname><given-names>C. M.</given-names></name><name><surname>Jacoby</surname><given-names>P. J.</given-names></name><name><surname>Bartu</surname><given-names>A.</given-names></name><name><surname>D'Antoine</surname><given-names>H.</given-names></name><name><surname>Bower</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal alcohol use and sudden infant death syndrome and infant mortality excluding SIDS</article-title>. <source>Pediatrics</source>
<volume>131</volume>, <fpage>e770</fpage>–<lpage>e778</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2012-1907</pub-id><?supplied-pmid 23439895?><pub-id pub-id-type="pmid">23439895</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pautassi</surname><given-names>R. M.</given-names></name><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Fabio</surname><given-names>M. C.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name></person-group> (<year>2011</year>). <article-title>An acetaldehyde-sequestering agent inhibits appetitive reinforcement and behavioral stimulation induced by ethanol in preweanling rats</article-title>. <source>Pharmacol. Biochem. Behav.</source>
<volume>97</volume>, <fpage>462</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2010.10.005</pub-id><?supplied-pmid 20951160?><pub-id pub-id-type="pmid">20951160</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pautassi</surname><given-names>R. M.</given-names></name><name><surname>Nizhnikov</surname><given-names>M. E.</given-names></name><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Prenatal ethanol exposure leads to greater ethanol-induced appetitive reinforcement</article-title>. <source>Alcohol</source>
<volume>46</volume>, <fpage>585</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2012.05.004</pub-id><?supplied-pmid 22698870?><pub-id pub-id-type="pmid">22698870</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pautassi</surname><given-names>R. M.</given-names></name><name><surname>Nizhnikov</surname><given-names>M.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name><name><surname>Boehm</surname><given-names>S. L.</given-names><suffix>II.</suffix></name><name><surname>Spear</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>Differential effects of ethanol and midazolam upon the devaluation of an aversive memory in infant rats</article-title>. <source>Alcohol</source>
<volume>41</volume>, <fpage>421</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.alcohol.2007.05.001</pub-id><?supplied-pmid 17936511?><pub-id pub-id-type="pmid">17936511</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pautassi</surname><given-names>R. M.</given-names></name><name><surname>Sanders</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><name><surname>Spear</surname><given-names>N.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Early ethanol's anxiolytic effects assessed through an unconditional stimulus revaluation procedure</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>30</volume>, <fpage>448</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2006.00049.x</pub-id><?supplied-pmid 16499485?><pub-id pub-id-type="pmid">16499485</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrov</surname><given-names>E. S.</given-names></name><name><surname>Varlinskaya</surname><given-names>E. I.</given-names></name><name><surname>Becker</surname><given-names>L. A.</given-names></name><name><surname>Smotherman</surname><given-names>W. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Endogenous mu opioid systems and suckling in the neonatal rat</article-title>. <source>Physiol. Behav.</source>
<volume>65</volume>, <fpage>591</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(98)00228-5</pub-id><?supplied-pmid 9877428?><pub-id pub-id-type="pmid">9877428</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillekamp</surname><given-names>F.</given-names></name><name><surname>Hermann</surname><given-names>C.</given-names></name><name><surname>Keller</surname><given-names>T.</given-names></name><name><surname>von Gontard</surname><given-names>A.</given-names></name><name><surname>Kribs</surname><given-names>A.</given-names></name><name><surname>Roth</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment</article-title>. <source>Neonatology</source>
<volume>91</volume>, <fpage>155</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1159/000097446</pub-id><?supplied-pmid 17377399?><pub-id pub-id-type="pmid">17377399</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quertemont</surname><given-names>E.</given-names></name><name><surname>Didone</surname><given-names>V.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of acetaldehyde in mediating the pharmacological and behavioral effects of alcohol</article-title>. <source>Alcohol Res. Health</source>
<volume>29</volume>, <fpage>258</fpage>–<lpage>265</lpage>. <?supplied-pmid 17718404?><pub-id pub-id-type="pmid">17718404</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quertemont</surname><given-names>E.</given-names></name><name><surname>Grant</surname><given-names>K. A.</given-names></name><name><surname>Correa</surname><given-names>M.</given-names></name><name><surname>Arizzi</surname><given-names>M. N.</given-names></name><name><surname>Salamone</surname><given-names>J. D.</given-names></name><name><surname>Tambour</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>The role of acetaldehyde in the central effects of ethanol</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>29</volume>, <fpage>221</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1097/01.ALC.0000156185.39073.D2</pub-id><?supplied-pmid 15714045?><pub-id pub-id-type="pmid">15714045</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>D. D.</given-names></name><name><surname>Becher</surname><given-names>M.</given-names></name><name><surname>de la Torre</surname><given-names>A. J.</given-names></name><name><surname>Sutherland</surname><given-names>R. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Dose-dependent effects of prenatal ethanol exposure on synaptic plasticity and learning in mature offspring</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>26</volume>, <fpage>1752</fpage>–<lpage>1758</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2002.tb02480.x</pub-id><?supplied-pmid 12436066?><pub-id pub-id-type="pmid">12436066</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrock</surname><given-names>A.</given-names></name><name><surname>Fidi</surname><given-names>C.</given-names></name><name><surname>Low</surname><given-names>M.</given-names></name><name><surname>Baumgarten</surname><given-names>K.</given-names></name></person-group> (<year>1989</year>). <article-title>Low-dose ethanol for inhibition of preterm uterine activity</article-title>. <source>Am. J. Perinatol.</source>
<volume>6</volume>, <fpage>191</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-999574</pub-id><?supplied-pmid 2712916?><pub-id pub-id-type="pmid">2712916</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname><given-names>N. E.</given-names></name><name><surname>Molina</surname><given-names>J. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Fetal or infantile exposure to ethanol promotes ethanol ingestion in adolescence and adulthood: a theoretical review</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>29</volume>, <fpage>909</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1097/01.ALC.0000171046.78556.66</pub-id><?supplied-pmid 15976517?><pub-id pub-id-type="pmid">15976517</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlinskaya</surname><given-names>E. I.</given-names></name><name><surname>Petrov</surname><given-names>E. S.</given-names></name><name><surname>Smotherman</surname><given-names>W. P.</given-names></name></person-group> (<year>1996</year>). <article-title>Classical conditioning in the fetal rat: reinforcing properties of dynorphin A (1-13)</article-title>. <source>Behav. Neurosci.</source>
<volume>110</volume>, <fpage>154</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.110.1.154</pub-id><?supplied-pmid 8652064?><pub-id pub-id-type="pmid">8652064</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vojcek</surname><given-names>L.</given-names></name><name><surname>Lampe</surname><given-names>L. G.</given-names></name><name><surname>Princzkel</surname><given-names>E.</given-names></name><name><surname>Turnbull</surname><given-names>A. C.</given-names></name></person-group> (<year>1988</year>). <article-title>Effects of ethanol infusion on foetal EEG and breathing movements</article-title>. <source>Acta Physiol. Hung.</source>
<volume>71</volume>, <fpage>511</fpage>–<lpage>515</lpage>. <?supplied-pmid 3207039?><pub-id pub-id-type="pmid">3207039</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>T. L.</given-names></name><name><surname>Thomasson</surname><given-names>H. R.</given-names></name><name><surname>Schuckit</surname><given-names>M. A.</given-names></name><name><surname>Ehlers</surname><given-names>C. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Subjective feelings of alcohol intoxication in Asians with genetic variations of ALDH2 alleles</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>16</volume>, <fpage>991</fpage>–<lpage>995</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.1992.tb01907.x</pub-id><?supplied-pmid 1443441?><pub-id pub-id-type="pmid">1443441</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Winer</surname><given-names>B. J.</given-names></name></person-group> (<year>1991</year>). <source>Statistical Principles in Experimental Design, 2nd Edn</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>R. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Brain reward circuitry: insights from unsensed incentives</article-title>. <source>Neuron</source>
<volume>36</volume>, <fpage>229</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00965-0</pub-id><?supplied-pmid 12383779?><pub-id pub-id-type="pmid">12383779</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>S. C.</given-names></name><name><surname>Ramsay</surname><given-names>D. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Pavlovian influences over food and drug intake</article-title>. <source>Behav. Brain Res.</source>
<volume>110</volume>, <fpage>175</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-4328(99)00194-1</pub-id><?supplied-pmid 10802313?><pub-id pub-id-type="pmid">10802313</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>W. R.</given-names></name><name><surname>Cadoret</surname><given-names>R. J.</given-names></name><name><surname>Troughton</surname><given-names>E. P.</given-names></name><name><surname>Stewart</surname><given-names>M.</given-names></name><name><surname>Giunta</surname><given-names>T. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Effect of fetal alcohol exposure on adult symptoms of nicotine, alcohol, and drug dependence</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>22</volume>, <fpage>914</fpage>–<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.1998.tb03889.x</pub-id><?supplied-pmid 9660322?><pub-id pub-id-type="pmid">9660322</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>C.</given-names></name><name><surname>Olney</surname><given-names>J. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuroapoptosis in the infant mouse brain triggered by a transient small increase in blood alcohol concentration</article-title>. <source>Neurobiol. Dis.</source>
<volume>22</volume>, <fpage>548</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.12.015</pub-id><?supplied-pmid 16459096?><pub-id pub-id-type="pmid">16459096</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimatkin</surname><given-names>S. M.</given-names></name><name><surname>Pronko</surname><given-names>S. P.</given-names></name><name><surname>Vasiliou</surname><given-names>V.</given-names></name><name><surname>Gonzalez</surname><given-names>F. J.</given-names></name><name><surname>Deitrich</surname><given-names>R. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Enzymatic mechanisms of ethanol oxidation in the brain</article-title>. <source>Alcohol. Clin. Exp. Res.</source>
<volume>30</volume>, <fpage>1500</fpage>–<lpage>1505</lpage>. <pub-id pub-id-type="doi">10.1111/j.1530-0277.2006.00181.x</pub-id><?supplied-pmid 16930212?><pub-id pub-id-type="pmid">16930212</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359533</identifier><datestamp>2017-04-04</datestamp><setSpec>frontimmu</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-3224</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359533</article-id>
      <article-id pub-id-type="pmcid">PMC5359533</article-id>
      <article-id pub-id-type="pmc-uid">5359533</article-id>
      <article-id pub-id-type="doi">10.3389/fimmu.2017.00246</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Immunology</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Preusse</surname>
            <given-names>Matthias</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>†</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/389173"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schughart</surname>
            <given-names>Klaus</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pessler</surname>
            <given-names>Frank</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/326630"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Institute for Experimental Infection Research, TWINCORE Center for Experimental and Clinical Infection Research</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Helmholtz Centre for Infection Research</institution>, <addr-line>Braunschweig</addr-line>, <country>Germany</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Department of Infection Genetics, Helmholtz Centre for Infection Research</institution>, <addr-line>Braunschweig</addr-line>, <country>Germany</country></aff>
      <aff id="aff4"><sup>4</sup><institution>University of Veterinary Medicine Hannover</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country></aff>
      <aff id="aff5"><sup>5</sup><institution>Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Centre</institution>, <addr-line>Memphis, TN</addr-line>, <country>USA</country></aff>
      <aff id="aff6"><sup>6</sup><institution>Centre for Individualised Infection Medicine</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Wenzhe Ho, Temple University School of Medicine, USA</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Dane Parker, Columbia University, USA; Debashree Chatterjee, Memorial Sloan Kettering Cancer Center, USA</p>
        </fn>
        <corresp content-type="corresp" id="cor1">*Correspondence: Frank Pessler, <email>frank.pessler@twincore.de</email>, <email>frank.pessler@helmholtz-hzi.de</email></corresp>
        <fn fn-type="present-address" id="fn001">
          <p><sup>†</sup>Present address: Matthias Preusse, Department of Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany</p>
        </fn>
        <fn fn-type="other" id="fn002">
          <p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>246</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Preusse, Schughart and Pessler.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Preusse, Schughart and Pessler</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="executive-summary">
        <sec id="ST1">
          <title>Background</title>
          <p>Expression of host microRNAs (miRNAs) changes markedly during influenza A virus (IAV) infection of natural and adaptive hosts, but their role in genetically determined host susceptibility to IAV infection has not been explored. We, therefore, compared pulmonary miRNA expression during IAV infection in two inbred mouse strains with differential susceptibility to IAV infection.</p>
        </sec>
        <sec id="ST2">
          <title>Results</title>
          <p>miRNA expression profiles were determined in lungs of the more susceptible strain DBA/2J and the less susceptible strain C57BL/6J within 120 h post infection (hpi) with IAV (H1N1) PR8. Even the miRNomes of uninfected lungs differed substantially between the two strains. After a period of relative quiescence, major miRNome reprogramming was detected in both strains by 48 hpi and increased through 120 hpi. Distinct groups of miRNAs regulated by IAV infection could be defined: (1) miRNAs (<italic>n</italic> = 39) whose expression correlated with hemagglutinin (HA) mRNA expression and represented the general response to IAV infection independent of host genetic background; (2) miRNAs (<italic>n</italic> = 20) whose expression correlated with HA mRNA expression but differed between the two strains; and (3) remarkably, miR-147-3p, miR-208b-3p, miR-3096a-5p, miR-3069b-3p, and the miR-467 family, whose abundance even in uninfected lungs differentiated nearly perfectly (area under the ROC curve &gt; 0.99) between the two strains throughout the time course, suggesting a particularly strong association with the differential susceptibility of the two mouse strains. Expression of subsets of miRNAs correlated significantly with peripheral blood granulocyte and monocyte numbers, particularly in DBA/2J mice; miR-223-3p, miR-142-3p, and miR-20b-5p correlated most positively with these cell types in both mouse strains. Higher abundance of antiapoptotic (e.g., miR-467 family) and lower abundance of proapoptotic miRNAs (e.g., miR-34 family) and those regulating the PI3K-Akt pathway (e.g., miR-31-5p) were associated with the more susceptible DBA/2J strain.</p>
        </sec>
        <sec id="ST3">
          <title>Conclusion</title>
          <p>Substantial differences in pulmonary miRNA expression between the two differentially susceptible mouse strains were evident even before infection, but evolved further throughout infection and could in part be attributed to differences in peripheral blood leukocyte populations. Thus, pulmonary miRNA expression both before and during IAV infection is in part determined genetically and contributes to susceptibility to IAV infection in this murine host, and likely in humans.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>biomarkers</kwd>
        <kwd>genetics</kwd>
        <kwd>infection</kwd>
        <kwd>influenza virus</kwd>
        <kwd>lung</kwd>
        <kwd>miRNA</kwd>
        <kwd>mouse</kwd>
        <kwd>susceptibility</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn01">European Commission<named-content content-type="fundref-id">10.13039/501100000780</named-content></funding-source>
        </award-group>
        <award-group>
          <funding-source id="cn02">Helmholtz-Gemeinschaft<named-content content-type="fundref-id">10.13039/501100001656</named-content></funding-source>
        </award-group>
        <award-group>
          <funding-source id="cn03">Bundesministerium für Bildung und Forschung<named-content content-type="fundref-id">10.13039/501100002347</named-content></funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="10"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="78"/>
        <page-count count="18"/>
        <word-count count="11806"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="S1">
      <title>Introduction</title>
      <p>microRNAs (miRNAs) are short regulatory RNA molecules that occur in most eukaryotic cells and may have profound effects on a broad range of biological processes, including apoptosis, development, differentiation, proliferation, and immune responses (<xref rid="B1" ref-type="bibr">1</xref>–<xref rid="B4" ref-type="bibr">4</xref>). It, therefore, comes as no surprise that major changes in miRNA expression and activity have been shown to occur as part of the host cell response to infection by a variety of viruses (<xref rid="B5" ref-type="bibr">5</xref>–<xref rid="B7" ref-type="bibr">7</xref>). Increasing attention has been paid to the role(s) of miRNAs in influenza virus infection, with most studies having focused on influenza A virus (IAV). Studies have involved cells or tissues from natural hosts, such as humans (<xref rid="B8" ref-type="bibr">8</xref>–<xref rid="B10" ref-type="bibr">10</xref>), birds (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>), pigs (<xref rid="B13" ref-type="bibr">13</xref>), and macaques (<xref rid="B14" ref-type="bibr">14</xref>) and mice as adaptive hosts (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>). Major insights have been gained by comparing differences in the miRNome responses to IAV strains of differential pathogenicity (<xref rid="B14" ref-type="bibr">14</xref>–<xref rid="B17" ref-type="bibr">17</xref>) or by comparing effects of different host backgrounds (<xref rid="B16" ref-type="bibr">16</xref>). The importance of some of the differentially expressed miRNAs has also been validated experimentally [e.g., Buggele et al. (<xref rid="B18" ref-type="bibr">18</xref>)], thus underscoring that miRNAs may substantially influence the course of IAV infection (<xref rid="B19" ref-type="bibr">19</xref>). However, in spite of this ever growing interest in the interactions between IAV and the host miRNome, there have been no studies investigating differences in the miRNA response in hosts of well characterized differential genetic susceptibility to IAV. This is all the more surprising since recent work with inbred mouse strains of differential susceptibility to IAV infection clearly showed that the transcriptomic (mRNA) response to IAV is to a great extent determined genetically (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). It is therefore quite plausible that major genetic differences might also manifest at the level of the miRNome’s response to IAV infection and that the description of this miRNome will enable identification of regulatory miRNA–mRNA networks that are critical for successful host defense against IAV infection and, perhaps, related viruses. Based on a well-established mouse model of IAV infection, and using deep sequencing of small RNAs (<xref rid="B22" ref-type="bibr">22</xref>), we have therefore used two inbred mouse strains of well characterized different genetic susceptibility to IAV infection to identify host strain-specific differences in the host miRNA response to this virus. We find substantial differences in the miRNA populations of the two strains, both at baseline and during infection, and an overall more rapid reprogramming in the more susceptible DBA/2J strain. The results suggest that host-strain-specific differences in abundance and regulation of miRNAs provide a link to host susceptibility to IAV infection.</p>
    </sec>
    <sec sec-type="materials|methods" id="S2">
      <title>Materials and Methods</title>
      <sec id="S2-1">
        <title>Availability of Data</title>
        <p>Small RNA sequencing data, a miRNA expression table, and tables with expression differences and correlations with hematological parameters in peripheral blood, including adjusted <italic>p</italic> values, are available in the Gene Expression Omnibus repository (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89064">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89064</uri>).</p>
        <p>Data tables contain the 473 miRNAs that passed pre-analytic filtering. Columns within the table with expression differences (GSE89064_edgeR_miR.xls) represent the effect of infection or mock treatment compared to untreated mice, differences between infection and mock treatment at each time point, and differences between mouse strains after mock treatment, infection, or without treatment. All results were obtained with the edgeR package. Data table (GSE89064_miRNA_vs_blood_spearman_correlations.xlsx) contains Spearman correlation coefficients of all miRNAs with peripheral blood indices.</p>
      </sec>
      <sec id="S2-2">
        <title>Statement on Ethics Approval</title>
        <p>All animal work was conducted according to the national guidelines of the animal welfare law of the Federal Republic of Germany and approved by the “Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany” (Permit Numbers: 3392 42502-04-13/1234 and 33.19-42502-04-13/1234).</p>
      </sec>
      <sec id="S2-3">
        <title>Virus</title>
        <p>Original stocks of mouse adapted A/Puerto Rico/8/34 (H1N1, PR8) virus were obtained from Stefan Ludwig (University of Münster) (<xref rid="B23" ref-type="bibr">23</xref>). Virus stocks were propagated in the chorioallantoic cavity of 10-day-old pathogen-free embryonated chicken eggs for 48 h at 37°C as described previously (<xref rid="B24" ref-type="bibr">24</xref>).</p>
      </sec>
      <sec id="S2-4">
        <title>Animal Procedures</title>
        <p>Infections were essentially carried out as described previously (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Briefly, female 12- to 13-week-old C57BL/6J and DBA/2J mice (<italic>n</italic> = 5–6 per time point and treatment) were anesthetized by intraperitoneal injection of 10 μl/g body weight of a stock solution of 0.5 ml ketamine (50 mg/ml, Invesa Arzneimittel GmbH, Freiburg, Germany), 0.5 ml 2% xylazine hydrochloride (Bayer Health-Care, Leverkusen, Germany), and 9 ml sterile NaCl 0.9% (Delta-Select GmbH, Dreieich, Germany). For intranasal infection, a viral dose of 2 × 10<sup>3</sup> focus forming units (ffu) in a total volume of 20 μl sterile PBS was used. During the infection procedure, mice were held in the upright position and additional anesthetic was reinjected as needed. Mock treatment was identical to the real anesthesia/infections except that vehicle only (sterile PBS), not containing virus, was used for intranasal instillation. Mice were weighed on day 0 just before induction of anesthesia and on each subsequent day. Mice were killed by CO<sub>2</sub> asphyxiation at 6, 12, 18, 24, 48, and 120 h with respect to infection or mock treatment. Untreated mice were used as <italic>t</italic> = 0 h control. Lungs were removed by cutting the five main bronchi and were washed in RNAlater RNA Stabilization Reagent (Qiagen Inc., Venlo, Netherlands), immediately after removal. After transfer into a new tube containing 2 ml RNAlater, lungs were stored overnight at 4°C and then at −20°C until further use.</p>
      </sec>
      <sec id="S2-5">
        <title>Hematological Measurements</title>
        <p>An analysis of the hematological data from this time course experiment has been published separately (<xref rid="B25" ref-type="bibr">25</xref>). Briefly, 50 μl of whole blood were obtained by cardiac puncture and then analyzed with a VetScan HM5™ (Abaxis, Union City, CA, USA) hematology analyzer.</p>
      </sec>
      <sec id="S2-6">
        <title>RNA Isolation</title>
        <p>Lungs were homogenized in 4 ml RLT buffer (Qiagen) containing 40 μl β-mercaptoethanol and stored in 450 μl aliquots at −80°C. After thawing, 450 μl of this suspension was mixed with 700 μl Qiazol (Qiagen), and all further steps of total RNA isolation were performed with the miRNeasy kit (Qiagen) according to the manufacturer’s recommendations.</p>
      </sec>
      <sec id="S2-7">
        <title>Small RNA Sequencing</title>
        <p>Five samples per condition were submitted for small RNA sequencing. Sequencing was performed using the TruSeq™ Small RNA Sequencing Kit, Version of January 2011 (Illumina, Inc., San Diego, CA, USA). Approximately 1,250 ng of input RNA was used and the synthesized cDNA was amplified with 15 PCR cycles. cDNA library fragments with a length of about 150 nt were separated by gel electrophoresis and then isolated from the corresponding excised gel slice. Four to five biological replicates per condition were analyzed. Use of the Illumina molecular barcode allowed sequencing of eight samples per lane. To reduce batch effects, samples from the same time point and mouse strain were never run on the same lane. Sequencing was done using the HiSeq 2500 (Illumina Inc.) sequencer. The TruSeq™ Small RNA Sequencing Kit is specific for miRNAs and other small RNAs that have a 3′OH group resulting from enzymatic cleavage by RNA processing enzymes.</p>
      </sec>
      <sec id="S2-8">
        <title>Quantitative Real-time PCR (RT-qPCR)</title>
        <p>Quantitative real-time PCR was performed with a LightCycler 480<sup>®</sup> (La Roche AG, Basel, Switzerland) in 96-well plates in 20 μl reaction volumes, using 3 ng cDNA per reaction for miRNAs (miScript Reverse Transcription Kit, miScript SYBR Green PCR Kit; Qiagen) or 15 ng cDNA per reaction for detection of IAV hemagglutinin (HA) mRNA. Aliquots from the same RNA samples as for the sequencing experiment were used, with five biological replicates for each condition. HA expression was normalized against the mean of the Ct values of <italic>Actb</italic> and <italic>Rpl4</italic> mRNAs. Ct values of the miRNAs were not normalized against an internal control.</p>
      </sec>
      <sec id="S2-9">
        <title>Data Analysis</title>
        <p>Illumina sequencing data were preprocessed using the CLC Genomics Workbench 6.04 (CLC Bio, Cambridge, MA, USA) and the resulting sequences were annotated using miRBase 19. Two additional downstream and upstream bases as well as two mismatches were allowed. 5′ and 3′ mature sequences (including variants) were used for further analysis. All subsequent analyses were done using the R environment and programming code (<xref rid="B26" ref-type="bibr">26</xref>). All <italic>p</italic> values were adjusted for false discovery rate (FDR).</p>
        <p>Two samples were excluded before sequencing due to poor RNA quality/quantity, and three samples were excluded after sequencing due to low read numbers. Thus, small RNA sequencing data of 125 of the 130 originally submitted samples (96%) were available for analysis, amounting to five biological replicates for most conditions, but only four for the following conditions: untreated (0 h), mock treated (6 h), and infected (18 hpi) DBA/2J mice, and mock treated (6 and 120 h) C57BL/6J mice. A total of 1,276 miRNAs were detected. Only the 476 annotated sequences that were detected at a level of &gt;1 count per million (CPM) in &gt;5 samples were included in subsequent analyses. This did not change the number of total reads appreciably. Three miRNAs with strong outlier samples were removed because of an SD/median ratio &gt;2.5 (calculated with cpm values of mouse strain and time post treatment). Line plots of these miRNAs did not show any relevant change in expression (data not shown).</p>
        <p>Differentially expressed miRNAs were identified using generalized linear models contained in the edgeR package (<xref rid="B27" ref-type="bibr">27</xref>). For expression changes within a time course or differences between mock treated and infected mice, a fold change (FC) of 1.5 and <italic>p</italic> value of 0.05 were used as cutoff.</p>
        <p>Differential miRNA expression in response to IAV infection was defined as follows: (1) significant (<italic>p</italic> ≤ 0.05) with respect to the untreated control (<italic>t</italic> = 0 h) and to the mock-treated mice at the same time point and (2) a ≥1.5 FC difference from the untreated mice. miRNAs that were differentially expressed due to the infection procedure, excluding the virus, were defined as follows: significant regulation after mock treatment and infection with respect to <italic>t</italic> = 0 h, but no significant expression difference between infected and mock samples from the same time point (<italic>p</italic> ≥ 0.05). A FC cutoff of ≥1.5 between untreated and mock-treated mice was used.</p>
        <p>To compare absolute miRNA abundance in DBA/2J vs C57BL/6J mice, we used miRNAs that were differentially expressed in response to infection in at least one mouse strain and differed between the mouse strains, using the more rigorous FC cutoff of 2 and <italic>p</italic> ≤ 0.01. Furthermore, we defined a miRNA subset with no significantly different abundance between both mouse strains at all tested time points (ratio ≤ 1.5; <italic>p</italic> ≥ 0.1), but differential expression after IAV infection in either mouse strain. Clusters using k-means for longitudinal data were calculated using the kml package (<xref rid="B28" ref-type="bibr">28</xref>). Graphs were made using lattice (<xref rid="B29" ref-type="bibr">29</xref>), gplots (<xref rid="B30" ref-type="bibr">30</xref>), or ggplot2 (<xref rid="B31" ref-type="bibr">31</xref>).</p>
      </sec>
      <sec id="S2-10">
        <title>Functional Prediction</title>
        <p>microRNAs that were found to differ between the two mouse strains were analyzed using three different approaches. From the significantly enriched pathways, we removed those that did not differ from putative pathways of miRNAs with similar abundance in both mouse strains. For the first approach, we used the DIANA mirPath v2 online tool (<xref rid="B32" ref-type="bibr">32</xref>) for annotated miRNA contained in miRBase 18. As settings, we used microT-CDS for target prediction with a threshold of 0.8. Results were visualized with a <italic>p</italic> value threshold of 0.05 using the option “pathways union.” This option shows the contribution of each miRNA to the pathways enrichment, showing only miRNAs whose targets are significantly (<italic>p</italic> ≤ 0.05) enriched for that pathway. From the significant pathways, we removed those with a 1.5-fold lower number of significant miRNAs for the same pathway in the control group of miRNAs with similar abundance between the two mouse strains.</p>
        <p>For the second strategy, we used putative miRNA targets that were found in at least three of four databases (MicroCosm, PITA, miRanda and miRDB) [MicroCosm (<xref rid="B33" ref-type="bibr">33</xref>); miRanda (<xref rid="B34" ref-type="bibr">34</xref>); miRDB (<xref rid="B35" ref-type="bibr">35</xref>); PITA (<xref rid="B36" ref-type="bibr">36</xref>)]. Targets that were shared by at least two miRNAs were chosen for functional analysis.</p>
        <p>Using the R packages “goseq” and “GO.db,” we identified significantly enriched GO Terms using putative targets of all 473 detected miRNAs as background. Of the significantly enriched terms for host strain-dependent miRNAs, we chose only those which had at least 1.5-fold more targets for a pathway, compared to the control group with similar miRNA abundance, or that were not found in the control group.</p>
        <p>Putative miRNA targets of step 2 were analyzed using the online tool DAVID (Database for Annotation, Visualization and Integrated Discovery) Bioinformatics Resources 6.7 (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>) and the <italic>Mus musculus</italic> genome as background. For functional observations, we used default settings. Results of the DAVID tool included a Functional Annotation Table with functional terms for each gene; a Functional Annotation Chart that calculates the enrichment of each term and a Functional Annotation Clustering that clusters Terms that are related. Of the Functional Annotation Table, we added the options fold enrichment and FDR. Functional Annotation Charts were downloaded and loaded into the R program to allow direct comparisons of different enrichment tables. To identify functions of miRNAs with different abundance in DBA/2J and C57BL/6J mice, only those significantly enriched terms (FDR ≤ 0.05) were chosen that were found for miRNAs with different, but not for miRNAs with similar abundance in both mouse strains or were at least 1.5-fold more highly enriched.</p>
      </sec>
      <sec id="S2-11">
        <title>Other Statistical Analyses</title>
        <p>For pairwise comparisons of miRNA or mRNA Ct values, we used Tukey’s Honest Significant Differences Test for homogeneous variances. We used a significance threshold of <italic>p</italic> ≤ 0.05. Receiver operating characteristic (ROC) curve analysis was performed using the R package ROCR (<xref rid="B39" ref-type="bibr">39</xref>) and counts per million (cpm) data.</p>
      </sec>
    </sec>
    <sec id="S3">
      <title>Results</title>
      <sec id="S3-1">
        <title>Brisker Progression of Infection and More Pronounced Weight Loss in the DBA/2J Mouse Strain</title>
        <p>Higher weight loss, compared to less susceptible mouse strains, is a hallmark of the high susceptibility of DBA/2J mice to IAV infection. Consistent with our previous observations (<xref rid="B40" ref-type="bibr">40</xref>), marked weight loss was observed after infection of this strain, which reached a maximum of approximately 25% by day 5 (Figure <xref ref-type="fig" rid="F1">1</xref>A). As shown previously (<xref rid="B40" ref-type="bibr">40</xref>), weight loss of the less susceptible strain, C57BL/6J, was less pronounced, as reflected in a mere 5–10% reduction by day 4–5. There was no significant weight loss among the mock-treated mice between day 1 and 5.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Weight loss and expression of influenza A virus (IAV) hemagglutinin (HA) mRNA</bold>. Weight loss and HA mRNA expression throughout the 5-day time course after mock treatment or infection with IAV strain PR8 as outlined in Section “<xref ref-type="sec" rid="S2">Materials and Methods</xref>.” <bold>(A)</bold> Weight loss, expressed as the mean percentage of body weight measured at <italic>t</italic> = 0 h before administration of anesthesia. No mice had to be killed because of &gt;30% weight loss. Data are based on the mice that were sacrificed at the 120 h time point (<italic>n</italic> = 5–6 per group). <bold>(B)</bold> Relative quantification of IAV HA mRNA in mouse lung by RT-qPCR in the 5-day time course shown in panel A. dCt refers to Ct<sub>reference</sub> − Ct<sub>target mRNA</sub>, where Ct<sub>reference</sub> is the arithmetic mean of the Ct values of β-actin and Rpl4. As expected, HA mRNA was not detected in the mock-treated mice (data not shown). Data are based on five mice per group except for DBA/2J at 18 h (<italic>n</italic> = 4). Solid lines, infection; interrupted lines, mock treatment. Left panels, DBA/2J strain; right panels, C57BL/6J strain. The colored areas around the lines indicate SD. Note that the <italic>x</italic>-axes of the panels are based on different scales. *<italic>p</italic> ≤ 0.05 for difference with respect to <italic>t</italic> = 0 h; <sup>‡</sup><italic>p</italic> ≤ 0.05 for difference between mock-treated and infected mice at the given time point (Tukey’s test). This figure is adapted from two articles published by BioMed Central (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B25" ref-type="bibr">25</xref>), which describe other aspects of this time course experiment.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g001"/>
        </fig>
        <p>Quantitative real-time PCR revealed a brisk rise of mRNA encoding IAV HA in lungs of both mouse strains after infection (Figure <xref ref-type="fig" rid="F1">1</xref>B). HA mRNA was detected at low levels as early as 6 hpi in both strains, followed by a rapid rise that peaked at 48 and 120 hpi in DBA/2J and C57BL/6J mice, respectively. HA mRNA levels were significantly higher in DBA/2J than in C57BL/6J. This difference was significant as early as 12 hpi with a ratio DBA/2J to C57BL/6J of 3.6:1 and increased to a constant ratio of about 23 to 24:1 between 18 and 48 hpi, which diminished markedly by 120 hpi due to a decline in HA transcript levels in the DBA/2J strain by this time point. Thus, the infection evolved more briskly and peaked sooner in the more susceptible DBA/2J strain, with differences manifesting as early as 12 hpi.</p>
      </sec>
      <sec id="S3-2">
        <title>Global Changes in miRNA Expression throughout the Time Course</title>
        <p>Eighty-eight percent (10.7 million on average) of all obtained sequences corresponded to annotated miRNAs. A total of 473 miRNA species passed pre-analytic data processing and were selected for subsequent analyses. In both mouse strains, analysis of the 473 selected miRNAs (Figures <xref ref-type="fig" rid="F2">2</xref>A,B) revealed a narrow range in miRNA expression FC during the time course. Accordingly, multidimensional scaling (MDS, Figure <xref ref-type="fig" rid="F2">2</xref>C) revealed that samples from mock-treated and infected mice at any time point between 6 and 24 h formed two tight clusters (one for each mouse strain) with the respective uninfected (<italic>t</italic> = 0 h) mice. In the DBA/2J mice, an apparent weak up and downregulation of some miRNAs due to the mock treatment was seen at 6 h (Figures <xref ref-type="fig" rid="F2">2</xref>A,B), but this was not statistically significant, and there was no apparent tendency toward a mock effect in the C57BL/6J strain. Thus, the infection/anesthesia procedure did not induce significant changes in miRNA populations in either mouse strain. Of note, a marked difference in miRNomes between the strains was apparent even in the uninfected lungs (Figure <xref ref-type="fig" rid="F2">2</xref>C). These strain-specific differences dominated the global differences in miRNomes throughout the time course, which remained relatively constant.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Global miRNA expression changes throughout the 120 h time course of influenza A virus infection</bold>. Values of all 473 miRNAs that passed preanalytical filtering are shown in panels <bold>(A,B)</bold> (turquoise lines, mock treatment; red lines, infection). <bold>(A,B)</bold> change in expression (log2); FC was calculated with the R package edgeR (<xref rid="B27" ref-type="bibr">27</xref>). <bold>(A)</bold> DBA/2J strain; <bold>(B)</bold> C57BL/6J strain. <bold>(C)</bold> Multidimensional scaling based on the expression data of all 473 detected miRNAs (edgeR package). The data, as well as the data shown in Figures <xref ref-type="fig" rid="F3">3</xref>–<xref ref-type="fig" rid="F6">6</xref>, are based on five mice per condition, except that four mice were available for untreated (0 h), mock treated (6 h), and infected (18 h) DBA/2J mice, and for mock treated (6 and 120 h) C57BL/6J mice.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g002"/>
        </fig>
        <p>In both mouse lines, line plots (Figures <xref ref-type="fig" rid="F2">2</xref>A,B), MDS (Figure <xref ref-type="fig" rid="F2">2</xref>C), and Euclidian distance dissimilarity analysis (EDDA, data not shown) consistently indicated a global miRNA reprogramming beginning at 48 hpi, followed by a pronounced further increase at 120 hpi. The overall mean FC was constant within the first 24 h and increased in DBA/2J and C57BL/6J mice after 48 h and 120 h, respectively. As indicated by MDS and confirmed using EDDA, miRNome reprogramming at 48 hpi was greater in the DBA/2J than the C57BL/6J strain, whereas the two strains reached a similar overall degree of reprogramming by 120 hpi. Notably, HA mRNA expression in DBA/2J mice decreased between 48 and 120 hpi (Figure <xref ref-type="fig" rid="F1">1</xref>B), but miRNome reprogramming increased further during the same time frame. Therefore, host miRNA reprogramming did not seem to be coupled directly to viral HA RNA expression.</p>
        <p>To test whether there was any association between the initial expression level of the infection-regulated miRNAs and the direction of their regulation, the 115 infection-regulated miRNAs (differentially expressed in DBA/2J or C57BL/6J mice with respect to mock-infected mice; FC ≥|1.5|, FDR adjusted <italic>p</italic> value ≤ 0.05) were grouped into three clusters according to baseline expression level and direction of regulation (Figure <xref ref-type="fig" rid="F3">3</xref>A). Indeed, a negative correlation between initial expression and direction of regulation was identified in both mouse strains: downregulated miRNAs tended to have a high baseline expression level, intermediately upregulated miRNAs an intermediate baseline expression level, and strongly upregulated miRNAs the lowest. The three clusters converged toward 120 hpi, at a point corresponding to approximately five normalized and log2 transformed reads (log2 counts per million; cpm). Thus, the direction of regulation of the miRNAs depended on their initial abundance (expression level). These observations are consistent with a model in which miRNAs with high baseline expression are predominantly expressed in resident lung cells, but miRNAs of low initial abundance are mainly expressed in immune cells and their abundance increases during infection due to their immigration into the lung combined with the corresponding changes in their activation state.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Potential contributions of infiltrating leukocytes to pulmonary miRNome reprogramming</bold>. <bold>(A)</bold> Line plots visualizing the associations between miRNA abundance and direction of regulation of miRNAs regulated in response to influenza A virus (IAV) infection (115 different miRNA species, FC ≥|1.5|, FDR adjusted <italic>p</italic> value ≤ 0.05 in either mouse strain, see Figure <xref ref-type="fig" rid="F4">4</xref>). The clusters were identified with the k means of longitudinal data (kml) package of R (<xref rid="B28" ref-type="bibr">28</xref>) using the FC (log2) data of IAV infected mice compared to untreated (<italic>t</italic> = 0 h) mice. <bold>(B)</bold> Correlation of miRNA expression with peripheral blood leukocyte parameters. Using data from infected and control (uninfected) mice, expression (cpm) of 473 miRNAs was correlated with hematological parameters of the same mice. Significant correlations (Spearman correlation; ρ ≥|0.5| and <italic>p</italic> ≤ 0.05) are indicated in different colors according to mouse strain: red, significant correlation in DBA/2J only; blue, significant correlation in C57BL/6J only; violet, significant correlation in both strains. The green smoothing line was generated using the R function smooth.spline (stats package) using default settings. WBC, white blood cells; LYM, LYM%, absolute and relative lymphocyte counts; MON, MON%, absolute and relative monocyte counts; GRA, GRA%, absolute and relative granulocyte counts.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g003"/>
        </fig>
        <p>To assess the contributions of changes in immune cell populations to changes in miRNA expression, we quantified correlations between peripheral blood leukocyte parameters and expression of each of the miRNAs (Figure <xref ref-type="fig" rid="F3">3</xref>B). Overall, higher numbers of significant correlations were measured in DBA/2J mice [compare red (DBA/2J) and and blue (C57BL/6J) circles in Figure <xref ref-type="fig" rid="F3">3</xref>], which was particularly pronounced in total leukocyte (WBC) and monocyte counts. Absolute granulocyte numbers and miRNA expression correlated most significantly in both mouse strains (23 miRNAs with significant correlations; violet circles in Figure <xref ref-type="fig" rid="F3">3</xref>), with miR-223-3p, miR-142-3p, and miR-20b-5p correlating the most positively in both mouse strains ([ρ<sub>DBA/2J</sub> + ρ<sub>C57BL/6J</sub>]/2 &gt; 0.7). There was only a negligible correlation (one miRNA in DBA/2J mice) with absolute lymphocyte counts. To test the above stated hypothesis that pulmonary miRNAs expressed in infiltrating immune cells are initially expressed at low level in the lung, we asked whether there was an association between miRNA correlation with peripheral blood indices and initial miRNA abundance. Indeed, miRNAs that correlate positively (ρ ≥ 0.2) with MON, GRA, GRA/LYM, and GRA% had a lower initial abundance (≥1.5-fold lower; <italic>p</italic> value ≤ 0.01, Wilcoxon test) than miRNAs that correlate negatively (ρ ≤ −0.2). Taken together, these results suggest that expression of pulmonary miRNAs during the first 120 h of infection may be in part explained by infiltration with myeloid immune cells, particularly in the more susceptible DBA/2J strain.</p>
      </sec>
      <sec id="S3-3">
        <title>Mouse Strain-Specific Differences in miRNome Regulation after IAV Infection</title>
        <p>As mentioned above, 115 miRNAs were significantly regulated after infection. The majority (75%) were upregulated and only about 25% were downregulated. Of note, the number of differentially expressed miRNAs and their FC direction was similar in both mouse strains (Figure <xref ref-type="fig" rid="F4">4</xref>), i.e., miRNAs that were upregulated in one strain, were also upregulated in the other, and <italic>vice versa</italic>. In both strains, a first significant response to the infection was apparent at 48 hpi, with a slightly higher number of differentially expressed miRNAs and higher FC values being observed in the DBA/2J strain than in the C57BL/6J strain. An at least twofold greater induction in C57BL6/J mice was detected in eight miRNAs (miR-190a-3p, miR-449a-5p, miR-449a-3p, miR-449c-5p, miR-3096a-5p, miR-3096b-5p, miR-3096b-3p, and miR-669c-5p). Consistent with MDS and EDDA, the two strains reached a similar overall degree of reprogramming by 120 hpi, but differences at the earlier time points were greatest at 48 h.</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>miRNAs regulated during influenza A virus (IAV) infection</bold>. Heat map showing all 115 miRNAs that were differentially expressed after IAV infection (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>) of DBA/2J and/or C57BL/6J mice. FC data and <italic>p</italic> values (FDR adjusted) represent the difference between infected and mock-treated mice. Red: upregulated; blue: downregulated. The right bar indicates log2 counts per million (edgeR package) of these miRNAs in DBA/2J and C57BL/6J mice together, ranging from low (white) and mid (blue) to high (black) abundance. Expression of 93 miRNAs changed during the infection in the DBA/2J strain and 95 in the C57BL/6J strain, corresponding to a total of 115 regulated miRNAs. Seventy-three of these were regulated in both strains (***<italic>p</italic> value ≤ 0.001; **<italic>p</italic> value ≤ 0.01; *<italic>p</italic> value ≤ 0.05). Stars are only shown for differences between infected and mock-treated mice and were also included for significant miRNAs with an FC &lt;|1.5|.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g004"/>
        </fig>
        <p>In a next step, we tried to identify miRNAs that might contribute to the differences in miRNomes between the two mouse strains revealed in Figure <xref ref-type="fig" rid="F2">2</xref> and, thus, might affect host strain susceptibility. Abundances of a subset of 37 infection-regulated miRNAs differed (FC ≥|2|, FDR adjusted <italic>p</italic> value ≤ 0.01) between the two mouse strains at any of the tested time-points (Figure <xref ref-type="fig" rid="F5">5</xref>), 22 of which were more abundant in DBA/2J and 15 more abundant in C57BL/6J mice. Six of these (16%) were significantly infection-regulated in DBA/2J only and 10 (27%) in C57BL/6J only. Pulmonary expression of eight miRNAs differed between the two mouse strains even before infection. Expression of 10 miRNAs differed significantly between the two strains between 6 and 18 hpi, expression of 13 miRNAs at 24 hpi, expression of 20 miRNAs at 48 hpi, and expression of 23 miRNAs at 120 hpi. The miRNAs whose expression was lower/higher in DBA/2J mice in the uninfected state mainly continued to be expressed at a lower/higher level after infection, even after 5 days. Thus, two major patterns could be discerned among the host strain-dependently regulated miRNAs: (1) miRNAs that were differentially expressed in the two strains throughout the entire time course, and (2) miRNAs whose differential expression manifested at the later time points. Most miRNAs of group two were more abundant in DBA/2J mice. miR-147-3p constituted an exception in that it was markedly overexpressed in C57BL/6J mice within the first 24 hpi and had a similar expression level as DBA/2J at 48 hpi. miR-3096b-3p and miR-3096b-5p showed the strongest host strain-dependent difference in both directions. The DNA Intelligent Analysis (DIANA), the Gene Ontology analyzer for RNA-seq data (R package goseq), and the Database for Annotation, Visualization, and Integrated Discovery (DAVID) were then used to search for putative mRNA targets of miRNAs whose expression was different between the two mouse strains (Figure <xref ref-type="fig" rid="F5">5</xref>) and the functional pathways putatively associated with these mRNAs. Among the pathways relating to immune functions, <italic>Fc gamma R-mediated phagocytosis, HIF-1 signaling pathway, positive regulation of protein kinase B signaling cascade, SH3 binding</italic>, and <italic>leukocyte differentiation</italic> were significantly over-represented.</p>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <p><bold>miRNAs that differ in absolute abundance between DBA/2J and C57BL/6J mice</bold>. Depiction of 37 miRNAs with a differential abundance of ≥|2| and a <italic>p</italic> value (FDR adjusted) of at ≤0.01 between DBA/2J and C57BL/6J mice throughout the time course. Red colors in the heat map indicate miRNAs that are more abundant in DBA/2J mice (22 miRNAs), blue colors indicate miRNAs that are more abundant in C57BL/6J mice (15 miRNAs). The 115 miRNAs that are infection dependently regulated in DBA/2J or C57BL/6J mice (Figure <xref ref-type="fig" rid="F4">4</xref>) were used as input miRNAs. The blue bar indicates mean miRNA abundance across all samples (log2 cpm). The FC of these miRNAs at 120 hpi is shown using shades of blue (low DBA/2J vs C57BL/6J ratio, i.e., higher abundance in C57BL/6J mice) and shades of red (high DBA/2J vs C57BL/6J ratio, i.e., higher abundance in DBA/2J mice) (***<italic>p</italic> value ≤ 0.001; **<italic>p</italic> value ≤ 0.01; *<italic>p</italic> value ≤ 0.05). Stars were also included for significant miRNAs with an absolute ratio &lt;2.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g005"/>
        </fig>
        <p>There were also distinctive features within each of the two major miRNA expression patterns mentioned above. For instance, miRNAs whose abundance did not differ between uninfected and incipiently infected mice tended to be more highly expressed in DBA/2J mice at 48 hpi. Furthermore, seven miRNAs were expressed more highly in C57BL/6J mice and were mainly downregulated across the time course (miR-92b-3p, miR-34b-5p, miR-672-5p, miR-31-5p, miR-34c-5p, miR-34b-3p, and miR-182-5p; listed in descending order according to the heat map in Figure <xref ref-type="fig" rid="F5">5</xref>). Although these miRNAs were less abundant in DBA/2J mice, they were downregulated even more strongly in this strain. In addition, the absolute abundance of these miRNAs was relatively high, suggesting that they are expressed in resident lung cells and not in infiltrating immune cells. Indeed, in DBA/2J all seven miRNAs (and four of seven in C57BL/6J) belong to the upper trajectory cluster in Figure <xref ref-type="fig" rid="F3">3</xref>. By using functional enrichment of putative targets, <italic>PI3K-Akt signaling pathway, Notch signaling pathway, hemopoiesis, leukocyte differentiation, natural killer cell mediated cytotoxicity</italic>, and different cancers were among the enriched functions. When considering all 37 infection-regulated miRNAs whose expression differed between the two mouse strains, nine miRNAs had targets that were significantly over-represented in the <italic>PI3K-Akt signaling</italic> pathway (DIANA tool). Five of these [miR-34b-3p, miR-34c-5p, miR-34b-5p, miR-92b-3p, and miR-182-5p; as well as miR-31-5p, which was identified through literature search (<xref rid="B41" ref-type="bibr">41</xref>)] belonged to the aforementioned seven miRNAs which were expressed more highly in the C57BL/6J mice and downregulated throughout the time course.</p>
      </sec>
      <sec id="S3-4">
        <title>miRNAs That Are More Abundant in the C57BL/6J Strain Contain More Putative Binding Sites for IAV RNA</title>
        <p>To test whether these 37 miRNAs (Figure <xref ref-type="fig" rid="F5">5</xref>) might contribute to the higher IAV resistance of C57BL/6J mice, we searched for putative binding sites for them in the IAV genome. Using the ViTa Database, the human homologs of miR-135b-5p, miR-147-3p, miR-31-5p, miR-379-5p, miR-7a-5p, as well as the miR-449 (-5p) and miR-34 (-5p) families, were predicted to bind to viral RNA segments of influenza A/Puerto Rico/8/34/Mount Sinai (H1N1). Most of these miRNAs were more abundant in C57BL/6J mice (<italic>p</italic> = 0.013, hypergeometric test) and might, therefore, contribute to the higher resistance of C57BL/6J mice to IAV infection.</p>
      </sec>
      <sec id="S3-5">
        <title>Potential Involvement of Apoptotic Processes in Host-Strain Susceptibility to IAV Infections</title>
        <p>Many miRNAs whose expression differed between DBA/2J and C57BL/6J mice during infection belong to the miR-467, miR-449, and miR-34 families. Of note, all three families have been shown to play roles in apoptosis (<xref rid="B42" ref-type="bibr">42</xref>–<xref rid="B44" ref-type="bibr">44</xref>), and several publications have demonstrated the relevance of apoptosis to IAV infection (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B45" ref-type="bibr">45</xref>–<xref rid="B47" ref-type="bibr">47</xref>). We therefore tested whether there might be an association between strain-specific miRNA expression and apoptosis. As shown in Figure <xref ref-type="fig" rid="F6">6</xref>, miRNAs that were more highly expressed in the susceptible DBA/2J strain tended to be antiapoptotic, whereas miRNAs that were more highly expressed in the resistant C57BL/6J strain tended to be pro-apoptotic (<italic>p</italic> = 0.002, two-tailed Fisher exact test) (<xref rid="B42" ref-type="bibr">42</xref>–<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B48" ref-type="bibr">48</xref>–<xref rid="B53" ref-type="bibr">53</xref>).</p>
        <fig id="F6" position="float">
          <label>Figure 6</label>
          <caption>
            <p><bold>Apoptosis-related miRNAs that differ in absolute abundance between DBA/2J and C57BL/6J mice</bold>. Data are based on those shown in Figure <xref ref-type="fig" rid="F5">5</xref>. Red, higher expression in DBA/2J mice; blue, higher expression in C57BL/6J mice. Functional information was found by literature research as described in the text above.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g006"/>
        </fig>
      </sec>
      <sec id="S3-6">
        <title>IAV-Regulated miRNAs with Host-Strain-Specific Expression in the Absence of Infection</title>
        <p>Considering the differences between the pulmonary miRNomes of the two mouse strains even before IAV infection (Figure <xref ref-type="fig" rid="F2">2</xref>C), we used receiver operating characteristic (ROC) curve analysis to identify miRNAs whose expression levels differed consistently between the two mouse strains in the absence of IAV infection and which might, therefore, be used in the uninfected state to predict intrinsic host susceptibility. To increase the sample size and, therefore, statistical power, this analysis comprised all treatments and time points that did not show evidence of infection-dependent miRNA expression changes, i.e., untreated mice (0 h), mock-treated mice (6–120 h), and infected mice in the first 24 hpi (6–24 h). This amounted to a sample size of 52 DBA/2J mice and 53 C57BL/6J mice. Five miRNAs were identified with areas under the ROC curve (AUC) = 1, indicating that there was no overlap in their expression levels between the two strains, and expression of four of them changed during infection (Figure <xref ref-type="fig" rid="F7">7</xref>). In total, there were eight differentially expressed miRNAs with AUCs &gt; 0.99 (miR-147-3p, miR-208b-3p, miR-467a-5p, miR-467c-5p, miR-467d-5p, miR-467e-5p, miR-3096a-5p, and miR-3096b-3p) whose abundance changed significantly during infection. Most of these highly strain-specifically expressed miRNAs (except miR-147-3p and miR-3069a-5p) were expressed more highly in the DBA/2J strain. Overall, miRNAs belonging to the miR-467 family were over-represented in this group of strain-specific miRNAs: 11 miRNAs of this family were among the 473 miRNAs that passed initial data filtering (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>), and nine of them had AUCs &gt; 0.946. Taken together, the above results suggest (1) that the selective expression of several IAV-regulated miRNAs, including miR-147-3p, miR-208b-3p, miR-3096a-5p, miR-3069b-3p, and the miR-467 family, in uninfected and incipiently infected DBA/2J lungs was specifically associated with higher susceptibility of this mouse strain to IAV infection at later time points and (2) that it accurately predicted this higher susceptibility.</p>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>miRNAs with consistently different expression in DBA/2J and C57BL/6J mice</bold>. miRNAs that have an AUC = 1 for the separation between uninfected, mock treated, and incipiently infected (6–24 h) DBA/2J from C57BL/6J mice. Data are based on 52 DBA/2J mice (4 at 0 h, 10 at 12 h, 9 at 18 h, 10 at 24 h, and 5 at 48 and 120 h) and 53 C57BL/2J mice (5 at 0 h, 10 at 12, 18 and 24 h, 5 at 48 h, and 4 at 120 h). Dots indicate the normalized (cpm) miRNA expression in DBA/2J (red) and C57BL/6J (blue) mice. All shown miRNAs are differentially expressed in at least one mouse strain after influenza A virus infection (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g007"/>
        </fig>
      </sec>
      <sec id="S3-7">
        <title>Technical Validation of RNAseq Results with RT-qPCR</title>
        <p>Five miRNAs were chosen that exemplify three patterns of expression differences between DBA/2J and C57BL/6J mice. These are comprised of miRNAs with a lower (miR-34b-5p and miR-92b-3p) or higher (miR-467e-5p) expression in DBA/2J vs C57BL/6J mice throughout the time course and those that are more highly expressed at 48 or 120 hpi only (miR-223-3p and miR-21a-3p). RNA from the same mice was used for both analyses. When expressing the RNAseq data as CPM, RT-qPCR data of four of the five miRNAs correlated strongly with the RNAseq data (ρ = 0.8 each, <italic>p</italic> ≤ 0.05, Spearman correlation), whereas miR-92b-3p did not correlate significantly (ρ = 0.25, <italic>p</italic> = ≥ 0.05). When FC values were used, RT-qPCR detected changes in miR-21a-3p, miR-223-3p, and miR-34b-5p expression in the same direction as measured by RNAseq, whereas no significant regulation was observed for miR-467e-5p and miR-92b-3p (Figure <xref ref-type="fig" rid="F8">8</xref>A). The RT-qPCR analysis confirmed the higher expression of miR-223-3p, miR-21a-3p, and miR-467e-5p in DBA/2J and the lower expression of miR-34b-5p and miR-92b-3p after infection, compared to C57BL/6J (Figure <xref ref-type="fig" rid="F8">8</xref>B). The RT-qPCR data differed in a minor way from the RNAseq data in that expression of miR-34b-5p and miR-92b-3p at <italic>t</italic> = 0 did not differ significantly between the mouse strains (Figure <xref ref-type="fig" rid="F8">8</xref>B). Taken together, these results suggest that there is substantial, but not perfect, agreement between the RT-qPCR and RNAseq data, thus validating our approach to use RNAseq for miRNA profiling.</p>
        <fig id="F8" position="float">
          <label>Figure 8</label>
          <caption>
            <p><bold>Validation of miRNA expression using quantitative real-time PCR (RT-qPCR)</bold>. RT-qPCR validation experiment for five selected miRNAs (compare Figures <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref>). The same mouse lungs were used as for the sequencing experiment. Colors indicate <bold>(A)</bold> mean log2 fold change expression with respect to the untreated control or <bold>(B)</bold> miRNA expression differences between the DBA/2J and the C57BL/6J mouse strain. Red: <bold>(A)</bold> upregulated miRNA, <bold>(B)</bold> higher expression in DBA/2J mice; blue: <bold>(A)</bold> downregulated miRNA, <bold>(B)</bold> higher expression in C57BL/6J mice (***<italic>p</italic> value ≤ 0.001; **<italic>p</italic> value ≤ 0.01; *<italic>p</italic> value ≤ 0.05). All <italic>p</italic> values were false discovery rate adjusted.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g008"/>
        </fig>
      </sec>
      <sec id="S3-8">
        <title>Identification of miRNA Subpopulations Whose Expression Correlates with HA mRNA Expression</title>
        <p>To assess the degree of synchronization between regulation of miRNA populations and viral replication, we then tested to what extent the expression changes of infection-regulated miRNAs correlated with IAV HA mRNA levels. Expression of 105 miRNAs correlated significantly (ρ ≥ |0.5|, <italic>p</italic> ≤ 0.05) with HA mRNA expression in at least one mouse strain (Figure <xref ref-type="fig" rid="F9">9</xref>), expression of 65 (62%) of which correlated positively. The degree of correlation with HA mRNA expression was similar to some extent between the two mouse strains, showing a significant (<italic>p</italic> ≤ 0.05) linear correlation between DBA/2J and C57BL/6J mice (Pearson correlation = 0.62). Of note, there were no miRNAs that correlated significantly in opposite directions in the two strains. Expression of the eight IAV-regulated miRNAs (except miR-467e-5p) that distinguished between the two mouse strains even before infection (AUC &gt; 0.99) also correlated significantly with HA mRNA levels. Expression of 75 miRNAs, including miRNAs of the miR-21, miR-223, miR-34, and miR-449 correlated with both HA mRNA expression and any of the hematological parameters. Of note, expression of 30 miRNAs correlated with HA mRNA expression in at least one mouse strain, but did not significantly correlate with peripheral blood cell indices. Out of these, miR-208b-3p, miR-467b-5p, miR-345-3p, and miR-744-3p were differentially expressed during infection in both mouse strains. The results suggest that there was substantial, but not perfect, synchronization between miRNome and HA mRNA expression. Accordingly, data shown in Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F4">4</xref> clearly show, for instance, that in the DBA/2J strain HA mRNA expression peaked at 48 hpi, but global miRNA reprogramming continued to evolve through 120 hpi. Taken together, these results suggest that pulmonary miRNA regulation is not driven by viral replication only, but also by aspects of the tissue response, including immune cell infiltration, that can be temporally dissociated from viral replication.</p>
        <fig id="F9" position="float">
          <label>Figure 9</label>
          <caption>
            <p><bold>Correlation of miRNA expression with hemagglutinin (HA) mRNA expression</bold>. Correlation of miRNA expression with HA mRNA expression using small RNA sequencing data of the 473 detected miRNAs (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>) and relative expression of HA mRNA obtained with quantitative real-time PCR (RT-qPCR). For the correlation analysis, cpm values of infected mice minus cpm values of mock-treated control mice were used. <bold>(A)</bold> Correlation of 473 miRNAs with HA mRNA expression in DBA/2J (<italic>x</italic>-axis) and C57BL/6J (<italic>y</italic>-axis) mice. Colors indicate 105 miRNAs that significantly correlated in at least one of the mouse strains. Red dots, miRNAs that correlate in DBA/2J only (ρ ≥ |0.5|, FDR ≤ 0.05); blue dots, miRNAs that correlate in C57BL/6J only (ρ ≥ |0.5|, FDR ≤ 0.05); violet dots, miRNAs whose expression correlates significantly in both mouse strains (FDR ≤ 0.05) with ρ ≥ |0.5| in at least one mouse strain. The Pearson correlation coefficient of 0.62 indicates the correlation of those data between the two mouse strains. <bold>(B)</bold> The 10 miRNAs with the strongest positive correlation with HA mRNA in each mouse strain. <bold>(C)</bold> The 10 miRNAs with the strongest negative correlation with HA mRNA in each mouse strain. <sup>§</sup>Significantly correlating (ρ ≥ |0.5|, FDR ≤ 0.05) when combining miRNA and HA mRNA expression data of DBA/2J and C57BL/6J mice. These miRNAs, therefore, correlate most strongly in both mouse strains (***<italic>p</italic> value ≤ 0.001; **<italic>p</italic> value ≤ 0.01; *<italic>p</italic> value ≤ 0.05). All <italic>p</italic> values were FDR corrected.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g009"/>
        </fig>
      </sec>
      <sec id="S3-9">
        <title>Stepwise Selection of Putative Functionally Important miRNAs</title>
        <p>The Venn diagram (Figure <xref ref-type="fig" rid="F10">10</xref>) illustrates the stepwise selection of the presumably functionally most meaningful infection-regulated miRNAs. The input consisted of all 473 miRNAs that passed the initial pre-analytical filter (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>). Criteria for selection were (1) differential expression at any time point after IAV infection (FC ≥|1.5|, FDR ≤0.05) in either mouse strain, (2) significant difference in expression between the two mouse strains (ratio ≥|2|, FDR ≤0.01) at any time point, and (3) significant correlation with HA mRNA expression (ρ ≥|0.5|, FDR ≤0.05). Ninety-three miRNAs were regulated in the DBA/2J strain, 95 in the C57BL/6J strain, and 63 were differentially expressed between the two strains at any point in the time course (label “DBA2/J vs C57BL/6J” in Figure <xref ref-type="fig" rid="F10">10</xref>). Thirty-nine miRNAs were commonly regulated after infection and correlated with HA mRNA expression, indicating that they represent the general miRNome response independent of the host genetic background (box below the diagram). Differential expression of 15 of these miRNAs (indicated in red) compared to uninfected mice was particularly similar between the two strains (FDR &gt;0.1 and FC ≤|1.5|). Expression of 20 miRNAs that were regulated after infection in both strains and correlated with HA mRNA expression in addition differed significantly between the two mouse strains (Figure <xref ref-type="fig" rid="F10">10</xref>, center intersect and right box). These 20 miRNAs (which included miR34 families, which are strongly associated with regulation of apoptosis and the PI3k-Akt pathway [e.g., Figure <xref ref-type="fig" rid="F6">6</xref>]) thus constituted part of a highly regulated response that can predominate in either strain, depending on the time after infection, and is likely to play a role in host susceptibility. Expression of six miRNAs (identified in the top and bottom boxes, right side of the figure) was specifically regulated in the C57BL/6J strain and correlated with HA mRNA expression. This suggests that they constitute part of the host response specific to this strain that is most closely associated with IAV replication and may contribute to the relative resistance of this strain to IAV infection.</p>
        <fig id="F10" position="float">
          <label>Figure 10</label>
          <caption>
            <p><bold>Venn diagram illustrating sequential identification of subpopulations of miRNAs associated with influenza A virus infection dependent and independent of host genetic background</bold>. The Venn diagram shows the number of miRNAs that are regulated after infection in DBA/2J or C57BL/6J mice, those that are differentially expressed between both mouse strains at any time point (DBA/2J vs C57BL/6J), and those that correlate significantly with viral hemagglutinin (HA) mRNA (HA correlation) expression (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>). The diagram is based on the data shown in Figures <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F9">9</xref>. The numbers of miRNAs whose expression differs depending on the host strain include also those miRNAs whose expression does not change during infection. The center box on the right identifies the 20 miRNAs that satisfy all these conditions. The box at the bottom indicates miRNAs that fit all conditions, except that their expression did not differ between the two host strains. Expression of the miRNAs marked in red was particularly similar between the two host strains, having a FC ≤|1.5| and FDR adjusted <italic>p</italic> value ≥ 0.1 (see <xref ref-type="sec" rid="S2">Materials and Methods</xref>). The top and bottom boxes on the right indicate miRNAs that are differentially expressed after infection in C57BL/6J mice only and whose expression correlates with HA mRNA expression.</p>
          </caption>
          <graphic xlink:href="fimmu-08-00246-g010"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S4">
      <title>Discussion</title>
      <p>We have performed a comprehensive comparison of global pulmonary miRNA reprogramming during IAV infection in two inbred mouse strains with genetically determined differential susceptibility to this virus. This analysis revealed common and distinct features in the global miRNA expression pattern, and specific differences even in uninfected lungs, suggesting that host strain resistance/susceptibility may be programmed, at least in part, by the abundance of several miRNAs in the uninfected state.</p>
      <sec id="S4-1">
        <title>Kinetics of miRNome Reprogramming and Role of Infiltrating Immune Cells</title>
        <p>In both mouse strains, substantial miRNome reprogramming became evident only by 48 hpi, i.e., well after completion of the first viral replication cycle. In contrast, in a related study using the same mouse strains, we detected infection-driven mRNA expression changes as early as 12 hpi (<xref rid="B21" ref-type="bibr">21</xref>). This suggests that miRNome reprogramming occurs with considerable delay compared to mRNA reprogramming and may thus be a reaction to, and not a cause of, mRNA-mediated changes in protein expression. The trajectory analysis suggested that infiltrating cells contribute significantly to pulmonary miRNome reprogramming. In addition, pulmonary abundance of miRNAs with positive correlations with peripheral blood granulocytes and monocyte numbers initially tended to be low. These correlations were most pronounced in the more susceptible DBA/2J strain, and immune cell infiltration of neutrophils and macrophages into the lung on day 2 pi is indeed more extensive in this strain than in C57BL/6J mice (<xref rid="B40" ref-type="bibr">40</xref>). These observations suggest a model in which a substantial change in pulmonary miRNA populations is due to immigration of leukocytes into the lung, which likely contribute further to changes in pulmonary miRNomes due to their highly activated phenotype in this intensely infected tissue. Indeed, consistent with reports in IAV in other species (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>), several of the differentially expressed miRNAs detected in our study are expressed in immune cells, including in peripheral blood. Of these, miR-223-3p (whose expression correlated the most strongly with granulocyte numbers) is known to play important roles in the differentiation of myeloid cells, including neutrophils (<xref rid="B56" ref-type="bibr">56</xref>). By the same token, miRNAs highly abundant in uninfected lungs would stem from resident lung cells, and their abundance would appear to be lower due to “dilution” by the miRNAs expressed by immigrating cells. Obviously, this is a simplified model, as some of the upregulation of the miRNAs with initially low expression can also be due to the response of resident cells, for instance due to the activation of pathways relating to tissue injury or intrinsic immunity. Of note, the major features of miRNA reprogramming observed here agree well with our previous analysis of changes in hematological parameters during IAV infection, using the same mice (<xref rid="B25" ref-type="bibr">25</xref>). Similar to miRNA expression, peripheral blood indices (particularly granulocyte numbers) differed between the two strains already before infection, and changes became fully manifest from 48 hpi onward. Thus, pre-programmed differences in leukocyte number and responsiveness likely contribute to the observed differences in pulmonary miRNA populations.</p>
      </sec>
      <sec id="S4-2">
        <title>The General Pulmonary miRNA Response to IAV Infection</title>
        <p>The Venn diagram (Figure <xref ref-type="fig" rid="F10">10</xref>) identifies 39 miRNAs whose expression levels were similar in the two host strains, changed significantly during IAV infection in both strains, and correlated with HA mRNA in either strain. Expression of 15 of these was particularly similar in the two strains (Figure <xref ref-type="fig" rid="F10">10</xref>, marked in red). Thus, these miRNAs likely constitute a major part of the general miRNA response to IAV infection in mouse lung irrespective of host genetic background. Functionally, this group can be linked to general responses expected in an infected organ. For instance, miR-142-5p plays critical roles in lymphocyte development and homeostasis (<xref rid="B57" ref-type="bibr">57</xref>), and miR-106a-5p, miR-130-3p, miR-20b-5p, miR-345-3p, and the miR-15 cluster have been associated with immune or stress responses (<xref rid="B58" ref-type="bibr">58</xref>–<xref rid="B62" ref-type="bibr">62</xref>). Of note, one of these miRNAs (miR-18a-5p) (as well as miR-223-3p, whose expression in addition differed between the two mouse strains) is among three miRNAs that were recently identified as being commonly regulated in the response to IAV infection in all four species screened, i.e., humans, pig, chicken, and mouse (<xref rid="B63" ref-type="bibr">63</xref>). This suggests that part of this general pulmonary response is conserved across evolutionarily diverse hosts of IAV.</p>
      </sec>
      <sec id="S4-3">
        <title>Potential Roles of miRNAs in Host-Strain-Specific Susceptibility and Resistance to IAV Infection</title>
        <p>How might differential expression and regulation of miRNAs affect susceptibility in the two strains used? It is not easy to answer this question, as any miRNA may have several mRNAs targets, more than one miRNA can regulate the same mRNA, and both up- and downregulation of miRNAs may significantly affect levels of a given protein. In addition, the DBA/2J strain is considered a more “inflammogenic” host (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B40" ref-type="bibr">40</xref>) and it is, therefore, possible that a good portion of the miRNome response in this strain relates to the inflammatory response and not antiviral immunity <italic>per se</italic>.</p>
        <p>The expression of 20 miRNAs with differential expression between the two host strains correlated significantly with HA mRNA expression, suggesting that they closely relate to host susceptibility or resistance (Figure <xref ref-type="fig" rid="F10">10</xref>, center). The expression of miRNAs that play a role in host-strain susceptibility or resistance is expected to correlate with the virulence of the pathogen. Indeed, changes in expression of several of these 20 miRNAs (miR-147-3p, miR-155-3p, miR-223-3p, as well as the miR-34 and miR-449 families) correlate with IAV virulence (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B64" ref-type="bibr">64</xref>). In addition, several of them have been implicated functionally in the host response to IAV (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>–<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B64" ref-type="bibr">64</xref>) or other viruses, suggesting that their differential expression in our model is functionally relevant. For instance, miR-449-5p exerts anti-IAV activities by inhibiting histone deacetylase and, therefore, inducing IFNβ expression (<xref rid="B18" ref-type="bibr">18</xref>), and inhibition of miR-223-3p (which was more highly expressed in the DBA/2J strain in our study) reduced mortality and delayed death of H5N2-infected mice (<xref rid="B64" ref-type="bibr">64</xref>). The miR-34 and miR-449 families control epithelial barrier repair (<xref rid="B65" ref-type="bibr">65</xref>) and regulate multiciliogenesis <italic>via</italic> the Delta/Notch pathway (<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>), which might help transport virions out of the respiratory tract (<xref rid="B68" ref-type="bibr">68</xref>) and reduce end-organ damage. Of these two, the miR-449 family is of considerable interest with respect to the higher resistance of C57BL/6J mice, because—in addition to their different abundance in the two strains—these miRNAs were more strongly induced in C57BL/6J mice, suggesting that their higher abundance is less due to mere leukocyte infiltration. Differential expression of several of these 20 miRNAs may affect the outcome of IAV infection by regulating overall inflammation. miR-147-3p has been reported to negatively regulate TLR signaling in murine macrophages (<xref rid="B69" ref-type="bibr">69</xref>). miR-223-3p dampens NLRP3 inflammasome activity (<xref rid="B70" ref-type="bibr">70</xref>) and can inhibit inflammation by targeting STAT3 (<xref rid="B71" ref-type="bibr">71</xref>). However, it was more highly upregulated in the DBA/2J strain, suggesting that its anti-inflammatory effects did not dominate. Two of the 20 miRNAs (miR-31-5p and miR-182-5p) can be linked to adaptive immunity, i.e., T cell activation and regulation of Treg differentiation, respectively (<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>). However, taken together the results suggest that immune functions of this central group of miRNAs predominantly affect host susceptibility to IAV infection by modulating innate immune responses and inflammation.</p>
      </sec>
      <sec id="S4-4">
        <title>Potential Roles of miRNA Regulation of Apoptosis and the PI3K Pathway in Host Susceptibility</title>
        <p>The higher abundance of potentially antiapoptotic miRNAs in the DBA/2J strain suggests a plausible role in the higher susceptibility of this strain. The IAV NS1 protein can activate the PI3K pathway, which leads to antiapoptotic responses and, subsequently, higher virulence (<xref rid="B74" ref-type="bibr">74</xref>). The higher abundance of antiapoptotic miRNAs even before infection in DBA/2J mice, therefore, supports the hypothesis that they contribute to host susceptibility by enhancing viral spread. In agreement with this model, several of the miRNAs with differential abundance in the two mouse strains have been shown to regulate the PI3K pathway, which relates strongly to apoptosis (see above) as well as phagocytosis (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B75" ref-type="bibr">75</xref>). In particular, a subgroup of seven downregulated and abundant miRNAs that were less abundant in DBA/2J mice were enriched for this pathway. The NS1 protein activates the PI3K pathway by binding the SH3 domain of PI3K, and overexpression of heterologous SH3 domain has been shown to inhibit viral replication (<xref rid="B76" ref-type="bibr">76</xref>). In our study, putative mRNA targets were enriched for SH3 domain binding proteins, and one may speculate that inhibiting expression of endogenous SH3-binding proteins might have a similar effect by making SH3 domains more accessible to the NS protein. Indeed, induction of <italic>Cxcl10</italic> requires the PI3K/Akt pathway (<xref rid="B77" ref-type="bibr">77</xref>), and <italic>Cxcl10</italic> is much more strongly upregulated in DBA/2J than in C57BL/6J mice (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>).</p>
      </sec>
      <sec id="S4-5">
        <title>Highly Discriminatory (Predictive) miRNAs</title>
        <p>Of note, we identified a group of regulated miRNAs whose abundances differentiated between the two mouse strains before infection and in the earliest stages of infection (Figure <xref ref-type="fig" rid="F7">7</xref>) and might, therefore, be used to predict the outcome of the infection in the uninfected host. The miR-467 family was strongly represented in this group. In addition to its role in apoptosis, miR-467b-5p targets the Lpl gene in macrophages and thereby limits lipid accumulation and pro-inflammatory cytokine secretion (<xref rid="B78" ref-type="bibr">78</xref>). Also, miR-147-3p can dampen TLR-signaling in murine macrophages (<xref rid="B69" ref-type="bibr">69</xref>). Thus, their likely function in the host response to IAV is to limit excessive inflammation. For the other miRNAs in this group, reports of functions relating to infection could not be found. However, they might play yet unknown roles and might be interesting candidates for future investigations regarding host-strain susceptibility to IAV infection. Interestingly, miR-3096a-5p and miR-3096b-3p, which by far showed the strongest host-strain differences, may constitute non-canonical (DICER independent) miRNAs (<uri xlink:type="simple" xlink:href="http://www.mirbase.org">www.mirBase.org</uri>).</p>
      </sec>
      <sec id="S4-6">
        <title>miRNAs with Potential Binding Sites in the IAV Genome</title>
        <p>The identification of miRNAs whose human homologs have potential binding sites in the IAV genome is of considerable interest. These miRNAs were more highly expressed in C57BL/6J than DBA/2J mice and might, therefore, contribute to the higher resistance of the C57BL/6J strain. Of note, miR-31-5p, miR-379-5p, miR-7a-5p, as well as some members of the miR-449 (-5p) and miR-34 (-5p) families were moderately to highly abundant (&gt;10 CPM), making it more likely that they would bind to a biologically relevant number of viral RNAs.</p>
      </sec>
      <sec id="S4-7">
        <title>miRNAs and Their Counterparts</title>
        <p>For some host strain-dependently regulated miRNAs, such as miR-21a-3p and miR-155-3p, we found a high number of validated functions for their counterparts miR-21a-5p and miR-155-5p. We propose that the ratio between these forms might also be relevant to their function. For example, a study found opposite roles of miR-155-3p and miR-155-5p, in that they activated and inhibited TLR7-mediated type I interferon production, respectively. In this model, predominance of miR-155-3p would favor activation of this process.</p>
      </sec>
      <sec id="S4-8">
        <title>Conclusion</title>
        <p>Using two mouse strains of greatly differing genetic susceptibility to IAV infection, we found substantial differences in pulmonary miRNA expression even before infection, which evolved further throughout infection and could in part be attributed to differences in leukocyte populations before and during infection. Before infection, host susceptibility was particularly associated with consistently higher expression of miR-208b-3p, miR-3096b-3p, and the miR-467 family and lower expression of miR-3096a-5p and the potentially anti-inflammatory miR-147-3p. During infection, susceptibility correlated with a shift toward higher expression of miRNAs inhibiting apoptosis but lower expression of miRNAs associated with regulation of PI3K-Akt signaling, i.e., two processes known to play important roles in the host response to IAV infection. These results suggest that pulmonary miRNA populations before and during IAV infection are in part determined genetically and contribute to susceptibility to IAV infection in this murine host, and likely in humans.</p>
      </sec>
    </sec>
    <sec id="S5">
      <title>Author Contributions</title>
      <p>MP: experimental design, animal work, laboratory analysis, data analysis, graphics, and preparation of manuscript. KS: experimental design and preparation of manuscript. FP: initial concept of the study, experimental design, preparation of the manuscript, and supervision of the study.</p>
    </sec>
    <sec id="S6">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank Robert Geffers and staff members, especially Michael Jarek and Tschong-Hun Im, of the Genome Analysis platform of the Helmholtz Centre for Infection Research (HZI) for performing the RNA sequencing and Frank Klawonn (HZI) and Esther Wilk (HZI) for helpful discussion, Mahmoud Bahgat-Riad (HZI) for helpful discussion and instruction, Mohamed Samir (TWINCORE Center for Experimental and Clinical Infection Research) for helpful discussion, technical assistance, and support in literature research, and Anja Gatzemeier (HZI) for technical assistance.</p>
    </ack>
    <sec id="S7">
      <title>Funding</title>
      <p>The study was supported by internal funds from the Helmholtz Association (Program Infection and Immunity), the Helmholtz Association’s Cross-programme Initiative on Personalized Medicine (iMed), and the Helmholtz International Graduate School for Infection Research to MP. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonkoly</surname><given-names>E</given-names></name><name><surname>Stahle</surname><given-names>M</given-names></name><name><surname>Pivarcsi</surname><given-names>A</given-names></name></person-group>. <article-title>microRNAs and immunity: novel players in the regulation of normal immune function and inflammation</article-title>. <source>Semin Cancer Biol</source> (<year>2008</year>) <volume>18</volume>:<fpage>131</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.semcancer.2008.01.005</pub-id><?supplied-pmid 18291670?><pub-id pub-id-type="pmid">18291670</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordes</surname><given-names>KR</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group>
<article-title>microRNA regulation of cardiovascular development</article-title>. <source>Circ Res</source> (<year>2009</year>) <volume>104</volume>:<fpage>724</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.192872</pub-id><pub-id pub-id-type="pmid">19325160</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostini</surname><given-names>M</given-names></name><name><surname>Tucci</surname><given-names>P</given-names></name><name><surname>Steinert</surname><given-names>JR</given-names></name><name><surname>Shalom-Feuerstein</surname><given-names>R</given-names></name><name><surname>Rouleau</surname><given-names>M</given-names></name><name><surname>Aberdam</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>microRNA-34a regulates neurite outgrowth, spinal morphology, and function</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2011</year>) <volume>108</volume>:<fpage>21099</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1112063108</pub-id><?supplied-pmid 22160706?><pub-id pub-id-type="pmid">22160706</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>W</given-names></name><name><surname>Nasu</surname><given-names>K</given-names></name><name><surname>Nakada</surname><given-names>C</given-names></name><name><surname>Kawano</surname><given-names>Y</given-names></name><name><surname>Moriyama</surname><given-names>M</given-names></name><name><surname>Narahara</surname><given-names>H</given-names></name></person-group>. <article-title>miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells</article-title>. <source>Hum Reprod</source> (<year>2013</year>) <volume>28</volume>:<fpage>750</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1093/humrep/des446</pub-id><?supplied-pmid 23293219?><pub-id pub-id-type="pmid">23293219</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>ST</given-names></name><name><surname>Thomas</surname><given-names>MJ</given-names></name><name><surname>Sova</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>RR</given-names></name><name><surname>Palermo</surname><given-names>RE</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name></person-group>. <article-title>Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microRNA expression patterns and candidate novel microRNAs differentially expressed upon infection</article-title>. <source>MBio</source> (<year>2013</year>) <volume>4</volume>:<fpage>e549</fpage>–<lpage>612</lpage>.<pub-id pub-id-type="doi">10.1128/mBio.00549-12</pub-id><?supplied-pmid 23386435?><pub-id pub-id-type="pmid">23386435</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group>
<article-title>microRNA expression profiling and bioinformatic analysis of dengue virus infected peripheral blood mononuclear cells</article-title>. <source>Mol Med Rep</source> (<year>2013</year>) <volume>7</volume>:<fpage>791</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.3892/mmr.2013.1288</pub-id><pub-id pub-id-type="pmid">23354650</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Daucher</surname><given-names>M</given-names></name><name><surname>Armistead</surname><given-names>D</given-names></name><name><surname>Russell</surname><given-names>R</given-names></name><name><surname>Kottilil</surname><given-names>S</given-names></name></person-group>
<article-title>microRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-alpha</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e55733</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0055733</pub-id><pub-id pub-id-type="pmid">23418453</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buggele</surname><given-names>WA</given-names></name><name><surname>Johnson</surname><given-names>KE</given-names></name><name><surname>Horvath</surname><given-names>CM</given-names></name></person-group>. <article-title>Influenza A virus infection of human respiratory cells induces primary microRNA expression</article-title>. <source>J Biol Chem</source> (<year>2012</year>) <volume>287</volume>:<fpage>31027</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M112.387670</pub-id><?supplied-pmid 22822053?><pub-id pub-id-type="pmid">22822053</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>WY</given-names></name><name><surname>Yeung</surname><given-names>AC</given-names></name><name><surname>Ngai</surname><given-names>KL</given-names></name><name><surname>Li</surname><given-names>MS</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Tsui</surname><given-names>SK</given-names></name><etal/></person-group>
<article-title>Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells</article-title>. <source>BMC Microbiol</source> (<year>2013</year>) <volume>13</volume>:<fpage>104</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-13-104</pub-id><?supplied-pmid 23663545?><pub-id pub-id-type="pmid">23663545</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1)</article-title>. <source>BMC Infect Dis</source> (<year>2013</year>) <volume>13</volume>:<fpage>257</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-13-257</pub-id><?supplied-pmid 23731466?><pub-id pub-id-type="pmid">23731466</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Brahmakshatriya</surname><given-names>V</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Lupiani</surname><given-names>B</given-names></name><name><surname>Reddy</surname><given-names>SM</given-names></name><name><surname>Yoon</surname><given-names>BJ</given-names></name><etal/></person-group>
<article-title>Identification of differentially expressed miRNAs in chicken lung and trachea with avian influenza virus infection by a deep sequencing approach</article-title>. <source>BMC Genomics</source> (<year>2009</year>) <volume>10</volume>:<fpage>512</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2164-10-512</pub-id><?supplied-pmid 19891781?><pub-id pub-id-type="pmid">19891781</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Brahmakshatriya</surname><given-names>V</given-names></name><name><surname>Lupiani</surname><given-names>B</given-names></name><name><surname>Reddy</surname><given-names>SM</given-names></name><name><surname>Soibam</surname><given-names>B</given-names></name><name><surname>Benham</surname><given-names>AL</given-names></name><etal/></person-group>
<article-title>Integrated analysis of microRNA expression and mRNA transcriptome in lungs of avian influenza virus infected broilers</article-title>. <source>BMC Genomics</source> (<year>2012</year>) <volume>13</volume>:<fpage>278</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-13-278</pub-id><pub-id pub-id-type="pmid">22726614</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skovgaard</surname><given-names>K</given-names></name><name><surname>Cirera</surname><given-names>S</given-names></name><name><surname>Vasby</surname><given-names>D</given-names></name><name><surname>Podolska</surname><given-names>A</given-names></name><name><surname>Breum</surname><given-names>SO</given-names></name><name><surname>Durrwald</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2)</article-title>. <source>Innate Immun</source> (<year>2013</year>) <volume>19</volume>(<issue>5</issue>):<fpage>531</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1177/1753425912473668</pub-id><?supplied-pmid 23405029?><pub-id pub-id-type="pmid">23405029</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Belisle</surname><given-names>S</given-names></name><name><surname>Baskin</surname><given-names>CR</given-names></name><name><surname>Tumpey</surname><given-names>TM</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name></person-group>. <article-title>Differential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses</article-title>. <source>Virology</source> (<year>2011</year>) <volume>421</volume>:<fpage>105</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.virol.2011.09.011</pub-id><?supplied-pmid 21999992?><pub-id pub-id-type="pmid">21999992</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>EY</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Rosenzweig</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>microRNA expression and virulence in pandemic influenza virus-infected mice</article-title>. <source>J Virol</source> (<year>2010</year>) <volume>84</volume>:<fpage>3023</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02203-09</pub-id><?supplied-pmid 20071585?><pub-id pub-id-type="pmid">20071585</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Gralinski</surname><given-names>L</given-names></name><name><surname>Ferris</surname><given-names>MT</given-names></name><name><surname>Frieman</surname><given-names>MB</given-names></name><name><surname>Thomas</surname><given-names>MJ</given-names></name><name><surname>Proll</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection</article-title>. <source>MBio</source> (<year>2011</year>) <fpage>e00198-11</fpage>.<pub-id pub-id-type="doi">10.1128/mBio.00198-11</pub-id><?supplied-pmid 22086488?><pub-id pub-id-type="pmid">22086488</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loveday</surname><given-names>EK</given-names></name><name><surname>Svinti</surname><given-names>V</given-names></name><name><surname>Diederich</surname><given-names>S</given-names></name><name><surname>Pasick</surname><given-names>J</given-names></name><name><surname>Jean</surname><given-names>F</given-names></name></person-group>. <article-title>Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection</article-title>. <source>J Virol</source> (<year>2012</year>) <volume>86</volume>:<fpage>6109</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.06892-11</pub-id><?supplied-pmid 22438559?><pub-id pub-id-type="pmid">22438559</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buggele</surname><given-names>WA</given-names></name><name><surname>Krause</surname><given-names>KE</given-names></name><name><surname>Horvath</surname><given-names>CM</given-names></name></person-group>. <article-title>Small RNA profiling of influenza A virus-infected cells identifies miR-449b as a regulator of histone deacetylase 1 and interferon beta</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e76560</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0076560</pub-id><?supplied-pmid 24086750?><pub-id pub-id-type="pmid">24086750</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Perwitasari</surname><given-names>O</given-names></name><name><surname>Mahalingam</surname><given-names>S</given-names></name><name><surname>Tripp</surname><given-names>RA</given-names></name></person-group>. <article-title>microRNA regulation of human genes essential for influenza A (H7N9) replication</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0155104</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0155104</pub-id><?supplied-pmid 27166678?><pub-id pub-id-type="pmid">27166678</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberts</surname><given-names>R</given-names></name><name><surname>Srivastava</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Viegas</surname><given-names>N</given-names></name><name><surname>Geffers</surname><given-names>R</given-names></name><name><surname>Klawonn</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection</article-title>. <source>Microbes Infect</source> (<year>2010</year>) <volume>12</volume>:<fpage>309</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2010.01.008</pub-id><?supplied-pmid 20114087?><pub-id pub-id-type="pmid">20114087</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preusse</surname><given-names>M</given-names></name><name><surname>Tantawy</surname><given-names>MA</given-names></name><name><surname>Klawonn</surname><given-names>F</given-names></name><name><surname>Schughart</surname><given-names>K</given-names></name><name><surname>Pessler</surname><given-names>F</given-names></name></person-group>
<article-title>Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice</article-title>. <source>BMC Microbiol</source> (<year>2013</year>) <volume>13</volume>:<fpage>293</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-13-293</pub-id><pub-id pub-id-type="pmid">24341411</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Preusse</surname><given-names>M</given-names></name><name><surname>Della Beffa</surname><given-names>C</given-names></name><name><surname>Pessler</surname><given-names>F</given-names></name></person-group>
<article-title>Profiling of miRNA expression: RNA sequencing in the spotlight</article-title>. In: <person-group person-group-type="editor"><name><surname>Yue</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name></person-group>, editors. <source>miRNAs and Human Diseases</source>. <publisher-loc>Kerala, India</publisher-loc>: <publisher-name>Research Signpost</publisher-name> (<year>2013</year>). p. <fpage>313</fpage>–<lpage>35</lpage>.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blazejewska</surname><given-names>P</given-names></name><name><surname>Koscinski</surname><given-names>L</given-names></name><name><surname>Viegas</surname><given-names>N</given-names></name><name><surname>Anhlan</surname><given-names>D</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name><name><surname>Schughart</surname><given-names>K</given-names></name></person-group>. <article-title>Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors</article-title>. <source>Virology</source> (<year>2011</year>) <volume>412</volume>:<fpage>36</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.virol.2010.12.047</pub-id><?supplied-pmid 21256531?><pub-id pub-id-type="pmid">21256531</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilk</surname><given-names>E</given-names></name><name><surname>Schughart</surname><given-names>K</given-names></name></person-group>. <article-title>The mouse as model system to study host-pathogen interactions in influenza A infections</article-title>. <source>Curr Protoc Mouse Biol</source> (<year>2012</year>) <volume>2</volume>:<fpage>177</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="doi">10.1002/9780470942390.mo110173</pub-id><?supplied-pmid 26069011?><pub-id pub-id-type="pmid">26069011</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preusse</surname><given-names>M</given-names></name><name><surname>Schughart</surname><given-names>K</given-names></name><name><surname>Wilk</surname><given-names>E</given-names></name><name><surname>Klawonn</surname><given-names>F</given-names></name><name><surname>Pessler</surname><given-names>F</given-names></name></person-group>. <article-title>Hematological parameters in the early phase of influenza A virus infection in differentially susceptible inbred mouse strains</article-title>. <source>BMC Res Notes</source> (<year>2015</year>) <volume>8</volume>:<fpage>225</fpage>.<pub-id pub-id-type="doi">10.1186/s13104-015-1195-8</pub-id><?supplied-pmid 26047817?><pub-id pub-id-type="pmid">26047817</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name></person-group>. <article-title>microRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase</article-title>. <source>Int J Mol Med</source> (<year>2015</year>) <volume>35</volume>:<fpage>1708</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.3892/ijmm.2015.2181</pub-id><?supplied-pmid 25872580?><pub-id pub-id-type="pmid">25872580</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>Mccarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group>. <article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source> (<year>2010</year>) <volume>26</volume>:<fpage>139</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genolini</surname><given-names>C</given-names></name><name><surname>Falissard</surname><given-names>B</given-names></name></person-group>
<article-title>KmL: k-means for longitudinal data</article-title>. <source>Comput Stat</source>. (<year>2010</year>) <volume>25</volume>:<fpage>317</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1007/s00180-009-0178-4</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>D</given-names></name></person-group>
<source>Lattice: Multivariate Data Visualization with R</source>. <publisher-loc>Paris</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2008</year>).</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Warnes</surname><given-names>GR</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Bonebakker</surname><given-names>L</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Liaw</surname><given-names>WHA</given-names></name><name><surname>Lumley</surname><given-names>T</given-names></name><etal/></person-group>
<source>gplots: Various R Programming Tools for Plotting Data</source>. R package (<year>2013</year>). Available from: <uri xlink:type="simple" xlink:href="http://cran.r-project.org/web/packages/gplots/index.html">http://cran.r-project.org/web/packages/gplots/index.html</uri></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group>
<source>ggplot2: Elegant Graphics for Data Analysis</source>. <publisher-name>Springer</publisher-name> (<year>2009</year>).</mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachos</surname><given-names>IS</given-names></name><name><surname>Kostoulas</surname><given-names>N</given-names></name><name><surname>Vergoulis</surname><given-names>T</given-names></name><name><surname>Georgakilas</surname><given-names>G</given-names></name><name><surname>Reczko</surname><given-names>M</given-names></name><name><surname>Maragkakis</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways</article-title>. <source>Nucleic Acids Res</source> (<year>2012</year>) <volume>40</volume>:<fpage>W498</fpage>–<lpage>504</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gks494</pub-id><?supplied-pmid 22649059?><pub-id pub-id-type="pmid">22649059</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="webpage"><collab>MicroCosm</collab>. <source>MicroCosm Targets Version 5</source>. Enright Lab (<year>2011</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/">http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/</uri></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betel</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Gabow</surname><given-names>A</given-names></name><name><surname>Marks</surname><given-names>DS</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group>
<article-title>The microRNA.org resource: targets and expression</article-title>. <source>Nucleic Acids Res</source> (<year>2008</year>) <volume>36</volume>:<fpage>D149</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gkm995</pub-id><pub-id pub-id-type="pmid">18158296</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name></person-group>
<article-title>miRDB: A microRNA target prediction and functional annotation database with a wiki interface</article-title>. <source>RNA</source> (<year>2008</year>) <volume>14</volume>(<issue>6</issue>):<fpage>1012</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1261/rna.965408</pub-id><pub-id pub-id-type="pmid">18426918</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kertesz</surname><given-names>M</given-names></name><name><surname>Iovino</surname><given-names>N</given-names></name><name><surname>Unnerstall</surname><given-names>U</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name></person-group>
<article-title>The role of site accessibility in microRNA target recognition</article-title>. <source>Nat Genet</source> (<year>2007</year>) <volume>39</volume>:<fpage>1278</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/ng2135</pub-id><pub-id pub-id-type="pmid">17893677</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang Da</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group>
<article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protoc</source> (<year>2009</year>) <volume>4</volume>:<fpage>44</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang Da</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group>
<article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res</source> (<year>2009</year>) <volume>37</volume>:<fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sing</surname><given-names>T</given-names></name><name><surname>Sander</surname><given-names>O</given-names></name><name><surname>Beerenwinkel</surname><given-names>N</given-names></name><name><surname>Lengauer</surname><given-names>T</given-names></name></person-group>. <article-title>ROCR: visualizing classifier performance in R</article-title>. <source>Bioinformatics</source> (<year>2005</year>) <volume>21</volume>:<fpage>3940</fpage>–<lpage>1</lpage>.<pub-id pub-id-type="doi">10.1093/bioinformatics/bti623</pub-id><?supplied-pmid 16096348?><pub-id pub-id-type="pmid">16096348</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>B</given-names></name><name><surname>Blazejewska</surname><given-names>P</given-names></name><name><surname>Hessmann</surname><given-names>M</given-names></name><name><surname>Bruder</surname><given-names>D</given-names></name><name><surname>Geffers</surname><given-names>R</given-names></name><name><surname>Mauel</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Host genetic background strongly influences the response to influenza a virus infections</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>:<fpage>e4857</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0004857</pub-id><?supplied-pmid 19293935?><pub-id pub-id-type="pmid">19293935</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XB</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Wen</surname><given-names>HJ</given-names></name><name><surname>Bai</surname><given-names>XX</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name><name><surname>Ma</surname><given-names>LJ</given-names></name></person-group>
<article-title>Upregulation of microRNA-31 targeting integrin alpha5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells</article-title>. <source>Tumour Biol</source> (<year>2016</year>) <volume>37</volume>:<fpage>8317</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1007/s13277-015-4511-y</pub-id><pub-id pub-id-type="pmid">26729197</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermeking</surname><given-names>H</given-names></name></person-group>. <article-title>The miR-34 family in cancer and apoptosis</article-title>. <source>Cell Death Differ</source> (<year>2010</year>) <volume>17</volume>:<fpage>193</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2009.56</pub-id><?supplied-pmid 19461653?><pub-id pub-id-type="pmid">19461653</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lize</surname><given-names>M</given-names></name><name><surname>Pilarski</surname><given-names>S</given-names></name><name><surname>Dobbelstein</surname><given-names>M</given-names></name></person-group>. <article-title>E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis</article-title>. <source>Cell Death Differ</source> (<year>2010</year>) <volume>17</volume>:<fpage>452</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/cdd.2009.188</pub-id><?supplied-pmid 19960022?><pub-id pub-id-type="pmid">19960022</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GX</given-names></name><name><surname>Ravi</surname><given-names>A</given-names></name><name><surname>Gould</surname><given-names>GM</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group>. <article-title>Genome-wide impact of a recently expanded microRNA cluster in mouse</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2011</year>) <volume>108</volume>:<fpage>15804</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1112772108</pub-id><?supplied-pmid 21911408?><pub-id pub-id-type="pmid">21911408</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>CW</given-names></name><name><surname>Kehren</surname><given-names>JC</given-names></name><name><surname>Dybdahl-Sissoko</surname><given-names>NR</given-names></name><name><surname>Hinshaw</surname><given-names>VS</given-names></name></person-group>. <article-title>bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation</article-title>. <source>J Virol</source> (<year>1996</year>) <volume>70</volume>:<fpage>663</fpage>–<lpage>6</lpage>.<?supplied-pmid 8523590?><pub-id pub-id-type="pmid">8523590</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wurzer</surname><given-names>WJ</given-names></name><name><surname>Planz</surname><given-names>O</given-names></name><name><surname>Ehrhardt</surname><given-names>C</given-names></name><name><surname>Giner</surname><given-names>M</given-names></name><name><surname>Silberzahn</surname><given-names>T</given-names></name><name><surname>Pleschka</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Caspase 3 activation is essential for efficient influenza virus propagation</article-title>. <source>EMBO J</source> (<year>2003</year>) <volume>22</volume>:<fpage>2717</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/cdg279</pub-id><?supplied-pmid 12773387?><pub-id pub-id-type="pmid">12773387</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isken</surname><given-names>B</given-names></name><name><surname>Genzel</surname><given-names>Y</given-names></name><name><surname>Reichl</surname><given-names>U</given-names></name></person-group>. <article-title>Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>:<fpage>5253</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.05.065</pub-id><?supplied-pmid 22698452?><pub-id pub-id-type="pmid">22698452</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatnagar</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Padi</surname><given-names>SK</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Tang</surname><given-names>MS</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name></person-group>. <article-title>Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells</article-title>. <source>Cell Death Dis</source> (<year>2010</year>) <volume>1</volume>:<fpage>e105</fpage>.<pub-id pub-id-type="doi">10.1038/cddis.2010.85</pub-id><?supplied-pmid 21368878?><pub-id pub-id-type="pmid">21368878</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>S</given-names></name><name><surname>Majid</surname><given-names>S</given-names></name><name><surname>Shahryari</surname><given-names>V</given-names></name><name><surname>Hirata</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>microRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells</article-title>. <source>Cancer Res</source> (<year>2011</year>) <volume>71</volume>:<fpage>6208</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-0073</pub-id><?supplied-pmid 21852381?><pub-id pub-id-type="pmid">21852381</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LP</given-names></name><name><surname>Ma</surname><given-names>XQ</given-names></name><name><surname>Cai</surname><given-names>JC</given-names></name></person-group>
<article-title>[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer]</article-title>. <source>Zhonghua Yi Xue Za Zhi</source> (<year>2012</year>) <volume>92</volume>:<fpage>3269</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.3760/cma.j.issn.0376-2491.2012.46.009</pub-id><pub-id pub-id-type="pmid">23328512</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Genistein down-regulates miR-223 expression in pancreatic cancer cells</article-title>. <source>Curr Drug Targets</source> (<year>2013</year>) <volume>14</volume>:<fpage>1150</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.2174/13894501113149990187</pub-id><?supplied-pmid 23834147?><pub-id pub-id-type="pmid">23834147</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WG</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>HD</given-names></name><name><surname>Li</surname><given-names>FL</given-names></name><etal/></person-group>
<article-title>mmu-miR-702 functions as an anti-apoptotic mirtron by mediating ATF6 inhibition in mice</article-title>. <source>Gene</source> (<year>2013</year>) <volume>531</volume>:<fpage>235</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.gene.2013.09.005</pub-id><pub-id pub-id-type="pmid">24035931</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>microRNA 34a contributes to virus-mediated apoptosis through binding to its target gene Bax in influenza A virus infection</article-title>. <source>Biomed Pharmacother</source> (<year>2016</year>) <volume>83</volume>:<fpage>1464</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopha.2016.08.049</pub-id><?supplied-pmid 27610823?><pub-id pub-id-type="pmid">27610823</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brogaard</surname><given-names>L</given-names></name><name><surname>Heegaard</surname><given-names>PM</given-names></name><name><surname>Larsen</surname><given-names>LE</given-names></name><name><surname>Mortensen</surname><given-names>S</given-names></name><name><surname>Schlegel</surname><given-names>M</given-names></name><name><surname>Durrwald</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Late regulation of immune genes and microRNAs in circulating leukocytes in a pig model of influenza A (H1N2) infection</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>21812</fpage>.<pub-id pub-id-type="doi">10.1038/srep21812</pub-id><?supplied-pmid 26893019?><pub-id pub-id-type="pmid">26893019</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Barr</surname><given-names>T</given-names></name><name><surname>Rais</surname><given-names>M</given-names></name><name><surname>Engelmann</surname><given-names>F</given-names></name><name><surname>Messaoudi</surname><given-names>I</given-names></name></person-group>. <article-title>microRNAs regulate host immune response and pathogenesis during influenza infection in rhesus macaques</article-title>. <source>Viral Immunol</source> (<year>2016</year>) <volume>29</volume>:<fpage>212</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1089/vim.2015.0074</pub-id><?supplied-pmid 27008411?><pub-id pub-id-type="pmid">27008411</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izumi</surname><given-names>B</given-names></name><name><surname>Nakasa</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Kamei</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>microRNA-223 expression in neutrophils in the early phase of secondary damage after spinal cord injury</article-title>. <source>Neurosci Lett</source> (<year>2011</year>) <volume>492</volume>:<fpage>114</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2011.01.068</pub-id><?supplied-pmid 21295111?><pub-id pub-id-type="pmid">21295111</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>NJ</given-names></name><name><surname>Wang</surname><given-names>WL</given-names></name><name><surname>Reyes</surname><given-names>EY</given-names></name><name><surname>Kumar</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Ramakrishna</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Altered lymphopoiesis and immunodeficiency in miR-142 null mice</article-title>. <source>Blood</source> (<year>2015</year>) <volume>125</volume>:<fpage>3720</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2014-10-603951</pub-id><?supplied-pmid 25931583?><pub-id pub-id-type="pmid">25931583</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Aich</surname><given-names>J</given-names></name><name><surname>Hariharan</surname><given-names>M</given-names></name><name><surname>Brahmachari</surname><given-names>SK</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>:<fpage>5761</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0808743106</pub-id><?supplied-pmid 19307576?><pub-id pub-id-type="pmid">19307576</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group>. <article-title>Dicer controls CD8+ T-cell activation, migration, and survival</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>21629</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1016299107</pub-id><?supplied-pmid 21098294?><pub-id pub-id-type="pmid">21098294</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Lv</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>microRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein alpha</article-title>. <source>J Allergy Clin Immunol</source> (<year>2013</year>) <volume>132</volume>:<fpage>426</fpage>–<lpage>436.e428</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2013.02.005</pub-id><pub-id pub-id-type="pmid">23562609</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>KL</given-names></name><name><surname>Zheng</surname><given-names>XM</given-names></name><name><surname>Li</surname><given-names>HX</given-names></name><name><surname>Wang</surname><given-names>GL</given-names></name></person-group>. <article-title>Identification and bioinformatics analysis of microRNAs associated with stress and immune response in serum of heat-stressed and normal Holstein cows</article-title>. <source>Cell Stress Chaperones</source> (<year>2014</year>) <volume>19</volume>:<fpage>973</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1007/s12192-014-0521-8</pub-id><?supplied-pmid 24917036?><pub-id pub-id-type="pmid">24917036</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XF</given-names></name><name><surname>Wang</surname><given-names>RQ</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>MC</given-names></name><name><surname>Zeng</surname><given-names>QM</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>microRNA miR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10</article-title>. <source>Clin Immunol</source> (<year>2016</year>) <volume>164</volume>:<fpage>106</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.clim.2015.12.009</pub-id><pub-id pub-id-type="pmid">26845678</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samir</surname><given-names>M</given-names></name><name><surname>Vaas</surname><given-names>L</given-names></name><name><surname>Pessler</surname><given-names>F</given-names></name></person-group>. <article-title>microRNAs in the host response to viral infections of veterinary importance</article-title>. <source>Front Vet Sci</source> (<year>2016</year>) <volume>3</volume>:<fpage>86</fpage>.<pub-id pub-id-type="doi">10.3389/fvets.2016.00086</pub-id><?supplied-pmid 27800484?><pub-id pub-id-type="pmid">27800484</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Baek</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Pascua</surname><given-names>PN</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><etal/></person-group>
<article-title>Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus</article-title>. <source>BMC Microbiol</source> (<year>2014</year>) <volume>14</volume>:<fpage>252</fpage>.<pub-id pub-id-type="doi">10.1186/s12866-014-0252-0</pub-id><?supplied-pmid 25266911?><pub-id pub-id-type="pmid">25266911</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>PS</given-names></name><name><surname>Plank</surname><given-names>M</given-names></name><name><surname>Collison</surname><given-names>A</given-names></name><name><surname>Tay</surname><given-names>HL</given-names></name><name><surname>Kaiko</surname><given-names>GE</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The emerging role of microRNAs in regulating immune and inflammatory responses in the lung</article-title>. <source>Immunol Rev</source> (<year>2013</year>) <volume>253</volume>:<fpage>198</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12058</pub-id><?supplied-pmid 23550648?><pub-id pub-id-type="pmid">23550648</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcet</surname><given-names>B</given-names></name><name><surname>Chevalier</surname><given-names>B</given-names></name><name><surname>Luxardi</surname><given-names>G</given-names></name><name><surname>Coraux</surname><given-names>C</given-names></name><name><surname>Zaragosi</surname><given-names>LE</given-names></name><name><surname>Cibois</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway</article-title>. <source>Nat Cell Biol</source> (<year>2011</year>) <volume>13</volume>:<fpage>693</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ncb2241</pub-id><?supplied-pmid 21602795?><pub-id pub-id-type="pmid">21602795</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>miR-34b regulates multiciliogenesis during organ formation in zebrafish</article-title>. <source>Development</source> (<year>2013</year>) <volume>140</volume>:<fpage>2755</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1242/dev.092825</pub-id><?supplied-pmid 23698347?><pub-id pub-id-type="pmid">23698347</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iravani</surname><given-names>J</given-names></name><name><surname>Melville</surname><given-names>GN</given-names></name><name><surname>Horstmann</surname><given-names>G</given-names></name></person-group>. <article-title>Tracheobronchial clearance in health and disease: with special reference to interciliary fluid</article-title>. <source>Ciba Found Symp</source> (<year>1978</year>) <volume>54</volume>:<fpage>235</fpage>–<lpage>52</lpage>.<?supplied-pmid 248013?><pub-id pub-id-type="pmid">248013</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Friggeri</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Tsuruta</surname><given-names>Y</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name></person-group>. <article-title>miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>:<fpage>15819</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0901216106</pub-id><?supplied-pmid 19721002?><pub-id pub-id-type="pmid">19721002</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauernfeind</surname><given-names>F</given-names></name><name><surname>Rieger</surname><given-names>A</given-names></name><name><surname>Schildberg</surname><given-names>FA</given-names></name><name><surname>Knolle</surname><given-names>PA</given-names></name><name><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group>. <article-title>NLRP3 inflammasome activity is negatively controlled by miR-223</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>:<fpage>4175</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1201516</pub-id><?supplied-pmid 22984082?><pub-id pub-id-type="pmid">22984082</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e42971</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0042971</pub-id><pub-id pub-id-type="pmid">22937006</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelada</surname><given-names>S</given-names></name><name><surname>Sethupathy</surname><given-names>P</given-names></name><name><surname>Okoye</surname><given-names>IS</given-names></name><name><surname>Kistasis</surname><given-names>E</given-names></name><name><surname>Czieso</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>SD</given-names></name><etal/></person-group>
<article-title>miR-182 and miR-10a are key regulators of Treg specialisation and stability during schistosome and <italic>Leishmania</italic>-associated inflammation</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003451</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003451</pub-id><?supplied-pmid 23825948?><pub-id pub-id-type="pmid">23825948</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name></person-group>. <article-title>miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation</article-title>. <source>Genes Immun</source> (<year>2013</year>) <volume>14</volume>:<fpage>127</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1038/gene.2012.58</pub-id><?supplied-pmid 23303246?><pub-id pub-id-type="pmid">23303246</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname><given-names>C</given-names></name><name><surname>Wolff</surname><given-names>T</given-names></name><name><surname>Pleschka</surname><given-names>S</given-names></name><name><surname>Planz</surname><given-names>O</given-names></name><name><surname>Beermann</surname><given-names>W</given-names></name><name><surname>Bode</surname><given-names>JG</given-names></name><etal/></person-group>
<article-title>Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses</article-title>. <source>J Virol</source> (<year>2007</year>) <volume>81</volume>:<fpage>3058</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02082-06</pub-id><?supplied-pmid 17229704?><pub-id pub-id-type="pmid">17229704</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Geng</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway</article-title>. <source>Tumour Biol</source> (<year>2014</year>) <volume>35</volume>:<fpage>1287</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1007/s13277-011-1171-7</pub-id><pub-id pub-id-type="pmid">24068565</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DG</given-names></name><name><surname>Li</surname><given-names>WZ</given-names></name><name><surname>Wang</surname><given-names>GF</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Heterologous SH3-p85beta inhibits influenza A virus replication</article-title>. <source>Virol J</source> (<year>2010</year>) <volume>7</volume>:<fpage>170</fpage>.<pub-id pub-id-type="doi">10.1186/1743-422X-7-170</pub-id><?supplied-pmid 20653952?><pub-id pub-id-type="pmid">20653952</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Masic</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group>. <article-title>Regulation of influenza A virus induced CXCL-10 gene expression requires PI3K/Akt pathway and IRF3 transcription factor</article-title>. <source>Mol Immunol</source> (<year>2011</year>) <volume>48</volume>:<fpage>1417</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2011.03.017</pub-id><?supplied-pmid 21497908?><pub-id pub-id-type="pmid">21497908</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>GP</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>He</surname><given-names>PP</given-names></name><name><surname>Tang</surname><given-names>SL</given-names></name><name><surname>Zhao</surname><given-names>GJ</given-names></name><name><surname>Lv</surname><given-names>YC</given-names></name><etal/></person-group>
<article-title>microRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion</article-title>. <source>Biochimie</source> (<year>2012</year>) <volume>94</volume>:<fpage>2749</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.biochi.2012.08.018</pub-id><?supplied-pmid 22963823?><pub-id pub-id-type="pmid">22963823</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359548</identifier><datestamp>2017-04-04</datestamp><setSpec>frontneurology</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-2295</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359548</article-id>
      <article-id pub-id-type="pmcid">PMC5359548</article-id>
      <article-id pub-id-type="pmc-uid">5359548</article-id>
      <article-id pub-id-type="doi">10.3389/fneur.2017.00094</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Onesti</surname>
            <given-names>Emanuela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/305446"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schettino</surname>
            <given-names>Ilenia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gori</surname>
            <given-names>Maria Cristina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/214437"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Frasca</surname>
            <given-names>Vittorio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/420776"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ceccanti</surname>
            <given-names>Marco</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/305438"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cambieri</surname>
            <given-names>Chiara</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/385578"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruoppolo</surname>
            <given-names>Giovanni</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/367789"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Inghilleri</surname>
            <given-names>Maurizio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/117285"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Rare Neuromuscular Diseases Centre, Department of Neurology and Psychiatry, Sapienza University</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Department of Sensorial Organs, Otorhinolaryngology Section, Sapienza University</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Ghazala Hayat, Saint Louis University, USA</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: James Gilchrist, Southern Illinois University School of Medicine, USA; Holli A. Horak, University of Arizona, USA</p>
        </fn>
        <corresp content-type="corresp" id="cor1">*Correspondence: Maurizio Inghilleri, <email>maurizio.inghilleri@uniroma1.it</email></corresp>
        <fn fn-type="other" id="fn002">
          <p>Specialty section: This article was submitted to Neuromuscular Diseases, a section of the journal Frontiers in Neurology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>94</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Onesti, Schettino, Gori, Frasca, Ceccanti, Cambieri, Ruoppolo and Inghilleri.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Onesti, Schettino, Gori, Frasca, Ceccanti, Cambieri, Ruoppolo and Inghilleri</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>This retrospective study aimed to investigate the clinical features associated with deteriorated swallow in amyotrophic lateral sclerosis (ALS) patients with spinal and bulbar onset, describe the modification of diet and liquid intake, and assess the impact of dysphagia on the use of riluzole. One hundred forty-five patients were observed periodically every 3–6 months. They underwent routinely fiberoptic endoscopic evaluation of swallowing (FEES) and spirometry; dysphagia severity was classified according to the Penetration Aspiration Scale and the Pooling score (<italic>P</italic>-score) integrated with other parameters such as sensation, collaboration, and age (P-SCA score). During a mean follow-up period of about 2 years, the percentage of ALS patients suffering from dysphagia increased to 85 (rising from 35 to 73% in patients with spinal onset and from 95 to 98% in those with bulbar onset). Also, 8% of patients with dysphagia by FEES did not perceive the disorder. The frequency of normal and semi-solid diets decreased over time, while that of pureed diets and percutaneous endoscopic gastrostomy (PEG) prescription increased. Forty-four percent of dysphagic patients refused thickeners or PEG. A significant difference was observed in the mortality rate between patients untreated with riluzole and patients treated with riluzole oral suspension (<italic>p</italic> &lt; 0.05). Disease duration mainly impacted on the frequency of dysphagia in spinal onset patients, appearing very early in those with bulbar onset. Riluzole oral suspension would allow the safe administration in dysphagic ALS patients to avoid tablet crushing and consequent dispersion in food, common practices that are inconsistent with the safe and effective use of the drug.</p>
      </abstract>
      <kwd-group>
        <kwd>amyotrophic lateral sclerosis</kwd>
        <kwd>dysphagia</kwd>
        <kwd>riluzole</kwd>
        <kwd>swallow</kwd>
        <kwd>diet</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="3"/>
        <equation-count count="0"/>
        <ref-count count="35"/>
        <page-count count="8"/>
        <word-count count="5283"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="S1">
      <title>Introduction</title>
      <p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a progressive loss of motor neurons that leads to paralysis and death within 2–5 years from the time of diagnosis (<xref rid="B1" ref-type="bibr">1</xref>). Generally, death occurs because of respiratory failure, aspiration pneumonia, malnutrition, and dehydration (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>About one-third of ALS patients show a bulbar onset with dysphagia and dysarthria. Yet, independent of the clinical onset, dysphagia emerges in more than 80% of patients during the advanced phases of the disease (<xref rid="B3" ref-type="bibr">3</xref>). In ALS, dysphagia is related to tongue atrophy, dysfunction in the closure of the soft palate and of the larynx due to the nuclear or supranuclear lesion of the cranial nerves, IX, X, and XII, and diaphragm dysfunction (<xref rid="B4" ref-type="bibr">4</xref>). A prompt assessment of the swallowing function is crucial to organize proper interventions and prevent rapid clinical deterioration (<xref rid="B5" ref-type="bibr">5</xref>). Irrespective of the poor prognosis of ALS, adequate adjustment of the diet and adoption of postural compensation maneuvers to preserve oral feeding could postpone the need for percutaneous endoscopic gastrostomy (PEG) (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Fiberoptic endoscopic evaluation of swallowing (FEES) and videofluoroscopic swallowing study are both considered the gold standard to evaluate dysphagia (<xref rid="B8" ref-type="bibr">8</xref>). However, the endoscopic assessment allows a direct examination of the laryngeal adductor reflex (LAR) and can be repeated as often as necessary due to absence of radiation exposure.</p>
      <p>Several methods have been suggested for the treatment of oropharyngeal dysphagia in adults to prevent airway aspiration during feeding (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). The guidelines for the management of ALS recommend PEG when the weight loss exceeds 10% of the baseline value and the forced vital capacity (FVC) decreases below 50% of the predicted level (<xref rid="B11" ref-type="bibr">11</xref>).</p>
      <p>Physiological swallowing is a crucial parameter also for the proper intake of drugs, and dysphagia can seriously compromise their effect. To date, only riluzole has been approved for the treatment of ALS, even if its clinical usefulness remains controversial (<xref rid="B12" ref-type="bibr">12</xref>). Moreover, since 2015, a new oral liquid formulation of riluzole has become available in Italy (Teglutik, Italfarmaco S.p.A.) (<xref rid="B13" ref-type="bibr">13</xref>).</p>
      <p>Actually, there are no data describing the behavior adopted by the patients because of dysphagia, the impact of swallowing management programs in prolonging survival and in delaying the use of tracheostomy and mechanical ventilation, and the use of riluzole in dysphagic ALS patients.</p>
      <p>The primary aim of the present study was to describe the different clinical features associated with dysphagia in ALS patients with spinal and bulbar onset. Furthermore, we aimed to investigate the impact of dysphagia on diet and riluzole intake, analyze the risk of dysphagia in patients unable to recognize disease symptoms, and evaluate the effect of riluzole taken in an uncommon way on survival.</p>
    </sec>
    <sec sec-type="materials|methods" id="S2">
      <title>Materials and Methods</title>
      <sec id="S2-1">
        <title>Study Design and Patients</title>
        <p>Since 2005, an ALS registry has been set up at the Rare Neuromuscular Diseases Center of Umberto I Hospital, University of Rome “Sapienza.” All consecutive patients with a probable or confirmed ALS diagnosis were included in the registry. Diagnosis of ALS was based on the El Escorial revised criteria (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). According to the most recent guidelines, patients underwent visits every 3–6 months, receiving regular support from a multidisciplinary care team (<xref rid="B16" ref-type="bibr">16</xref>).</p>
        <p>In December 2015, we retrospectively conducted an audit of the registry to collect dysphagia data in ALS patients who underwent visits every 3–6 months to analyze dysphagia onset and severity, patient disability, diet modification, and riluzole management. Patients were included in this retrospective study if they had at least three clinical evaluations comprehensive of swallowing assessment (FEES and LAR study) at each visit. Patients with concomitant disorders able to induce dysphagia were excluded.</p>
        <p>Participants were divided into two subgroups, bulbar and spinal ALS, according to the clinical onset of disease. These were further classified into dysphagic/non-dysphagic and treated/untreated with riluzole. We defined patients as having a “poor prognosis” when death or survival with tracheostomy occurred during the observational period.</p>
        <p>This study was performed according to the Declaration of Helsinki. The authorization to the processing of personal data carried out for scientific research purposes or the written consent for alive patients was provided by all participants.</p>
      </sec>
      <sec id="S2-2">
        <title>Clinical Assessments</title>
        <p>At each visit, the following assessments were performed: (i) FEES to evaluate the swallowing function plus completion of the Penetration Aspiration Scale (PAS) and Pooling score (<italic>P</italic>-score); (ii) spirometry to test the respiratory function; and (iii) ALS Functional Rating Scale Revised (ALSFRS-R) to evaluate the functional impairment in ALS.</p>
        <p>Fiberoptic endoscopic evaluation of swallowing and LAR, performed by an experienced phoniatrician according to the Langmore protocol (1999), evaluate objectively the swallowing function. A 3.7-mm-diameter flexible fiber-optic rhinolaryngoscope (Storz 11101) was used. The endoscopic evaluation was performed by checking details of pharyngeal and laryngeal surfaces, the competence of the velopharyngeal closure, the morphology, motility, and sensitivity of the larynx, LAR, and secretion residues. The swallowing test consisted in the administration of increasing volumes (i.e., 5, 10, and 20 ml) of puree consistency (351–1,750 mPa s) and liquids.</p>
        <p>Penetration Aspiration Scale grades the severity of swallowing dysfunction according to aspiration events (<xref rid="B17" ref-type="bibr">17</xref>). It is an 8-point scale quantifying penetration and aspiration in order to clarify the depth of airway invasion. ALS patients were considered dysphagic when the score was &gt;1.</p>
        <p>The <italic>P</italic>-score assesses the ability to control residue/bolus pooling (<xref rid="B18" ref-type="bibr">18</xref>). It takes into account (i) site, as identified by anatomical landmarks; (ii) amount, as determined in a semiquantitative fashion by the amount of pooling materials; (iii) management, i.e., the ability of the patient to clear the residue (cough, clearing, gurgling, dry swallow). The <italic>P</italic>-score may be integrated with other parameters of clinical assessment: sensation of the pharynx, patient collaboration, and age (P-SCA score) (<xref rid="B19" ref-type="bibr">19</xref>) (Table <xref ref-type="table" rid="T1">1</xref>). Both scores express, as a numerical value, a continuum of severity that may indicate the absence of signs of dysphagia, mild, moderate, and severe dysphagia (3–4 = minimum score, corresponding to no dysphagia; 5–8 = low score, mild dysphagia; 9–12 = middle score, moderate dysphagia; 13–16 = high score, severe dysphagia).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>The Pooling score (<italic>P</italic>-score) integrated with parameters as sensation, collaboration, and age (P-SCA score) [by Farneti et al. (8)]</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">Pooling</th>
                <th valign="top" align="left" rowspan="1" colspan="1">Endoscopic landmarks</th>
                <th valign="top" align="left" rowspan="1" colspan="1">Score</th>
                <th valign="top" align="center" colspan="3" rowspan="1">Bedside parameters<hr/></th>
              </tr>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1"/>
                <th valign="top" align="left" rowspan="1" colspan="1"/>
                <th valign="top" align="left" rowspan="1" colspan="1"/>
                <th valign="top" align="left" rowspan="1" colspan="1">Sensation</th>
                <th valign="top" align="left" rowspan="1" colspan="1">Collaboration</th>
                <th valign="top" align="left" rowspan="1" colspan="1">Age (years)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top" rowspan="7" colspan="1">Site</td>
                <td align="left" valign="top" rowspan="1" colspan="1">Vallecula</td>
                <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                <td align="left" valign="top" rowspan="4" colspan="1"/>
                <td align="left" valign="top" rowspan="4" colspan="1"/>
                <td align="left" valign="top" rowspan="4" colspan="1"/>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Marginal zone</td>
                <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Pyriform sinus</td>
                <td align="left" valign="top" rowspan="1" colspan="1">2</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Vestibule/vocal cords</td>
                <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">Lower vocal cords</td>
                <td align="left" valign="top" rowspan="2" colspan="1">4</td>
                <td align="left" valign="top" rowspan="1" colspan="1">Presence = −1</td>
                <td align="left" valign="top" rowspan="1" colspan="1">Presence = −1</td>
                <td align="left" valign="top" rowspan="1" colspan="1">1 (&lt;65)</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Absence = 1</td>
                <td align="left" valign="top" rowspan="1" colspan="1">Absence = 1</td>
                <td align="left" valign="top" rowspan="1" colspan="1">2 (65–75)</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Coating</td>
                <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                <td align="left" valign="top" rowspan="6" colspan="1"/>
                <td align="left" valign="top" rowspan="6" colspan="1"/>
                <td align="left" valign="top" rowspan="1" colspan="1">3 (&gt;75)</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">Amount</td>
                <td align="left" valign="top" rowspan="1" colspan="1">Minimum</td>
                <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                <td align="left" valign="top" rowspan="5" colspan="1"/>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Maximum</td>
                <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="3" colspan="1">Management</td>
                <td align="left" valign="top" rowspan="1" colspan="1">&lt;2</td>
                <td align="left" valign="top" rowspan="1" colspan="1">2</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">2–5</td>
                <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">&gt;5</td>
                <td align="left" valign="top" rowspan="1" colspan="1">4</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Score</td>
                <td align="left" valign="top" rowspan="1" colspan="1"/>
                <td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>: 4–11</td>
                <td align="left" valign="top" rowspan="1" colspan="1"/>
                <td align="left" valign="top" rowspan="1" colspan="1">P-SCA: 3–16</td>
                <td align="left" valign="top" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The ALSFRS-R is a validated measure of functional impairment in ALS (<xref rid="B20" ref-type="bibr">20</xref>). It is a questionnaire-based functional scale, containing 12 items rated from 0 (complete dependence for that function) to 4 (normal function), divided into 3 sub scores (bulbar 12, spinal 24, and respiratory 12), with normal function defined by a score of 48.</p>
        <p>Spirometry was carried out with participants in the sitting position wearing a nose clip, asked to blow into the mouthpiece of a spirometer (Winspiro PRO 5.8) as forcefully and quickly as possible and to continue blowing until all of the air was expelled from lungs. FVC (liters) and forced expiratory volume in first second (liters per second) were analyzed. The highest values were used in the analysis. The FVC values were expressed as percentages.</p>
        <p>The onset of dysphagic symptoms was reported by patients. The ability to swallow solid food and liquids was assessed by means of anamnestic and clinical criteria. All dietary advice, prescription of PEG, non-invasive ventilation (NIV), changes in pharmacological treatments, use of thickening agents, and adopted diet were collected. Specifically, the patient diet was categorized as described hereinafter: a normal diet without restrictions, a soft diet (&gt;10<sup>12</sup> Pa s), a pudding diet (1,750–4,000 mPa s), and a pureed diet (351).</p>
        <p>The intake of liquid was defined as follows: normal, postural (tucked chin), density 1 (syrup-nectar, 51–350 mPa s; it can be drunk with a straw or a cup, leaves a thin veneer on the back of the spoon), and density 2 (cream, 351–1,750 mPa s; it cannot be drunk with a straw; it can be drunk from a cup; it leaves a thin veneer on the back of the spoon).</p>
        <p>The ability to swallow the whole riluzole tablet has been collected within the description of riluzole modification (crushing/swallow with food) in case of inability to swallow.</p>
        <p>Patient survival has been calculated from the time of diagnosis until the date of death.</p>
      </sec>
      <sec id="S2-3">
        <title>Statistical Analysis</title>
        <p>Descriptive statistics, which summarizes data as percentages, was used. The Student’s <italic>T</italic> distribution was used to evaluate the baseline differences between dysphagic/non-dysphagic patients. The Chi-square test, with Yates’ correction if necessary, was used to compare qualitative values. Analysis of variance (ANOVA) for repeated measures assessed the differences, which were presented as percentage and 95% confidence interval. Statistically significant ANOVA was confirmed by <italic>post hoc</italic> Fisher analysis. Overall survival was analyzed using the Kaplan–Meier method, and <italic>P</italic> values were calculated using the log-rank test and Wilcoxon test. The level of significance was set at 0.05. The data of three assessments (i.e., initial, intermediate, and final visit) were used to measure disease evolution. The survival analysis was performed using Cox Regression.</p>
        <p>Generalized linear mixed logit regression models were used to examine the association between death and other variables (age at onset, type of ALS, PAS, and P-SCA scores).</p>
      </sec>
    </sec>
    <sec id="S3">
      <title>Results</title>
      <p>One hundred and forty five ALS patients (90 males and 55 females) met the inclusion criteria. They were followed for at least 9 months from baseline (mean duration of the clinical follow-up was 20.0 ± 18.3 months; range: 9–110). Mean age at onset was 62.2 ± 11.7 years. The disease duration at the first visit was 15.8 ± 12.7 months (range: 1–78). Fifty-seven patients (39%) had bulbar onset, while 88 patients (61%) had a spinal onset (Table <xref ref-type="table" rid="T2">2</xref>).</p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p><bold>Demographic and clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with or without dysphagia at the start and at the end of follow-up</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="2" colspan="1">Variable</th>
              <th valign="top" align="center" colspan="3" rowspan="1">At the start of follow-up<hr/></th>
              <th valign="top" align="center" colspan="3" rowspan="1">At the end of follow-up<hr/></th>
            </tr>
            <tr>
              <th valign="top" align="center" rowspan="1" colspan="1">Dysphagic pts</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Non-dysphagic pts</th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <italic>p</italic>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">Dysphagic pts</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Non-dysphagic pts</th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <italic>p</italic>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">ALS patients <italic>N</italic> (%)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">
                <bold>85 (58.6)</bold>
              </td>
              <td align="center" valign="top" rowspan="1" colspan="1">
                <bold>60 (41.4)</bold>
              </td>
              <td align="center" valign="top" rowspan="1" colspan="1"/>
              <td align="center" valign="top" rowspan="1" colspan="1">
                <bold>120 (82.8)</bold>
              </td>
              <td align="center" valign="top" rowspan="1" colspan="1">
                <bold>25 (17.2)</bold>
              </td>
              <td align="center" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Clinical onset <italic>N</italic> (%)</td>
              <td align="center" valign="top" colspan="6" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Bulbar</td>
              <td align="center" valign="top" rowspan="1" colspan="1">54 (63.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3 (5.0)</td>
              <td align="center" valign="top" rowspan="2" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">56 (46.7)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1 (4.0)</td>
              <td align="center" valign="top" rowspan="2" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Spinal</td>
              <td align="center" valign="top" rowspan="1" colspan="1">31 (36.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">57 (95.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">64 (53.3)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">24 (96.0)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Age (years) at onset mean (SD)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">64.0 (12.3)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">59.6</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
              <td align="center" valign="top" rowspan="1" colspan="1">63.2 (11.9)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">57.4 (9.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Sex <italic>N</italic> (%)</td>
              <td align="center" valign="top" colspan="6" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Male</td>
              <td align="center" valign="top" rowspan="1" colspan="1">45 (52.9)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">45 (75.0)</td>
              <td align="center" valign="top" rowspan="2" colspan="1">0.007</td>
              <td align="center" valign="top" rowspan="1" colspan="1">75 (62.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">15 (60.0)</td>
              <td align="center" valign="top" rowspan="2" colspan="1">ns</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Female</td>
              <td align="center" valign="top" rowspan="1" colspan="1">40 (47.1)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">15 (25.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">45 (37.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">10 (40.0)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Delay of ALS diagnosis (months) mean (SD)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">14.2 (10.7)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">18.0 (14.8)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
              <td align="center" valign="top" rowspan="1" colspan="1">36.1 (23.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">35.6 (22.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Penetration Aspiration Scale mean (SD)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2.4 (1.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.0 (−)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">4.0 (2.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.0 (0.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">P-SCA score mean (SD)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6.9 (1.8)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3.1 (0.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.6 (3.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3.4 (0.8)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">ALS Functional Rating Scale Revised mean (SD)</td>
              <td align="center" valign="top" colspan="6" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Total</td>
              <td align="center" valign="top" rowspan="1" colspan="1">38.3 (7.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">42.0 (5.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">27.1 (8.8)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">36.6 (8.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Bulbar</td>
              <td align="center" valign="top" rowspan="1" colspan="1">8.6 (2.6)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.6 (0.7)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6.8 (3.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.4 (1.6)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Spinal</td>
              <td align="center" valign="top" rowspan="1" colspan="1">18.8 (6.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">18.8 (5.1)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
              <td align="center" valign="top" rowspan="1" colspan="1">10.9 (7.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">14.4 (6.6)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Respiratory</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.0 (1.3)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">11.6 (0.9)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.002</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.4 (2.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">10.9 (2.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.002</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Forced vital capacity mean (SD)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">63.8 (21.9)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">85.2 (17.9)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">37.3 (31.5)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">60.0 (29.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Laryngeal adductor reflex <italic>N</italic> (%)</td>
              <td align="center" valign="top" colspan="6" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Present</td>
              <td align="center" valign="top" rowspan="1" colspan="1">52 (61.2)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">58 (96.6)</td>
              <td align="center" valign="top" rowspan="3" colspan="1">0.001</td>
              <td align="center" valign="top" rowspan="1" colspan="1">48 (40.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">22 (88.0)</td>
              <td align="center" valign="top" rowspan="3" colspan="1">0.001</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Poor</td>
              <td align="center" valign="top" rowspan="1" colspan="1">25 (29.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1 (1.7)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">30 (25.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2 (8.0)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"> Absent</td>
              <td align="center" valign="top" rowspan="1" colspan="1">8 (9.4)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1 (1.7)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">42 (35.0)</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1 (4.0)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>Data are expressed as mean (±SD) or frequencies [N = number (% = percentage value)]</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>At the beginning and at the end of the follow-up period, dysphagia was present in 58.6% (85/145) and 82.8% (120/145) of patients, respectively, with higher frequency in bulbar than in spinal patients (Figure <xref ref-type="fig" rid="F1">1</xref>). A delayed diagnosis of 14.2 and 18 months was found in dysphagic and non-dysphagic patients, respectively. Abnormal LAR and lower final FVC (<italic>F</italic> = 53.23, η<sup>2</sup> = 0.27, <italic>p</italic> = 0.001) were more frequent among patients with bulbar onset. As expected in a progressive disease, a gradual significant worsening in PAS score during the follow-up period was observed (Figure <xref ref-type="fig" rid="F2">2</xref>). Six patients (8%) with dysphagia found by FEES did not perceive the disorder (Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Incidence of dysphagia in the whole amyotrophic lateral sclerosis population and according to spinal or bulbar onset at the beginning and the end of follow-up</bold>.</p>
        </caption>
        <graphic xlink:href="fneur-08-00094-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Change in Penetration Aspiration Scale (PAS) score during the follow-up period in spinal and bulbar patients</bold>. Current effect: <italic>F</italic>(2.284) = 15.210, <italic>p</italic> = 0.001. Vertical bars denote 0.95 confidence intervals.</p>
        </caption>
        <graphic xlink:href="fneur-08-00094-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>The fiberoptic endoscopic evaluation of swallowing of one amyotrophic lateral sclerosis patient who did not perceive the objectified disorder but with abundant hypopharyngeal residues</bold>.</p>
        </caption>
        <graphic xlink:href="fneur-08-00094-g003"/>
      </fig>
      <p>Fifty-four patients died (35% bulbar, 65% spinal) during the follow-up, while nine patients survived positioning tracheostomy. At the end of follow-up, disease duration was lower in bulbar onset patients than in those with spinal onset.</p>
      <p>Sixty-three patients were deemed to have a poor prognosis (54 patients plus 9 who underwent tracheostomy). They showed a significant lower FVC (32.7 + 27.3 vs. 47.7 + 34.2, <italic>p</italic> = 0.004) in comparison to patients who survived. Fifty-five (87%) patients were dysphagic, and 25% of them refused the suggested thickening agents.</p>
      <p>Percutaneous endoscopic gastrostomy was applied 30.6 ± 19.8 months after the onset of symptoms. Also, 29% of patients with PEG died, showing, however, a longer mean disease duration (38.0 ± 21.0 months) when PEG was positioned earlier (28.7 ± 22.4 months).</p>
      <sec id="S3-1">
        <title>Diet Assessment</title>
        <p>At the beginning of the observation period 63 patients were on a normal diet, 64 on a soft diet, 13 on a pudding diet, and 5 on a puree diet. No patient used thickening agents or needed PEG. At the end of the follow-up, the following diets were adopted: normal in 24 patients, soft in 45 patients, pudding in 35 patients, and puree in 11 patients; 30 patients underwent a PEG. Bulbar dysphagic patients were given foods with modified consistency and underwent PEG more frequently than those with spinal onset (<italic>p</italic> = 0.01).</p>
        <p>A detailed description of liquid intake is reported in Table <xref ref-type="table" rid="T3">3</xref>. Only 56% (30/54) of patients used the suggested thickening agents. In particular, 49% of dysphagic patients with spinal onset refused the proposed thickeners, while only 15% with bulbar onset refused them (<italic>p</italic> = 0.001 for the difference between bulbar and spinal ALS patients). Fifteen patients (62%) who refused the proposed thickeners died, while three survived after placing PEG.</p>
        <table-wrap id="T3" position="float">
          <label>Table 3</label>
          <caption>
            <p><bold>Description of the liquid intake in dysphagic patients (entire population and subgrouped by onset)</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">Intake</th>
                <th valign="top" align="center" rowspan="1" colspan="1">All dysphagic patients (<italic>N</italic> = 120)</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Spinal onset dysphagic patients (<italic>N</italic> = 64)</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Bulbar onset dysphagic patients (<italic>N</italic> = 56)</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <italic>p</italic>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Normal</td>
                <td align="center" valign="top" rowspan="1" colspan="1">8 (7)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">7 (11)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1 (2)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Postural</td>
                <td align="center" valign="top" rowspan="1" colspan="1">31 (26)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">20 (31)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">11 (20)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Syrup/nectar</td>
                <td align="center" valign="top" rowspan="1" colspan="1">13 (11)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">12 (19)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1(2)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.007</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Cream</td>
                <td align="center" valign="top" rowspan="1" colspan="1">43 (36)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">22 (34)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">21 (37)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ns</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Percutaneous endoscopic gastrostomy</td>
                <td align="center" valign="top" rowspan="1" colspan="1">25 (20)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">3 (5)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">22 (39)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.0001</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Data are expressed as frequencies [numbers (%)]</italic>.</p>
            <p><italic>Normal; postural, tuck chin; density 1, syrup (nectar) 51–350 mPa s can be drunk with a straw or a cup if recommended; it leaves a thin veneer on the back of the spoon; and density 2, cream 351–1,750 mPa s cannot be drunk with a straw; it can be drunk from a cup; leaves a thin veneer on the back of the spoon</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Only 75% of patients with poor or absent LAR used thickeners, diets with modified consistence, or PEG. Twelve (63%) of the patients who refused the proposed thickeners died.</p>
      </sec>
      <sec id="S3-2">
        <title>Riluzole Management</title>
        <p>At the end of the follow-up period, 95 patients were on riluzole, while 50 patients did not take the drug because of excessive sedation, increase of levels of transaminases, or patient refusal. Among the treated patients, 80 had dysphagia. They took the drug as follows: 51 patients used whole tablets (45 with water, 3 with fruit juice, 2 with yogurt, and 1 with fruit or bread), 20 crushed the tablets (7 with a spoon and 13 with a hackneyed tablets), and 9 assumed the oral suspension (Teglutik<sup>®</sup>, available on the market since March 2013) (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Administration of riluzole in amyotrophic lateral sclerosis (ALS) patients according to dysphagia</bold>.</p>
          </caption>
          <graphic xlink:href="fneur-08-00094-g004"/>
        </fig>
        <p>Among the 20 patients crushing riluzole tablets, 17 mixed them with water (16 through PEG, 1 to swallow), 1 mixed with tea, 1 with fruit, and 1 with a thickening solution.</p>
        <p>The use of riluzole did not impact on survival either in dysphagic or in non-dysphagic patients (Gehan’s Wilcoxon test = 0.07; <italic>p</italic> = 0.93). In dysphagic patients, no difference in the time of death was observed between patients with bulbar and spinal onset (Gehan’s: Wilcoxon test = −1.23; <italic>p</italic> = 0.21).</p>
        <p>Forty-eight percent of patients untreated with riluzole died, compared to 45% of those treated with whole tablets, 35% with crushed riluzole, and 22% with riluzole oral suspension. A significant difference in terms of mortality was found between patients untreated with riluzole and those treated with riluzole oral suspension (<italic>p</italic> &lt; 0.05).</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S4">
      <title>Discussion</title>
      <p>In this study, we evaluated the clinical features associated with dysphagia in ALS patients and their impact on riluzole and food management.</p>
      <p>Our data are consistent with the literature: at the beginning of the disease, dysphagia was prevalent in patients with bulbar onset, and the duration of the disease affected mostly the frequency of dysphagia in spinal patients (<xref rid="B21" ref-type="bibr">21</xref>). Swallowing problems are often underestimated in ALS patients due to the progressive adaptation to slow deterioration of bulbar function, and the patient does not always recognize the disorder, leading to serious consequences and decreased survival. Dysphagia needs to be treated early and regularly to prevent complications, particularly in patients who do not initially perceive the disorder. This ensures adequate therapy through prevention of food aspiration and support of oral alimentation (<italic>via</italic> compensatory postures and dietary modifications), postponing PEG (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). In the present study, 8% of spinal patients presenting with signs of dysphagia by FEES did not report the disorder as symptomatic. These findings emphasize the importance of performing a periodic objective swallowing evaluation in all ALS patients. Strategies to prevent malnutrition have a positive impact also on survival and quality of life (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>).</p>
      <p>Recently, an important role has also been attributed to laryngeal sensitivity in the assessment of neurogenic oropharyngeal dysphagia (<xref rid="B26" ref-type="bibr">26</xref>). Laryngeal sensitivity is crucial for maintaining safe swallowing, thus avoiding silent aspiration. Until now, pharyngo-laryngeal sensitivity has received limited attention in patients with ALS, mainly because of the belief that ALS spares sensory function (<xref rid="B27" ref-type="bibr">27</xref>). In our study, FEES and PAS were able to objectively assess changes in the swallowing function over time, and this was particularly relevant in spinal patients, where the dysphagia may not even be recognized.</p>
      <p>In patients with silent dysphagia, early detection is critical to avoid complications such as pneumonia. The management of oropharyngeal secretion and the efficacy of cleaning mechanisms, such as coughing and throat clearing, can be assessed simply and directly by FEES (<xref rid="B28" ref-type="bibr">28</xref>). Moreover, it can be performed at the bedside, thus facilitating the examination of severely motor-impaired, bedridden, or uncooperative patients. The AAN practice parameters and European ALS Consortium suggests that nutrition education and management is the standard of care and recommends regular nutrition evaluation every 3 months in ALS patients (<xref rid="B29" ref-type="bibr">29</xref>). Treatment of dysphagia is based on swallowing techniques, which improve the patient swallowing abilities thus reducing aspiration risks, and on diet change to adapt the consistency of foods and liquids to the patient specific impairment (<xref rid="B30" ref-type="bibr">30</xref>). The multidisciplinary approach has improved the overall care of ALS patients. Nonetheless, otolaryngologists are often not included in ALS management until a tracheostomy is considered. In our series, 44% of dysphagic patients, above all dysphagic patients with spinal onset, refused requested thickeners or PEG, and 25% of them had an impaired LAR. Paradoxically, we noted that patients who accepted thickening agents worsened more frequently compared to patients who refused them (67 vs. 47%). An accurate analysis of data, however, showed that non-compliant patients had a low level of disability and a better lung capacity. This suggests that any person who considers himself really ill makes everything possible to survive.</p>
      <p>Seventy percent of patients who used PEG survived, and these data confirm that early recognition of dysphagia and of different grades of aspiration into the airways allows to identify patients who need PEG early on (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>).</p>
      <p>According to the literature, patients who were not treated with riluzole died more frequently compared to those receiving the drug, even if a significant difference was noted only for patients treated with oral suspension of riluzole (<xref rid="B33" ref-type="bibr">33</xref>). Since swallowing a pill is particularly problematic in these patients, the riluzole tablet is often crushed and dispensed with food. Both practices are not in line with riluzole label instruction, and no data are available about the efficacy and safety of crushed riluzole tablets. It is also important to remember that riluzole has anesthetic effects, as it partially blocks sodium channels, and it is usually administered in coated tablets to avoid oral paresthesia (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Considering the possible larynx sensory deficit in dysphagic ALS patients, the practice of crushing riluzole tablets could impair the swallowing ability, therefore increasing the risk of aspiration. Moreover, this potential anesthetic effect could be prolonged if riluzole is dispersed in food, given the long time required by ALS patients to finish a meal. A comparative study between whole, crushed, and oral suspension of riluzole on a large number of ALS patients may help to understand the possible conditioning effect of different absorption of riluzole. Actually, the oral suspension of riluzole allows patients who suffer from dysphagia to receive the only approved ALS treatment in a way that does not alter the drug and is in line with the riluzole dosing instructions. Moreover, the viscosity of riluzole oral suspension is 300–700 cP (European Teglutik Patent No. 2405890B1), therefore similar to nectar and honey, allowing to minimize the risk of aspiration.</p>
      <p>In conclusion, dysphagia is a very common symptom in ALS patients. The disease duration influences the occurrence of dysphagia especially in patients with spinal onset, appearing instead very early in patients with bulbar onset. Patients adapt food consistency according to the worsening of dysphagia, and they also alter riluzole tablet to swallow the drug. The pureed diets and PEG prescription increased over time, even if a high percentage of patients refused requested thickeners or PEG, despite LAR impairment. The oral suspension of riluzole would allow the safe administration of the drug in ALS patients with dysphagia without the need to crush the tablet or disperse it in food, practices that are inconsistent with their safe and effective use. An early and periodic nutrition assessment and therapeutic intervention is necessary to adequately modify the consistency of the diet and the proper use of thickening agents or PEG.</p>
    </sec>
    <sec id="S5">
      <title>Author Contributions</title>
      <p>EO and MI: design of the study, interpretation of the data, preparation, and approval of the manuscript. EO, GR, IS, MG, and MI: analysis and interpretation of the data, preparation, review, and approval of the manuscript. IS, VF, MC, and CC: collection and interpretation of the data as well as review and approval of the manuscript.</p>
    </sec>
    <sec id="S6">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors gratefully thank all ALS patients who made this study possible.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiernan</surname><given-names>MC</given-names></name><name><surname>Vucic</surname><given-names>S</given-names></name><name><surname>Cheah</surname><given-names>BC</given-names></name><name><surname>Turner</surname><given-names>MR</given-names></name><name><surname>Eisen</surname><given-names>A</given-names></name><name><surname>Hardiman</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Amyotrophic lateral sclerosis</article-title>. <source>Lancet</source> (<year>2011</year>) <volume>377</volume>(<issue>9769</issue>):<fpage>942</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(10)61156-7</pub-id><?supplied-pmid 21296405?><pub-id pub-id-type="pmid">21296405</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czaplinski</surname><given-names>A</given-names></name><name><surname>Yen</surname><given-names>AA</given-names></name><name><surname>Simpson</surname><given-names>EP</given-names></name><name><surname>Appel</surname><given-names>SH</given-names></name></person-group>. <article-title>Predictability of disease progression in amyotrophic lateral sclerosis</article-title>. <source>Muscle Nerve</source> (<year>2006</year>) <volume>34</volume>:<fpage>702</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/mus.20658</pub-id><?supplied-pmid 16967489?><pub-id pub-id-type="pmid">16967489</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muscaritoli</surname><given-names>M</given-names></name><name><surname>Kushta</surname><given-names>I</given-names></name><name><surname>Molfino</surname><given-names>A</given-names></name><name><surname>Inghilleri</surname><given-names>M</given-names></name><name><surname>Sabatelli</surname><given-names>M</given-names></name><name><surname>Rossi Fanelli</surname><given-names>F</given-names></name></person-group>. <article-title>Nutritional and metabolic support in patients with amyotrophic lateral sclerosis</article-title>. <source>Nutrition</source> (<year>2012</year>) <volume>28</volume>(<issue>10</issue>):<fpage>959</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.nut.2012.01.011</pub-id><?supplied-pmid 22677356?><pub-id pub-id-type="pmid">22677356</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchesi</surname><given-names>KF</given-names></name><name><surname>Kitamura</surname><given-names>S</given-names></name><name><surname>Mourão</surname><given-names>LF</given-names></name></person-group>. <article-title>Management of dysphagia in Parkinson’s disease and amyotrophic lateral sclerosis</article-title>. <source>Codas</source> (<year>2013</year>) <volume>25</volume>(<issue>4</issue>):<fpage>358</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1590/S2317-17822013000400010</pub-id><?supplied-pmid 24408486?><pub-id pub-id-type="pmid">24408486</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühnlein</surname><given-names>P</given-names></name><name><surname>Gdynia</surname><given-names>HJ</given-names></name><name><surname>Sperfeld</surname><given-names>AD</given-names></name><name><surname>Lindner-Pfleghar</surname><given-names>B</given-names></name><name><surname>Ludolph</surname><given-names>AC</given-names></name><name><surname>Prosiegel</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis</article-title>. <source>Nat Clin Pract Neurol</source> (<year>2008</year>) <volume>4</volume>:<fpage>366</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/ncpneuro0853</pub-id><pub-id pub-id-type="pmid">18560390</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>JA</given-names></name><name><surname>Reis</surname><given-names>C</given-names></name><name><surname>Simões</surname><given-names>F</given-names></name><name><surname>Fonseca</surname><given-names>J</given-names></name><name><surname>Mendes Ribeiro</surname><given-names>J</given-names></name></person-group>. <article-title>Diagnostic investigation and multidisciplinary management in motor neuron disease</article-title>. <source>J Neurol</source> (<year>2005</year>) <volume>252</volume>:<fpage>1435</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1007/s00415-005-0007-9</pub-id><?supplied-pmid 16362828?><pub-id pub-id-type="pmid">16362828</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibodeaux</surname><given-names>LS</given-names></name><name><surname>Gutierrez</surname><given-names>A</given-names></name></person-group>. <article-title>Management of symptoms in amyotrophic lateral sclerosis</article-title>. <source>Curr Treat Options Neurol</source> (<year>2008</year>) <volume>10</volume>:<fpage>77</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1007/s11940-008-0009-x</pub-id><?supplied-pmid 18334130?><pub-id pub-id-type="pmid">18334130</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farneti</surname><given-names>D</given-names></name></person-group>
<article-title>The instrumental gold standard: fees</article-title>. <source>J Gastroenterol Hepatol Res</source> (<year>2014</year>) <volume>3</volume>(<issue>10</issue>):<fpage>1281</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.6051/j.issn.2224-3992.2014.03.408-6</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasley</surname><given-names>A</given-names></name><name><surname>Logemann</surname><given-names>JA</given-names></name><name><surname>Kahrilas</surname><given-names>PJ</given-names></name><name><surname>Rademaker</surname><given-names>AW</given-names></name><name><surname>Pauloski</surname><given-names>BR</given-names></name><name><surname>Dodds</surname><given-names>WJ</given-names></name></person-group>. <article-title>Prevention of barium aspiration during videofluoroscopic swallowing studies: value of change in posture</article-title>. <source>AJR Am J Roentgenol</source> (<year>1993</year>) <volume>160</volume>:<fpage>1005</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2214/ajr.160.5.8470567</pub-id><?supplied-pmid 8470567?><pub-id pub-id-type="pmid">8470567</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Logemann</surname><given-names>JA</given-names></name></person-group>
<source>Evaluation and Treatment of Swallowing Disorders</source>. <edition>2nd ed</edition>
<publisher-loc>Austin, TX</publisher-loc>: <publisher-name>Pro-Ed</publisher-name> (<year>1998</year>).</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spataro</surname><given-names>R</given-names></name><name><surname>Ficano</surname><given-names>L</given-names></name><name><surname>Piccoli</surname><given-names>F</given-names></name><name><surname>La Bella</surname><given-names>V</given-names></name></person-group>. <article-title>Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival</article-title>. <source>J Neurol Sci</source> (<year>2011</year>) <volume>304</volume>(<issue>12</issue>):<fpage>44</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jns.2011.02.016</pub-id><?supplied-pmid 21371720?><pub-id pub-id-type="pmid">21371720</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>RG</given-names></name><name><surname>Mitchell</surname><given-names>JD</given-names></name><name><surname>Moore</surname><given-names>DH</given-names></name></person-group>
<article-title>Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2012</year>) <volume>3</volume>:<fpage>CD001447</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD001447</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>GM</given-names></name></person-group>
<article-title>Riluzole oral suspension in amyotrophic lateral sclerosis: a guide to its use</article-title>. <source>Drug Ther Perspect</source> (<year>2016</year>) <volume>32</volume>:<fpage>282</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1007/s40267-016-0312-7</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Miller</surname><given-names>RG</given-names></name><name><surname>Swash</surname><given-names>M</given-names></name><name><surname>Munsat</surname><given-names>TL</given-names></name><collab>World Federation of Neurology Research Group on Motor Neuron Diseases</collab></person-group>
<article-title>El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis</article-title>. <source>Amyotroph Lateral Scler Other Motor Neuron Disord</source> (<year>2000</year>) <volume>1</volume>:<fpage>293</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1080/146608200300079536</pub-id><pub-id pub-id-type="pmid">11464847</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carvalho</surname><given-names>M</given-names></name><name><surname>Dengler</surname><given-names>R</given-names></name><name><surname>Eisen</surname><given-names>A</given-names></name><name><surname>England</surname><given-names>JD</given-names></name><name><surname>Kaji</surname><given-names>R</given-names></name><name><surname>Kimura</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Electrodiagnostic criteria for diagnosis of ALS</article-title>. <source>Clin Neurophysiol</source> (<year>2008</year>) <volume>119</volume>:<fpage>497</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="doi">10.1016/j.clinph.2007.09.143</pub-id><?supplied-pmid 18164242?><pub-id pub-id-type="pmid">18164242</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis</collab><name><surname>Andersen</surname><given-names>PM</given-names></name><name><surname>Abrahams</surname><given-names>S</given-names></name><name><surname>Borasio</surname><given-names>GD</given-names></name><name><surname>de Carvalho</surname><given-names>M</given-names></name><name><surname>Chio</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS task force</article-title>. <source>Eur J Neurol</source> (<year>2012</year>) <volume>19</volume>(<issue>3</issue>):<fpage>360</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-1331.2011.03501.x</pub-id><pub-id pub-id-type="pmid">21914052</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbek</surname><given-names>JC</given-names></name><name><surname>Robbins</surname><given-names>JA</given-names></name><name><surname>Roecker</surname><given-names>EB</given-names></name><name><surname>Coyle</surname><given-names>JL</given-names></name><name><surname>Wood</surname><given-names>JL</given-names></name></person-group>
<article-title>A penetration-aspiration scale</article-title>. <source>Dysphagia</source> (<year>1996</year>) <volume>11</volume>:<fpage>93</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/BF00417897</pub-id><pub-id pub-id-type="pmid">8721066</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farneti</surname><given-names>D</given-names></name></person-group>. <article-title>Pooling score: an endoscopic model for evaluating severity of dysphagia</article-title>. <source>Acta Otorhinolaryngol Ital</source> (<year>2008</year>) <volume>28</volume>:<fpage>135</fpage>–<lpage>40</lpage>.<?supplied-pmid 18646575?><pub-id pub-id-type="pmid">18646575</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farneti</surname><given-names>D</given-names></name><name><surname>Fattori</surname><given-names>B</given-names></name><name><surname>Nacci</surname><given-names>A</given-names></name><name><surname>Mancini</surname><given-names>V</given-names></name><name><surname>Simonelli</surname><given-names>M</given-names></name><name><surname>Ruoppolo</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>The pooling-score (P-score): inter- and intra-rater reliability in endoscopic assessment of the severity of dysphagia</article-title>. <source>Acta Otorhinolaryngol Ital</source> (<year>2014</year>) <volume>34</volume>:<fpage>105</fpage>–<lpage>10</lpage>.<?supplied-pmid 24843220?><pub-id pub-id-type="pmid">24843220</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cedarbaum</surname><given-names>JM</given-names></name><name><surname>Stambler</surname><given-names>N</given-names></name><name><surname>Malta</surname><given-names>E</given-names></name><name><surname>Fuller</surname><given-names>C</given-names></name><name><surname>Hilt</surname><given-names>D</given-names></name><name><surname>Thurmond</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>The ALSFRS-R: a revised ALS functional rating scale that incorporates the assessments of respiratory function. BDNF ALS study group (phase III)</article-title>. <source>J Neurol Sci</source> (<year>1999</year>) <volume>169</volume>:<fpage>13</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/S0022-510X(99)00210-5</pub-id><pub-id pub-id-type="pmid">10540002</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamburrini</surname><given-names>S</given-names></name><name><surname>Solazzo</surname><given-names>A</given-names></name><name><surname>Sagnelli</surname><given-names>A</given-names></name><name><surname>Del Vecchio</surname><given-names>L</given-names></name><name><surname>Reginelli</surname><given-names>A</given-names></name><name><surname>Monsorro</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia</article-title>. <source>Radiol Med</source> (<year>2010</year>) <volume>115</volume>:<fpage>784</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1007/s11547-010-0523-2</pub-id><?supplied-pmid 20174881?><pub-id pub-id-type="pmid">20174881</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomik</surname><given-names>J</given-names></name><name><surname>Tomik</surname><given-names>B</given-names></name><name><surname>Skladzien</surname><given-names>J</given-names></name><name><surname>Gajec</surname><given-names>S</given-names></name><name><surname>Strek</surname><given-names>P</given-names></name><name><surname>Oles</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Analysis of oropharyngeal phase of swallowing in patients with amyotrophic lateral sclerosis</article-title>. <source>Przegl Lek</source> (<year>2009</year>) <volume>66</volume>:<fpage>905</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20297626</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Aguila</surname><given-names>MA</given-names></name><name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name><name><surname>McGuire</surname><given-names>V</given-names></name><name><surname>Koepsell</surname><given-names>TD</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name></person-group>. <article-title>Prognosis in amyotrophic lateral sclerosis: a population-based study</article-title>. <source>Neurology</source> (<year>2003</year>) <volume>60</volume>(<issue>5</issue>):<fpage>813</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1212/01.WNL.0000049472.47709.3B</pub-id><?supplied-pmid 12629239?><pub-id pub-id-type="pmid">12629239</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoccolella</surname><given-names>S</given-names></name><name><surname>Beghi</surname><given-names>E</given-names></name><name><surname>Palagano</surname><given-names>G</given-names></name><name><surname>Fraddosio</surname><given-names>A</given-names></name><name><surname>Guerra</surname><given-names>V</given-names></name><name><surname>Samarelli</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>2008</year>) <volume>79</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.2007.118018</pub-id><?supplied-pmid 17550991?><pub-id pub-id-type="pmid">17550991</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsumoto</surname><given-names>H</given-names></name><name><surname>Rabkin</surname><given-names>J</given-names></name></person-group>
<article-title>Palliative care for patients with amyotrophic lateral sclerosis: “prepare for the worst and hope for the best”</article-title>. <source>JAMA</source> (<year>2007</year>) <volume>298</volume>(<issue>2</issue>):<fpage>207</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1001/jama.298.2.207</pub-id><pub-id pub-id-type="pmid">17622602</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruoppolo</surname><given-names>G</given-names></name><name><surname>Schettino</surname><given-names>I</given-names></name><name><surname>Biasiotta</surname><given-names>A</given-names></name><name><surname>Roma</surname><given-names>R</given-names></name><name><surname>Greco</surname><given-names>A</given-names></name><name><surname>Soldo</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Afferent nerve ending density in the human laryngeal mucosa: potential implications on endoscopic evaluation of laryngeal sensitivity</article-title>. <source>Dysphagia</source> (<year>2015</year>) <volume>30</volume>(<issue>2</issue>):<fpage>139</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1007/s00455-014-9589-7</pub-id><?supplied-pmid 25519304?><pub-id pub-id-type="pmid">25519304</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruoppolo</surname><given-names>G</given-names></name><name><surname>Schettino</surname><given-names>I</given-names></name><name><surname>Frasca</surname><given-names>V</given-names></name><name><surname>Giacomelli</surname><given-names>E</given-names></name><name><surname>Prosperini</surname><given-names>L</given-names></name><name><surname>Cambieri</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings</article-title>. <source>Acta Neurol Scand</source> (<year>2013</year>) <volume>128</volume>(<issue>6</issue>):<fpage>397</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1111/ane.12136</pub-id><pub-id pub-id-type="pmid">23668293</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmore</surname><given-names>SE</given-names></name></person-group>
<article-title>Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior?</article-title>
<source>Curr Opin Otolaryngol Head Neck Surg</source> (<year>2003</year>) <volume>11</volume>(<issue>6</issue>):<fpage>485</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/00020840-200312000-00014</pub-id><pub-id pub-id-type="pmid">14631184</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>R</given-names></name><name><surname>Jackson</surname><given-names>C</given-names></name><name><surname>Kasarskis</surname><given-names>E</given-names></name><name><surname>England</surname><given-names>JD</given-names></name><name><surname>Forshew</surname><given-names>D</given-names></name><name><surname>Johnston</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology</article-title>. <source>Neurology</source> (<year>2009</year>) <volume>73</volume>(<issue>15</issue>):<fpage>1218</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181bc0141</pub-id><?supplied-pmid 19822872?><pub-id pub-id-type="pmid">19822872</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="book"><collab>National Dysphagia Diet Task Force</collab>. <source>National Dysphagia Diet: Standardization for Optimal Care</source>. <publisher-loc>Chicago, IL</publisher-loc>: <publisher-name>American Dietetic Association</publisher-name> (<year>2002</year>).</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorst</surname><given-names>J</given-names></name><name><surname>Dupuis</surname><given-names>L</given-names></name><name><surname>Petri</surname><given-names>S</given-names></name><name><surname>Kollewe</surname><given-names>K</given-names></name><name><surname>Abdulla</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study</article-title>. <source>J Neurol</source> (<year>2015</year>) <volume>262</volume>(<issue>4</issue>):<fpage>849</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1007/s00415-015-7646-2</pub-id><?supplied-pmid 25618254?><pub-id pub-id-type="pmid">25618254</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russ</surname><given-names>KB</given-names></name><name><surname>Phillips</surname><given-names>MC</given-names></name><name><surname>Mel Wilcox</surname><given-names>C</given-names></name><name><surname>Peter</surname><given-names>S</given-names></name></person-group>
<article-title>Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis</article-title>. <source>Am J Med Sci</source> (<year>2015</year>) <volume>350</volume>(<issue>2</issue>):<fpage>95</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1097/MAJ.0000000000000517</pub-id><pub-id pub-id-type="pmid">26135224</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name></person-group>. <article-title>Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China</article-title>. <source>Front Aging Neurosci</source> (<year>2016</year>) <volume>24</volume>(<issue>8</issue>):<fpage>246</fpage>.<pub-id pub-id-type="doi">10.3389/fnagi.2016.00246</pub-id><?supplied-pmid 27822184?><pub-id pub-id-type="pmid">27822184</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>E</given-names></name><name><surname>Escande</surname><given-names>D</given-names></name></person-group>. <article-title>Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre</article-title>. <source>Pflugers Arch</source> (<year>1991</year>) <volume>419</volume>(<issue>6</issue>):<fpage>603</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/BF00370302</pub-id><?supplied-pmid 1664937?><pub-id pub-id-type="pmid">1664937</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deflorio</surname><given-names>C</given-names></name><name><surname>Onesti</surname><given-names>E</given-names></name><name><surname>Lauro</surname><given-names>C</given-names></name><name><surname>Tartaglia</surname><given-names>G</given-names></name><name><surname>Giovannelli</surname><given-names>A</given-names></name><name><surname>Limatola</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Partial block by riluzole of muscle sodium channels in myotubes from amyotrophic lateral sclerosis patients</article-title>. <source>Neurol Res Int</source> (<year>2014</year>) <volume>2014</volume>:<fpage>946073</fpage>.<pub-id pub-id-type="doi">10.1155/2014/946073</pub-id><?supplied-pmid 25548669?><pub-id pub-id-type="pmid">25548669</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359625</identifier><datestamp>2017-04-04</datestamp><setSpec>frontplantsci</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Plant Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Plant Sci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Plant Sci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Plant Science</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-462X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359625</article-id>
      <article-id pub-id-type="pmcid">PMC5359625</article-id>
      <article-id pub-id-type="pmc-uid">5359625</article-id>
      <article-id pub-id-type="doi">10.3389/fpls.2017.00275</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Plant Science</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Interrelationship between Abscisic Acid and Reactive Oxygen Species Plays a Key Role in Barley Seed Dormancy and Germination</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ishibashi</surname>
            <given-names>Yushi</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/389344/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aoki</surname>
            <given-names>Nozomi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kasa</surname>
            <given-names>Shinsuke</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sakamoto</surname>
            <given-names>Masatsugu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kai</surname>
            <given-names>Kyohei</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tomokiyo</surname>
            <given-names>Reisa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watabe</surname>
            <given-names>Gaku</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yuasa</surname>
            <given-names>Takashi</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn002">
            <sup>†</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iwaya-Inoue</surname>
            <given-names>Mari</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Crop Science Laboratory, Faculty of Agriculture, Kyushu University</institution>
        <country>Fukuoka, Japan</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: <italic>Irene Murgia, University of Milan, Italy</italic></p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: <italic>Farida Minibayeva, Kazan Institute of Biochemistry and Biophysics (RAS), Russia; Hayat El-Maarouf-Bouteau, University Pierre and Marie Curie (UPMC), France</italic></p>
        </fn>
        <corresp id="fn001">*Correspondence: <italic>Yushi Ishibashi, <email xlink:type="simple">yushi@agr.kyushu-u.ac.jp</email></italic></corresp>
        <fn fn-type="other" id="fn002">
          <p><sup>†</sup>Present address: <italic>Takashi Yuasa, Department of Agricultural and Environmental Sciences, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan</italic></p>
        </fn>
        <fn fn-type="other" id="fn003">
          <p>This article was submitted to Plant Physiology, a section of the journal Frontiers in Plant Science</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>275</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Ishibashi, Aoki, Kasa, Sakamoto, Kai, Tomokiyo, Watabe, Yuasa and Iwaya-Inoue.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Ishibashi, Aoki, Kasa, Sakamoto, Kai, Tomokiyo, Watabe, Yuasa and Iwaya-Inoue</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Seed dormancy is one of the adaptive responses in the plant life cycle and an important agronomic trait. Reactive oxygen species (ROS) release seed dormancy and promote seed germination in several cereal crops; however, the key regulatory mechanism of ROS-mediated seed dormancy and germination remains controversial. Here, we focused on the relationship between hydrogen peroxide (a ROS) and abscisic acid (ABA) in dormant and non-dormant barley seeds. The hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) level produced in barley seed embryos after imbibition was higher in non-dormant seeds than in dormant seeds. H<sub>2</sub>O<sub>2</sub> regulated the ABA content in the embryos through ABA-8′-hydroxylase, an ABA catabolic enzyme. Moreover, compared with non-dormant seeds, in dormant seeds the activity of NADPH oxidase, which produces ROS, was lower, whereas the activity of catalase, which is a H<sub>2</sub>O<sub>2</sub> scavenging enzyme, was higher, as was the expression of <italic>HvCAT2</italic>. Furthermore, precocious germination of isolated immature embryos was suppressed by the transient introduction of HvCAT2 driven by the maize (<italic>Zea mays</italic>) ubiquitin promoter. <italic>HvCAT2</italic> expression was regulated through an ABA-responsive transcription factor (HvABI5) induced by ABA. These results suggest that the changing of balance between ABA and ROS is active in barley seed embryos after imbibition and regulates barley seed dormancy and germination.</p>
      </abstract>
      <kwd-group>
        <kwd>abscisic acid</kwd>
        <kwd>barley</kwd>
        <kwd>catalase</kwd>
        <kwd>embryo</kwd>
        <kwd>reactive oxygen species</kwd>
        <kwd>seed dormancy</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content></funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="67"/>
        <page-count count="10"/>
        <word-count count="0"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Seed dormancy and germination are crucial stages in a plant’s life. In wild plant species, seed dormancy plays a key role in ensuring survival by blocking germination until conditions become favorable for the later stages of germination and growth of that species (<xref rid="B8" ref-type="bibr">Bewley, 1997</xref>). Unlike many wild plant species, cultivated crops such as barley (<italic>Hordeum vulgare</italic> L.) and wheat (<italic>Triticum aestivum</italic> L.) display weak grain dormancy at maturity due to selective breeding against dormancy for uniform and vigorous germination on industrial and agricultural fields. For malting barley, long dormancy increases costs and potential damage resulting from grain storage (<xref rid="B10" ref-type="bibr">Carn, 1980</xref>). In addition, cool, moist conditions in the field can disrupt seed dormancy and cause PHS, resulting in serious losses of grain yield and quality (<xref rid="B24" ref-type="bibr">Gubler et al., 2005</xref>; <xref rid="B53" ref-type="bibr">Rodríguez et al., 2015</xref>). Therefore, research aimed at understanding environmental and genetic controls of dormancy will assist in the development of new strategies for industrial utilization and the elimination of PHS worldwide in domesticated crops.</p>
      <p>Plant hormones such as GAs and ABA play key roles in seed dormancy and germination. In particular, ABA is considered to be the key molecule in dormancy induction and maintenance (<xref rid="B19" ref-type="bibr">Finkelstein et al., 2008</xref>; <xref rid="B53" ref-type="bibr">Rodríguez et al., 2015</xref>; <xref rid="B56" ref-type="bibr">Shu et al., 2016</xref>). During seed development, embryonic ABA is required to impose lasting dormancy (<xref rid="B43" ref-type="bibr">Nambara and Marion-Poll, 2005</xref>), and <italic>de novo</italic> ABA synthesis in the embryo during imbibition ensures maintenance of dormancy (<xref rid="B33" ref-type="bibr">Kucera et al., 2005</xref>). Dormancy release by after-ripening is mediated by a decrease in ABA content in imbibed wheat and barley grains as a result of the coordinated promotion of ABA catabolism and repression of ABA biosynthesis genes (<xref rid="B40" ref-type="bibr">Millar et al., 2006</xref>; <xref rid="B30" ref-type="bibr">Jacobsen et al., 2013</xref>). In several species, the transcriptional regulation of nine-<italic>cis</italic>-epoxycarotenoid dioxygenase (<italic>NCED</italic>) and ABA-8′-hydroxylase (<italic>ABA8</italic>′<italic>OH</italic>) genes are considered key steps in this control mechanism (<xref rid="B44" ref-type="bibr">Nambara et al., 2010</xref>). In barley, <italic>HvNCED1</italic> is particularly important in the regulation of primary dormancy in blue light (<xref rid="B23" ref-type="bibr">Gubler et al., 2008</xref>) or at high temperatures (<xref rid="B37" ref-type="bibr">Leymarie et al., 2008</xref>), whereas <italic>HvNCED2</italic> expression has been implicated in the induction of primary dormancy (<xref rid="B13" ref-type="bibr">Chono et al., 2006</xref>) and the maintenance of secondary dormancy (<xref rid="B37" ref-type="bibr">Leymarie et al., 2008</xref>). The <italic>HvABA8</italic>′<italic>OH1</italic> gene plays a major role in that ABA catabolism that is required to alleviate barley grain dormancy (<xref rid="B13" ref-type="bibr">Chono et al., 2006</xref>; <xref rid="B40" ref-type="bibr">Millar et al., 2006</xref>; <xref rid="B23" ref-type="bibr">Gubler et al., 2008</xref>). ABA functions are regulated, in part, by crosstalk with other hormones such as GA and their associated signaling networks. Application of GA, an antagonist of ABA, can break dormancy in cereals (<xref rid="B31" ref-type="bibr">Jacobsen et al., 2002</xref>; <xref rid="B60" ref-type="bibr">Tuttle et al., 2015</xref>).</p>
      <p>Recently, it was reported that several signal molecules such as nitric oxide (NO) and ROS also regulate seed dormancy and germination (<xref rid="B39" ref-type="bibr">Ma et al., 2016</xref>). In barley, ROS break seed dormancy and promote germination (<xref rid="B20" ref-type="bibr">Fontaine et al., 1994</xref>; <xref rid="B28" ref-type="bibr">Ishibashi et al., 2010</xref>; <xref rid="B1" ref-type="bibr">Bahin et al., 2011</xref>). The relationships between ROS, seed dormancy, and germination have been described for many plant species, including <italic>Zinnia elegans</italic>, and sunflower (<xref rid="B45" ref-type="bibr">Ogawa and Iwabuchi, 2001</xref>; <xref rid="B47" ref-type="bibr">Oracz et al., 2007</xref>). Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), which is a ROS, is regarded as a signaling hub for the regulation of seed dormancy and germination; the precise regulation of H<sub>2</sub>O<sub>2</sub> accumulation by the cell antioxidant machinery is essential to achieve a balance between oxidative signaling that promotes germination and oxidative damage that prevents or delays germination (<xref rid="B64" ref-type="bibr">Wojtyla et al., 2016</xref>). These findings were clearly summarized and presented by <xref rid="B4" ref-type="bibr">Bailly et al. (2008)</xref> as the principle of the “oxidative window” for germination. According to this hypothesis, both lower and higher levels of ROS impair seed germination, which is only possible within a defined range of concentrations.</p>
      <p>Recent evidence shows that the selective oxidation of proteins and mRNAs can act as a positive regulator of seed germination (<xref rid="B32" ref-type="bibr">Job et al., 2005</xref>; <xref rid="B47" ref-type="bibr">Oracz et al., 2007</xref>; <xref rid="B5" ref-type="bibr">Barba-Espín et al., 2010</xref>; <xref rid="B7" ref-type="bibr">Bazin et al., 2011</xref>). <xref rid="B7" ref-type="bibr">Bazin et al. (2011)</xref> showed that approximately 24 stored mRNAs undergo oxidation during sunflower (<italic>Helianthus annuus</italic>) after-ripening. ROS production during germination contributes to reserve mobilization through oxidative modifications of stored proteins; storage organs may then recognize these modifications as signals to mobilize reserves to the rapidly growing axis. Due to the abundance of available seed storage proteins, the oxidized forms of these proteins such as heat shock proteins and elongation factors can also be considered as actor of ROS signaling in seed germination (<xref rid="B32" ref-type="bibr">Job et al., 2005</xref>; <xref rid="B5" ref-type="bibr">Barba-Espín et al., 2010</xref>). <xref rid="B47" ref-type="bibr">Oracz et al. (2007)</xref> proposed a mechanism for seed dormancy release that involves a change in proteome oxidation resulting from the accumulation of ROS during the after-ripening phase.</p>
      <p>The breaking of dormancy by ROS has also been reported in relation to plant hormone signaling in several seeds (<xref rid="B15" ref-type="bibr">El-Maarouf-Bouteau et al., 2013</xref>). Studies on phytohormone interactions in germinated seeds have shown that exogenously applied ABA inhibits ROS accumulation in barley (<xref rid="B27" ref-type="bibr">Ishibashi et al., 2012</xref>), rice (<italic>Oryza sativa</italic>; <xref rid="B65" ref-type="bibr">Ye et al., 2012</xref>), lettuce (<xref rid="B67" ref-type="bibr">Zhang et al., 2014</xref>), and sunflower (<xref rid="B16" ref-type="bibr">El-Maarouf-Bouteau et al., 2015</xref>). By contrast, the addition of GA enhances the production of ROS, mainly superoxide and H<sub>2</sub>O<sub>2</sub>, found in radish plants (<xref rid="B55" ref-type="bibr">Schopfer et al., 2001</xref>) and <italic>Arabidopsis</italic> (<xref rid="B38" ref-type="bibr">Liu et al., 2010</xref>; <xref rid="B35" ref-type="bibr">Lariguet et al., 2013</xref>). <xref rid="B1" ref-type="bibr">Bahin et al. (2011)</xref> suggested that exogenously applied H<sub>2</sub>O<sub>2</sub> does not influence ABA biosynthesis and signaling but has a pronounced effect on GA signaling, resulting in the modulation of hormonal balance and in subsequent germination initiation. The modulation of phytohormone balance during germination by exogenously applied H<sub>2</sub>O<sub>2</sub> is also a product of changes in H<sub>2</sub>O<sub>2</sub> levels in seeds treated with GA and ABA. Exogenous H<sub>2</sub>O<sub>2</sub> and NADPH oxidase inhibitor increased ABA catabolism by enhancing the expression of <italic>CYP707A</italic> genes, which encode ABA 8′-hydroxylases, and enhanced the expression of genes for GA synthesis in dormant <italic>Arabidopsis</italic> seeds (<xref rid="B38" ref-type="bibr">Liu et al., 2010</xref>) and non-dormant barley seeds (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). In non-dormant barley seeds, H<sub>2</sub>O<sub>2</sub> accumulation via superoxide produced by NADPH oxidases promote GA biosynthesis in embryos; the resulting GA induces and activates NADPH oxidases in aleurone cells, and the H<sub>2</sub>O<sub>2</sub> accumulated by the NADPH oxidases induce α-amylase in these cells (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). Therefore, it is likely that ROS is central molecule in the regulation of barley seed dormancy and germination through GA and ABA. However, the role of H<sub>2</sub>O<sub>2</sub> interactions with phytohormones in the regulation of barley seed dormancy and germination is still open to debate. The mechanism of dormancy breaking by ROS needs to be examined in detail. In this study, we, therefore, focused on the balance between plant hormones and ROS in dormant and non-dormant seeds.</p>
    </sec>
    <sec sec-type="materials|methods" id="s1">
      <title>Materials and Methods</title>
      <sec>
        <title>Plant Material</title>
        <p><italic>Hordeum vulgare</italic> L. ‘Ichibanboshi’ grains, which were grown at Kyushu University, were harvested on June 5, 2010. Experiments were carried out with dormant grains that had been stored at -28°C from harvest until the experiments began in order to maintain their initial dormancy (<xref rid="B36" ref-type="bibr">Lenoir et al., 1983</xref>). Non-dormant grains were used as controls (i.e., grains from the same harvest but stored for 6 months at 23°C).</p>
      </sec>
      <sec>
        <title>Germination Test</title>
        <p>Five replications of 20 seeds each sterilized with sodium hypochlorite were placed on filter paper in a 9-cm Petri dish, to which 6 mL of a solution of 100 mM hydrogen peroxide, 20 mM sodium ascorbate, and distilled water as control was added. The dishes were then incubated in the dark at 22°C (CRB-41L, HITACHI), and the germinating seeds, defined as seeds whose radical protruded through the seed coat, were counted daily for 5 days.</p>
      </sec>
      <sec>
        <title>Hydrogen Peroxide Content</title>
        <p>Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) content in embryos isolated from seed after imbibition was measured according to the method of <xref rid="B47" ref-type="bibr">Oracz et al. (2007)</xref> by using a peroxidase-based assay with 3-dimethylaminobenzoic acid and 1.3 mM 3-methyl-2-benzothiazolinone hydrazone to measure H<sub>2</sub>O<sub>2</sub> (<xref rid="B46" ref-type="bibr">O’Kane et al., 1996</xref>).</p>
      </sec>
      <sec>
        <title>ABA Content</title>
        <p>To measure the ABA content in embryos, we isolated embryos from 20 seeds that had imbibed for 48 h and stored them at -80°C. ABA levels were measured by using a Phytodetek Competitive ELISA kit (Agdia). Each experiment comprised five biological replicates.</p>
      </sec>
      <sec>
        <title>Quantitative Real-Time PCR</title>
        <p>Total RNA was extracted from embryos isolated after germination treatment or from embryoless half-seeds by using the SDS/phenol/LiCl method (<xref rid="B11" ref-type="bibr">Chirgwin et al., 1979</xref>). cDNA synthesis and amplification were conducted as described by <xref rid="B26" ref-type="bibr">Ishibashi et al. (2015)</xref>. The amount of each gene transcript was normalized against the amount of mRNA for <italic>HvActin</italic> (<xref rid="B59" ref-type="bibr">Trevaskis et al., 2006</xref>) by using the method of <xref rid="B50" ref-type="bibr">Pfaffl (2001)</xref>. The sequences for the <italic>HvActin</italic> primer came from <xref rid="B26" ref-type="bibr">Ishibashi et al. (2015)</xref>; the other primer sequences are shown in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
      </sec>
      <sec>
        <title>Barley Transient Expression Assay</title>
        <p>The plasmid was transformed by particle bombardment into immature embryos according to the method of <xref rid="B49" ref-type="bibr">Pellegrineschi et al. (2002)</xref> and <xref rid="B42" ref-type="bibr">Nakamura et al. (2011)</xref>. For this assay, <italic>H. vulgare</italic> L. ‘Seijo-17’ immature grains, which were grown at Kyushu University, were harvested, and immature embryos isolated from the immature grain. The immature embryos were bombarded with each plasmid, <italic>Ubi:HvCAT</italic> or <italic>Ubi:GUS</italic>, which was constructed to express each gene under the control of the promoter region and the first intron of the maize ubiquitin (<italic>Ubi-1</italic>) gene (<xref rid="B58" ref-type="bibr">Toki et al., 1992</xref>; <xref rid="B14" ref-type="bibr">Christensen and Quail, 1996</xref>). After bombardment, the immature embryos were transferred to 1/2MS medium containing 200 mg/L MES and 30 g/L maltose, and were incubated at 25°C for 2.5 days. We checked introduction of each genes using RT-PCR (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S1</xref>).</p>
      </sec>
      <sec>
        <title>Electrophoretic Mobility Shift Assay</title>
        <p>The EMSA was performed as described by <xref rid="B62" ref-type="bibr">Wang et al. (2011)</xref>. Recombinant pGEX-HvABI5 proteins were produced in <italic>Escherichia coli</italic> BL21 (DE3) pLysE. The <italic>E. coli</italic> cells were lysed by sonication, and purified with glutathione–Sepharose 4B beads (GE Healthcare). Double-stranded oligonucleotide spanning the ACGT core motif upstream of <italic>HvCAT2</italic> was prepared and carried out labeling according to the protocol provided with the DIG Kit (Roche Diagnostics). EMSAs were carried out using a DIG Gel Shift kit, 2nd Generation (Roche Diagnostics) according to the manufacturer’s instructions. The primer sequences for constructing the pGEX-HvABI5 vector and the probe sequences for the EMSA are shown in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
      </sec>
      <sec>
        <title>Enzyme Activities</title>
        <p>To measure enzyme activities, we isolated embryos from 20 seeds that had imbibed for 48 h and stored them at -80°C. The enzyme activities of APX, GPX, SOD, and CAT were measured as described by <xref rid="B29" ref-type="bibr">Ishibashi et al. (2008)</xref>. NADPH oxidase activity was assayed according to the method of <xref rid="B61" ref-type="bibr">Van Gestelen et al. (1997)</xref> and <xref rid="B54" ref-type="bibr">Sarath et al. (2007)</xref>. Protein concentration was determined by using the method <xref rid="B9" ref-type="bibr">Bradford (1976)</xref>. The results are expressed as μmol mg<sup>-1</sup> protein.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Germination Rate and Hydrogen Peroxide Content of Dormant and Non-dormant Seeds</title>
        <p>Non-dormant seeds had a germination rate of 22% at 1 day after imbibition (DAI), and 85% had germinated at 3 DAI. Dormant seeds had a germination rate of 27 and 50% at 3 and 5 DAI, respectively (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). At 2 DAI, the H<sub>2</sub>O<sub>2</sub> content in the non-dormant seeds was higher six times that in the dormant seeds (<bold>Figures <xref ref-type="fig" rid="F1">1B,C</xref></bold>). In addition, nine barley cultivars that were at different stages of dormancy had positive correlations with the H<sub>2</sub>O<sub>2</sub> contents of their embryos after imbibition (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref>). These data strongly suggest that non-dormant seeds accumulate H<sub>2</sub>O<sub>2</sub> in the embryo after imbibition, but dormant seeds do not.</p>
        <fig id="F1" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p><bold>Germination percentage and hydrogen peroxide content in dormant and non-dormant seeds. (A)</bold> Time course of the percentage of germination of dormant (closed circles) and non-dormant (open circles) seeds. Embryos removed from dormant <bold>(B)</bold> and non-dormant <bold>(C)</bold> seeds after imbibition were used to determine hydrogen peroxide contents (<italic>n</italic> = 5).</p>
          </caption>
          <graphic xlink:href="fpls-08-00275-g001"/>
        </fig>
      </sec>
      <sec>
        <title>Hydrogen Peroxide and Sodium Ascorbate Regulate Barley Seed Germination through ABA Catabolism</title>
        <p>The germination rate of dormant seeds treated with H<sub>2</sub>O<sub>2</sub> was significantly higher than that of the control (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>). In contrast, the germination rate of non-dormant seeds treated with sodium ascorbate was significantly lower than that of the control (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>). In addition, H<sub>2</sub>O<sub>2</sub> and sodium ascorbate treatments were increased and decreased the H<sub>2</sub>O<sub>2</sub> contents in the embryos after imbibition, respectively (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S4</xref>). We previously reported that a decrease in ROS, induced by the NADPH oxidase inhibitor DPI, in the embryos of barley seeds suppressed ABA catabolism in those embryos after imbibition (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). Therefore, we examined ABA content and biosynthesis, as well as the expression of ABA catabolism-related genes, in the embryos of dormant or non-dormant seeds treated with sodium ascorbate or H<sub>2</sub>O<sub>2</sub>, respectively. In the dormant seeds, the ABA content of the embryos treated with H<sub>2</sub>O<sub>2</sub> was significantly decreased compared with that in the control (<bold>Figure <xref ref-type="fig" rid="F2">2C</xref></bold>). In the non-dormant seeds, the ABA content of the embryos treated with sodium ascorbate was significantly higher than that in the control (<bold>Figure <xref ref-type="fig" rid="F2">2D</xref></bold>). The expression of <italic>HvNCED1</italic>, one of the ABA biosynthesis-related genes and a key gene regulating primary dormancy of barley (<xref rid="B40" ref-type="bibr">Millar et al., 2006</xref>), in the embryos did not differ significantly regardless of dormancy or treatment (<bold>Figures <xref ref-type="fig" rid="F2">2E,F</xref></bold>). However, the expression of <italic>ABA8</italic>′<italic>-OH1</italic>, one of the ABA catabolism-related genes and a key gene regulating primary dormancy of barley (<xref rid="B40" ref-type="bibr">Millar et al., 2006</xref>), in the embryo, was suppressed by sodium ascorbate in the non-dormant seeds and increased by H<sub>2</sub>O<sub>2</sub> in the dormant seeds (<bold>Figures <xref ref-type="fig" rid="F2">2G,H</xref></bold>). These results indicate that ROS regulate ABA catabolism in the embryos of non-dormant and dormant seeds by regulating HvABA8′-OH1.</p>
        <fig id="F2" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p><bold>Germination rate, ABA contents, and expression of ABA metabolism-related genes in dormant and non-dormant seeds.</bold> Embryos removed from seeds after 48 h imbibition were used to determine ABA contents and gene expression. <bold>(A,B)</bold> Germination rate after 48 h imbibition; <bold>(C,D)</bold> ABA contents; <bold>(E,F)</bold>
<italic>HvNCED1</italic> expression; <bold>(G,H)</bold>
<italic>HvABA8</italic>′<italic>-OH1</italic> expression. <bold>(C)</bold> control (distilled water); <bold>(H)</bold> 100 mM hydrogen peroxide; <bold>(A)</bold> 20 mM sodium ascorbate. (<sup>∗∗</sup><italic>P</italic> &lt; 0.01, Student’s test, <italic>n</italic> = 5).</p>
          </caption>
          <graphic xlink:href="fpls-08-00275-g002"/>
        </fig>
      </sec>
      <sec>
        <title>Activities of Antioxidant Enzymes and NADPH Oxidase in the Embryos of Non-dormant and Dormant Seeds</title>
        <p>Then, we examined the activities of antioxidant enzymes such as APX, GPX, SOD, and CAT, as well as the activity of NADPH oxidase (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), because the H<sub>2</sub>O<sub>2</sub> contents of the embryos during germination were higher in non-dormant seeds than in dormant seeds (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). APX activity in the embryos of dormant seeds was significantly higher than that of the embryos of non-dormant seeds (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>), although GPX activity was the same in the embryos of both non-dormant and dormant seeds (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). In contrast, SOD and CAT activities in the embryos of dormant seeds were significantly lower than those in the embryos of non-dormant seeds (<bold>Figures <xref ref-type="fig" rid="F3">3C,D</xref></bold>). We previously reported that NADPH oxidase plays a role in barley seed germination through the regulation of GA and ABA signaling (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). Therefore, we examined NADPH oxidase activity in the embryos of dormant and non-dormant seeds (<bold>Figure <xref ref-type="fig" rid="F3">3E</xref></bold>). NADPH oxidase activity was significantly higher in non-dormant seeds than in dormant seeds. These results suggest that the production of ROS in the embryos of barley seeds after imbibition is regulated by SOD, CAT, and NADPH oxidase.</p>
        <fig id="F3" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p><bold>Activity of antioxidant enzymes and NADPH oxidase in dormant and non-dormant seeds.</bold> Embryos removed from seeds after 48 h imbibition were used. <bold>(A)</bold> APX; <bold>(B)</bold>, GPX; <bold>(C)</bold>, SOD; <bold>(D)</bold>, CAT; <bold>(E)</bold>, NADPH oxidase. D, dormant seed; ND, non-dormant seed. (<sup>∗∗</sup><italic>P</italic> &lt; 0.01, Student’s test, <italic>n</italic> = 5).</p>
          </caption>
          <graphic xlink:href="fpls-08-00275-g003"/>
        </fig>
      </sec>
      <sec>
        <title>Transient Expression of CAT in Immature Embryos Decreases Their Ability to Germinate</title>
        <p>We examined the expression of <italic>HvSOD</italic> and <italic>HvCAT</italic> in the embryos of non-dormant and dormant seeds. After 24 h imbibition, the expression of <italic>HvSOD</italic> and <italic>HvCAT2</italic> was increased in the embryos of dormant seeds compared with that in the embryos of non-dormant seeds (<bold>Figures <xref ref-type="fig" rid="F4">4A,C</xref></bold>), while, after 48 h imbibition, the expression of <italic>HvSOD</italic> and <italic>HvCAT2</italic> were high in the embryo of non-dormant and dormant seeds, respectively (<bold>Figures <xref ref-type="fig" rid="F4">4B,D</xref></bold>). SOD catalyzes the reduction of the superoxide anion to hydrogen peroxide, and CAT catalyzes the decomposition of hydrogen peroxide to water. In wheat, the expression of CAT in dormant seeds was higher than that in non-dormant seeds during seed maturation (<xref rid="B29" ref-type="bibr">Ishibashi et al., 2008</xref>). In sunflower seed, relationship between CAT activity and germination is a quite close (<xref rid="B3" ref-type="bibr">Bailly et al., 1998</xref>). Additionally, <xref rid="B1" ref-type="bibr">Bahin et al. (2011)</xref> have reported that the CAT regulates hydrogen peroxide content in embryo of barley dormant seed. Therefore, we focus on the role of CAT in barley seed dormancy and germination. To examine the function of HvCAT2, which directly scavenges hydrogen peroxide, in barley seed germination, we transiently overexpressed HvCAT2 in immature embryos and examined their germination. HvCAT2 driven by the maize (<italic>Zea mays</italic>) ubiquitin promoter (Ubi:HvCAT2) was directly bombarded into immature embryos isolated from Himalaya seeds at approximately 10 days after anthesis. In general, cultured immature wheat embryos germinate precociously (<xref rid="B63" ref-type="bibr">Williamson et al., 1985</xref>). However, we observed a significant decrease in the germination percentage of immature embryos that were transformed with Ubi:HvCAT2 (<bold>Figure <xref ref-type="fig" rid="F4">4E</xref></bold>). In contrast, immature embryos transformed with the control construct β-glucuronidase (GUS) driven by the maize ubiquitin promoter (Ubi:GUS) germinated well (<bold>Figure <xref ref-type="fig" rid="F4">4E</xref></bold>). <xref rid="B42" ref-type="bibr">Nakamura et al. (2011)</xref> previously reported that the Ubi:TaMFT construct, in a similar transient assay, completely suppressed the germination of immature embryos of wheat because the TaMFT protein moved from the scutellum and coleorhiza to other parts of the seed. The partial effect of Ubi:HvCAT2 in our study was likely caused by scavenging H<sub>2</sub>O<sub>2</sub> which across cell membranes in plants (<xref rid="B25" ref-type="bibr">Hooijmaijers et al., 2012</xref>), even though HvCAT2 cannot move from the scutellum and coleorhiza to other parts of the seed.</p>
        <fig id="F4" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p><bold>Expression of HvSOD and HvCAT2 in dormant and non-dormant seeds and the germination percentage in the transient HvCAT2 expression assay.</bold> Embryos removed from seeds after 24 h <bold>(A,C)</bold> and 48 h <bold>(B,D)</bold> imbibition were used to determine gene expression levels. <bold>(A,B)</bold>
<italic>HvSOD</italic> expression; <bold>(C,D)</bold>
<italic>HvCAT2</italic> expression. <bold>(E)</bold> Time course of the germination percentage after transformation with Ubi:HvCAT2 (closed circles) or Ubi:GUS (open circles). The barley cultivar Himalaya was used. D, dormant seed; ND, non-dormant seed. (<sup>∗</sup><italic>P</italic> &lt; 0.05, <sup>∗∗</sup><italic>P</italic> &lt; 0.01, Student’s test, <italic>n</italic> = 5).</p>
          </caption>
          <graphic xlink:href="fpls-08-00275-g004"/>
        </fig>
      </sec>
      <sec>
        <title>ABA Regulates the Expression of <italic>HvCAT2</italic> through HvABI5</title>
        <p>Abscisic acid significantly increased the expression of <italic>HvCAT2</italic> in the barley seed embryo (<bold>Figures <xref ref-type="fig" rid="F5">5A,B</xref></bold>). To explore the underlying mechanisms by which ABA regulates the expression of <italic>HvCAT2</italic> during seed germination, we analyzed the promoter sequences of HvCAT2 and found an ABA response element (ABRE), which is a <italic>cis</italic>-acting element recognized by several bZIP transcription factors, such as ABI5, AREB1, AREB2, and ABF3, that function in ABA signal transduction (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S5</xref>; <xref rid="B18" ref-type="bibr">Finkelstein and Lynch, 2000</xref>). These bZIP transcription factors mediate downstream gene expression in <italic>Arabidopsis</italic> upon binding to the ABRE (<xref rid="B21" ref-type="bibr">Furihata et al., 2006</xref>; <xref rid="B66" ref-type="bibr">Yoshida et al., 2010</xref>). Our finding suggests that the expression of <italic>HvCAT2</italic> may be regulated by bZIP transcription factors involved in ABA signaling. Indeed, the expression of <italic>HvABI5</italic> in the barley seed embryo was increased by ABA (<bold>Figures <xref ref-type="fig" rid="F5">5C,D</xref></bold>). Therefore, to test this possibility, we used EMSA analyses to investigate whether HvABI5 directly binds to the promoter of HvCAT2 containing the ABRE element (<bold>Figure <xref ref-type="fig" rid="F5">5E</xref></bold>). The recombinant protein of GST–HvABI5 showed binding activities to HvCAT2 promoter fragment, and the DNA-binding activity was suppressed by competitor.</p>
        <fig id="F5" position="float">
          <label>FIGURE 5</label>
          <caption>
            <p><bold>Expression of HvCAT2 and HvABI5 in non-dormant seeds treated with 50 μM ABA and the direct interaction between HvABI5 and the HvHAT2 promoter as determined by EMSA.</bold> Embryos removed from seeds after 24 h <bold>(A,C)</bold> and 48 h <bold>(B,D)</bold> imbibition were used to determine gene expression levels. <bold>(A,B)</bold>
<italic>HvCAT2;</italic>
<bold>(C,D)</bold>
<italic>HvABI5</italic>. <bold>(E)</bold> The retarded DNA-protein complex was reduced by competition using either the wild-type or the unlabeled probes at a 100× molar excess. The arrows indicate the positions of the shifted bands and free probes, respectively. (<sup>∗∗</sup><italic>P</italic> &lt; 0.01, Student’s test, <italic>n</italic> = 5).</p>
          </caption>
          <graphic xlink:href="fpls-08-00275-g005"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The present study demonstrates that the balance between ABA and ROS in the barley seed embryo is involved in the regulation of seed dormancy and germination. The first line of evidence supporting this conclusion is the relationship between seed dormancy and H<sub>2</sub>O<sub>2</sub> level, because the degree of seed dormancy was dependent on the H<sub>2</sub>O<sub>2</sub> levels in the embryo after imbibition (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold> and Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref>). Additionally, germination rate of dormant seeds were promoted by H<sub>2</sub>O<sub>2</sub> and suppressed by sodium ascorbate, while that of non-dormant seeds were suppressed by sodium ascorbate, but not promoted by H<sub>2</sub>O<sub>2</sub> (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold> and Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S3</xref>). There have been several reports about the relationship between ROS and seed dormancy and germination, many of which are focused on phytohormone signaling and ROS involvement (<xref rid="B48" ref-type="bibr">Oracz and Karpiński, 2016</xref>). H<sub>2</sub>O<sub>2</sub> has been implicated in dormancy alleviation via its activation of GA signaling and synthesis rather than repression of ABA signaling (<xref rid="B1" ref-type="bibr">Bahin et al., 2011</xref>). In sunflower seed, however, ROS interact at the transcriptional level with the ABA signaling pathway (<xref rid="B16" ref-type="bibr">El-Maarouf-Bouteau et al., 2015</xref>). We previously reported that ROS produced by NADPH oxidase in the embryos of barley seeds promoted the catabolism of ABA (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). In the present study, NADPH oxidase activity in the embryos of non-dormant seeds was higher than that in the embryos of dormant seeds (<bold>Figure <xref ref-type="fig" rid="F3">3E</xref></bold>). In non-dormant seeds, ABA content in the embryos treated with ascorbate was higher than that in treated with distilled water, whereas, in dormant seeds, the ABA content in the embryos treated with H<sub>2</sub>O<sub>2</sub> was lower than in treated with distilled water (<bold>Figures <xref ref-type="fig" rid="F2">2C,D</xref></bold>). In addition, the regulation of ABA in the embryos of both dormant and non-dormant seeds could be attributed to the induction of <italic>HvABA8</italic>′<italic>-OH1</italic> by ROS (<bold>Figures <xref ref-type="fig" rid="F2">2G,H</xref></bold>). Two genes encoding ABA8′-OH have been identified in barley, and <italic>HvABA8</italic>′<italic>OH1</italic> is predominantly expressed in the embryos of imbibing seeds (<xref rid="B40" ref-type="bibr">Millar et al., 2006</xref>). Of note, <italic>HvABA8</italic>′<italic>OH1</italic> expression is closely associated with ABA level and germination capacity (<xref rid="B13" ref-type="bibr">Chono et al., 2006</xref>). Consistent with these facts, the knocking down of <italic>ABA8</italic>′<italic>OH1</italic> leads to increased seed ABA levels and to enhanced dormancy (<xref rid="B23" ref-type="bibr">Gubler et al., 2008</xref>). ROS produced after imbibition is involved in the regulation of barley seed dormancy and germination through the catabolism of ABA; therefore, we focused on the mechanism of ROS production. It had been reported that ROS generated by NADPH oxidases regulate barley seed germination through GA/ABA metabolism and signaling in the embryo and aleurone cells (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). In the present study, H<sub>2</sub>O<sub>2</sub> content and NADPH oxidase activity in the embryos of dormant seeds were lower than those in the embryos of non-dormant seeds (<bold>Figures <xref ref-type="fig" rid="F1">1B,C</xref>, <xref ref-type="fig" rid="F3">3E</xref></bold>). In the embryos of barley seeds, ABA suppressed the activity of NADPH oxidases (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). The decrease in ABA content by catabolism in the embryo after imbibition is promoted by ROS production through NADPH oxidase. In <italic>Arabidopsis</italic>, ABA treatment induces the expression of <italic>NADPH oxidases</italic> (<italic>AtrbohD</italic> and <italic>AtrbohF</italic>) in guard cells (<xref rid="B34" ref-type="bibr">Kwak et al., 2003</xref>). The ROS enhanced by NADPH oxidase could result in enhanced ABA accumulation, whereas enhanced ABA could result in enhanced ROS production in guard cells, creating a positive feedback loop to mediate stomatal closure (<xref rid="B41" ref-type="bibr">Mittler and Blumwald, 2015</xref>). Our results indicate that in the embryo after imbibition, ROS and ABA act antagonistically to regulate seed dormancy and germination, although this suggestion is inconsistent with other reports.</p>
      <p>In this study, we also examined the activity of the antioxidant enzymes SOD, CAT, and peroxidases (APX, GPX) that can scavenge ROS. The CAT activities in the embryos of the dormant seeds were significantly higher than those in the embryos of the non-dormant seeds (<bold>Figure <xref ref-type="fig" rid="F3">3D</xref></bold>). These results suggest that the H<sub>2</sub>O<sub>2</sub> contents in the embryos of dormant and non-dormant seeds depend on CAT activity. CAT is reported to play an important role in the seed germination process. CAT expression levels increase in germinating sunflower seeds prior to radicle protrusion, with a concomitant decrease in H<sub>2</sub>O<sub>2</sub> content (<xref rid="B2" ref-type="bibr">Bailly, 2004</xref>). A similar increase in CAT activity has been described during the germination of maize, soybean, <italic>Arabidopsis</italic>, and sweet corn seeds (<xref rid="B52" ref-type="bibr">Puntarulo et al., 1991</xref>; <xref rid="B22" ref-type="bibr">Gallardo et al., 2001</xref>; <xref rid="B51" ref-type="bibr">Posmyk et al., 2001</xref>; <xref rid="B12" ref-type="bibr">Chiu et al., 2002</xref>). In dormant barley seeds, H<sub>2</sub>O<sub>2</sub> treatment induced an increase in CAT activity that was associated with accumulation of the <italic>HvCAT2</italic> transcript in the embryos (<xref rid="B1" ref-type="bibr">Bahin et al., 2011</xref>). Barley has two CAT isozymes, HvCAT1 and HvCAT2; however, <italic>HvCAT1</italic> was not expressed in our embryos (data not shown). In the present study, the expression of <italic>HvCAT2</italic> in the embryos of dormant seeds was significantly higher than in those of non-dormant seeds (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>). In nine cultivars that were at different stages of dormancy, <italic>HvCAT2</italic> expression correlated with the germination index except for one cultivar (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S6</xref>). In addition, precocious germination of isolated immature embryos was suppressed by the transient introduction of HvCAT2 driven by the maize (<italic>Zea mays</italic>) ubiquitin promoter (<bold>Figure <xref ref-type="fig" rid="F4">4E</xref></bold>). These results indicated that CAT is involved in germination of barley seed after imbibition through the regulation of ROS.</p>
      <p>The expression of <italic>HvCAT2</italic> was suppressed by ABA (<bold>Figures <xref ref-type="fig" rid="F5">5A,B</xref></bold>, also <xref rid="B1" ref-type="bibr">Bahin et al., 2011</xref>); therefore, we investigated the promoter sequence of <italic>HvCAT2</italic>. The promoter sequence included an ABA-responsive element (ABRE), an ABRE-related coupling element (CE), and RY repeat motifs (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S5</xref>). Interestingly, the promoter of <italic>Sdr4</italic>, which regulates rice seed dormancy, has seven RY repeats, which are important for seed-specific gene expression and are the target of the VP1/ABI3 subfamily of B3 domain transcription factors (<xref rid="B6" ref-type="bibr">Baumlein et al., 1992</xref>), along with the ABRE and CE (<xref rid="B57" ref-type="bibr">Sugimoto et al., 2010</xref>). The dormancy state is characterized by the transcription of genes with large numbers of ABRE sequences to which transcription factors like ABI5 bind to regulate seed dormancy (<xref rid="B17" ref-type="bibr">Finch-Savage and Leubner-Metzger, 2006</xref>). In the present study, the expression of HvABI5 in the embryos was increased by ABA (<bold>Figure <xref ref-type="fig" rid="F5">5C</xref></bold>), but not HvVP1 (data not shown). Moreover, we determined that recombinant HvABI5 binds to the HvCAT2 promoter including the ABRE (<bold>Figure <xref ref-type="fig" rid="F5">5E</xref></bold>). These results suggest that the expression of <italic>HvCAT2</italic> is regulated through HvABI5 induced by ABA.</p>
      <p><xref rid="B1" ref-type="bibr">Bahin et al. (2011)</xref> suggested that H<sub>2</sub>O<sub>2</sub> plays a role in the alleviation of barley seed dormancy through the activation of GA signaling and/or biosynthesis rather than through the inhibition of ABA signaling. They found that exogenously applied H<sub>2</sub>O<sub>2</sub> does not influence ABA biosynthesis and signaling but does have a pronounced effect on GA signaling, resulting in the modulation of hormonal balance and in subsequent germination initiation. However, by using dormant and non-dormant seeds in this study, we found that H<sub>2</sub>O<sub>2</sub> regulated ABA content through HvABA8′-OH1-mediated catabolism of ABA (<bold>Figures <xref ref-type="fig" rid="F2">2C,D,G,H</xref></bold>). <xref rid="B38" ref-type="bibr">Liu et al. (2010)</xref> proposed a hypothetical model that explains the interrelationships between H<sub>2</sub>O<sub>2</sub> and NO in the regulation of <italic>Arabidopsis</italic> seed germination in terms of the joint actions of ABA and GA. According to this model, H<sub>2</sub>O<sub>2</sub> can interrupt the dormancy of <italic>Arabidopsis</italic> seeds through two pathways. The first pathway relies on the enhancement of ABA catabolism and GA biosynthesis. The signaling molecule (NO) does not regulate GA biosynthesis directly but instead acts as a temporary signaling molecule involved in the H<sub>2</sub>O<sub>2</sub> regulation of ABA catabolism. The second pathway assumes negative regulation of GA biosynthesis by ABA. We previously reported that ROS induced by NADPH oxidase regulate barley seed germination by promoting ABA catabolism and GA biosynthesis (<xref rid="B26" ref-type="bibr">Ishibashi et al., 2015</xref>). Our results in this study suggest that dormant seeds maintain high ABA contents, promoting <italic>HvCAT2</italic> expression through ABI5 for H<sub>2</sub>O<sub>2</sub> catabolism. In addition, ABA catabolism through HvABA8′OH1 was promoted by H<sub>2</sub>O<sub>2</sub>. Therefore, dormant seeds had low ROS contents with decreased <italic>HvABA8</italic>′<italic>OH1</italic> expression, which maintained high ABA contents. Taken together, our findings suggest that the interrelationship between ABA and ROS may play an important role in seed dormancy and germination, as shown in <bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>, although it should also be added that the mechanism might be included in seedling stage.</p>
      <fig id="F6" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p><bold>The interrelationship between ABA and ROS involved in barley seed dormancy and germination</bold>.</p>
        </caption>
        <graphic xlink:href="fpls-08-00275-g006"/>
      </fig>
    </sec>
    <sec>
      <title>Author Contributions</title>
      <p>Conceived and designed the experiments: YI, TY, and MI-I. Performed the experiments: YI, SK, MS, NA, KK, RT, and GW. Analyzed the data: YI, NA, TY, and MI-I. Contributed reagents/materials/analysis tools: YI, SK, MS, NA, KK, RT, and GW. Wrote the paper: YI and MI-I.</p>
    </sec>
    <sec>
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>This work was supported by JSPS KAKENHI Grant Number 16H06183.</p>
    </ack>
    <sec sec-type="supplementary material">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fpls.2017.00275/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fpls.2017.00275/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <media xlink:href="Table_1.PDF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <media xlink:href="Presentation_1.PDF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahin</surname><given-names>E.</given-names></name><name><surname>Bailly</surname><given-names>C.</given-names></name><name><surname>Sotta</surname><given-names>B.</given-names></name><name><surname>Kranner</surname><given-names>I.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name><name><surname>Leymarie</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Crosstalk between reactive oxygen species and hormonal signaling pathways regulates grain dormancy in barley.</article-title>
<source><italic>Plant Cell Environ.</italic></source>
<volume>34</volume>
<fpage>980</fpage>–<lpage>993</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3040.2011.02298.x</pub-id><pub-id pub-id-type="pmid">21388415</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Active oxygen species and antioxidants in seed biology.</article-title>
<source><italic>Seed Sci. Res.</italic></source>
<volume>4</volume>
<fpage>93</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1079/SSR2004159</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>C.</given-names></name><name><surname>Benamar</surname><given-names>A.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name><name><surname>Côme</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>Free radical scavenging as affected by accelerated ageing and subsequent priming in sunflower seeds.</article-title>
<source><italic>Physiol. Planta.</italic></source>
<volume>104</volume>
<fpage>646</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3054.1998.1040418.x</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>C.</given-names></name><name><surname>El-Maarouf-Bouteau</surname><given-names>H.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>From intracellular signaling networks to cell death: the dual role of reactive oxygen species in seed physiology.</article-title>
<source><italic>C. R. Biol.</italic></source>
<volume>331</volume>
<fpage>806</fpage>–<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1016/j.crvi.2008.07.022</pub-id><pub-id pub-id-type="pmid">18926495</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barba-Espín</surname><given-names>G.</given-names></name><name><surname>Díaz-Vivancos</surname><given-names>P.</given-names></name><name><surname>Clemente-Moreno</surname><given-names>M. J.</given-names></name><name><surname>Albacete</surname><given-names>A.</given-names></name><name><surname>Faize</surname><given-names>L.</given-names></name><name><surname>Faize</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Interaction between hydrogen peroxide and plant hormones during germination and the early growth of pea seedlings.</article-title>
<source><italic>Plant Cell Environ.</italic></source>
<volume>33</volume>
<fpage>981</fpage>–<lpage>994</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3040.2010.02120.x</pub-id><pub-id pub-id-type="pmid">20102539</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumlein</surname><given-names>H.</given-names></name><name><surname>Nagyt</surname><given-names>I.</given-names></name><name><surname>Villarroel</surname><given-names>R.</given-names></name><name><surname>Inzé</surname><given-names>D.</given-names></name><name><surname>Wobus</surname><given-names>U.</given-names></name></person-group> (<year>1992</year>). <article-title>Cis-analysis of a seed protein gene promoter: the conservative RY repeat CATGCATG within the legumin box is essential for tissue-specific expression of a legumin gene.</article-title>
<source><italic>Plant J.</italic></source>
<volume>2</volume>
<fpage>233</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">1338774</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazin</surname><given-names>J.</given-names></name><name><surname>Batlla</surname><given-names>D.</given-names></name><name><surname>Dussert</surname><given-names>S.</given-names></name><name><surname>Maarouf-Bouteau</surname><given-names>H. E.</given-names></name><name><surname>Bailly</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of relative humidity, temperature, and water status in dormancy alleviation of sunflower seeds during dry after-ripening.</article-title>
<source><italic>J. Exp. Bot.</italic></source>
<volume>62</volume>
<fpage>627</fpage>–<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/erq314</pub-id><pub-id pub-id-type="pmid">20978143</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bewley</surname><given-names>D.</given-names></name></person-group> (<year>1997</year>). <article-title>Seed germination and dormancy.</article-title>
<source><italic>Plant Cell</italic></source>
<volume>9</volume>
<fpage>1055</fpage>–<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1105/tpc.9.7.1055</pub-id><pub-id pub-id-type="pmid">12237375</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>M. M.</given-names></name></person-group> (<year>1976</year>). <article-title>Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.</article-title>
<source><italic>Anal. Biochem.</italic></source>
<volume>72</volume>
<fpage>248</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id><pub-id pub-id-type="pmid">942051</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carn</surname><given-names>J. D.</given-names></name></person-group> (<year>1980</year>). <article-title>“Detection of rain damaged barley at harvest (pre-harvest sprouting),” in</article-title>
<source><italic>Proceedings of the 30th Annual Australian Cereal Chemistry Conference</italic></source> (<publisher-loc>Melbourne, VIC</publisher-loc>: <publisher-name>Royal Australian Chemistry Institute</publisher-name>) <fpage>34</fpage>–<lpage>38</lpage>.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chirgwin</surname><given-names>J. M.</given-names></name><name><surname>Przybyla</surname><given-names>A. E.</given-names></name><name><surname>MacDonald</surname><given-names>R. J.</given-names></name><name><surname>Rutter</surname><given-names>W. J.</given-names></name></person-group> (<year>1979</year>). <article-title>Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>24</volume>
<fpage>5294</fpage>–<lpage>5299</lpage>. <pub-id pub-id-type="doi">10.1021/bi00591a005</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>K. Y.</given-names></name><name><surname>Chen</surname><given-names>C. L.</given-names></name><name><surname>Sung</surname><given-names>J. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Effect of priming temperature on storability of primed sh-2 sweet corn seed.</article-title>
<source><italic>Crop Sci.</italic></source>
<volume>42</volume>
<fpage>1996</fpage>–<lpage>2003</lpage>. <pub-id pub-id-type="doi">10.2135/cropsci2002.1996</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chono</surname><given-names>M.</given-names></name><name><surname>Honda</surname><given-names>I.</given-names></name><name><surname>Shinoda</surname><given-names>S.</given-names></name><name><surname>Kushiro</surname><given-names>T.</given-names></name><name><surname>Kamiya</surname><given-names>Y.</given-names></name><name><surname>Nambara</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Field studies on the regulation of abscisic acid content and germinability during grain development of barley: molecular and chemical analysis of pre-harvest sprouting.</article-title>
<source><italic>J. Exp. Bot.</italic></source>
<volume>57</volume>
<fpage>2421</fpage>–<lpage>2434</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/erj215</pub-id><pub-id pub-id-type="pmid">16798848</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>A. H.</given-names></name><name><surname>Quail</surname><given-names>P. H.</given-names></name></person-group> (<year>1996</year>). <article-title>Ubiquitin promoter-based vectors for high-level expression of selectable and/or screenable marker genes in monocotyledonous plants.</article-title>
<source><italic>Transgenic Res.</italic></source>
<volume>5</volume>
<fpage>213</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1007/BF01969712</pub-id><pub-id pub-id-type="pmid">8673150</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Maarouf-Bouteau</surname><given-names>H.</given-names></name><name><surname>Meimoun</surname><given-names>P.</given-names></name><name><surname>Job</surname><given-names>C.</given-names></name><name><surname>Job</surname><given-names>D.</given-names></name><name><surname>Bailly</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of protein and mRNA oxidation in seed dormancy and germination.</article-title>
<source><italic>Front. Plant Sci.</italic></source>
<volume>4</volume>:<issue>77</issue>
<pub-id pub-id-type="doi">10.3389/fpls.2013.00077</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Maarouf-Bouteau</surname><given-names>H.</given-names></name><name><surname>Sajjad</surname><given-names>Y.</given-names></name><name><surname>Bazin</surname><given-names>J.</given-names></name><name><surname>Langlade</surname><given-names>N.</given-names></name><name><surname>Cristescu</surname><given-names>S. M.</given-names></name><name><surname>Balzergue</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Reactive oxygen species, abscisic acid and ethylene interact to regulate sunflower seed germination.</article-title>
<source><italic>Plant Cell Environ.</italic></source>
<volume>38</volume>
<fpage>364</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1111/pce.12371</pub-id><pub-id pub-id-type="pmid">24811898</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finch-Savage</surname><given-names>W. E.</given-names></name><name><surname>Leubner-Metzger</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Seed dormancy and the control of germination.</article-title>
<source><italic>New Phytol.</italic></source>
<volume>171</volume>
<fpage>501</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8137.2006.01787.x</pub-id><pub-id pub-id-type="pmid">16866955</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkelstein</surname><given-names>R. R.</given-names></name><name><surname>Lynch</surname><given-names>T. J.</given-names></name></person-group> (<year>2000</year>). <article-title>The Arabidopsis abscisic acid response gene <italic>ABI5</italic> encodes a basic leucine zipper transcription factor.</article-title>
<source><italic>Plant Cell</italic></source>
<volume>12</volume>
<fpage>599</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1105/tpc.12.4.599</pub-id><pub-id pub-id-type="pmid">10760247</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkelstein</surname><given-names>R.</given-names></name><name><surname>Reeves</surname><given-names>W.</given-names></name><name><surname>Ariizumi</surname><given-names>T.</given-names></name><name><surname>Steber</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Molecular aspects of seed dormancy.</article-title>
<source><italic>Ann. Rev. Plant Biol.</italic></source>
<volume>59</volume>
<fpage>387</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.arplant.59.032607.092740</pub-id><pub-id pub-id-type="pmid">18257711</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>O.</given-names></name><name><surname>Huault</surname><given-names>C.</given-names></name><name><surname>Pavis</surname><given-names>N.</given-names></name><name><surname>Billard</surname><given-names>J. P.</given-names></name></person-group> (<year>1994</year>). <article-title>Dormancy breakage of Hordeum vulgare seeds: effects of hydrogen peroxide and scarification on glutathione level and glutathione reductase activity.</article-title>
<source><italic>Plant Physiol. Biochem.</italic></source>
<volume>32</volume>
<fpage>677</fpage>–<lpage>683</lpage>.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furihata</surname><given-names>T.</given-names></name><name><surname>Maruyama</surname><given-names>K.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Umezawa</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>R.</given-names></name><name><surname>Shinozaki</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>ABA-dependent multisite phosphorylation regulates the activity of a transcription activator AREB1.</article-title>
<source><italic>Proc. Nati. Acad. Sci. U.S.A.</italic></source>
<volume>103</volume>
<fpage>1988</fpage>–<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0505667103</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallardo</surname><given-names>K.</given-names></name><name><surname>Job</surname><given-names>C.</given-names></name><name><surname>Groot</surname><given-names>S. P.</given-names></name><name><surname>Puype</surname><given-names>M.</given-names></name><name><surname>Demol</surname><given-names>H.</given-names></name><name><surname>Vandekerckhove</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Proteomic analysis of <italic>Arabidopsis</italic> seed germination and priming.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>126</volume>
<fpage>835</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1104/pp.126.2.835</pub-id><pub-id pub-id-type="pmid">11402211</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubler</surname><given-names>F.</given-names></name><name><surname>Hughes</surname><given-names>T.</given-names></name><name><surname>Waterhouse</surname><given-names>P.</given-names></name><name><surname>Jacobsen</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Regulation of dormancy in barley by blue light and after-ripening: effects on abscisic acid and gibberellin metabolism.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>147</volume>
<fpage>886</fpage>–<lpage>896</lpage>. <pub-id pub-id-type="doi">10.1104/pp.107.115469</pub-id><pub-id pub-id-type="pmid">18408047</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubler</surname><given-names>F.</given-names></name><name><surname>Millar</surname><given-names>A. A.</given-names></name><name><surname>Jacobsen</surname><given-names>J. V.</given-names></name></person-group> (<year>2005</year>). <article-title>Dormancy release, ABA and pre-harvest sprouting.</article-title>
<source><italic>Curr. Opin. Plant Biol.</italic></source>
<volume>8</volume>
<fpage>183</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbi.2005.01.011</pub-id><pub-id pub-id-type="pmid">15752999</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooijmaijers</surname><given-names>C.</given-names></name><name><surname>Rhee</surname><given-names>J. Y.</given-names></name><name><surname>Kwak</surname><given-names>K. J.</given-names></name><name><surname>Chung</surname><given-names>G. C.</given-names></name><name><surname>Horie</surname><given-names>T.</given-names></name><name><surname>Katsuhara</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Hydrogen peroxide permeability of plasma membrane aquaporins of <italic>Arabidopsis thaliana</italic>.</article-title>
<source><italic>J. Plant Res.</italic></source>
<volume>125</volume>
<fpage>147</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1007/s10265-011-0413-2</pub-id><pub-id pub-id-type="pmid">21390558</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>Y.</given-names></name><name><surname>Kasa</surname><given-names>S.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Aoki</surname><given-names>N.</given-names></name><name><surname>Kai</surname><given-names>K.</given-names></name><name><surname>Yuasa</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A role for reactive oxygen species produced by NADPH oxidases in the embryo and aleurone cells in barley seed germination.</article-title>
<source><italic>PLoS ONE</italic></source>
<volume>10</volume>:<issue>e0143173</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0143173</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>Y.</given-names></name><name><surname>Tawaratsumida</surname><given-names>T.</given-names></name><name><surname>Kondo</surname><given-names>K.</given-names></name><name><surname>Kasa</surname><given-names>S.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Aoki</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Reactive oxygen species are involved in gibberellin/abscisic acid signaling in barley aleurone cells.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>158</volume>
<fpage>1705</fpage>–<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1104/pp.111.192740</pub-id><pub-id pub-id-type="pmid">22291200</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>Y.</given-names></name><name><surname>Tawaratsumida</surname><given-names>T.</given-names></name><name><surname>Zheng</surname><given-names>S. H.</given-names></name><name><surname>Yuasa</surname><given-names>T.</given-names></name><name><surname>Iwaya-Inoue</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>NADPH oxidases act as key enzyme on germination and seedling growth in barley (<italic>Hordeum vulgare</italic> L.).</article-title>
<source><italic>Plant Prod. Sci.</italic></source>
<volume>13</volume>
<fpage>45</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1626/pps.13.45</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Tawaratsumida</surname><given-names>T.</given-names></name><name><surname>Yuasa</surname><given-names>T.</given-names></name><name><surname>Iwaya-Inoue</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Hydrogen peroxide scavenging regulates germination ability during wheat (<italic>Triticum aestivum</italic> L.) seed maturation.</article-title>
<source><italic>Plant Signal. Behav.</italic></source>
<volume>3</volume>
<fpage>183</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.4161/psb.3.3.5540</pub-id><pub-id pub-id-type="pmid">19513213</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>J. V.</given-names></name><name><surname>Barrero</surname><given-names>J. M.</given-names></name><name><surname>Hughes</surname><given-names>T.</given-names></name><name><surname>Julkowska</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>J. M.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Roles for blue light, jasmonate and nitric oxide in the regulation of dormancy and germination in wheat grain (<italic>Triticum aestivum</italic> L).</article-title>
<source><italic>Planta</italic></source>
<volume>238</volume>
<fpage>121</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1007/s00425-013-1878-0</pub-id><pub-id pub-id-type="pmid">23588419</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>J. V.</given-names></name><name><surname>Pearce</surname><given-names>D. W.</given-names></name><name><surname>Poole</surname><given-names>A. T.</given-names></name><name><surname>Pharis</surname><given-names>R. P.</given-names></name><name><surname>Mander</surname><given-names>L. N.</given-names></name></person-group> (<year>2002</year>). <article-title>Abscisic acid, phaseic acid and gibberellin contents associated with dormancy and germination in barley.</article-title>
<source><italic>Physiol. Planta.</italic></source>
<volume>115</volume>
<fpage>428</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3054.2002.1150313.x</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Job</surname><given-names>C.</given-names></name><name><surname>Rajjou</surname><given-names>L.</given-names></name><name><surname>Lovigny</surname><given-names>Y.</given-names></name><name><surname>Belghazi</surname><given-names>M.</given-names></name><name><surname>Job</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Patterns of protein oxidation in <italic>Arabidopsis</italic> seeds during germination.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>138</volume>
<fpage>790</fpage>–<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1104/pp.105.062778</pub-id><pub-id pub-id-type="pmid">15908592</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucera</surname><given-names>B.</given-names></name><name><surname>Cohn</surname><given-names>M. A.</given-names></name><name><surname>Leubner-Metzger</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Plant hormone interactions during seed dormancy release and germination.</article-title>
<source><italic>Seed Sci. Res.</italic></source>
<volume>15</volume>
<fpage>281</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1079/SSR2005218</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>J. M.</given-names></name><name><surname>Mori</surname><given-names>I. C.</given-names></name><name><surname>Pei</surname><given-names>Z.-M.</given-names></name><name><surname>Leonhardt</surname><given-names>N.</given-names></name><name><surname>Torres</surname><given-names>M. A.</given-names></name><name><surname>Dangl</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>NADPH oxidase <italic>AtrbohD</italic> and <italic>AtrbohF</italic> genes function in ROS-dependent ABA signaling in <italic>Arabidopsis</italic>.</article-title>
<source><italic>EMBO J.</italic></source>
<volume>22</volume>
<fpage>2623</fpage>–<lpage>2633</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg277</pub-id><pub-id pub-id-type="pmid">12773379</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lariguet</surname><given-names>P.</given-names></name><name><surname>Ranocha</surname><given-names>P.</given-names></name><name><surname>De Meyer</surname><given-names>M.</given-names></name><name><surname>Barbier</surname><given-names>O.</given-names></name><name><surname>Penel</surname><given-names>C.</given-names></name><name><surname>Dunand</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Identification of a hydrogen peroxide signalling pathway in the control of light-dependent germination in <italic>Arabidopsis</italic>.</article-title>
<source><italic>Planta</italic></source>
<volume>238</volume>
<fpage>381</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1007/s00425-013-1901-5</pub-id><pub-id pub-id-type="pmid">23716184</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenoir</surname><given-names>C.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name><name><surname>Côme</surname><given-names>D.</given-names></name></person-group> (<year>1983</year>). <article-title>Rôle des glumelles dans la dormance des semences d’orge.</article-title>
<source><italic>Physiol. Végétale</italic></source>
<volume>121</volume>
<fpage>633</fpage>–<lpage>643</lpage>.</mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leymarie</surname><given-names>J.</given-names></name><name><surname>Robayo-Romero</surname><given-names>M. E.</given-names></name><name><surname>Gendreau</surname><given-names>E.</given-names></name><name><surname>Benech-Arnold</surname><given-names>R. L.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Involvement of ABA in induction of secondary dormancy in barley (<italic>Hordeum vulgare</italic> L.) seeds.</article-title>
<source><italic>Plant Cell Physiol.</italic></source>
<volume>49</volume>
<fpage>1830</fpage>–<lpage>1838</lpage>. <pub-id pub-id-type="doi">10.1093/pcp/pcn164</pub-id><pub-id pub-id-type="pmid">18974197</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>H<sub>2</sub>O<sub>2</sub> mediates the regulation of ABA catabolism and GA biosynthesis in <italic>Arabidopsis</italic> seed dormancy and germination.</article-title>
<source><italic>J. Exp. Bot.</italic></source>
<volume>61</volume>
<fpage>2979</fpage>–<lpage>2990</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/erq125</pub-id><pub-id pub-id-type="pmid">20460363</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Marsolais</surname><given-names>F.</given-names></name><name><surname>Bykova</surname><given-names>N. V.</given-names></name><name><surname>Igamberdiev</surname><given-names>A. U.</given-names></name></person-group> (<year>2016</year>). <article-title>Nitric oxide and reactive oxygen species mediate metabolic changes in barley seed embryo during germination.</article-title>
<source><italic>Front. Plant Sci.</italic></source>
<volume>7</volume>:<issue>138</issue>
<pub-id pub-id-type="doi">10.3389/fpls.2016.00138</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>A. A.</given-names></name><name><surname>Jacobsen</surname><given-names>J. V.</given-names></name><name><surname>Ross</surname><given-names>J. J.</given-names></name><name><surname>Helliwell</surname><given-names>C. A.</given-names></name><name><surname>Poole</surname><given-names>A. T.</given-names></name><name><surname>Scofield</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Seed dormancy and ABA metabolism in <italic>Arabidopsis</italic> and barley: the role of ABA 8′-hydroxylase.</article-title>
<source><italic>Plant J.</italic></source>
<volume>45</volume>
<fpage>942</fpage>–<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2006.02659.x</pub-id><pub-id pub-id-type="pmid">16507085</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittler</surname><given-names>R.</given-names></name><name><surname>Blumwald</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>The roles of ROS and ABA in systemic acquired acclimation.</article-title>
<source><italic>Plant Cell</italic></source>
<volume>27</volume>
<fpage>64</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1105/tpc.114.133090</pub-id><pub-id pub-id-type="pmid">25604442</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Abe</surname><given-names>F.</given-names></name><name><surname>Kawahigashi</surname><given-names>H.</given-names></name><name><surname>Nakazono</surname><given-names>K.</given-names></name><name><surname>Tagiri</surname><given-names>A.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>A wheat homolog of MOTHER OF FT AND TFL1 acts in the regulation of germination.</article-title>
<source><italic>Plant Cell</italic></source>
<volume>23</volume>
<fpage>3215</fpage>–<lpage>3229</lpage>. <pub-id pub-id-type="doi">10.1105/tpc.111.088492</pub-id><pub-id pub-id-type="pmid">21896881</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambara</surname><given-names>E.</given-names></name><name><surname>Marion-Poll</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Abscisic acid biosynthesis and catabolism.</article-title>
<source><italic>Ann. Rev. Plant Biol.</italic></source>
<volume>56</volume>
<fpage>165</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.arplant.56.032604.144046</pub-id><pub-id pub-id-type="pmid">15862093</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambara</surname><given-names>E.</given-names></name><name><surname>Okamoto</surname><given-names>M.</given-names></name><name><surname>Tatematsu</surname><given-names>K.</given-names></name><name><surname>Yano</surname><given-names>R.</given-names></name><name><surname>Seo</surname><given-names>M.</given-names></name><name><surname>Kamiya</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Abscisic acid and the control of seed dormancy and germination.</article-title>
<source><italic>Seed Sci. Res.</italic></source>
<volume>20</volume>
<fpage>55</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1017/S0960258510000012</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>K.</given-names></name><name><surname>Iwabuchi</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Mechanism for promoting the germination of <italic>Zinnia elegans</italic> seeds by hydrogen peroxide.</article-title>
<source><italic>Plant Cell Physiol.</italic></source>
<volume>42</volume>
<fpage>286</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1093/pcp/pce032</pub-id><pub-id pub-id-type="pmid">11266579</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Kane</surname><given-names>D.</given-names></name><name><surname>Gill</surname><given-names>V.</given-names></name><name><surname>Boyd</surname><given-names>P.</given-names></name><name><surname>Burdon</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Chilling, oxidative stress and antioxidant responses in <italic>Arabidopsis thaliana</italic> callus.</article-title>
<source><italic>Planta</italic></source>
<volume>198</volume>
<fpage>371</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1007/BF00620053</pub-id><pub-id pub-id-type="pmid">8717134</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oracz</surname><given-names>K.</given-names></name><name><surname>El-Maarouf-Bouteau</surname><given-names>H.</given-names></name><name><surname>Farrant</surname><given-names>J. M.</given-names></name><name><surname>Cooper</surname><given-names>K.</given-names></name><name><surname>Belghazi</surname><given-names>M.</given-names></name><name><surname>Job</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>ROS production and protein oxidation as a novel mechanism of seed dormancy alleviation.</article-title>
<source><italic>Plant J.</italic></source>
<volume>50</volume>
<fpage>452</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2007.03063.x</pub-id><pub-id pub-id-type="pmid">17376157</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oracz</surname><given-names>K.</given-names></name><name><surname>Karpiński</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Phytohormones signaling pathways and ROS involvement in seed germination.</article-title>
<source><italic>Front. Plant Sci.</italic></source>
<volume>7</volume>:<issue>864</issue>
<pub-id pub-id-type="doi">10.3389/fpls.2016.00864</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrineschi</surname><given-names>A.</given-names></name><name><surname>Noguera</surname><given-names>L. M.</given-names></name><name><surname>Skovmand</surname><given-names>B.</given-names></name><name><surname>Brito</surname><given-names>R. M.</given-names></name><name><surname>Velazquez</surname><given-names>L.</given-names></name><name><surname>Salgado</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Identification of highly transformable wheat genotypes for mass production of fertile transgenic plants.</article-title>
<source><italic>Genome</italic></source>
<volume>45</volume>
<fpage>421</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1139/g01-154</pub-id><pub-id pub-id-type="pmid">11962639</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>M. W.</given-names></name></person-group> (<year>2001</year>). <article-title>A new mathematical model for relative quantification in real-time RT-PCR.</article-title>
<source><italic>Nucl. Acids Res.</italic></source>
<volume>29</volume>
<fpage>2002</fpage>–<lpage>2007</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.9.e45</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posmyk</surname><given-names>M. M.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name><name><surname>Vinel</surname><given-names>D.</given-names></name><name><surname>Bailly</surname><given-names>C.</given-names></name><name><surname>Côme</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Osmoconditioning reduces physiological and biochemical damage induced by chilling in soybean seeds.</article-title>
<source><italic>Physiol. Planta.</italic></source>
<volume>111</volume>
<fpage>473</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3054.2001.1110407.x</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puntarulo</surname><given-names>S.</given-names></name><name><surname>Galleano</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>R. A.</given-names></name><name><surname>Boveris</surname><given-names>A.</given-names></name></person-group> (<year>1991</year>). <article-title>Superoxide anion and hydrogen peroxide metabolism in soybean embryonic axes during germination.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1074</volume>
<fpage>277</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/0304-4165(91)90164-C</pub-id><pub-id pub-id-type="pmid">1648400</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname><given-names>M. V.</given-names></name><name><surname>Barrero</surname><given-names>J. M.</given-names></name><name><surname>Corbineau</surname><given-names>F.</given-names></name><name><surname>Gubler</surname><given-names>F.</given-names></name><name><surname>Benech-Arnold</surname><given-names>R. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Dormancy in cereals (not too much, not so little): about the mechanisms behind this trait.</article-title>
<source><italic>Seed Sci. Res.</italic></source>
<volume>25</volume>
<fpage>99</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1017/S0960258515000021</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarath</surname><given-names>G.</given-names></name><name><surname>Mitchell</surname><given-names>R.</given-names></name><name><surname>Hou</surname><given-names>G.</given-names></name><name><surname>Baird</surname><given-names>L. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Reactive oxygen species, ABA and nitric oxide interactions on the germination of warm-season C4 grasses.</article-title>
<source><italic>Planta</italic></source>
<volume>226</volume>
<fpage>697</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1007/s00425-007-0517-z</pub-id><pub-id pub-id-type="pmid">17431667</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schopfer</surname><given-names>P.</given-names></name><name><surname>Plachy</surname><given-names>C.</given-names></name><name><surname>Frahry</surname><given-names>G.</given-names></name></person-group> (<year>2001</year>). <article-title>Release of reactive oxygen intermediates (superoxide radicals, hydrogen peroxide, and hydroxyl radicals) and peroxidase in germinating radish seeds controlled by light, gibberellin, and abscisic acid.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>125</volume>
<fpage>1591</fpage>–<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1104/pp.125.4.1591</pub-id><pub-id pub-id-type="pmid">11299341</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>X. D.</given-names></name><name><surname>Xie</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>Z. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Two faces of one seed: hormonal regulation of dormancy and germination.</article-title>
<source><italic>Mol. Plant</italic></source>
<volume>9</volume>
<fpage>34</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.molp.2015.08.010</pub-id><pub-id pub-id-type="pmid">26343970</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>K.</given-names></name><name><surname>Takeuchi</surname><given-names>Y.</given-names></name><name><surname>Ebana</surname><given-names>K.</given-names></name><name><surname>Miyao</surname><given-names>A.</given-names></name><name><surname>Hirochika</surname><given-names>H.</given-names></name><name><surname>Hara</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Molecular cloning of Sdr4, a regulator involved in seed dormancy and domestication of rice.</article-title>
<source><italic>Proc. Nati. Acad. Sci. U.S.A.</italic></source>
<volume>107</volume>
<fpage>5792</fpage>–<lpage>5797</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0911965107</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toki</surname><given-names>S.</given-names></name><name><surname>Takamatsu</surname><given-names>S.</given-names></name><name><surname>Nojiri</surname><given-names>C.</given-names></name><name><surname>Ooba</surname><given-names>S.</given-names></name><name><surname>Anzai</surname><given-names>H.</given-names></name><name><surname>Iwata</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1992</year>). <article-title>Expression of a maize ubiquitin gene promoter-bar chimeric gene in transgenic rice plants.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>100</volume>
<fpage>1503</fpage>–<lpage>1507</lpage>. <pub-id pub-id-type="doi">10.1104/pp.100.3.1503</pub-id><pub-id pub-id-type="pmid">16653150</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trevaskis</surname><given-names>B.</given-names></name><name><surname>Hemming</surname><given-names>M. N.</given-names></name><name><surname>Peacock</surname><given-names>W. J.</given-names></name><name><surname>Dennis</surname><given-names>E. J.</given-names></name></person-group> (<year>2006</year>). <article-title>HvVRN2 responds to daylength, whereas HvVRN1 is regulated by vernalization and developmental status.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>140</volume>
<fpage>1397</fpage>–<lpage>1405</lpage>. <pub-id pub-id-type="doi">10.1104/pp.105.073486</pub-id><pub-id pub-id-type="pmid">16500994</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuttle</surname><given-names>K. M.</given-names></name><name><surname>Martinez</surname><given-names>S. A.</given-names></name><name><surname>Schramm</surname><given-names>E. C.</given-names></name><name><surname>Takebayashi</surname><given-names>Y.</given-names></name><name><surname>Seo</surname><given-names>M.</given-names></name><name><surname>Steber</surname><given-names>C. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Grain dormancy loss is associated with changes in ABA and GA sensitivity and hormone accumulation in bread wheat, <italic>Triticum aestivum</italic> (L).</article-title>
<source><italic>Seed Sci. Res.</italic></source>
<volume>25</volume>
<fpage>179</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1017/S0960258515000057</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Gestelen</surname><given-names>P.</given-names></name><name><surname>Asard</surname><given-names>H.</given-names></name><name><surname>Caubergs</surname><given-names>R. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Solubilization and separation of a plant plasma membrane NADPH-O2- synthase from other NAD(P)H oxidoreductases.</article-title>
<source><italic>Plant Physiol.</italic></source>
<volume>115</volume>
<fpage>543</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1104/pp.115.2.543</pub-id><pub-id pub-id-type="pmid">12223822</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Hua</surname><given-names>D.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Duan</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Hong</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Auxin Response Factor2 (ARF2) and its regulated homeodomain gene HB33 mediate abscisic acid response in <italic>Arabidopsis</italic>.</article-title>
<source><italic>PLoS Genet.</italic></source>
<volume>7</volume>:<issue>e1002172</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002172</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>J. D.</given-names></name><name><surname>Quatrano</surname><given-names>R. S.</given-names></name><name><surname>Cuming</surname><given-names>A. C.</given-names></name></person-group> (<year>1985</year>). <article-title>Em polypep- tide and its messenger RNA levels are modulated by abscisic acid during embryogenesis in wheat.</article-title>
<source><italic>Eur. J. Biochem.</italic></source>
<volume>152</volume>
<fpage>501</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1985.tb09224.x</pub-id><pub-id pub-id-type="pmid">2932332</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtyla</surname><given-names>L.</given-names></name><name><surname>Lechowska</surname><given-names>K.</given-names></name><name><surname>Kubala</surname><given-names>S.</given-names></name><name><surname>Garnczarska</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Different modes of hydrogen peroxide action during seed germination.</article-title>
<source><italic>Front. Plant Sci.</italic></source>
<volume>7</volume>:<issue>66</issue>
<pub-id pub-id-type="doi">10.3389/fpls.2016.00066</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>N. H.</given-names></name><name><surname>Zhu</surname><given-names>G. H.</given-names></name><name><surname>Liu</surname><given-names>Y. G.</given-names></name><name><surname>Zhang</surname><given-names>A. Y.</given-names></name><name><surname>Li</surname><given-names>Y. X.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Ascorbic acid and reactive oxygen species are involved in the inhibition of seed germination by abscisic acid in rice seeds.</article-title>
<source><italic>J. Exp. Bot.</italic></source>
<volume>63</volume>
<fpage>1809</fpage>–<lpage>1822</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/err336</pub-id><pub-id pub-id-type="pmid">22200664</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Sayama</surname><given-names>H.</given-names></name><name><surname>Kidokoro</surname><given-names>S.</given-names></name><name><surname>Maruyama</surname><given-names>K.</given-names></name><name><surname>Mizoi</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>AREB1, AREB2, and ABF3 are master transcription factors that cooperatively regulate ABRE-dependent ABA signaling involved in drought stress tolerance and require ABA for full activation.</article-title>
<source><italic>Plant J.</italic></source>
<volume>61</volume>
<fpage>672</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2009.04092.x</pub-id><pub-id pub-id-type="pmid">19947981</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Involvement of reactive oxygen species in endosperm cap weakening and embryo elongation growth during lettuce seed germination.</article-title>
<source><italic>J. Exp. Bot.</italic></source>
<volume>65</volume>
<fpage>3189</fpage>–<lpage>3200</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/eru167</pub-id><pub-id pub-id-type="pmid">24744430</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list id="DL1">
        <def-item>
          <term>ABA</term>
          <def>
            <p>abscisic acid</p>
          </def>
        </def-item>
        <def-item>
          <term>ABI5</term>
          <def>
            <p>ABA insensitive 5</p>
          </def>
        </def-item>
        <def-item>
          <term>APX</term>
          <def>
            <p>ascorbate peroxidase</p>
          </def>
        </def-item>
        <def-item>
          <term>CAT</term>
          <def>
            <p>catalase</p>
          </def>
        </def-item>
        <def-item>
          <term>EMSA</term>
          <def>
            <p>electrophoretic mobility shift assay</p>
          </def>
        </def-item>
        <def-item>
          <term>GA</term>
          <def>
            <p>gibberellin</p>
          </def>
        </def-item>
        <def-item>
          <term>GPX</term>
          <def>
            <p>glutathione peroxidase </p>
          </def>
        </def-item>
        <def-item>
          <term>H<sub>2</sub>O<sub>2</sub></term>
          <def>
            <p>hydrogen peroxide</p>
          </def>
        </def-item>
        <def-item>
          <term>PHS</term>
          <def>
            <p>pre-harvest sprouting</p>
          </def>
        </def-item>
        <def-item>
          <term>ROS</term>
          <def>
            <p>reactive oxygen species</p>
          </def>
        </def-item>
        <def-item>
          <term>SOD</term>
          <def>
            <p>superoxide dismutase</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359696</identifier><datestamp>2017-04-04</datestamp><setSpec>fvets</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Vet Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Vet Sci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Veterinary Science</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2297-1769</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359696</article-id>
      <article-id pub-id-type="pmcid">PMC5359696</article-id>
      <article-id pub-id-type="pmc-uid">5359696</article-id>
      <article-id pub-id-type="doi">10.3389/fvets.2017.00039</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Veterinary Science</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mesenchymal Stem Cell-Derived Exosomes: Immunomodulatory Evaluation in an Antigen-Induced Synovitis Porcine Model</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Casado</surname>
            <given-names>Javier G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/84942"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Blázquez</surname>
            <given-names>Rebeca</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/191128"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vela</surname>
            <given-names>Francisco Javier</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/379900"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Álvarez</surname>
            <given-names>Verónica</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/191125"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tarazona</surname>
            <given-names>Raquel</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/169130"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sánchez-Margallo</surname>
            <given-names>Francisco Miguel</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/56922"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Stem Cell Therapy Unit, “Jesús Usón” Minimally Invasive Surgery Centre</institution>, <addr-line>Cáceres</addr-line>, <country>Spain</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Immunology Unit, Department of Physiology, University of Extremadura</institution>, <addr-line>Cáceres</addr-line>, <country>Spain</country></aff>
      <aff id="aff3"><sup>3</sup><institution>CIBER de Enfermedades Cardiovasculares</institution>, <addr-line>Cáceres</addr-line>, <country>Spain</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Fausto Cremonesi, University of Milan, Italy</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Anna Lange-Consiglio, University of Milan, Italy; Lauren Virginia Schnabel, North Carolina State University, USA; Ali Mobasheri, University of Surrey, UK</p>
        </fn>
        <corresp content-type="corresp" id="cor1">*Correspondence: Rebeca Blázquez, <email>rblazquez@ccmijesususon.com</email></corresp>
        <fn fn-type="other" id="fn002">
          <p>Specialty section: This article was submitted to Veterinary Regenerative Medicine, a section of the journal Frontiers in Veterinary Science</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>4</volume>
      <elocation-id>39</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Casado, Blázquez, Vela, Álvarez, Tarazona and Sánchez-Margallo.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Casado, Blázquez, Vela, Álvarez, Tarazona and Sánchez-Margallo</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Synovitis is an inflammatory process associated with pain, disability, and discomfort, which is usually treated with anti-inflammatory drugs or biological agents. Mesenchymal stem cells (MSCs) have been also successfully used in the treatment of inflammatory-related diseases such as synovitis or arthritis. In the last years, the exosomes derived from MSCs have become a promising tool for the treatment of inflammatory-related diseases and their therapeutic effect is thought to be mediated (at least in part) by their immunomodulatory potential. In this work, we aimed to evaluate the anti-inflammatory effect of these exosomes in an antigen-induced synovitis animal model. To our knowledge, this is the first report where exosomes derived from MSCs have been evaluated in an animal model of synovitis. Our results demonstrated a decrease of synovial lymphocytes together with a downregulation of TNF-α transcripts in those exosome-treated joints. These results support the immunomodulatory effect of these exosomes and point out that they may represent a promising therapeutic option for the treatment of synovitis.</p>
      </abstract>
      <kwd-group>
        <kwd>exosomes</kwd>
        <kwd>mesenchymal stem cells</kwd>
        <kwd>synovitis</kwd>
        <kwd>immunomodulation</kwd>
        <kwd>inflammation</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="73"/>
        <page-count count="10"/>
        <word-count count="7727"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="S1">
      <title>Introduction</title>
      <p>Osteoarticular disorders are the major cause of disability in western countries causing pain, discomfort, disability, and affecting the quality of life of millions of people. Osteoarticular disorders are usually linked to joint inflammation and accompanied by redness, swelling, and pain. This local inflammation is provoked by different causes such as trauma, injuries, microorganism infections, or autoimmune disorders such as rheumatoid arthritis. The inflammation of the synovium around a joint, also called synovitis, is frequently observed in the early phase of osteoarthritis (<xref rid="B1" ref-type="bibr">1</xref>) and in clinically active rheumatoid arthritis patients (<xref rid="B2" ref-type="bibr">2</xref>). One of the consequences of persistent synovitis is the cartilage matrix degradation (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>) and alterations in chondrocyte function. Moreover, synovitis causes hypoxia and acidity in synovial fluid (SF) and subchondral bone (<xref rid="B5" ref-type="bibr">5</xref>) and enhances angiogenesis (<xref rid="B6" ref-type="bibr">6</xref>).</p>
      <p>The treatments to reduce pain and swelling for transient synovitis includes anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids (<xref rid="B7" ref-type="bibr">7</xref>). Non-pharmacological treatments such as hip aspiration (<xref rid="B8" ref-type="bibr">8</xref>) as well as rest, ice, compression, and elevation are extremely helpful and effective in the treatment of synovitis (<xref rid="B9" ref-type="bibr">9</xref>). Additionally, intrasynovial injections of biologically based therapies such as platelet-rich plasma (<xref rid="B10" ref-type="bibr">10</xref>) and autologous conditioned serum (<xref rid="B11" ref-type="bibr">11</xref>) have been found to be very effective.</p>
      <p>Local or systemic administration of mesenchymal stem cell (MSC)-based therapies has recently emerged as a promising therapeutic approach for the treatment of inflammatory-related diseases (<xref rid="B12" ref-type="bibr">12</xref>). These cells have an immunomodulatory potential on cells of both the innate and adaptive immune system and recent clinical trials have demonstrated very promising results for the treatment of osteoarticular diseases (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). In the case of synovitis, the therapeutic use of MSCs has also been evaluated in veterinary medicine, specifically in horses with intra-articular injections of xenogeneic, allogeneic, and autologous MSCs (<xref rid="B15" ref-type="bibr">15</xref>). Moreover, in a recent randomized and blinded study using a LPS-induced synovitis model, equine allogeneic umbilical cord blood-derived mesenchymal stromal cells could reduce the nucleated cell counts in SF (<xref rid="B16" ref-type="bibr">16</xref>).</p>
      <p>Accumulative evidences have established that the effect of MSC transplantation is thought to be mediated, in part, by a paracrine effect. In this sense, the use of exosomes derived from MSCs (hereinafter referred exo-MSCs) has become a promising tool for the treatment of inflammatory-related diseases (<xref rid="B17" ref-type="bibr">17</xref>–<xref rid="B19" ref-type="bibr">19</xref>).</p>
      <p>Exosomes are small membranous vesicles secreted by most cell types. These vesicles participate in cell–cell communication and their content consists on RNA, lipids, and proteins. Some of these proteins (i.e., CD9, CD63, or CD81) are ubiquitously expressed, but depending on the cell source, cell type-specific proteins can be found being responsible of their functionality (<xref rid="B20" ref-type="bibr">20</xref>). The proteins, lipids, and RNA expression of exosomes from different cells and organisms are extensively described in ExoCarta database (<xref rid="B21" ref-type="bibr">21</xref>). Previous studies from our group have reported that exo-MSCs exerted an immunomodulatory potential against <italic>in vitro</italic> activated T cells (<xref rid="B22" ref-type="bibr">22</xref>). Additionally, several evidences have shown that exo-MSCs could play active roles in promoting angiogenesis (<xref rid="B23" ref-type="bibr">23</xref>), antiapoptotic effect (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>) as well as in cell proliferation (<xref rid="B26" ref-type="bibr">26</xref>).</p>
      <p>In the last years, the therapeutic potential of exo-MSCs has been demonstrated in disease-specific animal models. Very promising results have been obtained in small animal models for the treatment of cardiovascular diseases where exo-MSCs showed a reduction of myocardial ischemia/reperfusion injury (<xref rid="B27" ref-type="bibr">27</xref>). In renal fibrosis, where the microRNA-let7c secreted by the exosomes attenuated renal fibrosis (<xref rid="B28" ref-type="bibr">28</xref>). In wound healing, where released exosomes promoted angiogenesis (<xref rid="B29" ref-type="bibr">29</xref>). In necrotizing enterocolitis, where exosomes from bone marrow-derived stem cells protected the intestines (<xref rid="B30" ref-type="bibr">30</xref>). In acute lung injury, where the exosomes maintain the functional phenotype of the parent cell (<xref rid="B31" ref-type="bibr">31</xref>). In postischemic neurological impairment, where extracellular vesicles induce long-term neuroprotection, neuroregeneration, and neurological recovery (<xref rid="B32" ref-type="bibr">32</xref>). Finally, it is important to note that, although the therapeutic effect of exo-MSCs has been widely studied in small animals, only a few studies have evaluated their therapeutic effect in large animal models (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>).</p>
      <p>In summary, although the therapeutic effect of MSCs in osteoarticular diseases is widely accepted, the hypothetical beneficial effect of exo-MSCs in joint inflammation has not been evaluated. This paper aimed to evaluate the immunomodulatory effect of exo-MSCs in a clinically relevant animal model of antigen-induced synovitis. The analysis of leukocytes, lymphocytes, and inflammatory cytokines in SF revealed a potential therapeutic effect of exo-MSCs in the setting of inflammatory and osteoarticular disorders.</p>
    </sec>
    <sec sec-type="materials|methods" id="S2">
      <title>Materials and Methods</title>
      <sec id="S2-1">
        <title>Animals and Ethical Issues</title>
        <p>Eight large white pigs were housed in the animal facility at the Minimally Invasive Surgery Center and used for all experimental procedures. Animals aged 3 months and weighed 25–35 kg at the beginning of the study were used. All experimental protocols were approved by the Committee on the Ethics of Animal Experiments of Minimally Invasive Surgery Center and fully complied with recommendations outlined by the local government (Junta de Extremadura) and by the Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.</p>
      </sec>
      <sec id="S2-2">
        <title>Immunization Protocol and Antigen-Induced Synovitis</title>
        <p>For animal immunizations, a solution with 20 mg/ml of BSA (Sigma-Aldrich, St. Louis, MO, USA) was prepared and passed through a 0.2-μm sterilized microfilter. An equal volume of Freund Complete Adjuvant (Sigma-Aldrich, St. Louis, MO, USA) was mixed with the BSA solution and emulsified. The immunization was performed by subcutaneous injections of this emulsion. A total of 0.4 ml/kg was injected on days 0, 14, and 21. On day 28, a total of 0.5 ml of SF was aspirated from carpal joints. Intra-articular injections of BSA (0.5 ml at 20 mg/ml) were bilaterally performed to induce an antigen-mediated immune response. The left carpal joints were used as control (BSA co-administered with PBS) and the right carpal joints were used for exosome-based treatments (BSA co-administered with exosomes). The exosomes were used at the concentration of 500 μg protein/injection in a total volume of 500 μl.</p>
      </sec>
      <sec id="S2-3">
        <title>Anesthetics Procedures</title>
        <p>Every procedure was performed under anesthesia. For blood sampling and subcutaneous BSA injections, anesthesia was induced by intramuscular injection of 10 mg/kg ketamine hydrochloride and 0.02 mg/kg dexmedetomidine hydrochloride. The animals were recovered with 0.02 mg/kg atipamezole hydrochloride. For SF sampling, anesthesia was induced by the same procedure together with an intravenous bolus injection of 2 mg/kg propofol and 3 mg/kg of tramadol. According to ethical and animal welfare concerns, all the animals received analgesic treatment with a solution of buprenorphine hydrochloride at 0.3 mg/ml and 0.03 ml/kg for 7 days after intra-articular injection.</p>
      </sec>
      <sec id="S2-4">
        <title>Quantification of Anti-BSA Antibodies by ELISA</title>
        <p>In order to quantify the anti-BSA IgG titers on immunized animals, an ELISA test was performed on plasma samples at days 0, 7, 14, 21, and 28. Microplate coating was performed by an overnight incubation with BSA at 20 μg/ml. The coating solution was washed twice with 200 μl of PBS/Tween-20 (0.05%, 7.4 pH). In order to prevent the non-specific binding of the antibodies, the remaining protein-binding sites were blocked by adding 200 μl of BSA and incubated at 4°C for 2 h. The microplate was washed four times with 200 μl PBS/Tween-20. Plasma samples were diluted 1:200 with PBS and 100 μl of this dilution was added to each well. The plate was incubated at 4°C for 2 h. After washing four times with PBS/Tween-20, 100 μl of 1/5,000 diluted horseradish peroxidase-conjugated secondary antibody (Rabbit Anti-Pig IgG, Thermo Fisher Scientific, Waltham, MA, USA) was added to each well and the plate was incubated at 4°C for 2 h. Finally, the plate was washed four times and 100 μl of 3,3′,5,5′-Tetramethylbenzidine (Sigma-Aldrich) was added to each well. Then, 2 min later, 100 μl of 1M HCl was added to stop the reaction. Absorbance was measured at 450 nm on a Synergy Mx spectrophotometer (BioTech Industries, Newton, NC, USA) and quantified related to the baseline.</p>
      </sec>
      <sec id="S2-5">
        <title>Isolation and Expansion of Porcine Bone Marrow-Derived MSCs</title>
        <p>Bone marrow-derived MSCs were harvested from the iliac crest from anesthetized large white pigs. The mononuclear cells were isolated by centrifugation over Histopaque-1077 (Sigma, St. Louis, MO, USA). Mononuclear cells were recovered and washed twice with PBS. Finally, mononuclear cells were re-suspended in DMEM containing 10% FBS (Sigma), 5 μl/ml fungizone, and 1% Penicillin/streptomycin (Lonza BioWhittaker™, Basel, Switzerland). Cells were seeded onto tissue culture flasks and expanded at 37°C and 5% CO<sub>2</sub>. Following 48 h of culture, the non-adherent cells were removed. Adhered cells were passaged at 80–90% confluence by trypsinization (0.25% trypsin solution) and seeded to a new culture at a density of 5,000 cells/cm<sup>2</sup>. Culture medium was changed every 3–4 days.</p>
        <p>The porcine MSCs were phenotypically and functionally characterized by flow cytometry and <italic>in vitro</italic> differentiation assays. Cells were positive for CD29, CD44, CD90, CD105, and SLA-I and negative for CD45 and SLA-II. They also showed their ability to differentiate toward adipogenic, osteogenic, and chondrogenic lineages (<xref rid="B35" ref-type="bibr">35</xref>).</p>
      </sec>
      <sec id="S2-6">
        <title>Isolation, Purification, and Characterization of MSC-Derived Exosomes</title>
        <p>The MSCs-derived exosomes (exo-MSCs) were obtained from porcine bone marrow-derived MSCs cultured in 175 cm<sup>2</sup> flasks. When cells reached a confluence of 80%, culture medium (DMEM containing 10% FBS) was replaced by exosome isolation medium (DMEM containing 1% insulin-transferrin-selenium). The supernatants were collected every 3–4 days. To eliminate dead cells and debris, the supernatants were centrifuged at 1,000 × <italic>g</italic> for 10 min and 5,000 × <italic>g</italic> for 20 min at 4°C. About 15 ml of these supernatants were ultra-filtered through 3 kDa MWCO Amicon<sup>®</sup> Ultra devices (Merck-Millipore, MA, USA). Samples were spun at 4,000 × <italic>g</italic> for 60 min and 200–300 μl of concentrated supernatant was collected and stored at −20°C. Prior to <italic>in vivo</italic> experiments, the proteins were quantified by Bradford assays, a very common method to indirectly quantify exosomes (<xref rid="B36" ref-type="bibr">36</xref>–<xref rid="B39" ref-type="bibr">39</xref>). The concentration and size of the particles were measured by nanoparticle tracking analysis (NanoSight Ltd., Amesbury, UK) that relates the rate of Brownian motion to particle size. Results were analyzed using the software package version 2.2. Triplicate samples were diluted 1:10 in sterile-filtered PBS and analyzed. The mean size of isolated vesicles ranged from 150 to 200 nm (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>A in Supplementary Material).</p>
        <p>For flow cytometric analysis by fluorescent activated cells sorting, exosomes were conjugated with latex beads as previously described (<xref rid="B40" ref-type="bibr">40</xref>). Briefly, 5 μg of exosomes were incubated with 10 μl of latex beads 15 min at room temperature. After, PBS was added to a final volume of 1 ml and samples were incubated overnight at 4°C. Finally, 110 μl of 1M glycine were added to each tube. After 30 min of incubation, samples were centrifuged, washed, and re-suspended in a final volume of 0.5 ml PBS/0.5% BSA. These exosomes-coated beads were incubated for 1 h at room temperature with appropriate concentrations of monoclonal antibodies (mAbs) in the presence of PBS containing 0.5% BSA. The exosomes-coated beads were stained with FITC-conjugated human mAbs against CD44 and CD90 (porcine cross-reactive) from Serotec (Kidlington, UK). After incubation with antibodies, the exosomes-coated beads were washed and re-suspended in PBS/0.5% BSA. The flow cytometric analysis was performed on a FACScalibur cytometer (BD Biosciences, San Jose, CA, USA) after acquisition of 10<sup>5</sup> events. Exosomes-coated beads were primarily selected using forward and side scatter characteristics and fluorescence was analyzed using CellQuest software (BD Biosciences). Isotype-matched negative control antibodies were used in all the experiments. Exo-MSCs showed a positive expression for both markers (Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>B in Supplementary Material).</p>
        <p>Exo-MSCs were slowly thawed prior to allogeneic intra-articular injections and used at the concentration of 500 μg protein/injection in a total volume of 500 μl. The exo-MSCs doses were chosen by extrapolating from our previous <italic>in vitro</italic> results (<xref rid="B22" ref-type="bibr">22</xref>).</p>
      </sec>
      <sec id="S2-7">
        <title>Hematological Analysis and Phenotypic Characterization of SF Lymphocytes</title>
        <p>Synovial leukocytes were isolated from carpal joints just before intra-articular injections (at day 28) and 7 days after intra-articular injections (at day 35). A total of 0.5 ml of SF was aspirated and leukocytes were counted in an automatic hematology analyzer (Mindray BC-5300 Vet, Hamburg, Germany). The leukocytes were then isolated by centrifugation at 900 × <italic>g</italic> for 5 min and used for flow cytometry analysis or quantitative RT-PCR.</p>
        <p>For flow cytometry, synovial leukocytes were stained with fluorescent-labeled mAbs against porcine CD3, CD4, CD8α, and CD16 (AbD Serotec, Kidlington, UK). The cytometric analysis was performed as follows: 2 × 10<sup>5</sup> cells were incubated for 30 min at 4°C with appropriate concentrations of mAbs. The cells were washed and re-suspended in PBS. The flow cytometric analysis was performed in a FACScalibur cytometer (BD Biosciences) after acquisition of 10<sup>5</sup> events. Cells were primarily selected using forward and side scatter characteristics and fluorescence was analyzed using CellQuest software (BD Biosciences, San Jose, CA, USA). Isotype-matched negative control antibodies were used in all the experiments.</p>
      </sec>
      <sec id="S2-8">
        <title>Quantitative RT-PCR</title>
        <p>Total RNA was isolated from SF samples. The cDNA was synthesized from 1 μg of total RNA in a reverse transcription reaction for 1 h at 37°C using Superscript III reverse transcriptase (Thermo Fisher Scientific, Waltham, MA, USA). The sequences of the PCR primers were designed with the NCBI Primer-BLAST tool (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/tools/primerblast/">www.ncbi.nlm.nih.gov/tools/primer-blast/</uri>). The primers used for gene expression studies in the porcine model are detailed in Table <xref ref-type="table" rid="T1">1</xref>.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Sequences for the primers used in the quantitative qRT-PCR</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
                <th valign="top" align="left" rowspan="1" colspan="1">Primers sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">IL-1β</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-GCACCTCTCAAGCAGAACAAAA-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CCTCTGGGTATGGCTTTCCTT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">IL-4</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-GTCTGCTTACTGGCATGTACCA-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-GCTCCATGCACGAGTTCTTTCT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">IL-6</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CCCCTAACCCCACCACAAAT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-AAGGCTGCGCAGGATGAG-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">IL-8</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-GCCAACACAACTTCAATCAAATCTA-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-TGGGCATCCTGTGATTTCTCT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">IL-10</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CGGCGCTGTCATCAATTTCTG-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CCCCTCTCTTGGAGCTTGCTA-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">TNF-α</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-TCCCCTGTCCATCCCTTTATT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CCAGCCCCTCATTCTCTTTCT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">TGF-β</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CCCAGAGTGGTTGTCCTTTGA-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-GCGGAGCGTGTTATCTTTGCT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="2" colspan="1">β-2 microglobulin</td>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-ACTTTTCACACCGCTCCAGT-3′</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">5′-CGGATGGAACCCAGATACAT-3′</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>For transcriptional analysis, the RT-PCR products were quantified by the fluorescent method using the 2<sup>−ΔCt</sup> expression. To normalize gene expression, two constitutively expressed genes were included (β-actin and β-2 microglobulin) and the most stable one, which was β-2 microglobulin, was used as housekeeping.</p>
      </sec>
      <sec id="S2-9">
        <title>Pressure Platform (PP) Gait Analysis</title>
        <p>A 174.5 cm × 36.9 cm PP (Walkway™; Tekscan, South Boston, MA, USA), composed of individual sensors with a density of 1.4 sensor/cm<sup>2</sup> and 9,152 sensors in total, was used for the biomechanical evaluation. The sensors of the PP walkway were calibrated according to the manufacturer’s specifications. Also, 7 days after intra-articular injections of BSA co-administered with PBS or exosomes, different kinetic parameters such as stance time, swing time, stride time, vertical maximum force, and impulse were monitored in the animal model. Kinetic gait analysis was performed prior to experimental procedures, and all the measurements were normalized and considering the gain weight of individual pigs.</p>
      </sec>
      <sec id="S2-10">
        <title>Statistical Analysis</title>
        <p>Data were statistically analyzed using the Student’s <italic>t</italic>-test. The <italic>p</italic>-values ≤0.05 were considered statistically significant. All the statistical determinations were made using SPSS-21 software (SPSS, Chicago, IL, USA).</p>
      </sec>
    </sec>
    <sec id="S3">
      <title>Results</title>
      <sec id="S3-1">
        <title>Animal Model of Antigen-Induced Synovitis and Exosome-Based Therapy</title>
        <p>An antigen-induced synovitis model was used to evaluate the therapeutic effect of exosome-based therapy. In our large animal model of synovitis, the BSA was intra-articularly injected to trigger an antigen-induced inflammation. The BSA was simultaneously co-administered with PBS or exo-MSCs. White blood cell (WBC) counts, differential cell counting, flow cytometry, gene expression of inflammatory cytokines, and kinetic parameters were evaluated at day 35. The immunization protocol and the monitoring of antigen-induced synovitis model are summarized in the Figure <xref ref-type="fig" rid="F1">1</xref>.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Temporal scheme of the immunization protocol and monitoring</bold>. Subcutaneous BSA injections (black arrows), intra-articular injections of BSA or BSA co-administered with exo-mesenchymal stem cells (gray arrow), blood sampling (triangles), synovial fluid sampling (squares), and kinetic gait analysis (rhombus) are shown.</p>
          </caption>
          <graphic xlink:href="fvets-04-00039-g001"/>
        </fig>
        <p>Our results demonstrated that the BSA immunization protocol triggered a humoral response against BSA in this animal model, which is prerequisite to generate an antigen-induced synovitis. The anti-BSA IgG antibody titers were detected in all of the four animals and antibody concentrations significantly increased showing a maximum level at day 28 (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Humoral response in the antigen-induced animal model of synovitis</bold>. Plasma samples were weekly collected and anti-BSA IgG levels were quantified by ELISA immunoassay. The lower boundary of the box indicates the 25th percentile and the upper boundary the 75th percentile. Bars above and below the box indicate the 90th and 10th percentiles. The line within the box marks the median (<italic>n</italic> = 4).</p>
          </caption>
          <graphic xlink:href="fvets-04-00039-g002"/>
        </fig>
      </sec>
      <sec id="S3-2">
        <title>SF Leukocytes and Differential Counts</title>
        <p>On day 28, the BSA-immunized animals were anesthetized and a SF sample was aspirated to be used as basal reference for leukocyte counts. Once aspirated, the animals received an intra-articular injection of BSA to trigger a local inflammatory response. The BSA was co-administered with PBS (control joint) or with exo-MSCs. At day 7, after intra-articular injections, the SF from three animals was aspirated and analyzed by an automated hematological analyzer. As shown in Table <xref ref-type="table" rid="T2">2</xref>, those animals which received an intra-articular injection of BSA showed a significant increase in terms of WBC counts when compared to basal samples. However, no differences were found between those joints where BSA was co-administered with PBS and those where BSA was co-administered with exo-MSCs. Interestingly, the differential cell counting revealed a statistically significant decrease of lymphocytes when BSA stimulation was counteracted by exo-MSCs.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p><bold>White blood cell (WBC) counts, leukocyte distribution, and lymphocyte subsets on synovial fluids (SFs) from antigen-induced synovitis animal model</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="center" rowspan="1" colspan="1"/>
                <th valign="top" align="center" rowspan="1" colspan="1"/>
                <th valign="top" align="center" rowspan="1" colspan="1"/>
                <th valign="top" align="center" rowspan="1" colspan="1">Basal</th>
                <th valign="top" align="center" rowspan="1" colspan="1">BSA</th>
                <th valign="top" align="center" rowspan="1" colspan="1">BSA + exo-mesenchymal stem cells (MSCs)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="top" rowspan="10" colspan="1">SF</td>
                <td align="left" valign="top" rowspan="6" colspan="1">Leukocyte distribution</td>
                <td align="left" valign="top" rowspan="1" colspan="1">WBCs (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.753 ± 1.123</td>
                <td align="center" valign="top" rowspan="1" colspan="1">
                  <bold>2.348 ± 1.460<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></bold>
                </td>
                <td align="center" valign="top" rowspan="1" colspan="1">
                  <bold>3.030 ± 2.360<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></bold>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Neutrophils (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.608 ± 0.076</td>
                <td align="center" valign="top" rowspan="1" colspan="1">1.776 ± 1.783</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Lymphocytes (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">2.371 ± 0.370</td>
                <td align="center" valign="top" rowspan="1" colspan="1">
                  <bold>0.992 ± 0.600<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></bold>
                </td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Monocytes (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.039 ± 0.067</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.209 ± 0.182</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Eosinophils (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.202 ± 0.041</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.287 ± 0.423</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">Basophils (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.150 ± 0.064</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.049 ± 0.050</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="4" colspan="1">Fluorescent activated cells sorting analysis</td>
                <td align="left" valign="top" rowspan="1" colspan="1">CD4+ CD8α− T cells (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.171 ± 0.144</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.114 ± 0.112</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">CD4− CD8α+ T cells (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.476 ± 0.390</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.339 ± 0.291</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">CD16+/CD8α− cells (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.072 ± 0.045</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.379 ± 0.565</td>
              </tr>
              <tr>
                <td align="left" valign="top" rowspan="1" colspan="1">CD16+/CD8α+ cells (×10<sup>3</sup>/μl)</td>
                <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.151 ± 0.102</td>
                <td align="center" valign="top" rowspan="1" colspan="1">0.140 ± 0.091</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>SF samples were collected at day 28 just before intra-articular injections (basal). The BSA (co-administered with PBS or exo-MSCs) was injected at day 28 and SFs were collected at day 35. Synovial leukocytes were analyzed by automated hematological analyzer (<italic>n</italic> = 3). To identify the lymphocyte subsets, SF lymphocytes were isolated and analyzed by flow cytometry. Values represent the mean ± SD</italic>.</p>
            <p><italic>ND, non-detectable</italic>.</p>
            <p><italic>Bold values indicate significant differences</italic>.</p>
            <fn id="tfn1">
              <p><italic><sup>a</sup>Statistically significant differences in a paired <italic>t</italic>-test when compared to basal level (<italic>p</italic> ≤ 0.05)</italic>.</p>
            </fn>
            <fn id="tfn2">
              <p><italic><sup>b</sup>Statistically significant differences in a paired <italic>t</italic>-test when compared BSA and BSA + exo-MSCs (<italic>p</italic> ≤ 0.05)</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Additionally, the SFs were centrifuged and synovial leukocytes were processed for flow cytometry analysis. The analysis of synovial lymphocytes was performed on CD4+/CD8α− T cells, CD4−/CD8α+ T cells, CD16+/CD8α− cells, and CD16+/CD8α+ cells. Our results did not show any significant difference when compared BSA co-administered with PBS and BSA co-administered with exo-MSCs (Table <xref ref-type="table" rid="T2">2</xref>).</p>
      </sec>
      <sec id="S3-3">
        <title>Inflammatory Cytokines in SF</title>
        <p>Once evaluated, the changes in the leukocyte counts as well as in the synovial lymphocytes, we aimed to evaluate the inflammatory environment by quantifying inflammatory cytokines by quantitative RT-PCR. Porcine-specific primers were designed to amplify IL-1β, IL-4, IL-6, IL-8, IL-10, TNFα, and TGF-β. As shown in Figure <xref ref-type="fig" rid="F3">3</xref>, the 2<sup>−ΔCt</sup> values were compared between SFs where BSA was co-administered with PBS and SFs where BSA was co-administered with exo-MSCs. No differences were found in 7 out of 8 cytokines; however, a significant decrease (<italic>p</italic> = 0.05) was found for TNF-α when BSA was co-administered with exo-MSCs.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Gene expression of cytokines in synovial fluid (SF)</bold>. SF samples were collected 7 days after intra-articular injections and total RNA was isolated. The qRT-PCR products were quantified by the 2<sup>ΔCt</sup> method using β-2 microglobulin as a housekeeping gene. Graph represents the mean ± SD of three independently performed experiments (<italic>n</italic> = 4). *Statistically significant difference in a paired <italic>t</italic>-test (<italic>p</italic> ≤ 0.05).</p>
          </caption>
          <graphic xlink:href="fvets-04-00039-g003"/>
        </fig>
      </sec>
      <sec id="S3-4">
        <title>Kinetic Gait Parameters on Animal Model</title>
        <p>The kinetic parameters were evaluated in a gait analysis system. This analysis allowed us the capture of kinetic, timing, and physical measurements. Different kinetic parameters such as stance time, swing time, stride time, vertical maximum force, and impulse were compared. As shown in Figure <xref ref-type="fig" rid="F4">4</xref>, a non-statistically significant trend to increase was found for the impulse in those joints where BSA was co-administered with exo-MSCs.</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Pressure platform (PP) gait analysis</bold>. Then, 7 days after intra-articular injections of BSA or BSA co-administered with exo-mesenchymal stem cells (MSCs), a PP gait analysis was performed to evaluate plantar pressure distributions. <bold>(A)</bold> A representative image of the gait analysis (LF, left forelimb; LH, left hind limb; RF, right forelimb; RH, right hind limb) is represented. <bold>(B)</bold> Impulses in forelimbs with intra-articular BSA co-administered with PBS or exo-MSCs (<italic>n</italic> = 4). The lower boundary of the box indicates the 25th percentile and the upper boundary the 75th percentile. Bars above and below the box indicate the 90th and 10th percentiles. The line within the box marks the median. Measurements compared in a paired <italic>t</italic>-test.</p>
          </caption>
          <graphic xlink:href="fvets-04-00039-g004"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S4">
      <title>Discussion</title>
      <p>Synovitis is an inflammation of the synovial membrane, usually linked to osteoarthritis, rheumatoid arthritis or infections (<xref rid="B41" ref-type="bibr">41</xref>–<xref rid="B43" ref-type="bibr">43</xref>). It can be successfully treated with biologically based therapies such as platelet-rich plasma, or autologous conditioned serum (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>), or NSAIDs such as Ibuprofen or Naproxen (<xref rid="B46" ref-type="bibr">46</xref>). The MSCs-based therapies diminish the inflammatory response itself (<xref rid="B12" ref-type="bibr">12</xref>) and the intra-articular administration of MSCs has been found to reduce the nucleated cell counts in SF (<xref rid="B47" ref-type="bibr">47</xref>). Many authors have hypothesized that cell-free therapies may be safer and affordable than cell-based therapies (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). In this sense, exo-MSCs have been considered as anti-inflammatory agents (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>) and a therapeutic alternative to cell-based therapies (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>).</p>
      <p>The aim of this work was to evaluate the anti-inflammatory effect of exo-MSCs in a large animal model of synovitis. In this sense, our first sets of experiments were conducted to create an antigen-induced synovitis in a porcine model. This animal model has been immunologically characterized and our experience has demonstrated that it is particularly attractive in preclinical settings (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>), especially to evaluate the safety, feasibility, and dosage pattern of new therapies for synovitis.</p>
      <p>The exo-MSCs used in this study were characterized by nanoparticle tracking analysis and flow cytometry. The mean size of these exosomes was 167.3 ± 2.6 nm. Although this size is larger to classically defined exosomes, it has been found that, in aqueous solution, exosomes are surrounded by a surface charge that may be the responsible for this larger size (<xref rid="B52" ref-type="bibr">52</xref>). This phenomenon has been previously described for nanoparticle tracking analyzed exosomes (<xref rid="B53" ref-type="bibr">53</xref>). Moreover, and due to the lack of porcine antibodies for CD9, CD63, and CD81 (classically used for exosomes characterization), CD44 and CD90 surface markers have been used to identify MSCs-derived extracellular vesicles (<xref rid="B54" ref-type="bibr">54</xref>).</p>
      <p>In our antigen-induced synovitis model, a subcutaneous pre-sensitization with BSA was required before the intra-articular injection of BSA. This pre-sensitization induced a potent humoral response, which was found to be as effective as previously described antigen-induced synovitis in rabbits and dogs (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>). These BSA-presensitized animals received an intra-articular injection of BSA, which triggered a local inflammatory response with a significant increase of WBCs in SF. It is important to note that the WBC count is one of the most frequent tests in the analysis of SF. In this sense, human SFs with less than 200 cells/μl are classified as “normal” and those with less than 2,000 cells/μl are classified as “non-inflammatory.” In our antigen-induced synovitis model, those animals that received an intra-articular injection of BSA showed a WBC infiltration that can be classified as “inflammatory SF” (<xref rid="B41" ref-type="bibr">41</xref>).</p>
      <p>Once demonstrated that intra-articular BSA triggered a local inflammatory reaction, we aimed to counteract this reaction by an intra-articular administration of exo-MSCs. As shown in the results section, no differences were found in terms of WBCs when exo-MSCs were co-administered with BSA. However, the differential cell count of leukocytes showed statistically significant differences in the lymphocyte counts being lower in those joints where BSA was co-administered with exo-MSCs. Based on that, here, we assume that exo-MSCs efficiently counteracted the antigen-driven T cell response and point out that these exosomes may represent a therapeutic strategy for the treatment of T cell-mediated diseases such as rheumatoid arthritis. These <italic>in vivo</italic> results are in agreement with <italic>in vitro</italic> results using stimulated T cells co-cultured with human exosomes from adipose-derived stem cells (<xref rid="B22" ref-type="bibr">22</xref>). In these studies, the effect of exo-MSCs on proliferative, differentiation, and functional behavior of T cells was significantly modified by exosomes.</p>
      <p>Additionally, here, we hypothesized that exosomes may also inhibit or decrease the production of pro-inflammatory cytokines. In order to evaluate the inflammatory reaction after intra-articular BSA injections, a qRT-PCR analysis was performed for several cytokines (IL-1β, IL-4, TGF-β, IL-8, IL-10, TNF-α, and IL-6). This analysis revealed some differences in IL-1β, IL-8, and TNF-α after intra-articular injections of BSA (co-administered with PBS or with exo-MSCs).</p>
      <p>The IL-1β is a critical mediator of osteoarthritis and the intra-articular injection of this recombinant cytokine has been used to induce a transient inflammatory response in an experimentally induced synovitis (<xref rid="B57" ref-type="bibr">57</xref>). In the case of IL-8, this chemokine participates to the inflammatory process in the early synovitis of rheumatoid arthritis (<xref rid="B58" ref-type="bibr">58</xref>), and similar to IL-1β, the intra-articular administration has been also used to induce acute synovitis in rabbits (<xref rid="B59" ref-type="bibr">59</xref>). Finally, the level of TNF-α in synovia has been correlated with pain and disease progression (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>) and anti-TNF-α agents have been widely used for the treatment of active rheumatoid arthritis (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>).</p>
      <p>Based on the above-described relations between IL-1β, IL-8, TNF-α, and synovitis progression, we aimed to quantify their gene expression in SFs when exo-MSCs were co-administered in the joints. Uniquely, the TNF-α level was found to be statistically decreased by the co-administration of exo-MSCs. We suggest that this result is very relevant considering that TNF-α is a therapeutic target for the treatment of inflammatory diseases (<xref rid="B64" ref-type="bibr">64</xref>). Indeed, targeted treatments against synovitis and rheumatoid arthritis have been efficiently developed against this cytokine (<xref rid="B65" ref-type="bibr">65</xref>).</p>
      <p>Regarding to the not statistically significant increase of IL-8 observed with exo-MSCs, it is important to note that this chemokine is abundantly secreted by MSCs from adipose tissue and bone marrow (<xref rid="B66" ref-type="bibr">66</xref>). More importantly, this chemokine has been found to be contained in exosomes derived from umbilical cord-MSCs (<xref rid="B67" ref-type="bibr">67</xref>) as well as in menstrual blood-MSCs (<xref rid="B68" ref-type="bibr">68</xref>). Based on these observations, we assume that the increase of IL-8 is the consequence of an exogenous administration of IL-8 linked to exo-MSCs. Additionally, taking into account that IL-8 is one of the most potent chemoattractant molecule for neutrophils (<xref rid="B69" ref-type="bibr">69</xref>), this may also explain the increase (although not significant) of infiltrated neutrophils in SFs treated with exo-MSCs.</p>
      <p>It is important to note that the determination of the different cytokines in SF was firstly addressed with a multiplexed immunoassay by Luminex xMAP technology using the ProcartaPlex Porcine Cytokine and Chemokine Panel 1 (eBioscience, San Diego, CA, USA). The following cytokines were measured: IFNα, IFNγ, IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12p40, and TNFα. The cytokine analysis demonstrated that, probably because of the detection limit of commercially available swine immune reagents or because the evaluation time point was too short for protein translation, eight out of nine cytokines were undetectable in SFs with this technique. Uniquely, the IL-12p40 could be detected in all the samples but no differences were found between groups.</p>
      <p>Although this paper has not been focused on the biological mechanisms, which promote the decrease of TNF-α in the synovitis model, the bibliography has several references that support the association between exo-MSCs and TNF-α. As an example, recent studies have demonstrated that exosomes derived from human umbilical cord MSCs reduced the TNF-α release from CD3/CD28-stimulated PBLs (<xref rid="B70" ref-type="bibr">70</xref>). Moreover, exosomes from bone marrow-derived MSCs also suppressed the secretion of TNF-α from T cells (<xref rid="B71" ref-type="bibr">71</xref>). More recently, the immunomodulatory effect of these exosomes against TNF-α transcription was demonstrated <italic>in vivo</italic> in an experimental colitis model. In this animal model, the intravenous injection of exosomes from bone marrow-derived MSCs reduced the TNF-α in injured colon (<xref rid="B72" ref-type="bibr">72</xref>). Altogether, these <italic>in vitro</italic> and <italic>in vivo</italic> studies are in agreement with our results and support the immunomodulatory effect of these exosomes in the animal model.</p>
      <p>Finally, this paper aimed to evaluate the therapeutic effect of exo-MSCs in a functional kinetic assessment. Apart from the analysis of synovial leukocyte subsets and inflammatory cytokines in the animal model, different kinetic parameters such as stance time, swing time, stride time, vertical maximum force, and impulse were monitored in the animal model by PP gait analysis (<xref rid="B73" ref-type="bibr">73</xref>). The quadruped gait analysis demonstrated that exo-MSCs co-administered with the BSA had a non-significant trend for the improvement of the impulse. This trend may indicate a pain reduction linked to the anti-inflammatory effect of exo-MSCs. Finally, it is important to note that the absence of statistical differences would not necessarily imply that the kinetic was unaffected; since the pressure gait was performed under analgesia due to ethical consideration and animal welfare guidelines. In the same way, due to ethical limitations, animals could only be evaluated at day 7 after treatment. In this sense, this study can be considered a preliminary approach and further studies will be performed to evaluate the changes in a long-term study, including the histological follow-up of the lesions as well as the cytokine quantification using immunoassays.</p>
      <p>In conclusion, to our knowledge, this is the first report describing the use of exo-MSCs for the treatment of synovitis in a large animal model. The decrease of synovial lymphocytes, the downregulation of TNF-α transcripts, as well as the trend to improve the impulse in exosome-treated joints, point out that exosomes may represent a promising therapeutic option for the treatment of synovitis.</p>
    </sec>
    <sec id="S5">
      <title>Author Contributions</title>
      <p>RB, FS-M, and FJV equally contributed and should be regarded as co-first authors. FS-M, RT, and JGC conceived and designed the experiments. FJV, VA, and RB performed the experiments and analyzed the data. VA, FS-M, RT, and JGC wrote the manuscript.</p>
    </sec>
    <sec id="S6">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AL-C and handling Editor declared their shared affiliation, and the handling Editor states that the process nevertheless met the standards of a fair and objective review.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>Technical and human support for qRT-PCR studies was provided by Facility of Bioscience Applied Techniques of SAIUEx (financed by UEX, Junta de Extremadura, MICINN, FEDER, and FSE). <italic>In vivo</italic> experiments were performed by the ICTS “Nanbiosis,” more specifically by the Unit 14 (Cell Therapy), Unit 22 (Animal housing), Unit 21 (Experimental Operating Rooms), and Unit 24 (Medical Imaging) at CCMIJU. <italic>In vitro</italic> experiments were performed by the ICTS “Nanbiosis,” more specifically by the Unit 14 at CCMIJU. Exosomes characterization was performed by the ICTS “Nanbiosis,” more specifically by the Unit 6 (Biomaterial processing and Nanostructuring Unit).</p>
    </ack>
    <sec id="S7">
      <title>Funding</title>
      <p>This work was supported in part by Consejería de Economía e Infraestructuras, Junta de Extremadura (TA13042 to JGC), one grant from Consejería de Economía e Infraestructuras, Junta de Extremadura cofinanced by FEDER to JGC (IB13123), and one grant from GobEx (Ayuda a grupos catalogados de la Junta de Extremadura, GR15175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was awarded by the “Premio a la investigación traslacional en Traumatología y Ortopedia” from Fundación Real Academia de Medicina y Cirugía de Sevilla.</p>
    </sec>
    <sec id="S8" sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at <uri xlink:type="simple" xlink:href="http://journal.frontiersin.org/article/10.3389/fvets.2017.00039/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fvets.2017.00039/full#supplementary-material</uri>.</p>
      <supplementary-material content-type="local-data" id="SM1">
        <label>Figure S1</label>
        <caption>
          <p><bold>Characterization of exo-MSCs</bold>. Panel <bold>(A)</bold> shows the frequency size distribution graph of exo-MSCs. The nanoparticle tracking analysis was performed on exosomes samples to quantify size distribution and particle concentration (<italic>n</italic> = 3). Error bars indicate ±1 SEM. Panel <bold>(B)</bold> shows the expression of CD44 and CD90 in exosomes-coated latex beads. Exosomes adhered to latex beads were analyzed by multicolor flow cytometry. Representative histograms of CD44 and CD90 expression are shown (filled histograms) together with their negative control (gray lined histograms).</p>
        </caption>
        <media xlink:href="Image_1.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanzello</surname><given-names>CR</given-names></name><name><surname>Goldring</surname><given-names>SR</given-names></name></person-group>. <article-title>The role of synovitis in osteoarthritis pathogenesis</article-title>. <source>Bone</source> (<year>2012</year>) <volume>51</volume>:<fpage>249</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/j.bone.2012.02.012</pub-id><?supplied-pmid 22387238?><pub-id pub-id-type="pmid">22387238</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arend</surname><given-names>WP</given-names></name><name><surname>Firestein</surname><given-names>GS</given-names></name></person-group>. <article-title>Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis</article-title>. <source>Nat Rev Rheumatol</source> (<year>2012</year>) <volume>8</volume>:<fpage>573</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1038/nrrheum.2012.134</pub-id><?supplied-pmid 22907289?><pub-id pub-id-type="pmid">22907289</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIlwraith</surname><given-names>CW</given-names></name></person-group>
<article-title>Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review</article-title>. <source>Equine Vet J</source> (<year>2005</year>) <volume>37</volume>:<fpage>473</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.2746/042516405774480102</pub-id><pub-id pub-id-type="pmid">16163952</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIlwraith</surname><given-names>CW</given-names></name><name><surname>Frisbie</surname><given-names>DD</given-names></name><name><surname>Rodkey</surname><given-names>WG</given-names></name><name><surname>Kisiday</surname><given-names>JD</given-names></name><name><surname>Werpy</surname><given-names>NM</given-names></name><name><surname>Kawcak</surname><given-names>CE</given-names></name><etal/></person-group>
<article-title>Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects</article-title>. <source>Arthroscopy</source> (<year>2011</year>) <volume>27</volume>:<fpage>1552</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.arthro.2011.06.002</pub-id><?supplied-pmid 21862278?><pub-id pub-id-type="pmid">21862278</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofoed</surname><given-names>H</given-names></name></person-group>. <article-title>Synovitis causes hypoxia and acidity in synovial fluid and subchondral bone</article-title>. <source>Injury</source> (<year>1986</year>) <volume>17</volume>:<fpage>391</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/0020-1383(86)90078-1</pub-id><?supplied-pmid 3102376?><pub-id pub-id-type="pmid">3102376</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DA</given-names></name></person-group>. <article-title>Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes</article-title>. <source>Curr Opin Rheumatol</source> (<year>2004</year>) <volume>16</volume>:<fpage>609</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1097/01.bor.0000133662.60223.ee</pub-id><?supplied-pmid 15314503?><pub-id pub-id-type="pmid">15314503</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zayat</surname><given-names>AS</given-names></name><name><surname>Conaghan</surname><given-names>PG</given-names></name><name><surname>Sharif</surname><given-names>M</given-names></name><name><surname>Freeston</surname><given-names>JE</given-names></name><name><surname>Wenham</surname><given-names>C</given-names></name><name><surname>Hensor</surname><given-names>EMA</given-names></name><etal/></person-group>
<article-title>Do non-steroidal anti-inflammatory drugs have a significant effect on detection and grading of ultrasound-detected synovitis in patients with rheumatoid arthritis? Results from a randomised study</article-title>. <source>Ann Rheum Dis</source> (<year>2011</year>) <volume>70</volume>:<fpage>1746</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1136/annrheumdis-2011-200017</pub-id><?supplied-pmid 21803749?><pub-id pub-id-type="pmid">21803749</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberman</surname><given-names>B</given-names></name><name><surname>Herman</surname><given-names>A</given-names></name><name><surname>Schindler</surname><given-names>A</given-names></name><name><surname>Sherr-Lurie</surname><given-names>N</given-names></name><name><surname>Ganel</surname><given-names>A</given-names></name><name><surname>Givon</surname><given-names>U</given-names></name></person-group>. <article-title>The value of hip aspiration in pediatric transient synovitis</article-title>. <source>J Pediatr Orthop</source> (<year>2013</year>) <volume>33</volume>:<fpage>124</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1097/BPO.0b013e31827268b8</pub-id><?supplied-pmid 23389564?><pub-id pub-id-type="pmid">23389564</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Bekerom</surname><given-names>MPJ</given-names></name><name><surname>Struijs</surname><given-names>PAA</given-names></name><name><surname>Blankevoort</surname><given-names>L</given-names></name><name><surname>Welling</surname><given-names>L</given-names></name><name><surname>van Dijk</surname><given-names>CN</given-names></name><name><surname>Kerkhoffs</surname><given-names>GM</given-names></name></person-group>. <article-title>What is the evidence for rest, ice, compression, and elevation therapy in the treatment of ankle sprains in adults?</article-title>
<source>J Athl Train</source> (<year>2012</year>) <volume>47</volume>:<fpage>435</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.4085/1062-6050-47.4.14</pub-id><?supplied-pmid 22889660?><pub-id pub-id-type="pmid">22889660</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Tuan</surname><given-names>RS</given-names></name></person-group>. <article-title>Biology of platelet-rich plasma and its clinical application in cartilage repair</article-title>. <source>Arthritis Res Ther</source> (<year>2014</year>) <volume>16</volume>:<fpage>204</fpage>.<pub-id pub-id-type="doi">10.1186/ar4493</pub-id><?supplied-pmid 25164150?><pub-id pub-id-type="pmid">25164150</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutgers</surname><given-names>M</given-names></name><name><surname>Creemers</surname><given-names>LB</given-names></name><name><surname>Auw Yang</surname><given-names>KG</given-names></name><name><surname>Raijmakers</surname><given-names>NJH</given-names></name><name><surname>Dhert</surname><given-names>WJA</given-names></name><name><surname>Saris</surname><given-names>DBF</given-names></name></person-group>. <article-title>Osteoarthritis treatment using autologous conditioned serum after placebo</article-title>. <source>Acta Orthop</source> (<year>2015</year>) <volume>86</volume>:<fpage>114</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.3109/17453674.2014.950467</pub-id><?supplied-pmid 25140983?><pub-id pub-id-type="pmid">25140983</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Witte</surname><given-names>SFH</given-names></name><name><surname>Franquesa</surname><given-names>M</given-names></name><name><surname>Baan</surname><given-names>CC</given-names></name><name><surname>Hoogduijn</surname><given-names>MJ</given-names></name></person-group>
<article-title>Toward development of iMesenchymal stem cells for immunomodulatory therapy</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>648</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00648</pub-id><pub-id pub-id-type="pmid">26779185</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>C</given-names></name><name><surname>Noël</surname><given-names>D</given-names></name></person-group>. <article-title>Mesenchymal stem cells in osteoarticular diseases</article-title>. <source>Regen Med</source> (<year>2011</year>) <volume>6</volume>:<fpage>44</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.2217/rme.11.80</pub-id><?supplied-pmid 21999261?><pub-id pub-id-type="pmid">21999261</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pers</surname><given-names>Y-M</given-names></name><name><surname>Jorgensen</surname><given-names>C</given-names></name></person-group>. <article-title>Adipose derived stem cells for regenerative therapy in osteoarticular diseases</article-title>. <source>Horm Mol Biol Clin Investig</source> (<year>2016</year>) <volume>28</volume>:<fpage>113</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1515/hmbci-2016-0010</pub-id><?supplied-pmid 27092656?><pub-id pub-id-type="pmid">27092656</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pigott</surname><given-names>JH</given-names></name><name><surname>Ishihara</surname><given-names>A</given-names></name><name><surname>Wellman</surname><given-names>ML</given-names></name><name><surname>Russell</surname><given-names>DS</given-names></name><name><surname>Bertone</surname><given-names>AL</given-names></name></person-group>. <article-title>Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2013</year>) <volume>156</volume>:<fpage>99</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2013.09.003</pub-id><?supplied-pmid 24094688?><pub-id pub-id-type="pmid">24094688</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AR</given-names></name><name><surname>Suncion</surname><given-names>VY</given-names></name><name><surname>McCall</surname><given-names>F</given-names></name><name><surname>Guerra</surname><given-names>D</given-names></name><name><surname>Mather</surname><given-names>J</given-names></name><name><surname>Zambrano</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling</article-title>. <source>J Am Heart Assoc</source> (<year>2013</year>) <volume>2</volume>:<fpage>e000140</fpage>.<pub-id pub-id-type="doi">10.1161/JAHA.113.000140</pub-id><?supplied-pmid 23686370?><pub-id pub-id-type="pmid">23686370</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>OG</given-names></name><name><surname>Van Balkom</surname><given-names>BWM</given-names></name><name><surname>Schiffelers</surname><given-names>RM</given-names></name><name><surname>Bouten</surname><given-names>CVC</given-names></name><name><surname>Verhaar</surname><given-names>MC</given-names></name></person-group>. <article-title>Extracellular vesicles: potential roles in regenerative medicine</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>608</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00608</pub-id><?supplied-pmid 25520717?><pub-id pub-id-type="pmid">25520717</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>RC</given-names></name><name><surname>Lim</surname><given-names>SK</given-names></name></person-group>
<article-title>Immunotherapeutic potential of extracellular vesicles</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>518</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00518</pub-id><pub-id pub-id-type="pmid">25374570</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino</surname><given-names>AM</given-names></name><name><surname>Hoogduijn</surname><given-names>MJ</given-names></name><name><surname>Borras</surname><given-names>FE</given-names></name><name><surname>Franquesa</surname><given-names>M</given-names></name></person-group>
<article-title>Therapeutic potential of extracellular vesicles</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>658</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00658</pub-id><pub-id pub-id-type="pmid">25566267</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Kordelas</surname><given-names>L</given-names></name><name><surname>Rebmann</surname><given-names>V</given-names></name><name><surname>Radtke</surname><given-names>S</given-names></name><name><surname>Felderhoff-Müser</surname><given-names>U</given-names></name><name><surname>Horn</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Exosomes – from bench to bedside</article-title>. <source>Klin Pädiatr</source> (<year>2012</year>) <volume>224</volume>:<fpage>A6</fpage><pub-id pub-id-type="doi">10.1055/s-0032-1330775</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathivanan</surname><given-names>S</given-names></name><name><surname>Simpson</surname><given-names>RJ</given-names></name></person-group>. <article-title>ExoCarta: a compendium of exosomal proteins and RNA</article-title>. <source>Proteomics</source> (<year>2009</year>) <volume>9</volume>:<fpage>4997</fpage>–<lpage>5000</lpage>.<pub-id pub-id-type="doi">10.1002/pmic.200900351</pub-id><?supplied-pmid 19810033?><pub-id pub-id-type="pmid">19810033</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blazquez</surname><given-names>R</given-names></name><name><surname>Sanchez-Margallo</surname><given-names>FM</given-names></name><name><surname>de la Rosa</surname><given-names>O</given-names></name><name><surname>Dalemans</surname><given-names>W</given-names></name><name><surname>Alvarez</surname><given-names>V</given-names></name><name><surname>Tarazona</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>556</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00556</pub-id><?supplied-pmid 25414703?><pub-id pub-id-type="pmid">25414703</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>Z</given-names></name></person-group>. <article-title>Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation</article-title>. <source>Cell Physiol Biochem</source> (<year>2015</year>) <volume>37</volume>:<fpage>2415</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1159/000438594</pub-id><?supplied-pmid 26646808?><pub-id pub-id-type="pmid">26646808</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Gong</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Millard</surname><given-names>RW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection</article-title>. <source>Int J Cardiol</source> (<year>2015</year>) <volume>182</volume>:<fpage>349</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijcard.2014.12.043</pub-id><?supplied-pmid 25590961?><pub-id pub-id-type="pmid">25590961</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro</article-title>. <source>Stem Cell Res Ther</source> (<year>2013</year>) <volume>4</volume>:<fpage>34</fpage>.<pub-id pub-id-type="doi">10.1186/scrt194</pub-id><?supplied-pmid 23618405?><pub-id pub-id-type="pmid">23618405</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabbir</surname><given-names>A</given-names></name><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Rodriguez-Menocal</surname><given-names>L</given-names></name><name><surname>Salgado</surname><given-names>M</given-names></name><name><surname>Van Badiavas</surname><given-names>E</given-names></name></person-group>. <article-title>Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro</article-title>. <source>Stem Cells Dev</source> (<year>2015</year>) <volume>24</volume>:<fpage>1635</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1089/scd.2014.0316</pub-id><?supplied-pmid 25867197?><pub-id pub-id-type="pmid">25867197</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>RC</given-names></name><name><surname>Arslan</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>MM</given-names></name><name><surname>Sze</surname><given-names>NSK</given-names></name><name><surname>Choo</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>TS</given-names></name><etal/></person-group>
<article-title>Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury</article-title>. <source>Stem Cell Res</source> (<year>2010</year>) <volume>4</volume>:<fpage>214</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/j.scr.2009.12.003</pub-id><?supplied-pmid 20138817?><pub-id pub-id-type="pmid">20138817</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Yao</surname><given-names>K</given-names></name><name><surname>Huuskes</surname><given-names>BM</given-names></name><name><surname>Shen</surname><given-names>H-H</given-names></name><name><surname>Zhuang</surname><given-names>J</given-names></name><name><surname>Godson</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis</article-title>. <source>Mol Ther</source> (<year>2016</year>) <volume>24</volume>:<fpage>1290</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="doi">10.1038/mt.2016.90</pub-id><?supplied-pmid 27203438?><pub-id pub-id-type="pmid">27203438</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group>. <article-title>Exosomes secreted by human urine-derived stem cells accelerate skin wound healing by promoting angiogenesis in rat</article-title>. <source>Cell Biol Int</source> (<year>2016</year>).<pub-id pub-id-type="doi">10.1002/cbin.10615</pub-id><?supplied-pmid 27098397?><pub-id pub-id-type="pmid">27098397</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rager</surname><given-names>TM</given-names></name><name><surname>Olson</surname><given-names>JK</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Besner</surname><given-names>GE</given-names></name></person-group>. <article-title>Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis</article-title>. <source>J Pediatr Surg</source> (<year>2016</year>) <volume>51</volume>:<fpage>942</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpedsurg.2016.02.061</pub-id><?supplied-pmid 27015901?><pub-id pub-id-type="pmid">27015901</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsel</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>Y-G</given-names></name><name><surname>Gudapati</surname><given-names>V</given-names></name><name><surname>Lim</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name></person-group>. <article-title>Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases</article-title>. <source>Expert Opin Biol Ther</source> (<year>2016</year>) <volume>16</volume>:<fpage>859</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1517/14712598.2016.1170804</pub-id><?supplied-pmid 27011289?><pub-id pub-id-type="pmid">27011289</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doeppner</surname><given-names>TR</given-names></name><name><surname>Herz</surname><given-names>J</given-names></name><name><surname>Görgens</surname><given-names>A</given-names></name><name><surname>Schlechter</surname><given-names>J</given-names></name><name><surname>Ludwig</surname><given-names>A-K</given-names></name><name><surname>Radtke</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression</article-title>. <source>Stem Cells Transl Med</source> (<year>2015</year>) <volume>4</volume>:<fpage>1131</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.5966/sctm.2015-0078</pub-id><?supplied-pmid 26339036?><pub-id pub-id-type="pmid">26339036</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ophelders</surname><given-names>DR</given-names></name><name><surname>Wolfs</surname><given-names>TG</given-names></name><name><surname>Jellema</surname><given-names>RK</given-names></name><name><surname>Zwanenburg</surname><given-names>A</given-names></name><name><surname>Andriessen</surname><given-names>P</given-names></name><name><surname>Delhaas</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia</article-title>. <source>Stem Cells Transl Med</source> (<year>2016</year>) <volume>5</volume>:<fpage>754</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.5966/sctm.2015-0197</pub-id><?supplied-pmid 27160705?><pub-id pub-id-type="pmid">27160705</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez</surname><given-names>V</given-names></name><name><surname>Sánchez-Margallo</surname><given-names>F-M</given-names></name><name><surname>Blázquez</surname><given-names>R</given-names></name><name><surname>Tarazona</surname><given-names>R</given-names></name><name><surname>Casado</surname><given-names>JG</given-names></name></person-group>
<article-title>Comparison of mesenchymal stem cells and leukocytes from large white and Göttingen Minipigs: clues for stem cell-based immunomodulatory therapies</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2016</year>) <volume>179</volume>:<fpage>63</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2016.08.002</pub-id><pub-id pub-id-type="pmid">27590427</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casado</surname><given-names>JG</given-names></name><name><surname>Gomez-Mauricio</surname><given-names>G</given-names></name><name><surname>Alvarez</surname><given-names>V</given-names></name><name><surname>Mijares</surname><given-names>J</given-names></name><name><surname>Tarazona</surname><given-names>R</given-names></name><name><surname>Bernad</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Comparative phenotypic and molecular characterization of porcine mesenchymal stem cells from different sources for translational studies in a large animal model</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2012</year>) <volume>147</volume>:<fpage>104</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2012.03.015</pub-id><pub-id pub-id-type="pmid">22521281</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Andaloussi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lakhal-Littleton</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Seow</surname><given-names>Y</given-names></name><name><surname>Gardiner</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Exosome-mediated delivery of siRNA in vitro and in vivo</article-title>. <source>Nat Protoc</source> (<year>2012</year>) <volume>7</volume>:<fpage>2112</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2012.131</pub-id><?supplied-pmid 23154783?><pub-id pub-id-type="pmid">23154783</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roccaro</surname><given-names>AM</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Maiso</surname><given-names>P</given-names></name><name><surname>Azab</surname><given-names>AK</given-names></name><name><surname>Tai</surname><given-names>Y-T</given-names></name><name><surname>Reagan</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression</article-title>. <source>J Clin Invest</source> (<year>2013</year>) <volume>123</volume>:<fpage>1542</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1172/JCI66517</pub-id><?supplied-pmid 23454749?><pub-id pub-id-type="pmid">23454749</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>S</given-names></name><name><surname>Abd Elmageed</surname><given-names>ZY</given-names></name><name><surname>Hawke</surname><given-names>DH</given-names></name><name><surname>Wörner</surname><given-names>PM</given-names></name><name><surname>Jansen</surname><given-names>DA</given-names></name><name><surname>Abdel-Mageed</surname><given-names>AB</given-names></name><etal/></person-group>
<article-title>Molecular characterization of exosome-like vesicles from breast cancer cells</article-title>. <source>BMC Cancer</source> (<year>2014</year>) <volume>14</volume>:<fpage>44</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2407-14-44</pub-id><?supplied-pmid 24468161?><pub-id pub-id-type="pmid">24468161</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name></person-group>. <article-title>Identification and analysis of exosomes secreted from macrophages extracted by different methods</article-title>. <source>Int J Clin Exp Pathol</source> (<year>2015</year>) <volume>8</volume>:<fpage>6135</fpage>–<lpage>42</lpage>.<?supplied-pmid 26261491?><pub-id pub-id-type="pmid">26261491</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Théry</surname><given-names>C</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name><name><surname>Raposo</surname><given-names>G</given-names></name><name><surname>Clayton</surname><given-names>A</given-names></name></person-group>. <article-title>Isolation and characterization of exosomes from cell culture supernatants and biological fluids</article-title>. <source>Curr Protoc Cell Biol</source> (<year>2006</year>) <volume>22</volume>:<fpage>1</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1002/0471143030.cb0322s30</pub-id><?supplied-pmid 18228490?><pub-id pub-id-type="pmid">18228490</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Gabalawy</surname><given-names>H</given-names></name></person-group>
<article-title>The challenge of early synovitis: multiple pathways to a common clinical syndrome</article-title>. <source>Arthritis Res</source> (<year>1999</year>) <volume>1</volume>:<fpage>31</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1186/ar8</pub-id><pub-id pub-id-type="pmid">11094411</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastrissianakis</surname><given-names>K</given-names></name><name><surname>Beattie</surname><given-names>TF</given-names></name></person-group>. <article-title>Transient synovitis of the hip: more evidence for a viral aetiology</article-title>. <source>Eur J Emerg Med</source> (<year>2010</year>) <volume>17</volume>:<fpage>270</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1097/MEJ.0b013e32832b1664</pub-id><?supplied-pmid 20523221?><pub-id pub-id-type="pmid">20523221</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname><given-names>C</given-names></name><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Ohmura</surname><given-names>K</given-names></name><name><surname>Nakashima</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Three groups in the 28 joints for rheumatoid arthritis synovitis – analysis using more than 17,000 assessments in the KURAMA database</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e59341</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0059341</pub-id><pub-id pub-id-type="pmid">23555018</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltzer</surname><given-names>AWA</given-names></name><name><surname>Moser</surname><given-names>C</given-names></name><name><surname>Jansen</surname><given-names>SA</given-names></name><name><surname>Krauspe</surname><given-names>R</given-names></name></person-group>. <article-title>Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis</article-title>. <source>Osteoarthritis Cartilage</source> (<year>2009</year>) <volume>17</volume>:<fpage>152</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.joca.2008.06.014</pub-id><?supplied-pmid 18674932?><pub-id pub-id-type="pmid">18674932</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippross</surname><given-names>S</given-names></name><name><surname>Moeller</surname><given-names>B</given-names></name><name><surname>Haas</surname><given-names>H</given-names></name><name><surname>Tohidnezhad</surname><given-names>M</given-names></name><name><surname>Steubesand</surname><given-names>N</given-names></name><name><surname>Wruck</surname><given-names>CJ</given-names></name><etal/></person-group>
<article-title>Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint</article-title>. <source>Arthritis Rheum</source> (<year>2011</year>) <volume>63</volume>:<fpage>3344</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1002/art.30547</pub-id><?supplied-pmid 21769848?><pub-id pub-id-type="pmid">21769848</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouri</surname><given-names>A</given-names></name><name><surname>Walmsley</surname><given-names>D</given-names></name><name><surname>Pruszczynski</surname><given-names>B</given-names></name><name><surname>Synder</surname><given-names>M</given-names></name></person-group>
<article-title>Transient synovitis of the hip: a comprehensive review</article-title>. <source>J Pediatr Orthop B</source> (<year>2014</year>) <volume>23</volume>:<fpage>32</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1097/BPB.0b013e328363b5a3</pub-id><pub-id pub-id-type="pmid">23812087</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LB</given-names></name><name><surname>Koenig</surname><given-names>JB</given-names></name><name><surname>Black</surname><given-names>B</given-names></name><name><surname>Gibson</surname><given-names>TWG</given-names></name><name><surname>Sharif</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>TG</given-names></name></person-group>
<article-title>Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an LPS induced synovitis model</article-title>. <source>Equine Vet J</source> (<year>2015</year>) <volume>48</volume>:<fpage>619</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1111/evj.12477</pub-id><pub-id pub-id-type="pmid">26114736</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>
<article-title>Exosomes derived from mesenchymal stem cells</article-title>. <source>Int J Mol Sci</source> (<year>2014</year>) <volume>15</volume>:<fpage>4142</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.3390/ijms15034142</pub-id><pub-id pub-id-type="pmid">24608926</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Lai</surname><given-names>RC</given-names></name><name><surname>Tan</surname><given-names>SS</given-names></name><name><surname>Choo</surname><given-names>ABH</given-names></name><name><surname>Lim</surname><given-names>SK</given-names></name></person-group>. <article-title>Mesenchymal stem cells secrete immunologically active exosomes</article-title>. <source>Stem Cells Dev</source> (<year>2014</year>) <volume>23</volume>:<fpage>1233</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1089/scd.2013.0479</pub-id><?supplied-pmid 24367916?><pub-id pub-id-type="pmid">24367916</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barile</surname><given-names>L</given-names></name><name><surname>Moccetti</surname><given-names>T</given-names></name><name><surname>Marbán</surname><given-names>E</given-names></name><name><surname>Vassalli</surname><given-names>G</given-names></name></person-group>
<article-title>Roles of exosomes in cardioprotection</article-title>. <source>Eur Heart J</source> (<year>2016</year>) <fpage>ehw304</fpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehw304</pub-id><pub-id pub-id-type="pmid">27443883</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>AG-E</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Marbán</surname><given-names>E</given-names></name></person-group>. <article-title>Exosomes as critical agents of cardiac regeneration triggered by cell therapy</article-title>. <source>Stem Cell Reports</source> (<year>2014</year>) <volume>2</volume>:<fpage>606</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.04.006</pub-id><?supplied-pmid 24936449?><pub-id pub-id-type="pmid">24936449</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyshev</surname><given-names>VS</given-names></name><name><surname>Rachamadugu</surname><given-names>R</given-names></name><name><surname>Tseng</surname><given-names>YH</given-names></name><name><surname>Belnap</surname><given-names>DM</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Branch</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Size and shape characterization of hydrated and desiccated exosomes</article-title>. <source>Anal Bioanal Chem</source> (<year>2015</year>) <volume>407</volume>:<fpage>3285</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="doi">10.1007/s00216-015-8535-3</pub-id><?supplied-pmid 25821114?><pub-id pub-id-type="pmid">25821114</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallet</surname><given-names>R</given-names></name><name><surname>Dawkins</surname><given-names>J</given-names></name><name><surname>Valle</surname><given-names>J</given-names></name><name><surname>Simsolo</surname><given-names>E</given-names></name><name><surname>de Couto</surname><given-names>G</given-names></name><name><surname>Middleton</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction</article-title>. <source>Eur Heart J</source> (<year>2017</year>) <volume>38</volume>(<issue>3</issue>):<fpage>201</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1093/eurheartj/ehw240</pub-id><pub-id pub-id-type="pmid">28158410</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L Ramos</surname><given-names>T</given-names></name><name><surname>Sánchez-Abarca</surname><given-names>LI</given-names></name><name><surname>Muntión</surname><given-names>S</given-names></name><name><surname>Preciado</surname><given-names>S</given-names></name><name><surname>Puig</surname><given-names>N</given-names></name><name><surname>López-Ruano</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry</article-title>. <source>Cell Commun Signal</source> (<year>2016</year>) <volume>14</volume>:<fpage>2</fpage>.<pub-id pub-id-type="doi">10.1186/s12964-015-0124-8</pub-id><?supplied-pmid 26754424?><pub-id pub-id-type="pmid">26754424</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldlust</surname><given-names>MB</given-names></name><name><surname>Rich</surname><given-names>LC</given-names></name><name><surname>Brown</surname><given-names>WR</given-names></name></person-group>. <article-title>Immune synovitis in rabbits. Effects of differing schedules for intra-articular challenge with antigen</article-title>. <source>Am J Pathol</source> (<year>1978</year>) <volume>91</volume>:<fpage>329</fpage>–<lpage>44</lpage>.<?supplied-pmid 645828?><pub-id pub-id-type="pmid">645828</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>F</given-names></name><name><surname>Shimada</surname><given-names>T</given-names></name><name><surname>Sakurai</surname><given-names>M</given-names></name><name><surname>Ishihara</surname><given-names>S</given-names></name><name><surname>Kuwamura</surname><given-names>M</given-names></name><name><surname>Yamate</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The production of arthritis in beagles by an immunological reaction to bovine serum albumin</article-title>. <source>Exp Anim</source> (<year>1996</year>) <volume>45</volume>:<fpage>299</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="doi">10.1538/expanim.45.299</pub-id><?supplied-pmid 8902492?><pub-id pub-id-type="pmid">8902492</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>TN</given-names></name><name><surname>Kisiday</surname><given-names>JD</given-names></name><name><surname>Hess</surname><given-names>T</given-names></name><name><surname>McIlwraith</surname><given-names>CW</given-names></name></person-group>. <article-title>Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide</article-title>. <source>Osteoarthritis Cartilage</source> (<year>2012</year>) <volume>20</volume>:<fpage>1583</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.joca.2012.08.008</pub-id><?supplied-pmid 22917743?><pub-id pub-id-type="pmid">22917743</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Kasahara</surname><given-names>T</given-names></name><name><surname>Sawai</surname><given-names>T</given-names></name><name><surname>Rikimaru</surname><given-names>A</given-names></name><name><surname>Mukaida</surname><given-names>N</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>The participation of IL-8 in the synovial lesions at an early stage of rheumatoid arthritis</article-title>. <source>Tohoku J Exp Med</source> (<year>1999</year>) <volume>188</volume>:<fpage>75</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1620/tjem.188.75</pub-id><?supplied-pmid 10494903?><pub-id pub-id-type="pmid">10494903</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>H</given-names></name><name><surname>Akahoshi</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Tonegawa</surname><given-names>M</given-names></name><name><surname>Takagishi</surname><given-names>K</given-names></name><name><surname>Kashiwazaki</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints</article-title>. <source>Clin Exp Immunol</source> (<year>1994</year>) <volume>96</volume>:<fpage>31</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.1994.tb06225.x</pub-id><?supplied-pmid 7512008?><pub-id pub-id-type="pmid">7512008</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güven</surname><given-names>O</given-names></name><name><surname>Tekin</surname><given-names>U</given-names></name><name><surname>Salmanoğlu</surname><given-names>B</given-names></name><name><surname>Kaymak</surname><given-names>E</given-names></name></person-group>. <article-title>Tumor necrosis factor-alpha levels in the synovial fluid of patients with temporomandibular joint internal derangement</article-title>. <source>J Craniomaxillofac Surg</source> (<year>2015</year>) <volume>43</volume>:<fpage>102</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.jcms.2014.10.017</pub-id><?supplied-pmid 25465487?><pub-id pub-id-type="pmid">25465487</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos Savio</surname><given-names>A</given-names></name><name><surname>Machado Diaz</surname><given-names>AC</given-names></name><name><surname>Chico Capote</surname><given-names>A</given-names></name><name><surname>Miranda Navarro</surname><given-names>J</given-names></name><name><surname>Rodríguez Alvarez</surname><given-names>Y</given-names></name><name><surname>Bringas Pérez</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients</article-title>. <source>BMC Musculoskelet Disord</source> (<year>2015</year>) <volume>16</volume>:<fpage>51</fpage>.<pub-id pub-id-type="doi">10.1186/s12891-015-0516-3</pub-id><?supplied-pmid 25879761?><pub-id pub-id-type="pmid">25879761</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazzani</surname><given-names>C</given-names></name><name><surname>Filippini</surname><given-names>M</given-names></name><name><surname>Caporali</surname><given-names>R</given-names></name><name><surname>Bobbio-Pallavicini</surname><given-names>F</given-names></name><name><surname>Favalli</surname><given-names>EG</given-names></name><name><surname>Marchesoni</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes</article-title>. <source>Autoimmun Rev</source> (<year>2009</year>) <volume>8</volume>:<fpage>260</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.autrev.2008.11.001</pub-id><?supplied-pmid 19027090?><pub-id pub-id-type="pmid">19027090</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>A</given-names></name><name><surname>Brady</surname><given-names>A</given-names></name><name><surname>Blake</surname><given-names>C</given-names></name><name><surname>Mongey</surname><given-names>A-B</given-names></name><name><surname>Veale</surname><given-names>DJ</given-names></name><name><surname>FitzGerald</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication</article-title>. <source>BMC Musculoskelet Disord</source> (<year>2011</year>) <volume>12</volume>:<fpage>11</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2474-12-11</pub-id><?supplied-pmid 21232112?><pub-id pub-id-type="pmid">21232112</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>E</given-names></name><name><surname>Cuzzocrea</surname><given-names>S</given-names></name></person-group>. <article-title>TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma</article-title>. <source>Curr Med Chem</source> (<year>2009</year>) <volume>16</volume>:<fpage>3152</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.2174/092986709788803024</pub-id><?supplied-pmid 19689289?><pub-id pub-id-type="pmid">19689289</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boissier</surname><given-names>M-C</given-names></name><name><surname>Semerano</surname><given-names>L</given-names></name><name><surname>Challal</surname><given-names>S</given-names></name><name><surname>Saidenberg-Kermanac’h</surname><given-names>N</given-names></name><name><surname>Falgarone</surname><given-names>G</given-names></name></person-group>. <article-title>Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction</article-title>. <source>J Autoimmun</source> (<year>2012</year>) <volume>39</volume>:<fpage>222</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaut.2012.05.021</pub-id><?supplied-pmid 22704962?><pub-id pub-id-type="pmid">22704962</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyurkchiev</surname><given-names>D</given-names></name><name><surname>Bochev</surname><given-names>I</given-names></name><name><surname>Ivanova-Todorova</surname><given-names>E</given-names></name><name><surname>Mourdjeva</surname><given-names>M</given-names></name><name><surname>Oreshkova</surname><given-names>T</given-names></name><name><surname>Belemezova</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Secretion of immunoregulatory cytokines by mesenchymal stem cells</article-title>. <source>World J Stem Cells</source> (<year>2014</year>) <volume>6</volume>:<fpage>552</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.4252/wjsc.v6.i5.552</pub-id><pub-id pub-id-type="pmid">25426252</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Exosomes from human umbilical cord mesenchymal stem cells: identification, purification, and biological characteristics</article-title>. <source>Stem Cells Int</source> (<year>2016</year>) <volume>2016</volume>:<fpage>1929536</fpage>.<pub-id pub-id-type="doi">10.1155/2016/1929536</pub-id><?supplied-pmid 28105054?><pub-id pub-id-type="pmid">28105054</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xiang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xiang</surname><given-names>C</given-names></name></person-group>. <article-title>Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure</article-title>. <source>Stem Cell Res Ther</source> (<year>2017</year>) <volume>8</volume>:<fpage>9</fpage>.<pub-id pub-id-type="doi">10.1186/s13287-016-0453-6</pub-id><?supplied-pmid 28115012?><pub-id pub-id-type="pmid">28115012</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>S</given-names></name><name><surname>Reyes-Aldasoro</surname><given-names>CC</given-names></name><name><surname>Candel</surname><given-names>S</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Mulero</surname><given-names>V</given-names></name><name><surname>Calado</surname><given-names>A</given-names></name></person-group>. <article-title>Cxcl8 (IL-8) mediates neutrophil recruitment and behavior in the zebrafish inflammatory response</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>4349</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1203266</pub-id><?supplied-pmid 23509368?><pub-id pub-id-type="pmid">23509368</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group>. <article-title>[Study of immunomodulatory function of exosomes derived from human umbilical cord mesenchymal stem cells]</article-title>. <source>Zhonghua Yi Xue Za Zhi</source> (<year>2015</year>) <volume>95</volume>:<fpage>2630</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.3760/cma.j.issn.0376-2491.2015.32.014</pub-id><?supplied-pmid 26711615?><pub-id pub-id-type="pmid">26711615</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Immunomodulatory effects of mesenchymal stromal cells-derived exosome</article-title>. <source>Immunol Res</source> (<year>2016</year>) <volume>64</volume>:<fpage>831</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1007/s12026-016-8798-6</pub-id><?supplied-pmid 27115513?><pub-id pub-id-type="pmid">27115513</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X-X</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Shou</surname><given-names>Z-X</given-names></name><name><surname>Zuo</surname><given-names>D-M</given-names></name><etal/></person-group>
<article-title>Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0140551</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0140551</pub-id><?supplied-pmid 26469068?><pub-id pub-id-type="pmid">26469068</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lascelles</surname><given-names>BDX</given-names></name><name><surname>Roe</surname><given-names>SC</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Reynolds</surname><given-names>L</given-names></name><name><surname>Markham</surname><given-names>J</given-names></name><name><surname>Marcellin-Little</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Evaluation of a pressure walkway system for measurement of vertical limb forces in clinically normal dogs</article-title>. <source>Am J Vet Res</source> (<year>2006</year>) <volume>67</volume>:<fpage>277</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.2460/ajvr.67.2.277</pub-id><?supplied-pmid 16454633?><pub-id pub-id-type="pmid">16454633</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359753</identifier><datestamp>2017-04-04</datestamp><setSpec>frontcellneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Cellular Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5102</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359753</article-id>
      <article-id pub-id-type="pmcid">PMC5359753</article-id>
      <article-id pub-id-type="pmc-uid">5359753</article-id>
      <article-id pub-id-type="doi">10.3389/fncel.2017.00070</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Review</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Drosophila melanogaster</italic> As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Koon</surname>
            <given-names>Alex C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/351667/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Ho Yin Edwin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/139951/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Laboratory of Drosophila Research</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Biochemistry Program</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>Cell and Molecular Biology Program</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <aff id="aff4">
        <sup>4</sup>
        <institution>Molecular Biotechnology Program, Faculty of Science, School of Life Sciences</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <aff id="aff5">
        <sup>5</sup>
        <institution>School of Life Sciences, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Rosanna Parlato, University of Ulm, Germany</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Kah-Leong Lim, National Neuroscience Institute, Singapore; Kim A. Staats, University of Southern California, USA</p>
        </fn>
        <corresp id="fn001">*Correspondence: Ho Yin Edwin Chan <email xlink:type="simple">hyechan@cuhk.edu.hk</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>70</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>1</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Koon and Chan.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Koon and Chan</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>For nearly a century, the fruit fly, <italic>Drosophila melanogaster</italic>, has proven to be a valuable tool in our understanding of fundamental biological processes, and has empowered our discoveries, particularly in the field of neuroscience. In recent years, <italic>Drosophila</italic> has emerged as a model organism for human neurodegenerative and neuromuscular disorders. In this review, we highlight a number of recent studies that utilized the <italic>Drosophila</italic> model to study repeat-expansion associated diseases (READs), such as polyglutamine diseases, fragile X-associated tremor/ataxia syndrome (FXTAS), myotonic dystrophy type 1 (DM1) and type 2 (DM2), and C9ORF72-associated amyotrophic lateral sclerosis/frontotemporal dementia (C9-ALS/FTD). Discoveries regarding the possible mechanisms of RNA toxicity will be focused here. These studies demonstrate <italic>Drosophila</italic> as an excellent <italic>in vivo</italic> model system that can reveal novel mechanistic insights into human disorders, providing the foundation for translational research and therapeutic development.</p>
      </abstract>
      <kwd-group>
        <kwd>polyglutamine disease</kwd>
        <kwd>Huntington's disease</kwd>
        <kwd>C9orf72</kwd>
        <kwd>amyotrophic lateral sclerosis (ALS)</kwd>
        <kwd>frontotemporal dementia (FTD)</kwd>
        <kwd>myotonic dystrophy</kwd>
        <kwd>fragile X</kwd>
        <kwd>spinocerebellar ataxia</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">Research Grants Council, University Grants Committee<named-content content-type="fundref-id">10.13039/501100002920</named-content></funding-source>
          <award-id rid="cn001">460712</award-id>
          <award-id rid="cn001">461013</award-id>
          <award-id rid="cn001">14100714</award-id>
          <award-id rid="cn001">14122815</award-id>
          <award-id rid="cn001">A-CUHK401/14</award-id>
          <award-id rid="cn001">CUHK1/CRF/13G</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn002">Chinese University of Hong Kong<named-content content-type="fundref-id">10.13039/501100004853</named-content></funding-source>
          <award-id rid="cn002">8303404</award-id>
          <award-id rid="cn002">3110102</award-id>
          <award-id rid="cn002">4930713</award-id>
          <award-id rid="cn002">3132980</award-id>
          <award-id rid="cn002">4053148</award-id>
          <award-id rid="cn002">7105306</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn003">Chow Tai Fook Charity Foundation</funding-source>
          <award-id rid="cn003">6903898</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn004">Hong Kong Spinocerebellar Ataxia Association</funding-source>
          <award-id rid="cn004">6903291</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="224"/>
        <page-count count="22"/>
        <word-count count="18592"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>For nearly two decades, the fruit fly <italic>Drosophila melanogaster</italic> has been utilized as a model organism to study a number of human neurodegenerative and neuromuscular diseases (Chan and Bonini, <xref rid="B24" ref-type="bibr">2000</xref>; Muqit and Feany, <xref rid="B129" ref-type="bibr">2002</xref>; Zoghbi and Botas, <xref rid="B222" ref-type="bibr">2002</xref>; Sang and Jackson, <xref rid="B168" ref-type="bibr">2005</xref>; Marsh and Thompson, <xref rid="B114" ref-type="bibr">2006</xref>; Yu and Bonini, <xref rid="B212" ref-type="bibr">2011</xref>; Jaiswal et al., <xref rid="B78" ref-type="bibr">2012</xref>; McGurk et al., <xref rid="B116" ref-type="bibr">2015</xref>). The fruit fly offers multiple advantages for the investigation of the molecular mechanisms of diseases. Having short life cycle, high offspring numbers, low costs for maintenance, simple yet powerful genetic manipulations, the availability of mutants, and other genetic tools are only some of the many attractive features of <italic>Drosophila</italic> as a model system. <italic>Drosophila</italic> was introduced into scientific research over a 100 years ago, and quickly became an invaluable tool that empowers our discoveries and understanding of a wide range of biological processes, such as embryogenesis, neural development, synaptic plasticity, and even complex behaviors such as decision-making and learning and memory (Bellen et al., <xref rid="B10" ref-type="bibr">2010</xref>; Spindler and Hartenstein, <xref rid="B179" ref-type="bibr">2010</xref>; Harris and Littleton, <xref rid="B64" ref-type="bibr">2015</xref>). Sequencing of the <italic>Drosophila</italic> and the human genomes revealed remarkably high similarities between the fly and humans (Adams et al., <xref rid="B1" ref-type="bibr">2000</xref>; Rubin, <xref rid="B165" ref-type="bibr">2000</xref>), with ~75% of the genes implicated in human genetic disorders having at least one homolog in <italic>Drosophila</italic> (Rubin, <xref rid="B165" ref-type="bibr">2000</xref>; Reiter et al., <xref rid="B157" ref-type="bibr">2001</xref>). Most importantly, despite the obvious anatomic divergence between the fly and humans, the fundamental aspects of cell biology are highly conserved, including the regulation of gene expression, synaptogenesis, cell proliferation, cell differentiation, cell signaling, and cell death. Many genes and pathways that are being studied in mammals were originally identified in <italic>Drosophila</italic>. For instance, the mammalian <italic>Wnt</italic> gene was originally identified as <italic>wingless</italic> in <italic>Drosophila</italic> with its mutation resulting in flies having no wings (Sharma and Chopra, <xref rid="B172" ref-type="bibr">1976</xref>). <italic>Wnt</italic>/<italic>wingless</italic> is now widely known for its involvement in a broad variety of conserved cellular processes and human diseases (Korkut and Budnik, <xref rid="B90" ref-type="bibr">2009</xref>).</p>
    </sec>
    <sec id="s2">
      <title>The advantages of using <italic>Drosophila</italic> for studying human disease-associated genes</title>
      <p>Comparing with mammals, <italic>Drosophila</italic> has much simpler genetics. The fruit fly has only four pairs of homologous chromosomes, as compared to 20 in mice and 23 in humans. Flies also have a much simpler nervous system, with ~200,000 neurons in the fly brain comparing to ~100 billion neurons in humans. Despite its simplicity, the fly nervous system is comprehensive, allowing the fly to perform a wide variety of behaviors, such as feeding, walking, climbing, courtship, and communication. Fruit flies are even capable of being trained with fear/reward conditioning paradigms to examine complex biological processes like learning and memory. These features of <italic>Drosophila</italic> make it an ideal organism for modeling complex disorders because it can be used to model a specific subset of phenotypes associated with a particular disease, which will simplify the analysis.</p>
      <p>A wide range of genetic manipulation techniques have been developed in <italic>Drosophila</italic> which are impractical to be implemented in mammals. For instance, the availability of <italic>P</italic>-elements mutants in libraries is certainly an advantage that is exclusive to the <italic>Drosophila</italic> community. Originally, <italic>P</italic>-elements are stretches of transposable DNA consisting of inverted repeats surrounding a transposase gene to allow hopping of the mobile element on chromosomes (Rubin and Spradling, <xref rid="B166" ref-type="bibr">1982</xref>; O'Hare and Rubin, <xref rid="B138" ref-type="bibr">1983</xref>). <italic>Drosophila</italic> researchers exploited its mobility, and designed <italic>P</italic>-elements without the transposase but with reporter genes. By pairing up this modified <italic>P</italic>-element with an inducible transposase, the <italic>P</italic>-element can then be randomly inserted into the genome to disrupt the transcription of downstream genes. With this technique, libraries of “<italic>P</italic>-element mutants” for tenths of thousands of genes are constructed (Cooley et al., <xref rid="B31" ref-type="bibr">1988</xref>; Bier et al., <xref rid="B15" ref-type="bibr">1989</xref>; Spradling et al., <xref rid="B180" ref-type="bibr">1999</xref>; Bellen et al., <xref rid="B9" ref-type="bibr">2004</xref>). Researchers can now conveniently access the information of these mutants from FlyBase (<ext-link ext-link-type="uri" xlink:href="http://flybase.org">http://flybase.org</ext-link>), and order them from resource centers such as the Bloomington <italic>Drosophila</italic> Stock Center. In addition, due to the nature that the mobilization of the <italic>P</italic>-elements are typically imprecise, these fly lines provide a means to generate excision mutants (Hummel and Klämbt, <xref rid="B72" ref-type="bibr">2008</xref>). Lastly, the introduction of flipase recombination targets into <italic>P</italic>-elements have provided the option of generating precise chromosomal deletions between two <italic>P</italic>-elements (Hummel and Klämbt, <xref rid="B72" ref-type="bibr">2008</xref>). The development of these genetic tools have greatly enhanced the process of genome editing in <italic>Drosophila</italic>.</p>
      <p>Another popular technique used in <italic>Drosophila</italic> research is the GAL4/UAS binary transgene overexpression system, which is perhaps one of the most versatile expression system ever developed in <italic>Drosophila</italic> (Brand and Perrimon, <xref rid="B19" ref-type="bibr">1993</xref>). GAL4 is a yeast transcription factor that drives the expression of a transgene downstream of an <italic>Upstream Activation Sequence</italic> (<italic>UAS</italic>). Usually, a GAL4 fly line expresses GAL4 under the control of a cell- or tissue-specific promoter. This can be achieved by enhancer-trap screens, or the fusion of identified promoters with the GAL4 gene and subsequently microinjecting the constructs into fly embryos to produce specific GAL4 driver lines (Duffy, <xref rid="B42" ref-type="bibr">2002</xref>). For the operon, a human disease gene of interest is usually subcloned into an expression construct containing UAS, which is then also microinjected into fly embryos to produce transgenic fly lines. The UAS operon lines will be crossed to GAL4 fly lines, resulting in the overexpression of the human disease gene of interest in the desired cells/tissues (Duffy, <xref rid="B42" ref-type="bibr">2002</xref>). If the expression of pathological human genes in the fly successfully yields an abnormal phenotype, such as degeneration in the photoreceptor neurons of the fly eye, genetic screens, and pharmacological screens can then be performed to search for genetic modifiers and small molecules that may impact the etiology of the corresponding human disorders.</p>
      <p>One of the most prominent aspects of the fly model is its capacity to conduct genetic screens to identify novel molecular components of pathological pathways. Mice models of human diseases are absolutely vital to advancing our understanding of the diseases, but nevertheless with limitations. In <italic>Drosophila</italic>, the classical forward genetic screens can be performed using mutagens such as ethyl methane sulfonate to generate mutants (St Johnston, <xref rid="B183" ref-type="bibr">2002</xref>; Yamamoto et al., <xref rid="B211" ref-type="bibr">2014</xref>). Since this approach is unbiased, it allows the identification of novel genes from the entire genome, which would otherwise be extremely difficult to perform in mouse models. Due to having a short life cycle, the simplicity of having only four pairs of homologous chromosomes and the availability of balancer chromosomes for the suppression of recombination, the isolation of mutations from <italic>Drosophila</italic> is much easier than that from a mouse. Apart from forward genetic screens, tools for high throughput reverse genetic screens are also available. Genetic tools for RNAi-mediated knockdown are easily accessible from stock centers such as the Vienna <italic>Drosophila</italic> Resource Center and Harvard Transgenic RNAi Project, making it possible to conveniently perform reverse genetic screens in the fly model (Dietzl et al., <xref rid="B37" ref-type="bibr">2007</xref>).</p>
      <p>External features of <italic>Drosophila</italic> makes it suitable for performing large scale screens of genes and pharmacologicals. Bristles, wing veins and the compound eye are all external structures of the organism that can be affected by genetic or cellular changes, and can easily be observed and scored under a stereomicroscope (Yamamoto et al., <xref rid="B211" ref-type="bibr">2014</xref>). The compound eye is mostly composed of photoreceptor neurons, and is commonly used as a model to monitor neurodegeneration, allowing the identification of novel genetic modifiers and drugs in screens (St Johnston, <xref rid="B183" ref-type="bibr">2002</xref>). Using the GAL4/UAS system, toxic RNAs or toxic proteins that commonly occurs in human neurodegenerative and neuromuscular diseases can be expressed in the fly eye, which often results in a rough-eye phenotype. Since the eye is not required for viability, this allows effective screening of genes or pharmacologicals that can alleviate or enhance the degeneration. Most compounds can be simply mixed into standard <italic>Drosophila</italic> food to be consumed by larvae and adult flies. Alternatively, compounds can be injected into adult flies as well if a high, acute dosage is needed in the adult stage. The identification of novel genetic modifiers or drugs may reveal the physiological role of disease-related genes and promote our understanding of the disease pathology (Zoghbi and Botas, <xref rid="B222" ref-type="bibr">2002</xref>; Hirth, <xref rid="B67" ref-type="bibr">2010</xref>; Pandey and Nichols, <xref rid="B142" ref-type="bibr">2011</xref>; McGurk et al., <xref rid="B116" ref-type="bibr">2015</xref>). Thus, <italic>Drosophila</italic> serves as an important platform for the discoveries of new components of pathological pathways and the development of pioneer therapeutic approaches.</p>
    </sec>
    <sec id="s3">
      <title>The limitations of modeling human diseases in the fruit fly</title>
      <p>Although the use of classical genetic screens of <italic>Drosophila</italic> provides an unbiased approach to gain insights into human degenerative diseases, fly mutations may not be precise representations of human disease mutations. This is because the classical fly mutants from forward genetic screens are typically loss-of-function alleles. Yet in human diseases, mutations can have complex presentations, including both loss-of-function of the wild type allele and gain-of-function of the mutant allele. Most of the times, this gain-of-function effect can still be modeled in <italic>Drosophila</italic> by overexpressing the mutant protein using the GAL4/UAS system (St Johnston, <xref rid="B183" ref-type="bibr">2002</xref>). But for some diseases which the loss-of-function of the wild type protein plays a major role in the disease etiology, if there are no <italic>Drosophila</italic> orthologs of the corresponding human disease-associated genes, then perhaps the fly is not a suitable model for the particular disease.</p>
      <p>Furthermore, while the GAL4/UAS system is an extremely effective and versatile system, it is after all an overexpression system that may give rise to the typical caveats of overexpression studies. The magnitude of overexpression in a model can be tremendously different from the clinical situation (Floresco et al., <xref rid="B48" ref-type="bibr">2005</xref>). Sometimes, even overexpressing a wild type version of a gene may cause a disease phenotype (Prelich, <xref rid="B151" ref-type="bibr">2012</xref>). In fact, excess GAL4 protein in the <italic>Drosophila</italic> eye may lead to degeneration (Kramer and Staveley, <xref rid="B91" ref-type="bibr">2003</xref>). Hence, it is paramount for <italic>Drosophila</italic> researchers to set up appropriate controls to ensure that the phenotypes observed are not simply overexpression artifacts.</p>
      <p>Lastly, it is a concern of whether the fly models can faithfully recapitulate the selective neuronal death and associated phenotypes of human neurological disorders. Although the <italic>Drosophila</italic> photoreceptor degeneration provides a convenient readout, it mostly reflects generic neurotoxicity instead of selective neurotoxicity that is disease-specific. Thus, it is important to verify relevant phenotypes using other systems that are more specific to the particular types of disease. For instance, for myotonic dystrophy, it is crucial to verify any degeneration phenotype in a neuromuscular system, like the <italic>Drosophila</italic> or mouse neuromuscular junction (de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>; Panaite et al., <xref rid="B141" ref-type="bibr">2013</xref>).</p>
      <p>Despite all the limitations, <italic>Drosophila</italic> has so far proven to be a valid and useful tool in unraveling the etiology of human diseases and identifying compounds that can improve symptoms and modify the course of human diseases. Success examples include the rescuing of disease-like phenotypes in fly models of fragile X syndrome (Chang et al., <xref rid="B26" ref-type="bibr">2008</xref>), prolonged survival of dopaminergic neurons in fly models of Parkinson's disease (Auluck et al., <xref rid="B4" ref-type="bibr">2005</xref>; Faust et al., <xref rid="B44" ref-type="bibr">2009</xref>) and lifespan extension in fly models of Alzheimer's disease (Rajendran et al., <xref rid="B154" ref-type="bibr">2008</xref>).</p>
    </sec>
    <sec id="s4">
      <title>Repeat expansion-associated neurodegenerative and neuromuscular diseases</title>
      <p>As early as 1918, unstable nucleotide (microsatellite) repeat expansion had already been identified as a mutational mechanism underlying several human disease (Fleischer, <xref rid="B47" ref-type="bibr">1918</xref>). Originally, only trinucleotide repeats were associated with human diseases (Fu et al., <xref rid="B52" ref-type="bibr">1991</xref>; La Spada et al., <xref rid="B99" ref-type="bibr">1991</xref>). But over the years, other disease-causing expandable microsatellite repeats were gradually discovered including unstable tetra-, penta-, and hexa-nucleotide repeats (Mirkin, <xref rid="B122" ref-type="bibr">2007</xref>). Remarkably, the majority of the repeat expansion-associated diseases (READs) manifest with neurological and neuromuscular symptoms. Until today, more than 20 neurodegenerative and neuromuscular disorders have been linked with unstable nucleotide repeat expansions in the human genome (Pearson et al., <xref rid="B145" ref-type="bibr">2005</xref>; Brouwer et al., <xref rid="B21" ref-type="bibr">2009</xref>; Todd and Paulson, <xref rid="B192" ref-type="bibr">2010</xref>; Polak et al., <xref rid="B150" ref-type="bibr">2013</xref>).</p>
      <p>Repeat expansions can be coding or non-coding, and the underlying mechanism of a READ may involve (1) loss-of-function of wild-type protein, (2) gain-of-function of toxic RNAs, or (3) gain-of-function of toxic proteins (Figure <xref ref-type="fig" rid="F1">1</xref>). Coding expansion disorders usually result from smaller repeat copies (few to tens of copies) that manifest in exon coding regions of genes. This group of READs includes mostly polyglutamine (polyQ) diseases like Huntington's disease (HD) and several forms of spinocerebellar ataxia (SCA), which typically involves the translation of the gene products together with the repeat expansions into toxic proteins with gain-of-function (La Spada et al., <xref rid="B99" ref-type="bibr">1991</xref>; MacDonald et al., <xref rid="B110" ref-type="bibr">1993</xref>; Orr et al., <xref rid="B140" ref-type="bibr">1993</xref>; Kawaguchi et al., <xref rid="B84" ref-type="bibr">1994</xref>; Imbert et al., <xref rid="B74" ref-type="bibr">1996</xref>; Pulst et al., <xref rid="B152" ref-type="bibr">1996</xref>; Sanpei et al., <xref rid="B169" ref-type="bibr">1996</xref>; David et al., <xref rid="B32" ref-type="bibr">1997</xref>; Zhuchenko et al., <xref rid="B221" ref-type="bibr">1997</xref>; Nakamura et al., <xref rid="B132" ref-type="bibr">2001</xref>). In contrast, the non-coding expansions disorders typically involve larger expansions (from ~100 to 1000 copies), which reside in the non-coding regions of genes, such as promoters, introns or untranslated regions (UTRs). This groups includes fragile X-associated tremor/ataxia syndrome (FXTAS), Friedrich's ataxia, C9-ALS/FTD, myotonic dystrophy types 1 and 2 (DM1 and DM2) and SCA8 (Brook et al., <xref rid="B20" ref-type="bibr">1992</xref>; Montermini et al., <xref rid="B125" ref-type="bibr">1997</xref>; Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>; Mutsuddi et al., <xref rid="B130" ref-type="bibr">2004</xref>; DeJesus-Hernandez et al., <xref rid="B36" ref-type="bibr">2011</xref>; Renton et al., <xref rid="B160" ref-type="bibr">2011</xref>). Non-coding expansions usually results in repeat-containing transcripts with gain-of-function RNA toxicity. However, even non-coding expansions can still be translated into toxic peptides by repeat-associated non-ATG translation (Zu et al., <xref rid="B224" ref-type="bibr">2011</xref>). Thus, the pathologies of READs are complex, as both coding and non-coding repeat expansions may involve a combination of mechanisms, including wild-type proteins loss-of-function, toxic RNA gain-of-function, and toxic protein gain-of-function.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Classification of READs and their types of toxicity</bold>. READs can be classified into coding and non-coding. A repeat expansion that occur in the coding region of an affected gene may result in the loss-of-function of the wild type proteins, the gain-of-function of toxic RNAs, and the gain-of-function of toxic proteins. In contrast, a repeat expansion in the non-coding region of an affected gene would not lead to immediate protein toxicity, but could involve the loss-of-function of the wild type proteins and the gain-of-function of toxic RNAs. However, RAN translation may still occur in non-coding READs, which results in the production of toxic repeat-containing proteins/peptides.</p>
        </caption>
        <graphic xlink:href="fncel-11-00070-g0001"/>
      </fig>
    </sec>
    <sec id="s5">
      <title>RNA gain-of-function toxicty in reads and its pathogenic mechanisms</title>
      <p>The concept that RNA itself acts as a major toxic species in neurodegenerative/neuromuscular disorders was first described for DM1. DM1 is the most common form of muscular dystrophy in adults, caused by an expanded CTG repeat in the 3′UTR of the <italic>dystrophia myotonica protein kinase</italic> (<italic>DMPK</italic>) gene (Brook et al., <xref rid="B20" ref-type="bibr">1992</xref>; Fu et al., <xref rid="B53" ref-type="bibr">1992</xref>; Mahadevan et al., <xref rid="B111" ref-type="bibr">1992</xref>). Ribonuclear foci were found to be forming in the nuclei of the affected cells, and these foci contain the RNA transcripts from the CTG repeat expansion (Taneja et al., <xref rid="B187" ref-type="bibr">1995</xref>). In brief, the expanded repeats localized at the foci in turn sequester endogenous RNA binding proteins, impairing the alternatively splicing mechanisms and leading to cellular toxicity and degeneration (Figure <xref ref-type="fig" rid="F2">2</xref>; Renoux and Todd, <xref rid="B159" ref-type="bibr">2012</xref>; Belzil et al., <xref rid="B11" ref-type="bibr">2013</xref>; Fiszer and Krzyzosiak, <xref rid="B46" ref-type="bibr">2013</xref>; Nalavade et al., <xref rid="B133" ref-type="bibr">2013</xref>). This is the “sequestration hypothesis” or “alternative splicing impairment model,” which is one of the most supported mechanisms of the emerging “RNA toxicity model.” The ribonuclear foci are now a hallmark for most of the READs associated with non-coding repeats (Wojciechowska and Krzyzosiak, <xref rid="B206" ref-type="bibr">2011</xref>). Some even coined the term “RNAopathies” for these disorders due to the clear involvement of RNA toxicity. Noted that, despite the consensus that the formation of foci is a feature of pathogenesis, their role in pathogenesis is still unclear. The original belief was that they could be toxic since they harbor the toxic RNA transcripts. Yet, accumulating evidence from DM1, DM2 and C9-ALS/FTD studies now suggests that the foci <italic>per se</italic>, do not appear to be toxic, since cells with foci do not necessarily degenerate (Houseley et al., <xref rid="B70" ref-type="bibr">2005</xref>; Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>, <xref rid="B213" ref-type="bibr">2015</xref>; Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>; Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>). The fact that cells with the same amount of foci could very well be alive or dying indicating that toxicity is not proportional to foci numbers (Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>; Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>). Thus, ribonuclear foci could be neutral or even beneficial, at least in the beginning phase of the disease progression.</p>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Possible mechanisms of RNA toxicity in repeat expansion-associated diseases</bold>. Repeat expansion can occur in coding or non-coding regions of affected genes. Bidirectional transcription results in both sense and antisense transcripts containing the repeats. Both sense and antisense expanded RNAs can form ribonuclear foci. The foci may sequester RNA-binding proteins, such as MBNL1 in the case of DM1, leading to impairment of the alternative splicing and nucleocytoplasmic transport machineries. The sense and antisense ssRNAs can anneal to form dsRNAs. ssRNAs can also form hairpin structures by themselves, which are degradation resistant. Both dsRNAs and hairpin-forming RNAs may export the nucleus and be cleaved into sRNAs by Dicer. The sRNAs can then sequester RNA-binding proteins, leading to splicing and nucleocytoplasmic transport impairment. For hexanucleotide repeats such as GGGCC in C9-ALS/FTD, the ssRNA may form G-quadruplex structures. These structures facilitate DNA/RNA hybrid and impede transcription. They also form inclusions, leading to the sequestration of RNA-binding proteins as well. Repeat-containing transcripts, whether in hairpin or G-quadruplex structures, can bind to NCL, inducing nucleolar stress and caspase activation. Expanded transcripts that escape the nucleus associate themselves with ribosomes, leading to RAN translation. RAN translational products may form inclusions, which disrupts nucleocytoplasmic transport, impedes the ubiquitin protease system and impairs the assembly, dynamics, and functions of membrane-less organelles such as the nucleolar and stress granules. In neurons, the expanded transcripts may also be actively transported to neurites, resulting in neuritic branching, and transport granule defects. It is postulated that the local translational machinery may also be disrupted.</p>
        </caption>
        <graphic xlink:href="fncel-11-00070-g0002"/>
      </fig>
      <p>An alternative mechanism of RNA toxicity is bidirectional transcription. The original discovery for bidirectional transcription came from a study on SCA8. SCA8 is a type of spinocerebellar ataxia arises from a CTG expansion in the 3′ end of a non-protein coding RNA, <italic>Ataxin-8 Opposite Strand</italic> (<italic>ATXN8OS</italic>; Koob et al., <xref rid="B89" ref-type="bibr">1999</xref>). Its pathogenic mechanism was thought to be similar to DM1 since both disorders involves a CTG repeat. However, the antisense transcript, <italic>Ataxin-8</italic>, has a short cryptic open reading frame that results in CAG repeats in the glutamine reading frame (Moseley et al., <xref rid="B127" ref-type="bibr">2006</xref>). Moreover, nuclear polyQ inclusions were found, indicating that both toxic RNA and toxic proteins gain-of-function were being produced and could be involved in the pathogenesis of SCA8 (Moseley et al., <xref rid="B127" ref-type="bibr">2006</xref>). Bidirectional transcription was found in models of DM1, FXTAS and SCA7, suggesting that it is a common mechanism of RNA toxicity in READs (Cho et al., <xref rid="B28" ref-type="bibr">2005</xref>; Ladd et al., <xref rid="B97" ref-type="bibr">2007</xref>; Sopher et al., <xref rid="B178" ref-type="bibr">2011</xref>).</p>
      <p>A third mechanism of RNA toxicity is nucleolar stress and nucleocytoplasmic transport defects. Nucleolar stress is defined as the cellular pathways used by the nucleolus to communicate with cytosolic compartments in order to trigger apoptosis (Boulon et al., <xref rid="B18" ref-type="bibr">2010</xref>; Lindenboim et al., <xref rid="B106" ref-type="bibr">2011</xref>). Hence, nucleolar stress is a conserved and effective mechanism to eliminate ribosome biogenesis-defective cells. It has been reported that CAG repeat expansion in polyglutamine diseases interacts directly with nucleolin (NCL), a nucleolar protein that regulates rRNA transcription and ribosome biogenesis (Tsoi et al., <xref rid="B195" ref-type="bibr">2012</xref>). The CAG repeat-induced impairment of ribosome biogenesis in turn increases the concentration of p53 in mitochondria, disrupts the interaction between anti- and pro-apoptotic factors such as Bcl-xl and Bak, causes cytochrome c release and caspase activation, and eventually leads to cell death (Tsoi et al., <xref rid="B195" ref-type="bibr">2012</xref>). In polyQ diseases, the fact that CAG repeats-containing RNAs are retained in the nucleus indicates defective nucleocytoplasmic transport of the mutant transcripts (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>). It was reported that CAG repeats can directly bind to the U2 small nuclear ribonucleoprotein auxiliary factor 65 (U2AF65), the fly homolog of human U2AF50 that is involved in the nuclear export of mRNA. U2AF65 is capable of forming a complex with the nuclear export receptor NXF1 to regulate nucleocytoplasmic transport of RNAs (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>). Thus, the downregulation of U2AF65 due to sequestration by CAG repeats results in the nuclear accumulation of RNAs (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>). Furthermore, the researchers observed a neurodevelopmental downregulation of U2AF65 protein levels in a mouse model of HD, suggesting that the reduction in U2AF65 levels causes nuclear accumulation of expanded CAG-containing transcripts in HD. Apart from polyQ diseases, nucleocytoplasmic transport defects have also been demonstrated in models of C9-ALS/FTD (Freibaum et al., <xref rid="B50" ref-type="bibr">2015</xref>; Zhang et al., <xref rid="B218" ref-type="bibr">2015</xref>). These studies demonstrate the involvement of the nucleolar stress and nucleocytoplasmic transport defects in the RNA toxicity-mediated pathogenesis of READs.</p>
      <p>A forth mechanism of RNA toxicity is mediated by hairpin-forming single stranded RNAs (ssRNAs) and double-stranded RNAs (dsRNAs) containing the expanded repeats. Both of them would eventually lead to the generating of toxic repeat-containing small RNAs (sRNAs), which is the true culprit of this mechanism of RNA toxicity in READs. It is known that hairpin structures can be formed by single stranded CAG repeats in polyQ diseases and CGG repeats in FXTAS (Sobczak et al., <xref rid="B175" ref-type="bibr">2003</xref>, <xref rid="B176" ref-type="bibr">2010</xref>). Complex secondary structures like hairpin loops can significantly alter the transcripts' processing, transport, translation, and interactions with RNA binding proteins. Hairpin structures also strongly protects the RNAs from attacks by nucleases, rendering them more resistant to degradation (Sobczak et al., <xref rid="B176" ref-type="bibr">2010</xref>). Hence, the hairpin structure itself already conveys a type of toxicity. However, the more severe consequences come from the fact that it facilitates the production of sRNAs via the RNAi machinery. Dicer is an RNase III family ribonuclease that cleaves double-stranded precursor RNAs to generate sRNAs, and is a key enzyme involved in RNAi (Bernstein et al., <xref rid="B12" ref-type="bibr">2001</xref>). Since expanded ssRNAs in READs form double-stranded hairpin structures, they are valid substrates of Dicer, and will be cleaved into sRNAs. Even though these repeat-containing sRNAs cannot form ribonuclear foci, they are still capable of binding to key proteins of the alternative splicing machinery, such as MBNL1, and cause defects in RNA processing (Mykowska et al., <xref rid="B131" ref-type="bibr">2011</xref>). sRNAs with as few as seven CAG repeats have been shown to induce caspase activation and cellular toxicity in a disease model of HD (Bañez-Coronel et al., <xref rid="B6" ref-type="bibr">2012</xref>). It has been reported that the knockdown of Dicer expression can reduce sRNA in HD and SCA1 models, supporting the involvement of RNAi in the sRNA-induced toxicity of READs (Krol et al., <xref rid="B94" ref-type="bibr">2007</xref>; Bañez-Coronel et al., <xref rid="B6" ref-type="bibr">2012</xref>). Since bidirectional transcription is common with repeat expansions, the transcribed sense and antisense strands may form double-stranded RNAs (dsRNAs). Once again, dsRNA is a substrate of Dicer, thus it becomes a source of sRNAs. This mechanism was demonstrated in two <italic>Drosophila</italic> studies. One showed that that dsRNAs comprising CAG/CUG repeats can be a source of cellular toxicity via the Dicer pathway (Lawlor et al., <xref rid="B101" ref-type="bibr">2011</xref>). The other study showed that the co-expression of CAG and CUG repeats results in enhanced RNA toxicity in a Dicer-dependent manner by generating more sRNAs, which impedes the expression of CAG-containing genes, such as <italic>Ataxin-2</italic> and <italic>TATA-binding protein</italic> (<italic>TBP</italic>; Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>). Therefore, both ssRNA hairpins and dsRNAs can be a source of harmful sRNAs that results in cellular toxicity. For hexanucleotide repeat expansions such as GGGGCC in C9-ALS/FTD, the single stranded RNA repeats can even form G-quadruplex structures (Reddy et al., <xref rid="B155" ref-type="bibr">2013</xref>; Haeusler et al., <xref rid="B60" ref-type="bibr">2014</xref>). G-quadruplex structures can induce a number of detrimental consequences in the cell including transcription impairment, formation of inclusions and sequestration of ribonucleoproteins to impeded alternative splicing and induce nucleolar stress (Haeusler et al., <xref rid="B60" ref-type="bibr">2014</xref>; Conlon et al., <xref rid="B30" ref-type="bibr">2016</xref>).</p>
      <p>A fifth mechanism which non-coding expanded transcripts lead to cellular toxicity is by repeat-associated non-ATG (RAN) translation. Normally, protein synthesis is initiated by the start codon ATG, which leads to the translation of mRNA. Ranum and colleagues have discovered a novel mechanism which repeat expansions in READs can bypass the need of a start codon and mediate RAN translation of the repeat-containing transcripts (Zu et al., <xref rid="B224" ref-type="bibr">2011</xref>). In RAN translation, the accumulated expanded repeat RNA may undergo protein translation in all three possible reading frames, resulting in the production of proteins consisting of different amino acid combinations (Zu et al., <xref rid="B224" ref-type="bibr">2011</xref>). It has been shown in SCA8, FXTAS, and C9-ALS/FTD that the protein products from RAN translation are highly toxic and play an significant role in pathogenesis (Zu et al., <xref rid="B224" ref-type="bibr">2011</xref>; Todd et al., <xref rid="B190" ref-type="bibr">2013</xref>; Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>; Freibaum et al., <xref rid="B50" ref-type="bibr">2015</xref>; Oh et al., <xref rid="B139" ref-type="bibr">2015</xref>; Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>; Lee et al., <xref rid="B103" ref-type="bibr">2016</xref>).</p>
      <p>A sixth mechanism of RNA toxicity involves the expanded RNAs being actively transported to neurites by transport granules, which in turn induces a neuritic branching defect in neurons (Burguete et al., <xref rid="B22" ref-type="bibr">2015</xref>). This could be explained by the fact that the expanded RNA-bound transport granules cannot function normally, and the transport defects possibly interfere with the local translational machinery as well (Burguete et al., <xref rid="B22" ref-type="bibr">2015</xref>).</p>
    </sec>
    <sec id="s6">
      <title>Modeling the RNA toxicity of repeat expansions in <italic>Drosophila</italic></title>
      <p>Recent work in <italic>Drosophila</italic> has begun to shed light on the emerging “RNA toxicity model.” One of the earliest <italic>Drosophila</italic> studies that demonstrated this model was pioneered by Rebay and colleagues in the pathogenesis of SCA8 (Mutsuddi et al., <xref rid="B130" ref-type="bibr">2004</xref>). Unlike most other types of SCA, SCA8 is associated with a CTG repeat expansion within a non-coding region (Koob et al., <xref rid="B89" ref-type="bibr">1999</xref>). A <italic>Drosophila</italic> model of SCA8 was developed by overexpressing the non-coding transcript of the human <italic>SCA8</italic> locus in the fly eye, which results in retinal degeneration (Mutsuddi et al., <xref rid="B130" ref-type="bibr">2004</xref>). The <italic>Drosophila</italic> RNA binding protein genes, <italic>staufen, muscleblind (Mbl), split ends</italic>, and <italic>CG3249</italic>, were all subsequently identified as genetic modifiers of this degeneration, suggesting that RNA rather than expanded protein is the source of toxicity (Mutsuddi et al., <xref rid="B130" ref-type="bibr">2004</xref>). DM1 is another non-coding READ demonstrated to be caused by RNA toxicity. DM1 is associated with a CUG repeat expansion in the 3′ UTR of the <italic>DMPK</italic> gene. A <italic>Drosophila</italic> model of DM1 was established by expressing non-coding CUG repeats in either the <italic>Drosophila</italic> eyes or muscles. Degeneration was observed in both cases, indicating the presence of toxic RNA gain-of-function (de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>). In the case of FXTAS, a CGG repeat expansion occurs in the 5′ UTR of the <italic>FMR1</italic> gene. In <italic>Drosophila</italic>, it was reported that the expression of non-coding CGG repeats was sufficient to induce retinal degeneration in the absence of expressed proteins (Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>). All these studies in <italic>Drosophila</italic> support the notion that RNA toxicity play a significant role in the pathologies of many READs. More importantly, these studies also demonstrate the fruit fly as an excellent model for studying human READs and RNA toxicity. Currently, fly models have been established for at least 13 different READs (Table <xref ref-type="table" rid="T1">1</xref>). Below, we will cover a number of READs with RNA toxicity and highlight the discoveries made using their corresponding <italic>Drosophila</italic> models. These READs were selected base on the following two criteria: (i) It has been shown that gain-of-function RNA toxicity contributes to the pathology of these diseases, and (ii) there are established <italic>Drosophila</italic> models for studying the RNA toxicity of these diseases.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p><bold>Published transgenic <italic><bold>Drosophila</bold></italic> lines for modeling repeat expansion-associated diseases</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>READ</bold>
              </th>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Affected human gene</bold>
              </th>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Expansion region of the human gene</bold>
              </th>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Nucleotide repeat</bold>
              </th>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Established <italic>Drosophila</italic> lines for modeling READs (under UAS control)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">HD</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Huntingtin</italic> (<italic>HTT</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region (Exon 1)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><bold>With an exon1-derived HTT fragment</bold><break/>(Jackson et al., <xref rid="B75" ref-type="bibr">1998</xref>):<break/>HTT<sup>1−142</sup>-Q2<break/>HTT<sup>1−142</sup>-Q75<break/>HTT<sup>1−142</sup>-Q120</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Steffan et al., <xref rid="B182" ref-type="bibr">2001</xref>):<break/>Htt-ex1p-Q20<break/>Htt-ex1p-Q93<break/>UAS-Q48 + myc/flag</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Doumanis et al., <xref rid="B40" ref-type="bibr">2009</xref>):<break/>Nhtt-18Q-EGFP<break/>Nhtt-48Q-EGFP<break/>Nhtt-98Q-EGFP<break/>Nhtt-152Q-EGFP<break/>Nhtt-48Q-EGFP<sup>NLS</sup></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"><bold>With a HTT fragment of amino acids 1-336</bold><break/>(Kaltenbach et al., <xref rid="B82" ref-type="bibr">2007</xref>):<break/><italic>128Q-htt</italic><sup>[M64]</sup></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"><bold>With a HTT fragment of amino acids 1-548</bold><break/>(Lee et al., <xref rid="B104" ref-type="bibr">2004</xref>):<break/>Htt-Q0<break/>Htt-Q128</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"><bold>With a HTT fragment of amino acids 1-588</bold><break/>(Weiss et al., <xref rid="B204" ref-type="bibr">2012</xref>):<break/>mRFP-Htt-Q15<break/>mRFP-Htt-Q138<break/>EGFP-Htt-Q15<break/>EGFP-Htt-Q138<break/>EGFP-Htt-Q15-mRFP<break/>EGFP-Htt-Q138-mRFP<break/>Htt<sup>1−81</sup>-Q96-GFP (with HTT exon 1 amino acids 1-81)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"><bold>With full length HTT (3144 amino acids)</bold><break/>(Romero et al., <xref rid="B162" ref-type="bibr">2008</xref>):<break/>16Q-htt<sup>FL</sup><break/>128Q-htt<sup>FL</sup></td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SBMA</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Androgen receptor</italic> (<italic>AR</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region (N-terminus)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Takeyama et al., <xref rid="B186" ref-type="bibr">2002</xref>):<break/>AR-Q0<break/>AR-Q52</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">DRPLA</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Atrophin-1</italic> (<italic>AT1</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Nisoli et al., <xref rid="B137" ref-type="bibr">2010</xref>):<break/>At-1-wt<break/>At-1-65Q<break/>At-1-65ΔC<break/>Atro-wt<break/>Atro-75QN<break/>Atro-66QC</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA1</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Ataxin-1</italic> (<italic>ATXN1</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Fernandez-Funez et al., <xref rid="B45" ref-type="bibr">2000</xref>):<break/>Ataxin-1 Q30<break/>Ataxin-1 Q82</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA3 (MJD)</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Ataxin-3</italic> (<italic>ATXN3</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Warrick et al., <xref rid="B203" ref-type="bibr">1998</xref>):<break/>SCA3tr-Q27<break/>SCA3tr-Q78</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Warrick et al., <xref rid="B202" ref-type="bibr">2005</xref>):<break/>SCA3-Q27<break/>SCA3-Q78<break/>SCA3-Q84<break/>SCA3-Q27-UIM<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref><break/>SCA3-Q80-UIM<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref><break/>SCA3-Q27-C14A<break/>SCA3-Q88-C14A<break/>SCA3-delta</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Li et al., <xref rid="B105" ref-type="bibr">2008</xref>):<break/>SCA3tr-Q61<break/>SCA3tr-Q78CAA/G<break/>DsRed-CAG0<break/>DsRed-CAG100<break/>DsRed-CAG250</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA6</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>CACNA1A</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region (exon 47)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Tsou et al., <xref rid="B196" ref-type="bibr">2015</xref>):<break/>α1ACT-Q11<break/>α1ACT-Q70</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Tsou et al., <xref rid="B197" ref-type="bibr">2016</xref>):<break/>α1ACT-Q33</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA7</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Ataxin-7</italic> (<italic>ATXN7</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Jackson et al., <xref rid="B76" ref-type="bibr">2005</xref>):<break/>SCA7-Q90</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Latouche et al., <xref rid="B100" ref-type="bibr">2007</xref>):<break/>ATXN7T-Q10<break/>ATXN7T-Q102</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA8</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>ATXN8OS (non-protein coding Ataxin-8 opposite strand)</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">3′UTR</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CTG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Mutsuddi et al., <xref rid="B130" ref-type="bibr">2004</xref>):<break/>SCA8(CTG)<sub>9</sub><break/>SCA8(CTG)<sub>112</sub></td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">SCA17</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>TATA binding protein</italic> (<italic>TBP</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Coding region</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CAG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Ren et al., <xref rid="B158" ref-type="bibr">2011</xref>):<break/>TBP-Q34<break/>TBP-Q54<break/>TBP-Q80</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">FXTAS</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Fragile X mental retardation 1</italic> (<italic>FMR1</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">5′UTR</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CGG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>):<break/>(CGG)<sub>60</sub>-GFP<break/>(CGG)<sub>90</sub>-GFP</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Todd et al., <xref rid="B190" ref-type="bibr">2013</xref>):<break/>5′UTR: (CGG)<sub>100</sub>-(+1)-ATG-GFP<break/>5′ATG: ATG-(CGG)<sub>100</sub>-(+1)-ATG-GFP<break/>3′UTR: ATG-GFP-STOP-(CGG)<sub>100</sub>-(+1)<break/>5′Stop: STOP-(CGG)<sub>100</sub>-(+1)-ATG-GFP</td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">DM1</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><italic>Dystrophia myotonica protein kinase</italic> (<italic>DMPK</italic>)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">3′UTR</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CTG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Houseley et al., <xref rid="B70" ref-type="bibr">2005</xref>):<break/>GFP-(CTG)<sub>11</sub><break/>GFP-(CTG)<sub>48</sub><break/>GFP-(CTG)<sub>56</sub><break/>GFP-(CTG)<sub>162</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>):<break/>i(CTG)<sub>480</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Garcia-Lopez et al., <xref rid="B56" ref-type="bibr">2008</xref>):<break/>(CTG)<sub>60</sub><break/>i(CTG)<sub>480</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>):<break/>(CTG)<sub>19</sub><break/>(CTG)<sub>130</sub><break/>(CTG)<sub>200</sub><break/>(CTG)<sub>230</sub><break/>(CTG)<sub>250</sub><break/>(CTG)<sub>270</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Picchio et al., <xref rid="B149" ref-type="bibr">2013</xref>):<break/>i(CTG)<sub>240</sub><break/>i(CTG)<sub>480</sub><break/>i(CTG)<sub>600</sub><break/>i(CTG)<sub>960</sub><break/>(“i” indicates “interrupted repeats”.)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">DM2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>Zinc finger protein 9 (ZNF9)</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Intron 1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CCTG</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Yu et al., <xref rid="B213" ref-type="bibr">2015</xref>):<break/>(CCTG)<sub>16</sub><break/>(CCTG)<sub>200</sub><break/>(CCTG)<sub>475</sub><break/>(CCTG)<sub>525</sub><break/>(CCTG)<sub>700</sub><break/>(CCTG)<sub>720</sub></td>
            </tr>
            <tr style="border-top: thin solid #000000;">
              <td valign="top" align="left" rowspan="1" colspan="1">C9ORF72-associated ALS-FTD</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>C9ORF72</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Promoter and intron 1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">GGGGCC</td>
              <td valign="top" align="left" rowspan="1" colspan="1">(Xu et al., <xref rid="B209" ref-type="bibr">2013</xref>):<break/>(GGGGCC)<sub>3</sub><break/>(GGGGCC)<sub>30</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>):<break/>(GGGGCC)<sub>3</sub> Pure<break/>(GGGGCC)<sub>36</sub> Pure<break/>(GGGGCC)<sub>36</sub> RO<break/>(GGGGCC)<sub>108</sub> RO<break/>(GGGGCC)<sub>288</sub> RO<break/>(PA)<sub>36</sub><break/>(GA)<sub>36</sub><break/>(PR)<sub>36</sub><break/>(GR)<sub>36</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Freibaum et al., <xref rid="B50" ref-type="bibr">2015</xref>):<break/>(GGGGCC)<sub>8</sub><break/>(GGGGCC)<sub>28</sub><break/>(GGGGCC)<sub>58</sub><break/>GFP-(GP)<sub>47</sub><break/>GFP-(GA)<sub>50</sub><break/>GFP-(GR)<sub>50</sub></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">(Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>):<break/>(GGGGCC)<sub>5R</sub> (flanked by human intronic and exonic sequences)<break/>(GGGGCC)<sub>80R</sub> (flanked by human intronic and exonic sequences)<break/>(GGGGCC)<sub>160R</sub> (flanked by human intronic and exonic sequences)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>UIM</p>
          <fn id="TN1">
            <label>*</label>
            <p><italic>indicates that the highly conserved serine resides in the ubiquitin interaction motifs are mutated to alanine to disrupt ubiquitin binding</italic>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <sec>
        <title><italic>Drosophila</italic> models of polyglutamine diseases</title>
        <p>Polyglutamine diseases are caused by the expansion of unstable CAG repeats in the protein-coding region of the respective disease gene. The CAG repeats are translated into a string of glutamine in normal functioning proteins. Patients of polyQ diseases often develop progressive neurodegeneration and motor impairment (Rub et al., <xref rid="B164" ref-type="bibr">2013</xref>). PolyQ diseases include HD, spinobulbar muscular atrophy (SBMA; a.k.a. Kennedy disease), dentatorubral-pallidoluysian atrophy (DRPLA), spinocerebellar ataxia (SCA) types 1, 2, 3 (a.k.a. Machado-Joseph disease or MJD), 6, 7, and 17 (La Spada et al., <xref rid="B99" ref-type="bibr">1991</xref>; MacDonald et al., <xref rid="B110" ref-type="bibr">1993</xref>; Orr et al., <xref rid="B140" ref-type="bibr">1993</xref>; Kawaguchi et al., <xref rid="B84" ref-type="bibr">1994</xref>; Imbert et al., <xref rid="B74" ref-type="bibr">1996</xref>; Pulst et al., <xref rid="B152" ref-type="bibr">1996</xref>; Sanpei et al., <xref rid="B169" ref-type="bibr">1996</xref>; David et al., <xref rid="B32" ref-type="bibr">1997</xref>; Zhuchenko et al., <xref rid="B221" ref-type="bibr">1997</xref>; Nakamura et al., <xref rid="B132" ref-type="bibr">2001</xref>; Warrick et al., <xref rid="B202" ref-type="bibr">2005</xref>). HD is caused by an abnormal expansion of CAG repeats in exon 1 of the <italic>Huntingtin</italic> (<italic>HTT</italic>) gene (MacDonald et al., <xref rid="B110" ref-type="bibr">1993</xref>). For SBMA, the CAG repeat expansion lies in the N-terminus of the coding region of the androgen receptor gene (La Spada et al., <xref rid="B99" ref-type="bibr">1991</xref>; Zhou et al., <xref rid="B220" ref-type="bibr">1994</xref>). For DRPLA, the unstable CAG expansion occurs in the middle of the Atrophin-1 gene (Koide et al., <xref rid="B87" ref-type="bibr">1994</xref>). As for SCA1, 2, 3, 6, 7, and 17, the CAG expansion are located in the coding regions of <italic>Ataxin-1, Ataxin-2, Ataxin-3, CACNA1A, Ataxin-7</italic>, and <italic>TATA-binding protein</italic> (<italic>TBP</italic>), respectively (Nakamura et al., <xref rid="B132" ref-type="bibr">2001</xref>; Rub et al., <xref rid="B164" ref-type="bibr">2013</xref>). Despite the fact that the CAG repeat expansions in these polyQ diseases affect different genes, there are several shared features among the majority of polyQ diseases. First, a common hallmark is the abnormal aggregation of nuclear inclusions containing the mutant proteins. These inclusions that contain abnormal aggregated proteins were once regarded as a potential cause of cellular toxicity. However, a number of studies have demonstrated that the formation of inclusions could actually be a cellular protective response to mitigate the toxicity (Stefanis et al., <xref rid="B181" ref-type="bibr">2001</xref>; Petrucelli et al., <xref rid="B147" ref-type="bibr">2002</xref>; Arrasate et al., <xref rid="B3" ref-type="bibr">2004</xref>). Until today, the general belief is that the formation of aggregates is a dynamic process. Smaller oligomeric inclusions are likely to toxic, whereas the large aggregates might actually be protective (Ross and Poirier, <xref rid="B163" ref-type="bibr">2005</xref>). Further investigations will be required to elucidate their true nature. Second, the CAG repeat length is inversely proportional to the age of disease onset. Longer CAG lengths cause earlier onset of polyQ diseases (Zoghbi and Orr, <xref rid="B223" ref-type="bibr">2000</xref>; Ross and Poirier, <xref rid="B163" ref-type="bibr">2005</xref>). This is because once the polyQ repeat length exceeds a pathogenic threshold (typically ~35), the mutant proteins are likely to mis-fold into abnormal conformations that can resist normal cellular degradation machineries such as the ubiquitin-proteasome system (Sisodia, <xref rid="B174" ref-type="bibr">1998</xref>; Chan et al., <xref rid="B25" ref-type="bibr">2000</xref>; Ross and Poirier, <xref rid="B163" ref-type="bibr">2005</xref>).</p>
        <p>PolyQ diseases were among the first neurodegenerative diseases modeled in <italic>Drosophila</italic>. The earliest <italic>Drosophila</italic> models include HD and SCA3. Zipursky and colleagues fused a truncated form of wild-type human HTT with a polyQ tract of 2, 75, or 120 repeats (HTT<sup>1−142</sup>-Q2, HTT<sup>1−142</sup>-Q75 and HTT<sup>1−142</sup>-Q120; Jackson et al., <xref rid="B75" ref-type="bibr">1998</xref>), whereas Bonini and colleagues generated truncated forms of human Ataxin-3 with a polyQ tract of 27 or 78 repeats (SCA3tr-Q27 and SCA3tr-Q78) (Warrick et al., <xref rid="B203" ref-type="bibr">1998</xref>). When expressed in the fly eye, both studies found that only the constructs with pathogenic lengths (HTT<sup>1−142</sup>-Q75, HTT<sup>1−142</sup>-Q120, and SCA3tr-Q78) induced nuclear inclusions and degeneration, recapitulating the pathogenic features of polyQ diseases. These studies, for the first time, demonstrated that <italic>D. melanogaster</italic> can be a powerful model to study human neurodegenerative diseases. Subsequently, more <italic>Drosophila</italic> models of HD and SCA3 (Steffan et al., <xref rid="B182" ref-type="bibr">2001</xref>; Lee et al., <xref rid="B104" ref-type="bibr">2004</xref>; Warrick et al., <xref rid="B202" ref-type="bibr">2005</xref>; Kaltenbach et al., <xref rid="B82" ref-type="bibr">2007</xref>; Li et al., <xref rid="B105" ref-type="bibr">2008</xref>; Romero et al., <xref rid="B162" ref-type="bibr">2008</xref>; Doumanis et al., <xref rid="B40" ref-type="bibr">2009</xref>; Weiss et al., <xref rid="B204" ref-type="bibr">2012</xref>), as well as other polyQ diseases, including SCA1 (Fernandez-Funez et al., <xref rid="B45" ref-type="bibr">2000</xref>), SCA6 (Tsou et al., <xref rid="B196" ref-type="bibr">2015</xref>, <xref rid="B197" ref-type="bibr">2016</xref>), SCA7 (Jackson et al., <xref rid="B76" ref-type="bibr">2005</xref>; Latouche et al., <xref rid="B100" ref-type="bibr">2007</xref>), SCA17 (Ren et al., <xref rid="B158" ref-type="bibr">2011</xref>), SBMA (Takeyama et al., <xref rid="B186" ref-type="bibr">2002</xref>; Pandey et al., <xref rid="B143" ref-type="bibr">2007</xref>; Nedelsky et al., <xref rid="B135" ref-type="bibr">2010</xref>), and DRPLA (Nisoli et al., <xref rid="B137" ref-type="bibr">2010</xref>; Napoletano et al., <xref rid="B134" ref-type="bibr">2011</xref>) were developed. All these studies demonstrate that polyQ diseases, in most cases, can yield parallel neural degenerative effects in the fruit fly.</p>
        <p>Besides protein toxicity, there is now substantial evidence for RNA toxicity in polyQ diseases as well. One of the most compelling studies was performed by Bonini and colleagues in the studying of SCA3 in <italic>Drosophila</italic> (Li et al., <xref rid="B105" ref-type="bibr">2008</xref>), which they showed that the expression of both translated and untranslated CAG repeats caused neural degeneration, whereas the expression of CAA-interrupted CAG repeats resulted in significantly less pronounced neurodegenerative effects (Li et al., <xref rid="B105" ref-type="bibr">2008</xref>). Similar to CAG repeats, CAA repeats also encode for glutamine. Yet CAA repeats are unable to form a hairpin structure (Sobczak et al., <xref rid="B176" ref-type="bibr">2010</xref>). As the hairpin structure contributes to CAG repeat-containing sRNA generation, it is one of the major mechanisms of RNA toxicity (Krol et al., <xref rid="B94" ref-type="bibr">2007</xref>; Bañez-Coronel et al., <xref rid="B6" ref-type="bibr">2012</xref>). Therefore, the above findings suggest that RNA toxicity contributes significantly to neurodegeneration in SCA3.</p>
        <p>Apart from hairpin structures, it is also known that CAG repeats in polyQ diseases, similar to CUG repeats in DM1, can form ribonuclear foci that colocalize with RNA-binding proteins such as muscleblind-like 1 (MBNL1), and cause misregulation in alternative splicing (Ho et al., <xref rid="B68" ref-type="bibr">2004</xref>, <xref rid="B69" ref-type="bibr">2005</xref>; Yuan et al., <xref rid="B215" ref-type="bibr">2007</xref>; Hsu et al., <xref rid="B71" ref-type="bibr">2011</xref>; Mykowska et al., <xref rid="B131" ref-type="bibr">2011</xref>; Wang et al., <xref rid="B199" ref-type="bibr">2011</xref>). In fact, Krzyzosiak and colleagues demonstrated that expanded CAG repeats present in HTT and ATXN3 transcripts colocalize with MBNL1 in ribonuclear foci, further confirming the accumulation of mutant RNA in the nucleus (Mykowska et al., <xref rid="B131" ref-type="bibr">2011</xref>). Interestingly, although both CAG and CUG repeats form foci, sequester MBNL1 and affect alternative splicing, the splicing of some pre-mRNAs are only affected by CUG repeats but not CAG repeats (Ho et al., <xref rid="B69" ref-type="bibr">2005</xref>). Hence, despite the overlapping mechanisms of involvement of MBNL1, there are still differences in how splicing is disrupted by CAG repeats in polyQ diseases and CUG repeats in DM1.</p>
        <p>In addition to the sequestering of RNA-binding proteins, RNA toxicity in polyQ diseases may also arise from the perturbation of RNA export mechanisms and the induction of nucleolar stress (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>, <xref rid="B195" ref-type="bibr">2012</xref>). In the <italic>Drosophila</italic> model of SCA3, it has been demonstrated that U2AF65, which is involved in the nuclear export of mRNA, can bind directly to CAG repeats and form a complex with the nuclear export receptor NXF1 (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>), and the downregulation of U2AF65 correlates with the nuclear accumulation of expanded CAG RNA (Tsoi et al., <xref rid="B194" ref-type="bibr">2011</xref>). Apart from U2AF65, CAG repeat expansion can also interact directly with NCL, and induce apoptosis by the activation of the nucleolar stress pathway (Tsoi et al., <xref rid="B195" ref-type="bibr">2012</xref>). NCL is an essential protein involved in RNA polymerase I-mediated rRNA transcription in the nucleolus. The binding of expanded CAG repeats perturbs ribosome biogenesis, which in turn increases the levels of mitochondrial p53, and causes cytochrome c release and caspase activation (Tsoi et al., <xref rid="B195" ref-type="bibr">2012</xref>).</p>
        <p>Utilizing the established fly models of SCA3, much advances have been made in the search of genetic modifiers of polyQ toxicity and CAG-repeat RNA toxicity. Using the fly model of SCA3, HSP70 was found to colocalize with polyQ inclusion bodies, and was identified as a strong suppressor of polyQ toxicity (Warrick et al., <xref rid="B201" ref-type="bibr">1999</xref>; Chan et al., <xref rid="B25" ref-type="bibr">2000</xref>). A genome-wide genetic screen was also performed, and identified a number of other chaperones and ubiquitin pathway-related molecules as genetic modifiers of polyQ toxicity (Bilen and Bonini, <xref rid="B16" ref-type="bibr">2007</xref>). As for RNA toxicity in SCA3, a microarray analysis was performed to search for genes which expression levels are affected by CAG repeats (Shieh and Bonini, <xref rid="B173" ref-type="bibr">2011</xref>). Several iron ion binding and nucleotide binding molecules were found to be affected. Interestingly, HSP70, co-chaperone Tpr2, the transcriptional regulator Dpld, and the RNA-binding protein Orb2 were able to modify both polyQ and RNA toxicity, suggesting that there are overlapping mechanisms of RNA and protein based toxicity (Shieh and Bonini, <xref rid="B173" ref-type="bibr">2011</xref>).</p>
        <p>All the above studies demonstrated that both protein and RNA toxicity contribute to neurodegeneration in polyQ diseases, and both types of toxicity can involve a number of different underlying molecular mechanisms which can be studied using <italic>Drosophila</italic> models.</p>
      </sec>
      <sec>
        <title><italic>Drosophila</italic> models of fragile X syndrome and fragile X-associated tremor/ataxia syndrome</title>
        <p>Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability, often associated with autism spectrum disorders (Bhakar et al., <xref rid="B14" ref-type="bibr">2012</xref>; Santoro et al., <xref rid="B170" ref-type="bibr">2012</xref>). The disease was first described as mental retardation segregated in X-linked fashion (Martin and Bell, <xref rid="B115" ref-type="bibr">1943</xref>). The chromosomal variation was later mapped to Xq27.3 and was dubbed “the fragile X chromosome” (Harrison et al., <xref rid="B65" ref-type="bibr">1983</xref>). In FXS, a trinucleotide CGG expansion in the 5′ UTR of the <italic>FMR1</italic> gene results in transcriptional silencing and loss of the corresponding protein, Fragile X Mental Retardation Protein (FMRP; Fu et al., <xref rid="B52" ref-type="bibr">1991</xref>; Kremer et al., <xref rid="B93" ref-type="bibr">1991</xref>). Normal alleles contain 6–55 repeats, premutation alleles contain 55–200, and the disease alleles contain over 200 repeats. FMRP is an RNA-binding protein which negatively regulates the translation of mRNAs, especially at synapses in neurons. Loss of FMRP impairs synaptic plasticity, which is believed to be the molecular basis for the intellectual disability in FXS patients (Bassell and Warren, <xref rid="B7" ref-type="bibr">2008</xref>).</p>
        <p>The <italic>Drosophila</italic> genome contains a highly-conserved <italic>FMR1</italic> gene, <italic>dfmr1</italic> (Wan et al., <xref rid="B198" ref-type="bibr">2000</xref>). The first <italic>Drosophila</italic> FXS model was generated by imprecise excision of a <italic>P</italic>-element located upstream of the <italic>dfmr1</italic> locus to produce a null mutant (Zhang et al., <xref rid="B217" ref-type="bibr">2001</xref>). Subsequently, a wide array of <italic>dfmr1</italic> alleles and transgenes have been created to facilitate FXS research in this classic genetic model (Dockendorff et al., <xref rid="B38" ref-type="bibr">2002</xref>; Morales et al., <xref rid="B126" ref-type="bibr">2002</xref>; Lee et al., <xref rid="B102" ref-type="bibr">2003</xref>). Overexpression of either the human FMRP (<italic>FMR1</italic> gene) or the native <italic>Drosophila</italic> dFMRP (<italic>dfmr1</italic> gene) fully rescues all detectable disease-like phenotypes in the <italic>Drosophila</italic> FXS model (Coffee et al., <xref rid="B29" ref-type="bibr">2010</xref>), confirming the evolutionary conserved functions of <italic>FMR1</italic> in the nervous system.</p>
        <p>In 2003, Warren and colleagues expressed 90 CGG repeats with a reporter in the <italic>Drosophila</italic> compound eye and demonstrated retinal degeneration in the absence of expressed proteins (Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>). These findings suggest that, apart from loss-of-function of wild-type FMRP, there exists a toxic RNA gain-of-function component associated with the repeat expansion that occurs at the 5′ UTR of the <italic>FMR1</italic> gene. This RNA toxicity causes a late-onset neural degeneration phenotype, which is now identified as Fragile X-associated tremor/ataxia syndrome (FXTAS). While FXS is mostly caused by the loss-of-function of wild-type FMRP, which results in neurodevelopmental and behavioral disorders characterized by mental retardation, autism, anxiety and mood instability, FXTAS is mostly caused by the CGG repeat expansion that produces gain-of-function RNA toxicity in the CNS, which results in a late-onset neurodegenerative disorder, characterized by progressive intention tremor, gait ataxia, parkinsonism, and cognitive decline (Jacquemont et al., <xref rid="B77" ref-type="bibr">2007</xref>; Tassone and Hagerman, <xref rid="B188" ref-type="bibr">2012</xref>). FXTAS is found mostly in male premutation carriers after the age of 50 (Tassone and Hagerman, <xref rid="B188" ref-type="bibr">2012</xref>). Although at a much lower rate, female carriers may also develop FXTAS. The neuropathological hallmark of FXTAS is the ubiquitin-positive intranuclear inclusion, present in both neurons and astrocytes throughout the brain (Greco et al., <xref rid="B59" ref-type="bibr">2002</xref>). Warren and colleagues found that in their (CGG)<sub>90</sub> fly model of FXTAS, the inclusion bodies in the degenerating neurons contain HSP70 (Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>). Furthermore, when they overexpress HSP70, the CGG repeat-induced degeneration was suppressed (Jin et al., <xref rid="B80" ref-type="bibr">2003</xref>), which is similar to the case of SCA3 where HSP70 also presents suppressor activity of CAG repeat-induced toxicity (Warrick et al., <xref rid="B201" ref-type="bibr">1999</xref>; Chan et al., <xref rid="B25" ref-type="bibr">2000</xref>). Two subsequent studies have utilized this <italic>Drosophila</italic> model of FXTAS and identified a number of tropomyosin and RNA-binding proteins as genetic modifiers of the degeneration phenotype (Jin et al., <xref rid="B79" ref-type="bibr">2007</xref>; Sofola et al., <xref rid="B177" ref-type="bibr">2007</xref>). These findings strongly suggest that the RNA processing machinery play an important role in the pathogenesis of FXTAS. Interestingly, both studies have found that one of these RNA-binding proteins that interacts with the CGG repeats to be CUG-binding protein 1 (CUGBP1), which is a protein also involved in the pathogenesis of another READ, DM1. Indeed, CGG repeats have been shown to form RNA hairpin structures <italic>in vitro</italic>, similar to CAG repeats in SCA3 and CUG repeats in DM1 (Sobczak et al., <xref rid="B175" ref-type="bibr">2003</xref>, <xref rid="B176" ref-type="bibr">2010</xref>). Thus, it is possible that these RNA-binding proteins bind to the CGG repeats in an effort to disassemble these potentially toxic hairpins, but in the process neglected their other cellular functions.</p>
        <p>Recent studies in neurodegenerative and neuromuscular diseases have advanced toward the investigation of cellular transcriptional and translational profiles. Nelson and colleagues discovered that mice Purkinje neurons ectopically expressing 90 CGG repeats exhibit a dramatic change in their translational profile even prior to the onset of CGG repeat-induced phenotypes (Galloway et al., <xref rid="B54" ref-type="bibr">2014</xref>). Interestingly, the <italic>Tardbp</italic> gene, which encodes the TDP-43 protein was found to be reduced in Purkinje neurons (Galloway et al., <xref rid="B54" ref-type="bibr">2014</xref>). TDP-43 is a RNA-binding protein commonly found in the inclusion bodies in ALS (Xu and Yang, <xref rid="B210" ref-type="bibr">2014</xref>). In the fly model of FXTAS, overexpression of TDP-43 suppresses neurodegeneration in the fly eye, whereas knockdown of <italic>Drosophila</italic> TDP-43 results in enhancement of the degeneration phenotype (Galloway et al., <xref rid="B54" ref-type="bibr">2014</xref>). Todd and colleagues also discovered that overexpression of TDP-43 was capable of suppressing CGG repeat toxicity (He et al., <xref rid="B66" ref-type="bibr">2014</xref>). Interestingly, they found that the CGG repeat RNA levels and RAN translation levels are both not affected by TDP-43. Instead, they found TDP-43 alters the composition, behavior and distribution of multimeric RNA-binding protein complexes, preventing the sequestration of hnRNP A2/B1, and rescuing the alternative splicing machinery (He et al., <xref rid="B66" ref-type="bibr">2014</xref>). They also tested an ALS mutant form of TDP-43, which can still bind to hnRNP A2/B1, and yet it failed to rescue the CGG repeat toxicity, suggesting that wild type TDP-43 functions are necessary for this suppression of CGG repeat toxicity (He et al., <xref rid="B66" ref-type="bibr">2014</xref>).</p>
        <p>In the study above by Nelson and colleagues, the researchers discovered ~500 transcripts that are differentially associated with ribosomes in the CGG repeats-expressing Purkinje neurons (Galloway et al., <xref rid="B54" ref-type="bibr">2014</xref>). Theoretically, if ribosomes are recruited to the repeat expansions, translation of the repeats would be facilitated. Indeed, RAN translation has also been demonstrated in FXTAS models. Paulson and colleagues have demonstrated that CGG repeats lead to RAN translation of a cryptic polyglycine-containing protein, FMRpolyG, which is present in inclusion bodies in FXTAS fly models, mouse models and FXTAS patient brains (Todd et al., <xref rid="B190" ref-type="bibr">2013</xref>). The researchers constructed a <italic>Drosophila</italic> line expressing CGG repeats preceded by a stop codon just 5′ to the repeats. Production of FMRpolyG is inhibited by this stop codon, but the CGG repeat-containing RNA remained. This line gave rise to a much milder phenotype comparing with CGG repeats without the stop codon, indicating RAN translated FMRpolyG contribute to toxicity (Todd et al., <xref rid="B190" ref-type="bibr">2013</xref>). A follow-up <italic>Drosophila</italic> study revealed that FMRpolyG impairs the ubiquitin protease system (Oh et al., <xref rid="B139" ref-type="bibr">2015</xref>). Inhibition of RAN translation can reduce inclusion formation and attenuate the impairment of the ubiquitin protease system (Oh et al., <xref rid="B139" ref-type="bibr">2015</xref>).</p>
        <p>Taken together, these studies suggest that FXTAS pathogenesis may be mechanistically related to the polyQ diseases, myotonic dystrophy, and ALS. Thus, different READs that arise from different causes may converge and share some common molecular mechanisms in their pathogenesis.</p>
      </sec>
      <sec>
        <title><italic>Drosophila</italic> models of myotonic dystrophy type 1 and type 2</title>
        <p>Myotonic dystrophy is the most common form of muscular dystrophy affecting about 1 in 8,000 adults (Harper, <xref rid="B63" ref-type="bibr">2001</xref>). It is a multisystemic, autosomal dominant neuromuscular disorder, characterized by progressive myotonia (inability of muscles to relax after contraction), muscle degeneration, iridescent cataracts, cardiac arrhythmias, testicular atrophy, and symptoms of neuropathology (Harper, <xref rid="B63" ref-type="bibr">2001</xref>). DM1 is caused by a CTG repeat expansion in the 3′ UTR of the <italic>DMPK</italic> gene, which encodes a serine-threonine protein kinase (Brook et al., <xref rid="B20" ref-type="bibr">1992</xref>). Normal individuals typically have fewer than 37 CTG repeats, whereas DM1 patients can range from 50 to 4,000 repeats (Thornton et al., <xref rid="B189" ref-type="bibr">1994</xref>). The mutant transcripts containing CUG repeats fold into RNA hairpins that are retained in the nucleus (Davis et al., <xref rid="B33" ref-type="bibr">1997</xref>; Koch and Leffert, <xref rid="B86" ref-type="bibr">1998</xref>), whereas the levels of DMPK protein are correspondingly reduced (Fu et al., <xref rid="B51" ref-type="bibr">1993</xref>). <italic>Dmpk</italic> knockout mice have reduced force generation in skeletal muscles (Reddy et al., <xref rid="B156" ref-type="bibr">1996</xref>) and abnormal cardiac conduction (Berul et al., <xref rid="B13" ref-type="bibr">1999</xref>), which suggests that the loss of DMPK function may contribute to at least the muscle weakness and cardiac defects in DM1. However, <italic>Dmpk</italic> knockout mice do not display myotonia and muscle degeneration (Reddy et al., <xref rid="B156" ref-type="bibr">1996</xref>), which are some of the hallmark features of DM1. In contrast, transgenic mice expressing expanded CTG repeats display myotonia, degeneration, and several other muscular pathological abnormalities (Mankodi et al., <xref rid="B113" ref-type="bibr">2000</xref>). These results demonstrated that the expanded CTG repeats by themselves could account for at least some of the major pathological features of DM1 independent of the <italic>DMPK</italic> locus. It was eventually demonstrated that the CUG-repeat-containing transcripts retained in the nucleus aggregate into ribonuclear foci (Taneja et al., <xref rid="B187" ref-type="bibr">1995</xref>; Mankodi et al., <xref rid="B113" ref-type="bibr">2000</xref>). These foci binds to RNA-binding proteins like MBNL1 and CUGBP1 (Miller et al., <xref rid="B120" ref-type="bibr">2000</xref>; Kanadia et al., <xref rid="B83" ref-type="bibr">2003</xref>), which in turn compromises the RNA splicing machinery (Philips et al., <xref rid="B148" ref-type="bibr">1998</xref>; Ho et al., <xref rid="B68" ref-type="bibr">2004</xref>) and even disrupts the regulation of transcription (Ebralidze et al., <xref rid="B43" ref-type="bibr">2004</xref>).</p>
        <p>Monckton and colleagues developed a <italic>Drosophila</italic> model of DM1 by fusing 162 non-coding CTG repeats to a reporter gene and overexpressing the repeats in fly muscles (Houseley et al., <xref rid="B70" ref-type="bibr">2005</xref>). Although 162 CUG repeats results in the formation of ribonuclear foci, it did not result in detectable cellular toxicity. Botas and colleagues further examined the effect of non-coding CUG repeats by increasing the repeat number to 480 (interrupted repeats). With this amount of repeats, vacuolization and degeneration were then detected in adult fly muscles (de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>). Expression of 480 CUG repeats in the adult eye also results in disorganization of ommatidia and reduction of the eye size, suggesting gain-of-function RNA toxicity (de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>; Garcia-Lopez et al., <xref rid="B56" ref-type="bibr">2008</xref>). Similar to mammals, the molecular mechanisms of this CUG-induced toxicity involve the sequestration of <italic>Drosophila</italic> Mbl and CUGBP1 by the CUG repeat-containing ribonuclear foci, resulting in defective alternative splicing (de Haro et al., <xref rid="B34" ref-type="bibr">2006</xref>; Garcia-Lopez et al., <xref rid="B56" ref-type="bibr">2008</xref>). However, in contrast to CUGBP1, which has been shown to interact with CGG repeats and is involved in FXTAS, no evidence for the genetic interaction of muscleblind family proteins and CGG repeats had been found in <italic>Drosophila</italic> (Sofola et al., <xref rid="B177" ref-type="bibr">2007</xref>). Thus, although the pathogenesis of FXTAS and myotonic dystrophy may share some commonalities, there are certainly distinct mechanisms for the two READs as well. Utilizing this fly model of DM1, Botas and colleagues identified SMAUG, a myosin-binding protein, as suppressor of CUG repeat-induced toxicity (de Haro et al., <xref rid="B35" ref-type="bibr">2013</xref>). SMAUG interacts genetically and physically with CUGBP1, and its overexpression restores the translational activity of CUGBP1 in this DM1 model (de Haro et al., <xref rid="B35" ref-type="bibr">2013</xref>).</p>
        <p>Refinements of the DM1 fly models were made in some recent studies, with new discoveries being yield. Jagla and colleagues constructed fly lines with 240, 480, 600, and 960 interrupted CTG repeats, and established a novel <italic>Drosophila</italic> larval model of DM1 (Picchio et al., <xref rid="B149" ref-type="bibr">2013</xref>). Using this model, they constructed transcription profiles of DM1, and uncovers a number of splice-independent deregulated genes (Picchio et al., <xref rid="B149" ref-type="bibr">2013</xref>). Bonini and colleagues cloned 19, 130, 200, 230, 250, and 270 uninterrupted, pure CTG repeats into the 3′ UTR of the <italic>DsRed</italic> gene to better recapitulate the pathological condition of the disease (Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>). Repeat length-dependent toxicity was detected when the repeat length reaches 200 or more. Interestingly, the researchers discovered that there was a synergistic effect on the enhancement of toxicity when CAG repeats are co-expressed together with CUG repeats due to the biogenesis of sRNAs (Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>). This enhancement was Dicer-dependent, indicating the involvement of the RNAi machinery (Yu et al., <xref rid="B214" ref-type="bibr">2011</xref>).</p>
        <p>DM2 is caused by a tetranucleotide CCTG repeat expansion in the first intron of the <italic>zinc finger protein 9</italic> (<italic>ZNF9</italic>) gene, which encodes a RNA-binding protein (Liquori et al., <xref rid="B107" ref-type="bibr">2001</xref>). Affected individuals can have 75 to 11,000 CCTG repeats, with a mean of ~5,000 (Liquori et al., <xref rid="B107" ref-type="bibr">2001</xref>). DM2, much like DM1, involves the aggregation of expanded mutant transcripts into ribonuclear foci, which interfere with key molecules of the splicing machinery, such as MBNL1 and CUGBP1 (Liquori et al., <xref rid="B107" ref-type="bibr">2001</xref>). Although DM1 and DM2 share much similarities in their pathologies, DM2 has less-pronounced neurological involvement and cannot be congenital (Minnerop et al., <xref rid="B121" ref-type="bibr">2011</xref>). To develop a fly model of DM2, Bonini and colleagues generated constructs with 16, 200, 475, 525, 700, and 720 non-coding CCTG repeats to investigate length-dependent RNA toxicity (Yu et al., <xref rid="B213" ref-type="bibr">2015</xref>). Expression of 200 repeats was sufficient to induce the formation of ribonuclear foci, but impairment of alternative splicing and retinal degeneration were only observed when the repeat length was 475 or above. In addition, the researchers demonstrate that the expression of two different isoforms of MBNL1 (with or without the linker region between zinc finger domain 2 and 3) can lead to cleavage of non-coding CUG or CCUG RNA repeats, and mildly rescue CCUG-induced degeneration in the fly eye (Yu et al., <xref rid="B213" ref-type="bibr">2015</xref>).</p>
      </sec>
      <sec>
        <title><italic>Drosophila</italic> models of C9ORF72-associated amyotrophic lateral sclerosis/frontotemporal dementia</title>
        <p>Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is an adult-onset neurodegenerative disease characterized by the progressive loss of motor neurons in the cortex, brainstem, and spinal cord. Symptoms include the loss of movement control, difficulty in speaking, swallowing, and eventually breathing, which leads to fatality (Kurtzke, <xref rid="B96" ref-type="bibr">1982</xref>). ALS affects about 2 per 100,000 individuals in Europe and the United States (Kiernan et al., <xref rid="B85" ref-type="bibr">2011</xref>). Most cases of ALS are deemed sporadic, but 5–10% cases are inherited (Hand and Rouleau, <xref rid="B61" ref-type="bibr">2002</xref>). Mutations from more than 20 different genes have been linked to familial ALS (Chen et al., <xref rid="B27" ref-type="bibr">2013</xref>; Ajroud-Driss and Siddique, <xref rid="B2" ref-type="bibr">2015</xref>). Despite some of these identified genes play a role in RNA metabolism and axonal trafficking (Strong, <xref rid="B184" ref-type="bibr">2010</xref>; Ikenaka et al., <xref rid="B73" ref-type="bibr">2012</xref>; Millecamps and Julien, <xref rid="B119" ref-type="bibr">2013</xref>; Droppelmann et al., <xref rid="B41" ref-type="bibr">2014</xref>), most of them apparently do not function in the same molecular pathway, complicating the underlying mechanisms of the disease (Chen et al., <xref rid="B27" ref-type="bibr">2013</xref>; Ajroud-Driss and Siddique, <xref rid="B2" ref-type="bibr">2015</xref>).</p>
        <p>In 2011, the expansion of a GGGGCC hexanucleotide repeat in the non-coding region of <italic>C9ORF72</italic> was found to be associated with ALS combined with frontotemporal dementia (DeJesus-Hernandez et al., <xref rid="B36" ref-type="bibr">2011</xref>; Renton et al., <xref rid="B160" ref-type="bibr">2011</xref>). Frontotemporal dementia is a group of disorders caused by the progressive loss of neurons predominantly at the frontal and/or temporal lobes of the brain resulting in cognitive and behavioral impairment, and is one of the most common causes of dementia second only to Alzheimer's disease (Mercy et al., <xref rid="B117" ref-type="bibr">2008</xref>; Perry and Miller, <xref rid="B146" ref-type="bibr">2013</xref>; Baizabal-Carvallo and Jankovic, <xref rid="B5" ref-type="bibr">2016</xref>). Remarkably, over 6% of sporadic ALS/FTD cases and over 37% familial ALS/FTD cases are caused by the expansion of the GGGGCC hexanucleotide repeat in the first intron of the <italic>C9ORF72</italic> gene (Majounie et al., <xref rid="B112" ref-type="bibr">2012</xref>).</p>
        <p>Jin and colleagues pioneered the first <italic>Drosophila</italic> model of C9-ALS/FTD by expressing 30 GGGGCC repeats [(GGGGCC)<sub>30</sub>] with a reporter in the compound eye, which resulted in severe retinal degeneration (Xu et al., <xref rid="B209" ref-type="bibr">2013</xref>). When (GGGGCC)<sub>30</sub> was expressed in motor neurons, it resulted in defective locomotor activity; whereas when it was expressed in the central nervous system using a pan-neuronal driver, it resulted in lethality (Xu et al., <xref rid="B209" ref-type="bibr">2013</xref>). One important question to be answered was how GGGGCC repeats actually cause the disease. The pathogenesis could be due to: (1) loss-of-function of wild-type C9ORF72 protein, (2) gain-of-function of toxic RNA consisting of the GGGGCC repeats, and/or (3) gain-of-function of toxic dipeptide repeat (DPR) proteins generated by RAN translation. Although the mild phenotypes in a homozygous <italic>C9ORF72</italic> mutation case and the lack of <italic>C9ORF72</italic> coding mutations suggest that wild-type protein loss-of-function is unlikely the primary cause of C9-ALS/FTD (Fratta et al., <xref rid="B49" ref-type="bibr">2013</xref>; Harms et al., <xref rid="B62" ref-type="bibr">2013</xref>), loss-of-function of the wild type protein is still a possible mechanism that contribute to the disease pathogenesis. Since <italic>Drosophila</italic> does not have an ortholog of C9ORF72, the fly may not be a suitable model organism for investigating the haploinsufficiency aspect of C9ORF72. The fly, however, proved a valuable tool in determining the gain-of-function toxicity of GGGGCC repeats in C9-ALS/FTD. In the attempt to differentiate between repeat RNA and DPR protein toxicity, Isaacs and colleagues generated stop codon-interrupted RNA-only (RO) repeats of GGGGCC and compared it with pure GGGGCC repeats which can be RAN-translated into DPR proteins in <italic>Drosophila</italic> (Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>). Isaacs and colleagues found that, the expression of RO (GGGGCC)<sub>36</sub> or pure (GGGGCC)<sub>36</sub> results in the same amount of ribonuclear foci formation. However, the expression of all RO constructs, including RO (GGGGCC)<sub>36</sub>, RO (GGGGCC)<sub>108</sub>, and even RO (GGGGCC)<sub>288</sub>, had no detectable effect on the fly eye. In contrast, both pure (GGGGCC)<sub>36</sub> and pure (GGGGCC)<sub>103</sub> caused degeneration. These findings suggest that, although both RNA and DPR proteins may contribute to toxicity, degeneration was primarily attributable to DPR proteins (Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>). To further investigate whether DPR protein expression alone was sufficient to cause degeneration, they generated four “protein-only” constructs by using alternative codons. When expressed in the fly eye, only glycine-arginine (GR)<sub>36</sub> and proline-arginine (PR)<sub>36</sub> constructs resulted in degeneration, whereas glycine-alanine (GA)<sub>36</sub> and proline-alanine (PA)<sub>36</sub> had no detectable effect. Even at the repeat length of 100, same results were obtained for the above DPR proteins, indicating that high arginine-containing DPR protein is the major cause of neurodegeneration in C9-ALS/FTD (Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>).</p>
        <p>To determine the molecular mechanism that underlies DPR proteins-induced degeneration, Taylor, Gao and colleagues generated reporter-tagged (GGGGCC)<sub>58</sub> flies, and performed a screen to look for genetic modifiers of GGGGCC-induced eye degeneration (Freibaum et al., <xref rid="B50" ref-type="bibr">2015</xref>). Eighteen modifier genes were identified with the majority of them being transcription/export (TREX) complex proteins and nuclear pore complex proteins, involving particularly nuclear export of RNA. Lastly, Taylor, Gao and colleagues predicted that (GGGGCC)<sub>58</sub> can produce poly(GA), poly(GR), or poly(GP) DPR proteins by RAN translation. Consistent with an aforementioned study, they found that the arginine-containing poly(GR) to be highly toxic (Freibaum et al., <xref rid="B50" ref-type="bibr">2015</xref>). In summary, the researchers demonstrated that GGGGCC repeat expansion compromises nucleocytoplasmic transport, facilitating nuclear retention of toxic RNAs. Whereas the build-up of toxic poly(GR) DPR proteins by RAN translation is a major cause of GGGGCC-induced neurodegeneration. Rothstein and colleagues also conducted a screen to search for interactors for GGGGCC RNA, and uncovered RanGAP as a potent suppressor of neurodegeneration (Zhang et al., <xref rid="B218" ref-type="bibr">2015</xref>). RanGAP is a key regulator of nucleocytoplasmic transport, supporting that the nucleocytoplasmic transport mechanisms are involved in the neurodegeneration in C9-ALS/FTD (Zhang et al., <xref rid="B218" ref-type="bibr">2015</xref>). In the same year, another screen performed in yeast by Gitler and colleagues identified effectors of Ran-mediated nucleocytoplasmic transport and karyopherins as modifiers of GGGGCC-induced DPR protein toxicity (Jovicic et al., <xref rid="B81" ref-type="bibr">2015</xref>). A recent study by Van Den Bosch and colleagues also reported the results of a <italic>Drosophila</italic> genetic screen, which identified importins, exportins, Ran-GTP cycle regulators, nuclear pore components and arginine methylases as potent modifiers of DPR protein toxicity (Boeynaems et al., <xref rid="B17" ref-type="bibr">2016</xref>). Taking a different approach, Taylor and colleagues analyzed the interactome of all DPR proteins in human cells, and found that arginine-containing DPR proteins (GR and PR) interact with RNA-binding proteins with low complexity sequence domains (LCDs), such as TDP-43, FUS, hnRNPA1, hnRNPA2B1, Matrin-3, and Ataxin-2 (Lee et al., <xref rid="B103" ref-type="bibr">2016</xref>). Using the <italic>Drosophila</italic> eye, they confirmed that these proteins are genetic modifiers of DPR protein-induced toxicity. Remarkably, most of these genetic modifiers encode components of membrane-less organelles, including the nucleoli, the nuclear pore complexes and stress granules. The researchers showed that GR and PR bind to the LCD-containing RNA-binding proteins, alter their biophysical properties, and lead to impairment of their assembly, dynamics, and functions (Lee et al., <xref rid="B103" ref-type="bibr">2016</xref>).</p>
        <p>A consensus from all these studies was that the DPR proteins that cause toxicity in C9-ALS/FTD contain arginine. Arginine is a unique amino acid that has as many as five potential hydrogen-bond donors that are readily available to react with biological hydrogen-bond acceptors. In DNA-protein complexes, arginine residues are the most frequent hydrogen bond donors to backbone phosphate groups (Luscombe et al., <xref rid="B108" ref-type="bibr">2001</xref>). Networks of hydrogen bonds can be formed by arginine residues with phosphate groups of RNA loops as well (Calnan et al., <xref rid="B23" ref-type="bibr">1991</xref>). Whereas among the interactions between amino acids, the arginine-aspartate double hydrogen-bond interaction is also an extremely stable structure (Mitchell et al., <xref rid="B123" ref-type="bibr">1992</xref>). Each methylation of an arginine residue removes a potential hydrogen-bond donor, and changes the shape of the amino acid. Thus, methylation can reduce the chance of arginine bonding to its interactors, which in turn increases the chance of an arginine-containing DPR protein to be degraded. This is supported by the finding that arginine methylases are potent modifiers of DPR protein toxicity (Boeynaems et al., <xref rid="B17" ref-type="bibr">2016</xref>).</p>
        <p>Arginine-containing DPR proteins have been proven toxic in a number of studies by various groups. But the question remained whether the nuclear GGGGCC repeat-containing RNA induces toxicity. The study above by Isaacs and colleagues did not detect any significant degeneration when as many as 288 repeats (RO) were expressed in the fly eye (Mizielinska et al., <xref rid="B124" ref-type="bibr">2014</xref>). Gao and colleagues further explored this important question, and tested the effects of a <italic>Drosophila</italic> model expressing a <italic>C9ORF72</italic> minigene with 160 GGGGCC repeats (160R; Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>). The 160R in this model is flanked by human intronic and exonic sequences of <italic>C9ORF72</italic>. Intriguingly, even though the spliced intronic 160R formed abundant nuclear GGGGCC sense RNA foci, they gave rise to no detectable neurodevelopmental defects. Cells were also normal in their rRNA biogenesis and mRNA processing (Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>). When 160R flies were reared at 29°C instead of the normal 25°C, a modest level of toxicity was detected. But since the higher temperature induced 4-folds more DPR proteins, while the number of RNA foci did not change, it is likely that this toxicity was due to the increased DPR proteins instead of the RNA foci (Tran et al., <xref rid="B193" ref-type="bibr">2015</xref>).</p>
        <p>Summarizing the above studies, the GGGGCC repeat expansion in C9-ALS/FTD share much commonalities with other READs such as the formation of foci, sequestration of RNA-binding proteins, and induction of nucleolar stress. Yet, unlike most other READs described here, the RNA transcripts containing the GGGGCC repeat expansions and the foci in C9-ALS/FTD do not appear to be the main source of toxicity. Rather, it is the DPR proteins produced by RAN translation (which can still arguably be called a type of RNA toxicity) that are the major determinants of toxicity and degeneration in this disease.</p>
        <p>Nevertheless, just when everyone thought GGGGCC repeat-containing RNA does not give rise to any kind of toxicity, Bonini and colleagues discovered a new form of GGGGCC RNA toxicity that may be independent of DPR proteins. In cultured mice spinal cord neurons, GGGGCC and CAG repeat RNAs were found to localize to transport granules that travel to distal neuritic segments (Burguete et al., <xref rid="B22" ref-type="bibr">2015</xref>). Expression of the GGGGCC repeat-containing RNA gave rise to neuritic branching defects. Using a <italic>Drosophila</italic> model, the researchers found that this branching defects can be enhanced by the upregulation or suppressed by the downregulation of <italic>dfmr1</italic> or <italic>orb2</italic> (Burguete et al., <xref rid="B22" ref-type="bibr">2015</xref>). The researchers speculated that the presence of GGGGCC repeat RNA in neurites might result in local RAN translation of toxic DPR proteins. However, they were unable to detect RAN peptides in their study (Burguete et al., <xref rid="B22" ref-type="bibr">2015</xref>). These findings demonstrate that GGGGCC expanded repeat RNAs can cause transport granule dysfunction, which could be a novel RNA toxicity mechanism independent of DPR proteins, contributing to the neuronal defects in C9-ALS/FTD.</p>
        <p>It is important to note that, hexanucleotide repeats such as GGGGCC, are capable of forming distinct structures called DNA and RNA G-quadruplexes (Reddy et al., <xref rid="B155" ref-type="bibr">2013</xref>; Haeusler et al., <xref rid="B60" ref-type="bibr">2014</xref>). These structures facilitate DNA/RNA hybrids, impedes transcription and binds to ribonucleoproteins such as NCL, inducing nucleolar stress (Haeusler et al., <xref rid="B60" ref-type="bibr">2014</xref>). They also form inclusions and sequester hnRNP H, which impedes alternative splicing (Conlon et al., <xref rid="B30" ref-type="bibr">2016</xref>). The real impacts of these G-quadruplex structures on the pathogenesis of C9-ALS/FTD are only just beginning to be elucidated.</p>
      </sec>
    </sec>
    <sec id="s7">
      <title>Therapeutic development to combat RNA toxicity in reads</title>
      <p>Much progress has been made in the past decade regarding potential therapeutic strategies against the RNA toxicity in READs. The current three main streams of therapeutics are oligonucleotide-based therapeutics, peptoid-based therapeutics, and small molecule-based therapeutics. In oligonucleotide-based therapeutics, antisense-oligos (ASOs) have been demonstrated to disrupt foci formation and reduce RNA toxicity in both DM1 and C9-ALS/FTD (Mulders et al., <xref rid="B128" ref-type="bibr">2009</xref>; Wheeler et al., <xref rid="B205" ref-type="bibr">2012</xref>; Donnelly et al., <xref rid="B39" ref-type="bibr">2013</xref>; Lagier-Tourenne et al., <xref rid="B98" ref-type="bibr">2013</xref>; Sareen et al., <xref rid="B171" ref-type="bibr">2013</xref>; Riboldi et al., <xref rid="B161" ref-type="bibr">2014</xref>; Wojtkowiak-Szlachcic et al., <xref rid="B207" ref-type="bibr">2015</xref>). Peptoid-based therapeutics have shown some promising results in mitigating RNA toxicity in DM1 models by reducing the interaction between CUG repeats and MBNL1 and decreasing foci formation (Pushechnikov et al., <xref rid="B153" ref-type="bibr">2009</xref>; García-López et al., <xref rid="B55" ref-type="bibr">2011</xref>; Rzuczek et al., <xref rid="B167" ref-type="bibr">2013</xref>). It has also been reported that a 13-amino-acid peptide can bind to CAG repeats and suppress nucleolar stress and neurotoxicity in a <italic>Drosophila</italic> model of SCA3 (Zhang et al., <xref rid="B219" ref-type="bibr">2016</xref>). Last but not least, designs in small molecules designs have achieved much successes in combating DM1 and C9-ALS/FTD as well. Non-steroidal anti-inflammatory drugs like ketoprofen, histamine receptor inhibitors like orphenadrine and sodium/calcium metabolism modifiers like clenbuterol and spironolactone have been shown in <italic>Drosophila</italic> models of DM1 to mitigate the effects of CUG toxicity (Garcia-Lopez et al., <xref rid="B56" ref-type="bibr">2008</xref>). Pentamidine and neomycin B have been shown to disrupt MBNL1 binding to CUG repeats (Warf et al., <xref rid="B200" ref-type="bibr">2009</xref>). A number of small molecules, including bisamidinium inhibitors, can target toxic RNA-protein interactions and alleviate the sequestration of MBNL1 by repeat expansions (Gareiss et al., <xref rid="B57" ref-type="bibr">2008</xref>; Kumar et al., <xref rid="B95" ref-type="bibr">2012</xref>; Parkesh et al., <xref rid="B144" ref-type="bibr">2012</xref>; Wong et al., <xref rid="B208" ref-type="bibr">2014</xref>; Luu et al., <xref rid="B109" ref-type="bibr">2016</xref>). Porphyrins that distorts RNA G-quadruplex structures can ablate the GGGGCC repeat expansion's interaction with hnRNPA1 or ASF/SF2 (Zamiri et al., <xref rid="B216" ref-type="bibr">2014</xref>). There are small molecules that can even reduce DPR protein production in a model of C9-ALS/FTD (Su et al., <xref rid="B185" ref-type="bibr">2014</xref>). Histone deacetylase (HDAC) inhibitors like sodium butyrate and suberoylanilide hydroxamic acid had been shown to suppress degeneration in a <italic>Drosophila</italic> model of HD (Steffan et al., <xref rid="B182" ref-type="bibr">2001</xref>). Although, this suppression may involve protein toxicity instead of RNA toxicity. Furthermore, in a <italic>Drosophila</italic> model of SBMA and a <italic>Drosophila</italic> model of FXTAS, overexpression of the HDACs themselves actually suppressed the degeneration phenotypes (Pandey et al., <xref rid="B143" ref-type="bibr">2007</xref>; Todd et al., <xref rid="B191" ref-type="bibr">2010</xref>). Thus, the effects of HDACs inhibitors could be different for different types of READs.</p>
      <p>The newest trend in the designing of small molecules is driving toward compounds with multiple modes of actions in combating the pathogenesis of the disease. Zimmerman and colleagues have reported a type of small molecule can target DM1 pathology by acting as transcription inhibitors, by inhibiting aberrant protein binding to toxic RNA, and by acting as RNase mimics to degrade the toxic RNA (Nguyen et al., <xref rid="B136" ref-type="bibr">2015</xref>). Gitler and colleagues discovered that the transcription elongation factor Spt4 selectively decreased both sense and antisense GGGGCC expanded transcripts, and partially rescued retinal degeneration in the fly eye model of C9-ALS/FTD (Kramer et al., <xref rid="B92" ref-type="bibr">2016</xref>). Knockdown of <italic>SUPT4H1</italic>, the human ortholog of <italic>Spt4</italic>, decreased sense and antisense RNA foci and DPR protein production in C9-ALS/FTD patient-derived cells (Kramer et al., <xref rid="B92" ref-type="bibr">2016</xref>). The study demonstrated Spt4 as a new potential therapeutic target since the disruption of Spt4 can ameliorate degeneration induced by different modes of toxicity sources. Animal models such as the fly models described in this review are valuable tools in the testing of novel compounds and therapeutic targets before clinical trials. They will also continue to serve as important platforms for the discoveries of unknown mechanisms of diseases that may facilitate the development of new therapeutic approaches.</p>
    </sec>
    <sec id="s8">
      <title>Concluding remarks</title>
      <p>In this review, we highlighted <italic>Drosophila</italic> as an excellent model organism for the studying of READs. The studies mentioned above have revealed comprehensive information regarding the mechanisms of neurodegeneration in READs, demonstrating the elegant use of the fly models in pioneering discoveries of RNA toxicity. Despite the fact that protein toxicity is a major factor that contributes to the pathogenesis of many READs, we are now certain that RNA toxicity also plays a major role in inducing neural and muscle degeneration via a number of possible ways, including but not limited to the impairment of alternative splicing, the promotion of bidirectional transcription, the induction of nucleolar stress and disruption of nucleocytoplasmic transport, the generation of sRNA from hairpins and dsRNA, and RAN translation of repeat-containing peptides. Although the formation of visible ribonuclear foci is still a hallmark of pathogenesis, more, and more evidence is indicating that the initial emergence of foci does not equal to immediate detectable toxicity. The foci do not initiate the disease process <italic>per se</italic>. In fact, the formation of foci could possibly be a healthy response to temporarily sequester the toxic RNA. Although in the long run, foci may still contribute to the progression of the disease by sequestering RNA-binding proteins, and gradually lead to degeneration.</p>
      <p>Apart from the traditional advantages in genetics, the recent advances in CRISPR/Cas9 system and bioinformatics have become a powerful driving force that will surely aid <italic>Drosophila</italic> research to ascend to the next level. For instance, Liu and colleagues have developed an improved RNA injection-based CRISPR/Cas9 system that is highly efficient for creating desired mutagenesis in the <italic>Drosophila</italic> genome with a mutagenesis induction rate up to 88% (Bassett et al., <xref rid="B8" ref-type="bibr">2013</xref>). O'Connor-Giles and colleagues have expanded the system through homology-directed repair to facilitate complex genome engineering, enabling the insertion of sizable DNA sequences to create targeted knock-ins and conditional knockouts (Gratz et al., <xref rid="B58" ref-type="bibr">2014</xref>). The CRISPR/Cas9 system can also be used for tissue-specific tagging of endogenous proteins (T-STEP; Koles et al., <xref rid="B88" ref-type="bibr">2015</xref>). In contrast to the GAL4/UAS overexpression system, which sometimes may change the localization patterns of proteins, T-STEP retains the endogenous protein localization patterns. Furthermore, it achieves tissue-specific labeling, allowing researcher to dissect tissue-specific functions of the protein of interest. Next generation sequencing is now widely available, and the access of disease information is also becoming more convenient for <italic>Drosophila</italic> geneticists as well. Online databases such as FlyBase has even introduced “Human Disease Model Reports” recently, further facilitating the studies of human diseases using the fruit fly (Millburn et al., <xref rid="B118" ref-type="bibr">2016</xref>). With the development of these techniques and databases, we expect many new and improved fly models of human diseases to emerge soon.</p>
      <p>In conclusion, <italic>Drosophila</italic> is a useful <italic>in vivo</italic> model system that can reveal novel mechanistic insights into human disorders, providing the foundation for translational research and therapeutic development. Looking into the future, we anticipate the tiny fruit fly to continue playing an important role in gene and drug discoveries in the ongoing battle between humans and neurodegenerative and neuromuscular diseases.</p>
    </sec>
    <sec id="s9">
      <title>Author contributions</title>
      <p>ACK wrote the manuscript. HYEC contributed to the writing of the manuscript.</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>This work was supported by the General Research Fund (460712, 461013, 14100714, and 14122815), ANR/RGC Joint Research Scheme (A-CUHK401/14) and Collaborative Research Fund (CUHK1/CRF/13G) of the Hong Kong Research Grants Council; CUHK Lui Che Woo Institute of Innovative Medicine BRAIN Initiative (8303404); Direct Grant for Research from the Research Committee of CUHK (4053148); CUHK Group Research Scheme (3110102); Vice-Chancellor's One-Off Discretionary Fund (4930713); One-off Funding for Joint Lab/Research Collaboration (3132980); and Gerald Choa Neuroscience Centre (7105306); and donations from Chow Tai Fook Charity Foundation (6903898); and Hong Kong Spinocerebellar Ataxia Association (6903291).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M. D.</given-names></name><name><surname>Celniker</surname><given-names>S. E.</given-names></name><name><surname>Holt</surname><given-names>R. A.</given-names></name><name><surname>Evans</surname><given-names>C. A.</given-names></name><name><surname>Gocayne</surname><given-names>J. D.</given-names></name><name><surname>Amanatides</surname><given-names>P. G.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>The genome sequence of <italic>Drosophila melanogaster</italic></article-title>. <source>Science</source>
<volume>287</volume>, <fpage>2185</fpage>–<lpage>2195</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5461.2185</pub-id><?supplied-pmid 10731132?><pub-id pub-id-type="pmid">10731132</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajroud-Driss</surname><given-names>S.</given-names></name><name><surname>Siddique</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Sporadic and hereditary amyotrophic lateral sclerosis (ALS)</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1852</volume>, <fpage>679</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.08.010</pub-id><?supplied-pmid 25193032?><pub-id pub-id-type="pmid">25193032</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrasate</surname><given-names>M.</given-names></name><name><surname>Mitra</surname><given-names>S.</given-names></name><name><surname>Schweitzer</surname><given-names>E. S.</given-names></name><name><surname>Segal</surname><given-names>M. R.</given-names></name><name><surname>Finkbeiner</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</article-title>. <source>Nature</source>
<volume>431</volume>, <fpage>805</fpage>–<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1038/nature02998</pub-id><?supplied-pmid 15483602?><pub-id pub-id-type="pmid">15483602</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auluck</surname><given-names>P. K.</given-names></name><name><surname>Meulener</surname><given-names>M. C.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in Drosophila</article-title>. <source>J. Biol. Chem.</source>
<volume>280</volume>, <fpage>2873</fpage>–<lpage>2878</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M412106200</pub-id><?supplied-pmid 15556931?><pub-id pub-id-type="pmid">15556931</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baizabal-Carvallo</surname><given-names>J. F.</given-names></name><name><surname>Jankovic</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Parkinsonism, movement disorders and genetics in frontotemporal dementia</article-title>. <source>Nat. Rev. Neurol.</source>
<volume>12</volume>, <fpage>175</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.14</pub-id><?supplied-pmid 26891767?><pub-id pub-id-type="pmid">26891767</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bañez-Coronel</surname><given-names>M.</given-names></name><name><surname>Porta</surname><given-names>S.</given-names></name><name><surname>Kagerbauer</surname><given-names>B.</given-names></name><name><surname>Mateu-Huertas</surname><given-names>E.</given-names></name><name><surname>Pantano</surname><given-names>L.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity</article-title>. <source>PLoS Genet.</source>
<volume>8</volume>:<fpage>e1002481</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002481</pub-id><?supplied-pmid 22383888?><pub-id pub-id-type="pmid">22383888</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function</article-title>. <source>Neuron</source>
<volume>60</volume>, <fpage>201</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id><?supplied-pmid 18957214?><pub-id pub-id-type="pmid">18957214</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>A. R.</given-names></name><name><surname>Tibbit</surname><given-names>C.</given-names></name><name><surname>Ponting</surname><given-names>C. P.</given-names></name><name><surname>Liu</surname><given-names>J. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system</article-title>. <source>Cell Rep.</source>
<volume>4</volume>, <fpage>220</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.020</pub-id><?supplied-pmid 23827738?><pub-id pub-id-type="pmid">23827738</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellen</surname><given-names>H. J.</given-names></name><name><surname>Levis</surname><given-names>R. W.</given-names></name><name><surname>Liao</surname><given-names>G.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Carlson</surname><given-names>J. W.</given-names></name><name><surname>Tsang</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes</article-title>. <source>Genetics</source>
<volume>167</volume>, <fpage>761</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.104.026427</pub-id><?supplied-pmid 15238527?><pub-id pub-id-type="pmid">15238527</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellen</surname><given-names>H. J.</given-names></name><name><surname>Tong</surname><given-names>C.</given-names></name><name><surname>Tsuda</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>11</volume>, <fpage>514</fpage>–<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2839</pub-id><?supplied-pmid 20383202?><pub-id pub-id-type="pmid">20383202</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belzil</surname><given-names>V. V.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Petrucelli</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>RNA-mediated toxicity in neurodegenerative disease</article-title>. <source>Mol. Cell. Neurosci.</source>
<volume>56</volume>, <fpage>406</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2012.12.006</pub-id><?supplied-pmid 23280309?><pub-id pub-id-type="pmid">23280309</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>E.</given-names></name><name><surname>Caudy</surname><given-names>A. A.</given-names></name><name><surname>Hammond</surname><given-names>S. M.</given-names></name><name><surname>Hannon</surname><given-names>G. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Role for a bidentate ribonuclease in the initiation step of RNA interference</article-title>. <source>Nature</source>
<volume>409</volume>, <fpage>363</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1038/35053110</pub-id><?supplied-pmid 11201747?><pub-id pub-id-type="pmid">11201747</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berul</surname><given-names>C. I.</given-names></name><name><surname>Maguire</surname><given-names>C. T.</given-names></name><name><surname>Aronovitz</surname><given-names>M. J.</given-names></name><name><surname>Greenwood</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>C.</given-names></name><name><surname>Gehrmann</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model</article-title>. <source>J. Clin. Invest.</source>
<volume>103</volume>, <fpage>R1</fpage>–<lpage>R7</lpage>. <pub-id pub-id-type="doi">10.1172/JCI5346</pub-id><?supplied-pmid 10021468?><pub-id pub-id-type="pmid">10021468</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhakar</surname><given-names>A. L.</given-names></name><name><surname>Dölen</surname><given-names>G.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2012</year>). <article-title>The pathophysiology of fragile X (and what it teaches us about synapses)</article-title>. <source>Annu. Rev. Neurosci.</source>
<volume>35</volume>, <fpage>417</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153138</pub-id><?supplied-pmid 22483044?><pub-id pub-id-type="pmid">22483044</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bier</surname><given-names>E.</given-names></name><name><surname>Vaessin</surname><given-names>H.</given-names></name><name><surname>Shepherd</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>McCall</surname><given-names>K.</given-names></name><name><surname>Barbel</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>1989</year>). <article-title>Searching for pattern and mutation in the Drosophila genome with a P-lacZ vector</article-title>. <source>Genes Dev.</source>
<volume>3</volume>, <fpage>1273</fpage>–<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1101/gad.3.9.1273</pub-id><?supplied-pmid 2558049?><pub-id pub-id-type="pmid">2558049</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilen</surname><given-names>J.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila</article-title>. <source>PLoS Genet.</source>
<volume>3</volume>:<fpage>e177</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030177</pub-id><?supplied-pmid 17953484?><pub-id pub-id-type="pmid">17953484</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname><given-names>S.</given-names></name><name><surname>Bogaert</surname><given-names>E.</given-names></name><name><surname>Michiels</surname><given-names>E.</given-names></name><name><surname>Gijselinck</surname><given-names>I.</given-names></name><name><surname>Sieben</surname><given-names>A.</given-names></name><name><surname>Jovicic</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>:<fpage>20877</fpage>. <pub-id pub-id-type="doi">10.1038/srep20877</pub-id><?supplied-pmid 26869068?><pub-id pub-id-type="pmid">26869068</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulon</surname><given-names>S.</given-names></name><name><surname>Westman</surname><given-names>B. J.</given-names></name><name><surname>Hutten</surname><given-names>S.</given-names></name><name><surname>Boisvert</surname><given-names>F. M.</given-names></name><name><surname>Lamond</surname><given-names>A. I.</given-names></name></person-group> (<year>2010</year>). <article-title>The nucleolus under stress</article-title>. <source>Mol. Cell</source>
<volume>40</volume>, <fpage>216</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.024</pub-id><?supplied-pmid 20965417?><pub-id pub-id-type="pmid">20965417</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>A. H.</given-names></name><name><surname>Perrimon</surname><given-names>N.</given-names></name></person-group> (<year>1993</year>). <article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title>. <source>Development</source>
<volume>118</volume>, <fpage>401</fpage>–<lpage>415</lpage>. <?supplied-pmid 8223268?><pub-id pub-id-type="pmid">8223268</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>J. D.</given-names></name><name><surname>McCurrach</surname><given-names>M. E.</given-names></name><name><surname>Harley</surname><given-names>H. G.</given-names></name><name><surname>Buckler</surname><given-names>A. J.</given-names></name><name><surname>Church</surname><given-names>D.</given-names></name><name><surname>Aburatani</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>1992</year>). <article-title>Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member</article-title>. <source>Cell</source>
<volume>69</volume>, <fpage>385</fpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90154-5</pub-id><?supplied-pmid 1568252?><pub-id pub-id-type="pmid">1568252</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>J. R.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Microsatellite repeat instability and neurological disease</article-title>. <source>Bioessays</source>
<volume>31</volume>, <fpage>71</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1002/bies.080122</pub-id><?supplied-pmid 19154005?><pub-id pub-id-type="pmid">19154005</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burguete</surname><given-names>A. S.</given-names></name><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>F. B.</given-names></name><name><surname>Kalb</surname><given-names>R.</given-names></name><name><surname>Akins</surname><given-names>M. R.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2015</year>). <article-title>GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function</article-title>. <source>Elife</source>
<volume>4</volume>:<fpage>e08881</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.08881</pub-id><?supplied-pmid 26650351?><pub-id pub-id-type="pmid">26650351</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calnan</surname><given-names>B. J.</given-names></name><name><surname>Tidor</surname><given-names>B.</given-names></name><name><surname>Biancalana</surname><given-names>S.</given-names></name><name><surname>Hudson</surname><given-names>D.</given-names></name><name><surname>Frankel</surname><given-names>A. D.</given-names></name></person-group> (<year>1991</year>). <article-title>Arginine-mediated RNA recognition: the arginine fork</article-title>. <source>Science</source>
<volume>252</volume>, <fpage>1167</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1126/science.252.5009.1167</pub-id><?supplied-pmid 1709522?><pub-id pub-id-type="pmid">1709522</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>H. Y.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Drosophila models of human neurodegenerative disease</article-title>. <source>Cell Death Differ.</source>
<volume>7</volume>, <fpage>1075</fpage>–<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4400757</pub-id><?supplied-pmid 11139281?><pub-id pub-id-type="pmid">11139281</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>H. Y.</given-names></name><name><surname>Warrick</surname><given-names>J. M.</given-names></name><name><surname>Gray-Board</surname><given-names>G. L.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila</article-title>. <source>Hum. Mol. Genet.</source>
<volume>9</volume>, <fpage>2811</fpage>–<lpage>2820</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.19.2811</pub-id><?supplied-pmid 11092757?><pub-id pub-id-type="pmid">11092757</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Bray</surname><given-names>S. M.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila</article-title>. <source>Nat. Chem. Biol.</source>
<volume>4</volume>, <fpage>256</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.78</pub-id><?supplied-pmid 18327252?><pub-id pub-id-type="pmid">18327252</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Sayana</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Le</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Genetics of amyotrophic lateral sclerosis: an update</article-title>. <source>Mol. Neurodegener.</source>
<volume>8</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-8-28</pub-id><?supplied-pmid 23941283?><pub-id pub-id-type="pmid">23941283</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>D. H.</given-names></name><name><surname>Thienes</surname><given-names>C. P.</given-names></name><name><surname>Mahoney</surname><given-names>S. E.</given-names></name><name><surname>Analau</surname><given-names>E.</given-names></name><name><surname>Filippova</surname><given-names>G. N.</given-names></name><name><surname>Tapscott</surname><given-names>S. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF</article-title>. <source>Mol. Cell</source>
<volume>20</volume>, <fpage>483</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.002</pub-id><?supplied-pmid 16285929?><pub-id pub-id-type="pmid">16285929</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffee</surname><given-names>R. L.</given-names><suffix>Jr.</suffix></name><name><surname>Tessier</surname><given-names>C. R.</given-names></name><name><surname>Woodruff</surname><given-names>E. A.</given-names><suffix>III.</suffix></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P</article-title>. <source>Dis. Model. Mech.</source>
<volume>3</volume>, <fpage>471</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.004598</pub-id><?supplied-pmid 20442204?><pub-id pub-id-type="pmid">20442204</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>E. G.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Yamazaki</surname><given-names>T.</given-names></name><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Shneider</surname><given-names>N. A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains</article-title>. <source>elife</source>
<volume>5</volume>:<fpage>e17820</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.17820</pub-id><?supplied-pmid 27623008?><pub-id pub-id-type="pmid">27623008</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooley</surname><given-names>L.</given-names></name><name><surname>Kelley</surname><given-names>R.</given-names></name><name><surname>Spradling</surname><given-names>A.</given-names></name></person-group> (<year>1988</year>). <article-title>Insertional mutagenesis of the Drosophila genome with single P elements</article-title>. <source>Science</source>
<volume>239</volume>, <fpage>1121</fpage>–<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1126/science.2830671</pub-id><?supplied-pmid 2830671?><pub-id pub-id-type="pmid">2830671</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>G.</given-names></name><name><surname>Abbas</surname><given-names>N.</given-names></name><name><surname>Stevanin</surname><given-names>G.</given-names></name><name><surname>Dürr</surname><given-names>A.</given-names></name><name><surname>Yvert</surname><given-names>G.</given-names></name><name><surname>Cancel</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>1997</year>). <article-title>Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion</article-title>. <source>Nat. Genet.</source>
<volume>17</volume>, <fpage>65</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/ng0997-65</pub-id><?supplied-pmid 9288099?><pub-id pub-id-type="pmid">9288099</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>B. M.</given-names></name><name><surname>McCurrach</surname><given-names>M. E.</given-names></name><name><surname>Taneja</surname><given-names>K. L.</given-names></name><name><surname>Singer</surname><given-names>R. H.</given-names></name><name><surname>Housman</surname><given-names>D. E.</given-names></name></person-group> (<year>1997</year>). <article-title>Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>94</volume>, <fpage>7388</fpage>–<lpage>7393</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.14.7388</pub-id><?supplied-pmid 9207101?><pub-id pub-id-type="pmid">9207101</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Haro</surname><given-names>M.</given-names></name><name><surname>Al-Ramahi</surname><given-names>I.</given-names></name><name><surname>De Gouyon</surname><given-names>B.</given-names></name><name><surname>Ukani</surname><given-names>L.</given-names></name><name><surname>Rosa</surname><given-names>A.</given-names></name><name><surname>Faustino</surname><given-names>N. A.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1</article-title>. <source>Hum. Mol. Genet.</source>
<volume>15</volume>, <fpage>2138</fpage>–<lpage>2145</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl137</pub-id><?supplied-pmid 16723374?><pub-id pub-id-type="pmid">16723374</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Haro</surname><given-names>M.</given-names></name><name><surname>Al-Ramahi</surname><given-names>I.</given-names></name><name><surname>Jones</surname><given-names>K. R.</given-names></name><name><surname>Holth</surname><given-names>J. K.</given-names></name><name><surname>Timchenko</surname><given-names>L. T.</given-names></name><name><surname>Botas</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Smaug/SAMD4A restores translational activity of CUGBP1 and suppresses CUG-induced myopathy</article-title>. <source>PLoS Genet.</source>
<volume>9</volume>:<fpage>e1003445</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003445</pub-id><?supplied-pmid 23637619?><pub-id pub-id-type="pmid">23637619</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname><given-names>M.</given-names></name><name><surname>Mackenzie</surname><given-names>I. R.</given-names></name><name><surname>Boeve</surname><given-names>B. F.</given-names></name><name><surname>Boxer</surname><given-names>A. L.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Rutherford</surname><given-names>N. J.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS</article-title>. <source>Neuron</source>
<volume>72</volume>, <fpage>245</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id><?supplied-pmid 21944778?><pub-id pub-id-type="pmid">21944778</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietzl</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Schnorrer</surname><given-names>F.</given-names></name><name><surname>Su</surname><given-names>K. C.</given-names></name><name><surname>Barinova</surname><given-names>Y.</given-names></name><name><surname>Fellner</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila</article-title>. <source>Nature</source>
<volume>448</volume>, <fpage>151</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/nature05954</pub-id><?supplied-pmid 17625558?><pub-id pub-id-type="pmid">17625558</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><name><surname>Su</surname><given-names>H. S.</given-names></name><name><surname>McBride</surname><given-names>S. M.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>C. H.</given-names></name><name><surname>Siwicki</surname><given-names>K. K.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest</article-title>. <source>Neuron</source>
<volume>34</volume>, <fpage>973</fpage>–<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00724-9</pub-id><?supplied-pmid 12086644?><pub-id pub-id-type="pmid">12086644</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>C. J.</given-names></name><name><surname>Zhang</surname><given-names>P. W.</given-names></name><name><surname>Pham</surname><given-names>J. T.</given-names></name><name><surname>Haeusler</surname><given-names>A. R.</given-names></name><name><surname>Mistry</surname><given-names>N. A.</given-names></name><name><surname>Vidensky</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention</article-title>. <source>Neuron</source>
<volume>80</volume>, <fpage>415</fpage>–<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.015</pub-id><?supplied-pmid 24139042?><pub-id pub-id-type="pmid">24139042</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doumanis</surname><given-names>J.</given-names></name><name><surname>Wada</surname><given-names>K.</given-names></name><name><surname>Kino</surname><given-names>Y.</given-names></name><name><surname>Moore</surname><given-names>A. W.</given-names></name><name><surname>Nukina</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation</article-title>. <source>PLoS ONE</source>
<volume>4</volume>:<fpage>e7275</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007275</pub-id><?supplied-pmid 19789644?><pub-id pub-id-type="pmid">19789644</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droppelmann</surname><given-names>C. A.</given-names></name><name><surname>Campos-Melo</surname><given-names>D.</given-names></name><name><surname>Ishtiaq</surname><given-names>M.</given-names></name><name><surname>Volkening</surname><given-names>K.</given-names></name><name><surname>Strong</surname><given-names>M. J.</given-names></name></person-group> (<year>2014</year>). <article-title>RNA metabolism in ALS: when normal processes become pathological</article-title>. <source>Amyotroph. Lateral Scler. Frontotemporal Degener.</source>
<volume>15</volume>, <fpage>321</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.3109/21678421.2014.881377</pub-id><?supplied-pmid 24555412?><pub-id pub-id-type="pmid">24555412</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>J. B.</given-names></name></person-group> (<year>2002</year>). <article-title>GAL4 system in Drosophila: a fly geneticist's Swiss army knife</article-title>. <source>Genesis</source>
<volume>34</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/gene.10150</pub-id><?supplied-pmid 12324939?><pub-id pub-id-type="pmid">12324939</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebralidze</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Petkova</surname><given-names>V.</given-names></name><name><surname>Ebralidse</surname><given-names>K.</given-names></name><name><surname>Junghans</surname><given-names>R. P.</given-names></name></person-group> (<year>2004</year>). <article-title>RNA leaching of transcription factors disrupts transcription in myotonic dystrophy</article-title>. <source>Science</source>
<volume>303</volume>, <fpage>383</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1126/science.1088679</pub-id><?supplied-pmid 14657503?><pub-id pub-id-type="pmid">14657503</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>K.</given-names></name><name><surname>Gehrke</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name><name><surname>Lu</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease</article-title>. <source>BMC Neurosci.</source>
<volume>10</volume>:<fpage>109</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-10-109</pub-id><?supplied-pmid 19723328?><pub-id pub-id-type="pmid">19723328</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Funez</surname><given-names>P.</given-names></name><name><surname>Nino-Rosales</surname><given-names>M. L.</given-names></name><name><surname>de Gouyon</surname><given-names>B.</given-names></name><name><surname>She</surname><given-names>W. C.</given-names></name><name><surname>Luchak</surname><given-names>J. M.</given-names></name><name><surname>Martinez</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Identification of genes that modify ataxin-1-induced neurodegeneration</article-title>. <source>Nature</source>
<volume>408</volume>, <fpage>101</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1038/35040584</pub-id><?supplied-pmid 11081516?><pub-id pub-id-type="pmid">11081516</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiszer</surname><given-names>A.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W. J.</given-names></name></person-group> (<year>2013</year>). <article-title>RNA toxicity in polyglutamine disorders: concepts, models, and progress of research</article-title>. <source>J. Mol. Med.</source>
<volume>91</volume>, <fpage>683</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-013-1016-2</pub-id><?supplied-pmid 23512265?><pub-id pub-id-type="pmid">23512265</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleischer</surname><given-names>B.</given-names></name></person-group> (<year>1918</year>). <article-title>Über myotonische Dystrophie mit Katarakt</article-title>. <source>Albrecht. Von. Graefes. Arch. Klin. Exp. Ophthalmol.</source>
<volume>96</volume>, <fpage>91</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1007/BF02018704</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname><given-names>S. B.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name><name><surname>Gold</surname><given-names>L. H.</given-names></name><name><surname>Grace</surname><given-names>A. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia</article-title>. <source>Schizophr. Bull.</source>
<volume>31</volume>, <fpage>888</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbi041</pub-id><?supplied-pmid 16079387?><pub-id pub-id-type="pmid">16079387</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fratta</surname><given-names>P.</given-names></name><name><surname>Poulter</surname><given-names>M.</given-names></name><name><surname>Lashley</surname><given-names>T.</given-names></name><name><surname>Rohrer</surname><given-names>J. D.</given-names></name><name><surname>Polke</surname><given-names>J. M.</given-names></name><name><surname>Beck</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia</article-title>. <source>Acta Neuropathol.</source>
<volume>126</volume>, <fpage>401</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1147-0</pub-id><?supplied-pmid 23818065?><pub-id pub-id-type="pmid">23818065</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname><given-names>B. D.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Lopez-Gonzalez</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>N. C.</given-names></name><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>K. H.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport</article-title>. <source>Nature</source>
<volume>525</volume>, <fpage>129</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1038/nature14974</pub-id><?supplied-pmid 26308899?><pub-id pub-id-type="pmid">26308899</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Friedman</surname><given-names>D. L.</given-names></name><name><surname>Richards</surname><given-names>S.</given-names></name><name><surname>Pearlman</surname><given-names>J. A.</given-names></name><name><surname>Gibbs</surname><given-names>R. A.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy</article-title>. <source>Science</source>
<volume>260</volume>, <fpage>235</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1126/science.8469976</pub-id><?supplied-pmid 8469976?><pub-id pub-id-type="pmid">8469976</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Kuhl</surname><given-names>D. P.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Richards</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>1991</year>). <article-title>Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox</article-title>. <source>Cell</source>
<volume>67</volume>, <fpage>1047</fpage>–<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90283-5</pub-id><?supplied-pmid 1760838?><pub-id pub-id-type="pmid">1760838</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><name><surname>Fenwick</surname><given-names>R. G.</given-names><suffix>Jr.</suffix></name><name><surname>King</surname><given-names>J.</given-names></name><name><surname>Rajnarayan</surname><given-names>S.</given-names></name><name><surname>Dunne</surname><given-names>P. W.</given-names></name><etal/></person-group>. (<year>1992</year>). <article-title>An unstable triplet repeat in a gene related to myotonic muscular dystrophy</article-title>. <source>Science</source>
<volume>255</volume>, <fpage>1256</fpage>–<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1126/science.1546326</pub-id><?supplied-pmid 1546326?><pub-id pub-id-type="pmid">1546326</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname><given-names>J. N.</given-names></name><name><surname>Shaw</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Parghi</surname><given-names>D.</given-names></name><name><surname>Poidevin</surname><given-names>M.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome</article-title>. <source>Hum. Mol. Genet.</source>
<volume>23</volume>, <fpage>5906</fpage>–<lpage>5915</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu314</pub-id><?supplied-pmid 24986919?><pub-id pub-id-type="pmid">24986919</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-López</surname><given-names>A.</given-names></name><name><surname>Llamusí</surname><given-names>B.</given-names></name><name><surname>Orzáez</surname><given-names>M.</given-names></name><name><surname>Pérez-Payá</surname><given-names>E.</given-names></name><name><surname>Artero</surname><given-names>R. D.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>In vivo</italic> discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>108</volume>, <fpage>11866</fpage>–<lpage>11871</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1018213108</pub-id><?supplied-pmid 21730182?><pub-id pub-id-type="pmid">21730182</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Lopez</surname><given-names>A.</given-names></name><name><surname>Monferrer</surname><given-names>L.</given-names></name><name><surname>Garcia-Alcover</surname><given-names>I.</given-names></name><name><surname>Vicente-Crespo</surname><given-names>M.</given-names></name><name><surname>Alvarez-Abril</surname><given-names>M. C.</given-names></name><name><surname>Artero</surname><given-names>R. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Genetic and chemical modifiers of a CUG toxicity model in Drosophila</article-title>. <source>PLoS ONE</source>
<volume>3</volume>:<fpage>e1595</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0001595</pub-id><?supplied-pmid 18270582?><pub-id pub-id-type="pmid">18270582</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gareiss</surname><given-names>P. C.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>McNaughton</surname><given-names>B. R.</given-names></name><name><surname>Palde</surname><given-names>P. B.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Miller</surname><given-names>B. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction <italic>in vitro</italic>: discovery of lead compounds targeting myotonic dystrophy (DM1)</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>130</volume>, <fpage>16254</fpage>–<lpage>16261</lpage>. <pub-id pub-id-type="doi">10.1021/ja804398y</pub-id><?supplied-pmid 18998634?><pub-id pub-id-type="pmid">18998634</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratz</surname><given-names>S. J.</given-names></name><name><surname>Ukken</surname><given-names>F. P.</given-names></name><name><surname>Rubinstein</surname><given-names>C. D.</given-names></name><name><surname>Thiede</surname><given-names>G.</given-names></name><name><surname>Donohue</surname><given-names>L. K.</given-names></name><name><surname>Cummings</surname><given-names>A. M.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila</article-title>. <source>Genetics</source>
<volume>196</volume>, <fpage>961</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.113.160713</pub-id><?supplied-pmid 24478335?><pub-id pub-id-type="pmid">24478335</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>C. M.</given-names></name><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Chudley</surname><given-names>A. E.</given-names></name><name><surname>Del Bigio</surname><given-names>M. R.</given-names></name><name><surname>Jacquemont</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers</article-title>. <source>Brain</source>
<volume>125</volume>(<issue>Pt 8</issue>), <fpage>1760</fpage>–<lpage>1771</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awf184</pub-id><?supplied-pmid 12135967?><pub-id pub-id-type="pmid">12135967</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeusler</surname><given-names>A. R.</given-names></name><name><surname>Donnelly</surname><given-names>C. J.</given-names></name><name><surname>Periz</surname><given-names>G.</given-names></name><name><surname>Simko</surname><given-names>E. A.</given-names></name><name><surname>Shaw</surname><given-names>P. G.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>C9orf72 nucleotide repeat structures initiate molecular cascades of disease</article-title>. <source>Nature</source>
<volume>507</volume>, <fpage>195</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1038/nature13124</pub-id><?supplied-pmid 24598541?><pub-id pub-id-type="pmid">24598541</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hand</surname><given-names>C. K.</given-names></name><name><surname>Rouleau</surname><given-names>G. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Familial amyotrophic lateral sclerosis</article-title>. <source>Muscle Nerve</source>
<volume>25</volume>, <fpage>135</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1002/mus.10001</pub-id><?supplied-pmid 11870681?><pub-id pub-id-type="pmid">11870681</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>M. B.</given-names></name><name><surname>Cady</surname><given-names>J.</given-names></name><name><surname>Zaidman</surname><given-names>C.</given-names></name><name><surname>Cooper</surname><given-names>P.</given-names></name><name><surname>Bali</surname><given-names>T.</given-names></name><name><surname>Allred</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Lack of <italic>C9ORF72</italic> coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis</article-title>. <source>Neurobiol Aging</source>
<volume>34</volume>, <fpage>2234.e13</fpage>–<lpage>2234.e19</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.03.006</pub-id><?supplied-pmid 23597494?><pub-id pub-id-type="pmid">23597494</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>P. S.</given-names></name></person-group> (<year>2001</year>). <source>Myotonic Dystrophy, 3rd Eds</source>. <publisher-loc>London</publisher-loc>: <publisher-name>W.B. Saunders Company</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>K. P.</given-names></name><name><surname>Littleton</surname><given-names>J. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Transmission, development, and plasticity of synapses</article-title>. <source>Genetics</source>
<volume>201</volume>, <fpage>345</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.176529</pub-id><?supplied-pmid 26447126?><pub-id pub-id-type="pmid">26447126</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>C. J.</given-names></name><name><surname>Jack</surname><given-names>E. M.</given-names></name><name><surname>Allen</surname><given-names>T. D.</given-names></name><name><surname>Harris</surname><given-names>R.</given-names></name></person-group> (<year>1983</year>). <article-title>The fragile X: a scanning electron microscope study</article-title>. <source>J. Med. Genet.</source>
<volume>20</volume>, <fpage>280</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.20.4.280</pub-id><?supplied-pmid 6684694?><pub-id pub-id-type="pmid">6684694</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Krans</surname><given-names>A.</given-names></name><name><surname>Freibaum</surname><given-names>B. D.</given-names></name><name><surname>Taylor</surname><given-names>J. P.</given-names></name><name><surname>Todd</surname><given-names>P. K.</given-names></name></person-group> (<year>2014</year>). <article-title>TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1</article-title>. <source>Hum. Mol. Genet.</source>
<volume>23</volume>, <fpage>5036</fpage>–<lpage>5051</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu216</pub-id><?supplied-pmid 24920338?><pub-id pub-id-type="pmid">24920338</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirth</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Drosophila melanogaster</italic> in the study of human neurodegeneration</article-title>. <source>CNS Neurol. Disord. Drug Targets</source>
<volume>9</volume>, <fpage>504</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.2174/187152710791556104</pub-id><?supplied-pmid 20522007?><pub-id pub-id-type="pmid">20522007</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>T. H.</given-names></name><name><surname>Charlet</surname><given-names>B. N.</given-names></name><name><surname>Poulos</surname><given-names>M. G.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Swanson</surname><given-names>M. S.</given-names></name><name><surname>Cooper</surname><given-names>T. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Muscleblind proteins regulate alternative splicing</article-title>. <source>EMBO J.</source>
<volume>23</volume>, <fpage>3103</fpage>–<lpage>3112</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600300</pub-id><?supplied-pmid 15257297?><pub-id pub-id-type="pmid">15257297</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>T. H.</given-names></name><name><surname>Savkur</surname><given-names>R. S.</given-names></name><name><surname>Poulos</surname><given-names>M. G.</given-names></name><name><surname>Mancini</surname><given-names>M. A.</given-names></name><name><surname>Swanson</surname><given-names>M. S.</given-names></name><name><surname>Cooper</surname><given-names>T. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy</article-title>. <source>J. Cell Sci.</source>
<volume>118</volume>(<issue>Pt 13</issue>), <fpage>2923</fpage>–<lpage>2933</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02404</pub-id><?supplied-pmid 15961406?><pub-id pub-id-type="pmid">15961406</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houseley</surname><given-names>J. M.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Brock</surname><given-names>G. J.</given-names></name><name><surname>Soloway</surname><given-names>J.</given-names></name><name><surname>Artero</surname><given-names>R.</given-names></name><name><surname>Perez-Alonso</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila</article-title>. <source>Hum. Mol. Genet.</source>
<volume>14</volume>, <fpage>873</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi080</pub-id><?supplied-pmid 15703191?><pub-id pub-id-type="pmid">15703191</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>R. J.</given-names></name><name><surname>Hsiao</surname><given-names>K. M.</given-names></name><name><surname>Lin</surname><given-names>M. J.</given-names></name><name><surname>Li</surname><given-names>C. Y.</given-names></name><name><surname>Wang</surname><given-names>L. C.</given-names></name><name><surname>Chen</surname><given-names>L. K.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Long tract of untranslated CAG repeats is deleterious in transgenic mice</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e16417</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016417</pub-id><?supplied-pmid 21283659?><pub-id pub-id-type="pmid">21283659</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hummel</surname><given-names>T.</given-names></name><name><surname>Klämbt</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>P-element mutagenesis</article-title>. <source>Methods Mol. Biol.</source>
<volume>420</volume>, <fpage>97</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-59745-583-1_6</pub-id><?supplied-pmid 18641943?><pub-id pub-id-type="pmid">18641943</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikenaka</surname><given-names>K.</given-names></name><name><surname>Katsuno</surname><given-names>M.</given-names></name><name><surname>Kawai</surname><given-names>K.</given-names></name><name><surname>Ishigaki</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>F.</given-names></name><name><surname>Sobue</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Disruption of axonal transport in motor neuron diseases</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>13</volume>, <fpage>1225</fpage>–<lpage>1238</lpage>. <pub-id pub-id-type="doi">10.3390/ijms13011225</pub-id><?supplied-pmid 22312314?><pub-id pub-id-type="pmid">22312314</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imbert</surname><given-names>G.</given-names></name><name><surname>Saudou</surname><given-names>F.</given-names></name><name><surname>Yvert</surname><given-names>G.</given-names></name><name><surname>Devys</surname><given-names>D.</given-names></name><name><surname>Trottier</surname><given-names>Y.</given-names></name><name><surname>Garnier</surname><given-names>J. M.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats</article-title>. <source>Nat. Genet.</source>
<volume>14</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/ng1196-285</pub-id><?supplied-pmid 8896557?><pub-id pub-id-type="pmid">8896557</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>G. R.</given-names></name><name><surname>Salecker</surname><given-names>I.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Arnheim</surname><given-names>N.</given-names></name><name><surname>Faber</surname><given-names>P. W.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons</article-title>. <source>Neuron</source>
<volume>21</volume>, <fpage>633</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80573-5</pub-id><?supplied-pmid 9768849?><pub-id pub-id-type="pmid">9768849</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>S. M.</given-names></name><name><surname>Whitworth</surname><given-names>A. J.</given-names></name><name><surname>Greene</surname><given-names>J. C.</given-names></name><name><surname>Libby</surname><given-names>R. T.</given-names></name><name><surname>Baccam</surname><given-names>S. L.</given-names></name><name><surname>Pallanck</surname><given-names>L. J.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>A SCA7 CAG/CTG repeat expansion is stable in <italic>Drosophila melanogaster</italic> despite modulation of genomic context and gene dosage</article-title>. <source>Gene</source>
<volume>347</volume>, <fpage>35</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2004.12.008</pub-id><?supplied-pmid 15715978?><pub-id pub-id-type="pmid">15715978</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Hagerman</surname><given-names>P. J.</given-names></name><name><surname>Leehey</surname><given-names>M. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1</article-title>. <source>Lancet Neurol.</source>
<volume>6</volume>, <fpage>45</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(06)70676-7</pub-id><?supplied-pmid 17166801?><pub-id pub-id-type="pmid">17166801</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>M.</given-names></name><name><surname>Sandoval</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Bayat</surname><given-names>V.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Probing mechanisms that underlie human neurodegenerative diseases in Drosophila</article-title>. <source>Annu. Rev. Genet.</source>
<volume>46</volume>, <fpage>371</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-110711-155456</pub-id><?supplied-pmid 22974305?><pub-id pub-id-type="pmid">22974305</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Duan</surname><given-names>R.</given-names></name><name><surname>Qurashi</surname><given-names>A.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>D.</given-names></name><name><surname>Rosser</surname><given-names>T. C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome</article-title>. <source>Neuron</source>
<volume>55</volume>, <fpage>556</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.020</pub-id><?supplied-pmid 17698009?><pub-id pub-id-type="pmid">17698009</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Zarnescu</surname><given-names>D. C.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Pearson</surname><given-names>C. E.</given-names></name><name><surname>Lucchesi</surname><given-names>J. C.</given-names></name><name><surname>Moses</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in drosophila</article-title>. <source>Neuron</source>
<volume>39</volume>, <fpage>739</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00533-6</pub-id><?supplied-pmid 12948442?><pub-id pub-id-type="pmid">12948442</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovicic</surname><given-names>A.</given-names></name><name><surname>Mertens</surname><given-names>J.</given-names></name><name><surname>Boeynaems</surname><given-names>S.</given-names></name><name><surname>Bogaert</surname><given-names>E.</given-names></name><name><surname>Chai</surname><given-names>N.</given-names></name><name><surname>Yamada</surname><given-names>S. B.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS</article-title>. <source>Nat. Neurosci.</source>
<volume>18</volume>, <fpage>1226</fpage>–<lpage>1229</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4085</pub-id><?supplied-pmid 26308983?><pub-id pub-id-type="pmid">26308983</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaltenbach</surname><given-names>L. S.</given-names></name><name><surname>Romero</surname><given-names>E.</given-names></name><name><surname>Becklin</surname><given-names>R. R.</given-names></name><name><surname>Chettier</surname><given-names>R.</given-names></name><name><surname>Bell</surname><given-names>R.</given-names></name><name><surname>Phansalkar</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Huntingtin interacting proteins are genetic modifiers of neurodegeneration</article-title>. <source>PLoS Genet.</source>
<volume>3</volume>:<fpage>e82</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030082</pub-id><?supplied-pmid 17500595?><pub-id pub-id-type="pmid">17500595</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanadia</surname><given-names>R. N.</given-names></name><name><surname>Johnstone</surname><given-names>K. A.</given-names></name><name><surname>Mankodi</surname><given-names>A.</given-names></name><name><surname>Lungu</surname><given-names>C.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Esson</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>A muscleblind knockout model for myotonic dystrophy</article-title>. <source>Science</source>
<volume>302</volume>, <fpage>1978</fpage>–<lpage>1980</lpage>. <pub-id pub-id-type="doi">10.1126/science.1088583</pub-id><?supplied-pmid 14671308?><pub-id pub-id-type="pmid">14671308</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>T.</given-names></name><name><surname>Taniwaki</surname><given-names>M.</given-names></name><name><surname>Aizawa</surname><given-names>M.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Katayama</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1</article-title>. <source>Nat. Genet.</source>
<volume>8</volume>, <fpage>221</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1038/ng1194-221</pub-id><?supplied-pmid 7874163?><pub-id pub-id-type="pmid">7874163</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiernan</surname><given-names>M. C.</given-names></name><name><surname>Vucic</surname><given-names>S.</given-names></name><name><surname>Cheah</surname><given-names>B. C.</given-names></name><name><surname>Turner</surname><given-names>M. R.</given-names></name><name><surname>Eisen</surname><given-names>A.</given-names></name><name><surname>Hardiman</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Amyotrophic lateral sclerosis</article-title>. <source>Lancet</source>
<volume>377</volume>, <fpage>942</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)61156-7</pub-id><?supplied-pmid 21296405?><pub-id pub-id-type="pmid">21296405</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>K. S.</given-names></name><name><surname>Leffert</surname><given-names>H. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Giant hairpins formed by CUG repeats in myotonic dystrophy messenger RNAs might sterically block RNA export through nuclear pores</article-title>. <source>J. Theor. Biol.</source>
<volume>192</volume>, <fpage>505</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1006/jtbi.1998.0679</pub-id><?supplied-pmid 9680723?><pub-id pub-id-type="pmid">9680723</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>R.</given-names></name><name><surname>Ikeuchi</surname><given-names>T.</given-names></name><name><surname>Onodera</surname><given-names>O.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Igarashi</surname><given-names>S.</given-names></name><name><surname>Endo</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)</article-title>. <source>Nat. Genet.</source>
<volume>6</volume>, <fpage>9</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/ng0194-9</pub-id><?supplied-pmid 8136840?><pub-id pub-id-type="pmid">8136840</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koles</surname><given-names>K.</given-names></name><name><surname>Yeh</surname><given-names>A. R.</given-names></name><name><surname>Rodal</surname><given-names>A. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Tissue-specific tagging of endogenous loci in <italic>Drosophila melanogaster</italic></article-title>. <source>Biol. Open</source>
<volume>5</volume>, <fpage>83</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1242/bio.016089</pub-id><?supplied-pmid 26700726?><pub-id pub-id-type="pmid">26700726</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koob</surname><given-names>M. D.</given-names></name><name><surname>Moseley</surname><given-names>M. L.</given-names></name><name><surname>Schut</surname><given-names>L. J.</given-names></name><name><surname>Benzow</surname><given-names>K. A.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Day</surname><given-names>J. W.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)</article-title>. <source>Nat. Genet.</source>
<volume>21</volume>, <fpage>379</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/7710</pub-id><?supplied-pmid 10192387?><pub-id pub-id-type="pmid">10192387</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korkut</surname><given-names>C.</given-names></name><name><surname>Budnik</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>WNTs tune up the neuromuscular junction</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>10</volume>, <fpage>627</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2681</pub-id><?supplied-pmid 19693027?><pub-id pub-id-type="pmid">19693027</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>J. M.</given-names></name><name><surname>Staveley</surname><given-names>B. E.</given-names></name></person-group> (<year>2003</year>). <article-title>GAL4 causes developmental defects and apoptosis when expressed in the developing eye of <italic>Drosophila melanogaster</italic></article-title>. <source>Genet. Mol. Res.</source>
<volume>2</volume>, <fpage>43</fpage>–<lpage>47</lpage>. <?supplied-pmid 12917801?><pub-id pub-id-type="pmid">12917801</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>N. J.</given-names></name><name><surname>Carlomagno</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y. J.</given-names></name><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Cook</surname><given-names>C. N.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts</article-title>. <source>Science</source>
<volume>353</volume>, <fpage>708</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf7791</pub-id><?supplied-pmid 27516603?><pub-id pub-id-type="pmid">27516603</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>E. J.</given-names></name><name><surname>Pritchard</surname><given-names>M.</given-names></name><name><surname>Lynch</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Holman</surname><given-names>K.</given-names></name><name><surname>Baker</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>1991</year>). <article-title>Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n</article-title>. <source>Science</source>
<volume>252</volume>, <fpage>1711</fpage>–<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1126/science.1675488</pub-id><?supplied-pmid 1675488?><pub-id pub-id-type="pmid">1675488</pub-id></mixed-citation>
      </ref>
      <ref id="B94">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krol</surname><given-names>J.</given-names></name><name><surname>Fiszer</surname><given-names>A.</given-names></name><name><surname>Mykowska</surname><given-names>A.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>de Mezer</surname><given-names>M.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets</article-title>. <source>Mol. Cell</source>
<volume>25</volume>, <fpage>575</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.01.031</pub-id><?supplied-pmid 17317629?><pub-id pub-id-type="pmid">17317629</pub-id></mixed-citation>
      </ref>
      <ref id="B95">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Parkesh</surname><given-names>R.</given-names></name><name><surname>Sznajder</surname><given-names>L. J.</given-names></name><name><surname>Childs-Disney</surname><given-names>J. L.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>Disney</surname><given-names>M. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts</article-title>. <source>ACS Chem. Biol.</source>
<volume>7</volume>, <fpage>496</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1021/cb200413a</pub-id><?supplied-pmid 22252896?><pub-id pub-id-type="pmid">22252896</pub-id></mixed-citation>
      </ref>
      <ref id="B96">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtzke</surname><given-names>J. F.</given-names></name></person-group> (<year>1982</year>). <article-title>Epidemiology of amyotrophic lateral sclerosis</article-title>. <source>Adv. Neurol.</source>
<volume>36</volume>, <fpage>281</fpage>–<lpage>302</lpage>. <?supplied-pmid 6983824?><pub-id pub-id-type="pmid">6983824</pub-id></mixed-citation>
      </ref>
      <ref id="B97">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladd</surname><given-names>P. D.</given-names></name><name><surname>Smith</surname><given-names>L. E.</given-names></name><name><surname>Rabaia</surname><given-names>N. A.</given-names></name><name><surname>Moore</surname><given-names>J. M.</given-names></name><name><surname>Georges</surname><given-names>S. A.</given-names></name><name><surname>Hansen</surname><given-names>R. S.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals</article-title>. <source>Hum. Mol. Genet.</source>
<volume>16</volume>, <fpage>3174</fpage>–<lpage>3187</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm293</pub-id><?supplied-pmid 17921506?><pub-id pub-id-type="pmid">17921506</pub-id></mixed-citation>
      </ref>
      <ref id="B98">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier-Tourenne</surname><given-names>C.</given-names></name><name><surname>Baughn</surname><given-names>M.</given-names></name><name><surname>Rigo</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>H. R.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>110</volume>, <fpage>E4530</fpage>–<lpage>4539</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1318835110</pub-id><?supplied-pmid 24170860?><pub-id pub-id-type="pmid">24170860</pub-id></mixed-citation>
      </ref>
      <ref id="B99">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Spada</surname><given-names>A. R.</given-names></name><name><surname>Wilson</surname><given-names>E. M.</given-names></name><name><surname>Lubahn</surname><given-names>D. B.</given-names></name><name><surname>Harding</surname><given-names>A. E.</given-names></name><name><surname>Fischbeck</surname><given-names>K. H.</given-names></name></person-group> (<year>1991</year>). <article-title>Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy</article-title>. <source>Nature</source>
<volume>352</volume>, <fpage>77</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1038/352077a0</pub-id><?supplied-pmid 2062380?><pub-id pub-id-type="pmid">2062380</pub-id></mixed-citation>
      </ref>
      <ref id="B100">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latouche</surname><given-names>M.</given-names></name><name><surname>Lasbleiz</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>E.</given-names></name><name><surname>Monnier</surname><given-names>V.</given-names></name><name><surname>Debeir</surname><given-names>T.</given-names></name><name><surname>Mouatt-Prigent</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes</article-title>. <source>J. Neurosci.</source>
<volume>27</volume>, <fpage>2483</fpage>–<lpage>2492</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5453-06.2007</pub-id><?supplied-pmid 17344386?><pub-id pub-id-type="pmid">17344386</pub-id></mixed-citation>
      </ref>
      <ref id="B101">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawlor</surname><given-names>K. T.</given-names></name><name><surname>O'Keefe</surname><given-names>L. V.</given-names></name><name><surname>Samaraweera</surname><given-names>S. E.</given-names></name><name><surname>van Eyk</surname><given-names>C. L.</given-names></name><name><surname>McLeod</surname><given-names>C. J.</given-names></name><name><surname>Maloney</surname><given-names>C. A.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases</article-title>. <source>Hum. Mol. Genet.</source>
<volume>20</volume>, <fpage>3757</fpage>–<lpage>3768</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr292</pub-id><?supplied-pmid 21724553?><pub-id pub-id-type="pmid">21724553</pub-id></mixed-citation>
      </ref>
      <ref id="B102">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Bogert</surname><given-names>B. A.</given-names></name><name><surname>Su</surname><given-names>K.</given-names></name><name><surname>Gao</surname><given-names>F. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1</article-title>. <source>Development</source>
<volume>130</volume>, <fpage>5543</fpage>–<lpage>5552</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00792</pub-id><?supplied-pmid 14530299?><pub-id pub-id-type="pmid">14530299</pub-id></mixed-citation>
      </ref>
      <ref id="B103">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K. H.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Mitrea</surname><given-names>D. M.</given-names></name><name><surname>Sarkar</surname><given-names>M.</given-names></name><name><surname>Freibaum</surname><given-names>B. D.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles</article-title>. <source>Cell</source>
<volume>167</volume>, <fpage>774</fpage>–<lpage>788</lpage>.e17. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id><?supplied-pmid 27768896?><pub-id pub-id-type="pmid">27768896</pub-id></mixed-citation>
      </ref>
      <ref id="B104">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W. C.</given-names></name><name><surname>Yoshihara</surname><given-names>M.</given-names></name><name><surname>Littleton</surname><given-names>J. T.</given-names></name></person-group> (<year>2004</year>). <article-title>Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>101</volume>, <fpage>3224</fpage>–<lpage>3229</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0400243101</pub-id><?supplied-pmid 14978262?><pub-id pub-id-type="pmid">14978262</pub-id></mixed-citation>
      </ref>
      <ref id="B105">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L. B.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Teng</surname><given-names>X.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2008</year>). <article-title>RNA toxicity is a component of ataxin-3 degeneration in Drosophila</article-title>. <source>Nature</source>
<volume>453</volume>, <fpage>1107</fpage>–<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1038/nature06909</pub-id><?supplied-pmid 18449188?><pub-id pub-id-type="pmid">18449188</pub-id></mixed-citation>
      </ref>
      <ref id="B106">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenboim</surname><given-names>L.</given-names></name><name><surname>Borner</surname><given-names>C.</given-names></name><name><surname>Stein</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Nuclear proteins acting on mitochondria</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1813</volume>, <fpage>584</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.11.016</pub-id><?supplied-pmid 21130123?><pub-id pub-id-type="pmid">21130123</pub-id></mixed-citation>
      </ref>
      <ref id="B107">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liquori</surname><given-names>C. L.</given-names></name><name><surname>Ricker</surname><given-names>K.</given-names></name><name><surname>Moseley</surname><given-names>M. L.</given-names></name><name><surname>Jacobsen</surname><given-names>J. F.</given-names></name><name><surname>Kress</surname><given-names>W.</given-names></name><name><surname>Naylor</surname><given-names>S. L.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9</article-title>. <source>Science</source>
<volume>293</volume>, <fpage>864</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1126/science.1062125</pub-id><?supplied-pmid 11486088?><pub-id pub-id-type="pmid">11486088</pub-id></mixed-citation>
      </ref>
      <ref id="B108">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luscombe</surname><given-names>N. M.</given-names></name><name><surname>Laskowski</surname><given-names>R. A.</given-names></name><name><surname>Thornton</surname><given-names>J. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level</article-title>. <source>Nucleic Acids Res.</source>
<volume>29</volume>, <fpage>2860</fpage>–<lpage>2874</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.13.2860</pub-id><?supplied-pmid 11433033?><pub-id pub-id-type="pmid">11433033</pub-id></mixed-citation>
      </ref>
      <ref id="B109">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>L. M.</given-names></name><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H. Y.</given-names></name><name><surname>Wong</surname><given-names>C. H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>A potent inhibitor of protein sequestration by expanded triplet (CUG) repeats that shows phenotypic improvements in a Drosophila model of myotonic dystrophy</article-title>. <source>ChemMedChem</source>
<volume>11</volume>, <fpage>1428</fpage>–<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201600081</pub-id><?supplied-pmid 27245480?><pub-id pub-id-type="pmid">27245480</pub-id></mixed-citation>
      </ref>
      <ref id="B110">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>M. E.</given-names></name><name><surname>Ambrose</surname><given-names>C. M.</given-names></name><name><surname>Duyao</surname><given-names>M. P.</given-names></name><name><surname>Myers</surname><given-names>R. H.</given-names></name><name><surname>Lin</surname><given-names>C.</given-names></name><name><surname>Srinidhi</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group</article-title>. <source>Cell</source>
<volume>72</volume>, <fpage>971</fpage>–<lpage>983</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90585-e</pub-id><?supplied-pmid 8458085?><pub-id pub-id-type="pmid">8458085</pub-id></mixed-citation>
      </ref>
      <ref id="B111">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahadevan</surname><given-names>M.</given-names></name><name><surname>Tsilfidis</surname><given-names>C.</given-names></name><name><surname>Sabourin</surname><given-names>L.</given-names></name><name><surname>Shutler</surname><given-names>G.</given-names></name><name><surname>Amemiya</surname><given-names>C.</given-names></name><name><surname>Jansen</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>1992</year>). <article-title>Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene</article-title>. <source>Science</source>
<volume>255</volume>, <fpage>1253</fpage>–<lpage>1255</lpage>. <pub-id pub-id-type="doi">10.1126/science.1546325</pub-id><?supplied-pmid 1546325?><pub-id pub-id-type="pmid">1546325</pub-id></mixed-citation>
      </ref>
      <ref id="B112">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majounie</surname><given-names>E.</given-names></name><name><surname>Renton</surname><given-names>A. E.</given-names></name><name><surname>Mok</surname><given-names>K.</given-names></name><name><surname>Dopper</surname><given-names>E. G.</given-names></name><name><surname>Waite</surname><given-names>A.</given-names></name><name><surname>Rollinson</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study</article-title>. <source>Lancet Neurol.</source>
<volume>11</volume>, <fpage>323</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70043-1</pub-id><?supplied-pmid 22406228?><pub-id pub-id-type="pmid">22406228</pub-id></mixed-citation>
      </ref>
      <ref id="B113">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mankodi</surname><given-names>A.</given-names></name><name><surname>Logigian</surname><given-names>E.</given-names></name><name><surname>Callahan</surname><given-names>L.</given-names></name><name><surname>McClain</surname><given-names>C.</given-names></name><name><surname>White</surname><given-names>R.</given-names></name><name><surname>Henderson</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat</article-title>. <source>Science</source>
<volume>289</volume>, <fpage>1769</fpage>–<lpage>1773</lpage>. <pub-id pub-id-type="doi">10.1126/science.289.5485.1769</pub-id><?supplied-pmid 10976074?><pub-id pub-id-type="pmid">10976074</pub-id></mixed-citation>
      </ref>
      <ref id="B114">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>J. L.</given-names></name><name><surname>Thompson</surname><given-names>L. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Drosophila in the study of neurodegenerative disease</article-title>. <source>Neuron</source>
<volume>52</volume>, <fpage>169</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.025</pub-id><?supplied-pmid 17015234?><pub-id pub-id-type="pmid">17015234</pub-id></mixed-citation>
      </ref>
      <ref id="B115">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J. P.</given-names></name><name><surname>Bell</surname><given-names>J.</given-names></name></person-group> (<year>1943</year>). <article-title>A pedigree of mental defect showing sex-linkage</article-title>. <source>J. Neurol. Psychiatry</source>
<volume>6</volume>, <fpage>154</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.6.3-4.154</pub-id><?supplied-pmid 21611430?><pub-id pub-id-type="pmid">21611430</pub-id></mixed-citation>
      </ref>
      <ref id="B116">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGurk</surname><given-names>L.</given-names></name><name><surname>Berson</surname><given-names>A.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Drosophila as an <italic>in vivo</italic> model for human neurodegenerative disease</article-title>. <source>Genetics</source>
<volume>201</volume>, <fpage>377</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.179457</pub-id><?supplied-pmid 26447127?><pub-id pub-id-type="pmid">26447127</pub-id></mixed-citation>
      </ref>
      <ref id="B117">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercy</surname><given-names>L.</given-names></name><name><surname>Hodges</surname><given-names>J. R.</given-names></name><name><surname>Dawson</surname><given-names>K.</given-names></name><name><surname>Barker</surname><given-names>R. A.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Incidence of early-onset dementias in Cambridgeshire, United Kingdom</article-title>. <source>Neurology</source>
<volume>71</volume>, <fpage>1496</fpage>–<lpage>1499</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000334277.16896.fa</pub-id><?supplied-pmid 18981371?><pub-id pub-id-type="pmid">18981371</pub-id></mixed-citation>
      </ref>
      <ref id="B118">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millburn</surname><given-names>G. H.</given-names></name><name><surname>Crosby</surname><given-names>M. A.</given-names></name><name><surname>Gramates</surname><given-names>L. S.</given-names></name><name><surname>Tweedie</surname><given-names>S.</given-names></name><name><surname>FlyBase</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>FlyBase portals to human disease research using Drosophila models</article-title>. <source>Dis. Model. Mech.</source>
<volume>9</volume>, <fpage>245</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.023317</pub-id><?supplied-pmid 26935103?><pub-id pub-id-type="pmid">26935103</pub-id></mixed-citation>
      </ref>
      <ref id="B119">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millecamps</surname><given-names>S.</given-names></name><name><surname>Julien</surname><given-names>J. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Axonal transport deficits and neurodegenerative diseases</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>14</volume>, <fpage>161</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3380</pub-id><?supplied-pmid 23361386?><pub-id pub-id-type="pmid">23361386</pub-id></mixed-citation>
      </ref>
      <ref id="B120">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J. W.</given-names></name><name><surname>Urbinati</surname><given-names>C. R.</given-names></name><name><surname>Teng-Umnuay</surname><given-names>P.</given-names></name><name><surname>Stenberg</surname><given-names>M. G.</given-names></name><name><surname>Byrne</surname><given-names>B. J.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy</article-title>. <source>EMBO J.</source>
<volume>19</volume>, <fpage>4439</fpage>–<lpage>4448</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.17.4439</pub-id><?supplied-pmid 10970838?><pub-id pub-id-type="pmid">10970838</pub-id></mixed-citation>
      </ref>
      <ref id="B121">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minnerop</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>B.</given-names></name><name><surname>Schoene-Bake</surname><given-names>J. C.</given-names></name><name><surname>Roeske</surname><given-names>S.</given-names></name><name><surname>Mirbach</surname><given-names>S.</given-names></name><name><surname>Anspach</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease</article-title>. <source>Brain</source>
<volume>134</volume>(<issue>Pt 12</issue>), <fpage>3530</fpage>–<lpage>3546</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awr299</pub-id><?supplied-pmid 22131273?><pub-id pub-id-type="pmid">22131273</pub-id></mixed-citation>
      </ref>
      <ref id="B122">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirkin</surname><given-names>S. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Expandable DNA repeats and human disease</article-title>. <source>Nature</source>
<volume>447</volume>, <fpage>932</fpage>–<lpage>940</lpage>. <pub-id pub-id-type="doi">10.1038/nature05977</pub-id><?supplied-pmid 17581576?><pub-id pub-id-type="pmid">17581576</pub-id></mixed-citation>
      </ref>
      <ref id="B123">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J. B.</given-names></name><name><surname>Thornton</surname><given-names>J. M.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Price</surname><given-names>S. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Towards an understanding of the arginine-aspartate interaction</article-title>. <source>J. Mol. Biol.</source>
<volume>226</volume>, <fpage>251</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(92)90137-9</pub-id><?supplied-pmid 1619654?><pub-id pub-id-type="pmid">1619654</pub-id></mixed-citation>
      </ref>
      <ref id="B124">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname><given-names>S.</given-names></name><name><surname>Gronke</surname><given-names>S.</given-names></name><name><surname>Niccoli</surname><given-names>T.</given-names></name><name><surname>Ridler</surname><given-names>C. E.</given-names></name><name><surname>Clayton</surname><given-names>E. L.</given-names></name><name><surname>Devoy</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins</article-title>. <source>Science</source>
<volume>345</volume>, <fpage>1192</fpage>–<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1126/science.1256800</pub-id><?supplied-pmid 25103406?><pub-id pub-id-type="pmid">25103406</pub-id></mixed-citation>
      </ref>
      <ref id="B125">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montermini</surname><given-names>L.</given-names></name><name><surname>Andermann</surname><given-names>E.</given-names></name><name><surname>Labuda</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>A.</given-names></name><name><surname>Pandolfo</surname><given-names>M.</given-names></name><name><surname>Cavalcanti</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>1997</year>). <article-title>The Friedreich ataxia GAA triplet repeat: premutation and normal alleles</article-title>. <source>Hum. Mol. Genet.</source>
<volume>6</volume>, <fpage>1261</fpage>–<lpage>1266</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/6.8.1261</pub-id><?supplied-pmid 9259271?><pub-id pub-id-type="pmid">9259271</pub-id></mixed-citation>
      </ref>
      <ref id="B126">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J.</given-names></name><name><surname>Hiesinger</surname><given-names>P. R.</given-names></name><name><surname>Schroeder</surname><given-names>A. J.</given-names></name><name><surname>Kume</surname><given-names>K.</given-names></name><name><surname>Verstreken</surname><given-names>P.</given-names></name><name><surname>Jackson</surname><given-names>F. R.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain</article-title>. <source>Neuron</source>
<volume>34</volume>, <fpage>961</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00731-6</pub-id><?supplied-pmid 12086643?><pub-id pub-id-type="pmid">12086643</pub-id></mixed-citation>
      </ref>
      <ref id="B127">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname><given-names>M. L.</given-names></name><name><surname>Zu</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Mosemiller</surname><given-names>A. K.</given-names></name><name><surname>Daughters</surname><given-names>R. S.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8</article-title>. <source>Nat. Genet.</source>
<volume>38</volume>, <fpage>758</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1038/ng1827</pub-id><?supplied-pmid 16804541?><pub-id pub-id-type="pmid">16804541</pub-id></mixed-citation>
      </ref>
      <ref id="B128">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulders</surname><given-names>S. A.</given-names></name><name><surname>van den Broek</surname><given-names>W. J.</given-names></name><name><surname>Wheeler</surname><given-names>T. M.</given-names></name><name><surname>Croes</surname><given-names>H. J.</given-names></name><name><surname>van Kuik-Romeijn</surname><given-names>P.</given-names></name><name><surname>de Kimpe</surname><given-names>S. J.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>106</volume>, <fpage>13915</fpage>–<lpage>13920</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0905780106</pub-id><?supplied-pmid 19667189?><pub-id pub-id-type="pmid">19667189</pub-id></mixed-citation>
      </ref>
      <ref id="B129">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muqit</surname><given-names>M. M.</given-names></name><name><surname>Feany</surname><given-names>M. B.</given-names></name></person-group> (<year>2002</year>). <article-title>Modelling neurodegenerative diseases in Drosophila: a fruitful approach?</article-title>
<source>Nat. Rev. Neurosci.</source>
<volume>3</volume>, <fpage>237</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1038/nrn751</pub-id><?supplied-pmid 11994755?><pub-id pub-id-type="pmid">11994755</pub-id></mixed-citation>
      </ref>
      <ref id="B130">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutsuddi</surname><given-names>M.</given-names></name><name><surname>Marshall</surname><given-names>C. M.</given-names></name><name><surname>Benzow</surname><given-names>K. A.</given-names></name><name><surname>Koob</surname><given-names>M. D.</given-names></name><name><surname>Rebay</surname><given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila</article-title>. <source>Curr. Biol.</source>
<volume>14</volume>, <fpage>302</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.01.034</pub-id><?supplied-pmid 14972680?><pub-id pub-id-type="pmid">14972680</pub-id></mixed-citation>
      </ref>
      <ref id="B131">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mykowska</surname><given-names>A.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>Wojciechowska</surname><given-names>M.</given-names></name><name><surname>Kozlowski</surname><given-names>P.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W. J.</given-names></name></person-group> (<year>2011</year>). <article-title>CAG repeats mimic CUG repeats in the misregulation of alternative splicing</article-title>. <source>Nucleic Acids Res.</source>
<volume>39</volume>, <fpage>8938</fpage>–<lpage>8951</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr608</pub-id><?supplied-pmid 21795378?><pub-id pub-id-type="pmid">21795378</pub-id></mixed-citation>
      </ref>
      <ref id="B132">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Jeong</surname><given-names>S. Y.</given-names></name><name><surname>Uchihara</surname><given-names>T.</given-names></name><name><surname>Anno</surname><given-names>M.</given-names></name><name><surname>Nagashima</surname><given-names>K.</given-names></name><name><surname>Nagashima</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein</article-title>. <source>Hum. Mol. Genet.</source>
<volume>10</volume>, <fpage>1441</fpage>–<lpage>1448</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.14.1441</pub-id><?supplied-pmid 11448935?><pub-id pub-id-type="pmid">11448935</pub-id></mixed-citation>
      </ref>
      <ref id="B133">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalavade</surname><given-names>R.</given-names></name><name><surname>Griesche</surname><given-names>N.</given-names></name><name><surname>Ryan</surname><given-names>D. P.</given-names></name><name><surname>Hildebrand</surname><given-names>S.</given-names></name><name><surname>Krauss</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms of RNA-induced toxicity in CAG repeat disorders</article-title>. <source>Cell Death Dis.</source>
<volume>4</volume>, <fpage>e752</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2013.276</pub-id><?supplied-pmid 23907466?><pub-id pub-id-type="pmid">23907466</pub-id></mixed-citation>
      </ref>
      <ref id="B134">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napoletano</surname><given-names>F.</given-names></name><name><surname>Occhi</surname><given-names>S.</given-names></name><name><surname>Calamita</surname><given-names>P.</given-names></name><name><surname>Volpi</surname><given-names>V.</given-names></name><name><surname>Blanc</surname><given-names>E.</given-names></name><name><surname>Charroux</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Polyglutamine Atrophin provokes neurodegeneration in Drosophila by repressing fat</article-title>. <source>EMBO J.</source>
<volume>30</volume>, <fpage>945</fpage>–<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.1</pub-id><?supplied-pmid 21278706?><pub-id pub-id-type="pmid">21278706</pub-id></mixed-citation>
      </ref>
      <ref id="B135">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedelsky</surname><given-names>N. B.</given-names></name><name><surname>Pennuto</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>R. B.</given-names></name><name><surname>Palazzolo</surname><given-names>I.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>Z.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy</article-title>. <source>Neuron</source>
<volume>67</volume>, <fpage>936</fpage>–<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.08.034</pub-id><?supplied-pmid 20869592?><pub-id pub-id-type="pmid">20869592</pub-id></mixed-citation>
      </ref>
      <ref id="B136">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Luu</surname><given-names>L. M.</given-names></name><name><surname>Peng</surname><given-names>S.</given-names></name><name><surname>Serrano</surname><given-names>J. F.</given-names></name><name><surname>Chan</surname><given-names>H. Y.</given-names></name><name><surname>Zimmerman</surname><given-names>S. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>137</volume>, <fpage>14180</fpage>–<lpage>14189</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b09266</pub-id><?supplied-pmid 26473464?><pub-id pub-id-type="pmid">26473464</pub-id></mixed-citation>
      </ref>
      <ref id="B137">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisoli</surname><given-names>I.</given-names></name><name><surname>Chauvin</surname><given-names>J. P.</given-names></name><name><surname>Napoletano</surname><given-names>F.</given-names></name><name><surname>Calamita</surname><given-names>P.</given-names></name><name><surname>Zanin</surname><given-names>V.</given-names></name><name><surname>Fanto</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy</article-title>. <source>Cell Death Differ.</source>
<volume>17</volume>, <fpage>1577</fpage>–<lpage>1587</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2010.31</pub-id><?supplied-pmid 20339376?><pub-id pub-id-type="pmid">20339376</pub-id></mixed-citation>
      </ref>
      <ref id="B138">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hare</surname><given-names>K.</given-names></name><name><surname>Rubin</surname><given-names>G. M.</given-names></name></person-group> (<year>1983</year>). <article-title>Structures of P transposable elements and their sites of insertion and excision in the <italic>Drosophila melanogaster</italic> genome</article-title>. <source>Cell</source>
<volume>34</volume>, <fpage>25</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(83)90133-2</pub-id><?supplied-pmid 6309410?><pub-id pub-id-type="pmid">6309410</pub-id></mixed-citation>
      </ref>
      <ref id="B139">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>S. Y.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Krans</surname><given-names>A.</given-names></name><name><surname>Frazer</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>J. P.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome</article-title>. <source>Hum. Mol. Genet.</source>
<volume>24</volume>, <fpage>4317</fpage>–<lpage>4326</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv165</pub-id><?supplied-pmid 25954027?><pub-id pub-id-type="pmid">25954027</pub-id></mixed-citation>
      </ref>
      <ref id="B140">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>H. T.</given-names></name><name><surname>Chung</surname><given-names>M. Y.</given-names></name><name><surname>Banfi</surname><given-names>S.</given-names></name><name><surname>Kwiatkowski</surname><given-names>T. J.</given-names><suffix>Jr.</suffix></name><name><surname>Servadio</surname><given-names>A.</given-names></name><name><surname>Beaudet</surname><given-names>A. L.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1</article-title>. <source>Nat. Genet.</source>
<volume>4</volume>, <fpage>221</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/ng0793-221</pub-id><?supplied-pmid 8358429?><pub-id pub-id-type="pmid">8358429</pub-id></mixed-citation>
      </ref>
      <ref id="B141">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panaite</surname><given-names>P. A.</given-names></name><name><surname>Kuntzer</surname><given-names>T.</given-names></name><name><surname>Gourdon</surname><given-names>G.</given-names></name><name><surname>Lobrinus</surname><given-names>J. A.</given-names></name><name><surname>Barakat-Walter</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy</article-title>. <source>Dis. Model. Mech.</source>
<volume>6</volume>, <fpage>622</fpage>–<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.010512</pub-id><?supplied-pmid 23180777?><pub-id pub-id-type="pmid">23180777</pub-id></mixed-citation>
      </ref>
      <ref id="B142">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>U. B.</given-names></name><name><surname>Nichols</surname><given-names>C. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Human disease models in <italic>Drosophila melanogaster</italic> and the role of the fly in therapeutic drug discovery</article-title>. <source>Pharmacol. Rev.</source>
<volume>63</volume>, <fpage>411</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1124/pr.110.003293</pub-id><?supplied-pmid 21415126?><pub-id pub-id-type="pmid">21415126</pub-id></mixed-citation>
      </ref>
      <ref id="B143">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>U. B.</given-names></name><name><surname>Nie</surname><given-names>Z.</given-names></name><name><surname>Batlevi</surname><given-names>Y.</given-names></name><name><surname>McCray</surname><given-names>B. A.</given-names></name><name><surname>Ritson</surname><given-names>G. P.</given-names></name><name><surname>Nedelsky</surname><given-names>N. B.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS</article-title>. <source>Nature</source>
<volume>447</volume>, <fpage>859</fpage>–<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1038/nature05853</pub-id><?supplied-pmid 17568747?><pub-id pub-id-type="pmid">17568747</pub-id></mixed-citation>
      </ref>
      <ref id="B144">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkesh</surname><given-names>R.</given-names></name><name><surname>Childs-Disney</surname><given-names>J. L.</given-names></name><name><surname>Nakamori</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>134</volume>, <fpage>4731</fpage>–<lpage>4742</lpage>. <pub-id pub-id-type="doi">10.1021/ja210088v</pub-id><?supplied-pmid 22300544?><pub-id pub-id-type="pmid">22300544</pub-id></mixed-citation>
      </ref>
      <ref id="B145">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>C. E.</given-names></name><name><surname>Nichol Edamura</surname><given-names>K.</given-names></name><name><surname>Cleary</surname><given-names>J. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Repeat instability: mechanisms of dynamic mutations</article-title>. <source>Nat. Rev. Genet.</source>
<volume>6</volume>, <fpage>729</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1689</pub-id><?supplied-pmid 16205713?><pub-id pub-id-type="pmid">16205713</pub-id></mixed-citation>
      </ref>
      <ref id="B146">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>D. C.</given-names></name><name><surname>Miller</surname><given-names>B. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Frontotemporal dementia</article-title>. <source>Semin. Neurol.</source>
<volume>33</volume>, <fpage>336</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1055/s-0033-1359316</pub-id><?supplied-pmid 24234354?><pub-id pub-id-type="pmid">24234354</pub-id></mixed-citation>
      </ref>
      <ref id="B147">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrucelli</surname><given-names>L.</given-names></name><name><surname>O'Farrell</surname><given-names>C.</given-names></name><name><surname>Lockhart</surname><given-names>P. J.</given-names></name><name><surname>Baptista</surname><given-names>M.</given-names></name><name><surname>Kehoe</surname><given-names>K.</given-names></name><name><surname>Vink</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons</article-title>. <source>Neuron</source>
<volume>36</volume>, <fpage>1007</fpage>–<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)01125-X</pub-id><?supplied-pmid 12495618?><pub-id pub-id-type="pmid">12495618</pub-id></mixed-citation>
      </ref>
      <ref id="B148">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philips</surname><given-names>A. V.</given-names></name><name><surname>Timchenko</surname><given-names>L. T.</given-names></name><name><surname>Cooper</surname><given-names>T. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy</article-title>. <source>Science</source>
<volume>280</volume>, <fpage>737</fpage>–<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1126/science.280.5364.737</pub-id><?supplied-pmid 9563950?><pub-id pub-id-type="pmid">9563950</pub-id></mixed-citation>
      </ref>
      <ref id="B149">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picchio</surname><given-names>L.</given-names></name><name><surname>Plantie</surname><given-names>E.</given-names></name><name><surname>Renaud</surname><given-names>Y.</given-names></name><name><surname>Poovthumkadavil</surname><given-names>P.</given-names></name><name><surname>Jagla</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Novel Drosophila model of myotonic dystrophy type 1: phenotypic characterization and genome-wide view of altered gene expression</article-title>. <source>Hum. Mol. Genet.</source>
<volume>22</volume>, <fpage>2795</fpage>–<lpage>2810</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt127</pub-id><?supplied-pmid 23525904?><pub-id pub-id-type="pmid">23525904</pub-id></mixed-citation>
      </ref>
      <ref id="B150">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polak</surname><given-names>U.</given-names></name><name><surname>McIvor</surname><given-names>E.</given-names></name><name><surname>Dent</surname><given-names>S. Y.</given-names></name><name><surname>Wells</surname><given-names>R. D.</given-names></name><name><surname>Napierala</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Expanded complexity of unstable repeat diseases</article-title>. <source>Biofactors</source>
<volume>39</volume>, <fpage>164</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1060</pub-id><?supplied-pmid 23233240?><pub-id pub-id-type="pmid">23233240</pub-id></mixed-citation>
      </ref>
      <ref id="B151">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prelich</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Gene overexpression: uses, mechanisms, and interpretation</article-title>. <source>Genetics</source>
<volume>190</volume>, <fpage>841</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.111.136911</pub-id><?supplied-pmid 22419077?><pub-id pub-id-type="pmid">22419077</pub-id></mixed-citation>
      </ref>
      <ref id="B152">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulst</surname><given-names>S. M.</given-names></name><name><surname>Nechiporuk</surname><given-names>A.</given-names></name><name><surname>Nechiporuk</surname><given-names>T.</given-names></name><name><surname>Gispert</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>X. N.</given-names></name><name><surname>Lopes-Cendes</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2</article-title>. <source>Nat. Genet.</source>
<volume>14</volume>, <fpage>269</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1038/ng1196-269</pub-id><?supplied-pmid 8896555?><pub-id pub-id-type="pmid">8896555</pub-id></mixed-citation>
      </ref>
      <ref id="B153">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pushechnikov</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>M. M.</given-names></name><name><surname>Childs-Disney</surname><given-names>J. L.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>French</surname><given-names>J. M.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>131</volume>, <fpage>9767</fpage>–<lpage>9779</lpage>. <pub-id pub-id-type="doi">10.1021/ja9020149</pub-id><?supplied-pmid 19552411?><pub-id pub-id-type="pmid">19552411</pub-id></mixed-citation>
      </ref>
      <ref id="B154">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>L.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Schlechtingen</surname><given-names>G.</given-names></name><name><surname>Weidlich</surname><given-names>S.</given-names></name><name><surname>Ries</surname><given-names>J.</given-names></name><name><surname>Braxmeier</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting</article-title>. <source>Science</source>
<volume>320</volume>, <fpage>520</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1126/science.1156609</pub-id><?supplied-pmid 18436784?><pub-id pub-id-type="pmid">18436784</pub-id></mixed-citation>
      </ref>
      <ref id="B155">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K.</given-names></name><name><surname>Zamiri</surname><given-names>B.</given-names></name><name><surname>Stanley</surname><given-names>S. Y.</given-names></name><name><surname>Macgregor</surname><given-names>R. B.</given-names><suffix>Jr.</suffix></name><name><surname>Pearson</surname><given-names>C. E.</given-names></name></person-group> (<year>2013</year>). <article-title>The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures</article-title>. <source>J. Biol. Chem.</source>
<volume>288</volume>, <fpage>9860</fpage>–<lpage>9866</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C113.452532</pub-id><?supplied-pmid 23423380?><pub-id pub-id-type="pmid">23423380</pub-id></mixed-citation>
      </ref>
      <ref id="B156">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>D. B.</given-names></name><name><surname>Rich</surname><given-names>M. M.</given-names></name><name><surname>Leferovich</surname><given-names>J. M.</given-names></name><name><surname>Reilly</surname><given-names>P.</given-names></name><name><surname>Davis</surname><given-names>B. M.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy</article-title>. <source>Nat. Genet.</source>
<volume>13</volume>, <fpage>325</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1038/ng0796-325</pub-id><?supplied-pmid 8673132?><pub-id pub-id-type="pmid">8673132</pub-id></mixed-citation>
      </ref>
      <ref id="B157">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Potocki</surname><given-names>L.</given-names></name><name><surname>Chien</surname><given-names>S.</given-names></name><name><surname>Gribskov</surname><given-names>M.</given-names></name><name><surname>Bier</surname><given-names>E.</given-names></name></person-group> (<year>2001</year>). <article-title>A systematic analysis of human disease-associated gene sequences in <italic>Drosophila melanogaster</italic></article-title>. <source>Genome Res.</source>
<volume>11</volume>, <fpage>1114</fpage>–<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.1101/gr.169101</pub-id><?supplied-pmid 11381037?><pub-id pub-id-type="pmid">11381037</pub-id></mixed-citation>
      </ref>
      <ref id="B158">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Jegga</surname><given-names>A. G.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Gordon</surname><given-names>C. B.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome</article-title>. <source>Hum. Mol. Genet.</source>
<volume>20</volume>, <fpage>3424</fpage>–<lpage>3436</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr251</pub-id><?supplied-pmid 21653638?><pub-id pub-id-type="pmid">21653638</pub-id></mixed-citation>
      </ref>
      <ref id="B159">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renoux</surname><given-names>A. J.</given-names></name><name><surname>Todd</surname><given-names>P. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurodegeneration the RNA way</article-title>. <source>Prog. Neurobiol.</source>
<volume>97</volume>, <fpage>173</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.10.006</pub-id><?supplied-pmid 22079416?><pub-id pub-id-type="pmid">22079416</pub-id></mixed-citation>
      </ref>
      <ref id="B160">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname><given-names>A. E.</given-names></name><name><surname>Majounie</surname><given-names>E.</given-names></name><name><surname>Waite</surname><given-names>A.</given-names></name><name><surname>Simón-Sánchez</surname><given-names>J.</given-names></name><name><surname>Rollinson</surname><given-names>S.</given-names></name><name><surname>Gibbs</surname><given-names>J. R.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title>. <source>Neuron</source>
<volume>72</volume>, <fpage>257</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id><?supplied-pmid 21944779?><pub-id pub-id-type="pmid">21944779</pub-id></mixed-citation>
      </ref>
      <ref id="B161">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riboldi</surname><given-names>G.</given-names></name><name><surname>Zanetta</surname><given-names>C.</given-names></name><name><surname>Ranieri</surname><given-names>M.</given-names></name><name><surname>Nizzardo</surname><given-names>M.</given-names></name><name><surname>Simone</surname><given-names>C.</given-names></name><name><surname>Magri</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases</article-title>. <source>Mol. Neurobiol.</source>
<volume>50</volume>, <fpage>721</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8724-7</pub-id><?supplied-pmid 24809691?><pub-id pub-id-type="pmid">24809691</pub-id></mixed-citation>
      </ref>
      <ref id="B162">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>E.</given-names></name><name><surname>Cha</surname><given-names>G. H.</given-names></name><name><surname>Verstreken</surname><given-names>P.</given-names></name><name><surname>Ly</surname><given-names>C. V.</given-names></name><name><surname>Hughes</surname><given-names>R. E.</given-names></name><name><surname>Bellen</surname><given-names>H. J.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm</article-title>. <source>Neuron</source>
<volume>57</volume>, <fpage>27</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.11.025</pub-id><?supplied-pmid 18184562?><pub-id pub-id-type="pmid">18184562</pub-id></mixed-citation>
      </ref>
      <ref id="B163">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C. A.</given-names></name><name><surname>Poirier</surname><given-names>M. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Opinion: what is the role of protein aggregation in neurodegeneration?</article-title>
<source>Nat. Rev. Mol. Cell Biol.</source>
<volume>6</volume>, <fpage>891</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1742</pub-id><?supplied-pmid 16167052?><pub-id pub-id-type="pmid">16167052</pub-id></mixed-citation>
      </ref>
      <ref id="B164">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rüb</surname><given-names>U.</given-names></name><name><surname>Schöls</surname><given-names>L.</given-names></name><name><surname>Paulson</surname><given-names>H.</given-names></name><name><surname>Auburger</surname><given-names>G.</given-names></name><name><surname>Kermer</surname><given-names>P.</given-names></name><name><surname>Jen</surname><given-names>J. C.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7</article-title>. <source>Prog. Neurobiol.</source>
<volume>104</volume>, <fpage>38</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.01.001</pub-id><?supplied-pmid 23438480?><pub-id pub-id-type="pmid">23438480</pub-id></mixed-citation>
      </ref>
      <ref id="B165">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>G. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Biological annotation of the Drosophila genome sequence</article-title>. <source>Novartis Found Symp.</source>
<volume>229</volume>, <fpage>79</fpage>–<lpage>82</lpage>. discussion: 82–73. <?supplied-pmid 11084932?><pub-id pub-id-type="pmid">11084932</pub-id></mixed-citation>
      </ref>
      <ref id="B166">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>G. M.</given-names></name><name><surname>Spradling</surname><given-names>A. C.</given-names></name></person-group> (<year>1982</year>). <article-title>Genetic transformation of Drosophila with transposable element vectors</article-title>. <source>Science</source>
<volume>218</volume>, <fpage>348</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1126/science.6289436</pub-id><?supplied-pmid 6289436?><pub-id pub-id-type="pmid">6289436</pub-id></mixed-citation>
      </ref>
      <ref id="B167">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rzuczek</surname><given-names>S. G.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>Z. Z.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Kodadek</surname><given-names>T.</given-names></name><name><surname>Disney</surname><given-names>M. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Features of modularly assembled compounds that impart bioactivity against an RNA target</article-title>. <source>ACS Chem. Biol.</source>
<volume>8</volume>, <fpage>2312</fpage>–<lpage>2321</lpage>. <pub-id pub-id-type="doi">10.1021/cb400265y</pub-id><?supplied-pmid 24032410?><pub-id pub-id-type="pmid">24032410</pub-id></mixed-citation>
      </ref>
      <ref id="B168">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>T. K.</given-names></name><name><surname>Jackson</surname><given-names>G. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Drosophila models of neurodegenerative disease</article-title>. <source>NeuroRx</source>
<volume>2</volume>, <fpage>438</fpage>–<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1602/neurorx.2.3.438</pub-id><?supplied-pmid 16389307?><pub-id pub-id-type="pmid">16389307</pub-id></mixed-citation>
      </ref>
      <ref id="B169">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanpei</surname><given-names>K.</given-names></name><name><surname>Takano</surname><given-names>H.</given-names></name><name><surname>Igarashi</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Oyake</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT</article-title>. <source>Nat. Genet.</source>
<volume>14</volume>, <fpage>277</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/ng1196-277</pub-id><?supplied-pmid 8896556?><pub-id pub-id-type="pmid">8896556</pub-id></mixed-citation>
      </ref>
      <ref id="B170">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>M. R.</given-names></name><name><surname>Bray</surname><given-names>S. M.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective</article-title>. <source>Annu. Rev. Pathol.</source>
<volume>7</volume>, <fpage>219</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id><?supplied-pmid 22017584?><pub-id pub-id-type="pmid">22017584</pub-id></mixed-citation>
      </ref>
      <ref id="B171">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sareen</surname><given-names>D.</given-names></name><name><surname>O'Rourke</surname><given-names>J. G.</given-names></name><name><surname>Meera</surname><given-names>P.</given-names></name><name><surname>Muhammad</surname><given-names>A. K.</given-names></name><name><surname>Grant</surname><given-names>S.</given-names></name><name><surname>Simpkinson</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion</article-title>. <source>Sci. Transl. Med.</source>
<volume>5</volume>, <fpage>208r</fpage>a149. <pub-id pub-id-type="doi">10.1126/scitranslmed.3007529</pub-id><?supplied-pmid 24154603?><pub-id pub-id-type="pmid">24154603</pub-id></mixed-citation>
      </ref>
      <ref id="B172">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R. P.</given-names></name><name><surname>Chopra</surname><given-names>V. L.</given-names></name></person-group> (<year>1976</year>). <article-title>Effect of the Wingless (wg1) mutation on wing and haltere development in <italic>Drosophila melanogaster</italic></article-title>. <source>Dev. Biol.</source>
<volume>48</volume>, <fpage>461</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(76)90108-1</pub-id><?supplied-pmid 815114?><pub-id pub-id-type="pmid">815114</pub-id></mixed-citation>
      </ref>
      <ref id="B173">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shieh</surname><given-names>S. Y.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila</article-title>. <source>Hum. Mol. Genet.</source>
<volume>20</volume>, <fpage>4810</fpage>–<lpage>4821</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr420</pub-id><?supplied-pmid 21933837?><pub-id pub-id-type="pmid">21933837</pub-id></mixed-citation>
      </ref>
      <ref id="B174">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sisodia</surname><given-names>S. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?</article-title>
<source>Cell</source>
<volume>95</volume>, <fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81743-2</pub-id><?supplied-pmid 9778239?><pub-id pub-id-type="pmid">9778239</pub-id></mixed-citation>
      </ref>
      <ref id="B175">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>de Mezer</surname><given-names>M.</given-names></name><name><surname>Michlewski</surname><given-names>G.</given-names></name><name><surname>Krol</surname><given-names>J.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W. J.</given-names></name></person-group> (<year>2003</year>). <article-title>RNA structure of trinucleotide repeats associated with human neurological diseases</article-title>. <source>Nucleic Acids Res.</source>
<volume>31</volume>, <fpage>5469</fpage>–<lpage>5482</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg766</pub-id><?supplied-pmid 14500809?><pub-id pub-id-type="pmid">14500809</pub-id></mixed-citation>
      </ref>
      <ref id="B176">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>Michlewski</surname><given-names>G.</given-names></name><name><surname>de Mezer</surname><given-names>M.</given-names></name><name><surname>Kierzek</surname><given-names>E.</given-names></name><name><surname>Krol</surname><given-names>J.</given-names></name><name><surname>Olejniczak</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Structural diversity of triplet repeat RNAs</article-title>. <source>J. Biol. Chem.</source>
<volume>285</volume>, <fpage>12755</fpage>–<lpage>12764</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.078790</pub-id><?supplied-pmid 20159983?><pub-id pub-id-type="pmid">20159983</pub-id></mixed-citation>
      </ref>
      <ref id="B177">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofola</surname><given-names>O. A.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Duan</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>de Haro</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS</article-title>. <source>Neuron</source>
<volume>55</volume>, <fpage>565</fpage>–<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.021</pub-id><?supplied-pmid 17698010?><pub-id pub-id-type="pmid">17698010</pub-id></mixed-citation>
      </ref>
      <ref id="B178">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sopher</surname><given-names>B. L.</given-names></name><name><surname>Ladd</surname><given-names>P. D.</given-names></name><name><surname>Pineda</surname><given-names>V. V.</given-names></name><name><surname>Libby</surname><given-names>R. T.</given-names></name><name><surname>Sunkin</surname><given-names>S. M.</given-names></name><name><surname>Hurley</surname><given-names>J. B.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA</article-title>. <source>Neuron</source>
<volume>70</volume>, <fpage>1071</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.027</pub-id><?supplied-pmid 21689595?><pub-id pub-id-type="pmid">21689595</pub-id></mixed-citation>
      </ref>
      <ref id="B179">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spindler</surname><given-names>S. R.</given-names></name><name><surname>Hartenstein</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>The Drosophila neural lineages: a model system to study brain development and circuitry</article-title>. <source>Dev. Genes Evol.</source>
<volume>220</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/s00427-010-0323-7</pub-id><?supplied-pmid 20306203?><pub-id pub-id-type="pmid">20306203</pub-id></mixed-citation>
      </ref>
      <ref id="B180">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spradling</surname><given-names>A. C.</given-names></name><name><surname>Stern</surname><given-names>D.</given-names></name><name><surname>Beaton</surname><given-names>A.</given-names></name><name><surname>Rhem</surname><given-names>E. J.</given-names></name><name><surname>Laverty</surname><given-names>T.</given-names></name><name><surname>Mozden</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>The Berkeley Drosophila Genome Project gene disruption project: single P-element insertions mutating 25% of vital Drosophila genes</article-title>. <source>Genetics</source>
<volume>153</volume>, <fpage>135</fpage>–<lpage>177</lpage>. <?supplied-pmid 10471706?><pub-id pub-id-type="pmid">10471706</pub-id></mixed-citation>
      </ref>
      <ref id="B181">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanis</surname><given-names>L.</given-names></name><name><surname>Larsen</surname><given-names>K. E.</given-names></name><name><surname>Rideout</surname><given-names>H. J.</given-names></name><name><surname>Sulzer</surname><given-names>D.</given-names></name><name><surname>Greene</surname><given-names>L. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death</article-title>. <source>J. Neurosci.</source>
<volume>21</volume>, <fpage>9549</fpage>–<lpage>9560</lpage>. <?supplied-pmid 11739566?><pub-id pub-id-type="pmid">11739566</pub-id></mixed-citation>
      </ref>
      <ref id="B182">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffan</surname><given-names>J. S.</given-names></name><name><surname>Bodai</surname><given-names>L.</given-names></name><name><surname>Pallos</surname><given-names>J.</given-names></name><name><surname>Poelman</surname><given-names>M.</given-names></name><name><surname>McCampbell</surname><given-names>A.</given-names></name><name><surname>Apostol</surname><given-names>B. L.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila</article-title>. <source>Nature</source>
<volume>413</volume>, <fpage>739</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1038/35099568</pub-id><?supplied-pmid 11607033?><pub-id pub-id-type="pmid">11607033</pub-id></mixed-citation>
      </ref>
      <ref id="B183">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Johnston</surname><given-names>D.</given-names></name></person-group> (<year>2002</year>). <article-title>The art and design of genetic screens: <italic>Drosophila melanogaster</italic></article-title>. <source>Nat. Rev. Genet.</source>
<volume>3</volume>, <fpage>176</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/nrg751</pub-id><?supplied-pmid 11972155?><pub-id pub-id-type="pmid">11972155</pub-id></mixed-citation>
      </ref>
      <ref id="B184">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strong</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)</article-title>. <source>J. Neurol. Sci.</source>
<volume>288</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2009.09.029</pub-id><?supplied-pmid 19840884?><pub-id pub-id-type="pmid">19840884</pub-id></mixed-citation>
      </ref>
      <ref id="B185">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Bauer</surname><given-names>P. O.</given-names></name><name><surname>Chew</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>W. Y.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS</article-title>. <source>Neuron</source>
<volume>83</volume>, <fpage>1043</fpage>–<lpage>1050</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.041</pub-id><?supplied-pmid 25132468?><pub-id pub-id-type="pmid">25132468</pub-id></mixed-citation>
      </ref>
      <ref id="B186">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeyama</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Tanimoto</surname><given-names>H.</given-names></name><name><surname>Furutani</surname><given-names>T.</given-names></name><name><surname>Kanuka</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila</article-title>. <source>Neuron</source>
<volume>35</volume>, <fpage>855</fpage>–<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00875-9</pub-id><?supplied-pmid 12372281?><pub-id pub-id-type="pmid">12372281</pub-id></mixed-citation>
      </ref>
      <ref id="B187">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taneja</surname><given-names>K. L.</given-names></name><name><surname>McCurrach</surname><given-names>M.</given-names></name><name><surname>Schalling</surname><given-names>M.</given-names></name><name><surname>Housman</surname><given-names>D.</given-names></name><name><surname>Singer</surname><given-names>R. H.</given-names></name></person-group> (<year>1995</year>). <article-title>Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues</article-title>. <source>J. Cell Biol.</source>
<volume>128</volume>, <fpage>995</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.128.6.995</pub-id><?supplied-pmid 7896884?><pub-id pub-id-type="pmid">7896884</pub-id></mixed-citation>
      </ref>
      <ref id="B188">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>The fragile X-associated tremor ataxia syndrome</article-title>. <source>Results Probl. Cell Differ.</source>
<volume>54</volume>, <fpage>337</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-642-21649-7_18</pub-id><?supplied-pmid 22009361?><pub-id pub-id-type="pmid">22009361</pub-id></mixed-citation>
      </ref>
      <ref id="B189">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Johnson</surname><given-names>K.</given-names></name><name><surname>Moxley</surname><given-names>R. T.</given-names><suffix>III.</suffix></name></person-group> (<year>1994</year>). <article-title>Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes</article-title>. <source>Ann. Neurol.</source>
<volume>35</volume>, <fpage>104</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410350116</pub-id><?supplied-pmid 8285579?><pub-id pub-id-type="pmid">8285579</pub-id></mixed-citation>
      </ref>
      <ref id="B190">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>P. K.</given-names></name><name><surname>Oh</surname><given-names>S. Y.</given-names></name><name><surname>Krans</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>F.</given-names></name><name><surname>Sellier</surname><given-names>C.</given-names></name><name><surname>Frazer</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome</article-title>. <source>Neuron</source>
<volume>78</volume>, <fpage>440</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.026</pub-id><?supplied-pmid 23602499?><pub-id pub-id-type="pmid">23602499</pub-id></mixed-citation>
      </ref>
      <ref id="B191">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>P. K.</given-names></name><name><surname>Oh</surname><given-names>S. Y.</given-names></name><name><surname>Krans</surname><given-names>A.</given-names></name><name><surname>Pandey</surname><given-names>U. B.</given-names></name><name><surname>Di Prospero</surname><given-names>N. A.</given-names></name><name><surname>Min</surname><given-names>K. T.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome</article-title>. <source>PLoS Genet.</source>
<volume>6</volume>:<fpage>e1001240</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1001240</pub-id><?supplied-pmid 21170301?><pub-id pub-id-type="pmid">21170301</pub-id></mixed-citation>
      </ref>
      <ref id="B192">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>P. K.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name></person-group> (<year>2010</year>). <article-title>RNA-mediated neurodegeneration in repeat expansion disorders</article-title>. <source>Ann. Neurol.</source>
<volume>67</volume>, <fpage>291</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21948</pub-id><?supplied-pmid 20373340?><pub-id pub-id-type="pmid">20373340</pub-id></mixed-citation>
      </ref>
      <ref id="B193">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>H.</given-names></name><name><surname>Almeida</surname><given-names>S.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Chalasani</surname><given-names>U.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a Drosophila model of C9ORF72 FTD/ALS</article-title>. <source>Neuron</source>
<volume>87</volume>, <fpage>1207</fpage>–<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.015</pub-id><?supplied-pmid 26402604?><pub-id pub-id-type="pmid">26402604</pub-id></mixed-citation>
      </ref>
      <ref id="B194">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoi</surname><given-names>H.</given-names></name><name><surname>Lau</surname><given-names>C. K.</given-names></name><name><surname>Lau</surname><given-names>K. F.</given-names></name><name><surname>Chan</surname><given-names>H. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases</article-title>. <source>Hum. Mol. Genet.</source>
<volume>20</volume>, <fpage>3787</fpage>–<lpage>3797</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr297</pub-id><?supplied-pmid 21725067?><pub-id pub-id-type="pmid">21725067</pub-id></mixed-citation>
      </ref>
      <ref id="B195">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsoi</surname><given-names>H.</given-names></name><name><surname>Lau</surname><given-names>T. C.</given-names></name><name><surname>Tsang</surname><given-names>S. Y.</given-names></name><name><surname>Lau</surname><given-names>K. F.</given-names></name><name><surname>Chan</surname><given-names>H. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>CAG expansion induces nucleolar stress in polyglutamine diseases</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>109</volume>, <fpage>13428</fpage>–<lpage>13433</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1204089109</pub-id><?supplied-pmid 22847428?><pub-id pub-id-type="pmid">22847428</pub-id></mixed-citation>
      </ref>
      <ref id="B196">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsou</surname><given-names>W. L.</given-names></name><name><surname>Hosking</surname><given-names>R. R.</given-names></name><name><surname>Burr</surname><given-names>A. A.</given-names></name><name><surname>Sutton</surname><given-names>J. R.</given-names></name><name><surname>Ouyang</surname><given-names>M.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>DnaJ-1 and karyopherin alpha3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6</article-title>. <source>Hum. Mol. Genet.</source>
<volume>24</volume>, <fpage>4385</fpage>–<lpage>4396</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv174</pub-id><?supplied-pmid 25954029?><pub-id pub-id-type="pmid">25954029</pub-id></mixed-citation>
      </ref>
      <ref id="B197">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsou</surname><given-names>W. L.</given-names></name><name><surname>Qiblawi</surname><given-names>S. H.</given-names></name><name><surname>Hosking</surname><given-names>R. R.</given-names></name><name><surname>Gomez</surname><given-names>C. M.</given-names></name><name><surname>Todi</surname><given-names>S. V.</given-names></name></person-group> (<year>2016</year>). <article-title>Polyglutamine length-dependent toxicity from alpha1ACT in Drosophila models of spinocerebellar ataxia type 6</article-title>. <source>Biol. Open</source>
<volume>5</volume>, <fpage>1770</fpage>–<lpage>1775</lpage>. <pub-id pub-id-type="doi">10.1242/bio.021667</pub-id><?supplied-pmid 27979829?><pub-id pub-id-type="pmid">27979829</pub-id></mixed-citation>
      </ref>
      <ref id="B198">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Dockendorff</surname><given-names>T. C.</given-names></name><name><surname>Jongens</surname><given-names>T. A.</given-names></name><name><surname>Dreyfuss</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Characterization of dFMR1, a <italic>Drosophila melanogaster</italic> homolog of the fragile X mental retardation protein</article-title>. <source>Mol. Cell Biol.</source>
<volume>20</volume>, <fpage>8536</fpage>–<lpage>8547</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.20.22.8536-8547.2000</pub-id><?supplied-pmid 11046149?><pub-id pub-id-type="pmid">11046149</pub-id></mixed-citation>
      </ref>
      <ref id="B199">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L. C.</given-names></name><name><surname>Chen</surname><given-names>K. Y.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>C. C.</given-names></name><name><surname>Chen</surname><given-names>P. H.</given-names></name><name><surname>Liao</surname><given-names>Y. T.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans</article-title>. <source>Cell. Mol. Life Sci.</source>
<volume>68</volume>, <fpage>1255</fpage>–<lpage>1267</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-010-0522-4</pub-id><?supplied-pmid 20848157?><pub-id pub-id-type="pmid">20848157</pub-id></mixed-citation>
      </ref>
      <ref id="B200">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warf</surname><given-names>M. B.</given-names></name><name><surname>Nakamori</surname><given-names>M.</given-names></name><name><surname>Matthys</surname><given-names>C. M.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Berglund</surname><given-names>J. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Pentamidine reverses the splicing defects associated with myotonic dystrophy</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>106</volume>, <fpage>18551</fpage>–<lpage>18556</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0903234106</pub-id><?supplied-pmid 19822739?><pub-id pub-id-type="pmid">19822739</pub-id></mixed-citation>
      </ref>
      <ref id="B201">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrick</surname><given-names>J. M.</given-names></name><name><surname>Chan</surname><given-names>H. Y.</given-names></name><name><surname>Gray-Board</surname><given-names>G. L.</given-names></name><name><surname>Chai</surname><given-names>Y.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70</article-title>. <source>Nat. Genet.</source>
<volume>23</volume>, <fpage>425</fpage>–<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1038/70532</pub-id><?supplied-pmid 10581028?><pub-id pub-id-type="pmid">10581028</pub-id></mixed-citation>
      </ref>
      <ref id="B202">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrick</surname><given-names>J. M.</given-names></name><name><surname>Morabito</surname><given-names>L. M.</given-names></name><name><surname>Bilen</surname><given-names>J.</given-names></name><name><surname>Gordesky-Gold</surname><given-names>B.</given-names></name><name><surname>Faust</surname><given-names>L. Z.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism</article-title>. <source>Mol. Cell</source>
<volume>18</volume>, <fpage>37</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.02.030</pub-id><?supplied-pmid 15808507?><pub-id pub-id-type="pmid">15808507</pub-id></mixed-citation>
      </ref>
      <ref id="B203">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrick</surname><given-names>J. M.</given-names></name><name><surname>Paulson</surname><given-names>H. L.</given-names></name><name><surname>Gray-Board</surname><given-names>G. L.</given-names></name><name><surname>Bui</surname><given-names>Q. T.</given-names></name><name><surname>Fischbeck</surname><given-names>K. H.</given-names></name><name><surname>Pittman</surname><given-names>R. N.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila</article-title>. <source>Cell</source>
<volume>93</volume>, <fpage>939</fpage>–<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81200-3</pub-id><?supplied-pmid 9635424?><pub-id pub-id-type="pmid">9635424</pub-id></mixed-citation>
      </ref>
      <ref id="B204">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>K. R.</given-names></name><name><surname>Kimura</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>W. C.</given-names></name><name><surname>Littleton</surname><given-names>J. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model</article-title>. <source>Genetics</source>
<volume>190</volume>, <fpage>581</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.111.133710</pub-id><?supplied-pmid 22095086?><pub-id pub-id-type="pmid">22095086</pub-id></mixed-citation>
      </ref>
      <ref id="B205">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>T. M.</given-names></name><name><surname>Leger</surname><given-names>A. J.</given-names></name><name><surname>Pandey</surname><given-names>S. K.</given-names></name><name><surname>MacLeod</surname><given-names>A. R.</given-names></name><name><surname>Nakamori</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>S. H.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Targeting nuclear RNA for <italic>in vivo</italic> correction of myotonic dystrophy</article-title>. <source>Nature</source>
<volume>488</volume>, <fpage>111</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1038/nature11362</pub-id><?supplied-pmid 22859208?><pub-id pub-id-type="pmid">22859208</pub-id></mixed-citation>
      </ref>
      <ref id="B206">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojciechowska</surname><given-names>M.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Cellular toxicity of expanded RNA repeats: focus on RNA foci</article-title>. <source>Hum. Mol. Genet.</source>
<volume>20</volume>, <fpage>3811</fpage>–<lpage>3821</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr299</pub-id><?supplied-pmid 21729883?><pub-id pub-id-type="pmid">21729883</pub-id></mixed-citation>
      </ref>
      <ref id="B207">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtkowiak-Szlachcic</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>K.</given-names></name><name><surname>Stepniak-Konieczna</surname><given-names>E.</given-names></name><name><surname>Sznajder</surname><given-names>L. J.</given-names></name><name><surname>Mykowska</surname><given-names>A.</given-names></name><name><surname>Sroka</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy</article-title>. <source>Nucleic Acids Res.</source>
<volume>43</volume>, <fpage>3318</fpage>–<lpage>3331</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv163</pub-id><?supplied-pmid 25753670?><pub-id pub-id-type="pmid">25753670</pub-id></mixed-citation>
      </ref>
      <ref id="B208">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>C. H.</given-names></name><name><surname>Nguyen</surname><given-names>L.</given-names></name><name><surname>Peh</surname><given-names>J.</given-names></name><name><surname>Luu</surname><given-names>L. M.</given-names></name><name><surname>Sanchez</surname><given-names>J. S.</given-names></name><name><surname>Richardson</surname><given-names>S. L.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>136</volume>, <fpage>6355</fpage>–<lpage>6361</lpage>. <pub-id pub-id-type="doi">10.1021/ja5012146</pub-id><?supplied-pmid 24702247?><pub-id pub-id-type="pmid">24702247</pub-id></mixed-citation>
      </ref>
      <ref id="B209">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Poidevin</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Nelson</surname><given-names>D. L.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>110</volume>, <fpage>7778</fpage>–<lpage>7783</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1219643110</pub-id><?supplied-pmid 23553836?><pub-id pub-id-type="pmid">23553836</pub-id></mixed-citation>
      </ref>
      <ref id="B210">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>TDP-43-The key to understanding amyotrophic lateral sclerosis</article-title>. <source>Rare Dis.</source>
<volume>2</volume>:<fpage>e944443</fpage>. <pub-id pub-id-type="doi">10.4161/21675511.2014.944443</pub-id><?supplied-pmid 26942097?><pub-id pub-id-type="pmid">26942097</pub-id></mixed-citation>
      </ref>
      <ref id="B211">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Jaiswal</surname><given-names>M.</given-names></name><name><surname>Charng</surname><given-names>W. L.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Mirzaa</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>A drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases</article-title>. <source>Cell</source>
<volume>159</volume>, <fpage>200</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.002</pub-id><?supplied-pmid 25259927?><pub-id pub-id-type="pmid">25259927</pub-id></mixed-citation>
      </ref>
      <ref id="B212">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Modeling human trinucleotide repeat diseases in Drosophila</article-title>. <source>Int. Rev. Neurobiol.</source>
<volume>99</volume>, <fpage>191</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-387003-2.00008-2</pub-id><?supplied-pmid 21906541?><pub-id pub-id-type="pmid">21906541</pub-id></mixed-citation>
      </ref>
      <ref id="B213">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Goodman</surname><given-names>L. D.</given-names></name><name><surname>Shieh</surname><given-names>S. Y.</given-names></name><name><surname>Min</surname><given-names>M.</given-names></name><name><surname>Teng</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1</article-title>. <source>Hum. Mol. Genet.</source>
<volume>24</volume>, <fpage>954</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu507</pub-id><?supplied-pmid 25305073?><pub-id pub-id-type="pmid">25305073</pub-id></mixed-citation>
      </ref>
      <ref id="B214">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Teng</surname><given-names>X.</given-names></name><name><surname>Bonini</surname><given-names>N. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy</article-title>. <source>PLoS Genet.</source>
<volume>7</volume>:<fpage>e1001340</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1001340</pub-id><?supplied-pmid 21437269?><pub-id pub-id-type="pmid">21437269</pub-id></mixed-citation>
      </ref>
      <ref id="B215">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Compton</surname><given-names>S. A.</given-names></name><name><surname>Sobczak</surname><given-names>K.</given-names></name><name><surname>Stenberg</surname><given-names>M. G.</given-names></name><name><surname>Thornton</surname><given-names>C. A.</given-names></name><name><surname>Griffith</surname><given-names>J. D.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs</article-title>. <source>Nucleic Acids Res.</source>
<volume>35</volume>, <fpage>5474</fpage>–<lpage>5486</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm601</pub-id><?supplied-pmid 17702765?><pub-id pub-id-type="pmid">17702765</pub-id></mixed-citation>
      </ref>
      <ref id="B216">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamiri</surname><given-names>B.</given-names></name><name><surname>Reddy</surname><given-names>K.</given-names></name><name><surname>Macgregor</surname><given-names>R. B.</given-names><suffix>Jr.</suffix></name><name><surname>Pearson</surname><given-names>C. E.</given-names></name></person-group> (<year>2014</year>). <article-title>TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins</article-title>. <source>J. Biol. Chem.</source>
<volume>289</volume>, <fpage>4653</fpage>–<lpage>4659</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C113.502336</pub-id><?supplied-pmid 24371143?><pub-id pub-id-type="pmid">24371143</pub-id></mixed-citation>
      </ref>
      <ref id="B217">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. Q.</given-names></name><name><surname>Bailey</surname><given-names>A. M.</given-names></name><name><surname>Matthies</surname><given-names>H. J. G.</given-names></name><name><surname>Renden</surname><given-names>R. B.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Speese</surname><given-names>S. D.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function</article-title>. <source>Cell</source>
<volume>107</volume>, <fpage>591</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00589-X</pub-id><?supplied-pmid 11733059?><pub-id pub-id-type="pmid">11733059</pub-id></mixed-citation>
      </ref>
      <ref id="B218">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Donnelly</surname><given-names>C. J.</given-names></name><name><surname>Haeusler</surname><given-names>A. R.</given-names></name><name><surname>Grima</surname><given-names>J. C.</given-names></name><name><surname>Machamer</surname><given-names>J. B.</given-names></name><name><surname>Steinwald</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>The C9orf72 repeat expansion disrupts nucleocytoplasmic transport</article-title>. <source>Nature</source>
<volume>525</volume>, <fpage>56</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/nature14973</pub-id><?supplied-pmid 26308891?><pub-id pub-id-type="pmid">26308891</pub-id></mixed-citation>
      </ref>
      <ref id="B219">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Tsoi</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>P. P.</given-names></name><name><surname>Lau</surname><given-names>K. F.</given-names></name><name><surname>Rudnicki</surname><given-names>D. D.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila</article-title>. <source>Dis. Model. Mech.</source>
<volume>9</volume>, <fpage>321</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.022350</pub-id><?supplied-pmid 26839389?><pub-id pub-id-type="pmid">26839389</pub-id></mixed-citation>
      </ref>
      <ref id="B220">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z. X.</given-names></name><name><surname>Wong</surname><given-names>C. I.</given-names></name><name><surname>Sar</surname><given-names>M.</given-names></name><name><surname>Wilson</surname><given-names>E. M.</given-names></name></person-group> (<year>1994</year>). <article-title>The androgen receptor: an overview</article-title>. <source>Recent Prog. Horm. Res.</source>
<volume>49</volume>, <fpage>249</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-12-571149-4.50017-9</pub-id><?supplied-pmid 8146426?><pub-id pub-id-type="pmid">8146426</pub-id></mixed-citation>
      </ref>
      <ref id="B221">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuchenko</surname><given-names>O.</given-names></name><name><surname>Bailey</surname><given-names>J.</given-names></name><name><surname>Bonnen</surname><given-names>P.</given-names></name><name><surname>Ashizawa</surname><given-names>T.</given-names></name><name><surname>Stockton</surname><given-names>D. W.</given-names></name><name><surname>Amos</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>1997</year>). <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title>. <source>Nat. Genet.</source>
<volume>15</volume>, <fpage>62</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/ng0197-62</pub-id><?supplied-pmid 8988170?><pub-id pub-id-type="pmid">8988170</pub-id></mixed-citation>
      </ref>
      <ref id="B222">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Botas</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Mouse and fly models of neurodegeneration</article-title>. <source>Trends Genet.</source>
<volume>18</volume>, <fpage>463</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-9525(02)02729-4</pub-id><?supplied-pmid 12175807?><pub-id pub-id-type="pmid">12175807</pub-id></mixed-citation>
      </ref>
      <ref id="B223">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Orr</surname><given-names>H. T.</given-names></name></person-group> (<year>2000</year>). <article-title>Glutamine repeats and neurodegeneration</article-title>. <source>Annu. Rev. Neurosci.</source>
<volume>23</volume>, <fpage>217</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.217</pub-id><?supplied-pmid 10845064?><pub-id pub-id-type="pmid">10845064</pub-id></mixed-citation>
      </ref>
      <ref id="B224">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>T.</given-names></name><name><surname>Gibbens</surname><given-names>B.</given-names></name><name><surname>Doty</surname><given-names>N. S.</given-names></name><name><surname>Gomes-Pereira</surname><given-names>M.</given-names></name><name><surname>Huguet</surname><given-names>A.</given-names></name><name><surname>Stone</surname><given-names>M. D.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Non-ATG-initiated translation directed by microsatellite expansions</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>108</volume>, <fpage>260</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1013343108</pub-id><?supplied-pmid 21173221?><pub-id pub-id-type="pmid">21173221</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359755</identifier><datestamp>2017-04-04</datestamp><setSpec>frontmicrobio</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Microbiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-302X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359755</article-id>
      <article-id pub-id-type="pmcid">PMC5359755</article-id>
      <article-id pub-id-type="pmc-uid">5359755</article-id>
      <article-id pub-id-type="doi">10.3389/fmicb.2017.00478</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bifid Shape Is Intrinsic to <italic>Bifidobacterium adolescentis</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dhanashree</surname>
            <given-names/>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rajashekharan</surname>
            <given-names>Sharika</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krishnaswamy</surname>
            <given-names>Balamurugan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kammara</surname>
            <given-names>Rajagopal</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/258285/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Department of Protein Chemistry and Technology, Council of Scientific and Industrial Research – Central Food Technological Research Institute, Mysore</institution>
        <country>India</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Department of Biotechnology, Alagappa Univeristy, Karaikudi</institution>
        <country>India</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: <italic>Andrea Gomez-Zavaglia, Center for Research and Development in Food Cryotechnology (CONICET), Argentina</italic></p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: <italic>Atte Von Wright, University of Eastern Finland, Finland; Alberto Finamore, Food and Nutrition Research Center (CREA), Italy</italic></p>
        </fn>
        <corresp id="fn001">*Correspondence: <italic>Rajagopal Kammara, <email xlink:type="simple">krgopal22@rediffmail.com</email></italic></corresp>
        <fn fn-type="other" id="fn002">
          <p>This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>478</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Dhanashree, Rajashekharan, Krishnaswamy and Kammara.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Dhanashree, Rajashekharan, Krishnaswamy and Kammara</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Although the genus <italic>Bifidobacterium</italic> was originally named for its bifid morphology, not all bifidobacterial species have a similar structure, and very few of them adopt a bifid shape under stress conditions. The exposure of respective bifidobacterial species to various conditions, such as different pH, temperatures, medium components, <italic>in vivo</italic> growth in <italic>Caenorhabditis elegans</italic>, and subculture, did not affect their diverse morphologies. Extensive scanning electron microscopy studies suggested that the bifid shape of <italic>B. adolescentis</italic> are maintained irrespective of the conditions. Hence, we conclude that the bifid morphology is intrinsic to <italic>B. adolescentis</italic>. Most bifidobacterial species are anaerobic and rod-shaped, whereas, after the first generation, they become microaerophilic or aerophilic. CaCl<sub>2</sub> (treatment of <italic>B. animalis</italic>) signaling triggered a change from the rod shape to the bifid shape and vice versa in <italic>B. adolescentis</italic>.</p>
      </abstract>
      <kwd-group>
        <kwd>bifid</kwd>
        <kwd>polymorphic</kwd>
        <kwd>
          <italic>Bifidobacterium</italic>
        </kwd>
        <kwd>intrinsic</kwd>
        <kwd>aerophilic</kwd>
        <kwd>microaerophilic</kwd>
      </kwd-group>
      <counts>
        <fig-count count="10"/>
        <table-count count="1"/>
        <equation-count count="1"/>
        <ref-count count="38"/>
        <page-count count="12"/>
        <word-count count="0"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>The genus <italic>Bifidobacterium</italic> is so designated because in the reference species, one end was a rocket-shaped and the other, longitudinally split (<xref rid="B31" ref-type="bibr">Tissier, 1900</xref>). Various bifidobacterial species have been classified based on the nucleotide sequence encoding the 16S rRNA, Hsp60, and xylulose-5-phosphate (XFP; also called fructose-6-phosphate phosphoketolase/F6PPK). However, the lack of cutting-edge research into the taxonomy of the genus <italic>Bifidobacterium</italic> has meant that these species have been retained in <italic>Bifidobacterium</italic>, regardless of morphological differences. Because very few bifidobacterial strains have a bifid shape, even though some are polymorphic both rod-shaped and bifid-shaped species are retained in the single genus <italic>Bifidobacterium</italic>.</p>
      <p>Investigators in the field, such as <xref rid="B37" ref-type="bibr">Weiss (1933)</xref>, <xref rid="B2" ref-type="bibr">Blaurock (1937)</xref>, <xref rid="B5" ref-type="bibr">Boventer (1938)</xref>, <xref rid="B38" ref-type="bibr">Weiss and Rettger (1938)</xref>, and <xref rid="B34" ref-type="bibr">Tomarelli et al. (1949a</xref>,<xref rid="B35" ref-type="bibr">b</xref>), have stressed the demand to develop optimal media for bifidobacterial s pecies. The reflection of variations in the bifid structures of <italic>Bifidobacterium</italic> and <italic>Lactobacillus acidophilus</italic> was confirmed by <xref rid="B10" ref-type="bibr">Herter (1907)</xref>, <xref rid="B3" ref-type="bibr">Bliuhdorn (1910)</xref>, <xref rid="B15" ref-type="bibr">Kendall and Haner (1924)</xref>. Since then, some have suggested that <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> are two different genera (<xref rid="B29" ref-type="bibr">Sundman et al., 1959</xref>). Exposure to stress conditions causes the latter to adopt pleomorphic forms, including the bifid form. These observations were confirmed by <xref rid="B24" ref-type="bibr">Rodella (1908)</xref>, <xref rid="B7" ref-type="bibr">Cruickshank (1925)</xref>, <xref rid="B25" ref-type="bibr">Roos (1927)</xref>, and <xref rid="B30" ref-type="bibr">Synder et al. (1967)</xref> who reported that the alternative forms are uncommon and give an illusion of branching. <xref rid="B21" ref-type="bibr">Norris et al. (1950)</xref> confirmed that stress conditions induce the polymorphic forms of <italic>Bifidobacterium</italic>. However, the mechanisms underlying the bifid conformation are unknown, and there has been no account of this polymorphic/bifid morphology. Therefore, in this study, we investigated the bifid nature of <italic>Bifidobacterium</italic>. Studies of polymorphic bacterial morphologies by <xref rid="B20" ref-type="bibr">Moro (1905)</xref> and <xref rid="B32" ref-type="bibr">Tissier (1905)</xref> demonstrated that bifid-shaped organisms are present in the fecal material of breastfed infants. Populations of these organisms (bifid form) in the intestine represent the disease-free condition and are physiological significance. However, the cellular elements and physical parameters responsible for the upkeep of the bifid form <italic>in vivo</italic> and <italic>in vitro</italic> are yet to be determined.</p>
      <p>According to available reports, there are about 63 different <italic>Bifidobacterium</italic> species. The nomenclature and taxonomy of these microbes are incomplete. Hence, it is critical to understand the diverse nature of <italic>Bifidobacterium</italic> and to determine the characteristic morphologies of all the <italic>Bifidobacterium</italic>. It is essential to determine whether this polymorphism is intrinsic to a particular species of <italic>Bifidobacterium</italic>. <xref rid="B38" ref-type="bibr">Weiss and Rettger (1938)</xref>, reported that these bacteria lose their bifid structure and change to the rod-shaped form in the subculture. Moreover, before subculture, they are strictly anaerobic, whereas after subculture, they are aerobic. The mechanisms of all these phenomena are yet obscure. In this study, we examine the polymorphic morphologies of the <italic>Bifidobacterium</italic>, and conclude that the bifid morphology is an intrinsic characteristic of <italic>B. adolescentis</italic>, whereas (very few) other species, including <italic>B. animalis</italic>, display polymorphic behavior only under stress conditions. However, all the other bifidobacterial species maintain their rod shape, regardless of the culture conditions, and rarely adopt the bifid shape.</p>
      <p>In the <xref rid="B11" ref-type="bibr">Homma et al. (1960)</xref> showed that univalent cations induce this unique phenomenon. <xref rid="B17" ref-type="bibr">Kojima et al. (1970)</xref> confirmed the role of monovalent cations, including sodium chloride, sodium sulfate, sodium nitrate, tribasic sodium phosphate, and sodium acetate, in the induction of the bifid form. Later, the roles of chlorides of Ca<sup>++</sup>, Ba<sup>++</sup>, Mg<sup>++</sup>, Mn<sup>++</sup>, and Zn<sup>++</sup> were shown to play no role in this pleomorphism (<xref rid="B17" ref-type="bibr">Kojima et al., 1970</xref>). In the 1960s, glucose and sucrose were also proven to positively affect this polymorphism (<xref rid="B16" ref-type="bibr">Kojima et al., 1968</xref>).</p>
      <p><xref rid="B33" ref-type="bibr">Tissier (1899)</xref>, <italic>L. bifidus</italic> was the only organism that was exhaustively dissected for its morphological variability. However, this work was incomplete because many bifidobacterial species are recognized today and many decades-old comparative morphological studies have not survived. In response to the original studies, the name ‘<italic>Bifidobacterium</italic>’ was suggested, but was considered equivocal, even then. In those days, fewer <italic>Bifidobacterium</italic> species were available, and <italic>L. bifidus</italic> may have been the only recognized bifidobacterial species. In 1950, 1968, and 1970, <italic>L. bifidus</italic> was the only strain in which this polymorphism was investigated. <xref rid="B17" ref-type="bibr">Kojima et al. (1970)</xref> demonstrated the role of CaCl<sub>2</sub> in inhibiting various bacterial morphological forms. The comparative study (by <xref rid="B17" ref-type="bibr">Kojima et al., 1970</xref>) of cell wall composition of the bifid and bacilloid forms reported are clearly shown the restriction of amino acid phenylalanine and methionine to bifid form and the presence of high content of the glucose compared to bacilloid form. Surprisingly, larger peptidoglycans were found in the bacilliform, whereas the average-sized peptidoglycans occur in the bifid form. These observations also support the contention that ‘<italic>Bifidobacterium</italic>’ is a misnomer. Not all <italic>Bifidobacterium</italic> shows the bifid morphology because it is not an intrinsic characteristic, and may be restricted to very few members of the genus.</p>
      <p>To examine the different morphologies of the species included in the genus <italic>Bifidobacterium</italic>, we selected several bifidobacterial groups constructed by <xref rid="B4" ref-type="bibr">Bottacini et al. (2014)</xref>, each selected species corresponds to a particular group and subjected them to different stress conditions. The different Bifidobacterial groups were fed to the model system, <italic>Caenorhabditis elegans</italic> to assess their morphological changes during <italic>in vivo</italic> stress conditions and was characterized and analyzed through scanning electron microscopy (SEM). In this manuscript, we report our findings on the varied morphologies of the <italic>Bifidobacterium</italic>, detected with SEM and compound microscopy.</p>
    </sec>
    <sec sec-type="materials|methods" id="s1">
      <title>Materials and Methods</title>
      <p>Organisms: <italic>Bifidobacterium</italic> species, including <italic>B. animalis, B. longum</italic>, and <italic>B. adolescentis</italic>, etc., were obtained from the German collection of Microorganisms and Cell Cultures (Inhoffenstraße 7B, 38124 Braunschweig, Germany). For details, see <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>. <italic>C. elegans</italic> and OP 50 <italic>Escherichia coli</italic> was a kind gift of Dr. Balamurugan.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Strains used in this study.</p>
        </caption>
        <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">Bacterial strain</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Strain no.</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Reference</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1 <italic>B. animalis</italic> subspp. <italic>lactis</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 10140</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B18" ref-type="bibr">Meile et al., 1997</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">2 <italic>B. thermoacidophilum</italic> subspp. <italic>thermoacidophilum</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 15837</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B8" ref-type="bibr">Dong et al., 2000</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3 <italic>B. adolescentis</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20083</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B23" ref-type="bibr">Reuter, 1963</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">4 <italic>B. longum</italic> subspp. <italic>infantis</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20088</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B23" ref-type="bibr">Reuter, 1963</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">5 <italic>B. longum</italic> subspp. <italic>longum</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20219</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B23" ref-type="bibr">Reuter, 1963</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">6 <italic>B. asteroides</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20089</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B27" ref-type="bibr">Scardovi and Trovatelli, 1969</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">7 <italic>B. animalis</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20105</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B19" ref-type="bibr">Mitsuoka, 1969</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">8 <italic>B. breve</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20213</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B23" ref-type="bibr">Reuter, 1963</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">9 <italic>B. indicum</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1">DSMZ 20214</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B27" ref-type="bibr">Scardovi and Trovatelli, 1969</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">10 <italic>E. coli OP50</italic></td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">A gift from Prof. Balamurugan</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <attrib>
            <italic>B, Refers to Bifidobacterium.</italic>
          </attrib>
        </table-wrap-foot>
      </table-wrap>
      <sec>
        <title>Media and Culture Conditions</title>
        <p>Commercially available media, such as MRS (Oxoid, Milano, Italy) and Bifidobacterial broth (Hi-Media Laboratories, A-516, Swastik Disha Business Park, via Vadhani Industrial Estate, L.B.S. Marg, Mumbai-400 086, India) and agar medium, were used to grow the different Bifidobacterial species. The first generation of the Bifidobacteria was cultured in MRS broth (and also in Bifidobacterial broth when appropriate) at 37°C (without shaking) in an anaerobic chamber for 36 h. They were sub-cultured and grown in aerobic condition in the second generation.</p>
      </sec>
      <sec>
        <title>Growing, Harvesting, and Growth Curve Studies</title>
        <p>Bifidobacterial strains, <italic>B. animalis</italic>, <italic>B. longum</italic>, and <italic>B. adolescentis</italic>, were grown at different temperatures: room temperature, 30, 37, and 42°C. The bifidobacterial strains were streaked onto the MRS agar plate to produce single isolated colonies. The streaked plates were incubated at 37°C (for 36 h) under anaerobic conditions. A single colony was isolated, used to inoculate 10 ml of fresh MRS medium, and grown in an anaerobic growth chamber. An aliquot (1%) of each inoculum was subculture in 15 ml of fresh MRS medium to construct growth curves. The bacterial samples were collected every 6 h and the OD<sub>600</sub> measured. All the experiments were performed in triplicates.</p>
      </sec>
      <sec>
        <title>Growth, Maturation, and Harvesting of <italic>C. elegans</italic></title>
        <p>Wild-type <italic>C. elegans</italic> were obtained from CGC and maintained on NGM at 20°C. The standard <italic>E. coli</italic> OP50 strain was used as a food source. Age synchronized young adult worms were used in all experiments. Synchronization was obtained through bleaching of gravid hermaphrodites to obtain eggs that were plated onto seeded plates. The young adult nematodes were harvested from NGM plates by using M9 buffer and used for experiments. Was grown on NGM agar plates and fed internationally accepted feed (the standard <italic>E. coli</italic> OP50 strain), as described previously (<xref rid="B36" ref-type="bibr">Ward, 1973</xref>). Standard techniques (<xref rid="B12" ref-type="bibr">Hope, 1999</xref>; <xref rid="B28" ref-type="bibr">Stiernagle, 1999</xref>) for the maintenance and growth of nematodes on NGM were used.</p>
      </sec>
      <sec>
        <title>Bacterial Strains and Growth Conditions for <italic>C. elegans</italic> Feeding</title>
        <p><italic>Escherichia coli</italic> OP50 was grown overnight at 37°C at 200 rpm in Luria-Bertani medium. The bacterial lawns used for the <italic>C. elegans</italic> studies were prepared by spreading 10 μl of the bacterial strain onto nematode growth media (NGM) agar (0.25% peptone) in 3.5-cm plates. The plates were incubated overnight in an incubator at 37°C. They were allowed to equilibrate to room temperature before they were seeded with <italic>C. elegans</italic> and incubated at 20°C throughout the experiment.</p>
        <p>All the bifidobacterial strains cited in the <bold>Table <xref ref-type="table" rid="T1">1</xref></bold> (except <italic>E. coli</italic>) were grown as shown above. Bacterial lawns were made by spreading 10 μl of the bifidobacterial strains onto MRS agar in 3.5-cm plates. A similar procedure to that described above was followed, but <italic>C. elegans</italic> was fed different Bifidobacterial (<italic>B. longum</italic> and <italic>B. adolescentis</italic>) strains rather than <italic>E. coli</italic> OP50. <italic>B. longum</italic> and <italic>B. adolescentis</italic> were considered further for these studies as it is preferred by the <italic>C. elegans</italic>. The second generation of this bacteria is microaerophilic therefore they can grow in aerobic condition, where <italic>C. elegans</italic> also grows.</p>
      </sec>
      <sec>
        <title>Chemotaxis Assay</title>
        <p>To determine whether the <italic>Bifidobacterium</italic> and their products (ocins) are non-toxic and safe for <italic>C. elegans</italic>, several experiments were performed (<xref rid="B6" ref-type="bibr">Brenner, 1974</xref>). The procedure follows as below. A Petri plate was divided into four parts, two opposite and one adjacent part labeled “Test”(A, B, and D) and the remaining as “Control” (C). All the sectors (A, B, C, and D) were equidistant from one another. Part A contained <italic>B. animalis</italic>, part B <italic>B. longum</italic>, part C the control <italic>E. coli</italic> OP50, and part D <italic>B. adolescentis</italic>. Approximately, 25 wild-type <italic>C. elegans</italic> that had been grown on <italic>E. coli</italic> OP50 were washed thoroughly and introduced into the center of the plate and the origin was marked with a circle to allow non-motile worms to be eliminated. The plates were incubated under optimal conditions, and analyzed the following day. All the bacteria were equidistant from the center where the worms started their journeys. The numbers of worms in each bacterial sector were scored after 12 and 24 h and the chemotaxis index (CI) was calculated by using the following formula.</p>
        <disp-formula id="E1">
          <mml:math id="M1">
            <mml:mrow>
              <mml:mi>CI</mml:mi>
              <mml:mo>=</mml:mo>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi>Worms on test bacterium</mml:mi>
                  <mml:mo>−</mml:mo>
                  <mml:mi>Worms in</mml:mi>
                  <mml:mi/>
                  <mml:mi/>
                  <mml:mi/>
                  <mml:mi>
</mml:mi>
                  <mml:mi>E</mml:mi>
                  <mml:mn>.</mml:mn>
                  <mml:mi>c</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>l</mml:mi>
                  <mml:mi>i</mml:mi>
                  <mml:mo>⁢</mml:mo>
                  <mml:mi> </mml:mi>
                  <mml:mi> OP50 </mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>Total number of worms</mml:mi>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>Phenotypic Observations of <italic>Bifidobacterium</italic>-Fed <italic>C. elegans</italic> and <italic>C. elegans</italic> as a Model Organism to Understand the Polymorphic Morphologies of <italic>Bifidobacterium</italic></title>
        <p><italic>Caenorhabditis elegans</italic> was used as a model organism to determine the ability of the nematode to consume <italic>Bifidobacterium</italic> and to understand the intrinsic morphology of <italic>B. adolescentis</italic>. Different <italic>Bifidobacterium</italic> (<italic>B. animalis</italic>, <italic>B. longum</italic>, and <italic>B. adolescentis</italic>) were grown in the appropriate medium, as described above. They were harvested, washed, and resuspended in the appropriate medium. <italic>C. elegans</italic> were fed with different ratios (1:10, 1:20, and so on) of <italic>Bifidobacterium</italic> and left for 72–96 h. They were harvested at different intervals (after 12, 24, 32 h, and so on) without rupture, and then smashed so that the internal microbes could be observed. The worms were washed, fixed with glutaraldehyde, after a series of wash animals were crushed on the slide and analyzed with SEM. The phenotypic changes in the nematodes fed <italic>Bifidobacterium</italic> were observed microscopically. The cells of <italic>B. adolescentis</italic>-fed worms were also lysed, and the supernatants observed with SEM and the bacteria were quantified (CFU).</p>
      </sec>
      <sec>
        <title>Bifidobacterial (<italic>B. longum</italic> and <italic>B. adolescentis</italic>) Colonization of the <italic>C. elegans</italic> Digestive Tract</title>
        <p>The method of <xref rid="B9" ref-type="bibr">Garsin et al. (2001)</xref>, with minor modifications, was used to estimate the approximate numbers of bacterial cells in the worms. Ten worms were selected, and the surface bacteria were removed by washing the worms 4–5 times with 5 μl of M9 buffer on agar plates. Each worm was transferred to a 0.5 ml centrifuge tube containing 20 μl of M9 buffer and mechanically disrupted with a Microtube pestle (Scientific Specialties, Inc., Lodi, CA, USA). The volume was then adjusted to 100 μl with M9 buffer (serially dilute and spread) and the numbers of bacteria [colony-forming units (cfu)] were estimated by spreading the culture on MRS agar plates. The plates were incubated at the appropriate temperature until the colonies were observed. The same colonies were washed well with M9 buffer and immediately fixed and observed with SEM. Genomic DNA was isolated from some bacteria and subjected to 16S rRNA amplification and alignment.</p>
      </sec>
      <sec>
        <title>Understanding the Bifidobacterial Morphology through SEM</title>
        <p>Scanning electron microscopy studies were conducted to understand the diverse morphology of <italic>Bifidobacterium</italic>. Various <italic>Bifidobacterium</italic> species were subjected to different conditions, including different media (MRS or <italic>Bifidobacterium</italic> broth) and different temperatures (in MRS at room temperature, 30, 37, or 42°C for SEM and Growth curve studies). They were also grown in MRS medium (for three generations also), with or without amino acids (667 mg/lt) (alanine + asparagine + glutamine + serine, or individually with alanine, asparagine, tryptophan, etc.) in the presence and absence of CaCl<sub>2</sub> (<xref rid="B13" ref-type="bibr">Husain et al., 1972</xref>), and on MRS with and without salts (0.2 M Na<sub>2</sub>SO<sub>4</sub>, 0.2 M NaCl, or 0.2 M CH<sub>3</sub>COONa) (<xref rid="B16" ref-type="bibr">Kojima et al., 1968</xref>, the effect of salt concentration studies) and at different pH (5–7.5). The pleomorphism of Bifidobacteria was understood by growing them <italic>in vivo</italic> (in <italic>C. elegans</italic>).</p>
      </sec>
      <sec>
        <title>The Procedure Followed for SEM</title>
        <p>The various bifidobacterial strains were harvested, and washed twice with phosphate buffer. The pelleted bacteria were fixed in 2% glutaraldehyde and incubated at 4°C 1 h/overnight. The cells were then harvested and washed with a 10–100% gradient of ethanol. The cells were resuspended in 50–100 μl of absolute alcohol. Approximately 2 μl of the sample was placed on a cover slip, dessicated and examined with SEM. The images were collected at 20,000 magnifications. Only appropriate and convincing images were considered in the analysis.</p>
      </sec>
      <sec>
        <title>Genomic DNA Isolation</title>
        <p>The commercial GeneJET Genomic DNA Purification Kit (Fermentas, Inc., 830 Harrington Court, Burlington, ON L7N 3N4, Canada) was used for genomic DNA isolation. In brief, a single isolated colony was used to inoculate 10 ml of MRS broth and grown overnight at 37°C without shaking under anaerobic conditions. The following day, the cells were harvested and heat treated at 37°C in the presence of 20 μg of lysozyme in Tris- HCl and EDTA buffer (pH 8.0). After treatment with proteinase K, RNAse A was added and the cells were incubated for 10 min at room temperature. The resulting mix was centrifuged at 12,000 rpm for 20 min, and the supernatant was transferred to a GeneJET column. After two washes with wash buffer, the DNA was finally eluted with Tris buffer (pH 8.0).</p>
      </sec>
      <sec>
        <title>16S rRNA Amplification, Sequence Analysis, and Alignment</title>
        <p>The genomic DNA extracted as described above was used as the template for the PCR amplification of 16S rRNA using the bifido16S universal primers 357F/926R (357F 5′-CCTACGGGAGGCAGCAG-3′; 926R 5′-CCGTCAATTCMTTTRAGT-3′) and DyNAzyme II DNA polymerase (Thermo Scientific). The cycling parameters were: initial denaturation at 95°C for 5 min, followed by 35 cycles at 95°C for 30 s, 56°C for 45 s, and 72°C for 1 min, and a final extension at 72°C for 5 min. Each reaction was analyzed on 1% agarose gel. The resulting PCR products were subjected to DNA sequencing with an ABI 310 DNA sequencer (institutional facility). Sequence similarity was determined with the National Center for Biotechnology Information BLAST tool (NCBI).</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>The analysis of the 16S rRNA nucleotide sequences, Hsp60, and F6PPK showed distinct differences between the <italic>Bifidobacterium</italic> species. From the group three species were chosen for the study as they symbolize all the Bifidobacteria species. Certainly temperature does play a major part in the growth of Bifidobacteria. All together the three species [<italic>B. animalis</italic> subsp. <italic>lactis</italic> (DSM accession no. 10140), <italic>B. adolescentis</italic> (DSM accession no. 20083), and <italic>B. longum</italic> (DSM accession number: <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="20219">20219</ext-link>)] grew well at 37°C reaching an OD<sub>600</sub> of 3.0–5.0 after 66 h of culturing (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). When the temperatures were reduced to 30°C the growth rates were drastically reduced (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). The whole of the Bifidobacteria species were unable to come to an OD<sub>600</sub> of 3.0 even after 72 h of growth. Nevertheless, considerable growth was observed for <italic>B</italic>. <italic>adolescentis</italic>. The remaining two Bifidobacteria grew very slowly, and an extended lag phase was discovered. When the growth curves were observed at an increased temperature of 42°C (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>) an outcome similar to that discovered at lower temperatures was observed (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). Nevertheless, the cells did not obtain an OD<sub>600</sub> above 3.0, even after 72 h of growth. These results indicate that 37°C may be an optimal temperature for the growth of these bacterial strains (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). The growth curve studies further emphasize that <italic>B. animalis</italic> subsp. <italic>lactis</italic> is very slow growing (obtained an OD<sub>600</sub> of 2.0–2.5), and it maintained this growth rate at different temperatures (30–42°C). <italic>B. longum</italic> showed the greatest growth rates at 37°C, and its growth rate was greater than either of the other strains. Strikingly, <italic>B. adolescentis</italic> grew faster at 37°C, reaching an OD<sub>600</sub> of 3.0 in 30 h, a task which takes 48 h at 30°C and 72 h at 42°C.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p><bold>Growth curves of DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis)</italic>, DSM 20083 (<italic>B. adolescentis</italic>), DSM 20219 (<italic>B. longum)</italic> at different temperatures. (A)</bold> 30°C, <bold>(B)</bold> 37°C, <bold>(C)</bold> 42°C.</p>
        </caption>
        <graphic xlink:href="fmicb-08-00478-g001"/>
      </fig>
      <p>Three different Bifidobacteria such as <italic>Bifidobacterium adolescentis, B. animalis</italic>, and <italic>B. longum</italic> was grown under different concentrations of oxygen and their growth curves analyzed. The results clearly demonstrated that as the concentration of oxygen in the system increased, the multiplication rate of the bacteria decreased and <italic>vice versa</italic> (data not shown). The different Bifidobacterial species displayed different resistance and susceptibility to oxygen (in the first generation). In the second generation, all the species grew aerobically, irrespective of the presence (of different concentrations) of oxygen. An oximetric study also showed that each <italic>Bifidobacterium</italic> species required different amounts of oxygen for growth, especially in the first generation. This further confirms that Bifidobacteria does show intolerance in the IInd generation, equally it is sensitive in the first generation (<xref rid="B1" ref-type="bibr">Beerens et al., 2000</xref>; <xref rid="B14" ref-type="bibr">Kawasaki et al., 2006</xref>; <xref rid="B26" ref-type="bibr">Ruiz et al., 2011</xref>).</p>
      <p>To investigate the various morphologies of the Bifidobacterial species, they were subjected to various conditions and analyzed with SEM (<bold>Figures <xref ref-type="fig" rid="F2">2A–H</xref></bold>). The experiments were performed at different temperatures (37, 42°C; <bold>Figures <xref ref-type="fig" rid="F2">2A,B</xref></bold>), in different media (Supplementary Information), supplemented with an amino acid mixture containing alanine, aspartate, glutamate, and serine (<bold>Figure <xref ref-type="fig" rid="F2">2C</xref></bold>), and also individually supplemented with alanine (<bold>Figure <xref ref-type="fig" rid="F2">2D</xref></bold>), asparagine (<bold>Figure <xref ref-type="fig" rid="F2">2F</xref></bold>), tryptophan (<bold>Figure <xref ref-type="fig" rid="F2">2E</xref></bold>), or salts such as 0.2 M CH<sub>3</sub>COONa (<bold>Figure <xref ref-type="fig" rid="F2">2G</xref></bold>) and 0.25 M NaCl (<bold>Figure <xref ref-type="fig" rid="F2">2H</xref></bold>). The growth rate of the bacteria varied between species when the temperature was increased. All the species reached stationary phase after 36–48 h, at 37°C and after 42–60 h, at 42°C (<bold>Figures <xref ref-type="fig" rid="F1">1B,C</xref></bold>). Rather than considering all 63 different species of <italic>Bifidobacterium</italic>, we selected species representative of the groups of <xref rid="B4" ref-type="bibr">Bottacini et al. (2014)</xref>: <italic>B. animalis</italic> (DSM 10140), <italic>B. adolescentis</italic> (DSM 20083), and <italic>B. longum</italic> (DSM 20219) (<xref rid="B4" ref-type="bibr">Bottacini et al., 2014</xref>). We subjected them to different conditions, and observed any morphological changes with SEM. <bold>Figures <xref ref-type="fig" rid="F2">2</xref></bold>, <bold><xref ref-type="fig" rid="F10">10</xref></bold> clearly demonstrates the effects of each condition on the Bifidobacterial morphology. <italic>Bifidobacterium adolescentis</italic> (DSM 20083) metamorphosed from a bifid to a rod when grown on medium supplemented with alanine (A), asparagine (N), or 0.25 M NaCl. When <italic>B. longum</italic> (DSM 20219) was grown on medium supplemented with the four amino acids (Ala, Asp, Glu, and Ser), or separately with alanine (A) or asparagine (N), its morphology changed from elongated rods to bifids. However, <italic>B. animalis.</italic> subsp. <italic>lactis</italic> (DSM 10140) remained in the rod form, irrespective of its growth conditions.</p>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p><bold>Scanning electron microscopy (SEM) of strains DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis</italic>), DSM 20083 (<italic>B. adolescentis</italic>), DSM 20219 (<italic>B. longum)</italic> with different conditions like (A)</bold> 37°C, <bold>(B)</bold> 42°C, <bold>(C)</bold> media with alanine, aspartate, glutamate, serine, <bold>(D)</bold> media with alanine, <bold>(E)</bold> media with tryptophan, <bold>(F)</bold> media with asparagine, <bold>(G)</bold> media with 0.2 M sodium acetate, <bold>(H)</bold> media with 0.25 M sodium chloride.</p>
        </caption>
        <graphic xlink:href="fmicb-08-00478-g002"/>
      </fig>
      <sec>
        <title>Supplementary Data to Understand the Other Bifidobacterial Species</title>
        <p>Another five species, <italic>B. thermacidophilum</italic> (DSM 15837), <italic>B. infantis</italic> (DSM 20088), <italic>B. asteroides</italic> (DSM 20089), <italic>B. animalis</italic> (DSM 20105), and <italic>B. breve</italic> (DSM 20213) was also subjected to the different conditions described above, and the results are shown in the <bold>Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref></bold>. We noted a marked change in the morphology of <italic>B. thermacidophilum</italic> from rod- to bifid-shaped when grown on medium containing tryptophan. When <italic>B. asteroides</italic> was grown at 37°C, a mixed population of rod- and bifid-shaped bacteria were observed. Morphological changes were also observed when <italic>B. breve</italic> was grown with all four amino acids or with alanine alone, when it metamorphosed from rod- to bifid-shaped cells. <italic>Bifidobacterium infantis</italic> changed from rods to coccoids at 42°C. Almost all the other strains of <italic>Bifidobacterium</italic> maintained the rod shape under all the conditions tested, except as noted above. These findings confirm that <italic>B. animalis</italic> maintains its rod form irrespective of the conditions, implying that this morphology is an intrinsic characteristic. Therefore, <italic>B. animalis</italic> may be used as a reliable control when investigating the bifid nature of <italic>B. adolescentis</italic> (in MRS, at 37°C, and under anaerobic conditions). <italic>B. adolescentis and B. animalis</italic> (a control for rod shape) were exposed to other variable conditions, including various pH (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), for different growth periods (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>), and in different concentrations of salt (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>). The bifid shape was maintained by <italic>B. adolescentis</italic> under all the conditions tested, whereas the control, <italic>B. animalis</italic>, retained the rod form. The bifid shape of <italic>B. adolescentis</italic> were also retained when it was grown for three successive generations under normal conditions (<bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>), in all of which the bifid shape was retained. This further affirms that the intrinsic bifid nature in the case of <italic>B. adolescentis</italic>, and rod shape in the case of <italic>B. animalis</italic>.</p>
        <fig id="F3" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p><bold>Scanning electron microscopy of strains DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis</italic>), DSM 20083 (<italic>B. adolescentis</italic>) in different pH condition</bold>.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g003"/>
        </fig>
        <fig id="F4" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p><bold>Scanning electron microscopy of strains DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis</italic>), DSM 20083 (<italic>B. adolescentis</italic>) in different time interval</bold>.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g004"/>
        </fig>
        <fig id="F5" position="float">
          <label>FIGURE 5</label>
          <caption>
            <p><bold>Scanning electron microscopy of strain DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis</italic>), and DSM 20083 (<italic>B. adolescentis</italic>) in different salts with varied concentration</bold>.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g005"/>
        </fig>
        <fig id="F6" position="float">
          <label>FIGURE 6</label>
          <caption>
            <p><bold>Scanning electron microscopy of strain DSM 20083 (<italic>B. adolescentis</italic>) at three different generations</bold>.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g006"/>
        </fig>
        <p>We also found that most <italic>Bifidobacterium</italic> species stably maintained their morphological (rod) shape, irrespective of the conditions. As shown in the <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, all the <italic>Bifidobacterium</italic> species were intrinsically rod-shaped, except <italic>B. adolescentis</italic>. Few of them adopted the bifid structure, and only under stress conditions (<bold>Figures <xref ref-type="fig" rid="F2">2C,D,F,G</xref></bold>
<italic>B. longum</italic>; where C, D conditions corresponds to <italic>B. breve</italic> [shown in the Supplementary Information], E condition corresponds to <italic>B. thermacidophilum</italic> [shown in the Supplementary Information], and D, F, G conditions corresponds to <italic>B. adolescentis</italic>) [where C refers to the combination of four amino acids; D refer to alanine; E refers to tryptophan; F refers to asparagine; G refers to 0.2 M sodium acetate). However, <italic>B. adolescentis</italic> is intrinsically bifid-shaped and maintains its bifid morphology irrespective of the ambient conditions.</p>
      </sec>
      <sec>
        <title><italic>Caenorhabditis elegans</italic> as a Model Organism for Pleomorphism Studies</title>
        <p>To understand the bifid form of <italic>B. adolescentis</italic> and the forms of other <italic>Bifidobacterium</italic>, <italic>C. elegans</italic> was fed with different <italic>Bifidobacterium</italic> species and observed microscopically and by SEM. Based on chemotaxis study <italic>B. adolescentis</italic> and <italic>B. longum</italic> was considered for the study. Only <italic>B. adolescentis</italic> maintained the bifid shape in the gut of <italic>C. elegans</italic>. The <italic>B. adolescentis</italic>-fed <italic>C. elegans</italic> were dissected and centrifuged, and the supernatant was spread on an MRS agar plate. The numbers of bacteria were counted. The bacterial genomic DNA was isolated, and the 16S rRNA was amplified and analyzed, confirming that the isolated bacteria were <italic>B</italic>. <italic>adolescentis</italic>. The same culture was also subjected to an F6PPK assay, which confirmed the bacterial identity. The same bacteria were examined with confocal microscopy (<bold>Figure <xref ref-type="fig" rid="F7">7</xref></bold>), which confirmed their bifid morphology. Bifidobacteria species other than <italic>B. adolescentis</italic> maintained their intrinsic rod shape in the digestive tracts of the worms, confirming that this is their intrinsic shape, and changes only under stress conditions.</p>
        <fig id="F7" position="float">
          <label>FIGURE 7</label>
          <caption>
            <p><bold>Confocal images of <italic>B. adolescentis</italic> at different magnification (a)</bold> Mag- 10x, <bold>(b,c)</bold> Mag- 60x.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g007"/>
        </fig>
      </sec>
      <sec>
        <title><italic>Bifidobacterium</italic> is the Preferred Food of <italic>C. elegans</italic></title>
        <p>Experiments were performed to understand the ability of <italic>C. elegans</italic> to consume <italic>Bifidobacterium</italic>. The food chosen by <italic>C. elegans</italic> from among probiotic organisms and a control was estimated both qualitatively (<bold>Figures <xref ref-type="fig" rid="F8">8A–D</xref></bold>) and quantitatively (<bold>Figure <xref ref-type="fig" rid="F8">8E</xref></bold>), and represented as the CI. The CI for <italic>B. longum</italic> was 8.5 and 9.8 at 12 and 24 h, respectively, and was 0.7 for <italic>B. adolescentis</italic> at 12 h. <italic>C. elegans</italic> contained no <italic>B. animalis</italic> or <italic>B. adolescentis</italic> at 24 h, indicating that <italic>C. elegans</italic> had not selected them. To validate the bacterial morphology <italic>in vivo</italic>, nematodes that had consumed <italic>B. longum</italic> or <italic>B. adolescentis</italic> were fixed and examined with SEM to determine the shapes of the bacteria at different magnifications (<bold>Figure <xref ref-type="fig" rid="F9">9</xref></bold>).</p>
        <fig id="F8" position="float">
          <label>FIGURE 8</label>
          <caption>
            <p><bold>Chemotaxis assay and chemotactic index (CI) for understanding the food of choice among the other strains by the <italic>Caenorhabditis elegans</italic> in comparison with control <italic>Escherichia coli</italic> OP50 vs. (A)</bold> DSM 10140 <bold>(B)</bold> DSM 20083 <bold>(C)</bold> DSM 20219 and <bold>(D)</bold> in combination with all. <bold>(E)</bold> If CI = –1.0 represents complete preference for <italic>E. coli</italic> OP50. +1.0 represents complete preference for the test bacterium. 0.0 represents an equal distribution.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g008"/>
        </fig>
        <fig id="F9" position="float">
          <label>FIGURE 9</label>
          <caption>
            <p><bold>Morphology of <italic>B. adolescentis</italic> (DSM 20083) and, <italic>B. longum</italic> (DSM 20219) in <italic>C. elegans</italic> with different magnification (Mag). (A)</bold> DSM 20083 (<italic>B. adolescentis</italic>) in <italic>C. elegans</italic> Mag-1000x; <bold>(B)</bold> DSM 20083 (<italic>B. adolescentis</italic>) in <italic>C. elegans</italic> Mag-20,000x; <bold>(C)</bold> DSM 20219 (<italic>B. longum</italic>) in <italic>C. elegans</italic> Mag-5000x; <bold>(D)</bold> DSM 20219 (<italic>B. longum</italic>) in <italic>C. elegans</italic> Mag-50, 000x.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g009"/>
        </fig>
        <p>The results in the <bold>Figure <xref ref-type="fig" rid="F8">8E</xref></bold> clearly show that the nematodes greatly preferred <italic>Bifidobacterium</italic> to <italic>E. coli</italic> OP50 as its staple food. <italic>Caenorhabditi</italic>s also expressed a preference among the three different <italic>Bifidobacterium</italic> species tested, so <italic>C. elegans</italic> may be the best model organism in which to investigate this polymorphism of <italic>Bifidobacterium</italic>. We assayed the preference of <italic>C. elegans</italic> for bacterial species <italic>B. longum, B. adolescentis</italic>, and <italic>B. animalis</italic>. The nematodes showed a preference for <italic>B. longum</italic> over <italic>B. adolescentis</italic> and <italic>B. animalis</italic> (<bold>Figures <xref ref-type="fig" rid="F8">8A–D</xref></bold>). The histogram shows the CIs of wild-type <italic>C. elegans</italic> for bacterial strains <italic>B. longum</italic>, <italic>B. adolescentis</italic>, and <italic>B. animalis</italic> at 12 and 24 h (<bold>Figure <xref ref-type="fig" rid="F8">8E</xref></bold>). The data are the means ± SD of three independent biological replicates.</p>
        <p>The health benefits of probiotic microbes are only observed when they reach the colon, after passing through the small intestine (low pH), and large intestine (alkaline conditions). During their progress, they are exposed to very harsh conditions. To understand the effects on their morphology, these Bifidobacteria were subjected to different pH. When exposed to increasing pH (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), <italic>B. adolescentis</italic> slowly became coccoid, with a dramatic reduction in bifid bacteria. At pH 5.5, they maintained the bifid structure, but as the pH increased to 6, the bifid structure started to diminish, and at pH 7 and 7.5, the number of coccoid structures predominated, although no pointed elongated rods were observed (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). This phenomenon indicates that before it reaches its destination, the morphology of <italic>B. adolescentis</italic> changes frequently to accommodate the ambient conditions. Bacterial movement may be faster in the coccoid state, and this state may be favored when no adhesion is required. For adhesion, a larger and rougher bacterial surface area is required, and therefore a bifid shape is favored. Thus, <italic>B. adolescentis</italic> always maintained its bifid shape, unless it senses adverse conditions, when its morphology changes.</p>
        <p>When Bifidobacterial species were grown in the presence of different salts (0.2 M sodium acetate or 0.25 M sodium chloride) (<xref rid="B16" ref-type="bibr">Kojima et al., 1968</xref>), SEM clearly showed that there were no dramatic changes in their morphologies (<bold>Figures <xref ref-type="fig" rid="F2">2G,H</xref></bold>). A slight elongation of the rods was the only visible difference between salt-exposed <italic>B. longum</italic> and control <italic>B. longum</italic>. Importantly, the presence of lower concentration (0.001–0.01 M) NaCl did not affect the morphology of <italic>B. adolescentis</italic>, and its bifid structure did not change to the rod form. The bifid structure was observed at lower concentrations of salt, and as the concentration of salt increased, the bacteria assumed the rod shape. The rod structures started to diminish at a salt concentration of 0.005–0.01 M, whereas the bifid form started to shorten, until at 0.25 M salt, no bifid structures were seen (<bold>Figure <xref ref-type="fig" rid="F2">2H</xref></bold>, condition of <italic>B. adolescentis</italic>).</p>
        <p>Scanning electron microscopy also showed that <italic>Bifidobacterium</italic> other than <italic>B. adolescentis</italic> adopted the bifid form, but only very rarely, and only under stress conditions (<bold>Figures <xref ref-type="fig" rid="F2">2B–H</xref></bold>). Therefore, it is clear that the bifid form is an intrinsic to <italic>B. adolescentis</italic>, but not to the other <italic>Bifidobacterium</italic> species, although a few Bifidobacterial species adopt the bifid form under stress conditions. <xref rid="B16" ref-type="bibr">Kojima et al. (1968)</xref> reported that changes to the bifid form occurred in different generations of <italic>Bifidobacterium</italic>, but our study clearly shows that the first, second and third generations of <italic>B. adolescentis</italic> maintained the bifid morphology (<bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>). Dramatic changes in <italic>B. adolescentis</italic> were only observed when it was exposed to different pH (pH 5.5–7.5), when it adopted a coccoid shape (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Therefore, the number of coccus-shaped bacteria was much higher depicted in the initiation of coccus formation, but reverted back to the bifid form. CaCl<sub>2</sub> plays a significant role in the conversion of <italic>Bifidobacterium</italic> from the bifid shape to the rod form, suggesting the involvement of calmodulin or a similar molecule. This phenomenon was observed when <italic>B. adolescentis</italic> were subjected to different concentrations of CaCl<sub>2</sub> (0.001–0.01 M). As the calcium concentration increased, the cells became rod-shaped, short, and bulging, with terminal buttons, and they also aggregated (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>).</p>
        <p>We examined <italic>B. longum</italic> in experiments similar to those described above because it bears an intrinsic elongated rod structure. As recorded in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, no dramatic changes were observed under different conditions, except when the cells were exposed to 42°C, their rod structures changed to extend elongated rods. At higher oxygen concentrations (10%), they aggregated and became elongated, with button/hyphal structures at their ends. When the concentration of oxygen was reduced, the hypha-like structures and cell aggregation, decreased (data not shown). A low concentration of calcium chloride (0.001 M) caused some defects, including cell shrinkage, the formation of wrinkles or holes, etc. As the levels increased from 0.005 to 0.01 M, the cells started out to change from rod-shaped to extensively elongated rods, as well as the bifid form. At all concentrations of CaCl<sub>2</sub>, the ratio of bifid-shaped <italic>B. adolescentis</italic> were drastically reduced in number (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>, DSM 20083). Structural alterations of different Bifidobacterial species subjected to different conditions are summarized in <bold>Figure <xref ref-type="fig" rid="F10">10</xref></bold>.</p>
        <fig id="F10" position="float">
          <label>FIGURE 10</label>
          <caption>
            <p><bold>Bifidobacterial species subjected to different conditions and their response are shown in the form of a wheel. (A–E)</bold> Shows summary of the Bifidobacteria and their morphologies after exposure to different conditions. Different strains of Bifidobacteria and their inter changed morphologies after subjected to different conditions are depicted. <bold>(A)</bold> bifid shape, <bold>(B)</bold> elongated rod (ER), <bold>(C)</bold> short rod (SR), <bold>(D)</bold> cocci, <bold>(E)</bold> different conditions.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00478-g010"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Many researchers have claimed that the <italic>Bifidobacterium</italic> species are strictly anaerobic, but no research has supported this theory. From our findings, we conclude that the <italic>Bifidobacterium</italic> species are microaerophilic because they can grow in the presence of a certain level of oxygen after the first generation. <xref rid="B37" ref-type="bibr">Weiss (1933)</xref> and <xref rid="B38" ref-type="bibr">Weiss and Rettger (1938)</xref> reported that <italic>L. bifidus</italic> and <italic>L. acidophilus</italic> is closely related, and are variants of the same species. This hypothesis was rejected for lack of evidence. Subsequently, <xref rid="B22" ref-type="bibr">Orla-Jensen (1943)</xref> reported that <italic>B. bifidum</italic> should be included in the order Actinomycetales. Weiss and Rettger later concluded that respect were two different kinds of <italic>Bifidobacterium</italic>: type 1 is aerobic and unbranched during primary isolation, and type 2 is anaerobic and branched. <xref rid="B38" ref-type="bibr">Weiss and Rettger (1938)</xref> proposed that all these organisms should be retained in <italic>Lactobacillus</italic>, but not in Actinomycetales. Established on the hypothesis of Weiss and Rettger, the Topley and Wilson’s Microbiology and Microbial Infection and Bergey’s Manual of Systematic Bacteriology adopted this classification. Orla-Jensen then proposed that the genus name should be converted to ‘<italic>Corynebacterium.</italic>’ It was reasoned that the use of different growth media for these bacteria may have caused the confusion concerning their nomenclature. These matters remain open today because most of these species are nevertheless brought up to as <italic>Bifidobacterium</italic>, although most are rod-formed. In 1967, using simple microscopy (not SEM), Masami Kojima found that cations play a significant role in the initiation of the bifid form. Nevertheless, we found that cations do not play a substantial role in bifid formation, although they induce the formation of elongated rods. To see the effects of NaCl on the bifidobacterial bifid and rod shapes, <italic>B. animalis</italic> subsp. <italic>lactis</italic> and <italic>B. adolescentis</italic> were grown in media containing 0.001–0.01 M salt (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>) (<xref rid="B16" ref-type="bibr">Kojima et al., 1968</xref>). Both strains maintained their intrinsic morphologies, although at 0.25 M NaCl, <italic>B. adolescentis</italic> reverted from a bifid to a rod-shaped structure (<bold>Figure <xref ref-type="fig" rid="F2">2H</xref></bold>). The <italic>B. adolescentis</italic> changes its intrinsic nature of bifid to rod when they are grown in bifid media (<bold>Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">S2</xref></bold>) and remains same in the presence of amino acid such as asparagine, tryptophan, alanine (individually) (<bold>Supplementary Figure <xref ref-type="supplementary-material" rid="SM3">S3</xref></bold>) which is necessary for the branching of the bacteria (<xref rid="B13" ref-type="bibr">Husain et al., 1972</xref>).</p>
      <p>These present studies showed that CaCl<sub>2</sub> plays a major part in abolishing the bifid shape, which is the intrinsic morphology of <italic>B. adolescentis</italic>. Nevertheless, no significant conclusions were drawn from <xref rid="B17" ref-type="bibr">Kojima et al. (1970)</xref> research group involving the effects of cations on the bifid form of <italic>Bifidobacterium</italic>. <xref rid="B16" ref-type="bibr">Kojima et al. (1968)</xref> concluded that a calcium-free environment induces the bifid state, whereas the presence of calcium induces the bacilloid form. Yet, in the present study, CaCl<sub>2</sub> induced the bacillus form of <italic>B. adolsecentis</italic>, despite its intrinsic bifid morphology. Therefore, although the bifid form is the intrinsic morphology of a few <italic>Bifidobacterial</italic> species, this is not absolute. CaCl<sub>2</sub> may be considered a suppressor of the bifid state, supporting the proposition that there are calmodulins, calmodulin-like proteins in the <italic>Bifidobacterium</italic> species.</p>
      <p>Our SEM analysis clearly shows that the growth medium (bifidobacteria broth or MRS) and different conditions (such as various temperatures, pH, and salts) do play a major part in the pleomorphic morphology of the <italic>Bifidobacterium</italic>. The presence and absence of amino acids did not (dramatically) affect their morphologies, converting the rod structure to the bifid form or to cocci, or the bifid form to the rod form. Not all <italic>Bifidobacterium</italic> have a bifid morphology, and only a very few are intrinsically bifid-shaped, such as <italic>B. adolescentis.</italic> It is well-demonstrated in this study that the intrinsic morphologies of these bacteria are rod-shaped, and all but a few do not adopt the bifid form, even after exposure to stress conditions. Thus, the rod structure is the intrinsic morphology of most bifidobacterial species. These data confirm the theory that the name ‘<italic>Bifidobacterium</italic>’ is a misnomer. Therefore, taxonomists must revisit this name by picking up more data in the near future.</p>
      <p>As we expected, <italic>Bifidobacterium</italic> was the intellectual nourishment of choice for the eukaryotic model system, <italic>C. elegans</italic>, although the standard food offered <italic>C. elegans</italic> experimentally has been <italic>E. coli</italic> OP50. The nematodes tended to indicate a preference for <italic>Bifidobacterium</italic> over <italic>E. coli</italic> OP50. <italic>C. elegans</italic> also differentiates among the <italic>Bifidobacterium</italic>, as seen in <bold>Figure <xref ref-type="fig" rid="F8">8</xref></bold>. Of the three <italic>Bifidobacterium</italic> species given as food, <italic>C. elegans</italic> preferred <italic>B. longum</italic> over <italic>B. adolescentis</italic> and <italic>B. animalis</italic>. The morphology of Bifidobacteria is intrinsically determined; the external factors don’t have anything to do with the same, example <italic>B. adolescentis.</italic> Equally it is the only strain out of eight tested in our study retained its bifid shape in the extremities.</p>
    </sec>
    <sec>
      <title>Author Contributions</title>
      <p>D executed the idea; RK conceptualized, planned, designed, analyzed, Interpreted results and wrote the manuscript. SR and BK all the <italic>C. elegans</italic> work planning and execution.</p>
    </sec>
    <sec>
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The Department of Biotechnology, India, the Director CFTRI, Mysore are appreciated for providing the facilities and funds. We also acknowledge Mr. Anbalagan, Department of CIFS, SEM and Confocal expert for helping us to capture the best possible pictures. The UGC-CSIR fellowship for D has been highly appreciated.</p>
    </ack>
    <sec sec-type="supplementary material">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.00478/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2017.00478/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <label>FIGURE S1</label>
        <caption>
          <p><bold>Scanning electron microscopy of strains DSM 15837 (<italic>B. thermoacidophilus</italic>), DSM 20088 (<italic>B. infantis</italic>), DSM 20089 (<italic>B. asteroides</italic>), DSM 20105 (<italic>B. animalis</italic>), DSM 20213 (<italic>B. breve</italic>) with different conditions like (A)</bold> 37°C, <bold>(B)</bold> 42°C, <bold>(C)</bold> media with alanine, aspartate, glutamate, serine, <bold>(D)</bold> media with alanine, <bold>(E)</bold> media with tryptophan, <bold>(F)</bold> media with asparagine, media with 0.2 M sodium acetate, media with 0.25 M sodium chloride, <bold>(G)</bold> media with 0.2 M sodium acetate, <bold>(H)</bold> media with 0.25 M sodium chloride.</p>
        </caption>
        <media xlink:href="Image_1.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S1">
        <media xlink:href="Image_1.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <label>FIGURE S2</label>
        <caption>
          <p><bold>Scanning electron microscopy of strains DSM 10140 (<italic>B. animalis</italic> subspp. <italic>lactis</italic>), DSM 20083 (<italic>B. adolescentis</italic>) in bifid media at time interval</bold>.</p>
        </caption>
        <media xlink:href="Image_2.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <media xlink:href="Image_2.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM3">
        <label>FIGURE S3</label>
        <caption>
          <p><bold>Scanning electron microscopy of strains DSM 10140 (<italic>B. animalis</italic> subspp. lactis), DSM 20083 (<italic>B. adolescentis</italic>) in bifid media with (A)</bold> asparagine, <bold>(B)</bold> tryptophan, <bold>(C)</bold> alanine. Food choice assay: assaying the preference of <italic>C. elegans</italic> for bacterial species <italic>B. longum, B. adolescentis</italic>, and <italic>B. animalis</italic>. Nematodes showed a greater preference for <italic>B. longum</italic> than for <italic>B. adolescentis</italic>, or <italic>B. animalis</italic>. Chemotaxis assay: the histogram shows the chemotaxis index (CI) of wild-type <italic>C. elegans</italic> toward bacterial strains 20219, 20083, and 10140 after 12 and 24 h. Data are the means ± SD of three independent biological replicates.</p>
        </caption>
        <media xlink:href="Image_3.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S3">
        <media xlink:href="Image_3.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beerens</surname><given-names>H.</given-names></name><name><surname>Gavini</surname><given-names>E.</given-names></name><name><surname>Neet</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>Effect of exposure to air on 84 different strains of Bifidobacteria.</article-title>
<source><italic>Anaerobe</italic></source>
<volume>6</volume>
<fpage>65</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1006/anae.1999.0317</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaurock</surname><given-names>G.</given-names></name></person-group> (<year>1937</year>). <article-title>Zur Physiologie der Bifidusbakterien.</article-title>
<source><italic>Monatsschr. Kinderheilk.</italic></source>
<volume>68</volume>
<fpage>304</fpage>–<lpage>309</lpage>.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliuhdorn</surname><given-names>K.</given-names></name></person-group> (<year>1910</year>). <article-title>Untersuchugen uiber den <italic>Bacillus</italic> bifidus communis und den so gen. <italic>Bacillus acidophilus</italic> (<italic>Streptobacillus faecalis</italic>).</article-title>
<source><italic>Jahrb. Kinderheilk</italic></source>
<volume>72</volume>
<fpage>693</fpage>–<lpage>704</lpage>.</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottacini</surname><given-names>F.</given-names></name><name><surname>Ventura</surname><given-names>M.</given-names></name><name><surname>van Sinderen</surname><given-names>D.</given-names></name><name><surname>Motherway</surname><given-names>M. O. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Diversity, ecology and intestinal function of bifidobacteria.</article-title>
<source><italic>Microb. Cell Fact.</italic></source>
<volume>13(Suppl. 1)</volume>
<issue>S4</issue>
<pub-id pub-id-type="doi">10.1186/1475-2859-13-S1-S4</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boventer</surname><given-names>K.</given-names></name></person-group> (<year>1938</year>). <article-title>Untersuchungen fiber das bacterium bifidum.</article-title>
<source><italic>Zentralbl. Bakteriol. Parasitenk. Infektionskr. Hyg. Abt. Orig.</italic></source>
<volume>142</volume>
<fpage>419</fpage>–<lpage>430</lpage>.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>S.</given-names></name></person-group> (<year>1974</year>). <article-title>The genetics of <italic>Caenorhabditis elegans</italic>.</article-title>
<source><italic>Genetics</italic></source>
<volume>77</volume>
<fpage>71</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">4366476</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruickshank</surname><given-names>R.</given-names></name></person-group> (<year>1925</year>). <article-title><italic>Bacillus</italic> bifidus: its characters and isolation from the intestine of infants.</article-title>
<source><italic>J. Hyg.</italic></source>
<volume>24</volume>
<fpage>241</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1017/S0022172400008718</pub-id><pub-id pub-id-type="pmid">20474862</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Xin</surname><given-names>Y.</given-names></name><name><surname>Jian</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ling</surname><given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title><italic>Bifidobacterium thermacidophilum</italic> sp. nov., isolated from an anaerobic digester.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>50</volume>
<fpage>119</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1099/00207713-50-1-119</pub-id><pub-id pub-id-type="pmid">10826794</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garsin</surname><given-names>D. A.</given-names></name><name><surname>Sifri</surname><given-names>C. D.</given-names></name><name><surname>Mylonakis</surname><given-names>E.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name><name><surname>Singh</surname><given-names>K. V.</given-names></name><name><surname>Murray</surname><given-names>B. E.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>A simple model host for identifying gram-positive virulence factors.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>98</volume>
<fpage>10892</fpage>–<lpage>10897</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.191378698</pub-id><pub-id pub-id-type="pmid">11535834</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Herter</surname><given-names>C. A.</given-names></name></person-group> (<year>1907</year>). <source><italic>The Common Bacterial Infections of the Digestive Tract and the Intoxications Arising from Them.</italic></source>
<publisher-loc>London</publisher-loc>: <publisher-name>Macmillan</publisher-name>
<pub-id pub-id-type="doi">10.5962/bhl.title.30633</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homma</surname><given-names>N.</given-names></name><name><surname>Ota</surname><given-names>J.</given-names></name><name><surname>Arai</surname><given-names>S.</given-names></name></person-group> (<year>1960</year>). <article-title>Various carbonates affecting the branching of <italic>Lactobacillus</italic> bifidus.</article-title>
<source><italic>Jpn. J. Pediatr.</italic></source>
<volume>13</volume>:<issue>1274</issue>.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hope</surname><given-names>I. A.</given-names></name></person-group>
<role>(ed.)</role> (<year>1999</year>). <source><italic>C. elegans: A Practical Approach</italic></source>
<volume>(Vol. 213)</volume>
<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>I.</given-names></name><name><surname>Poupard</surname><given-names>J. A.</given-names></name><name><surname>Norris</surname><given-names>R. F.</given-names></name></person-group> (<year>1972</year>). <article-title>Influence of nutrition on the morphology of a strain of <italic>Bifidobacterium bifidum</italic>.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>111</volume>
<fpage>841</fpage>–<lpage>844</lpage>.<pub-id pub-id-type="pmid">5053884</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>S.</given-names></name><name><surname>Mimura</surname><given-names>T.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Nimura</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Response of the microaerophilic <italic>Bifidobacteria</italic> spp <italic>B. boum</italic> and <italic>B. thermophilum</italic> to oxygen.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>72</volume>
<fpage>6854</fpage>–<lpage>6858</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01216-06</pub-id><pub-id pub-id-type="pmid">16950914</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>A. I.</given-names></name><name><surname>Haner</surname><given-names>R. C.</given-names></name></person-group> (<year>1924</year>). <article-title><italic>Bacillus</italic> Bifidus: LXXI. studies in bacterial metabolism.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>35</volume>
<fpage>77</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/35.1.77</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>M.</given-names></name><name><surname>Suda</surname><given-names>S.</given-names></name><name><surname>Hotta</surname><given-names>S.</given-names></name><name><surname>Hamada</surname><given-names>K.</given-names></name></person-group> (<year>1968</year>). <article-title>Induction of pleomorphism in <italic>Lactobacillus</italic> bifidus.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>95</volume>
<fpage>710</fpage>–<lpage>711</lpage>.<pub-id pub-id-type="pmid">5640389</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>M.</given-names></name><name><surname>Suda</surname><given-names>S.</given-names></name><name><surname>Hotta</surname><given-names>S.</given-names></name><name><surname>Hamada</surname><given-names>K.</given-names></name></person-group> (<year>1970</year>). <article-title>Induction of pleomorphy and calcium ion deficiency in <italic>Lactobacillus</italic> bifidus.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>102</volume>
<fpage>217</fpage>–<lpage>220</lpage>.<pub-id pub-id-type="pmid">5437726</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meile</surname><given-names>L.</given-names></name><name><surname>Ludwig</surname><given-names>W.</given-names></name><name><surname>Rueger</surname><given-names>U.</given-names></name><name><surname>Gut</surname><given-names>C.</given-names></name><name><surname>Kaufmann</surname><given-names>P.</given-names></name><name><surname>Dasen</surname><given-names>G.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title><italic>Bifidobacterium lactis</italic> sp. nov., a moderately oxygen tolerant species isolated from fermented milk.</article-title>
<source><italic>Syst. Appl. Microbiol.</italic></source>
<volume>20</volume>
<fpage>57</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/S0723-2020(97)80048-3</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>1969</year>). <article-title>Comparative studies on bifidobacteria isolated from the alimentary tract of man and animals (including descriptions of <italic>Bifidobacterium thermophilum</italic> nov. spec. and <italic>Bifidobacterium pseudolongum</italic> nov. spec).</article-title>
<source><italic>Zentralbl. Bakteriol. Orig.</italic></source>
<volume>210</volume>
<fpage>52</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">5361078</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>E.</given-names></name></person-group> (<year>1905</year>). <article-title>Morphologische und biologische Untersuchungen über die Darmbakterien des Säuglings.</article-title>
<source><italic>Jb. Kinderheik</italic></source>
<volume>62</volume>:<issue>687</issue>.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>R. F.</given-names></name><name><surname>Flanders</surname><given-names>T.</given-names></name><name><surname>Tomarelli</surname><given-names>R. M.</given-names></name><name><surname>György</surname><given-names>P.</given-names></name></person-group> (<year>1950</year>). <article-title>The isolation and cultivation of <italic>Lactobacillus</italic> bifidus: a comparison of branched and unbranched strains.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>60</volume>
<fpage>681</fpage>–<lpage>696</lpage>.<pub-id pub-id-type="pmid">14824062</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orla-Jensen</surname><given-names>S.</given-names></name></person-group> (<year>1943</year>). <article-title>The lactic acid bacteria.</article-title>
<source><italic>Ergainzungsband. Mem. Acad. Roy. Sci., Danemark, Sect. Sci. Biol.</italic></source>
<volume>2</volume>
<fpage>1</fpage>–<lpage>145</lpage>.</mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><collab>Reuter</collab> (<year>1963</year>). <article-title>Identisch mit <italic>Bifidobacterium</italic> adolescentis.</article-title>
<source><italic>Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. Reihe A</italic></source>
<volume>226</volume>
<fpage>257</fpage>–<lpage>263</lpage>.</mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodella</surname><given-names>A.</given-names></name></person-group> (<year>1908</year>). <article-title>Magen Carcinoma und Milchsaure Bacillen.</article-title>
<source><italic>Centralbl. f. Bakt., Abt. I</italic></source>
<volume>47</volume>
<fpage>445</fpage>–<lpage>466</lpage>.</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>C.</given-names></name></person-group> (<year>1927</year>). <article-title>Cultural characteristics (variation of <italic>Bacillus</italic> acidophilus).</article-title>
<source><italic>J. Lab. Clin. Med.</italic></source>
<volume>12</volume>:<issue>1053</issue>.</mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>L.</given-names></name><name><surname>Gueimonde</surname><given-names>M.</given-names></name><name><surname>Ruas-Madiedo</surname><given-names>P.</given-names></name><name><surname>Ribbera</surname><given-names>A.</given-names></name><name><surname>Delos Reyes-Gavilan</surname><given-names>C.</given-names></name><name><surname>Ventura</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Molecular clues to understand the aerotolerance phenotype of <italic>Bifidobacterium</italic> animalis subsp. lactis.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>78</volume>
<fpage>644</fpage>–<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.05455-11</pub-id><pub-id pub-id-type="pmid">22101052</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scardovi</surname><given-names>V.</given-names></name><name><surname>Trovatelli</surname><given-names>L. D.</given-names></name></person-group> (<year>1969</year>). <article-title>New species of bifid bacteria from <italic>Apis mellifica</italic> L. and <italic>Apis indica</italic> F. A contribution to the taxonomy and biochemistry of the genus <italic>Bifidobacterium</italic>.</article-title>
<source><italic>Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg.</italic></source>
<volume>123</volume>
<fpage>64</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">4908741</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stiernagle</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>“Maintenance of <italic>C. elegans</italic>,” in</article-title>
<source><italic>C. elegans A Practical Approached</italic></source>
<role>ed.</role>
<person-group person-group-type="editor"><name><surname>Hope</surname><given-names>I. A.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>) <fpage>51</fpage>–<lpage>67</lpage>.</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundman</surname><given-names>V.</given-names></name><name><surname>Björksten</surname><given-names>K. A.</given-names></name><name><surname>Gyllenberg</surname><given-names>H. G.</given-names></name></person-group> (<year>1959</year>). <article-title>Morphology of the bifid bacteria (organisms previously incorrectly designated <italic>Lactobacillus</italic> bifidus) and some related genera.</article-title>
<source><italic>Microbiology</italic></source>
<volume>21</volume>
<fpage>371</fpage>–<lpage>384</lpage>.</mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synder</surname><given-names>M. L.</given-names></name><name><surname>Slawson</surname><given-names>M. S.</given-names></name><name><surname>Bullock</surname><given-names>W.</given-names></name><name><surname>Parker</surname><given-names>R. B.</given-names></name></person-group> (<year>1967</year>). <article-title>Studies on oral filamentous bacteria. II. Serological relationships within the genera <italic>Actinomyces</italic>, <italic>Nocardia</italic>, <italic>Bacterionema</italic> and <italic>Leptotrichia</italic>.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>117</volume>
<fpage>341</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/117.4.341</pub-id><pub-id pub-id-type="pmid">4965337</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tissier</surname><given-names>H.</given-names></name></person-group> (<year>1900</year>). <source><italic>Recherches sur la Flore Intestinale des Nourrissons: état Normal et Pathologique.</italic></source>
<publisher-loc>Paris</publisher-loc>: <publisher-name>G. Carré et C. Naud</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tissier</surname><given-names>H.</given-names></name></person-group> (<year>1905</year>). <article-title>Repartition des microbes dans l’intestin du nourisson.</article-title>
<source><italic>Ann. Inst. Pasteur</italic></source>
<volume>19</volume>
<fpage>109</fpage>–<lpage>123</lpage>.</mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tissier</surname><given-names>M. H.</given-names></name></person-group> (<year>1899</year>). <article-title>La reaction chromophile d’Escherich et le Bacterium coli.</article-title>
<source><italic>CR Acad. Sci. Ser. III Sci. Life Sci.</italic></source>
<volume>51</volume>
<fpage>943</fpage>–<lpage>945</lpage>.</mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomarelli</surname><given-names>R. M.</given-names></name><name><surname>Norris</surname><given-names>R. F.</given-names></name><name><surname>Gyorgy</surname><given-names>P.</given-names></name></person-group> (<year>1949a</year>). <article-title>Inability of vitamin B12 to replace the deoxyriboside requirement of a <italic>Lactobacillus</italic> bifidus.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>179</volume>
<fpage>485</fpage>–<lpage>486</lpage>.<pub-id pub-id-type="pmid">18119262</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomarelli</surname><given-names>R. M.</given-names></name><name><surname>Norris</surname><given-names>R. F.</given-names></name><name><surname>Gyorgy</surname><given-names>P.</given-names></name><name><surname>Hassinen</surname><given-names>J. B.</given-names></name><name><surname>Bernhart</surname><given-names>F. W.</given-names></name></person-group> (<year>1949b</year>). <article-title>The nutrition of variants of <italic>Lactobacillus</italic> bifidus.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>181</volume>
<fpage>879</fpage>–<lpage>888</lpage>.<pub-id pub-id-type="pmid">15407057</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>S.</given-names></name></person-group> (<year>1973</year>). <article-title>Chemotaxis by the nematode <italic>Caenorhabditis elegans</italic>: identification of attractants and analysis of the response by use of mutants.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>70</volume>
<fpage>817</fpage>–<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.70.3.817</pub-id><pub-id pub-id-type="pmid">4351805</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. E.</given-names></name></person-group> (<year>1933</year>). Lactobacillus bifidus Tissier and Its Biological Position in the Group of Aciduric Organisms. Ph.D. Dissertation, Yale University, New Haven, CT.</mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. E.</given-names></name><name><surname>Rettger</surname><given-names>L. F.</given-names></name></person-group> (<year>1938</year>). <article-title>Taxonomic relationships of Lactobacillus bifidus (B. bifidus Tissier) and <italic>Bacteroides</italic> bifidus.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>62</volume>
<fpage>115</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/62.1.115</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list id="DL1">
        <def-item>
          <term>bp</term>
          <def>
            <p>base pair</p>
          </def>
        </def-item>
        <def-item>
          <term>F6PPK</term>
          <def>
            <p>fructose-6-phosphate phosphoketolase</p>
          </def>
        </def-item>
        <def-item>
          <term>Ocins</term>
          <def>
            <p>antimicrobial peptides/proteins of <italic>Lactobacillus, Bifidobacteria</italic> and <italic>Enterococcus</italic> spp.</p>
          </def>
        </def-item>
        <def-item>
          <term>OD</term>
          <def>
            <p>optical density</p>
          </def>
        </def-item>
        <def-item>
          <term>
            <italic>xfp</italic>
          </term>
          <def>
            <p>xylulose-5-phosphate/fructose-6-phosphate phosphoketolase.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359851</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359851</article-id>
      <article-id pub-id-type="pmcid">PMC5359851</article-id>
      <article-id pub-id-type="pmc-uid">5359851</article-id>
      <article-id pub-id-type="publisher-id">jri-17-151</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Are Scholarly Journals in Search for Top Quality Articles or Authors in Search for High Quality Journals?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sadeghi</surname>
            <given-names>Mohammad Reza</given-names>
          </name>
          <role>Editor-in-chief</role>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>151</fpage>
      <lpage>152</lpage>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>The end of the industrial era began from the middle of the twentieth century and the world has entered a new era of information and communication. The rapid developments in science and technology were the driving force of this transformation. In the 21st century, the need for qualitative and quantitative changes in access to information and knowledge resources is quite evident. Without a doubt, one of the most important resources for quick and easy access to updated research and scientific contents for researchers and scientists is academic journals. These journals contribute to the quantitative and qualitative development and evolution of research and they are very important tools for solving underlying problems in the field of sciences and community and also the transfer of knowledge between scientists and the community. The development of universities, institutes and research centers led to increased scientific findings and subsequently the increase in the number and diversity of academic journals. Currently, scientific journals are highly specialized in various topics. In each topic, over tens to hundreds of specialty and subspecialty journals are published. Therefore, the need for ranking and separating high-quality journals from poor-quality journals is quite evident and necessary. Although the content of human scientific findings is growing with incredible speed, the issue of concern is accelerating the publication of academic journals on the scientific contents and findings of researchers.</p>
    <p>According to data published in Scientometrics journal (2010), growth rate of publication of scholarly journals is more than 5.6% per year; therefore, the number of journals was doubled in the period of 10–15 years. The growth was in such a way that the number of scholarly journals in the year 1950 was estimated about 60,000 and according to above growth rate, 50 years later in 2000, it reached to about 1,000,000 (<xref rid="B1" ref-type="bibr">1</xref>). Recently, the number is estimated to be 2,000,000 with reference to the double increase during the previous 10–15 years. However, it seems that this estimation of growth rate and total numbers is not a correct calculation and far from reality.</p>
    <p>On the other hand, the STM report about the occasion on celebrating the 350th anniversary of scientific and scholarly journals has revealed that the number of active scholarly peer-reviewed journals was 28100 in English language and 6450 in other languages in 2014 (<xref rid="B2" ref-type="bibr">2</xref>).</p>
    <p>In addition, the research of Arif Jinha at Ottawa University declared that the number of scholarly articles passed 50 million in 2009 (<xref rid="B3" ref-type="bibr">3</xref>).</p>
    <p>It is estimated that 2.5 million articles will be added in this collection annually (<xref rid="B2" ref-type="bibr">2</xref>).</p>
    <p>If the last two above numbers (50 and 2.5 million articles) are taken into account, it seems that the number of about 35000 is more similar to reality for scholarly journals and two or even one million are too far from reality.</p>
    <p>Despite the crucial role of academic journals in the development and dissemination of science and knowledge, especially high quality journals, a lot of scholarly journals do not have minimum quality requirements. Unfortunately, as the number of publishing journals increases, the number of fake and low quality journals also rises. The growth rate of scholarly journals is estimated to be about 3.5% per year; however, this rate for published articles is less than 3% (<xref rid="B2" ref-type="bibr">2</xref>). This led to intense competition among the journals to get top quality articles; therefore, it is obvious that the journals with lower quality and discipline are inevitable losers in this competition.</p>
    <p>Moreover, although open access strategy of many scholarly journals is an excellent policy for free access of scientists, researchers and students to updated research and knowledge, but this makes the suppliers to receive the journal’s cost from students, research centers and universities and transfer it to the authors of articles. As a result, a lot of journals for meeting their expenses are forced to accept low quality papers. All of us as researchers, who have at least a few articles published in qualified journals, are witness of this struggle and competition between journals when we receive various and frequent e-mails to supply their expenses.</p>
    <p>Therefore, a systematic review on journals’ outline including their establishment, identity of owner, identity of publisher, financing, supplying, evaluation and publication of articles, and finally quality assessment and condition of journals should be performed by the scientific community and professional societies.</p>
    <p>Actually, the scientific community is a wanderer in a real forest of scholarly journals in which the absence of a roadmap and full attention will thus lead to deviation from the main road.</p>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>PO</given-names></name><name><surname>von Ins</surname><given-names>M.</given-names></name></person-group>
<article-title>The rate of growth in scientific publication and the decline in coverage provided by Science Citation Index</article-title>. <source>Scientometrics</source>. <year>2010</year>;<volume>84</volume>(<issue>3</issue>):<fpage>575</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">20700371</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>M</given-names></name><name><surname>Mabe</surname><given-names>M.</given-names></name></person-group>
<source>The STM Report: An overview of scientific and scholarly journal publishing</source>. <edition>4th ed.</edition>
<publisher-loc>Netherlands</publisher-loc>: <publisher-name>International Association of Scientific, Technical and Medical Publishers</publisher-name>; <year>2015</year>
<fpage>180</fpage> p.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jinha</surname><given-names>AE.</given-names></name></person-group>
<article-title>Article 50 million: an estimate of the number of scholarly articles in existence</article-title>. <source>Learn Publ</source>. <year>2010</year>;<volume>23</volume>(<issue>3</issue>):<fpage>258</fpage>–<lpage>63</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359852</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359852</article-id>
      <article-id pub-id-type="pmcid">PMC5359852</article-id>
      <article-id pub-id-type="pmc-uid">5359852</article-id>
      <article-id pub-id-type="publisher-id">jri-17-153</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sociological Study on the Transformation of Fertility and Childbearing Concept in Iran</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Behjati-Ardakani</surname>
            <given-names>Zohreh</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navabakhsh</surname>
            <given-names>Mehrdad</given-names>
          </name>
          <xref ref-type="aff" rid="AFF3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hosseini</surname>
            <given-names>Seyed Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="AFF4">
            <sup>4</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
        <aff id="AFF2"><label>2-</label> Avicenna Infertility Clinic, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
        <aff id="AFF3"><label>3-</label> Faculty of Humanistic and Social Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</aff>
        <aff id="AFF4"><label>4-</label> Department of Sociology, University of Tehran, Tehran, Iran</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Seyed Hassan Hosseini, Department of Sociology, University of Tehran, Tehran, Iran, <italic>E-mail:</italic><email>shhoseini@uti.ac.ir</email>; <email>hosseini_1332@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>153</fpage>
      <lpage>161</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Fertility and childbearing, in addition to the biological aspects, has always been regarded as a social phenomenon and, therefore, to understand the incident, values and beliefs, norms, and in short, the culture of any society should be scrutinized. Since the concept, condition, and value of childbearing is associated with cultural, social, political and economic dimensions, it has undergone various transformations during passage of time from past to present. The sociological approach of the current study investigated the evolution of the concept and value of fertility and childbearing in light of historical, social, cultural and economic upheavals. This study shows that the methods of rationalizing and legitimizing decisions about fertility and childbearing are defined and specified in the context of society. The rational for selecting the decisions is intermingled with social, cultural, economic, and political evolutions of the society like modernization, urbanization and the level of development in human communities. Today, fertility, childbearing and the number of children are not only connected with the interpretations of the individuals about the conditions and micro and macro subjective and objective factors surrounding them, but they are also linked with factors such as family income, the amount of time parents allocate to their children, quality of child nurturing and other family variables.</p>
      </abstract>
      <kwd-group>
        <kwd>Childbearing</kwd>
        <kwd>Cultural change</kwd>
        <kwd>Individualism</kwd>
        <kwd>Social change</kwd>
        <kwd>Socio economic transformation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Fertility is deemed as an important event for couples during connubial life. In all cultures worldwide, fertility is a necessary and desirable goal to the extent that it is conceived as the ultimate ideal in life (<xref rid="B1" ref-type="bibr">1</xref>). During the development and evolution of societies, various aspects of reproduction have been generated and that is why despite the expansion and development of societies, economic growth and technological advances, inability in childbearing in many places is still a justifiable reason for disruption of couples and families’ relationships.</p>
      <p>People’s concept of fertility during history, as one of the significant goals of creation, has transformed into a social expectation and is a pivotal factor in explaining and evaluating the status of individuals in the society. Through a survey on the history of civilizations and different societies, it reveals that the great portion of mythology, religion, rituals and traditions (cultural norms), literature and art which are reflexives of values and cultural norms in particular societies, is allocated to concepts and symbols of reproduction and childbearing (<xref rid="B2" ref-type="bibr">2</xref>). Such a huge volume and range of works and cultural beliefs about fertility in all parts of the world unfold the significance and status of childbearing and reproduction as the permanent human desire for survival and immortality (<xref rid="B3" ref-type="bibr">3</xref>). For most individuals, the concept of family is formed by the birth of children.</p>
      <p>Instinctive, emotional and social needs of individuals after marriage propel couples to have children. In human mind and instinct, the concept of evolution and immortality is intermingled with reproductive power and childbearing and thereby, the biological, psychological, and social success in life is contingent upon reproductive power of individuals and the fulfilment of societies’ expectations (<xref rid="B4" ref-type="bibr">4</xref>).</p>
      <p>In terms of demographics, the fertility and child-bearing is also a remarkable phenomenon among the four main events of life. Childbearing, like other human phenomena, has multiple cultural, social, economic and political dimensions. Hence, in very long historical processes, its place and value has undergone several changes. In this study, an attempt was made to scrutinize the significance of fertility and childbearing in the light of social and economic developments.</p>
      <sec sec-type="background">
        <label>1.</label>
        <title>The concept of family, fertility and childbearing in history:</title>
        <p>Throughout history, the family functions have been inextricably bound with the living and generally economy, the production, distribution and consumption. During hunting and fishing period, families were homogenous and extended. A lot of people (<xref rid="B40" ref-type="bibr">40</xref>–50) lived under the same roof and consumed collected food resources and the prey and their sex relationships were defined. In agricultural societies, economic activity leads to greater productivity and the emergence of extended families. In this period, with an increase in the number of family members, more fields are cultivated and the harvest is plentiful (<xref rid="B5" ref-type="bibr">5</xref>). In this course, individual families were formed and through the change in type of work, men and women took responsibilities for the economic roles. In addition, in this period, women were responsible for child-bearing. However, in industrial period, the role of human beings as the main workforce in the economic turned out to be negligible and families became more limited with fewer children (<xref rid="B6" ref-type="bibr">6</xref>). In modern and postmodern era, part of the social promotion of the family is investing for the future generations. Higher levels of fixed income in families with two children in comparison to families with more children provide better recreation, nutrition and educational facilities, and ultimately results in better nurture of children. In fact, the transition from an agriculture-based economy to an industry-based economy with a complex nature based on modern services and the importance of the level of expertise of human as working resources were the impetus to alter the priorities. Therefore, the significance in number of children was replaced by the quality of their nurturing and the necessary skills and information required for each individual to work efficiently in the labor market.</p>
        <p>In a society based on agriculture, there is a relationship between the family and the organization for agricultural production. More specifically, the family as a group and the organization for agricultural production are mixed together and they construct a single coherent team. In such a community, all members of the family are involved in the production process; each member is responsible for part of the team work. In such a society, the task of financing for the life expenses based on the needs is on the shoulder of the family (<xref rid="B7" ref-type="bibr">7</xref>) and it seems that the main responsibility of a rural family is childbearing. Thus, having a child is deemed as a kind of social prestige for the rural family.</p>
        <p>Urban families are the developed types of rural families. In urban lifestyle, such features like having more privacy, less neighborliness and separation of work place and living place are common. In urban lifestyle, consumption, luxury, freedom, media and virtual environment are the typical characteristics. In fact, modern families share the usual features of the modern world, namely, urbanization. It seems that lack of child and infertility is less destructive for urban families in comparison to rural ones (<xref rid="B3" ref-type="bibr">3</xref>).</p>
        <p>The biological process of reproduction is influenced by complex social and environmental factors surrounded by social organizations, beliefs, norms and practices and in different cultures, it has multiple manifestations. Also, the process is embodied in politics, economics, law, religion and kinship. Today, the social value of childbearing has changed and like the old time, childbearing is not deemed as the practice for production of working power and the concept is dependent on cultural, economic and political conditions in each period (<xref rid="B8" ref-type="bibr">8</xref>). In a traditional society, infertile women are perceived as having incomplete sexual identity and are worthless. These women are exposed to violence, marginalization and threads of divorce or remarriage of their husbands.</p>
        <p>In Iranian and Islamic culture, marriage is deemed as a positive value and parenthood is the ultimate end for the couples in the family framework. The concept of family is vivified with the practice of childbearing. In this vein, infertile women would face many limitations, problems and psychological pressures. Women who fail to achieve motherhood are deemed as defeated females and unfeminine and therefore, they make their hard attempts to solve the problem by any means. Such enormous pressures on women can be traced in one of the important works of contemporary fiction, “a stone on a grave”, and the masculinely narrated story of writer and his wife for having a child depicts such tortures (<xref rid="B9" ref-type="bibr">9</xref>). Of course, nowadays in many societies, the importance of child-bearing as the determining factor for identifying a woman has been reduced to some extent.</p>
      </sec>
      <sec>
        <label>2.</label>
        <title>Theoretical approaches to the concept of child-bearing:</title>
        <p>The concept of childbearing and fertility are encircled by religious values and beliefs, norms and, in short, the culture of any society (<xref rid="B10" ref-type="bibr">10</xref>). In fact, it is influenced by social, cultural, and political factors in each society, so that even in times of war or peace, increase or decrease in birth rate are affected by social and political philosophy of that specific society (<xref rid="B11" ref-type="bibr">11</xref>). In the following part, the proposed theoretical approaches, each focusing on a determining factors involved in fertility, are scrutinized.</p>
      </sec>
      <sec>
        <label>2-1-</label>
        <title>Attitude and religious beliefs:</title>
        <p>Religious orientation, for sociologists like Durkheim, is one of the main cultural factors in childbearing. But in the modern world, particularly with emphasis on personal relationships and the saliency of privacy, individualistic interpretations of religion become prominent; thus, the deep ties, faith, belief and conscience as collective features with relatively strong religious characteristics are less seen among individuals (<xref rid="B12" ref-type="bibr">12</xref>). In such an environment, daily life loses its spiritual sense and thereby, family like other social institutions transforms from its initial state and the previous religious beliefs and opinions would be changed (<xref rid="B13" ref-type="bibr">13</xref>). Weber defines religion as a belief system which constructs the essence of powers and it is an independent and affective variable which has influence on all social aspects besides individual and social life (<xref rid="B6" ref-type="bibr">6</xref>). According to Durkheim and Weber’s theory, with the change in religious beliefs in society, fertility rate will change as a consequence. The public culture in Iranian society holds childbearing in high regard both religiously and historically. Children are considered blessing from God and childlessness is unpleasant. In one study, the failure of government to control the population in the years 1968–1976, is attributed to the lack of approval regarding the policy by scholars and clerics and the success of the government in the policy for controlling the population in the years after 1981, is ascribed to the role of religious leaders and their support in using birth control methods (<xref rid="B14" ref-type="bibr">14</xref>).</p>
      </sec>
      <sec>
        <label>2-2-</label>
        <title>Utilitarianism and exchange theory:</title>
        <p>Utilitarianism and exchange theory specify economic factor as affecting the tendency in childbearing and consider personal benefit as the motivation for the practice. In this theory, the social group is simply a set of individuals who make the group for their personal benefit and predicting and explaining the behavior of individuals is contingent up on their motivations which are based on their self-interest. From the perspective of the school, people are rational calculative individuals in costs and benefits. In their constant interaction with others, they keep their own interest in mind. Thus, any kind of relationship with others is deemed as an exchange. Social exchange theory shows that the interaction between two people may alter according to estimates of received rewards and the spent costs. In this perspective, the relationship between husband and wife is an exchange that starts from the beginning of life (<xref rid="B15" ref-type="bibr">15</xref>). Accordingly, all human relationships are based on subjective analysis of the costs and benefits and their comparisons (<xref rid="B16" ref-type="bibr">16</xref>). When the couples, based on calculation of profit and costs, evaluate the benefits of having children, they decide to have a child though it reduces the possibility of their social participation. In contrast, if the couples estimate the costs of having children are more than the benefits, the tendency to have the child would be reduced. In this approach, the indicators of economic satisfaction and child care costs are important in estimation and parents assess the outcome of these indicators and estimate the costs and benefits for having a rational decision about having children besides the number. In fact, in this theory, the fertility behavior is the result of rational economic decisions (<xref rid="B17" ref-type="bibr">17</xref>).</p>
      </sec>
      <sec>
        <label>2-3-</label>
        <title>Community involvement:</title>
        <p>Community involvement is another key factor in childbearing and the scholars focused on its effect for changing the patterns of life. René König, the German sociologist, refers to reduction of family functions as a problem. In his view, through the evolution in industry, the internal structure of the family is destroyed and its secondary functions such as financial, education and health functions, the care for the elderly and even the family’s leisure have been granted to institutions and governmental, social and economic agencies (<xref rid="B6" ref-type="bibr">6</xref>). On the other hand, the shrinking of families and their powerlessness from economic perspective provide a barrier to protect the elderly and sick family members. In modern societies, the family members dedicate a lot of time to their leisure and thereby the members based on their talents and expertise are able to choose a separate job besides their traditional hereditary jobs. Friendly clubs and associations have reduced the function of childbearing whereby people have the convenience and comfort to actively participate in society and social events. In modern social relations, women enter the labor market and they change the family structure by their employment, so there would be a delay in their motherhood. Therefore, the participation of women in society is an important factor in the decline in childbearing (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      </sec>
      <sec>
        <label>2-4-</label>
        <title>Social acceptance:</title>
        <p>Social acceptance is another important factor in the regulation of fertility. Several theories have been proposed to explain the social acceptance. Among them, one can refer to Fazio, Fishbein, and Ajzin theory. Fazio mentions controlled and automatic cognitive processes. In his view, controlled cognitive processes reinforce the relationship between attitude and behavior. Therefore, information and experience have pivotal roles in this vein. Some part of the experience is related to attitudes of people in society about social acceptability or non-acceptability (lack of social acceptance) of a social action (such as childbearing) and the attitude in turn can inhibit the social action or increase the motivation for doing it (<xref rid="B6" ref-type="bibr">6</xref>). In Fishbein and Ajzin view, contrary to previous theory in which attitudes have direct influence on formation of behavior, the attitudes have indirect impact on behavior and their target is our intentions; thereby, intentions mold our behavior. In other words, according to this theory, the behavior is rooted in intentions and the intentions for the behavior are rooted in the attitudes toward the behavior (the expected benefit and benefit assessment) and that subjective norm (the expectations of important people or the expectations of others and the motivation to follow the expectations of others) (<xref rid="B19" ref-type="bibr">19</xref>). Based on Fazio, Fishbein and Ajzin, each individual in his decision making for any act incorporates the opinions of friends, groups, parents and community. If the person in performing a specific action, such as childbearing, is informed about the social acceptance of her behavior, intentionally or not, she would follow the action; otherwise, she would not put the decision into practice. Based on the above-mentioned theoretical frameworks, the effective indices in childbearing will be examined in the context of social, economic, political and cultural history of societies.</p>
      </sec>
      <sec>
        <label>3.</label>
        <title>Effective indices in reducing the rate of child-bearing:</title>
        <p>Until half a century ago, childbearing was a natural process in the world and each family had an average of six children (<xref rid="B20" ref-type="bibr">20</xref>). But during the transition to modernity and in light of the individual, cultural, social factors and even international policy, this trend has changed and was hastily reversed, so that today fertility in many countries is a social challenge for the following decades (<xref rid="B6" ref-type="bibr">6</xref>). The Family Protection Act of Iran (1974) also indicates the importance of fertility in Iranian society. According to Article 8 of the Act, infertility can be one of the reasons for divorce and if one of the spouses applies for divorce, it is permitted to be performed (<xref rid="B21" ref-type="bibr">21</xref>).</p>
        <p>The slope of population graph in Iran, like many other countries, is downward. This reduction has many reasons. Among them, women’s literacy, increasing urbanization, increased employment of women and implementation of government policies for population control are effective factors. Government efforts to control the population in the past two decades led to a cultural belief that reduction in childbearing should be an accepted model (<xref rid="B22" ref-type="bibr">22</xref>). In fact, this trend is in line with demands of society and the ideals of couples and it is not easy to be changed unless a more powerful and rational culture at different levels of society replaces the old one. Another contributing factor to the decline in fertility is the change in the structure of the family. Some of these include changes in individual, social and cultural levels.</p>
      </sec>
      <sec>
        <title>Changes in individuals:</title>
        <p>The promotion of individualism, an increase in age of marriage, the growth in divorce rate, increased levels of education and employment of women are some individual changes (<xref rid="B23" ref-type="bibr">23</xref>). Among these, individualism has a key role in reduction of childbearing which will be reviewed.</p>
      </sec>
      <sec>
        <label>A-1-</label>
        <title>The concept of individualism:</title>
        <p>Individualists try to promote the goals and objectives of the individual and they value independence and self-reliance. They prioritize the interests of the individual rather than the government or social group interests, and individual is the focus of attention (<xref rid="B24" ref-type="bibr">24</xref>). In individualism, all the collective rules and regulations are defined in terms of individual rules (motivation, strength, faith, personal capabilities) (<xref rid="B25" ref-type="bibr">25</xref>) and people are considered free, empowered and responsible individuals for their actions when facing many forces and pressures (<xref rid="B26" ref-type="bibr">26</xref>). The development of individual values and individualism in contemporary Iranian society is a widespread event. In large cities like Tehran, the examples of the development of individualism are evident. For instance, 74% of people in Tehran believe that most individuals only think of themselves and 79% pointed that one cannot trust anybody (<xref rid="B27" ref-type="bibr">27</xref>). Now, Iranian families which in their traditional framework were usually collective and religion oriented have individualistic features and the evidences are clearly seen in their ceremonies and gatherings. Nowadays, individualistic gatherings like birthdays, graduation and Valentine’s celebration in which the main themes are the respect for the individual replace the collective national holidays like New Year celebration and religious ceremonies (<xref rid="B28" ref-type="bibr">28</xref>).</p>
      </sec>
      <sec>
        <label>A-2-</label>
        <title>Examples of individualism:</title>
        <p>The most crucial examples of individualism include the tendency to have fewer children and improvement of the quality of spouses’ lives, regardless of the family as an institution and children.</p>
        <p>The reduction in number of children and families is not a demographic event, but more importantly, is a fundamental upheaval in the pattern of family life. From this perspective, the small family can be described as one type of cultural pattern since this institution has many cultural implications for all aspects of family relations (<xref rid="B28" ref-type="bibr">28</xref>).</p>
        <p>In a study in 2009 on the ideal number of children for citizens of Tehran, having two children by the highest frequency of 60%, and having three children by the lowest frequency of 15%, indicated the opinions of citizens in Tehran. In this study, 3% of the population preferred not to have children at all and the choice reflects the revolution of values and cultural transformation in child-bearing and fertility (<xref rid="B29" ref-type="bibr">29</xref>).</p>
        <p>Therefore, the tendency to have fewer children and a better life is a modern claim which attracted many fans in the past few decades in Iran. The results of the analysis suggest that the tendency of the families to have few children in the society today is the offshoot of the change of patterns and gender clichés, especially the role of women in the family.</p>
        <p>In the modern time, the main role of the women in the family, unlike the traditional families, is not pregnancy and raising children. Women in modern societies, as social beings, have distinct identities and are independent in urban areas. Moreover, learning knowledge and skills and employment are as important for them as creating the family.</p>
        <p>Therefore, based on the results of the investigations, in a city like Tehran, families have tendency toward fewer children and new types of families are emerging in which there is the absence of any children. The relevant evidence is related to the statistics which show that in the year 2011, 35% of the families in Tehran were childless and 75% of them did not have any grandchildren (<xref rid="B30" ref-type="bibr">30</xref>). Such families did not exist in Iran in the past, but in recent years, the Iranian families are free to delay childbearing or remain childless during the rest of their life (<xref rid="B31" ref-type="bibr">31</xref>). Therefore, unwanted childbearing and unplanned pregnancies are obsolete practices and in turn, childbearing is now a systematic, planned and rational action in which the couples determine its suitable time and the number of children. The experience of families in Tehran reveals that such planning culminates in reduction in the number of children.</p>
        <p>Today, women’s experience and desires, interests, tastes, and their feelings are gradually developing. In the past, women did not have a high status in public arena, but the status of women within and outside the family has got a prominent place nowadays since women are now more aware of their rights and the global status of females’ lives in the world. Moreover, through modernization, they have achieved more social freedom. In other words, the most important variable that determines the equal responsibilities of men and women in household chores is the awareness of women about the global conditions and globalization. This kind of awareness and knowledge is not acquired in vacuum but is the result of different factors like the use of information and communication technologies, social networks and mass media. Another outcome of globalization is the division of responsibilities in household chores, women’s participation in decision-making about house-hold affairs, women’s economic participation in activities outside the home, women’s political participation, changes in lifestyle and the increase in social and cultural capital of the family which all compensate for the unpaid responsibilities of women in the house (<xref rid="B32" ref-type="bibr">32</xref>). All of these changes and redefinition of the role, identity and status of women in social arena can be seen as examples of the development of individualistic thinking in the society.</p>
      </sec>
      <sec>
        <label>B-</label>
        <title>Social changes:</title>
        <p>Among the social changes, the transformation of families from extended type to nuclear one, the increase in the rate of urbanization in recent years and economic problems which eventually lead to unemployment and inflation are more prominent. All these factors result in reduction of childbearing rate (<xref rid="B33" ref-type="bibr">33</xref>). In addition, among fixed-income families, the inflation in the economy of the community has always been associated with economic insecurity. Therefore, the current condition of the urban society in Iran besides global factors makes the couples cautious in their decision for having children and leads the couples to have only a single child or remain childless.</p>
      </sec>
      <sec>
        <label>C-</label>
        <title>Cultural changes:</title>
        <p>Among them, one can refer to factors like the women tendency to work and participate in society which reflect the change in women attitudes towards marriage, marital role, and motherhood. By being employed, women are not considered as the inferior sex anymore, because they can underpin their identity in the work place and their identity (<xref rid="B34" ref-type="bibr">34</xref>). Also, consumerism is a new trend in the modern era that has altered the lifestyle of families. With the development of consumerism, the living costs increase which culminate in a decline in childbearing.</p>
        <p>From another perspective, some changes of today’s Iranian families like having a single life, temporary marriages, initial agreements to delay having children for 5 or 10 years later, or agreement to remain childless but adopting a child are the great shifts which are required to be investigated in detail.</p>
        <p>The issue of equality of women and men is one of the cultural revolutions. Before the modern era, females were considered the inferior sex. However, the attitude changed gradually and women believe that in both social arena and in family, they have rights similar to men. In the context of family, women are more cautious about their physical capital. The change in the physical appearance of women who experience pregnancy once and who experience pregnancy three times is apparent, causing women to be more worried than their husbands about losing their physical capital.</p>
        <p>Thus, the importance of physical capital for a woman becomes so crucial that the agreement for having only one child in marriage becomes a significant criterion (<xref rid="B35" ref-type="bibr">35</xref>).</p>
        <p>In addition, in recent years, the supports in having fewer children, as a serious dialogue regarding women’s rights, are fully approved. Maintaining and strengthening the economic and social capital for women are the typical examples of equality in women’s rights in society. A woman with a single child compared with a woman who has more than three children is more successful and active in her social responsibilities. According to females’ opinion, large number of children leads to marginal role of women both in public and in working environment. For this reason, especially in big cities of Iran and among women, the tendency is towards having fewer children.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The investigations indicate that fertility and childbearing have been exposed to immense alterations from the beginning of creation. Since human beings are rational individuals, in facing the environment and the means which are at their disposal, they make decisions about the structure of their lives. These options are chosen by the individuals in terms of cultural, social, economic and political considerations of the particular society.</p>
      <p>The methods to rationalize and legitimize decisions about fertility, childbearing and delivery do not occur in a vacuum. Selection and decision processes are somehow entangled with social, cultural, economic, and political upheavals, including modernization, urbanization and the development of human societies (<xref rid="B36" ref-type="bibr">36</xref>).</p>
      <p>Childbearing is not necessarily a biomedical event and numerous studies have shown that individuals and interest groups, especially women have various beliefs, perceptions and experiences of childbearing and childbirth or childlessness, whether intentional or unintentional. The concepts and meanings related to this event favor considerable cultural or intercultural diversities in human societies and rationalization and legalization of these decisions and behaviors besides the narrative process of the issues relevant to fertility are related to economic, social and cultural context of the particular society (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      <p>Today, the number of children is not only connected with the interpretations of the individuals about the conditions and micro and macro subjective and objective factors surrounding them (social construct), but it is also linked with factors such as family income, the amount of time parents allocate to their children (especially mothers), quality of child nurturing and other family variables (objective conditions of individuals). Since the traditional division of responsibilities is the common practice in the family, and women spend most of their time to raise their children, there is the chance of increasing the number of children in the family.</p>
      <p>However, the gradual significance of human resources and the presence of women (especially married ones) in labor market and their prominent role in economics of the family in conjunction with their increased level of education, result in the collapse of the traditional division of responsibility in the family and consequently the number of children would be reduced.</p>
      <p>In sum, it seems that population growth in case of ignoring the existing infrastructure of a country, economic growth, market potentials, the quality of education and other unenumerated factors, will be followed by negative consequences. Worthy to mention that socio-economic changes have more direct and quick effect on the attitudes and decisions of individuals who made a family or decide to create a family in comparison to the policies of the government.</p>
      <p>With higher levels of education and the increase in living costs, the reduction trend in population growth will continue and the trend cannot be changed by centralized policy-making and planning (<xref rid="B38" ref-type="bibr">38</xref>). In industrialized countries, for the prevention of aging in the population and having a reasonable population size, social welfare policies are strengthened and with application of levers of economic, employment and social welfare, such as giving subsidies, giving time off to people (with maintaining job security) and social encouragement, families are motivated to have more children. For example, the Medal of Honor would be granted to a French mother who has the maximum number of children in a year. Such incentive programs have a great role in increasing the rate of childbearing in any particular community.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>Childbearing, or having few children, or unintentional childlessness as a social practice is under the influence of institutional resources and the structure of society (Attitude and religious beliefs and Utilitarianism and exchange theory) (<xref rid="B39" ref-type="bibr">39</xref>). On the other hand, the interpretations of people about the forces and conditions in the community are determining factors in the practice. The institutional resources for defining the practice can be local or international and the resources have connections with interpretations of the people about the practices and actions. Consequently, people rely on these resources and use their creativity and recognition of the needs to make the decision about childbearing (<xref rid="B40" ref-type="bibr">40</xref>).</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>The authors thank Homa Mahmoodzadeh and Sepideh Hanifehzadeh for editing of this paper.</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>The authors declare no conflict of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi-Shavazi</surname><given-names>MJ</given-names></name><name><surname>Razeghi Nasrabad</surname><given-names>HB</given-names></name><name><surname>Behjati Ardakani</surname><given-names>Z</given-names></name><name><surname>Akhondi</surname><given-names>MM.</given-names></name></person-group>
<article-title>[Attitudes of infertile women towards gamete donation: a case study in Tehran]</article-title>. <source>J Reprod Infertil</source>. <year>2006</year>;<volume>7</volume>(<issue>2</issue>):<fpage>139</fpage>–<lpage>48</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Behjati Ardakani</surname><given-names>Z.</given-names></name></person-group>
<source>[Sociological approach of lived experience of infertile couples seek ART treatment]</source> [master’s thesis]. [<publisher-loc>Tehran</publisher-loc>]: <publisher-name>Tehran University</publisher-name>; <year>2014</year>: <fpage>176</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behjati-Ardakani</surname><given-names>Z</given-names></name><name><surname>Akhondi</surname><given-names>MM</given-names></name><name><surname>Mahmoodzadeh</surname><given-names>H</given-names></name><name><surname>Hosseini</surname><given-names>SH.</given-names></name></person-group>
<article-title>An evaluation of the historical importance of fertility and its reflection in ancient mythology</article-title>. <source>J Reprod Infertil</source>. <year>2016</year>;<volume>17</volume>(<issue>1</issue>):<fpage>2</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26962477</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazandeh</surname><given-names>F</given-names></name><name><surname>Sharghi Somae</surname><given-names>N</given-names></name><name><surname>Karami Nouri</surname><given-names>R</given-names></name><name><surname>Alavi Majd</surname><given-names>H.</given-names></name></person-group>
<article-title>[An investigation on the relationship between infertility and marriage satisfaction]</article-title>. <source>Pajoohandeh J</source>. <year>2005</year>;<volume>9</volume>(<issue>6</issue>):<fpage>9</fpage>–<lpage>15</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>N.</given-names></name></person-group>
<article-title>[The incompatibility of only children with society]</article-title>. <source>Shargh Daily</source>. <year>2013</year>
<season>Octob</season>
<day>31</day>:Sect. Iranian culture:<fpage>12</fpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalantari</surname><given-names>S</given-names></name><name><surname>Abbaszadeh</surname><given-names>M</given-names></name><name><surname>Amin-Mozafari</surname><given-names>F</given-names></name><name><surname>Rakeei Bonab</surname><given-names>N.</given-names></name></person-group>
<article-title>The sociological study of attitude to child bearing and it’s some related factors (Case study: married youth In Tabriz City)</article-title>. <source>J Appl Sociol</source>. <year>2010</year>;<volume>21</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>104</lpage>.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nik Kholgh</surname><given-names>AA.</given-names></name></person-group>
<source>[Rural sociology in Iran]</source>. <edition>1st ed.</edition>
<publisher-loc>Tehran</publisher-loc>: <publisher-name>Chapakhsh</publisher-name>; <year>2015</year>
<fpage>248</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Aghajanian</surname><given-names>A.</given-names></name></person-group>
<article-title>Development gender and fertility in Iran</article-title>. Sociology Department Working Papers; <year>1990</year>. Paper 5.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Al-e-Ahmad</surname><given-names>J.</given-names></name></person-group>
<source>[A Stone on a grave]</source>. <publisher-loc>Tehran</publisher-loc>: <publisher-name>Ravagh Publication</publisher-name>;<year>1981</year>
<fpage>96</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khadivzade</surname><given-names>T</given-names></name><name><surname>Arghavani</surname><given-names>E.</given-names></name></person-group>
<article-title>Religious beliefs and fertility preferences among engaged couples, referring to premarital counseling centers of Mashhad</article-title>. <source>J Midwifery Reprod Health</source>. <year>2014</year>;<volume>2</volume>(<issue>4</issue>):<fpage>238</fpage>–<lpage>45</lpage>.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedadhir</surname><given-names>AA</given-names></name><name><surname>Hossein Nejad</surname><given-names>F</given-names></name><name><surname>Hani Sadati</surname><given-names>SM</given-names></name><name><surname>Taghavi</surname><given-names>S.</given-names></name></person-group>
<article-title>[Childbearing as a socio-cultural problem: A realistic reflection on cesarean section]</article-title>. <source>Iran J Anthropol Res</source>. <year>2012</year>;<volume>1</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>35</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>A.</given-names></name></person-group>
<source>Sociologie de la famille et du marriage</source>. <edition>1st ed.</edition>
<publisher-loc>France</publisher-loc>: <publisher-name>Presses universitaires de France</publisher-name>; <year>1978</year>
<fpage>263</fpage> p.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Durkheim</surname><given-names>E.</given-names></name></person-group>
<article-title>The elementary forms of the religious life</article-title>. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>1995</year>
<fpage>344</fpage> p.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaveh Firouz</surname><given-names>Z.</given-names></name></person-group>
<source>The evaluation of the policies in population control in previous three decades and their effect on fertility</source> [master’s thesis]. [<publisher-loc>Tehran</publisher-loc>]: <publisher-name>Tehran University</publisher-name>
<year>1988</year>.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Skidmore</surname><given-names>W.</given-names></name></person-group>
<source>Theoretical thinking in Sociology</source>. <edition>2nd ed.</edition>
<publisher-loc>London</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>; <year>1979</year>
<fpage>265</fpage> p.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeeni</surname><given-names>M</given-names></name><name><surname>Pourreza</surname><given-names>A</given-names></name><name><surname>Torabi</surname><given-names>F</given-names></name><name><surname>Heydari</surname><given-names>H</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group>
<article-title>Analysis of economic determinants of fertility in Iran: a multilevel approach</article-title>. <source>Int J Health Policy Manag</source>. <year>2014</year>;<volume>3</volume>(<issue>3</issue>):<fpage>135</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">25197678</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>H</given-names></name><name><surname>Bagi</surname><given-names>B.</given-names></name></person-group>
<article-title>[Socioeconomic, cultural and demographic determinants of childbearing desires among married women attending health centers in Hamedan (2012)]</article-title>. <source>J Kermanshah Univ Med Sci</source>. <year>2014</year>;<volume>18</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>43</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virtala</surname><given-names>A</given-names></name><name><surname>Vilska</surname><given-names>S</given-names></name><name><surname>Huttunen</surname><given-names>T</given-names></name><name><surname>Kunttu</surname><given-names>K.</given-names></name></person-group>
<article-title>Child-bearing, the desire to have children, and awareness about the impact of age on female fertility among Finnish university students</article-title>. <source>Eur J Contracept Reprod Health Care</source>. <year>2011</year>;<volume>16</volume>(<issue>2</issue>):<fpage>108</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">21281094</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khadivzadeh</surname><given-names>T</given-names></name><name><surname>Latifnejad Roudsari</surname><given-names>R</given-names></name><name><surname>Bahrami</surname><given-names>M</given-names></name><name><surname>Taghipour</surname><given-names>A</given-names></name><name><surname>Abbasi Shavazi</surname><given-names>J.</given-names></name></person-group>
<article-title>The influence of social network on couples’ intention to have the first child</article-title>. <source>Iran J Reprod Med</source>. <year>2013</year>;<volume>11</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">24639748</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbasi Shavazi</surname><given-names>MJ</given-names></name><name><surname>Askari Nodoushan</surname><given-names>A.</given-names></name></person-group>
<article-title>[Family changes and fertility decline in Iran: case study in Yazd province]</article-title>. <source>Nameh-ye Olum-e Ejtemai</source>. <year>2005</year>; <volume>25</volume>:<fpage>25</fpage>–<lpage>75</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beigzadeh</surname><given-names>S.</given-names></name></person-group>
<source>[Code of saba]</source>. <publisher-loc>Tehran</publisher-loc>: <publisher-name>Celck Saba Press</publisher-name>; <year>2014</year>
<fpage>1552</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behboudi-Gandevani</surname><given-names>S</given-names></name><name><surname>Ziaei</surname><given-names>S</given-names></name><name><surname>Farahani</surname><given-names>FK</given-names></name><name><surname>Jasper</surname><given-names>M.</given-names></name></person-group>
<article-title>The perspectives of Iranian women on delayed childbearing: A qualitative study</article-title>. <source>J Nurs Res</source>. <year>2015</year>;<volume>23</volume>(<issue>4</issue>):<fpage>313</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">26562463</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalajabadi Farahani</surname><given-names>F.</given-names></name></person-group>
<article-title>[Reasons for low fertility in Iran]</article-title>. <source>Iran newspaper (Vige Name Jameite)</source>. <year>2011</year>
<month>9</month>
<volume>21</volume>:<fpage>37</fpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hofstede</surname><given-names>G</given-names></name><name><surname>Hofstede</surname><given-names>GJ</given-names></name><name><surname>Minkov</surname><given-names>M.</given-names></name></person-group>
<source>Cultures and organizations: software of the mind</source>. <edition>3rd ed</edition>
<publisher-loc>USA</publisher-loc>: <publisher-name>McGraw-Hill books</publisher-name>; <year>2010</year>
<fpage>549</fpage> p.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Little</surname><given-names>D.</given-names></name></person-group>
<source>Varieties of social explanation: An introduction to the philosophy of social science</source>. <edition>1st ed.</edition>
<publisher-loc>Boulder, Colorado</publisher-loc>: <publisher-name>Westview Press</publisher-name>
<year>1991</year>
<fpage>258</fpage> p.</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ghanadan</surname><given-names>M</given-names></name><name><surname>Moti</surname><given-names>N.</given-names></name></person-group>
<source>[Sociology: Key concepts]</source>. <publisher-loc>Tehran</publisher-loc>: <publisher-name>Avaye Noor Publications</publisher-name>; <year>2015</year>
<fpage>288</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mohammadi Shakiba</surname><given-names>A.</given-names></name></person-group>
<article-title>[The opinion of Iranian individuals about the individual and collective interests]</article-title>. <publisher-loc>Tehran</publisher-loc>: <publisher-name>Research studies and evaluation center of IRIB</publisher-name>; <year>2001</year>
<fpage>58</fpage> p. Report No. 79/495. Persian.</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fazeli</surname><given-names>N.</given-names></name></person-group>
<source>[Culture and city: Cultural changes in urban dialogs based on studies in Tehran]</source>. <edition>1st ed.</edition>
<publisher-loc>Tehran</publisher-loc>: <publisher-name>Teesa Publication</publisher-name>; <year>2012</year>
<fpage>474</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Azad Armaki</surname><given-names>T</given-names></name><name><surname>Ghiasvand</surname><given-names>A.</given-names></name></person-group>
<source>[Sociological perspectives in Iran’s cultural changes]</source>. <edition>1st ed.</edition>
<publisher-loc>Tehran</publisher-loc>: <publisher-name>An Publication</publisher-name>; <year>2012</year>
<fpage>240</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vaezi</surname><given-names>M.</given-names></name></person-group>
<source>The project for evaluation and determining the indicators of the public culture of country in 2010 (unrecorded indicators): the report from the central province</source>. <edition>1st ed.</edition>
<publisher-name>Institute for Publishing Book Publishing</publisher-name>; <publisher-loc>Tehran</publisher-loc>
<year>2012</year>: <fpage>276</fpage> p.</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariman</surname><given-names>N</given-names></name><name><surname>Simbar</surname><given-names>M</given-names></name><name><surname>Ahmadi</surname><given-names>F</given-names></name><name><surname>Vedadhir</surname><given-names>AA.</given-names></name></person-group>
<article-title>Socioeconomic and emotional predictors of decision making for timing motherhood among Iranian women in 2013</article-title>. <source>Iran Red Crescent Med J</source>. <year>2014</year>; <volume>16</volume>(<issue>2</issue>):<fpage>e13629</fpage>.<pub-id pub-id-type="pmid">24719733</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajenuri</surname><given-names>B.</given-names></name></person-group>
<article-title>[The impact of globalization on division of responsibilities in household chores: The case of married women in Tehran, Shiraz, Estahban]</article-title>. <source>J Soc Sci</source>. <year>2006</year>;<volume>3</volume>(<issue>2</issue>):<fpage>1</fpage>–<lpage>24</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ezazi</surname><given-names>Sh.</given-names></name></person-group><source>[Sociology of the family: With emphasis on the role of family structure and function in modern times]</source>. <edition>1st ed.</edition>
<publisher-loc>Tehran</publisher-loc>: <publisher-name>Roshangaran publication and women Studies</publisher-name>; <year>2015</year>
<fpage>228</fpage> p. Persian.</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>P</given-names></name><name><surname>Tyler</surname><given-names>M</given-names></name><name><surname>Wallace</surname><given-names>C.</given-names></name></person-group>
<source>An introduction to sociology: feminist perspective</source>. <edition>4th ed.</edition>
<publisher-loc>London</publisher-loc>: <publisher-name>Routledge</publisher-name>; <year>2005</year>
<fpage>429</fpage> p.</mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoudian</surname><given-names>H</given-names></name><name><surname>Rezaei</surname><given-names>M.</given-names></name></person-group>
<article-title>[Women and low child-bearing action: The case study of Kurdish women]</article-title>. <source>Womens Strateg Stud</source>. <year>2012</year>;<volume>14</volume>(<issue>55</issue>):<fpage>173</fpage>–<lpage>225</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>JG.</given-names></name></person-group>
<article-title>Trends in Human Fertility</article-title>. In: <person-group person-group-type="editor"><name><surname>Heggenhougen</surname><given-names>HK</given-names></name></person-group>, editor. <source>International Encyclopedia of Public Health</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Academic Press</publisher-name>; <year>2008</year> p. <fpage>364</fpage>–<lpage>71</lpage>.</mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saberi</surname><given-names>F.</given-names></name></person-group>
<article-title>Attitudes of Iranian women toward population growth: A questionnaire-based study</article-title>. <source>Nurs Midwifery Stud</source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e33325</fpage>.<pub-id pub-id-type="pmid">27331060</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khadivzadeh</surname><given-names>T</given-names></name><name><surname>Latifnejad</surname><given-names>Roudsari R</given-names></name><name><surname>Bahrami</surname><given-names>M</given-names></name><name><surname>Taghipour</surname><given-names>A</given-names></name><name><surname>Abbasi</surname><given-names>Shavazi</given-names></name></person-group>
<article-title>The influence of social network on couples’ intention to have the first child</article-title>. <source>Iran J Reprod Med</source>. <year>2013</year>;<volume>11</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">24639748</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrokh-Eslamlou</surname><given-names>HR</given-names></name><name><surname>Vahabzadeh</surname><given-names>Z</given-names></name><name><surname>Moeini</surname><given-names>SR</given-names></name><name><surname>Moghaddam Tabrizi</surname><given-names>F.</given-names></name></person-group>
<article-title>[Pre-marriage couples fertility attitude following recent childbearing persuasive policies in Iran]</article-title>. <source>J Urmia Nurs Midwifery</source>. <year>2014</year>;<volume>11</volume>(<issue>10</issue>):<fpage>836</fpage>–<lpage>46</lpage>. Persian.</mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagheri Lankarani</surname><given-names>K.</given-names></name></person-group>
<article-title>Changing population policy in Iran</article-title>. <source>Shiraz E Med J</source>. <year>2015</year>;<volume>16</volume>(<issue>2</issue>):<fpage>e27537</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359853</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359853</article-id>
      <article-id pub-id-type="pmcid">PMC5359853</article-id>
      <article-id pub-id-type="pmc-uid">5359853</article-id>
      <article-id pub-id-type="publisher-id">jri-17-162</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Short Term Culture of Vitrified Human Ovarian Cortical Tissue to Assess the Cryopreservation Outcome: Molecular and Morphological Analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ramezani</surname>
            <given-names>Mehdi</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salehnia</surname>
            <given-names>Mojdeh</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jafarabadi</surname>
            <given-names>Mina</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> Department of Anatomical Sciences, Medical Sciences Faculty, Tarbiat Modares University, Tehran, Iran</aff>
        <aff id="AFF2"><label>2-</label> Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Mojdeh Salehnia, Department of Anatomical Sciences, Medical Sciences Faculty, Tarbiat Modares University, P. O. BOX: 14115-111, Tehran, Iran, <italic>E-mail:</italic><email>salehnim@modares.ac.ir</email>, <email>mogdeh@dr.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>162</fpage>
      <lpage>171</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>The aim of the present study was to evaluate the effectiveness of human ovarian vitrification protocol followed with <italic>in vitro</italic> culture at the morphological and molecular levels.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Ovarian tissues were obtained from 10 normal transsexual women and cut into small pieces and were divided into non-vitrified and vitrified groups and some of the tissues fragments in both groups were randomly cultured for two weeks. The morphological study using hematoxylin and eosin and Masson’s trichrome staining was done. The analysis of mean follicular density, 17-β estradiol (E2) and anti mullerian hormone (AMH), and real-time RT-PCR was down for the evaluation of expression of genes related to folliculogenesis. Data were compared by paired-samples and independent-samples T test. Values of p&lt;0.05 were considered statistically significant.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>The proportion of normal follicles did not show significant difference between vitrified and non-vitrified groups before and after culture but these rates and the mean follicle density significantly decreased in both cultured tissues (p&lt;0.05). The expression of genes was similar in vitrified and non-vitrified groups but in cultured tissues the expression of GDF9 and FSHR genes increased and the expression of FIGLA and KIT-L genes decreased (p&lt;0.05). An increase in E2 and AMH concentration was observed after 14 days of culture in both groups.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>In conclusion, the present study indicated that the follicular development and gene expression in vitrified ovarian tissue was not altered before and after <italic>in vitro</italic> culture, thus this method could be useful for fertility preservation; however, additional studies are needed to improve the culture condition.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>17 beta- Estradiol</kwd>
        <kwd>Anti- mullerian hormone</kwd>
        <kwd>Gene expression</kwd>
        <kwd>Vitrification</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>At present, there are some reliable options for preserving fertility in cancer patients (<xref rid="B1" ref-type="bibr">1</xref>). Dysfunction of gonads occurs due to the toxic effects of chemotherapy and radiotherapy. However, some of these methods, such as ovarian tissue cryopreservation are still considered experimental (<xref rid="B2" ref-type="bibr">2</xref>–<xref rid="B5" ref-type="bibr">5</xref>).</p>
      <p>Cryopreservation of human ovarian tissue was done at first in 1996 by Hovatta et al., and at now it is performed by slow freezing and vitrification methods (<xref rid="B6" ref-type="bibr">6</xref>). This methods are considered complex because of the nature of human ovarian tissue which consists of different cell types. More attempts have focused on improving ovarian tissue cryopreservation by vitrification (<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B10" ref-type="bibr">10</xref>). It is an ultra-rapid cooling process that produces a glass-like solidification of cells by high concentration of cryoprotectants.</p>
      <p>The effects of vitrification on the morphology, ultrastructure and function of human ovarian tissue showed conflicting results (<xref rid="B8" ref-type="bibr">8</xref>–<xref rid="B12" ref-type="bibr">12</xref>). Also, at the molecular level, there were limited investigations to evaluate the gene expression of human ovarian tissue just after vitrification and warming procedure (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B15" ref-type="bibr">15</xref>). Recently, Shams et al. demonstrated that after vitrification/warming of human ovarian tissue using dimethylsulphoxide (DMSO) and ethylene glycol (EG), the expression of gene related to folliculogenesis did not change (<xref rid="B13" ref-type="bibr">13</xref>). Isachenko showed the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene in vitrified ovarian tissue was reduced (<xref rid="B14" ref-type="bibr">14</xref>). Abdollahi et al. showed that the expression of some genes involved in apoptosis have changed after vitrification and warming of human ovarian tissue (<xref rid="B15" ref-type="bibr">15</xref>).</p>
      <p><italic>In vitro</italic> culture of ovarian tissue following the cryopreservation is an alternative method for follicular maturation and also for assessment of safety of cryopreservation technique (<xref rid="B15" ref-type="bibr">15</xref>–<xref rid="B17" ref-type="bibr">17</xref>).</p>
      <p>During <italic>in vitro</italic> culture of ovarian tissue, the follicles are in connection with stromal cells that provide the factors for initiation of growing of follicles (<xref rid="B18" ref-type="bibr">18</xref>), although by tissue culture, the normal structure of follicles within the tissue is maintained. Several genes are expressed and they controlled the development of follicles from primordial to ovulatory stage (<xref rid="B19" ref-type="bibr">19</xref>–<xref rid="B21" ref-type="bibr">21</xref>). Factor in Germ Line alpha (FIGLA) is expressed by oocytes in primordial follicles and it has an important regulatory role in the expression of the zona pellucid (ZP) glycoprotein and the formation of primordial follicles (<xref rid="B22" ref-type="bibr">22</xref>). The mice with homozygous mutation in FIGLA genes are unfertile because of defects in the formation of ZP1, ZP2 and ZP3 (<xref rid="B23" ref-type="bibr">23</xref>).</p>
      <p>Growth differentiation factor-9 (GDF9) is a family member of transforming growth factor-ß (TGFβ) and is expressed by oocytes at a primary follicle stage and controls of gene expression in granulosa cells. The mice with mutation in GDF9 have arrest in the primary follicle development (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>).</p>
      <p>Kit ligand (KIT-L) is expressed by granulosa cells and induced proliferation of theca cells and transition of follicle from primordial to primary stage (<xref rid="B26" ref-type="bibr">26</xref>). It also increases the mRNA level of several growth factors such as hepatocyte growth factor and keratinocyte growth factor in theca cells (<xref rid="B27" ref-type="bibr">27</xref>).</p>
      <p>The follicle stimulating hormone receptor (FSHR) expression is required for differentiation of granulosa cells and follicular maturation (<xref rid="B28" ref-type="bibr">28</xref>). Oktay et al. demonstrated that the FSHR gene was not expressed in any of primordial follicles, while was shown in all of secondary follicles (<xref rid="B29" ref-type="bibr">29</xref>).</p>
      <p>According to our knowledge, there was very limited information regarding evaluation of expression of genes related to follicular development after <italic>in vitro</italic> culture of cryopreserved human ovarian tissue. Recently, Wang et al. (2016) demonstrated that vitrification down-regulated the mRNA levels of ZP3, CYP11A and anti mullerian hormone (AMH) after short term <italic>in vitro</italic> culture of isolated follicles derived from cryopreserved human ovarian tissue (<xref rid="B30" ref-type="bibr">30</xref>).</p>
      <p><italic>In vitro</italic> culture studies of human ovarian tissue is the best insight into the effects of vitrification/warming procedure on the expression of genes related to folliculogenesis, thus the aim of the present study was to evaluate the effectiveness of human ovarian vitrification protocol using ethylene glycol based solution followed by <italic>in vitro</italic> culture at the morphological and molecular levels by assessments of the follicular survival and density and the expression of genes related to follicular development. The function of ovarian tissue was evaluated by the level of 17-β estradiol (E2) and AMH.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>All reagents and materials of this research were obtained from Sigma-Alderich (Germany) except mentioned otherwise.</p>
      <sec sec-type="methods">
        <title>Experimental design:</title>
        <p>In this study, in order to assess the effect of vitrification and <italic>in vitro</italic> culture of human ovarian tissue on follicular survival and the growth and expression of some genes related to follicular development, the ovarian fragments were divided into two non-vitrified and vitrified groups and some of the tissues fragments in both groups were randomly cultured for two weeks. The following assessments were done for non-cultured and cultured tissues as the same. The morphology of tissues was evaluated using hematoxylin and eosin (H&amp;E) and Masson’s Trichrome (MTC) staining. The expression of genes related to folliculogenesis (FIGLA, KIT-L, GDF9 and FSHR) was evaluated using real-time RT- PCR before and after two weeks of <italic>in vitro</italic> culture period. The E2 and AMH assay was done in collected culture media in the beginning and end of the culture period.</p>
      </sec>
      <sec>
        <title>Ovarian tissue collection:</title>
        <p>An informed consent was collected from 10 normal transsexual women (female to male) aged 18–35 years old (median 26.1) under a protocol approved by the Ethics Committee of the Faculty of Medical Science of Tarbiat Modares University (Ref. No. 52/883). The ovarian tissue samples during laparoscopic surgery were obtained and then were transferred to the laboratory within 1–2 <italic>hr</italic> with sterile 50 <italic>ml</italic> tubes containing 30–50 <italic>ml</italic> pre-warmed and equilibrated Leibovitz’s L-15 medium supplemented with 10 <italic>mg/ml</italic> human serum albumin (HSA), 100 <italic>IU/ml</italic> penicillin and 100 <italic>μg/ml</italic> streptomycin. The ovarian cortical tissues were cut into small pieces (approximately 2×1×1 <italic>mm</italic>) under a sterile condition. The tissue taken from each woman was randomly divided into vitrified and non-vitrified groups (n=272 fragments in total).</p>
      </sec>
      <sec>
        <title>Vitrification protocol:</title>
        <p>The ovarian cortical fragments were vitrified according to the protocol described earlier by Salehnia et al. with some modifications (<xref rid="B31" ref-type="bibr">31</xref>). Vitrification solution named EFS 40% containing 40% ethylene glycol (<italic>v/v</italic>), 30% ficoll 70 (<italic>w/v</italic>), and 1 <italic>M</italic> sucrose was supplemented with 0.21% HSA. The human ovarian tissues were equilibrated in three changes of vitrification solutions for 5 <italic>min</italic>, and then they were placed into cryovials containing 100 <italic>μl</italic> vitrification solution. The cryovials were put on the nitrogen vapor phase for 30 <italic>s</italic>, immersed and stored in liquid nitrogen until assessment after one month.</p>
      </sec>
      <sec>
        <title>Warming of vitrified tissue:</title>
        <p>The fragments were warmed by immersing the cryovials in 37°<italic>C</italic> water bath with gentle agitation until melting the samples. Then, they were washed serially in 1, 0.5, 0.25 <italic>M</italic> sucrose and phosphate buffer I (PBI) containing 10 <italic>mg/ml</italic> human serum albumin at room temperature for 5 <italic>min</italic>. The samples were equilibrated in α–minimum essential medium (α-MEM) culture media for 30 <italic>min</italic>. In vitrified group (n=136 fragments in total), 68 fragments (from 10 women) were considered as non-cultured tissues. Among these tissues, 50 fragments were fixed in Bouin’s solution for histological evaluation, and 18 fragments (from 6 women) were stored at −80°<italic>C</italic> for molecular assessments. The 68 remaining vitrified fragments (from 10 women) were cultured <italic>in vitro</italic> for two weeks. The non-vitrified samples were also considered for histological and molecular assessments, in the same as vitrified group.</p>
      </sec>
      <sec>
        <title>Ovarian tissue culture:</title>
        <p>Non-vitrified and vitrified tissue fragments were cultured (n=136 fragments in total) individually in 96-well V-bottomed culture plates for 2 weeks in 300 <italic>μl</italic> of α-MEM supplemented with 5 <italic>mg/ml</italic> HSA, 0.1 <italic>mg/ml</italic> penicillin G, 0.1 <italic>mg/ml</italic> streptomycin, 10 <italic>μg/ml</italic> insulin transferrin selenium (ITS), 0.5 <italic>IU/ml</italic> human recombinant follicle stimulating hormone (rFSH) at 37°<italic>C</italic> in humidified air with 5% CO<sub>2</sub>.</p>
        <p>At 48 <italic>hr</italic> intervals, the half of culture media (150 <italic>μl</italic>) was removed and replaced with fresh medium. The collected media were stored at −20°<italic>C</italic> for subsequent E2 and AMH hormonal analysis. After 2 weeks, the cultured tissues (100 fragments from 10 women in both groups) were fixed in Bouin’s solution for histological evaluation and the others were stored at −80°<italic>C</italic> for subsequent molecular assessment.</p>
      </sec>
      <sec>
        <title>Tissue evaluation:</title>
        <p>After fixation of tissue fragments, they were dehydrated in ascending concentrations of ethanol (70–100%) and embedded in paraffin wax. Five micrometer thickness serial sections were cut and the sections were mounted on glass slides and stained with H&amp;E. Then each section was examined for follicular counting.</p>
        <p>Another set of serial sections was stained with MTC staining and observed under light microscope for evaluation of stromal tissue (<xref rid="B32" ref-type="bibr">32</xref>).</p>
      </sec>
      <sec>
        <title>Follicules counting:</title>
        <p>The follicles were counted at different developmental stages field by field under ×10 objective lense of the light microscope according to the classification described by Gougeon (<xref rid="B33" ref-type="bibr">33</xref>). To avoid counting the follicles more than once, only those with an obvious nucleus of oocytes were counted.</p>
        <p>The follicles containing a single layer of flattened granulosa cells were considered as primordial, those having cuboidal granulosa cells in a single layer identified as primary and those having two or more layers of granulosa cells identified as growing follicles (those having two or more layers of granulosa cells). Atretic follicles had oocyte with a pyknotic nucleus of oocyte and granulosa cells and shrunken ooplasm.</p>
      </sec>
      <sec>
        <title>Assessment of mean ovarian follicle density per mm<sup>3</sup>:</title>
        <p>The photomicrographs of each tissue section were prepared and imported into Image J software (National Institutes of Health, Bethesda). Then the area of each section was measured in units of pixels and converted to millimeters based on the conversion determined by measuring the image of the calibrated millimeter. Tissue volume was calculated as the sum of the area in <italic>mm</italic><sup>2</sup> of all tissue sections analyzed per patient, multiplied by 0.005 <italic>mm</italic> (the thickness of each section) to give a value in <italic>mm</italic><sup>3</sup>. The number of follicles in each histological fragment was categorized according to their stage of development as previously described (<xref rid="B33" ref-type="bibr">33</xref>). Then, mean follicle density was determined by dividing the total number of follicles per patient by the volume of tissue analyzed and expressing this value as follicles per cubic millimeter.</p>
      </sec>
      <sec>
        <title>RNA extraction and cDNA synthesis:</title>
        <p>Total RNA was extracted from non-vitrified and vitrified groups before and after culture, using Trizol reagent (Invitrogen, USA) according to the manufacturer’s instructions. The RNA samples were treated with DNase to remove any genomic DNA contamination prior to proceeding with the cDNA synthesis. Then, the RNA concentration was determined by spectrophotometry and adjusted to a concentration of 250 <italic>ng/ml</italic>. Finally, 1000 <italic>ng</italic> of the extracted RNA was used for cDNA synthesis by the commercial Kit (Thermo Scientific, EU) according to the manufacturer’s instructions. Using Oligo dT, RNA was reverse transcribed by Maloney murine leukemia virus reverse transcriptase. The cDNA synthesis reaction was performed at 42°<italic>C</italic> for 60 <italic>min</italic> and terminated the reaction by heating at 70°<italic>C</italic> for 5 <italic>min</italic>, and the obtained cDNA was stored at −80°<italic>C</italic> until utilized.</p>
      </sec>
      <sec>
        <title>Real-time RT-PCR:</title>
        <p>The primers (<xref ref-type="table" rid="T1">Table 1</xref>) for realtime RT-PCR were newly designed using Gen Bank (<ext-link ext-link-type="uri" xlink:href="http://.ncbi.nlm.nih.gov">http://.ncbi.nlm.nih.gov</ext-link>) and online software (primer3), synthesized by Generary Biotech co (China).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1.</label>
          <caption>
            <p>The characteristics of primers used for real-time RT-PCR assays</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Accession number</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Target gene</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Primer sequence</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Product size (<italic>bp</italic>)</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>NM_001101.3</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">β-actin</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Forward: 5′ –TCAGAGCAAGAGAGGCATCC- 3′<break/>Reverse: 5′ –GGTCATCTTCTCACGGTTGG- 3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">187</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>NM_001004311.3</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Figla</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Forward: 5′ –TCGTCCACTGAAAACCTCCAG- 3′<break/>Reverse: 5′ –TTCTTATCCGCTCACGCTCC- 3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">76</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>NM_000899.4</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Kit ligand</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Forward: 5′ –AATCCTCTCGTCAAAACTGAAGG- 3′<break/>Reverse: 5′ –CCATCTCGCTTATCCAACACTGA- 3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">163</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>NM_001288828.2</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Gdf9</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Forward: 5′ – GAAGTGGGCTGACTGGGTG - 3′<break/>Reverse: 5′ – TGCAAAGCTCTGGAGTCTGG - 3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">166</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>NM_181446.2</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Fshr</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">Forward: 5′ –CTGGCAGAAGAGAATGAGTCC- 3′<break/>Reverse: 5′ –TGAGGATGTTGTACCCGATGATA- 3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">157</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>After extraction of total RNA and cDNA synthesis, one-step RT-PCR was performed on the Applied Biosystems (UK) real-time thermal cycler according to Quanti Tect SYBR Green RT-PCR kit (Applied Biosystems, UK, Lot No:1201416). Real-time thermal condition included holding step at 95°<italic>C</italic> for 5 <italic>min</italic>, cycling step at 95°<italic>C</italic> for 15 <italic>s</italic>, 60°<italic>C</italic> for 30 <italic>s</italic> and it was continued by a melt curve step at 95°<italic>C</italic> for 15 <italic>s</italic>, 60°<italic>C</italic> for 1 <italic>min</italic>, and 95°<italic>C</italic> for 15 <italic>s</italic>. Then, relative quantification of target genes was determined using the Pfaffle method (<xref rid="B34" ref-type="bibr">34</xref>). These experiments were repeated at least three times.</p>
      </sec>
      <sec>
        <title>Hormonal assay:</title>
        <p>To evaluate the endocrine function of ovarian tissue, the concentration of E2 and AMH were measured in the collected media derived from cultured ovarian fragments on day 2 and 14 of culture period. The levels of E2 were measured by a Microplate Enzyme Immunoassay kit (Monobind, USA, sensitivity=6.5 <italic>pg/ml</italic>) and AMH by an Enzyme-Linked Immunosorbent Assay (Ultra-sensitive AMH/MIS, USA, sensitivity= 4.4±0.9 <italic>pg/ml</italic>).</p>
      </sec>
      <sec sec-type="methods">
        <title>Statistical analysis:</title>
        <p>Statistical analysis was carried out using the SPSS 19.0 software. Quantitative variables were expressed as mean±SEM. The results of follicular counting, E2 and AMH concentration and real-time RT-PCR data were compared by paired-samples and independent-samples T test. Values of p≤0.05 were considered statistically significant.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Histological evaluation:</title>
        <p>The morphology of non-cultured and cultured ovarian cortical sections in both vitrified and non-vitrified groups is shown in <xref ref-type="fig" rid="F1">figures 1</xref> and <xref ref-type="fig" rid="F2">2</xref>. The morphology of follicles and stromal cells in vitrified tissues was similar to non-vitrified group. The oocytes were in close contact with the surrounding granulosa cells. No pyknotic nuclei or any sign of shrinkage or swelling were seen in granulosa cells.</p>
        <fig id="F1" position="float">
          <label>Figure 1.</label>
          <caption>
            <p>Light microscopic images of human ovarian cortical tissue after hematoxylin and eosin (A and B) and Masson Trichrome (C and D) staining before <italic>in vitro</italic> culture. A and C: non-vitrified group; B and D: vitrified group. The normal morphology of primary follicles was indicated in A, B and D</p>
          </caption>
          <graphic xlink:href="JRI-17-162-g001"/>
        </fig>
        <fig id="F2" position="float">
          <label>Figure 2.</label>
          <caption>
            <p>Light microscopic images of human ovarian cortical tissue after hematoxylin and eosin (A and B) and Masson Trichrome (C and D) staining after <italic>in vitro</italic> culture. A and C: non-vitrified group; Band D: vitrified group. The primary follicle has normal morphology in A, B and D and degenerating secondary follicle was indicated in C</p>
          </caption>
          <graphic xlink:href="JRI-17-162-g002"/>
        </fig>
        <p>The light microscopic photomicrographs obtained by Masson’s Trichrome staining showed that ovarian stromal tissue after vitrification was similar to that of non-vitrified one (<xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="fig" rid="F2">2</xref>).</p>
      </sec>
      <sec>
        <title>The percentage of normal follicle before in vitro culture of ovarian tissue:</title>
        <p>A total of 885 follicles were counted and analyzed in both vitrified and non-vitrified fragments (443 follicles in the non-vitrified fragments and 450 follicles in the vitrified fragments). Overall, 89.22% of the follicles in non-vitrified group and 84.60% in vitrified group showed normal morphology after warming (<xref ref-type="table" rid="T2">Table 2</xref>). In non-vitrified group, the percentage of primordial, primary and secondary follicles were 68.64%, 28.69% and 3.62% and these rates in vitrified group were 67.82%, 29.44% and 2.70%, respectively (<xref ref-type="table" rid="T2">Table 2</xref>). There was no significant difference in the percentage of normal follicles at different developmental stages between two groups.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2.</label>
          <caption>
            <p>The number of different follicles at developmental stages in all groups of study</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Groups</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Total follicles</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Normal F. (Mean%±SE)</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Degenerated F. (Mean%±SE)</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Various primordial F. (Mean%±SE)</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Primary F. (Mean%±SE)</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Growing F. (Mean%±SE)</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Non –vitrified</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">443</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">383(89.22±4.5)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">60(10.76±1.52)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">263(68.64±1.60)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">110(28.69±1.72)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">10(3.62±0.66)</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Vitrified</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">450</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">378(84.60±4.01)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">72(15.38±2.30)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">258(67.82±3.71)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">112(29.44±3.51)</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">8(2.70±1.20)</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured non-vitrified</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">366</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">305(83.25±2.23)<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">61(16.73±0.23)<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">78(25.33±1.40)<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">180(58.89±0.75)<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">47(15.76±1.55)<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured Vitrified</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">347</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">269(77.29±1.40)<xref ref-type="table-fn" rid="TFN2"><sup>b</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">78(22.70±0.40)<xref ref-type="table-fn" rid="TFN2"><sup>b</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">71(26.79±1.22)<xref ref-type="table-fn" rid="TFN2"><sup>b</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">156(58.24±0.67)<xref ref-type="table-fn" rid="TFN2"><sup>b</sup></xref></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">42(15.54±1.34)<xref ref-type="table-fn" rid="TFN2"><sup>b</sup></xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN1">
              <label>a:</label>
              <p>Significant differences between cultured non-vitrified and non-vitrified group in the same column (p&lt;0.05)</p>
            </fn>
            <fn id="TFN2">
              <label>b:</label>
              <p>Significant differences between cultured vitrified and vitrified group in the same column (p&lt;0.05)</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Normal follicles assessment after in vitro culture of ovarian tissue:</title>
        <p>After 14 days of <italic>in vitro</italic> culture, the percentage of the morphological normal follicles at different developmental stages in non-vitrified and vitrified groups were compared and summarized in <xref ref-type="table" rid="T2">table 2</xref>. Overall, 83.25% of the follicles in non-vitrified group and 77.29% in vitrified group had normal morphology. In non-vitrified ovarian tissue, the percentages of primordial, primary and secondary follicle were 25.33%, 58.89% and 15.76%, respectively. These rates in the vitrified group were 26.19%, 58.24% and 15.54%, respectively. There was no significant difference in the percentage of normal follicles at different developmental stages between these two groups at the end of culture period.</p>
        <p>In both the <italic>in vitro</italic> cultured groups, the percentage of normal follicles significantly decreased in comparison with non-cultured groups (p&lt;0.05). However, the percentage of secondary follicles increased in both cultured tissues groups in comparison to their respected non-cultured groups (p&lt;0.05).</p>
      </sec>
      <sec>
        <title>The follicular density in ovarian biopsies:</title>
        <p>The follicular densities in non-vitrified and vitrified groups before culturing were 26.59 and 25.54 follicles per <italic>mm</italic><sup>3</sup> and after two weeks of <italic>in vitro</italic> culture, the follicular densities significantly decreased to 22.98 and 20.80 follicles per mm<sup>3</sup> respectively (p&lt;0.05). There was no significant difference between non-vitrified and vitrified groups.</p>
      </sec>
      <sec>
        <title>The growing index in ovarian biopsies:</title>
        <p>The ratio of primary and secondary follicles to primordial follicles was considered as the growing index and in non-vitrified and vitrified groups before culturing, these indexes were 0.47 and 0.46 and after two weeks of <italic>in vitro</italic> culture, they were 2.94 and 2.81 respectively. There was no significant difference between non-vitrified and vitrified groups but these indexes significantly increased in both cultured tissues than their non-cultured respective groups (p&lt;0.05).</p>
      </sec>
      <sec>
        <title>Gene expression in ovarian tissue:</title>
        <p>As the results demonstrated (<xref ref-type="table" rid="T3">Table 3</xref>), among the studied genes, the ratios of expression of GDF-9, FIGLA, KIT-L and FSHR genes to β-actin gene in non-vitrified group before culturing were 24.5×10<sup>−4</sup>, 65×10<sup>−4</sup>, 61×10<sup>−4</sup>, 17.8×10<sup>−4</sup> and in vitrified group were 22.8×10<sup>−4</sup>, 60×10<sup>−4</sup>, 58×10<sup>−4</sup>, 15.8×10<sup>−4</sup>, respectively. In non-vitrified group after <italic>in vitro</italic> culture, the ratio expression of previous genes were 171×10<sup>−4</sup>, 35×10<sup>−4</sup>, 37×10<sup>−4</sup>, 28×10<sup>−4</sup> and in the vitrified group were 169×10<sup>−4</sup>, 34.5×10<sup>−4</sup>, 34.3×10<sup>−4</sup>, 25×10<sup>−4</sup>, respectively. There was no significant difference between the expression of all examined genes in vitrified and non-vitrified groups. However, in both cultured tissues in comparison with non-cultured tissues, the level of GDF-9 and FSHR mRNA significantly increased and the level of FIGLA and KIT-L mRNA significantly decreased (p&lt;0.05).</p>
        <table-wrap id="T3" position="float">
          <label>Table 3.</label>
          <caption>
            <p>The relative expression ratio of GDF-9, FIGLA, KIT-Land FSHR to β-actin in non-vitrified and vitrified human ovarian</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Non-vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured non-vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured vitrified</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>GDF-9</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">24.5×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">22.80×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">18.3×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">18×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>FIGLA</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">65×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">60×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">34×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">33.4×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>KIT-L</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">61×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">58×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">32.9×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">29.7×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>FSHR</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">17.8×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">15.8×10<sup>−4</sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">28.4×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">25.7×10<sup>−4
</sup><bold><xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref></bold></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN3">
              <label>a:</label>
              <p>Significant differences with non-cultured group in the same group (p&lt;0.05)</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Hormone assay:</title>
        <p>The concentrations of E2 in collected media at the beginning and end of culture period were shown and compared in <xref ref-type="table" rid="T4">table 4</xref> in studied groups. A significant increase in E2 concentration was observed in both cultured groups (51.86±0.63 and 47±1.15 <italic>pg/ml</italic>) in comparison to day 2 of culture (32.5±0.76 <italic>pg/ml</italic> and 31.53± 0.85 <italic>pg/ml</italic>), respectively (<italic>p</italic>&lt;0.05). There was no significant difference between vitrified and non-vitrified groups in this regard.</p>
        <table-wrap id="T4" position="float">
          <label>Table 4.</label>
          <caption>
            <p>The concentration of 17-β estradiol and anti mullerian hormones (AMH) in supernatants of non-vitrified and vitrified groups during two weeks of <italic>in vitro</italic> culture (<italic>pg/ml</italic>)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Hormone</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Non-vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured non-vitrified</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Cultured vitrified</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>17-β stradiol</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">32.5±0.76</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">31.53±0.85</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">251.86±0.52</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">247±0.57<sup><xref ref-type="table-fn" rid="TFN4">*</xref></sup></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>AMH</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.15±0.0057</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.15±0.0057</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.160±0.0057<sup><xref ref-type="table-fn" rid="TFN4">*</xref></sup></td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.158±0.0057<sup><xref ref-type="table-fn" rid="TFN4">*</xref></sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN4">
              <label>*</label>
              <p>Significant difference with day 2 (p&lt;0.05)</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>An increase in AMH level was observed after 14 days of <italic>in vitro</italic> culture in both non-vitrified and vitrified groups (0.160±0.01 and 0.158±0.01 <italic>pg/ml</italic>) respectively in comparison with day 2 of culture (0.15 <italic>pg/ml</italic>). There was no significant difference between vitrified and non-vitrified groups in this regard.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>In the present study, morphological observation showed that the normality rate of follicles is similar in vitrified and non-vitrified groups not only before culture but also after culturing period. In addition, our results demonstrated that the vitrified samples have follicular development such as non-vitrified tissue. Optimization of vitrification method for human ovarian tissue using cryoprotectants with low toxicity effects is an important subject in the field of cryobiology. In several studies, it was shown that ethylene glycol is a permeable cryoprotectant and had the best results in terms of survival of tissue (<xref rid="B35" ref-type="bibr">35</xref>–<xref rid="B38" ref-type="bibr">38</xref>). The adequacy of the EFS40 which mainly composed of ethylene glycol in the preservation of follicles has been shown in various studies (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B38" ref-type="bibr">38</xref>).</p>
      <p>From another point of view, our morphological observations using MTC staining showed that the stromal tissues were preserved normally in vitrified tissue similar to the non-vitrified samples. It is concluded that the cryoprotectants solution which was used in this study had no harmful effects on the integrity of stromal tissue and the stromal cells and tissue were well preserved. Similar to our results, Fabbri et al. (<xref rid="B39" ref-type="bibr">39</xref>) showed that after vitrification/warming, the stromal compartment maintained morphological and ultra-structural features similar to the fresh tissue.</p>
      <p>The stromal cells play an important role in the proliferation and differentiation of the granulosa cells so their preservation during cryopreservation procedure is critical. The interaction between stromal and follicular cells and the integrity of these components for normal ovarian function is important (<xref rid="B40" ref-type="bibr">40</xref>).</p>
      <p>Moreover, in other parts of the present study, it was demonstrated that the proportion of normal follicles did not significantly decline after two weeks of <italic>in vitro</italic> culture in comparison with the non-cultured tissue. In addition, the growing index increased in both cultured groups. It seems that the culture media which have been used in this study could sufficiently support the activation and development of primordial follicles. Different <italic>in vitro</italic> culture systems were introduced for follicular development and these systems have showed different results (<xref rid="B41" ref-type="bibr">41</xref>–<xref rid="B44" ref-type="bibr">44</xref>). However, the supplementation of culture media with PTEN inhibitor could activate the follicular development in the present study. Similar reports showed that PTEN inhibitor affects human ovarian follicle development by promoting the initiation of follicle growth and development to the secondary stage (<xref rid="B45" ref-type="bibr">45</xref>–<xref rid="B48" ref-type="bibr">48</xref>).</p>
      <p>Our molecular analysis by real time RT-PCR showed that the profile of gene expression related to development of follicles was similar in vitrified and non-vitrified ovarian tissue and also during two weeks of <italic>in vitro</italic> culture, this pattern was not changed in comparison with non-vitrified group. This observation is parallel to data obtained from developmental potential of vitrified samples than non-vitrified ones. It is concluded that vitrification of human ovarian tissue using EFS40 solution either has no remarkable effect on the morphology and follicular development and on the expression of developmental genes related to primordial, primary and secondary follicles during <italic>in vitro</italic> culture. In addition, at the end of <italic>in vitro</italic> culture period, the expression of GDF9 and FSHR increased and the expression of FIGLA and KIT-L genes was reduced in comparison with non-cultured samples. As mentioned before, the expression of FIGLA and KIT-L genes is related to primordial follicles and GDF9 and FSHR genes correspond to primary and secondary follicles, thus this data revealed an increase in the number of growing follicles from primordial to primary and secondary stages.</p>
      <p>In addition, studies on the effects of long-term culture period on the gene expression of vitrified human ovarian tissue were limited.</p>
      <p>The level of E2 as a marker for ovarian function during <italic>in vitro</italic> culture was analyzed and our results showed that an increase in the level of E2 at the end of culture period in comparison with the beginning of culture is correlated with the increase in the proportion of growing follicles during culturing period. The estradiol hormone was produced mainly by the granulosa cells; however, the stromal cells could contribute to steroid production (<xref rid="B49" ref-type="bibr">49</xref>).</p>
      <p>For the first time, the level of AMH was measured in collected media at the beginning and end of <italic>in vitro</italic> culture to show if this hormone could be a suitable indicator for demonstration of follicular development and reserve within the cultured tissue or not. However, the level of this hormone showed the slight changes during <italic>in vitro</italic> culture and this data may be related to small number of pre-antral and small antral follicles within cultured ovarian tissue because AMH is expressed in granulosa cells of growing follicles in the ovary and the high level of AMH expression is related to granulosa cells of pre-antral and small antral follicles (<xref rid="B50" ref-type="bibr">50</xref>–<xref rid="B52" ref-type="bibr">52</xref>).</p>
      <p>In another part of this study, the changes in the follicular density of human ovarian tissue were evaluated during <italic>in vitro</italic> culture in comparison with non-cultured groups. The results revealed that the decline in the follicular density was observed in both vitrified and non-vitrified samples. This reduction may be due to the insufficient culture condition to provide essential factors for survival and development of follicles. Other suggestion is that ischemic damages or other types of cell death may take place. Thus, additional studies for improvement of <italic>in vitro</italic> culture condition are needed.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>In conclusion, the present study indicated that the follicular development and gene expression in vitrified ovarian tissue were not altered before and after <italic>in vitro</italic> culture, thus this method could be useful for fertility preservation; however, additional studies are needed to improve the culture condition.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>This study was part of the Anatomy Act of Tarbiat Modarres University and is completed with the financial support of the university.</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>There is no conflict of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loren</surname><given-names>AW</given-names></name><name><surname>Mangu</surname><given-names>PB</given-names></name><name><surname>Beck</surname><given-names>LN</given-names></name><name><surname>Brennan</surname><given-names>L</given-names></name><name><surname>Magdalinski</surname><given-names>AJ</given-names></name><name><surname>Partridge</surname><given-names>AH</given-names></name><etal/></person-group>
<article-title>Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update</article-title>. <source>J Clin Oncol</source>. <year>2013</year>;<volume>31</volume>(<issue>19</issue>):<fpage>2500</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">23715580</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaznik-Wikiel</surname><given-names>ME</given-names></name><name><surname>Gilbert</surname><given-names>SB</given-names></name><name><surname>Meacham</surname><given-names>RB</given-names></name><name><surname>Kondapalli</surname><given-names>LA.</given-names></name></person-group>
<article-title>Fertility Preservation Options for Men and Women With Cancer</article-title>. <source>Rev Urol</source>. <year>2015</year>;<volume>17</volume>(<issue>4</issue>): <fpage>211</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26839518</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>CY</given-names></name><name><surname>Kristensen</surname><given-names>SG</given-names></name><name><surname>Greve</surname><given-names>T</given-names></name><name><surname>Schmidt K</surname><given-names>T.</given-names></name></person-group>
<article-title>Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients</article-title>. <source>Future Oncol</source>. <year>2012</year>;<volume>8</volume>(<issue>5</issue>):<fpage>595</fpage>–<lpage>608</lpage>.<pub-id pub-id-type="pmid">22646773</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grynberg</surname><given-names>M</given-names></name><name><surname>Poulain</surname><given-names>M</given-names></name><name><surname>Sebag-Peyrelevade</surname><given-names>S</given-names></name><name><surname>le Parco</surname><given-names>S</given-names></name><name><surname>Fanchin</surname><given-names>R</given-names></name><name><surname>Frydman</surname><given-names>N.</given-names></name></person-group>
<article-title>Ovarian tissue and follicle transplantation as an option for fertility preservation</article-title>. <source>Fertil Steril</source>. <year>2012</year>;<volume>97</volume>(<issue>6</issue>):<fpage>1260</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">22656306</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>K</given-names></name><name><surname>Aslan</surname><given-names>E</given-names></name><name><surname>Ozkaya</surname><given-names>E</given-names></name><name><surname>Sonmezer</surname><given-names>M</given-names></name><name><surname>Oktay</surname><given-names>K.</given-names></name></person-group>
<article-title>Ovarian cryopreservation</article-title>. <source>Minerva Med</source>. <year>2012</year>; <volume>103</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">22278067</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovatta</surname><given-names>O</given-names></name><name><surname>Silye</surname><given-names>R</given-names></name><name><surname>Krausz</surname><given-names>T</given-names></name><name><surname>Abir</surname><given-names>R</given-names></name><name><surname>Margara</surname><given-names>R</given-names></name><name><surname>Trew</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants</article-title>. <source>Hum Reprod</source>. <year>1996</year>;<volume>11</volume> (<issue>6</issue>):<fpage>1268</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">8671438</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandolfi</surname><given-names>F</given-names></name><name><surname>Paffoni</surname><given-names>A</given-names></name><name><surname>Papasso Brambilla</surname><given-names>E</given-names></name><name><surname>Bonetti</surname><given-names>S</given-names></name><name><surname>Brevini</surname><given-names>TA</given-names></name><name><surname>Ragni</surname><given-names>G.</given-names></name></person-group>
<article-title>Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue: comparative analysis between human and animal models</article-title>. <source>Fertil Steril</source>. <year>2006</year>;<volume>85</volume>
<issue>Suppl 1</issue>:<fpage>1150</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">16616087</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikhi</surname><given-names>M</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Niklasson</surname><given-names>B</given-names></name><name><surname>Lundqvist</surname><given-names>M</given-names></name><name><surname>Hovatta</surname><given-names>O.</given-names></name></person-group>
<article-title>Clinical grade vitrification of human ovarian tissue: an ultrastructural analysis of follicles and stroma in vitrified tissue</article-title>. <source>Hum Reprod</source>. <year>2011</year>;<volume>26</volume> (<issue>3</issue>):<fpage>594</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">21217141</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amorim</surname><given-names>CA</given-names></name><name><surname>David</surname><given-names>A</given-names></name><name><surname>Van Langendonckt</surname><given-names>A</given-names></name><name><surname>Dolmans</surname><given-names>MM</given-names></name><name><surname>Donnez</surname><given-names>J.</given-names></name></person-group>
<article-title>Vitrification of human ovarian tissue: effect of different solutions and procedures</article-title>. <source>Fertil Steril</source>. <year>2011</year>;<volume>95</volume>(<issue>3</issue>):<fpage>1094</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">21168134</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehnia</surname><given-names>M</given-names></name><name><surname>Sheikhi</surname><given-names>M</given-names></name><name><surname>Pourbeiranvand</surname><given-names>S</given-names></name><name><surname>Lundqvist</surname><given-names>M.</given-names></name></person-group>
<article-title>Apoptosis of human ovarian tissue is not increased by either vitrification or rapid cooling</article-title>. <source>Reprod Biomed Online</source>. <year>2012</year>;<volume>25</volume>(<issue>5</issue>):<fpage>492</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">22999557</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandeira</surname><given-names>FT</given-names></name><name><surname>Carvalho</surname><given-names>AA</given-names></name><name><surname>Castro</surname><given-names>SV</given-names></name><name><surname>Lima</surname><given-names>LF</given-names></name><name><surname>Viana</surname><given-names>DA</given-names></name><name><surname>Evangelista</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>Two methods of vitrification followed by in vitro culture of the ovine ovary: evaluation of the follicular development and ovarian extracellular matrix</article-title>. <source>Reprod Domest Anim</source>. <year>2015</year>;<volume>50</volume>(<issue>2</issue>):<fpage>177</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">25545956</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youm</surname><given-names>HW</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Jee</surname><given-names>BC</given-names></name><name><surname>Suh</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>SH.</given-names></name></person-group>
<article-title>Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival</article-title>. <source>Hum Reprod</source>. <year>2014</year>;<volume>29</volume>(<issue>4</issue>): <fpage>720</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">24365801</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shams Mofarahe</surname><given-names>Z</given-names></name><name><surname>Ghaffari Novin</surname><given-names>M</given-names></name><name><surname>Jafarabadi</surname><given-names>M</given-names></name><name><surname>Salehnia</surname><given-names>M</given-names></name><name><surname>Noroozian</surname><given-names>M</given-names></name><name><surname>Ghorbanmehr</surname><given-names>N.</given-names></name></person-group>
<article-title>Effect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis</article-title>. <source>Iran Biomed J</source>. <year>2015</year>;<volume>19</volume>(<issue>4</issue>):<fpage>220</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">26175108</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isachenko</surname><given-names>V</given-names></name><name><surname>Lapidus</surname><given-names>I</given-names></name><name><surname>Isachenko</surname><given-names>E</given-names></name><name><surname>Krivokharchenko</surname><given-names>A</given-names></name><name><surname>Kreienberg</surname><given-names>R</given-names></name><name><surname>Woriedh</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation</article-title>. <source>Reproduction</source>. <year>2009</year>; <volume>138</volume>(<issue>2</issue>):<fpage>319</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">19439559</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdollahi</surname><given-names>M</given-names></name><name><surname>Salehnia</surname><given-names>M</given-names></name><name><surname>Salehpour</surname><given-names>S</given-names></name><name><surname>Ghorbanmehr</surname><given-names>N.</given-names></name></person-group>
<article-title>Human ovarian tissue vitrification/warming has minor effect on the expression of apoptosis-related genes</article-title>. <source>Iran Biomed J</source>. <year>2013</year>;<volume>17</volume>(<issue>4</issue>):<fpage>179</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">23999713</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Catt</surname><given-names>S</given-names></name><name><surname>Pangestu</surname><given-names>M</given-names></name><name><surname>Temple-Smith</surname><given-names>P.</given-names></name></person-group>
<article-title>Successful in vitro culture of pre-antral follicles derived from vitrified murine ovarian tissue: oocyte maturation, fertilization, and live births</article-title>. <source>Reproduction</source>. <year>2011</year>;<volume>141</volume>(<issue>2</issue>):<fpage>183</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">21075829</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>F</given-names></name><name><surname>Reid</surname><given-names>RL</given-names></name><name><surname>Moini</surname><given-names>A</given-names></name><name><surname>Abolhassani</surname><given-names>F</given-names></name><name><surname>Valojerdi</surname><given-names>MR</given-names></name><name><surname>Kan</surname><given-names>FW.</given-names></name></person-group>
<article-title>In vitro development of human primordial follicles to preantral stage after vitrification</article-title>. <source>J Assist Reprod Genet</source>. <year>2013</year>;<volume>30</volume>(<issue>11</issue>): <fpage>1397</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">24254400</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Van Der Elst</surname><given-names>J</given-names></name><name><surname>Van Den Broecke</surname><given-names>R</given-names></name><name><surname>Dumortier</surname><given-names>F</given-names></name><name><surname>Dhont</surname><given-names>M.</given-names></name></person-group>
<article-title>Maturation of mouse primordial follicles by combination of grafting and in vitro culture</article-title>. <source>Biol Reprod</source>. <year>2000</year>;<volume>62</volume>(<issue>5</issue>):<fpage>1218</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">10775169</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGee</surname><given-names>EA</given-names></name><name><surname>Hsueh</surname><given-names>AJ.</given-names></name></person-group>
<article-title>Initial and cyclic recruitment of ovarian follicles</article-title>. <source>Endocr Rev</source>. <year>2000</year>;<volume>21</volume>(<issue>2</issue>): <fpage>200</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">10782364</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edson</surname><given-names>MA</given-names></name><name><surname>Nagaraja</surname><given-names>AK</given-names></name><name><surname>Matzuk</surname><given-names>MM.</given-names></name></person-group>
<article-title>The mammalian ovary from genesis to revelation</article-title>. <source>Endocr Rev</source>. <year>2009</year>;<volume>30</volume>(<issue>6</issue>):<fpage>624</fpage>–<lpage>712</lpage>.<pub-id pub-id-type="pmid">19776209</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adhikari</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name></person-group>
<article-title>Molecular mechanisms underlying the activation of mammalian primordial follicles</article-title>. <source>Endocr Rev</source>. <year>2009</year>;<volume>30</volume>(<issue>5</issue>):<fpage>438</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">19589950</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Canning</surname><given-names>J</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Pru</surname><given-names>JK</given-names></name><name><surname>Tilly</surname><given-names>JL.</given-names></name></person-group>
<article-title>Germline stem cells and follicular renewal in the postnatal mammalian ovary</article-title>. <source>Nature</source>. <year>2004</year>;<volume>428</volume> (<issue>6979</issue>):<fpage>145</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">15014492</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>RS</given-names></name><name><surname>Jimenez-Movilla</surname><given-names>M</given-names></name><name><surname>Dean</surname><given-names>J.</given-names></name></person-group>
<article-title>Figla-Cre transgenic mice expressing myristoylated EGFP in germ cells provide a model for investigating perinatal oocyte dynamics</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>1</issue>): <fpage>e84477</fpage>.<pub-id pub-id-type="pmid">24400092</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNatty</surname><given-names>KP</given-names></name><name><surname>Juengel</surname><given-names>JL</given-names></name><name><surname>Reader</surname><given-names>KL</given-names></name><name><surname>Lun</surname><given-names>S</given-names></name><name><surname>Myllymaa</surname><given-names>S</given-names></name><name><surname>Lawrence</surname><given-names>SB</given-names></name><etal/></person-group>
<article-title>Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function</article-title>. <source>Reproduction</source>. <year>2005</year>;<volume>129</volume>(<issue>4</issue>):<fpage>473</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">15798022</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oron</surname><given-names>G</given-names></name><name><surname>Fisch</surname><given-names>B</given-names></name><name><surname>Ao</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>XY</given-names></name><name><surname>Farhi</surname><given-names>J</given-names></name><name><surname>Ben-Haroush</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Expression of growth-differentiating factor 9 and its type 1 receptor in human ovaries</article-title>. <source>Reprod Biomed Online</source>. <year>2010</year>;<volume>21</volume>(<issue>1</issue>):<fpage>109</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">20427239</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>IB</given-names></name><name><surname>Laitinen</surname><given-names>MP</given-names></name><name><surname>Scott</surname><given-names>JE</given-names></name><name><surname>Louhio</surname><given-names>H</given-names></name><name><surname>Velentzis</surname><given-names>L</given-names></name><name><surname>Tuuri</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture</article-title>. <source>Reproduction</source>. <year>2006</year>;<volume>131</volume>(<issue>4</issue>):<fpage>641</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">16595715</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuck</surname><given-names>AR</given-names></name><name><surname>Robker</surname><given-names>RL</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Tilley</surname><given-names>WD</given-names></name><name><surname>Hickey</surname><given-names>TE.</given-names></name></person-group>
<article-title>Expression and localisation of c-kit and KITL in the adult human ovary</article-title>. <source>J Ovarian Res</source>. <year>2015</year>;<volume>8</volume>:<fpage>31</fpage>.<pub-id pub-id-type="pmid">26008799</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjali</surname><given-names>G</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Lakra</surname><given-names>R</given-names></name><name><surname>Taneja</surname><given-names>J</given-names></name><name><surname>Kalsey</surname><given-names>GS</given-names></name><name><surname>Nagendra</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>FSH stimulates IRS-2 expression in human granulosa cells through cAMP/SP1, an inoperative FSH action in PCOS patients</article-title>. <source>Cell Signal</source>. <year>2015</year>;<volume>27</volume>(<issue>12</issue>):<fpage>2452</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">26388164</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oktay</surname><given-names>K</given-names></name><name><surname>Briggs</surname><given-names>D</given-names></name><name><surname>Gosden</surname><given-names>RG.</given-names></name></person-group>
<article-title>Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1997</year>;<volume>82</volume>(<issue>11</issue>):<fpage>3748</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">9360535</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TR</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>CL</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>TL</given-names></name><name><surname>Zhi</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification</article-title>. <source>Hum Reprod</source>. <year>2016</year>;<volume>31</volume>(<issue>4</issue>):<fpage>763</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">26851603</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehnia</surname><given-names>M</given-names></name><name><surname>Abbasian Moghadam</surname><given-names>E</given-names></name><name><surname>Rezazadeh Velojerdi</surname><given-names>M.</given-names></name></person-group>
<article-title>Ultrastructure of follicles after vitrification of mouse ovarian tissue</article-title>. <source>Fertil Steril</source>. <year>2002</year>; <volume>78</volume>(<issue>3</issue>):<fpage>644</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">12215351</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Drury</surname><given-names>RAB</given-names></name><name><surname>Wallington</surname><given-names>EA.</given-names></name></person-group>
<source>Carleton’s histological technique</source>. <edition>5th ed.</edition>
<publisher-loc>UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>1980</year> p. <fpage>183</fpage>–<lpage>5</lpage>.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gougeon</surname><given-names>A.</given-names></name></person-group>
<article-title>Regulation of ovarian follicular development in primates: facts and hypotheses</article-title>. <source>Endocr Rev</source>. <year>1996</year>;<volume>17</volume>(<issue>2</issue>):<fpage>121</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">8706629</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>MW.</given-names></name></person-group>
<article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title>. <source>Nucleic Acids Res</source>. <year>2001</year>;<volume>29</volume>(<issue>9</issue>):<fpage>e45</fpage>.<pub-id pub-id-type="pmid">11328886</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikhi</surname><given-names>M</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Niklasson</surname><given-names>B</given-names></name><name><surname>Lundqvist</surname><given-names>M</given-names></name><name><surname>Hovatta</surname><given-names>O.</given-names></name></person-group>
<article-title>Preservation of human ovarian follicles within tissue frozen by vitrification in a xeno-free closed system using only ethylene glycol as a permeating cryoprotectant</article-title>. <source>Fertil Steril</source>. <year>2013</year>; <volume>100</volume>(<issue>1</issue>):<fpage>170</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">23566598</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>YC</given-names></name><name><surname>Tang</surname><given-names>HR</given-names></name><name><surname>Zeng</surname><given-names>LP</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>GP</given-names></name><name><surname>Wu</surname><given-names>RF.</given-names></name></person-group>
<article-title>Assessment of the effect of different vitrification solutions on human ovarian tissue after short-term xenotransplantation onto the chick embryo chorioallantoic membrane</article-title>. <source>Mol Reprod Dev</source>. <year>2016</year>;<volume>83</volume>(<issue>4</issue>):<fpage>359</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">26924442</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanfilippo</surname><given-names>S</given-names></name><name><surname>Canis</surname><given-names>M</given-names></name><name><surname>Smitz</surname><given-names>J</given-names></name><name><surname>Sion</surname><given-names>B</given-names></name><name><surname>Darcha</surname><given-names>C</given-names></name><name><surname>Janny</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezing</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2015</year>;<volume>13</volume>:<fpage>67</fpage>.<pub-id pub-id-type="pmid">26109179</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Effects of vitrification cryopreservation on follicular morphology and stress relaxation behaviors of human ovarian tissues: sucrose versus trehalose as the non-permeable protective agent</article-title>. <source>Hum Reprod</source>. <year>2015</year>;<volume>30</volume>(<issue>4</issue>):<fpage>877</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">25662812</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbri</surname><given-names>R</given-names></name><name><surname>Vicenti</surname><given-names>R</given-names></name><name><surname>Macciocca</surname><given-names>M</given-names></name><name><surname>Pasquinelli</surname><given-names>G</given-names></name><name><surname>Paradisi</surname><given-names>R</given-names></name><name><surname>Battaglia</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Good preservation of stromal cells and no apoptosis in human ovarian tissue after vitrification</article-title>. <source>Biomed Res Int</source>. <year>2014</year>; <volume>2014</volume>:<fpage>673537</fpage>.<pub-id pub-id-type="pmid">24804230</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orisaka</surname><given-names>M</given-names></name><name><surname>Tajima</surname><given-names>K</given-names></name><name><surname>Tsang</surname><given-names>BK</given-names></name><name><surname>Kotsuji</surname><given-names>F.</given-names></name></person-group>
<article-title>Oocyte-granulosa-theca cell interactions during preantral follicular development</article-title>. <source>J Ovarian Res</source>. <year>2009</year>; <volume>2</volume>(<issue>1</issue>):<fpage>9</fpage>.<pub-id pub-id-type="pmid">19589134</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isachenko</surname><given-names>V</given-names></name><name><surname>Montag</surname><given-names>M</given-names></name><name><surname>Isachenko</surname><given-names>E</given-names></name><name><surname>van der Ven</surname><given-names>K</given-names></name><name><surname>Dorn</surname><given-names>C</given-names></name><name><surname>Roesing</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Effective method for in-vitro culture of cryopreserved human ovarian tissue</article-title>. <source>Reprod Biomed Online</source>. <year>2006</year>;<volume>13</volume>(<issue>2</issue>):<fpage>228</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">16895638</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telfer</surname><given-names>EE</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Thong</surname><given-names>KJ.</given-names></name></person-group>
<article-title>A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin</article-title>. <source>Hum Reprod</source>. <year>2008</year>;<volume>23</volume> (<issue>5</issue>):<fpage>1151</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">18326514</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovatta</surname><given-names>O</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Krausz</surname><given-names>T</given-names></name><name><surname>Hardy</surname><given-names>K</given-names></name><name><surname>Winston</surname><given-names>RM.</given-names></name></person-group>
<article-title>Human primordial, primary and secondary ovarian follicles in long-term culture: effect of partial isolation</article-title>. <source>Hum Reprod</source>. <year>1999</year>;<volume>14</volume>(<issue>10</issue>):<fpage>2519</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">10527981</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovatta</surname><given-names>O.</given-names></name></person-group>
<article-title>Cryopreservation and culture of human primordial and primary ovarian follicles</article-title>. <source>Mol Cell Endocrinol</source>. <year>2000</year>;<volume>169</volume>(<issue>1–2</issue>):<fpage>95</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">11155962</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Kinnell</surname><given-names>HL</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Telfer</surname><given-names>EE.</given-names></name></person-group>
<article-title>Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles</article-title>. <source>Mol Hum Reprod</source>. <year>2014</year>;<volume>20</volume>(<issue>8</issue>):<fpage>736</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">24830779</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morohaku</surname><given-names>K</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Sasada</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>E.</given-names></name></person-group>
<article-title>Incorporation of phosphatase inhibitor in culture prompts growth initiation of isolated non-growing oocytes</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e77533</fpage>.<pub-id pub-id-type="pmid">24223714</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smitz</surname><given-names>JE</given-names></name><name><surname>Cortvrindt</surname><given-names>RG.</given-names></name></person-group>
<article-title>The earliest stages of folliculogenesis in vitro</article-title>. <source>Reproduction</source>. <year>2002</year>;<volume>123</volume> (<issue>2</issue>):<fpage>185</fpage>–<lpage>202</lpage>.<pub-id pub-id-type="pmid">11866686</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Kawamura</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Activation of dormant ovarian follicles to generate mature eggs</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>(<issue>22</issue>):<fpage>10280</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">20479243</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>KL</given-names></name><name><surname>Byskov</surname><given-names>AG</given-names></name><name><surname>Nyboe Andersen</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>J</given-names></name><name><surname>Yding Andersen</surname><given-names>C.</given-names></name></person-group>
<article-title>Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries</article-title>. <source>Hum Reprod</source>. <year>2003</year>;<volume>18</volume>(<issue>6</issue>):<fpage>1158</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">12773440</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>IB</given-names></name><name><surname>Scott</surname><given-names>JE</given-names></name><name><surname>Visser</surname><given-names>JA</given-names></name><name><surname>Ritvos</surname><given-names>O</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>Hovatta</surname><given-names>O.</given-names></name></person-group>
<article-title>Anti-Müllerian hormone in hibits initiation of growth of human primordial ovarian follicles in vitro</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>9</issue>): <fpage>2223</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">16720622</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Marca</surname><given-names>A</given-names></name><name><surname>Broekmans</surname><given-names>FJ</given-names></name><name><surname>Volpe</surname><given-names>A</given-names></name><name><surname>Fauser</surname><given-names>BC</given-names></name><name><surname>Macklon</surname><given-names>NS.</given-names></name></person-group>
<article-title>Anti-Mullerian hormone (AMH): what do we still need to know?</article-title>
<source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume>(<issue>9</issue>):<fpage>2264</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">19520713</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Disseldorp</surname><given-names>J</given-names></name><name><surname>Lambalk</surname><given-names>CB</given-names></name><name><surname>Kwee</surname><given-names>J</given-names></name><name><surname>Looman</surname><given-names>CW</given-names></name><name><surname>Eijkemans</surname><given-names>MJ</given-names></name><name><surname>Fauser</surname><given-names>BC</given-names></name><etal/></person-group>
<article-title>Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts</article-title>. <source>Hum Reprod</source>. <year>2010</year>;<volume>25</volume>(<issue>1</issue>):<fpage>221</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19840990</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359854</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359854</article-id>
      <article-id pub-id-type="pmcid">PMC5359854</article-id>
      <article-id pub-id-type="pmc-uid">5359854</article-id>
      <article-id pub-id-type="publisher-id">jri-17-172</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Leptin Improves Sperm Cryopreservation via Antioxidant Defense</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fontoura</surname>
            <given-names>Paula</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mello</surname>
            <given-names>Mariana Duque</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gallo-Sá</surname>
            <given-names>Paulo</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Erthal-Martins</surname>
            <given-names>Maria Cecília</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cardoso</surname>
            <given-names>Maria Cecília Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Cristiane</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> University Hospital Pedro Ernesto, State University of Rio de Janeiro, Rio de Janeiro, Brazil</aff>
        <aff id="AFF2"><label>2-</label> Vida Centro de Fertilildade da Rede D’Or Clinic, Rio de Janeiro, Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Cristiane da Fonte Ramos, University Hospital Pedro Ernesto, State University of Rio de Janeiro, Street 28 de setembro, 77 -Vila Isabel, Rio de Janeiro, RJ, Brazil, Zip Code: 20551-030, <italic>E-mail:</italic><email>cristiane@pesquisador.cnpq.br</email>; <email>cramos_uerj@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>172</fpage>
      <lpage>178</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>Leptin and its receptor are present in spermatozoa; however, the role of leptin in sperm function is still controversial. Our present study aimed at demonstrating the effect of cryopreservation on sperm DNA fragmentation (DNAf) and investigating the possible effects of sperm capacitation techniques and leptin <italic>in vitro</italic> incubation on frozen-thawed sperm DNAf and oxidative stress.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Samples of 45 normospermic men attending for infertility investigation at Vida Centro de Fertilidade, Rio de Janeiro, Brazil, were frozen and thawed with or without capacitation and leptin incubation prior to freezing. Sperm DNA fragmentation was evaluated by Sperm Chromatin Dispersion Assay before and after cryopreservation and oxidative stress parameters were measured by spectrophotometry with and without leptin incubation. Statistical analysis was performed using paired t test to compare DNAf between groups before and after freeze-thaw cycle, to compare groups before and after capacitation and leptin incubation and oxidative measurements before and after leptin incubation. Statistical significance was considered when p≤0.05.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Our results revealed a significant post-thaw rise in sperm DNAf compared with fresh samples (p=0.0003). Sperm DNAf was significantly reduced when sperm capacitation was performed before freezing, when compared to those frozen with no previous capacitation (p=0.01). The addition of leptin to capacitated sperm before freezing reduced DNAf (p&lt;0.0001) and enhanced superoxide dismutase (p=0.001) and glutathione peroxidase (p=0.02) antioxidant enzymes activity.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>The addition of leptin to capacitated sperm can improve sperm DNA quality following cryopreservation, possibly by inducing the activity of certain antioxidant enzymes.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>DNA fragmentation</kwd>
        <kwd>Freeze-thaw cycle</kwd>
        <kwd>Leptin</kwd>
        <kwd>Oxidative stress</kwd>
        <kwd>Sperm</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Cryopreservation of gametes and embryos has a wide importance among assisted reproductive techniques. Taken into account the spermatozoa, cryopreservation has several applications, such as seminal storage prior to prostate and vasectomy surgeries, before chemotherapy and radiotherapy treatments, prior to fertility treatments and for donor sperm banking (<xref rid="B1" ref-type="bibr">1</xref>). However, sperm freezing and thawing processes lead to intracellular ice crystals formation which causes organelles and cell membrane rupture (<xref rid="B1" ref-type="bibr">1</xref>), modifies the structure and integrity of plasma membranes (<xref rid="B2" ref-type="bibr">2</xref>), and alters mitochondrial membrane potential and release of reactive oxygen species (ROS) (<xref rid="B3" ref-type="bibr">3</xref>). In addition, cryopreservation has been shown to diminish the antioxidant activity of the spermatozoa making them more susceptible to ROS damage (<xref rid="B4" ref-type="bibr">4</xref>).</p>
      <p>Oxidative stress occurs when excessive ROS generation overcomes the ROS scavenging ability of spermatozoa. Spermatozoa and seminal plasma contain antioxidant enzymes such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx), although its lack of cytoplasm leads to a decrease of antioxidant defense. Moreover, spermatozoa are particularly more susceptible to lipid peroxidation because of the high proportion of polyunsaturated fatty acid in their membranes (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Deleterious effects of oxidative stress can result in several structural alterations of spermatozoa, such as protein fragmentation, lipid peroxidation and DNA fragmentation (DNAf) (<xref rid="B7" ref-type="bibr">7</xref>). Increase in DNAf is related to reduced implantation and pregnancy rates and increased recurrent pregnancy loss (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). In order to minimize deleterious effects of cryopreservation, some studies have focused on testing antioxidants action on sperm cryopreservation (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). Zhang et al. observed a protective effect of L-carnitine, leading to a significant improvement in post-thawed sperm parameters, including DNAf levels (<xref rid="B10" ref-type="bibr">10</xref>). Mata-Campuzano et al. also observed a reduction of lipid peroxidation and DNAf following antioxidant supplementation of spermatozoa during cryopreservation (<xref rid="B11" ref-type="bibr">11</xref>).</p>
      <p>Leptin, a peptide hormone mainly secreted by adipose tissue, is widely known by its functions related to obesity, appetite and food intake inhibition and energy expenditure. However, it has been shown to have roles in diverse physiologic systems, including reproductive system (<xref rid="B12" ref-type="bibr">12</xref>). Although presence of leptin and its receptor has been demonstrated in spermatozoa (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B15" ref-type="bibr">15</xref>), its role on spermatogenesis and sperm still needs to be clarified. Literature has some controversial results concerning sperm parameters after leptin <italic>in vitro</italic> incubation (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B16" ref-type="bibr">16</xref>). Lampiao and Du Plessis (2008) found an increase in total and progressive motility, in acrosome reaction and nitric oxide (NO) production after leptin incubation. In contrast, the study by Li et al. (2008) demonstrated no significant effects of leptin incubation on motility, and percentage of capacitated and acrosome reacted sperm after leptin incubation (<xref rid="B13" ref-type="bibr">13</xref>). Additionally, studies have suggested that leptin has a role in oxidative stress (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>) which is still controversial. Zheng et al. demonstrated that leptin increased sod activity in cardiomyocytes (<xref rid="B19" ref-type="bibr">19</xref>), while Yamagishi et al. observed a leptin-induced lipid oxidation in endothelial cells (<xref rid="B20" ref-type="bibr">20</xref>). However, leptin role in oxidative stress and sperm cryopreservation remains unclear.</p>
      <p>Our present study aimed at demonstrating the effect of cryopreservation on sperm DNAf and investigating the possible effects of sperm capacitation and leptin incubation on frozen-thawed sperm DNAf and oxidative stress.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec sec-type="methods|subjects">
        <title>Patients and semen analysis:</title>
        <p>Semen samples were collected from 45 normospermic patients aged 28–45 years (35.3±4.8) from November 2014 to June 2015, by masturbation after 2 to 3 days of ejaculatory abstinence attending for male infertility investigation at Vida Centro de Fertilidade da Rede D’Or in Rio de Janeiro, Brazil. Samples were collected into sterile vials and were left to be liquefied at 37°<italic>C</italic> for 30 <italic>min</italic>. Semen samples were analyzed according to WHO criteria (2010) for concentration (≥15×10<sup>6</sup>
<italic>sperm/ml</italic>) and motility (≥32% progressive motility or 40% total motility) and according to Kruger’s criteria for morphology (≥4% normal morphology). The evaluation of concentration, motility and morphology were performed using Neubauer chamber, Makler chamber and Spermac staining (Sermacstain<sup>TM</sup> Sperm Morphology kit, FertiPro; Belgium), respectively. The criteria for exclusion from the study were urogenital infection, varicocele, hydrocele, use of drugs and medications and other diseases such as diabetes mellitus, obesity and malnutrition. The study was approved by the Ethics Committee of University Hospital Pedro Ernesto (CEP/HUPE 432.202) and all patients provided written informed consent.</p>
      </sec>
      <sec sec-type="methods">
        <title>Experimental design:</title>
        <p>In order to achieve the goal of this study, an experiment was initially done comparing fresh raw (FR) and frozen-thawed raw (F-T) semen samples from 15 patients to evaluate the effect of cryopreservation on DNAf. Based on the results observed, a second experiment was done using frozen-thawed raw (F-T) and capacitated (F-Tcap) semen samples from other 15 patients. In order to evaluate if leptin had some additional effect on the DNAf and oxidative stress of capacitated samples, a new experiment was performed using other 15 semen samples of previously capacitated frozen-thawed treated (F-TcapL) or not treated (F-Tcap) ones with leptin.</p>
      </sec>
      <sec>
        <title>Sperm freeze-thaw cycle:</title>
        <p>Samples were placed with 1:2 cryoprotectants (SpermFreeze; Vitrolife; Sweden) on cryovials and frozen in vapor liquid nitrogen for 30 <italic>min</italic>, followed by liquid nitrogen immersion. Samples remained in liquid nitrogen for two months when analysis was performed. For sperm thawing, cryovials were taken from liquid nitrogen and immediately immersed in water bath at 37°<italic>C</italic> for 5 <italic>min</italic>.</p>
      </sec>
      <sec>
        <title>Sperm capacitation:</title>
        <p>For sperm capacitation, samples were centrifuged at 180 <italic>g</italic> for 20 <italic>min</italic> using 2-layered density gradient centrifugation (DGC) solutions of 45% and 90% (SpermGrad; Vitrolife; Sweden). The supernatant was then removed and the pellet was washed in 1.5 <italic>ml</italic> human tubal fluid medium (HTF HEPES; Irvine Scientific; United States) supplemented with 10% SPS (SPS; Irvine Scientific; United States) at 180 <italic>g</italic> for 10 <italic>min</italic>. The supernatant was discarded and 1 <italic>ml</italic> of medium was gently layered on the pellet. Then, the tube was inclined at an angle of 45 degrees and incubated at 37°<italic>C</italic> for 1 <italic>hr</italic>. The upper interface was aspirated to obtain the motile fraction, which was divided in aliquots for leptin incubation.</p>
      </sec>
      <sec>
        <title>Leptin incubation:</title>
        <p>Capacitated samples were incubated with 10 <italic>ng</italic> leptin at 37°<italic>C</italic> and 6% CO<sub>2</sub> overnight, before freezing. The leptin dose was used based on previous studies (
<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>).</p>
      </sec>
      <sec>
        <title>Sperm DNA fragmentation assay:</title>
        <p>Sperm DNA integrity was assessed using SCD assay (Halosperm kit). Semen samples were diluted using 1:1 concentration in melt agarose microgel and placed in pretreated slides. Denaturing solution was used to denature nuclear DNA protein. Sperm were lysed and dispersed a large or medium DNA halo in non-fragmented sperm cells and a small or none DNA halo in fragmented sperm cells. At least 300 spermatozoa per sample were examined at 1000x magnification by oil immersion. The cut-off of SCD test is 30% (<xref rid="B21" ref-type="bibr">21</xref>). DNAf was performed to compare FR versus F-T; F-T versus F-Tcap; F-Tcap versus F-TcapL.</p>
      </sec>
      <sec>
        <title>Oxidative stress</title>
        <p>Pro-oxidant mechanisms were evaluated in F-Tcap and F-TcapL.</p>
        <list list-type="simple">
          <list-item>
            <p>- Lipid peroxidation was evaluated through measurement of thiobarbituric acid reactive substances (TBARS) at 532 <italic>nm</italic> using a spectrophotometer (<xref rid="B22" ref-type="bibr">22</xref>).</p>
          </list-item>
          <list-item>
            <p>- Protein oxidation: This method is based on reaction of 5,5′-dithiobis-2-nitrobenzoic acid (DTNB) with sulfhydryl (SH) group, which was measured at 412 <italic>nm</italic> using a spectrophotometer (<xref rid="B23" ref-type="bibr">23</xref>).</p>
          </list-item>
        </list>
        <p>Antioxidant mechanisms were evaluated in F-Tcap and F-TcapL.</p>
        <list list-type="simple">
          <list-item>
            <p>- Superoxide dismutase (SOD): In this method, adrenaline undergoes oxidation by anion superoxide action, which is inhibited by SOD activity. This oxidation generates adrenochrome, which is measured at 480 <italic>nm</italic> with a spectrophotometer (<xref rid="B24" ref-type="bibr">24</xref>).</p>
          </list-item>
          <list-item>
            <p>- Catalase: Catalase activity was measured by H<sub>2</sub>O<sub>2</sub> quantification at 240 <italic>nm</italic> with a spectrophotometer (240 <italic>nm</italic>) (<xref rid="B25" ref-type="bibr">25</xref>).</p>
          </list-item>
          <list-item>
            <p>- Glutathione peroxidase (GPx): GPx activity was determined through decay rate of reduced nicotinamide adenine dinucleotide phosphate (NADPH) at 340 <italic>nm</italic> with a spectrophotometer (<xref rid="B26" ref-type="bibr">26</xref>).</p>
          </list-item>
        </list>
      </sec>
      <sec sec-type="methods">
        <title>Statistical analysis:</title>
        <p>Statistical analysis was performed using Graphpad Prism version 6.0 software. Data are represented as mean and standard error. D’Agostino-Pearson was used to test normality of samples distribution. Paired t test was used to compare DNAf between groups before and after freeze-thaw cycle, to compare groups before and after capacitation and leptin incubation and oxidative measurements before and after leptin incubation. Statistical significance was considered when p≤0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Sperm DNAf:</title>
        <p>There was a significant increase in sperm DNAf evaluation after freeze-thaw cycle compared to evaluation with the same fresh raw sample (FR=17.6±1.7, F-T=36.2±3.5; p=0.0003; <xref ref-type="fig" rid="F1">figure 1A</xref>). Besides that, this increase occurred in such a way that 53.3% of the samples classified as fragmented (above 30%) after freeze-thaw cycle were found to be non-fragmented (under 30%) in the fresh raw evaluation.</p>
        <fig id="F1" position="float">
          <label>Figure 1.</label>
          <caption>
            <p>Percentage of sperm DNAf in fresh raw (FR) and frozen-thawed (F-T) samples. Horizontal line corresponds to cutoff value of the test; n=15 (Figure 1A). Percentage of sperm DNA fragmentation in capacitated (F-TCap) and non-capacitated (F-T) samples before freeze-thaw cycle; n=15 (Figure 1B) and capacitated samples with (F-TCapL) or without (F-TCap) leptin addition before freeze-thaw cycle; n=15 (Figure 1C). Data are represented as mean and standard error</p>
          </caption>
          <graphic xlink:href="JRI-17-172-g001"/>
        </fig>
        <p>Sperm DNAf was significantly reduced when sperm capacitation was performed before freezing samples, when compared to those frozen with no previous capacitation (raw). (F-T=37.4±4.0, F-Tcap=19.7±5.3; p=0.01; <xref ref-type="fig" rid="F1">figure 1B</xref>). Leptin addition to culture media in capacitated samples, before sperm freezing increased this reduction (F-Tcap=19.3±2.8, F-TcapL=9.5±2.0; p&lt;0.0001; <xref ref-type="fig" rid="F1">figure 1C</xref>) in sperm DNAf.</p>
      </sec>
      <sec>
        <title>Pro-oxidant mechanisms:</title>
        <p>Leptin addition to capacitated spermatozoa before freezing had no effect on lipid peroxidation (F-Tcap=0.04±0.004, F-TcapL=0.03±0.002; p=0.6; <xref ref-type="table" rid="T1">table 1</xref>) and protein oxidation (F-Tcap=4.1±0.1, F-TcapL=4.0±0.1; p= 0.2; <xref ref-type="table" rid="T1">table 1</xref>).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1.</label>
          <caption>
            <p>Oxidative damage measured by lipid peroxidation (TBARS), protein oxidation (SH) in capacitated spermatozoa with (F-TCapL) and without (F-TCap) leptin incubation before freezing. Antioxidant activity measured by superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) in capacitated spermatozoa with (F-TCapL) and without (F-TCap) leptin incubation before freezing. Data are represented as mean and standard error; n=15</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Oxidative stress parameter</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>F-Tcap</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>F-TcapL</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>p-value</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>TBARS</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.04±0.004</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.03±0.002</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.6</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>SH</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">4.1±0.1</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">4.0±0.1</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.2</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>SOD</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">82.4±6.9</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">100.8±6.2</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>CAT</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.02±0.006</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.02±0.007</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.9</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>GPx</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">88.8±9.8</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">110.7±8.7</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">0.02</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Antioxidant activity:</title>
        <p>There was a significant increase in antioxidant activity of SOD (F-Tcap= 82.4±6.9, F-TcapL=100.8±6.2; p=0.001; <xref ref-type="table" rid="T1">table 1</xref>) and GPx (88.8±9.8, F-TcapL=110.7±8.7; p=0.02; <xref ref-type="table" rid="T1">table 1</xref>) when comparing samples with and without leptin addition. However, catalase activity did not differ between groups (F-Tcap=0.02±0.006, F-TcapL=0.02±0.007; p=0.9; <xref ref-type="table" rid="T1">table 1</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>While cryo-induced damage to motility, viability, morphology and fertility capacity is already well documented, the possible DNA damage following sperm freezing is still not confirmed. There appears to be some contradictions concerning whether or not freezing can affect and the extent of the effect on sperm DNAf (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Some authors reported a significant increase on sperm DNA fragmentation caused by cryopreservation (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>), while others suggest there is no harm to DNA integrity (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). This controversy could be explained by several factors: 1) patients selection; in the study of Ozkavukcu et al. (2008) (<xref rid="B32" ref-type="bibr">32</xref>), 30% of the patients were smokers and it is known that smoking can alter DNA fragmentation (<xref rid="B33" ref-type="bibr">33</xref>); 2) different sperm capacitation techniques before freezing, <italic>i.e</italic> some studies used raw semen (<xref rid="B34" ref-type="bibr">34</xref>), others have isolated sperm by washing (<xref rid="B35" ref-type="bibr">35</xref>) or DGC (<xref rid="B36" ref-type="bibr">36</xref>); 3) different cryoprotectors were used in the studies; 4) different freezing and thawing protocols; 5) and the use of different techniques to measure sperm DNAf. In our study, a rise in DNAf after sperm freeze-thaw cycle was observed corroborating some previous studies. In order to decrease the variability in the present study, only patients who had no diseases, or used no medication were evaluated. Besides, only normospermic patients according to WHO criteria were included in the study since sperm of infertile men are less resistant to freezing process, showing poor results concerning sperm DNAf, compared to fertile men (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B37" ref-type="bibr">37</xref>). In this study, raw semen was used for comparison between before freezing and post-thaw DNAf, taking into account that raw semen has a strong antioxidant defense that could protect sperm against oxidative stress during cryopreservation, which in turn, could induce an increase on DNAf (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). The present results can be explained by previous evidence that the process of freezing and thawing can lead to ice crystals formation, provoking plasma membrane disruption, organelle and nuclear membrane, reaching cell DNA (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>). The mechanism by which these alterations occur is still unknown. However, a possible reason for this cryo-induced injury could be oxidative stress (<xref rid="B40" ref-type="bibr">40</xref>) and the activation of apoptotic cascades (<xref rid="B41" ref-type="bibr">41</xref>).</p>
      <p>There is still controversy in literature regarding sperm capacitation previous to cryopreservation. Some studies observed better DNAf results by addition of cryoprotectors directly to raw semen, supporting the idea that seminal plasma protects spermatozoa during freeze-thaw cycle, once it is rich in antioxidant enzymes (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Other researchers support that seminal plasma needs to be removed before freezing, otherwise it can damage sperm motility and vitality after thawing (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Also, sperm DNAf rates were compared using raw semen for cryopreservation and capacitated samples. Our results showed that sperm preparation previous to cryopreservation had reduced sperm DNAf rates. For sperm capacitation, DGC was performed, followed by sperm wash and pellet swim-up. The likely reason why better results were obtained concerning sperm DNAf of capacitated sperm before freezing can be raised on the hypothesis that the morphologically abnormal sperm are more susceptible to DNA damage during the freezing process than sperm with normal morphology (<xref rid="B37" ref-type="bibr">37</xref>). Additionally, head abnormalities and irregular chromatin organization may have altered membrane physical properties and thereby have altered tolerance to cold stress (<xref rid="B37" ref-type="bibr">37</xref>). By selecting a subpopulation of spermatozoa through sperm capacitation before freezing, a better quality sample can be obtained after thawing. This procedure allows selecting high quality spermatozoa and the removal of seminal plasma which contains germ cells, not viable, apoptotic and other components that can cause oxidative damage and apoptosis during freeze and thaw procedures (<xref rid="B43" ref-type="bibr">43</xref>).</p>
      <p>Several studies have been searching for mechanisms to attenuate deleterious effects caused by cryopreservation (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). Some of these attempt for a better sperm preparation before freezing, some for an ideal freeze and thaw protocol and others for better cryoprotector agents. As it is known that oxidative stress is one of the most detrimental factors during cryopreservation, recent studies have been reaching for cryoprotective substances which could minimize this damage (<xref rid="B44" ref-type="bibr">44</xref>).</p>
      <p>Due to its exclusive structural composition, such as lack of cytoplasm, which leads to decrease of antioxidant defense and a high proportion of polyunsaturated fatty acid in their membranes, making it more susceptible to lipid peroxidation, sperm became more vulnerable to ROS actions (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Deleterious effects of oxidative stress can result in several structural alterations of spermatozoa, such as protein fragmentation, lipid peroxidation and membrane and DNAf (<xref rid="B7" ref-type="bibr">7</xref>). This was the first study to focus on the possible cryoprotective effect of leptin on spermatozoa.</p>
      <p>Our results showed that leptin incubation with capacitated spermatozoa before cryopreservation could lead to increase in antioxidant enzymes SOD and GPx, but not catalase. The major cellular enzymatic antioxidants are SOD, catalase and GPx. However, catalase is known to be very effective in high-level oxidative stress and especially important in case of limited glutathione content or reduced GPx activity (<xref rid="B45" ref-type="bibr">45</xref>).</p>
      <p>A likely mechanism by which leptin can act against oxidative stress is by dissipating the excess energy via thermogenic mechanism and thus, preventing the development of excessive mitochondrial membrane potential (<xref rid="B18" ref-type="bibr">18</xref>). In another study, Zheng et al. demonstrated that leptin had anti-apoptotic effects on cardiomyocytes by increasing SOD activity. Leptin signaling could induce SOD2 gene expression and directly activate SOD2 promoter in cardiomyocytes (<xref rid="B19" ref-type="bibr">19</xref>). Interestingly, this effect was specific for SOD2 which is mitochondria-located, whereas the cytoplasm-located SOD1 remained unchanged following leptin treatment. In our study, leptin did not change pro-oxidant mechanisms. Leptin does not inhibit ROS formation directly. The reduction of oxidative stress is likely to be due to a rise of antioxidant enzymes activity. Controversially, leptin has shown to induce lipid oxidation in endothelial cells, leading to increased mitochondrial potential and consequent elevation of mitochondrial production of ROS (<xref rid="B20" ref-type="bibr">20</xref>). In the present study, leptin also potentiated DNAf reduction in frozen-thawed capacitated samples in relation to sperm capacitation. It can be speculated that the reduction of DNAf after leptin incubation could be explained by increased antioxidant defense, minimizing deleterious effects of oxidative stress during freezing and thawing processes.</p>
      <p>In summary, our results show that leptin has a cryoprotective effect and if added to the sample before freezing could reduce deleterious effect of cryopreservation. However, it remains unclear if the addition of this hormone could add value to <italic>in vitro</italic> fertilization techniques.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>Sperm DNAf increased after freeze-thaw cycle compared to evaluation with the same fresh raw sample. Sperm capacitation and leptin addition to culture media showed a cryoprotective effect on spermatozoa by reducing DNAf and increasing antioxidant enzymes activity. However, leptin did not inhibit ROS formation directly. The addition of leptin to capacitated sperm samples before freezing could possibly reduce deleterious effects of cryopreservation.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>The National Council for Scientific and Technological Development (CNPq) and Rio de Janeiro Foundation for Research Support (FAPERJ)</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>Authors declare no conflict of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petyim</surname><given-names>S</given-names></name><name><surname>Neungton</surname><given-names>C</given-names></name><name><surname>Thanaboonyawat</surname><given-names>I</given-names></name><name><surname>Laokirkkiat</surname><given-names>P</given-names></name><name><surname>Choavaratana</surname><given-names>R.</given-names></name></person-group>
<article-title>Sperm preparation before freezing improves sperm motility and reduces apoptosis in post-freezing-thawing sperm compared with post-thawing sperm preparation</article-title>. <source>J Assist Reprod Genet</source>. <year>2014</year>;<volume>31</volume>(<issue>12</issue>):<fpage>1673</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">25212531</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieme</surname><given-names>H</given-names></name><name><surname>Oldenhof</surname><given-names>H</given-names></name><name><surname>Wolkers</surname><given-names>WF.</given-names></name></person-group>
<article-title>Sperm membrane behaviour during cooling and cryopreservation</article-title>. <source>Reprod Domest Anim</source>. <year>2015</year>;<volume>50</volume>
<issue>Suppl 3</issue>:<fpage>20</fpage>–<lpage>6</lpage>.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeste</surname><given-names>M</given-names></name><name><surname>Estrada</surname><given-names>E</given-names></name><name><surname>Rocha</surname><given-names>LG</given-names></name><name><surname>Marin</surname><given-names>H</given-names></name><name><surname>Rodriguez-Gil</surname><given-names>JE</given-names></name><name><surname>Miro</surname><given-names>J.</given-names></name></person-group>
<article-title>Cryotolerance of stallion spermatozoa is related to ROS production and mitochondrial membrane potential rather than to the integrity of sperm nucleus</article-title>. <source>Andrology</source>. <year>2015</year>;<volume>3</volume>(<issue>2</issue>):<fpage>395</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">25294093</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Santo</surname><given-names>M</given-names></name><name><surname>Tarozzi</surname><given-names>N</given-names></name><name><surname>Nadalini</surname><given-names>M</given-names></name><name><surname>Borini</surname><given-names>A.</given-names></name></person-group>
<article-title>Human Sperm Cryopreservation: Update on Techniques, Effect on DNA Integrity, and Implications for ART</article-title>. <source>Adv Urol</source>. <year>2012</year>;<volume>2012</volume>:<fpage>854837</fpage>.<pub-id pub-id-type="pmid">22194740</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitken</surname><given-names>RJ</given-names></name><name><surname>Baker</surname><given-names>MA</given-names></name><name><surname>De Iuliis</surname><given-names>GN</given-names></name><name><surname>Nixon</surname><given-names>B.</given-names></name></person-group>
<article-title>New insights into sperm physiology and pathology</article-title>. <source>Handb Exp Pharmacol</source>. <year>2010</year>;(<issue>198</issue>):<fpage>99</fpage>–<lpage>115</lpage>.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfenstein</surname><given-names>F</given-names></name><name><surname>Losdat</surname><given-names>S</given-names></name><name><surname>Moller</surname><given-names>AP</given-names></name><name><surname>Blount</surname><given-names>JD</given-names></name><name><surname>Richner</surname><given-names>H.</given-names></name></person-group>
<article-title>Sperm of colourful males are better protected against oxidative stress</article-title>. <source>Ecol Lett</source>. <year>2010</year>;<volume>13</volume> (<issue>2</issue>):<fpage>213</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">20059524</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocuzza</surname><given-names>M</given-names></name><name><surname>Sikka</surname><given-names>SC</given-names></name><name><surname>Athayde</surname><given-names>KS</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name></person-group>
<article-title>Clinical relevance of oxidative stress and sperm chromatin damage in male infertility: an evidence based analysis</article-title>. <source>Int Braz J Urol</source>. <year>2007</year>;<volume>33</volume>(<issue>5</issue>):<fpage>603</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">17980058</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakkas</surname><given-names>D</given-names></name><name><surname>Alvarez</surname><given-names>JG.</given-names></name></person-group>
<article-title>Sperm DNA fragmentation: mechanisms of origin, impact on reproductive outcome, and analysis</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>93</volume>(<issue>4</issue>):<fpage>1027</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">20080235</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group>
<article-title>Whether sperm deoxyribonucleic acid fragmentation has an effect on pregnancy and miscarriage after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis</article-title>. <source>Fertil Steril</source>. <year>2014</year>;<volume>102</volume>(<issue>4</issue>): <fpage>998</fpage>–<lpage>1005</lpage>.<pub-id pub-id-type="pmid">25190048</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Protective effects of l-carnitine on astheno- and normozoospermic human semen samples during cryopreservation</article-title>. <source>Zygote</source>. <year>2016</year>;<volume>24</volume>(<issue>2</issue>):<fpage>293</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">26081351</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata-Campuzano</surname><given-names>M</given-names></name><name><surname>Alvarez-Rodriguez</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>M</given-names></name><name><surname>Tamayo-Canul</surname><given-names>J</given-names></name><name><surname>Anel</surname><given-names>L</given-names></name><name><surname>de Paz</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Post-thawing quality and incubation resilience of cryopreserved ram spermatozoa are affected by antioxidant supplementation and choice of extender</article-title>. <source>Theriogenology</source>. <year>2015</year>;<volume>83</volume>(<issue>4</issue>):<fpage>520</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">25499089</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Galiano</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>SJ</given-names></name><name><surname>Elias</surname><given-names>CF.</given-names></name></person-group>
<article-title>Role of the adipocyte-derived hormone leptin in reproductive control</article-title>. <source>Horm Mol Biol Clin Investig</source>. <year>2014</year>;<volume>19</volume>(<issue>3</issue>): <fpage>141</fpage>–<lpage>9</lpage>.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HW</given-names></name><name><surname>Chiu</surname><given-names>PC</given-names></name><name><surname>Cheung</surname><given-names>MP</given-names></name><name><surname>Yeung</surname><given-names>WS</given-names></name><name><surname>O</surname><given-names>WS.</given-names></name></person-group>
<article-title>Effect of leptin on motility, capacitation and acrosome reaction of human spermatozoa</article-title>. <source>Int J Androl</source>. <year>2009</year>;<volume>32</volume>(<issue>6</issue>):<fpage>687</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">19076257</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jope</surname><given-names>T</given-names></name><name><surname>Lammert</surname><given-names>A</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Paasch</surname><given-names>U</given-names></name><name><surname>Glander</surname><given-names>HJ.</given-names></name></person-group>
<article-title>Leptin and leptin receptor in human seminal plasma and in human spermatozoa</article-title>. <source>Int J Androl</source>. <year>2003</year>;<volume>26</volume>(<issue>6</issue>):<fpage>335</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">14636218</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquila</surname><given-names>S</given-names></name><name><surname>Giordano</surname><given-names>F</given-names></name><name><surname>Guido</surname><given-names>C</given-names></name><name><surname>Rago</surname><given-names>V</given-names></name><name><surname>Carpino</surname><given-names>A.</given-names></name></person-group>
<article-title>Nitric oxide involvement in the acrosome reaction triggered by leptin in pig sperm</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2011</year>;<volume>9</volume>:<fpage>133</fpage>.<pub-id pub-id-type="pmid">21970701</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampiao</surname><given-names>F</given-names></name><name><surname>du Plessis</surname><given-names>SS.</given-names></name></person-group>
<article-title>Insulin and leptin enhance human sperm motility, acrosome reaction and nitric oxide production</article-title>. <source>Asian J Androl</source>. <year>2008</year>; <volume>10</volume>(<issue>5</issue>):<fpage>799</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">18645684</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haron</surname><given-names>MN</given-names></name><name><surname>D’Souza</surname><given-names>UJ</given-names></name><name><surname>Jaafar</surname><given-names>H</given-names></name><name><surname>Zakaria</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>HJ.</given-names></name></person-group>
<article-title>Exogenous leptin administration decreases sperm count and increases the fraction of abnormal sperm in adult rats</article-title>. <source>Fertil Steril</source>. <year>2010</year>; <volume>93</volume>(<issue>1</issue>):<fpage>322</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">19709655</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solinas</surname><given-names>G.</given-names></name></person-group>
<article-title>Leptin signalling coordinates lipid oxidation with thermogenesis and defence against oxidative stress</article-title>. <source>Clin Exp Pharmacol Physiol</source>. <year>2010</year>; <volume>37</volume>(<issue>10</issue>):<fpage>953</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">20626418</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>XC</given-names></name><name><surname>Ren</surname><given-names>AJ</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Leptin protects cardiomyocytes from serum-deprivation-induced apoptosis by increasing anti-oxidant defence</article-title>. <source>Clin Exp Pharmacol Physiol</source>. <year>2010</year>;<volume>37</volume>(<issue>10</issue>):<fpage>955</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">20557321</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>SI</given-names></name><name><surname>Edelstein</surname><given-names>D</given-names></name><name><surname>Du</surname><given-names>XL</given-names></name><name><surname>Kaneda</surname><given-names>Y</given-names></name><name><surname>Guzman</surname><given-names>M</given-names></name><name><surname>Brownlee</surname><given-names>M.</given-names></name></person-group>
<article-title>Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A</article-title>. <source>J Biol Chem</source>. <year>2001</year>;<volume>276</volume>(<issue>27</issue>): <fpage>25096</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">11342529</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feijo</surname><given-names>CM</given-names></name><name><surname>Esteves</surname><given-names>SC.</given-names></name></person-group>
<article-title>Diagnostic accuracy of sperm chromatin dispersion test to evaluate sperm deoxyribonucleic acid damage in men with unexplained infertility</article-title>. <source>Fertil Steril</source>. <year>2014</year>;<volume>101</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">24140035</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draper</surname><given-names>HH</given-names></name><name><surname>Hadley</surname><given-names>M.</given-names></name></person-group>
<article-title>Malondialdehyde determination as index of lipid peroxidation</article-title>. <source>Methods Enzymol</source>. <year>1990</year>;<volume>18</volume><issue>6</issue>:<fpage>421</fpage>–<lpage>31</lpage>.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellman</surname><given-names>GL.</given-names></name></person-group>
<article-title>Tissue sulfhydryl groups</article-title>. <source>Arch Biochem Biophys</source>. <year>1959</year>;<volume>82</volume>(<issue>1</issue>):<fpage>70</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">13650640</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>JV</given-names></name><name><surname>Calabrese</surname><given-names>L.</given-names></name></person-group>
<article-title>Assays for superoxide dismutase</article-title>. <source>Methods Biochem Anal</source>. <year>1987</year>;<volume>3</volume><issue>2</issue>:<fpage>279</fpage>–<lpage>312</lpage>.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aebi</surname><given-names>H.</given-names></name></person-group>
<article-title>Catalase in vitro</article-title>. <source>Methods Enzymol</source>. <year>1984</year>;<volume>10</volume><issue>5</issue>:<fpage>121</fpage>–<lpage>6</lpage>.</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flohe</surname><given-names>L</given-names></name><name><surname>Gunzler</surname><given-names>WA.</given-names></name></person-group>
<article-title>Assays of glutathione peroxidase</article-title>. <source>Methods Enzymol</source>. <year>1984</year>;<volume>10</volume><issue>5</issue>:<fpage>114</fpage>–<lpage>21</lpage>.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoli</surname><given-names>D</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Lenzi</surname><given-names>A</given-names></name><name><surname>Gandini</surname><given-names>L.</given-names></name></person-group>
<article-title>Sperm cryopreservation: effects on chromatin structure</article-title>. <source>Adv Exp Med Biol</source>. <year>2014</year>;<volume>79</volume><issue>1</issue>:<fpage>137</fpage>–<lpage>50</lpage>.</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Kattoor</surname><given-names>AJ</given-names></name><name><surname>Ghulmiyyah</surname><given-names>J</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name></person-group>
<article-title>Effect of sperm storage and selection techniques on sperm parameters</article-title>. <source>Syst Biol Reprod Med</source>. <year>2015</year>;<volume>61</volume> (<issue>1</issue>):<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">25354153</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meamar</surname><given-names>M</given-names></name><name><surname>Zribi</surname><given-names>N</given-names></name><name><surname>Cambi</surname><given-names>M</given-names></name><name><surname>Tamburrino</surname><given-names>L</given-names></name><name><surname>Marchiani</surname><given-names>S</given-names></name><name><surname>Filimberti</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Sperm DNA fragmentation induced by cryopreservation: new insights and effect of a natural extract from Opuntia ficus-indica</article-title>. <source>Fertil Steril</source>. <year>2012</year>;<volume>98</volume>(<issue>2</issue>):<fpage>326</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">22633258</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tataru</surname><given-names>DA</given-names></name><name><surname>Markova</surname><given-names>EV</given-names></name><name><surname>Osadchuk</surname><given-names>LV</given-names></name><name><surname>Sheina</surname><given-names>EV</given-names></name><name><surname>Svetlakov</surname><given-names>AV.</given-names></name></person-group>
<article-title>[The optimal conditions of storage of spermatozoa for analysis of DNA fragmentation]</article-title>. <source>Klin Lab Diagn</source>. <year>2015</year>;<volume>60</volume>(<issue>4</issue>):<fpage>52</fpage>–<lpage>6</lpage>. Russian.</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vutyavanich</surname><given-names>T</given-names></name><name><surname>Piromlertamorn</surname><given-names>W</given-names></name><name><surname>Nunta</surname><given-names>S.</given-names></name></person-group>
<article-title>Rapid freezing versus slow programmable freezing of human spermatozoa</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>93</volume>(<issue>6</issue>):<fpage>1921</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">19243759</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozkavukcu</surname><given-names>S</given-names></name><name><surname>Erdemli</surname><given-names>E</given-names></name><name><surname>Isik</surname><given-names>A</given-names></name><name><surname>Oztuna</surname><given-names>D</given-names></name><name><surname>Karahuseyinoglu</surname><given-names>S.</given-names></name></person-group>
<article-title>Effects of cryopreservation on sperm parameters and ultrastructural morphology of human spermatozoa</article-title>. <source>J Assist Reprod Genet</source>. <year>2008</year>;<volume>25</volume> (<issue>8</issue>):<fpage>403</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">18704674</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Pant</surname><given-names>M</given-names></name><name><surname>Rachana</surname><given-names>R.</given-names></name></person-group>
<article-title>Protective effect of Salacia oblonga against tobacco smoke-induced DNA damage and cellular changes in pancreatic β-cells</article-title>. <source>Pharm Biol</source>. <year>2016</year>;<volume>54</volume>(<issue>3</issue>):<fpage>458</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">25973644</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olaciregui</surname><given-names>M</given-names></name><name><surname>Luno</surname><given-names>V</given-names></name><name><surname>Gonzalez</surname><given-names>N</given-names></name><name><surname>De Blas</surname><given-names>I</given-names></name><name><surname>Gil</surname><given-names>L.</given-names></name></person-group>
<article-title>Freeze-dried dog sperm: Dynamics of DNA integrity</article-title>. <source>Cryobiology</source>. <year>2015</year>;<volume>71</volume>(<issue>2</issue>):<fpage>286</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">26247315</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodayari Naeini</surname><given-names>Z</given-names></name><name><surname>Hassani Bafrani</surname><given-names>H</given-names></name><name><surname>Nikzad</surname><given-names>H.</given-names></name></person-group>
<article-title>Evaluation of ebselen supplementation on cryopreservation medium in human semen</article-title>. <source>Iran J Reprod Med</source>. <year>2014</year>;<volume>12</volume>(<issue>4</issue>):<fpage>249</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">24976819</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghorbani</surname><given-names>M</given-names></name><name><surname>Amiri</surname><given-names>I</given-names></name><name><surname>Khodadadi</surname><given-names>I</given-names></name><name><surname>Fattahi</surname><given-names>A</given-names></name><name><surname>Atabakhsh</surname><given-names>M</given-names></name><name><surname>Tavilani</surname><given-names>H.</given-names></name></person-group>
<article-title>Influence of BHT inclusion on post-thaw attributes of human semen</article-title>. <source>Syst Biol Reprod Med</source>. <year>2015</year>;<volume>61</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">25285571</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalthur</surname><given-names>G</given-names></name><name><surname>Adiga</surname><given-names>SK</given-names></name><name><surname>Upadhya</surname><given-names>D</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name></person-group>
<article-title>Effect of cryopreservation on sperm DNA integrity in patients with teratospermia</article-title>. <source>Fertil Steril</source>. <year>2008</year>;<volume>89</volume>(<issue>6</issue>):<fpage>1723</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">17953963</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saritha</surname><given-names>KR</given-names></name><name><surname>Bongso</surname><given-names>A.</given-names></name></person-group>
<article-title>Comparative evaluation of fresh and washed human sperm cryopreserved in vapor and liquid phases of liquid nitrogen</article-title>. <source>J Androl</source>. <year>2001</year>;<volume>22</volume>(<issue>5</issue>):<fpage>857</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">11545300</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Soto</surname><given-names>JC</given-names></name><name><surname>Landeras</surname><given-names>J</given-names></name><name><surname>Gadea</surname><given-names>J.</given-names></name></person-group>
<article-title>Spermatozoa and seminal plasma fatty acids as predictors of cryopreservation success</article-title>. <source>Andrology</source>. <year>2013</year>;<volume>1</volume>(<issue>3</issue>): <fpage>365</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">23596043</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>LK</given-names></name><name><surname>Fleming</surname><given-names>SD</given-names></name><name><surname>Aitken</surname><given-names>RJ</given-names></name><name><surname>De Iuliis</surname><given-names>GN</given-names></name><name><surname>Zieschang</surname><given-names>JA</given-names></name><name><surname>Clark</surname><given-names>AM.</given-names></name></person-group>
<article-title>Cryopreservation-induced human sperm DNA damage is predominantly mediated by oxidative stress rather than apoptosis</article-title>. <source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume>(<issue>9</issue>):<fpage>2061</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">19525298</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zribi</surname><given-names>N</given-names></name><name><surname>Feki Chakroun</surname><given-names>N</given-names></name><name><surname>El Euch</surname><given-names>H</given-names></name><name><surname>Gargouri</surname><given-names>J</given-names></name><name><surname>Bahloul</surname><given-names>A</given-names></name><name><surname>Ammar Keskes</surname><given-names>L.</given-names></name></person-group>
<article-title>Effects of cryopreservation on human sperm deoxyribonucleic acid integrity</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>93</volume>(<issue>1</issue>):<fpage>159</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">19027111</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorn</surname><given-names>B</given-names></name><name><surname>Ihan</surname><given-names>A</given-names></name><name><surname>Kopitar</surname><given-names>AN</given-names></name><name><surname>Kolbezen</surname><given-names>M</given-names></name><name><surname>Sesek-Briski</surname><given-names>A</given-names></name><name><surname>Meden-Vrtovec</surname><given-names>H.</given-names></name></person-group>
<article-title>Changes in sperm apoptotic markers as related to seminal leukocytes and elastase</article-title>. <source>Reprod Biomed Online</source>. <year>2010</year>;<volume>21</volume>(<issue>1</issue>): <fpage>84</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">20462795</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugnon</surname><given-names>F</given-names></name><name><surname>Ouchchane</surname><given-names>L</given-names></name><name><surname>Pons-Rejraji</surname><given-names>H</given-names></name><name><surname>Artonne</surname><given-names>C</given-names></name><name><surname>Farigoule</surname><given-names>M</given-names></name><name><surname>Janny</surname><given-names>L.</given-names></name></person-group>
<article-title>Density gradient centrifugation prior to cryopreservation and hypotaurine supplementation improve post-thaw quality of sperm from infertile men with oligoasthenoterato-zoospermia</article-title>. <source>Hum Reprod</source>. <year>2013</year>;<volume>28</volume>(<issue>8</issue>):<fpage>2045</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">23760160</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateni</surname><given-names>Z</given-names></name><name><surname>Azadi</surname><given-names>L</given-names></name><name><surname>Tavalaee</surname><given-names>M</given-names></name><name><surname>Kiani-Esfahani</surname><given-names>A</given-names></name><name><surname>Fazilati</surname><given-names>M</given-names></name><name><surname>Nasr-Esfahani</surname><given-names>MH.</given-names></name></person-group>
<article-title>Addition of Tempol in semen cryopreservation medium improves the post-thaw sperm function</article-title>. <source>Syst Biol Reprod Med</source>. <year>2014</year>;<volume>60</volume>(<issue>4</issue>):<fpage>245</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">24702585</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paravicini</surname><given-names>TM</given-names></name><name><surname>Touyz</surname><given-names>RM.</given-names></name></person-group>
<article-title>NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities</article-title>. <source>Diabetes Care</source>. <year>2008</year>;<volume>31</volume>
<issue>Suppl 2</issue>:<fpage>S170</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">18227481</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359855</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359855</article-id>
      <article-id pub-id-type="pmcid">PMC5359855</article-id>
      <article-id pub-id-type="pmc-uid">5359855</article-id>
      <article-id pub-id-type="publisher-id">jri-17-179</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Relationship of Number of Embryos Transferred with Perinatal Outcome of Singleton Pregnancy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bhandari</surname>
            <given-names>Shilpa</given-names>
          </name>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ganguly</surname>
            <given-names>Ishita</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Agarwal</surname>
            <given-names>Pallavi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Munaganuru</surname>
            <given-names>Niharika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Nitika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>Aparna</given-names>
          </name>
        </contrib>
        <aff id="AFF1">- Department of Reproductive Medicine and Surgery, Sri Aurobindo Medical College and Post Graduate Institute, Indore, India</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Shilpa Bhandari, Department of Reproductive Medicine and Surgery, Sri Aurobindo Medical College and Post graduate Institute Indore Ujjain Highway, Indore, Madhya Pradesh, India, <italic>E-mail:</italic><email>drshilpa.b@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>179</fpage>
      <lpage>184</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>Singleton pregnancy with a live birth beyond 37 weeks of gestation is the ultimate goal of any assisted reproductive technology. However, singletons conceived after ART are found to have a poor perinatal outcome in comparison to naturally conceived singletons. It was hypothesized that the outcome of singleton conceived after transfer of two or more embryos may be dependent on the sharing of uterine space with other embryos.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Patients who had single gestational sac visualized at 6 weeks after transfer of 4, 3 or 2 embryos were considered for the study. 195 singleton pregnancies were selected for final evaluation such that as per implantation rates of 25%, 33%, and 50%, they were divided into 3 groups of 50, 82 and 63 cases, respectively. The basic characteristics of pregnancy (gestational age, birth weight) were compared using analysis of variance (continuous variables), and categorical variables were evaluated with chi-squared test. The p&lt;0.05 was considered statistically significant.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Among the various variables including maternal age, conception, type of infertility, type of abortion, total live birth, gestational age in live birth, birth weight, kind of embryo transfer and gestational age, there was not significant statistical differences between groups except gestational age that it was higher in group with 50% (p&lt;0.04) implantation rate. Therefore, higher number of initial embryos may affect the perinatal outcome of singleton conceived subsequently.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>There is higher chance of missed abortion in patients with singleton pregnancies conceived after multiple embryo transfer. Gestational age at delivery and birth weight were correlated with number of embryo transfered.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Assisted Reproductive Technology</kwd>
        <kwd>Embryo transfer</kwd>
        <kwd>Implantation rate</kwd>
        <kwd>Perinatal outcome</kwd>
        <kwd>Singleton pregnancy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Singleton pregnancy is the desired outcome of any assisted reproductive technique (ART). With advances in the field of embryology and laboratory practices, great advances have been made such that the average pregnancy rate per cycle has increased. However, implantation remains the bottleneck of any ART cycle. Even though transfer of a single good quality embryo is advocated by most of the guidelines (<xref rid="B1" ref-type="bibr">1</xref>), it has not become a routine practice globally. Sometimes, in certain circumstances, as in repeated failure cases or, owing to a limited ability to select the embryos with the highest chance for implantation, a large cohort of embryos is transferred deliberately. In all these cases, though the chance of multifetal pregnancy is increased, singleton pregnancies are also seen. Limited implantation potential of the transferred embryo or of the uterus itself may lead to variable implantation rate of the cycle.</p>
      <p>Different embryo transfer strategies have resulted in different multiple pregnancy rates ranging from 38.3% in Siberia to 5.7% in Sweden (<xref rid="B2" ref-type="bibr">2</xref>). Therefore, as the number of children born by ART is significant, knowledge of factors affecting perinatal outcome in ART singletons is crucial. It is known that singletons conceived by ART are at increased risk of adverse pregnancy outcomes (<xref rid="B2" ref-type="bibr">2</xref>–<xref rid="B4" ref-type="bibr">4</xref>) whether this outcome is related to infertility itself, ART technology or the embryo (<xref rid="B4" ref-type="bibr">4</xref>). This study aimed to find if the obstetric outcomes are also affected by implantation rate.</p>
      <p>Many previous studies have considered aspects which alter or influence implantation rate and thereby predict/determine the number of embryos to be transferred (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>). This study examined implantation rate from a different perspective. The purpose was to evaluate the perinatal outcome in singleton pregnancies as a function of different implantation rates. This may help understand two aspects of conception: 1) does embryonic crowding initially affect the implanted embryo? and 2) does higher implantation rate translates into better reproductive and perinatal performance?</p>
      <p>To the best of our knowledge, there have been no studies evaluating the possible effects of implantation rate on singleton pregnancies resulting from transfer of 4 or less cleavage stage embryos. The purpose of this study was to compare the perinatal outcomes of singleton pregnancies according to implantation rate.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>This is a retrospective analysis done in the department of reproductive medicine and surgery at Sri Aurobindo Institute of Medical sciences from the year 2012 to 2014. Women who conceived after <italic>in vitro</italic> fertilization (IVF) or intracytoplasmic sperm injection (ICSI) with a single gestation sac visible on ultrasound (USG) at 6 weeks (approximately 4 weeks after embryo transfer) were included in the study. Records of the patients were studied to exclude patients with elective single embryo transfers, blastocyst transfers, with donor oocyte, surrogacies and monochorionic gestation. As this was a retrospective study, informed consent could not be taken from patients. Both fresh and frozen thaw cycles were included in the study. For all cases in the study, less than 4 cleavage stage embryos transfer was done at a time. The following data was recorded from case file of patients included in this study– age, previous conception (parity), cause of infertility, type of transfer (fresh or frozen), number of embryos transferred, pregnancy outcome in terms of abortion, live birth and birth weight at delivery. Average number of IVF cycles was 2–3. Patients who had chronic diseases like diabetes mellitus, hypertension, thyroiditis and autoimmune disorders were excluded from the study.</p>
      <p>For purpose of stimulation, antagonist protocol was used in all patients included in the study (<xref rid="B6" ref-type="bibr">6</xref>). The stimulation started with recombinant gonadotropins from day 2 or 3 of cycle when estradiol levels were &lt;50 <italic>pg/ml</italic> and ovarian quiescence seen on USG. The dose of recombinant gonadotropin Gonal F (Merck serono SpA, Italy) was decided as per patient’s age, antral follicle count, BMI and previous response to stimulation if any. Gonadotropin releasing hormone antagonist (cetrorelix 0.25 <italic>mg</italic>, Serum Institute of India Ltd, India) was initiated as per flexible protocol when at least 1 follicle reached the average diameter of 14 <italic>mm</italic> till the day of trigger. Ovulation trigger was given using either 10,000 <italic>IU</italic> (250 <italic>μg</italic>) recombinant HCG (Sanzyme Ltd., India) or leuprolide (Celon Laboratories Ltd., India) 2 <italic>mg</italic> when 3 or more follicles reached an average diameter of 17 <italic>mm</italic>. The choice of trigger depended on pre-trigger estradiol values and risk of ovarian hyperstimulation syndrome. Patients given agonist trigger underwent frozen-thawed cycle in subsequent months wherein, down regulation was done using 3.75 <italic>mg</italic> leuprolide (BDR Pharmaceutical International Pvt Ltd., India) depot on day 21. Endometrial preparation was done with estradiol valerate (in incremental doses) (<xref rid="B7" ref-type="bibr">7</xref>). Transfer was done when endometrial thickness was more than 7 <italic>mm</italic> with trilaminar pattern. All patients were given luteal phase support from day of oocyte retrieval till 14 weeks of gestation in the form of micronized progesterone vaginal gel once daily (Naturogest- East Sikkim) once daily. Concentration of vaginal gel was 8% (1.35 <italic>gr</italic> in a pack which delivers 90 <italic>mg</italic> progesterone daily) (<xref rid="B8" ref-type="bibr">8</xref>).</p>
      <p>Based on semen quality, the oocytes were inseminated 3–6 <italic>hr</italic> after oocyte retrieval with either ICSI or conventional insemination. Fertilization was indicated by the appearance of two distinct pronuclei and two polar bodies 16–18 <italic>hr</italic> after insemination. The zygotes were cultured in cleavage medium (Cook Medical, Australia). Embryonic development was assessed on day 2 (41–43 <italic>hr</italic>) and on day 3 (65–67 <italic>hr</italic>) after insemination. Cleavage stage embryo transfer was performed using embryos with the highest number of blastomeres with the highest embryo score. All embryo transfers were performed by the same person under ultrasound guidance and a serum beta-hCG pregnancy test was performed 16 days after embryo transfer.</p>
      <p>As per departmental protocol, all patients had conceived after embryo transfer and had transvaginal USG done at around 6 weeks (4 weeks after embryo transfer). All patients were followed up every 2 to 4 weeks in the department till delivery/abortion and records were periodically updated.</p>
      <p>Missed abortion was defined as absence of cardiac activity at 6 weeks of gestation. Early abortion was defined as loss of cardiac activity or disappearance of gestational sac before 12 weeks after documentation of live fetus at 6 weeks. Loss of fetus between 13 to 28 weeks was defined as late abortion. Any birth after 28 completed weeks of gestation (period of viability for present study) was considered as live birth with those between 29–32 weeks being very preterm, 33 to 36 weeks as preterm and after 37 weeks as term birth.</p>
      <p>Implantation rate was calculated by dividing number of gestational sacs seen (<xref rid="B1" ref-type="bibr">1</xref>) by the number of embryo transferred (4, 3 or 2).</p>
      <p>Quantitative data was expressed as mean±standard deviation. The basic characteristics of pregnancy (gestational age, birth weight) were compared using analysis of variance (continuous variables), and categorical variables were evaluated with chi-squared tests and t test as applicable. P-value of &lt;0.05 was considered statistically significant.</p>
      <p>Ethical clearance from institutional ethical committee was taken for the study.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>As per the inclusion criteria, 195 patients conceived with singleton after ART and delivered/aborted by the completion of study period. Depending on the number of cleavage stage embryos, patients were divided into 3 groups as per calculated implantation rate (25%, 33.33%, and 50%).</p>
      <p>The age and previous conception were similar in all three groups, and the age of patients with an implantation rate of 50% was lesser than the other two groups (<xref ref-type="table" rid="T1">Table 1</xref>) though the difference was not statistically significant. Tubal factor infertility was the most common cause of treatment in the entire cohort.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Patients characteristics in different implantation rate groups</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1">
                <bold>Variables</bold>
              </th>
              <th colspan="3" align="center" valign="middle" rowspan="1">
                <bold>Implantation rate</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1"/>
            </tr>
            <tr>
              <th colspan="3" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>25%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>33.33%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>50%</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Age (years)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">32.46±6.0 (20–45 years)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">32.19±5.9 (25–42 years)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">30.67±4.0 (20–39 years)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.142</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Previous conception</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">8 (16)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">24(29.2)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">13(20.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.184</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Type of Infertility</bold>
              </td>
              <td align="left" valign="middle" rowspan="1" colspan="1"/>
              <td align="left" valign="middle" rowspan="1" colspan="1"/>
              <td align="left" valign="middle" rowspan="1" colspan="1"/>
              <td align="left" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Male factor</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">12 (24)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">24 (29.27)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">18 (28.57)</td>
              <td align="center" valign="middle" rowspan="5" colspan="1">0.076</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Ovarian factor</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">14 (28)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">24 (29.27)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">8 (12.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Tubal factor</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">15 (30)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">18 (21.95)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">25 (39.68)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Uterine factor</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">5 (10)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">5 (6.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1 (1.59)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Unexplained</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">4 (8)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">11 (13.41)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">11 (17.46)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Total</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">50</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">82</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">63</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">195</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>Numbers in parenthesis denote percentage</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Out of 195 patients included in the study, a total of 157 had a live birth (<xref ref-type="table" rid="T2">Table 2</xref>). A majority, 68.15% (107/157) had term delivery (at or beyond 37 weeks of gestation). The number of preterm and term deliveries between the three groups was not statistically significant. The average gestational age in live births showed an increasing trend as the implantation rate increased; however, this does not appear to be statistically significant (p=0.66). When the average gestational age of the entire cohort was considered (live births and abortions), a statistically higher probability of delivering later in gestation was found when the implantation rate was 50% (p=0.04).</p>
      <table-wrap id="T2" position="float">
        <label>Table 2.</label>
        <caption>
          <p>Implantation rate and delivery outcome</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1">
                <bold>Variable</bold>
              </th>
              <th colspan="3" align="center" valign="middle" rowspan="1">
                <bold>Implantation rate</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1">
                <bold>p-value</bold>
              </th>
            </tr>
            <tr>
              <th colspan="3" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>25%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>33.33%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>50%</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Very preterm delivery (&lt;32 weeks)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2(5.4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3 (4.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 (3.5)</td>
              <td align="center" valign="middle" rowspan="3" colspan="1">0.97</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Preterm delivery (32–37 weeks)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">10 (27.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">16 (25.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">17 (30.4)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Term delivery (&gt;37 weeks)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">25 (67.5)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">45 (70.3)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">37 (66.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Total Live births</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">37 (74)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">64 (78)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">56 (88.8)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.11</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Mean gestational age at live birth</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">36.57±2.67</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">36.78±2.25</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">37.02±2.26</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.66</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Mean gestational age of delivery</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">29.52±12.63</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">30.6±12.17</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">34.40±8.20</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <p>Numbers in parenthesis denote percentage</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Out of 195 patients, a total of 38 patients aborted or delivered at or before 28 weeks of gestation. The rate of abortion gestation did not appear to be statistically related to the implantation rate (p= 0.37) (<xref ref-type="table" rid="T3">Table 3</xref>). In the group of 25% implantation rate, 26% patients (13/50) had undergone spontaneous abortion as against 11.11% (7/63) in the group of 50% implantation though this result did not reach statistical significance.</p>
      <table-wrap id="T3" position="float">
        <label>Table 3.</label>
        <caption>
          <p>Implantation rate and spontaneous miscarriage</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1">
                <bold>Variable</bold>
              </th>
              <th colspan="3" align="center" valign="middle" rowspan="1">
                <bold>Implantation rate</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1">
                <bold>p-value</bold>
              </th>
            </tr>
            <tr>
              <th colspan="3" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>25% (n=50)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>33.33% (n=82)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>50% (n=63)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Missed abortion (up to 6 weeks)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">8 (16)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">12 (14.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 (3.1)</td>
              <td align="center" valign="middle" rowspan="3" colspan="1">0.37</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Early abortion (up to 12 weeks</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3 (6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">4 (4.8)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 (3.1)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Late abortion (13–28 weeks)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 (4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 (2.4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3 (4.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Total No of abortion</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">13 (26%)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">18 (21.95%)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">7 (11.11%)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.1059</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN3">
            <p>Numbers in parenthesis denote percentage</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In the present study, 157 patients had a live birth with a majority 61.78% (97/157) with a birth weight of over 2.6 <italic>kg</italic> (<xref ref-type="table" rid="T4">Table 4</xref>). No statistical significance was found in the birth weight amongst the 3-implantation groups. However, the percentage of babies with birth weight of more than 2.6 <italic>kg</italic> (66.07%) and the average birth weight (2.71 <italic>kg</italic>) was the highest in the 50% implantation group.</p>
      <table-wrap id="T4" position="float">
        <label>Table 4.</label>
        <caption>
          <p>Implantation rate and birth weight in live births</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1">
                <bold>Birth weight</bold>
              </th>
              <th colspan="3" align="center" valign="middle" rowspan="1">
                <bold>Implantation rate</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1">
                <bold>p-value</bold>
              </th>
            </tr>
            <tr>
              <th colspan="3" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>25% (37)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>33.33% (64)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>50% (56)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Very low birth weight (1 to 1.5 <italic>kg</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3 (8.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3 (4.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">4 (7.1)</td>
              <td align="center" valign="middle" rowspan="3" colspan="1">0.82</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Low birth weight (1.6 to 2.5 <italic>kg</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">13 (35.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">22 (34.2)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">15 (26.7)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Normal birth weight (≥2.6 <italic>kg</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">21 (56.75)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">39 (60.94)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">37 (66.07)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Average weight (In <italic>kg</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.68±0.63 <italic>kg</italic></td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.7±0.59 <italic>kg</italic></td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.71±0.52 <italic>kg</italic></td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0.98</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN4">
            <p>Numbers in parenthesis denote percentage</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In the present study, out of 195 patients, 110 had frozen-thawed embryo transfers while 85 had fresh transfers. The type of embryo transfer (fresh or frozen–thawed) does not appear to be statistically associated with the 3-implantation groups (<xref ref-type="table" rid="T5">Table 5</xref>).</p>
      <table-wrap id="T5" position="float">
        <label>Table 5.</label>
        <caption>
          <p>Implantation rate and fresh/frozen-thawed transfers</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1">
                <bold>Embryo transfer</bold>
              </th>
              <th colspan="3" align="center" valign="middle" rowspan="1">
                <bold>Implantation Rate</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1">
                <bold>p-value</bold>
              </th>
            </tr>
            <tr>
              <th colspan="3" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>25%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>33.33%</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>50%</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Fresh transfers</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">19 (38)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">34 (41.4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">32 (50.7)</td>
              <td align="center" valign="middle" rowspan="3" colspan="1">0.767</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Frozen transfers</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">31(62)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">48 (58.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">31 (49.3)</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Total</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">50</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">82</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">63</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN5">
            <p>Numbers in parenthesis denote percentage</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Embryo quality and endometrial receptivity are two determinants for pregnancy success in patients undergoing IVF-ET program. With respect to embryos, clinical data show that 70% of embryos selected for transfer fail to implant. To increase pregnancy rates, multiple embryos are transferred, which is responsible for complications due to multiple gestation pregnancy (<xref rid="B9" ref-type="bibr">9</xref>); therefore, it is essential to develop better understanding of implantation and factors determining its rate. In an elaborate study done on rodent uteri (<xref rid="B10" ref-type="bibr">10</xref>), embryo implantation at unfavorable site was postulated to be associated with pregnancy complication as well. The authors also suggested that one cause of vanishing twin syndrome seen in IVF conceptions might be due to embryo crowding at implantation and subsequent resorption of one embryo as the result of competition for space and nutrient supply. It is an open but intriguing possibility that maternal stress at the time of embryo transfer and/or implantation may cause similar sympathetic activation of uterine β<sub>2</sub>-AR (Beta 2 adrenergic receptor) in humans, resulting in sub-optimal embryo location and pregnancy complications (<xref rid="B10" ref-type="bibr">10</xref>).</p>
      <p>Oren et al. (<xref rid="B3" ref-type="bibr">3</xref>) have demonstrated that embryo quality had no effect on perinatal outcomes but it does affect pregnancy rate and implantation rate (<xref rid="B11" ref-type="bibr">11</xref>). Also, in our study, no significant association was found between live birth rate and birth weight and implantation rate in singleton conception/deliveries. However, regarding gestational age at termination of pregnancy (abortion or delivery), a decreasing age with lower implantation rate was found. Therefore, it is believed that early pregnancy events may depend on implantation rate though once the singleton progresses beyond the luteo-placental shift, number of initial embryos may not be relevant anymore. Pinborg et al. (<xref rid="B12" ref-type="bibr">12</xref>) have suggested that with increasing fetal/embryo number, the obstetric outcome of surviving singleton is adversely affected. They too have supported the hypothesis that early implantation site crowding leads to first trimester losses.</p>
      <p>A meta-analysis (<xref rid="B2" ref-type="bibr">2</xref>) found high-grade evidence that singleton IVF babies have higher risk of worse perinatal outcome in comparison to singleton of unselected spontaneously conceived women. Also, in this study, it was shown that number of embryos transferred does not affect the outcome of a singleton pregnancy conceived consequently. This in turn indicates that there may be factors inherent to ART technique or the infertile patient herself that may lead to poorer outcome. This meta-analysis also looked into the evidence comparing perinatal outcomes of singleton pregnancies after single or double embryo transfer. They found low quality evidence of similar outcome in both groups. Our own result is similar when live births are compared. However, a slightly higher average birth weight and gestational age at delivery (of live born) were found when implantation rate was higher (50%) as against lower implantation rates (25% and 33%). Even the percentage of abortion was higher in lower implantation rate group though none of these results reached a statistical significance.</p>
      <p>A retrospective cohort study (<xref rid="B13" ref-type="bibr">13</xref>) showed that in older women, the chance of multiple sacs leading to delivery of multiple babies is low and likely reflects aneuploidy. Therefore, they have advocated a more aggressive embryo transfer strategy to maximize the chance of actual live birth. In cases of multiple embryo transfer, especially in absence of pre implantation genetic screening, implantation rate will depend on the quality of the embryos themselves. Presuming that only the best embryo implants in a singleton pregnancy, it can be further concluded that this naturally selected embryo will have similar obstetric outcome irrespective of its initial competition. In other words, correct measure of uterine receptivity and embryo quality will help pre select the one embryo that will implant and thereby reduces the potential for multiple pregnancies.</p>
      <p>ASRM guidelines (<xref rid="B1" ref-type="bibr">1</xref>) have defined the number of embryos transferred on basis of patient age, embryo quality, the opportunity for cryopreservation, and results of previous IVF cycles if any. Transfer of multiple embryos (2 or more) has been suggested in cases with relatively poor prognosis secondary to age, previous failure or embryo quality. For patients with previous IVF failures, additional embryos may be considered for transfer. However, our study shows that as the implantation rate decreases, chances of live birth also decrease. Therefore, in view of our own study, it is believed that the best outcome in terms of live birth may be achieved by increasing the implantation rate by transferring better quality embryo itself.</p>
      <p>In a large retrospective cohort analysis, over 35000 ET after oocyte donation (<xref rid="B14" ref-type="bibr">14</xref>), the authors concluded that as the number of embryos transferred per cycle increased, so did the total number of cycles required to achieve a newborn. This study also showed that percentage of miscarriage also increased along with total number of embryo transferred. This study, however, did not evaluate single-, double-, or triple-embryo transfers per se and the researchers did not take into consideration the quality of embryos transferred. Despite these differences, the result of our own study appears to be similar.</p>
      <p>Previous studies have demonstrated a poorer neonatal outcome in singleton pregnancies of ART especially in fresh transfers (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). An improvement in the outcome with frozen transfers (<xref rid="B15" ref-type="bibr">15</xref>) is attributed to better endometrial receptivity. Our study shows that as the implantation potential improves, the possibility of better outcome especially in terms of live birth also increases. Hsu et al. (<xref rid="B16" ref-type="bibr">16</xref>), in their retrospective controlled clinical study, found an inverse relation between implantation rate and number of embryos transferred irrespective of their quality.</p>
      <p>A major strength of our study is that it was a single center study with close follow up by a single physician in all conceived patients.</p>
      <sec sec-type="methods">
        <title>Limitations of the study:</title>
        <p>Our results are limited by the retrospective nature of the study and smaller numbers. Due to the study design itself, nature of endometrium at time of transfer and previously failed IVF cycles were not considered for evaluation.</p>
      </sec>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>Our study shows that in patients with singleton pregnancies conceived after multiple embryo transfer, there is higher chance of missed abortion which is significant if more than 2 embryos are transferred. However, there is a correlation between the number of embryos transferred with gestational age at delivery and birth weight.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>Conflict of Interest: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology.</collab></person-group>
<article-title>Criteria for number of embryos to transfer: a committee opinion</article-title>. <source>Fertil Steril</source>. <year>2013</year>;<volume>99</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">23095140</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinborg</surname><given-names>A</given-names></name><name><surname>Wennerholm</surname><given-names>UB</given-names></name><name><surname>Romundstad</surname><given-names>LB</given-names></name><name><surname>Loft</surname><given-names>A</given-names></name><name><surname>Aittomaki</surname><given-names>K</given-names></name><name><surname>Soderstrom-Anttila</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis</article-title>. <source>Hum Reprod Update</source>. <year>2013</year>;<volume>19</volume>(<issue>2</issue>):<fpage>87</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">23154145</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oron</surname><given-names>G</given-names></name><name><surname>Son</surname><given-names>WY</given-names></name><name><surname>Buckett</surname><given-names>W</given-names></name><name><surname>Tulandi</surname><given-names>T</given-names></name><name><surname>Holzer</surname><given-names>H.</given-names></name></person-group>
<article-title>The association between embryo quality and perinatal outcome of singletons born after single embryo transfers: a pilot study</article-title>. <source>Hum Reprod</source>. <year>2014</year>:<volume>29</volume>(<issue>7</issue>): <fpage>1444</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">24812313</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poikkeus</surname><given-names>P</given-names></name><name><surname>Unkila-Kallio</surname><given-names>L</given-names></name><name><surname>Vilska</surname><given-names>S</given-names></name><name><surname>Repokari</surname><given-names>L</given-names></name><name><surname>Punamaki</surname><given-names>RL</given-names></name><name><surname>Aitokallio-Tallberg</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Impact of infertility characteristics and treatment modalities on singleton pregnancies after assisted reproduction</article-title>. <source>Reprod Biomed Online</source>. <year>2006</year>;<volume>13</volume>(<issue>1</issue>):<fpage>135</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">16820125</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunault</surname><given-names>CC</given-names></name><name><surname>Eijkemans</surname><given-names>MJ</given-names></name><name><surname>Pieters</surname><given-names>MH</given-names></name><name><surname>te Velde</surname><given-names>ER</given-names></name><name><surname>Habbema</surname><given-names>JD</given-names></name><name><surname>Fauser</surname><given-names>BC</given-names></name><etal/></person-group>
<article-title>A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer</article-title>. <source>Fertil Steril</source>. <year>2002</year>;<volume>77</volume>(<issue>4</issue>):<fpage>725</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">11937124</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillier</surname><given-names>SG.</given-names></name></person-group>
<article-title>The Parkes lecture: controlled ovarian stimulation in women</article-title>. <source>J Reprod Fertil</source>. <year>2010</year>;<volume>120</volume>(<issue>2</issue>): <fpage>201</fpage>–<lpage>10</lpage>.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casper</surname><given-names>RF</given-names></name><name><surname>Yanushpolsky</surname><given-names>EH.</given-names></name></person-group>
<article-title>Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support</article-title>. <source>Fertil Steril</source>. <year>2016</year>;<volume>105</volume>(<issue>4</issue>):<fpage>867</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">26820769</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Practice Committee of the American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility.</collab></person-group>
<article-title>Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin</article-title>. <source>Fertil Steril</source>. <year>2008</year>;<volume>90</volume>(<issue>5 Suppl</issue>):<fpage>S150</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">19007614</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Kong</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Physiological and molecular determinants of embryo implantation</article-title>. <source>Mol Aspects Med</source>. <year>2013</year>;<volume>34</volume> (<issue>5</issue>):<fpage>939</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">23290997</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>L</given-names></name><name><surname>Kuang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Transient {beta}2-adrenoceptor activation confers pregnancy loss by disrupting embryo spacing at implantation</article-title>. <source>J Biol Chem</source>. <year>2011</year>;<volume>286</volume>(<issue>6</issue>): <fpage>4349</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">21148315</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terriou</surname><given-names>P</given-names></name><name><surname>Sapin</surname><given-names>C</given-names></name><name><surname>Giorgetti</surname><given-names>C</given-names></name><name><surname>Hans</surname><given-names>E</given-names></name><name><surname>Spach</surname><given-names>JL</given-names></name><name><surname>Roulier</surname><given-names>R.</given-names></name></person-group>
<article-title>Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age</article-title>. <source>Fertil steril</source>. <year>2001</year>;<volume>75</volume>(<issue>3</issue>):<fpage>525</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">11239536</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinborg</surname><given-names>A</given-names></name><name><surname>Lidegaard</surname><given-names>O</given-names></name><name><surname>la Cour Freiesleben</surname><given-names>N</given-names></name><name><surname>Andersen</surname><given-names>AN.</given-names></name></person-group>
<article-title>Consequences of vanishing twins in IVF/ICSI pregnancies</article-title>. <source>Hum Reprod</source>. <year>2005</year>;<volume>20</volume>(<issue>10</issue>): <fpage>2821</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">15979998</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balassiano</surname><given-names>E</given-names></name><name><surname>Malik</surname><given-names>S</given-names></name><name><surname>Vaid</surname><given-names>P</given-names></name><name><surname>Knochenhauer</surname><given-names>ES</given-names></name><name><surname>Traub</surname><given-names>ML.</given-names></name></person-group>
<article-title>The presence of multiple gestational sacs confers a higher live birth rate in women with infertility who achieve a positive pregnancy test after fresh and frozen embryo transfer: a retrospective local cohort</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2014</year>; <volume>12</volume>:<fpage>104</fpage>.<pub-id pub-id-type="pmid">25422171</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido</surname><given-names>N</given-names></name><name><surname>Bellver</surname><given-names>J</given-names></name><name><surname>Remohi</surname><given-names>J</given-names></name><name><surname>Alama</surname><given-names>P</given-names></name><name><surname>Pellicer</surname><given-names>A.</given-names></name></person-group>
<article-title>Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles</article-title>. <source>Fertil Steril</source>. <year>2012</year>;<volume>98</volume>(<issue>2</issue>):<fpage>341</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">22633263</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelkonen</surname><given-names>S</given-names></name><name><surname>Koivunen</surname><given-names>R</given-names></name><name><surname>Gissler</surname><given-names>M</given-names></name><name><surname>Nuojua-Huttunen</surname><given-names>S</given-names></name><name><surname>Suikkari</surname><given-names>AM</given-names></name><name><surname>Hyden-Granskog</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006</article-title>. <source>Hum Reprod</source>. <year>2010</year>;<volume>25</volume>(<issue>4</issue>):<fpage>914</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">20124395</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>MI</given-names></name><name><surname>Mayer</surname><given-names>J</given-names></name><name><surname>Aronshon</surname><given-names>M</given-names></name><name><surname>Lanzendorf</surname><given-names>S</given-names></name><name><surname>Muasher</surname><given-names>S</given-names></name><name><surname>Kolm</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Embryo implantation in in vitro fertilization and intracytoplasmic sperm injecttion: impact of cleavage status, morphology grade, and number of embryos transferred</article-title>. <source>Fertil Steril</source>. <year>1999</year>;<volume>72</volume>(<issue>4</issue>):<fpage>679</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">10521110</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359856</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359856</article-id>
      <article-id pub-id-type="pmcid">PMC5359856</article-id>
      <article-id pub-id-type="pmc-uid">5359856</article-id>
      <article-id pub-id-type="publisher-id">jri-17-185</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>BMP15 and GDF9 Gene Mutations in Premature Ovarian Failure</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Ravindra</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alwani</surname>
            <given-names>Madhuri</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kosta</surname>
            <given-names>Susmit</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaur</surname>
            <given-names>Ravjyot</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Agarwal</surname>
            <given-names>Sarita</given-names>
          </name>
          <xref ref-type="aff" rid="AFF3">
            <sup>3</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> Central Research Laboratory, Sri Aurobindo Medical College and PG Institute, Indore, India</aff>
        <aff id="AFF2"><label>2-</label> Department of Obstetrics &amp; Gynaecology, Sri Aurobindo Medical College and PG Institute, Indore, India</aff>
        <aff id="AFF3"><label>3-</label> Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Ravindra Kumar, Scientist and Head Central Research Laboratory, Sri Aurobindo Medical College and Post Graduate Institute, Indore Ujjain Highway, Indore Madhya Pradesh, India, <italic>E-mail:</italic><email>ravindrachhabra@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>185</fpage>
      <lpage>189</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>Premature ovarian failure (POF) is an ovarian defect characterized by the premature depletion of ovarian follicles before the age of 40, representing one major cause of female infertility. Mutations in bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) have been shown to be associated with POF.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>Genomic DNA was isolated from 52 idiopathic premature ovarian failure patients and 100 normal control individuals. Exons of BMP15 and GDF9 gene were amplified using PCR method and subjected to directed sequencing. Variants were identified by comparing the sequences obtained with normal sequences from NCBI database.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Four BMP15 gene variants were identified in 6 patients in heterozygous condition. Out of these 4 variants, 3 variants namely, c.165A&gt;T (p.Glu55Asp), c.538 G&gt;T (p.Aln180 Ser) and c. 510_512 delT were novel variants. In silico analysis using SIFT, Provean and Polyphen 2 score predicted the non-deleterious effect of c.165A&gt;T and c.538 G&gt;T variant. 788insTCT variant was identified in 3 patients. No variant was identified in GDF9 gene in any patients and controls.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>Although the variant has been identified in BMP15 gene but it may not be associated with the premature ovarian failure.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Bone morphogenetic protein 15</kwd>
        <kwd>Female infertility</kwd>
        <kwd>Gene mutation</kwd>
        <kwd>Growth differentiation factor 9</kwd>
        <kwd>Premature ovarian failure</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Premature ovarian failure (POF) is characterized by hyper gonadotropic ovarian deficiency with primary or secondary amenorrhoea (<xref rid="B1" ref-type="bibr">1</xref>). It affects 0.0001% of females by the age of 20 years, 0.001% by 30 years and 0.01% by 40 years, showing the one major cause of female infertility (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>Ovarian function is regulated by a combined stimulus of gonadotropins, follicular stimulating hormone (FSH), luteinizing hormone, and local ovarian factors such as inhibins, activins, bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9). A familial accumulation of the POF syndrome has been observed in between 4 and 31% of the patients with POF which suggests dominant genetic etiology (<xref rid="B3" ref-type="bibr">3</xref>).</p>
      <p>BMP15 and GDF9 belong to transforming growth factor-β (TGF-β) superfamily (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Genes belonging to TGF β superfamily regulate many aspects of development by activating transmembrane serine/threonine kinase receptors (<xref rid="B6" ref-type="bibr">6</xref>). BMP15 has been shown to stimulate granulosa cell growth and promotes the progression of folliculogenesis from the primary stage to the follicle stimulating hormone (FSH) dependent stage (<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B9" ref-type="bibr">9</xref>). Mutations in BMP15 gene have been found as a culprit for POF in several worldwide cohorts with a variable prevalence between 1.5 and 12% (<xref rid="B10" ref-type="bibr">10</xref>–<xref rid="B12" ref-type="bibr">12</xref>). However, Zhang et al. (<xref rid="B13" ref-type="bibr">13</xref>) and Ledig et al. (<xref rid="B14" ref-type="bibr">14</xref>) failed to find any association between BMP15 and POF.</p>
      <p>GDF9 is also expressed in the oocyte and its products can form noncovalent heterodimers acting in a synergistic manner on the function of surrounding follicular granulosa cells (<xref rid="B15" ref-type="bibr">15</xref>). GDF9 gene variations in humans described so far in different ethnicities are all heterozygous, affect exclusively the pro-region with a prevalence of 1.4%, and are not detected in the control samples (<xref rid="B16" ref-type="bibr">16</xref>–<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <p>Due to these conflicting results of various studies, this study was planned to evaluate the association between growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) genes mutations with premature ovarian failure.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec sec-type="subjects">
        <title>Subjects:</title>
        <p>Patients with a diagnosis of POF were recruited from the Department of Obstetrics and Gynaecology, Sri Aurobindo Medical Collage and PG Institute, Indore during the period between September 2012 and March 2015. A total of 52 patients with idiopathic premature ovarian failure or insufficiency subjects with 46XX karyotype were enrolled in the present study. The patients had a mean age of 29.82±6.0 years (range, 17–39 years). Less than 40 year old healthy individuals visiting the department for routine investigations were selected as the control group. All the control individuals had a regular menstrual cycle, and normal reproductive hormone levels and chromosomes.</p>
        <p>The inclusion criteria of all participants were ≤40 years of age, duration of amenorrhea ≥6 months, serum FSH level ≥40 <italic>IU/l</italic> on two or more occasions with the presence of amenorrhea. Individuals with a history of ovarian surgery, radiotherapy, chemotherapy or other factors, which may damage ovarian functions, were excluded. The present study was approved by the Ethics Review Committee of the Sri Aurobindo Medical Collage and PG Institute. Written informed consent was obtained from all participants following a detailed description of the potential benefits of the investigation.</p>
      </sec>
      <sec sec-type="methods">
        <title>DNA extraction, sequencing and analysis:</title>
        <p>All the laboratory investigations were performed in Central Research Laboratory of the institute; 5 <italic>ml</italic> venous blood sample was drawn in EDTA vacutainer. Genomic DNA was extracted from the blood using a QIAamp DNA isolation kit according to the manufacturer’s instructions, and the concentration was determined using Qubit Fluorometer (Life Technologies). PCR amplification of the GDF9 and BMP15 genes was performed using the primers shown in <xref ref-type="table" rid="T1">table 1</xref>, in a 50 <italic>μl</italic> reaction volume containing 50 <italic>nmol</italic> DNA template, 200 <italic>nmol</italic> dNTP, 10 <italic>pmol</italic> forward and reverse primers, 1 <italic>U</italic> Taq DNA polymerase and ddH2O, under the PCR amplification conditions shown in <xref ref-type="table" rid="T1">table 1</xref>. The PCR products were purified by DNA purification kit and subjected to direct sequencing using big dye terminator kit 3.1 (Applied Biosystems).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1.</label>
          <caption>
            <p>Primers and protocols used for PCR amplification of GDF9 and BMP15</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Location</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Primer sequence</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>PCR amplification protocol</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>GDF9</bold>
                </td>
                <td align="left" valign="middle" rowspan="1" colspan="1"/>
                <td align="center" valign="middle" rowspan="1" colspan="1"/>
                <td align="center" valign="middle" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1"/>
                <td align="left" valign="middle" rowspan="1" colspan="1">Exon 1</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">F,5′-TAGTCCACCCACACACCTGA-3′;<break/>R,5′-CCAGAAGCCTGAGAACCA -3′<break/>F,5′-TTCCTCCTTTGGTTTTGCTG-3′;<break/>R,5′-AAAGCTCTGGAGTCTGGCTG -3′<break/>F,5′-TTCTATCTGTTGGGCGAGGT-3′;<break/>R,5′-CATCTTCCCTCCACCCAGT-3′<break/>F, 5′-CTGCCTGTTGTGTTGACTGA-3′;<break/>R,5′-TCTGAATCCATTTGTGTTTCTTTC-3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">94°<italic>C</italic> for 5 <italic>min</italic>, followed by 30 cycles at 94°<italic>C</italic> for 30 <italic>s</italic>, 58°<italic>C</italic> for 30 <italic>s</italic> and 72°<italic>C</italic> for 30 <italic>s</italic>, then finally 72°<italic>C</italic> for 7 <italic>min</italic></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1"/>
                <td align="left" valign="middle" rowspan="1" colspan="1">Exon 2</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">F,5′-CTCTCGGCAGAGCTCCATAC-3′;<break/>R,5′-GGGGACACCAGAGTCATGTT-3′<break/>F,5′-CGCAGAGGTCAGGAAACTGT-3′;<break/>R,5′-GGTCTTGGCACTGAGGAGTC-3′<break/>F,5′-TGAAAGACCAGCTGGAGCA-3′;<break/>R,5′-TCAGATTGAAGGAAGCTGGG-3′<break/>F,5′-TCGGTATGGCTCTCCAGTTC-3′;<break/>R,5′-AATATATCAAGCTTTCTCTTGAAG-3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">94°<italic>C</italic> for 5 <italic>min</italic>, followed by 30 cycles at 94°<italic>C</italic> for 30 <italic>s</italic>, 58°<italic>C</italic> for 30 <italic>s</italic> and 72°<italic>C</italic> for 30 <italic>s</italic>, then finally 72°<italic>C</italic> for 7 <italic>min</italic></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>BMP15</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1"/>
                <td align="center" valign="middle" rowspan="1" colspan="1"/>
                <td align="center" valign="middle" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1"/>
                <td align="left" valign="middle" rowspan="1" colspan="1">Exon 1</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">F, 5′-TTGTGTTGGGGCCTGTTGTT-3′;<break/>R,5′-GGTACAACTCCAGCATGTACC-3′<break/>F,5′-GCTGCTAGAAGAATCCCCTG-3′;<break/>R,5′-AACCCACCAATTCCCTTTT-3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">94°<italic>C</italic> for 5 <italic>min</italic>, followed by 30 cycles at 94°<italic>C</italic> for 60 <italic>s</italic>, 58°<italic>C</italic> for 60 <italic>s</italic> and 72°<italic>C</italic> for 60 <italic>s</italic>, then finally 72°<italic>C</italic> for 7 <italic>min</italic></td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1"/>
                <td align="left" valign="middle" rowspan="1" colspan="1">Exon 2</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">F,5′-AATATTCATGTTAAGAGGTAAGA-3′;<break/>R,5′-AGGAAGGGAAGTGGTTGGTT-3′<break/>F,5′-TCAATCTCTCCTGCCATGTGG-3′;<break/>R,5′-TGTCCAAGGATGAAGAGCC -3′<break/>F,5′-TGGTCTTGAGCTCTGGCATG-3′;<break/>R,5′-CTGATTTGGAAAGGGTGGAG-3′</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">94°<italic>C</italic> for 5 <italic>min</italic>, followed by 30 cycles at 94°<italic>C</italic> for 30 <italic>s</italic>, 58°<italic>C</italic> for 30 <italic>s</italic> and 72°<italic>C</italic> for 30 <italic>s</italic>, then finally 72°<italic>C</italic> for 7 <italic>min</italic></td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The sequencing chromatograms were assessed using the ABI sequence scanner program and the sequences of the GDF9 and BMP15 genes were aligned to those registered in Gene Bank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genbank/">http://www.ncbi.nlm.nih.gov/genbank/</ext-link>) for the identification of mutant loci.</p>
        <p>To determine the potentially deleterious effect of the amino acid changes, Provean software (<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org/index.php</ext-link>), SIFT software (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">http://sift.jcvi.org</ext-link>) and Polyphen 2 software (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>) were used. Provean software predicts whether an amino acid substitution or indel has an impact on the biological function of a protein (<xref rid="B19" ref-type="bibr">19</xref>). The SIFT software predicts whether an amino acid substitution affects protein function based on sequence homology and the physical properties of amino acids (<xref rid="B20" ref-type="bibr">20</xref>). PolyPhen-2 (Polymorphism Phenotyping v2) predicts possible impact of amino acid substitutions on the structure and function of human proteins using straightforward physical and evolutionary comparative considerations (<xref rid="B21" ref-type="bibr">21</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>Sequencing data collection and analysis were successfully performed for the GDF9 and BMP15 genes in all the cases and controls, which included non-familial POF cases; no variant was observed in the coding region of the GDF9 gene of any case and control sample. Four variants of BMP15 gene were observed in cases which included two missense substitutions, one in exon I and the other in exon II position (<xref ref-type="table" rid="T2">Table 2</xref>). FS 788-ins-TCT was present in 3 cases. Three novel variants were observed in our cohort namely, c.510–512del T, c.165A&gt;T (p.Glu55Asp) and c.538 G&gt;T (p.Aln 180Ser). c.510–512del T is the frameshift variant resulting in elongated chain and by dominant negative effect it impairs the function of normal protein. The c.165A&gt;T (p.Glu.55Asp) is a missense variant and changes the glutamic acid to asparagine at position 55. Provean score for this missense variant was −0.61(cut off score &gt;−2.5) and SIFT prediction score was 0.108 (Cut off &gt;0.05). Both of these scores predicted the neutral effect of this missense variant. This variant was predicted to be benign with a score of 0.007 (sensitivity: 0.96; specificity: 0.75) by PolyPhen 2 software.</p>
      <table-wrap id="T2" position="float">
        <label>Table 2.</label>
        <caption>
          <p>Sequence variation in the BMP15 gene in POF patients</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Sequence variation</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>AA change</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Protein domain</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>No. of patients</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>No. of controls</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>165A&gt;T</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Glu55Asp</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Exon 1</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1/52</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0/100</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>538 G&gt;T</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Arg180Leu</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Exon 2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1/52</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0/100</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>788insTCT</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">ins263L</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Exon 2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3/52</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0/100</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>510–512 Del T</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Exon 2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1/52</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">0/100</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>In other patients of POF, c.538 G&gt;T (p. Aln 180 Ser) missense variant was observed. This variant also has neutral effect on the protein function as predicted by Provean (0.17) and SIFT score (0.418). PolyPhen 2 also predicted this variant as benign with score of 0.156 (sensitivity: 0.92; specificity: 0.87). The clinical characteristics of the patients carrying BMP15 variants are detailed in <xref ref-type="table" rid="T3">table 3</xref>. No variant in BMP15 gene was observed in the control group.</p>
      <table-wrap id="T3" position="float">
        <label>Table 3.</label>
        <caption>
          <p>Characteristics of patients having BMP15 gene mutation</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1">
                <bold>BMP15 gene variant</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Ethnic origin</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Age</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Amenorrhoea</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>FSH level (<italic>mIU/ml</italic>)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>165A&gt;T</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">31</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">109</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>538 G&gt;T</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">96</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>788insTCT</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">28</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">136</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>788insTCT</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">32</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">116</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>788insTCT</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">35</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">98</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>510–512-deletion</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Indian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">35</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Secondary</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">138</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>POF is mostly portrayed as a heterogeneous genetic disorder but its etiology still remains elusive. Studies have illuminated the comprehensive role of two oocyte derived growth factors, GDF9 and BMP15, as the main driving force for the proliferation and progression of somatic follicle cells (<xref rid="B22" ref-type="bibr">22</xref>). The BMP15 gene plays a vital role in early human folliculogenesis and it is characterized as a strong candidate gene for POF. BMP15 is a member of the large superfamily of the transforming growth factor β (TGFβ) proteins involved in diverse cellular processes during embryonic development and tissue formation (<xref rid="B23" ref-type="bibr">23</xref>). The main roles of BMP15 include a) the promotion of follicle maturation from the primordial gonadotropin independent phases of folliculogenesis; b) regulation of follicular GC sensitivity to FSH action; c) prevention of GC apoptosis; d) promotion of oocyte developmental competence; and e) regulation of ovulation quota (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B24" ref-type="bibr">24</xref>).</p>
      <p>In the present study, four variants in BMP15 gene were identified of which three variants were novel.</p>
      <p>c.165A&gt;T (p.Glu55Asp) and c.538 G&gt;T (p.Aln 180Ser) variants has no deleterious effect as predicted by in silico analysis.</p>
      <p>Previous studies reported different variant C. 538G&gt;A (p.Aln180Thr) at the same position at which we observed C.538G&gt;T (p.Aln180Ser) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Similar to our prediction previous reports also shows no deleterious effect of this variant.</p>
      <p>788insTCT variant was observed in three patients in our study. This variant has been identified in patients presenting with POF in many previous studies (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B27" ref-type="bibr">27</xref>). This insertion may be considered as a polymorphism as it was previously identified in controls as well (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). This variant was not found in any of the control subjects.</p>
      <p>No variant was observed in GDF9 gene in either patients or controls. This is in contrast to the study done by dixit et al. (<xref rid="B17" ref-type="bibr">17</xref>) and Laissue et al. (<xref rid="B11" ref-type="bibr">11</xref>) which show the GDF9 variants in POF patients.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>In conclusion, the present study provided evidence for naturally occurring variants in association with POF and points to the massive importance of BMP15 as a vital candidate gene, which should also be studied in other populations. Although software assessment of the variants reveals their neutral effect, their functional implication cannot be ruled out altogether. Experimental studies should be conducted to determine the real implication of those variations.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>This study was financed by the Department of Science and Technology, New Delhi, India.</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>The authors report no declarations of interest. Source of funding was DST, New Delhi, India.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulam</surname><given-names>CB.</given-names></name></person-group>
<article-title>Premature gonadal failure</article-title>. <source>Fertil Steril</source>. <year>1982</year>;<volume>38</volume>(<issue>6</issue>):<fpage>645</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">7141005</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulam</surname><given-names>CB</given-names></name><name><surname>Adamson</surname><given-names>SC</given-names></name><name><surname>Annegers</surname><given-names>JF.</given-names></name></person-group>
<article-title>Incidence of premature ovarian failure</article-title>. <source>Obstet Gynecol</source>. <year>1986</year>; <volume>67</volume>(<issue>4</issue>):<fpage>604</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">3960433</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>L</given-names></name><name><surname>Padmalatha</surname><given-names>V</given-names></name><name><surname>Raseswari</surname><given-names>T</given-names></name><name><surname>Kapu</surname><given-names>AK</given-names></name><name><surname>Panda</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Genes governing premature ovarian failure</article-title>. <source>Reprod Biomed Online</source>. <year>2010</year>;<volume>20</volume>(<issue>6</issue>): <fpage>724</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">20382564</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chand</surname><given-names>AL</given-names></name><name><surname>Ponnampalam</surname><given-names>AP</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Winship</surname><given-names>IM</given-names></name><name><surname>Shelling</surname><given-names>AN.</given-names></name></person-group>
<article-title>Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure</article-title>. <source>Fertil Steril</source>. <year>2006</year>;<volume>86</volume>(<issue>4</issue>):<fpage>1009</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">17027369</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>JS</given-names></name><name><surname>Russell</surname><given-names>DL</given-names></name><name><surname>Ochsner</surname><given-names>S</given-names></name><name><surname>Hsieh</surname><given-names>M</given-names></name><name><surname>Doyle</surname><given-names>KH</given-names></name><name><surname>Falender</surname><given-names>AE</given-names></name><etal/></person-group>
<article-title>Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization</article-title>. <source>Recent Prog Horm Res</source>. <year>2002</year>;<volume>5</volume><issue>7</issue>:<fpage>195</fpage>–<lpage>220</lpage>.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pasquale</surname><given-names>E</given-names></name><name><surname>Beck-Peccoz</surname><given-names>P</given-names></name><name><surname>Persani</surname><given-names>L.</given-names></name></person-group>
<article-title>Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene</article-title>. <source>Am J Hum Genet</source>. <year>2004</year>;<volume>75</volume> (<issue>1</issue>):<fpage>106</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">15136966</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>CW</given-names></name><name><surname>Matzuk</surname><given-names>MM.</given-names></name></person-group>
<article-title>Genetic analysis of the mammalian transforming growth factor-beta superfamily</article-title>. <source>Endocr Rev</source>. <year>2002</year>;<volume>23</volume>(<issue>6</issue>):<fpage>787</fpage>–<lpage>823</lpage>.<pub-id pub-id-type="pmid">12466190</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname><given-names>F</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Erickson</surname><given-names>GF</given-names></name><name><surname>Shimasaki</surname><given-names>S.</given-names></name></person-group>
<article-title>Bone morphogenetic protein-15. Identification of target cells and biological functions</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>50</issue>):<fpage>39523</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">10998422</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimasaki</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>RK</given-names></name><name><surname>Otsuka</surname><given-names>F</given-names></name><name><surname>Erickson</surname><given-names>GF.</given-names></name></person-group>
<article-title>The bone morphogenetic protein system in mammalian reproduction</article-title>. <source>Endocr Rev</source>. <year>2004</year>;<volume>25</volume>(<issue>1</issue>):<fpage>72</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">14769828</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pasquale</surname><given-names>E</given-names></name><name><surname>Rossetti</surname><given-names>R</given-names></name><name><surname>Marozzi</surname><given-names>A</given-names></name><name><surname>Bodega</surname><given-names>B</given-names></name><name><surname>Borgato</surname><given-names>S</given-names></name><name><surname>Cavell</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2006</year>;<volume>91</volume>(<issue>5</issue>):<fpage>1976</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">16464940</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laissue</surname><given-names>P</given-names></name><name><surname>Christin-Maitre</surname><given-names>S</given-names></name><name><surname>Touraine</surname><given-names>P</given-names></name><name><surname>Kuttenn</surname><given-names>F</given-names></name><name><surname>Ritvos</surname><given-names>O</given-names></name><name><surname>Aittomaki</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure</article-title>. <source>Eur J Endocrinol</source>. <year>2006</year>;<volume>154</volume>(<issue>5</issue>):<fpage>739</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">16645022</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>R</given-names></name><name><surname>Di Pasquale</surname><given-names>E</given-names></name><name><surname>Marozzi</surname><given-names>A</given-names></name><name><surname>Bione</surname><given-names>S</given-names></name><name><surname>Toniolo</surname><given-names>D</given-names></name><name><surname>Grammatico</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein</article-title>. <source>Hum Mutat</source>. <year>2009</year>;<volume>30</volume>(<issue>5</issue>):<fpage>804</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">19263482</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>LC</given-names></name><name><surname>Chen</surname><given-names>ZJ.</given-names></name></person-group>
<article-title>Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2007</year>;<volume>86</volume>(<issue>5</issue>):<fpage>585</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17464588</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledig</surname><given-names>S</given-names></name><name><surname>Röpke</surname><given-names>A</given-names></name><name><surname>Haeusler</surname><given-names>G</given-names></name><name><surname>Hinney</surname><given-names>B</given-names></name><name><surname>Wieacker</surname><given-names>P.</given-names></name></person-group>
<article-title>BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>198</volume>(<issue>1</issue>):<fpage>84.e1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">17826728</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>DeMayo</surname><given-names>J</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Elvin</surname><given-names>JA</given-names></name><name><surname>Carino</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function</article-title>. <source>Mol Endocrinol</source>. <year>2001</year>;<volume>15</volume>(<issue>6</issue>): <fpage>854</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">11376106</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takebayashi</surname><given-names>K</given-names></name><name><surname>Takakura</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>F</given-names></name><name><surname>Kasahara</surname><given-names>K</given-names></name><name><surname>Noda</surname><given-names>Y.</given-names></name></person-group>
<article-title>Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome</article-title>. <source>Fertil Steril</source>. <year>2000</year>;<volume>74</volume>(<issue>5</issue>): <fpage>976</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">11056243</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>LK</given-names></name><name><surname>Padmalatha</surname><given-names>V</given-names></name><name><surname>Kanakavalli</surname><given-names>M</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure</article-title>. <source>Menopause</source>. <year>2005</year>;<volume>12</volume>(<issue>6</issue>):<fpage>749</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">16278619</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Kovanci</surname><given-names>E</given-names></name><name><surname>Simpson</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name><name><surname>Rajkovic</surname><given-names>A.</given-names></name></person-group>
<article-title>Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure</article-title>. <source>Fertil Steril</source>. <year>2007</year>;<volume>88</volume>(<issue>5</issue>):<fpage>1474</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">17482612</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Sims</surname><given-names>GE</given-names></name><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Chan</surname><given-names>AP.</given-names></name></person-group>
<article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>10</issue>): <fpage>e46688</fpage>.<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>PC</given-names></name><name><surname>Henikoff</surname><given-names>S.</given-names></name></person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res</source>. <year>2003</year>;<volume>31</volume>(<issue>13</issue>):<fpage>3812</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>I</given-names></name><name><surname>Jordan</surname><given-names>DM</given-names></name><name><surname>Sunyaev</surname><given-names>SR.</given-names></name></person-group>
<article-title>Predicting functional effect of human missense mutations using PolyPhen-2</article-title>. <source>Curr Protoc Hum Genet</source>. <year>2013</year>; Chapter 7:Unit7.<fpage>20</fpage>.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZZ</given-names></name><name><surname>Painter</surname><given-names>JN</given-names></name><name><surname>Palmer</surname><given-names>JS</given-names></name><name><surname>Webb</surname><given-names>PM</given-names></name><name><surname>Hayward</surname><given-names>NK</given-names></name><name><surname>Whiteman</surname><given-names>DC</given-names></name><etal/></person-group>
<article-title>Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning</article-title>. <source>Hum Reprod</source>. <year>2008</year>;<volume>23</volume>(<issue>10</issue>):<fpage>2372</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18614612</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>BL.</given-names></name></person-group>
<article-title>Bone morphogenetic proteins: multifunctional regulators of vertebrate development</article-title>. <source>Genes Dev</source>. <year>1996</year>;<volume>10</volume>(<issue>13</issue>):<fpage>1580</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">8682290</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>O</given-names></name><name><surname>Moore</surname><given-names>RK</given-names></name><name><surname>Shimasaki</surname><given-names>S.</given-names></name></person-group>
<article-title>Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2005</year>;<volume>102</volume> (<issue>15</issue>):<fpage>5426</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">15809424</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiotiu</surname><given-names>D</given-names></name><name><surname>Alvaro Mercadal</surname><given-names>B</given-names></name><name><surname>Imbert</surname><given-names>R</given-names></name><name><surname>Verbist</surname><given-names>J</given-names></name><name><surname>Demeestere</surname><given-names>I</given-names></name><name><surname>De Leener</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Variants of the BMP15 gene in a cohort of patients with premature ovarian failure</article-title>. <source>Hum Reprod</source>. <year>2010</year>;<volume>25</volume>(<issue>6</issue>):<fpage>1581</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">20364024</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>LK</given-names></name><name><surname>Padmalatha</surname><given-names>VV</given-names></name><name><surname>Kanakavalli</surname><given-names>M</given-names></name><name><surname>Deenadayal</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Missense mutations in the BMP15 gene are associated with ovarian failure</article-title>. <source>Hum Genet</source>. <year>2006</year>;<volume>119</volume>(<issue>4</issue>):<fpage>408</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">16508750</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Ni</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP 15) mutation in Chinese women with premature ovarian failure</article-title>. <source>Clin Endocrinol (Oxf)</source>. <year>2010</year>;<volume>72</volume>(<issue>1</issue>): <fpage>135</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">19438907</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359857</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359857</article-id>
      <article-id pub-id-type="pmcid">PMC5359857</article-id>
      <article-id pub-id-type="pmc-uid">5359857</article-id>
      <article-id pub-id-type="publisher-id">jri-17-190</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Certain Less Invasive Infertility Treatments Associated with Different Levels of Pregnancy-Related Anxiety in Pregnancies Conceived via <italic>In Vitro</italic> Fertilization</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Stevenson</surname>
            <given-names>Eleanor Lowndes</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sloane</surname>
            <given-names>Richard</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> Division of Health for Women, Children and Families, School of Nursing, Duke University, Durham, USA</aff>
        <aff id="AFF2"><label>2-</label> School of Medicine, Duke University, Durham, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Eleanor L Stevenson, Division of Health for Women, Children and Families, School of Nursing, Duke University, 307 Trent Drive, Durham, NC 27710, USA <italic>E-mail:</italic><email>eleanor.stevenson@duke.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>190</fpage>
      <lpage>196</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>Research supports that <italic>in vitro</italic> fertilization causes anxiety and that anxiety can continue into the resulting pregnancy. Most women who have IVF will have a less invasive treatment for infertility prior to IVF; however, it is unclear if specific less invasive treatment cycles impact anxiety that is experienced in the pregnancy resulting from IVF.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>A prospective study was conducted for women who became pregnant via IVF, and data was collected about reported previous non-IVF treatment cycles as well as Pregnancy Related Anxiety Measure. Latent Class Analysis was conducted A p-value of ≤0.05 was considered significant.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>144 subjects participated and were highly educated, affluent, married, and primarily white. The LCA process yielded two groups that on average had similar levels on most items except for use of intra uterine insemination and/or ovarian stimulation. This information was used to generate four exhaustive and mutually exclusive groups: Stimulation Only (stim-only), Stimulation and Intra uterine Insemination (stim-IUI), Intra uterine Insemination only (IUI only), or No Treatment (No Tx). ANOVA found that those in the Stim Only group had statistically significantly higher PRAM scores than the Stim IUI (p=0.0036), the IUI only group (p=0.05), and the No Tx group (p=0.0013).</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>Women who become pregnant via IVF and had a history of non-<italic>in vitro</italic> fertilization cycles that only involved ovarian stimulation experienced more pregnancy-specific anxiety in the pregnancy that results from <italic>in vitro</italic> fertilization.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Infertility</kwd>
        <kwd>Intra uterine insemination</kwd>
        <kwd><italic>In vitro</italic> fertilization</kwd>
        <kwd>Pregnancy anxiety</kwd>
        <kwd>Stress</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Fifteen percent of women worldwide experience infertility during their lifetime (<xref rid="B1" ref-type="bibr">1</xref>). Use of assisted reproductive technology (ART) such as <italic>in vitro</italic> fertilization (IVF) to treat fertility problems continues to rise due to successes and advances in science (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Despite this trend, there is a lack of clear understanding of the psychological experience especially anxiety a woman experiences during the pregnancy that follows successful treatment with IVF. Additionally, it is unclear what may put women who ultimately achieve a pregnancy at increased risk for experiencing increases in anxiety in the pregnancy that follows successful IVF. Understanding how anxiety is experienced during pregnancy is critical because of potential impact on pregnancy outcomes. In the general preterm birth literature, there is support for a positive relationship between pregnancy-related anxiety and preterm birth (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>).</p>
      <p>Treatment for infertility is expensive and physically invasive which can be repeated for months or years before a pregnancy is achieved, or the decision is made to discontinue treatment. Treatment can vary greatly based on the diagnosis. Most couples will be offered less invasive treatment options including ovulation stimulating medications with or without intra uterine insemination (IUI), IUI without use of medication prior to ART including IVF (Stevenson, Hersheberger &amp; Bergh, 2016) and some will seek IVF upon definitive diagnosis of underlying infertility cause such as complete blockage of fallopian tubes or severe male-factor infertility, thus bypassing less invasive treatment options.</p>
      <p>Women who are being treated for infertility report increasing amounts of emotional distress during the treatment process (<xref rid="B5" ref-type="bibr">5</xref>) with infertility-related stress impacting emotional distress (<xref rid="B6" ref-type="bibr">6</xref>). The emotional distress experienced can carry over into resulting pregnancy from infertility treatment. Qualitative research has found that women who are pregnant following IVF experience their pregnancies differently than women who conceive without assistance, specifically, perceiving their pregnancies as special and hard won (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Additionally, quantitative research has found increases in stress, particularly pregnancy-related anxiety, in women pregnant via IVF as compared to women who conceive without assistance (<xref rid="B9" ref-type="bibr">9</xref>).</p>
      <p>The process of infertility treatment can take a long time to navigate. One study found that the average time spent on fertility care was 125 hours in an 18-month period of time. This translated to 15.6 working days, with the majority of time spent on visits with the provider. Additionally, there was a direct relationship between time spent on care and fertility-related stress (<xref rid="B10" ref-type="bibr">10</xref>). Data supports that emotional distress increases over time in treatment (<xref rid="B11" ref-type="bibr">11</xref>). While anxiety has been shown to increase during a treatment cycle of IVF and length of IVF treatment has been associated with increases in stress (<xref rid="B12" ref-type="bibr">12</xref>), what is less clear is whether utilization of specific less invasive treatment leading up to IVF contributes to anxiety experienced in a resulting pregnancy. Therefore, the aim of this exploratory study of women in the early second trimester of a post-IVF pregnancy was to assess whether certain less invasive treatment options including ovarian stimulation-only cycles, ovarian stimulation with IUI cycles, IUI only cycles, and no previous treatment affect pregnancy-specific anxiety levels.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>The study had a prospective design targeting a population of pregnant women via IVF. Participants were recruited upon discharge to their obstetrician or midwife, typically at gestational week 8, from a large, private infertility practice in the North Eastern United States. Participation in the study commenced at gestational week 12, and women who expressed interest were sent several reminders about participation until gestational week 18. Inclusion criteria were female, 25–40 years of age, single or twin fetus gestation between weeks 12 and 20 gestation and ability to read and write English. Exclusion criteria included having a selective reduction in current pregnancy, and being medically or obstetrically high-risk requiring perinatologist to follow the pregnancy. Between weeks 12–18, participants logged onto the dedicated website, completed consent, and answered the study questionnaires. Approval was obtained from the New York University Committee on Activities Involving Human Subjects, and all subjects provided informed consent prior to participation in this study. The analysis sample included 144 women, which was as many participants that the study team had capacity to recruit and manage. All participants provided informed consent and submitted study questionnaires.</p>
      <p>Subjects completed survey questions about their demographic data, as well as the number of previous treatment cycles for infertility prior to IVF including stimulated cycles (<italic>i.e</italic>. clomiphene citrate or gonadotrophins) either with or without IUI, non-stimulated IUI cycles, or no previous treatment. The demographic questionnaire included age, marital status, education, income, and race. Clinical characteristics such as history of miscarriage, number of IVF cycles, and length of infertility were also collected. Number of miscarriages was dichotomized as either a history of miscarriage or no history of miscarriage. IVF count data was also recoded as either one IVF cycle or more than one cycle.</p>
      <p>They were also asked about their perception of anxiety specific to pregnancy using the Pregnancy-Related Anxiety Measure (PRAM). The Pregnancy-Related Anxiety Measure (PRAM) (<xref rid="B13" ref-type="bibr">13</xref>) is a 5-item scale assessed maternal fears and anxiety related to the health of the baby and the labor and delivery process and confidence in the obstetrician and other health care providers. The revised 10-item version used in this study was comprised of an expanded set of items 48 that was used to assess the extent to which women worry or feel concerned about their health, their baby’s health, labor and delivery, and caring for the baby. The pregnancy-related anxiety score ranged from 10–40, with a higher score indicating more pregnancy-related anxiety. The internal reliability of the scale was found to be acceptable (Cronbach’s α= 0.78).</p>
      <p>Descriptive statistics were used to summarize the demographic and clinical characteristics of the sample. In order to explore groups of subjects in the database, Latent Class Analysis (LCA) was conducted to identify patterns with the group definition variables. Unlike standard clustering techniques, LCA allows for statistical testing of model fit and class membership is probabilistic, with membership probabilities computed from the estimated model parameters. In the initial step of the analyses, increasingly complex models (adding more latent classes) were estimated to determine the optimal number of latent classes to fit the data. Following standard practice, the optimal number of latent classes was determined by comparing the Bayesian Information Criterion (BIC) of the candidate models, as well as applying substantive interpretability and clinical judgment to select between candidate models (<italic>i.e</italic>., Do the classes defined by a given model possess a more discernible clinical significance or meaning than those defined by another model?).</p>
      <p>As described below, the LCA process yielded 2 classes of subjects which on average agreed on all response items except for use of IUI and/or ovarian stimulation. Post hoc to the LCA process, four analytic groups were developed: Stim Only, Stim IUI, IUI only, or No Tx.</p>
      <p>Groups were evaluated for differences in PRAM levels using ANOVA. The level of significance was set at 0.05 for each test due the exploratory phase of this research. Cronbach’s alphas were calculated on the PRAM.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p><xref ref-type="table" rid="T1">Table 1</xref> presents a summary of the demographic, clinical, and PRAM characteristics of the 144 women in the early second trimester of a post-IVF pregnancy. The mean age was 33.5 years, (range of 25 to 40, SD=3.9, median=34), and the majority of the sample was Caucasian (74.8%). Approximately, 8% of the sample was Hispanic or Latino. Among the 144 women, 98.6% were married or living with a partner, 81.3% reported having a bachelor’s degree or higher, and 70.0% had an annual household income of $100K or greater. The mean length of infertility was 31.5 months (range of 3 to 168 months, SD=27.6, median=24). Those with months of infertility less than 12 were likely due to a previously identified diagnosis that required a clinical decision to pursue IVF without following traditional guidelines of waiting for 12 months of unprotected intercourse without success first. Most of the women reported only one IVF cycle (59.0%), a negative history of miscarriage (61.1%), and gave birth to a singleton (72.9%). PRAM mean score was 20.5 (range of 10–38, SD= 6.0, median=20.0).</p>
      <table-wrap id="T1" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Sample characteristics</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Characteristic</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Frequency</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>%</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Married/Living with partner (n=144)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">142</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">98.6%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Education level (n=144)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: High school graduate or GED</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  2: Trade/Technical school/Other</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">9</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">6.2%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  3: Associate’s degree/Some college</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">10.4%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  4: Bachelor’s degree</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">46</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">31.9%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  5: Some graduate school</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">5.6%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  6: Graduate/Professional degree</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">63</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">43.8%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Income (n=143)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: Under $50,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  2: $50,000–75,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">11.9%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  3: $75,001–100,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">23</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">16.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  4: $100,001–125,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">30</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">21.0%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  5: $125,001–$150,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">10.5%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  6: &gt; $150,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">55</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">38.5%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Ethnicity/Race (n=143)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: Black/African American</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: Asian</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">23</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">16.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: Other</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">10</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">7.0%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: White</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">107</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">74.8%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  Hispanic/Latino (n=143)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">8.0%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Miscarriage history (n=144)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">88</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">61.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: One miscarriage</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">28</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">26.4%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: Two or miscarriages</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">12.5%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Twin pregnancy (n=144)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: Singleton</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">105</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">72.9%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: Twins</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">39</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">27.1%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Number of IVF cycles (n=144)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: One cycle</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">85</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">59.0%</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: More than one cycle</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">59</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">41.0%</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The LCA process yielded two groups that on average had similar levels on most items (age, number of IVF cycles, number of previous miscarriages, previous living children, gestational size, and use of laparoscopy, amniocentesis, and saline sonography). There were two items in which they differed, use of IUI and/or ovarian stimulation. This information was used to generate four exhaustive and mutually exclusive groups: Stim Only, Stim IUI, IUI only, or No Tx. ANOVA found that those in the Stim Only group had statistically significantly higher PRAM scores than the Stim IUI group (p=0.0036) and the No Tx group (p= 0.0013), and the IUI only group (p=0.05) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
      <table-wrap id="T2" position="float">
        <label>Table 2.</label>
        <caption>
          <p>LCA results</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="3" align="left" valign="middle" colspan="1"/>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Neither IUI or Clomid (N)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>IUI alone (I)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Clomid alone (C)</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>IUI and Clomid (IC)</bold>
              </th>
              <th rowspan="3" align="center" valign="middle" colspan="1">
                <bold>Significant pairwise tests <sup><xref ref-type="table-fn" rid="TFN2">*</xref></sup></bold>
              </th>
            </tr>
            <tr>
              <th colspan="4" align="left" valign="middle" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>N=52</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>6</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>15</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>71</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Characteristic</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">Age, in year (mean, sd)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.4 (4.0)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">37.8 (0.8)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">30.7 (3.4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.8 (3.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">N/SO, N/I, I/SI, SO/SI, SO/I</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">Length of infertility, in months (mean, sd)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.2 (2.3)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3.5 (4.0)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.3 (1.9)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2.3 (2.4)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">PRAM pregnancy-related anxiety score (mean, sd)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">19.6 (5.6)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">19.7 (4.1)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">25.1 (7.5)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">20.3 (5.7)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">N/SO, SI/SO</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Characteristic</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  Married/Living with partner (%)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">98.1</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">100</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">100</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">98.6</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  Some graduate school or more (%)</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">42.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">100</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">53.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">59.2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  Income at least $100,000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">67.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">66.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">74.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  White ethnicity/Race</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">71.2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">50.0</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">66.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">80.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Miscarriage history</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  0: No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">75.0</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">53.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">54.9</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  1: One miscarriage</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">15.4</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">16.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">20.0</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">36.6</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Twin pregnancy</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  Twins</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">21.2</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">16.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">20.0</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.8</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Number of IVF cycles</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">  One cycle</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">59.6</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">66.7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">33.3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">63.4</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>SD=Standard deviation; PRAM=Pregnancy-Related Anxiety Scale; N=No Tx, I=IUI only, SO=Stim only, SI=Stim IUI</p>
          </fn>
          <fn id="TFN2">
            <p><sup>*</sup>Significant at p=0.05</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The present study sought to understand if certain previous less invasive infertility treatments leading up to a successful IVF cycle were associated with increased pregnancy-related anxiety. Surprisingly, the findings showed that women with a history of stimulated only cycles (<italic>i.e</italic>. clomiphene citrate and intercourse) had more pregnancy-related anxiety following a successful IVF than women who had more complex previous treatment including IUI (with or without stimulation) or no treatment at all.</p>
      <p>The subjects for this study were recruited from a very large Reproductive Endocrinology (RE) center that serviced a densely populated geographic area in the Northeast of the U.S. Typical care for women with fertility concerns was to initially be seen by their primary women’s care provider for evaluation and possible treatment which could often include an ovulation inducing medication such as clomiphene citrate (<xref rid="B14" ref-type="bibr">14</xref>). Sometimes, these medications are prescribed for several cycles without a comprehensive medical evaluation of the underlying condition, and following unsuccessful treatment the women are then referred on to the RE for complete evaluation and initiation of a comprehensive treatment plan. For some, a diagnosis of unexplained infertility is determined, which supports utilization of IVF instead of less invasive methods such as IUI with or without ovarian stimulation (<xref rid="B15" ref-type="bibr">15</xref>), therefore many of these women may not be treated with cycles that include IUI. While these women have a tangible treatment plan, those for whom no identifiable reason can be found for their infertility may be left with uncertainty about their status including the ability to maintain a health pregnancy.</p>
      <p>Uncertainty in disease processes can have a significant role in how anxiety may manifest for individuals. The unpredictability associated with not having a definitive diagnosis plays an important role in determining emotional responses and can create a reaction of sustained anxiety instead of short-term fear (<xref rid="B16" ref-type="bibr">16</xref>). For women who are experiencing unexplained infertility, they have already had many unsuccessful natural cycles before even liaising with medical professionals. If they continue under the care of their primary women’s care provider, they will experience even more cycles before ultimately seeking evaluation from the RE. A comprehensive evaluation (<xref rid="B17" ref-type="bibr">17</xref>) that ultimately does not find an underlying cause of the infertility may contribute to the feeling of unpredictability. For those who ultimately achieve a pregnancy via IVF, they acknowledge that their pregnancy was very difficult to achieve and if something were to negatively occur, there is uncertainty they would be able to achieve another (<xref rid="B8" ref-type="bibr">8</xref>). Women pregnant after IVF report certain activities that underscore their belief about the fragility of the pregnancy including checking for vaginal bleeding often and the feeling of assurance after each normal ultrasound scan (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <p>When examining other literature, the uncertainty of the diagnosis has been evaluated in women with infertility issues. In one study, researchers found that anxiety played a significant role for women with unexplained infertility going through treatment as compared to those with a definitive diagnosis (<xref rid="B19" ref-type="bibr">19</xref>) because of a reaction to the ambiguous medical situation with its uncertain prognosis. This anxiety can change throughout the evaluation and treatment process. Early on, the main anxiety was thought to be related to a physical inferiority complex, while later it was influenced by anxiety related to what others outside the family say about the inability to conceive and give birth to a child (<xref rid="B20" ref-type="bibr">20</xref>). In another study examining the psychological experience of infertility treatment over the course of several years, women experienced an acute stress response to the initial diagnosis and treatment plan. Emotional strain was higher during the first year, and then dropped in the second year. If treatment continued into year three, this strain markedly increased. Additionally, aspects of women’s personal relationship with partners were affected in the third year including negatively impacting marital adjustment and sexual satisfaction (<xref rid="B11" ref-type="bibr">11</xref>).</p>
      <p>Not surprisingly, the ambiguity and uncertainty of unexplained infertility causes a higher level of anxiety, which has the potential to carry into the pregnancy. Once pregnant, women have more anxiety about whether the pregnancy will be successful (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). This may be because of a perception that their body is “broken” and may lead them to think that whatever was the roadblock to achieving a pregnancy will also affect the ability to have a successful birth outcome. In one qualitative study, women who had previous unsuccessful treatments were more focused on possible physical problems in the pregnancy (<xref rid="B23" ref-type="bibr">23</xref>).</p>
      <p>Having a better understanding of risk factors for anxiety experienced by women undergoing infertility treatment who subsequently became pregnant has significant implications for improved clinical practice. For women still navigating the process of treatment, having a comprehensive understanding of how women navigate the evaluation and treatment process will help providers better meet the psychosocial needs of women, particularly those for whom no definitive cause of the infertility is found. It is important to appreciate that this study represented women who continued treatment through a successful IVF procedure. A substantial number of couples being treated for fertility will discontinue fertility care before achieving pregnancy with main contributing reasons for withdrawal including emotional distress and poor prognosis (<xref rid="B24" ref-type="bibr">24</xref>). Only half of women with infertility will receive the treatment that is needed to achieve a pregnancy. One significant contributor for this disparity is the discontinuation of care. Many will stop for reasons other than poor prognosis or the cost of treatment, but rather because of burden of treatment (<xref rid="B22" ref-type="bibr">22</xref>). The burden of treatment is so great for many women who ultimately decide to pursue other avenues such as adoption or child-free living. Based on the results of this study, it is clear that there is a level of anxiety that is tolerable to be able to continue treatment through a successful IVF cycle. Additional research is needed to uncover a potential threshold of acceptable anxiety, as well mediating and moderating factors that contribute to the experience of anxiety during the process of infertility treatment. Regardless, the evidence supports that despite the threshold, women who have only been treated with ovulation induction medications still have increases in anxiety about the resulting pregnancy following IVF.</p>
      <p>This is an important consideration for those caring for women who become pregnant via IVF, as these patients may require additional emotional support during treatment. It has been suggested in the literature that patients who have IVF have their care experience improved by minimizing the burden associated with the process. First, patient vulnerability to anxiety and other negative psychosocial experiences can be improved with evidence-based screening for psychological distress at the start of treatment and when indicated, appropriate referral for support (<xref rid="B25" ref-type="bibr">25</xref>). Additionally, staff caring for women can reduce the potential for negative patient-staff interactions with increased staff training about issues in communication/interaction skills, promoting shared decision making (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>).</p>
      <p>This study had limitations that should be acknowledged. While current trends in clinical care support the notion that women have been treated with an ovulation induction medication such as clomiphene citrate prior to comprehensive evaluation with the RE, the study would have benefited from ascertaining the specific diagnosis of women reporting their pregnancy-specific anxiety and therefore could have been incorporated into the data analysis, thus strengthening the findings. Also, capturing the number of less invasive treatment cycles subjects had prior to utilizing IVF would help to add dimension to the understanding of this phenomena. Finally, as anxiety has been shown to fluctuate throughout pregnancy (<xref rid="B27" ref-type="bibr">27</xref>), measuring this variable over multiple time points would allow for elucidation of how women who are pregnant via IVF experience pregnancy anxiety more comprehensively.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>This study showed that the impact of previous less invasive infertility treatments prior to a successful IVF cycle was associated with increased pregnancy-related anxiety in the resulting pregnancy and women who had a history of stimulated only cycles (<italic>i.e</italic>. clomiphene citrate and intercourse) previous to their successful IVF had more pregnancy-related anxiety during their pregnancy conceived via IVF than those who had more complex previous treatment which included IUI (with or without stimulation) or no treatment at all. The understanding of the fact that the women who had only been previously treated with ovulation inducing medications without IUI helps understand the patient care experience such that better identification of those at risk for increased anxiety in pregnancy can be made, and an appropriate clinical response can be made for women who are experiencing increases in pregnancy-specific anxiety.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>Authors declare no conflict of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephen</surname><given-names>EH</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>RB.</given-names></name></person-group>
<article-title>Supply of and demand for assisted reproductive technologies in the United States: clinic- and population-based data, 1995–2010</article-title>. <source>Fertil Steril</source>. <year>2016</year>;<volume>105</volume>(<issue>2</issue>):<fpage>451</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">26597629</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderam</surname><given-names>S</given-names></name><name><surname>Kissin</surname><given-names>DM</given-names></name><name><surname>Crawford</surname><given-names>SB</given-names></name><name><surname>Folger</surname><given-names>SG</given-names></name><name><surname>Jamieson</surname><given-names>DJ</given-names></name><name><surname>Barfield</surname><given-names>WD.</given-names></name></person-group>
<article-title>Assisted reproductive technology surveillance-United States, 2011</article-title>. <source>MMWR Surveill Summ</source>. <year>2014</year>;<volume>63</volume>(<issue>10</issue>):<fpage>1</fpage>–<lpage>28</lpage>.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sazonova</surname><given-names>A</given-names></name><name><surname>Källen</surname><given-names>K</given-names></name><name><surname>Thurin-Kjellberg</surname><given-names>A</given-names></name><name><surname>Wennerholm</surname><given-names>UB</given-names></name><name><surname>Bergh</surname><given-names>C.</given-names></name></person-group>
<article-title>Obstetric outcome after in vitro fertilization with single or double embryo transfer</article-title>. <source>Hum Reprod</source>. <year>2011</year>;<volume>26</volume>(<issue>2</issue>):<fpage>442</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">21126967</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisborg</surname><given-names>K</given-names></name><name><surname>Ingerslev</surname><given-names>HJ</given-names></name><name><surname>Henriksen</surname><given-names>TB.</given-names></name></person-group>
<article-title>In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>94</volume> (<issue>6</issue>):<fpage>2102</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">20188361</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greil</surname><given-names>AL</given-names></name><name><surname>Slauson-Blevins</surname><given-names>K</given-names></name><name><surname>McQuillan</surname><given-names>J.</given-names></name></person-group>
<article-title>The experience of infertility: a review of recent literature</article-title>. <source>Sociol Health Illn</source>. <year>2010</year>;<volume>32</volume>(<issue>1</issue>):<fpage>140</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">20003036</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gana</surname><given-names>K</given-names></name><name><surname>Jakubowska</surname><given-names>S.</given-names></name></person-group>
<article-title>Relationship between infertility-related stress and emotional distress and marital satisfaction</article-title>. <source>J Health Psychol</source>. <year>2016</year>;<volume>21</volume>(<issue>6</issue>):<fpage>1043</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">25139894</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olshansky</surname><given-names>EF.</given-names></name></person-group>
<article-title>Psychosocial implications of pregnancy after infertility</article-title>. <source>NAACOGS Clin Issu Perinat Womens Health Nurs</source>. <year>1990</year>;<volume>1</volume>(<issue>3</issue>):<fpage>342</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">2206754</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandelowski</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>BG</given-names></name><name><surname>Black</surname><given-names>BP.</given-names></name></person-group>
<article-title>Relinquishing infertility: the work of pregnancy for infertile couples</article-title>. <source>Qual Health Res</source>. <year>1992</year>;<volume>2</volume>(<issue>3</issue>):<fpage>282</fpage>–<lpage>301</lpage>.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourounti</surname><given-names>K.</given-names></name></person-group>
<article-title>Psychological stress and adjustment in pregnancy following assisted reproductive technology and spontaneous conception: A systematic review</article-title>. <source>Women Health</source>. <year>2016</year>;<volume>56</volume>(<issue>1</issue>):<fpage>98</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">26212077</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>AK</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Katz</surname><given-names>PP</given-names></name><name><surname>Smith</surname><given-names>JF.</given-names></name></person-group>
<article-title>Time costs of fertility care: the hidden hardship of building a family</article-title>. <source>Fertil Steril</source>. <year>2013</year>;<volume>99</volume>(<issue>7</issue>):<fpage>2025</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">23454007</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>BJ</given-names></name><name><surname>Wilson</surname><given-names>JF.</given-names></name></person-group>
<article-title>Psychological functioning across stages of treatment for infertility</article-title>. <source>J Behav Med</source>. <year>1991</year>;<volume>14</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">2038042</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>NN</given-names></name><name><surname>Turnbull</surname><given-names>DA</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name><name><surname>Jindal</surname><given-names>UN</given-names></name><name><surname>Briggs</surname><given-names>NE</given-names></name><name><surname>Taplin</surname><given-names>JE.</given-names></name></person-group>
<article-title>Changes in affect and state anxiety across an in vitro fertilization/intracytoplasmic sperm injection cycle</article-title>. <source>Fertil Steril</source>. <year>2010</year>; <volume>93</volume>(<issue>2</issue>):<fpage>517</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">19243748</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadhwa</surname><given-names>PD</given-names></name><name><surname>Sandman</surname><given-names>CA</given-names></name><name><surname>Porto</surname><given-names>M</given-names></name><name><surname>Dunkel-Schetter</surname><given-names>C</given-names></name><name><surname>Garite</surname><given-names>TJ.</given-names></name></person-group>
<article-title>The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation</article-title>. <source>Am J Obstet Gynecol</source>. <year>1993</year>;<volume>169</volume>(<issue>4</issue>):<fpage>858</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">8238139</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Check</surname><given-names>JH.</given-names></name></person-group>
<article-title>A practical approach to diagnosing and treating infertility by the generalist in obstetrics and gynecology</article-title>. <source>Clin Exp Obstet Gynecol</source>. <year>2015</year>; <volume>42</volume>(<issue>4</issue>):<fpage>405</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">26411200</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandian</surname><given-names>Z</given-names></name><name><surname>Gibreel</surname><given-names>A</given-names></name><name><surname>Bhattacharya</surname><given-names>S.</given-names></name></person-group>
<article-title>In vitro fertilisation for unexplained subfertility</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2015</year>;<volume>11</volume>:<fpage>CD003357</fpage>.</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>CD</given-names></name><name><surname>Craske</surname><given-names>MG.</given-names></name></person-group>
<article-title>Psychophysiological responses to unpredictable threat: effects of cue and temporal unpredictability</article-title>. <source>Emotion</source>. <year>2015</year>;<volume>15</volume>(<issue>2</issue>): <fpage>195</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">25603130</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>EL</given-names></name><name><surname>Hershberger</surname><given-names>PE</given-names></name><name><surname>Bergh</surname><given-names>PA.</given-names></name></person-group>
<article-title>Evidence-Based Care for Couples With Infertility</article-title>. <source>J Obstet Gynecol Neonatal Nurs</source>. <year>2016</year>;<volume>45</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>10</lpage>.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjelmstedt</surname><given-names>A</given-names></name><name><surname>Widstrom</surname><given-names>AM</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name></person-group>
<article-title>Psychological correlates of prenatal attachment in women who conceived after in vitro fertilization and women who conceived naturally</article-title>. <source>Birth</source>. <year>2006</year>;<volume>33</volume>(<issue>4</issue>):<fpage>303</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">17150069</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhaliwal</surname><given-names>LK</given-names></name><name><surname>Gupta</surname><given-names>KR</given-names></name><name><surname>Gopalan</surname><given-names>S</given-names></name><name><surname>Kulhara</surname><given-names>P.</given-names></name></person-group>
<article-title>Psychological aspects of infertility due to various causes--prospective study</article-title>. <source>Int J Fertil Womens Med</source>. <year>2004</year>;<volume>49</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">15038509</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Morioka</surname><given-names>Y</given-names></name><name><surname>Kashiwakura</surname><given-names>M</given-names></name><name><surname>Nadaoka</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Stress of female infertility: relations to length of treatment</article-title>. <source>Gynecol Obstet Invest</source>. <year>1997</year>;<volume>43</volume>(<issue>3</issue>):<fpage>171</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">9127130</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darwiche</surname><given-names>J</given-names></name><name><surname>Lawrence</surname><given-names>C</given-names></name><name><surname>Vial</surname><given-names>Y</given-names></name><name><surname>Wunder</surname><given-names>D</given-names></name><name><surname>Stiefel</surname><given-names>F</given-names></name><name><surname>Germond</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Anxiety and psychological stress before prenatal screening in first-time mothers who conceived through IVF/ICSI or spontaneously</article-title>. <source>Women Health</source>. <year>2014</year>;<volume>54</volume>(<issue>5</issue>):<fpage>474</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">24794917</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>CA</given-names></name><name><surname>Boivin</surname><given-names>J</given-names></name><name><surname>Gibson</surname><given-names>FL</given-names></name><name><surname>Hammarberg</surname><given-names>K</given-names></name><name><surname>Wynter</surname><given-names>K</given-names></name><name><surname>Saunders</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Pregnancy-specific anxiety, ART conception and infant temperament at 4 months post-partum</article-title>. <source>Hum Reprod</source>. <year>2013</year>;<volume>28</volume> (<issue>4</issue>):<fpage>997</fpage>–<lpage>1005</lpage>.<pub-id pub-id-type="pmid">23427229</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dornelles</surname><given-names>LM</given-names></name><name><surname>MacCallum</surname><given-names>F</given-names></name><name><surname>Lopes</surname><given-names>RC</given-names></name><name><surname>Piccinini</surname><given-names>CA</given-names></name><name><surname>Passos</surname><given-names>EP.</given-names></name></person-group>
<article-title>The experience of pregnancy resulting from Assisted Reproductive Technology (ART) treatment: A qualitative Brazilian study</article-title>. <source>Women Birth</source>. <year>2016</year>;<volume>29</volume>(<issue>2</issue>):<fpage>123</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">26388215</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname><given-names>M</given-names></name><name><surname>van der Steen</surname><given-names>JO</given-names></name><name><surname>Bokdam</surname><given-names>SB</given-names></name><name><surname>Hamilton</surname><given-names>CJ</given-names></name><name><surname>de Bruin</surname><given-names>JP</given-names></name><name><surname>Nelen</surname><given-names>WL</given-names></name><etal/></person-group>
<article-title>When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population</article-title>. <source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume> (<issue>12</issue>):<fpage>3127</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">19783833</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gameiro</surname><given-names>S</given-names></name><name><surname>Boivin</surname><given-names>J</given-names></name><name><surname>Domar</surname><given-names>A.</given-names></name></person-group>
<article-title>Optimal in vitro fertilization in 2020 should reduce treatment burden and enhance care delivery for patients and staff</article-title>. <source>Fertil Steril</source>. <year>2013</year>;<volume>100</volume>(<issue>2</issue>):<fpage>302</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">23830151</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>J</given-names></name><name><surname>Stevenson</surname><given-names>EL.</given-names></name></person-group>
<article-title>Team communication: critical in the care of the couple with fertility challenges</article-title>. In: <person-group person-group-type="editor"><name><surname>Stevenson</surname><given-names>EL</given-names></name><name><surname>Hershberger</surname><given-names>PE</given-names></name></person-group>, editors. <source>Fertility and Assisted Reproductive Technology (ART): Theory, practice, policy, and research for health care professionals</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer Publishing Company</publisher-name>; <year>2016</year> p. <fpage>295</fpage>–<lpage>309</lpage>.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjelmstedt</surname><given-names>A</given-names></name><name><surname>Widström</surname><given-names>A</given-names></name><name><surname>Wramsby</surname><given-names>HM</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name></person-group>
<article-title>Patterns of emotional responses to pregnancy, experience of pregnancy and attitudes to parenthood among IVF couples: a longitudinal study</article-title>. <source>J Psychosom Obstet Gynaecol</source>. <year>2003</year>;<volume>24</volume>(<issue>3</issue>):<fpage>153</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">14584302</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359858</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359858</article-id>
      <article-id pub-id-type="pmcid">PMC5359858</article-id>
      <article-id pub-id-type="pmc-uid">5359858</article-id>
      <article-id pub-id-type="publisher-id">jri-17-197</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>New Approach</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Loop Mediated Isothermal Amplification (LAMP) for Embryo Sex Determination in Pregnant Women at Eight Weeks of Pregnancy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Almasi</surname>
            <given-names>Mohammad Amin</given-names>
          </name>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almasi</surname>
            <given-names>Galavizh</given-names>
          </name>
        </contrib>
        <aff id="AFF1">- Young Researchers and Elites Club, North Tehran Branch, Islamic Azad University, Tehran, Iran</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Mohammad Amin Almasi, Young Researchers and Elites Club, North Tehran Branch, Islamic Azad University, Tehran, Iran <italic>E-mail:</italic><email>aminalmasi63@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>197</fpage>
      <lpage>204</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>In human, SRY (sex-determining region of the Y chromosome) is the major gene for the testis-determining factor which is found in normal XY males and in the rare XX males, and it is absent in normal XX females and many XY females. There are several methods which can indicate a male genotype by the presence of the amplified product of SRY gene. The aim of this study was to identify the SRY gene for embryo sex determination in human during pregnancy using loop mediated isothermal amplification (LAMP) method.</p>
        </sec>
        <sec>
          <title>Methods:</title>
          <p>A total of 15 blood samples from pregnant women at eight weeks of pregnancy were collected, and Plasma DNA was extracted. LAMP assay was performed using DNA obtained for detection of SRY gene. Furthermore, colorimetric LAMP assay for rapid and easy detection of SRY gene was developed.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>LAMP results revealed that the positive reaction was highly specific only with samples containing XY chromosomes, while no amplification was found in samples containing XX chromosomes. A total of 15 blood samples from pregnant women were seven male embryos (46.6%) and eight female embryos (53.4%). All used visual components in the colorimetric assay could successfully make a clear distinction between positive and negative ones.</p>
        </sec>
        <sec>
          <title>Conclusion:</title>
          <p>The LAMP assay developed in this study is a valuable tool capable of monitoring the purity and detection of SRY gene for sex determination.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Detection dyes</kwd>
        <kwd>Embryo sexing</kwd>
        <kwd>LAMP assay</kwd>
        <kwd>Pregnancy</kwd>
        <kwd>Sex determination analysis</kwd>
        <kwd>SRY gene</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Molecular mechanisms of sex determination involve a growing network of genes, a large number, which are transcription factors. The transcription factors so far are identified as having a major role in sex determination (<xref rid="B1" ref-type="bibr">1</xref>). In humans, the gene for the testis-determining factor resides on the short arm of the Y chromosome. Individuals who are born with the short arm but not the long arm of the Y chromosome are male, while individuals born with the long arm of the Y chromosome but not the short arm are female (<xref rid="B2" ref-type="bibr">2</xref>). By analyzing the DNA of rare XX men and XY women, the position of the testis-determining gene has been narrowed down to a 35,000-base-pair region of the Y chromosome located near the tip of the short arm (<xref rid="B3" ref-type="bibr">3</xref>). In this region, a male-specific DNA sequence was found that could encode a peptide of 223 amino acids. This peptide is probably a transcription factor, since it contains a DNA-binding domain called the HMG (high-mobility group) box (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). This domain is found in several transcription factors and non-histone chromatin proteins, and it induces bending in the region of DNA to which it binds (<xref rid="B6" ref-type="bibr">6</xref>). This gene is called SRY (sex-determining region of the Y chromosome), and there is extensive evidence that it is indeed the gene that encodes the human testis-determining factor (<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B10" ref-type="bibr">10</xref>).</p>
      <p>Methods for sex determination using PCR for amplification of SRY gene have also been reported (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). These methods can indicate a male genotype by the presence of the amplified product of SRY gene. Nonetheless, the need for trained staff, operating space, equipment, and reagents has impeded its usefulness (<xref rid="B13" ref-type="bibr">13</xref>). Hence, there has been an increasing demand for simple and cost-effective molecular tests. Loop mediated isothermal amplification (LAMP), a novel nucleic acid amplification method that relies on an auto-cycling strand displacement DNA synthesis, is performed by Bst DNA polymerase (<xref rid="B14" ref-type="bibr">14</xref>–<xref rid="B17" ref-type="bibr">17</xref>). Four or six primers that identify six or eight distinct regions are used in this method. It is operated under a constant temperature (60 to 65°<italic>C</italic>), and it eliminates the need for specialized thermal cycler equipment (<xref rid="B18" ref-type="bibr">18</xref>–<xref rid="B23" ref-type="bibr">23</xref>). An important advantage of LAMP is its ability to amplify specific sequences of DNA under isothermal conditions (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Detection of amplification product can be determined via turbidity caused by an increasing quantity of the magnesium pyrophosphate precipitate in solution (<xref rid="B26" ref-type="bibr">26</xref>–<xref rid="B36" ref-type="bibr">36</xref>). LAMP positive amplicons have been confirmed by adding a number of fluorescent dsDNA intercalating dye including ethidium bromide and SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II after the reaction is completed or metal indicators such as magnesium sulphate (MgSO<sub>4</sub>), calcium chloride (CaCl<sub>2</sub>), SYBR Green I, propidium iodide, GeneFinder<sup>TM</sup>, calcein, hydroxynaphthol blue (HNB), phenol red and Gel-Red<sup>TM</sup> prior to the reaction, allowing observation with the naked eye (<xref rid="B37" ref-type="bibr">37</xref>–<xref rid="B40" ref-type="bibr">40</xref>). The purpose of this study was to establish a rapid, sensitive, specific, and easy method to detect SRY gene using a visualized detection system.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Sample collection and plasma DNA extraction:</title>
        <p>A total of 15 blood samples from pregnant women at eight weeks of pregnancy were collected. Another set of blood samples from non-pregnant women and men were also obtained using them as plasma negative and positive controls for the study, respectively. Fresh blood samples were drawn into Vacutainer EDTA tubes (BD Cat. 366643) immediately and were centrifuged at 3000 <italic>rpm</italic> for 10 <italic>min</italic> in a refrigerated centrifuge; their plasma fractions were collected and stored at −80°<italic>C</italic> for further analysis. Plasma DNA was extracted using QIAamp Circulating Nucleic Acid Kit (Qiagen, Cat. 55114) by following manufacturer’s protocol. Briefly, 2 <italic>ml</italic> of plasma was mixed with 200 <italic>μl</italic> proteinase K, 2.4 <italic>ml</italic> on ACL buffer by pulse-vortexing for 1 <italic>min</italic> in a 50 <italic>ml</italic> conical tube. Then the mixture was incubated in a 60°<italic>C</italic> water bath for 30 <italic>min</italic>. Then, 3.6 <italic>ml</italic> ACB buffer was added to the sample lysate and mixed by pulse-vortexing for 1 <italic>min</italic>, incubated for 5 <italic>min</italic> on ice and applied to the QIAamp mini column. Following the multiple wash and centrifugation steps, columns were incubated for 10 <italic>min</italic> at 56°<italic>C</italic> and DNA was eluted with 100 <italic>μl</italic> of AVE buffer and stored at −20°<italic>C</italic> for further analyses. The extraction quality of nucleic acid was confirmed by 1.5% agarose gel electrophoresis. The nucleic acid was stained with ethidium bromide. The purity of DNA was estimated by measuring the absorbance values at 260 <italic>nm</italic> and 280 <italic>nm</italic> using UV-Vis spectrophotometer (Shimadzu UV-1700, Japan).</p>
      </sec>
      <sec>
        <title>Amplification of SRY gene using LAMP:</title>
        <p>By means of the Primer Explorer V.4 software (specific for LAMP), specific primers were designed based on SRY genes (GenBank accession JQ811934.1) (<xref ref-type="table" rid="T1">Table 1</xref>). <xref ref-type="fig" rid="F1">Figure 1A</xref> shows the schematic position of LAMP primers within SRY gene. A basic set of four primers was needed, including FIP (Forward Inner Primer), BIP (Backward Inner Primer), F3 (Forward Outer Primer), and B3 (Backward Outer Primer) to identify six distinct regions on the target DNA. To accelerate the LAMP reaction, two additional primers, <italic>i.e</italic>., LF (Loop Forward Primer) and LB (Loop Backward Primer) were also used. FIP consisted of the complementary sequence of F1, a T-T-T-T linker, and F2. BIP consisted of B1c, a T-T-T-T linker, and the complementary sequence of B2c. Primers F3 and B3 were located outside F2 and B2 regions, while loop primers LF and LB were located between F2 and F1 and between B1 and B2, respectively (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B16" ref-type="bibr">16</xref>). Finally, the primers were tested for similarities with other sequences available in the GenBank databases using the BLASTN algorithm. LAMP assay was separately performed in a total volume of 25 <italic>μl</italic> using DNA obtained in a way described before, using designed primers in pregnant women, non-pregnant women (negative control) and men (positive control) samples. Initially, DNA was added to 23 <italic>μl</italic> of LAMP mixture to provide a final concentration of 20 <italic>mM</italic> supplied buffer (Thermopol buffer containing 50 <italic>mM</italic> Tris-HCl, pH=8.8, 10 <italic>mM</italic> KCl, 10 (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>
<italic>mM</italic>, 0.1% Triton X100), 2 <italic>mM</italic> Betaine (Sigma-Aldrich, USA), 1 <italic>mM</italic> MgSO<sub>4</sub>, 10 <italic>mM</italic> dNTP, 0.2 <italic>μM</italic> of primer F3 and B3, 0.4 <italic>μM</italic> of primer LF and LB, 0.8 <italic>μM</italic> of primer FIP and BIP and 8 <italic>U</italic> of Bst DNA polymerase (New England Biolabs, UK). Tubes were then incubated at 63°<italic>C</italic> for 60 <italic>min</italic> in water bath. An agarose gel electrophoresis system (optional, 1.5%) under UV illumination could be also employed to visualize positive reaction.</p>
        <fig id="F1" position="float">
          <label>Figure 1.</label>
          <caption>
            <p>A: Schematic representation of position primers used in LAMP assay; B: Quantity assessment of isolated DNA by spectrophotometric</p>
          </caption>
          <graphic xlink:href="JRI-17-197-g001"/>
        </fig>
        <table-wrap id="T1" position="float">
          <label>Table 1.</label>
          <caption>
            <p>Oligonucleotide primers used for LAMP assay</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>Name</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Length</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Sequence (5–3)</bold>
                </th>
                <th align="center" valign="middle" rowspan="1" colspan="1">
                  <bold>Length of product</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>F3</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">18 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">AACGTCCAGGATAGAGTG</td>
                <td rowspan="6" align="center" valign="middle" colspan="1">Fragment with different sizes</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>B3</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">18 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">AGCATCTTCGCCTTCCGA</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>FIB (F1c+F2)</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">44 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">ATCTCTGAGTTTCGCATTCTTTTTAACGCATTCATCGTGTGGTC</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>BIP (B1c+B2)</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">44 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">TGGGATACCAGTGGAAAATGTTTTTCTCTCTGTGCATGGCCTGT</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>LF</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">22 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">TCTAGAGCCATCTTGCGCCTCT</td>
              </tr>
              <tr>
                <td align="left" valign="middle" rowspan="1" colspan="1">
                  <bold>LB</bold>
                </td>
                <td align="center" valign="middle" rowspan="1" colspan="1">22 nt</td>
                <td align="center" valign="middle" rowspan="1" colspan="1">CCGAAAAATGGCCATTCTTCCA</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Visual detection and confirmation of LAMP products (colorimetric assay):</title>
        <p>The validations of positive LAMP reactions were justified by means of eight staining approaches. In doing so, several dyes were added to the LAMP reaction as described previously (<xref rid="B40" ref-type="bibr">40</xref>). Prior to amplification, 2 <italic>μl</italic> magnesium sulphate (8 <italic>mM</italic> MgSO<sub>4</sub>), 1 <italic>μl</italic> of GeneFinder<sup>TM</sup> (diluted to 1:10 with 6×loading buffer) (Biov. Bio. China), 1 <italic>μl</italic> of SYBR Green I (diluted to 1:10 with 6×loading buffer) (Invitrogen, Australia), 1 <italic>μl</italic> of the hydroxynaphthol blue dye (HNB) (3 <italic>mM</italic>, Lemongreen, Shanghai, China), 1 <italic>μl</italic> of phenol red (diluted to 1:10 with 6×loading buffer) (Sigma-Aldrich Chemie GmbH) or 1 <italic>μl</italic> of the GelRed<sup>TM</sup> dye (Biotum, India) were separately added from a stock solution to the master mix. After amplification, 0.5 <italic>μl</italic> ethidium bromide (Sigma) and 2 <italic>μl</italic> SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II (Perfect Real-time, Takara Bio Co., Ltd., RR081A) were added to LAMP reaction separately. The tubes containing MgSO<sub>4</sub>, GeneFinder<sup>TM</sup>, SYBR Green I, HNB and phenol red dyes were easily monitored for color change by simply looking at them in daylight, while the ones containing GelRed<sup>TM</sup>, ethidium bromide and SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II were examined under UV light (302 <italic>nm</italic>) after a short vortex.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>DNA isolation:</title>
        <p>DNA must be purified from cellular material in such a manner to prevent degradation. The absorbance ratios (A260/A280) of DNA samples were found to be in range of 1.68–1.73, indicating the purity of DNA (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
      </sec>
      <sec>
        <title>LAMP assay:</title>
        <p>The initial optimization of the assay was conducted using a set of four basic primers, and optimal concentrations were determined. The reaction mixture was incubated at temperatures ranging from 60 to 65°<italic>C</italic>. The optimal temperature was found to be 63°<italic>C</italic> for 60 <italic>min</italic>. Values and concentrations of other components of the reaction were optimized. After detection of LAMP by gel electrophoresis, the smeared bands of amplified product indicated the positive reaction (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Our results revealed the positive reaction was highly specific only with fresh blood samples containing XY chromosomes, while no amplification was found in blood samples containing XX chromosomes. Our new LAMP protocol could successfully identify positive samples and positive control. LAMP amplicons were electrophoresed and a large number of fragments (a ladder like pattern) were eventually visualized. As shown in <xref ref-type="fig" rid="F2">figure 2A</xref> typical ladder pattern of the amplified LAMP products with agarose gel electrophoresis was only observed for the positive samples and positive control. The LAMP assay showed no detectable amplification of other samples, including the negative control and negative samples. A total of 15 blood samples from pregnant women were seven male embryos (46.6%) and eight female embryos (53.4%). The authenticity of the results by the follow up was performed after delivery and finally the diagnosis of gender in 15 pregnant women was determined by plasma LAMP method.</p>
        <fig id="F2" position="float">
          <label>Figure 2.</label>
          <caption>
            <p>A: Gel electrophoresis pattern of LAMP amplicons on 1.5% agarose gel; B: Details of eight different visualization methods to analyze LAMP products. Lane M: DNA size marker (100 <italic>bp</italic>), lanes and tubes 1–7: positive samples, lanes and tubes 8–15: negative samples, lane and tube N: non-pregnant women sample (negative sample) and, lane and tube P: men sample (positive control)</p>
          </caption>
          <graphic xlink:href="JRI-17-197-g002"/>
        </fig>
      </sec>
      <sec>
        <title>Colorimetric assay:</title>
        <p>LAMP amplicons could be detected with the naked eye by adding different visual dyes followed by color changing in the solutions. In this regard, all used visual components could successfully make a clear distinction between positive and negative ones (<xref ref-type="fig" rid="F2">Figure 2B</xref>). It is noticeable that positive results by MgSO<sub>4</sub>, Gene-Finder<sup>TM</sup>, SYBR Green I, HNB, phenol red, Gel-Red<sup>TM</sup>, ethidium bromide and SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II were turbidity, green, green, sky blue, red, orange, yellow and green, respectively.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The LAMP method, generally, had the following advantages over the other methods such as easy detection, high sensitivity, high efficiency, simple manipulation, safety, low cost and being user friendly. In reality, except for section one which takes equal time (see “Material and Methods” section), LAMP overall requires just 60 <italic>min</italic> to accomplish (as the least demanding detection method) (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B21" ref-type="bibr">21</xref>). This, in turn, would simplify the detection procedure and result in saving significant time needed for separating the amplified products on the gel and analyzing the data which are commonly used in other PCR-based methods, including nested PCR, reverse transcription PCR, multiplex PCR and immunocapture PCR (<xref rid="B29" ref-type="bibr">29</xref>–<xref rid="B39" ref-type="bibr">39</xref>). Such visual methods not only involve some expensive instruments but also during a period of time, exposure to the UV light (because it is harmful to the eyes, even watching for a short period would irritate the eyes and cause symptoms similar to conjunctivitis) as well as ethidium bromide could induce a number of serious negative effects on researchers who use these methods (<xref rid="B13" ref-type="bibr">13</xref>). More surprisingly, in LAMP amplified products can be easily visualized by means of different in-tube color indicators with no essential requirement of additional staining systems; thus, toxic staining materials would be significantly avoided (<xref rid="B39" ref-type="bibr">39</xref>). Simple, cost effective and user friendly equipped labs with some molecular instruments as well as trained personnel are prerequisites to perform PCR assays (<xref rid="B35" ref-type="bibr">35</xref>). On the contrary, LAMP can be easily accomplished just in a water bath or temperature block with no need of thermocycler and gel electrophoresis as the same results were recorded by other researchers (<xref rid="B29" ref-type="bibr">29</xref>–<xref rid="B40" ref-type="bibr">40</xref>). Likewise, exclusive of the primer designing process which is somehow complicated and sensitive, other phases are simply applicable. On the other hand, the presence of LAMP positive amplicons proved to be confirmed by adding a number of fluorescent or metal dyes to the reaction tubes, allowing observation with the naked eye (<xref rid="B24" ref-type="bibr">24</xref>–<xref rid="B37" ref-type="bibr">37</xref>). In the current study, therefore, LAMP amplified products were confirmed by adding all aforementioned visual systems (see “Methods” section), either prior to or after the reaction along with forming diverse color patterns depending upon the chemical characteristics of the applied chemical substances as dye. According to our results, despite the precise detection of positive LAMP products using all dyes, some were significantly superior when the time of stability, cost and the safety were taken into consideration (<xref ref-type="table" rid="T2">Table 2</xref>). For instance, regardless of its reasonable color change stability (≥2 weeks), when employing ethidium bromide, a UV transilluminator must be available; both of them are toxic, resulting in deleterious consequences on human health and the environment (<xref rid="B25" ref-type="bibr">25</xref>–<xref rid="B30" ref-type="bibr">30</xref>). More interestingly, in some cases, just a little fluorescent emission could be observed in negative tubes, presumably arising from the presence of primers and/or DNA templates, leading to an increase in false-positive results (<xref rid="B30" ref-type="bibr">30</xref>–<xref rid="B35" ref-type="bibr">35</xref>). Alternative to such problems, the first metal dye called magnesium sulphate was utilized, but just an ephemeral color change (<italic>i.e</italic>. turbidity; no more than a few seconds) was observed as the same result was reported (<xref rid="B31" ref-type="bibr">31</xref>–<xref rid="B39" ref-type="bibr">39</xref>). Even though short stability of the color change probably cannot be a significant problem as long as just a few numbers of suspicious samples are used, during assessment of a great quantity of infected samples, most of the time, inaccurate results will be accordingly achieved (<xref rid="B29" ref-type="bibr">29</xref>–<xref rid="B35" ref-type="bibr">35</xref>). The method, nevertheless, could be thereby attributed as a reliable visual observation approach since on the one hand, it is exploited prior to the reaction and on the other hand, there is no need for toxic devices. Anyway, to provide a situation to increase time stability, the second fluorescent dye SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II was employed, leading to a clear green color pattern. Notably, regardless of observing a significant growth on time stability (about 1–3 days), the method not only requires UV transilluminator but also its stability is more negatively sensitive (in daylight). Indeed, since the dye must be added after the amplification as it requires opening of the tubes, the occurrence of cross-contamination risk will be accordingly enhanced (<xref rid="B28" ref-type="bibr">28</xref>–<xref rid="B35" ref-type="bibr">35</xref>). To avoid such contaminations, using separate rooms can be a solution for LAMP setup and analysis. More recently, it has also been pointed out that the visualized LAMP assay demands a high concentration of SYBR Green I, which will hamper the LAMP reaction if it is added before LAMP reaction, so the close-tube LAMP detection based on SYBR Green I might be difficult (<xref rid="B32" ref-type="bibr">32</xref>–<xref rid="B38" ref-type="bibr">38</xref>). To abbreviate the contamination hazard and also increase color stability, as a result, two additional metal indicators (<italic>i.e</italic>. HNB and GeneFinder<sup>TM</sup>) known as close-tube LAMP detection were lastly used. Interestingly, among several different visual dyes to accurately detect LAMP products, both HNB and GeneFinder<sup>TM</sup> could produce long stable color change and brightness in a close tube-based approach to prevent cross-contamination risk as the best alternatives (35, 37, 40). Two additional metal indicators (phenol red and GelRed<sup>TM</sup>) were added before LAMP reaction but UV transilluminator was required. Meanwhile, the visual inspection of LAMP products by means of HNB and GeneFinder<sup>TM</sup> metal dyes was seen as advantageous as there was no need for electrophoresis and subsequent staining with carcinogenic ethidium bromide (<xref rid="B40" ref-type="bibr">40</xref>). Lastly, the color brightness and stability of both HNB and GeneFinder<sup>TM</sup> in the solutions with positive/negative reactions remained constant after 2 weeks of exposure to ambient light, whereas turbidity caused by precipitation of MgSO<sub>4</sub> or SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> II was stable for only 5–10 <italic>s</italic> and 1–3 days, respectively, which were in agreement with the results reported by previous researchers (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B39" ref-type="bibr">39</xref>). However, the results obtained here represent those achievable in the research laboratory setting, and it is uncertain whether these results also apply to actual specimens compared with other LAMP assays (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
      <table-wrap id="T2" position="float">
        <label>Table 2.</label>
        <caption>
          <p>Comparison of colorimetric assays for detection of SRY gene</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Visual system</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Detection method</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Safety</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Positive reaction</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Negative sample</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Apply UV ray</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Stability</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Cross contamination</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Use time</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Magnesium Sulfate (MgSO<sub>4</sub>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Turbidity</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No turbidity</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">5–10 <italic>s</italic></td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>GeneFinder</bold>
                <sup>
                  <underline>TM</underline>
                </sup>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Green</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Orange</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2–3 weeks</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>SYBR Green I</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Green</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Orange</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2–3 weeks</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Hydroxynaphthol blue (HNB)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Sky blue</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Violet</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2–3 weeks</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Phenol red</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Red</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Orange</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1 week</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Ethidium bromide</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yellow</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No color</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 weeks</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">After amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1"><bold>SYBR Premix Ex Taq</bold><sup><underline>TM</underline></sup>
<bold>II</bold></td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Green</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No color</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1–3 days</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">After amplification</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>GelRedTM</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Orange</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No color</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">2 weeks</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Prior to amplification</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T3" position="float">
        <label>Table 3.</label>
        <caption>
          <p>Comparison of different LAMP assays</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Assay</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Detection method</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Safety</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Apply UV ray</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Apply detect instruments</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>Cost</bold>
              </th>
              <th align="center" valign="middle" rowspan="1" colspan="1">
                <bold>User friendly</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>LAMP with gel detection</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Gel electrophoresis</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">High</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">High</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Colorimetric LAMP without UV</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Very low</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Very high</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Colorimetric LAMP with UV</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Visual</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">High</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">high</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>In conclusion, sex determination using detection of SRY gene by LAMP method in fresh human blood shows the smear and/or ladder band only in male blood samples, but not in female samples. The LAMP assay developed in this study is a valuable tool capable of helping in monitoring the purity and identification of SRY gene for sex determination. LAMP method, all in all, had the following advantages over the other mentioned procedures: (I) no requirement for expensive and sophisticated tools in amplification and detection; (II) no post-amplification treatment of the amplicons; (III) a flexible and easy detection approach, by detecting with naked eyes using diverse visual dyes; (IV) high sensitivity; (V) high efficiency; (VI) safety; and (VII) being user friendly. This robust assay is quick, sensitive and specific enough to be applied for gene detection.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>This study was funded by Young Researchers and Elites Club, North Tehran Branch, Islamic Azad University, Tehran, Iran.</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>The authors have no conflict of interest. This study was supported by Islamic Azad University, North Tehran Branch.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Yoshitome</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>O</given-names></name><name><surname>Shigeta</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Forensic study of sex determination using PCR on teeth samples</article-title>. <source>Acta Med Okayama</source>. <year>2000</year>;<volume>54</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">10709619</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assumpção</surname><given-names>JG</given-names></name><name><surname>Benedetti</surname><given-names>CE</given-names></name><name><surname>Maciel-Guerra</surname><given-names>AT</given-names></name><name><surname>Guerra</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Baptista</surname><given-names>MT</given-names></name><name><surname>Scolfaro</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>Novel mutations affecting SRY DNA-binding activity: the HMG box N65H associated with 46, XY pure gonadal digenesis and the familial non-HMG box R30I associated with variable phenotypes</article-title>. <source>J Mol Med (Berl)</source>. <year>2002</year>;<volume>80</volume>(<issue>12</issue>):<fpage>782</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">12483463</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimelli</surname><given-names>G</given-names></name><name><surname>Gimelli</surname><given-names>S</given-names></name><name><surname>Dimasi</surname><given-names>N</given-names></name><name><surname>Bocciardi</surname><given-names>R</given-names></name><name><surname>Di Battista</surname><given-names>E</given-names></name><name><surname>Pramparo</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Identification and molecular modelling of a novel familial mutation in the SRY gene implicated in the pure gonadal dysgenesis</article-title>. <source>Eur J Hum Genet</source>. <year>2007</year>;<volume>15</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">17063144</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellermayer</surname><given-names>R</given-names></name><name><surname>Halvax</surname><given-names>L</given-names></name><name><surname>Czakó</surname><given-names>M</given-names></name><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Dhillon</surname><given-names>VS</given-names></name><name><surname>Husain</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>A novel frame shift mutation in the HMG box of the SRY gene in a patient with complete 46, XY pure gonadal dysgenesis</article-title>. <source>Diagn Mol Pathol</source>. <year>2005</year>;<volume>14</volume>(<issue>3</issue>):<fpage>159</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">16106197</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>TF</given-names></name><name><surname>Conway</surname><given-names>GS.</given-names></name></person-group>
<article-title>Swyer syndrome</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source>. <year>2014</year>;<volume>21</volume>(<issue>6</issue>):<fpage>504</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">25314337</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>NB</given-names></name><name><surname>Jancso-Radek</surname><given-names>A</given-names></name><name><surname>Ittah</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>G</given-names></name><name><surname>Haas</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>SRY and human sex determination: the basic tail of the HMG box functions as a kinetic clamp to augment DNA bending</article-title>. <source>J Mol Biol</source>. <year>2006</year>; <volume>358</volume>(<issue>1</issue>):<fpage>172</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">16504207</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racca</surname><given-names>JD</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name><name><surname>Maloy</surname><given-names>JD</given-names></name><name><surname>Wickramasinghe</surname><given-names>N</given-names></name><name><surname>Phillips</surname><given-names>NB</given-names></name><name><surname>Weiss</surname><given-names>MA.</given-names></name></person-group>
<article-title>Structure-function relationships in human testis-determining factor SRY: an aromatic buttress underlies the specific DNA-bending surface of a high mobility group (HMG) box</article-title>. <source>J Biol Chem</source>. <year>2014</year>;<volume>289</volume>(<issue>47</issue>):<fpage>32410</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">25258310</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizvi</surname><given-names>AA.</given-names></name></person-group>
<article-title>46, XX man with SRY gene translocation: cytogenetic characteristics, clinical features and management</article-title>. <source>Am J Med Sci</source>. <year>2006</year>;<volume>335</volume>(<issue>4</issue>):<fpage>307</fpage>–<lpage>9</lpage>.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Dhillion</surname><given-names>VS</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Hedau</surname><given-names>S</given-names></name><name><surname>Diwakar</surname><given-names>S</given-names></name><name><surname>Sachdeva</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Two new novel point mutations localized upstream and downstream of the HMG box region of the SRY gene in three Indian 46,XY females with sex reversal and gonadal tumour formation</article-title>. <source>Mol Hum Reprod</source>. <year>2004</year>;<volume>10</volume>(<issue>7</issue>):<fpage>521</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">15155818</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>PD</given-names></name><name><surname>Wallis</surname><given-names>MC</given-names></name><name><surname>Marshall Graves</surname><given-names>JA.</given-names></name></person-group>
<article-title>Mammalian sex--Origin and evolution of the Y chromosome and SRY</article-title>. <source>Semin Cell Dev Biol</source>. <year>2007</year>;<volume>18</volume>(<issue>3</issue>): <fpage>389</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">17400006</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>FR</given-names></name><name><surname>Pandya</surname><given-names>A</given-names></name><name><surname>Tyler-Smith</surname><given-names>C.</given-names></name></person-group>
<article-title>Reliability of DNA-based sex tests</article-title>. <source>Nat Genet</source>. <year>1998</year>;<volume>18</volume>(<issue>2</issue>):<fpage>103</fpage>.<pub-id pub-id-type="pmid">9462733</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thangaraj</surname><given-names>K</given-names></name><name><surname>Reddy</surname><given-names>AG</given-names></name><name><surname>Singh</surname><given-names>L.</given-names></name></person-group>
<article-title>Is the amelogenin gene reliable for gender identification in forensic casework and prenatal diagnosis?</article-title>
<source>Int J Legal Med</source>. <year>2002</year>;<volume>116</volume>(<issue>2</issue>):<fpage>121</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">12056520</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notomi</surname><given-names>T</given-names></name><name><surname>Okayama</surname><given-names>H</given-names></name><name><surname>Masubuchi</surname><given-names>H</given-names></name><name><surname>Yonekawa</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Amino</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Loop-mediated isothermal amplification of DNA</article-title>. <source>Nucleic Acids Res</source>. <year>2000</year>;<volume>28</volume>(<issue>12</issue>):<fpage>E63</fpage>.<pub-id pub-id-type="pmid">10871386</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirayama</surname><given-names>H</given-names></name><name><surname>Katagiri</surname><given-names>S</given-names></name><name><surname>Kageyama</surname><given-names>S</given-names></name><name><surname>Minamihashi</surname><given-names>A</given-names></name><name><surname>Moriyasu</surname><given-names>S</given-names></name><name><surname>Sawai</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Rapid sex chromosomal chimerism analysis in heterosexual twin female calves by Loop-mediated Isothermal Amplification</article-title>. <source>Anim Reprod Sci</source>. <year>2007</year>;<volume>101</volume>(<issue>1–2</issue>):<fpage>38</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">17011732</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>ZP</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name><name><surname>Zhang</surname><given-names>JT</given-names></name><name><surname>An</surname><given-names>ZX</given-names></name><name><surname>Quan</surname><given-names>FS</given-names></name><etal/></person-group>
<article-title>Codeposition of dNTPs detection for rapid LAMP-based sexing of bovine embryos</article-title>. <source>Reprod Domest Anim</source>. <year>2009</year>;<volume>44</volume>(<issue>1</issue>):<fpage>116</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">19019067</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>KW</given-names></name><name><surname>Liu</surname><given-names>PC</given-names></name><name><surname>Yang</surname><given-names>WC</given-names></name><name><surname>Kuo</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>CY.</given-names></name></person-group>
<article-title>A novel loop-mediated isothermal amplification approach for sex identification of Columbidae birds</article-title>. <source>Theriogenology</source>. <year>2012</year>;<volume>78</volume>(<issue>6</issue>):<fpage>1329</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">22898019</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanchanaphum</surname><given-names>P</given-names></name><name><surname>Sarataphan</surname><given-names>T</given-names></name><name><surname>Thirasan</surname><given-names>W</given-names></name><name><surname>Anatasomboon</surname><given-names>G.</given-names></name></person-group>
<article-title>Development of Loop mediated isothermal amplification (LAMP) of SRY gene in human blood samples for sex determination</article-title>. <source>Rangsit J Arts Sci</source>. <year>2013</year>;<volume>3</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>35</lpage>.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>T</given-names></name><name><surname>Sonobe</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name></person-group>
<article-title>Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples</article-title>. <source>J Clin Microbiol</source>. <year>2003</year>;<volume>41</volume>(<issue>6</issue>):<fpage>2616</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">12791888</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Notomi</surname><given-names>T.</given-names></name></person-group>
<article-title>Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases</article-title>. <source>J Infect Chemother</source>. <year>2009</year>;<volume>15</volume>(<issue>2</issue>):<fpage>62</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19396514</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadersdorfer</surname><given-names>J</given-names></name><name><surname>Neumuller</surname><given-names>M</given-names></name><name><surname>Treutter</surname><given-names>D</given-names></name><name><surname>Fischer</surname><given-names>T.</given-names></name></person-group>
<article-title>Fast and reliable detection of Plum pox virus in woody host plants using the Blue LAMP protocol</article-title>. <source>Ann Appl Biol</source>. <year>2011</year>;<volume>159</volume>(<issue>3</issue>):<fpage>456</fpage>–<lpage>66</lpage>.</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>TC</given-names></name><name><surname>Ferrari</surname><given-names>HF</given-names></name><name><surname>Bregano</surname><given-names>LC</given-names></name><name><surname>Silva-Frade</surname><given-names>C</given-names></name><name><surname>Rosa</surname><given-names>AC</given-names></name><name><surname>Andrade</surname><given-names>AL.</given-names></name></person-group>
<article-title>Visual detection of turkey coronavirus RNA in tissues and feces by reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with hydroxynaphthol blue dye</article-title>. <source>Mol Cell Probes</source>. <year>2010</year>;<volume>24</volume>(<issue>6</issue>):<fpage>415</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">20732411</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>M</given-names></name><name><surname>Honda</surname><given-names>E</given-names></name><name><surname>Ogura</surname><given-names>A</given-names></name><name><surname>Nomoto</surname><given-names>A</given-names></name><name><surname>Hanaki</surname><given-names>K.</given-names></name></person-group>
<article-title>Colorimetric detection of loopmediated isothermal amplification reaction by using hydroxyl naphthol blue</article-title>. <source>Biotechniques</source>. <year>2009</year>;<volume>46</volume>(<issue>3</issue>):<fpage>167</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">19317660</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Qu</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Applications of loop-mediated isothermal DNA amplification</article-title>. <source>Appl Biochem Biotechnol</source>. <year>2011</year>;<volume>163</volume> (<issue>7</issue>):<fpage>845</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">20844984</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Jafary</surname><given-names>H</given-names></name><name><surname>Moradi</surname><given-names>A</given-names></name><name><surname>Zand</surname><given-names>N</given-names></name><name><surname>Ojaghkandi</surname><given-names>MA</given-names></name><name><surname>Aghaei</surname><given-names>S.</given-names></name></person-group>
<article-title>Detection of coat protein gene of the Potato Leafroll Virus by reverse transcription loop-mediated isothermal amplification</article-title>. <source>J Plant Pathol Microbiol</source>. <year>2013</year>;<volume>4</volume>(<issue>1</issue>):<fpage>156</fpage>.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>A</given-names></name><name><surname>Nasiri</surname><given-names>J</given-names></name><name><surname>Abdollahi</surname><given-names>H</given-names></name><name><surname>Almasi</surname><given-names>MA.</given-names></name></person-group>
<article-title>Development and evaluation of a loopmediated isothermal amplification assay for detection of Erwinia amylovora based on chromosomal DNA</article-title>. <source>Eur J Plant Pathol</source>. <year>2012</year>;<volume>133</volume>(<issue>3</issue>):<fpage>609</fpage>–<lpage>20</lpage>.</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parida</surname><given-names>M</given-names></name><name><surname>Shukla</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Ranghia Santhosh</surname><given-names>S</given-names></name><name><surname>Ravi</surname><given-names>V</given-names></name><name><surname>Mani</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Development and evaluation of reverse transcription loop-mediated isothermal amplification assay for rapid and real-time detection of the swine-origin influenza A H1N1 virus</article-title>. <source>J Mol Diagn</source>. <year>2011</year>;<volume>13</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">21227400</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>N</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Kanda</surname><given-names>H</given-names></name><name><surname>Notomi</surname><given-names>T.</given-names></name></person-group>
<article-title>Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products</article-title>. <source>Nat Protoc</source>. <year>2008</year>;<volume>3</volume>(<issue>5</issue>):<fpage>877</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">18451795</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>SM</given-names></name><name><surname>Chan</surname><given-names>KW</given-names></name><name><surname>Hsu</surname><given-names>WL</given-names></name><name><surname>Chang</surname><given-names>TJ</given-names></name><name><surname>Wong</surname><given-names>ML</given-names></name><name><surname>Wang</surname><given-names>CY.</given-names></name></person-group>
<article-title>Development of a loop-mediated isothermal amplification for rapid detection of orf virus</article-title>. <source>J Virol Methods</source>. <year>2009</year>;<volume>157</volume>(<issue>2</issue>):<fpage>200</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">19186192</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>S</given-names></name><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Fatehi</surname><given-names>F</given-names></name><name><surname>Struik</surname><given-names>PC</given-names></name><name><surname>Moradi</surname><given-names>A.</given-names></name></person-group>
<article-title>Visual detection of potato leafroll virus by one-step reverse transcription loop-mediated isothermal amplification of DNA with hydroxynaphthol blue dye</article-title>. <source>J phytopathol</source>. <year>2012</year>;<volume>161</volume>(<issue>2</issue>):<fpage>120</fpage>–<lpage>4</lpage>.</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dukes</surname><given-names>JP</given-names></name><name><surname>King</surname><given-names>DP</given-names></name><name><surname>Alexandersen</surname><given-names>S.</given-names></name></person-group>
<article-title>Novels reverse transcription loop-mediated isothermal amplification for rapid detection of foot-and-mouth disease virus</article-title>. <source>Arch Virol</source>. <year>2006</year>;<volume>151</volume>(<issue>6</issue>):<fpage>1093</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">16453084</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Hosseyni-Dehabadi</surname><given-names>SM</given-names></name><name><surname>Aghapour-Ojaghkandi</surname><given-names>M.</given-names></name></person-group>
<article-title>Comparison and evaluation of three diagnostic methods for detection of Beet Curly Top Virus in sugar beet using different visualizing systems</article-title>. <source>Appl Biochem Biotechnol</source>. <year>2014</year>;<volume>173</volume>(<issue>7</issue>): <fpage>1836</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">24894659</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Moradi</surname><given-names>A</given-names></name><name><surname>Nasiri</surname><given-names>J</given-names></name><name><surname>Karami</surname><given-names>S</given-names></name><name><surname>Nasiri</surname><given-names>M.</given-names></name></person-group>
<article-title>Assessment of performance ability of three diagnostic methods for detection of Potato Leafroll Virus (PLRV) using different visualizing systems</article-title>. <source>Appl Biochem Biotechnol</source>. <year>2012</year>;<volume>168</volume>(<issue>4</issue>):<fpage>770</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">22907514</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Dehabadi</surname><given-names>SH</given-names></name><name><surname>Eftekhari</surname><given-names>Z.</given-names></name></person-group>
<article-title>Immunocapture loop mediated isothermal amplification for rapid detection of Tomato Yellow Leaf curl Virus (TYLCV) without DNA extraction</article-title>. <source>J Plant Pathol Microbiol</source>. <year>2013</year>;<volume>4</volume>(<issue>7</issue>):<fpage>185</fpage>.</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Hosseini</surname><given-names>SMD</given-names></name><name><surname>Moradi</surname><given-names>A</given-names></name><name><surname>Eftekhari</surname><given-names>Z</given-names></name><name><surname>Ojaghkandi</surname><given-names>MA</given-names></name><name><surname>Aghaei</surname><given-names>S.</given-names></name></person-group>
<article-title>Development and application of loop-mediatred Isothermal amplification assay for rapid detection of fusarium oxysporum f. sp. Lycopersici</article-title>. <source>J Plant Pathol Microbiol</source>. <year>2013</year>;<volume>4</volume>(<issue>5</issue>):<fpage>177</fpage>.</mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>A</given-names></name><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Jafary</surname><given-names>H</given-names></name><name><surname>Mercado-Blanco</surname><given-names>J.</given-names></name></person-group>
<article-title>A novel and rapid loop-mediated isothermal amplification assay for the specific detection of Verticillium dahlia</article-title>. <source>J Appl Microbiol</source>. <year>2014</year>;<volume>116</volume>(<issue>4</issue>):<fpage>942</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">24329885</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuta</surname><given-names>S</given-names></name><name><surname>Iida</surname><given-names>T</given-names></name><name><surname>Mizukami</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>A</given-names></name><name><surname>Ueda</surname><given-names>J</given-names></name><name><surname>Kanbe</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Detection of Japanese yam mosaic virus by RT-LAMP</article-title>. <source>Arch Virol</source>. <year>2003</year>;<volume>148</volume>(<issue>9</issue>): <fpage>1713</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">14505084</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Erfan manesh</surname><given-names>M</given-names></name><name><surname>Jafary</surname><given-names>H</given-names></name><name><surname>Dehabadi</surname><given-names>SM.</given-names></name></person-group>
<article-title>Visual detection of Potato Leafroll virus by one-step reverse transcription loop-mediated isothermal amplification of DNA with the genefinder<sup>TM</sup> dye</article-title>. <source>J Virol Methods</source>. <year>2013</year>;<volume>192</volume>(<issue>1–2</issue>):<fpage>51</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">23680094</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Ojaghkandi</surname><given-names>MA</given-names></name><name><surname>Hemmatabadi</surname><given-names>A</given-names></name><name><surname>Hamidi</surname><given-names>F</given-names></name><name><surname>Aghaei</surname><given-names>S.</given-names></name></person-group>
<article-title>Development of colorimetric loop-mediated isothermal amplification assay for rapid detection of the Tomato Yellow Leaf Curl Virus</article-title>. <source>J Plant Pathol Microbiol</source>. <year>2013</year>;<volume>4</volume>(<issue>1</issue>):<fpage>153</fpage>.</mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>MA</given-names></name><name><surname>Aghapour-ojaghkandi</surname><given-names>M</given-names></name><name><surname>Bagheri</surname><given-names>K</given-names></name><name><surname>Ghazvini</surname><given-names>M</given-names></name><name><surname>Hosseyni-dehabadi</surname><given-names>SM.</given-names></name></person-group>
<article-title>Comparison and evaluation of two diagnostic methods for detection of npt II and GUS genes in Nicotiana tabacum</article-title>. <source>Appl Biochem Biotechnol</source>. <year>2015</year>;<volume>175</volume>(<issue>8</issue>): <fpage>3599</fpage>–<lpage>616</lpage>.<pub-id pub-id-type="pmid">25820356</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almasi</surname><given-names>M.</given-names></name></person-group>
<article-title>Establishment and application of a reverse transcription loop-mediated isothermal amplification assay for detection of grapevine Fanleaf Virus</article-title>. <source>Mol Biol</source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>149</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5359859</identifier><datestamp>2017-04-04</datestamp><setSpec>jri</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Reprod Infertil</journal-id>
      <journal-id journal-id-type="publisher-id">JRI</journal-id>
      <journal-id journal-id-type="pmc">JRI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5359859</article-id>
      <article-id pub-id-type="pmcid">PMC5359859</article-id>
      <article-id pub-id-type="pmc-uid">5359859</article-id>
      <article-id pub-id-type="publisher-id">jri-17-205</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Unusual Presentation of Invasive Mole: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aminimoghaddam</surname>
            <given-names>Soheila</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="C1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maghsoudnia</surname>
            <given-names>Andisheh</given-names>
          </name>
          <xref ref-type="aff" rid="AFF2">
            <sup>2</sup>
          </xref>
        </contrib>
        <aff id="AFF1"><label>1-</label> Department of Obstetrics and Gynecology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran</aff>
        <aff id="AFF2"><label>2-</label> Tarbiat Modares University, Tehran, Iran</aff>
      </contrib-group>
      <author-notes>
        <corresp id="C1"><label>*</label><italic>Corresponding Author:</italic> Soheila Aminimoghadam, Gynecology Oncology Department, Firoozgar Hospital, Iran University of Medical Sciences, Valiasr Square, Tehran, Iran, <italic>E-mail:</italic><email>Dr_aminimoghaddam@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2017</year>
      </pub-date>
      <volume>18</volume>
      <issue>1</issue>
      <fpage>205</fpage>
      <lpage>209</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright© 2017, Avicenna Research Institute.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background:</title>
          <p>Invasive mole is responsible for most cases of localized gestational trophoblastic neoplasia. Gestational trophoblastic disease describes a number of gynecologic tumors that originate in trophoblastic layer including hydatidiform mole (complete or partial), invasive mole, choriocarcinoma, placental site trophoblastic tumor and epitheloid trophoblastic tumor. Invasive mole may arise from any pregnancy event although in most cases is diagnosed after molar pregnancy. Overall cure rate in low risk patients is nearly 100% and in high-risk patient 90%. In rare cases, molar tissue traverses thickness of myometrium and leads to perforation and acute abdomen and invasive mole infrequently metastasis. The best treatment option is chemotherapy (according to stage and score with single or multiple agent) and in patients that fertility is not the matter, hysterectomy can be done.</p>
        </sec>
        <sec>
          <title>Case Presentation:</title>
          <p>A 41 years old G3P2ab1 woman referred to Firouzgar hospital 2 months after curettage of molar pregnancy with vaginal bleeding and acute abdomen. In workup, HCG 224000 <italic>mIU/ml</italic> and evidence of metastasis was detected. Chemotherapy due to stage 3 and score 9 and surgery due to acute abdomen was done. This case was reported for its rarity.</p>
        </sec>
        <sec>
          <title>Discussion:</title>
          <p>This case reported about ovarian metastasis and uterine rupture with acute abdomen and involvement of omentum in metastatic invasive mole. Lack of surveillance led to extensive morbidity. Management of this patient was successful. In follow up, she was free of disease without sequel of any kind for five years now.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Complete mole</kwd>
        <kwd>Gestational trophoblastic neoplasia</kwd>
        <kwd>Haemoperitoneum</kwd>
        <kwd>Invasive mole</kwd>
        <kwd>Trophoblast</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Invasive mole is penetration of molar tissue (complete or partial mole) into myometrium or uterine vasculature (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Edematous villus and proliferative trophoblasts invade myometrium so they can be distinguished from choriocarcinoma. Pathologists mention the existence of villi in trophoblastic tissue (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Locally invasive gestational trophoblastic neoplasia develops in 15% of patients and metastatic form in 4% of patients after evacuation of complete mole and infrequently after partial mole (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>HCG level (&gt;100000 <italic>mIU/ml</italic>), excessive uterine enlargement, theca lutein cyst size ≥6 <italic>cm</italic> are considered as high risks for developing post molar tumors (high risk mole) (<xref rid="B3" ref-type="bibr">3</xref>). The most common symptom of invasive mole is persistent vaginal bleeding after evacuation of molar pregnancy (sub involution of uterus and persistent theca lutein cyst is another symptom). The rise in βHCG titer is a laboratory test for diagnosis of invasive mole in follow up of molar pregnancy. Although definite diagnosis of invasive mole is based on pathology (<xref rid="B8" ref-type="bibr">8</xref>), with βHCG or radiologic diagnosis (<xref rid="B9" ref-type="bibr">9</xref>), invasive mole is diagnosed as well.</p>
      <p>In rare cases, metastasis occurred and the most common sites were lungs (80%) (<xref rid="B4" ref-type="bibr">4</xref>), vagina (30%), pelvis (20%), liver (10%), brain (10%), bowel and kidney and spleen (&lt;5%) were other metastatic sites. However, metastasis to ovary from invasive mole is rare. About 5% to 6% of ovarian tumors come from metastasis of other organs. Metastasis can occur from direct extension of another pelvic neoplasm or by hematogenous or lymphatic spread or by transcelomic dissemination. Possibility of metastasis to ovary is extremely rare which is even much lower than that of nongestational primary ovary choriocarcinoma with an incidence of 1 in 3.7×10<sup>8</sup> (<xref rid="B5" ref-type="bibr">5</xref>). Ovarian non gestational choriocarcinoma is a major differential diagnosis. Metastasis to the omentum is very rare in invasive mole. Invasive mole is curable with chemotherapy but hysterectomy decreases the need for multiple courses of chemotherapy and in patients with heavy bleeding or sepsis for control of complication and stabilization, chemotherapy is needed (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>).</p>
      <p>Here a case with invasive mole after evacuation of molar pregnancy, presented with acute abdomen and in surgery metastasis to ovary and omentum and parametrium was detected. Management and treatment with hysterectomy and chemotherapy in this case was successful.</p>
    </sec>
    <sec>
      <title>Case Presentation</title>
      <p>A 41- year- old housewife woman, gravid 3 para 2 live child 2 (all NVD) with a last 10 years old child referred to Firouzgar hospital on 24 August 2010 with a history of a dilation and curettage and 2 months of cough. On examination, she was febrile (38°<italic>C</italic>., tachycardia, leukocytosis (16000) and uterus was tender and enlarged. Primary management of her problem was carried out in another hospital. Vaginal bleeding persisted and second curettage was done in another hospital. At that time, chest x-ray was normal. In our hospital, report of sample pathology given from first and second curettage was complete mole. After molar evacuation, the patient was not monitored for weekly determination of βHCG level. She received antibiotics (due to fever) and work up for malignant trophoblastic disease or persistent GTN was done because of high βHCG level (224000 <italic>mIU/ml</italic>) and much too enlarged uterus and involvement of the whole uterine parenchyma, which was detected on sonography (largest tumor size in uterus was 6 <italic>cm</italic>). The liver and renal function tests were also normal. Thyroid function test demonstrated hyperthyroidism. In the metastatic work up, CT scan of chest and abdomen and brain was carried out. CT scan of the abdomen and pelvis showed involvement of the left adnexa and pelvic lymphadenopathy.</p>
      <p>The patient’s chest CT scan showed multiple bilateral round pulmonary metastatic lesions that were 2 <italic>cm</italic> in diameter, illustrated in <xref ref-type="fig" rid="F1">figure 1</xref>. The liver and brain scans were both normal.</p>
      <fig id="F1" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Pulmonary Metastasis in invasive mole</p>
        </caption>
        <graphic xlink:href="JRI-17-205-g001"/>
      </fig>
      <p>Once the disease was diagnosed, the patient chemotherapy with EMA started (<xref ref-type="table" rid="T1">Table 1</xref>). Because of acute abdomen and severe abdominal pain and unstable vital signs with diagnosis of perforative peritonitis, the patient was taken up for emergency laparotomy. Due to hyperthyroid state, in induction of anesthesia, β blocker agent was administered. In this patient, subtotal hysterectomy and left salpingo oophorectomy and resection of omentum were done. In gross uterus, chorionic villus was seen. Uterine wall was perforated by tumoral invasion on the left side of posterior wall (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
      <fig id="F2" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Enlarged uterus, ovarian metastasis, perforation of uterus, and myometrium invasion</p>
        </caption>
        <graphic xlink:href="JRI-17-205-g002"/>
      </fig>
      <table-wrap id="T1" position="float">
        <label>Table 1.</label>
        <caption>
          <p>The patient was III:9 according to FIGO staging and WHO scoring (<xref rid="B7" ref-type="bibr">7</xref>)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" valign="middle" rowspan="1" colspan="1"/>
              <th align="center" valign="middle" rowspan="1" colspan="1">0</th>
              <th align="center" valign="middle" rowspan="1" colspan="1">1</th>
              <th align="center" valign="middle" rowspan="1" colspan="1">2</th>
              <th align="center" valign="middle" rowspan="1" colspan="1">4</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Age (year)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&lt;40</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">≥40</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Antecedent pregnancy</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">mole</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">abortion</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Term</td>
              <td align="center" valign="middle" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Interval months from index pregnancy</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&lt;4</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">4–7</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">7–13</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">≥13</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Pretreatment HCG serum (<italic>mIU/ml</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&lt;1000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1000–10000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">10000–100000</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">≥100000</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Largest tumor size (<italic>cm</italic>)</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&lt;3</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">3–5</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&gt;5</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Site of metastasis</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">lung</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Kidney/spleen</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">GI</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Liver/brain</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Number of metastasis</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">1–4</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">5–8</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">&gt;8</td>
            </tr>
            <tr>
              <td align="left" valign="middle" rowspan="1" colspan="1">
                <bold>Previous failed chemotherapy</bold>
              </td>
              <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">-</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Single drug</td>
              <td align="center" valign="middle" rowspan="1" colspan="1">Two or more drugs</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The bilateral uterine parameters, the external surface of the endocervical canal and the omentum were invaded by tumors. A hemorrhagic luteal cyst was seen in the right ovary. The left ovary was totally invaded by tumors. Final diagnosis was invasive mole (<xref ref-type="fig" rid="F3">Figures 3</xref> and <xref ref-type="fig" rid="F4">4</xref>).</p>
      <fig id="F3" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>Villous formation in myometrium</p>
        </caption>
        <graphic xlink:href="JRI-17-205-g003"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4.</label>
        <caption>
          <p>Villosity with necrosis in invasive mole</p>
        </caption>
        <graphic xlink:href="JRI-17-205-g004"/>
      </fig>
      <p>This patient was treated with 4 courses of chemotherapy with EMA-CO. After negative βHCG (&lt;5), she received an additional 3 courses of chemotherapy to reduce the relapse.</p>
      <p>βHCG titer was later tested monthly for1 year. When the first year of testing βHCG terminated, HCG testing on a bimonthly basis for 2 years was done. The patient was followed up to 5 years and after that the patient was free of tumor and the βHCG was negative.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Invasive mole with rupture of uterus and metastasis to ovary and omentum and manifestation of acute abdomen was rare (<xref rid="B5" ref-type="bibr">5</xref>). According to epidemiological retrospective survey, invasive mole secondary to hydatidiform mole occurred in six months after evacuation (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Local invasion in the uterus occurred in about 15% of cases (<xref rid="B12" ref-type="bibr">12</xref>). Overall invasive mole occurred in 1/15000 pregnancies (<xref rid="B12" ref-type="bibr">12</xref>).</p>
      <p>Partial and complete hydatidiform mole are distinct disease processes with characteristic cytogenetic, histologic, and clinical features (<xref rid="B8" ref-type="bibr">8</xref>).</p>
      <p>Kumar et al. in 2014 (<xref rid="B13" ref-type="bibr">13</xref>) reported a case of invasive mole presenting as acute hemoperitoneum that was similar to the present case. In invasive mole, proliferation of trophoblast in stroma was seen. Molar tissue can penetrate myometrium (<xref rid="B9" ref-type="bibr">9</xref>) and lead to uterine perforation (<xref rid="B13" ref-type="bibr">13</xref>) and cause vaginal bleeding due to erosion of uterine vessels (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>).</p>
      <p>Similar to Atala et al.’s case report in 1991(<xref rid="B14" ref-type="bibr">14</xref>), in our case, uterine perforation with acute intra peritoneal hemorrhage was seen. Due to ease of entry of molar tissue into large venous lake present in myometrium and pelvis in pregnancy or trophoblastic disease metastasis of invasive mole commonly in lungs and after lungs in vagina, cervix, broad ligament (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B19" ref-type="bibr">19</xref>), in our case metastasis to lung and ovary and omentum was seen. Although theca lutein cysts in high-risk mole due to high serum HCG level are seen normally, they regress spontaneously within 2–4 months (<xref rid="B17" ref-type="bibr">17</xref>). Non gestational choriocarcinoma of ovary is differential diagnosis (<xref rid="B5" ref-type="bibr">5</xref>) but due to occurrence of metastasis to ovary in our case after molar pregnancy, this differential diagnosis was not a matter.</p>
      <p>As in a report of invasive mole in fallopian tube (<xref rid="B21" ref-type="bibr">21</xref>), the first misdiagnosis of our case in another hospital, repeat curettage was done, although the first diagnosis could be persistent GTN.</p>
      <p>In another case report (<xref rid="B15" ref-type="bibr">15</xref>) from Bruner, similarity with our case was seen.</p>
      <p>Invasive mole is highly sensitive to chemotherapy (<xref rid="B11" ref-type="bibr">11</xref>). Combination chemotherapy should be continued in such cases as far as toxicity permits until the patient achieves 3 consecutive normal HCG levels (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B18" ref-type="bibr">18</xref>). As normal HCG levels are attained, 3 additional courses of chemotherapy are administered to reduce the risk of relapse. In low risk patients, one or two courses are adequate (<xref rid="B19" ref-type="bibr">19</xref>).</p>
      <p>In our case, 3 courses of chemotherapy after normalization of βHCG were done.</p>
      <p>Hysterectomy may be required in invasive mole in order to control vaginal bleeding and in unstable patient or in sepsis (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Hysterectomy is a reasonable option for patients who do not wish to preserve their fertility, but it does not prevent metastasis (<xref rid="B20" ref-type="bibr">20</xref>). Furthermore, in patients with extensive uterine tumor, hysterectomy may substantially reduce the trophoblastic tumor burden (<xref rid="B20" ref-type="bibr">20</xref>) and thereby limit the need for multiple courses of chemotherapy.</p>
      <p>In our case, due to unstable and uterine rupture, hysterectomy was done but the need for chemotherapy courses was not removed and after several courses of chemotherapy with EMA-CO courses, it was cured.</p>
      <p>However, final diagnosis of our patient was invasive mole with metastasis to ovary and omentum and lung (stage 3) and uterine rupture.</p>
      <p>The patient responded to the treatment well and in follow up this patient was still fine for 5 years after definite care for metastasis invasive mole with surgery and chemotherapy.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>Conclusion</title>
      <p>An invasive mole in uterus with ovarian and omental metastasis was diagnosed and the patient was successfully treated by hysterectomy and chemotherapy and she was fine for 5 years in follow up.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Conflict of Interest</bold>
        </p>
        <p>Authors declare no conflict of interest</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>KY</given-names></name><name><surname>Chan</surname><given-names>KK</given-names></name><name><surname>Tam</surname><given-names>KF</given-names></name><name><surname>Ngan</surname><given-names>HY.</given-names></name></person-group>
<article-title>An update on gestational trophoblastic disease</article-title>. <source>Obstet Gynaecol Reprod Med</source>. <year>2012</year>;<volume>22</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>15</lpage>.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seckl</surname><given-names>MJ</given-names></name><name><surname>Fisher</surname><given-names>RA</given-names></name><name><surname>Salerno</surname><given-names>G</given-names></name><name><surname>Rees</surname><given-names>H</given-names></name><name><surname>Paradinas</surname><given-names>FJ</given-names></name><name><surname>Foskett</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Choriocarcinoma and partial hydatidiform moles</article-title>. <source>Lancet</source>. <year>2000</year>;<volume>356</volume>(<issue>9223</issue>):<fpage>36</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10892763</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uberti</surname><given-names>EM</given-names></name><name><surname>Fajardo Mdo</surname><given-names>C</given-names></name><name><surname>da Cunha</surname><given-names>AG</given-names></name><name><surname>Rosa</surname><given-names>MW</given-names></name><name><surname>Ayub</surname><given-names>AC</given-names></name><name><surname>Graudenz Mda</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment</article-title>. <source>Gynecol Oncol</source>. <year>2009</year>;<volume>114</volume>(<issue>2</issue>): <fpage>299</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">19427681</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darby</surname><given-names>S</given-names></name><name><surname>Jolley</surname><given-names>I</given-names></name><name><surname>Pennington</surname><given-names>S</given-names></name><name><surname>Hancock</surname><given-names>BW.</given-names></name></person-group>
<article-title>Does chest CT matter in the staging of GTN?</article-title>
<source>Gynecol Oncol</source>. <year>2009</year>;<volume>112</volume>(<issue>1</issue>):<fpage>155</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">19019416</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>E.</given-names></name></person-group>
<article-title>Solid tumor section</article-title>. <source>Atlas Genet Cytogenet Oncol Haematol</source>. <year>2009</year>;<volume>13</volume>(<issue>9</issue>):<fpage>683</fpage>–<lpage>5</lpage>.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>KM</given-names></name><name><surname>Soper</surname><given-names>JT.</given-names></name></person-group>
<article-title>The role of surgery in the management of gestational trophoblastic neoplasia</article-title>. <source>Obstet Gynecol Surv</source>. <year>2013</year>;<volume>68</volume>(<issue>7</issue>):<fpage>533</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">23803756</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Helw</surname><given-names>LM</given-names></name><name><surname>Coleman</surname><given-names>RE</given-names></name><name><surname>Everard</surname><given-names>JE</given-names></name><name><surname>Tidy</surname><given-names>JA</given-names></name><name><surname>Horsman</surname><given-names>JM</given-names></name><name><surname>Elkhenini</surname><given-names>HF</given-names></name><etal/></person-group>
<article-title>Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia</article-title>. <source>Gynecol Oncol</source>. <year>2009</year>;<volume>113</volume>(<issue>3</issue>):<fpage>306</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">19269684</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>M.</given-names></name></person-group>
<article-title>The pathology of gestational trophoblastic disease: recent advances</article-title>. <source>Pathology</source>. <year>2007</year>;<volume>39</volume>(<issue>1</issue>):<fpage>88</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">17365825</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>CL</given-names></name><name><surname>Angtuaco</surname><given-names>TL</given-names></name><name><surname>Shah</surname><given-names>HR</given-names></name><name><surname>Parmley</surname><given-names>TH.</given-names></name></person-group>
<article-title>Gestational trophoblastic disease: a spectrum of radiologic diagnosis</article-title>. <source>Radiographics</source>. <year>1996</year>;<volume>16</volume>(<issue>6</issue>):<fpage>1371</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">8946542</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Helw</surname><given-names>LM</given-names></name><name><surname>Hancock</surname><given-names>BW.</given-names></name></person-group>
<article-title>Treatment of metastatic gestational trophoblastic neoplasia</article-title>. <source>Lancet Oncol</source>. <year>2007</year>;<volume>8</volume>(<issue>8</issue>):<fpage>715</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">17679081</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tidy</surname><given-names>J</given-names></name><name><surname>Hancock</surname><given-names>BW.</given-names></name></person-group>
<source>The Management of Gestational Trophoblastic Disease</source>. <publisher-loc>UK</publisher-loc>: <publisher-name>Royal College of Obstetricians and Gynaecologists</publisher-name>; <year>2010</year>
<month>2</month>
<fpage>11</fpage> p. RCOG Green-top Guideline No.: 38.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balagopal</surname><given-names>P</given-names></name><name><surname>Pandey</surname><given-names>M</given-names></name><name><surname>Chandramohan</surname><given-names>K</given-names></name><name><surname>Somanathan</surname><given-names>T</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group>
<article-title>Unusual presentation of choriocarcinoma</article-title>. <source>World J Surg Oncol</source>. <year>2003</year>;<volume>1</volume> (<issue>1</issue>):<fpage>4</fpage>.<pub-id pub-id-type="pmid">12773221</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Vimala</surname><given-names>N</given-names></name><name><surname>Mittal</surname><given-names>S.</given-names></name></person-group>
<article-title>Invasive Mole Presenting as Acute Haemoperitoneum</article-title>. <source>JK Sci</source>. <year>2004</year>; <volume>6</volume>(<issue>3</issue>):<fpage>159</fpage>–<lpage>60</lpage>.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atala</surname><given-names>C</given-names></name><name><surname>Riedemann</surname><given-names>R</given-names></name><name><surname>Biotti</surname><given-names>M</given-names></name><name><surname>Ramírez</surname><given-names>F</given-names></name><name><surname>Paublo</surname><given-names>M.</given-names></name></person-group>
<article-title>[Invasive mole with uterine rupture]</article-title>. <source>Rev Chil Obstet Ginecol</source>. <year>1992</year>;<volume>57</volume>(<issue>5</issue>):<fpage>356</fpage>–<lpage>8</lpage>. Spanish.<pub-id pub-id-type="pmid">1342467</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruner</surname><given-names>DI</given-names></name><name><surname>Pritchard</surname><given-names>AM</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name></person-group>
<article-title>Uterine rupture due to invasive metastatic gestational trophoblastic neoplasm</article-title>. <source>West J Emerg Med</source>. <year>2013</year>;<volume>14</volume>(<issue>5</issue>):<fpage>444</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">24106538</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>M</given-names></name><name><surname>Fushida</surname><given-names>K</given-names></name><name><surname>Pulcineli Vieira Francisco</surname><given-names>R</given-names></name><name><surname>Schultz</surname><given-names>R</given-names></name><name><surname>Zugaib</surname><given-names>M.</given-names></name></person-group>
<article-title>Sonographic appearance of an advanced invasive mole and associated metastatic thrombus in the inferior vena cava</article-title>. <source>J Clin Ultrasound</source>. <year>2013</year>;<volume>41</volume>(<issue>2</issue>):<fpage>113</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">22238139</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngan</surname><given-names>HY</given-names></name><name><surname>Kohorn</surname><given-names>EI</given-names></name><name><surname>Cole</surname><given-names>LA</given-names></name><name><surname>Kurman</surname><given-names>RJ</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Lurain</surname><given-names>JR</given-names></name><etal/></person-group>
<article-title>Trophoblastic disease</article-title>. <source>Int J Gynecol Obstet</source>. <year>2012</year>;<volume>119</volume>
<issue>Suppl 2</issue>:<fpage>S130</fpage>–<lpage>6</lpage>.</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname><given-names>RS</given-names></name><name><surname>Goldstein</surname><given-names>DP.</given-names></name></person-group>
<article-title>Current advances in the management of gestational trophoblastic disease</article-title>. <source>Gynecol Oncol</source>. <year>2013</year>;<volume>128</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">22846466</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lybol</surname><given-names>C</given-names></name><name><surname>Sweep</surname><given-names>FC</given-names></name><name><surname>Harvey</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>H</given-names></name><name><surname>Short</surname><given-names>D</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia</article-title>. <source>Gynecol Oncol</source>. <year>2012</year>;<volume>125</volume>(<issue>3</issue>): <fpage>576</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">22410329</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>An</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name></person-group>
<article-title>Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia</article-title>. <source>Int J Gynecol Cancer</source>. <year>2012</year>;<volume>22</volume>(<issue>3</issue>):<fpage>509</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">22315093</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HY</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name></person-group>
<article-title>Unilateral hydronephrosis caused by invasive mole: a case report</article-title>. <source>Int J Clin Exp Med</source>. <year>2013</year>;<volume>6</volume>(<issue>10</issue>):<fpage>1010</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">24260613</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360009</identifier><datestamp>2017-04-04</datestamp><setSpec>frontmicrobio</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Microbiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-302X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360009</article-id>
      <article-id pub-id-type="pmcid">PMC5360009</article-id>
      <article-id pub-id-type="pmc-uid">5360009</article-id>
      <article-id pub-id-type="doi">10.3389/fmicb.2017.00471</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Comparative Genomic Analysis Reveals Organization, Function and Evolution of <italic>ars</italic> Genes in <italic>Pantoea</italic> spp.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Liying</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/389646/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Jin</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/389655/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jing</surname>
            <given-names>Chuanyong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/93236/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences</institution>
        <country>Beijing, China</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>College of Resources and Environment, University of Chinese Academy of Sciences</institution>
        <country>Beijing, China</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>Department of Municipal and Environmental Engineering, School of Civil Engineering, Beijing Jiaotong University</institution>
        <country>Beijing, China</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: <italic>Manuel Espinosa, Consejo Superior de Investigaciones Científicas (CSIC), Spain</italic></p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: <italic>Yunyoung Kwak, Kyungpook National University, South Korea; Lukasz Drewniak, University of Warsaw, Poland; Ji-Hoon Lee, Chonbuk National University, South Korea</italic></p>
        </fn>
        <corresp id="fn001">*Correspondence: <italic>Chuanyong Jing, <email xlink:type="simple">cyjing@rcees.ac.cn</email></italic></corresp>
        <fn fn-type="other" id="fn002">
          <p>This article was submitted to Evolutionary and Genomic Microbiology, a section of the journal Frontiers in Microbiology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>471</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Wang, Wang and Jing.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Wang, Wang and Jing</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Numerous genes are involved in various strategies to resist toxic arsenic (As). However, the As resistance strategy in genus <italic>Pantoea</italic> is poorly understood. In this study, a comparative genome analysis of 23 <italic>Pantoea</italic> genomes was conducted. Two vertical genetic <italic>arsC</italic>-like genes without any contribution to As resistance were found to exist in the 23 <italic>Pantoea</italic> strains. Besides the two <italic>arsC</italic>-like genes, As resistance gene clusters <italic>arsRBC</italic> or <italic>arsRBCH</italic> were found in 15 <italic>Pantoea</italic> genomes. These <italic>ars</italic> clusters were found to be acquired by horizontal gene transfer (HGT) from sources related to <italic>Franconibacter helveticus, Serratia marcescens</italic>, and <italic>Citrobacter freundii</italic>. During the history of evolution, the <italic>ars</italic> clusters were acquired more than once in some species, and were lost in some strains, producing strains without As resistance capability. This study revealed the organization, distribution and the complex evolutionary history of As resistance genes in <italic>Pantoea</italic> spp.. The insights gained in this study improved our understanding on the As resistance strategy of <italic>Pantoea</italic> spp. and its roles in the biogeochemical cycling of As.</p>
      </abstract>
      <kwd-group>
        <kwd>comparative genomic</kwd>
        <kwd>arsenic</kwd>
        <kwd><italic>Pantoea</italic> spp.</kwd>
        <kwd>arsenic resistance</kwd>
        <kwd><italic>ars</italic> genes</kwd>
      </kwd-group>
      <counts>
        <fig-count count="7"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="43"/>
        <page-count count="12"/>
        <word-count count="0"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Arsenic (As), one of the earliest known toxic elements, occurs naturally worldwide (<xref rid="B31" ref-type="bibr">Smith et al., 2002</xref>). To adapt to habitats with elevated As, microbes have evolved dynamic resistance mechanisms. The most ubiquitous and important strategy of As resistance is to reduce As(V) to As(III) and extrude it using <italic>ars</italic> operons with various genomic configurations in specific bacterial strains (<xref rid="B21" ref-type="bibr">Páezespino et al., 2009</xref>). The core genes of <italic>ars</italic> systems, however, are <italic>arsR</italic> (encoding the transcriptional repressor ArsR), <italic>arsB</italic> (encoding the arsenite efflux pump ArsB) and <italic>arsC</italic> (encoding arsenate reductase ArsC) (<xref rid="B40" ref-type="bibr">Xu et al., 1998</xref>). Besides this detoxification mechanism using <italic>ars</italic> systems, some strains possess the mechanism of As methylation-demethylation, changing inorganic As into organic forms using a distinct gene <italic>arsM</italic> (<xref rid="B22" ref-type="bibr">Qin et al., 2006</xref>; <xref rid="B42" ref-type="bibr">Zhao et al., 2015</xref>). Some strains are able to oxidize As(III) to As(V), which involve membrane-associated proteins, AoxAB (<xref rid="B13" ref-type="bibr">Levin and Tal, 2003</xref>; <xref rid="B9" ref-type="bibr">Ghosh et al., 2014</xref>). Some strains are able to reduce As(V) to As(III) with ArrAB as part of their respiratory processes transferring electrons to As and producing the energy for strains (<xref rid="B29" ref-type="bibr">Saltikov and Newman, 2003</xref>). The reported genes related to the strategy of As resistance are listed in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Genes involved in arsenic resistance and transformation.</p>
        </caption>
        <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">Function</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
              <th valign="top" align="left" rowspan="1" colspan="1">Protein</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>Arsenate reduction</bold>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsR</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Transcriptional regulator ArsR</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsB</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">As(III) efflux pump protein</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsC</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">As(V) reductase ArsC</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsH</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Putative flavoprotein</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsA</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">As(III) active ATPase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsD</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">As metallochaperone</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsO</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Monooxygenase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsT</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Putative thioredoxin system</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsX</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Unknown function</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsN</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Acetyltransferases</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>Respiratory reduction</bold>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arrA</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Large subunit of respiratory As(V) reductase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arrB</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Small subunit of respiratory As(V) reductase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>Arsenite oxidation</bold>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioA</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Large subunit of As oxidase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioB</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Small subunit of As oxidase</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioD</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Biosynthesis protein A with molybdenum cofactor</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioX</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Phosphonate-binding periplasmic protein</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioS</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Histidine kinase for signal transduction</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>aioC</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">Cytochrome c</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>Arsenic methylation</bold>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <italic>arsM</italic>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">As(III) S-adenosylmethyltransferase</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>In traditional molecular biology research, As resistance traits are revealed primarily based on the cultivation of a specific strain, and it is impossible to study the As strategy of all strains in a genus. Nevertheless, understanding of such traits in all strains of a genus is sometime more desirable. Gaining this knowledge is no longer a challenge with the explosive development of high-throughput sequencing technology. The genomic sequence of a strain contains nearly all of the genetic information. Therefore, fundamental knowledge such as the phylogenetic, the genetic traits of As resistance and its evolutionary history can be obtained through comparative genomic analysis (<xref rid="B1" ref-type="bibr">Arsène-Ploetze et al., 2010</xref>; <xref rid="B5" ref-type="bibr">Colston et al., 2014</xref>). So here we use genomic information of <italic>Pantoea</italic> spp. and compared these genomes to explore and predict the strategy of As resistance and their evolutionary patterns in genus <italic>Pantoea</italic> as an example.</p>
      <p><italic>Pantoea</italic> is a genus of Gram-negative, facultative anaerobic bacteria. This genus belongs to gamma <italic>Proteobacteria</italic>, family <italic>Gammaproteobacteria</italic>, and was recently separated from the genus <italic>Enterobacter</italic> (<xref rid="B7" ref-type="bibr">Gavini et al., 1989</xref>). Currently, the genus contains 26 species<sup><xref ref-type="fn" rid="fn01">1</xref></sup>. Members of this genus are found in various environmental matrices (<xref rid="B17" ref-type="bibr">Meng et al., 1995</xref>; <xref rid="B41" ref-type="bibr">Zhang and Birch, 1997</xref>; <xref rid="B23" ref-type="bibr">Rezzonico et al., 2009</xref>). In 2013, the strain <italic>Pantoea</italic> sp. IMH was an isolate that reported firstly as the strain having the As resistance capability within <italic>Pantoea</italic> species (<xref rid="B38" ref-type="bibr">Wu et al., 2013</xref>). Further, we sequenced the genome of <italic>Pantoea</italic> sp. IMH and found two <italic>ars</italic> clusters (<italic>arsR1B1C1H1</italic> and <italic>arsR2B2C2H2</italic>) co-contributing to its As resistance (<xref rid="B35" ref-type="bibr">Tian and Jing, 2014</xref>; <xref rid="B37" ref-type="bibr">Wang et al., 2016</xref>). However, the evolutionary history and genetic traits of As resistance in genus <italic>Pantoea</italic> are not fully understood.</p>
      <p>Herein, we present the first study of the genetic traits of As resistance in <italic>Pantoea</italic> spp., as well as their evolutionary history. Two vertically transmitted <italic>arsC</italic>-like genes without any contribution to As resistance were found to exist in the 23 <italic>Pantoea</italic> strains. Besides these two <italic>arsC</italic>-like genes, As resistance gene clusters <italic>arsRBC</italic> or <italic>arsRBCH</italic> were found in 15 <italic>Pantoea</italic> genomes. These <italic>ars</italic> clusters were acquired by horizontal gene transfer (HGT) from sources related to <italic>Franconibacter helveticus, Serratia marcescens</italic>, and <italic>Citrobacter freundii</italic>. The insights gained in this study improve our understanding on the complex evolutionary history of As resistance genes and their roles in the biogeochemical cycling of As.</p>
    </sec>
    <sec sec-type="materials|methods" id="s1">
      <title>Materials and Methods</title>
      <sec>
        <title>Phylogenetic Analysis</title>
        <p>Phylogenetic trees of <italic>Pantoea</italic> species were constructed based on 100 single-copy core proteins shared by 23 <italic>Pantoea</italic> genomes and the genome of <italic>Tatumella</italic> sp. NML 06-3099 according to the following three methods: maximum likelihood (ML), neighbor joining (NJ), and Bayesian inference (BI). ML and NJ trees were computed by applying models with 1,000 bootstrap replicates and uniform rates in MEGA5 (<xref rid="B33" ref-type="bibr">Tamura, 2011</xref>). Multiple alignments of amino acid sequences were carried out by ClustalW, and the CONSEL program was used to select the best model of the trees (<xref rid="B30" ref-type="bibr">Shimodaira and Hasegawa, 2001</xref>; <xref rid="B34" ref-type="bibr">Thompson et al., 2002</xref>). The BI tree was generated using the MrBayes package with mixed models (<xref rid="B27" ref-type="bibr">Ronquist et al., 2012</xref>). The NJ tree of concatenated <italic>arsRBC</italic> homologs was generated according to the same method described above. MEGA5 or FigTree v.1.3.1<sup><xref ref-type="fn" rid="fn02">2</xref></sup> was used to illustrate the constructed trees.</p>
      </sec>
      <sec>
        <title>Average Nucleotide Identity (ANI)</title>
        <p>Assembled contigs were reconstituted from the RAST-generated GenBank files for 23 genomes by using the seqret function of the EMBOSS package (<xref rid="B24" ref-type="bibr">Rice et al., 2000</xref>). These 23 genomes were treated in the same manner to ensure that any biases were consistent across the entire dataset. JSpecies1.2.1 was used to analyze these contig sets for the ANI and tetramer usage patterns, using default parameters (<xref rid="B26" ref-type="bibr">Richter and Rosselló-Móra, 2009</xref>).</p>
      </sec>
      <sec>
        <title>Comparative Genomics</title>
        <p>All of the orthologous pairs between <italic>Pantoea</italic> test genomes were identified by Pan Genome Analysis Pipeline (PGAP) (<xref rid="B43" ref-type="bibr">Zhao et al., 2012</xref>). The common dataset of shared genes among test strains was defined as their core genome. The total set of genes with test genomes was defined as the pan genome. The set of genes in each strain not shared with other strains was defined as the unique genes. The details of the strains used are listed in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
      </sec>
      <sec>
        <title>Construction of the Recombinant Plasmids and <italic>Escherichia coli</italic> Strains</title>
        <p>A 3.86 kb <italic>Bam</italic>HI-<italic>Xba</italic>I DNA fragment containing the complete <italic>ars1</italic> cluster of <italic>Pantoea stewartii</italic> S301 (promoter region, 342 bp upstream of the start codon ATG of <italic>arsR</italic>, the contiguous four genes <italic>arsR1B1C1H1</italic> and 281 bp upstream of the start codon ATG of <italic>arsH</italic>) was PCR amplified with primers Ars1-F and Ars1-R (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>). A 3.43 kb <italic>Bam</italic>HI-<italic>Xba</italic>I DNA fragment containing the complete <italic>ars2</italic> gene cluster of <italic>P. agglomerans</italic> Tx10 (a 280 bp region downstream of the stop codon TAA of <italic>arsC2</italic> and the contiguous ten genes <italic>arsR2B2C2H2</italic> and 328 bp downstream of the stop codon TAA of <italic>arsH2</italic>) was PCR amplified with primers Ars2-F and Ars2-R (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>).</p>
        <p>An 860 bp <italic>Bam</italic>HI-<italic>Xba</italic>I DNA fragment containing the complete <italic>arsC1-</italic>like gene of <italic>P. stewartii</italic> DC283 (promoter region, 221 bp upstream of the start codon ATG of <italic>arsC1</italic>-like gene, <italic>arsC1</italic>-like and 209 bp downstream of the stop codon TTA of <italic>arsC1</italic>-like gene) was PCR amplified with primers ArsC1-like-F and ArsC1-like-R (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>). A 942 bp <italic>Bam</italic>HI-<italic>Xba</italic>I DNA fragment containing the complete <italic>arsC2</italic>-like gene of <italic>P. stewartii</italic> DC283 (promoter region, 265 bp upstream of the start codon ATG of <italic>arsC2</italic>-like gene, <italic>arsC2</italic>-like and 236 bp downstream of the stop codon TTA of <italic>arsC2</italic>-like gene) was PCR amplified with primers ArsC2-like-F and ArsC2-like-R (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S2</xref>).</p>
        <p>The above PCR products were ligated to the <italic>Bam</italic>HI-<italic>Xba</italic>I site of plasmid pUC18, yielding plasmids pUC18-ars1, pUC18-ars2, pUC18-arsC1-like, and pUC18-arsC2-like. Then the plasmids were transferred to <italic>E. coli</italic> AW3110, yielding the recombinant <italic>E. coli</italic> AW3110-ars1, <italic>E. coli</italic> AW3110-ars2, <italic>E. coli</italic> AW3110-arsC1-like and <italic>E. coli</italic> AW3110-arsC2-like strains, respectively.</p>
      </sec>
      <sec>
        <title>Strains, Plasmids, and Culture Conditions</title>
        <p>The strains and plasmids used in this work are summarized in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>. <italic>E. coli</italic> and <italic>Pantoea</italic> strains were grown in LB medium (per liter contains: 10 g tryptone, 5 g yeast, and 10 g NaCl) or LB plates (LB medium with w/v 1.5% agar) at 30°C. When appropriate, antibiotics were added at the following concentration: 100 μg/mL ampicillin. Resistance to As species was tested by plating serial dilutions of cultures of each strain onto agar plates containing filtered sodium arsenate (Na<sub>3</sub>AsO<sub>4</sub>).</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Genomic Features</title>
        <p>To date, 26 species have been reported in genus <italic>Pantoea</italic> and strains of nine species (<italic>P. ananatis, P. agglomerans, P. stewartii, P. vagans, P. dispersa, P. septica, P. rodasii, P. rwandensis</italic>, and <italic>P. anthophila</italic>) have been sequenced<sup><xref ref-type="fn" rid="fn03">3</xref></sup>. To study the genetic traits and phylogenetic history of As resistance in genus <italic>Pantoea</italic>, 23 strains were chosen, containing two to three standard strains sequenced in each species and five unidentified strains (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>). A summary of features for these 23 sequenced genomes is listed in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>. The G+C contents of the 23 genomes range from 53.4 to 59.1. These genomes vary in size by approximately 1.6 mega-bases in average (ranging from 4.02 to 5.68 Mb) with coding sequence (CDS) numbers ranging from 3580 to 8894, indicating a substantial strain-to-strain variation.</p>
      </sec>
      <sec>
        <title>Strain-Specific and Core Genes</title>
        <p>To reveal the genomic features specific to each strain, we identified all orthologous pairs between the tested <italic>Pantoea</italic> genomes using PGAP. Our analysis of the total of 23 genomes revealed that a pan genome contains 48,207 putative protein-coding genes in the genus <italic>Pantoea</italic>. Out of these 48,207 genes, 10,896 (22.6%) were represented in the specific genomes of <italic>Pantoea</italic> spp., suggesting some frequency of horizontal gene acquisition from other taxa. The number of specific genes ranges from 131 to 1,285, with the smallest encoded by <italic>P. vagans</italic> C9-1 and the largest identified in <italic>P. agglomerans</italic> Tx10 (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>). The cluster of orthologous groups (COG) assignments reveal that a higher proportion of strain-specific genes in most of the strains can be assigned to the K (transcription), L (DNA replication), and M (cell wall/membrane/envelope biogenesis) categories (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S2</xref>).</p>
        <p>In contrast to the pan-genome, the core genome of <italic>Pantoea</italic> spp. contains 1,994 putative protein-coding genes, which represents 38.8–56.1% of the repertoire of protein coding genes of each strain, illustrating a small degree of genomic diversity in this group of bacteria (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>). The genomic analysis agrees with the fact that <italic>Pantoea</italic> strains are consistent in morphological and physiological appearance. Furthermore, the COG assignment results show that these core genes are in different functional categories (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S3</xref>). In fact, the percentage of genes in each functional category remains rather similar (with an average divergence of 8.6%). This is consistent with an earlier report that larger prokaryotic genomes preferentially accumulate genes directly or indirectly involved in metabolism (<xref rid="B12" ref-type="bibr">Konstantinidis and Tiedje, 2004</xref>). These genes support a broader metabolic diversity, which, in turn, would improve the ecological success of <italic>Pantoea</italic> under more diverse environmental conditions.</p>
      </sec>
      <sec>
        <title>Phylogenic Analyses</title>
        <p>To associate the distribution of As resistance genes in <italic>Pantoea</italic> spp. with their phylogenetic affiliation, we constructed the phylogeny tree of the 23 <italic>Pantoea</italic> spp. based on 16S rRNA gene sequences using NJ methods rooted by <italic>Tatumella</italic> sp. NML 06-3099 (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S9</xref>). This phylogenetic tree showed that the strains in the same species reported were grouped together except strain 848PVAG. At the same time, we constructed the phylogeny of the 23 genomes based on concatenation of the 100 core genes that are present as single copies in a genome using the ML method and rooted by <italic>Tatumella</italic> sp. NML 06-3099 (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). The phylogenetic trees, inferred using BI and NJ methods (Supplementary Figures <xref ref-type="supplementary-material" rid="SM1">S4, S5</xref>), were congruent with the ML phylogenetic tree. These trees show that some strains in different species reported were grouped together, such as, FF5 and 848PVAG, ZBG6, GB1, MP2, and Tx10. The phylogeny based on the 100 core genes that are present as single copies in a genome showed a good correlation with that of 16S rRNA gene sequences, except for three strains ZBG6, GB1, and 299R. These results suggested that there were mistakes in the classification of <italic>Pantoea</italic> spp.. Further identification of the phylogenetic status of these strains was carried out as follows.</p>
        <fig id="F1" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p><bold>Phylogenetic relationship of 23 <italic>Pantoea</italic> strains.</bold> Maximum likelihood (ML) phylogenetic tree was constructed based on 100 single-copy core proteins shared by 23 genomes and an out-group <italic>Tatumella</italic> sp. NML 06-3099.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g001"/>
        </fig>
        <p>The information gained from the phylogenetic analysis provides an important depiction of the evolutionary relationship between different strains, but it does not translate directly into the overall similarity of the genomes, which is usually determined through the DNA-DNA hybridization (DDH). Herein, ANI approach was used to overcome the difficulty of conventional laboratory-based DDH in evaluating the genomic similarity of bacteria (<xref rid="B26" ref-type="bibr">Richter and Rosselló-Móra, 2009</xref>). The ANI results justified the conclusion of phylogenetic analysis. As shown in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, 23 strains were classified into 12 species based on their ANI ≥ 96%. For examples, LMG2665 and LMG20103 resulted in a higher ANI (99.3%), suggesting that they belong to the same species (<italic>P. ananatis</italic>). Strain 9140 and C91 resulted in a higher ANI (98.6%), suggesting that they belong to the same species (<italic>P. vagans</italic>). It was noteworthy that <italic>Panotea</italic> sp. IMH represented a novel species for the ANI ≥ 96% between IMH and other strains.</p>
        <fig id="F2" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p><bold>Average Nucleotide Identity (ANI) (%) based on whole genome alignments.</bold> ANI values are colored red according to historical species cutoff value (≥96%). Strains in one species are marked out the same color.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g002"/>
        </fig>
        <p>Strains MP2, Tx10, GB1, and ZBG6 which grouped together were identified as strains of <italic>P. agglomerans</italic>. Meanwhile, this result confirms the synonymy of <italic>P.</italic> FF5 and 848 PVAG (<italic>P. vagans</italic>), and suggests that 299R is not a member of species <italic>P. agglomerans.</italic> In agreement with the phylogenetic analysis, our ANI results indicate that there are mistakes in the classification of strain 299R, 848PVAG, GB1, and ZBG6. This mis-classification was also reported in other genus and generally corrected with the advance in technology (<xref rid="B11" ref-type="bibr">Goris et al., 2007</xref>). To associate the distribution of As-related genes with their phylogenetic affiliation, in this article below we renamed strain 299R to <italic>P. reagglomerans</italic> 299R (<italic>P. agglomerans</italic> 299R), 848PVAG to <italic>P. septica</italic> 848PVAG (<italic>P. vagans</italic> 848PVAG), GB1 to <italic>P. agglomerans</italic> GB1 (<italic>P. ananatis</italic> GB1), and ZBG6 to <italic>P. agglomerans</italic> ZBG6 (<italic>P. vagans</italic> ZBG6).</p>
      </sec>
      <sec>
        <title>Distribution and Organization of As-Related Genes in <italic>Pantoea</italic> Genomes</title>
        <p>Only As resistance genes (<italic>ars</italic> genes) including <italic>arsR, arsB, arsC</italic>, and <italic>arsH</italic> were detected in most <italic>Pantoea</italic> genomes (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S4</xref> and <bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). The <italic>arsC</italic> gene encoding arsenate reductase is involved in the transformation of As(V) to As(III), which is then excreted by the As efflux pump ArsB encoded by the <italic>arsB</italic> gene. Nevertheless, <italic>aio, arr</italic>, and <italic>arsM</italic> were not found in <italic>Pantoea</italic> genomes, suggesting that cytoplasmic As(V) reduction and As(III) extrusion are the As resistance strategy used in genus <italic>Pantoea</italic> spp.. This mechanism benefits the bacteria itself, though it enhances the toxicity to the surrounding environment.</p>
        <fig id="F3" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p><bold>Distribution and organization of <italic>ars</italic> genes and <italic>arsC</italic>-like genes in 23 <italic>Pantoea</italic> strains.</bold>
<italic>arsC, arsB, arsR, arsH</italic>, and <italic>arsC</italic>-like genes are marked with different colors. There are only <italic>arsC</italic>-like genes in Sub-group I, <italic>arsR1B1C1</italic> or <italic>arsR1B1C1H1</italic> in Sub-group II, <italic>arsR2B2C2</italic> or <italic>arsR2B2C2H2</italic> in Sub-group III, and both <italic>arsR1B1C1H1</italic> and <italic>arsR2B2C2H2</italic> in Sub-group IV.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g003"/>
        </fig>
        <p>The <italic>ars</italic> genes in a genome are prone to group together as <italic>ars</italic> clusters (<italic>arsRBC</italic> and <italic>arsRBCH</italic>). Although comparison of the COG assignments of 23 genomes revealed that the DNA sequences between homologous genes within these <italic>ars</italic> clusters are conserved, some variations exist in DNA sequences, which can be divided into two sub-groups (<italic>ars1</italic> and <italic>ars2</italic>) (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Unlike the two <italic>ars</italic> clusters in <italic>Pantoea</italic> sp. IMH, only one <italic>ars</italic> cluster, either <italic>ars1</italic> or <italic>ars2</italic>, was observed in other strains (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S2</xref> and <bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). The <italic>ars</italic> gene clusters generally exhibited more than 80% identity within each sub-group and about 54% identity between two sub-groups. Actually, the <italic>ars</italic> clusters were not detected in eight strains including Sc1, BL1, 9140, DC283, MP7, C91, ND04, and FF5. Moreover, two <italic>arsC</italic>-like genes with only 25% homology (<italic>arsC1</italic>-like and <italic>arsC2</italic>-like) were found in the 23 genomes. Based on the different <italic>ars</italic> genes distributions, the 23 strains were categorized into four sub-groups and discussed as follows. The overall distribution and organization of As resistance genes in 23 <italic>Pantoea</italic> strains are summarized in <bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>.</p>
      </sec>
      <sec>
        <title>Evolution and the Origin of <italic>ars</italic> Clusters</title>
        <p>The distribution and organization of <italic>ars</italic> genes in <italic>Pantoea</italic> raise a question as to their evolution. The deviant G+C content is used as a detect method of HGT (<xref rid="B19" ref-type="bibr">Ochman et al., 2000</xref>; <xref rid="B39" ref-type="bibr">Xie et al., 2014</xref>). We detected the G+C content of <italic>ars</italic> clusters and their corresponding genomes. The results showed that the G+C contents of the <italic>ars1</italic> clusters are higher than those of the genomes in <italic>Pantoea</italic> strains (56.3–57.8 vs. 53.4–54.7) except <italic>P. septica</italic> 848PVAG (<italic>P. vagans</italic> 848PVAG) and <italic>P. dispersa</italic> EGD-AAK13; the G+C contents of the <italic>ars2</italic> clusters are lower than those of the genomes in <italic>Pantoea</italic> strains (50.6–52.4 vs. 53.7–58.8), showing variation of G+C content between clusters and the corresponding genomes. These results indicated that these <italic>ars</italic> clusters may be acquired in <italic>Pantoea</italic> strains by HGT (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S4</xref> and Figure <xref ref-type="supplementary-material" rid="SM1">S6</xref>). To further elucidate the evolution of the <italic>ars</italic> gene clusters, we compared the chromosomal regions flanking the <italic>ars</italic> gene clusters among the 23 <italic>Pantoea</italic> strains and found that the genes in the upstream and downstream regions were conserved among strains of the same species (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>). For example, the DNA polymerase V subunit UmuC gene and adenosine deaminase gene in the upstream and Cd(II)/Pb(II)-responsive transcriptional regulator gene and ATPase P gene in the downstream are conserved for the <italic>ars</italic> clusters in the strain Tx10, MP2, ZBG6, and GB1 within the species <italic>P. agglomerans</italic> strains. The same species strains share the same insertion sites, whereas the different species’ strains result in different insertion sites, suggesting that <italic>ars</italic> clusters may be acquired more than once.</p>
        <fig id="F4" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p><bold>Synteny of the chromosomal regions flanking the <italic>ars</italic> gene cluster among each species-group</bold>.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g004"/>
        </fig>
        <p>Interestingly, as shown in <bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, the flanking regions of the <italic>ars</italic> gene clusters in strain <italic>P. stewartii</italic> S301 and <italic>P. stewartii</italic> A206 were homologous to the corresponding regions of strain <italic>P. stewartii</italic> DC283; the same phenomenon was found in strain <italic>P. septica</italic> 848PVAG (<italic>P. vagans</italic> 848PVAG) and <italic>P. septica</italic> FF5, and strain <italic>P. anthophila</italic> 11-2 and <italic>Pantoea</italic> sp. Sc1. This result suggests that <italic>ars</italic> clusters may be lost in <italic>P. stewartii</italic> DC283, <italic>P. septica</italic> FF5, and <italic>Pantoea</italic> sp. Sc1.</p>
        <p>To gain insights into the origin of <italic>ars</italic> genes clusters in <italic>Pantoea</italic>, a NJ phylogenetic tree was constructed based on the ArsRBC protein sequences. As shown in <bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>, the strains possessing <italic>ars1</italic> and <italic>ars2</italic> clusters form separate groups. Notably, the phylogeny reveals that the <italic>ars1</italic> and <italic>ars</italic> clusters of <italic>F. helveticus</italic> were sister groups, and <italic>ars2</italic> grouped to <italic>ars</italic> clusters of <italic>S. marcescens</italic> and <italic>C. freundii</italic>. These results imply that the <italic>ars1</italic> cluster may be acquired via HGT from <italic>F. helveticus</italic>, and <italic>ars2</italic> from <italic>S. marcescens and C. freundii</italic> in early evolutionary history.</p>
        <fig id="F5" position="float">
          <label>FIGURE 5</label>
          <caption>
            <p><bold>Neighbor joining phylogenetic tree of the ArsRBC protein sequences derived from <italic>Pantoea</italic> spp. strains and other representative species.</bold> A total of 1,000 bootstrap replicates was made, and bootstrap values are indicated at each node. <italic>ars1</italic> cluster grouped together marked in red, <italic>ars2</italic> cluster formed in another group marked in blue.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g005"/>
        </fig>
      </sec>
      <sec>
        <title>Two <italic>arsC</italic>-Like Genes in <italic>Pantoea</italic></title>
        <p>Our studies reveal that two <italic>arsC</italic>-like genes (<italic>arsC1</italic>-like and <italic>arsC2</italic>-like) are found in the 23 genomes with just 25% homology (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Our phylogenetic analysis showed that the ArsC-like sequences formed distinct groups, which were clearly divergent from conventional arsenate reductase (<bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>). It was reported that Cys-12, Arg-60, Arg-94, and Arg-107 were four conserved residues of the ArsC protein in the process of arsenic resistance (<xref rid="B10" ref-type="bibr">Gladysheva et al., 1996</xref>). Cys-12 was identified as a catalytic residue and was activated by nearby residues Arg-60, Arg-94, and Arg-107 (<xref rid="B16" ref-type="bibr">Martin et al., 2001</xref>). Alignment analysis of a<italic>rsC</italic> and <italic>arsC</italic>-like genes shows that Cys-12 and Arg-94 residues were conserved, but residues Arg-107 and Arg-60 in two ArsC-like proteins were not conserved (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S8</xref>). These results suggest that these two <italic>arsC</italic>-like genes are not involved in the As resistance.</p>
        <fig id="F6" position="float">
          <label>FIGURE 6</label>
          <caption>
            <p><bold>Neighbor-joining tree based on ArsC/ArsC-like proteins.</bold> ArsC/ArsC-like sequences were derived from 23 <italic>Pantoea</italic> strains and the representative microorganisms. ArsC sequence of <italic>Bacillus subtilis</italic> 168 was used as an out group.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g006"/>
        </fig>
        <p>To explore the evolution of these two <italic>arsC</italic>-like genes in <italic>Pantoea</italic>, molecular phylogenetic analysis, molecular conservation, and linear representation analysis were used (<xref rid="B25" ref-type="bibr">Rice and Lampson, 1995</xref>; <xref rid="B18" ref-type="bibr">Nelson et al., 1999</xref>; <xref rid="B2" ref-type="bibr">Brochier-Armanet and Forterre, 2006</xref>; <xref rid="B6" ref-type="bibr">Dagan et al., 2008</xref>). The comparative analysis showed that the two <italic>arsC</italic>-like genes are conserved in all of the 23 (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S7</xref>). Phylogenetic analysis showed that <italic>arsC1</italic>-like and <italic>arsC2</italic>-like genes were grouped together, respectively (<bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>). These results suggested that the two <italic>arsC</italic>-like genes evolved with a possible evolutionary scenario of that there is a common ancestor. Further, we compared the flanking regions of the two <italic>arsC</italic>-like genes. Interestingly, two genes in the upstream (the uracil phosphoribosyl transferase genes and uracil/xanthine transporter genes) and two genes in the downstream (sulfur reduction protein DsrE and GntR family transcriptional regulator genes) are conserved for <italic>arsC1</italic>-like genes. The two genes in the upstream (DNA-binding response regulator genes and multidrug efflux RND transporter permease genes) and two genes in the downstream (succinyl-diaminopimelate desuccinylase genes and membrane protein genes) are also conserved for <italic>arsC2</italic>-like genes (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S7</xref>). This observation also suggests that <italic>arsC1</italic>-like and <italic>arsC2</italic>-like genes were the vertical genetic genes in the genus <italic>Pantoea</italic>. Possibility, they may have been the main As resistance contributors in early times and later had evolved with deviance.</p>
      </sec>
      <sec>
        <title>Functional Analysis of <italic>ars</italic> Gene and <italic>arsC</italic>-Like Genes</title>
        <p>To verify that the <italic>ars</italic> gene clusters are the contributors to the As resistance, the <italic>ars1</italic> cluster with its promoter from <italic>P. stewartii</italic> S301, a representative strain with the <italic>ars1</italic> cluster, and the <italic>ars2</italic> cluster with its promoter from <italic>P. agglomerans</italic> Tx10, a representative strain with the <italic>ars2</italic> cluster, were PCR amplified and then ligated into vector pUC18 and further transferred to <italic>E. coli</italic> AW3110 (without any As resistance genes). The growth of the yielded recombinant <italic>E. coli</italic> strains <italic>E. coli-</italic>ars1 and <italic>E. coli-</italic>ars2, was tested in 5 mM concentration As(V). As shown in <bold>Figure <xref ref-type="fig" rid="F7">7</xref></bold>, both <italic>E. coli-</italic>ars1 and <italic>E. coli-</italic>ars2 survived in 5 mM As(V), and <italic>E. coli-</italic>ars1 grew better than <italic>E. coli-</italic>ars2. This result suggests that both the <italic>ars1</italic> and <italic>ars2</italic> clusters enabled <italic>E. coli</italic> AW3110 to resist As, and <italic>ars1</italic> seemed to have a more effective As resistance capability than <italic>ars2</italic>.</p>
        <fig id="F7" position="float">
          <label>FIGURE 7</label>
          <caption>
            <p><bold>The heterologous expression of <italic>ars1, ars2, arsC1</italic>-like and <italic>arsC2</italic>-like in <italic>E. coli</italic> AW3110.</bold> The pUC18-<italic>ars1</italic>, pUC18-<italic>ars2</italic>, pUC18-<italic>arsC1</italic>-like and pUC18-<italic>arsC2</italic>-like plasmids (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S3</xref>) were transformed, along with the empty vector pUC18 in <italic>Escherichia coli</italic> AW3110. <italic>E. coli</italic> W3110 (with <italic>arsRBC</italic> cluster) as a control. Serial 5 μl dilutions of the strains were then plated on LB agar medium with 5 mM As(V). Pictures were taken after 48 h at 30°C.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00471-g007"/>
        </fig>
        <p>To test the functions of <italic>arsC1</italic>-like and <italic>arsC2</italic>-like genes, the <italic>arsC1-</italic>like gene and <italic>arsC2</italic>-like gene with their promoters from <italic>P. stewartii</italic> DC283 were PCR amplified and then ligated into vector pUC18 and further transferred to <italic>E. coli</italic> AW3110. As shown in <bold>Figure <xref ref-type="fig" rid="F7">7</xref></bold>, neither the <italic>arsC1</italic>-like nor <italic>arsC2-</italic>like gene enables <italic>E. coli</italic> AW3110 to resist As. In line with the alignment result, the function analysis demonstrates that these two <italic>arsC</italic>-like genes do not contribute to As resistance.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p><italic>Pantoea</italic> is a genus with 26 members identified by DDH, a gold standard for prokaryotic species identification. However, laboratory-based DDH results may be irreproducible, and vary depending on the reannealing temperature (<xref rid="B8" ref-type="bibr">Gevers et al., 2005</xref>). With the rapid development in technology and decline in sequencing cost, promising new measurements such as ANI are being developed to evaluate the genomic similarity of bacteria (<xref rid="B26" ref-type="bibr">Richter and Rosselló-Móra, 2009</xref>). In this study, we identified the 23 <italic>Pantoea</italic> spp. phylogenetic status using ANI, together with phylogenetic trees based on concatenated sequences of the 100 core genes (<bold>Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref></bold>). Our results showed that strain 299R, 848PVAG, GB1, and ZBG6 were misnamed. We reclassified strain 299R to <italic>P. reagglomerans</italic> 299R (<italic>P. agglomerans</italic> 299R), 848PVAG to <italic>P. septica</italic> 848PVAG (<italic>P. vagans</italic> 848PVAG), GB1 to <italic>P. agglomerans</italic> GB1 (<italic>P. ananatis</italic> GB1), and ZBG6 to <italic>P. agglomerans</italic> ZBG6 (<italic>P. vagans</italic> ZBG6). Our study provided data from genus <italic>Pantoea</italic> with a complex and controversial taxonomy and demonstrated the accuracy of a bioinformatics approach, such as ANI, to identify new species and to correct erroneous identifications from previous studies.</p>
      <p>A previous study suggested that the <italic>ars</italic> system is a widespread As resistance mechanism (<xref rid="B21" ref-type="bibr">Páezespino et al., 2009</xref>). <italic>Pantoea</italic> sp. IMH was found to resist As by means of <italic>ars</italic> clusters. <italic>arsRBC</italic> is located on the large universal <italic>Pantoea</italic> plasmids of four stains including <italic>P. agglomerans</italic> E325, <italic>P. agglomerans</italic> MP2, <italic>P. eucalypti</italic>αB, and <italic>P. anthophila</italic> Sc1 (<xref rid="B14" ref-type="bibr">Maayer et al., 2012</xref>). This information leads to the hypothesis that plasmids may be involved in the evolution of As resistance mechanism by <italic>ars</italic> genes in <italic>Pantoea</italic> spp. However, there are untouched questions such as what are the mechanisms of the other <italic>Pantoea</italic> spp. and what is the evolutionary history of genetic elements involved in the As resistance? To answer these questions, we collected the genome sequences of 23 strains in nine species in NCBI (<italic>P. ananatis, P. agglomerans, P. stewartii, P. vagans, P. dispersa, P. septica, P. rodasii, P. rwandensis</italic>, and <italic>P. anthophila</italic>). The sequencing results provided us with mass genomic information to detect the presence and the locations of As-related genes in <italic>Pantoea</italic> spp. Our study for the first time systematically analyzed the As resistance genes and revealed the As resistance traits in genus <italic>Pantoea</italic>. Our research provided the definitive evidence that that As resistance strategy in <italic>Pantoea</italic> spp. only involved the detoxification mechanism through <italic>ars</italic> clusters, not the respiratory reduction mechanism through <italic>arr</italic> clusters. This detoxification strategy was obtained by HGT. This conclusion can likely to be extended to most bacteria. We speculate that evolutionarily ancient microbes were exposed to As surroundings on ancient earth (<xref rid="B20" ref-type="bibr">Oremland et al., 2009</xref>). To overcome the As-induced selection pressure, microbes evolved <italic>ars</italic> genes in their genomes for survival by HGT. Therefore, <italic>ars</italic> has very early origins and represents a widespread As resistance mechanism.</p>
      <p>Two scattered <italic>arsC</italic>-like genes exist in each genome of the 23 <italic>Pantoea</italic> strains, but they exhibited no functional As resistance. It is rare for <italic>arsC</italic>-like genes to show no As resistance capabilities (<xref rid="B3" ref-type="bibr">Butcher et al., 2000</xref>; <xref rid="B29" ref-type="bibr">Saltikov and Newman, 2003</xref>). Compared to functional protein ArsC, residues Arg-107 and Arg-60 of ArsC-like protein were variant (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S8</xref>). We speculate that in early times, the ancestor of <italic>Pantoea</italic> spp. evolved the <italic>arsC</italic> gene to resist As, but later evolved with deviance during adaption to As-free niches, and thus retained non-functional <italic>arsC</italic>-like genes in some genomes.</p>
      <p>The <italic>ars</italic> genes are abundant and tend to organize in typical <italic>arsRBC</italic> cluster structures (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Apart from these operons, <italic>arsRBCH</italic> operons are widely observed. In genus <italic>Pantoea</italic>, these kinds of structures were anticipated, for these strains descended from a recent common ancestor. Our study suggests that <italic>ars</italic> clusters may be acquired by HGT from <italic>F. helveticus, S. marcescens</italic>, and <italic>C. freundii</italic> strains. This is consistent with recent literature showing that bacterial As resistance and transformation was a trait acquired via HGT, driven by adaptation to habitats containing As (<xref rid="B4" ref-type="bibr">Cai et al., 2009</xref>; <xref rid="B36" ref-type="bibr">Villegas-Torres et al., 2011</xref>). Interestingly, <italic>ars</italic> clusters are absent in some strains, suggesting that some microbes may have lost their As resistance genes during adaption to As-free niches. In addition, the number of As resistance genes in strains isolated from As-rich environments is much higher than in strains from other environments (<xref rid="B15" ref-type="bibr">Macur et al., 2004</xref>; <xref rid="B32" ref-type="bibr">Sutton et al., 2009</xref>). Compared to the evolutionary pattern of <italic>ars</italic> operons (<xref rid="B28" ref-type="bibr">Rosen, 1999</xref>), the evolution of As resistance genes (<italic>ars</italic> clusters) in <italic>Pantoea</italic> spp. involves a mix of HGT and loss, providing insight into the complex evolutionary history of As resistance.</p>
    </sec>
    <sec>
      <title>Author Contributions</title>
      <p>LW and CJ conceived and designed the study. LW performed the laboratory work and data analysis. LW, JW, and CJ drafted the tables and figures, and prepared the main manuscript.</p>
    </sec>
    <sec>
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <sec>
      <title>Data Accessibility</title>
      <p>The NCBI accession numbers of 23 draft genome sequences of <italic>Pantoea</italic> are listed in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We acknowledge the financial support of the National Basic Research Program of China (2015CB932003), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB14020302), and the National Natural Science Foundation of China (41373123, 41425016, 41503094, and 21321004). We thank Yongguan Zhu for the strain <italic>E. coli</italic> AW3110.</p>
    </ack>
    <fn-group>
      <fn id="fn01">
        <label>1</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://www.bacterio.net/pantoea.html">http://www.bacterio.net/pantoea.html</ext-link>
        </p>
      </fn>
      <fn id="fn02">
        <label>2</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/figtree/">http://tree.bio.ed.ac.uk/software/figtree/</ext-link>
        </p>
      </fn>
      <fn id="fn03">
        <label>3</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genome/?term=pantoea">http://www.ncbi.nlm.nih.gov/genome/?term=pantoea</ext-link>
        </p>
      </fn>
    </fn-group>
    <sec sec-type="supplementary material">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.00471/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2017.00471/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <media xlink:href="Data_Sheet_1.PDF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsène-Ploetze</surname><given-names>F.</given-names></name><name><surname>Koechler</surname><given-names>S.</given-names></name><name><surname>Marchal</surname><given-names>M.</given-names></name><name><surname>Coppée</surname><given-names>J. Y.</given-names></name><name><surname>Chandler</surname><given-names>M.</given-names></name><name><surname>Bonnefoy</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Structure, function, and evolution of the <italic>Thiomonas</italic> spp. genome.</article-title>
<source><italic>PLoS Genet.</italic></source>
<volume>6</volume>:<issue>e1000859</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000859</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochier-Armanet</surname><given-names>C.</given-names></name><name><surname>Forterre</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Widespread distribution of archaeal reverse gyrase in thermophilic bacteria suggests a complex history of vertical inheritance and lateral gene transfers.</article-title>
<source><italic>Archaea</italic></source>
<volume>2</volume>
<fpage>83</fpage>–<lpage>93</lpage>.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname><given-names>B. G.</given-names></name><name><surname>Deane</surname><given-names>S. M.</given-names></name><name><surname>Rawlings</surname><given-names>D. E.</given-names></name></person-group> (<year>2000</year>). <article-title>The chromosomal arsenic resistance genes of <italic>Thiobacillus ferrooxidans</italic> have an unusual arrangement and confer increased arsenic and antimony resistance to <italic>Escherichia coli</italic>.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>66</volume>
<fpage>1826</fpage>–<lpage>1833</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.66.5.1826-1833.2000</pub-id><pub-id pub-id-type="pmid">10788346</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Rensing</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Genes involved in arsenic transformation and resistance associated with different levels of arsenic-contaminated soils.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>9</volume>:<issue>4</issue>
<pub-id pub-id-type="doi">10.1186/1471-2180-9-4</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colston</surname><given-names>S. M.</given-names></name><name><surname>Fullmer</surname><given-names>M. S.</given-names></name><name><surname>Beka</surname><given-names>L.</given-names></name><name><surname>Lamy</surname><given-names>B.</given-names></name><name><surname>Gogarten</surname><given-names>J. P.</given-names></name><name><surname>Graf</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Bioinformatic genome comparisons for taxonomic and phylogenetic assignments using aeromonas as a test case.</article-title>
<source><italic>MBio</italic></source>
<volume>5</volume>:<issue>e2136-14</issue>
<pub-id pub-id-type="doi">10.1128/mBio.02136-14</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagan</surname><given-names>T.</given-names></name><name><surname>Artzyrandrup</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Modular networks and cumulative impact of lateral transfer in prokaryote genome evolution.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>105</volume>
<fpage>10039</fpage>–<lpage>10044</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0800679105</pub-id><pub-id pub-id-type="pmid">18632554</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavini</surname><given-names>F.</given-names></name><name><surname>Mergaert</surname><given-names>J.</given-names></name><name><surname>Bej</surname><given-names>A.</given-names></name><name><surname>Mielcarek</surname><given-names>C.</given-names></name><name><surname>Izard</surname><given-names>D.</given-names></name><name><surname>Kersters</surname><given-names>K.</given-names></name><etal/></person-group> (<year>1989</year>). <article-title>Transfer of <italic>Enterobacter agglomerans</italic> (Beijerinck 1888) Ewing and Fife 1972 to <italic>Pantoea</italic> gen. nov. as <italic>Pantoea agglomerans</italic> comb. nov. and description of <italic>Pantoea dispersa</italic> sp. nov.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>39</volume>
<fpage>337</fpage>–<lpage>345</lpage>.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gevers</surname><given-names>D.</given-names></name><name><surname>Cohan</surname><given-names>F. M.</given-names></name><name><surname>Lawrence</surname><given-names>J. G.</given-names></name><name><surname>Spratt</surname><given-names>B. G.</given-names></name><name><surname>Coenye</surname><given-names>T.</given-names></name><name><surname>Feil</surname><given-names>E. J.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Opinion: re-evaluating prokaryotic species.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>3</volume>
<fpage>733</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1236</pub-id><pub-id pub-id-type="pmid">16138101</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Bhadury</surname><given-names>P.</given-names></name><name><surname>Routh</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Diversity of arsenite oxidizing bacterial communities in arsenic-rich deltaic aquifers in West Bengal, India.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>5</volume>:<issue>602</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2014.00602</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladysheva</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Rosen</surname><given-names>B. P.</given-names></name></person-group> (<year>1996</year>). <article-title>His-8 lowers the pKa of the essential Cys-12 residue of the ArsC arsenate reductase of plasmid R773.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>271</volume>
<fpage>33256</fpage>–<lpage>33260</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.52.33256</pub-id><pub-id pub-id-type="pmid">8969183</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goris</surname><given-names>J.</given-names></name><name><surname>Konstantinidis</surname><given-names>K. T.</given-names></name><name><surname>Klappenbach</surname><given-names>J. A.</given-names></name><name><surname>Coenye</surname><given-names>T.</given-names></name><name><surname>Vandamme</surname><given-names>P.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2007</year>). <article-title>DNA-DNA hybridization values and their relationship to whole-genome sequence similarities.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>57</volume>
<fpage>81</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.64483-0</pub-id><pub-id pub-id-type="pmid">17220447</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinidis</surname><given-names>K. T.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Trends between gene content and genome size in prokaryotic species with larger genomes.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>101</volume>
<fpage>3160</fpage>–<lpage>3165</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308653100</pub-id><pub-id pub-id-type="pmid">14973198</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>D.</given-names></name><name><surname>Tal</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Arsenite oxidase aox genes from a metal-resistant beta-proteobacterium.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>185</volume>
<fpage>135</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-11-709</pub-id><pub-id pub-id-type="pmid">12486049</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maayer</surname><given-names>P. D.</given-names></name><name><surname>Chan</surname><given-names>W. Y.</given-names></name><name><surname>Blom</surname><given-names>J.</given-names></name><name><surname>Venter</surname><given-names>S. N.</given-names></name><name><surname>Duffy</surname><given-names>B.</given-names></name><name><surname>Smits</surname><given-names>T. H. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The large universal <italic>Pantoea</italic> plasmid LPP-1 plays a major role in biological and ecological diversification.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>13</volume>:<issue>625</issue>
<pub-id pub-id-type="doi">10.1186/1471-2164-13-625</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macur</surname><given-names>R. E.</given-names></name><name><surname>Jackson</surname><given-names>C. R.</given-names></name><name><surname>Botero</surname><given-names>L. M.</given-names></name><name><surname>Mcdermott</surname><given-names>T. R.</given-names></name><name><surname>Inskeep</surname><given-names>W. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Bacterial populations associated with the oxidation and reduction of arsenic in an unsaturated soil.</article-title>
<source><italic>Environ. Sci. Technol.</italic></source>
<volume>38</volume>
<fpage>104</fpage>–<lpage>111</lpage>.<pub-id pub-id-type="pmid">14740724</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>DeMel</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Gladysheva</surname><given-names>T.</given-names></name><name><surname>Gatti</surname><given-names>D. L.</given-names></name><name><surname>Rosen</surname><given-names>B. P.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Insights into the structure, solvation, and mechanism of ArsC arsenate reductase, a novel arsenic detoxification enzyme.</article-title>
<source><italic>Structure</italic></source>
<volume>9</volume>
<fpage>1071</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-2126(01)00672-4</pub-id><pub-id pub-id-type="pmid">11709171</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>W. Q.</given-names></name><name><surname>Geelhaar</surname><given-names>L. A.</given-names></name><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Patel</surname><given-names>A. R.</given-names></name><name><surname>Payne</surname><given-names>G. F.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Denitration of glycerol trinitrate by resting cells and cell extracts of <italic>Bacillus thuringiensis/cereus</italic> and <italic>Enterobacter agglomerans</italic>.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>61</volume>
<fpage>2548</fpage>–<lpage>2553</lpage>.<pub-id pub-id-type="pmid">7618866</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>K. E.</given-names></name><name><surname>Clayton</surname><given-names>R. A.</given-names></name><name><surname>Gill</surname><given-names>S. R.</given-names></name><name><surname>Gwinn</surname><given-names>M. L.</given-names></name><name><surname>Dodson</surname><given-names>R. J.</given-names></name><name><surname>Haft</surname><given-names>D. H.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Evidence for lateral gene transfer between Archaea and Bacteria from genome sequence of <italic>Thermotoga maritima</italic>.</article-title>
<source><italic>Nature</italic></source>
<volume>399</volume>
<fpage>323</fpage>–<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1038/20601</pub-id><pub-id pub-id-type="pmid">10360571</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochman</surname><given-names>H.</given-names></name><name><surname>Lawrence</surname><given-names>J. G.</given-names></name><name><surname>Groisman</surname><given-names>E. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Lateral gene transfer and the nature of bacterial innovation.</article-title>
<source><italic>Nature</italic></source>
<volume>405</volume>
<fpage>299</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/35012500</pub-id><pub-id pub-id-type="pmid">10830951</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oremland</surname><given-names>R. S.</given-names></name><name><surname>Saltikov</surname><given-names>C. W.</given-names></name><name><surname>Wolfe-Simon</surname><given-names>F.</given-names></name><name><surname>Stolz</surname><given-names>J. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Arsenic in the evolution of earth and extraterrestrial ecosystems.</article-title>
<source><italic>Geomicrobiol. J.</italic></source>
<volume>26</volume>
<fpage>522</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1080/01490450903102525</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Páezespino</surname><given-names>D.</given-names></name><name><surname>Tamames</surname><given-names>J.</given-names></name><name><surname>De</surname><given-names>L. V.</given-names></name><name><surname>Cánovas</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Microbial responses to environmental arsenic.</article-title>
<source><italic>Biometals</italic></source>
<volume>22</volume>
<fpage>117</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-008-9195-y</pub-id><pub-id pub-id-type="pmid">19130261</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Rosen</surname><given-names>B. P.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Franke</surname><given-names>S.</given-names></name><name><surname>Rensing</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Arsenic detoxification and evolution of trimethylarsine gas by a microbial arsenite S-adenosylmethionine methyltransferase.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>103</volume>
<fpage>2075</fpage>–<lpage>2080</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506836103</pub-id><pub-id pub-id-type="pmid">16452170</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezzonico</surname><given-names>F.</given-names></name><name><surname>Smits</surname><given-names>T. H.</given-names></name><name><surname>Montesinos</surname><given-names>E.</given-names></name><name><surname>Frey</surname><given-names>J. E.</given-names></name><name><surname>Duffy</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Genotypic comparison of <italic>Pantoea agglomerans</italic> plant and clinical strains.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>9</volume>:<issue>204</issue>
<pub-id pub-id-type="doi">10.1186/1471-2180-9-204</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>P.</given-names></name><name><surname>Longden</surname><given-names>I.</given-names></name><name><surname>Bleasby</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>EMBOSS: the european molecular biology open software suite.</article-title>
<source><italic>Trends Genet.</italic></source>
<volume>16</volume>
<fpage>276</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-9525(00)02024-2</pub-id><pub-id pub-id-type="pmid">10827456</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>S. A.</given-names></name><name><surname>Lampson</surname><given-names>B. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Phylogenetic comparison of retron elements among the myxobacteria: evidence for vertical inheritance.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>177</volume>
<fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1128/jb.177.1.37-45.1995</pub-id><pub-id pub-id-type="pmid">7798147</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>M.</given-names></name><name><surname>Rosselló-Móra</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Shifting the genomic gold standard for the prokaryotic species definition.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>106</volume>
<fpage>19126</fpage>–<lpage>19131</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906412106</pub-id><pub-id pub-id-type="pmid">19855009</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronquist</surname><given-names>F.</given-names></name><name><surname>Teslenko</surname><given-names>M.</given-names></name><name><surname>van</surname><given-names>der Mark P.</given-names></name><name><surname>Ayres</surname><given-names>D. L.</given-names></name><name><surname>Darling</surname><given-names>A.</given-names></name><name><surname>Höhna</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space.</article-title>
<source><italic>Syst. Biol.</italic></source>
<volume>61</volume>
<fpage>539</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1093/sysbio/sys029</pub-id><pub-id pub-id-type="pmid">22357727</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>B. P.</given-names></name></person-group> (<year>1999</year>). <article-title>Families of arsenic transporters.</article-title>
<source><italic>Trends Microbiol.</italic></source>
<volume>7</volume>
<fpage>207</fpage>–<lpage>212</lpage>.<pub-id pub-id-type="pmid">10354596</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltikov</surname><given-names>C. W.</given-names></name><name><surname>Newman</surname><given-names>D. K.</given-names></name></person-group> (<year>2003</year>). <article-title>Genetic identification of a respiratory arsenate reductase.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>100</volume>
<fpage>10983</fpage>–<lpage>10988</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1834303100</pub-id><pub-id pub-id-type="pmid">12939408</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimodaira</surname><given-names>H.</given-names></name><name><surname>Hasegawa</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>CONSEL: for assessing the confidence of phylogenetic tree selection.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>17</volume>
<fpage>1246</fpage>–<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/17.12.1246</pub-id><pub-id pub-id-type="pmid">11751242</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A. H.</given-names></name><name><surname>Lopipero</surname><given-names>P. A.</given-names></name><name><surname>Bates</surname><given-names>M. N.</given-names></name><name><surname>Steinmaus</surname><given-names>C. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Public health. Arsenic epidemiology and drinking water standards.</article-title>
<source><italic>Science</italic></source>
<volume>296</volume>
<fpage>2145</fpage>–<lpage>2146</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072896</pub-id><pub-id pub-id-type="pmid">12077388</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>N. B.</given-names></name><name><surname>van</surname><given-names>der Kraan G. M.</given-names></name><name><surname>van</surname><given-names>Loosdrecht M. C.</given-names></name><name><surname>Muyzer</surname><given-names>G.</given-names></name><name><surname>Bruining</surname><given-names>J.</given-names></name><name><surname>Schotting</surname><given-names>R. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Characterization of geochemical constituents and bacterial populations associated with As mobilization in deep and shallow tube wells in Bangladesh.</article-title>
<source><italic>Water Res.</italic></source>
<volume>43</volume>
<fpage>1720</fpage>–<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1016/j.watres.2009.01.006</pub-id><pub-id pub-id-type="pmid">19215956</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.</article-title>
<source><italic>Mol. Biol. Evol.</italic></source>
<volume>28</volume>
<fpage>2731</fpage>–<lpage>2739</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msr121</pub-id><pub-id pub-id-type="pmid">21546353</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>J. D.</given-names></name><name><surname>Gibson</surname><given-names>T. J.</given-names></name><name><surname>Higgins</surname><given-names>D. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple sequence alignment using ClustalW and ClustalX.</article-title>
<source><italic>Curr. Protoc. Bioinformatics</italic></source>
<comment>Chater 2:Unit 2.3</comment>
<pub-id pub-id-type="doi">10.1002/0471250953.bi0203s00</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Jing</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Genome sequence of the aerobic arsenate-reducing bacterium <italic>Pantoea</italic> sp. strain IMH.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>2</volume>:<issue>e267-14</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.00267-14</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villegas-Torres</surname><given-names>M. F.</given-names></name><name><surname>Bedoya-Reina</surname><given-names>O. C.</given-names></name><name><surname>Salazar</surname><given-names>C.</given-names></name><name><surname>Vives-Florez</surname><given-names>M. J.</given-names></name><name><surname>Dussan</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Horizontal <italic>arsC</italic> gene transfer among microorganisms isolated from arsenic polluted soil.</article-title>
<source><italic>Int. Biodeter. Biodegradation</italic></source>
<volume>65</volume>
<fpage>147</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.ibiod.2010.10.007</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name><name><surname>Zhuang</surname><given-names>G.</given-names></name><name><surname>Jing</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Arsenic resistance strategy in <italic>Pantoea</italic> sp. IMH: organization, function and evolution of ars genes.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>39195</issue>
<pub-id pub-id-type="doi">10.1038/srep39195</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Zhuang</surname><given-names>G.</given-names></name><name><surname>Jing</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Bacillus</italic> sp. SXB and <italic>Pantoea</italic> sp. IMH, aerobic As(V)-reducing bacteria isolated from arsenic-contaminated soil.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>114</volume>
<fpage>713</fpage>–<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1111/jam.12093</pub-id><pub-id pub-id-type="pmid">23210693</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J. B.</given-names></name><name><surname>Du</surname><given-names>Z.</given-names></name><name><surname>Bai</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>J. Y.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Comparative genomic analysis of N2-fixing and non-N2-fixing <italic>Paenibacillus</italic> spp.: organization, evolution and expression of the nitrogen fixation genes.</article-title>
<source><italic>PLoS Genet.</italic></source>
<volume>10</volume>:<issue>e1004231</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004231</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Kuroda</surname><given-names>M.</given-names></name><name><surname>Rosen</surname><given-names>B. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Metalloid resistance mechanisms in prokaryotes.</article-title>
<source><italic>J. Biochem.</italic></source>
<volume>123</volume>
<fpage>16</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">9504403</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Birch</surname><given-names>R. G.</given-names></name></person-group> (<year>1997</year>). <article-title>The gene for albicidin detoxification from <italic>Pantoea dispersa</italic> encodes an esterase and attenuates pathogenicity of <italic>Xanthomonas albilineans</italic> to sugarcane.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>94</volume>
<fpage>9984</fpage>–<lpage>9989</lpage>.<pub-id pub-id-type="pmid">9275238</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chan</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Insights into arsenic multi-operons expression and resistance mechanisms in <italic>Rhodopseudomonas palustris</italic> CGA009.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>986</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00986</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>PGAP: pan-genomes analysis pipeline.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>28</volume>
<fpage>416</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr655</pub-id><pub-id pub-id-type="pmid">22130594</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360010</identifier><datestamp>2017-04-04</datestamp><setSpec>frontmicrobio</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Microbiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-302X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360010</article-id>
      <article-id pub-id-type="pmcid">PMC5360010</article-id>
      <article-id pub-id-type="pmc-uid">5360010</article-id>
      <article-id pub-id-type="doi">10.3389/fmicb.2017.00456</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Comparative Genomics Analysis of a New <italic>Exiguobacterium</italic> Strain from Salar de Huasco Reveals a Repertoire of Stress-Related Genes and Arsenic Resistance</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Castro-Severyn</surname>
            <given-names>Juan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn002">
            <sup>†</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/344778/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Remonsellez</surname>
            <given-names>Francisco</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn002">
            <sup>†</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/362659/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valenzuela</surname>
            <given-names>Sandro L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/306332/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salinas</surname>
            <given-names>Cesar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/408929/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fortt</surname>
            <given-names>Jonathan</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/361868/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aguilar</surname>
            <given-names>Pablo</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/314141/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pardo-Esté</surname>
            <given-names>Coral</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/359347/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dorador</surname>
            <given-names>Cristina</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/144520/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quatrini</surname>
            <given-names>Raquel</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/29631/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Molina</surname>
            <given-names>Franck</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aguayo</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff8">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro-Nallar</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/306807/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saavedra</surname>
            <given-names>Claudia P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/361645/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Laboratorio de Microbiología Molecular, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas, Universidad Andres Bello</institution>
        <country>Santiago, Chile</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Centro de Bioinformática y Biología Integrativa, Facultad de Ciencias Biológicas, Universidad Andrés Bello</institution>
        <country>Santiago, Chile</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>Laboratorio de Tecnologías de Membranas, Biotecnología y Medio Ambiente, Departamento de Ingeniería Química, Facultad de Ingeniería y Ciencias Geológicas, Universidad Católica del Norte</institution>
        <country>Antofagasta, Chile</country>
      </aff>
      <aff id="aff4">
        <sup>4</sup>
        <institution>Laboratorio de Complejidad Microbiana y Ecología Funcional, Instituto Antofagasta and Departamento de Biotecnología, Facultad de Ciencias del Mar y Recursos Biológicos, Universidad de Antofagasta</institution>
        <country>Antofagasta, Chile</country>
      </aff>
      <aff id="aff5">
        <sup>5</sup>
        <institution>Centre for Biotechnology and Bioengineering</institution>
        <country>Antofagasta, Chile</country>
      </aff>
      <aff id="aff6">
        <sup>6</sup>
        <institution>Laboratorio de Ecofisiología Microbiana, Fundación Ciencia and Vida</institution>
        <country>Santiago, Chile</country>
      </aff>
      <aff id="aff7">
        <sup>7</sup>
        <institution>Sys2Diag CNRS/Bio-Rad UMR3145</institution>
        <country>Montpellier, France</country>
      </aff>
      <aff id="aff8">
        <sup>8</sup>
        <institution>Centro Interdisciplinario de Neurociencia de Valparaíso, Facultad de Ciencias, Universidad de Valparaíso</institution>
        <country>Valparaíso, Chile</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: <italic>Martin G. Klotz, Queens College (CUNY), USA</italic></p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: <italic>Adrian Gustavo Turjanski, University of Buenos Aires, Argentina; Tatiana A. Vishnivetskaya, University of Tennessee, Knoxville, USA</italic></p>
        </fn>
        <corresp id="fn001">*Correspondence: <italic>Eduardo Castro-Nallar, <email xlink:type="simple">eduardo.castro@unab.cl</email> Claudia P. Saavedra, <email xlink:type="simple">csaavedra@unab.cl</email></italic></corresp>
        <fn fn-type="other" id="fn002">
          <p>
            <sup>†</sup>
            <italic>These authors have contributed equally to this work.</italic>
          </p>
        </fn>
        <fn fn-type="other" id="fn003">
          <p>This article was submitted to Evolutionary and Genomic Microbiology, a section of the journal Frontiers in Microbiology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>456</elocation-id>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>8</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Castro-Severyn, Remonsellez, Valenzuela, Salinas, Fortt, Aguilar, Pardo-Esté, Dorador, Quatrini, Molina, Aguayo, Castro-Nallar and Saavedra.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Castro-Severyn, Remonsellez, Valenzuela, Salinas, Fortt, Aguilar, Pardo-Esté, Dorador, Quatrini, Molina, Aguayo, Castro-Nallar and Saavedra</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The Atacama Desert hosts diverse ecosystems including salt flats and shallow Andean lakes. Several heavy metals are found in the Atacama Desert, and microorganisms growing in this environment show varying levels of resistance/tolerance to copper, tellurium, and arsenic, among others. Herein, we report the genome sequence and comparative genomic analysis of a new <italic>Exiguobacterium</italic> strain, sp. SH31, isolated from an altiplanic shallow athalassohaline lake. <italic>Exiguobacterium</italic> sp. SH31 belongs to the phylogenetic Group II and its closest relative is <italic>Exiguobacterium</italic> sp. S17, isolated from the Argentinian Altiplano (95% average nucleotide identity). Strain SH31 encodes a wide repertoire of proteins required for cadmium, copper, mercury, tellurium, chromium, and arsenic resistance. Of the 34 <italic>Exiguobacterium</italic> genomes that were inspected, only isolates SH31 and S17 encode the arsenic efflux pump Acr3. Strain SH31 was able to grow in up to 10 mM arsenite and 100 mM arsenate, indicating that it is arsenic resistant. Further, expression of the <italic>ars</italic> operon and <italic>acr3</italic> was strongly induced in response to both toxics, suggesting that the arsenic efflux pump Acr3 mediates arsenic resistance in <italic>Exiguobacterium</italic> sp. SH31.</p>
      </abstract>
      <kwd-group>
        <kwd>
          <italic>Exiguobacterium</italic>
        </kwd>
        <kwd>polyextremophile</kwd>
        <kwd>stress</kwd>
        <kwd>comparative genomics</kwd>
        <kwd>Chilean Altiplano</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">ComisiÃ³n Nacional de InvestigaciÃ³n CientÃ-fica y TecnolÃ³gica<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source>
          <award-id rid="cn001">FONDECYT 1160315</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="112"/>
        <page-count count="14"/>
        <word-count count="0"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Extremophiles are microorganisms from all three domains of life (Bacteria, Archaea and Eukarya) that grow in the most hostile environments found on Earth, where they must withstand conditions including extreme pH, temperature, salinity, pressure, UV radiation, and the presence of heavy metals or toxic compounds. In some cases, extremophiles face more than one extreme condition simultaneously, and are called polyextremophiles (<xref rid="B88" ref-type="bibr">Seufferheld et al., 2008</xref>; <xref rid="B14" ref-type="bibr">Bowers et al., 2009</xref>; <xref rid="B38" ref-type="bibr">Farías et al., 2013</xref>; <xref rid="B59" ref-type="bibr">Kurth et al., 2015</xref>). To survive under extreme conditions, microbes finely tune gene expression, modulating the levels of proteins implicated in the response to stress (<xref rid="B35" ref-type="bibr">Duché et al., 2002</xref>). Since their discovery, extremophiles have attracted researchers because of their unique physiology, ability to adapt to different environments, and for their potential use in biotechnology (<xref rid="B83" ref-type="bibr">Rothschild and Mancinelli, 2001</xref>).</p>
      <p>The Andean Plateau region in West Central South America, the Altiplano, hosts a rich microbial diversity and remains an untapped resource for understanding the genetic diversity and distribution of polyextremophiles (<xref rid="B20" ref-type="bibr">Catalán et al., 2006</xref>). High-altitude Andean Lakes (HAALs) are exposed to some of the highest levels of solar radiation on Earth (<xref rid="B4" ref-type="bibr">Albarracín et al., 2015</xref>). Further, water bodies found in the Altiplano (i.e., shallow lakes, ponds, streams, etc.) are highly diverse, showing different chemical compositions, temperatures, evaporation rates, and depths, among other conditions. Together, these factors drive the changing community structure of rich polyextreme microbiota that populates these lakes (<xref rid="B64" ref-type="bibr">Márquez-García et al., 2009</xref>; <xref rid="B34" ref-type="bibr">Dorador et al., 2013</xref>; <xref rid="B24" ref-type="bibr">Cordero et al., 2014</xref>). Despite these harsh conditions, almost 500 strains of prokaryotes (archaea, cyanobacteria and eubacteria) and lower eukaryotes (fungi and yeast) have been isolated from bacterioplankton, benthos, microbial mats, and soils surrounding HAALs (<xref rid="B28" ref-type="bibr">Dib et al., 2008</xref>; <xref rid="B40" ref-type="bibr">Flores et al., 2009</xref>; <xref rid="B72" ref-type="bibr">Ordoñez et al., 2009</xref>; <xref rid="B27" ref-type="bibr">Di Capua et al., 2011</xref>; <xref rid="B62" ref-type="bibr">Lynch et al., 2012</xref>; <xref rid="B15" ref-type="bibr">Bull and Asenjo, 2013</xref>; <xref rid="B16" ref-type="bibr">Bull et al., 2016</xref>). Microbial communities that evolved in HAALs tolerate a wide range of chemical and physical stresses, including wide fluctuations in temperature, low nutrient levels, alkalinity, and hypersalinity (up to 30%). Further, high concentrations of heavy metals and metalloids, especially arsenic (up to 200 ppm), are found in HAALs, primarily because of the geological foundation (<xref rid="B39" ref-type="bibr">Fernandez-Zenoff et al., 2006</xref>; <xref rid="B111" ref-type="bibr">Zenoff et al., 2006</xref>; <xref rid="B29" ref-type="bibr">Dib et al., 2009</xref>; <xref rid="B37" ref-type="bibr">Farias et al., 2009</xref>; <xref rid="B5" ref-type="bibr">Albarracín et al., 2012</xref>).</p>
      <p>Salar de Huasco is a saline wetland located at 3,800 m above sea level in the Chilean Altiplano (-20.303436, -68.880918) and is considered an athalassohaline system. It exhibits typical conditions of the Altiplano: low temperatures (mean annual temperature &lt;5°C), low atmospheric pressure, high solar radiation (up to 72 Wm<sup>-2</sup> UVA radiation: <xref rid="B44" ref-type="bibr">Hernández et al., 2016</xref>), negative water balance, and variable salinity ranging from freshwater to saturated salt waters. Despite these conditions, communities composed of microbial groups from all major branches of the microbial tree of life, including <italic>Proteobacteria, Cyanobacteria, Bacteroidetes</italic>, and <italic>Archaea</italic>, thrive and grow in water bodies of the Salar de Huasco (<xref rid="B30" ref-type="bibr">Dorador et al., 2008a</xref>,<xref rid="B33" ref-type="bibr">b</xref>, <xref rid="B31" ref-type="bibr">2009</xref>, <xref rid="B32" ref-type="bibr">2010</xref>, <xref rid="B34" ref-type="bibr">2013</xref>; <xref rid="B1" ref-type="bibr">Aguilar et al., 2016</xref>; <xref rid="B67" ref-type="bibr">Molina et al., 2016</xref>). It has been proposed that this exceptional microbial diversity results from species diversification, caused by the adaptation of microorganisms to the constantly changing environment (<xref rid="B3" ref-type="bibr">Albarracín et al., 2016</xref>). Consequently, Salar de Huasco represents a potential reservoir of undescribed microbial diversity that could serve to study and identify novel mechanisms of stress resistance.</p>
      <p>The <italic>Exiguobacterium</italic> genus (<xref rid="B22" ref-type="bibr">Collins et al., 1983</xref>) includes psychrotrophic, mesophilic, and moderate thermophilic species with variable morphologies (ovoid, rods, double rods, and chains) that grow in a wide range of habitats, including cold and hot environments with temperatures ranging from -12 to 55°C (<xref rid="B99" ref-type="bibr">Vishnivetskaya and Kathariou, 2005</xref>; <xref rid="B102" ref-type="bibr">Vishnivetskaya et al., 2007</xref>). Taxonomic and phylogenetic classification of the genus by 16S rRNA gene sequence analysis shows that <italic>Exiguobacterium</italic> forms two distinct groups: Group I includes strains isolated from cold or low temperature environments, and Group II from hot springs or slightly alkaline and marine environments (<xref rid="B100" ref-type="bibr">Vishnivetskaya et al., 2009</xref>). One exception is <italic>Exiguobacterium</italic> sp. GIC31, which belongs to group II, but was isolated from a glacier in Greenland (<xref rid="B98" ref-type="bibr">Vishnivetskaya et al., 2014</xref>).</p>
      <p>Members of the <italic>Exiguobacterium</italic> genus display traits that could be of biotechnological interest, e.g., bioremediation and agriculture applications. For example, strains Z8 and 2Sz can neutralize highly alkaline industry wastewater and remove pesticides, respectively (<xref rid="B61" ref-type="bibr">Lopez et al., 2005</xref>; <xref rid="B58" ref-type="bibr">Kumar et al., 2006</xref>); strain WK6 reduces arsenate to arsenite (<xref rid="B7" ref-type="bibr">Anderson and Cook, 2004</xref>), and other strains reduce chrome and mercury in a wide range of temperatures, pH, and salt concentrations (<xref rid="B76" ref-type="bibr">Pattanapipitpaisal et al., 2002</xref>; <xref rid="B77" ref-type="bibr">Petrova et al., 2002</xref>; <xref rid="B71" ref-type="bibr">Okeke, 2008</xref>); <italic>Exiguobacterium oxidotolerans</italic> T-2-2T shows high catalase activity in response to H<sub>2</sub>O<sub>2</sub> as a function of the growth phase and oxygen levels, which could be used to remove peroxides used in the bleaching industry (<xref rid="B92" ref-type="bibr">Takebe et al., 2007</xref>); <italic>Exiguobacterium</italic> sp. S17, isolated from Laguna Socompa in the Argentinian altiplanic desert, tolerates high arsenic concentrations (<xref rid="B11" ref-type="bibr">Belfiore et al., 2013</xref>; <xref rid="B74" ref-type="bibr">Ordoñez et al., 2013</xref>). Further, members of the <italic>Exiguobacterium</italic> genus are a source of enzymes that exhibit a broad range of thermal stability (<xref rid="B96" ref-type="bibr">Usuda et al., 1998</xref>; <xref rid="B90" ref-type="bibr">Suga and Koyama, 2000</xref>; <xref rid="B47" ref-type="bibr">Hwang et al., 2005</xref>; <xref rid="B43" ref-type="bibr">Hara et al., 2007</xref>; <xref rid="B51" ref-type="bibr">Kasana and Yadav, 2007</xref>).</p>
      <p>In the present study, we aimed to understand the phylogenetic placement and to identify genetic determinants required for the response to stress in a new psychro-halotolerant strain isolated from Salar de Huasco, <italic>Exiguobacterium</italic> sp. SH31. We investigated whether <italic>Exiguobacterium</italic> sp. SH31 belongs to Group II, and to what extent species from this genus share functional features based on the group to which they belong. Additionally, we searched the genomes of <italic>Exiguobacterium</italic> sp. SH31 and other species for the presence of genes encoding proteins known to be involved in stress and metal resistance, e.g., arsenic, copper, cadmium, and oxidative and UV stress. Finally, we show that <italic>Exiguobacterium</italic> SH31 is resistant to arsenic, which might be mediated, at least in part, by the Acr3 arsenic efflux pump.</p>
    </sec>
    <sec sec-type="materials|methods" id="s1">
      <title>Materials and Methods</title>
      <sec>
        <title>Bacterial Growth Conditions and DNA Extraction</title>
        <p><italic>Exiguobacterium</italic> sp. SH31 was isolated from Salar de Huasco, an altiplanic shallow saline wetland in the Atacama Desert, Chile, located between -20.303436, -68.880918 at an altitude of 3,800 m. Salinity of the sampling point was 12.3% NaCl, with 20.6 mS/cm of conductivity, pH 8.8 and 8°C at the sampling point. Strain SH31 was grown for 48 h at room temperature (∼25°C) with shaking at 120 rpm in 1 L of YP culture media (2 g/L yeast extract, 5 g/L Peptone and 25 g/L NaCl), with a 10% v/v inoculum. DNA extraction was performed with the AxyPrep Bacterial Genomic DNA miniprep kit (AXYGEN) following the manufacturer’s instructions. DNA quantity and quality was determined spectrophotometrically (OD<sub>260/280</sub> ratio).</p>
      </sec>
      <sec>
        <title>DNA Hybridization Assay</title>
        <p>To assess the relatedness of <italic>Exiguobacterium</italic> SH31 to the type strain <italic>Exiguobacterium aurantiacum</italic> DSM 6208<sup>T</sup>, we performed a hybridization assay in 2 X SSC + 5% formamide medium at 69°C. We evaluated the results per the recommendations of the <italic>ad hoc</italic> committee for the definition of bacterial species (threshold value of 70% DNA–DNA similarity; <xref rid="B103" ref-type="bibr">Wayne et al., 1987</xref>). The assay was performed at the Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures<sup><xref ref-type="fn" rid="fn01">1</xref></sup>.</p>
      </sec>
      <sec>
        <title>Sequencing and Assembly</title>
        <p>Purified genomic DNA was used to construct two different types of sequencing libraries, namely a single-end (prepared from 500 ng of fragmented DNA (nebulization)) and a mate paired-end (prepared with 5 μg of DNA fragmented by hydroshear), using the GS FLX Titanium Rapid Library, GS FLX Titanium Rapid Library prep Paired-End Adaptors, and FastStart PCR System kits, following the manufacturer’s recommendations (average fragments size was between 500 and 900 bp). An equimolar mix was then sequenced using the Roche 454 FLX platform. SFF files were separated into two FASTQ files, one for each library type, using sff_extract utility from seq_crumbs<sup><xref ref-type="fn" rid="fn02">2</xref></sup>. Single-end reads were trimmed at &lt;Q17 and all the resulting reads of &lt;70 bp were discarded. Reads longer than the targeted length (500 bp) were clipped at the 3′ end so that only reads &lt;500 bp were used. Mate paired-end reads were separated into two groups, corresponding to each sequenced end of the fragment (5′ and 3′ ends reads of the sequenced fragment) and both groups were saved as backward sense reads. Trimming was performed as described for single-end reads. Only those paired reads that conserved their mates were employed for the assembly. The final number of reads obtained after this procedure was 81.675 single-end and 61.226 mate paired-reads (approximately 11X and 4X depth coverage respectively), with a read length average of 200 bp after trimming internal adapters. Assembly was performed using both mate paired and single-end reads as in the Celera genome assembler version 7.0 (<xref rid="B68" ref-type="bibr">Myers et al., 2000</xref>); unitigger BOG, unitigger error ratio 0.03, with the final parameter values by default. The final assembly included 120 contigs with a length of 3,031,801 bp. The Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession LYTG00000000. The version described in this paper is LYTG01000000 (Bioproject <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJNA319980">PRJNA319980</ext-link>).</p>
      </sec>
      <sec>
        <title><italic>Exiguobacterium</italic> Genomic Dataset</title>
        <p>All available genome sequences used in the analyses have been deposited in GenBank as of December 2015 (Accession numbers in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>), including a status of complete, scaffolds, or contigs. The resulting 33 genomes were organized into 18 described species plus 15 not classified at the species level. All the genome sequences (including the new <italic>Exiguobacterium</italic> sp. Strain SH31 from this study), were re-annotated using a combination of <italic>ab initio</italic> and similarity methods as implemented in Prokka version 1.10 (<xref rid="B86" ref-type="bibr">Seemann, 2014</xref>) and NCBI Prokaryotic Genome Annotation Pipeline (<xref rid="B94" ref-type="bibr">Tatusova et al., 2016</xref>). Some genomes were also annotated using the following databases: Gene3d 3.5.0, HAMAP 201511.02, PANTHER 10.0, PFam 28.0, PIRSF 3.01, PRINTS 42.0, ProDom 2006.1, prosite 20.113, SignalP 4.0, Smart 6.2, SuperFamily 1.75, TigerFam 15.0, and TMHMM 2.0, as implemented in InterProScan.5.16-55.0 (<xref rid="B50" ref-type="bibr">Jones et al., 2014</xref>; <xref rid="B66" ref-type="bibr">Mitchell et al., 2014</xref>).</p>
      </sec>
      <sec>
        <title>Circular sp. SH31 Genome Map Generation</title>
        <p>The plotMyGBK<sup><xref ref-type="fn" rid="fn03">3</xref></sup> pipeline was used to generate a circular map of the <italic>Exiguobacterium sp.</italic> SH31genome. The plotMyGBK is written in Python and extracts contigs from a.gbk file using the SeqlO module generating a.faa file that is then used to search for genes on the conserved domains database (CDD) through RPS-blast using an <italic>e-value</italic> of 1E<sup>-2</sup> to avoid false positives. Then, genes were classified according to the Clusters of Orthologous Groups (COG) nomenclature (<xref rid="B63" ref-type="bibr">Marchler-Bauer et al., 2003</xref>). Finally, COG annotations were used to plot genes, GC content, GC skew, tRNA and rRNA positions, using the OmicCircos v 1.8.1. R package<sup><xref ref-type="fn" rid="fn04">4</xref></sup> (<xref rid="B45" ref-type="bibr">Hu et al., 2015</xref>).</p>
      </sec>
      <sec>
        <title>Orthologous Gene Search</title>
        <p>Bi-directional best hit searches using Blast was used to infer homology between reference genes from Swiss-prot and the predicted genes from our <italic>Exiguobacterium</italic> dataset (<xref rid="B6" ref-type="bibr">Altschul et al., 1990</xref>). A minimum <italic>e-value</italic> of 1E<sup>-05</sup> and a query coverage filter of 85% was used to avoid partial alignments. This strategy was used to compare stress-response genes and genes involved in metal/metalloid resistance/tolerance.</p>
      </sec>
      <sec>
        <title>Phylogenetic Analysis</title>
        <p>Thirty phylogenetic gene markers implemented in AMPHORA2 were used (<italic>dnaG, frr, infC, nusA, pgk, pyrG, rplA, rplB, rplC, rplD, rplE, rplF, rplK, rplL, rplN, rplP, rplS, rplT, rpmA, rpoB, rpsB, rpsC, rpsE, rpsI, rpsJ, rpsK, rpsM, rpsS, smpB</italic>, and <italic>tsf)</italic> from the data set (<xref rid="B107" ref-type="bibr">Wu and Scott, 2012</xref>). All nucleotide sequences were translation aligned using MAFFT (<xref rid="B52" ref-type="bibr">Katoh and Standley, 2013</xref>) as implemented in Geneious v 7.1.9 software (<xref rid="B53" ref-type="bibr">Kearse et al., 2012</xref>). The alignments were then concatenated using Seqotron version 1.0.1 (<xref rid="B41" ref-type="bibr">Fourment and Holmes, 2016</xref>). A distribution of probable trees using Bayesian Inference as implemented in MrBayes 3.2.5 was used. Two separate runs of 20 million generations were executed (four chains each run; sampling every 1000 generations; nst = 6, nucmodel = 4by4, rates = gamma ngammacat = 4). Then, the tree distributions were summarized as the Maximum a Posteriori estimate removing the first 5 thousand trees as implemented in SumTrees from DendroPy 4.1.0 (<xref rid="B91" ref-type="bibr">Sukumaran and Holder, 2010</xref>). The phylogeny and stress-response gene matrix was plotted using the R package ggtree v 1.0.21 (<xref rid="B109" ref-type="bibr">Yu et al., 2016</xref>).</p>
      </sec>
      <sec>
        <title>Average Nucleotide Identity Analysis</title>
        <p>Genome-wide nucleotide identity trends were explored in the genome dataset by estimating all-against-all pairwise Average Nucleotide Identity (ANI). The ANIm approach that uses MUMmer (NUCmer) was used to align the input sequences as implemented in pyANI (<xref rid="B60" ref-type="bibr">Kurtz et al., 2004</xref><sup><xref ref-type="fn" rid="fn05">5</xref></sup>). The average between any given pair was used as the final value. Heat maps were generated using pheatmap V 1.0.8 R package (<xref rid="B54" ref-type="bibr">Kolde, 2015</xref>). Genomic clusters were defined using hierarchical clustering (method: average) based on a 75% ANI threshold, which represents a conservative boundary for genus/species level classification (<xref rid="B79" ref-type="bibr">Qin et al., 2014</xref>).</p>
      </sec>
      <sec>
        <title>Pan Genome Analysis</title>
        <p>Protein-coding gene families were defined as gene clusters with at least 70% sequence identity using three different methods (COG triangle, orthoMCL and bidirectional best-hit) as implemented in GET_HOMOLOGUES v 2.0 (<xref rid="B23" ref-type="bibr">Contreras-Moreira and Vinuesa, 2013</xref>). The core genome was defined as the set of genes present in at least 95% of the genomes. Likewise, the accessory genome set was defined as genes present in less than 95% of genomes. This analysis was performed at two levels: the complete 34 genome dataset, and on each of the ANI 75% clusters. To gain insights into the functional potential of the accessory genome, the core genome was subtracted from each of the 34 genomes and annotated the remaining genes using Gene Ontology (GO) terms (<xref rid="B9" ref-type="bibr">Ashburner et al., 2000</xref>). All plots were generated in the ggplot2 R package (<xref rid="B105" ref-type="bibr">Wickham, 2009</xref>).</p>
      </sec>
      <sec>
        <title>Functional Analysis of the Core and Accessory Genomes</title>
        <p>The core and accessory genomes were separated for each of the six 75% ANI clusters, and GO terms were assigned to both sets. Gene locus tags were used to map GO terms from the Pfam entries (supplied by InterProScan5 annotated file) for each genome. GO terms for each gene cluster was converted to their parent GO terms at the second level on a GO graph (go-basic.obo obtained from <ext-link ext-link-type="uri" xlink:href="http://geneontology.org/page/download-ontology">http://geneontology.org/page/download-ontology</ext-link>) (<xref rid="B95" ref-type="bibr">The Gene Ontology Consortium, 2015</xref>). Statistically significant functional terms between core and accessory genomes were determined by applying the Mann–Whitney–Wilcoxon test (<italic>p-value</italic> &lt;0.05). Results were also plotted with the ggplot2 R package (<xref rid="B105" ref-type="bibr">Wickham, 2009</xref>).</p>
      </sec>
      <sec>
        <title>Growth Curves, Minimum Inhibitory Concentration (MIC), and Expression of Arsenic Resistance Genes</title>
        <p>Growth curve assays were performed to determine the ability of <italic>Exiguobacterium</italic> SH31 to grow at different concentrations of arsenite (AsIII) and arsenate (AsV). Briefly, a liquid culture of <italic>Exiguobacterium</italic> SH31 grown to an OD<sub>600</sub> = 0.4 (LB medium) was diluted by adding liquid media supplemented with different concentrations of arsenic species: AsIII (NaAsO<sub>2</sub>; 4, 6, 10 mM) and AsV (Na<sub>2</sub>HAsO<sub>4</sub>; 25, 50, 100 mM) until reaching an OD<sub>600</sub> ≈ 0.004. Growth (25°C) was monitored in a microplate reader (TECAN Infinite 200 PRO Nanoquant) at 600 nm every 60 min over a 48-h period. MIC was determined from a bacterial culture grown in LB medium (OD<sub>600</sub> ≈ 0.004) by taking a 190 μL aliquot and diluting it with solutions of AsIII and AsV to final concentrations of 1–15 mM and 5–500 mM, respectively (200 μL final volume). Then, samples were incubated at 25°C for 72 h with constant agitation, and the OD<sub>600</sub> was measured in a TECAN Infinite 200 PRO Nanoquant.</p>
        <p>Finally, to determine the relative expression of genes known to be involved in arsenic resistance and present in <italic>Exiguobacterium</italic> SH31, the transcript levels of <italic>arsB, arsR, arsC</italic> and <italic>acr3</italic>, were quantified by qRT-PCR. <italic>Exiguobacterium</italic> SH31 was grown in LB medium at 25°C with constant agitation until reaching an OD<sub>600</sub> of 0.4. The culture was divided into three fractions: control, 3 mM NaAsO<sub>2</sub>, and 20 mM Na<sub>2</sub>HAsO<sub>4</sub>, and incubated for 20 min. RNA extraction was carried out using the Phenol/Chloroform method and RNA integrity was monitored using 1% agarose electrophoresis. cDNA was synthesized using the M-MLV Reverse Transcriptase kit (Promega) and Random Primer oligonucleotides hexamers (Invitrogen<sup>TM</sup>). The PCR reaction was carried out as follows: 10 min at 95°C followed by 40 amplification cycles (95°C × 30 s, 58°C × 30 s; 72°C × 30 s), and a final step of 95°C × 15 s; 25°C × 1 s; 70°C × 15 s and 95°C × 1 s) using primers specific for each gene (Primers in Supplementary Table <xref ref-type="supplementary-material" rid="SM2">S2</xref>). Transcript levels were quantified using the Brilliant II SYBR Green QPCR Master mix kit (Agilent Technologies) on a Stratagene Mx3000P thermal cycler. Relative expression was normalized using 16S rRNA gene expression levels (<xref rid="B78" ref-type="bibr">Pfaffl, 2001</xref>).</p>
      </sec>
      <sec>
        <title>Modeling and Alignment of ACR3</title>
        <p>Structural modeling and visualization of Acr3 from strains SH31 and S17 strains was performed using iterative threading assembly refinement (I-TASSER software) (<xref rid="B108" ref-type="bibr">Yang et al., 2015</xref>).</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>Strain SH31 showed a 99% similarity at the 16S rRNA gene sequence with <italic>Exiguobacterium aurantiacum</italic> DSM 6208 (type strain) and <italic>Exiguobacterium</italic> sp. S17 (Argentinian Altiplano), and was classified as a member of the <italic>Exiguobacterium</italic> genus. However, an <italic>in vitro</italic> DNA–DNA hybridization assay revealed that SH31 does not belong to the same species than <italic>E. aurantiacum</italic> DSM 6208 (39.5% similarity; threshold is 70% for species; <xref rid="B103" ref-type="bibr">Wayne et al., 1987</xref>; <xref rid="B42" ref-type="bibr">Goris et al., 2007</xref>).</p>
      <sec>
        <title>Genome Assembly and Nucleotide Identity Analysis</title>
        <p><italic>Exiguobacterium</italic> genomes range from 2.8 to 3.3 Mb in length with an average GC content of 46–53%. The genome of <italic>Exiguobacterium</italic> sp. strain SH31 resulted in 120 contigs totaling 3.03 Mb in length with a GC content of 51.6%. In agreement with what was found in other isolates, 2992 coding sequences (CDS; including 902 hypothetical proteins), 23 ribosomal RNA (rRNA) genes, and 49 transference RNA (tRNA) genes were identified in strain SH31. Most of the CDS found in <italic>Exiguobacterium</italic> sp. strain SH31 were annotated using the COG system (2,079 genes annotated; <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>).</p>
        <fig id="F1" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p><bold>(A)</bold> Circular map of the <italic>Exiguobacterium sp</italic>. SH31 draft genome (3031801 bases, 3214 genes, 23 rRNA and 51 tRNA). Gene functions were annotated based on COG categories: (A) RNA processing and modification 0.01%; (B) Chromatin structure and dynamics 0.03%; (C) Energy production and conversion 4.5%; (D) Cell cycle control, cell division, chromosome partitioning 1.9%; (E) Amino acid transport and metabolism 10.3%; (F) Nucleotide transport and metabolism 1.6%; (G) Carbohydrate transport and metabolism 5.6%; (H) Coenzyme transport and metabolism 3.6%; (I) Lipid transport and metabolism 1.4%; (J) Translation, ribosomal structure and biogenesis 3.3%; (K) Transcription 4.8%; (L) Replication, recombination and repair 3.9%; (M) Cell wall/membrane/envelope biogenesis 4.3%; (N) Cell motility 1.3%; (O) Posttranslational modification, protein turnover, chaperones 4.4%; (P) Inorganic ion transport and metabolism 12.6%; (Q) Secondary metabolites biosynthesis, transport and catabolism 2.5%; (R) General function prediction only 19.3%; (S) Unknown function 3.4%; (T) Signal transduction mechanisms 7.1%; (U) Intracellular trafficking, secretion, and vesicular transport 0.9%; (V) Defense mechanisms 3.3%; (W) Extracellular structures 0.0%; (Y) Nuclear structure 0.0%; (Z) Cytoskeleton 0.02%. <bold>(B)</bold> Average Nucleotide Identity of 34 <italic>Exiguobacterium</italic> isolates. <italic>Exiguobacterium</italic> sp. SH31 is very distinct and is most similar to isolate <italic>Exiguobacterium</italic> S17.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00456-g001"/>
        </fig>
        <p>To understand the overall genetic similarity of strain SH31 with members of the <italic>Exiguobacterium</italic> genus, an ANI analysis was conducted (<xref rid="B55" ref-type="bibr">Konstantinidis and Tiedje, 2005a</xref>,<xref rid="B56" ref-type="bibr">b</xref>; <xref rid="B42" ref-type="bibr">Goris et al., 2007</xref>; <xref rid="B81" ref-type="bibr">Richter and Rosselló-Mora, 2009</xref>) against other 33 publicly available <italic>Exiguobacterium</italic> genomes (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>). The analysis revealed distinct genomic clusters and that strain S17 was the most similar isolate to SH31 with a 95% ANI (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>), suggesting that they belong to the same species, according to the classification defined by <xref rid="B42" ref-type="bibr">Goris et al. (2007)</xref>. Strain S17 was isolated from a stromatolite sample of Lake Socompa in the Argentinian Altiplano (-24.525681, -68.207912), an environment with similar conditions to Salar de Huasco (<xref rid="B18" ref-type="bibr">Cabrol et al., 2007</xref>; <xref rid="B72" ref-type="bibr">Ordoñez et al., 2009</xref>; <xref rid="B4" ref-type="bibr">Albarracín et al., 2015</xref>). In general, as previously reported (<xref rid="B100" ref-type="bibr">Vishnivetskaya et al., 2009</xref>), isolates tended to cluster by habitat, i.e., strains isolated from cold environments were more similar to each other than to strains isolated from marine/alkaline/temperate environments, and vice versa. Using the proposed boundaries for species delimitation, i.e., 95% ANI (<xref rid="B97" ref-type="bibr">Varghese et al., 2015</xref>), 21 clusters were recognized. Because at a 95% ANI clusters were mostly composed of singletons, we used a more conservative estimate for species/genus boundary. Using a 75% ANI cut-off value, six clusters were obtained: <bold>cluster I</bold> (12 isolates) <italic>E.</italic> strain MH3, <italic>E. indicum</italic> RSA11, <italic>E. enclensis</italic> NIO-1103, <italic>E.</italic> strain OS-77, <italic>E.</italic> strain leaf 187, <italic>E. acetylicum</italic> DSM 20416, <italic>E.</italic> strain ZWU0009, <italic>E. indicum</italic> RSA42, <italic>E. acetylicum</italic> ZBG2, <italic>E.</italic> strain BCM-KP, <italic>E.</italic> strain RIT341, and <italic>E.</italic> strain leaf 196; <bold>cluster II</bold> (4 isolates) <italic>E. marinum</italic> DSM 16307, <italic>E.</italic> strain NG55, <italic>E.</italic> strain AT1b, and <italic>E.</italic> strain JLM-2; <bold>cluster III</bold> (7 isolates) <italic>E. oxidotolerans</italic> JCM 12280, <italic>E. antarcticum</italic> DSM 14480, <italic>E. antarcticum</italic> B7, <italic>E. undae</italic> DSM 14481, <italic>E. undae</italic> 190-11, <italic>E. sibiricum</italic> 7-3, and <italic>E. sibiricum</italic> 255-15; <bold>cluster IV</bold> (5 isolates) <italic>E. aurantiacum</italic> DSM 6208, <italic>E.</italic> strain 8-11-1, <italic>E.</italic> strain ZOR0005, <italic>E. alkaliphilum</italic> 12/1, and <italic>E.</italic> strain AB2; <bold>cluster V</bold> (2 isolates) <italic>E.</italic> strain SH31 and <italic>E.</italic> strain S17; <bold>cluster VI</bold> (4 isolates) <italic>E. mexicanum</italic> HUD, <italic>E. pavilionensis</italic> N139, <italic>E. pavilionensis</italic> RW-2, and <italic>E.</italic> strain GIC31.</p>
        <p>Because <italic>Exiguobacterium</italic> sp. SH31 thrives in an environment where it is exposed to multiple stress conditions including UV radiation, high salinity, and high temperature, among others, we hypothesized that its genome encoded known genetic determinants required for stress resistance/tolerance. Using BLAST searches against SwissProt protein sets for known stress related-genes, we found that strain SH31 possesses several genes encoding proteins related to the response or adaptation to oxidative stress detoxification (<italic>katA, katE, sodA, gpo, ahpC, ahpF, ohrR</italic>); DNA repair systems (<italic>uvrABC, mutLS, mutM, ruvAB, rec</italic> systems, <italic>ssb, lexA</italic>); photolyases (<italic>phrB, cry</italic>-DASH); photoprotective pigments (<italic>car, crt</italic> systems); osmotic stress (<italic>opu</italic> systems, <italic>putP, gltA, glnA, proC</italic>); heat shock (<italic>dnaJK, groLS, htpG, hrcA</italic>); cold shock (<italic>csp</italic>); capsule biosynthesis (<italic>capAD, pgaB, pgaC</italic>); and resistance to toxic compounds such as antibiotics (<italic>marR, liaRS</italic>) and heavy metals (arsenic <italic>arsA, arsB</italic>; cadmium <italic>cadA, cadC</italic>; copper <italic>copA, csoR</italic>; mercury <italic>merA, merB, merR</italic>; tellurium <italic>tehB, terC</italic>; chromium <italic>chrR, srpC</italic>). In agreement with the ANI analysis, strain SH31 shared many of these determinants with its closest relative, strain S17, including the <italic>acr3</italic> gene that encodes an accessory or secondary arsenic efflux pump (see <xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>).</p>
      </sec>
      <sec>
        <title>Phylogenetic Analysis of <italic>Exiguobacterium</italic> sp. Strain SH31</title>
        <p>We further investigated if members of the <italic>Exiguobacterium</italic> genus showed a similar pattern as in the ANI analysis, but under a phylogenetic framework. To avoid the detrimental effects of horizontally transferred genes in phylogenetic inference, 30 genes related to ribosome and replication were selected to infer the phylogenetic relationships of the group (Bayesian Inference, partitioned analysis; see Materials and Methods). Interestingly, the topology of the tree mirrors the classification proposed by <xref rid="B100" ref-type="bibr">Vishnivetskaya et al. (2009)</xref> and is consistent with the ANI results (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>; column 1 and 2). Some species seem to be monophyletic (<italic>E. undae; E. antarcticum; E. sibiricum</italic>), while others do not form monophyletic groups (<italic>E. indicum; E. acetylicum</italic>), suggesting that more extensive sampling and clearer taxonomic classification schemes are needed.</p>
        <fig id="F2" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p><bold>Multi-locus phylogenetic analysis of 34 <italic>Exiguobacterium</italic> isolates.</bold> Tree: Mid-point rooted phylogeny of <italic>Exiguobacterium</italic> recovers Group I and II phylogenetic groups. Note that <italic>Exiguobacterium</italic> sp. SH31 is part of Group II. <italic>Matrix</italic>: Distribution and copy number of stress-related genes among <italic>Exiguobacterium</italic> genomes. The first two columns indicate <xref rid="B100" ref-type="bibr">Vishnivetskaya et al., 2009</xref> groupings and 75% ANI clustering, respectively. Stress-related genes are color-coded by copy number.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00456-g002"/>
        </fig>
        <p>A previous work investigated the genomes of several <italic>Exiguobacterium</italic> strains to determine if there could be group-specific genes by using southernblot hybridization and <italic>Exiguobacterium sibiricum</italic> 255-15 as the reference strain. Group II does not contain the selected genes or may contain them with &lt;70% identity (<xref rid="B100" ref-type="bibr">Vishnivetskaya et al., 2009</xref>). Given the current availability of genome sequences, we set out to confirm if the group pattern found by <xref rid="B100" ref-type="bibr">Vishnivetskaya et al. (2009)</xref> was also present in our dataset. Using a bidirectional blast hit approach, 15 of the 16 genes described by <xref rid="B100" ref-type="bibr">Vishnivetskaya et al. (2009)</xref> were found to be present in both groups. This finding was confirmed by annotating those genes using the InterProScan5 suite, with similar results. The only gene found exclusively in one group was <italic>flgM</italic> (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Genes used as conservative markers of the two distinctive <italic>Exiguobacterium</italic> groups by <xref rid="B100" ref-type="bibr">Vishnivetskaya et al. (2009)</xref>.</p>
          </caption>
          <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">Function</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Gene ID<sup>∗</sup></th>
                <th valign="top" align="center" rowspan="1" colspan="1">Genes</th>
                <th valign="top" align="center" colspan="4" rowspan="1">Detectable homologous<hr/></th>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1"/>
                <th valign="top" align="center" colspan="2" rowspan="1">
                  <xref rid="B100" ref-type="bibr">Vishnivetskaya et al., 2009</xref>
                  <hr/>
                </th>
                <th valign="top" align="center" colspan="2" rowspan="1">This work<hr/></th>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1"/>
                <th valign="top" align="center" rowspan="1" colspan="1">Group I</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Group II</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Group I</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Group II</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Replication and repair</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0006</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>gyrA</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0005</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>gyrB</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2932</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>srmB/csh</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_3033</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>dnaB</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Transcription</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2463</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>flgM</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0137</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Anti-sigma factor</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0136</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>rpoE</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Translation and biogenesis</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0119</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>infA</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_1837</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>infB</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0047</td>
                <td valign="top" align="center" rowspan="1" colspan="1">RNA-binding S4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2427</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Sigma54 S30EA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Posttranslational modification,</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2147</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>tig</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">chaperones</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0781</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>dnaK</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2768</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>groL</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Signal transduction</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_0364</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>uspA</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">-</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Lipid metabolism</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Exig_2596</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <italic>desA</italic>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <attrib>
              <italic><sup>∗</sup>Gene IDs are given as defined in <ext-link ext-link-type="uri" xlink:href="http://genome.ornl.gov/microbial/exig/">http://genome.ornl.gov/microbial/exig/</ext-link>.</italic>
            </attrib>
          </table-wrap-foot>
        </table-wrap>
        <p>Using the same bidirectional BLAST-based approach and validation with InterProScan5, the genomes of all 34 <italic>Exiguobacterium</italic> strains were searched for the presence of stress-response genes. The analysis showed that there are differences between the two groups (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>; matrix), which were observed in <italic>katE, ohrA</italic> and <italic>gpo</italic> (oxidative stress compound detoxification), <italic>carD</italic> and <italic>crtB</italic> (pigment biosynthesis), <italic>capA</italic> (capsule biosynthesis), <italic>glnA</italic> (osmoadaptation), <italic>csp</italic> (cold shock), <italic>mutS</italic> and <italic>ruvB</italic> (DNA repair) genes. The copy number of stress-response genes correlated with the environmental conditions from where each strain was isolated, e.g., <italic>E. oxydotolerans</italic> genome encodes proteins required for the response to oxidative stress and <italic>E. antarcticum</italic> and <italic>E. sibiricum</italic> for cold shock. A full list of stress-response genes analyzed and their copy numbers is found in Supplementary Table <xref ref-type="supplementary-material" rid="SM3">S3</xref>.</p>
      </sec>
      <sec>
        <title>Pan Genome and Gene Ontology Analysis</title>
        <p>As the strains used for the analyses come from disparate environments (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>), we evaluated whether the core and accessory genome varied in size and biological function (by GO). <italic>Exiguobacterium</italic> genomes are highly divergent (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>), and hence, a pan genome analysis was conducted (at 70% identity; pan genome size = 7716). The analysis showed that the core genome is composed of 1,798 genes (23.3%) and the accessory genome of 5,918 genes (76.7%). The pan genome size and functional composition was also evaluated according to clusters defined at 75% ANI. Overall, pan genome size ranged from 22 to 50%, was consistent between groups, and increased according to the number of genomes within a cluster (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). Cluster V, which only includes the genomes of strains S17 and SH31, had the largest accessory genome sampled so far in the genus, explaining the increased genome size of strains in this cluster. These results highlight the high degree of variability in gene content among strains from the <italic>Exiguobacterium</italic> genus, and suggest that a more thorough sampling of the Altiplano region would likely yield novel gene families.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p>Pan genome results of the six <italic>Exiguobacterium</italic> strains clusters.</p>
          </caption>
          <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">Cluster</th>
                <th valign="top" align="center" rowspan="1" colspan="1"># Strains</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Pan genome</th>
                <th valign="top" align="center" rowspan="1" colspan="1">Core genome<sup>∗</sup></th>
                <th valign="top" align="center" rowspan="1" colspan="1">Accessory genome<sup>∗</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">I</td>
                <td valign="top" align="center" rowspan="1" colspan="1">12</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4684</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2722 (58,1%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1962 (41,9%)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">II</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3557</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2754 (77,4%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">803 (22,6%)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">III</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4310</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2615 (60,7%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1695 (39,3%)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">IV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3649</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2604 (71,4%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1045 (28,6%)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">V</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3632</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2466 (67,8%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1166 (32,2%)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">VI</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3658</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2814 (76,9%)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">844 (23,1%)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <attrib>
              <italic>Asterisks indicate the number of gene families (percentage of core or accessory genes on the pan genome of each cluster).</italic>
            </attrib>
          </table-wrap-foot>
        </table-wrap>
        <p>To further investigate the composition of the accessory genome, we interrogated gene distribution according to GO categories. Accessory genes related to the GO categories Binding and Catalytic Activity were more abundant within the accessory genome, while other functions such as Antioxidant Activity, Biological Regulation, and Cell Part were homogeneously distributed (Supplementary Figure <xref ref-type="supplementary-material" rid="SM5">S1A</xref>). Interestingly, the genomes of cluster V (strains SH31 and S17) showed a higher proportion of genes belonging to GO categories such as Catalytic activity, Cell part, Membrane, Metabolic process, Structural molecule activity, and Cellular process (Supplementary Figure <xref ref-type="supplementary-material" rid="SM5">S1B</xref>).</p>
      </sec>
      <sec>
        <title>Metal/Metalloid Response Genes in <italic>Exiguobacterium</italic> Genomes</title>
        <p>The genomes of all 34 strains were searched for the presence and patterns of metal/metalloid response genes, and whether their distribution matched the phylogenetic and ANI classifications. The analysis revealed the presence of several genes involved in metal/metalloid response, of which most were related to cobalt, zinc, cadmium, copper, mercury, tellurium, chromium, and arsenic resistance (Supplementary Table <xref ref-type="supplementary-material" rid="SM4">S4</xref>). Previous studies showed that strain S17 is resistant to arsenic (<xref rid="B11" ref-type="bibr">Belfiore et al., 2013</xref>; <xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>) and that it encodes a secondary arsenic efflux pump, named Acr3. Because SH31 and S17 are closely related, we investigated if strain SH31 and other members of the <italic>Exiguobacterium</italic> genus also encoded the genetic determinants required for arsenic resistance, including <italic>acr3</italic>. For this purpose, strain S17 was used as a reference. Based on the presence and identity of the genes and operon organization, two distinct patterns were observed. In most cases, these patterns matched the two phylogenetic groups described before, with the exception of <italic>E. marinum</italic> DSM 16307 from group II and <italic>E. indicum</italic> RSA42, <italic>E. antarcticum</italic> DSM 14480, and <italic>E. undae</italic> 190-11 from group I (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). The <italic>acr3</italic> (arsenite efflux pump) gene is less frequent in <italic>Exiguobacterium</italic> genomes and was only found in strains S17 and SH31, showing an identity of 94%.</p>
        <fig id="F3" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p><bold>Arsenic resistance genes in sequenced <italic>Exiguobacterium</italic> strains Genetic organization of the genes colored by function.</bold>
<italic>arsR</italic> arsenical resistance operon repressor; <italic>arsD</italic> arsenical resistance operon <italic>trans</italic>-acting repressor; <italic>arsA</italic> arsenical pump-driving ATPase; Fe–S putative iron sulfur protein; <italic>arsB</italic> arsenical pump membrane protein; <italic>arsC</italic> arsenate reductase; <italic>acr3</italic> arsenite efflux pump. Heat scale shows identity percentage of all strains sequence, using as reference the <italic>Exiguobacterium</italic> S17 genes. The first two columns indicate <xref rid="B100" ref-type="bibr">Vishnivetskaya et al. (2009)</xref> groupings and 75% ANI clustering, respectively.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00456-g003"/>
        </fig>
      </sec>
      <sec>
        <title>Arsenic Resistance and Expression of Genes Required for Arsenic Detoxification</title>
        <p>To determine if the presence of genes required for arsenic detoxification in strain SH31 correlated with increased arsenic resistance, we conducted growth curves with different As (III) and As (V) concentrations (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>) and determined the MIC for each compound. Strain SH31 was able to grow in media containing up to 10 mM As (III) and 100 mM As(V), indicating that it is resistant to arsenic. A similar result was observed for strain S17.</p>
        <fig id="F4" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p><bold>Arsenic resistance of strain SH31.</bold> Strain SH31 was grown in LB medium supplemented with different concentrations of As (III) <bold>(A)</bold> and As (V) <bold>(B)</bold>. OD<sub>600</sub> readings were recorded every hour during 48 h. The results represent the mean of three experiments. Growth in media without arsenic was used as a control.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00456-g004"/>
        </fig>
        <p>The high arsenic resistance of strain S17 has been explained in part by the presence of the <italic>acr3</italic> gene (<xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>). A structural analysis showed that Acr3 from strains SH31 and S17 have an amino acid sequence identity of 94% and that key amino acids are conserved between both proteins. For example, residues Arg264, Asp109, and Glu294 are part of the core transmembrane segment and together with Cys107 could be required for As (III) binding. However, some variations were observed at different sections of the protein, (locus_02597-SP17) i.e., residues H92Y, R187Q, A311D, S34V, and S164A. We speculate that S34V, and S164A could be regulated by serine kinases (Supplementary Figure <xref ref-type="supplementary-material" rid="SM6">S2</xref>).</p>
        <p>To gain insights into the mechanism of arsenic resistance, strain SH31 was grown to mid-exponential growth phase, challenged with 3 mM As (III) or 20 mM As (V), and the transcript levels of genes required for arsenic resistance were quantified by qRT-PCR (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>) and compared to the levels in untreated cells (control). The expression of <italic>arsB</italic>, encoding a membrane efflux transporter, increased in the presence of both As (III) and As (V), although in the later case a greater increase was observed (200 fold). Previous studies found a similar trend and showed that As (V) exposure resulted in higher transcript and protein levels of ArsB than with As (III) (<xref rid="B21" ref-type="bibr">Cleiss-Arnold et al., 2010</xref>; <xref rid="B11" ref-type="bibr">Belfiore et al., 2013</xref>; <xref rid="B8" ref-type="bibr">Andres and Bertin, 2016</xref>). No significant differences in the transcript levels of <italic>arsC</italic>, encoding arsenate reductase, were observed after As (V) exposure. Conversely, after As (III) exposure, <italic>arsC</italic> expression was strongly repressed. Previous studies reported that <italic>arsC</italic> is part of the <italic>ars</italic> operon in most bacteria (<xref rid="B75" ref-type="bibr">Páez-Espino et al., 2009</xref>; <xref rid="B57" ref-type="bibr">Kruger et al., 2013</xref>; <xref rid="B8" ref-type="bibr">Andres and Bertin, 2016</xref>); however, in the <italic>Exiguobacterium</italic> genus, <italic>arsC</italic> is not within the context of an operon (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). The expression of <italic>arsR</italic>, encoding the negative regulator of the <italic>ars</italic> operon, increased after As (III) exposure. As ArsR directly detects As (III) (<xref rid="B89" ref-type="bibr">Slyemi and Bonnefoy, 2012</xref>), this suggests that in strain SH31 As (III) exposure results in increased expression of the <italic>ars</italic> operon by decreasing the levels of ArsR.</p>
        <fig id="F5" position="float">
          <label>FIGURE 5</label>
          <caption>
            <p><bold>Expression of genes required for arsenic resistance in <italic>Exiguobacterium</italic> sp. SH31 in response to As(III) and As(V) exposure.</bold> Expression of the 16S rRNA gene was used as a normalizer. <sup>∗∗∗</sup><italic>p</italic> &lt; 0.001.</p>
          </caption>
          <graphic xlink:href="fmicb-08-00456-g005"/>
        </fig>
        <p>The expression of <italic>acr3</italic> increased after As (V), but not As (III) exposure, in strain SH31. Interestingly, it was proposed that <italic>acr3</italic> expression is constitutive in strain S17 and does not change in response to arsenic (<xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>). This suggests that the expression of genes required for arsenic resistance could be different in both strains, although we cannot rule out that the observed result is caused by different experimental conditions between the studies.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The Chilean Altiplano harbors a series of ‘extreme’ environmental conditions that configures a specific and unique microbiota (e.g., <xref rid="B34" ref-type="bibr">Dorador et al., 2013</xref>; <xref rid="B3" ref-type="bibr">Albarracín et al., 2016</xref>). <italic>Exiguobacterium</italic> is a frequently isolated from different environments including other saline wetlands (e.g., Cuatro Ciénagas: <xref rid="B80" ref-type="bibr">Rebollar et al., 2012</xref>), where it has been determined that genetic differentiation of <italic>Exiguobacterium</italic> are defined by the ecology of diverse habitats.</p>
      <p>Members of the <italic>Exiguobacterium</italic> genus carry a number of stress-related genetic determinants, including metal/metalloid resistance genes, which largely correlate with the phylogenetic structure (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). In particular, <italic>Exiguobacterium</italic> SH31 (Group II) encodes proteins required for arsenic resistance, including Acr3, which has only been described in <italic>Exiguobacterium</italic> S17 (<xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>) (<bold>Figures <xref ref-type="fig" rid="F3">3</xref></bold>, <bold><xref ref-type="fig" rid="F5">5</xref></bold>). We also found that the accessory genome of <italic>Exiguobacterium</italic> is large, and that the presence of genes involved in interactions with the environment (e.g., catalytic activity, binding, metabolic process) is variable (Supplementary Figure <xref ref-type="supplementary-material" rid="SM5">S1</xref>). Altogether, these results suggest that the <italic>Exiguobacterium</italic> genus is cosmopolitan, diverse, and possibly ancient, with a broad repertoire of genetic elements that allow them to efficiently adapt to local environmental conditions (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>).</p>
      <p><italic>Exiguobacterium</italic> strains showed variability in the GO categories related to adaptation, such as catalytic activity, transporter activity, nucleic acid binding, transcription factor activity, metabolic process, etc. Conversely, less variability was observed in the GO categories related to fundamental cellular functions, e.g., structural molecule activity, membrane constituents, macromolecular complex, cell parts, and biological regulation. In agreement with our findings, <xref rid="B110" ref-type="bibr">Yumoto et al. (2004)</xref> reported that <italic>E. oxidotolerans</italic> JCM 12280 differed from other closely related strains in their physiological and biochemical characteristics, e.g., growth temperature range, acid production from several substrates and enzymatic activities. Our analyses support these results, showing that <italic>E. oxidotolerans</italic> JCM 12280 appears to be distinct based on its phylogenetic position, ANI similarity, and stress-response gene repertoire.</p>
      <p>In agreement with the high levels of radiation that it must withstand in its environment (<xref rid="B44" ref-type="bibr">Hernández et al., 2016</xref>; <xref rid="B67" ref-type="bibr">Molina et al., 2016</xref>), the genome of strain SH31 comprises several genes encoding proteins required for UV radiation resistance, including the <italic>uvr, mut, rec</italic> and <italic>ruv</italic> systems; the <italic>ssb, lexA, phrB</italic> and <italic>cry-DASH</italic> genes, photoprotective pigments and those required for detoxifying oxidative stress (<xref rid="B59" ref-type="bibr">Kurth et al., 2015</xref>). Surprisingly, strain SH31 did not show any highly relevant distinctive features. For example, previous studies found four copies of <italic>ssb</italic> in the genome of strain S17 (<xref rid="B74" ref-type="bibr">Ordoñez et al., 2013</xref>, <xref rid="B73" ref-type="bibr">2015</xref>). In <italic>Deinococcus radiodurans</italic>, the presence of high copy numbers of <italic>ssb</italic> was proposed to be responsible for its superior radioresistance and DNA repair efficiency (<xref rid="B36" ref-type="bibr">Eggington et al., 2004</xref>; <xref rid="B25" ref-type="bibr">Cox and Battista, 2005</xref>; <xref rid="B70" ref-type="bibr">Norais et al., 2009</xref>). Long read sequencing technologies such as PacBio or Oxford Nanopores could aid in determining with certainty whether SH31 has experienced the duplication of gene families involved in stress response.</p>
      <p>Some <italic>Exiguobacterium</italic> strains are resistant to NaCl and heavy metals such as Pb, Cu, and Hg (<xref rid="B77" ref-type="bibr">Petrova et al., 2002</xref>; <xref rid="B12" ref-type="bibr">Bian et al., 2011</xref>). In particular, <italic>Exiguobacterium</italic> isolated from permafrost sediments in Russia and Canada that contained 0.001 – 2.9% of mercury carried the <italic>mer</italic> operon (<xref rid="B77" ref-type="bibr">Petrova et al., 2002</xref>). Our results show that all of the <italic>Exiguobacterium</italic> strains included in the analyses have the <italic>merA</italic> gene, but that only 6 strains had additional genes of the operon (Supplementary Table <xref ref-type="supplementary-material" rid="SM4">S4</xref>). The <italic>mer</italic> operon can be located in the chromosome, plasmids, or transposons, and has been studied as a mechanism of horizontal dissemination that confers a broad spectrum of mercury resistance among <italic>Bacillus</italic> and related species (<xref rid="B13" ref-type="bibr">Bogdanova et al., 2001</xref>). Other strains such as ZM-2, isolated from agricultural soils irrigated with tannery effluents in India, resist up to 12.4 mM of potassium chromate (<xref rid="B2" ref-type="bibr">Alam and Malik, 2008</xref>), and some isolates tolerate up to 1.5 mM and reduce 0.75 mM of Cr(VI) (<xref rid="B85" ref-type="bibr">Sarangi and Krishnan, 2008</xref>). Additionally, some <italic>Exiguobacterium</italic> isolates are able to reduce Cr(VI) anaerobically in a large range of temperatures, pH and salt concentrations (<xref rid="B76" ref-type="bibr">Pattanapipitpaisal et al., 2002</xref>; <xref rid="B71" ref-type="bibr">Okeke, 2008</xref>). Our comparative genomics approach confirms that all 34 <italic>Exiguobacterium</italic> strains possess the genes encoding proteins required for chromate reduction and efflux, namely <italic>chrR</italic> and <italic>srpC</italic>, respectively, which could be responsible for chromate resistance in this genus.</p>
      <p><italic>Exiguobacterium</italic> sp. SH31 is more closely related to the arsenic resistant strain S17 (<xref rid="B11" ref-type="bibr">Belfiore et al., 2013</xref>). The high arsenic resistance of strain S17 has been explained by an increased number of genes encoding proteins required to detoxify this toxic compound and by the presence of the <italic>acr3</italic> gene, which confers increased arsenite and arsenate resistance (10 and 150 mM, respectively; <xref rid="B11" ref-type="bibr">Belfiore et al., 2013</xref>; <xref rid="B73" ref-type="bibr">Ordoñez et al., 2015</xref>). In agreement, strain SH31 is also arsenic resistant, which could be explained by the presence of several proteins required for its detoxification, including Acr3.</p>
      <p>In the post-genomic era, high-throughput technologies have enabled researchers with the power to interrogate genomes from the dark matter of the microbial tree of life (<xref rid="B106" ref-type="bibr">Wu et al., 2009</xref>). Yet, the traditional use of morphology, phenotype, biochemical traits, and single-gene inferences to classify microorganisms implies that our current understanding of what constitutes a species or genus is imperfect (<xref rid="B46" ref-type="bibr">Hugenholtz et al., 2016</xref>). Herein, we show that using an extreme cut-off of 75% ANI in a relatively small dataset yielded as many as six clusters in an otherwise unified genus. While comparative genomics studies of polyextremohiles are needed to understand their distribution, evolutionary history, and biotechnological potential, thorough sampling designs, metagenomics-based studies, and functional assays such as those based on metabolomics, transcriptomics, and proteomics, will enable researchers to develop a systems level understanding of the patterns and processes leading to molecular adaptation.</p>
    </sec>
    <sec>
      <title>Author Contributions</title>
      <p>JF, PA, CD, and FR performed field work, processed samples and sequenced data; JC-S, EC-N, and CPS conceived and designed the study; JC-S, FR, and CS performed the experiments; JC-S, SV, DA, and EC-N analyzed data; RQ, FM, EC-N, CD, FR, and CPS contributed with reagents/materials/analysis tools; JC-S, CP-E, EC-N, FR, and CPS wrote the paper. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding.</bold> This research was sponsored by CONICYT (Comisión Nacional para la Investigación Científica y Tecnológica) grants: CPS was funded by CONICYT FONDECYT 1160315 and Universidad Andrés Bello UNAB DI-786-15/R grant; FR was funded by CONICYT FONDECYT 11100414; EC-N was funded by CONICYT 2014 PAI 82140008 and FONDECYT 11160905; CD was funded by FONDECYT 1110953 and 1140179; JC-S and CP-E were founded by 2015 CONICYT National Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>EC-N would like to thank the George Washington University’s high-performance computing facility, Colonial One, for providing data storage, support, and computing power for genomic analyses (<ext-link ext-link-type="uri" xlink:href="https://colonialone.gwu.edu/">colonialone.gwu.edu/</ext-link>). The authors would like to thank Eduardo H. Morales for critical reading and editing of the manuscript.</p>
    </ack>
    <fn-group>
      <fn id="fn01">
        <label>1</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://www.dsmz.de">www.dsmz.de</ext-link>
        </p>
      </fn>
      <fn id="fn02">
        <label>2</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://bioinf.comav.upv.es/seq_crumbs/index.html">http://bioinf.comav.upv.es/seq_crumbs/index.html</ext-link>
        </p>
      </fn>
      <fn id="fn03">
        <label>3</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="https://github.com/microgenomics/plotMyGBK">https://github.com/microgenomics/plotMyGBK</ext-link>
        </p>
      </fn>
      <fn id="fn04">
        <label>4</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/release/bioc/html/OmicCircos.html">http://bioconductor.org/packages/release/bioc/html/OmicCircos.html</ext-link>
        </p>
      </fn>
      <fn id="fn05">
        <label>5</label>
        <p>
          <ext-link ext-link-type="uri" xlink:href="https://github.com/widdowquinn/pyani">https://github.com/widdowquinn/pyani</ext-link>
        </p>
      </fn>
    </fn-group>
    <sec sec-type="supplementary material">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.00456/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2017.00456/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <media xlink:href="Table_1.XLSX">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <media xlink:href="Table_2.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM3">
        <media xlink:href="Table_3.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM4">
        <media xlink:href="Table_4.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM5">
        <media xlink:href="Image_1.PDF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM6">
        <media xlink:href="Image_2.PDF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>P.</given-names></name><name><surname>Acosta</surname><given-names>E.</given-names></name><name><surname>Dorador</surname><given-names>C. Y.</given-names></name><name><surname>Sommaruga</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Large differences in bacterial community composition among three nearby extreme waterbodies of the high Andean plateau.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>7</volume>:<issue>976</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.00976</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Malik</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Chromate resistance, transport and bioreduction by <italic>Exiguobacterium</italic> sp. ZM-2 isolated from agricultural soil irrigated with tannery effluent.</article-title>
<source><italic>J. Basic Microbiol.</italic></source>
<volume>48</volume>
<fpage>416</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1002/jobm.200800046</pub-id><pub-id pub-id-type="pmid">18759228</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarracín</surname><given-names>V.</given-names></name><name><surname>Gärtner</surname><given-names>W.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Forged under the sun: life and art of extremophiles from Andean Lakes.</article-title>
<source><italic>Photochem. Photobiol.</italic></source>
<volume>1</volume>
<fpage>14</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/php.12555</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarracín</surname><given-names>V.</given-names></name><name><surname>Kurth</surname><given-names>D.</given-names></name><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Belfiore</surname><given-names>C.</given-names></name><name><surname>Luccini</surname><given-names>E.</given-names></name><name><surname>Salum</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>High-up: a remote reservoir of microbial extremophiles in central Andean wetlands.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>1404</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.01404</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarracín</surname><given-names>V.</given-names></name><name><surname>Pathak</surname><given-names>G.</given-names></name><name><surname>Douki</surname><given-names>T.</given-names></name><name><surname>Cadet</surname><given-names>J.</given-names></name><name><surname>Borsarelli</surname><given-names>C.</given-names></name><name><surname>Gärtner</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Extremophilic <italic>Acinetobacter</italic> strains from high-altitude lakes in Argentinean Puna: remarkable UV-B resistance and efficient DNA damage repair.</article-title>
<source><italic>Orig. Life Evol. Biosph.</italic></source>
<volume>42</volume>
<fpage>201</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1007/s11084-012-9276-3</pub-id><pub-id pub-id-type="pmid">22644565</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>S.</given-names></name><name><surname>Gish</surname><given-names>W.</given-names></name><name><surname>Miller</surname><given-names>W.</given-names></name><name><surname>Myers</surname><given-names>E.</given-names></name><name><surname>Lipman</surname><given-names>D.</given-names></name></person-group> (<year>1990</year>). <article-title>Basic local alignment search tool.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>215</volume>
<fpage>403</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>C. R.</given-names></name><name><surname>Cook</surname><given-names>G. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Isolation and characterization of arsenate-reducing bacteria from arsenic-contaminated sites in New Zealand.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>48</volume>
<fpage>341</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-003-4205-3</pub-id><pub-id pub-id-type="pmid">15060729</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>J.</given-names></name><name><surname>Bertin</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>The microbial genomics of arsenic.</article-title>
<source><italic>FEMS Microbiol. Rev.</italic></source>
<volume>40</volume>
<fpage>299</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1093/femsre/fuv050</pub-id><pub-id pub-id-type="pmid">26790947</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>C.</given-names></name><name><surname>Blake</surname><given-names>J.</given-names></name><name><surname>Botstein</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>H.</given-names></name><name><surname>Cherry</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Gene ontology: tool for the unification of biology.</article-title>
<source><italic>Nat. Genet.</italic></source>
<volume>25</volume>
<fpage>25</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1038/7556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Müller</surname><given-names>D. B.</given-names></name><name><surname>Srinivas</surname><given-names>G.</given-names></name><name><surname>Garrido-Oter</surname><given-names>R.</given-names></name><name><surname>Potthoff</surname><given-names>E.</given-names></name><name><surname>Rott</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Functional overlap of the <italic>Arabidopsis</italic> leaf and root microbiota.</article-title>
<source><italic>Nature</italic></source>
<volume>528</volume>
<fpage>364</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1038/nature16192</pub-id><pub-id pub-id-type="pmid">26633631</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belfiore</surname><given-names>C.</given-names></name><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Farías</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Proteomic approach of adaptive response to arsenic stress in <italic>Exiguobacterium</italic> sp. S17, an extremophile strain isolated from a high-altitude Andean Lake stromatolite.</article-title>
<source><italic>Extremophiles</italic></source>
<volume>17</volume>
<fpage>421</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-013-0523-y</pub-id><pub-id pub-id-type="pmid">23525943</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><name><surname>Xing</surname><given-names>K.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Isolation and biodiversity of heavy metal tolerant endophytic bacteria from halotolerant plant species located in coastal shoal of Nantong.</article-title>
<source><italic>Wei Sheng Wu Xue Bao</italic></source>
<volume>51</volume>
<fpage>1538</fpage>–<lpage>1547</lpage>.<pub-id pub-id-type="pmid">22260052</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanova</surname><given-names>E.</given-names></name><name><surname>Minakhin</surname><given-names>L.</given-names></name><name><surname>Bass</surname><given-names>I.</given-names></name><name><surname>Volodin</surname><given-names>A.</given-names></name><name><surname>Hobman</surname><given-names>J.</given-names></name><name><surname>Nikiforov</surname><given-names>V.</given-names></name></person-group> (<year>2001</year>). <article-title>Class II broad-spectrum mercury resistance transposons in gram-positive bacteria from natural environments.</article-title>
<source><italic>Res. Microbiol.</italic></source>
<volume>152</volume>
<fpage>503</fpage>–<lpage>514</lpage>.<pub-id pub-id-type="doi">10.1016/S0921-2508(01)01224-4</pub-id><pub-id pub-id-type="pmid">11446519</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>K.</given-names></name><name><surname>Mesbah</surname><given-names>N.</given-names></name><name><surname>Wiegel</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Biodiversity of poly-extremophilic Bacteria: does combining the extremes of high salt, alkaline pH and elevated temperature approach a physico-chemical boundary for life?</article-title>
<source><italic>Saline Systems</italic></source>
<volume>5</volume>:<issue>9</issue>
<pub-id pub-id-type="doi">10.1186/1746-1448-5-9</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bull</surname><given-names>A.</given-names></name><name><surname>Asenjo</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Microbiology of hyper-arid environments: recent insights from the Atacama Desert. Chile.</article-title>
<source><italic>Antonie Van Leeuwenhoek</italic></source>
<volume>103</volume>
<fpage>1173</fpage>–<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1007/s10482-013-9911-7</pub-id><pub-id pub-id-type="pmid">23564162</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bull</surname><given-names>A. T.</given-names></name><name><surname>Asenjo</surname><given-names>J.</given-names></name><name><surname>Goodfellow</surname><given-names>M. Y.</given-names></name><name><surname>Gómez-Silva</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>The Atacama Desert: technical resources and the growing importance of novel microbial diversity.</article-title>
<source><italic>Annu. Rev. Microbiol.</italic></source>
<volume>70</volume>
<fpage>215</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-micro-102215-095236</pub-id><pub-id pub-id-type="pmid">27607552</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabria</surname><given-names>G.</given-names></name><name><surname>Argayosa</surname><given-names>V.</given-names></name><name><surname>Lazaro</surname><given-names>J.</given-names></name><name><surname>Argayosa</surname><given-names>A.</given-names></name><name><surname>Arcilla</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Draft genome sequence of haloalkaliphilic <italic>Exiguobacterium</italic> sp. strain AB2 from Manleluag Ophiolitic Spring. Philippines.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>2</volume>:<issue>e00840</issue>-14.<pub-id pub-id-type="doi">10.1128/genomeA.00840-14</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrol</surname><given-names>N.</given-names></name><name><surname>Wettergreen</surname><given-names>D.</given-names></name><name><surname>Warren-Rhodes</surname><given-names>K.</given-names></name><name><surname>Grin</surname><given-names>E.</given-names></name><name><surname>Moersch</surname><given-names>J.</given-names></name><name><surname>Diaz</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Life in the Atacama: searching for life with rovers (science overview).</article-title>
<source><italic>J. Geophys. Res. Biogeosci.</italic></source>
<volume>112</volume> G04S02. <pub-id pub-id-type="doi">10.1029/2006JG000298</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>A.</given-names></name><name><surname>Ramos</surname><given-names>R.</given-names></name><name><surname>Dall’Agnol</surname><given-names>H.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>de Castro Soares</surname><given-names>S.</given-names></name><name><surname>Santos</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Genome sequence of <italic>Exiguobacterium antarcticum</italic> B7, isolated from a biofilm in Ginger Lake, King George Island, Antarctica.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>194</volume>
<fpage>6689</fpage>–<lpage>6690</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01791-12</pub-id><pub-id pub-id-type="pmid">23144424</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalán</surname><given-names>J.</given-names></name><name><surname>Camarero</surname><given-names>L.</given-names></name><name><surname>Felip</surname><given-names>M.</given-names></name><name><surname>Pla</surname><given-names>S.</given-names></name><name><surname>Ventura</surname><given-names>M.</given-names></name><name><surname>Buchaca</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>High mountain lakes: extreme habitats and witnesses of environmental change.</article-title>
<source><italic>Limnetica</italic></source>
<volume>25</volume>
<fpage>551</fpage>–<lpage>584</lpage>.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleiss-Arnold</surname><given-names>J.</given-names></name><name><surname>Koechler</surname><given-names>S.</given-names></name><name><surname>Proux</surname><given-names>C.</given-names></name><name><surname>Fardeau</surname><given-names>M.</given-names></name><name><surname>Dillies</surname><given-names>M.</given-names></name><name><surname>Coppee</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Temporal transcriptomic response during arsenic stress in <italic>Herminiimonas arsenicoxydans</italic>.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>11</volume>:<issue>709</issue>
<pub-id pub-id-type="doi">10.1186/1471-2164-11-709</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>M.</given-names></name><name><surname>Lund</surname><given-names>B.</given-names></name><name><surname>Farrow</surname><given-names>J.</given-names></name><name><surname>Schleifer</surname><given-names>K.</given-names></name></person-group> (<year>1983</year>). <article-title>Chemotaxonomic study of an alkalophilic bacterium, <italic>Exiguobacterium aurantiacum</italic> gen. nov., sp. nov.</article-title>
<source><italic>J. Gen. Microbiol.</italic></source>
<volume>129</volume>
<fpage>2037</fpage>–<lpage>2042</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-129-7-2037</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras-Moreira</surname><given-names>B.</given-names></name><name><surname>Vinuesa</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>GET_HOMOLOGUES, a versatile software package for scalable and robust microbial pangenome analysis.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>79</volume>
<fpage>7696</fpage>–<lpage>7701</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02411-13</pub-id><pub-id pub-id-type="pmid">24096415</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordero</surname><given-names>R.</given-names></name><name><surname>Seckmeyer</surname><given-names>G.</given-names></name><name><surname>Damiani</surname><given-names>A.</given-names></name><name><surname>Riechelmann</surname><given-names>S.</given-names></name><name><surname>Rayas</surname><given-names>J.</given-names></name><name><surname>Labbe</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The world’s highest levels of surface UV.</article-title>
<source><italic>Photochem. Photobiol. Sci.</italic></source>
<volume>13</volume>
<fpage>70</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1039/c3pp50221j</pub-id><pub-id pub-id-type="pmid">24202188</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>M.</given-names></name><name><surname>Battista</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title><italic>Deinococcus radiodurans</italic> - the consummate survivor.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>3</volume>
<fpage>882</fpage>–<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1264</pub-id><pub-id pub-id-type="pmid">16261171</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dastager</surname><given-names>S.</given-names></name><name><surname>Mawlankar</surname><given-names>R.</given-names></name><name><surname>Sonalkar</surname><given-names>V.</given-names></name><name><surname>Thorat</surname><given-names>M.</given-names></name><name><surname>Mual</surname><given-names>P.</given-names></name><name><surname>Verma</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title><italic>Exiguobacterium enclense</italic> sp. nov., isolated from sediment.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>65</volume>
<fpage>1611</fpage>–<lpage>1616</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.000149</pub-id><pub-id pub-id-type="pmid">25716950</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Capua</surname><given-names>C.</given-names></name><name><surname>Bortolotti</surname><given-names>A.</given-names></name><name><surname>Farías</surname><given-names>M. E.</given-names></name><name><surname>Cortez</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>UV-resistant <italic>Acinetobacter</italic> sp. isolates from Andean wetlands display high catalase activity.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>317</volume>
<fpage>181</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2011.02231.x</pub-id><pub-id pub-id-type="pmid">21276048</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dib</surname><given-names>J.</given-names></name><name><surname>Motok</surname><given-names>J.</given-names></name><name><surname>Zenoff</surname><given-names>V.</given-names></name><name><surname>Ordonez</surname><given-names>O.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Occurrence of resistance to antibiotics, UV-B, and arsenic in bacteria isolated from extreme environments in high-altitude (above 4400 m) andean wetlands.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>56</volume>
<fpage>510</fpage>–<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-008-9103-2</pub-id><pub-id pub-id-type="pmid">18330637</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dib</surname><given-names>J.</given-names></name><name><surname>Weiss</surname><given-names>A.</given-names></name><name><surname>Neumann</surname><given-names>A.</given-names></name><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Estévez</surname><given-names>M.</given-names></name><name><surname>Farías</surname><given-names>M. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Isolation of bacteria from remote high altitude Andean lakes able to grow in the presence of antibiotics.</article-title>
<source><italic>Recent Pat. Antiinfect. Drug Discov.</italic></source>
<volume>4</volume>
<fpage>66</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.2174/157489109787236300</pub-id><pub-id pub-id-type="pmid">19149698</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Busekow</surname><given-names>A.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Imhoff</surname><given-names>J.</given-names></name><name><surname>Witzel</surname><given-names>K. P.</given-names></name></person-group> (<year>2008a</year>). <article-title>Molecular analysis of enrichment cultures of ammonia oxidizers from the Salar de Huasco, a high altitude saline wetland in northern Chile.</article-title>
<source><italic>Extremophiles</italic></source>
<volume>12</volume>
<fpage>405</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-008-0146-x</pub-id><pub-id pub-id-type="pmid">18305895</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Meneses</surname><given-names>D.</given-names></name><name><surname>Urtuvia</surname><given-names>V.</given-names></name><name><surname>Demergasso</surname><given-names>C.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Witzel</surname><given-names>K. P.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Diversity of Bacteroidetes in high altitude saline evaporitic basins in northern Chile.</article-title>
<source><italic>J. Geophys. Res.</italic></source>
<volume>114</volume> G00D05. <pub-id pub-id-type="doi">10.1029/2008JG000837</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Remonsellez</surname><given-names>F.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Imhoff</surname><given-names>J. F.</given-names></name><name><surname>Witzel</surname><given-names>K. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Unique clusters of Archaea in Salar de Huasco, an athalassohaline evaporitic basin of the Chilean Altiplano.</article-title>
<source><italic>FEMS Microbiol. Ecol.</italic></source>
<volume>73</volume>
<fpage>291</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6941.2010.00891.x</pub-id><pub-id pub-id-type="pmid">20491927</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Imhoff</surname><given-names>J. F.</given-names></name><name><surname>Witzel</surname><given-names>K. P.</given-names></name></person-group> (<year>2008b</year>). <article-title>Cyanobacterial diversity in Salar de Huasco, a high altitude saline wetland in northern Chile: an example of geographical dispersion?</article-title>
<source><italic>FEMS Microbiol. Ecol.</italic></source>
<volume>64</volume>
<fpage>419</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6941.2008.00483.x</pub-id><pub-id pub-id-type="pmid">18410357</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Witzel</surname><given-names>K. P.</given-names></name><name><surname>Imhoff</surname><given-names>J. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Bacterial and archaeal diversity in high altitude wetlands of the Chilean Altiplano.</article-title>
<source><italic>Fundam. Appl. Limnol.</italic></source>
<volume>182</volume>
<fpage>135</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1127/1863-9135/2013/0393</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duché</surname><given-names>O.</given-names></name><name><surname>Trémoulet</surname><given-names>F.</given-names></name><name><surname>Glaser</surname><given-names>P.</given-names></name><name><surname>Labadie</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Salt stress proteins induced in <italic>Listeria monocytogenes</italic>.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>68</volume>
<fpage>1491</fpage>–<lpage>1498</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.68.4.1491-1498.2002</pub-id><pub-id pub-id-type="pmid">11916660</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggington</surname><given-names>J.</given-names></name><name><surname>Haruta</surname><given-names>N.</given-names></name><name><surname>Wood</surname><given-names>E.</given-names></name><name><surname>Cox</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The single-stranded DNA-binding protein of <italic>Deinococcus radiodurans</italic>.</article-title>
<source><italic>BMC Microbiol.</italic></source>
<volume>4</volume>:<issue>2</issue><pub-id pub-id-type="doi">10.1186/1471-2180-4-2</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>M.</given-names></name><name><surname>Fernandez-Zenoff</surname><given-names>V.</given-names></name><name><surname>Flores</surname><given-names>R.</given-names></name><name><surname>Ordonez</surname><given-names>O.</given-names></name><name><surname>Estevez</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Impact of solar radiation on bacterioplankton in Laguna Vilama, a hypersaline Andean lake (4650 m).</article-title>
<source><italic>J. Geophys. Res.</italic></source>
<volume>114</volume>
<issue>G00D04</issue>
<pub-id pub-id-type="doi">10.1029/2008JG000784</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farías</surname><given-names>M. E.</given-names></name><name><surname>Rascovan</surname><given-names>N.</given-names></name><name><surname>Toneatti</surname><given-names>D. M.</given-names></name><name><surname>Albarracín</surname><given-names>V. H.</given-names></name><name><surname>Flores</surname><given-names>M. R.</given-names></name><name><surname>Poiré</surname><given-names>D. G.</given-names></name><etal/></person-group> (<year>2013</year>). The discovery of stromatolites developing at 3570 m above sea level in a high-altitude volcanic lake Socompa, Argentinean Andes.<source><italic>PLoS ONE</italic></source>
<volume>8</volume>:<issue>e53497</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0053497</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Zenoff</surname><given-names>V.</given-names></name><name><surname>Sineriz</surname><given-names>F.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Diverse responses to UV-B radiation and repair mechanisms of bacteria isolated from high-altitude aquatic environments.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>72</volume>
<fpage>7857</fpage>–<lpage>7863</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01333-06</pub-id><pub-id pub-id-type="pmid">17056692</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>M.</given-names></name><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Farías</surname><given-names>M. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Isolation of UV-B resistant bacteria from two high altitude Andean lakes (4,400 m) with saline and non saline conditions.</article-title>
<source><italic>J. Gen. Appl. Microbiol.</italic></source>
<volume>55</volume>
<fpage>447</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.2323/jgam.55.447</pub-id><pub-id pub-id-type="pmid">20118609</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourment</surname><given-names>M.</given-names></name><name><surname>Holmes</surname><given-names>E. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Seqotron: a user-friendly sequence editor for Mac OS X.</article-title>
<source><italic>BMC Res. Notes</italic></source>
<volume>9</volume>:<issue>106</issue>
<pub-id pub-id-type="doi">10.1186/s13104-016-1927-4</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goris</surname><given-names>J.</given-names></name><name><surname>Konstantinidis</surname><given-names>K.</given-names></name><name><surname>Klappenbach</surname><given-names>J.</given-names></name><name><surname>Coenye</surname><given-names>T.</given-names></name><name><surname>Vandamme</surname><given-names>P.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2007</year>). <article-title>DNA-DNA hybridization values and their relationship to whole-genome sequence similarities.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>57</volume>
<fpage>81</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.64483-0</pub-id><pub-id pub-id-type="pmid">17220447</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>I.</given-names></name><name><surname>Ichise</surname><given-names>N.</given-names></name><name><surname>Kojima</surname><given-names>K.</given-names></name><name><surname>Kondo</surname><given-names>H.</given-names></name><name><surname>Ohgiya</surname><given-names>S.</given-names></name><name><surname>Matsuyama</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Relationship between the size of the bottleneck 15 angstrom from iron in the main channel and the reactivity of catalase corresponding to the molecular size of substrates.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>46</volume>
<fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1021/bi061519w</pub-id><pub-id pub-id-type="pmid">17198371</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández</surname><given-names>K.</given-names></name><name><surname>Yannicelli</surname><given-names>B.</given-names></name><name><surname>Olsen</surname><given-names>L.</given-names></name><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Menschel</surname><given-names>E.</given-names></name><name><surname>Molina</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Microbial activity response to solar radiation across contrasting environmental conditions in Salar de Huasco, Northern Chilean Altiplano.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>7</volume>:<issue>1857</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.01857</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>C.</given-names></name><name><surname>Hsu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Niu</surname><given-names>K.</given-names></name><name><surname>Komatsoulis</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>OmicCircos: a simple-to-use R package for the circular visualization of multidimensional omics data.</article-title>
<source><italic>Cancer Inform.</italic></source>
<volume>13</volume>
<fpage>13</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.4137/CIN.S13495</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugenholtz</surname><given-names>P.</given-names></name><name><surname>Skarshewski</surname><given-names>A.</given-names></name><name><surname>Parks</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Genome-based microbial taxonomy coming of age.</article-title>
<source><italic>Cold Spring Harb. Perspect. Biol.</italic></source>
<volume>8</volume>:<issue>a018085</issue><pub-id pub-id-type="doi">10.1101/cshperspect.a018085</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>B. Y.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>B. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Screening of <italic>Exigubacterium acetylicum</italic> from soil samples showing enantioselective and alkalitolerant esterase activity.</article-title>
<source><italic>Biotechnol. Bioprocess Eng.</italic></source>
<volume>10</volume>
<fpage>367</fpage>–<lpage>371</lpage>.</mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyson</surname><given-names>P.</given-names></name><name><surname>Shapiro</surname><given-names>J.</given-names></name><name><surname>Wien</surname><given-names>M. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Draft genome sequence of <italic>Exiguobacterium</italic> sp. strain BMC-KP, an environmental isolate from Bryn Mawr, Pennsylvania.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>3</volume>:<issue>e01164</issue>-15. <pub-id pub-id-type="doi">10.1128/genomeA.01164-1115</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Genome sequence of a novel polymer-grade l-lactate-producing alkaliphile, <italic>Exiguobacterium</italic> sp. strain 8-11-1.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>1</volume>:<issue>e00616-13</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.00616-13</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>P.</given-names></name><name><surname>Binns</surname><given-names>D.</given-names></name><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>McAnulla</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>InterProScan 5: genome-scale protein function classification.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>30</volume>
<fpage>1236</fpage>–<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu031</pub-id><pub-id pub-id-type="pmid">24451626</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasana</surname><given-names>R. C.</given-names></name><name><surname>Yadav</surname><given-names>S. K.</given-names></name></person-group> (<year>2007</year>). <article-title>Isolation of a psychrotrophic <italic>Exiguobacterium</italic> sp. SKPB5 (MTCC 7803) and characterization of its alkaline protease.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>54</volume>
<fpage>224</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-006-0402-1</pub-id><pub-id pub-id-type="pmid">17294327</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K.</given-names></name><name><surname>Standley</surname><given-names>D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability.</article-title>
<source><italic>Mol. Biol. Evol.</italic></source>
<volume>30</volume>
<fpage>772</fpage>–<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id><pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearse</surname><given-names>M.</given-names></name><name><surname>Moir</surname><given-names>R.</given-names></name><name><surname>Wilson</surname><given-names>A.</given-names></name><name><surname>Stones-Havas</surname><given-names>S.</given-names></name><name><surname>Cheung</surname><given-names>M.</given-names></name><name><surname>Sturrock</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>28</volume>
<fpage>1647</fpage>–<lpage>1649</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts199</pub-id><pub-id pub-id-type="pmid">22543367</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolde</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <source><italic>pheatmap: Pretty Heatmaps. R Package Version</italic> 1.0.8</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pheatmap">https://CRAN.R-project.org/package=pheatmap</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinidis</surname><given-names>K. T.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2005a</year>). <article-title>Towards a genome-based taxonomy for prokaryotes.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>187</volume>
<fpage>6258</fpage>–<lpage>6264</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.18.6258-6264.2005</pub-id><pub-id pub-id-type="pmid">16159757</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinidis</surname><given-names>K. T.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2005b</year>). <article-title>Genomic insights that advance the species definition for prokaryotes.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>102</volume>
<fpage>2567</fpage>–<lpage>2572</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409727102</pub-id><pub-id pub-id-type="pmid">15701695</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>M.</given-names></name><name><surname>Bertin</surname><given-names>P. N.</given-names></name><name><surname>Heipieper</surname><given-names>H.</given-names></name><name><surname>Arsene-Ploetze</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Bacterial metabolism of environmental arsenic—mechanisms and biotechnological applications.</article-title>
<source><italic>Appl. Microbiol. Biotechnol.</italic></source>
<volume>97</volume>
<fpage>3827</fpage>–<lpage>3841</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-013-4838-5</pub-id><pub-id pub-id-type="pmid">23546422</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>“Characterization of an alkaliphile, <italic>Exiguobacterium</italic> sp. and it’s application in bioremediation”, in</article-title>
<source><italic>Proceedings of the International Conference on Extremophiles</italic></source>
<publisher-loc>Brest-France</publisher-loc>
<volume>115</volume>.</mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>D.</given-names></name><name><surname>Belfiore</surname><given-names>C.</given-names></name><name><surname>Gorriti</surname><given-names>M.</given-names></name><name><surname>Cortez</surname><given-names>N.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name><name><surname>Albarracín</surname><given-names>V. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Genomic and proteomic evidences unravel the UV-resistome of the poly-extremophile <italic>Acinetobacter</italic> sp. Ver3.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>328</issue><pub-id pub-id-type="doi">10.3389/fmicb.2015.00328</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtz</surname><given-names>S.</given-names></name><name><surname>Phillippy</surname><given-names>A.</given-names></name><name><surname>Delcher</surname><given-names>A.</given-names></name><name><surname>Smoot</surname><given-names>M.</given-names></name><name><surname>Shumway</surname><given-names>M.</given-names></name><name><surname>Antonescu</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Versatile and open software for comparing large genomes.</article-title>
<source><italic>Genome Biol.</italic></source>
<volume>5</volume>:<issue>R12</issue>
<pub-id pub-id-type="doi">10.1186/gb-2004-5-2-r12</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>L.</given-names></name><name><surname>Pozo</surname><given-names>C.</given-names></name><name><surname>Rodelas</surname><given-names>B.</given-names></name><name><surname>Calvo</surname><given-names>C.</given-names></name><name><surname>Juarez</surname><given-names>B.</given-names></name><name><surname>Martinez-Toledo</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Identification of bacteria isolated from an oligotrophic lake with pesticide removal capacities.</article-title>
<source><italic>Ecotoxicology</italic></source>
<volume>14</volume>
<fpage>299</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1007/s10646-003-6367-y</pub-id><pub-id pub-id-type="pmid">15943106</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>R.</given-names></name><name><surname>King</surname><given-names>A.</given-names></name><name><surname>Farías</surname><given-names>M. E.</given-names></name><name><surname>Sowell</surname><given-names>P.</given-names></name><name><surname>Vitry</surname><given-names>C.</given-names></name><name><surname>Schmidt</surname><given-names>S. K.</given-names></name></person-group> (<year>2012</year>). <article-title>The potential for microbial life in the highest-elevation (&gt; 6000 masl) mineral soils of the Atacama region.</article-title>
<source><italic>J. Geophys. Res. Atmos.</italic></source>
<volume>117</volume>
<issue>G02028</issue>
<pub-id pub-id-type="doi">10.1029/2012JG001961</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name><name><surname>Anderson</surname><given-names>J. B.</given-names></name><name><surname>DeWeese-Scott</surname><given-names>C.</given-names></name><name><surname>Fedorova</surname><given-names>N. D.</given-names></name><name><surname>Geer</surname><given-names>L. Y.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>CDD: a curated Entrez database of conserved domain alignments.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>31</volume>
<fpage>383</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg087</pub-id><pub-id pub-id-type="pmid">12520028</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Márquez-García</surname><given-names>M.</given-names></name><name><surname>Vila</surname><given-names>I.</given-names></name><name><surname>Hinojosa</surname><given-names>L. F.</given-names></name><name><surname>Mendez</surname><given-names>M. A.</given-names></name><name><surname>Carvajal</surname><given-names>J.</given-names></name><name><surname>Sabando</surname><given-names>M. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Distribution and seasonal fluctuations in the aquatic biodiversity of the southern Altiplano.</article-title>
<source><italic>Limnologica</italic></source>
<volume>39</volume>
<fpage>314</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.limno.2009.06.007</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midha</surname><given-names>S.</given-names></name><name><surname>Bansal</surname><given-names>K.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Patil</surname><given-names>P.</given-names></name><name><surname>Chaudhry</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Genomic resource of rice seed associated bacteria.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>1551</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.01551</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>A.</given-names></name><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Daugherty</surname><given-names>L.</given-names></name><name><surname>Fraser</surname><given-names>M.</given-names></name><name><surname>Hunter</surname><given-names>S.</given-names></name><name><surname>Lopez</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The InterPro protein families database: the classification resource after 15 years.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>43</volume>
<fpage>D213</fpage>–<lpage>D221</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1243</pub-id><pub-id pub-id-type="pmid">25428371</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>V.</given-names></name><name><surname>Hernández</surname><given-names>K.</given-names></name><name><surname>Dorador</surname><given-names>C.</given-names></name><name><surname>Eissler</surname><given-names>Y.</given-names></name><name><surname>Hengst</surname><given-names>M.</given-names></name><name><surname>Pérez</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Bacterial active community cycling in response to solar radiation and their influence on nutrient changes in a high-altitude wetland.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>7</volume>:<issue>1823</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.01823</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>E.</given-names></name><name><surname>Sutton</surname><given-names>G.</given-names></name><name><surname>Delcher</surname><given-names>A.</given-names></name><name><surname>Dew</surname><given-names>I.</given-names></name><name><surname>Fasulo</surname><given-names>D.</given-names></name><name><surname>Flanigan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>A whole-genome assembly of <italic>Drosophila</italic>.</article-title>
<source><italic>Science</italic></source>
<volume>287</volume>
<fpage>2196</fpage>–<lpage>2204</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5461.2196</pub-id><pub-id pub-id-type="pmid">10731133</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonaka</surname><given-names>K.</given-names></name><name><surname>Yoon</surname><given-names>K.</given-names></name><name><surname>Ogo</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Biochemical characterization of psychrophilic Mn-superoxide dismutase from newly isolated <italic>Exiguobacterium</italic> sp. OS-77.</article-title>
<source><italic>Extremophiles</italic></source>
<volume>18</volume>
<fpage>363</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-013-0621-x</pub-id><pub-id pub-id-type="pmid">24414928</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norais</surname><given-names>C.</given-names></name><name><surname>Chitteni-Pattu</surname><given-names>S.</given-names></name><name><surname>Wood</surname><given-names>E.</given-names></name><name><surname>Inman</surname><given-names>R.</given-names></name><name><surname>Cox</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>DdrB protein, an alternative <italic>Deinococcus radiodurans</italic> SSB induced by ionizing radiation.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>284</volume>
<fpage>21402</fpage>–<lpage>21411</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.010454</pub-id><pub-id pub-id-type="pmid">19515845</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>B. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Bioremoval of hexavalent chromium from water by a salt tolerant bacterium, <italic>Exiguobacterium</italic> sp. GS1.</article-title>
<source><italic>J. Ind. Microbiol. Biotechnol.</italic></source>
<volume>35</volume>
<fpage>1571</fpage>–<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-008-0399-5</pub-id><pub-id pub-id-type="pmid">18663504</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Flores</surname><given-names>M.</given-names></name><name><surname>Dib</surname><given-names>J.</given-names></name><name><surname>Paz</surname><given-names>A.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Extremophile culture collection from Andean lakes: extreme pristine environments that host a wide diversity of microorganisms with tolerance to UV radiation.</article-title>
<source><italic>Microb. Ecol.</italic></source>
<volume>58</volume>
<fpage>461</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1007/s00248-009-9527-7</pub-id><pub-id pub-id-type="pmid">19495855</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Lanzarotti</surname><given-names>E.</given-names></name><name><surname>Kurth</surname><given-names>D.</given-names></name><name><surname>Cortez</surname><given-names>N.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name><name><surname>Turjanski</surname><given-names>A. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Genome comparison of two <italic>Exiguobacterium</italic> strains from high altitudeandean lakes with different arsenic resistance: identification and 3Dmodeling of the Acr3 efflux pump.</article-title>
<source><italic>Front. Environ. Sci.</italic></source>
<volume>3</volume>:<issue>50</issue>
<pub-id pub-id-type="doi">10.3389/fenvs.2015.00050</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordoñez</surname><given-names>O.</given-names></name><name><surname>Lanzarotti</surname><given-names>E.</given-names></name><name><surname>Kurth</surname><given-names>D.</given-names></name><name><surname>Gorriti</surname><given-names>M.</given-names></name><name><surname>Revale</surname><given-names>S.</given-names></name><name><surname>Cortez</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Draft genome sequence of the polyextremophilic <italic>Exiguobacterium</italic> sp. strain S17, isolated from hyperarsenic lakes in the Argentinian Puna.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>1</volume>:<issue>e00480-13</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.00480-13</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Páez-Espino</surname><given-names>D.</given-names></name><name><surname>Tamames</surname><given-names>J.</given-names></name><name><surname>de Lorenzo</surname><given-names>V.</given-names></name><name><surname>Cánovas</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Microbial responses to environmental arsenic.</article-title>
<source><italic>Biometals</italic></source>
<volume>22</volume>
<fpage>117</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-008-9195-y</pub-id><pub-id pub-id-type="pmid">19130261</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattanapipitpaisal</surname><given-names>P.</given-names></name><name><surname>Mabbett</surname><given-names>A.</given-names></name><name><surname>Finlay</surname><given-names>J.</given-names></name><name><surname>Beswick</surname><given-names>A.</given-names></name><name><surname>Paterson-Beedle</surname><given-names>M.</given-names></name><name><surname>Essa</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Reduction of Cr (VI) and bioaccumulation of chromium by gram positive and gram negative microorganisms not previously exposed to Cr-stress.</article-title>
<source><italic>Environ. Technol.</italic></source>
<volume>23</volume>
<fpage>731</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1080/09593332308618367</pub-id><pub-id pub-id-type="pmid">12164635</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrova</surname><given-names>M.</given-names></name><name><surname>Mindlin</surname><given-names>S.</given-names></name><name><surname>Gorlenko</surname><given-names>Z.</given-names></name><name><surname>Kalyaeva</surname><given-names>E.</given-names></name><name><surname>Soina</surname><given-names>V.</given-names></name><name><surname>Bogdanova</surname><given-names>E. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Mercury-resistant bacteria from permafrost sediments and prospects for their use in comparative studies of mercury resistance determinants.</article-title>
<source><italic>Russ. J. Genet.</italic></source>
<volume>38</volume>
<fpage>1330</fpage>–<lpage>1334</lpage>.</mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>M. W.</given-names></name></person-group> (<year>2001</year>). <article-title>A new mathematical model for relative quantification in real-time RT–PCR.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>29</volume>:<issue>e45</issue>.</mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>A proposed genus boundary for the prokaryotes based on genomic insights.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>196</volume>
<fpage>2210</fpage>–<lpage>2215</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01688-14</pub-id><pub-id pub-id-type="pmid">24706738</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebollar</surname><given-names>E. A.</given-names></name><name><surname>Avitia</surname><given-names>M.</given-names></name><name><surname>Eguiarte</surname><given-names>L.</given-names></name><name><surname>González-González</surname><given-names>A.</given-names></name><name><surname>Mora</surname><given-names>L.</given-names></name><name><surname>Bonilla-Rosso</surname><given-names>G. Y.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Water–sediment niche differentiation in ancient marine lineages of <italic>Exiguobacterium</italic> endemic to the Cuatro Cienegas Basin.</article-title>
<source><italic>Environ. Microbiol.</italic></source>
<volume>14</volume>
<fpage>2323</fpage>–<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-2920.2012.02784.x</pub-id><pub-id pub-id-type="pmid">22639906</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>M.</given-names></name><name><surname>Rosselló-Mora</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Shifting the genomic gold standard for the prokaryotic species definition.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>106</volume>
<fpage>19126</fpage>–<lpage>19131</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906412106</pub-id><pub-id pub-id-type="pmid">19855009</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>D.</given-names></name><name><surname>Goris</surname><given-names>J.</given-names></name><name><surname>Vishnivetskaya</surname><given-names>T.</given-names></name><name><surname>Gilichinsky</surname><given-names>D.</given-names></name><name><surname>Thomashow</surname><given-names>M. F.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Characterization of <italic>Exiguobacterium</italic> isolates from the Siberian permafrost. Description of <italic>Exiguobacterium sibiricum</italic> sp. nov.</article-title>
<source><italic>Extremophiles</italic></source>
<volume>10</volume>
<fpage>285</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-005-0497-5</pub-id><pub-id pub-id-type="pmid">16489412</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothschild</surname><given-names>L. J.</given-names></name><name><surname>Mancinelli</surname><given-names>R. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Life in extreme environments.</article-title>
<source><italic>Nature</italic></source>
<volume>409</volume>
<fpage>1092</fpage>–<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1038/35059215</pub-id><pub-id pub-id-type="pmid">11234023</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rout</surname><given-names>S.</given-names></name><name><surname>Rai</surname><given-names>A.</given-names></name><name><surname>Humphreys</surname><given-names>P. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Draft genome sequence of alkaliphilic <italic>Exiguobacterium</italic> sp. strain HUD, isolated from a polymicrobial consortia.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>3</volume>:<issue>e01451</issue>-14. <pub-id pub-id-type="doi">10.1128/genomeA.01451-14</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarangi</surname><given-names>A.</given-names></name><name><surname>Krishnan</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Comparison of in vitro Cr (VI) reduction by CFEs of chromate resistant bacteria isolated from chromate contaminated soil.</article-title>
<source><italic>Bioresour. Technol.</italic></source>
<volume>99</volume>
<fpage>4130</fpage>–<lpage>4137</lpage>. <pub-id pub-id-type="doi">10.1016/j.biortech.2007.08.059</pub-id><pub-id pub-id-type="pmid">17920879</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Prokka: rapid prokaryotic genome annotation.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>30</volume>
<fpage>2068</fpage>–<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id><pub-id pub-id-type="pmid">24642063</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semova</surname><given-names>I.</given-names></name><name><surname>Carten</surname><given-names>J. D.</given-names></name><name><surname>Stombaugh</surname><given-names>J.</given-names></name><name><surname>Mackey</surname><given-names>L.</given-names></name><name><surname>Knight</surname><given-names>R.</given-names></name><name><surname>Farber</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish.</article-title>
<source><italic>Cell Host Microbe</italic></source>
<volume>12</volume>
<fpage>277</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2012.08.003</pub-id><pub-id pub-id-type="pmid">22980325</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seufferheld</surname><given-names>M. J.</given-names></name><name><surname>Alvarez</surname><given-names>H. M.</given-names></name><name><surname>Farias</surname><given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of polyphosphates in microbial adaptation to extreme environments.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>74</volume>
<fpage>5867</fpage>–<lpage>5874</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00501-08</pub-id><pub-id pub-id-type="pmid">18708516</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slyemi</surname><given-names>D.</given-names></name><name><surname>Bonnefoy</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>How prokaryotes deal with arsenic.</article-title>
<source><italic>Environ. Microbiol. Rep.</italic></source>
<volume>4</volume>
<fpage>571</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1111/j.1758-2229.2011.00300.x</pub-id><pub-id pub-id-type="pmid">23760928</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>S.</given-names></name><name><surname>Koyama</surname><given-names>N.</given-names></name></person-group> (<year>2000</year>). <article-title>Purification and properties of a novel azide-sensitive ATPase of <italic>Exiguobacterium aurantiacum</italic>.</article-title>
<source><italic>Arch. Microbiol.</italic></source>
<volume>173</volume>
<fpage>200</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1007/s002039900129</pub-id><pub-id pub-id-type="pmid">10763752</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukumaran</surname><given-names>J.</given-names></name><name><surname>Holder</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>DendroPy: a python library for phylogenetic computing.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>26</volume>
<fpage>1569</fpage>–<lpage>1571</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq228</pub-id><pub-id pub-id-type="pmid">20421198</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takebe</surname><given-names>F.</given-names></name><name><surname>Hara</surname><given-names>I.</given-names></name><name><surname>Matsuyama</surname><given-names>H.</given-names></name><name><surname>Yumoto</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of H2O2 under low- and high-aeration-level conditions on growth and catalase activity in <italic>Exiguobacterium oxidotolerans</italic> T-2-2T.</article-title>
<source><italic>J. Biosci. Bioeng.</italic></source>
<volume>104</volume>
<fpage>464</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1263/jbb.104.464</pub-id><pub-id pub-id-type="pmid">18215632</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Meng</surname><given-names>H.</given-names></name><name><surname>Xue</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Complete genome sequence of <italic>Exiguobacterium</italic> sp. strain MH3, isolated from rhizosphere of <italic>Lemna minor</italic>.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>1</volume>:<issue>e01059-13</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.01059-13</pub-id></mixed-citation>
      </ref>
      <ref id="B94">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatusova</surname><given-names>T.</given-names></name><name><surname>DiCuccio</surname><given-names>M.</given-names></name><name><surname>Badretdin</surname><given-names>A.</given-names></name><name><surname>Chetvernin</surname><given-names>V.</given-names></name><name><surname>Nawrocki</surname><given-names>E.</given-names></name><name><surname>Zaslavsky</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>NCBI prokaryotic genome annotation pipeline.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>1</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw569</pub-id></mixed-citation>
      </ref>
      <ref id="B95">
        <mixed-citation publication-type="journal"><collab>The Gene Ontology Consortium</collab> (<year>2015</year>). <article-title>Gene ontology consortium: going forward.</article-title>
<source><italic>Nucleic acids Res.</italic></source>
<volume>43</volume>
<fpage>D1049</fpage>–<lpage>D1056</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id><pub-id pub-id-type="pmid">25428369</pub-id></mixed-citation>
      </ref>
      <ref id="B96">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usuda</surname><given-names>Y.</given-names></name><name><surname>Kawasaki</surname><given-names>H.</given-names></name><name><surname>Shimaoka</surname><given-names>M.</given-names></name><name><surname>Utagawa</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Molecular characterization of guanosine kinase gene from a facultative alkalophile, <italic>Exiguobacterium aurantiacum</italic> ATCC 35652.</article-title>
<source><italic>Biochim. Biophys. Acta</italic></source>
<volume>1442</volume>
<fpage>373</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-4781(98)00166-3</pub-id><pub-id pub-id-type="pmid">9804993</pub-id></mixed-citation>
      </ref>
      <ref id="B97">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>N.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Ivanova</surname><given-names>N.</given-names></name><name><surname>Konstantinidis</surname><given-names>K.</given-names></name><name><surname>Mavrommatis</surname><given-names>K.</given-names></name><name><surname>Kyrpides</surname><given-names>N. C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Microbial species delineation using whole genome sequences.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>43</volume>
<fpage>6761</fpage>–<lpage>6771</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv657</pub-id><pub-id pub-id-type="pmid">26150420</pub-id></mixed-citation>
      </ref>
      <ref id="B98">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>T. A.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name><name><surname>Layton</surname><given-names>A.</given-names></name><name><surname>Pfiffner</surname><given-names>S.</given-names></name><name><surname>Huntemann</surname><given-names>M.</given-names></name><name><surname>Copeland</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Draft genome sequences of 10 strains of the genus <italic>Exiguobacterium</italic>.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>2</volume>:<issue>e01058-14</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.01058-14</pub-id></mixed-citation>
      </ref>
      <ref id="B99">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>T. A.</given-names></name><name><surname>Kathariou</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Putative transposases conserved in <italic>Exiguobacterium</italic> isolates from ancient Siberian permafrost and from contemporary surface habitats.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>71</volume>
<fpage>6954</fpage>–<lpage>6962</lpage>.<pub-id pub-id-type="doi">10.1128/AEM.71.11.6954-6962.2005</pub-id><pub-id pub-id-type="pmid">16269730</pub-id></mixed-citation>
      </ref>
      <ref id="B100">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>T. A.</given-names></name><name><surname>Kathariou</surname><given-names>S.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name></person-group> (<year>2009</year>). <article-title>The <italic>Exiguobacterium</italic> genus: biodiversity and biogeography.</article-title>
<source><italic>Extremophiles</italic></source>
<volume>13</volume>
<fpage>541</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-009-0243-5</pub-id><pub-id pub-id-type="pmid">19381755</pub-id></mixed-citation>
      </ref>
      <ref id="B101">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>T. A.</given-names></name><name><surname>Lucas</surname><given-names>S.</given-names></name><name><surname>Copeland</surname><given-names>A.</given-names></name><name><surname>Lapidus</surname><given-names>A.</given-names></name><name><surname>Glavina del Rio</surname><given-names>T.</given-names></name><name><surname>Dalin</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Complete genome sequence of the Thermophilic Bacterium <italic>Exiguobacterium</italic> sp. AT1b.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>193</volume>
<fpage>2880</fpage>–<lpage>2881</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00303-11</pub-id><pub-id pub-id-type="pmid">21460088</pub-id></mixed-citation>
      </ref>
      <ref id="B102">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>T. A.</given-names></name><name><surname>Siletzky</surname><given-names>R.</given-names></name><name><surname>Jefferies</surname><given-names>N.</given-names></name><name><surname>Tiedje</surname><given-names>J. M.</given-names></name><name><surname>Kathariou</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of low temperature and culture media on the growth and freeze-thawing tolerance of <italic>Exiguobacterium</italic> strains.</article-title>
<source><italic>Cryobiology</italic></source>
<volume>54</volume>
<fpage>234</fpage>–<lpage>240</lpage>.<pub-id pub-id-type="doi">10.1016/j.crybiol.2007.01.008</pub-id><pub-id pub-id-type="pmid">17382311</pub-id></mixed-citation>
      </ref>
      <ref id="B103">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wayne</surname><given-names>L.</given-names></name><name><surname>Brenner</surname><given-names>D.</given-names></name><name><surname>Colwell</surname><given-names>R.</given-names></name><name><surname>Grimont</surname><given-names>P.</given-names></name><name><surname>Kandler</surname><given-names>O.</given-names></name><name><surname>Krichevsky</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1987</year>). <article-title>Report of the ad hoc committee on reconciliation of approaches to bacterial systematics.</article-title>
<source><italic>Int. J. Syst. Bacteriol.</italic></source>
<volume>37</volume>
<fpage>463</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1099/00207713-37-4-463</pub-id></mixed-citation>
      </ref>
      <ref id="B104">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>R.</given-names></name><name><surname>Grassa</surname><given-names>C.</given-names></name><name><surname>Suttle</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Draft genome sequence of <italic>Exiguobacterium pavilionensis</italic> strain RW-2, with wide thermal, salinity, and pH tolerance, isolated from modern freshwater microbialites.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>1</volume>:<issue>e00597-13</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.00597-13</pub-id></mixed-citation>
      </ref>
      <ref id="B105">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <source><italic>ggplot2: Elegant Graphics for Data Analysis</italic>.</source>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B106">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Hugenholtz</surname><given-names>P.</given-names></name><name><surname>Mavromatis</surname><given-names>K.</given-names></name><name><surname>Pukall</surname><given-names>R.</given-names></name><name><surname>Dalin</surname><given-names>E.</given-names></name><name><surname>Ivanova</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea.</article-title>
<source><italic>Nature</italic></source>
<volume>462</volume>
<fpage>1056</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1038/nature08656</pub-id><pub-id pub-id-type="pmid">20033048</pub-id></mixed-citation>
      </ref>
      <ref id="B107">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Scott</surname><given-names>A. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Phylogenomic analysis of bacterial and archaeal sequences with AMPHORA2.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>28</volume>
<fpage>1033</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts079</pub-id><pub-id pub-id-type="pmid">22332237</pub-id></mixed-citation>
      </ref>
      <ref id="B108">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Poisson</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>The I-TASSER Suite: protein structure and function prediction.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>12</volume>
<fpage>7</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nmeth.3213</pub-id><pub-id pub-id-type="pmid">25549265</pub-id></mixed-citation>
      </ref>
      <ref id="B109">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Guan</surname><given-names>Y.</given-names></name><name><surname>Lam</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data.</article-title>
<source><italic>Methods Ecol. Evol.</italic></source>
<volume>8</volume>
<fpage>28</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1111/2041-210X.12628</pub-id></mixed-citation>
      </ref>
      <ref id="B110">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yumoto</surname><given-names>I.</given-names></name><name><surname>Hishinuma-Narisawa</surname><given-names>M.</given-names></name><name><surname>Hirota</surname><given-names>K.</given-names></name><name><surname>Shingyo</surname><given-names>T.</given-names></name><name><surname>Takebe</surname><given-names>F.</given-names></name><name><surname>Nodasaka</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title><italic>Exiguobacterium oxidotolerans</italic> sp. nov., a novel alkaliphile exhibiting high catalase activity.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>54</volume>
<fpage>2013</fpage>–<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.63129-0</pub-id><pub-id pub-id-type="pmid">15545426</pub-id></mixed-citation>
      </ref>
      <ref id="B111">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenoff</surname><given-names>V.</given-names></name><name><surname>Heredia</surname><given-names>J.</given-names></name><name><surname>Ferrero</surname><given-names>M.</given-names></name><name><surname>Sineriz</surname><given-names>F.</given-names></name><name><surname>Farias</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Diverse UV-B resistance of culturable bacterial community from high-altitude wetland water.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>52</volume>
<fpage>359</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-005-0241-5</pub-id><pub-id pub-id-type="pmid">16604419</pub-id></mixed-citation>
      </ref>
      <ref id="B112">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Huo</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Draft genome sequence of Thermophilic <italic>Exiguobacterium</italic> sp. strain JLM-2, isolated from deep-sea ferromanganese nodules.</article-title>
<source><italic>Genome Announc.</italic></source>
<volume>3</volume>:<issue>e00794-15</issue>
<pub-id pub-id-type="doi">10.1128/genomeA.00794-15</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360011</identifier><datestamp>2017-04-04</datestamp><setSpec>fronthumneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Hum Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Hum Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Human Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5161</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360011</article-id>
      <article-id pub-id-type="pmcid">PMC5360011</article-id>
      <article-id pub-id-type="pmc-uid">5360011</article-id>
      <article-id pub-id-type="doi">10.3389/fnhum.2017.00132</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Increased Evoked Potentials to Arousing Auditory Stimuli during Sleep: Implication for the Understanding of Dream Recall</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vallat</surname>
            <given-names>Raphael</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/413465/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lajnef</surname>
            <given-names>Tarek</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/211927/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eichenlaub</surname>
            <given-names>Jean-Baptiste</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/87227/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berthomier</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/202604/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jerbi</surname>
            <given-names>Karim</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1676/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morlet</surname>
            <given-names>Dominique</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/43911/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruby</surname>
            <given-names>Perrine M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/28767/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Brain Dynamics and Cognition Team—Lyon Neuroscience Research Center (CRNL), INSERM U1028, CNRS UMR 5292, Centre Hospitalier Le Vinatier (Bat. 452)</institution>
        <country>Bron, France</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Lyon 1 University</institution>
        <country>Lyon, France</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>LETI Lab, Sfax National Engineering School, University of Sfax</institution>
        <country>Sfax, Tunisia</country>
      </aff>
      <aff id="aff4">
        <sup>4</sup>
        <institution>Department of Psychology, Université de Montréal</institution>
        <country>Montréal, QC, Canada</country>
      </aff>
      <aff id="aff5">
        <sup>5</sup>
        <institution>Department of Neurology, Massachusetts General Hospital, Harvard Medical School</institution>
        <country>Boston, MA, USA</country>
      </aff>
      <aff id="aff6">
        <sup>6</sup>
        <institution>Physip</institution>
        <country>Paris, France</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Juliana Yordanova, Institute of Neurobiology (BAS), Bulgaria</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Axel Steiger, Max Planck Institute of Psychiatry, Germany; Luigi De Gennaro, Sapienza University of Rome, Italy</p>
        </fn>
        <corresp id="fn001">*Correspondence: Perrine M. Ruby <email xlink:type="simple">perrine.ruby@inserm.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>132</elocation-id>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>2</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Vallat, Lajnef, Eichenlaub, Berthomier, Jerbi, Morlet and Ruby.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Vallat, Lajnef, Eichenlaub, Berthomier, Jerbi, Morlet and Ruby</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>High dream recallers (HR) show a larger brain reactivity to auditory stimuli during wakefulness and sleep as compared to low dream recallers (LR) and also more intra-sleep wakefulness (ISW), but no other modification of the sleep macrostructure. To further understand the possible causal link between brain responses, ISW and dream recall, we investigated the sleep microstructure of HR and LR, and tested whether the amplitude of auditory evoked potentials (AEPs) was predictive of arousing reactions during sleep. Participants (18 HR, 18 LR) were presented with sounds during a whole night of sleep in the lab and polysomnographic data were recorded. Sleep microstructure (arousals, rapid eye movements (REMs), muscle twitches (MTs), spindles, KCs) was assessed using visual, semi-automatic and automatic validated methods. AEPs to arousing (awakenings or arousals) and non-arousing stimuli were subsequently computed. No between-group difference in the microstructure of sleep was found. In N2 sleep, auditory arousing stimuli elicited a larger parieto-occipital positivity and an increased late frontal negativity as compared to non-arousing stimuli. As compared to LR, HR showed more arousing stimuli and more long awakenings, regardless of the sleep stage but did not show more numerous or longer arousals. These results suggest that the amplitude of the brain response to stimuli during sleep determine subsequent awakening and that awakening duration (and not arousal) is the critical parameter for dream recall. Notably, our results led us to propose that the minimum necessary duration of an awakening during sleep for a successful encoding of dreams into long-term memory is approximately 2 min.</p>
      </abstract>
      <kwd-group>
        <kwd>EEG</kwd>
        <kwd>dreaming</kwd>
        <kwd>awakenings</kwd>
        <kwd>arousals</kwd>
        <kwd>sleep</kwd>
        <kwd>oddball paradigm</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">Agence Nationale de la Recherche<named-content content-type="fundref-id">10.13039/501100001665</named-content></funding-source>
          <award-id rid="cn001">ANR-07-JCJC-0095</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="57"/>
        <page-count count="12"/>
        <word-count count="9869"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="s1">
      <title>Introduction</title>
      <p>Nearly everyone has awakened once with a dream in mind. The dream recall frequency however can vary substantially between individuals and even within one person from time to time. For more than a century, researchers have investigated whether some psychological parameters could explain dream recall frequency variability (for a review see Ruby, <xref rid="B46" ref-type="bibr">2011</xref>), but it’s only recently that physiological parameters have been considered. Using Electroencephalogram (EEG) and PET we found neurophysiological differences between high dream-recallers (HR) and low dream-recallers (LR) during both sleep and wakefulness (Ruby et al., <xref rid="B48" ref-type="bibr">2013b</xref>; Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>,<xref rid="B29" ref-type="bibr">b</xref>). Notably, during wakefulness, in response to auditory novel stimuli, the attention-orienting brain response (P3a) and a late parietal component were found to be larger in HR than in LR. During sleep, between-group differences were also observed for auditory evoked potentials (AEPs) to the same stimuli, at the latency of the P3a in N2 and at later latencies during all sleep stages. Finally, at the behavioral level HR showed more intra-sleep wakefulness (ISW) than LR (~15 min more on average, see Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>).</p>
      <p>Taken together, these results suggest a causal link between neurophysiological responses to auditory stimuli and ISW. We proposed that this link could be subserved by the amplitude of the brain response to external stimuli (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>), and hypothesized that large neurophysiological responses to sounds during sleep are responsible for subsequent awakenings. Indeed, Bastuji et al. (<xref rid="B10" ref-type="bibr">2008</xref>) demonstrated that during sleep (N2 and rapid eye movements (REMs)), the amplitude of a late parietal positive component (450–650 ms) in response to painful stimulation was significantly enhanced in trials that were followed by an arousing reaction (be it a short arousal of 3–15 s or an awakening lasting more than 15 s). The authors concluded that laser-evoked response to nociceptive stimuli during sleep predicted subsequent arousing reactions. However, such results remain to be demonstrated for auditory stimuli. This hypothesis was not tested in our previous study because of a too small number of sounds followed by an awakening which prevented us from computing reliable AEPs (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>). Awakenings (lasting at least 15 s by definition) are indeed far less frequent for auditory stimuli than for painful stimuli (Bastuji et al., <xref rid="B10" ref-type="bibr">2008</xref>). Nonetheless, considering that arousals (short awakenings lasting less than 15 s) are also far more frequent than full awakenings (twice more numerous in Bastuji et al.’s (<xref rid="B10" ref-type="bibr">2008</xref>) study), we hoped that considering arousals in addition to awakenings would allow us to investigate event-related potentials (ERPs) to auditory arousing stimuli (which are far more frequent than painful stimuli during sleep in everyday life).</p>
      <p>Mechanisms responsible for arousing reactions are important to consider regarding dream recall since the arousal-retrieval model postulates that ISW is the enabling factor for dreams to be encoded in long term memory (Koulack and Goodenough, <xref rid="B39" ref-type="bibr">1976</xref>). Previous results from our group and other teams (Schredl et al., <xref rid="B50" ref-type="bibr">2003</xref>; De Gennaro et al., <xref rid="B26" ref-type="bibr">2010</xref>) argue in favor of this hypothesis but several parameters remain to be investigated to clarify and strengthen our understanding of the link between ISW and dream recall. Notably, sleep macro and microstructure need to be exhaustively investigated to identify or exclude the involvement of other sleep parameters in dream recall, and to specify the characteristics of awakenings associated with a higher dream recall frequency (e.g., distribution in the sleep cycle, duration and alpha frequency).</p>
      <p>The goals of the present study were to further investigate the hypothesis of a causal link between AEPs and subsequent arousing reactions (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>) and the hypothesis of a causal link between ISW and dream recall (Koulack and Goodenough, <xref rid="B39" ref-type="bibr">1976</xref>; Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>). To this purpose, we first scored arousals in data previously acquired and reported in Eichenlaub et al. (<xref rid="B28" ref-type="bibr">2014a</xref>), to have a full assessment of the arousing reactions in the subjects’ sleep. Thanks to this scoring, AEPs to arousing stimuli (i.e., stimuli followed by an arousal or a full awakening in the first 15 s post stimulus) and to non-arousing stimuli were then computed. Second, several parameters of the sleep macrostructure were computed such as the distribution of awakenings and the number of stage shifts across the sleep cycle, spectral power of the delta rhythm during the first sleep cycle, frequency and spectral power of the alpha rhythm during intra-sleep and before-sleep wakefulness (BSW). Finally, as many previous results justified to investigate sleep microstructural components regarding dream recall, a thorough analysis of the sleep microstructure of HR and LR was conducted. Sleep spindles and the alpha frequency during wakefulness have been related to memory abilities (Klimesch, <xref rid="B38" ref-type="bibr">1997</xref>; Ulrich, <xref rid="B52" ref-type="bibr">2016</xref>), the REMs of REM sleep to dream content (Dement and Kleitman, <xref rid="B27" ref-type="bibr">1957</xref>; Roffwarg et al., <xref rid="B45" ref-type="bibr">1962</xref>; Molinari and Foulkes, <xref rid="B42" ref-type="bibr">1969</xref>), K-complexes (KCs) to sleep stability (Bastien et al., <xref rid="B7" ref-type="bibr">2000</xref>; Colrain, <xref rid="B18" ref-type="bibr">2005</xref>; Halász, <xref rid="B33" ref-type="bibr">2005</xref>) and muscles twitches may be considered as the physiological expression of oneiric behaviors thought to be an acting out of dreams (Wolpert, <xref rid="B56" ref-type="bibr">1960</xref>; Sastre and Jouvet, <xref rid="B49" ref-type="bibr">1979</xref>). Each of these parameters was computed using either visual (arousals), semi-automatic (REMs, muscle twitches (MTs), KCs) and automatic validated methods (alpha, spindles). Such a systematic analysis of macrostructural and microstructural sleep parameters have scarcely been reported in healthy subjects, especially using automatic methods, and never among HR and LR.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and Methods</title>
      <p>We re-analyzed data presented in previous articles (Eichenlaub et al., <xref rid="B30" ref-type="bibr">2012</xref>, <xref rid="B28" ref-type="bibr">2014a</xref>; Ruby et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B48" ref-type="bibr">b</xref>).</p>
      <sec id="s2-1">
        <title>Subjects</title>
        <p>Eighteen HR (age = 22.7 ± 0.6 years old; dream recall = 4.4 ± 0.25 mornings per week) and 18 LR (age = 22.4 ± 0.9 years old; dream recall = 0.25 ± 0.02 morning per week) were selected out of 1000 participants who completed an online questionnaire on their sleep and dream habits (importantly, they were unaware that dream recall frequency was an inclusion criterion). Participants were subsequently contacted by telephone and selected as HR or LR upon confirming dream recall on &gt;3 mornings per week or &lt;2 mornings per month respectively. Gender, age, habitual sleep duration, habitual sleep time, education level and the size of the place of residence of the subjects were controlled and did not differ between the two groups. The local ethics committee (Centre Leon Bérard, Lyon) approved this study, and subjects provided written, informed consent in accordance with the Declaration of Helsinki. The subjects were paid for their participation. For more details concerning inclusion criteria refer to Eichenlaub et al. (<xref rid="B28" ref-type="bibr">2014a</xref>).</p>
      </sec>
      <sec id="s2-2">
        <title>Stimuli</title>
        <p>During both sleep and pre-sleep wakefulness subjects were presented with two different first names included as novels in an oddball novelty paradigm. The first names consisted of the first name of the subject (novel 1) and an unfamiliar first name (novel 2). They were normalized for duration and amplitude and presented with a probability of occurrence of 0.02 each. Responses to frequent standard tones (<italic>p</italic> = 0.82) and rare deviant tones (<italic>p</italic> = 0.14) were not considered in this study. Stimulus onset asynchrony was set at 650 ms, except for the standard following a novel, which appeared 1260 ms after the novel onset, whatever the duration of the novel. Stimuli were presented in a pseudo-randomized order (Eichenlaub et al., <xref rid="B30" ref-type="bibr">2012</xref>), binaurally and at 50 dB above the hearing threshold of the subject.</p>
      </sec>
      <sec id="s2-3">
        <title>Electrophysiological Recordings</title>
        <p>EEG data were recorded from 21-Ag/AgCl electrodes placed according to the extended International 10–20 System. The electro-oculogram (EOG) was recorded from two electrodes placed on the supraorbital ridge of the left eye and on the infraorbital ridge of the right eye. Muscle activity electromyogram (EMG) was recorded from two electrodes attached to the chin. Polysomnographic data (EEG, EMG, EOG) were continuously recorded using a BrainAmp system (Brain Products GmbH, Germany) with an amplification gain of 12,500, a high-pass filter of 0.1 Hz, and a sampling rate of 1000 Hz.</p>
      </sec>
      <sec id="s2-4">
        <title>Procedure</title>
        <p>Subjects slept at night in a bed in the lab while polysomnographic data were acquired. Stimuli were presented through earphones during the whole night, thus ensuring constancy of stimulus input throughout the night despite head movements (Cote et al., <xref rid="B20" ref-type="bibr">1999</xref>). When possible, subjects were awakened in the morning by the experimenters after 5–10 min of REM sleep and were subsequently asked to report any dreams or sleep mentation. For more details see Eichenlaub et al. (<xref rid="B28" ref-type="bibr">2014a</xref>).</p>
      </sec>
      <sec id="s2-5">
        <title>Data Analysis</title>
        <sec id="s2-5-1">
          <title>Sleep Macrostructure</title>
          <p>Polysomnographic data have been scored according to the standard guidelines (Iber et al., <xref rid="B36" ref-type="bibr">2007</xref>; Silber et al., <xref rid="B51" ref-type="bibr">2007</xref>) using 30-s epochs to identify the sleep macrostructure of the subjects. Scoring was done both by an automatic software (ASEEGA version 3.30.14, Physip, France, Berthomier et al., <xref rid="B13" ref-type="bibr">2007</xref>) and by an expert scorer (JBE; for more details see Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>). The epoch-by-epoch comparison between JBE and ASEEGA shown 83.6% of agreement with a Cohen’s kappa coefficient of 0.77. All further analyses in the present study are based solely on the visually-scored hypnograms. For each group, the following sleep parameters were measured.</p>
          <sec id="s2-5-1-1">
            <title>Awakenings</title>
            <p>Total number of awakenings over the sleep period time; Awakening index, defined as the number of awakenings per hour of sleep, computed for the total sleep time (TST), N1, N2, N3 and REM sleep; Awakening duration, defined as the average duration of awakenings; Awakening type, defined as the percentage of long and short awakenings (0–1 min, 1–5 min and 5–30 min, as in Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>).</p>
          </sec>
          <sec id="s2-5-1-2">
            <title>Stage shifts</title>
            <p>Total number of stage shifts over the sleep period time (includes transitions from and to W, N1, N2, N3 and REM).</p>
          </sec>
        </sec>
        <sec id="s2-5-2">
          <title>Sleep Microstructure</title>
          <sec id="s2-5-2-1">
            <title>Arousals</title>
            <p>Arousals were visually scored according to the ASDA 92 criteria (American Sleep Disorders Association, <xref rid="B4" ref-type="bibr">1992</xref>). They were defined as any shift in the EEG frequency to alpha or theta for at least 3 s irrespective of changes in submental EMG during NREM sleep but accompanied by a at least 3 s increase in EMG amplitude during REM sleep. Typically, arousals last between 3 s and 15 s (see Supplementary Figure S1 for an example of arousal). However, since arousal scoring is independent from the scoring of sleep macrostructure, arousals may last more than 15 s (but not more than 30 s without being considered as awakenings according to the standard guidelines (if they start on one page and continue on the next one). Moreover, the ASDA rules also state that an arousal has to be preceded by at least 10 s of continuous sleep which means that a minimum of 10 s of intervening sleep is necessary between two arousals. Arousal were scored by RV and PR. RV scored arousal first, PR reviewed the scoring realized by RV and proposed modifications, then RV checked the propositions and in case of disagreement a consensus was reached after discussion. The parameters that were considered in the present study are: (1) the total number of arousals over the sleep period time; (2) the arousal index (AI), defined as the number of arousals per hour of sleep, computed for TST, N1, N2, N3, REM as well as for epochs scored as indeterminate (Inds) and movements (Mvts); and (3) the arousal duration, defined as the average duration of arousals.</p>
          </sec>
          <sec id="s2-5-2-2">
            <title>Rapid eye movements</title>
            <p>REMs are a core feature of REM sleep (Iber et al., <xref rid="B36" ref-type="bibr">2007</xref>; Silber et al., <xref rid="B51" ref-type="bibr">2007</xref>). In order to assess if there is any difference in the amount of REMs during REM sleep between HR and LR, we developed a semi-automatic detection of saccades in the EOG (see Supplementary Figure S2). We used independent component analysis to extract EOG-components free from artifacts from the original polysomnographic data. Then for each subject, two components showing eye movements were visually selected and subsequently analyzed with the following method. The signal was smoothed using a moving average with a window of 100 ms. The first derivative of the signal was computed and converted into absolute value. A 40 ms step was chosen for the derivative since most of naturally occurring human saccades have magnitudes of 15° or less and last thus no more than 30–40 ms (the maximum velocity of a saccade is above 500°/s, see Bahill et al., <xref rid="B6" ref-type="bibr">1975</xref>). We then applied an arbitrary threshold (mean + 4 standard deviations (SD)) to allow for an optimal detection of REMs. Finally, the quality of the detection was visually checked on a subpart of the data of several subjects. The total number of REMs was defined as the sum of non-concomitant REMs detected in the two components during REM sleep.</p>
          </sec>
          <sec id="s2-5-2-3">
            <title>Muscle twitches</title>
            <p>REM sleep is characterized by a flat muscle tone (atonia) and MTs which can be identified using electromyographic recordings with electrodes on the chin (Iber et al., <xref rid="B36" ref-type="bibr">2007</xref>; Silber et al., <xref rid="B51" ref-type="bibr">2007</xref>). To compare MTs between HR and LR, a semi-automatic analysis of the EMG was developed (see Supplementary Figure S3). First, a notch filter at 50 Hz was applied on the EMG signal. Second, the envelope of the signal was computed using standard Hilbert transform (frequency band: 60–450 Hz; Vidal et al., <xref rid="B53" ref-type="bibr">2012</xref>). The obtained envelope was normalized and smoothed using a moving average with a 500-ms window. As for REMs, a threshold (3.25 SD) was empirically chosen to obtain an optimal detection of MTs. Each supra-threshold clusters with a duration superior to 100 ms were scored as MTs. Finally, the quality of the detection was visually checked on a subpart of the data of several subjects. Three subjects were excluded from the analysis because of a too noisy EMG signal. We assessed the total number of REMs and MTs in REM sleep and the density of REMs/MTs, defined as the average number of REMs/MTs per minute for the total REM sleep duration.</p>
          </sec>
          <sec id="s2-5-2-4">
            <title>Sleep spindles</title>
            <p>A sleep spindle is a train of distinct 11–16 Hz waves, predominant over central EEG derivations and lasting more than 0.5 s (Iber et al., <xref rid="B36" ref-type="bibr">2007</xref>; Silber et al., <xref rid="B51" ref-type="bibr">2007</xref>). An automatic data-driven method was used to detect sleep spindles (ASEEGA). This iterative approach uses recording-specific automatic thresholds, based on EEG power ratios in frequency bands. The detection was performed on CzPz channel, both raw EEG data and sigma-filtered EEG were used in the analysis (for more details refer to Dang-Vu et al., <xref rid="B24" ref-type="bibr">2015</xref>).</p>
          </sec>
          <sec id="s2-5-2-5">
            <title>K-complexes</title>
            <p>K-complexes (KCs) are defined by the AASM (Iber et al., <xref rid="B36" ref-type="bibr">2007</xref>; Silber et al., <xref rid="B51" ref-type="bibr">2007</xref>) as <italic>“a well delineated negative sharp wave immediately followed by a positive component with a total duration ≥0.5 s, typically maximal at frontal electrodes”</italic>. KCs were semi-automatically detected using an open-access validated method (Lajnef et al., <xref rid="B40" ref-type="bibr">2015</xref>, <xref rid="B41" ref-type="bibr">2017</xref>) which is based on a combination of the tunable Q-factor wavelet transform and a morphological component analysis. This approach requires an initial calibration step where a small subset of the data is visually scored for KCs and then used to derive an optimal threshold. Once the training is achieved, the algorithm runs on the entire dataset to automatically detect KCs. For both KCs and spindles, the outcome measures were the total number of KCs/spindles detected and the density which is the number per min of N2 sleep.</p>
          </sec>
        </sec>
        <sec id="s2-5-3">
          <title>Spectral and Frequency Analysis</title>
          <sec id="s2-5-3-1">
            <title>Delta power</title>
            <p>EEG delta spectral power in the first sleep cycle is a marker of homeostatic sleep pressure (Achermann et al., <xref rid="B2" ref-type="bibr">1993</xref>; Huber et al., <xref rid="B35" ref-type="bibr">2004</xref>). Calculation of the normalized spectral power of CzPz in the delta band (0.1–4 Hz) was performed using a fast Fourier transform with Hanning window for consecutive 30-s epochs after automatic artifact rejection (ASEEGA).</p>
          </sec>
          <sec id="s2-5-3-2">
            <title>Alpha power and predominant frequency</title>
            <p>A specific analysis of the alpha band (8–12 Hz) was performed after automatic artifact rejection. For each 30 s epoch of the EEG CzPz signal, the alpha normalized power and the mean of the instantaneous frequency weighted by the alpha power (Berthomier, <xref rid="B12" ref-type="bibr">1983</xref>) were computed (ASEEGA). We assessed the predominant frequency and normalized power of alpha band for intra-sleep wakefulness (ISW) and BSW epochs and the normalized power of delta band in the first sleep cycle.</p>
            <p>For both delta and alpha power, values are reported in percent after band-wise normalization in five frequency bands (delta = 0.1–4 Hz, theta = 4–8 Hz, alpha = 8–12 Hz, beta = 12–16 Hz, sigma = 16–50 Hz) in order to avoid low frequency artifact and powerline artifacts. Hence, for each 30-s epoch, the sum of normalized values in the five bands is equal to 100.</p>
          </sec>
        </sec>
        <sec id="s2-5-4">
          <title>Event-Related Potentials Analysis</title>
          <p>AEPs were analyzed using Elan pack software (Aguera et al., <xref rid="B3" ref-type="bibr">2011</xref>) and Matlab (Mathworks). AEPs elicited by first names were averaged over an epoch of 1100 ms, including a prestimulus period of 100 ms. Prior to averaging, trials were automatically excluded if the overall electrophysiological signal amplitude exceeded 400 μV during N2. Epoch were baseline corrected according to the pre-stimulus period and a 30-Hz low-pass butterworth (order 3) digital filter was applied to averaged responses. Arousing reactions were considered as stimulus-related if occurring within 15 s after stimulus onset (American Sleep Disorders Association, <xref rid="B4" ref-type="bibr">1992</xref>).</p>
        </sec>
        <sec id="s2-5-5">
          <title>Statistical Analysis</title>
          <p>Between-group comparisons of the sleep characteristics were achieved using Student <italic>t</italic>-tests (two-tailed, level of significance, <italic>p</italic> &lt; 0.05). In addition, a nested two-way ANOVA tested the sleep stage (four levels: N1, N2, N3, REM sleep) and the group (two levels: HR, LR) effects on the parameters of the macrostructure (number and duration of awakenings) and microstructure of sleep (number and duration of arousals). <italic>Post hoc</italic> analyses (<italic>t</italic>-tests) were used in case of significance.</p>
          <p>The analysis of the AEPs was performed using non-parametric tests at each sampling point and at each <italic>a priori</italic> chosen electrode (Fp1, Fp2, F3, Fz, F4, C3, Cz, C4, P3, Pz, P4, O1, O2) for grand averaged responses. We used Wilcoxon matched rank sign tests to compare AEPs between conditions (arousing vs. non-arousing; two-tailed, <italic>p</italic> &lt; 0.05). To take into account the issue of multiple comparisons, we chose to apply both spatial limitations based on previous results (according to the results of Bastuji et al. (<xref rid="B10" ref-type="bibr">2008</xref>) and Eichenlaub et al. (<xref rid="B28" ref-type="bibr">2014a</xref>), we expected condition effects for the contrast arousing stimuli vs. non-arousing stimuli on AEPs at frontal and parieto-occipital electrodes), i.e., to consider only a limited amount of electrodes, and temporal and spatial constraints to decrease the chances of false positive, i.e., considering a difference significant only if more than 15 consecutive samples (15 ms) were significantly different for at least two adjacent electrodes (Guthrie and Buchwald, <xref rid="B330" ref-type="bibr">1991</xref>). This method has the advantage of taking spatial and temporal priors into account and is classically used in electrophysiology to correct for multiple comparisons (e.g., Caclin et al., <xref rid="B16" ref-type="bibr">2008</xref>; Bidet-Caulet et al., <xref rid="B14" ref-type="bibr">2012</xref>; Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>).</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec id="s3-1">
        <title>Sleep Parameters</title>
        <p>Table <xref ref-type="table" rid="T1">1</xref> shows the main sleep parameters of the experimental night in the lab for the two groups reported in Eichenlaub et al.’s (<xref rid="B28" ref-type="bibr">2014a</xref>) study (reproduced with permission). HR showed more ISW (wake after sleep onset, WASO) in average than LR and consequently a shorter TST. Except for these parameters, no other between groups difference was observed in the sleep architecture (notably in the proportion and latency of each sleep stage).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Mean ± SEM of the main sleep parameters obtained in the original study</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Sleep parameters</th>
                <th align="center" rowspan="1" colspan="1">High-recallers</th>
                <th align="center" rowspan="1" colspan="1">Low-recallers</th>
                <th align="center" rowspan="1" colspan="1">Standard</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">TIB (min)</td>
                <td align="center" rowspan="1" colspan="1">449 ± 10</td>
                <td align="center" rowspan="1" colspan="1">479 ± 15</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>390–510</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">SPT (min)</td>
                <td align="center" rowspan="1" colspan="1">428 ± 11</td>
                <td align="center" rowspan="1" colspan="1">449 ± 11</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">WASO (min)</td>
                <td align="center" rowspan="1" colspan="1">30 ± 4*</td>
                <td align="center" rowspan="1" colspan="1">14 ± 5</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>20–30</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TST (min)</td>
                <td align="center" rowspan="1" colspan="1">398 ± 11*</td>
                <td align="center" rowspan="1" colspan="1">435 ± 12</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Sleep efficiency (%)</td>
                <td align="center" rowspan="1" colspan="1">89 ± 1.4</td>
                <td align="center" rowspan="1" colspan="1">91 ± 1.8</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>80–90</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Sleep stage, % of TST</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N1 (%)</td>
                <td align="center" rowspan="1" colspan="1">4 ± 0.6</td>
                <td align="center" rowspan="1" colspan="1">2 ± 0.6</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>5–10</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N2 (%)</td>
                <td align="center" rowspan="1" colspan="1">39 ± 1.7</td>
                <td align="center" rowspan="1" colspan="1">41 ± 2.1</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>40–55</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N3 (%)</td>
                <td align="center" rowspan="1" colspan="1">36 ± 1.5</td>
                <td align="center" rowspan="1" colspan="1">36 ± 2.3</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>25–30</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  REM sleep (%)</td>
                <td align="center" rowspan="1" colspan="1">21 ± 1.2</td>
                <td align="center" rowspan="1" colspan="1">21 ± 1.1</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>20–25</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">N2 latency from lights out (min)</td>
                <td align="center" rowspan="1" colspan="1">19 ± 2.6</td>
                <td align="center" rowspan="1" colspan="1">29 ± 6.2</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>20–30</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">N3 latency from lights out (min)</td>
                <td align="center" rowspan="1" colspan="1">21 ± 3.3</td>
                <td align="center" rowspan="1" colspan="1">32 ± 6.3</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">REM latency from lights out (min)</td>
                <td align="center" rowspan="1" colspan="1">120 ± 13.2</td>
                <td align="center" rowspan="1" colspan="1">133 ± 16.4</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">N3 latency from N2 (min)</td>
                <td align="center" rowspan="1" colspan="1">5 ± 1.8</td>
                <td align="center" rowspan="1" colspan="1">5 ± 1.5</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">REM latency from N2 (min)</td>
                <td align="center" rowspan="1" colspan="1">104 ± 11.9</td>
                <td align="center" rowspan="1" colspan="1">106 ± 12.9</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>60–120</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">WASO (%)</td>
                <td align="center" rowspan="1" colspan="1">7 ± 0.9*</td>
                <td align="center" rowspan="1" colspan="1">3 ± 1.1</td>
                <td align="center" rowspan="1" colspan="1">
                  <italic>5</italic>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Movements (%)</td>
                <td align="center" rowspan="1" colspan="1">4 ± 0.5</td>
                <td align="center" rowspan="1" colspan="1">4 ± 0.5</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Indeterminate (%)</td>
                <td align="center" rowspan="1" colspan="1">10 ± 1.4</td>
                <td align="center" rowspan="1" colspan="1">10 ± 0.9</td>
                <td rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Table 1 is reproduced and modified from Eichenlaub et al. (<xref rid="B28" ref-type="bibr">2014a</xref>) with permission of the authors. Only values obtained with visual scoring (JBE) are reported. TIB refers to time in bed; SPT, sleep period time; WASO, wakefulness after sleep onset; TST, total sleep time; REM, rapid eye movement sleep; min, minutes. In comparison with the standard values presented in the last column (Hirshkowitz, <xref rid="B34" ref-type="bibr">2004</xref>), the quality of sleep was generally preserved for the 36 subjects. *<italic>p</italic> &lt; 0.05</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Table <xref ref-type="table" rid="T2">2</xref> presents the new parameters of the macrostructure (notably the distribution of awakenings across the sleep cycle and the proportion of long and short awakenings) and several parameters of the microstructure of sleep that have been investigated thanks to the re-analysis of the data.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p><bold>Mean ± SEM of supplementary macrostructural and microstructural sleep parameters calculated in this study</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Sleep parameters</th>
                <th align="center" rowspan="1" colspan="1">High-recallers</th>
                <th align="center" rowspan="1" colspan="1">Low-recallers</th>
                <th align="center" rowspan="1" colspan="1">Standard</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">
                  <bold>Sleep macrostructure</bold>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Awakenings, no.</td>
                <td align="center" rowspan="1" colspan="1">17.5 ± 2.1</td>
                <td align="center" rowspan="1" colspan="1">12.1 ± 2.9</td>
                <td align="left" rowspan="1" colspan="1">9.6 (Hirshkowitz, <xref rid="B34" ref-type="bibr">2004</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Awakenings, duration (min)</td>
                <td align="center" rowspan="1" colspan="1">1.9 ± 0.2**</td>
                <td align="center" rowspan="1" colspan="1">0.95 ± 0.1</td>
                <td align="left" rowspan="1" colspan="1">1.4 (Benoit et al., <xref rid="B11" ref-type="bibr">1981</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Awakenings index, no. per hour</td>
                <td align="center" rowspan="1" colspan="1">3.2 ± 0.4</td>
                <td align="center" rowspan="1" colspan="1">2.2 ± 0.6</td>
                <td align="left" rowspan="1" colspan="1">4.2 (Wamsley et al., <xref rid="B55" ref-type="bibr">2012</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N1</td>
                <td align="center" rowspan="1" colspan="1">27.3 ± 4.8</td>
                <td align="center" rowspan="1" colspan="1">34.6 ± 7</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N2</td>
                <td align="center" rowspan="1" colspan="1">3.3 ± 0.7</td>
                <td align="center" rowspan="1" colspan="1">1.8 ± 0.7</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  N3</td>
                <td align="center" rowspan="1" colspan="1">0.9 ± 0.2</td>
                <td align="center" rowspan="1" colspan="1">1.1 ± 0.3</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  REM</td>
                <td align="center" rowspan="1" colspan="1">3.6 ± 1.5</td>
                <td align="center" rowspan="1" colspan="1">1.0 ± 0.3</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Awakenings duration (%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  0–1 min</td>
                <td align="center" rowspan="1" colspan="1">66.1 ± 3.2**</td>
                <td align="center" rowspan="1" colspan="1">82.9 ± 3.3</td>
                <td align="left" rowspan="1" colspan="1">87 (Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  1–5 min</td>
                <td align="center" rowspan="1" colspan="1">24.6 ± 2.1*</td>
                <td align="center" rowspan="1" colspan="1">16.1 ± 3.3</td>
                <td align="left" rowspan="1" colspan="1">11 (Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">  5–30 min</td>
                <td align="center" rowspan="1" colspan="1">9.4 ± 2.5**</td>
                <td align="center" rowspan="1" colspan="1">1.0 ± 0.6</td>
                <td align="left" rowspan="1" colspan="1">3 (Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Number of stage shifts</td>
                <td align="center" rowspan="1" colspan="1">63.6 ± 4.2</td>
                <td align="center" rowspan="1" colspan="1">71.6 ± 7.2</td>
                <td align="left" rowspan="1" colspan="1">47 (Hirshkowitz, <xref rid="B34" ref-type="bibr">2004</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alpha power (%), in B.S.W</td>
                <td align="center" rowspan="1" colspan="1">32 ± 4.6</td>
                <td align="center" rowspan="1" colspan="1">30.5 ± 3.9</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alpha power (%), in I.S.W</td>
                <td align="center" rowspan="1" colspan="1">21 ± 3.1</td>
                <td align="center" rowspan="1" colspan="1">24.4 ± 2.5</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alpha frequency (Hz), in B.S.W</td>
                <td align="center" rowspan="1" colspan="1">9.88 ± 0.1</td>
                <td align="center" rowspan="1" colspan="1">9.86 ± 0.1</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alpha frequency (Hz), in I.S.W</td>
                <td align="center" rowspan="1" colspan="1">9.64 ± 0.1</td>
                <td align="center" rowspan="1" colspan="1">9.65 ± 0.1</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Delta power (%), in first sleep cycle</td>
                <td align="center" rowspan="1" colspan="1">79.7 ± 1.7</td>
                <td align="center" rowspan="1" colspan="1">80.8 ± 1.6</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Arousing stimuli (%)</td>
                <td align="center" rowspan="1" colspan="1">2.9 ± 0.3**</td>
                <td align="center" rowspan="1" colspan="1">1.6 ± 0.2</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Arousing, latency after stim. onset</td>
                <td align="center" rowspan="1" colspan="1">5.3 ± 0.2</td>
                <td align="center" rowspan="1" colspan="1">5.8 ± 0.3</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
                  <bold>Sleep microstructure</bold>
                </td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Arousals, no.</td>
                <td align="center" rowspan="1" colspan="1">76.3 ± 8.5</td>
                <td align="center" rowspan="1" colspan="1">61.2 ± 7.2</td>
                <td align="left" rowspan="1" colspan="1">83 (Bonnet and Arand, <xref rid="B15" ref-type="bibr">2007</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Arousals, duration (sec)</td>
                <td align="center" rowspan="1" colspan="1">10.2 ± 0.3</td>
                <td align="center" rowspan="1" colspan="1">11.2 ± 0.4</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Arousal index</td>
                <td align="center" rowspan="1" colspan="1">11.1 ± 1</td>
                <td align="center" rowspan="1" colspan="1">8.3 ± 1</td>
                <td align="left" rowspan="1" colspan="1">10.8 (Bonnet and Arand, <xref rid="B15" ref-type="bibr">2007</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Spindles, no. per min. of N2</td>
                <td align="center" rowspan="1" colspan="1">3.5 ± 0.3</td>
                <td align="center" rowspan="1" colspan="1">3.5 ± 0.4</td>
                <td align="left" rowspan="1" colspan="1">2.1 (Wamsley et al., <xref rid="B55" ref-type="bibr">2012</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">K-complex density, no. per min. of N2</td>
                <td align="center" rowspan="1" colspan="1">2.0 ± 0.2</td>
                <td align="center" rowspan="1" colspan="1">2.5 ± 0.2</td>
                <td align="left" rowspan="1" colspan="1">1–3 (Halász, <xref rid="B33" ref-type="bibr">2005</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">REMs, no. per min of REM sleep</td>
                <td align="center" rowspan="1" colspan="1">10.9 ± 0.3</td>
                <td align="center" rowspan="1" colspan="1">10.3 ± 0.3</td>
                <td align="left" rowspan="1" colspan="1">3.7 (Andrillon et al., <xref rid="B5" ref-type="bibr">2015</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MTs, no. per min of REM sleep</td>
                <td align="center" rowspan="1" colspan="1">0.8 ± 0.1</td>
                <td align="center" rowspan="1" colspan="1">0.8 ± 0.1</td>
                <td rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>REMs refers to rapid eye movements; ISW, intra-sleep wakefulness; BSW, before-sleep wakefulness; TST, total sleep time; Normalized spectral power (alpha and delta) is relative to the power in the other frequency bands; MT, muscle twitches; min, minute; no, number. Sleep onset was considered as the first epoch of N2 for the calculation of intra-sleep awakenings. Sleep onset was considered as the first epoch of N1 for arousals. Supplementary Table S1 reports awakening parameters using the first epoch of N1 as sleep onset. Last column represents standard values. One-way and two-way ANOVA for independent samples (High-recallers vs. Low-recallers) are presented: *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
        <sec id="s3-1-1">
          <title>Awakenings</title>
          <p>A two-way ANOVA yielded a significant sleep stage effect on the awakening index (<italic>F</italic><sub>(1,3)</sub> = 47.0, <italic>p</italic> &lt; 0.000), no significant group effect and no group × sleep stage interaction (Figure <xref ref-type="fig" rid="F1">1A</xref>). <italic>Post hoc</italic> tests revealed that the awakening index in N1 was significantly higher than in all other sleep stages (<italic>p</italic> &lt; 0.000 for all the comparisons between N1 and another sleep stage) and that it was also higher in N2 than in N3 (<italic>p</italic> = 0.003). Regarding the duration of awakenings, a two-way ANOVA showed a group effect (<italic>F</italic><sub>(1,3)</sub> = 13.6, <italic>p</italic> &lt; 0.001) but no sleep stage effect or interaction group × sleep stage (Figure <xref ref-type="fig" rid="F1">1D</xref>). After classifying awakenings into three categories according to their duration i.e., 0–1 min, 1–5 min and 5–30 min (Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>), we observed a significant interaction group × duration (<italic>F</italic><sub>(1,2)</sub> = 14.75, <italic>p</italic> &lt; 0.001; Figure <xref ref-type="fig" rid="F1">1C</xref>). <italic>Post hoc</italic> comparisons revealed that HR showed less short awakenings lasting less than 1 min (66.1 ± 3% in HR vs. 82.9 ± 3% in LR, <italic>p</italic> &lt; 0.001) but more long awakenings lasting more than 1 min than LR (1–5 min, 24.6 ± 2% in HR vs. 16.1 ± 3% in LR, <italic>p</italic> = 0.03; 5–30 min, 9.4 ± 2.5% in HR vs. 1 ± 0.6% in LR, <italic>p</italic> = 0.003).</p>
          <fig id="F1" position="float">
            <label>Figure 1</label>
            <caption>
              <p><bold>Means and SEM of sleep parameters for High and Low dream recallers (HR and LR). (A)</bold> Awakening index per sleep stage (number of awakenings per hour in each sleep stage). <bold>(B)</bold> Arousal index (AI) per sleep stage (number of arousals per hour in each sleep stage). <bold>(C)</bold> Percentage of short and long awakenings. <bold>(D)</bold> Mean duration of awakenings per sleep stages. Hatched columns represent standards values. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01.</p>
            </caption>
            <graphic xlink:href="fnhum-11-00132-g0001"/>
          </fig>
        </sec>
        <sec id="s3-1-2">
          <title>Arousals</title>
          <p>The total number of arousals was not significantly different between the two groups (<italic>p</italic> = 0.19). A two-way ANOVA on the AI showed a significant sleep stage effect (<italic>F</italic><sub>(1,5)</sub> = 88, <italic>p</italic> &lt; 0.001), no group effect (a tendency towards a larger AI in HR than in LR was observed regardless of the sleep stages, <italic>p</italic> = 0.07) and no group × sleep stage interaction (Table <xref ref-type="table" rid="T2">2</xref>). The distribution of arousals across sleep stages is in accordance with previous studies (De Gennaro et al., <xref rid="B25" ref-type="bibr">2001</xref>) even if AI was slightly lower than expected in all sleep stages (Figure <xref ref-type="fig" rid="F1">1B</xref>). In De Gennaro et al.’s (<xref rid="B25" ref-type="bibr">2001</xref>) study, the categories indeterminate (Inds) and movements (Mvts) were not considered in the sleep scoring whereas in the present study the majority of arousals were found in epochs scored as Inds or Mvts. This could explain the lower AI in each sleep stage (N1, N2, N3 and REM sleep) found in our study. The AI did not correlate significantly with any other sleep parameters, including the awakening index (Pearson’s <italic>r</italic> = 0.24, <italic>N</italic> = 36, <italic>p</italic> = 0.15, two-tailed). A two-way ANOVA on arousals duration showed a significant sleep stage effect (<italic>F</italic><sub>(1,5)</sub> = 35, <italic>p</italic> &lt; 0.000), but no group effect nor interaction group × sleep stage. Arousals were significantly longer in epochs scored as Mvts than all other epochs (N1, 9.7 ± 0.6 s, N2, 8.5 ± 0.4, N3, 9.5 ± 0.7, REM, 9.3 ± 0.5, Inds, 9.1 ± 0.3, Mvts, 16.4 ± 2.0, <italic>p</italic> &lt; 0.000 for all pairwise comparisons between Mvts and the other stages).</p>
        </sec>
        <sec id="s3-1-3">
          <title>Arousing Stimuli</title>
          <p>In average (<italic>N</italic> = 36), 2.2 ± 0.2% of auditory stimuli (first names) that occurred during either N2, N3 or REM sleep were associated with an arousing reaction (be it an arousal or an awakening) in the following 15 s (see Supplementary Figure S1 for examples of arousing and non arousing stimuli). A two-way ANOVA showed a sleep stage effect (<italic>F</italic><sub>(1,2)</sub> = 13.2, <italic>p</italic> &lt; 0.001), a group effect (<italic>F</italic><sub>(1,2)</sub> = 13.1, <italic>p</italic> = 0.001) and no interaction effect on the rate of arousing stimuli. <italic>Post hoc</italic> comparisons revealed that there was a higher rate of arousing stimuli in N2 and REM as compared to N3 sleep (N2, 3.1 ± 0.4%; REM, 2.4 ± 0.3%; N3, 1.4 ± 0.2%; <italic>p</italic> &lt; 0.000 for the two comparisons), but no differences between N2 and REM. HR showed a higher proportion of arousing reactions than LR (HR, 2.9 ± 0.3%, LR, 1.6 ± 0.2%, <italic>p</italic> = 0.001), whatever the sleep stage (no significant interaction was observed). The latency between the stimulus onset and the beginning of the arousing reaction was 5.6 ± 0.2 s in average. A two-way analysis of variance revealed a significant sleep stage effect on this delay (<italic>F</italic><sub>(1,2)</sub> = 3.7, <italic>p</italic> = 0.03), no group effect or interaction group × sleep stage. <italic>Post hoc</italic> tests showed that arousing reactions were more delayed in REM sleep (6.5 ± 0.4 s) than in N2 (5.0 ± 0.2 s) and N3 (5.2 ± 0.3 s) (<italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.05 respectively). Most arousing stimuli were associated with short arousing reactions (75.6 ± 2.5% of the arousing stimuli were followed by an arousal, the remaining 24.4% were followed by an awakening). A two-way ANOVA yielded a significant sleep stage effect on the type of arousing reaction (<italic>F</italic><sub>(1,2)</sub> = 23.7, <italic>p</italic> &lt; 0.000) but no group effect or interaction group × sleep stage. Arousing reaction in N3 were less often short arousals (50.8 ± 6.1%) than in N2 (89.1 ± 2.7%) or REM sleep (87.8 ± 3.1%; <italic>p</italic> &lt; 0.000 for the two tests).</p>
        </sec>
        <sec id="s3-1-4">
          <title>Other Microstructural Parameters</title>
          <p>Number of stage shifts, sleep spindles density, KCs density, REMs density and MTs density were not significantly different between the two groups (<italic>p</italic> = 0.35, <italic>p</italic> = 0.98, <italic>p</italic> = 0.16, <italic>p</italic> = 0.25 and <italic>p</italic> = 0.74 respectively; see Table <xref ref-type="table" rid="T2">2</xref> for details).</p>
        </sec>
        <sec id="s3-1-5">
          <title>Spectral Power and Predominant Frequency</title>
          <p>Two-way ANOVAs yielded that the alpha predominant frequency and spectral power were significantly decreased during ISW as compared to BSW (<italic>Frequency</italic>, <italic>F</italic><sub>(1,1)</sub> = 32.1, <italic>p</italic> &lt; 0.000. <italic>Power</italic>, <italic>F</italic><sub>(1,1)</sub> = 22.2, <italic>p</italic> &lt; 0.000). For both parameters there were no group effect or interaction between group and time of the night. Moreover, delta power in the first sleep cycle was not significantly different between the two groups.</p>
        </sec>
      </sec>
      <sec id="s3-2">
        <title>Auditory Evoked Potentials</title>
        <sec id="s3-2-1">
          <title>Arousing Stimuli after Artifact Rejection</title>
          <p>N2—3.0 ± 0.4% of auditory stimuli were associated with an arousing reaction within 15 s (13.6 ± 1.8 stimuli in average per subject). Arousals prevailed (89.5%) over awakenings (10.5%). The mean latency between stimulus onset and arousing reactions was 4.5 s in N2.</p>
          <p>REM sleep —2.2 ± 0.3% of auditory stimuli were associated with an arousing reaction within 15 s (4.2 ± 0.5 stimuli in average per subject). Arousals prevailed (87.7%) over awakenings (12.3%) The mean latency between stimulus onset and arousing reactions was 6.2 s in REM sleep.</p>
          <p>As expected for auditory stimuli (Bastuji et al., <xref rid="B10" ref-type="bibr">2008</xref>; Bastuji and Lavigne, <xref rid="B9" ref-type="bibr">2016</xref>), a small percentage of stimuli led to an arousing reaction. For the evoked potential analysis, to avoid a poor signal-to-noise ratio, we retained for further analysis subjects with at least 10 arousing stimuli in the same sleep stage. These constraints restricted the analysis to the most represented sleep stage i.e., N2, for which 19 subjects (12 HR and 7 LR) showed more than 10 arousing stimuli after artifact rejection.</p>
        </sec>
        <sec id="s3-2-2">
          <title>AEPs to Arousing vs. Non-Arousing Stimuli in N2</title>
          <p>Grand averaged responses to arousing and non-arousing stimuli in N2 are displayed in Figure <xref ref-type="fig" rid="F2">2</xref>. A sample of non-arousing stimuli was randomly selected so that the number of averaged stimuli was equivalent for the arousing and non-arousing conditions. Significant differences between the two conditions in N2 were found at frontal and occipital topographies. The amplitudes of a late positive and a late negative (peaking at 800–1000 ms) components were significantly enhanced for arousing stimuli at occipital electrodes (O1 and O2) and frontal electrodes respectively (FP1, FP2, Fz, F3).</p>
          <fig id="F2" position="float">
            <label>Figure 2</label>
            <caption>
              <p><bold>Brain responses to first names according to the presence or absence of an arousing reaction following the stimulus in N2 sleep. (A)</bold> Grand averaged responses. Gray vertical bars highlight significant differences (sample-by-sample Wilcoxon test, <italic>p</italic> &lt; 0.05 for more than 15 ms). <bold>(B)</bold> Statistical significance of sample-by-sample Wilcoxon test (<italic>p</italic> &lt; 0.05 for more than 15 ms) performed at 10 electrodes in the post-stimulus period.</p>
            </caption>
            <graphic xlink:href="fnhum-11-00132-g0002"/>
          </fig>
        </sec>
        <sec id="s3-2-3">
          <title>AEPs to Arousing vs. Non-Arousing Stimuli in N2 as a Function of the Delay Between Stimuli and Arousing Reactions</title>
          <p>According to the hypothesis that the amplitude of the AEPs to stimuli presented during sleep is related to the subsequent reaction of the sleeper, one would expect that the shorter the delay between the stimulus and the arousing reaction, the larger the amplitude of the evoked response to the stimulus. To test this hypothesis, we compared AEPs to stimuli quickly followed by an arousing reaction (arousing reaction in the 5 s after stimulus onset) and to stimuli followed by a late arousing reaction (5–15 s after stimulus onset). For this analysis paired statistics were not possible because of an insufficient number of subjects having more than 10 events in both conditions. Instead, we used the Kruskal-Wallis test to compare nine subjects with more than 10 events within 0–5 s post-stimuli (18.5 ± 2.1 events in average) and 10 subjects with more than 10 events within 5–15 s post-stimuli (16.7 ± 1.7 events in average). Grand averaged responses are displayed in Figure <xref ref-type="fig" rid="F3">3</xref>. At occipital electrodes, the amplitude of a late parietal positivity was significantly enhanced when the arousing reaction occurred within the first 5 s as compared to the last 10 s. A comparable effect was observed at frontal electrodes for the amplitude of a large negative wave peaking between 800 ms and 1000 ms.</p>
          <fig id="F3" position="float">
            <label>Figure 3</label>
            <caption>
              <p><bold>Brain responses to first names leading to a rapid arousing reaction (in the 5 s post stimulus, black thick line), to a delayed arousing reaction (between 5 s and 15 s post-stimulus, gray thick line) and to no arousing reactions (dotted line) in N2 sleep.</bold> Gray vertical bars highlight significant differences between rapid and delayed arousing reactions (sample-by-sample Kruskal-Wallis test, <italic>p</italic> &lt; 0.05 for more than 15 ms).</p>
            </caption>
            <graphic xlink:href="fnhum-11-00132-g0003"/>
          </fig>
        </sec>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>In this study, we further investigated the hypothesis of a causal link between ERPs to auditory stimuli and subsequent arousing reactions (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>), and the hypothesis of a causal link between ISW and dream recall (Koulack and Goodenough, <xref rid="B39" ref-type="bibr">1976</xref>; Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>). The reanalysis of EEG data (Eichenlaub et al., <xref rid="B30" ref-type="bibr">2012</xref>, <xref rid="B28" ref-type="bibr">2014a</xref>; Ruby et al., <xref rid="B47" ref-type="bibr">2013a</xref>,<xref rid="B48" ref-type="bibr">b</xref>) enabled us to characterize more precisely the sleep macro and microstructure of HR and LR thanks to visual, semi-automatic and validated automatic methods. For intra-sleep awakenings no interaction between group and sleep stages was found (be it for the awakening index or for awakenings duration) showing that awakenings were longer in HR than in LR whatever the sleep stage. We also observed significantly more long awakenings (longer than 1 min) and less short ones in HR than in LR. Regarding the alpha predominant frequency and alpha power during ISW and BSW, no between-group differences were found, but the overall frequency and power of the alpha rhythm was slightly lower in ISW than in BSW. There were no between-group differences in the delta power during the first sleep cycle or in the number of stage shifts during SPT. Moreover, no between-group difference was found for the parameters of the sleep microstructure considered, namely arousals (density, duration and distribution), sleep spindles (density in N2), KCs (total number and density in N2), REMs (total number and density in REM sleep), MTs (total number and density in REM sleep). Finally, thanks to the scoring of arousals, we could compute AEPs to arousing and non-arousing stimuli and reproduce the results obtained for painful stimuli showing that the amplitude of the AEPs was predictive of the subsequent arousing reaction.</p>
      <sec id="s4-1">
        <title>AEPs to Arousing and Non-Arousing Stimuli</title>
        <p>The scoring of arousals in Eichenlaub et al.’s (<xref rid="B28" ref-type="bibr">2014a</xref>) data resulted in a great increase of the stimuli categorized as arousing. Still, auditory stimuli presented at an average intensity (50 dB above the hearing level of the subject) induced far less arousing reaction (2.2%) than did laser nociceptive stimuli (30.6% in Bastuji et al., <xref rid="B10" ref-type="bibr">2008</xref>). Among all the arousing reactions, arousals largely prevailed over awakenings (three-to-one ratio). Considering both arousals and awakening improved our ability to test whether AEPs amplitude to stimuli presented during sleep was related to subsequent arousing reactions, but only in N2, the most represented sleep stage. Results revealed that auditory first names followed within 15 s by an arousing reaction elicited a larger occipital positivity and also a larger frontal negative wave than non-arousing stimuli. Similarly Bastuji et al. (<xref rid="B10" ref-type="bibr">2008</xref>) found that arousing laser nociceptive stimuli induced a larger late parietal positive component than non-arousing stimuli in N2 and REM sleep. We further found that the shorter (less than 5 s vs. more than 5 s) the delay between the stimulus onset and the subsequent arousing reaction, the larger the amplitude of the AEPs. These results tie convincingly the AEPs’ amplitude to subsequent arousing reaction and question the fact that arousing reaction arising between 5 s and 15 s after the stimulus onset are truly stimulus related. Our results show that arousing auditory stimuli induce arousing reaction through a cerebral mechanism similar to the one described for nociceptive stimuli i.e., an increased amplitude of the evoked response. Interestingly the topographies of the responses for the two sensory modalities are different. No frontal difference was found between ERPs to arousing and non-arousing stimuli in Bastuji et al.’s (<xref rid="B10" ref-type="bibr">2008</xref>) study whereas we found a large one in our study. The large amplitude of this frontal wave might have masked the parietal component that was reported in Bastuji et al.’s (<xref rid="B10" ref-type="bibr">2008</xref>) study on parietal electrodes. It may explain that the arousing effect appeared only on occipital electrodes in our study since they are less influenced by frontal components.</p>
        <p>The late parieto-occipital components have traditionally been associated with complex cognitive processes, such as semantic or memory processes (Curran, <xref rid="B23" ref-type="bibr">2004</xref>; Eichenlaub et al., <xref rid="B30" ref-type="bibr">2012</xref>). This could reflect a high level cognitive processing of the stimuli possibly triggering a subsequent arousing reaction. The frontal component, larger for arousing auditory stimuli, is thought to reflect evoked KCs or N550 (Cote et al., <xref rid="B20" ref-type="bibr">1999</xref>; Bastien et al., <xref rid="B8" ref-type="bibr">2002</xref>; Bastuji et al., <xref rid="B10" ref-type="bibr">2008</xref>). According to previous work, KCs have been traditionally viewed as indicative of an arousal process (for a review see Colrain, <xref rid="B18" ref-type="bibr">2005</xref>). Halász (<xref rid="B33" ref-type="bibr">2005</xref>) also suggested that they could reflect an arousal response to exogenous stimuli, since they are often followed by arousing reactions. This view fits well with the fact that this frontal response is enhanced for auditory arousing stimuli as compared to non-arousing stimuli, but it does not fit with the fact that this component is more prominent for the auditory stimuli than for painful stimuli which are more arousing. This frontal response may rather be explained by an opposite functional role proposed for KCs. Some studies have shown that there is an increased proportion of KCs in situation of increased sleep drive and thus decreased arousability (Bastien et al., <xref rid="B7" ref-type="bibr">2000</xref>, <xref rid="B8" ref-type="bibr">2002</xref>; Nicholas et al., <xref rid="B43" ref-type="bibr">2002</xref>; Peszka and Harsh, <xref rid="B44" ref-type="bibr">2002</xref>; Colrain, <xref rid="B18" ref-type="bibr">2005</xref>). These latter results are more in favor of an endogenous nature of KCs which could help maintaining sleep (Jahnke et al., <xref rid="B37" ref-type="bibr">2012</xref>). This interpretation of KCs may explain that auditory stimuli are less arousing than painful ones due to their elicitation of a sleep-protective component (the frontal component) in addition to an arousing component (the parieto-occipital one).</p>
        <p>These findings suggest that the amplitude of ERPs to stimuli presented during sleep is predictive, whatever the sensory modality, of a subsequent arousing reaction. Such a link was previously shown for somatosensory painful stimulation—i.e., potentially dangerous stimuli—but not for sounds which are much more frequent in our daily life and far less often dangerous than painful ones.</p>
      </sec>
      <sec id="s4-2">
        <title>Intra-Sleep Awakenings and Dream Recall</title>
        <p>The increased amount of ISW in HR reported in our previous work raised several questions. If ISW is increased in HR as compared to LR, is it also true for arousals? What is the minimum duration of an awakening to allow for the encoding of some information into long term memory? What about the other components of the sleep microstructure?</p>
        <p>Many previous results justified to investigate sleep microstructural components regarding dream recall. Sleep spindles and the alpha frequency during wakefulness have been related to memory abilities (Klimesch, <xref rid="B38" ref-type="bibr">1997</xref>; Ulrich, <xref rid="B52" ref-type="bibr">2016</xref>), the REMs of REM sleep to dream content (Dement and Kleitman, <xref rid="B27" ref-type="bibr">1957</xref>; Roffwarg et al., <xref rid="B45" ref-type="bibr">1962</xref>; Molinari and Foulkes, <xref rid="B42" ref-type="bibr">1969</xref>), KCs to sleep stability (Bastien et al., <xref rid="B7" ref-type="bibr">2000</xref>; Colrain, <xref rid="B18" ref-type="bibr">2005</xref>; Halász, <xref rid="B33" ref-type="bibr">2005</xref>) and muscles twitches may be considered as the physiological expression of oneiric behaviors thought to be an acting out of dreams (Wolpert, <xref rid="B56" ref-type="bibr">1960</xref>; Sastre and Jouvet, <xref rid="B49" ref-type="bibr">1979</xref>). Interestingly, our in-depth analysis of the sleep structure revealed no differences in the sleep microstructure of HR and LR for any of the parameters considered (i.e., arousals, sleep spindles, KCs, REMs and MTs). Since the number of stage shifts and the delta power in the first sleep cycle were also not significantly different between groups, these results leave awakenings as the only sleep parameter differentiating HR and LR sleep architectures. Our further analysis of these awakenings, notably their distribution in the sleep cycle, revealed that the higher dream recall frequency of HR could not be explained by the REM sleep hypothesis of dreaming (Dement and Kleitman, <xref rid="B27" ref-type="bibr">1957</xref>; Ruby, <xref rid="B46" ref-type="bibr">2011</xref>) since awakenings were not found to be more numerous or longer in REM sleep in HR as compared to LR (Figures <xref ref-type="fig" rid="F1">1A,D</xref>). Interestingly, we found that the frequency of the alpha predominant rhythm was slightly lower (of ~0.2 Hz) during ISW as compared to BSW. This is consistent with previous results that showed an increased power in the lower alpha range in the first minutes following an awakening as compared to the corresponding pre-sleep period (Ferrara et al., <xref rid="B31" ref-type="bibr">2006</xref>). According to Klimesch (<xref rid="B38" ref-type="bibr">1997</xref>) which showed that the alpha frequency of good memory performers is about 1 Hz higher than those of bad performers, the decrease of alpha frequency in ISW could explain the difficulties in memory recall at awakening (recall of dreams or of awakenings during sleep). However alpha frequency was not different in HR and LR and can thus not explain their differences in dream recall.</p>
        <p>What seems to be the best predictor of dream recall is the intra-sleep awakenings duration. During a night of sleep in the lab with sound presentation, in average, the awakenings of HR were twice longer than those of LR. The reanalysis of the data further showed that if the distribution of short (&lt;1 min) and long awakenings (&gt;1 min) is as expected in young healthy subjects (Goldenberg et al., <xref rid="B32" ref-type="bibr">1981</xref>) i.e., with a great majority of short awakenings—the proportion of each category of awakenings was significantly different between the two groups. HR experienced a significantly higher proportion of long awakenings than LR, while LR experienced more short awakenings than HR. This result is interesting to discuss regarding those of a study which investigated the relationship between the duration of polysomnographic-defined awakenings and awakenings’ awareness (Campbell and Webb, <xref rid="B17" ref-type="bibr">1981</xref>). The subjects’ task was to press a push-button whenever they gained awareness of being awake during sleep while polysomnographic data were acquired. They found that 84% of the unreported arousals/awakenings were shorter than 2 min (1.88 min). This result in addition to ours (awakenings but no arousals difference between HR and LR, average awakenings duration of 2 min vs. 1 min in HR vs. LR, more awakenings longer than 1 min in HR than in LR) suggest that awareness and/or memory of intra-sleep awakenings and dreams is dependent on the duration of intra-sleep awakenings and that the minimum duration for an awakening to allow for memory encoding is approximately 2 min. Given that according to available data the brain is not able to encode new information into explicit memory during sleep (Aarons, <xref rid="B1" ref-type="bibr">1976</xref>), and that the brain is in a very different state during sleep and wakefulness, it seems not unrealistic that some time is needed to restore the encoding-in-memory ability of the brain at awakening.</p>
        <p>Our results support but also extend and precise the arousal-retrieval model proposed by Koulack and Goodenough (<xref rid="B39" ref-type="bibr">1976</xref>). We found that intra-sleep awakenings duration is the only candidate among the numerous tested parameters assessing sleep macro and microstructure to explain dream recall, that the duration of awakenings rather than the frequency was the critical factor and that the required duration for an awakening to allow for memory encoding was approximately 2 min.</p>
        <p>A limitation of this study is the smaller number of stimulus-related arousing reactions as compared to Bastuji et al. (<xref rid="B10" ref-type="bibr">2008</xref>) study with painful stimuli. For this reason we could not investigate AEPs in all the sleep stages. Second, automatic vs. visual detection of microstructural sleep parameters is a debated issue in the sleep community (e.g., Wallant et al., <xref rid="B54" ref-type="bibr">2016</xref>). As a consequence even if no between groups difference have been observed, the figures (number of K complexes, spindles, MTs and REMs during REM sleep) have to be considered cautiously since they may have been different if the detection had been made visually. Thirdly, it should be kept in mind that our sleep measures does not reflect natural sleep since sounds were presented to participants during the whole night. That said, most of the computed sleep parameters were close or within the range of standard values, and it is therefore reasonable to assume that sleep quality was generally preserved despite the experimental setup and auditory stimuli. Finally, regarding the interpretation of the AEPs to arousing stimuli it should be kept in mind that the functional role of KCs regarding sleep depth is still unclear and debated, since it has been found that: (1) KCs do not change in the recovery night after sleep deprivation (Curcio et al., <xref rid="B22" ref-type="bibr">2003</xref>); (2) KCs show a linear decline across the adult lifespan (Colrain et al., <xref rid="B19" ref-type="bibr">2010</xref>); (3) they drop in patients with Alzheimer disease (Crowley et al., <xref rid="B21" ref-type="bibr">2005</xref>); and (4) sensory stimulation increases their probability in the ascending slopes of the sleep cycles to a higher degree than in the descending ones (Colrain, <xref rid="B18" ref-type="bibr">2005</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="conclusion" id="s5">
      <title>Conclusion</title>
      <p>We have shown that brain responses to auditory stimuli in N2 are larger when followed by a subsequent arousing reaction in the 5 s. Coherently with our previous results suggesting a greater brain reactivity in HR, HR demonstrated more arousing stimuli than LR during sleep. Finally, the reanalysis of our previous data (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>) highlighted that HR do not show any other sleep differences with LR apart from longer intra-sleep awakenings and, more precisely, more long and less short intra-sleep awakenings than LR. The results of our team lead us to propose the following mechanism leading to a better recall of dreams in HR than in LR. An increased activity in the temporo-parietal junction at rest in HR as compared to LR (Eichenlaub et al., <xref rid="B29" ref-type="bibr">2014b</xref>) would lead to a greater brain reactivity to external stimuli (Eichenlaub et al., <xref rid="B28" ref-type="bibr">2014a</xref>), i.e., larger brain responses to stimuli, which in turn would trigger more and longer arousing reactions during sleep. These intra-sleep awakenings would finally give more opportunities to the brain to restore his memory-encoding abilities and therefore to encode the dream in long term memory.</p>
    </sec>
    <sec id="s6">
      <title>Author Contributions</title>
      <p>PMR, DM, J-BE designed the experiment and acquired data. RV, TL, J-BE, CB, KJ, DM and PMR participated in the data analysis. RV and PMR wrote the initial draft.</p>
    </sec>
    <sec id="s7">
      <title>Funding</title>
      <p>This research was financially supported by a grant from the French National research Agency (Agence Nationale de la Recherche, ANR-07-JCJC-0095). This work was partly performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) of Université de Lyon, within the program ANR-11-IDEX-0007.</p>
    </sec>
    <sec id="s8">
      <title>Conflict of Interest Statement</title>
      <p>CB has ownership and directorship in Physip S.A. Company. The other authors declare no conflict of interest.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="supplementary material" id="s9">
      <title>Supplementary Material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnhum.2017.00132/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnhum.2017.00132/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <media xlink:href="Image_1.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <media xlink:href="Image_2.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM3">
        <media xlink:href="Image_3.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM4">
        <media xlink:href="Table_1.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarons</surname><given-names>L.</given-names></name></person-group> (<year>1976</year>). <article-title>Sleep-assisted instruction</article-title>. <source>Psychol. Bull.</source>
<volume>83</volume>, <fpage>1</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.83.1.1</pub-id><?supplied-pmid 1019279?><pub-id pub-id-type="pmid">1019279</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achermann</surname><given-names>P.</given-names></name><name><surname>Dijk</surname><given-names>D.-J.</given-names></name><name><surname>Brunner</surname><given-names>D. P.</given-names></name><name><surname>Borbély</surname><given-names>A. A.</given-names></name></person-group> (<year>1993</year>). <article-title>A model of human sleep homeostasis based on EEG slow-wave activity: quantitative comparison of data and simulations</article-title>. <source>Brain Res. Bull.</source>
<volume>31</volume>, <fpage>97</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/0361-9230(93)90016-5</pub-id><?supplied-pmid 8453498?><pub-id pub-id-type="pmid">8453498</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguera</surname><given-names>P.-E.</given-names></name><name><surname>Jerbi</surname><given-names>K.</given-names></name><name><surname>Caclin</surname><given-names>A.</given-names></name><name><surname>Bertrand</surname><given-names>O.</given-names></name></person-group> (<year>2011</year>). <article-title>ELAN: a software package for analysis and visualization of MEG, EEG, and LFP signals</article-title>. <source>Comput. Intell. Neurosci.</source>
<volume>2011</volume>:<fpage>158970</fpage>. <pub-id pub-id-type="doi">10.1155/2011/158970</pub-id><?supplied-pmid 21687568?><pub-id pub-id-type="pmid">21687568</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>American Sleep Disorders Association</collab></person-group> (<year>1992</year>). <article-title>EEG arousals: scoring rules and examples</article-title>. <source>Sleep</source>
<volume>15</volume>:<fpage>173</fpage>
<pub-id pub-id-type="doi">10.1093/sleep/15.2.173</pub-id><pub-id pub-id-type="pmid">11032543</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrillon</surname><given-names>T.</given-names></name><name><surname>Nir</surname><given-names>Y.</given-names></name><name><surname>Cirelli</surname><given-names>C.</given-names></name><name><surname>Tononi</surname><given-names>G.</given-names></name><name><surname>Fried</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Single-neuron activity and eye movements during human REM sleep and awake vision</article-title>. <source>Nat. Commun.</source>
<volume>6</volume>:<fpage>7884</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8884</pub-id><?supplied-pmid 26262924?><pub-id pub-id-type="pmid">26262924</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahill</surname><given-names>A. T.</given-names></name><name><surname>Clark</surname><given-names>M. R.</given-names></name><name><surname>Stark</surname><given-names>L.</given-names></name></person-group> (<year>1975</year>). <article-title>Glissades—eye movements generated by mismatched components of the saccadic motoneuronal control signal</article-title>. <source>Math. Biosci.</source>
<volume>26</volume>, <fpage>303</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/0025-5564(75)90018-8</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastien</surname><given-names>C. H.</given-names></name><name><surname>Crowley</surname><given-names>K. E.</given-names></name><name><surname>Colrain</surname><given-names>I. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Evoked potential components unique to non-REM sleep: relationship to evoked KCs and vertex sharp waves</article-title>. <source>Int. J. Psychophysiol.</source>
<volume>46</volume>, <fpage>257</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-8760(02)00117-4</pub-id><?supplied-pmid 12445952?><pub-id pub-id-type="pmid">12445952</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastien</surname><given-names>C. H.</given-names></name><name><surname>Ladouceur</surname><given-names>C.</given-names></name><name><surname>Campbell</surname><given-names>K. B.</given-names></name></person-group> (<year>2000</year>). <article-title>EEG characteristics prior to and following the evoked K-Complex</article-title>. <source>Can. J. Exp. Psychol. Can. Psychol.</source>
<volume>54</volume>, <fpage>255</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1037/h0087345</pub-id><?supplied-pmid 11195716?><pub-id pub-id-type="pmid">11195716</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bastuji</surname><given-names>H.</given-names></name><name><surname>Lavigne</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). “<article-title>Pain perception during sleep</article-title>,” in <source>Pain and the Conscious Brain</source>, eds <person-group person-group-type="editor"><name><surname>Garcia-Larrea</surname><given-names>L.</given-names></name><name><surname>Jackson</surname><given-names>P. L.</given-names></name></person-group> (<publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Wolters Kluwer Health</publisher-name>), <fpage>61</fpage>–<lpage>74</lpage>.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastuji</surname><given-names>H.</given-names></name><name><surname>Perchet</surname><given-names>C.</given-names></name><name><surname>Legrain</surname><given-names>V.</given-names></name><name><surname>Montes</surname><given-names>C.</given-names></name><name><surname>Garcia-Larrea</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Laser evoked responses to painful stimulation persist during sleep and predict subsequent arousals</article-title>. <source>Pain</source>
<volume>137</volume>, <fpage>589</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2007.10.027</pub-id><?supplied-pmid 18063478?><pub-id pub-id-type="pmid">18063478</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>O.</given-names></name><name><surname>Lacombe</surname><given-names>J.</given-names></name><name><surname>Bouard</surname><given-names>G.</given-names></name><name><surname>Foret</surname><given-names>J.</given-names></name><name><surname>Marc</surname><given-names>M.-E.</given-names></name></person-group> (<year>1981</year>). <article-title>Durée habituelle de sommeil, modifications du rythme veille-sommeil et éveils nocturnes</article-title>. <source>Rev. Electroencephalogr. Neurophysiol. Clin.</source>
<volume>11</volume>, <fpage>89</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/s0370-4475(81)80038-x</pub-id><?supplied-pmid 7313261?><pub-id pub-id-type="pmid">7313261</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthomier</surname><given-names>C.</given-names></name></person-group> (<year>1983</year>). <article-title>Instantaneous frequency and energy distribution of a signal</article-title>. <source>Signal Process.</source>
<volume>5</volume>, <fpage>31</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1684(83)90033-6</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthomier</surname><given-names>C.</given-names></name><name><surname>Drouot</surname><given-names>X.</given-names></name><name><surname>Herman-Stoïca</surname><given-names>M.</given-names></name><name><surname>Berthomier</surname><given-names>P.</given-names></name><name><surname>Prado</surname><given-names>J.</given-names></name><name><surname>Bokar-Thire</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Automatic analysis of single-channel sleep EEG: validation in healthy individuals</article-title>. <source>Sleep</source>
<volume>30</volume>, <fpage>1587</fpage>–<lpage>1595</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/30.11.1587</pub-id><?supplied-pmid 18041491?><pub-id pub-id-type="pmid">18041491</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidet-Caulet</surname><given-names>A.</given-names></name><name><surname>Barbe</surname><given-names>P.-G.</given-names></name><name><surname>Roux</surname><given-names>S.</given-names></name><name><surname>Viswanath</surname><given-names>H.</given-names></name><name><surname>Barthélémy</surname><given-names>C.</given-names></name><name><surname>Bruneau</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Dynamics of anticipatory mechanisms during predictive context processing</article-title>. <source>Eur. J. Neurosci.</source>
<volume>36</volume>, <fpage>2996</fpage>–<lpage>3004</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08223.x</pub-id><?supplied-pmid 22780698?><pub-id pub-id-type="pmid">22780698</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>M. H.</given-names></name><name><surname>Arand</surname><given-names>D. L</given-names></name></person-group>. (<year>2007</year>). <article-title>EEG arousal norms by age</article-title>. <source>J. Clin. Sleep Med.</source>
<volume>3</volume>, <fpage>271</fpage>–<lpage>274</lpage>. <?supplied-pmid 17557423?><pub-id pub-id-type="pmid">17561594</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caclin</surname><given-names>A.</given-names></name><name><surname>McAdams</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>B. K.</given-names></name><name><surname>Giard</surname><given-names>M.-H.</given-names></name></person-group> (<year>2008</year>). <article-title>Interactive processing of timbre dimensions: an exploration with event-related potentials</article-title>. <source>J. Cogn. Neurosci.</source>
<volume>20</volume>, <fpage>49</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1162/jocn.2008.20.1.49</pub-id><?supplied-pmid 17919079?><pub-id pub-id-type="pmid">17919079</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>S. S.</given-names></name><name><surname>Webb</surname><given-names>W. B.</given-names></name></person-group> (<year>1981</year>). <article-title>The perception of wakefulness within sleep</article-title>. <source>Sleep</source>
<volume>4</volume>, <fpage>177</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/4.2.177</pub-id><?supplied-pmid 7256078?><pub-id pub-id-type="pmid">7256078</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colrain</surname><given-names>I. M.</given-names></name></person-group> (<year>2005</year>). <article-title>The K-complex: a 7-decade history</article-title>. <source>Sleep</source>
<volume>28</volume>, <fpage>255</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/28.2.255</pub-id><?supplied-pmid 16171251?><pub-id pub-id-type="pmid">16171251</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colrain</surname><given-names>I. M.</given-names></name><name><surname>Crowley</surname><given-names>K. E.</given-names></name><name><surname>Nicholas</surname><given-names>C. L.</given-names></name><name><surname>Afifi</surname><given-names>L.</given-names></name><name><surname>Baker</surname><given-names>F. C.</given-names></name><name><surname>Padilla</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Sleep evoked delta frequency responses show a linear decline in amplitude across the adult lifespan</article-title>. <source>Neurobiol. Aging</source>
<volume>31</volume>, <fpage>874</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.06.003</pub-id><?supplied-pmid 18657881?><pub-id pub-id-type="pmid">18657881</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cote</surname><given-names>K. A.</given-names></name><name><surname>de Lugt</surname><given-names>D. R.</given-names></name><name><surname>Langley</surname><given-names>S. D.</given-names></name><name><surname>Campbell</surname><given-names>K. B.</given-names></name></person-group> (<year>1999</year>). <article-title>Scalp topography of the auditory evoked K-complex in stage 2 and slow wave sleep</article-title>. <source>J. Sleep Res.</source>
<volume>8</volume>, <fpage>263</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2869.1999.00164.x</pub-id><?supplied-pmid 10646166?><pub-id pub-id-type="pmid">10646166</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname><given-names>K.</given-names></name><name><surname>Sullivan</surname><given-names>E. V.</given-names></name><name><surname>Adalsteinsson</surname><given-names>E.</given-names></name><name><surname>Pfefferbaum</surname><given-names>A.</given-names></name><name><surname>Colrain</surname><given-names>I. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Differentiating pathologic delta from healthy physiologic delta in patients with Alzheimer disease</article-title>. <source>Sleep</source>
<volume>28</volume>, <fpage>865</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/28.7.865</pub-id><?supplied-pmid 16124667?><pub-id pub-id-type="pmid">16124667</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curcio</surname><given-names>G.</given-names></name><name><surname>Ferrara</surname><given-names>M.</given-names></name><name><surname>Pellicciari</surname><given-names>M. C.</given-names></name><name><surname>Cristiani</surname><given-names>R.</given-names></name><name><surname>De Gennaro</surname><given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>Effect of total sleep deprivation on the landmarks of stage 2 sleep</article-title>. <source>Clin. Neurophysiol.</source>
<volume>114</volume>, <fpage>2279</fpage>–<lpage>2285</lpage>. <pub-id pub-id-type="doi">10.1016/s1388-2457(03)00276-1</pub-id><?supplied-pmid 14652087?><pub-id pub-id-type="pmid">14652087</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Effects of attention and confidence on the hypothesized ERP correlates of recollection and familiarity</article-title>. <source>Neuropsychologia</source>
<volume>42</volume>, <fpage>1088</fpage>–<lpage>1106</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2003.12.011</pub-id><?supplied-pmid 15093148?><pub-id pub-id-type="pmid">15093148</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang-Vu</surname><given-names>T. T.</given-names></name><name><surname>Salimi</surname><given-names>A.</given-names></name><name><surname>Boucetta</surname><given-names>S.</given-names></name><name><surname>Wenzel</surname><given-names>K.</given-names></name><name><surname>O’Byrne</surname><given-names>J.</given-names></name><name><surname>Brandewinder</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Sleep spindles predict stress-related increases in sleep disturbances</article-title>. <source>Front. Hum. Neurosci.</source>
<volume>9</volume>:<fpage>68</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2015.00068</pub-id><?supplied-pmid 25713529?><pub-id pub-id-type="pmid">25713529</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gennaro</surname><given-names>L.</given-names></name><name><surname>Ferrara</surname><given-names>M.</given-names></name><name><surname>Bertini</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>EEG arousals in normal sleep: variations induced by total and selective slow-wave sleep deprivation</article-title>. <source>Sleep</source>
<volume>24</volume>, <fpage>673</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/24.6.673</pub-id><?supplied-pmid 11560180?><pub-id pub-id-type="pmid">11560180</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gennaro</surname><given-names>L.</given-names></name><name><surname>Marzano</surname><given-names>C.</given-names></name><name><surname>Moroni</surname><given-names>F.</given-names></name><name><surname>Curcio</surname><given-names>G.</given-names></name><name><surname>Ferrara</surname><given-names>M.</given-names></name><name><surname>Cipolli</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Recovery sleep after sleep deprivation almost completely abolishes dream recall</article-title>. <source>Behav. Brain Res.</source>
<volume>206</volume>, <fpage>293</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2009.09.030</pub-id><?supplied-pmid 19788898?><pub-id pub-id-type="pmid">19788898</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dement</surname><given-names>W.</given-names></name><name><surname>Kleitman</surname><given-names>N.</given-names></name></person-group> (<year>1957</year>). <article-title>The relation of eye movements during sleep to dream activity: an objective method for the study of dreaming</article-title>. <source>J. Exp. Psychol.</source>
<volume>53</volume>, <fpage>339</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1037/h0048189</pub-id><?supplied-pmid 13428941?><pub-id pub-id-type="pmid">13428941</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Bertrand</surname><given-names>O.</given-names></name><name><surname>Morlet</surname><given-names>D.</given-names></name><name><surname>Ruby</surname><given-names>P.</given-names></name></person-group> (<year>2014a</year>). <article-title>Brain reactivity differentiates subjects with high and low dream recall frequencies during both sleep and wakefulness</article-title>. <source>Cereb. Cortex</source>
<volume>24</volume>, <fpage>1206</fpage>–<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhs388</pub-id><?supplied-pmid 23283685?><pub-id pub-id-type="pmid">23283685</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Nicolas</surname><given-names>A.</given-names></name><name><surname>Daltrozzo</surname><given-names>J.</given-names></name><name><surname>Redouté</surname><given-names>J.</given-names></name><name><surname>Costes</surname><given-names>N.</given-names></name><name><surname>Ruby</surname><given-names>P.</given-names></name></person-group> (<year>2014b</year>). <article-title>Resting brain activity varies with dream recall frequency between subjects</article-title>. <source>Neuropsychopharmacology</source>
<volume>39</volume>, <fpage>1594</fpage>–<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.6</pub-id><?supplied-pmid 24549103?><pub-id pub-id-type="pmid">24549103</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Ruby</surname><given-names>P.</given-names></name><name><surname>Morlet</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>What is the specificity of the response to the own first-name when presented as a novel in a passive oddball paradigm? An ERP study</article-title>. <source>Brain Res.</source>
<volume>1447</volume>, <fpage>65</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.01.072</pub-id><?supplied-pmid 22361115?><pub-id pub-id-type="pmid">22361115</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>M.</given-names></name><name><surname>Curcio</surname><given-names>G.</given-names></name><name><surname>Fratello</surname><given-names>F.</given-names></name><name><surname>Moroni</surname><given-names>F.</given-names></name><name><surname>Marzano</surname><given-names>C.</given-names></name><name><surname>Pellicciari</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>The electroencephalographic substratum of the awakening</article-title>. <source>Behav. Brain Res.</source>
<volume>167</volume>, <fpage>237</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2005.09.012</pub-id><?supplied-pmid 16242789?><pub-id pub-id-type="pmid">16242789</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>F.</given-names></name><name><surname>Goldenberg</surname><given-names>E.</given-names></name><name><surname>LaComber</surname><given-names>J.</given-names></name><name><surname>Benoit</surname><given-names>O.</given-names></name></person-group> (<year>1981</year>). <article-title>Eveil intra-sommeil chez de mauvais dormeurs de 20 a 30 ans. Correlation avec le niveau d’anxiete et la personnalite</article-title>. <source>Rev. Electroencephalogr. Neurophysiol. Clin.</source>
<volume>11</volume>, <fpage>102</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/s0370-4475(81)80040-8</pub-id><?supplied-pmid 7313242?><pub-id pub-id-type="pmid">7313242</pub-id></mixed-citation>
      </ref>
      <ref id="B330">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guthrie</surname><given-names>D.</given-names></name><name><surname>Buchwald</surname><given-names>J. S.</given-names></name></person-group> (<year>1991</year>). <article-title>Significance testing of difference potentials</article-title>. <source>Psychophysiology</source>
<volume>28</volume>, <fpage>240</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8986.1991.tb00417.x</pub-id><?supplied-pmid 16122950?><pub-id pub-id-type="pmid">1946890</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halász</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>K-complex, a reactive EEG graphoelement of NREM sleep: an old chap in a new garment</article-title>. <source>Sleep Med. Rev.</source>
<volume>9</volume>, <fpage>391</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/j.smrv.2005.04.003</pub-id><?supplied-pmid 16122950?><pub-id pub-id-type="pmid">16122950</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirshkowitz</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Normal human sleep: an overview</article-title>. <source>Med. Clin. North Am.</source>
<volume>88</volume>, <fpage>551</fpage>–<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcna.2004.01.001</pub-id><?supplied-pmid 15087204?><pub-id pub-id-type="pmid">15087204</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>R.</given-names></name><name><surname>Ghilardi</surname><given-names>M. F.</given-names></name><name><surname>Massimini</surname><given-names>M.</given-names></name><name><surname>Tononi</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Local sleep and learning</article-title>. <source>Nature</source>
<volume>430</volume>, <fpage>78</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1038/nature02663</pub-id><?supplied-pmid 15184907?><pub-id pub-id-type="pmid">15184907</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Iber</surname><given-names>C.</given-names></name><name><surname>Ancoli-Israel</surname><given-names>S.</given-names></name><name><surname>Chesson</surname><given-names>A. L.</given-names><suffix>Jr.</suffix></name><name><surname>Quan</surname><given-names>S. F.</given-names></name></person-group> (<year>2007</year>). <source>The AASM Manual for The Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications.</source>
<publisher-loc>Westchester, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahnke</surname><given-names>K.</given-names></name><name><surname>von Wegner</surname><given-names>F.</given-names></name><name><surname>Morzelewski</surname><given-names>A.</given-names></name><name><surname>Borisov</surname><given-names>S.</given-names></name><name><surname>Maischein</surname><given-names>M.</given-names></name><name><surname>Steinmetz</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>To wake or not to wake? The two-sided nature of the human K-complex</article-title>. <source>Neuroimage</source>
<volume>59</volume>, <fpage>1631</fpage>–<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.013</pub-id><?supplied-pmid 21945697?><pub-id pub-id-type="pmid">21945697</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klimesch</surname><given-names>W.</given-names></name></person-group> (<year>1997</year>). <article-title>EEG-alpha rhythms and memory processes</article-title>. <source>Int. J. Psychophysiol.</source>
<volume>26</volume>, <fpage>319</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-8760(97)00773-3</pub-id><?supplied-pmid 9203012?><pub-id pub-id-type="pmid">9203012</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koulack</surname><given-names>D.</given-names></name><name><surname>Goodenough</surname><given-names>D. R.</given-names></name></person-group> (<year>1976</year>). <article-title>Dream recall and dream recall failure: an arousal-retrieval model</article-title>. <source>Psychol. Bull.</source>
<volume>83</volume>, <fpage>975</fpage>–<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.83.5.975</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lajnef</surname><given-names>T.</given-names></name><name><surname>Chaibi</surname><given-names>S.</given-names></name><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Ruby</surname><given-names>P. M.</given-names></name><name><surname>Aguera</surname><given-names>P.-E.</given-names></name><name><surname>Samet</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Sleep spindle and K-complex detection using tunable Q-factor wavelet transform and morphological component analysis</article-title>. <source>Front. Hum. Neurosci.</source>
<volume>9</volume>:<fpage>414</fpage>. <pub-id pub-id-type="doi">10.3389/fnhum.2015.00414</pub-id><?supplied-pmid 26283943?><pub-id pub-id-type="pmid">26283943</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lajnef</surname><given-names>T.</given-names></name><name><surname>O’Reilly</surname><given-names>C.</given-names></name><name><surname>Combrisson</surname><given-names>E.</given-names></name><name><surname>Chaibi</surname><given-names>S.</given-names></name><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Ruby</surname><given-names>P. M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Meet spinky: an open-source spindle and K-complex detection toolbox validated on the open-access montreal archive of sleep studies (MASS)</article-title>. <source>Front. Neuroinform.</source>
<volume>11</volume>:<fpage>15</fpage>
<pub-id pub-id-type="doi">10.3389/fninf.2017.00015</pub-id><pub-id pub-id-type="pmid">28303099</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinari</surname><given-names>S.</given-names></name><name><surname>Foulkes</surname><given-names>D.</given-names></name></person-group> (<year>1969</year>). <article-title>Tonic and phasic events during sleep: psychological correlates and implications</article-title>. <source>Percept. Mot. Skills</source>
<volume>29</volume>, <fpage>343</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.2466/pms.1969.29.2.343</pub-id><?supplied-pmid 4310916?><pub-id pub-id-type="pmid">4310916</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholas</surname><given-names>C. L.</given-names></name><name><surname>Trinder</surname><given-names>J.</given-names></name><name><surname>Colrain</surname><given-names>I. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Increased production of evoked and spontaneous KCs following a night of fragmented sleep</article-title>. <source>Sleep</source>
<volume>25</volume>, <fpage>882</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/25.8.42</pub-id><?supplied-pmid 12489895?><pub-id pub-id-type="pmid">12489895</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peszka</surname><given-names>J.</given-names></name><name><surname>Harsh</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Effect of sleep deprivation on NREM sleep ERPs and related activity at sleep onset</article-title>. <source>Int. J. Psychophysiol.</source>
<volume>46</volume>, <fpage>275</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-8760(02)00115-0</pub-id><?supplied-pmid 12445953?><pub-id pub-id-type="pmid">12445953</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roffwarg</surname><given-names>H. P.</given-names></name><name><surname>Dement</surname><given-names>W. C.</given-names></name><name><surname>Muzio</surname><given-names>J. N.</given-names></name><name><surname>Fisher</surname><given-names>C.</given-names></name></person-group> (<year>1962</year>). <article-title>Dream imagery: relationship to rapid eye movements of sleep</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>7</volume>, <fpage>235</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1962.01720040001001</pub-id><?supplied-pmid 13982370?><pub-id pub-id-type="pmid">13982370</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruby</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Experimental research on dreaming: state of the art and neuropsychoanalytic perspectives</article-title>. <source>Front. Psychol.</source>
<volume>2</volume>:<fpage>286</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2011.00286</pub-id><?supplied-pmid 22121353?><pub-id pub-id-type="pmid">22121353</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruby</surname><given-names>P.</given-names></name><name><surname>Blochet</surname><given-names>C.</given-names></name><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Bertrand</surname><given-names>O.</given-names></name><name><surname>Morlet</surname><given-names>D.</given-names></name><name><surname>Bidet-Caulet</surname><given-names>A.</given-names></name></person-group> (<year>2013a</year>). <article-title>Alpha reactivity to complex sounds differs during REM sleep and wakefulness</article-title>. <source>PLoS One</source>
<volume>8</volume>:<fpage>e79989</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0079989</pub-id><?supplied-pmid 24260331?><pub-id pub-id-type="pmid">24260331</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruby</surname><given-names>P.</given-names></name><name><surname>Blochet</surname><given-names>C.</given-names></name><name><surname>Eichenlaub</surname><given-names>J.-B.</given-names></name><name><surname>Bertrand</surname><given-names>O.</given-names></name><name><surname>Morlet</surname><given-names>D.</given-names></name><name><surname>Bidet-Caulet</surname><given-names>A.</given-names></name></person-group> (<year>2013b</year>). <article-title>Alpha reactivity to first names differs in subjects with high and low dream recall frequency</article-title>. <source>Front. Psychol.</source>
<volume>4</volume>:<fpage>419</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2013.00419</pub-id><?supplied-pmid 23966960?><pub-id pub-id-type="pmid">23966960</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sastre</surname><given-names>J.-P.</given-names></name><name><surname>Jouvet</surname><given-names>M.</given-names></name></person-group> (<year>1979</year>). <article-title>Le comportement onirique du chat</article-title>. <source>Physiol. Behav.</source>
<volume>22</volume>, <fpage>979</fpage>–<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9384(79)90344-5</pub-id><pub-id pub-id-type="pmid">228328</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schredl</surname><given-names>M.</given-names></name><name><surname>Wittmann</surname><given-names>L.</given-names></name><name><surname>Ciric</surname><given-names>P.</given-names></name><name><surname>GÖtz</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Factors of home dream recall: a structural equation model</article-title>. <source>J. Sleep Res.</source>
<volume>12</volume>, <fpage>133</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2869.2003.00344.x</pub-id><?supplied-pmid 12753350?><pub-id pub-id-type="pmid">12753350</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silber</surname><given-names>M. H.</given-names></name><name><surname>Ancoli-Israel</surname><given-names>S.</given-names></name><name><surname>Bonnet</surname><given-names>M. H.</given-names></name><name><surname>Chokroverty</surname><given-names>S.</given-names></name><name><surname>Grigg-Damberger</surname><given-names>M. M.</given-names></name><name><surname>Hirshkowitz</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>The visual scoring of sleep in adults</article-title>. <source>J. Clin. Sleep Med.</source>
<volume>3</volume>, <fpage>121</fpage>–<lpage>131</lpage>. <?supplied-pmid 17557422?><pub-id pub-id-type="pmid">17557422</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Sleep spindles as facilitators of memory formation and learning</article-title>. <source>Neural Plast.</source>
<volume>2016</volume>:<fpage>1796715</fpage>. <pub-id pub-id-type="doi">10.1155/2016/1796715</pub-id><?supplied-pmid 27119026?><pub-id pub-id-type="pmid">27119026</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>J. R.</given-names></name><name><surname>Freyermuth</surname><given-names>S.</given-names></name><name><surname>Jerbi</surname><given-names>K.</given-names></name><name><surname>Hamamé</surname><given-names>C. M.</given-names></name><name><surname>Ossandon</surname><given-names>T.</given-names></name><name><surname>Bertrand</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Long-distance amplitude correlations in the high gamma band reveal segregation and integration within the reading network</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>6421</fpage>–<lpage>6434</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4363-11.2012</pub-id><?supplied-pmid 22573665?><pub-id pub-id-type="pmid">22573665</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallant</surname><given-names>D.</given-names></name><name><surname>Maquet</surname><given-names>P.</given-names></name><name><surname>Phillips</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Sleep spindles as an electrographic element: description and automatic detection methods</article-title>. <source>Neural Plast.</source>
<volume>2016</volume>:<fpage>6783812</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6783812</pub-id><?supplied-pmid 27478649?><pub-id pub-id-type="pmid">27478649</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wamsley</surname><given-names>E. J.</given-names></name><name><surname>Tucker</surname><given-names>M. A.</given-names></name><name><surname>Shinn</surname><given-names>A. K.</given-names></name><name><surname>Ono</surname><given-names>K. E.</given-names></name><name><surname>McKinley</surname><given-names>S. K.</given-names></name><name><surname>Ely</surname><given-names>A. V.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation?</article-title>
<source>Biol. Psychiatry</source>
<volume>71</volume>, <fpage>154</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2011.08.008</pub-id><?supplied-pmid 21967958?><pub-id pub-id-type="pmid">21967958</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpert</surname><given-names>E. A.</given-names></name></person-group> (<year>1960</year>). <article-title>Studies in psychophysiology of dreams: II. An electromyographic study of dreaming</article-title>. <source>JAMA. Arch. Gen. Psychiatry</source>
<volume>2</volume>, <fpage>231</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1960.03590080107014</pub-id><?supplied-pmid 13845777?><pub-id pub-id-type="pmid">13845777</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <glossary>
      <def-list>
        <title>Abbreviations</title>
        <def-item>
          <term>AEP</term>
          <def>
            <p>Auditory evoked potential</p>
          </def>
        </def-item>
        <def-item>
          <term>AI</term>
          <def>
            <p>Arousal Index</p>
          </def>
        </def-item>
        <def-item>
          <term>BSW</term>
          <def>
            <p>Before sleep wakefulness</p>
          </def>
        </def-item>
        <def-item>
          <term>EEG</term>
          <def>
            <p>Electroencephalogram</p>
          </def>
        </def-item>
        <def-item>
          <term>EMG</term>
          <def>
            <p>Electromyogram</p>
          </def>
        </def-item>
        <def-item>
          <term>EOG</term>
          <def>
            <p>Electro-oculogram</p>
          </def>
        </def-item>
        <def-item>
          <term>ERP</term>
          <def>
            <p>Event related potential</p>
          </def>
        </def-item>
        <def-item>
          <term>HR</term>
          <def>
            <p>High dream recallers</p>
          </def>
        </def-item>
        <def-item>
          <term>Inds</term>
          <def>
            <p>Indeterminate</p>
          </def>
        </def-item>
        <def-item>
          <term>ISW</term>
          <def>
            <p>Intra sleep wakefulness</p>
          </def>
        </def-item>
        <def-item>
          <term>KCs</term>
          <def>
            <p>K-complexes</p>
          </def>
        </def-item>
        <def-item>
          <term>LR</term>
          <def>
            <p>Low dream recallers</p>
          </def>
        </def-item>
        <def-item>
          <term>MTs</term>
          <def>
            <p>Muscle twitches</p>
          </def>
        </def-item>
        <def-item>
          <term>Mvts</term>
          <def>
            <p>Movements</p>
          </def>
        </def-item>
        <def-item>
          <term>REMs</term>
          <def>
            <p>Rapid eyes movements</p>
          </def>
        </def-item>
        <def-item>
          <term>TST</term>
          <def>
            <p>Total Sleep Time.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360093</identifier><datestamp>2017-04-04</datestamp><setSpec>frontneurosci</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1662-4548</issn>
      <issn pub-type="epub">1662-453X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360093</article-id>
      <article-id pub-id-type="pmcid">PMC5360093</article-id>
      <article-id pub-id-type="pmc-uid">5360093</article-id>
      <article-id pub-id-type="doi">10.3389/fnins.2017.00120</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Changing Landscape of Neuroscience Research, 2006–2015: A Bibliometric Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yeung</surname>
            <given-names>Andy Wai Kan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/363181/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goto</surname>
            <given-names>Tazuko K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leung</surname>
            <given-names>W. Keung</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Oral and Maxillofacial Radiology, Applied Oral Sciences, Faculty of Dentistry, University of Hong Kong</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Department of Oral and Maxillofacial Radiology, Tokyo Dental College</institution>
        <country>Tokyo, Japan</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>Periodontology, Faculty of Dentistry, University of Hong Kong</institution>
        <country>Hong Kong, Hong Kong</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Mikhail Lebedev, Duke University, USA</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Ping Zhou, Zhejiang University, China; Francisco Lopez-Munoz, Universidad Camilo José Cela, Spain; Andreas Charidimou, Harvard Medical School, USA</p>
        </fn>
        <corresp id="fn001">*Correspondence: Andy Wai Kan Yeung <email xlink:type="simple">ndyeung@hku.hk</email></corresp>
        <fn fn-type="other" id="fn002">
          <p>This article was submitted to Neuroprosthetics, a section of the journal Frontiers in Neuroscience</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>120</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Yeung, Goto and Leung.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Yeung, Goto and Leung</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><bold>Background:</bold> It is beneficial to evaluate changes in neuroscience research field regarding research directions and topics over a defined period. Such information enables stakeholders to quickly identify the most influential research and incorporate latest evidence into research-informed education. To our knowledge, no study reported changes in neuroscience literature over the last decade. Therefore, the current study determined research terms with highest citation scores, compared publication shares of research areas and contributing countries in this field from 2006 to 2015 and identified the most productive journals.</p>
        <p><bold>Methods:</bold> Data were extracted from Web of Science and Journal Citation Reports (JCR). Only articles and reviews published in journals classified under the JCR “Neurosciences” category over the period of interest were included. Title and abstract fields of each included publication were extracted and analyzed via VOSviewer to identify recurring terms with high relative citation scores. Two term maps were produced for publications over the study period to illustrate the extent of co-occurrence, and the impact of terms was evaluated based on their relative citation scores. To further describe the recent research priority or “hot spots,” 10 terms with the highest relative citation scores were identified annually. In addition, by applying Bradford's law, we identified 10 journals being the most productive journals per annum over the survey period and evaluated their bilbiometric performances.</p>
        <p><bold>Results:</bold> From 2006 to 2015, there were 47 terms involved in the annual lists of top 10 terms with highest relative citation scores. The most frequently recurring terms were autism (8), meta-analysis (7), functional connectivity (6), default mode network (4) and neuroimaging (4). Neuroscience research related to psychology and behavioral sciences showed an increase in publication share over the survey period, and China has become one of the major contributors to neuroscience research. Ten journals were frequently identified (≥8 years) as core journals within the survey period.</p>
        <p><bold>Discussion:</bold> The landscape of neuroscience research has changed recently, and this paper provides contemporary overview for researchers and health care workers interested in this field's research and developments. Brain imaging and brain connectivity terms had high relative citation scores.</p>
      </abstract>
      <kwd-group>
        <kwd>bibliometrics</kwd>
        <kwd>cells</kwd>
        <kwd>diagnostic imaging</kwd>
        <kwd>functional neuroimaging</kwd>
        <kwd>information science</kwd>
        <kwd>literature-based discovery</kwd>
        <kwd>neurosciences</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">Research Grants Council, University Grants Committee<named-content content-type="fundref-id">10.13039/501100002920</named-content></funding-source>
          <award-id rid="cn001">HKU 766212M</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="4"/>
        <equation-count count="0"/>
        <ref-count count="43"/>
        <page-count count="10"/>
        <word-count count="7029"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Neuroscience is an exciting research field, and many recent discoveries have informed paradigm-shifts and innovations. For instance, the 2014 Nobel Prize in Physiology or Medicine was awarded to Professors John O'Keefe, May-Britt Moser and Edvard Moser, neuroscientists who discovered place cells and grid cells that form a built-in, global positioning system inside the brain (O'keefe and Burgess, <xref rid="B26" ref-type="bibr">2005</xref>; Moser et al., <xref rid="B24" ref-type="bibr">2008</xref>). Indeed, neuroscience research has received substantial support across the globe. In the United States, the Human Connectome Project was launched in 2009 (Battery, <xref rid="B2" ref-type="bibr">2010</xref>), followed by the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative in 2013 (Insel et al., <xref rid="B11" ref-type="bibr">2013</xref>). Concurrently, the Human Brain Project was initiated in Europe (Markram, <xref rid="B23" ref-type="bibr">2012</xref>). In Japan, the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) program started in 2014, and the Brain Science and Brain-Like Intelligence Technology project will soon be officially launched by China, though significant preliminary research has already been done (Grillner et al., <xref rid="B9" ref-type="bibr">2016</xref>). With these abundant investments in neuroscience in recent years, more explorative, fundamental or basic research could be conducted, which eventually led to today's paradigm shifts—or paradigm shifts yet to come. For instance, the emergence of brain connectivity studies (Friston, <xref rid="B6" ref-type="bibr">2011</xref>) in recent years may enable us to compare and contrast the normal and diseased brains, and thus identify abnormal brain connectivity patterns as potential biomarkers for neurologic diseases. These advances in the neuroscience field not only drive significant progress in brain biology but also confer practical implications to medicine. We should evaluate and track the changes regarding the landscape of neuroscience research, to indicate evolution regarding research directions, health care priorities and prime translational research topics over a defined period. Such information enables stakeholders to clearly and quickly identify the most influential research works and incorporate the latest evidence into research-informed education.</p>
      <p>Bibliometric studies could provide relevant evaluations and assessments of the social and scientific relevance of a specific discipline or research field of interest (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>, <xref rid="B21" ref-type="bibr">2014</xref>). There have been numerous bibliometric studies on the performance of neuroscience research outputs in specific countries, including China (Xu et al., <xref rid="B40" ref-type="bibr">2003</xref>), India (Shahabuddin, <xref rid="B28" ref-type="bibr">2013</xref>) and Sweden (Glänzel et al., <xref rid="B8" ref-type="bibr">2003</xref>). In addition, similar studies have been conducted in relevant research fields such as psychiatry and psychopharmacology (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>, <xref rid="B21" ref-type="bibr">2014</xref>). However, to our knowledge, no published study has reported overall changes in the landscape of neuroscience literature across the globe over the last decade.</p>
      <p>Therefore, the aims of this study was to identify the most productive core journals in the field from 2006 to 2015, determine the research terms with the highest citation impact, and compare the publication shares of research areas and contributing countries across these 10 years.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and methods</title>
      <sec>
        <title>Date source</title>
        <p>Data analyzed in this study were extracted from Web of Science (WoS) and Journal Citation Reports (JCR). Both required a subscription and were hosted by Thomson Reuters.</p>
      </sec>
      <sec>
        <title>Data extraction</title>
        <p>Publications indexed in WoS were included if they were: (1) articles or reviews; (2) published in journals under the JCR “Neurosciences” category; and (3) published from 2006 to 2015. Full records and cited references of the included publications were manually downloaded. The analyses at the literature level (term maps, annual high-impact terms and changes in research areas and contributing countries) were based on all these records; and for each publication, citations were counted until the end of November, 2016.</p>
      </sec>
      <sec>
        <title>Term maps</title>
        <p>For each year, the title and abstract fields of each included publication were extracted and analyzed via VOSviewer (van Eck and Waltman, <xref rid="B30" ref-type="bibr">2009</xref>). Two term maps, one for 2006 and one for 2015, were produced to illustrate a network of recurring keywords, showing their co-occurrence and relative citation impacts. The details of the established methods and algorithms have been described in previous publications (van Eck et al., <xref rid="B32" ref-type="bibr">2010</xref>; Waltman et al., <xref rid="B38" ref-type="bibr">2010</xref>). In brief, for each term map, only terms that occurred at least 100 times under binary counting were considered. Note that binary counting only considers the number of publications in which a term was present; it disregards the number of occurrences of a term within a single publication. General noun phrases were removed using an algorithm (van Eck and Waltman, <xref rid="B31" ref-type="bibr">2011</xref>). Of the remaining terms, 500 with the highest relevance score calculated via VOSviewer were used to form a term map to allow for network visualization. The algorithm was designed to ensure that terms that co-occurred more frequently were positioned closer to each other. Terms that occurred more frequently had larger bubbles. Before the final map was created, we visually inspected the map, removed irrelevant terms and combined the abbreviated forms of the noun phrases (Heersmink et al., <xref rid="B10" ref-type="bibr">2011</xref>). Depending on the citation counts of the respective publications, each term received a relative citation score (beginning at zero) that is represented by color. Blue (0) indicates below average, green (1) indicates average and red (≥2) indicates above average. The coloring scheme was based on previous publications (van Eck et al., <xref rid="B33" ref-type="bibr">2013</xref>; Waltman et al., <xref rid="B39" ref-type="bibr">2014</xref>).</p>
      </sec>
      <sec>
        <title>Annual high-impact terms</title>
        <p>For each year, we examined terms that occurred at least 100 times. We then used VOSviewer to calculate a relative citation score for each term based on citation counts. Normalized citation score based on average citation counts is one of the key concepts in bibliometrics (Waltman, <xref rid="B37" ref-type="bibr">2016</xref>). The calculation was performed as follows. For each year, each publication was given a normalized citation score by dividing its number of citations (received in that year) by the average number of citations of all publications (received in that year) of the neuroscience field. A score of 1 implies the citation count of that particular publication equals the average of all publications appearing in neuroscience field in that year. Subsequently, each term received its own relative citation score by averaging the normalized citation scores of all publications in which the term occurred in the title or abstract. Previous studies have documented the details of this automated procedure to identify terms with higher-than-average citation scores (van Eck et al., <xref rid="B33" ref-type="bibr">2013</xref>; Waltman et al., <xref rid="B39" ref-type="bibr">2014</xref>). We identified 10 relevant terms with the highest relative citation score (highest impact) for each year in the survey period. Their relative citation scores were tracked annually.</p>
      </sec>
      <sec>
        <title>Growth of publication</title>
        <p>Price's Law, one of the most widely utilized indicators for analyzing the growth of publication within a specific research field, which was regularly applied to evaluate whether publication in a research field has experienced an exponential growth over a pre-defined survey period (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>, <xref rid="B21" ref-type="bibr">2014</xref>), was utilized to assess the annual change in publication count in neuroscience journals in the current study. After plotting the annual publication count (y) against year (x), we applied the best-fitting linear and exponential trend lines to the plot and recorded the mathematical equations forming the trend lines. If the data fitted better to the exponential line than the linear line, results will be considered as fulfilling the Price's Law.</p>
      </sec>
      <sec>
        <title>Changes in research areas and contributing countries</title>
        <p>We identified the research areas and contributing countries of the publications in 2006 and 2015, the first and last year of the study period, respectively. These data were obtained by analyzing the search results in WoS. In WoS, publications (according to the journals where they were published) were classified into over 250 research areas in which each area contains papers similar in scope and citation characteristics<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>. To illustrate the relationship with social-health parameters, the relationship between the publication shares of the most productive countries and their respective total per capita expenditure on health<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> were evaluated, as described in previous bibliometric studies (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>, <xref rid="B17" ref-type="bibr">2008a</xref>, <xref rid="B21" ref-type="bibr">2014</xref>).</p>
      </sec>
      <sec>
        <title>Core journals under Bradford's law and their performance</title>
        <p>For each year, Bradford's law of scattering was applied to identify the core journals in the neuroscience category. The core journals identified for each year are those that contributed one-third of total publications for that year (Vickery, <xref rid="B35" ref-type="bibr">1948</xref>). To evaluate the bibliometric performance of the top 10 core journals (the 10 journals with highest frequency of occurrence in the annual core journal lists over the survey period), time trends of their Impact Factor (IF), Immediacy Index (II), and Eigenfactor Score (ES) were evaluated. IF indicates the yearly average citation count of its recent publications, II refers to the average citation count of current-year publications and ES, though similar to IF, weights citations according to the ranking of the citing journals. The time trends of IF, II, and ES were evaluated by separate linear regressions, with year as the independent variable (López-Abente and Muñoz-Tinoco, <xref rid="B16" ref-type="bibr">2005</xref>; Jayaratne and Zwahlen, <xref rid="B12" ref-type="bibr">2015</xref>). The slope, β, indicated the average magnitude of change over time, and <italic>R</italic><sup>2</sup> indicated the fitness of the regression model. Statistical analyses were performed with SPSS 23.0 (IBM, New York, USA). Results were significant if <italic>P</italic> &lt; 0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <p>From 2006 to 2015, a total of 340,210 publications matched with the selection criteria of this study (all articles and reviews in JCR “Neurosciences” category), of which 305,175 were articles and 35,035 were reviews. The marked annual increase in the number of neuroscience publications from 2006 to 2015 followed a linear trend more closely than an exponential curve (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1</xref>). The linear fitting of the data obtained a coefficient of determination of <italic>r</italic><sup>2</sup> = 0.9959, whereas the exponential fitting only obtained a coefficient of determination of <italic>r</italic><sup>2</sup> = 0.9914.</p>
      <sec>
        <title>Term maps</title>
        <p>The term maps for 2006 and 2015 are shown in Figure <xref ref-type="fig" rid="F1">1</xref>. For both maps, terms on the left are more related to cellular, molecular or genetic neuroscience research using animal models, such as cell, protein, receptor, expression and mice. Terms on the right are more related to brain imaging involving humans, such as functional magnetic resonance imaging (fMRI), perception, task, performance and patient. For 2006, the red and orange bubbles are more concentrated on the right side of the map, e.g., fMRI and neuroimaging. For 2015, the red and orange bubbles are more concentrated on the left side of the map, e.g., microglia and neuroinflammation. Across the survey period, some of the basic terms remained red and orange, such as inflammation, microglia, mitochondria and tau. Clinical terms remained blue and green, such as mortality, multiple sclerosis, intracerebral hemorrhage and ischemic stroke.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Term maps for neuroscience literature</bold>. In general, terms on the left are more related to cellular, molecular or genetic neuroscience, whereas terms on the right are more related to brain imaging. Bubble size is related to the occurrence of terms in the titles and abstracts in the included publications. Color is related to relative citation impact attributable to the terms, with blue indicating below average, green indicating average and red indicating above average. Moving from 2006 to 2015, it could be observed that the terms on the left were gaining relative citation impact compared to the terms on the right. Certain terms remained having relatively high citation scores, such as inflammation, microglia, mitochondria and tau (colored red and orange). Some remained having relatively low citation scores, such as ischemic stroke, intracerebral hemorrhage and mortality.</p>
          </caption>
          <graphic xlink:href="fnins-11-00120-g0001"/>
        </fig>
      </sec>
      <sec>
        <title>Annual high-impact terms</title>
        <p>Ten relevant terms with highest impact were identified for each year from 2006 to 2015; they are listed in Table <xref ref-type="table" rid="T1">1</xref>. There were 47 terms over the survey period (Table <xref ref-type="table" rid="T1">1</xref>). The most frequently recurring term was autism (top 10 in 8 years out of 10). Next were meta-analysis (7 years out of 10), functional connectivity (6 years out of 10), default mode network (4 years out of 10) and neuroimaging (4 years out of 10). Over the last 3 years (2013–2015), three terms appeared on the top 10 list: melatonin, microglia and neurofibrillary tangle.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Relative citation scores of recurring top 10 high impact terms (bold) from 2006 to 2015</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Term</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2006</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2007</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2008</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2009</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2010</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2011</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2012</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2013</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2014</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2015</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Autism</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.05</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.17</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.68</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.99</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.99</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.42</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.11</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.93</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.59</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Cognitive control</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.22</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.37</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.83</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.66</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.47</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.23</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Decision making</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.40</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.88</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.94</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.66</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.35</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.15</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.20</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Default mode network</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.52</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.28</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.82</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.80</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.62</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Diffusion tensor imaging</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.35</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.36</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.44</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.77</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.76</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.56</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.34</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.14</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Functional connectivity</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.05</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.56</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.79</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.37</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.15</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.86</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.74</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.47</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Insula</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.12</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.01</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.21</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.75</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.62</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.38</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.32</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Melatonin</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.76</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.90</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.94</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.07</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.19</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.35</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.85</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.87</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.17</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Meta-analysis</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.98</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.30</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.10</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.61</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.34</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.26</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.86</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.53</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Microglia</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.58</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.88</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.56</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.58</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.54</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.87</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.88</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.77</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">MicroRNA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.81</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.91</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.82</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.55</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Neurofibrillary tangle</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.16</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.48</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.50</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.77</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.86</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.86</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.74</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Neuroimaging</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.97</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.51</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.66</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.96</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.71</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.95</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.83</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.43</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.74</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.54</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Orbitofrontal cortex</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.05</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.02</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.12</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.70</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.34</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Systematic review</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.94</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.92</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.90</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.52</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.60</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.55</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>NA, not available. Only terms that occupied a place in the annual top 10 list thrice or more over 2006–2015 were listed (n = 15). Other terms (n = 32) that were in the annual top 10 list ≤ 2 times over 2006–2015 included alpha synuclein, Alzheimer's disease, anterior cingulate cortex, astrocyte, autophagy, blood-oxygen-level dependent signal, brain function, brain network, cognition, drug addiction, emotion, executive function, fractional anisotropy, immune system, ketamine, Lewy body, major depressive disorder, medial prefrontal cortex, mild cognitive impairment, mind, mitochondrial dysfunction, morphometry, neurogenesis, obesity, oxytocin, posterior cingulate cortex, potential therapeutic target, rapamycin, social interaction, transcranial direct current stimulation, ventral striatum and voxel</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Research areas with largest publication shares in 2006 and 2015</title>
        <p>In 2006, the most productive research area was psychiatry, accounting for nearly one-tenth of relevant publications (2,762/29,379, Table <xref ref-type="table" rid="T2">2</xref>). In 2015, its share reduced to 7.35% (2,852/38,792) apparently as a result of 32.0% increase in total publication. It was replaced by psychology (3,076/38,792) as the most productive research area. By 2015, ophthalmology and zoology no longer occupied a place on the list, and they were replaced by immunology and “geriatrics, gerontology.” In fact, the publication share of “geriatrics, gerontology” in 2015 (676/38,792) was 1.74%, two times of that in 2006 (205/29,379).</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p><bold>Top 10 research areas with largest publication shares in 2006 and 2015</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Research area</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2006 rank</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>% of share</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2015 rank</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>% of share</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Differences in % share</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Psychiatry</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9.40</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7.35</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−2.05</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Physiology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.69</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.89</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−1.80</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Behavioral sciences</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.43</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7.77</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+1.34</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Pharmacology, pharmacy</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7.20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.81</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Biochemistry, molecular biology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.18</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.48</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−1.70</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Psychology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7.93</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+2.21</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Endocrinology, metabolism</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.24</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.14</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Radiology, nuclear medicine, medical imaging</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.03</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.06</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.03</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Ophthalmology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.82</td>
                <td valign="top" align="center" rowspan="1" colspan="1">26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.71</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−1.11</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Zoology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.69</td>
                <td valign="top" align="center" rowspan="1" colspan="1">27</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.71</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−0.98</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Immunology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">12</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.92</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.64</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Geriatrics, gerontology</td>
                <td valign="top" align="center" rowspan="1" colspan="1">20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.74</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+1.04</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Research areas were defined by Web of Science hosted by Thomson Reuters</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Most productive countries</title>
        <p>The United States remained the leading country in neuroscience research output over the 10-year survey period. Despite a reduction in its publication share, the United States still accounted for 37% (14,279/38,792) of total publications and was the largest contributor in 2015. European countries, such as Germany and the United Kingdom, were also major contributors to the field. One country with a substantial increase in publication share was China: Between 2006 and 2015, its publication share in this field tripled (2006: 870/29,379 = 2.96%, vs. 2015: 4,358/38,792 = 11.23%, Table <xref ref-type="table" rid="T3">3</xref>). With regard to social-health data, it seemed that the publication shares of the most productive countries were directly proportional to their respective total per capita expenditure on health (Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">2</xref>). However, if data from China and United States were excluded, the relationship became much less apparent.</p>
        <table-wrap id="T3" position="float">
          <label>Table 3</label>
          <caption>
            <p><bold>Top 10 most productive neuroscience research countries in 2006 and 2015</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
                  <bold>2015</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2006 rank</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>% of share</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2015 rank</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>% of share</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Differences in % share</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">USA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                <td valign="top" align="center" rowspan="1" colspan="1">41.05</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                <td valign="top" align="center" rowspan="1" colspan="1">36.81</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−4.24</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Germany</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9.93</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10.20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.27</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">UK</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8.63</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8.75</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.12</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Japan</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8.36</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5.69</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−2.67</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Canada</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.47</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.88</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.41</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Italy</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5.91</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6.49</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.58</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">France</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5.48</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.99</td>
                <td valign="top" align="center" rowspan="1" colspan="1">−0.49</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Netherlands</td>
                <td valign="top" align="center" rowspan="1" colspan="1">8</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.42</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.20</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.78</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Australia</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.39</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.54</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+1.15</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Spain</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">11</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.62</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+0.39</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">China</td>
                <td valign="top" align="center" rowspan="1" colspan="1">11</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2.96</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">11.23</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+8.27</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Each country had one count if it appears in the author affiliations field of a publication, as counted by Web of Science hosted by Thomson Reuters</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Identification of core journals under Bradford's law</title>
        <p>The number of neuroscience journals increased from 200 in 2006 to 256 in 2015. In parallel, the number of core journals doubled from 11 (11/200 = 5.5%) in 2006 to 22 (22/256 = 8.6%) in 2015 (Table <xref ref-type="table" rid="T4">4</xref>). Six journals were consistently included as core journals throughout 2006–2015, namely <italic>Brain Research, Journal of Neurophysiology, Journal of Neuroscience, NeuroImage, Neuroscience</italic>, and <italic>Neuroscience Letters</italic>. Together with four other journals, namely <italic>Behavioural Brain Research</italic> (9 years), <italic>Experimental Brain Research</italic> (9 years), <italic>European Journal of Neuroscience</italic> (8 years), and <italic>Journal of the Neurological Sciences</italic> (8 years), they formed the top ten core neuroscience journals. The complete list of 33 core neuroscience journals is presented in Supplementary Table <xref ref-type="supplementary-material" rid="SM3">1</xref>.</p>
        <table-wrap id="T4" position="float">
          <label>Table 4</label>
          <caption>
            <p><bold>Division of neuroscience journals and publications from 2006 to 2015 according to Bradford's law</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;" rowspan="1">
                  <bold>Journal number (publication count)</bold>
                </th>
              </tr>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
                  <bold>Year</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Zone 1: core</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Zone 2</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Zone 3</bold>
                </th>
                <th valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Total</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2006</td>
                <td valign="top" align="center" rowspan="1" colspan="1">11 (8,901)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">38 (8,989)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">151 (9,267)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">200 (27,157)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2007</td>
                <td valign="top" align="center" rowspan="1" colspan="1">13 (9,472)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">40 (9,412)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">158 (9,550)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">211 (28,434)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2008</td>
                <td valign="top" align="center" rowspan="1" colspan="1">15 (9,839)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">43 (9,918)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">163 (9,838)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">221 (29,595)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2009</td>
                <td valign="top" align="center" rowspan="1" colspan="1">16 (10,283)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">47 (10,252)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">168 (10,016)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">231 (30,551)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2010</td>
                <td valign="top" align="center" rowspan="1" colspan="1">16 (10,614)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">49 (10,770)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">174 (10,804)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">239 (32,188)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2011</td>
                <td valign="top" align="center" rowspan="1" colspan="1">18 (11,131)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">51 (11,151)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">175 (11,029)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">244 (33,311)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2012</td>
                <td valign="top" align="center" rowspan="1" colspan="1">19 (11,466)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">53 (11,449)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">180 (11,517)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">252 (34,432)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2013</td>
                <td valign="top" align="center" rowspan="1" colspan="1">21 (11,818)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">54 (11,912)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">177 (11,789)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">252 (35,519)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2014</td>
                <td valign="top" align="center" rowspan="1" colspan="1">21 (12,223)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">54 (12,273)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">177 (12,367)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">252 (36,863)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2015</td>
                <td valign="top" align="center" rowspan="1" colspan="1">22 (12,388)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">53 (12,392)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">181 (12,539)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">256 (37,319)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>According to Bradford's law, journals were divided into three zones, and each zone should contain one-third of total publication count. Zone 1 journals were identified as core journals. Publication count here refers to the total count of articles and reviews</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Bibliometric performance of core journals</title>
        <p>In general, the core journals maintained their performance levels over the survey period. Most (7/10) core journals did not exhibit a significant change in IF from 2006 to 2015 (Figure <xref ref-type="fig" rid="F2">2A</xref>). One journal, <italic>Brain Research</italic>, had a significantly improved IF (β = 0.06, <italic>P</italic> &lt; 0.01), whereas two journals experienced a significant decrease in IF, namely <italic>Journal of Neurophysiology</italic> (β = −0.11, <italic>P</italic> &lt; 0.001) and <italic>Journal of Neuroscience</italic> (β = −0.16, <italic>P</italic> &lt; 0.001).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Bibliometric performances of the key core journals. (A)</bold> Time trends of Impact Factor. <bold>(B)</bold> Time trends of Immediacy Index. <bold>(C)</bold> Time trends of Eigenfactor Score.</p>
          </caption>
          <graphic xlink:href="fnins-11-00120-g0002"/>
        </fig>
        <p>Six of the core journals did not have a significant change in II over the survey period (Figure <xref ref-type="fig" rid="F2">2B</xref>). Three journals had significantly improved II, namely <italic>Brain Research</italic> (β = 0.03, <italic>P</italic> = 0.01), <italic>NeuroImage</italic> (β = 0.07, <italic>P</italic> &lt; 0.01) and <italic>Neuroscience Letters</italic> (β = 0.01, <italic>P</italic> = 0.05). One journal, <italic>Journal of Neurophysiology</italic>, had a decreased II (β = −0.03, <italic>P</italic> &lt; 0.01).</p>
        <p>In terms of ES, most (7/10) core journals were subject to a decrease, and only two an increase (Figure <xref ref-type="fig" rid="F2">2C</xref>). However, these changes were small (β = −0.02–0.00).</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>Using data from WoS and JCR, the results of the current study revealed transformations in the field of neuroscience research from 2006 to 2015 in terms of leading or core journals, distribution of publications, research context and contributions by country. No attempt was made to retrospectively analyze data earlier than 2006, because this study's focus only concerns recent bibliometric growth rather than the complete history of this research field. The annual growth of neuroscience publications over the survey period indicated non-fulfillment of Price's Law, i.e., no exponential growth was observed. It experienced a linear growth instead. This linear increment was consistent with publications in adjacent research fields such as psychiatry (López-Muñoz et al., <xref rid="B19" ref-type="bibr">2008b</xref>) and psychopharmacology (López-Muñoz et al., <xref rid="B18" ref-type="bibr">2013</xref>). On the other hand, there was an exponential increase in publications in melatonin (López-Muñoz et al., <xref rid="B20" ref-type="bibr">2016</xref>), bipolar disorder (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>) and attention-deficit hyperactivity disorder (López-Muñoz et al., <xref rid="B17" ref-type="bibr">2008a</xref>). Since the current study aimed at providing an overview of the neuroscience literature, we did not apply Lotka's Law to evaluate the productivity of individual researchers.</p>
      <sec>
        <title>Shifting of citation focus as seen from term maps</title>
        <p>The term maps from Figure <xref ref-type="fig" rid="F1">1</xref> illustrated the shift of citation focus from general brain imaging terms to cellular, molecular and genetic terms. In recent years, molecular imaging of the brain is gaining attention, such as that related to neuroinflammation of microglia and macrophages (Venneti et al., <xref rid="B34" ref-type="bibr">2013</xref>) and neurodegeneration related to tau protein and Lewy body (Wakabayashi et al., <xref rid="B36" ref-type="bibr">2013</xref>). These research topics investigated in experimental animal models probably led to the increased relative citation impacts of these terms. Certain clinical topics remained having low citation impacts, such as multiple sclerosis, intracerebral hemorrhage and ischemic stroke.</p>
      </sec>
      <sec>
        <title>Brain imaging terms as recurring high-impact terms</title>
        <p>Results in Table <xref ref-type="table" rid="T1">1</xref> demonstrated that brain imaging terms occupied three of the top five recurring high-impact terms, namely default mode network, functional connectivity and neuroimaging. The rise in relative citation impact of brain connectivity terms was consistent with the launches of several research funds, including the aforementioned BRAIN Initiative, Human Brain Project and Human Connectome Project. There were two other terms related to brain connectivity among the top 10 highest impact terms (diffusion tensor imaging and fractional anisotropy). One popular research topic was to investigate the co-activation (also known as functional connectivity) of different brain regions (Yeung et al., <xref rid="B42" ref-type="bibr">2017b</xref>). One such network of co-activation during a resting state is called the default mode network, which is believed to be robust across populations, and, as a result, it has gained attention in recent years (Raichle and Snyder, <xref rid="B27" ref-type="bibr">2007</xref>). Another area that merits mention is the advancement in the use of statistics, such as the implementation of dynamic causal modeling to neuroimaging data in 2003 (Friston et al., <xref rid="B7" ref-type="bibr">2003</xref>), which have enabled an inference of effective connectivity. This application illustrates the directionality of communications between brain regions during particular experimental tasks (Nakamura et al., <xref rid="B25" ref-type="bibr">2013</xref>; Yeung et al., <xref rid="B43" ref-type="bibr">2016</xref>). Though the terms related to effective connectivity were not in the annual top 10 lists of high-impact terms during the survey period, they may well be a potential hot spot in the field in the future (Friston, <xref rid="B6" ref-type="bibr">2011</xref>).</p>
      </sec>
      <sec>
        <title>The high impact of terms related to Alzheimer's disease over the last 3 years</title>
        <p>As reported, three terms always appeared on the top 10 list of high-impact terms over the last 3 years, namely melatonin, microglia and neurofibrillary tangle. Collectively, these three terms are related to Alzheimer's disease. Evidence has suggested that Alzheimer's disease, with intracellular neurofibrillary tangle a widely recognized biomarker, is linked to neuroinflammatory changes caused by overactivation of microglia that can be alleviated by administration of melatonin (Smith et al., <xref rid="B29" ref-type="bibr">2012</xref>; Lin et al., <xref rid="B15" ref-type="bibr">2013</xref>). This effect of melatonin may be related to regulation of autophagy (Choi et al., <xref rid="B4" ref-type="bibr">2013</xref>). Moreover, we identified <italic>Journal of Alzheimer's Disease</italic> as one of the core journals (2010–2015) in the current study. Together, these findings suggest that topics relevant to this disease have recently become high impact.</p>
      </sec>
      <sec>
        <title>Attention to autism</title>
        <p>Autism appeared in the annual list of top 10 high-impact terms eight times in the 10-year survey period. On average, its relative citation score was 2.05 (citation count 2.05 times that of an average term), outperforming the relative citation score of other neurological disorders such as major depressive disorder (1.68) and mild cognitive impairment (1.33).</p>
      </sec>
      <sec>
        <title>Research directions, health care priorities and prime translational research topics</title>
        <p>Results of the current bibliometric study may help identify three important areas of neuroscience research: research directions, health care priorities and prime translational research topics. First, with regard to research directions, it could be observed that brain imaging was one of the highest impact over the last decade. Looking at health care priorities, as it was demonstrated that meta-analysis was a high-impact term in neuroscience field, researchers may consider conducting more meta-analyses to answer priority questions for better evidence-based practices in health care industry or health care services. As for prime translational research topics, brain connectivity had high impact; thus, its aberrations among patients with various neurodegenerative or neurological disorders can now be further investigated.</p>
      </sec>
      <sec>
        <title>Increased publication share of geriatrics and gerontology</title>
        <p>The publication share of geriatrics and gerontology doubled from 2006 to 2015. This was reasonably expected due to the aging population of the developed countries. As the elderly people are more prone to neurodegenerative and neuroinflammatory diseases such as Alzheimer's disease (Clegg et al., <xref rid="B5" ref-type="bibr">2013</xref>), the citation impact of terms relevant to neurodegeneration and neuroinflammation also increased over the study period.</p>
      </sec>
      <sec>
        <title>The United States and European countries as major contributors</title>
        <p>Despite changes in research hot spots, the most productive or research-leading countries did not change significantly between 2006 and 2015. Developed countries, mainly ones in the Western world, were still major contributors to neuroscience research, i.e., Australia, Canada, France, Germany, Japan, Netherlands, Italy, the United Kingdom and the United States. Incidentally, these countries were also previously identified as major contributors to various topics within or relevant to neuroscience, such as neuroimaging (Kim et al., <xref rid="B13" ref-type="bibr">2016</xref>; Yeung et al., <xref rid="B41" ref-type="bibr">2017a</xref>) and Parkinson's disease (Li et al., <xref rid="B14" ref-type="bibr">2008</xref>), which means these countries may have relatively more established research backgrounds and research funding. However, with more economic development and financial input into academic research, China has emerged as one of the important contributors in neuroscience research field in recent years. The correlation of publication share in neuroscience with the per capita health expenditure of the most productive countries might be consistent with the notion that the higher the spending on health, the more the research publication (López-Muñoz et al., <xref rid="B22" ref-type="bibr">2006</xref>, <xref rid="B21" ref-type="bibr">2014</xref>). However, it should be interpreted with caution because data from China and the United States were relatively influential as potential outliers.</p>
      </sec>
      <sec>
        <title>Growth in publication and stability of key core journals identified by Bradford's law</title>
        <p>The annual publication (articles and reviews) count of neuroscience research increased every year, as did the number of neuroscience journals. By applying Bradford's law of scattering, we revealed that the percentage of journals classified as core journals likewise increased over the study years. These changes indicated that this field has been growing and becoming more dispersed. Besides, the bibliometric performances of the key core journals were mostly stable over the study period.</p>
      </sec>
      <sec>
        <title>Implications and future perspectives</title>
        <p>The shift of citation focus as seen from term maps and Table <xref ref-type="table" rid="T1">1</xref> indicated the importance of co-existing animal models and <italic>in vitro</italic> studies together with human neuroimaging studies. While neuroimaging studies may continue to unveil the brain function or neural mechanism of relevant physiological processes, animal models and <italic>in vitro</italic> studies may also be required to explore and explain the details down to genetic, cellular or molecular levels.</p>
        <p>Moreover, with the increasing publication count and wider distribution of publications among neuroscience journals, future publications should devise keywords, titles and abstracts more thoughtfully. Search strategy of fellow researchers should be taken into careful consideration so that the relevant works can be identified/retrieved from search engines or databases.</p>
        <p>By considering the specific hot topics having high relative citation scores altogether, future work may focus on utilizing brain imaging and connectivity analyses to identify biomarkers that may signify neurodegenerative or neuroinflammatory tendency among the aging population.</p>
      </sec>
      <sec>
        <title>Study limitations</title>
        <p>This study has certain limitations. First, this study is retrospective, and, though it tracked past or recent trends, rapidly developing interests in a short (recent) period may not be accurately reflected. Second, the work examined in this study consists exclusively of articles and reviews published from 2006 to 2015 in JCR “Neurosciences” journals as indexed by WoS. It may not be sufficient to represent all neuroscience literature, such as other document formats published in journals or publications not included in this study. As neuroscience interacts with many other academic fields, some arguably relevant studies may have been published in journals not classified as neuroscience journals. However, it would be difficult to define search terms that effectively cover all papers touching on neuroscience across all scientific literature while simultaneously excluding irrelevant ones. Therefore, we focused on JCR “Neurosciences” journals. Third, the analyses in this study were based on data recorded in the WoS database. Although Google Scholar and other databases may offer broader coverage, much of this “extra” coverage may be attributed to journals with potentially limited audience. Given that we aimed to determine research changes in the core of the neuroscience community, we followed previous neuroscience bibliometric publications by only accessing WoS (Glänzel et al., <xref rid="B8" ref-type="bibr">2003</xref>; Li et al., <xref rid="B14" ref-type="bibr">2008</xref>; Bishop, <xref rid="B3" ref-type="bibr">2010</xref>). Therefore, the results from the current study should be interpreted with considerations that journals of other sections of JCR (pharmacology, diagnostic imaging, biochemistry, biology, etc.) were not included. Future studies may expand to them and consider the access to other databases such as PubMed/Medline, Scopus or Embase when deemed appropriate. Besides VOSviewer, future studies may consider using other bibliometric tools to further dissect the evidence, such as using Pajek to analyze the citation and co-authorship networks of selected data subsets (Batagelj and Mrvar, <xref rid="B1" ref-type="bibr">1998</xref>), and using Publish or Perish<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> to evaluate the distribution of citations received by selected authors in terms of h-index or g-index.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="s5">
      <title>Conclusions</title>
      <p>To conclude, our findings revealed changes in the landscape of neuroscience research over the study period and provided a contemporary overview of neuroscience research for researchers and health care workers interested in this field. Brain imaging and brain connectivity have been shown to be hot topics, and Alzheimer's disease and associated topics have recently gained traction.</p>
    </sec>
    <sec id="s6">
      <title>Author contributions</title>
      <p>AY conceived the work, acquired and analyzed data and drafted the work. TG and WK facilitated the acquisition of data and critically revised the work. All authors have approved the final content of the manuscript.</p>
    </sec>
    <sec id="s7">
      <title>Funding</title>
      <p>This work was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (HKU 766212M).</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Ms. Samantha Li from Faculty of Dentistry, The University of Hong Kong for statistical assistance.</p>
    </ack>
    <fn-group>
      <fn id="fn0001">
        <p>
          <sup>1</sup>
          <ext-link ext-link-type="uri" xlink:href="http://ipscience-help.thomsonreuters.com/inCites2Live/filterValuesGroup/researchAreaSchema.html">http://ipscience-help.thomsonreuters.com/inCites2Live/filterValuesGroup/researchAreaSchema.html</ext-link>
        </p>
      </fn>
      <fn id="fn0002">
        <p><sup>2</sup>Data available from <ext-link ext-link-type="uri" xlink:href="http://www.who.int/countries/en/">http://www.who.int/countries/en/</ext-link></p>
      </fn>
      <fn id="fn0003">
        <p><sup>3</sup>Harzing, A. W. (2007) <italic>Publish or Perish</italic>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.harzing.com/pop.htm">http://www.harzing.com/pop.htm</ext-link></p>
      </fn>
    </fn-group>
    <sec sec-type="supplementary-material" id="s8">
      <title>Supplementary material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnins.2017.00120/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnins.2017.00120/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <label>Supplementary Figure 1</label>
        <caption>
          <p><bold>Annual growth of neuroscience publication from 2006 to 2015</bold>. After plotting the annual publication count (y) against year (x), we applied the best-fitting linear (solid) and exponential (dash) trend lines to the plot. Results indicated the growth followed a linear trend (y = 1168.8x–2 × 10<sup>6</sup>, <italic>r</italic><sup>2</sup> = 0.9959) more closely than an exponential trend (y = 7 × 10<sup>−28</sup>e<sup>0.0363<italic>x</italic></sup>, <italic>r</italic><sup>2</sup> = 0.9914).</p>
        </caption>
        <media xlink:href="Image1.TIFF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <label>Supplementary Figure 2</label>
        <caption>
          <p><bold>The relationship between the neuroscience publication share and the total per capita expenditure on health (USD$) among the most productive countries as surveyed in 2006 and 2015</bold>. The economic data was obtained from World Health Organization (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/county/en/">http://www.who.int/county/en/</ext-link>). It seemed that the publication shares of the most productive countries were directly proportional to their respective total per capita expenditure on health (2006: <italic>r</italic><sup>2</sup> = 0.560, <italic>p</italic> = 0.005; 2015: <italic>r</italic><sup>2</sup> = 0.352, <italic>p</italic> = 0.054). However, if data from China and United States were excluded, the relationship became much less apparent (2006: <italic>r</italic><sup>2</sup> = 0.008, <italic>p</italic> = 0.817; 2015: <italic>r</italic><sup>2</sup> = 0.010, <italic>p</italic> = 0.800). AUS, Australia; CAN, Canada; CHI, China; FRA, France; GER, Germany; ITA, Italy; JAP, Japan; NET, Netherlands; SPA, Spain; UK, United Kingdom; USA, United States.</p>
        </caption>
        <media xlink:href="Image2.TIFF">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM3">
        <label>Supplementary Table 1</label>
        <caption>
          <p><bold>List of core neuroscience journals from 2006 to 2015</bold>. A black dot denoted that journal belonged to the core journals (assigned to Zone 1 according to Bradford's law) in that year. NA, non-applicable because that journal did not exist in that year. Core journals are the most productive journals; together they contributed to one-third of total count of articles and reviews in the census year (Table <xref ref-type="table" rid="T4">4</xref>).</p>
        </caption>
        <media xlink:href="Table1.DOCX">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batagelj</surname><given-names>V.</given-names></name><name><surname>Mrvar</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Pajek-program for large network analysis</article-title>. <source>Connections</source>
<volume>21</volume>, <fpage>47</fpage>–<lpage>57</lpage>.</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battery</surname><given-names>R. O.</given-names></name></person-group> (<year>2010</year>). <article-title>Human connectome project Awards $40 Million</article-title>. <source>J. Invest. Med.</source>
<volume>58</volume>, <fpage>929</fpage>–<lpage>935</lpage>. <pub-id pub-id-type="doi">10.2310/JIM.0b013e3182025955</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>D. V.</given-names></name></person-group> (<year>2010</year>). <article-title>Which neurodevelopmental disorders get researched and why?</article-title>
<source>PLoS ONE</source>
<volume>5</volume>:<fpage>e15112</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015112</pub-id><?supplied-pmid 21152085?><pub-id pub-id-type="pmid">21152085</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>A. M.</given-names></name><name><surname>Ryter</surname><given-names>S. W.</given-names></name><name><surname>Levine</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Autophagy in human health and disease</article-title>. <source>New Engl. J. Med.</source>
<volume>368</volume>, <fpage>651</fpage>–<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1205406</pub-id><?supplied-pmid 23406030?><pub-id pub-id-type="pmid">23406030</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clegg</surname><given-names>A.</given-names></name><name><surname>Young</surname><given-names>J.</given-names></name><name><surname>Iliffe</surname><given-names>S.</given-names></name><name><surname>Rikkert</surname><given-names>M. O.</given-names></name><name><surname>Rockwood</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Frailty in elderly people</article-title>. <source>Lancet</source>
<volume>381</volume>, <fpage>752</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)62167-9</pub-id><?supplied-pmid 23395245?><pub-id pub-id-type="pmid">23395245</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friston</surname><given-names>K. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Functional and effective connectivity: a review</article-title>. <source>Brain Connect.</source>
<volume>1</volume>, <fpage>13</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1089/brain.2011.0008</pub-id><?supplied-pmid 22432952?><pub-id pub-id-type="pmid">22432952</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friston</surname><given-names>K. J.</given-names></name><name><surname>Harrison</surname><given-names>L.</given-names></name><name><surname>Penny</surname><given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Dynamic causal modelling</article-title>. <source>Neuroimage</source>
<volume>19</volume>, <fpage>1273</fpage>–<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1016/S1053-8119(03)00202-7</pub-id><?supplied-pmid 12948688?><pub-id pub-id-type="pmid">12948688</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glänzel</surname><given-names>W.</given-names></name><name><surname>Danell</surname><given-names>R.</given-names></name><name><surname>Persson</surname><given-names>O.</given-names></name></person-group> (<year>2003</year>). <article-title>The decline of Swedish neuroscience: decomposing a bibliometric national science indicator</article-title>. <source>Scientometrics</source>
<volume>57</volume>, <fpage>197</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1023/A:1024185601555</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillner</surname><given-names>S.</given-names></name><name><surname>Ip</surname><given-names>N.</given-names></name><name><surname>Koch</surname><given-names>C.</given-names></name><name><surname>Koroshetz</surname><given-names>W.</given-names></name><name><surname>Okano</surname><given-names>H.</given-names></name><name><surname>Polachek</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Worldwide initiatives to advance brain research</article-title>. <source>Nat. Neurosci.</source>
<volume>19</volume>, <fpage>1118</fpage>–<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4371</pub-id><?supplied-pmid 27571190?><pub-id pub-id-type="pmid">27571190</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heersmink</surname><given-names>R.</given-names></name><name><surname>van den Hoven</surname><given-names>J.</given-names></name><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>van den Berg</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Bibliometric mapping of computer and information ethics</article-title>. <source>Ethics Inf. Technol.</source>
<volume>13</volume>, <fpage>241</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1007/s10676-011-9273-7</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name><name><surname>Landis</surname><given-names>S. C.</given-names></name><name><surname>Collins</surname><given-names>F. S.</given-names></name></person-group> (<year>2013</year>). <article-title>The NIH brain initiative</article-title>. <source>Science</source>
<volume>340</volume>, <fpage>687</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1126/science.1239276</pub-id><?supplied-pmid 23661744?><pub-id pub-id-type="pmid">23661744</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaratne</surname><given-names>Y. S. N.</given-names></name><name><surname>Zwahlen</surname><given-names>R. A.</given-names></name></person-group> (<year>2015</year>). <article-title>The evolution of dental journals from 2003 to 2012: a bibliometric analysis</article-title>. <source>PLoS ONE</source>
<volume>10</volume>:<fpage>e0119503</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0119503</pub-id><?supplied-pmid 25781486?><pub-id pub-id-type="pmid">25781486</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Yoon</surname><given-names>D. Y.</given-names></name><name><surname>Kim</surname><given-names>E. S.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Bae</surname><given-names>J. S.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name></person-group> (<year>2016</year>). <article-title>The 100 most-cited articles in neuroimaging: a bibliometric analysis</article-title>. <source>Neuroimage</source>
<volume>139</volume>, <fpage>149</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.06.029</pub-id><?supplied-pmid 27327516?><pub-id pub-id-type="pmid">27327516</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Ho</surname><given-names>Y.-S.</given-names></name><name><surname>Li</surname><given-names>C.-Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Bibliometric analysis on global Parkinson's disease research trends during 1991–2006</article-title>. <source>Neurosci. Lett.</source>
<volume>441</volume>, <fpage>248</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2008.06.044</pub-id><?supplied-pmid 18582532?><pub-id pub-id-type="pmid">18582532</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>Q.-X.</given-names></name><name><surname>Yang</surname><given-names>S.-S.</given-names></name><name><surname>Chu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.-Z.</given-names></name><name><surname>Tian</surname><given-names>Q.</given-names></name></person-group> (<year>2013</year>). <article-title>Melatonin in Alzheimer's disease</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>14</volume>, <fpage>14575</fpage>–<lpage>14593</lpage>. <pub-id pub-id-type="doi">10.3390/ijms140714575</pub-id><?supplied-pmid 23857055?><pub-id pub-id-type="pmid">23857055</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Abente</surname><given-names>G.</given-names></name><name><surname>Muñoz-Tinoco</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Time trends in the impact factor of Public Health journals</article-title>. <source>BMC Public Health</source>
<volume>5</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2458-5-24</pub-id><?supplied-pmid 15777471?><pub-id pub-id-type="pmid">15777471</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Alamo</surname><given-names>C.</given-names></name><name><surname>Quintero-Gutiérrez</surname><given-names>F. J.</given-names></name><name><surname>García-García</surname><given-names>P.</given-names></name></person-group> (<year>2008a</year>). <article-title>A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980–2005</article-title>. <source>Eur. Child Adolesc. Psychiatry</source>, <volume>17</volume>, <fpage>381</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-008-0680-1</pub-id><?supplied-pmid 18431538?><pub-id pub-id-type="pmid">18431538</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Castle</surname><given-names>D.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Moreno</surname><given-names>R.</given-names></name><name><surname>Huelves</surname><given-names>L.</given-names></name><name><surname>Pérez-Nieto</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>The Australian contribution to the literature on atypical antipsychotic drugs: a bibliometric study</article-title>. <source>Australasian Psychiatry</source>, <volume>21</volume>, <fpage>343</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1177/1039856213492352</pub-id><?supplied-pmid 23804115?><pub-id pub-id-type="pmid">23804115</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>García-García</surname><given-names>P.</given-names></name><name><surname>Sáiz-Ruiz</surname><given-names>J.</given-names></name><name><surname>Mezzich</surname><given-names>J. E.</given-names></name><name><surname>Rubio</surname><given-names>G.</given-names></name><name><surname>Vieta</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2008b</year>). <article-title>A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years</article-title>. <source>Psychopathology</source>
<volume>41</volume>, <fpage>214</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1159/000125555</pub-id><?supplied-pmid 18408417?><pub-id pub-id-type="pmid">18408417</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Povedano</surname><given-names>F. J.</given-names></name><name><surname>Alamo</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Bibliometric study of scientific research on melatonin during the last 25 years</article-title>, in <source>Melatonin, Neuroprotective Agents and Antidepressant Therapy</source>, eds <person-group person-group-type="editor"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Srinivasan</surname><given-names>V.</given-names></name><name><surname>de Berardis</surname><given-names>D.</given-names></name><name><surname>Álamo</surname><given-names>C.</given-names></name><name><surname>Kato</surname><given-names>T. A.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>25</fpage>–<lpage>42</lpage>.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Shen</surname><given-names>W. W.</given-names></name><name><surname>Shinfuku</surname><given-names>N.</given-names></name><name><surname>Pae</surname><given-names>C. U.</given-names></name><name><surname>Castle</surname><given-names>D. J.</given-names></name><name><surname>Chung</surname><given-names>A. K.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>A bibliometric study on second-generation antipsychotic drugs in the Asia–Pacific region</article-title>. <source>J. Exp. Clin. Med.</source>
<volume>6</volume>, <fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.jecm.2014.06.001</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Muñoz</surname><given-names>F.</given-names></name><name><surname>Vieta</surname><given-names>E.</given-names></name><name><surname>Rubio</surname><given-names>G.</given-names></name><name><surname>García-García</surname><given-names>P.</given-names></name><name><surname>Alamo</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach</article-title>. <source>J. Affect. Disord.</source>
<volume>92</volume>, <fpage>161</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2006.02.006</pub-id><?supplied-pmid 16530847?><pub-id pub-id-type="pmid">16530847</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>The human brain project</article-title>. <source>Sci. Am.</source>
<volume>306</volume>, <fpage>50</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/scientificamerican0612-50</pub-id><?supplied-pmid 22649994?><pub-id pub-id-type="pmid">22649994</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>E. I.</given-names></name><name><surname>Kropff</surname><given-names>E.</given-names></name><name><surname>Moser</surname><given-names>M.-B.</given-names></name></person-group> (<year>2008</year>). <article-title>Place cells, grid cells, and the brain's spatial representation system</article-title>. <source>Neuroscience</source>
<volume>31</volume>, <fpage>69</fpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.31.061307.090723</pub-id><?supplied-pmid 18284371?><pub-id pub-id-type="pmid">18284371</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Tokumori</surname><given-names>K.</given-names></name><name><surname>Tanabe</surname><given-names>H. C.</given-names></name><name><surname>Yoshiura</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Localization of the primary taste cortex by contrasting passive and attentive conditions</article-title>. <source>Exp. Brain Res.</source>
<volume>227</volume>, <fpage>185</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-013-3499-z</pub-id><?supplied-pmid 23604572?><pub-id pub-id-type="pmid">23604572</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'keefe</surname><given-names>J.</given-names></name><name><surname>Burgess</surname><given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>Dual phase and rate coding in hippocampal place cells: theoretical significance and relationship to entorhinal grid cells</article-title>. <source>Hippocampus</source>
<volume>15</volume>, <fpage>853</fpage>–<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20115</pub-id><?supplied-pmid 16145693?><pub-id pub-id-type="pmid">16145693</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raichle</surname><given-names>M. E.</given-names></name><name><surname>Snyder</surname><given-names>A. Z.</given-names></name></person-group> (<year>2007</year>). <article-title>A default mode of brain function: a brief history of an evolving idea</article-title>. <source>Neuroimage</source>
<volume>37</volume>, <fpage>1083</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.02.041</pub-id><?supplied-pmid 17719799?><pub-id pub-id-type="pmid">17719799</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahabuddin</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Mapping neuroscience research in India-a bibliometric approach</article-title>. <source>Curr. Sci.</source>
<volume>104</volume>, <fpage>1619</fpage>–<lpage>1626</lpage>.</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>J. A.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Ray</surname><given-names>S. K.</given-names></name><name><surname>Banik</surname><given-names>N. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases</article-title>. <source>Brain Res. Bull.</source>
<volume>87</volume>, <fpage>10</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.10.004</pub-id><?supplied-pmid 22024597?><pub-id pub-id-type="pmid">22024597</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>Waltman</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Software survey: VOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source>
<volume>84</volume>, <fpage>523</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-009-0146-3</pub-id><?supplied-pmid 20585380?><pub-id pub-id-type="pmid">20585380</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>Waltman</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Text mining and visualization using VOSviewer</article-title>. <source>ISSI Newslett.</source>
<volume>7</volume>, <fpage>50</fpage>–<lpage>54</lpage>.</mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>Waltman</surname><given-names>L.</given-names></name><name><surname>Dekker</surname><given-names>R.</given-names></name><name><surname>van den Berg</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>A comparison of two techniques for bibliometric mapping: multidimensional scaling and VOS</article-title>. <source>J. Am. Soc. Inform. Sci. Technol.</source>
<volume>61</volume>, <fpage>2405</fpage>–<lpage>2416</lpage>. <pub-id pub-id-type="doi">10.1002/asi.21421</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>Waltman</surname><given-names>L.</given-names></name><name><surname>van Raan</surname><given-names>A. F.</given-names></name><name><surname>Klautz</surname><given-names>R. J.</given-names></name><name><surname>Peul</surname><given-names>W. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Citation analysis may severely underestimate the impact of clinical research as compared to basic research</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e62395</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062395</pub-id><?supplied-pmid 23638064?><pub-id pub-id-type="pmid">23638064</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venneti</surname><given-names>S.</given-names></name><name><surname>Lopresti</surname><given-names>B. J.</given-names></name><name><surname>Wiley</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Molecular imaging of microglia/macrophages in the brain</article-title>. <source>Glia</source>
<volume>61</volume>, <fpage>10</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22357</pub-id><?supplied-pmid 22615180?><pub-id pub-id-type="pmid">22615180</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickery</surname><given-names>B. C.</given-names></name></person-group> (<year>1948</year>). <article-title>Bradford's law of scattering</article-title>. <source>J. Doc.</source>
<volume>4</volume>, <fpage>198</fpage>–<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1108/eb026133</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakabayashi</surname><given-names>K.</given-names></name><name><surname>Tanji</surname><given-names>K.</given-names></name><name><surname>Odagiri</surname><given-names>S.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Mori</surname><given-names>F.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>The Lewy body in Parkinson's disease and related neurodegenerative disorders</article-title>. <source>Mol. Neurobiol.</source>
<volume>47</volume>, <fpage>495</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8280-y</pub-id><?supplied-pmid 22622968?><pub-id pub-id-type="pmid">22622968</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltman</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>A review of the literature on citation impact indicators</article-title>. <source>J. Inform.</source>
<volume>10</volume>, <fpage>365</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.joi.2016.02.007</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltman</surname><given-names>L.</given-names></name><name><surname>van Eck</surname><given-names>N. J.</given-names></name><name><surname>Noyons</surname><given-names>E. C.</given-names></name></person-group> (<year>2010</year>). <article-title>A unified approach to mapping and clustering of bibliometric networks</article-title>. <source>J. Informetr.</source>
<volume>4</volume>, <fpage>629</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.joi.2010.07.002</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltman</surname><given-names>L.</given-names></name><name><surname>van Raan</surname><given-names>A. F.</given-names></name><name><surname>Smart</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Exploring the relationship between the Engineering and Physical Sciences and the Health and Life Sciences by advanced bibliometric methods</article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e111530</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0111530</pub-id><?supplied-pmid 25360616?><pub-id pub-id-type="pmid">25360616</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Y.-Z.</given-names></name><name><surname>Shen</surname><given-names>Z.-C.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroscience output of China: a MEDLINE-based bibliometric study</article-title>. <source>Scientometrics</source>
<volume>57</volume>, <fpage>399</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1023/A:1025060819495</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>A. W. K.</given-names></name><name><surname>Goto</surname><given-names>T. K.</given-names></name><name><surname>Leung</surname><given-names>W. K.</given-names></name></person-group> (<year>2017a</year>). <article-title>A bibliometric review of research trends in neuroimaging</article-title>. <source>Curr. Sci.</source>
<volume>112</volume>, <fpage>725</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.18520/cs/v112/i04/725-734</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>A. W. K.</given-names></name><name><surname>Goto</surname><given-names>T. K.</given-names></name><name><surname>Leung</surname><given-names>W. K.</given-names></name></person-group> (<year>2017b</year>). <article-title>Basic taste processing recruits bilateral anteroventral and middle dorsal insulae: an activation likelihood estimation meta-analysis of fMRI studies</article-title>. <source>Brain Behav.</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1002/brb3.655</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>A. W. K.</given-names></name><name><surname>Tanabe</surname><given-names>H. C.</given-names></name><name><surname>Suen</surname><given-names>J. L. K.</given-names></name><name><surname>Goto</surname><given-names>T. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Taste intensity modulates effective connectivity from the insular cortex to the thalamus in humans</article-title>. <source>Neuroimage</source>
<volume>135</volume>, <fpage>214</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.04.057</pub-id><?supplied-pmid 27132544?><pub-id pub-id-type="pmid">27132544</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360094</identifier><datestamp>2017-04-04</datestamp><setSpec>sicotj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">SICOT J</journal-id>
      <journal-id journal-id-type="iso-abbrev">SICOT J</journal-id>
      <journal-id journal-id-type="publisher-id">sicotj</journal-id>
      <journal-title-group>
        <journal-title>SICOT-J</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2426-8887</issn>
      <publisher>
        <publisher-name>EDP Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360094</article-id>
      <article-id pub-id-type="pmcid">PMC5360094</article-id>
      <article-id pub-id-type="pmc-uid">5360094</article-id>
      <article-id pub-id-type="pmid">28322719</article-id>
      <article-id pub-id-type="doi">10.1051/sicotj/2017004</article-id>
      <article-id pub-id-type="publisher-id">sicotj170007</article-id>
      <article-id pub-id-type="other">10.1051/sicotj/2017004</article-id>
      <article-categories>
        <subj-group subj-group-type="section">
          <subject>Knee</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>PRP in OA knee – update, current confusions and future options</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dhillon</surname>
            <given-names>Mandeep S.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>Sandeep</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
          <xref ref-type="corresp" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>John</surname>
            <given-names>Rakesh</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AFF1">
        <label>1</label>
        <addr-line>
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research Chandigarh
160012 India
</addr-line>
      </aff>
      <author-notes>
        <corresp id="FN1"><label>*</label>Corresponding author: <email>sandeepdrpatelortho@gmail.com</email></corresp>
      </author-notes>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2017</year>
      </pub-date>
      <pub-date date-type="pub" publication-format="electronic">
        <day>22</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>3</volume>
      <issue-id pub-id-type="publisher-id">sicotj/2017/01</issue-id>
      <elocation-id>27</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>1</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>1</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Authors, published by EDP Sciences, 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>The Authors</copyright-holder>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Positive results have been uniformly observed by various researchers for platelet-rich plasma (PRP) in early osteoarthritis (OA) knee in the past few years. PRP has clearly demonstrated its supremacy in comparison to hyaluronic acid (HA) and placebo in various clinical trials and is undoubtedly the best option available for symptomatic treatment in early OA. The release of growth factors from PRP occurs immediately and lasts for around three weeks and the clinical effect tends to wane down by the end of the year. Prolonged and sustained release of growth factors from platelets could possibly help in much better biological healing and sustained clinical effects. PRP in combination with biocompatible carriers could be one way of achieving this. Gelatin hydrogel PRP and chitosan PRP seem to be promising based on early in vitro studies and animal studies. PRP in combination with hyaluronic acid also seems to be additive. This article intends to discuss the present status of the PRP, confusions surrounding its use, upcoming trends and ideas for improvising PRP for use early OA knees based on available evidence.</p>
      </abstract>
      <kwd-group>
        <kwd>Early OA knee</kwd>
        <kwd>Platelet-rich plasma</kwd>
        <kwd>Hyaluronic acid</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="59"/>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S1">
      <title>Introduction</title>
      <p>Osteoarthritis (OA) of the knee is one of the commonest problems faced by ageing adults and in order to alleviate the pain and morbidity associated with OA, a variety of non-surgical treatment modalities ranging from oral chondroprotectives, intra-articular steroids to viscosupplements have been tried by pain physicians and orthopaedicians worldwide. Platelet-rich plasma (PRP) is evolving into a promising solution for various orthopaedic conditions like tendinopathies, non-union and arthritis of knee. The success of PRP in treating sports injuries in several high-profile sportsmen has contributed to the hype surrounding the PRP therapy, leading to increasing use of PRP for treating OA knees over the last seven years.</p>
      <sec id="S2">
        <title>Mechanism by which PRP works for knee OA</title>
        <p>Osteoarthritis alters the normal joint metabolism favouring increased catabolism and decreased anabolism. Platelet alpha-granules contain and release numerous growth factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and transforming growth factor-b (TGF-b) [<xref rid="R1" ref-type="bibr">1</xref>], which could alter the changing joint mileu in OA.</p>
        <p>PRP acts at various levels to alter the joint homeostasis.</p>
        <p>In cartilage it decreases catabolism, improves anabolism and promotes chondral remodelling. Higher amounts of collagen II and prostaglandin (PG) synthesis have been documented by Akeda et al. [<xref rid="R2" ref-type="bibr">2</xref>] and Pereira et al. [<xref rid="R3" ref-type="bibr">3</xref>]. Increasing chondrocyte proliferation and production of matrix molecules have also been documented [<xref rid="R4" ref-type="bibr">4</xref>–<xref rid="R7" ref-type="bibr">7</xref>].</p>
        <p>Synoviocytes are influenced by increased hyaluronic acid (HA) secretion [<xref rid="R8" ref-type="bibr">8</xref>], creating a more favourable and balanced state of angiogenesis [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R9" ref-type="bibr">9</xref>], and a decreased interleukin-1 (IL-1)-mediated rise in some matrix metalloproteinases (MMPs) [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>].</p>
        <p>The apoptotic pathway of osteoarthritic chondrocytes is influenced as insulin-like growth factor 1 (IGF-1) in PRP may downregulate the expression of programmed cell death 5 (PDCD5) [<xref rid="R10" ref-type="bibr">10</xref>]. Lower levels of apoptosis were detected in in vivo studies by Mifune et al. [<xref rid="R11" ref-type="bibr">11</xref>] and the authors suggested that complex interaction of PRP within joint might positively influence chondrocyte apoptosis.</p>
        <p>An overall downmodulation of the joint inflammation can explain the well-documented pain reduction, which is the most prominent and disabling symptom of knee OA. This could be through the regulation of nuclear factor kappa B (NF-κB) and cyclooxygenase-2 (COX-2), the principal actors of inflammatory cascade [<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>]. Other factors could be the inhibition of NF-κB transactivation activity mediated by HGF, a key cytokine present in PRP alpha-granules or an anti-inflammatory action by inhibiting monocyte-like cell chemotaxis [<xref rid="R13" ref-type="bibr">13</xref>]. Wu et al. [<xref rid="R14" ref-type="bibr">14</xref>]. showed that PRP counteracted the inflammatory cascade elicited by IL-1ß and tumor necrosis factor-alpha (TNF-α), showing an inhibition of IL-1ß, COX-2 and MMP-2 gene expression.</p>
        <p>Lee et al. [<xref rid="R15" ref-type="bibr">15</xref>] noticed increase in mRNA levels of cannabinoid receptors CB1 and CB2 (receptors involved in analgesic and anti-inflammatory effects) and this could explain the analgesic effect of PRP.</p>
      </sec>
      <sec id="S3">
        <title>Preparation of platelet-rich plasma</title>
        <p>PRP is the plasma fraction of autologous blood with platelet concentration above baseline. Platelet counts of 4–5 times of the baseline (1.5–4.5 × 10<sup>5</sup>/μL) label the product as PRP. Autogenous platelet gel, platelet enriched plasma (PeRP) and platelet-rich concentrate (PRC) are the synonyms for PRP.</p>
        <p>There are various methods of PRP preparation and at least 25–30 ready-to-use kits are commercially available. Initial studies used PRP prepared in the laboratory by different techniques and based on these studies, the commercial kits have evolved. Broadly PRP can be prepared in two ways: “single-spinning” and “double-spinning”. Anitua et al. [<xref rid="R16" ref-type="bibr">16</xref>] had prepared PRP in a single-spin technique and open procedure which included micro-pipetting and named the product as EndoRet (plasma rich in growth factors). Patel et al. [<xref rid="R17" ref-type="bibr">17</xref>] also prepared PRP by the open technique which involved a single-spin, micro-pipetting and additional white blood cell (WBC) filtration, and their product was leucocyte-poor PRP. Kon et al. [<xref rid="R18" ref-type="bibr">18</xref>] have prepared PRP by the double-spin technique and cryopreserved the product and used it at three-weekly intervals.</p>
        <p>Centrifugal forces and time, as well as the number of spins (double vs single) alter the PRP product in terms of platelet count and leucocyte concentration. Based on the variability in yield, it became necessary to classify PRP in order to compare studies and two classification systems have evolved. One is the Sports Medicine Platelet-Rich Plasma classification system by Mishra et al. [<xref rid="R19" ref-type="bibr">19</xref>], which takes into consideration the activation method (activated or not activated) and the leucocyte count (increased or absent) to divide the PRP into four types, with each having two further subtypes A and B based on the platelet concentration. The other international classification system is the PAW classification by DeLong et al. [<xref rid="R20" ref-type="bibr">20</xref>], which also takes into consideration the absolute platelet count (P1- low to P4- high), the manner of platelet activation and presence or absence of leucocytes.</p>
      </sec>
      <sec id="S4">
        <title>Platelet activation</title>
        <p>Platelet activation can be achieved by different activators. Bovine or autologous thrombin is a traditional activator of platelets but there are concerns regarding its tolerability and adverse effects. Calcium chloride is the most common activator used in the majority of clinical studies. Collagen type-1 and batroxobin are some other activators which can be used. Rodeo et al. [<xref rid="R21" ref-type="bibr">21</xref>] showed that activated platelets release 70% of their growth factors (GFs) within the first 10 min and release most of the GFs within the next one hour. These growth factors are absorbed by the fibrin gel formed, which subsequently releases the various growth factors in a controlled way. The content of fibrin in the gel is the most important factor controlling subsequent release. Platelet concentration, fibrinogen concentration and the enzymes involved in procoagulant pathway influence the final fibrin content. The above factors regulate the duration of GF release at the injection site.</p>
        <p>Studies aimed at improving the controlled delivery of GFs from PRP at the target site may bring out better results. Some novel approaches under consideration are the use of chitosan (scaffolds) [<xref rid="R22" ref-type="bibr">22</xref>, <xref rid="R23" ref-type="bibr">23</xref>] and gelatin hydrogel as carriers of PRP. In a rabbit OA model, Saito et al. [<xref rid="R24" ref-type="bibr">24</xref>] demonstrated that gelatin hydrogel microspheres impregnated with PRP injections markedly suppressed OA progression both morphologically and histologically than the use of PRP alone.</p>
      </sec>
      <sec id="S5">
        <title>Should leucocytes be always filtered out?</title>
        <p>The type of PRP to be used is another topic of debate. The confusion is between leucocyte-rich and leucocyte-poor PRP. We raised our concern regarding this previously [<xref rid="R25" ref-type="bibr">25</xref>]. The initial hypothesis that leucocytes could be proinflammatory inside the joint (due to supposed deleterious effects of proteases and reactive oxygen species released from white cells) has been subsequently corroborated.<list list-type="order"><list-item><p>Pifer et al. [<xref rid="R26" ref-type="bibr">26</xref>] showed in an in vivo study that PRP with leucocytes contains MMP-2, -3 and -9, which is released over a period of at least six days, and can be deleterious.</p></list-item><list-item><p>Braun et al. [<xref rid="R27" ref-type="bibr">27</xref>] compared the effects of leucocyte-rich PRP (LR-PRP), leucocyte-poor PRP (LP-PRP), red blood cell (RBC) concentrate and platelet-poor plasma (PPP) and concluded that “Treatment of synovial cells with LR-PRP and RBCs resulted in significant cell death and proinflammatory mediator production”.</p></list-item><list-item><p>Dragoo et al. [<xref rid="R28" ref-type="bibr">28</xref>], in a rabbit study, showed that the (LR-PRP) group had more undesirable side effects owing to greater inflammatory reactions following injection at the lesion site than at the LP-PRP group.</p></list-item><list-item><p>Filardo et al. [<xref rid="R29" ref-type="bibr">29</xref>] – These authors were the only ones to conduct a clinical trial comparing two different PRP preparations: high-concentrate leucocyte-rich PRP versus low concentrate leucocyte-free PRP. They treated 144 patients and evaluated up to 12 months and comparable positive results were obtained in both treatments, with the only difference being that the PRP leucocyte group suffered from more swelling and pain reaction immediately after the injections.</p></list-item></list>
</p>
        <p>To add to the confusion, there are some in vivo studies which document some beneficiary effects of leucocyte released products for the OA knee. Cavallo et al. [<xref rid="R30" ref-type="bibr">30</xref>] in their in vitro study noticed that chondrocyte proliferation and hyaluronan secretion were more prevalent in L-PRP than in P-PRP. Riboh et al. [<xref rid="R31" ref-type="bibr">31</xref>] in a recent meta-analysis compared clinical outcomes and rates of adverse reactions between LP-PRP and LR-PRP for the OA knee. They concluded that both are clinically effective over HA and placebo. LP-PRP and LR-PRP had similar safety profiles, and adverse reactions to PRP may not be directly related to leucocyte concentration.</p>
        <p>Thus, there is still a need of research on this topic so as to standardize the concentration of leucocytes needed in ideal PRP preparation injected in OA.</p>
      </sec>
      <sec id="S6">
        <title>What specific type of PRP is ideal for Knee OA?</title>
        <p>Based on the available literature, there are some answers and but more questions which need to be answered.</p>
        <p>Different PRP preparations – Magalon et al. [<xref rid="R32" ref-type="bibr">32</xref>] studied five different commercial PRP preparations in a single donor model and noticed significant biological variation in the PRP product among different preparations and postulated this to be a reason for the variability of results in PRP studies.</p>
        <p>Intra-individual variations were observed by Mazzocca et al. [<xref rid="R33" ref-type="bibr">33</xref>] in the same individual, and there were variations in the PRP yield by the same method in samples drawn at different time periods.</p>
        <p>In the debate about fresh PRP versus freeze thawed PRP, the fresh PRP appears to be better. Storing platelets in freezing conditions can alter the morphology and decrease the functional properties of platelets by degranulation of alpha-granules [<xref rid="R34" ref-type="bibr">34</xref>]. We had expressed our concerns regarding cryopreservation of PRP in our initial work [<xref rid="R25" ref-type="bibr">25</xref>]. However, freeze thawing PRP is better in terms of patient compliance as the PRP can be prepared in a single sitting. Roffi et al. [<xref rid="R35" ref-type="bibr">35</xref>] studied the effect of freezing/thawing on the PRP molecule release, and its effects on the metabolism of chondrocytes and synoviocytes. They noticed decreased protein level secretion in the freeze thawed PRP but the gene expression in cultured chondroctyes and synoviocytes was similar to that in fresh PRP. They concluded that PRP cryopreservation is a safe procedure, which sufficiently preserves PRP quality and its ability to induce proliferation and the production of Extra Cellular Matrix (ECM) components in chondrocytes and synoviocytes.</p>
        <p>For knee OA, leucocyte-poor PRP appears to be better than leucocyte-rich PRP.</p>
      </sec>
      <sec id="S7">
        <title>Clinical studies</title>
        <p>Over 35 clinical trials have been conducted in the past seven years, which reflects the growing interest in exploring PRP as treatment modality in the OA knee. It is surprising to notice that in all previous studies (case series as well as comparative studies), superiority of PRP has been demonstrated in alleviating pain symptoms and improving knee scores.</p>
        <p>Sanchez et al. established the safety of autologous PRP for intra-articular use in the first PRP trial in 2008 [<xref rid="R36" ref-type="bibr">36</xref>]. It was followed by subsequent studies which compared PRP with hyaluronic acid (HA) and demonstrated the safety profile and beneficial effects of PRP in the OA knee. Spakova et al. [<xref rid="R37" ref-type="bibr">37</xref>] compared three PRP injections with three hyaluronic acid injections in their randomized control trial (RCT) on 120 patients and concluded the effectiveness and safety of autologous PRP in early osteoarthritis knee (Kellgren and Lawrence Grades 1, 2 or 3 Osteoarthritis). Better Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores and Numerical Rating Scale (NRS) were noted in the autologous PRP group in comparison to the HA group. Cerza et al. [<xref rid="R38" ref-type="bibr">38</xref>] in their RCT on 120 patients compared four PRP injections at one-week interval with low molecular weight hyaluronan (LMW-HA) and observed better improvement of WOMAC scores at 24 weeks in the PRP group. They did not find any correlation with the grade of OA.</p>
        <p>Kon et al. [<xref rid="R18" ref-type="bibr">18</xref>] treated 91 patients with three PRP injections at three-week intervals (freeze thawed PRP) and noted improvement at six and 12 months from baseline in International Knee Documentation Committee (IKDC) and visual analogue scale (VAS) scores, with a tendency of worsening between six and 12 months. In a subsequent comparative study, Kon et al. [<xref rid="R39" ref-type="bibr">39</xref>] observed better symptom control and sustained effects (better IKDC and EQ-VAS scores) in autologous PRP group (three injections at two-week intervals) compared to high molecular weight hyaluronan (HMW-HA) injections (50 patients) and LMW-HA injections (50 patients). They have established good outcomes (IKDC scores) of intra-articular PRP in early degenerative cartilage lesions. They have quoted on better results in younger patients, low body mass index (BMI) patients and those with less degree of cartilage degeneration. They also followed the same patients for two years and noticed sustained improvement compared to baseline in the PRP group than HA, with a slight worsening after the first year [<xref rid="R40" ref-type="bibr">40</xref>]. However in their recent RCT, they found a similar benefit in both HA and PRP groups in early OA [<xref rid="R41" ref-type="bibr">41</xref>].</p>
        <p>Sanchez et al. [<xref rid="R42" ref-type="bibr">42</xref>] in their RCT of 176 patients with Ahlbacks grade 1–3 OA compared three PRP injections at one-week intervals (79 patients) with those of HMW-HA (74 patients). The primary outcome measure was the percentage of patients having a 50% decrease in the WOMAC pain subscore. The secondary outcome measures being other WOMAC subscores, Lequesne index and Osteoarthritis Research Society International (OARSI) responders. They noticed better outcomes in the PRP group at 24 weeks in respect to primary outcome. No differences for secondary outcome measures and amount of acetaminophen consumption were observed.</p>
        <p>Similarly better outcomes were documented in the PRP group in comparison to HA groups at six months by Li et al. [<xref rid="R43" ref-type="bibr">43</xref>] and Say et al. [<xref rid="R44" ref-type="bibr">44</xref>] in their prospective studies.</p>
        <p>Patel et al. were the first to compare normal saline (physiological control) with PRP and established the superiority of PRP over placebo as manifested by improved WOMAC scores which were sustained at six months [<xref rid="R17" ref-type="bibr">17</xref>]. They noticed that patients were experiencing benefits as early as 18 days and also noted a slight worsening of benefits by six months, based on which they hypothesized that anti-inflammatory role could be the reason for the clinical effect, as for chondral remodelling it would have required much more time and would have given much sustained results [<xref rid="R45" ref-type="bibr">45</xref>].</p>
        <p>There is also a lot of confusion regarding the dosage schedule of PRP for OA knees. Initial studies used three injections at three weekly interval (without any rational though); probably in a bid to compare with HA which is used similarly. The literature is confusing, with studies available which have used two injections, three injections to four injections. The duration between injections is also variable (one week to four weeks). We were the first to compare two different PRP injection groups, and found that single injection was as good as two injections of PRP, shown by similar improvement in WOMAC scores [<xref rid="R17" ref-type="bibr">17</xref>]. Recently Görmeli et al. [<xref rid="R46" ref-type="bibr">46</xref>] in their double-blind placebo-controlled randomized trial noted a statistically significant improvement in the IKDC and EQ-VAS scores in all the treatment groups compared with the control group (Normal Saline). The knee scores of patients treated with three PRP injections were significantly better than those patients of single PRP and HA groups.</p>
        <p>Another alternative is to use PRP at yearly intervals or when the patient demands it again after the effect wanes out. Gobbi et al. [<xref rid="R47" ref-type="bibr">47</xref>] have used PRP at yearly interval and established the clinical efficacy. A lot more research in this direction needs to be carried out as to how long we can prolong the pain-free status with multiple yearly injections.</p>
        <p>Hart et al. [<xref rid="R48" ref-type="bibr">48</xref>] have used another interesting approach in their trial wherein they compared PRP (50 patients) with 1% mesocaine (50 patients) in knee articular damage grade 2 (fibrillation) and grade 3 (fissuring and fragmentation). The PRP group received a total of nine injections within a year. The first six injections (loading dose) at weekly interval followed by a three-month gap; followed by three injections at three month interval (maintenance dose). They noticed a better improvement of PRP groups at 12 months with respect to IKDC, Tegner, Lysholm and Cincinnati scores. However, no significant influence on cartilage was observed in magnetic resonance imaging (MRI). So, no clear benefit of such PRP loaded procedure could be validated.</p>
        <p>Hassan et al. [<xref rid="R49" ref-type="bibr">49</xref>] looked at 20 patients with mild to moderate OA, giving 5 mL PRP at monthly intervals for six months (six injections); they noticed significant improvement in knee stiffness, IKDC scores and VAS scores compared to baseline. Maximal improvement was obtained in patients with young age, less BMI and short disease duration.</p>
        <p>Majority of the previous studies have included early OA for PRP therapy and consistently showed benefits in terms of symptomatic improvement. Kon et al. [<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R39" ref-type="bibr">39</xref>] and Hassan et al. [<xref rid="R49" ref-type="bibr">49</xref>] have compared early OA with late OA and found better results in early OA. Recently Sánchez et al. [<xref rid="R50" ref-type="bibr">50</xref>] and his team have described a novel approach of PRP delivery in severe OA by intraosseous infiltration of PRP in subchondral area of femoral condyle, tibial condyle and patella. They also simultaneously gave intra-articular injections of PRP for addressing synovial and cartilage pathology in OA.</p>
        <p>Another interesting approach towards PRP administration in OA is the use of photo-activated PRP (PA-PRP). Paterson et al. [<xref rid="R51" ref-type="bibr">51</xref>] in a randomized controlled pilot study (23 patients) observed the safety profile and feasibility of use of PA-PRP in OA knee. Better scores were observed in comparison with the HA group. However, studies are required to compare the PA-PRP with PRP to show any additional effect of photo-activation over conventional PRP.</p>
        <p>There have been a few studies [<xref rid="R52" ref-type="bibr">52</xref>–<xref rid="R54" ref-type="bibr">54</xref>] demonstrating the PRP efficacy over HA in hip OA. Mei-Dan et al. [<xref rid="R55" ref-type="bibr">55</xref>] demonstrated better outcomes in the PRP group at 28 weeks in talar osteochondral lesions.</p>
        <p>With the availability of commercial PRP kits in market, more and more people can receive the treatment. However, it is advisable for the clinicians to not get carried away with the initial results and to keep track of the patient’s outcome so as to contribute to the existing literature. It is also advisable to look at the yield and the product obtained to classify the PRP type.</p>
        <p>Anitua et al. [<xref rid="R56" ref-type="bibr">56</xref>] had postulated that PRP in combination with HA may be synergistic, by enhancing the migratory potential of fibroblast based on her in vitro studies. The same has also been supported by Marmotti et al. in his in vitro study [<xref rid="R57" ref-type="bibr">57</xref>]. Both HA and PRP are biological approaches and their use may be critical in the initial phase of OA environment where tissue healing may benefit. Based on these concepts Andia et al. [<xref rid="R58" ref-type="bibr">58</xref>] have expressed that HA+PRP may be better than PRP alone. Dallari et al. [<xref rid="R54" ref-type="bibr">54</xref>] in their RCT in hip primary OA compared ultrasound guided injections of PRP, HA and HA+PRP and noticed a significant improvement in WOMAC and Harris Hip score in the PRP group over HA. However, the addition of PRP+HA did not lead to significant improvement in pain symptoms. A recent RCT by Lana et al. [<xref rid="R59" ref-type="bibr">59</xref>] compared HA+PRP versus PRP versus HA in mild to moderate knee OA and noticed better outcomes in the HA+PRP combination over HA alone up to one year and over PRP alone up to three months. They also noted better functional outcomes in the first 30 days after treatment in the combination group over HA and PRP alone groups. Clinical studies on combination therapy are limited and further well-designed studies with a larger sample size are required before a definitive comment can made. Several key aspects concerning molecular weight, ideal combination and dosage schedule of both need to be evaluated before conducting clinical trials. HA+PRP definitely seems like a good future option.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="S8">
      <title>Conclusion</title>
      <p>The present state of knowledge holds promise for PRP of certain specifications for pain management in the early OA knee. PRP has consistently been shown by various clinical studies to be superior to HA. Nevertheless, a lot of grey areas remain in our understanding of PRP and OA, and many more focused clinical and in vitro studies are required. HA+PRP seems to be an evolving future trend. Researchers are also focused on developing a better PRP product by combining it with various molecules such as gelatin, chitosan and others. PRP is definitely there to stay for OA therapy use in future.</p>
    </sec>
    <sec id="S9">
      <title>Conflict of interest</title>
      <p>The authors declare no conflict of interest in relation with this paper.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Boswell</surname>
<given-names>SG</given-names></string-name>, <string-name><surname>Cole</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Sundman</surname>
<given-names>EA</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Platelet-rich plasma: a milieu of bioactive factors</article-title>. <source>Arthroscopy</source>
<volume>28</volume>(<issue>3</issue>), <fpage>429</fpage>–<lpage>439</lpage>.<pub-id pub-id-type="pmid">22284405</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Akeda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>An</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Okuma</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>) <article-title>Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis</article-title>. <source>Osteoarthritis Cartil</source>
<volume>14</volume>(<issue>12</issue>), <fpage>1272</fpage>–<lpage>1280</lpage>.</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Pereira</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Scaranari</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Benelli</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution</article-title>. <source>Tissue Eng Part A</source>
<volume>19</volume>(<issue>11–12</issue>), <fpage>1476</fpage>–<lpage>1488</lpage>.<pub-id pub-id-type="pmid">23360471</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Park</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Time sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures</article-title>. <source>Mol Cell Biochem</source>
<volume>361</volume>(<issue>1–2</issue>), <fpage>9</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">21956670</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Yang</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Ahn</surname>
<given-names>ST</given-names></string-name>, <string-name><surname>Rhie</surname>
<given-names>JW</given-names></string-name>, <etal>et al.</etal> (<year>2000</year>) <article-title>Platelet supernatant promotes proliferation of auricular chondrocytes and formation of chondrocyte mass</article-title>. <source>Ann Plast Surg</source>
<volume>44</volume>(<issue>4</issue>), <fpage>405</fpage>–<lpage>411</lpage>.<pub-id pub-id-type="pmid">10783097</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Spreafico</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chellini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Frediani</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>) <article-title>Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes</article-title>. <source>J Cell Biochem</source>
<volume>108</volume>(<issue>5</issue>), <fpage>1153</fpage>–<lpage>1165</lpage>.<pub-id pub-id-type="pmid">19731249</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Gaissmaier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Fritz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Krackhardt</surname>
<given-names>T</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>) <article-title>Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures</article-title>. <source>Biomaterials</source>
<volume>26</volume>(<issue>14</issue>), <fpage>1953</fpage>–<lpage>1960</lpage>.<pub-id pub-id-type="pmid">15576169</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sundman</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Cole</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Karas</surname>
<given-names>V</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis</article-title>. <source>Am J Sports Med</source>
<volume>42</volume>(<issue>1</issue>), <fpage>35</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">24192391</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Anitua</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nurden</surname>
<given-names>AT</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>) <article-title>Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patientsm</article-title>. <source>Rheumatology (Oxford)</source>
<volume>46</volume>(<issue>12</issue>), <fpage>1769</fpage>–<lpage>1772</lpage>.<pub-id pub-id-type="pmid">17942474</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Yin</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study</article-title>. <source>J Biomater Appl</source>
<volume>28</volume>(<issue>7</issue>), <fpage>1039</fpage>–<lpage>1050</lpage>.<pub-id pub-id-type="pmid">23828781</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Mifune</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Matsumoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Takayama</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair</article-title>. <source>Osteoarthritis Cartil</source>
<volume>21</volume>(<issue>1</issue>), <fpage>175</fpage>–<lpage>185</lpage>.</mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<string-name><surname>van Buul</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Koevoet</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Kops</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes</article-title>. <source>Am J Sports Med</source>
<volume>39</volume>(<issue>11</issue>), <fpage>2362</fpage>–<lpage>2370</lpage>.<pub-id pub-id-type="pmid">21856929</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Bendinelli</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Matteucci</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Dogliotti</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>) <article-title>Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-jB inhibition via HGF</article-title>. <source>J Cell Physiol</source>
<volume>225</volume>(<issue>3</issue>), <fpage>757</fpage>–<lpage>766</lpage>.<pub-id pub-id-type="pmid">20568106</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Wu</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>WH</given-names></string-name>, <string-name><surname>Zao</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis</article-title>. <source>Biomaterials</source>
<volume>32</volume>(<issue>25</issue>), <fpage>5847</fpage>–<lpage>5854</lpage>.<pub-id pub-id-type="pmid">21616530</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Lee</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Joung</surname>
<given-names>YK</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Platelet rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2</article-title>. <source>J Control Release</source>
<volume>159</volume>(<issue>3</issue>), <fpage>332</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">22366523</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Anitua</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Orive</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>) <article-title>The potential impact of the preparation rich in growth factors (PRGF) in different medical fields</article-title>. <source>Biomaterials</source>
<volume>28</volume>, <fpage>4551</fpage>–<lpage>4560</lpage>.<pub-id pub-id-type="pmid">17659771</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Patel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dhillon</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Aggarwal</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial</article-title>. <source>Am J Sports Med</source>
<volume>41</volume>, <fpage>356</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">23299850</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kon</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Buda</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>) <article-title>Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>18</volume>, <fpage>472</fpage>–<lpage>479</lpage>.<pub-id pub-id-type="pmid">19838676</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Mishra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Harmon</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Woodall</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Sports medicine applications of platelet rich plasma</article-title>. <source>Curr Pharm Biotechnol</source>
<volume>13</volume>, <fpage>1185</fpage>–<lpage>1195</lpage>.<pub-id pub-id-type="pmid">21740373</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<string-name><surname>DeLong</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Mazzocca</surname>
<given-names>AD</given-names></string-name> (<year>2012</year>) <article-title>Platelet-rich plasma: the PAW classification system</article-title>. <source>J Arthrosc Relat Surg</source>
<volume>28</volume>, <fpage>998</fpage>–<lpage>1009</lpage>.</mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Arnoczky</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Delos</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rodeo</surname>
<given-names>SA</given-names></string-name> (<year>2011</year>) <article-title>What is platelet-rich plasma?</article-title>
<source>Oper Tech Sports Med</source>
<volume>19</volume>(<issue>3</issue>), <fpage>142</fpage>–<lpage>148</lpage>.</mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Busilacchi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gigante</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mattioli-Belmonte</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration</article-title>. <source>Carbohydr Polym</source>
<volume>98</volume>(<issue>1</issue>), <fpage>665</fpage>–<lpage>676</lpage>.<pub-id pub-id-type="pmid">23987397</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kutlu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Aydın</surname>
<given-names>RST</given-names></string-name>, <string-name><surname>Akman</surname>
<given-names>AC</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Platelet-rich plasma-loaded chitosan scaffolds: preparation and growth factor release kinetics</article-title>. <source>J Biomed Materials Res Part B: Applied Biomaterials</source>
<volume>101</volume>(<issue>1</issue>), <fpage>28</fpage>–<lpage>35</lpage>.</mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Saito</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Arai</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>) <article-title>Intra-articular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee</article-title>. <source>Clin Exp Rheumatol</source>
<volume>27</volume>(<issue>2</issue>), <fpage>201</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">19473558</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Dhillon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bali</surname>
<given-names>K</given-names></string-name> (<year>2011</year>) <article-title>Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>19</volume>, <fpage>863</fpage>–<lpage>864</lpage>, <comment>author reply 865-866</comment>.<pub-id pub-id-type="pmid">21161706</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Pifer</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Maerz</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Baker</surname>
<given-names>KC</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts</article-title>. <source>Am J Sports Med</source>
<volume>42</volume>(<issue>5</issue>), <fpage>1211</fpage>–<lpage>1218</lpage>.<pub-id pub-id-type="pmid">24627579</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Braun</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>CR</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy</article-title>. <source>Am J Sports Med</source>
<volume>42</volume>(<issue>5</issue>), <fpage>1204</fpage>–<lpage>1210</lpage>.<pub-id pub-id-type="pmid">24634448</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Dragoo</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Braun</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Durham</surname>
<given-names>JL</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons</article-title>. <source>Am J Sports Med</source>
<volume>40</volume>(<issue>6</issue>), <fpage>1274</fpage>–<lpage>1281</lpage>.<pub-id pub-id-type="pmid">22495144</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kon</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Pereira Ruiz</surname>
<given-names>MT</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double- spinning approach</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>20</volume>(<issue>10</issue>), <fpage>2082</fpage>–<lpage>2091</lpage>.<pub-id pub-id-type="pmid">22203046</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Cavallo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mariani</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Comparison of platelet rich plasma formulations for cartilage healing: an in vitro study</article-title>. <source>J Bone Joint Surg (Am)</source>
<volume>96</volume>(<issue>5</issue>), <fpage>5423</fpage>–<lpage>5429</lpage>.</mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Riboh</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Saltzman</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Yanke</surname>
<given-names>AB</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis</article-title>. <source>Am J Sports Med</source>
<volume>44</volume>(<issue>3</issue>), <fpage>792</fpage>–<lpage>800</lpage>.<pub-id pub-id-type="pmid">25925602</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Magalon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bausset</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Serratrice</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model</article-title>. <source>Arthroscopy</source>
<volume>30</volume>(<issue>5</issue>), <fpage>629</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">24725317</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Mazzocca</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>MBR</given-names></string-name>, <string-name><surname>Chowaniec</surname>
<given-names>DM</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Platelet-rich plasma differs according to preparation method and human variability</article-title>. <source>J Bone Joint Surg (Am)</source>
<volume>94</volume>(<issue>4</issue>), <fpage>308</fpage>–<lpage>316</lpage>.<pub-id pub-id-type="pmid">22336969</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Blajchman</surname>
<given-names>MA</given-names></string-name> (<year>2001</year>) <article-title>Novel platelet products, substitutes and alternatives</article-title>. <source>Transfus Clin Biol</source>
<volume>8</volume>, <fpage>267</fpage>–<lpage>271</lpage>.<pub-id pub-id-type="pmid">11499975</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Roffi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Assirelli</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?</article-title>
<source>Biomed Res Int</source>
<volume>2014</volume>, <fpage>692913</fpage>.<pub-id pub-id-type="pmid">25136613</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Anitua</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Azofra</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>) <article-title>Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study</article-title>. <source>Clin Exp Rheumatol</source>
<volume>26</volume>, <fpage>910</fpage>–<lpage>913</lpage>.<pub-id pub-id-type="pmid">19032827</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Spakova</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rosocha</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lacko</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid</article-title>. <source>Am J Phys Med Rehabil</source>
<volume>91</volume>, <fpage>411</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">22513879</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Cerza</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Carnì</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Carcangiu</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis</article-title>. <source>Am J Sports Med</source>
<volume>40</volume>, <fpage>2822</fpage>–<lpage>2827</lpage>.<pub-id pub-id-type="pmid">23104611</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kon</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mandelbaum</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Buda</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Platelet-rich plasma intraarticular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis</article-title>. <source>Arthroscopy</source>
<volume>27</volume>, <fpage>1490</fpage>–<lpage>1501</lpage>.<pub-id pub-id-type="pmid">21831567</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kon</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Buda</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>19</volume>, <fpage>528</fpage>–<lpage>535</lpage>.<pub-id pub-id-type="pmid">20740273</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Filardo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Di Matteo</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Martino</surname>
<given-names>Di</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial</article-title>. <source>Am J Sports Med</source>
<volume>43</volume>(<issue>7</issue>), <fpage>1575</fpage>–<lpage>1582</lpage>.<pub-id pub-id-type="pmid">25952818</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fiz</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Azofra</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis</article-title>. <source>Arthroscopy</source>
<volume>28</volume>(<issue>8</issue>), <fpage>1070</fpage>–<lpage>1078</lpage>.<pub-id pub-id-type="pmid">22840987</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ai</surname>
<given-names>Z</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration</article-title>. <source>Zhongguo Xiu Fu Chong JianWai Ke Za Zhi</source>
<volume>25</volume>(<issue>10</issue>), <fpage>1192</fpage>–<lpage>1196</lpage>.</mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Say</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gürler</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Yener</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis</article-title>. <source>Acta Chir Ortho Traumatol Cech</source>
<volume>80</volume>(<issue>4</issue>), <fpage>278</fpage>–<lpage>283</lpage>.</mixed-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Patel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dhillon</surname>
<given-names>MS</given-names></string-name> (<year>2014</year>) <article-title>The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis: letter to the editor</article-title>. <source>Am J Sports Med</source>
<volume>30</volume>, <fpage>42</fpage>.</mixed-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <mixed-citation publication-type="other">
<string-name><surname>Görmeli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Görmeli</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Ataoglu</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>, DOI: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00167-015-3705-6">10.1007/s00167-015-3705-6</ext-link>.</mixed-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Gobbi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lad</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Karnatzikos</surname>
<given-names>G</given-names></string-name> (<year>2015</year>) <article-title>The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>23</volume>(<issue>8</issue>), <fpage>2170</fpage>–<lpage>2177</lpage>.<pub-id pub-id-type="pmid">24748286</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Hart</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Safi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Komázk</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Platelet-rich plasma in patients with tibiofemoral cartilage degeneration</article-title>. <source>Arch Orthop Trauma Surg</source>
<volume>133</volume>(<issue>9</issue>), <fpage>1295</fpage>–<lpage>1301</lpage>.<pub-id pub-id-type="pmid">23736793</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Hassan</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>El-Shafey</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>HS</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Effectiveness of the intra-articular injection of platelet rich plasma in the treatment of patients with primary knee osteoarthritis</article-title>. <source>Egypt Rheumatol</source>
<volume>37</volume>(<issue>3</issue>), <fpage>119</fpage>–<lpage>124</lpage>.</mixed-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sánchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fiz</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Guadilla</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Intraosseous infiltration of platelet-rich plasma for severe knee osteoarthritis</article-title>. <source>Arthrosc Tech</source>
<volume>3</volume>(<issue>6</issue>), <fpage>e713</fpage>–<lpage>e717</lpage>.<pub-id pub-id-type="pmid">25685680</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Paterson</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Nicholls</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bennell</surname>
<given-names>KL</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study</article-title>. <source>BMC Musculoskelet Disord</source>
<volume>17</volume>, <fpage>67</fpage>.<pub-id pub-id-type="pmid">26861957</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guadilla</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fiz</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip</article-title>. <source>Rheumatology</source>
<volume>51</volume>, <fpage>144</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">22075062</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Battaglia</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guaraldi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vannini</surname>
<given-names>F</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis</article-title>. <source>Orthopedics</source>
<volume>36</volume>(<issue>12</issue>), <fpage>e1501</fpage>–<lpage>e1508</lpage>.<pub-id pub-id-type="pmid">24579221</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Dallari</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stagni</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rani</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study</article-title>. <source>Am J Sports Med</source>
<volume>44</volume>(<issue>3</issue>), <fpage>664</fpage>–<lpage>671</lpage>.<pub-id pub-id-type="pmid">26797697</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Mei-Dan</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Carmont</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Laver</surname>
<given-names>L</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus</article-title>. <source>Am J Sports Med</source>
<volume>40</volume>(<issue>3</issue>), <fpage>534</fpage>–<lpage>541</lpage>.<pub-id pub-id-type="pmid">22253252</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Anitua</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sanchez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>De la Fuente</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>20</volume>, <fpage>1657</fpage>–<lpage>1665</lpage>.<pub-id pub-id-type="pmid">21987365</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Marmotti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bruzzone</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bonasia</surname>
<given-names>DE</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>One-step osteochondral repair with cartilage fragments in a composite scaffold</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>
<volume>20</volume>, <fpage>2590</fpage>–<lpage>2601</lpage>.<pub-id pub-id-type="pmid">22349601</pub-id></mixed-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Andia</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Abate</surname>
<given-names>M</given-names></string-name>(<year>2014</year>) <article-title>Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association?</article-title>
<source>Expert Opin Biol Ther</source>
<volume>14</volume>, <fpage>635</fpage>–<lpage>649</lpage>.<pub-id pub-id-type="pmid">24533435</pub-id></mixed-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Lana</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Weglein</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sampson</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>) <article-title>Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee</article-title>. <source>J Stem Cells Regen Med</source>
<volume>12</volume>(<issue>2</issue>), <fpage>69</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">28096631</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <notes>
      <boxed-text position="float" orientation="portrait">
        <p>
<bold>Cite this article as:</bold> Dhillon MS, Patel S &amp; John R (2017) PRP in OA knee – update, current confusions and future options. SICOT J, <bold>3</bold>, 27</p>
      </boxed-text>
    </notes>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360095</identifier><datestamp>2017-04-04</datestamp><setSpec>sicotj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">SICOT J</journal-id>
      <journal-id journal-id-type="iso-abbrev">SICOT J</journal-id>
      <journal-id journal-id-type="publisher-id">sicotj</journal-id>
      <journal-title-group>
        <journal-title>SICOT-J</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2426-8887</issn>
      <publisher>
        <publisher-name>EDP Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360095</article-id>
      <article-id pub-id-type="pmcid">PMC5360095</article-id>
      <article-id pub-id-type="pmc-uid">5360095</article-id>
      <article-id pub-id-type="pmid">28322718</article-id>
      <article-id pub-id-type="doi">10.1051/sicotj/2017012</article-id>
      <article-id pub-id-type="publisher-id">sicotj160158</article-id>
      <article-id pub-id-type="other">10.1051/sicotj/2017012</article-id>
      <article-categories>
        <subj-group subj-group-type="section">
          <subject>Hip</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pseudoaneurysm of a branch of the femoral circumflex artery as a complication of revision arthroscopic release of the iliopsoas tendon</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nakano</surname>
            <given-names>Naoki</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lisenda</surname>
            <given-names>Laughter</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khanduja</surname>
            <given-names>Vikas</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
          <xref ref-type="corresp" rid="FN1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="AFF1">
        <label>1</label>
        <addr-line>
Department of Trauma and Orthopaedics, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust Hills Road Cambridge
CB2 0QQ UK
</addr-line>
      </aff>
      <author-notes>
        <corresp id="FN1"><label>*</label>Corresponding author: <email>vk279@cam.ac.uk</email></corresp>
      </author-notes>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2017</year>
      </pub-date>
      <pub-date date-type="pub" publication-format="electronic">
        <day>22</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>3</volume>
      <issue-id pub-id-type="publisher-id">sicotj/2017/01</issue-id>
      <elocation-id>26</elocation-id>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Authors, published by EDP Sciences, 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>The Authors</copyright-holder>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Treatment of painful internal snapping hip via arthroscopic release of the iliopsoas tendon is becoming the preferred option over open techniques because of the benefits of minimal dissection and fewer complications. However, complications do occur with arthroscopic techniques as well. We present the case of a 33-year-old woman who presented with painful internal snapping of her right hip and underwent arthroscopic release of the iliopsoas tendon. Following the procedure she continued to complain of pain in her groin and was therefore investigated further with a magnetic resonance imaging (MRI) which revealed a swelling near the femoral circumflex vessels. A computed tomography (CT) angiogram revealed a 15 mm pseudoaneurysm of the femoral circumflex artery, which was successfully treated by selective catheterisation and embolisation. Hip arthroscopists should be sufficiently familiar with the vascular anatomy around the hip and keep this complication in mind when releasing the iliopsoas tendon arthroscopically especially in revision cases with adhesions.</p>
      </abstract>
      <kwd-group>
        <kwd>Pseudoaneurysm</kwd>
        <kwd>Femoral circumflex artery</kwd>
        <kwd>Arthroscopic iliopsoas tendon release</kwd>
        <kwd>Iliopsoas snapping</kwd>
        <kwd>Embolisation</kwd>
      </kwd-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="12"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S1">
      <title>Introduction</title>
      <p>Internal snapping of the hip occurs when the iliopsoas tendon snaps over the iliopectineal eminence or across the femoral head as the hip is brought from flexion, abduction and external rotation to extension. If non-operative treatment, which includes physiotherapy to stretch the muscle, fails then open or arthroscopic release of the iliopsoas tendon has been described as being effective in relieving the snapping sensation, reducing pain and restoring function [<xref rid="R1" ref-type="bibr">1</xref>]. Complications from open procedures such as transient sensory loss in the anterolateral aspect of the thigh have been reported to occur with high frequency [<xref rid="R2" ref-type="bibr">2</xref>], thus, arthroscopic release of the iliopsoas tendon was introduced as an adjunct to hip arthroscopy for operative treatment of this problem [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. Arthroscopic release of the iliopsoas consists of dividing the tendinous portion of the iliopsoas between the level of the acetabulum and the lesser trochanter, which leads to functional lengthening of the musculotendinous unit while leaving the muscle belly intact, and it has been shown to effectively alleviate pain associated with internal snapping of the hip [<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>].</p>
      <p>Except for persistent snapping after release, complications following arthroscopic release of the iliopsoas tendon have not been reported thus far [<xref rid="R4" ref-type="bibr">4</xref>]. In this report, we present a rare case of a pseudoaneurysm, which occurred in the femoral circumflex artery after arthroscopic release of the iliopsoas tendon.</p>
    </sec>
    <sec id="S2">
      <title>Case presentation</title>
      <p>A 33-year-old woman was referred to our tertiary young adult hip service for evaluation of right hip pain, which had been affecting her for over six months along with mechanical symptoms of snapping. She had undergone an arthroscopy of her hip previously for an acetabular labral tear and recovered well following the same. She did not report of any definite history of injury, which had led to the onset of her symptoms.</p>
      <p>The examination of her right hip revealed that she had a normal gait, and flexion was limited to 90°. Internal rotation in 90°of flexion was limited to 20° and external rotation in 90°of flexion was 40°. The impingement test was positive and there was definite snapping palpable in the groin on extending her hip from a flexed and abducted position, which was painful. Dorsalis pedis was well palpable. Plain radiographs did not reveal any signs of dysplasia and showed a well-preserved joint space. A dynamic ultrasound scan showed that the iliopsoas tendon snapped as she extended her hip from flexed and externally rotated position.</p>
      <p>Physiotherapy to stretch her iliopsoas and an ultrasound guided injection of steroid was not quite successful and since she was quite symptomatic, revision arthroscopic intervention was planned. At arthroscopy, the labrum was frayed and therefore debrided but was stable and the iliopsoas was released from the peripheral compartment via the transcapsular approach. Whilst dissecting the iliopsoas tendon, a gush of blood was found, and the oozing channel was coagulated with the radiofrequency probe. After 20 min of the pressure dressing, there was no further ooze found. There was also no evidence of any distal vascular deficit, and the Doppler showed a good pulse at the dorsalis pedis and the posterior tibial artery.</p>
      <p>However, two weeks following the procedure, she still had an uncomfortable feeling in her right hip. A magnetic resonance imaging (MRI) scan was arranged which showed a 20 mm reasonably well-defined focus of abnormal signal immediately medial to the psoas tendon just proximal to its insertion, which was consistent with a haematoma. An angiogram showed that there was a 15 mm pseudoaneurysm in the right groin, which arose from a circumflex femoral branch that arose directly from the posterior aspect of the femoral circumflex artery, immediately proximal to the profunda bifurcation (<xref ref-type="fig" rid="F1">Figure 1</xref>). She underwent selective catheterisation and embolisation with micro coils (<xref ref-type="fig" rid="F2">Figure 2</xref>). The aneurysm was accessed from the left common femoral artery by retrograde puncture, and 4Fr sheath was used. Following embolisation, she was asymptomatic and a repeat X-ray, computed tomography (CT) (<xref ref-type="fig" rid="F3">Figure 3</xref>) and MRI showed satisfactory embolisation of the pseudoaneurysm with preservation of perfusion of the surrounding muscles.</p>
      <p>
<fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>An angiogram of pre-embolisation. A 15 mm pseudoaneurysm which arose from a circumflex femoral branch that arose directly from the posterior aspect of the femoral circumflex artery is shown (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-26-fig1"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-26-fig1_small"/></alternatives></fig>
</p>
      <p>
<fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>An angiogram of post-embolisation. A pseudoaneurysm was embolised with micro coils.</p></caption><alternatives><graphic xlink:href="sicotj-3-26-fig2"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-26-fig2_small"/></alternatives></fig>
</p>
      <p>
<fig id="F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>A CT appearance of pre- and post-embolisation. A pseudoaneurysm was embolised with micro coils (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-26-fig3"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-26-fig3_small"/></alternatives></fig>
</p>
    </sec>
    <sec sec-type="discussion" id="S3">
      <title>Discussion</title>
      <p>We present a rare case of a pseudoaneurysm following arthroscopic release of the iliopsoas tendon for painful iliopsoas snapping. Although, arthroscopy has been thought of as a relatively safe procedure, it is not free of complications [<xref rid="R5" ref-type="bibr">5</xref>–<xref rid="R11" ref-type="bibr">11</xref>]. An endoscopic release of the iliopsoas tendon can be done at the level of the hip capsule via the central or peripheral compartments or at its attachment at the lesser trochanter [<xref rid="R3" ref-type="bibr">3</xref>]. The posterior surface of the iliopsoas muscle and tendon is in close contact with the anterior capsule of the hip. This close relationship allows performing an iliopsoas tenotomy from the peripheral compartment of the hip.</p>
      <p>The femoral circumflex artery consists of two branches: medial femoral circumflex artery (MFCA) and lateral femoral circumflex artery (LFCA). The MFCA has its origin from the deep femoral artery of the femoral artery [<xref rid="R12" ref-type="bibr">12</xref>]. The MFCA usually has five branches: ascending, descending, acetabular, superficial, and deep. The deep branch of the MFCA is the one which is the most responsible for the vascularisation of the femoral head and neck. It has its origin medially from the femoral artery between the pectineus and iliopsoas tendons, along the inferior border of externus obturator muscle. The LFCA arises from the lateral side of the deep femoral artery in most of the cases. From this point, it goes to a lateral position just behind the sartorius and rectus femoris and between the divisions of the femoral nerve. At this level, it gives origin to the ascending, transverse and descending branches (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
      <p>
<fig id="F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Arteries around the proximal femur. (A) Iliopsoas muscle, (B) profunda femoris artery, (C) medial femoral circumflex artery, (D) lateral femoral circumflex artery, (E) ascending branch of lateral femoral circumflex artery, (F) transverse branch of lateral femoral circumflex artery, (G) descending branch of lateral femoral circumflex artery.</p></caption><alternatives><graphic xlink:href="sicotj-3-26-fig4"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-26-fig4_small"/></alternatives></fig>
</p>
      <p>In this current case, adhesions around the hip joint due to the previous arthroscopy could have contributed to the tethering of the vessels around the zona orbicularis leading to the formation of the pseudoaneurysm. It should also be noted that a vessel is not the only structure which could be damaged during arthroscopic release of the iliopsoas tendon. Some branches of the femoral nerve lie directly over the anterior surface of the iliopsoas muscle. These branches are at risk when a release of the iliopsoas tendon is performed, although, in a more distal position, they are protected by the presence of the iliopsoas bursa and the vastus intermedius [<xref rid="R3" ref-type="bibr">3</xref>]. Hip arthroscopists should bear the possibility of adhesions and these complications especially when performing revision hip arthroscopy; however, it is not difficult to comprehend that such a complication could happen even during an open procedure.</p>
      <p>As a conclusion, we present a rare case of a pseudoaneurysm, which occurred in the femoral circumflex artery after revision arthroscopic release of the iliopsoas tendon. Hip arthroscopists should bear this complication in mind when releasing the snapping iliopsoas tendon arthroscopically especially in the background of adhesions in revision cases.</p>
    </sec>
    <sec id="S4">
      <title>Conflict of interest</title>
      <p>NN, LL and VK certify that they have no financial conflict of interest in connection with this article.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Flanum</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Keene</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Blankenbaker</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Desmet</surname>
<given-names>AA</given-names></string-name> (<year>2007</year>) <article-title>Arthroscopic treatment of the painful “internal” snapping hip: results of a new endoscopic technique and imaging protocol</article-title>. <source>Am J Sports Med</source>
<volume>35</volume>(<issue>5</issue>), <fpage>770</fpage>–<lpage>779</lpage>.<pub-id pub-id-type="pmid">17351120</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Jacobson</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>WC</given-names></string-name> (<year>1990</year>) <article-title>Surgical correction of the snapping iliopsoas tendon</article-title>. <source>Am J Sports Med</source>
<volume>18</volume>(<issue>5</issue>), <fpage>470</fpage>–<lpage>474</lpage>.<pub-id pub-id-type="pmid">2252086</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Ilizaliturri</surname>
<given-names>VM</given-names>
<suffix>Jr.</suffix></string-name>, <string-name><surname>Villalobos</surname>
<given-names>FE</given-names>
<suffix>Jr.</suffix></string-name>, <string-name><surname>Chaidez</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Valero</surname>
<given-names>FS</given-names></string-name>, <string-name><surname>Aguilera</surname>
<given-names>JM</given-names></string-name> (<year>2005</year>) <article-title>Internal snapping hip syndrome treatment by endoscopic release of the iliopsoas tendon</article-title>. <source>Arthroscopy</source>
<volume>21</volume>(<issue>11</issue>), <fpage>1375</fpage>–<lpage>1380</lpage>.<pub-id pub-id-type="pmid">16325091</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Shu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Safran</surname>
<given-names>MR</given-names></string-name> (<year>2011</year>) <article-title>Case report: bifid iliopsoas tendon causing refractory internal snapping hip</article-title>. <source>Clin Orthop Relat Res</source>
<volume>469</volume>(<issue>1</issue>), <fpage>289</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">20593254</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Leunig</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ganz</surname>
<given-names>R</given-names></string-name> (<year>2014</year>) <article-title>The evolution and concepts of joint-preserving surgery of the hip</article-title>. <source>Bone Joint J.</source>
<volume>96-B</volume>(<issue>1</issue>), <fpage>5</fpage>–<lpage>18</lpage>.</mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Fayad</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Haddad</surname>
<given-names>FS</given-names></string-name> (<year>2013</year>) <article-title>Femoroacetabular impingement: an arthroscopic solution</article-title>. <source>Bone Joint J.</source>
<volume>95-B</volume>(<issue>11 Suppl A</issue>), <fpage>26</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">24187347</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Bedi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Khanduja</surname>
<given-names>V</given-names></string-name> (<year>2013</year>) <article-title>Arthroscopic hip preservation surgery: current concepts and perspective</article-title>. <source>Bone Joint J.</source>
<volume>95-B</volume>(<issue>1</issue>), <fpage>10</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">23307667</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Griffiths</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Khanduja</surname>
<given-names>V</given-names></string-name> (<year>2012</year>) <article-title>Hip arthroscopy: evolution, current practice and future developments</article-title>. <source>Int Orthop.</source>
<volume>36</volume>(<issue>6</issue>), <fpage>1115</fpage>–<lpage>1121</lpage>.<pub-id pub-id-type="pmid">22371112</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Imam</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Khanduja</surname>
<given-names>V</given-names></string-name> (<year>2011</year>) <article-title>Current concepts in the diagnosis and management of femoroacetabular impingement</article-title>. <source>Int Orthop.</source>
<volume>35</volume>(<issue>10</issue>), <fpage>1427</fpage>–<lpage>1435</lpage>.<pub-id pub-id-type="pmid">21755334</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Khanduja</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Villar</surname>
<given-names>RN</given-names></string-name> (<year>2006</year>) <article-title>Arthroscopic surgery of the hip: current concepts and recent advances</article-title>. <source>J Bone Joint Surg Br.</source>
<volume>88</volume>(<issue>12</issue>), <fpage>1557</fpage>–<lpage>1566</lpage>.<pub-id pub-id-type="pmid">17159164</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Khanduja</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Villar</surname>
<given-names>RN</given-names></string-name> (<year>2007</year>) <article-title>The arthroscopic management of femoroacetabular impingement</article-title>. <source>Knee Surg Sports Traumatol Arthrosc.</source>
<volume>15</volume>(<issue>8</issue>), <fpage>1035</fpage>–<lpage>1040</lpage>.<pub-id pub-id-type="pmid">17534600</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Gautier</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ganz</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Krugel</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gill</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ganz</surname>
<given-names>R</given-names></string-name> (<year>2000</year>) <article-title>Anatomy of the medial femoral circumflex artery and its surgical implications</article-title>. <source>J Bone Joint Surg Br</source>
<volume>82</volume>(<issue>5</issue>), <fpage>679</fpage>–<lpage>683</lpage>.<pub-id pub-id-type="pmid">10963165</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <notes>
      <boxed-text position="float" orientation="portrait">
        <p>
<bold>Cite this article as:</bold> Nakano N, Lisenda L &amp; Khanduja V (2017) Pseudoaneurysm of a branch of the femoral circumflex artery as a complication of revision arthroscopic release of the iliopsoas tendon. SICOT J, <bold>3</bold>, 26</p>
      </boxed-text>
    </notes>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360096</identifier><datestamp>2017-04-04</datestamp><setSpec>frontcompneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Comput Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Comput Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Comput. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Computational Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5188</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360096</article-id>
      <article-id pub-id-type="pmcid">PMC5360096</article-id>
      <article-id pub-id-type="pmc-uid">5360096</article-id>
      <article-id pub-id-type="doi">10.3389/fncom.2017.00013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Role of Architectural and Learning Constraints in Neural Network Models: A Case Study on Visual Space Coding</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Testolin</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/75580/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Filippo De Grazia</surname>
            <given-names>Michele</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/82432/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zorzi</surname>
            <given-names>Marco</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn002">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/9606/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Department of General Psychology and Padova Neuroscience Center, University of Padova</institution>
        <country>Padova, Italy</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>San Camillo Hospital IRCCS</institution>
        <country>Venice, Italy</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Marcel van Gerven, Radboud University Nijmegen, Netherlands</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Michael W. Spratling, King's College London, UK; Kandan Ramakrishnan, University of Amsterdam, Netherlands</p>
        </fn>
        <corresp id="fn001">*Correspondence: Alberto Testolin <email xlink:type="simple">alberto.testolin@unipd.it</email></corresp>
        <corresp id="fn002">Marco Zorzi <email xlink:type="simple">marco.zorzi@unipd.it</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>13</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Testolin, De Filippo De Grazia and Zorzi.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Testolin, De Filippo De Grazia and Zorzi</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The recent “deep learning revolution” in artificial neural networks had strong impact and widespread deployment for engineering applications, but the use of deep learning for neurocomputational modeling has been so far limited. In this article we argue that unsupervised deep learning represents an important step forward for improving neurocomputational models of perception and cognition, because it emphasizes the role of generative learning as opposed to discriminative (supervised) learning. As a case study, we present a series of simulations investigating the emergence of neural coding of visual space for sensorimotor transformations. We compare different network architectures commonly used as building blocks for unsupervised deep learning by systematically testing the type of receptive fields and gain modulation developed by the hidden neurons. In particular, we compare Restricted Boltzmann Machines (RBMs), which are stochastic, generative networks with bidirectional connections trained using contrastive divergence, with autoencoders, which are deterministic networks trained using error backpropagation. For both learning architectures we also explore the role of sparse coding, which has been identified as a fundamental principle of neural computation. The unsupervised models are then compared with supervised, feed-forward networks that learn an explicit mapping between different spatial reference frames. Our simulations show that both architectural and learning constraints strongly influenced the emergent coding of visual space in terms of distribution of tuning functions at the level of single neurons. Unsupervised models, and particularly RBMs, were found to more closely adhere to neurophysiological data from single-cell recordings in the primate parietal cortex. These results provide new insights into how basic properties of artificial neural networks might be relevant for modeling neural information processing in biological systems.</p>
      </abstract>
      <kwd-group>
        <kwd>connectionist modeling</kwd>
        <kwd>unsupervised deep learning</kwd>
        <kwd>restricted Boltzmann machines</kwd>
        <kwd>autoencoders</kwd>
        <kwd>sparseness</kwd>
        <kwd>space coding</kwd>
        <kwd>gain modulation</kwd>
        <kwd>sensorimotor transformations</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">European Research Council<named-content content-type="fundref-id">10.13039/501100000781</named-content></funding-source>
        </award-group>
        <award-group>
          <funding-source id="cn002">Università degli Studi di Padova<named-content content-type="fundref-id">10.13039/501100003500</named-content></funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="9"/>
        <table-count count="1"/>
        <equation-count count="8"/>
        <ref-count count="78"/>
        <page-count count="17"/>
        <word-count count="11363"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Artificial neural network models aim at explaining human cognition and behavior in terms of the emergent consequences of a large number of simple, subcognitive processes (McClelland et al., <xref rid="B46" ref-type="bibr">2010</xref>). Within this framework, the pattern seen in overt behavior (macroscopic dynamics of the system) reflects the coordinated operations of simple biophysical mechanisms (microscopic dynamics of the system), such as the propagation of activation and inhibition among elementary processing units. Though this general tenet is shared by all connectionist models, there is large variability in processing architectures and learning algorithms, which turns into varying degrees of psychological and biological realism (e.g., Thorpe and Imbert, <xref rid="B72" ref-type="bibr">1989</xref>; O'Reilly, <xref rid="B51" ref-type="bibr">1998</xref>). When the aim is to investigate high-level cognitive functions, simplification is essential (McClelland, <xref rid="B45" ref-type="bibr">2009</xref>) and the underlying processing mechanisms do not need to faithfully implement the neuronal circuits supposed to carry out such functions in the brain. However, modelers should strive to consider biological plausibility if this can bridge different levels of description (Testolin and Zorzi, <xref rid="B71" ref-type="bibr">2016</xref>).</p>
      <p>Recent theoretical and technical progress in artificial neural networks has significantly expanded the range of tasks that can be solved by machine intelligence. In particular, the advent of powerful parallel computing architectures based on Graphic Processing Units (GPUs), coupled with the availability of “big data,” has allowed to create and train large-scale, hierarchical neural networks known as <italic>deep neural networks</italic> (LeCun et al., <xref rid="B40" ref-type="bibr">2015</xref>, for review). These powerful learning systems achieve impressive performance in many challenging cognitive tasks, such as visual object recognition (Krizhevsky et al., <xref rid="B39" ref-type="bibr">2012</xref>), speech processing (Mohamed et al., <xref rid="B49" ref-type="bibr">2012</xref>) and natural language understanding (Collobert et al., <xref rid="B12" ref-type="bibr">2011</xref>). However, while the impact of deep learning for engineering applications is undisputed, its relevance for modeling neural information processing in biological systems still needs to be fully evaluated (for seminal attempts, see Stoianov and Zorzi, <xref rid="B67" ref-type="bibr">2012</xref>; Khaligh-Razavi and Kriegeskorte, <xref rid="B37" ref-type="bibr">2014</xref>; Güçlü and van Gerven, <xref rid="B26" ref-type="bibr">2015</xref>).</p>
      <p>One critical aspect of most deep learning systems is the reliance on a feed-forward architecture trained with error backpropagation (Rumelhart et al., <xref rid="B60" ref-type="bibr">1986</xref>), which has been repeatedly shown to yield state-of-the-art performance in a variety of problems (LeCun et al., <xref rid="B40" ref-type="bibr">2015</xref>). However, the assumptions that learning is largely discriminative (e.g., classification or function learning) and that an external teaching signal is always available at each learning event (i.e., all training data is “labeled”) are clearly implausible from both a cognitive and a biological perspective (Zorzi et al., <xref rid="B78" ref-type="bibr">2013</xref>; Cox and Dean, <xref rid="B13" ref-type="bibr">2014</xref>). Reinforcement learning is a valuable alternative and it has already shown promising results when combined with deep learning (Mnih et al., <xref rid="B48" ref-type="bibr">2015</xref>; Silver et al., <xref rid="B65" ref-type="bibr">2016</xref>), but there is a broad range of situations where learning seems to be fully unsupervised and its only objective is that of discovering the latent structure of the input data in order to build rich, internal representations of the environment (Hinton and Sejnowski, <xref rid="B34" ref-type="bibr">1999</xref>). We argue that more realistic neurocognitive models should therefore also exploit unsupervised forms of deep learning, where the objective is not to explicitly classify the input patterns but rather to discover internal representations by fitting a hierarchical generative model to the sensory data (Hinton, <xref rid="B29" ref-type="bibr">2007</xref>, <xref rid="B31" ref-type="bibr">2013</xref>; Zorzi et al., <xref rid="B78" ref-type="bibr">2013</xref>). Compared to its supervised counterpart, this modeling approach emphasizes the role of feedback, recurrent connections (Sillito et al., <xref rid="B64" ref-type="bibr">2006</xref>), which carry top-down expectations that are gradually adjusted to better reflect the observed data (Hinton and Ghahramani, <xref rid="B32" ref-type="bibr">1997</xref>; Friston, <xref rid="B22" ref-type="bibr">2010</xref>) and which can be used to implement concurrent probabilistic inference along the whole cortical hierarchy (Lee and Mumford, <xref rid="B42" ref-type="bibr">2003</xref>; Gilbert and Sigman, <xref rid="B24" ref-type="bibr">2007</xref>). Notably, top-down processing is also relevant for understanding attentional mechanisms in terms of modulation of neural information processing (Kastner and Ungerleider, <xref rid="B35" ref-type="bibr">2000</xref>).</p>
      <p>A powerful class of stochastic neural networks that learn a generative model of the data is that of Restricted Boltzmann Machines (RBMs), which can efficiently discover internal representations (i.e., latent features) using Hebbian-like learning mechanisms (Hinton, <xref rid="B28" ref-type="bibr">2002</xref>). RBMs constitute the building block of hierarchical generative models such as Deep Belief Networks (Hinton and Salakhutdinov, <xref rid="B33" ref-type="bibr">2006</xref>) and Deep Boltzmann Machines (Salakhutdinov, <xref rid="B62" ref-type="bibr">2015</xref>). These unsupervised deep learning models have been successfully used to simulate a variety of cognitive functions, such as numerosity perception (Stoianov and Zorzi, <xref rid="B67" ref-type="bibr">2012</xref>), letter perception (Testolin et al., under review), location-invariant visual word recognition (Di Bono and Zorzi, <xref rid="B18" ref-type="bibr">2013</xref>), and visual hallucinations in psychiatric syndromes (Reichert et al., <xref rid="B57" ref-type="bibr">2013</xref>). A similar approach has been used to simulate how early visual cortical representations are adapted to statistical regularities in natural images, in order to predict single voxel responses to natural images and identify images from stimulus-evoked multiple voxel responses (Güçlü and van Gerven, <xref rid="B27" ref-type="bibr">2014</xref>). A temporal extension of RBMs has also been recently used to model sequential orthographic processing and spontaneous pseudoword generation (Testolin et al., <xref rid="B70" ref-type="bibr">2016</xref>).</p>
      <p>Unsupervised deep learning can be implemented using an alternative architecture based on autoencoders (Bengio et al., <xref rid="B4" ref-type="bibr">2007</xref>), which are deterministic, feed-forward networks whose learning goal is to accurately reconstruct the input data into a separate layer of output units. Single-layer autoencoders are trained using error backpropagation, and can be stacked in order to build more complex, multi-layer architectures. However, despite the common view that RBMs and autoencoders could be considered equivalent (Ranzato et al., <xref rid="B56" ref-type="bibr">2007</xref>), we note that their underlying architectural and learning assumptions are significantly different. In this study we empirically compare RBMs and autoencoders in terms of the type of internal encoding emerging in the hidden neurons. Moreover, we investigate how additional learning constraints, such as sparsity and limitation of computational resources (i.e., hidden layer size), could influence the representations developed by the networks. As a case study, we focus on the problem of learning visuospatial coding for sensorimotor transformations, which is a prominent example of how the emergentist approach based on learning in artificial neural networks has offered important insights into the computations performed by biological neurons (Zipser and Andersen, <xref rid="B77" ref-type="bibr">1988</xref>).</p>
      <p>Sensorimotor transformations refer to the process by which sensory stimuli are converted into motor commands. For example, reaching requires to map visual information, represented in retinal coordinates, into a system of coordinates that is centered on the effector. Coordinate transformations can be accomplished by combining sensory information with extra-retinal information, such as postural signals representing the position of eyes, head, or hand, thereby obtaining abstract representations of the space interposed between the sensory input and the motor output (Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>). Single-neuron recordings from monkey posterior parietal cortex have shown that the response amplitude of many neurons indeed depends on the position of the eyes, thereby unveiling a fundamental coding principle used to perform this type of signal integration (Andersen et al., <xref rid="B2" ref-type="bibr">1985</xref>). The term <italic>gain field</italic> was coined to describe this gaze-dependent response of parietal neurons, and since then the notion of <italic>gain modulation</italic> has been generalized to indicate the multiplicative control of one neuron's responses by the responses of another set of neurons (Salinas and Thier, <xref rid="B63" ref-type="bibr">2000</xref>). Another fundamental property unveiled by neuronal recordings is that the encoding of space used for coordinate transformations involves a variety of different, complementary frames of reference. For example, although many parietal neurons are centered on retinal coordinates (Andersen et al., <xref rid="B2" ref-type="bibr">1985</xref>; Duhamel et al., <xref rid="B19" ref-type="bibr">1992</xref>), others represent space using body-centered (Snyder et al., <xref rid="B66" ref-type="bibr">1998</xref>) or effector-centered (Sakata et al., <xref rid="B61" ref-type="bibr">1995</xref>) coordinate systems. Moreover, some neurons exhibit multiple gain modulation (Chang et al., <xref rid="B8" ref-type="bibr">2009</xref>), suggesting more complex forms of spatial coding. For example, postural information related to both eye and head positions can be combined in order to encode “gaze” direction (Brotchie et al., <xref rid="B5" ref-type="bibr">1995</xref>; Stricanne et al., <xref rid="B68" ref-type="bibr">1996</xref>; Duhamel et al., <xref rid="B20" ref-type="bibr">1997</xref>).</p>
      <p>From a computational perspective, the seminal work of Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>) showed that gain modulation could spontaneously emerge in supervised, feed-forward neural networks trained to explicitly map visual targets into head-centered coordinates, giving as input any arbitrary pair of eye and retinal positions. Similar results have been observed using more biologically-plausible learning settings, such as reinforcement learning (Mazzoni et al., <xref rid="B44" ref-type="bibr">1991</xref>) and predictive coding (De Meyer and Spratling, <xref rid="B16" ref-type="bibr">2011</xref>). Note that these learning settings assume that gain modulation emerges because the task implies to establish a mapping between different reference frames. However, it is unclear whether the form of modulation and the distribution of neuronal tuning functions is influenced by the type of learning algorithm and/or by the nature of the learning task (i.e., learning input-output mappings vs. unsupervised learning of internal representations). We also note that a popular alternative framework for modeling sensorimotor transformations is not based on learning, but rather stipulates that parietal neurons represent a set of basis functions that combine visual and postural information (for review, see Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>).</p>
      <p>In summary, space coding represents an interesting case study for testing the adequacy of different neural network architectures and learning algorithms, because it provides a wealth of neurophysiological data (both at the population and single-neuron levels), and it departs from the classic problem of visual object recognition investigated in the large majority of deep learning research.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and methods</title>
      <p>In this section we describe the space coding tasks used in our simulations, including training and test stimuli, the different learning architectures, and the procedures for analyzing the emergent neural representations.</p>
      <sec>
        <title>Space coding tasks</title>
        <p>In this study we consider a visual signal in retinotopic coordinates and two different postural signals, one for eye position and another for a generic “effector,” which might represent, for example, the position of the hand. We do not consider the integration between different modalities (see Xing and Andersen, <xref rid="B76" ref-type="bibr">2000</xref>, for a computational investigation of multimodal integration in several coordinate frames). We implemented three types of space coding tasks to test the different learning architectures.</p>
        <sec>
          <title>Unsupervised learning with no coordinate transformation</title>
          <p>The first learning architecture is depicted in Figure <xref ref-type="fig" rid="F1">1A</xref>. Unsupervised learning is represented by undirected arrows, which connect the sensory input to a separate layer of hidden neurons. The input signal to the network consists of a visual map, which represents target location in retinotopic coordinates, and two postural maps, which represent eye and effector positions. The learning goal is only to build a compact representation of these input signals in the hidden layer, which is later read-out by a simple linear associator in order to establish a mapping with the corresponding motor program. Details of input and output representations are provided in Section Dataset and Stimuli. The unsupervised learning phase does not involve any coordinate transformation because information about the motor program is not available.</p>
          <fig id="F1" position="float">
            <label>Figure 1</label>
            <caption>
              <p><bold>Graphical representations of the learning architectures used to simulate the space coding tasks</bold>. Undirected edges entail bidirectional (recurrent) connections, while directed arrows represent feed-forward connections. <bold>(A)</bold> Unsupervised learning with no coordinate transformation. <bold>(B)</bold> Unsupervised learning with coordinate transformation. <bold>(C)</bold> Supervised learning with coordinate transformation.</p>
            </caption>
            <graphic xlink:href="fncom-11-00013-g0001"/>
          </fig>
        </sec>
        <sec>
          <title>Unsupervised learning with coordinate transformation</title>
          <p>The second learning architecture is depicted in Figure <xref ref-type="fig" rid="F1">1B</xref>. The input signal to the network still consists of a visual map and two postural maps, but in this case we also provide as input the corresponding motor program. In this setting the unsupervised learning phase implicitly involves coordinate transformation (i.e., different coordinate systems become associated). In order to compare the mapping accuracy of different learning architectures using the same method, the motor program is still read-out from hidden neurons via a simple linear associator.</p>
        </sec>
        <sec>
          <title>Supervised learning with coordinate transformation</title>
          <p>The third learning architecture is depicted in Figure <xref ref-type="fig" rid="F1">1C</xref>, and it corresponds to the model used by Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>). The input is the same of the unsupervised architecture shown in Figure <xref ref-type="fig" rid="F1">1A</xref>, but in this case supervised learning (directed arrows) is used to establish an explicit mapping between input signals and motor programs. As for the previous architectures, accuracy of the motor program is also tested by read-out from hidden neurons via linear association.</p>
        </sec>
      </sec>
      <sec>
        <title>Dataset and stimuli</title>
        <p>The representation format adopted for the sensory stimuli was the same used in previous computational investigations (Zipser and Andersen, <xref rid="B77" ref-type="bibr">1988</xref>; Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>; De Filippo De Grazia et al., <xref rid="B15" ref-type="bibr">2012</xref>), which is broadly consistent with neurophysiological data recorded in animals performing tasks involving coordinate transformations (e.g., Andersen et al., <xref rid="B2" ref-type="bibr">1985</xref>).</p>
        <p>The visual input to the models consisted in a real-valued vector representing the position of the stimulus as a Gaussian peak of activity in a specific location. These visible neurons simulate the activity of the cortical areas supplying retinotopic sensory information to the posterior parietal cortex. The retinotopic map consisted in a square matrix of 17 × 17 neurons, which employed a population code with Gaussian tuning functions (standard deviation = 4°). Visual receptive fields were uniformly spread between −9° and +9° with increments of 3°, both in the horizontal and vertical dimensions.</p>
        <p>Four postural maps, each one consisting of 17 neurons, were used to represent the horizontal and vertical positions of the eye and the effector. These visible neurons used a sigmoid activation function (steepness parameter = 0.125) to represent postural information between −18 and +18°, with steps of 3°.</p>
        <p>The motor program consisted in a real-valued vector representing the target position of the stimulus. Similarly to the retinotopic map, it was coded as a square matrix of 25 × 25 neurons, which employed a population code with Gaussian tuning functions to represent target position in coordinates centered on the effector (standard deviation = 6°). Motor programs were uniformly spread between −9° and +9° with increments of 3°, both in the horizontal and vertical dimensions.</p>
        <p>In order to create the stimuli dataset, all possible combinations of visual input and postural signals were first generated, and the corresponding motor program (target location) was computed. We then balanced the patterns to ensure that target locations were equally distributed across the motor map to avoid position biases when decoding the motor program. This resulted in a total of 28,880 patterns, which were randomly split into a training set (20,000 patterns) and an independent test set (8,880 patterns). The latter was used to assess the generalization performance of the models.</p>
      </sec>
      <sec>
        <title>Learning architectures</title>
        <p>Despite they differ in several aspects, Boltzmann machines and autoencoders can both be defined within the mathematical framework of energy-based models (Ranzato et al., <xref rid="B56" ref-type="bibr">2007</xref>), where the learning objective is to carve the surface of an energy function so as to minimize the energies of training points and maximize the energies of unobserved points. A set of latent variables is used to learn an internal code that can efficiently represent the observed data points, and since the number of latent variables is usually smaller than that of the observed variables the encoding process can be interpreted as a form of dimensionality reduction (Hinton and Salakhutdinov, <xref rid="B33" ref-type="bibr">2006</xref>). In this unsupervised setting, the model learns the statistical structure of the data without the need for any explicit, external label.</p>
        <sec>
          <title>Restricted boltzmann machines (RBMs)</title>
          <p>Boltzmann machines are stochastic neural networks that use a set of hidden neurons to model the latent causes of the observed data vectors, which are presented to the network through a set of visible neurons (Ackley et al., <xref rid="B1" ref-type="bibr">1985</xref>). In the “restricted” case, the network connectivity is constrained in order to obtain a bipartite graph (i.e., there are no connections within the same layer; see Figure <xref ref-type="fig" rid="F2">2A</xref> for a graphical representation). The behavior of the network is driven by an energy function <italic>E</italic>, which defines the joint distribution of the hidden and visible neurons by assigning a probability value to each of their possible configurations:
<disp-formula id="E1"><mml:math id="M1"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>,</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mi>Z</mml:mi></mml:mfrac></mml:mrow></mml:math></disp-formula>
where <italic>v</italic> and <italic>h</italic> are the column vectors containing the values of visible and hidden neurons, respectively, and <italic>Z</italic> is the partition function. The energy function is defined as a linear combination of visible and hidden neurons' activation:
<disp-formula id="E2"><mml:math id="M2"><mml:mrow><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>,</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mi>v</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mi>c</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mi>h</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mi>h</mml:mi><mml:mi>T</mml:mi></mml:msup><mml:mi>W</mml:mi><mml:mi>v</mml:mi></mml:mrow></mml:math></disp-formula>
where <italic>W</italic> is the matrix of connections weights, <italic>b</italic> and <italic>c</italic> are two additional parameters known as unit biases and <italic>T</italic> denotes the transpose operator. Since there are no connections within the same layer, hidden neurons are conditionally independent given the state of visible neurons (and vice versa). In particular, the activation probability of the neurons in each layer conditioned on the activation of the neurons in the opposite layer can be efficiently computed in one parallel step:
<disp-formula id="E3"><mml:math id="M3"><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:mi>v</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>σ</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:msup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mtext>​</mml:mtext></mml:msup></mml:mrow><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>σ</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:msup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mtext>​</mml:mtext></mml:msup></mml:mrow><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
where σ is the sigmoid function, <italic>c</italic><sub><italic>j</italic></sub> and <italic>b</italic><sub><italic>i</italic></sub> are the biases of hidden and visible neurons (<italic>h</italic><sub><italic>j</italic></sub> and <italic>v</italic><sub><italic>i</italic></sub> respectively), and <italic>w</italic><sub><italic>ij</italic></sub> is the connection weight between <italic>h</italic><sub><italic>j</italic></sub> and <italic>v</italic><sub><italic>i</italic></sub>. Learning in RBMs can be performed through maximum-likelihood, where each weight should be changed at each step according to a Hebbian-like learning rule:
<disp-formula id="E4"><mml:math id="M4"><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>W</mml:mi><mml:mo>=</mml:mo><mml:mi>η</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>v</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msup><mml:mi>h</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>−</mml:mo><mml:msup><mml:mi>v</mml:mi><mml:mo>−</mml:mo></mml:msup><mml:msup><mml:mi>h</mml:mi><mml:mo>−</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula>
where η represents the learning rate, <italic>v</italic><sup>+</sup><italic>h</italic><sup>+</sup> are the visible-hidden correlations computed on the training data (positive phase), and <italic>v</italic><sup>−</sup><italic>h</italic><sup>−</sup> are the visible-hidden correlations computed according to the model's expectations (negative phase). Model's expectations have been traditionally computed by running Gibbs sampling algorithms until the network reached equilibrium (Ackley et al., <xref rid="B1" ref-type="bibr">1985</xref>). However, more efficient algorithms such as contrastive divergence (Hinton, <xref rid="B28" ref-type="bibr">2002</xref>) speed-up learning by approximating the log-probability gradient. The reader is referred to Hinton (<xref rid="B30" ref-type="bibr">2010</xref>) and Zorzi et al. (<xref rid="B78" ref-type="bibr">2013</xref>) for more details about RBMs and for the discussion of hyper-parameters of the learning algorithm.</p>
          <fig id="F2" position="float">
            <label>Figure 2</label>
            <caption>
              <p><bold>Graphical representations of the different learning architectures used in the simulations. (A)</bold> Restricted Boltzmann Machine (RBM): the learning objective is to accurately reconstruct the input patterns presented through the visible layer (<italic>v</italic>) by relying on a set of hidden units (<italic>h</italic>), which represent the latent structure of the data. The reconstruction is performed by using a weight matrix (<italic>W</italic>) that contains symmetric (i.e., undirected) connections. <bold>(B)</bold> Autoencoder: as for RBMs, the learning objective is to accurately reconstruct the input patterns presented through the visible layer (<italic>v</italic>) by relying on a set of hidden units (<italic>h</italic>). However, the reconstruction is performed on a separate layer of units (<italic>v_rec</italic>) by using two weight matrices (<italic>W</italic><sup>1</sup> and <italic>W</italic><sup>2</sup>) that contain directed connections. <bold>(C)</bold> Feed-forward, supervised network: in contrast to RBMs and autoencoders, the learning objective is to minimize the mapping error between the input patterns presented through the visible layer (<italic>v</italic>) and a distinct set of output patterns presented through a dedicated layer (<italic>out</italic>).</p>
            </caption>
            <graphic xlink:href="fncom-11-00013-g0002"/>
          </fig>
          <p>In our simulations, RBMs were trained using 1-step contrastive divergence with a learning rate of 0.03, a weight decay of 0.0002 and a momentum coefficient of 0.9, which was initialized to 0.5 for the first few epochs. Learning was performed using a mini-batch scheme, with a mini-batch size of 4 patterns, for a total of 100 learning epochs (reconstruction error always converged). Sparse representations were encouraged by forcing the network's internal representations to rely on a limited number of active hidden units, that is, by driving the probability <italic>q</italic> of a unit to be active to a certain desired (low) probability <italic>p</italic> (Lee et al., <xref rid="B41" ref-type="bibr">2008</xref>). For logistic units, this can be practically implemented by first calculating the quantity <italic>q-p</italic>, which is then multiplied by a scaling factor and added to the biases of each hidden units at every weight update. When the sparsity constraint was applied, we always verified that the average activation of hidden units was indeed maintained below the desired level. All the simulations were performed using an efficient implementation of RBMs on graphic processors (Testolin et al., <xref rid="B69" ref-type="bibr">2013</xref>). The complete source code is available for download<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>.</p>
        </sec>
        <sec>
          <title>Autoencoders</title>
          <p>Similarly to RBMs, autoencoders rely on a single layer of nonlinear hidden units to compactly represent the statistical regularities of the training data. However, autoencoders are feed-forward, deterministic networks trained with error backpropagation (Bengio et al., <xref rid="B4" ref-type="bibr">2007</xref>). The training data is presented to a layer of input units, and the learning goal is to accurately reconstruct such input vector into a separate, output layer. An autoencoder is therefore composed of a set of encoding weights <italic>W</italic><sup>1</sup> that are used to compute the activation of hidden <italic>h</italic> units given the activation of input units <italic>v</italic>, and a set of decoding weights <italic>W</italic><sup>2</sup> that are used to compute the network reconstructions <italic>v_rec</italic> from the activations of hidden units:</p>
          <disp-formula id="E5">
            <mml:math id="M5">
              <mml:mtable columnalign="left">
                <mml:mtr>
                  <mml:mtd>
                    <mml:mtext>           </mml:mtext>
                    <mml:mi>h</mml:mi>
                    <mml:mo>=</mml:mo>
                    <mml:mi>σ</mml:mi>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msup>
                      <mml:mi>W</mml:mi>
                      <mml:mn>1</mml:mn>
                    </mml:msup>
                    <mml:mi>v</mml:mi>
                    <mml:mo>+</mml:mo>
                    <mml:mi>c</mml:mi>
                    <mml:mo stretchy="false">)</mml:mo>
                  </mml:mtd>
                </mml:mtr>
                <mml:mtr>
                  <mml:mtd>
                    <mml:mi>v</mml:mi>
                    <mml:mo>_</mml:mo>
                    <mml:mi>r</mml:mi>
                    <mml:mi>e</mml:mi>
                    <mml:mi>c</mml:mi>
                    <mml:mo>=</mml:mo>
                    <mml:mi>σ</mml:mi>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msup>
                      <mml:mi>W</mml:mi>
                      <mml:mn>2</mml:mn>
                    </mml:msup>
                    <mml:mi>h</mml:mi>
                    <mml:mo>+</mml:mo>
                    <mml:mi>b</mml:mi>
                    <mml:mo stretchy="false">)</mml:mo>
                  </mml:mtd>
                </mml:mtr>
              </mml:mtable>
            </mml:math>
          </disp-formula>
          <p>where <italic>b</italic> and <italic>c</italic> are the vectors of output and hidden unit biases, and σ is the sigmoid function (see Figure <xref ref-type="fig" rid="F2">2B</xref> for a graphical representation). The error function <italic>E</italic> to be minimized corresponds to the average reconstruction error, which is quantified by the sum across all output units of the squared difference between the original and the reconstructed values:</p>
          <disp-formula id="E6">
            <mml:math id="M6">
              <mml:mrow>
                <mml:mi>E</mml:mi>
                <mml:mo>=</mml:mo>
                <mml:mfrac>
                  <mml:mn>1</mml:mn>
                  <mml:mi>N</mml:mi>
                </mml:mfrac>
                <mml:munderover>
                  <mml:mrow>
                    <mml:msup>
                      <mml:mstyle mathsize="140%" displaystyle="true">
                        <mml:mo>∑</mml:mo>
                      </mml:mstyle>
                      <mml:mtext>​</mml:mtext>
                    </mml:msup>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mi>n</mml:mi>
                    <mml:mtext> </mml:mtext>
                    <mml:mo>=</mml:mo>
                    <mml:mn>1</mml:mn>
                  </mml:mrow>
                  <mml:mi>N</mml:mi>
                </mml:munderover>
                <mml:munderover>
                  <mml:mrow>
                    <mml:msup>
                      <mml:mstyle mathsize="140%" displaystyle="true">
                        <mml:mo>∑</mml:mo>
                      </mml:mstyle>
                      <mml:mtext>​</mml:mtext>
                    </mml:msup>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mi>k</mml:mi>
                    <mml:mo> </mml:mo>
                    <mml:mo>=</mml:mo>
                    <mml:mo> </mml:mo>
                    <mml:mn>1</mml:mn>
                  </mml:mrow>
                  <mml:mi>K</mml:mi>
                </mml:munderover>
                <mml:msup>
                  <mml:mrow>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mi>v</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                    <mml:mo>−</mml:mo>
                    <mml:mi>v</mml:mi>
                    <mml:mo>_</mml:mo>
                    <mml:mi>r</mml:mi>
                    <mml:mi>e</mml:mi>
                    <mml:msub>
                      <mml:mi>c</mml:mi>
                      <mml:mi>k</mml:mi>
                    </mml:msub>
                    <mml:mo stretchy="false">)</mml:mo>
                  </mml:mrow>
                  <mml:mn>2</mml:mn>
                </mml:msup>
                <mml:mo>+</mml:mo>
                <mml:msup>
                  <mml:mi>β</mml:mi>
                  <mml:mo>*</mml:mo>
                </mml:msup>
                <mml:msub>
                  <mml:mi>Ω</mml:mi>
                  <mml:mrow>
                    <mml:mi>s</mml:mi>
                    <mml:mi>p</mml:mi>
                    <mml:mi>a</mml:mi>
                    <mml:mi>r</mml:mi>
                    <mml:mi>s</mml:mi>
                    <mml:mi>i</mml:mi>
                    <mml:mi>t</mml:mi>
                    <mml:mi>y</mml:mi>
                  </mml:mrow>
                </mml:msub>
              </mml:mrow>
            </mml:math>
          </disp-formula>
          <p>where <italic>K</italic> is the number of output units and <italic>N</italic> is the number of training patterns. Similarly to RBMs, sparse representations can be induced by adding to the cost function a regularization term Ω<sub><italic>sparsity</italic></sub> that takes a large value when the average activation value <italic>q</italic> of each hidden neuron diverges from a certain desired (low) value <italic>p</italic>. In particular, the sparsity constraint was implemented as the Kullback-Leibler divergence from <italic>q</italic> to <italic>p</italic>:</p>
          <disp-formula id="E7">
            <mml:math id="M7">
              <mml:mtable columnalign="left">
                <mml:mtr columnalign="left">
                  <mml:mtd columnalign="left">
                    <mml:mrow>
                      <mml:msub>
                        <mml:mi>Ω</mml:mi>
                        <mml:mrow>
                          <mml:mi>s</mml:mi>
                          <mml:mi>p</mml:mi>
                          <mml:mi>a</mml:mi>
                          <mml:mi>r</mml:mi>
                          <mml:mi>s</mml:mi>
                          <mml:mi>i</mml:mi>
                          <mml:mi>t</mml:mi>
                          <mml:mi>y</mml:mi>
                        </mml:mrow>
                      </mml:msub>
                      <mml:mo>=</mml:mo>
                      <mml:munderover>
                        <mml:mo>∑</mml:mo>
                        <mml:mrow>
                          <mml:mi>i</mml:mi>
                          <mml:mo>=</mml:mo>
                          <mml:mn>1</mml:mn>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mi>H</mml:mi>
                        </mml:mrow>
                      </mml:munderover>
                      <mml:mi>K</mml:mi>
                      <mml:mi>L</mml:mi>
                      <mml:mrow>
                        <mml:mo>(</mml:mo>
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mo> </mml:mo>
                          <mml:mo>|</mml:mo>
                          <mml:mo>|</mml:mo>
                          <mml:mo> </mml:mo>
                          <mml:msub>
                            <mml:mi>q</mml:mi>
                            <mml:mi>i</mml:mi>
                          </mml:msub>
                        </mml:mrow>
                        <mml:mo>)</mml:mo>
                      </mml:mrow>
                    </mml:mrow>
                  </mml:mtd>
                </mml:mtr>
              </mml:mtable>
            </mml:math>
          </disp-formula>
          <p>where <italic>H</italic> is the number of hidden units. As for RBMs, when sparsity was applied we always verified that the average activation of hidden units was indeed maintained below the desired level.</p>
          <p>In our simulations, we used an efficient implementation of autoencoders provided by the MATLAB Neural Network toolbox (Demuth and Beale, <xref rid="B17" ref-type="bibr">1993</xref>). Learning was performed using standard scaled conjugate gradient descent (Møller, <xref rid="B47" ref-type="bibr">1993</xref>) with adaptive learning rate, using a weight decay factor of 0.0002 and a batch processing scheme, for a total of 150 learning epochs (reconstruction error always converged).</p>
        </sec>
        <sec>
          <title>Feed-forward, supervised networks</title>
          <p>In order to better assess the impact of the learning regimen, we compared the unsupervised learning architectures described above with a standard, supervised architecture implemented as a feed-forward network with one hidden layer (Zipser and Andersen, <xref rid="B77" ref-type="bibr">1988</xref>). Similarly to autoencoders, learning can be performed using error backpropagation (see Figure <xref ref-type="fig" rid="F2">2C</xref> for a graphical representation). We used an efficient implementation of feed-forward networks provided by the MATLAB Neural Network toolbox<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref>. Learning rate was set to 0.05 and training was performed for a total of 2500 learning epochs (output error always converged).</p>
        </sec>
      </sec>
      <sec>
        <title>Testing procedure</title>
        <p>For each experimental setting, we run 10 different networks in order to collect simulation statistics. In the results, we therefore always report mean values along with standard deviations.</p>
        <sec>
          <title>Decoding internal representations by linear read-out</title>
          <p>Following unsupervised learning, a linear read-out was performed from the internal (hidden layer) distributed representations of the networks in order to assess how well they could support a supervised mapping to the target motor program through a simple linear projection (Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>). The read-out was implemented using a linear neural network trained with the delta rule (Widrow and Hoff, <xref rid="B75" ref-type="bibr">1960</xref>). Learning was performed for 250 epochs using mini-batches of 20 patterns. Learning rate was set to 0.07, and weight decay of 0.000001 was used as a regularizer. Classifier performance was always measured on the separate test set. Test errors always matched those obtained on the training set, indicating that the read-out was robust to overfitting.</p>
          <p>The output of the classifier was first compared with the target motor program by computing the Root Mean Squared Error (RMSE) between the two matrices. However, a more useful performance measure was obtained by first decoding the Center Of Mass (COM) of the output distribution, which was then compared with the actual coordinates of the motor program. This measure allows to quantify the read-out error in degrees: following Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>), the mapping was considered to be successful if the error was below the distance between the centers of the Gaussian tuning functions in the retinotopic map (i.e., 3°). If the latter mapping accuracy was not achieved, we did not consider the network for subsequent analyses. We found the RMSE and COM measures to be always consistent with each other, so we only report COM results.</p>
        </sec>
        <sec>
          <title>Measuring single-neuron and population sparseness</title>
          <p>An index of <italic>single-neuron sparseness</italic> was computed using a well-established procedure employed in neurophysiological investigations (Rolls and Tovee, <xref rid="B59" ref-type="bibr">1995</xref>; Vinje and Gallant, <xref rid="B74" ref-type="bibr">2000</xref>), which describes the activity fraction <italic>a</italic> of each neuron across stimuli as:</p>
          <disp-formula id="E8">
            <mml:math id="M8">
              <mml:mtable columnalign="left">
                <mml:mtr columnalign="left">
                  <mml:mtd columnalign="left">
                    <mml:mrow>
                      <mml:mi>a</mml:mi>
                      <mml:mo>=</mml:mo>
                      <mml:mfrac>
                        <mml:mrow>
                          <mml:msup>
                            <mml:mrow>
                              <mml:mrow>
                                <mml:mo>(</mml:mo>
                                <mml:mrow>
                                  <mml:msup>
                                    <mml:mstyle mathsize="140%" displaystyle="true">
                                      <mml:mo>∑</mml:mo>
                                    </mml:mstyle>
                                    <mml:mtext>​</mml:mtext>
                                  </mml:msup>
                                  <mml:msub>
                                    <mml:mi>r</mml:mi>
                                    <mml:mi>i</mml:mi>
                                  </mml:msub>
                                  <mml:mo>/</mml:mo>
                                  <mml:mi>n</mml:mi>
                                </mml:mrow>
                                <mml:mo>)</mml:mo>
                              </mml:mrow>
                            </mml:mrow>
                            <mml:mn>2</mml:mn>
                          </mml:msup>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:msup>
                            <mml:mstyle mathsize="140%" displaystyle="true">
                              <mml:mo>∑</mml:mo>
                            </mml:mstyle>
                            <mml:mtext>​</mml:mtext>
                          </mml:msup>
                          <mml:mo stretchy="false">(</mml:mo>
                          <mml:msup>
                            <mml:mrow>
                              <mml:msub>
                                <mml:mi>r</mml:mi>
                                <mml:mi>i</mml:mi>
                              </mml:msub>
                            </mml:mrow>
                            <mml:mn>2</mml:mn>
                          </mml:msup>
                          <mml:mo>/</mml:mo>
                          <mml:mi>n</mml:mi>
                          <mml:mo stretchy="false">)</mml:mo>
                        </mml:mrow>
                      </mml:mfrac>
                    </mml:mrow>
                  </mml:mtd>
                </mml:mtr>
              </mml:mtable>
            </mml:math>
          </disp-formula>
          <p>where <italic>r</italic><sub><italic>i</italic></sub> is the firing rate of the neuron to the <italic>i</italic>-th stimulus in the set of <italic>n</italic> stimuli. This is a useful measure of the extent of the tail of the distribution, in this case of the firing rates of the neuron to each stimulus. Mean single-neuron sparseness for each network was then calculated by averaging the activity fraction <italic>a</italic> across all hidden neurons. A low value (minimum value is 0, maximum value is 1) indicates that the distribution has a long tail, which means that, on average, each neuron has high activation levels only for a small subset of input patterns. This method for quantifying sparseness has a number of advantages (Rolls and Tovee, <xref rid="B59" ref-type="bibr">1995</xref>): (a) it results from formal analyses of the capacity of neural networks using an approach derived from theoretical physics (Treves and Rolls, <xref rid="B73" ref-type="bibr">1991</xref>); (b) it can be applied both to binary neurons and to neurons with continuous (graded) firing rates; (c) it makes no assumption about the form of the firing rate distribution and (d) it makes no assumption about the mean and the variance of the firing rate.</p>
          <p>Following Froudarakis et al. (<xref rid="B23" ref-type="bibr">2014</xref>) we also computed an index of <italic>population sparseness</italic>, on which the activity fraction is computed over the entire hidden layer, that is, by considering <italic>r</italic><sub><italic>i</italic></sub> as the firing rate of the <italic>i</italic>-th neuron and <italic>n</italic> as the total number of neurons. Mean population sparseness for each network was then calculated by averaging the activity fraction <italic>a</italic> across all stimuli. A low value of population sparseness indicates that, on average, each stimulus elicits high activations only for a small subset of hidden neurons.</p>
        </sec>
        <sec>
          <title>Receptive fields emerging in the hidden neurons</title>
          <p>In order to qualitatively assess the type of visual features extracted by individual hidden neurons, we first analyzed the weight matrices by separately plotting the strengths of the connections between each hidden neuron and all the visible neurons corresponding to the retinal input. Weights were plotted on a gray scale, with dark colors indicating strong inhibitory connections and light colors representing positive, excitatory connections. This allowed to assess whether hidden neurons learned location-specific receptive fields, for example by developing stronger projections to specific regions of the visual field.</p>
        </sec>
        <sec>
          <title>Gain modulation indexes</title>
          <p>We then analyzed the response of hidden neurons using a standard approach adopted in neurophysiological studies to assess gain modulation in parietal neurons (Andersen et al., <xref rid="B2" ref-type="bibr">1985</xref>). First, we probed the hidden neurons in order to only select the “visual” ones, that is, those responding to the portion of input vectors representing the retinotopic map (De Filippo De Grazia et al., <xref rid="B15" ref-type="bibr">2012</xref>). To this aim, we first recorded all hidden neurons' activations when the network received as input only all possible combinations of eye and effector positions (i.e., the retinotopic map and, if present, the motor program, were set to zero), and for each neuron we selected the positions corresponding to maximum activation. We then probed again each neuron, this time providing as input all possible retinotopic signals along with the preferred combination of postural signals. The neuron was considered as visual if its maximum activity differed by more than 10% from that recorded in the absence of visual input. Non-visual neurons were discarded from subsequent analyses<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref>. We then computed a gain modulation index (GMI) for each neuron by recording its response to each target location as a function of eye and effector position (Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>). We first identified the combination of postural and retinal input producing the maximum neuron activation value. Starting from this input combination, we systematically varied each postural variable (one at a time, keeping all the others fixed) and computed gain modulation as the normalized ratio between the maximum and minimum activation values. Therefore, each neuron was characterized by four different GMIs, representing the gain for each postural variable with respect to horizontal and vertical axes. We finally sorted all hidden neurons into four different categories based on the combination of GMI indexes (using a threshold of 0.5 to establish modulation): (i) no modulation (i.e., purely visual neurons), (ii) modulation by eye position only, (iii) modulation by effector position only, and (iv) modulation by both eye and effector position.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <p>Learning always converged for all models. For unsupervised models, convergence was monitored by measuring the mean reconstruction error on the whole training set. Autoencoders required more learning epochs to converge, but also achieved a lower reconstruction error compared to RBMs. This is probably due to the fact that autoencoders are natively real-valued. Existing real-valued extensions of RBMs (Cho et al., <xref rid="B9" ref-type="bibr">2011</xref>) assume that the input values are normally distributed, which was not our case, so we preferred to use standard RBMs. Learning in the feed-forward, supervised models required almost 20 times more epochs to converge (the number of epochs required by each learning architecture is reported in Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p><bold>Read-out errors for each learning architecture and space coding task, as a function of hidden layer size</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">
                <bold>Space coding task</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Layer size</bold>
              </th>
              <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                <bold>RBMs</bold>
              </th>
              <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                <bold>Autoencoders</bold>
              </th>
              <th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1">
                <bold>Supervised Feed-forward</bold>
              </th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Read-out</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Epochs</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Read-out</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Epochs</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Read-out</bold>
              </th>
              <th valign="top" align="center" rowspan="1" colspan="1">
                <bold>Epochs</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">No transformation</td>
              <td valign="top" align="center" rowspan="1" colspan="1">200</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.59 (0.08)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.05 (0.05)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">300</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.39 (0.07)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.91 (0.04)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">400</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.30 (0.08)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.86 (0.04)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">500</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.25 (0.04)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.89 (0.02)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">600</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.23 (0.05)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.02)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr style="border-bottom: thin solid #000000;">
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">700</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.33 (0.04)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.03)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Coordinate transformation</td>
              <td valign="top" align="center" rowspan="1" colspan="1">500</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.55 (0.15)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.45 (0.05)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.46 (0.06)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">600</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.47 (0.12)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.46 (0.06)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.45 (0.02)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">700</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.52 (0.11)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.45 (0.05)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.46 (0.05)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">800</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.57 (0.11)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.47 (0.08)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.47 (0.08)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">900</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.56 (0.16)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">100</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.45 (0.07)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">150</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1.47 (0.04)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>Read-out errors are in degrees, and standard deviations are reported in parentheses. The “Epochs” column shows the number of epochs required by each learning architecture to converge</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>A first, qualitative analysis shows that RBMs and autoencoders developed different types of receptive fields. As shown in Figure <xref ref-type="fig" rid="F3">3</xref>, autoencoders learned homogeneous, location-specific receptive fields that uniformly covered the central regions of the visual input. On the other hand, while some neurons in the RBMs learned location-specific receptive fields resembling those of autoencoders, other neurons developed more complex receptive fields covering larger regions of the visual fields, sometimes also simultaneously covering symmetrical portions of the input image.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Visual receptive fields</bold>. Samples of receptive fields emerging from RBMs (top panel) and autoencoders (bottom panel) on the unsupervised learning task that did not require coordinate transformations. Similar receptive fields emerged from the unsupervised learning task involving coordinate transformations.</p>
        </caption>
        <graphic xlink:href="fncom-11-00013-g0003"/>
      </fig>
      <p>The quantitative analyses (see Section Testing Procedure) allowed to group hidden neurons into different categories according to their response profiles. In line with empirical findings (Duhamel et al., <xref rid="B20" ref-type="bibr">1997</xref>), there were always some neurons that did not exhibit any form of gain modulation (i.e., “purely visual” neurons), that is, they responded to visual stimuli at a given spatial location regardless of eye- or effector- positions. However, the majority of neurons developed gain fields, which in some cases were modulated exclusively by either eye or effector position (see, for example, top panels of Figure <xref ref-type="fig" rid="F4">4</xref>), while in other cases were modulated by both eye and effector position, resulting in multiple gain fields (bottom panels of Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Gain field coding</bold>. Examples of single (top panels) and multiple (bottom panels) gain fields emerging in the hidden neurons of RBMs <bold>(left)</bold> and autoencoders <bold>(right)</bold>. Colors represent the amount of activation, with yellow indicating highest activation and dark blue indicating lowest activation. Single gain fields are characterized by a modulation of the neuron's activation that depends only on one postural signal (in the figure, effector position for the RBM and eye position for the autoencoder). In multiple gain fields, the activation is modulated by both signals.</p>
        </caption>
        <graphic xlink:href="fncom-11-00013-g0004"/>
      </fig>
      <sec>
        <title>Unsupervised learning without coordinate transformation</title>
        <p>In a first set of simulations, the number of hidden units was fixed to 400<xref ref-type="fn" rid="fn0004"><sup>4</sup></xref>, while the sparsity constraint was varied between 0.004 (very strong sparsity constraint, requiring low average activation) and 0.3 (mild sparsity constraint). As shown in Figure <xref ref-type="fig" rid="F5">5</xref>, the effect of sparsity constraints on the two unsupervised architectures was markedly different. Levels of sparsity constraints in the first two rows are represented using a color scale, where lighter tones indicate stronger sparsity and dark tones indicate mild sparsity. Gain modulation in RBMs (Figure <xref ref-type="fig" rid="F5">5A</xref>) was not affected by imposing sparsity constraints. In all cases, we found a modest percentage (around 10%) of purely visual neurons, which were not modulated by any postural information. A more consistent percentage of neurons (20–25%) were modulated either by eye or by effector positions, while the remaining neurons (40–50%) exhibited multiple gain fields. Read-out accuracy (Figure <xref ref-type="fig" rid="F5">5C</xref>) was always good, except for the networks trained with very strong sparsity constraints (0.01 and 0.004), where learning failed and read-out accuracy did not achieve a mean error lower than 3°. The lowest read-out error (around 1.3°) was obtained with a sparsity constraint of 0.05. In contrast, autoencoders were extremely sensitive to sparsity constraints: Strong sparsity constraints resulted in a compressed code where the majority of hidden neurons (60%) exhibited multiple gain fields (Figure <xref ref-type="fig" rid="F5">5B</xref>). When the sparsity pressure was reduced gain fields gradually disappeared, and the majority of neurons did not exhibit any modulation at all. Read-out error was generally lower compared to RBMs, and learning failed only for the networks trained with extreme (0.004) or without any sparsity constraints (Figure <xref ref-type="fig" rid="F5">5D</xref>). Notably, also for autoencoders the lowest read-out error (around 0.9°) was obtained with a sparsity constraint of 0.05, which also resulted in a distribution of gain fields more similar to that of RBMs.</p>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <p><bold>Effect of sparsity constraints</bold>. Distribution of gain field types emerging in the hidden neurons of RBMs <bold>(A)</bold> and autoencoders <bold>(B)</bold> with varying levels of sparsity constraint. Sparsity constraints are represented in different columns using a color scale, where lighter tones indicate stronger sparsity constraints and dark red indicates mild sparsity constraints. Read-out errors obtained at each level of sparsity constraint for RBMs <bold>(C)</bold> and autoencoders <bold>(D)</bold>. Single-neuron and population sparseness as a function of sparsity constraints for RBMs <bold>(E)</bold>, and autoencoders <bold>(F)</bold>. Note that small values indicate stronger sparseness.</p>
          </caption>
          <graphic xlink:href="fncom-11-00013-g0005"/>
        </fig>
        <p>Interestingly, the objective indexes of sparseness revealed that RBMs are naturally much sparser than autoencoders (see bottom panels of Figure <xref ref-type="fig" rid="F5">5</xref>). Indeed, the level of sparsity constraint turned out to have a very weak effect on population sparseness in RBMs (Figure <xref ref-type="fig" rid="F5">5E</xref>), as also confirmed by linear regression [<italic>r</italic><sup>2</sup> = 0.32, b = 0.05, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 50]. Single-neuron sparseness was only affected when the sparsity constraint operated below a critical level of 0.1. In order to measure what would be the “spontaneous” index of sparseness in RBMs, we trained an additional set of networks without imposing any sparsity constraint, which resulted in a single-neuron sparseness of 0.56 and a population sparseness of 0.28, showing that RBMs naturally exhibit a remarkable sparseness. In contrast, sparsity constraints in autoencoders had a marked effect on both single-neuron sparseness and population sparseness (Figure <xref ref-type="fig" rid="F5">5F</xref>), suggesting that this architecture naturally develops extremely distributed internal representations. In particular, the effect of level of sparsity constraint on population sparseness for autoencoders [linear regression: <italic>r</italic><sup>2</sup> = 0.88, b = 0.43, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 50] was almost one order of magnitude higher compared to RBMs. In order to measure the spontaneous index of sparseness in autoencoders, we trained an additional set of networks with a very low sparsity constraint (0.8), which is the borderline condition that still guaranteed successful learning. The latter simulations yielded sparseness values indicating non-sparse, highly distributed representations (single-neuron sparseness = 0.97; population sparseness = 0.98).</p>
        <p>In a second set of simulations, the sparsity constraint for both architectures was fixed to the value leading to the best performance (0.05), while the size of the hidden layer was varied systematically between 200 and 700 neurons in steps of 100. This range allowed to explore the effect of relatively large increases and decreases of hidden layer sizes with respect to the previous simulations, without compromising the learning accuracy. For both architectures, the read-out accuracy was not affected by hidden layer size, and the mapping error was always below 2° (read-out errors for all different hidden layer sizes are reported in Table <xref ref-type="table" rid="T1">1</xref>). However, as shown in Figure <xref ref-type="fig" rid="F6">6</xref>, also in this case the manipulation had different effects for the two architectures (lighter colors indicate smaller sizes). The type of encoding developed by RBMs (Figure <xref ref-type="fig" rid="F6">6A</xref>) was affected by hidden layer size: When the number of hidden neurons decreased the network developed more compressed codes, by increasing the percentage of multiple gain fields and reducing the percentage of neurons modulated by only eye or effector positions. Interestingly, it turned out that the manipulation of hidden layer size had a clear impact also on the underlying sparseness of the representation (Figure <xref ref-type="fig" rid="F6">6C</xref>). Indeed, both single-neuron and population sparseness decreased as a function of number of hidden neurons [linear regressions: single-neuron sparseness, <italic>r</italic><sup>2</sup> = 0.92, b = 0.22, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60; population sparseness, <italic>r</italic><sup>2</sup> = 0.96, b = 0.21, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60]. This result suggests that the distribution of gain fields in RBMs might in fact be modulated by the underlying sparseness of the representation. This was confirmed by the high correlation between the percentage of multiple gain-fields and the objective sparseness indexes [Pearson correlations: single-neuron sparseness: <italic>r</italic> = −0.85, <italic>p</italic> &lt; 0.001; population sparseness, <italic>r</italic> = −0.92, <italic>p</italic> &lt; 0.001].</p>
        <fig id="F6" position="float">
          <label>Figure 6</label>
          <caption>
            <p><bold>Effect of hidden layer size, with strong sparsity constraint</bold>. Distribution of gain field types emerging at the hidden layer of RBMs <bold>(A)</bold> and autoencoders <bold>(B)</bold> with varying number of hidden neurons and sparsity constraint fixed to 0.05. Lighter tones indicate smaller layers and dark blue indicates larger layers. Single-neuron and population sparseness as a function of hidden layer size for RBMs <bold>(C)</bold> and autoencoders <bold>(D)</bold>. Note that small values indicate stronger sparseness.</p>
          </caption>
          <graphic xlink:href="fncom-11-00013-g0006"/>
        </fig>
        <p>On the contrary, neuronal tuning functions in autoencoders were not affected by hidden layer size, as this architecture always developed uniformly distributed types of gain fields (Figure <xref ref-type="fig" rid="F6">6B</xref>). Interestingly, as for RBMs the reduction of hidden layer size caused a decrease in both single-neuron sparseness and population sparseness [linear regressions: single-neuron sparseness, <italic>r</italic><sup>2</sup> = 0.98, b = 0.25, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60; population sparseness, <italic>r</italic><sup>2</sup> = 0.98, b = 0.23, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60]. However, the sparseness indexes did not correlate with the percentage of multiple gain-fields [all <italic>p</italic> &gt; 0.05]. This suggests that similar changes in the underlying sparseness do not produce the same effect on the gain field distribution in RBMs and autoencoders.</p>
        <p>In order to better clarify if the size of the hidden layer in RBMs modulates the distribution of gain fields only when sparseness is externally forced (i.e., when using a sparsity constraint of 0.05), in a subsequent set of simulations the sparsity constraint was set to a weak level (0.2) and the size of the hidden layer was manipulated as in the previous condition. In this case the distribution of gain fields did not systematically change (Figure <xref ref-type="fig" rid="F7">7A</xref>) but, notably, also the population sparseness was not affected (Figure <xref ref-type="fig" rid="F7">7C</xref>) [linear regression: <italic>r</italic><sup>2</sup> = 0.24, b = 0.03, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60]. Correlation analyses still revealed a correlation between population sparseness and the percentage of multimodal gain fields [<italic>r</italic> = −0.54, <italic>p</italic> &lt; 0.001], while the correlation with single-neuron sparseness was not significant [<italic>p</italic> &gt; 0.05]. These results show that, for RBMs, population sparseness is a robust predictor of the distribution of gain fields: if RBMs must rely only of few active neurons to represent each sensory stimulus, they will develop more compressed spatial codes, such as those based on multiple gain fields. The corresponding simulation with autoencoders was relatively uninformative, because the weak level of sparsity constraint resulted in the absence of multimodal gain fields (Figure <xref ref-type="fig" rid="F7">7B</xref>).</p>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>Effect of hidden layer size, with moderate sparsity constraint</bold>. Distribution of gain field types emerging at the hidden layer of RBMs <bold>(A)</bold> and autoencoders <bold>(B)</bold> with varying number of hidden neurons and sparsity constraint fixed to 0.2. Lighter tones indicate smaller layers and dark blue indicates larger layers. Single-neuron and population sparseness as a function of hidden layer size for RBMs <bold>(C)</bold> and autoencoders <bold>(D)</bold>. Note that small values indicate stronger sparseness.</p>
          </caption>
          <graphic xlink:href="fncom-11-00013-g0007"/>
        </fig>
      </sec>
      <sec>
        <title>Unsupervised learning with coordinate transformation</title>
        <p>As discussed before, in this learning setting the motor program was included as input during unsupervised learning. This implies that two different coordinate systems (i.e., retinotopic and motor) are implicitly associated during training. For these simulations, we focused on hidden layer size, which was varied between 500 and 900 neurons in steps of 100. Note that the larger number of hidden neurons with respect to the previous simulations is motivated by the increased size and complexity of the training patterns. The sparsity constraint was fixed to 0.05, which was the value resulting in more accurate read-outs and more balanced distribution of gain fields for both RBMs and autoencoders in the previous set of simulations. For both architectures, read-out accuracy was always good (mapping error below 2°) and it was not affected by hidden layer size (see Table <xref ref-type="table" rid="T1">1</xref>). As shown in Figure <xref ref-type="fig" rid="F8">8</xref>, RBMs generally developed a larger percentage of gain fields compared to autoencoders. In particular, the number of multiple gain fields was much higher for RBMs. Interestingly, for both architectures also in this case the manipulation of hidden layer size produced a systematic change in the sparseness indexes [linear regressions: RBMs single-neuron sparseness, <italic>r</italic><sup>2</sup> = 0.98, b = 0.14, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 50; RBMs population sparseness, <italic>r</italic><sup>2</sup> = 0.95, b = 0.07, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 50; autoencoders single-neuron sparseness, <italic>r</italic><sup>2</sup> = 0.98, b = 0.10, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60; autoencoders population sparseness, <italic>r</italic><sup>2</sup> = 0.98, b = 0.06, <italic>p</italic> &lt; 0.001, <italic>n</italic> = 60]. For both architectures, population and single-neuron sparseness were highly correlated with the percentage of multiple gain fields [Pearson correlations: RBMs single-neuron sparseness, <italic>r</italic> = −0.94, <italic>p</italic> &lt; 0.001; RBMs population sparseness, <italic>r</italic> = −0.96, <italic>p</italic> &lt; 0.001; autoencoders single-neuron sparseness, <italic>r</italic> = −0.88, <italic>p</italic> &lt; 0.001; autoencoders population sparseness, <italic>r</italic> = −0.88, <italic>p</italic> &lt; 0.001]. This finding corroborates the hypothesis that, especially for RBMs, reducing the number of active neurons results in more compressed codes based on multiple gain fields, which might be particularly advantageous in the current scenario since learning involved coordinate transformations. In contrast, fewer neurons in autoencoders exhibited multiple gain modulation (Figure <xref ref-type="fig" rid="F8">8B</xref>), even if also in this case the percentage of multiple gain fields was proportional to the underlying level of sparseness.</p>
        <fig id="F8" position="float">
          <label>Figure 8</label>
          <caption>
            <p><bold>Unsupervised learning involving coordinate transformations</bold>. Distribution of gain field types emerging at the hidden layer of RBMs <bold>(A)</bold> and autoencoders <bold>(B)</bold> with varying number of hidden neurons. Lighter tones indicate smaller layers and dark blue indicates larger layers. Single-neuron and population sparseness as a function of hidden layer size for RBMs <bold>(C)</bold> and autoencoders <bold>(D)</bold>. Note that small values indicate stronger sparseness.</p>
          </caption>
          <graphic xlink:href="fncom-11-00013-g0008"/>
        </fig>
      </sec>
      <sec>
        <title>Supervised learning with coordinate transformation</title>
        <p>The final set of simulations reproduced the feed-forward, supervised architecture used by Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>). As in their original work, we did not enforce sparse coding. The size of the hidden layer was varied between 500 and 900 in steps of 100. Learning always converged and both the feed-forward mapping error and the read-out error were below 3° (see Table <xref ref-type="table" rid="T1">1</xref>). As shown in Figure <xref ref-type="fig" rid="F9">9</xref>, this type of learning architecture developed a strikingly lower proportion of gain-modulated neurons in the hidden layer: Almost 80% of the neurons did not exhibit any form of gain field. The remaining ones were almost uniformly distributed across the three other types (about 8% for either eye or effector position; 10% for multiple gain modulation). Moreover, differently from the unsupervised architectures, the type of gain modulation was not affected by changes in the hidden layer size. This result is remarkable, because it suggests that feed-forward, supervised architectures are much less prone to develop efficient forms of space coding based on gain fields. One possible explanation for this finding is that the type of coding used to represent the motor program might have affected the efficiency of error backpropagation, which was not able to properly propagate the error signals across the hidden layer. Indeed, also Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>) found some discrepancy between the type of gain modulations developed when using a monotonic output format compared to the Gaussian output format (which was adopted in the present study). However, the previous simulations with autoencoders showed that backpropagation can give rise to a variety of strong gain modulations when it is applied within an unsupervised learning setting. Another, more critical factor might instead be the absence of sparsity constraints, which were not used in the feed-forward models but turned out to be fundamental with autoencoders.</p>
        <fig id="F9" position="float">
          <label>Figure 9</label>
          <caption>
            <p><bold>Supervised learning of coordinate transformations</bold>. Distribution of gain field types emerging at the hidden layer of a feed-forward, supervised neural network similar to that used by Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>) with varying number of hidden neurons. Lighter tones indicate smaller layers and dark blue indicates larger layers.</p>
          </caption>
          <graphic xlink:href="fncom-11-00013-g0009"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>In this study we investigated the role of architectural and learning constraints in neural network models that learned to encode spatial information resulting from the combination of visual and postural signals. Results showed that, compared to the supervised architecture originally proposed by Zipser and Andersen (<xref rid="B77" ref-type="bibr">1988</xref>), unsupervised architectures like Restricted Boltzmann Machines (RBMs) and autoencoders discover space codes that more closely reproduce the distribution of neuronal tuning functions observed in neurophysiological experiments. In particular, the majority of hidden neurons of RBMs and autoencoders exhibited gain modulation, which in some cases only depended either on eye or effector position, while in other cases depended on both eye and effector positions, thereby resulting in multiple gain fields. In fact, all unsupervised models developed a much higher percentage of gain modulated neurons compared to the supervised models. Although the precise distribution of gain field types in the cerebral cortex depends on the exact recording site (Colby and Goldberg, <xref rid="B11" ref-type="bibr">1999</xref>), our simulations suggest that this efficient form of encoding emerges more naturally if the task requires to reconstruct the whole sensory input, rather than to simply discover a feed-forward mapping to a target motor program. In other words, gain field coding might be useful when the goal is to discover “good” internal representations of the input data, that is, when the aim is to unveil and more explicitly encode the latent factors underlying the input data distribution.</p>
      <p>As a general principle, the quality of an internal representation should reflect how well the learned features disentangle as many factors of variation as possible, at the same time discarding as little information about the data as is practical (Bengio et al., <xref rid="B3" ref-type="bibr">2013</xref>). In the specific case of sensorimotor transformations, it has been proposed that good internal representations should have a variety of properties, such as the ability to combine the input signal in a nonlinear way, the ability to fully cover the range of possible input values, and the ability to represent multiple reference frames simultaneously within the same neurons (Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>). Populations of gain modulated neurons satisfy these requirements, allowing to encode visual space using a flexible set of basis functions. Notably, our simulations showed that this allows to learn coordinate transformations in two separate stages, by first learning the set of basis functions in a completely unsupervised way, and then learning appropriate mappings to target motor commands by relying on explicit supervision or reinforcement signals (Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>).</p>
      <p>Our analyses also highlighted several differences in the spatial codes learned by RBMs and autoencoders, despite the fact that these two unsupervised architectures are often considered similar, if not equivalent (Ranzato et al., <xref rid="B56" ref-type="bibr">2007</xref>; Coates et al., <xref rid="B10" ref-type="bibr">2011</xref>). Even from a simple, qualitative analysis of the visual receptive fields, it turned out that these models developed different internal representations. Subsequent analyses conducted to investigate the emergence of gain fields further revealed that the distribution of hidden neurons' tuning functions in RBMs and autoencoders was similar only for a very narrow choice of the hyper-parameters. An important finding was that RBMs spontaneously exhibited a remarkable level of sparseness, which made them insensitive to external sparsity constraints, and which encouraged the emergence of compressed forms of spatial coding based on gain modulation. The spontaneous level of sparseness in RBMs could be manipulated only within a narrow range, by imposing an extreme sparsity constraint and jointly reducing the size of the hidden layer. This forced the internal representations to rely on even fewer neurons, and produced an increase in the percentage of multiple gain fields. These findings are consistent with the intuition that reducing the computational resources forces the networks to discover more complex (and compressed) forms of encoding, such as those resulting from the combination of many sensory/postural variables into multiple gain fields. Notably, for RBMs this was the case even when the task did not involve any coordinate transformations, which implied that postural variables were orthogonal. In other words, despite the fact that eye and effector positions were varied independently across training patterns, the RBMs with fewer active neurons often combined these signals together, resulting in an increase of multiple gain fields. Nevertheless, unlike autoencoders, RBMs always dedicated some representational resources also to encode eye and effector positions independently.</p>
      <p>Autoencoders turned out to rely on much more distributed representations compared to RBMs, and were therefore extremely sensitive to external sparsity constraints. This implies that, compared to RBMs, autoencoders have an additional hyper-parameter that must be carefully tuned. Notably, when the sparsity pressure was reduced hidden neurons in the autoencoders did not develop any form of gain modulation. Only for specific values of sparsity constraints autoencoders could reproduce the variety of gain field types observed in neurophysiological data (Brotchie et al., <xref rid="B5" ref-type="bibr">1995</xref>; Graziano et al., <xref rid="B25" ref-type="bibr">1997</xref>; Snyder et al., <xref rid="B66" ref-type="bibr">1998</xref>; Chang et al., <xref rid="B8" ref-type="bibr">2009</xref>), with a distribution compatible with that of RBMs. However, in autoencoders the underlying sparseness indexes did not seem to be systematically related to the complexity of the emergent spatial codes. Though these findings alone do not allow to adjudicate between models, they call for a more systematic investigation of these different learning architectures, possibly spanning other domains and using a more direct comparison to neurophysiological data.</p>
      <p>A plausible explanation for the striking differences in the spontaneous level of sparseness between RBMs and autoencoders can be found when considering the different processing dynamics embedded in these two neural network models. Indeed, in autoencoders the activation of each hidden neuron is deterministic, and simply corresponds to the (possibly graded) value returned by the non-linear, logistic activation function. In RBMs, instead, the value returned by the logistic function is treated as a probability, and the final activation of each hidden neuron is obtained by performing a stochastic binarization step. This important difference likely produces more sharp neuronal activations, driving RBMs to develop more sparse representations compared to autoencoders.</p>
      <p>From a broader perspective, we believe that stochastic neural networks such as RBMs and their extension into hierarchical generative models will have an increasingly central role in neurocomputational modeling, because they provide a unique bridge between high-level descriptions of cognition in terms of Bayesian computation and low-level, mechanistic explanations inspired by the biophysical properties of real neuronal networks (Testolin and Zorzi, <xref rid="B71" ref-type="bibr">2016</xref>). For example, generative neural networks are compatible with Bayesian approaches based on probabilistic population codes (Ma et al., <xref rid="B43" ref-type="bibr">2006</xref>), which have been successfully used to simulate sensorimotor transformations with basis functions (Pouget and Sejnowski, <xref rid="B53" ref-type="bibr">1997</xref>; Pouget and Snyder, <xref rid="B54" ref-type="bibr">2000</xref>). RBMs extend the basis function approach by explaining how learning might shape the emergent neuronal gain fields, and they could similarly be combined with attractor dynamics to simulate optimal statistical inference over multisensory spatial representations (cf. Pouget et al., <xref rid="B52" ref-type="bibr">2002</xref>) and spatial remapping in attention orienting (cf. Casarotti et al., <xref rid="B7" ref-type="bibr">2012</xref>).</p>
      <p>Moreover, the fact that generative networks can simulate both evoked (feed-forward) and intrinsic (feedback) neuronal activity makes them particularly suited to investigate spontaneous brain activity, which has been recognized as a fundamental property of the brain (Raichle, <xref rid="B55" ref-type="bibr">2015</xref>) but whose computational role is still largely unknown. An intriguing hypothesis suggests that intrinsic activity could help with driving the brain close to states that are probable to be valid inferences once an external input arrives, thus potentially shortening the reaction time of the system (Fiser et al., <xref rid="B21" ref-type="bibr">2010</xref>). Stochastic, generative networks are consistent with this “sampling-based” framework, and also support the idea that neuronal noise could play an important role during sampling (Kirkpatrick et al., <xref rid="B38" ref-type="bibr">1983</xref>), for example by keeping the system in a metastable state that facilitates flexible settling into the most appropriate configuration (Kelso, <xref rid="B36" ref-type="bibr">2012</xref>; Deco et al., <xref rid="B14" ref-type="bibr">2013</xref>). Notably, we are also beginning to better understand how these powerful models could be implemented with biologically more realistic architectures, such as those incorporating temporal dynamics and spike-based communication (Buesing et al., <xref rid="B6" ref-type="bibr">2011</xref>; Nessler et al., <xref rid="B50" ref-type="bibr">2013</xref>).</p>
      <p>In conclusion, we hope that the recent breakthroughs in neurally-inspired machine learning will attract the interest of the neuroscience community, as these models hold great promise for improving our understanding of how learning shapes and organizes information processing in complex neuronal networks.</p>
    </sec>
    <sec id="s5">
      <title>Author contributions</title>
      <p>AT, MD, and MZ equally contributed to the research design. AT implemented the simulations. AT and MD analyzed the data. AT and MZ wrote the paper. All the authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>This research was supported by grants from the European Research Council (no. 210922) and by the University of Padova (Strategic Grant NEURAT) to MZ. We are grateful to the Reviewers for their helpful comments on a previous version of this article.</p>
    </ack>
    <fn-group>
      <fn id="fn0001">
        <p>
          <sup>1</sup>
          <ext-link ext-link-type="uri" xlink:href="http://ccnl.psy.unipd.it/research/deeplearning">http://ccnl.psy.unipd.it/research/deeplearning</ext-link>
        </p>
      </fn>
      <fn id="fn0002">
        <p><sup>2</sup>MATLAB provides several improved versions of the standard backpropagation algorithm. An extended set of preliminary simulations was used to establish the best performing variant. In particular, these training functions were tested: <italic>traingdm</italic> (gradient descent with momentum); <italic>traingda</italic> (gradient descent with adaptive learning rate); <italic>traingdx</italic> (gradient descent with momentum and adaptive learning rate); <italic>trainscg</italic> (scaled conjugate gradient) and <italic>trainrp</italic> (resilient backpropagation). The most stable and accurate learning algorithm was resilient backpropagation (Riedmiller and Braun, <xref rid="B58" ref-type="bibr">1993</xref>).</p>
      </fn>
      <fn id="fn0003">
        <p><sup>3</sup>It turned out that more than 95% of hidden neurons responded to the visual input, with a minimum activation value exceeding a threshold of 0.1.</p>
      </fn>
      <fn id="fn0004">
        <p><sup>4</sup>The initial size of the hidden layer was determined empirically based on a set of pilot simulations to guarantee reliable and relatively fast convergence of learning.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackley</surname><given-names>D.</given-names></name><name><surname>Hinton</surname><given-names>G. E.</given-names></name><name><surname>Sejnowski</surname><given-names>T. J.</given-names></name></person-group> (<year>1985</year>). <article-title>A learning algorithm for Boltzmann machines</article-title>. <source>Cogn. Sci.</source>
<volume>9</volume>, <fpage>147</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1207/s15516709cog0901_7</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>R. A.</given-names></name><name><surname>Essick</surname><given-names>G. K.</given-names></name><name><surname>Siegel</surname><given-names>R. M.</given-names></name></person-group> (<year>1985</year>). <article-title>Encoding of spatial location by posterior parietal neurons</article-title>. <source>Science</source>
<volume>230</volume>, <fpage>456</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1126/science.4048942</pub-id><?supplied-pmid 4048942?><pub-id pub-id-type="pmid">4048942</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengio</surname><given-names>Y.</given-names></name><name><surname>Courville</surname><given-names>A.</given-names></name><name><surname>Vincent</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Representation learning: a review and new perspectives</article-title>. <source>IEEE Trans. Pattern Anal. Mach. Intell</source>. <volume>35</volume>, <fpage>1798</fpage>–<lpage>1828</lpage>. <pub-id pub-id-type="doi">10.1109/TPAMI.2013.50</pub-id><?supplied-pmid 23787338?><pub-id pub-id-type="pmid">23787338</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengio</surname><given-names>Y.</given-names></name><name><surname>Lamblin</surname><given-names>P.</given-names></name><name><surname>Popovici</surname><given-names>D.</given-names></name><name><surname>Larochelle</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Greedy layer-wise training of deep networks</article-title>. <source>Adv. Neural Inf. Process. Syst.</source>
<volume>19</volume>, <fpage>153</fpage>–<lpage>170</lpage>.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brotchie</surname><given-names>P. R.</given-names></name><name><surname>Andersen</surname><given-names>R. A.</given-names></name><name><surname>Snyder</surname><given-names>L. H.</given-names></name><name><surname>Goodman</surname><given-names>S. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Head position signals used by parietal neurons to encode locations of visual stimuli</article-title>. <source>Nature</source>
<volume>375</volume>, <fpage>232</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1038/375232a0</pub-id><?supplied-pmid 7746323?><pub-id pub-id-type="pmid">7746323</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buesing</surname><given-names>L.</given-names></name><name><surname>Bill</surname><given-names>J.</given-names></name><name><surname>Nessler</surname><given-names>B.</given-names></name><name><surname>Maass</surname><given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>Neural dynamics as sampling: a model for stochastic computation in recurrent networks of spiking neurons</article-title>. <source>PLoS Comput. Biol.</source>
<volume>7</volume>:<fpage>e1002211</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1002211</pub-id><?supplied-pmid 22096452?><pub-id pub-id-type="pmid">22096452</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casarotti</surname><given-names>M.</given-names></name><name><surname>Lisi</surname><given-names>M.</given-names></name><name><surname>Umiltà</surname><given-names>C.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Paying attention through eye movements: a computational investigation of the premotor theory of spatial attention</article-title>. <source>J. Cogn. Neurosci.</source>
<volume>24</volume>, <fpage>1519</fpage>–<lpage>1531</lpage>. <pub-id pub-id-type="doi">10.1162/jocn_a_00231</pub-id><?supplied-pmid 22452561?><pub-id pub-id-type="pmid">22452561</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. W.</given-names></name><name><surname>Papadimitriou</surname><given-names>C.</given-names></name><name><surname>Snyder</surname><given-names>L. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Using a compound gain field to compute a reach plan</article-title>. <source>Neuron</source>
<volume>64</volume>, <fpage>744</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.11.005</pub-id><?supplied-pmid 20005829?><pub-id pub-id-type="pmid">20005829</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>K.</given-names></name><name><surname>Ilin</surname><given-names>A.</given-names></name><name><surname>Raiko</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Improved learning algorithms for restricted boltzmann machines</article-title>, in <source>International Conference on Artificial Neural Networks</source> (<publisher-loc>Espoo</publisher-loc>), <fpage>10</fpage>–<lpage>17</lpage>.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coates</surname><given-names>A.</given-names></name><name><surname>Arbor</surname><given-names>A.</given-names></name><name><surname>Ng</surname><given-names>A. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>An analysis of single-layer networks in unsupervised feature learning</article-title>. <source>Int. Conference Artif. Intell. Stat.</source>
<volume>15</volume>, <fpage>215</fpage>–<lpage>223</lpage>.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colby</surname><given-names>C. L.</given-names></name><name><surname>Goldberg</surname><given-names>M. E.</given-names></name></person-group> (<year>1999</year>). <article-title>Space and attention in parietal cortex</article-title>. <source>Annu. Rev. Neurosci.</source>
<volume>22</volume>, <fpage>319</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.22.1.319</pub-id><?supplied-pmid 10202542?><pub-id pub-id-type="pmid">10202542</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collobert</surname><given-names>R.</given-names></name><name><surname>Weston</surname><given-names>J.</given-names></name><name><surname>Bottou</surname><given-names>L.</given-names></name><name><surname>Karlen</surname><given-names>M.</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K.</given-names></name><name><surname>Kuksa</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Natural language processing (almost) from scratch</article-title>. <source>J. Mach. Learn. Res.</source>
<volume>12</volume>, <fpage>2493</fpage>–<lpage>2537</lpage>.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>D. D.</given-names></name><name><surname>Dean</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Neural networks and neuroscience-inspired computer vision</article-title>. <source>Curr. Biol.</source>
<volume>24</volume>, <fpage>R921</fpage>–<lpage>R929</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2014.08.026</pub-id><?supplied-pmid 25247371?><pub-id pub-id-type="pmid">25247371</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deco</surname><given-names>G.</given-names></name><name><surname>Jirsa</surname><given-names>V. K.</given-names></name><name><surname>McIntosh</surname><given-names>A. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Resting brains never rest: computational insights into potential cognitive architectures</article-title>. <source>Trends Neurosci.</source>
<volume>36</volume>, <fpage>268</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2013.03.001</pub-id><?supplied-pmid 23561718?><pub-id pub-id-type="pmid">23561718</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Filippo De Grazia</surname><given-names>M.</given-names></name><name><surname>Cutini</surname><given-names>S.</given-names></name><name><surname>Lisi</surname><given-names>M.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Space coding for sensorimotor transformations can emerge through unsupervised learning</article-title>. <source>Cogn. Process.</source>
<volume>13</volume>, <fpage>141</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1007/s10339-012-0478-4</pub-id><?supplied-pmid 22802037?><pub-id pub-id-type="pmid">22802037</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Meyer</surname><given-names>K.</given-names></name><name><surname>Spratling</surname><given-names>M. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Multiplicative gain modulation arises through unsupervised learning in a predictive coding model of cortical function</article-title>. <source>Neural Comput.</source>
<volume>23</volume>, <fpage>1536</fpage>–<lpage>1567</lpage>. <pub-id pub-id-type="doi">10.1162/NECO_a_00130</pub-id><?supplied-pmid 21395434?><pub-id pub-id-type="pmid">21395434</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Demuth</surname><given-names>H.</given-names></name><name><surname>Beale</surname><given-names>M.</given-names></name></person-group> (<year>1993</year>). <source>Neural Network Toolbox for Use with MATLAB</source>. <publisher-loc>Natick, MA</publisher-loc>: <publisher-name>The MathWorks, Inc</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Bono</surname><given-names>M. G.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Deep generative learning of location-invariant visual word recognition</article-title>. <source>Front. Psychol.</source>
<volume>4</volume>:<fpage>635</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2013.00635</pub-id><?supplied-pmid 24065939?><pub-id pub-id-type="pmid">24065939</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duhamel</surname><given-names>J. R.</given-names></name><name><surname>Colby</surname><given-names>C. L.</given-names></name><name><surname>Goldberg</surname><given-names>M. E.</given-names></name></person-group> (<year>1992</year>). <article-title>The updating of the representation of visual space in parietal cortex by intended eye movements</article-title>. <source>Science</source>
<volume>255</volume>, <fpage>90</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1126/science.1553535</pub-id><?supplied-pmid 1553535?><pub-id pub-id-type="pmid">1553535</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duhamel</surname><given-names>J. R.</given-names></name><name><surname>Bremmer</surname><given-names>F.</given-names></name><name><surname>Ben Hamed</surname><given-names>S.</given-names></name><name><surname>Graf</surname><given-names>W.</given-names></name></person-group> (<year>1997</year>). <article-title>Spatial invariance of visual receptive fields in parietal cortex neurons</article-title>. <source>Nature</source>
<volume>389</volume>, <fpage>845</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1038/39865</pub-id><?supplied-pmid 9349815?><pub-id pub-id-type="pmid">9349815</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiser</surname><given-names>J.</given-names></name><name><surname>Berkes</surname><given-names>P.</given-names></name><name><surname>Orbán</surname><given-names>G.</given-names></name><name><surname>Lengyel</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Statistically optimal perception and learning: from behavior to neural representations</article-title>. <source>Trends Cogn. Sci.</source>
<volume>14</volume>, <fpage>119</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2010.01.003</pub-id><?supplied-pmid 20153683?><pub-id pub-id-type="pmid">20153683</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friston</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>The free-energy principle: a unified brain theory?</article-title>
<source>Nat. Rev. Neurosci.</source>
<volume>11</volume>, <fpage>127</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2787</pub-id><?supplied-pmid 20068583?><pub-id pub-id-type="pmid">20068583</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froudarakis</surname><given-names>E.</given-names></name><name><surname>Berens</surname><given-names>P.</given-names></name><name><surname>Ecker</surname><given-names>A. S.</given-names></name><name><surname>Cotton</surname><given-names>R. J.</given-names></name><name><surname>Sinz</surname><given-names>F. H.</given-names></name><name><surname>Yatsenko</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Population code in mouse V1 facilitates readout of natural scenes through increased sparseness</article-title>. <source>Nat. Neurosci.</source>
<volume>17</volume>, <fpage>851</fpage>–<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3707</pub-id><?supplied-pmid 24747577?><pub-id pub-id-type="pmid">24747577</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>C. D.</given-names></name><name><surname>Sigman</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain states: top-down influences in sensory processing</article-title>. <source>Neuron</source>
<volume>54</volume>, <fpage>677</fpage>–<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.05.019</pub-id><?supplied-pmid 17553419?><pub-id pub-id-type="pmid">17553419</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graziano</surname><given-names>M. S.</given-names></name><name><surname>Hu</surname><given-names>X. T.</given-names></name><name><surname>Gross</surname><given-names>C. G.</given-names></name></person-group> (<year>1997</year>). <article-title>Visuospatial properties of ventral premotor cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>77</volume>, <fpage>2268</fpage>–<lpage>2292</lpage>. <?supplied-pmid 9163357?><pub-id pub-id-type="pmid">9163357</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güçlü</surname><given-names>U.</given-names></name><name><surname>van Gerven</surname><given-names>M. A. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Deep neural networks reveal a gradient in the complexity of neural representations across the ventral stream</article-title>. <source>J. Neurosci.</source>
<volume>35</volume>, <fpage>10005</fpage>–<lpage>10014</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5023-14.2015</pub-id><?supplied-pmid 26157000?><pub-id pub-id-type="pmid">26157000</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güçlü</surname><given-names>U.</given-names></name><name><surname>van Gerven</surname><given-names>M. A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Unsupervised feature learning improves prediction of human brain activity in response to natural images</article-title>. <source>PLoS Comput. Biol.</source>
<volume>10</volume>:<fpage>e1003724</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003724</pub-id><?supplied-pmid 25101625?><pub-id pub-id-type="pmid">25101625</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Training products of experts by minimizing contrastive divergence</article-title>. <source>Neural Comput.</source>
<volume>14</volume>, <fpage>1771</fpage>–<lpage>1800</lpage>. <pub-id pub-id-type="doi">10.1162/089976602760128018</pub-id><?supplied-pmid 12180402?><pub-id pub-id-type="pmid">12180402</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Learning multiple layers of representation</article-title>. <source>Trends Cogn. Sci.</source>
<volume>11</volume>, <fpage>428</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2007.09.004</pub-id><?supplied-pmid 17921042?><pub-id pub-id-type="pmid">17921042</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2010</year>). <source>A Practical Guide to Training Restricted Boltzmann Machines</source>. Tech. Rep. UTML TR 2010-003, <publisher-name>Univ. Toronto</publisher-name>
<volume>9</volume>, <fpage>1</fpage>.</mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Where do features come from?</article-title>. <source>Cogn. Sci</source>. <volume>38</volume>, <fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/cogs.12049</pub-id><?supplied-pmid 23800216?><pub-id pub-id-type="pmid">24070563</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name><name><surname>Ghahramani</surname><given-names>Z.</given-names></name></person-group> (<year>1997</year>). <article-title>Generative models for discovering sparse distributed representations</article-title>. <source>Philos. Trans. R. Soc. Lond. B. Biol. Sci.</source>
<volume>352</volume>, <fpage>1177</fpage>–<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.1997.0101</pub-id><?supplied-pmid 9304685?><pub-id pub-id-type="pmid">9304685</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name><name><surname>Salakhutdinov</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Reducing the dimensionality of data with neural networks</article-title>. <source>Science</source>
<volume>313</volume>, <fpage>504</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1126/science.1127647</pub-id><?supplied-pmid 16873662?><pub-id pub-id-type="pmid">16873662</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hinton</surname><given-names>G. E.</given-names></name><name><surname>Sejnowski</surname><given-names>T. J.</given-names></name></person-group> (<year>1999</year>). <source>Unsupervised Learning: Foundations of Neural Computation.</source>
<publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>MIT Press</publisher-name> Available at: <ext-link ext-link-type="uri" xlink:href="http://books.google.com/books?hl=it&amp;lr=&amp;id=yj04Y0lje4cC&amp;pgis=1">http://books.google.com/books?hl=it&amp;lr=&amp;id=yj04Y0lje4cC&amp;pgis=1</ext-link> [Accessed July 4, 2012].</mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastner</surname><given-names>S.</given-names></name><name><surname>Ungerleider</surname><given-names>L. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Mechanisms of visual attention in the human cortex</article-title>. <source>Annu. Rev. Neurosci.</source>
<volume>23</volume>, <fpage>315</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.23.1.315</pub-id><?supplied-pmid 10845067?><pub-id pub-id-type="pmid">10845067</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelso</surname><given-names>J. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Multistability and metastability: understanding dynamic coordination in the brain</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source>
<volume>367</volume>, <fpage>906</fpage>–<lpage>918</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2011.0351</pub-id><?supplied-pmid 22371613?><pub-id pub-id-type="pmid">22371613</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaligh-Razavi</surname><given-names>S. M.</given-names></name><name><surname>Kriegeskorte</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Deep Supervised, but not unsupervised, models may explain IT cortical representation</article-title>. <source>PLoS Comput. Biol.</source>
<volume>10</volume>:<fpage>e1003915</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003915</pub-id><?supplied-pmid 25375136?><pub-id pub-id-type="pmid">25375136</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>S.</given-names></name><name><surname>Gelatt</surname><given-names>C. D.</given-names><suffix>Jr.</suffix></name><name><surname>Vecchi</surname><given-names>M. P.</given-names></name></person-group> (<year>1983</year>). <article-title>Optimization by simmulated annealing</article-title>. <source>Science</source>
<volume>220</volume>, <fpage>671</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1126/science.220.4598.671</pub-id><?supplied-pmid 17813860?><pub-id pub-id-type="pmid">17813860</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krizhevsky</surname><given-names>A.</given-names></name><name><surname>Sutskever</surname><given-names>I.</given-names></name><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2012</year>). <article-title>ImageNet classification with deep convolutional neural networks</article-title>. <source>Adv. Neural Inf. Process. Syst.</source>
<volume>24</volume>, <fpage>609</fpage>–<lpage>616</lpage>.</mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeCun</surname><given-names>Y.</given-names></name><name><surname>Bengio</surname><given-names>Y.</given-names></name><name><surname>Hinton</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Deep learning</article-title>. <source>Nature</source>
<volume>521</volume>, <fpage>436</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1038/nature14539</pub-id><?supplied-pmid 26017442?><pub-id pub-id-type="pmid">26017442</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Ekanadham</surname><given-names>C.</given-names></name><name><surname>Ng</surname><given-names>A. Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Sparse deep belief net models for visual area V2</article-title>. <source>Adv. Neural Inf. Process. Syst</source>. <volume>20</volume>, <fpage>873</fpage>–<lpage>880</lpage>.</mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T. S.</given-names></name><name><surname>Mumford</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>Hierarchical Bayesian inference in the visual cortex</article-title>. <source>J. Opt. Soc. Am. A</source>
<volume>20</volume>:<fpage>1434</fpage>. <pub-id pub-id-type="doi">10.1364/josaa.20.001434</pub-id><?supplied-pmid 12868647?><pub-id pub-id-type="pmid">12868647</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W. J.</given-names></name><name><surname>Beck</surname><given-names>J. M.</given-names></name><name><surname>Latham</surname><given-names>P. E.</given-names></name><name><surname>Pouget</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Bayesian inference with probabilistic population codes</article-title>. <source>Nat. Neurosci.</source>
<volume>9</volume>, <fpage>1432</fpage>–<lpage>1438</lpage>. <pub-id pub-id-type="doi">10.1038/nn1790</pub-id><?supplied-pmid 17057707?><pub-id pub-id-type="pmid">17057707</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname><given-names>P.</given-names></name><name><surname>Andersen</surname><given-names>R. A.</given-names></name><name><surname>Jordan</surname><given-names>M. I.</given-names></name></person-group> (<year>1991</year>). <article-title>A more biologically plausible learning rule for neural networks</article-title>. <source>Proc. Natl. Acad. Sci. U.S. A.</source>
<volume>88</volume>:<fpage>4433</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.10.4433</pub-id><?supplied-pmid 1903542?><pub-id pub-id-type="pmid">1903542</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>J. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The place of modeling in cognitive science</article-title>. <source>Top. Cogn. Sci.</source>
<volume>1</volume>, <fpage>11</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1756-8765.2008.01003.x</pub-id><?supplied-pmid 25164798?><pub-id pub-id-type="pmid">25164798</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>J. L.</given-names></name><name><surname>Botvinick</surname><given-names>M. M.</given-names></name><name><surname>Noelle</surname><given-names>D. C.</given-names></name><name><surname>Plaut</surname><given-names>D. C.</given-names></name><name><surname>Rogers</surname><given-names>T. T.</given-names></name><name><surname>Seidenberg</surname><given-names>M. S.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Letting structure emerge: connectionist and dynamical systems approaches to cognition</article-title>. <source>Trends Cogn. Sci.</source>
<volume>14</volume>, <fpage>348</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2010.06.002</pub-id><?supplied-pmid 20598626?><pub-id pub-id-type="pmid">20598626</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Møller</surname><given-names>M. F.</given-names></name></person-group> (<year>1993</year>). <article-title>A scaled conjugate gradient algorithm for fast supervised learning</article-title>. <source>Neural Netw.</source>
<volume>6</volume>, <fpage>525</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/S0893-6080(05)80056-5</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mnih</surname><given-names>V.</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K.</given-names></name><name><surname>Silver</surname><given-names>D.</given-names></name><name><surname>Rusu</surname><given-names>A. A.</given-names></name><name><surname>Veness</surname><given-names>J.</given-names></name><name><surname>Bellemare</surname><given-names>M. G.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Human-level control through deep reinforcement learning</article-title>. <source>Nature</source>
<volume>518</volume>, <fpage>529</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1038/nature14236</pub-id><?supplied-pmid 25719670?><pub-id pub-id-type="pmid">25719670</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>A.</given-names></name><name><surname>Dahl</surname><given-names>G. E.</given-names></name><name><surname>Hinton</surname><given-names>G. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Acoustic modeling using deep belief networks</article-title>. <source>IEEE Trans. Audio. Speech. Lang. Proces.</source>
<volume>20</volume>, <fpage>14</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1109/TASL.2011.2109382</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nessler</surname><given-names>B.</given-names></name><name><surname>Pfeiffer</surname><given-names>M.</given-names></name><name><surname>Buesing</surname><given-names>L.</given-names></name><name><surname>Maass</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Bayesian computation emerges in generic cortical microcircuits through spike-timing-dependent plasticity</article-title>. <source>PLoS Comput. Biol.</source>
<volume>9</volume>:<fpage>e1003037</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003037</pub-id><?supplied-pmid 23633941?><pub-id pub-id-type="pmid">23633941</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Reilly</surname><given-names>R. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Six principles for biologically based computational models of cortical cognition</article-title>. <source>Trends Cogn. Sci.</source>
<volume>2</volume>, <fpage>455</fpage>–<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1016/S1364-6613(98)01241-8</pub-id><?supplied-pmid 21227277?><pub-id pub-id-type="pmid">21227277</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouget</surname><given-names>A.</given-names></name><name><surname>Deneve</surname><given-names>S.</given-names></name><name><surname>Duhamel</surname><given-names>J.-R.</given-names></name></person-group> (<year>2002</year>). <article-title>A computational perspective on the neural basis of multisensory spatial representations</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>3</volume>, <fpage>741</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1038/nrn914</pub-id><?supplied-pmid 12209122?><pub-id pub-id-type="pmid">12209122</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouget</surname><given-names>A.</given-names></name><name><surname>Sejnowski</surname><given-names>T. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Spatial transformations in the parietal cortex using basis functions</article-title>. <source>J. Cogn. Neurosci.</source>
<volume>9</volume>, <fpage>222</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1162/jocn.1997.9.2.222</pub-id><?supplied-pmid 23962013?><pub-id pub-id-type="pmid">23962013</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouget</surname><given-names>A.</given-names></name><name><surname>Snyder</surname><given-names>L. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Computational approaches to sensorimotor transformations</article-title>. <source>Nat. Neurosci.</source>
<volume>3</volume>, <fpage>1192</fpage>–<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1038/81469</pub-id><?supplied-pmid 11127837?><pub-id pub-id-type="pmid">11127837</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raichle</surname><given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The restless brain: how intrinsic activity organizes brain function</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source>
<volume>370</volume>, <fpage>20140172</fpage>–<lpage>20140172</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2014.0172</pub-id><?supplied-pmid 25823869?><pub-id pub-id-type="pmid">25823869</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranzato</surname><given-names>M. A.</given-names></name><name><surname>Boureau</surname><given-names>L.</given-names></name><name><surname>Chopra</surname><given-names>S.</given-names></name><name><surname>LeCun</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>A unified energy-based framework for 913 unsupervised learning</article-title>, in <source>Proceedings Conference on AI</source>. Available online at: 914 <ext-link ext-link-type="uri" xlink:href="http://scholar.google.com/scholar?hl=en&amp;btnG=Search&amp;q=intitle:A+Unified+Energy-Based+Framework+for+Unsupervised+Learning#0">http://scholar.google.com/scholar?hl=en&amp;btnG=Search&amp;q=intitle:A+Unified+Energy-Based+Framework+for+Unsupervised+Learning#0</ext-link> [Accessed July 16, 2014].</mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichert</surname><given-names>D. P.</given-names></name><name><surname>Seriès</surname><given-names>P.</given-names></name><name><surname>Storkey</surname><given-names>A. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Charles Bonnet syndrome: evidence for a generative model in the cortex?</article-title>
<source>PLoS Comput. Biol.</source>
<volume>9</volume>:<fpage>e1003134</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003134</pub-id><?supplied-pmid 23874177?><pub-id pub-id-type="pmid">23874177</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Riedmiller</surname><given-names>M.</given-names></name><name><surname>Braun</surname><given-names>H.</given-names></name></person-group> (<year>1993</year>). <article-title>A direct adaptive method for faster backpropagation learning: The RPROP algorithm</article-title>, in <source>IEEE International Conference on Neural Networks</source> (<publisher-loc>San Francisco, CA</publisher-loc>), <fpage>586</fpage>–<lpage>591</lpage>.</mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolls</surname><given-names>E. T.</given-names></name><name><surname>Tovee</surname><given-names>M. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Sparseness of the neuronal representation of stimuli in the primate temporal visual cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>73</volume>, <fpage>713</fpage>–<lpage>26</lpage>. <?supplied-pmid 7760130?><pub-id pub-id-type="pmid">7760130</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumelhart</surname><given-names>D. E.</given-names></name><name><surname>Hinton</surname><given-names>G. E.</given-names></name><name><surname>Williams</surname><given-names>R. J.</given-names></name></person-group> (<year>1986</year>). <article-title>Learning representations by back-propagating errors</article-title>. <source>Nature</source>
<volume>323</volume>, <fpage>533</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1038/323533a0</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>H.</given-names></name><name><surname>Taira</surname><given-names>M.</given-names></name><name><surname>Murata</surname><given-names>A.</given-names></name><name><surname>Mine</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>Neural mechanisms of visual guidance of hand action in the parietal cortex of the monkey</article-title>. <source>Cereb. Cortex</source>
<volume>5</volume>, <fpage>429</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/5.5.429</pub-id><?supplied-pmid 8547789?><pub-id pub-id-type="pmid">8547789</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salakhutdinov</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Learning deep generative models</article-title>. <source>Annu. Rev. Stat. Appl.</source>
<volume>2</volume>, <fpage>361</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-statistics-010814-020120</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salinas</surname><given-names>E.</given-names></name><name><surname>Thier</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Gain modulation: a major computational principle of the central nervous system</article-title>. <source>Neuron</source>
<volume>27</volume>, <fpage>15</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00004-0</pub-id><?supplied-pmid 10939327?><pub-id pub-id-type="pmid">10939327</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sillito</surname><given-names>A. M.</given-names></name><name><surname>Cudeiro</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>H. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Always returning: feedback and sensory processing in visual cortex and thalamus</article-title>. <source>Trends Neurosci.</source>
<volume>29</volume>, <fpage>307</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2006.05.001</pub-id><?supplied-pmid 16713635?><pub-id pub-id-type="pmid">16713635</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>A.</given-names></name><name><surname>Maddison</surname><given-names>C. J.</given-names></name><name><surname>Guez</surname><given-names>A.</given-names></name><name><surname>Sifre</surname><given-names>L.</given-names></name><name><surname>van den Driessche</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Mastering the game of Go with deep neural networks and tree search</article-title>. <source>Nature</source>
<volume>529</volume>, <fpage>484</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1038/nature16961</pub-id><?supplied-pmid 26819042?><pub-id pub-id-type="pmid">26819042</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>L. H.</given-names></name><name><surname>Grieve</surname><given-names>K. L.</given-names></name><name><surname>Brotchie</surname><given-names>P.</given-names></name><name><surname>Andersen</surname><given-names>R. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Separate body- and world-referenced representations of visual space in parietal cortex</article-title>. <source>Nature</source>
<volume>394</volume>, <fpage>887</fpage>–<lpage>891</lpage>. <?supplied-pmid 9732870?><pub-id pub-id-type="pmid">9732870</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoianov</surname><given-names>I.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Emergence of a “visual number sense” in hierarchical generative models</article-title>. <source>Nat. Neurosci.</source>
<volume>15</volume>, <fpage>194</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2996</pub-id><?supplied-pmid 22231428?><pub-id pub-id-type="pmid">22231428</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stricanne</surname><given-names>B.</given-names></name><name><surname>Andersen</surname><given-names>R. A.</given-names></name><name><surname>Mazzoni</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Eye-centered, head-centered, and intermediate coding of remembered sound locations in area LIP</article-title>. <source>J. Neurophysiol.</source>
<volume>76</volume>, <fpage>2071</fpage>–<lpage>2076</lpage>. <?supplied-pmid 8890315?><pub-id pub-id-type="pmid">8890315</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testolin</surname><given-names>A.</given-names></name><name><surname>Stoianov</surname><given-names>I.</given-names></name><name><surname>De Filippo De Grazia</surname><given-names>M.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Deep unsupervised learning on a desktop PC : a primer for cognitive scientists</article-title>. <source>Front. Psychol.</source>
<volume>4</volume>:<fpage>251</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2013.00251</pub-id><?supplied-pmid 23653617?><pub-id pub-id-type="pmid">23653617</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testolin</surname><given-names>A.</given-names></name><name><surname>Stoianov</surname><given-names>I.</given-names></name><name><surname>Sperduti</surname><given-names>A.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Learning orthographic structure with sequential generative neural networks</article-title>. <source>Cogn. Sci.</source>
<volume>40</volume>, <fpage>579</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1111/cogs.12258</pub-id><?supplied-pmid 26073971?><pub-id pub-id-type="pmid">26073971</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testolin</surname><given-names>A.</given-names></name><name><surname>Zorzi</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Probabilistic models and generative neural networks: towards an unified framework for modeling normal and impaired neurocognitive functions</article-title>. <source>Front. Comput. Neurosci.</source>
<volume>10</volume>:<fpage>73</fpage>. <pub-id pub-id-type="doi">10.3389/fncom.2016.00073</pub-id><?supplied-pmid 27468262?><pub-id pub-id-type="pmid">27468262</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorpe</surname><given-names>S. J.</given-names></name><name><surname>Imbert</surname><given-names>M.</given-names></name></person-group> (<year>1989</year>). <article-title>Biological constraints on connectionist modelling</article-title>. <source>Connect. Perspect.</source>
<volume>1</volume>, <fpage>1</fpage>–<lpage>36</lpage>.</mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treves</surname><given-names>A.</given-names></name><name><surname>Rolls</surname><given-names>E. T.</given-names></name></person-group> (<year>1991</year>). <article-title>What determines the capacity of autoassociative memories in the brain?</article-title>
<source>Netw. Comput. Neural Syst.</source>
<volume>2</volume>, <fpage>371</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1088/0954-898X_2_4_004</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinje</surname><given-names>W. E.</given-names></name><name><surname>Gallant</surname><given-names>J. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Sparse Coding and decorrelation in primary visual cortex during natural vision</article-title>. <source>Science</source>
<volume>287</volume>, <fpage>1273</fpage>–<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5456.1273</pub-id><?supplied-pmid 10678835?><pub-id pub-id-type="pmid">10678835</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widrow</surname><given-names>B.</given-names></name><name><surname>Hoff</surname><given-names>M.</given-names></name></person-group> (<year>1960</year>). <article-title>Adaptive Switching Circuits</article-title>, in <source>IRE WESCON Convention Record</source>, <fpage>96</fpage>–<lpage>140</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www-isl.stanford.edu/people/widrow/papers/c1960adaptiveswitching.pdf">http://www-isl.stanford.edu/people/widrow/papers/c1960adaptiveswitching.pdf</ext-link> [Accessed November 29, 2014].</mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Andersen</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Models of the posterior parietal cortex which perform multimodal integration and represent space in several coordinate frames</article-title>. <source>J. Cogn. Neurosci.</source>
<volume>12</volume>, <fpage>601</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1162/089892900562363</pub-id><?supplied-pmid 10936913?><pub-id pub-id-type="pmid">10936913</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipser</surname><given-names>D.</given-names></name><name><surname>Andersen</surname><given-names>R.</given-names></name></person-group> (<year>1988</year>). <article-title>A back-propagation programmed network that simulates response properties of a subset of posterior parietal neurons</article-title>. <source>Nature</source>
<volume>331</volume>, <fpage>679</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1038/331679a0</pub-id><?supplied-pmid 3344044?><pub-id pub-id-type="pmid">3344044</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorzi</surname><given-names>M.</given-names></name><name><surname>Testolin</surname><given-names>A.</given-names></name><name><surname>Stoianov</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Modeling language and cognition with deep unsupervised learning: a tutorial overview</article-title>. <source>Front. Psychol.</source>
<volume>4</volume>:<fpage>515</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2013.00515</pub-id><?supplied-pmid 23970869?><pub-id pub-id-type="pmid">23970869</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360097</identifier><datestamp>2017-04-04</datestamp><setSpec>sicotj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">SICOT J</journal-id>
      <journal-id journal-id-type="iso-abbrev">SICOT J</journal-id>
      <journal-id journal-id-type="publisher-id">sicotj</journal-id>
      <journal-title-group>
        <journal-title>SICOT-J</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2426-8887</issn>
      <publisher>
        <publisher-name>EDP Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360097</article-id>
      <article-id pub-id-type="pmcid">PMC5360097</article-id>
      <article-id pub-id-type="pmc-uid">5360097</article-id>
      <article-id pub-id-type="pmid">28322717</article-id>
      <article-id pub-id-type="doi">10.1051/sicotj/2017014</article-id>
      <article-id pub-id-type="publisher-id">sicotj160108</article-id>
      <article-id pub-id-type="other">10.1051/sicotj/2017014</article-id>
      <article-categories>
        <subj-group subj-group-type="section">
          <subject>Knee</subject>
        </subj-group>
        <subj-group subj-group-type="topic">
          <subject>Special Issue: "Deformity correction, limb lengthening and reconstruction" Guest Editor: Y. ElBatrawy</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Surgical Technique</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lengthening and deformity correction about the knee using a magnetic internal lengthening nail</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fragomen</surname>
            <given-names>Austin T.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
          <xref ref-type="corresp" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rozbruch</surname>
            <given-names>S. Robert</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AFF1">
        <label>1</label>
        <addr-line>
Limb Lengthening and Complex Reconstruction Service, Hospital for Special Surgery, Weill Medical College of Cornell University New York NY
10021 USA
</addr-line>
      </aff>
      <author-notes>
        <corresp id="FN1"><label>*</label>Corresponding author: <email>fragomena@hss.edu</email>; <email>afragomen@gmail.com</email></corresp>
      </author-notes>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2017</year>
      </pub-date>
      <pub-date date-type="pub" publication-format="electronic">
        <day>22</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>3</volume>
      <issue-id pub-id-type="publisher-id">sicotj/2017/01</issue-id>
      <elocation-id>25</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Authors, published by EDP Sciences, 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>The Authors</copyright-holder>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
<italic>Introduction</italic>: The introduction of the internal lengthening nail (ILN) has changed the treatment of complex malalignment and shortening about the knee. Acute correction of the deformity and gradual lengthening through this osteotomy site has greatly simplified postoperative recovery. This manuscript is a review of the techniques that are currently being used in surgery.</p>
        <p>
<italic>Methods</italic>: The article is broken into two sections: distal femur osteotomy and tibia osteotomy. Each is addressed separately since they have different personalities. Also included are topics of particular interest that surface in ongoing conferences regarding the ILN. This work is a mix of expert opinion and best practice supported by peer reviewed publications on the topic.</p>
        <p>
<italic>Results</italic>: Most published series demonstrate excellent results with the ILN. Certain precautions are reiterated including avoiding mechanical failure, need for a percutaneous osteotomy, need for over-reaming, and the need for blocking screws.</p>
        <p>
<italic>Discussion</italic>: Current controversies will be brought to light and discussed. The reader should find this aspect particularly helpful in navigating this rapidly evolving field.</p>
      </abstract>
      <kwd-group>
        <kwd>Internal lengthening nail</kwd>
        <kwd>Limb deformity</kwd>
        <kwd>Limb lengthening</kwd>
        <kwd>Distraction</kwd>
        <kwd>Malalignment</kwd>
      </kwd-group>
      <counts>
        <fig-count count="15"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="27"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S1">
      <title>Introduction</title>
      <p>The introduction of the internal lengthening nail (ILN) has revolutionized how deformity surgeons approach the treatment of complex malalignment and shortening about the knee. Where once external fixation was required to manage simultaneous deformity with lengthening, internal fixation has utilized the tactic of acutely correcting the malalignment and gradually lengthening through this osteotomy site [<xref rid="R1" ref-type="bibr">1</xref>]. Some studies have even shown that the regenerate heals faster (a lower consolidation index) with ILN when compared with external fixation [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. Certain technical considerations are important to the success of this newer approach including well-placed blocking screws and the intraoperative use of external fixation to control the bony reduction during reaming. This review article aims to present successful strategies for deformity correction and lengthening through the distal femur and proximal tibia.</p>
    </sec>
    <sec id="S2">
      <title>Methods: femur</title>
      <sec id="S3">
        <title>Retrograde femoral nailing: surgical technique</title>
        <p>The retrograde approach to the femur offers excellent control over distal femoral deformity. The distal femur is an ideal location for osteotomy due to its reliable bone formation during distraction osteogenesis. The challenge of the distal femur lies in its width which allows for the reamer and intramedullary (IM) nail to move in many possible directions. In order to secure a path for the nail to pass, blocking screws have been implemented. Well-placed blocking screws ensure that the reamer and IM nail will head in the proper direction both correcting the acute deformity and preventing lengthening-induced deformity. This concept of lengthening-induced deformity is well known to deformity surgeons with experience using external fixators but may not be so obvious to other orthopedic surgeons attempting deformity correction and lengthening with the IM nail. For retrograde nailing with a distal femoral osteotomy the distal bone fragment can be expected to flex during lengthening. This requires that a blocking screw be placed posterior to the nail at the time of the index surgery in anticipation of the impending deformity [<xref rid="R3" ref-type="bibr">3</xref>]. The mechanical axis will deviate laterally during lengthening at an expected quantity of 1 mm of translation per 1 cm of lengthening [<xref rid="R4" ref-type="bibr">4</xref>]. This circumstance is of particular relevance for lengthenings of 8 cm where 8 mm of lateral translation can occur. This scenario is less common in the setting of periarticular deformity correction, where average lengthening is 3 cm, and more common in the practice of stature lengthening, which is not the focus of this paper. With regard to stature lengthening, where an antegrade approach is typically used, an interesting phenomenon occurs: the nail and femur tend to bend into a few degrees of varus. This varus deflection counteracts the lateralization of the mechanical axis. Therefore, in more aggressive lengthenings, the use of an antegrade technique will typically keep the mechanical axis neutral. For a retrograde lengthening, the mechanical axis would need to be shifted the appropriate number of millimeters medially during planning to anticipate the valgus deviation. This will add a small amount of varus correction acutely to the correction. The reverse planning technique can be used as well [<xref rid="R5" ref-type="bibr">5</xref>].</p>
      </sec>
      <sec id="S4">
        <title>Location of the deformity</title>
        <p>The location of the deformity in the distal femur is important to determine. This technique is best suited for meta-diaphyseal deformities [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>]. A far distal deformity requiring a very “low” osteotomy may be better treated with a plate. An ILN can be inserted proximally to address rotation and shortening (<xref ref-type="fig" rid="F1">Figures 1a</xref>–<xref ref-type="fig" rid="F1">1c</xref>).</p>
        <p>
<fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>(a) This preop lateral radiograph shows a 13° flexion deformity of the distal femur. (b) Postop lateral shows a correction of the apex anterior deformity through an posterior opening wedge osteotomy stabilized with a plate and a proximal femoral lengthening with an ILN. (c) This far distal osteotomy would be difficult to control with an intramedullary implant.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig1"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig1_small"/></alternatives></fig>
</p>
        <p>Surgical steps:<list list-type="order"><list-item><p>Preoperative planning: There are many ways to plan for the deformity correction and lengthening [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R8" ref-type="bibr">8</xref>]. Whatever technique is used will require two considerations: first, the existing deformity needs to be measured. Second, the expected lateral deviation of the mechanical axis that occurs during lengthening [<xref rid="R4" ref-type="bibr">4</xref>] needs to be considered. Then an osteotomy site is picked, translation is accounted for, blocking screw position is planned, and nail length and width are selected (<xref ref-type="fig" rid="F2">Figures 2a</xref>–<xref ref-type="fig" rid="F2">2c</xref>) [<xref rid="R8" ref-type="bibr">8</xref>].</p><p>
<fig id="F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>(a) This 51 inch AP radiograph allows for deformity planning with correction of varus and shortening. The mechanical axis planning is used to determine the magnitude and location of the deformity. (b) The red lines show the planned path of the ILN that will ensure correction of mechanical axis. The lines also show the length of the nail. (c) The white lines are placed to designate the path of the nail, and the circles are used to mark the location of the blocking screws. These radiographic plans are brought into the OR for comparison with intraop fluoroscopy shots.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig2"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig2_small"/></alternatives></fig>
</p></list-item><list-item><p>Osteotomy site: The osteotomy site that was selected on the preoperative plan is located on the femur under fluoroscopy. A 10 mm incision is made in the lateral thigh at this level and taken through the iliotibial (IT) band. The incision can be extended for an IT band release. We release the IT band routinely for correction of valgus and lengthening and for large lengthenings (over 4 cm). A drill is then inserted with a protective sleeve, and multiple drill holes are created in one plane. This creates vent holes during reaming and marks the osteotomy site to help with blocking screw placement.</p></list-item><list-item><p>Blocking screws: When correcting coronal plane deformity blocking screws are inserted. The position of the screw needs to be decided as a part of the preoperative planning and replicated in the OR. For valgus deformity a blocking screw is placed lateral to the proposed path of the ILN (<xref ref-type="fig" rid="F3">Figure 3a</xref>). For varus deformity the blocking screw is placed medial to the path of the nail (<xref ref-type="fig" rid="F3">Figure 3b</xref>). An additional screw can be placed in the proximal fragment as well for optimal control. A blocking screw needs to be placed posterior to the path of the ILN (<xref ref-type="fig" rid="F3">Figures 3c</xref> and <xref ref-type="fig" rid="F3">3d</xref>).</p><p>
<fig id="F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>(a) This illustration shows the suggested position of the blocking screws for correction of a valgus deformity. The screws centered around the osteotomy are more typically used leaving the peripheral screws as an option. (b) The same planning can be used for correction of a varus deformity. The overlay of the hands is showing a principle called the “reverse rule of thumbs” whereby the bone is grabbed with the thumb and index fingers of both hands and a correction simulated. The blocking screws should be placed opposite the location of the thumb and index fingers. (c) In the sagittal plane, the blocking screws are inserted posterior to the ILN at the osteotomy site. The distal screw is the most important, but the proximal screw can also be used for a shorter nail. The peripheral screws are seldom needed. (d). This fluoroscopy shot shows ideal posterior blocking screw placement: close to the osteotomy site and lying against the ILN (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig3"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig3_small"/></alternatives></fig>
</p></list-item><list-item><p>Half pins: A half pin is inserted into the distal femur using cannulated technique. A K-wire is inserted posterior to the path of the IM nail and checked using C-arm. The wire is then over-drilled with a cannulated drill bit through a small incision. The solid half pin (5–6 mm) is then inserted (<xref ref-type="fig" rid="F4">Figure 4</xref>). A second half pin is inserted in the proximal femur, proximal to the tip of the ILN. Rotation should be accounted for in this step for later correction.</p><p>
<fig id="F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>A 6 mm half pin is seen in the typical location posterior to the path of the ILN.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig4"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig4_small"/></alternatives></fig>
</p></list-item><list-item><p>Distal fragment: The knee is flexed, and the distal femur is prepared through an arthrotomy either through or medial to the patellar tendon. A 2.4 mm K-wire is drilled in the center of the notch under AP and lateral fluoroscopy until it reaches the osteotomy site. The ACL 12 mm reamer is then inserted over the guide wire up to the osteotomy site taking care not to damage the patellar cartilage.</p></list-item><list-item><p>Osteotomy: The osteotomy is then performed with an osteotome through the previous drill hole incision under fluoroscopy. The reduction is performed with translation and rotational correction. The external fixator can then be placed to hold this reduction (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p><p>
<fig id="F5" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>A simple pin-to-bar frame is used to hold the reduction of the osteotomy.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig5"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig5_small"/></alternatives></fig>
</p></list-item><list-item><p>Reaming: Sequential reaming is then performed 1.5–2 mm over the nail diameter. There are different teachings on the correct way to prepare the canal. This will be further discussed.</p></list-item><list-item><p>ILN insertion: The external fixator is removed. The nail should slide into the canal without too much resistance. A mallet can be used, but if aggressive tapping is needed then we suggest removing the nail and reaming an additional 0.5–1.0 mm. The distal locking is then performed with the targeting device (<xref ref-type="fig" rid="F6">Figure 6</xref>). The rotation and alignment are checked and adjusted with the half pins. The proximal screws are inserted with a free hand technique.</p><p>
<fig id="F6" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>The AP fluoroscopy shot shows the distal femur after successful distal interlocking with the varus deformity corrected. The peri-osteotomy blocking screws are positioned to prevent varus deviation during lengthening. The external half pin is also seen in the field.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig6"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig6_small"/></alternatives></fig>
</p></list-item><list-item><p>Follow-up: Lengthening begins after a latency period and proceeds at approximately 1 mm per day. The patient is followed at regular intervals with radiographs checking for regenerate quality and joint contractures (<xref ref-type="fig" rid="F7">Figures 7a</xref> and <xref ref-type="fig" rid="F7">7b</xref>).</p><p>
<fig id="F7" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>(a) The lengthening is complete and the limb length is checked. The regenerate bone is filling in but is still plastic enough to allow for fine-tuning of the length. The long-standing X-ray can be affected by hip and knee joint muscle contractures yielding a false length measurement. This needs to be considered before over-lengthening the limb. (b) The final alignment and length are checked after ILN removal.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig7"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig7_small"/></alternatives></fig>
</p></list-item></list>
</p>
      </sec>
    </sec>
    <sec id="S5">
      <title>Results: femur</title>
      <sec id="S6">
        <title>Effect of acute deformity correction on the growth of the regenerate</title>
        <p>An acute correction of the femur coronal plane deformity (average 7°, maximum 15–20°) will not impact the ability of regenerate bone to form through a distal femoral osteotomy [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R9" ref-type="bibr">9</xref>–<xref rid="R11" ref-type="bibr">11</xref>]. At the 2016 Limb Lengthening and Reconstruction Society (LLRS) an abstract was presented reviewing a series of 27 patients all treated with simultaneous distal femoral deformity correction and lengthening with an ILN. In this cohort there were no nonunions after an acute correction of an average of 8° of deformity and gradual lengthening of an average of 3 cm of lengthening [<xref rid="R12" ref-type="bibr">12</xref>].</p>
      </sec>
      <sec id="S7">
        <title>Rate of lengthening</title>
        <p>As a general rule G.A. Ilizarov taught the world that bony distraction achieved optimal osteogenesis when performed at a rate of 1 mm per day split into at least four separate adjustments of 0.25 mm per day. With the precision interlocking (IL) nails available, rate can be strictly controlled. In our practice, distraction needs to be started four days after surgery at the accelerated rate of 1.32 mm per day (0.33 mm four times daily) for four days and then slowed to a rate of 0.99 mm per day (0.33 mm three times daily). Rate is then further fine-tuned based on regenerate formation observed during the postop period. We have not experienced any implant-related premature consolidation or nonunion in the femur using this formula (one premature consolidation occurred due to a non-compliant patient) [<xref rid="R13" ref-type="bibr">13</xref>]. Singh et al. [<xref rid="R14" ref-type="bibr">14</xref>] reported excellent results starting lengthening post operative day (POD) 3 at 1 mm/day. Other authors have used a more classic rate of 1 mm per day following seven days of latency, however, in their series the external magnet was unresponsive and they had difficulty achieving the final goal and had premature consolidation. These problems may have been related to excess “drag” at the distraction site created by too slow a lengthening rate [<xref rid="R15" ref-type="bibr">15</xref>].</p>
      </sec>
      <sec id="S8">
        <title>Minimally invasive osteotomy</title>
        <p>The role of minimally invasive osteotomy is believed to be paramount to the success of acute deformity correction followed by distraction. The creation of drill holes at the osteotomy site followed by reaming leads to the deposition of endosteal autograft at the osteotomy site. This pre-grafting is noticeable on the intraop radiographs (<xref ref-type="fig" rid="F8">Figure 8</xref>). Osteotomy is then achieved without ever visualizing the bone. The osteotome is directed by feel and by fluoroscopy. It is possible that the success of acute correction is in part due to the minimally invasive nature of this osteotomy [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R11" ref-type="bibr">11</xref>–<xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R15" ref-type="bibr">15</xref>–<xref rid="R17" ref-type="bibr">17</xref>]. An open osteotomy may drain the site of the autograft and ruin the regeneration potential. Therefore, the excellent results achieved with this combination of techniques cannot be assigned to any one variable and deserve further study to determine the impact of each variable on the end product. One series reported 4/10 nonunions which may be due to a distraction rhythm of 0.5 mm BID or due to use of the reamer-irrigator-aspirator or due to a more open osteotomy technique [<xref rid="R18" ref-type="bibr">18</xref>].</p>
        <p>
<fig id="F8" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>This intraop fluoroscopy frame shows a radio-opaque blush at the lateral aspect of the osteotomy site (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig8"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig8_small"/></alternatives></fig>
</p>
      </sec>
      <sec id="S9">
        <title>Pain control</title>
        <p>The United States is exiting an era of heavy narcotic prescribing by launching an initiative to drastically cut down on opioids. The field of limb deformity surgery in the US has relied greatly on prolonged narcotic use for the duration of the lengthening process and often the entire time that external fixator is on the patient. Based on promising results in pediatric patients [<xref rid="R19" ref-type="bibr">19</xref>], adult surgeons are moving toward the aggressive use of acetaminophen and non-steroidal anti-inflammatories (NSAIDs) with minimal narcotic backup [<xref rid="R20" ref-type="bibr">20</xref>]. There is concern that the use of NSAIDs may slow the healing requiring a different rate of distraction. Alternatively, the use of narcotics may have negatively affected the regenerate formation [<xref rid="R21" ref-type="bibr">21</xref>] and abandoning them could positively affect the bone formation going forward. The results of this paradigm shift will be seen in the coming months.</p>
      </sec>
      <sec id="S10">
        <title>Intraoperative external fixation</title>
        <p>The use of external fixation during this surgery is helpful for maintaining the deformity correction during the reaming process. Since the ILN will follow the path of the reamer we believe it is best to create that path with the bony deformity reduced and stabilized. The half pins also offer rigid control of the bone fragments. This helps to rotate the osteotomy to ensure it is complete, translate the bone fragments to achieve the desired reduction, and control the final rotation prior to interlocking. Some surgeons feel that the half pins and the external fixator are not necessary [<xref rid="R6" ref-type="bibr">6</xref>], however, they ensure a smooth procedure with reliable results [<xref rid="R17" ref-type="bibr">17</xref>]. One study showed that larger half pin size was associated with a more accurate correction of the mechanical axis [<xref rid="R12" ref-type="bibr">12</xref>].</p>
      </sec>
      <sec id="S11">
        <title>Rigid vs. flexible reaming</title>
        <p>The decision of whether to ream the femoral canal using rigid reamers or flexible reamers has been debated extensively. The advantage of rigid reaming is that the sagittal curve of the femur is minimized allowing for less over-reaming of the canal. This in turn gives the ILN a tighter fit with less potential for malalignment at the time of insertion or during the lengthening process [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R11" ref-type="bibr">11</xref>]. If performed correctly the rigid reamer can preferentially remove posterior cortical bone which some surgeons feel is important [<xref rid="R22" ref-type="bibr">22</xref>]. There are several advantages to flexible reaming. It is more convenient since it does not require special reamers. Rigid reamers have the potential to notch the anterior cortex putting the femur at greater risk for fracture [<xref rid="R16" ref-type="bibr">16</xref>], a problem unlikely to happen with flexible reamers. Over-reaming with flexible reamers has not been a problem with excellent alignment and healing obtained [<xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R17" ref-type="bibr">17</xref>].</p>
      </sec>
      <sec id="S12">
        <title>Distal curved vs. straight ILN</title>
        <p>The ILN comes with both curved and straight distal options. There has been little discussion as to the advantages of each. There may be an increased tendency to create a procurvatum deformity when using the curved nail [<xref rid="R22" ref-type="bibr">22</xref>]. In cases where the surgeon wants to correct a procurvatum deformity at the osteotomy site, a curved nail can be rotated 180° to extend the osteotomy site. We have found that the straight entry ILN will often contact the posterior cortex obviating the need for a blocking screw (<xref ref-type="fig" rid="F9">Figures 9a</xref> and <xref ref-type="fig" rid="F9">9b</xref>).</p>
        <p>
<fig id="F9" orientation="portrait" position="float"><label>Figure 9.</label><caption><p>(a) The intraop fluoroscopy image shows contact of the posterior cortex of the distal fragment with the ILN at the osteotomy site (arrow). (b) After 5 cm of lengthening the distal fragment has not been able to flex due to the cortical abutment (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig9"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig9_small"/></alternatives></fig>
</p>
      </sec>
    </sec>
    <sec id="S13">
      <title>Methods: tibia</title>
      <sec id="S14">
        <title>Tibial nailing: surgical technique</title>
        <p>Acute deformity correction of the tibia followed by distraction with an ILN is gaining popularity. Tibial nailing is more challenging than retrograde femoral nailing with regard to alignment control. The entry point of the tibial nail is difficult to pinpoint due to the need to flex the knee with subsequent poor AP fluoroscopic imaging. The suprapatellar approach to tibial preparation may help with alignment precision [<xref rid="R23" ref-type="bibr">23</xref>] although this has never been studied in deformity patients. Proximal tibia osteotomy, much like proximal tibial fractures, often requires the use of blocking screws and external fixation. The posterior blocking screw is critical in preventing flexion of the osteotomy. Coronal plane blocking screws also ensure that the nail stays central on the AP view.</p>
        <p>Surgical steps:<list list-type="order"><list-item><p>Preoperative planning: The tibia does not deviate from the mechanical axis during lengthening making planning straightforward. An osteotomy site is picked, translation is accounted for, blocking screw position is planned, and nail length and width are selected (<xref ref-type="fig" rid="F10">Figures 10a</xref> and <xref ref-type="fig" rid="F10">10b</xref>). Nail width is often quite limited in the isthmus requiring either a thinner nail or a shorter nail.</p><p>
<fig id="F10" orientation="portrait" position="float"><label>Figure 10.</label><caption><p>(a) The 51 inch standing film shows a diaphyseal valgus deformity and limb length discrepancy. (b) The path of the ILN is planned with the osteotomy site at the intersection of the red lines.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig10"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig10_small"/></alternatives></fig>
</p></list-item><list-item><p>Osteotomy site: The osteotomy site that was selected on the preoperative plan is located on the tibia under fluoroscopy. A 10 mm incision is made in proximal leg. A drill is then inserted with a protective sleeve, and multiple drill holes are created in one plane. This creates vent holes during reaming and marks the osteotomy site to help with blocking screw placement.</p></list-item><list-item><p>Blocking screws: When correcting coronal plane deformity, blocking screws are inserted. The position of the screw needs to be decided as a part of the preoperative planning. The distance of the screws from the osteotomy site and cortex should be replicated in the OR. For valgus deformity a blocking screw is placed lateral to the proposed path of the ILN (<xref ref-type="fig" rid="F11">Figure 11a</xref>). For varus deformity the blocking screw is placed medial to the path of the nail. An additional screw can be placed in the distal fragment as well for optimal control. The most critical blocking screw is placed posterior to the path of the IM nail in the proximal fragment. This will ensure the nail is not inserted in flexion and will prevent flexion from developing during lengthening (<xref ref-type="fig" rid="F11">Figures 11b</xref> and <xref ref-type="fig" rid="F11">11c</xref>).</p><p>
<fig id="F11" orientation="portrait" position="float"><label>Figure 11.</label><caption><p>(a) This shows a different patient’s X-rays. The valgus correction is maintained by placing blocking screws in the concavity of the deformity (lateral aspect). Peripheral blocking screws can be used as well. (b) The sagittal plane requires at least one blocking screw in the proximal fragment near the osteotomy (the screw shown at the entry site of the ILN is theoretical and is never used). (c) This lateral film shows a well-placed posterior blocking screw (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig11"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig11_small"/></alternatives></fig>
</p></list-item><list-item><p>Half pins: A half pin is inserted into the proximal tibia using cannulated technique. A K-wire is inserted posterior to the path of the IM nail usually superior and anterior to the fibular head and checked using C-arm. The wire is then over-drilled with a cannulated drill bit through a small incision. The solid half pin (5–6 mm) is then inserted. A second half pin is inserted in the distal tibia, distal to the tip of the ILN. Rotation should be accounted for in this step for later correction (<xref ref-type="fig" rid="F12">Figure 12</xref>).</p><p>
<fig id="F12" orientation="portrait" position="float"><label>Figure 12.</label><caption><p>In this unrelated case, the external fixator helps to maintain the reduction of the deformity correction after osteotomy during reaming. A suprapatellar approach was used in this case.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig12"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig12_small"/></alternatives></fig>
</p></list-item><list-item><p>Distal syndesmotic screw: The distal syndesmotic screw is placed to protect the ankle during distraction. We recommend a 4.5 mm fully threaded solid cortical screw.</p></list-item><list-item><p>Fibular osteotomy: The fibula is cut percutaneously by pre-drilling with a K-wire and then using an osteotome (<xref ref-type="fig" rid="F13">Figure 13</xref>).</p><p>
<fig id="F13" orientation="portrait" position="float"><label>Figure 13.</label><caption><p>The osteotome is inserted through a limited incision under fluoroscopy.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig13"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig13_small"/></alternatives></fig>
</p></list-item><list-item><p>Proximal fragment: The knee is flexed, and the proximal tibia is prepared through an arthrotomy either through or near the patellar tendon. A suprapatellar approach can also be used. A 2.4 mm K-wire is drilled under AP and Lateral fluoroscopy until it reaches the osteotomy site. The ACL 12 mm reamer is then inserted over the guide wire up to the osteotomy site.</p></list-item><list-item><p>Osteoplasty: The osteotomy is then performed with an osteotome through the previous drill hole incision under fluoroscopy. The reduction is performed with translation and rotational correction. The external fixator can then be secured to hold this reduction.</p></list-item><list-item><p>Reaming: Sequential reaming is then performed over-reaming the canal by 1.5–2 mm.</p></list-item><list-item><p>ILN insertion. The external fixator is loosened. The nail should slide into the canal without too much resistance. A mallet can be used, but if aggressive tapping is needed then we suggest removing the nail and reaming an additional 0.5–1.0 mm. The proximal locking is then performed with the targeting device. The rotation and alignment are checked and adjusted with the half pins. The distal interlock screws are inserted with a free hand technique.</p></list-item><list-item><p>Proximal syndesmotic screw: The proximal screw is placed using a cannulated technique. A guide wire is placed through the fibular head from lateral to medial. It is over-drilled and then a solid screw is inserted to prevent migration of the fibula during lengthening (<xref ref-type="fig" rid="F14">Figure 14</xref>).</p><p>
<fig id="F14" orientation="portrait" position="float"><label>Figure 14.</label><caption><p>In this unrelated case, the proximal syndesmotic screw also served as the posterior blocking screw (arrow).</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig14"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig14_small"/></alternatives></fig>
</p></list-item><list-item><p>Fasciotomy: It is routine to perform a percutaneous fasciotomy of the anterior compartment when acutely correcting a tibial deformity to prevent compartment syndrome [<xref rid="R18" ref-type="bibr">18</xref>].</p></list-item><list-item><p>Follow-up: Lengthening begins after a latency period and proceeds at approximately 0.75 mm per day. The patient is followed at regular intervals with radiographs checking for regenerate quality and joint contractures (<xref ref-type="fig" rid="F15">Figures 15a</xref> and <xref ref-type="fig" rid="F15">15b</xref>).</p><p>
<fig id="F15" orientation="portrait" position="float"><label>Figure 15.</label><caption><p>(a) The X-rays shown in <xref ref-type="fig" rid="F15">Figures 15a</xref> and <xref ref-type="fig" rid="F15">15b</xref> are a continuation of the patient presented in <xref ref-type="fig" rid="F10">Figures 10a</xref> and <xref ref-type="fig" rid="F10">10b</xref>. The end of distraction long-standing radiograph shows equal limb length and ideal alignment. (b) A lateral radiograph shows interval healing of the regenerate and ideal sagittal alignment.</p></caption><alternatives><graphic xlink:href="sicotj-3-25-fig15"/><graphic specific-use="thumbnail" xlink:href="sicotj-3-25-fig15_small"/></alternatives></fig>
</p></list-item></list>
</p>
      </sec>
    </sec>
    <sec id="S15">
      <title>Results: tibia</title>
      <sec id="S16">
        <title>Prophylactic peroneal nerve decompression</title>
        <p>It is clear that tibial lengthening places tension on the common peroneal nerve and can cause nerve damage [<xref rid="R24" ref-type="bibr">24</xref>, <xref rid="R25" ref-type="bibr">25</xref>]. Special consideration is given to the correction of valgus or rotational deformities in conjunction with lengthening. These realignment procedures will further stretch the peroneal nerve and therefore, require a peroneal nerve release. This is done at the beginning of the surgery under tourniquet. For varus deformity correction with lengthening the peroneal nerve release is not standard. For larger lengthening goals (stature lengthening or greater than 27% increase in tibial length) the release should be strongly considered [<xref rid="R26" ref-type="bibr">26</xref>]. In all cases of tibia lengthening the common peroneal nerve is at risk for injury, and nerve function needs to be closely monitored postoperatively during the lengthening process [<xref rid="R27" ref-type="bibr">27</xref>].</p>
      </sec>
      <sec id="S17">
        <title>Will acute deformity correction affect the growth of the regenerate?</title>
        <p>This topic is not as well studied as in the femoral counterpart. Acute deformity correction of in the tibia may affect the quality of the regenerate, as measured by the consolidation index and circumferential healing, greater than the effect seen in the femur. The consolidation index (CI) for femoral lengthening has been excellent, averaging 24–32 days/cm [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R16" ref-type="bibr">16</xref>] (faster than that seen with external fixation lengthening). These studies include very few tibia cases obscuring our ability to compare CI among tibia lengthening cases. The protocol we use for the tibial lengthening is slower than for femoral lengthening. The latency is seven days after which the tibia is lengthened at a rate of 1 mm per day split into four 0.25 mm lengthening sessions. This is done for four days and then slowed to 0.25 mm three times per day. This slower lengthening schedule has been helpful in protecting the osteotomy site’s ability to heal.</p>
      </sec>
      <sec id="S18">
        <title>Tibial bone healing</title>
        <p>The tibial consolidation rate is significantly slower than that of the femur using ILN [<xref rid="R11" ref-type="bibr">11</xref>]. The situation is further complicated by the asymmetric healing of the different tibial cortices. The deficiency is typically in the anterior portion of the regenerate. Responding to the deficient regenerate is complicated since a slower rate of distraction will help the anterior cortex while placing the posterior cortex at risk for premature consolidation. Most surgeons will avoid consolidation in favor of the posterior cortical healing. Surgical treatment is varied depending on the severity of the anterior defect but can include observation, percutaneous drilling, and injection of bone marrow aspirate concentrate, exchange nailing, open bone grafting, or a combination.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S19">
      <title>Discussion</title>
      <p>The ILN is a great advancement in the area of limb deformity and lengthening, particularly in the femur. Surgeons are still learning the capabilities and shortcomings of these devices. The quality of the available implants continues to improve. The tibia continues to challenge surgeons’ abilities to control deformity and bone formation during lengthening and remains an area where external fixation is incredibly useful.</p>
    </sec>
    <sec id="S20">
      <title>Conflict of interest</title>
      <p>Author ATF received no funding or financial benefit related to this work. Author ATF does function as a consultant for NuVasive, Smith &amp; Nephew, and Synthes. Author SRR received no funding or financial benefit related to this work. Author SRR does function as a consultant for NuVasive, Smith &amp; Nephew, and Stryker.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Landge</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Shabtai</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gesheff</surname>
<given-names>Specht SC</given-names></string-name>, <string-name><surname>Herzenberg</surname>
<given-names>JE</given-names></string-name> (<year>2015</year>) <article-title>Patient satisfaction after limb lengthening with internal and external devices</article-title>. <source>J Surg Orthop Adv</source>
<volume>24</volume>(<issue>3</issue>), <fpage>174</fpage>–<lpage>179</lpage>.<pub-id pub-id-type="pmid">26688988</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Karakoyun</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Kucukkaya</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Erol</surname>
<given-names>MF</given-names></string-name> (<year>2015</year>) <article-title>Does lengthening after acute correction negatively affect bone healing during distraction osteogenesis?</article-title>
<source>Acta Orthop Traumatol Turc</source>
<volume>49</volume>(<issue>4</issue>), <fpage>405</fpage>–<lpage>409</lpage>.<pub-id pub-id-type="pmid">26312468</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Horn</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Grimsrud</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Dagsgard</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Femoral lengthening with a motorized intramedullary nail</article-title>. <source>Acta Orthop</source>
<volume>86</volume>(<issue>2</issue>), <fpage>248</fpage>–<lpage>256</lpage>.<pub-id pub-id-type="pmid">25191936</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Burghardt</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Paley</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Specht</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Herzenberg</surname>
<given-names>JE</given-names></string-name> (<year>2012</year>) <article-title>The effect on mechanical axis deviation of femoral lengthening with an intramedullary telescopic nail</article-title>. <source>J Bone Joint Surg Br</source>
<volume>94</volume>(<issue>9</issue>), <fpage>1241</fpage>–<lpage>1245</lpage>.<pub-id pub-id-type="pmid">22933497</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Baumgart</surname>
<given-names>R</given-names></string-name> (<year>2009</year>) <article-title>The reverse planning method for lengthening of the lower limb using a straight intramedullary nail with or without deformity correction. A new method</article-title>. <source>Oper Orthop Traumatol</source>
<volume>21</volume>(<issue>2</issue>), <fpage>221</fpage>–<lpage>233</lpage>.<pub-id pub-id-type="pmid">19685230</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Baumgart</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Betz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schweiberer</surname>
<given-names>L</given-names></string-name> (<year>1997</year>) <article-title>A fully implantable motorized intramedullary nail for limb lengthening and bone transport</article-title>. <source>Clin Orthop</source>
<volume>343</volume>, <fpage>135</fpage>–<lpage>143</lpage>.</mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Accadbled</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Pailhé</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Cavaignac</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sales de Gauzy</surname>
<given-names>J</given-names></string-name> (<year>2016</year>) <article-title>Bone lengthening using the Fitbone(®) motorized intramedullary nail: the first experience in France</article-title>. <source>Orthop Traumatol Surg Res</source>
<volume>102</volume>(<issue>2</issue>), <fpage>217</fpage>–<lpage>222</lpage>.<pub-id pub-id-type="pmid">26874445</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Fragomen</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Rozbruch</surname>
<given-names>SR</given-names></string-name> (<year>2016</year>) <article-title>Lengthening of the femur with a remote controlled magnetic intramedullary nail: Retrograde technique</article-title>. <source>JBJS Essent Surg Tech</source>
<volume>6</volume>(<issue>2</issue>), <fpage>e20</fpage>.</mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Al-Sayyad</surname>
<given-names>MJ</given-names></string-name> (<year>2012</year>) <article-title>Lower limb lengthening and deformity correction using the Fitbone motorized nail system in the adolescent patient</article-title>. <source>J Pediatr Orthop B</source>
<volume>21</volume>(<issue>2</issue>), <fpage>131</fpage>–<lpage>136</lpage>.<pub-id pub-id-type="pmid">22301429</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Dinçyürek</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kocaoğlu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Eralp</surname>
<given-names>IL</given-names></string-name>, <string-name><surname>Bilen</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>Dikmen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Eren</surname>
<given-names>I</given-names></string-name> (<year>2012</year>) <article-title>Functional results of lower extremity lengthening by motorized intramedullary nails</article-title>. <source>Acta Orthop Traumatol Turc</source>
<volume>46</volume>(<issue>1</issue>), <fpage>42</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">22441451</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Krieg</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Lenze</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Speth</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Hasler</surname>
<given-names>CC</given-names></string-name> (<year>2011</year>) <article-title>Intramedullary leg lengthening with a motorized nail</article-title>. <source>Acta Orthop</source>
<volume>82</volume>(<issue>3</issue>), <fpage>344</fpage>–<lpage>350</lpage>.<pub-id pub-id-type="pmid">21561309</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="confproc">
<string-name><surname>Iobst</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rozbruch</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fragomen</surname>
<given-names>AT</given-names></string-name> (<year>2016</year>) <article-title>Simultaneous acute femoral deformity correction and gradual limb lengthening using the retrograde precice femoral nail: technique and clinical results</article-title>. <conf-name>Presented at the 25th Annual Scientific Meeting of the Limb Lengthening and Reconstruction Society: ASAMI North America</conf-name>, <conf-loc>Charleston, SC</conf-loc>, <conf-date>July 23</conf-date>.</mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kirane</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Fragomen</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Rozbruch</surname>
<given-names>SR</given-names></string-name> (<year>2014</year>) <article-title>Precision of the Precice internal bone lengthening nail</article-title>. <source>Clin Orthop Relat Res</source>, <volume>472</volume>(<issue>12</issue>), <fpage>3869</fpage>–<lpage>3878</lpage>.<pub-id pub-id-type="pmid">24682741</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lahiri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Igbal</surname>
<given-names>M</given-names></string-name> (<year>2006</year>) <article-title>The results of limb lengthening by callus distraction using an extending intramedullary nail (Fitbone) in non-traumatic disorders</article-title>. <source>J Bone Joint Surg Br</source>
<volume>88</volume>(<issue>7</issue>), <fpage>938</fpage>–<lpage>942</lpage>.<pub-id pub-id-type="pmid">16799000</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Schiedel</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Vogt</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Schuhknecht</surname>
<given-names>B</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>) <article-title>How precise is the Precice comparted to the ISKD in intramedullary limb lengthening? Reliability and safety in 26 procedures</article-title>. <source>Acta Orthop</source>
<volume>85</volume>(<issue>3</issue>), <fpage>293</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">24758320</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kucukkaya</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karakoyun</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Sokucu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Soydan</surname>
<given-names>R</given-names></string-name> (<year>2015</year>) <article-title>Femoral lengthening a deformity correction using the Fitbone motorized lengthening nail</article-title>. <source>J Orthop Sci</source>
<volume>20</volume>(<issue>1</issue>), <fpage>149</fpage>–<lpage>154</lpage>.<pub-id pub-id-type="pmid">25326815</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Rozbruch</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Birch</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Dahl</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Herzenberg</surname>
<given-names>JE</given-names></string-name> (<year>2014</year>) <article-title>Motorized intramedullary nail for management of limb length discrepancy and deformity</article-title>. <source>L Am Acad Orthop Surg</source>
<volume>22</volume>(<issue>7</issue>), <fpage>403</fpage>–<lpage>409</lpage>.</mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Tiefenboeck</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Zak</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bukaty</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wozasek</surname>
<given-names>GE</given-names></string-name> (<year>2016</year>) <article-title>Pitfalls in automatic limb lengthening – first results with an intramedullary lengthening device</article-title>. <source>Orthop Traumatol Surg Res</source>
<volume>102</volume>, <fpage>851</fpage>–<lpage>855</lpage>.<pub-id pub-id-type="pmid">27527249</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kay</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Leathers</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Directo</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Myung</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Skaggs</surname>
<given-names>DL</given-names></string-name> (<year>2011</year>) <article-title>Perioperative ketorolac use in children undergoing lower extremity osteotomies</article-title>. <source>J Pediatr Orthop</source>
<volume>31</volume>(<issue>7</issue>), <fpage>783</fpage>–<lpage>786</lpage>.<pub-id pub-id-type="pmid">21926877</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Dodwell</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Latorre</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>Parisini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Zwettler</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Chandra</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mulpuri</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Snyder</surname>
<given-names>B</given-names></string-name> (<year>2010</year>) <article-title>NSAID exposure and risk of nonunion: a meta-anaylsis of case-control and cohort studies</article-title>. <source>Calcif Tissue Int</source>
<volume>87</volume>(<issue>3</issue>), <fpage>193</fpage>–<lpage>202</lpage>.<pub-id pub-id-type="pmid">20552333</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Chrastil</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sampson</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Higgins</surname>
<given-names>TF</given-names></string-name> (<year>2013</year>) <article-title>Postoperative opioid administration inhibits bone healing in an animal model</article-title>. <source>Clin Orthop Relat Res</source>
<volume>471</volume>(<issue>12</issue>), <fpage>4076</fpage>–<lpage>4081</lpage>.<pub-id pub-id-type="pmid">23955193</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Kucukkaya</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karakoyun</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Erol</surname>
<given-names>MF</given-names></string-name> (<year>2016</year>) <article-title>The importance of reaming the posterior femoral cortex before inserting lengthening nails calculation of the amount of reaming</article-title>. <source>J Orthop Surg Res</source>
<volume>11</volume>, <fpage>11</fpage>.<pub-id pub-id-type="pmid">26772540</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Sanders</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>DiPasquale</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Jordan</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Arrington</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Sagi</surname>
<given-names>HC</given-names></string-name> (<year>2014</year>) <article-title>Semiextended intramedullary nailing of the tibia using a suprapatellar approach: radiographic results and clinical outcomes at a minimum of 12 months follow up</article-title>. <source>J Orthop Trauma</source>
<volume>28</volume>(<issue>Suppl 8</issue>), <fpage>S29</fpage>–<lpage>S39</lpage>.</mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Simpson</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Halliday</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hamilton</surname>
<given-names>DF</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Limb lengthening and peripheral nerve function – factors associated with deterioration of conduction</article-title>. <source>Acta Orthop</source>
<volume>84</volume>(<issue>6</issue>), <fpage>579</fpage>–<lpage>584</lpage>.<pub-id pub-id-type="pmid">24171677</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Nogueira</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Paley</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bhave</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title>Nerve lesions associated with limb lengthening</article-title>. <source>J Bone Joint Surg Am</source>
<volume>85-A</volume>(<issue>8</issue>), <fpage>1502</fpage>–<lpage>1510</lpage>.<pub-id pub-id-type="pmid">12925630</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Galardi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Comi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lozza</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Marchettini</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Novarino</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Facchini</surname>
<given-names>R</given-names></string-name> (<year>1990</year>) <article-title>Peripheral nerve damage during limb lengthening. Neurophysiology in five cases of bilateral tibial lengthening</article-title>. <source>J Bone Joint Surg (Br)</source>
<volume>72</volume>(<issue>1</issue>), <fpage>121</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">2298769</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<string-name><surname>Simpson</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Halliday</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hamilton</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mills</surname>
<given-names>K</given-names></string-name> (<year>2013</year>) <article-title>Limb lengthening and peripheral nerve function-factors associated with deterioration of conduction</article-title>. <source>Acta Orthop</source>
<volume>84</volume>(<issue>6</issue>), <fpage>579</fpage>–<lpage>584</lpage>.<pub-id pub-id-type="pmid">24171677</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <notes>
      <boxed-text position="float" orientation="portrait">
        <p>
<bold>Cite this article as:</bold> Fragomen AT &amp; Rozbruch SR (2017) Lengthening and deformity correction about the knee using a magnetic internal lengthening nail. SICOT J, <bold>3</bold>, 25</p>
      </boxed-text>
    </notes>
  </back>
</article>

</metadata></record><record><header><identifier>oai:pubmedcentral.nih.gov:5360108</identifier><datestamp>2017-04-04</datestamp><setSpec>frontsysneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Syst Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Syst Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Syst. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Systems Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5137</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5360108</article-id>
      <article-id pub-id-type="pmcid">PMC5360108</article-id>
      <article-id pub-id-type="pmc-uid">5360108</article-id>
      <article-id pub-id-type="doi">10.3389/fnsys.2017.00014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Breaking the Excitation-Inhibition Balance Makes the Cortical Network's Space-Time Dynamics Distinguish Simple Visual Scenes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Roland</surname>
            <given-names>Per E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/5375/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bonde</surname>
            <given-names>Lars H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/351635/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Forsberg</surname>
            <given-names>Lars E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harvey</surname>
            <given-names>Michael A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Faculty of Health Sciences, Center for Neuroscience, University of Copenhagen</institution>
        <country>Copenhagen, Denmark</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Department of Physiology, University of Fribourg</institution>
        <country>Fribourg, Switzerland</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Gilad Silberberg, Karolinska Institutet, Sweden</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Dirk Jancke, Ruhr University Bochum, Germany; Paolo Medini, Umeå University, Sweden</p>
        </fn>
        <corresp id="fn001">*Correspondence: Per E. Roland <email xlink:type="simple">mgt875@ku.dk</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>14</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2017 Roland, Bonde, Forsberg and Harvey.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Roland, Bonde, Forsberg and Harvey</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Brain dynamics are often taken to be temporal dynamics of spiking and membrane potentials in a balanced network. Almost all evidence for a balanced network comes from recordings of cell bodies of few single neurons, neglecting more than 99% of the cortical network. We examined the space-time dynamics of excitation and inhibition simultaneously in dendrites and axons over four visual areas of ferrets exposed to visual scenes with stationary and moving objects. The visual stimuli broke the tight balance between excitation and inhibition such that the network exhibited longer episodes of net excitation subsequently balanced by net inhibition, in contrast to a balanced network. Locally in all four areas the amount of net inhibition matched the amount of net excitation with a delay of 125 ms. The space-time dynamics of excitation-inhibition evolved to reduce the complexity of neuron interactions over the whole network to a flow on a low-(3)-dimensional manifold within 80 ms. In contrast to the pure temporal dynamics, the low dimensional flow evolved to distinguish the simple visual scenes.</p>
      </abstract>
      <kwd-group>
        <kwd>cerebral cortex</kwd>
        <kwd>mechanics of vision</kwd>
        <kwd>dynamical systems</kwd>
        <kwd>balanced network</kwd>
        <kwd>inhibition</kwd>
        <kwd>voltage sensitive dye</kwd>
      </kwd-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="0"/>
        <equation-count count="6"/>
        <ref-count count="64"/>
        <page-count count="19"/>
        <word-count count="14963"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>How do neurons in the brain collaborate to produce visual perception? This question has no satisfactory answer yet. The idea of neuron coding in vision builds on the notion that the temporal sequence of spikes from single neurons or a population of neurons is sufficient to distinguish different visual objects or scenes (Barlow, <xref rid="B5" ref-type="bibr">1961</xref>; Gross et al., <xref rid="B24" ref-type="bibr">1972</xref>; Richmond and Optican, <xref rid="B51" ref-type="bibr">1990</xref>). The spike trains are analyzed statistically or analyzed for their information content to find a match or correlation with the present scene or object. An alternative to these objectives is to use a dynamical systems approach and examine the evolution of the spiking in (abstract) state space. Forsberg et al. (<xref rid="B22" ref-type="bibr">2016</xref>) used both approaches, i.e., examined the temporal dynamics of spiking populations of neurons in the primary visual cortex in state space and examined the spike rates in single trials from the same population. Although both the temporal spike rate changes and the temporal spiking dynamics in state space reported whether a sharp or a smooth visual transient changed the visual scene, neither could differentiate simple visual scenes on a single trial basis. When one examines temporal structures of spike trains or membrane currents for information about a current visual scene and when one analyzes the temporal aspects of these variables in state space, one neglects what goes on in the remaining network, and one neglects the possibility that combinations of temporal and spatial evolution of spiking or membrane potential changes might be more efficient in distinguishing visual scenes.</p>
      <p>Therefore, we examined the space-time dynamics of the membrane potential changes of the visual areas 17, 18, 19, and 21 of the ferrets used by Forsberg et al. (<xref rid="B22" ref-type="bibr">2016</xref>). By space-time dynamics, we mean the progression of membrane current changes in the topological space made up of the cortical network of neurons. The cortical network of neurons is formed by the synaptic connected neurons having their cell bodies in the cerebral cortex. The evolutions of the membrane potentials over the four visual areas are described as trajectories and vectors in (mathematical abstract) state space. We found that within 50–90 ms after exposure to the visual scenes, the space-time dynamics reduced to a 3-dimensional state space where the trajectories of the membrane potential changes caused by the individual scenes clearly separated. These diverging flows on a low dimensional manifold show that the connectivity and spiking dynamics in the visual cortical network swiftly constrain the patterns of membrane potential changes to simple low dimensional solutions unique for each of the scenes. Although this succinctly describes the space-time interactions of the membrane potential changes in mathematical terms, it does not provide a biophysical explanation of the mechanisms.</p>
      <p>The visual scenes were very simple, composed of one stationary or moving bar. Creutzfeldt et al. (<xref rid="B13" ref-type="bibr">1974</xref>) showed that a moving bar first depolarized and then hyperpolarized the neurons in the primary visual cortex of the cat. Currently there seems to be a consensus that neurons in the primary visual cortex of carnivores and primates have a balance between excitation and inhibition during visual stimulation (Destexhe and Pare, <xref rid="B17" ref-type="bibr">1999</xref>; Anderson et al., <xref rid="B2" ref-type="bibr">2000</xref>; Monier et al., <xref rid="B40" ref-type="bibr">2003</xref>, <xref rid="B41" ref-type="bibr">2008</xref>; Priebe and Ferster, <xref rid="B47" ref-type="bibr">2005</xref>; Haider et al., <xref rid="B25" ref-type="bibr">2006</xref>; Rudolph et al., <xref rid="B57" ref-type="bibr">2007</xref>; Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>; Xue et al., <xref rid="B64" ref-type="bibr">2014</xref>; Dehghani et al., <xref rid="B15" ref-type="bibr">2016</xref>). The terms excitation and inhibition are used in several ways. In this context, balance between excitation and inhibition in the cortical network means that the excitatory membrane currents = inhibitory membrane currents (van Vreeswijk and Sompolinsky, <xref rid="B62" ref-type="bibr">1996</xref>). Alternatively the balance has been interpreted as balanced ratio between excitatory and inhibitory membrane conductances (Denéve and Machens, <xref rid="B16" ref-type="bibr">2016</xref> for a recent review). It does not matter too much which of these definitions of balance one adheres to, the point is that the balance is not instantaneous. If it were, there would be no excitatory spiking of the neurons. The membrane potential, however, cannot show the balance between excitatory and inhibitory membrane currents, because the membrane potential can be high during large inhibitory currents and conductances and currents can change markedly without affecting the membrane potential too much (Anderson et al., <xref rid="B2" ref-type="bibr">2000</xref>; Monier et al., <xref rid="B40" ref-type="bibr">2003</xref>, <xref rid="B41" ref-type="bibr">2008</xref>; Priebe and Ferster, <xref rid="B47" ref-type="bibr">2005</xref>; Haider et al., <xref rid="B25" ref-type="bibr">2006</xref>; Rudolph et al., <xref rid="B57" ref-type="bibr">2007</xref>; Okun and Lampl, <xref rid="B43" ref-type="bibr">2008</xref>; Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>; Xue et al., <xref rid="B64" ref-type="bibr">2014</xref>). The finding of Creutzfeldt et al. (<xref rid="B13" ref-type="bibr">1974</xref>) is still valid, although it does not say anything about the instantaneous balance between excitation and inhibition. The time derivative of the membrane potential reports this balance, because it equals the sum of the ionic currents through the membrane divided by the specific capacitance (the specific capacitance is regarded constant) (Equation 2, Methods). If the inhibition first increases after a delay, there would be a chance that excitation can spread through the cortical network. The question is how big this delay is.</p>
      <p><italic>In vivo</italic> patch clamp recordings of individual neurons in primary visual cortex have generally shown two types of responses. The excitatory conductance increased while the inhibitory conductance decreased or did not change initially, but thereafter increased with a delay of some 100–400 ms. For other stimuli and for other neurons, the excitatory and inhibitory conductances increased almost simultaneously; or the inhibitory conductances lagged the excitatory conductances with a small 10–20 ms delay (Anderson et al., <xref rid="B2" ref-type="bibr">2000</xref>; Monier et al., <xref rid="B40" ref-type="bibr">2003</xref>, <xref rid="B41" ref-type="bibr">2008</xref>; Priebe and Ferster, <xref rid="B47" ref-type="bibr">2005</xref>; Haider et al., <xref rid="B25" ref-type="bibr">2006</xref>; Rudolph et al., <xref rid="B57" ref-type="bibr">2007</xref>; Okun and Lampl, <xref rid="B43" ref-type="bibr">2008</xref>; Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>; Xue et al., <xref rid="B64" ref-type="bibr">2014</xref>). In these studies, the excitatory (inward) currents and inhibitory (outward) currents were measured in the cell bodies of only a limited number of neurons (typically 25–40). As cell body membranes only make up an estimated 2% of the total membrane surface of cortical neurons (Fiala and Harris, <xref rid="B21" ref-type="bibr">1999</xref>), such measurements say little about the balance of excitatory and inhibitory currents in the dendrites and axon terminals of the measured neurons (Williams and Mitchell, <xref rid="B63" ref-type="bibr">2008</xref>).</p>
      <p>In this report, we take a network approach and examine the space-time dynamics of the membrane potential changes with a voltage sensitive dye (VSD) (Cohen et al., <xref rid="B12" ref-type="bibr">1974</xref>) simultaneously in areas 17, 18, 19, 21. The cortical surface exposed for measurement was 12 mm<sup>2</sup> (assuming 70,000 neurons/mm<sup>3</sup> and that 50% of these contribute fluorescence to the VSD signal, VSD(t), the estimate of the number of neurons measured would be around 400,000). Voltage sensitive dyes reliably report changes in membrane potential of neurons (Cohen et al., <xref rid="B12" ref-type="bibr">1974</xref>). The voltage sensitive dye signal, VSD(t), reports relative increases and decreases of population membrane potential compared to baseline at the network scale and without any bias toward spiking probabilities, receptive fields and stimulus feature preferences (Berger et al., <xref rid="B8" ref-type="bibr">2007</xref>). Under the assumption that the membranes in a small volume of the cortical network from where the fluorescence originates can be regarded as one compartment, the dVSD(t)/dt of that compartment is the sum of the membrane currents multiplied by a constant (Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>) (Equation 3, Methods). The dVSD(t)/dt thus reports the instantaneous balance between excitatory currents and inhibitory currents in the network (Methods). If the balance changes toward net inhibition (no matter whether this is due to reduced excitatory currents or increased inhibitory currents) the dVSD(t)/dt significantly decreases below baseline fluctuations. Thus, we label significant decreases of the dVSD(t)/dt as net inhibition, NINH, and significant increases as net excitations, NEX.</p>
      <p>The dVSD(t)/dt has been used to measure excitation-inhibition balance in the cortex (Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>; Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>; Onat et al., <xref rid="B44" ref-type="bibr">2011a</xref>; Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). Onat et al. (<xref rid="B44" ref-type="bibr">2011a</xref>) showed that the balance between excitation and inhibition in response to a drifting grating, at 100 ms goes into NINH and then switches to NEX. This and the other dVSD(t)/dt studies showed the temporal characteristics of the excitation- inhibition balance at one location or averaged from all locations. However, to our knowledge, the space-time evolution of inhibition and the balance between excitation and inhibition has not been explored.</p>
      <p>NEX and NINH evolved with similar space-time dynamics in all four visual areas and distinguished the visual scenes. The visual stimuli disrupted the tight balance between excitation and inhibition and drove the network into a regime tolerating large amplitude NEX and NINHs. However, at each cortical spot in the four visual areas, the amount of integrated NEX and NINH were strongly correlated, showing that net-excitation after longer delays became balanced with net-inhibition overall in the exposed part of the cortical network.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and methods</title>
      <sec>
        <title>Animals</title>
        <p>The voltage sensitive signals VSDi(t) were measured in 8 female adult ferrets. These animals also participated in the study of Harvey and Roland (<xref rid="B27" ref-type="bibr">2013</xref>) but none of the results presented in this study have been presented in Harvey and Roland (<xref rid="B27" ref-type="bibr">2013</xref>) or elsewhere. Laminar action potentials were measured at the border between areas 17/18 in 10 adult female ferrets of which 6 also had their VSD<sub>i</sub>(t) measured. The Regional Ethics Committee of Stockholm had approved all procedures. The ferrets were anesthetized and artificially ventilated with 1% isofluran mixed with N<sub>2</sub>O:O<sub>2</sub>, 1:1 and paralyzed with pancuronium bromide throughout the experiments. A left-sided craniotomy with a chamber affixed to the skull exposed cortical areas 17, 18, 19 and 21. The end-expiratory partial pressure of CO<sub>2</sub>, pCO2, was maintained between 3.5 and 4.5 KPa.</p>
      </sec>
      <sec>
        <title>Stimuli</title>
        <p>In all animals, known cortical landmarks were used to guide a single electrode penetration at the estimated crossing of the vertical and horizontal meridian in areas 17/18. The receptive field (RF) at this area was then mapped using an m-sequence method (Reid et al., <xref rid="B50" ref-type="bibr">1997</xref>). The monitor position was then adjusted to be precisely centered to this RF location.</p>
        <p>Stimuli were presented in a pseudorandom order on a video monitor with a refresh rate of 144 Hz located 57 cm in front of the animal (Cambridge Research Systems, Kent UK). Stimuli consisted of 1° × 2° horizontal bars (64.5 cd m<sup>−2</sup>) on a homogenous gray background (7.2 cd m<sup>−2</sup>). There were six conditions: (1) A bar moving downwards from the center of field of view (CFOV) with a velocity of 25.4° s<sup>−1</sup> for 413 ms along the vertical meridian. (2) A bar moving upward from the CFOV with a velocity of 25.4° s<sup>−1</sup> for 413 ms along the vertical meridian. (3) Upward and (4) downward moving bars initially flashed 10.5° below and 10.5° above the center of field of view (CFOV) respectively and moving a total of 21° with a velocity of 25.4° s<sup>−1</sup> along the vertical meridian for a period of 825 ms with start and end points equidistant from the screens center. (5) A single stationary bar was presented at the CFOV for 250 ms. In addition (6) a no-stimulus condition was included, consisting of a homogenous gray screen (7.2 cd m<sup>−2</sup>) presented continuously in between the stimulus conditions. Each of these six conditions was repeated 50 times.</p>
      </sec>
      <sec>
        <title>Voltage sensitive dye measurements</title>
        <p>The procedures were described in detail recently (Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>).</p>
        <p>The cortex was stained for 2 h with the voltage sensitive dye RH1838 (0.53 mg ml<sup>−1</sup>; <italic>n</italic> = 3) or RH1691 (0.53 mg ml<sup>−1</sup>; <italic>n</italic> = 5) (Optical Imaging, Rehovot, Israel). Imaging was centered on the initial recording site and acquired using a 464-channel photodiode array, (H469-IV WuTech Instruments Gaithersburg, MD) Images of the voltage sensitive dye signal were acquired at a rate of 1.6 kHz, stimulus presentation was synchronized to the electrocardiogram, and respiration stopped during stimulus presentation. The voltage sensitive dye signal, VSD(t), in most animals (<italic>n</italic> = 7) covered both the representations of the CFOV at the 17/18 border and the CFOV representation at 19/21 border.</p>
      </sec>
      <sec>
        <title>Laminar electrophysiology</title>
        <sec>
          <title>A: ferrets having the VSD(t) measured</title>
          <p>The multiunit activity was recorded with single shank, 16 channel, laminar probes (NeuroNexus, Ann Arbor, MI) with recording site resistances of 2–3 MΩ, and leads separated by 100 μm. The signal was digitally band pass filtered between100 Hz and 10 KHz. At each recording site, receptive fields were first mapped using the methodology noted above. For electrode penetrations in cortex mapping the CFOV, the receptive fields in the granular layer were less than 3°.</p>
        </sec>
        <sec>
          <title>Current source density</title>
          <p>We estimated current source densities from the second spatial derivative of the local field potentials in filtered (0.5–600 Hz) original data files (Rappelsberger et al., <xref rid="B49" ref-type="bibr">1981</xref>). The data files were averaged over 50 trials for each lead either from a single stationary bar or from whole screen flashes of 1 Hz. Layer 4 was estimated to start where the early sink appeared (the sink being at the upper part of layer 4), the supragranular and infragranular layers above respective below layer 4 (Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>).</p>
        </sec>
      </sec>
      <sec>
        <title>Data analysis voltage sensitive dye</title>
        <p>The voltage sensitive dye signals were analyzed up to 800 ms after the start of the stimulus. The details of the analysis have been described elsewhere (Roland et al., <xref rid="B55" ref-type="bibr">2006</xref>; Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>; Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). The signal in the blank (background alone) condition was subtracted from the signal of the stimulus conditions and divided by the background fluorescence to yield the fractional fluorescence (ΔF/F<sub>0</sub>) referred to here as VSD<sub>i</sub>(t). Usually the VSD<sub>i</sub>(t) of 8–12 trials were averaged to give one time-series VSD(t).</p>
        <sec>
          <title>Cytoarchitectonics</title>
          <p>Six of the eight ferrets had their cytoarchitectural borders determined between areas 17 and 18, 18 and 19 and 19 and 21. Their brains were sectioned, stained and the cytoarchitectural borders determined. The sections were reconstructed to a volume and the borders overlaid the hexagonal map of the VSD(t) (<bold>Figure 4</bold>) as described in detail in Harvey and Roland (<xref rid="B27" ref-type="bibr">2013</xref>). The individual VSD(t) with the cytoarchitectural borders were aligned as described in detail in Harvey et al. (<xref rid="B28" ref-type="bibr">2009</xref>), to produce the average cytoarchitectural borders in Figures <xref ref-type="fig" rid="F1">1</xref>, <bold>3</bold>, <bold>4</bold> and Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>.</p>
          <fig id="F1" position="float">
            <label>Figure 1</label>
            <caption>
              <p><bold>Original averaged data from the cortex at the red retinotopic zone for the CFOV. (A)</bold> Relation between dVSD(t)/dt (peak value 4.2 10<sup>−5</sup>) in upper layers (red curve) and supragranular MUA spiking rate (peak value 41 Hz) from cortex mapping the CFOV; (Animal 4, penetration 6). <bold>(B)</bold> The contour plots are identical snapshots of the mean VSD(t) of 6 animals at absolute maximum (103 ms, stationary bar stimulus) to show the red sampling area mapping the CFOV from where the temporal course of the mean VSD (t) and mean dVSD(t)/dt were sampled. The red arrow (left) marks the location where the mapping of the bar started for the 3 stimuli initially presented at CFOV. The 2 arrows (right) mark where the mappings of the bars moving from the peripheral FOV started. Stimulus start 0 ms. The stationary square displayed for 250 ms had an OFF response, moving bars did not. Mean ± standard error of mean (SEM) shown (<italic>n</italic> = 7 animals) for respective stimulus (top). Bars starting in the C-zone evoked sharp net excitatory transients followed by net inhibitions, shown in the dVSD(t)/dt plots; whereas the bars moving toward the CFOV evoked early and late net excitations (blue arrows), which after the bar had been mapped at cortex representing the CFOV (after 450 ms) was followed by net inhibition.</p>
            </caption>
            <graphic xlink:href="fnsys-11-00014-g0001"/>
          </fig>
        </sec>
        <sec>
          <title>State space analysis of dVSD(t) trajectory differences in the time domain</title>
          <p>In each animal, the 4 photodiode channels sampling from the cortex mapping the CFOV, were chosen. The mean of dVSD(t)/dt from these 4 channels in one animal is a time vector for one stimulus condition. A principal component analysis, PCA, was then performed on the data matrix for the 2 stimulus conditions to be compared in state space for all 8 animals. The first 3 components accounted for 88–97% of the total variance. For each condition and animal, the first three principal components were used as regressors against the time vector of the condition to obtain a beta-estimate for each principal component, showing how well it describes the condition. The polynomial of principal components times the beta-estimates was then calculated to show how a particular condition is described by all three principal components. The difference between two conditions' polynomials within an animal was further calculated to describe how the two conditions differ in the same 3-dimensional state space as a function of time. Features in the time series of the conditions that are not part of the common 3-dimensional state space are thus effectively removed and thereby not compared between conditions. Across animals, a statistical <italic>t</italic>-test was used to test if the null-hypothesis “no difference between conditions” in any given time point could be rejected in the given state space. False Discovery Rate was finally used to correct for multiple comparisons over time (FDR at 0.05).</p>
        </sec>
        <sec>
          <title>Net excitation and net inhibition</title>
          <p>Experimentally the change in the VSD(t) is proportional to the change in the average membrane potential Vm(t) of a small population of neurons (Petersen et al., <xref rid="B46" ref-type="bibr">2003</xref>; Ferezou et al., <xref rid="B20" ref-type="bibr">2006</xref>). Thus:</p>
          <disp-formula id="E1">
            <label>(1)</label>
            <mml:math id="M1">
              <mml:mrow>
                <mml:mtext>dVSD</mml:mtext>
                <mml:mo stretchy="false">(</mml:mo>
                <mml:mtext>t</mml:mtext>
                <mml:mo stretchy="false">)</mml:mo>
                <mml:mo>/</mml:mo>
                <mml:mtext>dt </mml:mtext>
                <mml:mo>≈</mml:mo>
                <mml:mtext>k </mml:mtext>
                <mml:msub>
                  <mml:mrow>
                    <mml:mtext>dV</mml:mtext>
                  </mml:mrow>
                  <mml:mtext>m</mml:mtext>
                </mml:msub>
                <mml:mo stretchy="false">(</mml:mo>
                <mml:mtext>t</mml:mtext>
                <mml:mo stretchy="false">)</mml:mo>
                <mml:mo>/</mml:mo>
                <mml:mtext>dt</mml:mtext>
              </mml:mrow>
            </mml:math>
          </disp-formula>
          <p>The change in the membrane potential is the sum of the ionic currents divided by the specific capacitance:</p>
          <disp-formula id="E2">
            <label>(2)</label>
            <mml:math id="M2">
              <mml:mtable columnalign="left">
                <mml:mtr>
                  <mml:mtd>
                    <mml:msub>
                      <mml:mtext>dV</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>/</mml:mo>
                    <mml:mtext>dt</mml:mtext>
                    <mml:mo>=</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:mn>1</mml:mn>
                    <mml:mo>/</mml:mo>
                    <mml:msub>
                      <mml:mtext>C</mml:mtext>
                      <mml:mrow>
                        <mml:mtext>m</mml:mtext>
                      </mml:mrow>
                    </mml:msub>
                    <mml:mtext> </mml:mtext>
                    <mml:mo stretchy="false">[</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Na</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msub>
                      <mml:mtext>E</mml:mtext>
                      <mml:mrow>
                        <mml:msup>
                          <mml:mtext>Na</mml:mtext>
                          <mml:mo>+</mml:mo>
                        </mml:msup>
                      </mml:mrow>
                    </mml:msub>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>+</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Ca</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                        <mml:mo>+</mml:mo>
                      </mml:mrow>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Ca</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                        <mml:mo>+</mml:mo>
                      </mml:mrow>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                  </mml:mtd>
                </mml:mtr>
                <mml:mtr>
                  <mml:mtd>
                    <mml:mtext>                          </mml:mtext>
                    <mml:mo>+</mml:mo>
                    <mml:mtext> </mml:mtext>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Cl</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>−</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Cl</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>−</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>+</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mtext>K</mml:mtext>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mtext>k</mml:mtext>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo stretchy="false">]</mml:mo>
                  </mml:mtd>
                </mml:mtr>
              </mml:mtable>
            </mml:math>
          </disp-formula>
          <p>In which C<sub>m</sub> is the specific capacitance of these membranes, E is the reversal potential, and g the conductance. Then under the assumption that the membranes in a small volume of the cortex from where the fluorescence originates can be regarded as one compartment (Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>; Roland, <xref rid="B54" ref-type="bibr">2010</xref>), the dVSD(t)/dt of that compartment is:</p>
          <disp-formula id="E3">
            <label>(3)</label>
            <mml:math id="M3">
              <mml:mtable columnalign="left">
                <mml:mtr>
                  <mml:mtd>
                    <mml:mtext>dVSD</mml:mtext>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>/</mml:mo>
                    <mml:mtext>dt</mml:mtext>
                    <mml:mo>≈</mml:mo>
                    <mml:mtext>  </mml:mtext>
                    <mml:mo>−</mml:mo>
                    <mml:mtext>  k</mml:mtext>
                    <mml:mo>/</mml:mo>
                    <mml:msub>
                      <mml:mtext>C</mml:mtext>
                      <mml:mrow>
                        <mml:mtext>m</mml:mtext>
                      </mml:mrow>
                    </mml:msub>
                    <mml:mo stretchy="false">[</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Na</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msub>
                      <mml:mtext>E</mml:mtext>
                      <mml:mrow>
                        <mml:msup>
                          <mml:mtext>Na</mml:mtext>
                          <mml:mo>+</mml:mo>
                        </mml:msup>
                      </mml:mrow>
                    </mml:msub>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>+</mml:mo>
                    <mml:mtext>  </mml:mtext>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Ca</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                        <mml:mo>+</mml:mo>
                      </mml:mrow>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Ca</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                        <mml:mo>+</mml:mo>
                      </mml:mrow>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                  </mml:mtd>
                </mml:mtr>
                <mml:mtr>
                  <mml:mtd>
                    <mml:mtext>                                    </mml:mtext>
                    <mml:mo>+</mml:mo>
                    <mml:mtext> </mml:mtext>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Cl</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>−</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mrow>
                            <mml:mtext>Cl</mml:mtext>
                          </mml:mrow>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>−</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>+</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>g</mml:mtext>
                          <mml:mtext>K</mml:mtext>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:msub>
                      <mml:mtext>V</mml:mtext>
                      <mml:mtext>m</mml:mtext>
                    </mml:msub>
                    <mml:mo stretchy="false">(</mml:mo>
                    <mml:mtext>t</mml:mtext>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo>−</mml:mo>
                    <mml:msup>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mtext>E</mml:mtext>
                          <mml:mtext>k</mml:mtext>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                    </mml:msup>
                    <mml:mo stretchy="false">)</mml:mo>
                    <mml:mo stretchy="false">]</mml:mo>
                  </mml:mtd>
                </mml:mtr>
              </mml:mtable>
            </mml:math>
          </disp-formula>
          <p>At the network scale, at which our measurements of the dVSD(t)/dt were done, the membrane compartment comprises the membranes of thousands of neurons at a single spot. Although a few of these neurons may be depolarized over their spiking threshold, these action potentials will not be detectable in the VSD(t) (Grinvald et al., <xref rid="B23" ref-type="bibr">1994</xref>; Arieli et al., <xref rid="B3" ref-type="bibr">1995</xref>; Senseman, <xref rid="B58" ref-type="bibr">1996</xref>; Roland, <xref rid="B53" ref-type="bibr">2002</xref>; Slovin et al., <xref rid="B59" ref-type="bibr">2002</xref>; Petersen et al., <xref rid="B46" ref-type="bibr">2003</xref>; Jancke et al., <xref rid="B32" ref-type="bibr">2004</xref>; Ferezou et al., <xref rid="B20" ref-type="bibr">2006</xref>; Roland et al., <xref rid="B55" ref-type="bibr">2006</xref>; Ahmed et al., <xref rid="B1" ref-type="bibr">2008</xref>; Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>; Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>; Ayzenshtat et al., <xref rid="B4" ref-type="bibr">2010</xref>; Chavane et al., <xref rid="B9" ref-type="bibr">2011</xref>; Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>; Müller et al., <xref rid="B42" ref-type="bibr">2014</xref>). The reason most likely is that the fraction of membrane depolarized over spiking threshold is too minute. Consequently, the VSD(t) will reflect a population membrane potential above the reversal potentials for Cl<sup>−</sup> and K<sup>+</sup> currents and below the reversal potentials for Na<sup>+</sup> and Ca<sup>2+</sup>. The dVSD(t)/dt, thus indicates the (weighted sum of) membrane currents of the membranes in the compartment.</p>
          <p>Definition of net excitation and net inhibition: For a single spot in the network where the dVSD(t)/dt is measured a significant decrease from baseline fluctuations of dVSD(t)/dt is a net inhibition, NINH(t) and a significant increase is a net excitation, NEX(t).</p>
          <p>The baseline fluctuations were determined in the pre-stimulus period. Statistically significant decreases and increases from baseline fluctuations <italic>p</italic> &lt; 0.05 (see below).</p>
          <p>For the analysis of net-excitation and net-inhibition, the VSD(t) was filtered with a temporal Gaussian filter σ = 40 ms and then the temporal derivative dVSD(t)/dt was calculated (Matlab®). A filter of σ = 12 ms did not change the results. No spatial filtering was done, but in the figures and movies the original hexagon pixels were sub-sampled.</p>
        </sec>
      </sec>
      <sec>
        <title>Statistical significance</title>
        <p>In each animal, statistical comparisons between the pre-stimulus time interval and the post-stimulus interval for all 464 photodiode channels are corrected for mass significance with a false discovery rate of 0.05 (Benjamini and Hochberg, <xref rid="B7" ref-type="bibr">1995</xref>). The results are movies and snapshot sequences of only statistically significant dVSD(t)/dt increases and decreases (<italic>p</italic> &lt; 0.05). As our definition of NEX and NINH is significant increases and decreases from baseline fluctuations in the dVSD(t)/dt in the pre-stimulus period, it implies that these fluctuations will be smaller than the NEX(t) and NINH(t), and that there might be periods in the post-stimulus interval in which NEX(t) and NINH(t) are not defined. Non-statistically significant parts of the cortex will have the same color as the pre-stimulus interval in figures and movies. Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref> and <bold>Figures 3</bold>, <bold>4</bold> show the spatio-temporal evolution of the NEX(t) and NINH(t) (FDR at 0.05).</p>
      </sec>
      <sec>
        <title>State space analysis of dVSD(t)/dt trajectories</title>
        <p>To produce Figure <xref ref-type="fig" rid="F2">2</xref>, The dVSD(t)/dt time-series underwent PCA. For each of the 6 cortical zones in the figure, the data matrix comprised 6 conditions. The PCA was done using Singular Value Decomposition as implemented in the Matlab® PCA routine.</p>
        <disp-formula id="E4">
          <label>(4)</label>
          <mml:math id="M4">
            <mml:mrow>
              <mml:mstyle mathvariant="bold" mathsize="normal">
                <mml:mi>X</mml:mi>
              </mml:mstyle>
              <mml:mo>=</mml:mo>
              <mml:mstyle mathvariant="bold" mathsize="normal">
                <mml:mi>U</mml:mi>
                <mml:mi>Σ</mml:mi>
              </mml:mstyle>
              <mml:msup>
                <mml:mstyle mathvariant="bold" mathsize="normal">
                  <mml:mi>V</mml:mi>
                </mml:mstyle>
                <mml:mtext>T</mml:mtext>
              </mml:msup>
              <mml:mo>,</mml:mo>
              <mml:mo> </mml:mo>
              <mml:mstyle mathvariant="bold" mathsize="normal">
                <mml:mi>X</mml:mi>
              </mml:mstyle>
              <mml:mo>∈</mml:mo>
              <mml:msup>
                <mml:mi>ℝ</mml:mi>
                <mml:mrow>
                  <mml:mi>N</mml:mi>
                  <mml:mo>×</mml:mo>
                  <mml:mi>L</mml:mi>
                </mml:mrow>
              </mml:msup>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p>where [<italic>N</italic> = <italic>N</italic><sub><italic>times</italic></sub> · <italic>N</italic><sub><italic>animals</italic></sub> · <italic>N</italic><sub><italic>conditions</italic></sub> = 1, 000 · 8 · 6 = 48, 000] is the number of observations and <italic>L</italic> is the number of photodiode channels (for example 15 if the zone of cortex was monitored by 15 channels). When all of the exposed cortex was examined, <italic>L</italic> = 464 (corresponding to the 464 photodiode channels monitoring all 4 cortical areas).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>State space trajectories of the dVSD(t)/dt in different cortical zones are similar. (A)</bold> The 5 visual scenes and their associated trajectories in 3-dimensional state space (Methods) from the red zone. Each trajectory is a projection of the first 3 principal components (for all 8 animals) over time shown in ms after the stimulus start by the black numbers. FP is the origo of the state space (fixed-point). The first row of trajectories comes from the red zone, i.e., the cortex mapping the CFOV. The red parts of the trajectories show the time intervals with the largest acceleration. <bold>(B)</bold> Trajectories from the red (19/21 area) zone also mapping the CFOV. Red parts of trajectories show the fastest acceleration for the bars initially mapped in cortex representing CFOV; the last two red parts are shown for comparison with A. <bold>(C)</bold> Cortical zones in which the stimulus in the top row was <italic>not</italic> mapped according to retinotopy and active evoked spiking. <bold>(D)</bold> The dVSD(t)/dt trajectories for each of the non-mapping zones in <bold>(C)</bold>. Red parts of trajectories only shown for comparison with <bold>(A,B)</bold>. In all zones the trajectories were significantly different (FDR at 0.05) from the pre-stimulus period in the time interval 40–200 ms for conditions with stimulus starting in CFOV and for interval 105–525 ms for the last 2 conditions. Notice the similarities in trajectories irrespective of whether the stimulus was mapped by retinotopic localized spiking or not.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0002"/>
        </fig>
        <p>The vectors <bold>U</bold> = [<italic>u</italic><sub>1</sub><italic>u</italic><sub>2</sub><italic>u</italic><sub>3</sub> … <italic>u</italic><sub><italic>N</italic></sub>] hold the coordinates of the observations in the PCA vector space spanned by <inline-formula><mml:math id="M8"><mml:msup><mml:mrow><mml:mstyle mathvariant="bold"><mml:mtext>V</mml:mtext></mml:mstyle></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext class="textrm" mathvariant="normal">T</mml:mtext></mml:mstyle></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>…</mml:mo><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mstyle class="text"><mml:mtext class="textrm" mathvariant="normal">T</mml:mtext></mml:mstyle></mml:mrow></mml:msup></mml:math></inline-formula>. The diagonal matrix <inline-formula><mml:math id="M7"><mml:mrow><mml:mstyle mathvariant="bold" mathsize="normal"><mml:mi>Σ</mml:mi></mml:mstyle><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mtext> </mml:mtext></mml:mrow></mml:mtd><mml:mtd><mml:mo>⋱</mml:mo></mml:mtd><mml:mtd><mml:mrow><mml:mtext> </mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> holds the singular values which scales vectors in <bold>U</bold> to reflect the variance explained by each of the <italic>L</italic> principal components. The state-space trajectories in 3 dimensions are the (<italic>u</italic><sub>1<italic>i</italic></sub>, <italic>u</italic><sub>2<italic>i</italic></sub>, <italic>u</italic><sub>3<italic>i</italic></sub>) coordinates, plotted over a time series of i's (Figures <xref ref-type="fig" rid="F2">2</xref>, <bold>5</bold>, Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). Note that the (<italic>u</italic><sub>1<italic>i</italic></sub>, <italic>u</italic><sub>2<italic>i</italic></sub>, <italic>u</italic><sub>3<italic>i</italic></sub>) ≠ (<italic>x</italic><sub><italic>i</italic>1</sub><italic>x</italic><sub><italic>i</italic>2</sub><italic>x</italic><sub><italic>i</italic>3.</sub>). Figure <xref ref-type="fig" rid="F2">2</xref> shows the trajectories of the first three components.</p>
      </sec>
      <sec>
        <title>Balance of net excitation net inhibition and delay</title>
        <p>To examine the balance between NEX and NINH we calculated the time-averages, E(NEX) and E(NINH) of the NEX(t) and NINH(t) for the post-stimulus time intervals in which NEX(t) and NINH(t) were defined in the post-stimulus period from 0 to 800 ms. We calculated the integrals of NEX(t) over the time interval the NEX(t) was defined, added the integrals and divided by the number of time frames in the interval the NEX(t) was defined. Similar for NINH(t).</p>
        <p>This produced the hexagon maps of E(NEX) and E(NINH) in <bold>Figure 6</bold>.</p>
        <p>Thereafter we determined the delay between the maximum NEX, NEXmax; and minimum of NINH, NINHmin, in all pixels where NEX(t) and NINH(t) were defined for each condition in each animal and calculated a mean delay for that condition in each animal.</p>
        <p>We also calculated the correlation between E(NEX) and E(NINH) pixel by pixel for each condition and animal (<bold>Figure 6</bold>).</p>
      </sec>
      <sec>
        <title>NEX and NINH velocities</title>
        <p>The NEX and NINH velocities of propagation were determined by the wave-front algorithm of Ahmed et al. (<xref rid="B1" ref-type="bibr">2008</xref>). As the algorithm assumes that the parameter amplitude progresses as an increase (see Figure 3 in Ahmed et al., <xref rid="B1" ref-type="bibr">2008</xref>) the –NINH(t) = −dVSD(t)/dt file was used. Shortly, a region of interest was made covering the progress of the NEX or NINH in an animal. The mean dVSD(t)/dt for the time interval chosen, dVSD (respective −dVSD(t)/dt) was calculated. Then all values of dVSD(t)/dt &gt; dVSD were divided in 10 amplitude levels and the cortical positions (mm) of these amplitude levels vs. time (ms) were plotted and a linear regression was made giving the velocity in mm/ms and its statistical significance determined (in this paper &lt; 0.01; <bold>Figure 7</bold>. For further details see Ahmed et al. (<xref rid="B1" ref-type="bibr">2008</xref>). The algorithm, thus, does not require a progress with constant amplitude and velocity.</p>
      </sec>
      <sec>
        <title>NEX and NINH phase lags between areas</title>
        <p>We used the algorithm of Müller et al. (<xref rid="B42" ref-type="bibr">2014</xref>). This algorithm makes a Hilbert transform of the data under the assumption that all parts of the cortex monitored can be seen as one wave of NEX or one wave of NINH. The different positions on the cortex, x, and hence the different cortical areas will be in different phases if there are delays in the propagation of NEX or NINH between areas. The real part at position x is dVSD<sub><italic>x</italic></sub>(t) = Re (x, t). The phase, z = x + iy, is a complex number.</p>
        <p>The algorithm calculates the imaginary part as:</p>
        <disp-formula id="E5">
          <label>(5)</label>
          <mml:math id="M5">
            <mml:mrow>
              <mml:mi>I</mml:mi>
              <mml:mi>m</mml:mi>
              <mml:mo> </mml:mo>
              <mml:mtext> </mml:mtext>
              <mml:mi>z</mml:mi>
              <mml:mrow>
                <mml:mtext> </mml:mtext>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mi>x</mml:mi>
                  <mml:mo>,</mml:mo>
                  <mml:mi>t</mml:mi>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
              <mml:mo>=</mml:mo>
              <mml:mo> </mml:mo>
              <mml:mi>P</mml:mi>
              <mml:munder>
                <mml:mrow>
                  <mml:mover>
                    <mml:mstyle mathsize="140%" displaystyle="true">
                      <mml:mo>∫</mml:mo>
                    </mml:mstyle>
                    <mml:mi>∞</mml:mi>
                  </mml:mover>
                </mml:mrow>
                <mml:mrow>
                  <mml:mo>−</mml:mo>
                  <mml:mi>∞</mml:mi>
                </mml:mrow>
              </mml:munder>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi>d</mml:mi>
                  <mml:msup>
                    <mml:mi>t</mml:mi>
                    <mml:mo>′</mml:mo>
                  </mml:msup>
                </mml:mrow>
                <mml:mi>π</mml:mi>
              </mml:mfrac>
              <mml:mi>R</mml:mi>
              <mml:mi>e</mml:mi>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi>z</mml:mi>
                  <mml:mrow>
                    <mml:mtext> </mml:mtext>
                    <mml:mo>(</mml:mo>
                    <mml:mrow>
                      <mml:mi>x</mml:mi>
                      <mml:mo>,</mml:mo>
                      <mml:msup>
                        <mml:mi>t</mml:mi>
                        <mml:mo>′</mml:mo>
                      </mml:msup>
                    </mml:mrow>
                    <mml:mo>)</mml:mo>
                  </mml:mrow>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>t</mml:mi>
                  <mml:mo>−</mml:mo>
                  <mml:msup>
                    <mml:mi>t</mml:mi>
                    <mml:mo>′</mml:mo>
                  </mml:msup>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p>from this the phase</p>
        <disp-formula id="E6">
          <label>(6)</label>
          <mml:math id="M6">
            <mml:mrow>
              <mml:mi>θ</mml:mi>
              <mml:mo> </mml:mo>
              <mml:mrow>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mi>x</mml:mi>
                  <mml:mo>,</mml:mo>
                  <mml:mi>t</mml:mi>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
              <mml:mo>=</mml:mo>
              <mml:mi>t</mml:mi>
              <mml:mi>a</mml:mi>
              <mml:msup>
                <mml:mi>n</mml:mi>
                <mml:mrow>
                  <mml:mo>−</mml:mo>
                  <mml:mn>1</mml:mn>
                </mml:mrow>
              </mml:msup>
              <mml:mo> </mml:mo>
              <mml:mrow>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mo> </mml:mo>
                  <mml:mfrac>
                    <mml:mrow>
                      <mml:mi>I</mml:mi>
                      <mml:mi>m</mml:mi>
                      <mml:mo> </mml:mo>
                      <mml:mi>z</mml:mi>
                      <mml:mrow>
                        <mml:mtext> </mml:mtext>
                        <mml:mo>(</mml:mo>
                        <mml:mrow>
                          <mml:mi>x</mml:mi>
                          <mml:mo>,</mml:mo>
                          <mml:mi>t</mml:mi>
                        </mml:mrow>
                        <mml:mo>)</mml:mo>
                      </mml:mrow>
                    </mml:mrow>
                    <mml:mrow>
                      <mml:mi>R</mml:mi>
                      <mml:mi>e</mml:mi>
                      <mml:mo> </mml:mo>
                      <mml:mi>z</mml:mi>
                      <mml:mrow>
                        <mml:mtext> </mml:mtext>
                        <mml:mo>(</mml:mo>
                        <mml:mrow>
                          <mml:mi>x</mml:mi>
                          <mml:mo>.</mml:mo>
                          <mml:mi>t</mml:mi>
                        </mml:mrow>
                        <mml:mo>)</mml:mo>
                      </mml:mrow>
                    </mml:mrow>
                  </mml:mfrac>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
              <mml:mo>=</mml:mo>
              <mml:mi>t</mml:mi>
              <mml:mi>a</mml:mi>
              <mml:msup>
                <mml:mi>n</mml:mi>
                <mml:mrow>
                  <mml:mo>−</mml:mo>
                  <mml:mn>1</mml:mn>
                  <mml:mo> </mml:mo>
                </mml:mrow>
              </mml:msup>
              <mml:mrow>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mfrac>
                    <mml:mrow>
                      <mml:mi>I</mml:mi>
                      <mml:mi>m</mml:mi>
                      <mml:mo> </mml:mo>
                      <mml:mi>Z</mml:mi>
                      <mml:mrow>
                        <mml:mtext> </mml:mtext>
                        <mml:mo>(</mml:mo>
                        <mml:mrow>
                          <mml:mi>x</mml:mi>
                          <mml:mo>,</mml:mo>
                          <mml:mi>t</mml:mi>
                        </mml:mrow>
                        <mml:mo>)</mml:mo>
                      </mml:mrow>
                    </mml:mrow>
                    <mml:mrow>
                      <mml:mi>d</mml:mi>
                      <mml:mi>V</mml:mi>
                      <mml:mi>S</mml:mi>
                      <mml:mi>D</mml:mi>
                      <mml:mrow>
                        <mml:mo>(</mml:mo>
                        <mml:mrow>
                          <mml:mi>x</mml:mi>
                          <mml:mo>,</mml:mo>
                          <mml:mi>t</mml:mi>
                        </mml:mrow>
                        <mml:mo>)</mml:mo>
                      </mml:mrow>
                    </mml:mrow>
                  </mml:mfrac>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p>giving the phase. Phase delays between the earliest point x<sub>0</sub> and the other x<sub><italic>s</italic></sub> are then calculated in ms (<bold>Figure 8</bold>).</p>
        <p>To visualize the phase in Movie <xref ref-type="supplementary-material" rid="SM15">15</xref> of the VSD(t), the VSD(t) was normalized to the maximum VSD(t) value in the post-stimulus time interval, VSDmax, i.e., pixel values were VSD(t)/VSDmax.</p>
      </sec>
      <sec>
        <title>The spatio-temporal evoked spiking in areas 17 and 18, 19, and 21</title>
        <p>The positions of the electrode penetrations were transferred to a map of the cortex monitored by the photodiode-array. The electrode penetrations preserved their relation to the cytoarchtectural border between areas 17 and 18. The photo-diode cortical map was centered to the electrodes mapping the very center of the field of view (see <italic>Stimulation</italic> section). The electrode penetrations are marked with white circles in the movies.</p>
        <p>The treatments of the spike data and the calculation of the proportion evoked trials ms by ms for each electrode penetration was done separately for supragranular, granular, and infragranular layers as described in Forsberg et al. (<xref rid="B22" ref-type="bibr">2016</xref>).</p>
        <p>For each electrode penetration the proportion of <italic>evoked trials</italic> (maximum 50 trials) was calculated for the specific layer. Evoked trials of spiking are trials in which the spiking trajectories are outside the separatrix separating the spontaneous states from the evoked spiking states in state space (for state-space analysis of spiking see Forsberg et al., <xref rid="B22" ref-type="bibr">2016</xref>). First episodes of a single spiking trial were detected as evoked if the velocity vectors of the trajectory of the spiking in state space were located outside the separatrix (threshold) separating the state space into spontaneous ongoing spiking and evoked spiking (for details see Forsberg et al., <xref rid="B22" ref-type="bibr">2016</xref>). The proportion of trials evoked is shown color-coded for each ms for each penetration. The number of encircled positions is less than 82, because one position may represent more than 1 electrode penetration (up to 3), and a few electrode positions were outside the map. (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <p>In the experiments, the anesthetized ferrets were exposed to a gray screen in an otherwise dark room. The scene suddenly, within 7 ms, shifted and a continuously moving bar, or occasionally a stationary bar appeared (Figure <xref ref-type="fig" rid="F1">1</xref>). We measured the voltage sensitive dye signal, VSD<sub>i</sub>(t), simultaneously from all points of the exposed cortex comprising visual areas 17, 18, 19, and 21. The multi-unit activity, MUA(t), was also measured from all layers in areas 17 and 18 to the same stimuli; albeit not simultaneously with the VSD<sub>i</sub>(t) measurements. The VSD<sub>i</sub> data (Methods) presented in this report were averaged over 8–12 trials belonging to one stimulus condition to give the averaged signal, VSD(t) and the dVSD(t)/dt (Figure <xref ref-type="fig" rid="F1">1</xref>). Figure <xref ref-type="fig" rid="F1">1A</xref> shows the typical time relation between the average spike rate and the time derivative d(VSD(t))/dt. For the scenes with stimuli appearing in the center of field of view, CFOV, the dVSD(t)/dt shows a strong NEX transient at the arrival of the increased spiking from layer 4 (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>, <xref ref-type="supplementary-material" rid="SM3">3</xref>) and thereafter NINH. For the scenes, in which the stimulus passed through the CFOV after 450 ms, the network at the retinotopic site for the CFOV showed two smaller NEXes prior to the passage (arrows), followed by a smooth further NEX that at 450 ms was replaced by a NINH (Figure <xref ref-type="fig" rid="F1">1B</xref>). The fluctuations of the dVSD(t)/dt in the pre-stimulus period were significantly smaller than the deviations caused by the changes of the visual scene (FDR at 0.05, Methods).We interpret these smaller fluctuations as reflecting a tight balance between inhibition and excitation.</p>
      <sec>
        <title>Temporal dynamics of dVSD(t) in different cortical zones</title>
        <p>When stimuli are presented in the center of field of view, they first increase the spiking in a small zone at the border between areas 17 and 18 and then, with a delay, in a similar zone at the border between areas 19 and 21 (Roland et al., <xref rid="B55" ref-type="bibr">2006</xref>; Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>). First we examined the space-time dynamics of the balance between excitation and inhibition, dVSD(t)/dt, inside and outside zones in the network where the bars were retinotopically mapped. We used a dynamical systems approach (Huys et al., <xref rid="B30" ref-type="bibr">2015</xref>; Forsberg et al., <xref rid="B22" ref-type="bibr">2016</xref>) and examined the evolution of the dVSD(t)/dt for each zone in multidimensional state space (Methods). In this state space, the time evolution of the dVSD(t)/dt evolves as a trajectory. Each coordinate of the trajectory corresponds to one state of the network in one zone. Figure <xref ref-type="fig" rid="F2">2A</xref> shows the temporal dynamics of the derivative of the dye signal, dVSD(t)/dt for the two retinotopic sites mapping the CFOV in areas 17/18 and areas 19/21. Prior to stimulus onset, the trajectories evolve in a narrow part of state space close to (0,0,0) (marked with FP in Figure <xref ref-type="fig" rid="F2">2</xref>). When the stimulus drives the evolution of the trajectories, they accelerate, make a smooth loop and return slowly by another route to the space near (0,0,0). This is the typical stimulus evoked behavior of a mono-excitable dynamical system (Huys et al., <xref rid="B30" ref-type="bibr">2015</xref>). The trajectories did not show any sign of equilibrium points outside the (0,0,0).</p>
        <p>In addition to these 2 zones the cortex was subdivided into 5 other zones, shown in the colored inserts (Figure <xref ref-type="fig" rid="F2">2C</xref>). These 5 zones comprise the cortex that did <italic>not</italic> show stimulus related retinotopic localized spiking. For example, the stationary bar did not lead to continuous spiking outside the red zones (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>, <xref ref-type="supplementary-material" rid="SM2">2</xref>). The trajectories of the dVSD(t)/dt systematically showed stimulus evoked dynamics in all zones no matter whether the zone mapped the stimulus or not (Figures <xref ref-type="fig" rid="F2">2B–D</xref>).</p>
        <p>The evoked parts of the trajectories were significantly different from the trajectories in the pre-stimulus period. (False discovery rate of 0.05; Methods) (Figure <xref ref-type="fig" rid="F2">2</xref>). We then tested whether the trajectories from the zone mapping the CFOV in the population of animals (<italic>n</italic> = 8) distinguished the 5 scenes shown in Figure <xref ref-type="fig" rid="F2">2</xref> (Methods). There were no significant differences in the evoked part of the trajectories between the scenes with objects moving from the center of field of view, (FDR at 0.05, paired comparison). The scene with the stationary object could be distinguished from scenes with the object moving from the CFOV in the interval 420–460 ms (i.e., after the OFF response). Scenes with a bar moving up or down from the peripheral field of view could be distinguished from 470 to 520 ms post-stimulus (FDR at 0.05 for both conditions). The temporal dynamics of dVSD(t)/dt thus could not differentiate the visual scenes in all cases.</p>
      </sec>
      <sec>
        <title>Space-time sequences of NEX and NINH in areas 17, 18, 19, and 21</title>
        <p>Next we examined the space-time evolution of the statistically significant changes in the balance between excitation and inhibition in the cortical network, i.e., the NEX and NINH space-time changes in anatomical space in each of the 8 animals (FDR at 0.05; Methods). The NEX and NINH were defined as significant increases and decreases above the pre-stimulus, spontaneous state fluctuations in dVSD(t)/dt for each animal (Methods). The appearance of the visual scenes changed the balance into a series of NEX and NINH evolutions in space-time engaging most of the exposed cortex (Figure <xref ref-type="fig" rid="F3">3</xref>). Identical scenes evoked nearly identical space-time sequences of NEX and NINH in the animals.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Space-time dynamics of NEX and NINH to a visual scene with bar moving up from the CFOV</bold>. Non-statistically significant cortex is light blue. Statistically significant NINH dark blue to black scale (FDR at 0.05); statistically significant NEX colors from green to red (FDR at 0.05). Maximum scale values 5 10<sup>−6</sup>. The time after the stimulus start is shown in ms on top and below. Space-time dynamics associated with scene in which a bar moves upwards from the CFOV in animal 2. Non-significant parts, amplitudes from −5 10<sup>−7</sup> to 5 10<sup>−7</sup>. The sequence of events: The NEX appears and spreads in all directions into the adjacent cortex from the two CFOV mapping sites (8/8). Then an offshoot of the NEX in 19/21 moves toward area 17/18 (7/7) and the NEX at 17/18 moves left (8/8). The NEX reached its maximal amplitude in areas 17/18 (7/8) and in areas 19/21 (5/7). The NEX diminishes and the NINH took over almost simultaneously in areas 17/18 and 19/21 (7/7). The NINH spreads in all directions gaining amplitude (7/7) into all exposed areas (7/8). The NINH shrinks and moves pursuing the earlier NEX in both areas 17/18 (7/8) and areas 19/21 (6/6).</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0003"/>
        </fig>
        <p>For the scenes in which the object appeared in the CFOV and moved either up or down, the statically significant NEX and NINH typical space-time events are summarized by a representative animal in Figure <xref ref-type="fig" rid="F3">3</xref> (see also Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>, <xref ref-type="supplementary-material" rid="SM5">5</xref> which show the dynamics in anatomical space much better than any figure can convey). The legend to Figure <xref ref-type="fig" rid="F3">3</xref> gives the proportion of animals having a particular statistically significant space-time event. The times, after stimulus onset, when these changes of NEX and NINH occurred varied among the animals by up to 70 ms, but the sequence of events was consistent in space-time (Figure <xref ref-type="fig" rid="F3">3</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>, <xref ref-type="supplementary-material" rid="SM5">5</xref>).</p>
        <p>The variability in the timing of the NEX and NINH became even more pronounced in the conditions in which the scenes started with a bar moving from the peripheral field of view. This is characteristic for a dynamical system. The sequence of space-time dynamical events was consistent in the animals also in these conditions, although minor variations could appear in the later part of the space-time evolution (Figure <xref ref-type="fig" rid="F4">4</xref>). NEX always preceded the first NINH. The NEXs and NINHs had similar space-time dynamics in anatomical space; the NINH space-time dynamics roughly replicated that of the preceding NEX (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>).</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Space-time dynamics of NEX and NINH for bar moving upwards from peripheral field of view</bold>. One animal shown. Non-significant parts, amplitudes from (−1 to 0.95) 10<sup>−6</sup>. As the bars started 10.5°. From the CFOV, the cortex that was initially active was outside the network monitored by the photodiode array in the majority of the animals. Statistically significant NEX first appeared in area 19/21 (5/7) and in 2/7 animals in area 17/18. The NEX then spreads and an offshoot of the NEX in areas 19/21 moves to the area of 17/18 NEX (7/8). The NEX in areas 17/18 becomes further elongated in the cortical direction of the bar motion (7/7). Then the NEXes in areas 17/18 and 19/21 almost simultaneously attained maximal amplitude (7/7; not shown). NEXes subsequently decrease and switch to NINH almost simultaneously in areas 17/18 and 19/21 (5/8) after which the NINH spreads. In the other 3 animals the NEX was replaced by the balanced state for a while. A second NEX appears in areas 17/18 (7/7) and 19/21 (6/6) spreading from the cortex mapping the CFOV. In 5/7 animals, the NEX decreased and the exposed cortex went into a balanced NEX-NIMH state (shown), in 3 animals, a third NEX appeared immediately and in 5/8 after a little while moving away from the CFOV mapping cortex areas 17/18 (7/7) and areas 19/21 (7/7). Behind the moving NEX a similar moving NINH appeared spreading in all directions. In 7/8 animals the moving NEX and following NINH disappeared from monitoring photodiodes and left the cortex in a balanced NEX/NINH state.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0004"/>
        </fig>
        <p>Neither the NEX nor the NINH evolved to a state with motion of constant amplitude and velocity over the network. In contrast, the balance between excitation and inhibition changed throughout the whole space-time evolution. The changes in the balance engaged large populations of neurons in all animals. (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). The return to small amplitude baseline fluctuations of the excitation-inhibition balance may take 600–700 ms (Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>).</p>
      </sec>
      <sec>
        <title>Space-time dynamics, but not temporal dynamics alone, distinguish the visual scenes</title>
        <p>Figure <xref ref-type="fig" rid="F1">1</xref> showed that the mean VSD(t) and the mean dVSD(t)/dt of the population of neurons mapping the CFOV do not distinguish the visual scenes with a bar moving upwards from a bar moving downward from the CFOV. Neither do the temporal course of the dVSD(t)/dt distinguish a stationary bar flashed in the CFOV from the bars moving from the CFOV until the stationary bar disappears and elicits an OFF response (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>). Averaging spatially over the CFOV mapping population or any other neuron population removes the spatio-temporal dynamics.</p>
        <p>In contrast, just by looking at the space-time evolution of the balance between excitation and inhibition over the four visual areas, one can distinguish the five scenes (Figures <xref ref-type="fig" rid="F1">1B</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>; Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). Similarly, just by looking at the space-time evolution of the population membrane potentials, i.e., the VSD(t) caused by stationary and moving objects, over the same four areas, one can distinguish such simple visual scenes in carnivores and primates (Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>; Ayzenshtat et al., <xref rid="B4" ref-type="bibr">2010</xref>; Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref> show how, when, and where large populations of neurons change their balance between excitation and inhibition or change the membrane potentials at the network scale. However, they do not show how the brain reduces this multidimensional evolution (as many dimensions as points of the network measured) to lower dimension solutions characteristic for a single scene- or if such a reduction is at all possible. For this reason, we examined the space-time dynamics in multidimensional state space. This is in a state space that had as many dimensions as the number of channels in our photodiode camera, namely 464.</p>
        <p>We calculated the <italic>spatial</italic> PCA (Methods) of the VSD(t) in 464 localizations of the visual cortical network and plotted the first four components. The first 4 components explained 92–99.9% of the total variance. The state-space made of the first 3 principal components explained between 92 and 99% of the space-time variance in the VSD(t) (Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). The animals in Movies <xref ref-type="supplementary-material" rid="SM10">10</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref> had an extra condition in which two bars moved toward each other (Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). In state space, the VSD(t) caused by one visual scene produced one trajectory. The trajectories of the VSD(t)s of all scenes first evolved in a chaotic like manner in a small part of the state space throughout the pre-stimulus period and into the post-stimulus period (Figure <xref ref-type="fig" rid="F5">5</xref>, Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). Within 47–82 ms (full range), the trajectories accelerated, diverged, and continued to diverge in state space. This was especially clearly seen in the projection of principal components 2 and 3 (Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). This result was consistent in all 8 animals (Figure <xref ref-type="fig" rid="F5">5</xref>). The time the individual trajectories left the chaotic like state in small part of state space where this behavior took place depended on the time the first statistically significant NEX appeared in the monitored cortex. This delay ranged from −4 to 44 ms (mean 14.0 ms ± 9.0 ms standard deviation). The longer delays seemed related to the time it took for the NEX to spread in the four visual areas.</p>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <p><bold>Space-time evolution of VSD(t) in areas 17, 18, 19, 21 produce flow on low dimension manifold</bold>. State space projection of principal components 2 and 3 of the 464 <italic>spatial</italic> dimension state space (Methods) of all five visual scenes. Each condition's trajectory has a “head” marking its position in state space at the time of the snapshot marked in ms, and a “tail” of its previous 25 ms course. Condition codes: (blue) bar moving down from CFOV, (green) bar moving up from CFOV, (turquoise) bar moving down from periphery, (lilac) bar moving up from periphery, (yellow) stationary bar <bold>(A,E)</bold> Snapshots showing evolution from chaotic-like trajectories to accelerating diverging trajectories (Animal 2). <bold>(F–L)</bold> moment at which the trajectories diverge in animals 1, 3, 4, 5, 6, 7, 8 respectively. For the true dynamics see Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0005"/>
        </fig>
        <p>This means that the evolution of the VSD(t) in all parts of the exposed network first evolved in a chaotic like manner by spatial cooperative activity, similarly to the temporal dynamics in Figure <xref ref-type="fig" rid="F2">2</xref>. Soon after the upper cortical layers became net excited and the VSD(t) thus increased and this increase spread in the network reducing the complexity of the network membrane potential changes to roughly a 3-dimensional evolution at 47–88 ms progressing in time uniquely for each of the 5 or 6 visual scenes (Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>).</p>
      </sec>
      <sec>
        <title>Space-time evolution of spiking in areas 17 and 18</title>
        <p>We had 82 electrode penetrations in areas 17 and 18. In Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref> the reconstructed position of each site is mapped on the hexagonal photodiode array monitoring the visual areas. Depending on how many of the 50 trials that showed evoked spiking in a certain ms (see Methods for definition of evoked spiking), the color changed from light blue to red. Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref> show initial spreading of the evoked spiking in the network up to 100 ms. For the stationary object, the evoked spiking outside the retinotopic mapping of the object in areas 17 and 18 ceased in the granular layer, but continued albeit weakly in the supragranular layers (Movie <xref ref-type="supplementary-material" rid="SM2">2</xref>). For the scenes with moving objects, there was some spiking ahead of the retinotopic evoked spiking at 120–200 ms, characteristic for each scene (as described by Harvey et al., <xref rid="B28" ref-type="bibr">2009</xref>) (Movie <xref ref-type="supplementary-material" rid="SM3">3</xref>). Thereafter there was a more ordered progression of retinotopic spiking (Movie <xref ref-type="supplementary-material" rid="SM3">3</xref>) (additional movies for spiking to the other scenes at <ext-link ext-link-type="uri" xlink:href="https://www.dropbox.com/sh/o6qtfrhmt5jwev2/AABbxksHtkd0UxTlFCrA_b0ca?dl=0">https://www.dropbox.com/sh/o6qtfrhmt5jwev2/AABbxksHtkd0UxTlFCrA_b0ca?dl=0</ext-link>). However, only the spikes from a single penetration were obtained simultaneously, therefore it made no sense to perform a spatial PCA on these reconstructed data (Methods).</p>
        <p>If one compares the space-time evolution of the evoked spiking (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>) with the space-time evolution of dVSD(t)/dt and VSD(t) (Figures <xref ref-type="fig" rid="F1">1</xref>–<xref ref-type="fig" rid="F4">4</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>) the VSD(t) changes and the changes of excitation-inhibition balance take up a larger territory of the network in areas 17 and 18. Furthermore, it is obvious that the spiking, even in the upper cortical layers from ~125 to 300 ms and in periods thereafter, continues seemingly unaffected by the NINH regimes.</p>
      </sec>
      <sec>
        <title>Delayed balance</title>
        <p>So far our results unambiguously showed that the smaller fluctuations in the balance after the impact of the visual scenes is replaced by a large amplitude NEX that after some 100 150 ms switches to a NINH (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). The network of the four visual areas could still be balanced, in the sense that inhibition sooner or later would bring it back to a stable state when the impact of the scenes cease (Huys et al., <xref rid="B30" ref-type="bibr">2015</xref>).</p>
        <p>We examined the local amount of NEX and NINH (<italic>p</italic> &lt; 0.05, Methods) in the four areas by integrating the NEX over the whole post-stimulus period 0–800 ms and then dividing by the number of samples and then repeating this for the NINH (Methods).</p>
        <p>The integrated NEX matched the integrated NINH in distribution and amount in all 4 areas (Figure <xref ref-type="fig" rid="F6">6</xref>). The correlations between the average integrated NEX and average integrated NINH for all cortical locations in all animals and all 4 conditions of moving bars (<italic>n</italic> = 32) were all highly significant (F-statistics <italic>p</italic> &lt; 10<sup>−10</sup>). The average delays between the maximum NEX and the minimum of the NINH (<italic>n</italic> = 16; Methods) were for the two conditions with the bar starting at the CFOV 118 ± 25 ms (mean ± stand. deviation). For the two conditions with the bar starting in the peripheral field of view 138 ± 26 ms and for the stationary square condition 125 ± 37 ms. The average slope of the regression was 1.00 ± 0.31 (mean ± stand. deviation) indicating that on the average, the amount of NEX became balanced by an equal amount NINH. These results were largely independent of the duration of the period over which the NEX and NINHs were integrated. For example, reducing the period to be from 0 to 400 ms and even from 0 to 210 ms after stimulus onset did not affect the strong correlation between NEX and NINH. The figures of average integrated NEXs, NINHs and their spatial correlations in all animals and conditions are available at <ext-link ext-link-type="uri" xlink:href="https://www.dropbox.com/sh/j6bs1eegvh14fth/AAB-HYQPhallfh-wH9SDe4nPa?dl=0">https://www.dropbox.com/sh/j6bs1eegvh14fth/AAB-HYQPhallfh-wH9SDe4nPa?dl=0</ext-link>.</p>
        <fig id="F6" position="float">
          <label>Figure 6</label>
          <caption>
            <p><bold>Spatial distribution and correlation of average NEX and NINH</bold>. First column: stimuli and correlations of average NEX and NINH at the cortical locations having (statistically significant) NEX and NINH. Second column: Top images: distributions of the delay between maximum NEX and the NINH minimum for each cortical location. Bottom: time-varying significant (<italic>p</italic> &lt; 0.05) NEX and NINH from each of the locations in the four visual areas. X-axis ms. Third column: spatial distribution of average NEX in the 4 visual areas. Last column: spatial distribution of NINH in the 4 visual areas. Scale values should be multiplied with 10<sup>−7</sup>. The average NINH at each location is proportional to the average NEX. Across animals and conditions, the slope of the correlation was not significantly different from 1. <bold>(A)</bold> Object moving down from CFOV, one animal. <bold>(B)</bold> Object moving up from CFOV, one animal. <bold>(C)</bold> Object moving down from peripheral FOV, one animal. <bold>(D)</bold> Object moving up from peripheral FOV, one animal.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0006"/>
        </fig>
        <p>These results showed that there was no instantaneous or fast, tight balance between NEX and NINH after the perturbation by the stimuli. Instead, at any spot in the participating cortical network, the net-excitation was after a delay of ~125 ms balanced by an equal amount of net-inhibition. This also implied that the NEX and NINH occupied identical network territory (Figure <xref ref-type="fig" rid="F6">6</xref>).</p>
      </sec>
      <sec>
        <title>Propagation speeds of NEX and NINH</title>
        <p>There were several forms of propagation of the NEX and NINH in the cortical network. First, the VSD(t) spreads out from the retinotopic mapping site in area 17 when a visual object is flashed in the FOV (Grinvald et al., <xref rid="B23" ref-type="bibr">1994</xref>; Roland et al., <xref rid="B55" ref-type="bibr">2006</xref>). Then the NEX became oriented in the direction mapping the trajectory of the object and then the NEX branched out from areas 19/21 moving toward the NEX in areas 17/18. Examination of these dynamics show that they were partly superimposed, i.e., after a while it is not possible to describe the NEX of the membranes as a single “wave” having one direction (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). As seen in Figure <xref ref-type="fig" rid="F7">7</xref> there was a relatively large range of speeds of both NEX and NINH spanning from 0.08 to 0.4 mm ms<sup>−1</sup>. The distribution of speeds was similar in areas 17/18 and areas 19/21. The mean speed ± square root of the variance was 0.23 ± 0.10 mm ms<sup>−1</sup> for the initial NEX and 0.21 ± 0.08 mm ms<sup>−1</sup> for the first NINH in areas 17/18 with no statistical difference between NEX and NINH (<italic>p</italic> &gt; 0.2; <italic>t</italic>-test). In areas 19/21 the speeds were 0.20 ± 0 .08 mm ms<sup>−1</sup> for the first NEX and 0.22 ± 0.12 mm ms<sup>−1</sup> for the first NINH with no statistical significance (<italic>p</italic> &gt; 0.1, <italic>t</italic>-test). In summary there were no differences between the speeds of the first NEX and the first NINH propagation and no difference in speeds between the primary visual areas 17/18 and the higher areas 19/21. The progression speed of the second NEX was (<italic>n</italic> = 10) 0.25 ± 0.10 mm ms<sup>−1</sup> and the second NINH (<italic>n</italic> = 16) 0.19 ± 0.09 mm ms<sup>−1</sup>.</p>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>Speeds of NEX and NINH and delays between areas. (A)</bold> Distribution of speeds of propagation in areas 17 and 18 of the first NEX and NINH for all four scenes with moving objects <bold>(B)</bold> Same but for areas 19 and 21. <bold>(C)</bold> Distributions of minimum latencies of the first NEX and NINH in ms between areas 17/18 and area 19/21.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0007"/>
        </fig>
      </sec>
      <sec>
        <title>Phase delays</title>
        <p>When the objects moved along on the display screen, first the neurons in areas 17 and 18 spiked and went into NEX, then the neurons in areas 19 and 21 spiked and went into NEX. Thus, the NEX will appear in several versions in several visual areas, each delayed more and more compared to the primary visual cortex. We asked whether there existed a mechanism that brought the membrane potentials into phase. In order to calculate the phase differences in the cortex, we Hilbert transformed the data files (Müller et al., <xref rid="B42" ref-type="bibr">2014</xref>; Methods). Calculated over a time interval of 100 ms, the Hilbert transformed data gives a single image of the cortex showing the phase latencies in ms (Figure <xref ref-type="fig" rid="F8">8</xref>). The NEX delay between areas 17/18 and areas 19/21 in all animals and conditions is shown in Figure <xref ref-type="fig" rid="F7">7</xref> and was 8.35 ± 5.74 ms (mean ± square root of variance) and significantly greater than 0 (<italic>p</italic> &lt; 0.00002; <italic>n</italic> = 30). The NINH delay between area 17/18 and areas 19/21 was not significantly different from 0 (<italic>p</italic> &gt; 0.9; <italic>n</italic> = 23) in mean −4.30 ± 9.92 ms. This indicated that when the NINH starts, the phase differences were not obvious. To further illustrate this we spatially aligned the VSD(t) measurements of animals with roughly matching cytoarchitectural borders by simple affine transformations (Methods) to show the space-time evolution of the normalized nVSD(t) across animals. Normalizing all pixels to their max being 1, removes the amplitude differences but maintains their phase relations. Movie <xref ref-type="supplementary-material" rid="SM15">15</xref> (<italic>n</italic> = 6) shows that, for the bar moving down from the peripheral field of view, the nVSD(t) in areas 19/21 leads that of areas 17/18 from 60 ms up to 116 ms and thereafter the area 17/18 nVSD(t) catches up to nullify the phase differences at 160 ms and onwards.</p>
        <fig id="F8" position="float">
          <label>Figure 8</label>
          <caption>
            <p><bold>Phase latency maps of first NEX and NINH in four scenes</bold>. The Hilbert plots (Methods) show the phase latencies of the first NEX and NINH in ms between the start location in cortex (having the minimum latency) and the remaining parts of the cortex. Note the 5–10 ms delays between area 17/18 (top of the hexagon) and areas 19/21 (bottom of hexagon) for NEX start. Animal 1.</p>
          </caption>
          <graphic xlink:href="fnsys-11-00014-g0008"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>We presented the following main results. The appearance of the visual scenes drove the network away from a more tightly balanced state into space-time sequences of expansive NEXs and NINHs. NEX and NINH propagated through the network with similar speeds. Locally in the network, the amount of NINH was strongly correlated with the amount of NEX appearing 125 ms earlier. This implied that the NIMH matched the NEX spatially and dynamically, albeit with a delay. The temporal dynamics of the NEX and NINH could not distinguish the visual scenes in all cases. The space-time dynamics in all parts of the exposed network evolved early to reduce the complexity of the network membrane potential changes to roughly a 3-dimensional evolution progressing in time uniquely for each of the visual scenes.</p>
      <sec>
        <title>Temporal dynamics</title>
        <p>Our <italic>in vivo</italic> measurements and data treatment of the VSD<sub>i</sub>(t) impose some constraints on the interpretation of the results. First, we averaged the single trials to get the VSD(t). Second we applied a temporal filter on the VSD(t) to exclude high frequency (photon) fluctuations. Third, the VSD<sub>i</sub>(t), at each cortical point of measurement, stems from dendrites and axons belonging to tens of thousands of neurons (Roland, <xref rid="B54" ref-type="bibr">2010</xref>). This implies that individual fluctuations of the sum of membrane currents have been suppressed, and therefore we can only characterize the average behavior of the network. Fourth, because the cell bodies only make up a minute proportion of the total membrane surfaces of neurons (Fiala and Harris, <xref rid="B21" ref-type="bibr">1999</xref>), the NEX and NINH may not agree with somatic patch clamp data (Williams and Mitchell, <xref rid="B63" ref-type="bibr">2008</xref>). Fifth, the dye signal is proportional to the surface of the stained membranes, thus signaling mainly the membrane potential changes in large populations of dendrites and un-myelinated axons in the upper layers of the network. This means that the membrane compartment providing the NEX and NINH is a mixture of pre- and post-synaptic elements. Sixth, in <italic>in vitro</italic> experiments, 1% isoflurane concentration increase a K<sup>+</sup> leak current modestly and linearly in thalamic neurons (Ries and Puil, <xref rid="B52" ref-type="bibr">1999</xref>), which could depress the spiking driving the NEX. In another <italic>in vitro</italic> experiment the dye RH 1691 enhanced the GABA-A response at concentrations used in our experiments (Mennerick et al., <xref rid="B39" ref-type="bibr">2010</xref>). Thus, the dVSD(t)/dt results may be slightly biased toward NINH. However, a recent modeling study show that these inhibitory effects might be negligible (Chemla and Chavane, <xref rid="B10" ref-type="bibr">2016</xref>). In addition, inhibition in anesthetized mice (isofluran and chlorproxtiene) was weaker than in awake mice (Haider et al., <xref rid="B26" ref-type="bibr">2013</xref>). Finally, at each point of measurement, the NEX and NINH only report relative changes in the sum of the ion currents in the membrane compartment. Consequently, the NINH cannot distinguish decreases in the sum of inward currents from increases in the sum of outward currents and the NEX does not distinguish increases in inward currents from decreases in outward currents.</p>
        <p>These limitations, however, cannot effect the results that the presentations of visual scenes with moving objects lead to longer, 70–200 ms lasting episodes of NEX and NINH; nor that the amount of NEX locally in the four visual areas subsequently is matched by an equal amount of NINH. The impact of the afferent potentials switched the balance in the visual cortex from a tight temporal balance to a delayed balance. The period of net-excitation permits active spiking to propagate through the network. When the network is perturbed by stimuli, its connectivity and the behavior of the inhibitory neurons allow larger deviations from the spontaneous state. When the visual scenes disappear, the delayed balance implies that the network will return to the regime of smaller fluctuations from the baseline, although slowly (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>; Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>).</p>
        <p>Our results complement studies of balanced excitation and inhibition performed on single cell bodies. Although our results are incompatible with a tight temporal balance of excitatory and inhibitory currents after the impact of a change in the visual scene and although our cortical VSD(t) is practically blind to what happens at the somata of the neurons, the result that there is a 125 ms delay in the cortical network between maximal net excitatory and maximal net inhibitory currents is similar to recordings from the cell body. In a subset of earlier single neuron patch clamp findings in lightly anesthetized cats and ferrets similar or even longer delays were found between excitatory and inhibitory conductances (Anderson et al., <xref rid="B2" ref-type="bibr">2000</xref>; Martinez et al., <xref rid="B38" ref-type="bibr">2002</xref>; Monier et al., <xref rid="B40" ref-type="bibr">2003</xref>; Priebe and Ferster, <xref rid="B47" ref-type="bibr">2005</xref>; Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>; Baudot et al., <xref rid="B6" ref-type="bibr">2013</xref>). However, the delay between excitation and inhibition may depend on animal order (Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>). For carnivores it may also depend on the type of visual stimulus, e.g., drifting grating, object or a natural scene (Anderson et al., <xref rid="B2" ref-type="bibr">2000</xref>; Martinez et al., <xref rid="B38" ref-type="bibr">2002</xref>; Monier et al., <xref rid="B40" ref-type="bibr">2003</xref>; Priebe and Ferster, <xref rid="B47" ref-type="bibr">2005</xref>; Tan et al., <xref rid="B60" ref-type="bibr">2011</xref>; Baudot et al., <xref rid="B6" ref-type="bibr">2013</xref>). Natural scenes might evoke shorter delays than those we observed (Baudot et al., <xref rid="B6" ref-type="bibr">2013</xref>). Our results are compatible with observations that the spiking of excitatory and inhibitory neurons matches over longer time scales (seconds) (Dehghani et al., <xref rid="B15" ref-type="bibr">2016</xref>). Our result gives the overall delay in dendrites, un-myelinated axon terminals and cell bodies belonging to an estimated 400,000 neurons, that the cell body measurements cannot predict. As seen from Figure <xref ref-type="fig" rid="F6">6</xref> (second column) the delay varied locally from 60 to 250 ms. This is what would be expected from large network with space-time dynamics. Our overall result does not exclude shorter or longer delays in selected single neurons.</p>
        <p>Onat et al. (<xref rid="B44" ref-type="bibr">2011a</xref>) computed the average time courses for a drifting grating and natural scenes and estimated the decay VSD signal, VSD(t), by a straight line. “The processing of different gratings showed a strong adaptational decay of net excitation levels. For gratings, its negative slope was equal to −48%/s (99% CI = [−59%/s, 35%/s]), meaning that after only 1 s of presentation time amplitudes declined to half of the peak activity levels. During stimulation with natural movies, the mean adaptational decay was −24%/s (99% CI = [−44%/s, −5%/s], and the median slope was found to be only marginally different from zero (sign test, <italic>P</italic> = 0.065).” From which they drew the conclusion: “Thus, drifting oriented gratings are processed in a non-stationary regime and in contrast, natural movies processing is generally characterized by overall stationary balance between excitation and inhibition” (Onat et al., <xref rid="B44" ref-type="bibr">2011a</xref>). Neither Eriksson et al. (<xref rid="B18" ref-type="bibr">2008</xref>), Harvey et al. (<xref rid="B28" ref-type="bibr">2009</xref>), Harvey and Roland (<xref rid="B27" ref-type="bibr">2013</xref>) nor we (Figures <xref ref-type="fig" rid="F1">1B</xref>, <xref ref-type="fig" rid="F6">6</xref>) could fine any time segments over the first 800 ms in which the temporal course of the dVSD(t)/dt of the post-stimulus period to stationary and moving stimuli was approximately linear. This indicates that the time course of the balance between excitation and inhibition in response to these stimuli most likely is dynamic, i.e., changing continuously.</p>
        <p>The time course of the inhibition may depend on the duration of the stimuli. The shorter the stimulus, the deeper the inhibition elicited by the stimulus offset (Eriksson et al., <xref rid="B18" ref-type="bibr">2008</xref>). When two bars move toward each other in the field of view, the local balance between excitation and inhibition turn to inhibition in advance of their mutual occlusion. For the time interval of occlusion, the spiking locally at the retinotopical spot in primary visual cortex becomes tuned to that representing one single bar (Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). This might illustrate a property of the local network to modulate the balance for fine-tuning of local visual details.</p>
        <p>It is often claimed that the cerebral cortex is similar to a balanced neuronal network.</p>
        <p>The visual cortex is continuously spiking <italic>in vivo</italic>, even when it is not driven by external stimuli (Hubel and Wiesel, <xref rid="B29" ref-type="bibr">1959</xref>). The spiking in this spontaneous state is slow and irregular (chaotic like) associated with moderate amplitude fluctuations of the membrane currents indicating a relatively tight balance of excitation-inhibition (Haider et al., <xref rid="B25" ref-type="bibr">2006</xref>; Monier et al., <xref rid="B41" ref-type="bibr">2008</xref>; Huys et al., <xref rid="B30" ref-type="bibr">2015</xref>; Figure <xref ref-type="fig" rid="F1">1A</xref>). This however does not necessarily mean that the cerebral cortex behaves like a balanced neuronal network. Even in very large balanced neuronal networks with many biologically relevant details, the spiking rapidly dies out unless it is driven by an external (artificial) input (Izhikevich and Edelman, <xref rid="B31" ref-type="bibr">2008</xref>; Kumar et al., <xref rid="B34" ref-type="bibr">2008</xref>; Markram et al., <xref rid="B37" ref-type="bibr">2015</xref>). This holds also for the classical balanced neuronal network that swift and nearly linearly responds to an increase in the external drive with a new equilibrium between excitatory and inhibitory currents (van Vreeswijk and Sompolinsky, <xref rid="B62" ref-type="bibr">1996</xref>), which is in contrast to our results (Figures <xref ref-type="fig" rid="F1">1</xref>–<xref ref-type="fig" rid="F6">6</xref>, Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>).</p>
      </sec>
      <sec>
        <title>Space-time dynamics in the cortical network</title>
        <p>We described the space-time dynamics of the membrane potential changes in two different spaces: the topological (anatomical) space made of the cortical network of synaptic connected neurons (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F8">8</xref>; Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>, <xref ref-type="supplementary-material" rid="SM15">15</xref>) and the (abstract) state space depicted as orthogonal principal component projections (Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F5">5</xref>, Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). In the cortical network anatomical space one can see the spatial evolution of NEX and NINH in time and get an intuitive sense of their space-time dynamics.</p>
        <p>The visually evoked space-time dynamics of the dVSD(t)/dt started with a NEX in a small zone spreading in all directions, including the direction opposite to that mapping of the moving object. After this followed a NINH with similar space-time dynamics (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F8">8</xref>; Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). Although the VSD(t) increase appearing after visual scene shifts always spreads laterally in the cortex (reviewed in Roland et al., <xref rid="B56" ref-type="bibr">2014</xref>), we now show that this is composed of NEX dynamics followed by a similar spreading NINH dynamics. The spreading NEX dynamics enable the spiking related to two different objects to interact at a distance and interact with the visual background (Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>).</p>
        <p>The speed of NEX spread varied from 0.1 to 0.4 mm ms<sup>−1</sup> in all four areas from the two cortical sites mapping the retinotopic position in areas 17/18 and 19/21 (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F8">8</xref>), indicating that the NEX spread may be fast mono-synaptic from the mapping neurons as well as more slowly poly-synaptic via neurons not mapping the bar in the cortical surround. The poly-synaptic hypothesis is in accordance with the result that there were neurons entering the evoked spiking state, outside the CFOV retinotopic site, for a short instance initially (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>). These speeds are also in accordance with the spread of VSD(t) increases observed in primates V1 and V2 by Müller et al. (<xref rid="B42" ref-type="bibr">2014</xref>).</p>
        <p>Speculatively, the high-speed spread of the NINH into the adjacent cortex could be done mono-synaptically by long axons from inhibitory neurons spiking in the mapping zone (Kisvarday et al., <xref rid="B33" ref-type="bibr">1997</xref>). The slower spreading of NINH could hardly be poly-synaptic, but caused by the disappearance of excitation locally combined with local spiking of inhibitory neurons. At the mapping site, the spiking increased again after 80 ms this might be an increase of spiking mainly by inhibitory neurons, because this spiking increase coincided with the NINH getting deeper (Figure <xref ref-type="fig" rid="F1">1</xref>). As the excitatory drive now was gone (because the object moved) this would cause the excitation to decrease also locally in the surroundings of the mapping zone where the always spiking inhibitory neurons would take over (Rudolph et al., <xref rid="B57" ref-type="bibr">2007</xref>).</p>
        <p>The first NINH covered large regions, including the retinotopic spiking zones related to the object 125 ms after the NEX (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). However, the layer 4 and 2, 3 neurons continued to spike at these subsequent retinotopic sites during the NINH, (Movie <xref ref-type="supplementary-material" rid="SM2">2</xref>). Apparently, this spiking was insufficient to drive the network into NEX. This is not so surprising as the VSD-signal reflects membrane potential changes of all membranes (Methods). The finding, though, illustrates that the network around spiking excitatory neurons can be in a different regime. The widespread inhibitory regime might prevent the spread of the evoked spiking in the interval 100–200 ms after the start of the stimuli and hence confine the evoked spiking to the retinotopic zone (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>).</p>
        <p>The individual variations in appearance of second NEXs and NINHs and third NEXs and NINHs became more pronounced as time after the stimulus onset increased, as expected for a dynamical system. A full description of individual variations should ideally be on a single trial basis, which was not possible for the present data of dVSD(t)/dt.</p>
        <p>Some theoretical models replicate essential parts of the VSD(t) space-time dynamics to stationary and moving objects in the primary visual cortex of primates and carnivores. This includes the lateral spreading of the VSD(t) increases and VSD(t) space-time dynamics giving rise to visual illusions (Rangan et al., <xref rid="B48" ref-type="bibr">2005</xref>; Deco and Roland, <xref rid="B14" ref-type="bibr">2010</xref>; Markounikau et al., <xref rid="B36" ref-type="bibr">2010</xref>). Markounikau et al. (<xref rid="B36" ref-type="bibr">2010</xref>) show that the VSD(t) most likely is composed to a large extent of inhibition, modeled as the time derivative of the population membrane potentials, which is in accordance with our results (Figure <xref ref-type="fig" rid="F1">1</xref>). However, none of the models have spontaneous ongoing membrane current fluctuations and hence do not predict the transition from tight to delayed balance. In the Chemla and Chavane's (<xref rid="B10" ref-type="bibr">2016</xref>) model different delays between excitatory and inhibitory spiking modulates the shape of the VSD(t) and hence affect also the dVSD(t)/dt. Although many models, including the above mentioned, have a strong local coupling between excitation and inhibition, in accordance with (Figure <xref ref-type="fig" rid="F6">6</xref>), to our knowledge, this has not lead to predictions of the space-time dynamics of the long delays between NEX and NINH (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F6">6</xref>). One model study predicts the NEX propagation from area 19/21 toward areas 17/18 at 80–100 ms (Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>; Deco and Roland, <xref rid="B14" ref-type="bibr">2010</xref>). One recent model predicts that excitation and inhibition under certain synaptic regimes can segregate spatially at the mesoscopic (network) scale (Malagarriga et al., <xref rid="B35" ref-type="bibr">2015</xref>). This is in contrast to our finding of a strong local correlation between NEX and NINH in the four visual areas and the results in Figures <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F6">6</xref>.</p>
        <p>When the scene appears at time 0, first the spiking from the lateral geniculate nucleus breaks the tight balance between excitation and inhibition and drives the network into NEX and evoked spiking at the retinotopic spot for the bar (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>; Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>, <xref ref-type="supplementary-material" rid="SM3">3</xref>). The temporal dynamics of the NEX at this spot of the network does not distinguish a stationary bar from bars moving up or down (Figure <xref ref-type="fig" rid="F2">2</xref>), neither do the temporal course and the temporal dynamics of the evoked spiking (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>; Forsberg et al., <xref rid="B22" ref-type="bibr">2016</xref>). The evoked spiking at this initial spot drives the surrounding network into NEX with similar temporal dynamics engaging the network over nearly all of the exposed cortical surface (Figure <xref ref-type="fig" rid="F2">2</xref>; Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>). However, after 40 ms, the driving by the retinal input spikes has moved to an adjacent spot in the network where the previous spreading NEX facilitates the evoked spiking (in accordance with the models of Rangan et al., <xref rid="B48" ref-type="bibr">2005</xref>; Markounikau et al., <xref rid="B36" ref-type="bibr">2010</xref>). At this new spot, the spreading NEX changes to be more specific to the visual scene driving it, at 45–90 ms and onwards (Movies <xref ref-type="supplementary-material" rid="SM4">4</xref>–<xref ref-type="supplementary-material" rid="SM7">7</xref>).</p>
        <p>The evolution of the NEX and NINH in state-space is a succinct mathematical description of the collaboration of all parts of the exposed cortical network comprising the four visual areas. The state-space made of the first 3 principal components, i.e., a manifold, is a mathematical object on which the flow of the NEX and NINH for each scene evolves. The evolution of the specific space-time dynamics starts with the divergence of the trajectories at 30–90 ms showing the cooperative membrane potential changes of the total network. The departure from the chaotic like behavior and divergence of the trajectories coincided with the NEX spreading to cover most of the exposed cortex. The trajectories continued to diverge over the next 50 ms when the net inhibitory regime takes over at 110–120 ms (Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>). It is at this point of time the evoked spiking becomes more clearly related to current scene (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>; Eriksson et al., <xref rid="B19" ref-type="bibr">2010</xref>). The trajectories on the 3-dimensional manifold thus show the space-time dynamics of the membrane potential changes leading up to the 110-120 ms when the scene is likely to be perceived (Thorpe et al., <xref rid="B61" ref-type="bibr">1996</xref>; Chen et al., <xref rid="B11" ref-type="bibr">2007</xref>; Eriksson et al., <xref rid="B19" ref-type="bibr">2010</xref>).</p>
        <p>Onat et al. (<xref rid="B44" ref-type="bibr">2011a</xref>,<xref rid="B45" ref-type="bibr">b</xref>) using a drifting grating as stimulus and principal component analysis showed that some components reflected the wave propagation from the moving gratings, whereas the first 2 components reflected the stationary feature, i.e., the orientation of the grating. If one looks at Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>, one can see that the first 3 components contribute to the divergent flows over the manifold, although the divergence was slightly larger in the projection of the 2nd and 3rd component. Thus, in our case there was no (clear) separation of space vs. time in the space-time dynamics. In our case, the retinotopic mapping of the moving object moved over the cortical network, so one could think that this was the reason for the discrepancy. However, if one focus on the flow associated with the stationary square (yellow in Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>, <xref ref-type="supplementary-material" rid="SM9">9</xref>, gray in Movies <xref ref-type="supplementary-material" rid="SM10">10</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>) this was also affected by the first 3 components. Another reason for the discrepancy could be that the first 400 ms were discarded from the analysis in the Onat et al. (<xref rid="B45" ref-type="bibr">2011b</xref>) study. In contrast, our stimuli and analysis was starting from 0 ms and thus biased toward spatio-temporal transients.</p>
        <p>The evolution to low dimensional flow would not have been possible if the network had remained in tight balance, as also seen in Movies <xref ref-type="supplementary-material" rid="SM8">8</xref>–<xref ref-type="supplementary-material" rid="SM14">14</xref>. The spontaneous state is a stable state (Huys et al., <xref rid="B30" ref-type="bibr">2015</xref>; Forsberg et al., <xref rid="B22" ref-type="bibr">2016</xref>). For sensory areas, in general, the tight balance between excitation and inhibition must be broken to allow the evoked spiking and NEX to propagate in the network to engage as many neurons as possible in the dynamics driven by the scene. Even if the neurons are only engaged sub-threshold, this makes the solution of the network robust. The subsequent NINH appearing locally in the network at 100–110 ms, removes excess spiking outside the part of the network engaged in mapping the progress of the bar, and hence probably sharpens and further stabilizes perception (Movies <xref ref-type="supplementary-material" rid="SM1">1</xref>–<xref ref-type="supplementary-material" rid="SM3">3</xref>). It remains to be tested whether the dynamic separation also works in single trials. This question was not possible to answer with our present data.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="s5">
      <title>Conclusions</title>
      <p>We measured the balance between net-excitation, NEX, and net-inhibition, NINH, in the network of dendrites and un-myelinated axons in the upper layers of four visual areas. Our results complement studies of the excitation-inhibition balance in the cell bodies of single neurons. The appearance of visual scenes with moving objects elicited longer, 70–200 ms lasting episodes with larger deviations of NEX and NINH from baseline, and at times, sequences of several NEXs and NINHs, implying that it took some 600–700 ms for the balance to return to the state of small fluctuations. These results are incompatible with a fast, tight balance between excitatory and inhibitory currents and with the behavior of a classic balanced network (van Vreeswijk and Sompolinsky, <xref rid="B62" ref-type="bibr">1996</xref>). Locally in the network, in all four areas, the amount of NINH with a delay matched the amounts of NEX for these episodes. The NEX and NINH thus were also matched spatially in the network, in our case within 800 ms, by local inhibition. Thus, the network should return to the baseline or pre-stimulus state, when the last episode of NINH is finished.</p>
      <p>The <italic>temporal</italic> dynamics of the changes in the population membrane potentials, the dVSD(t)/dt, spread to all zones of the visual areas with similar trajectories resembling those of a mono-stable excitable system. In contrast to the temporal dynamics of the dVSD(t)/dt and hence the NEX and NINH, the NINH and NEX space-time dynamics in anatomical space as well as in abstract state space explained how differences evolved to distinguish simple visual scenes. We do not know whether these mechanisms also will explain differences in natural, complex scenes. Space-time dynamics of the changes in the balance between excitation and inhibition evolved at a much larger scale than that used to examine receptive fields changes in single neurons. The space-time dynamics are missed with local probes, and are only captured by a high frequency sampling network approach. The results of the collaboration in this large network were succinctly described as diverging trajectories after 50–88 ms on a low-dimensional (manifold) in state space. The network in the four areas operated with similar local temporal dynamics to the presentation of the visual scenes, whereas its (average) spatio-temporal dynamics evolved to distinguish the scenes.</p>
    </sec>
    <sec id="s6">
      <title>Author contributions</title>
      <p>PR and MH designed the experiments, MH did the experiments, LB, LF, and PR designed and did the data analysis. PR wrote the final version of the manuscript.</p>
      <sec>
        <title>Conflict of interest statement</title>
        <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Sofie Phødenphant Jensen, Anne Brandt Nielsen for programming, Lyle Müller for the Hilbert phase lag code, and John Hertz for comments. Supported by the Dynamical Systems Interdisciplinary Network, Copenhagen University.</p>
    </ack>
    <sec sec-type="supplementary-material" id="s7">
      <title>Supplementary material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnsys.2017.00014/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnsys.2017.00014/full#supplementary-material</ext-link></p>
      <supplementary-material content-type="local-data" id="SM1">
        <label>Movie 1</label>
        <caption>
          <p><bold>Evoked spiking in the granular layer to a scene with a stationary bar shown at time 0–250 ms</bold>. The movie starts 200 ms prior to stimulus onset. The electrode penetrations are marked with white circles on the photodiode map. The magenta curve marks the position of the cytoarchtectural border between areas 17 and 18 (Methods), which obscured one channel to the right. The color scale shows how many trials (out of maximum number of trials) that are evoked. Note the evoked spiking outside the zone mapping the CFOV shortly after stimulus onset.</p>
        </caption>
        <media xlink:href="Video1.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM2">
        <label>Movie 2</label>
        <caption>
          <p><bold>Evoked spiking in the supragranular layers to a scene with a stationary bar shown at time 0–250 ms</bold>. Conventions as in Movie <xref ref-type="supplementary-material" rid="SM1">1</xref>.</p>
        </caption>
        <media xlink:href="Video2.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM3">
        <label>Movie 3</label>
        <caption>
          <p><bold>Evoked spiking in the granular layer to a scene with a bar moving up from the CFOV</bold>.</p>
        </caption>
        <media xlink:href="Video3.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM4">
        <label>Movie 4</label>
        <caption>
          <p><bold>Space-time dynamics of statistically significant NEX and NINH (FDR methods &lt; 0.05) in one animal to a scene with a bar moving down from the CFOV</bold>. The color scale values should be multiplied with 10<sup>−6</sup>. Magenta curves show cytoarchitectural borders between areas. The time in ms after the start is shown in yellow. Light blue marks non-significant changes in dVSD(t)/dt, here between −3 and 3 10<sup>−7</sup>. NINH in blue and dark blue, NEX in green yellow, beige red.</p>
        </caption>
        <media xlink:href="Video4.MPG">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM5">
        <label>Movie 5</label>
        <caption>
          <p><bold>Space-time dynamics of statistically significant NEX and NINH (FDR methods &lt; 0.05) in one animal to a scene with a bar moving up from the CFOV</bold>. The color scale values should be multiplied with 10<sup>−6</sup>. Light blue marks non-significant changes in dVSD(t)/dt, here between −4 and 4 10<sup>−7</sup>. Other conventions as in Movie <xref ref-type="supplementary-material" rid="SM4">4</xref>.</p>
        </caption>
        <media xlink:href="Video5.MPG">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM6">
        <label>Movie 6</label>
        <caption>
          <p><bold>Space-time dynamics of statistically significant NEX and NINH (FDR methods &lt; 0.05) in one animal to a scene with a bar moving down from the peripheral field of view</bold>. The color scale values should be multiplied with 10<sup>−6</sup>. Light blue marks non-significant changes in dVSD(t)/dt, here between −7 and 7 10<sup>−7</sup>. Other conventions as in Movie <xref ref-type="supplementary-material" rid="SM11">11</xref>.</p>
        </caption>
        <media xlink:href="Video6.MPG">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM7">
        <label>Movie 7</label>
        <caption>
          <p><bold>Space-time dynamics of statistically significant NEX and NINH (FDR methods &lt; 0.05) in one animal to a scene with a bar moving up from the peripheral field of view</bold>. The color scale values should be multiplied with 10<sup>−6</sup>. Light blue marks non-significant changes in dVSD(t)/dt, here between −10 and 10 10<sup>−7</sup>. Other conventions as in Movie <xref ref-type="supplementary-material" rid="SM11">11</xref>.</p>
        </caption>
        <media xlink:href="Video7.MPG">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM8">
        <label>Movie 8</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all visual scenes for animal 2</bold>. The panels are 6 projections of the 4-dimensional state-space explaining more than 94% of the total variance. Color codes: blue, scene with bar moving down from the CFOV, green, scene with bar moving up from CFOV; light blue, scene with bar moving down from the peripheral field of view; purple, scene with bar moving up from the peripheral field of view; yellow, scene with stationary bar. Remaining animals had similar good separation of the scenes, especially by principal components 2 and 3.</p>
        </caption>
        <media xlink:href="Video8.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM9">
        <label>Movie 9</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 5 visual scenes for animal 3</bold>.</p>
        </caption>
        <media xlink:href="Video9.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM10">
        <label>Movie 10</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 6 visual scenes for animal 4</bold>. The 6th scene was two bars moving toward each other to occlude each other at 413 ms (Harvey and Roland, <xref rid="B27" ref-type="bibr">2013</xref>). This condition is now yellow; the stationary object condition now gray.</p>
        </caption>
        <media xlink:href="Video10.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM11">
        <label>Movie 11</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 6 visual scenes for animal 5</bold>.</p>
        </caption>
        <media xlink:href="Video11.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM12">
        <label>Movie 12</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 6 visual scenes for animal 6</bold>.</p>
        </caption>
        <media xlink:href="Video12.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM13">
        <label>Movie 13</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 6 visual scenes for animal 7</bold>.</p>
        </caption>
        <media xlink:href="Video13.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM14">
        <label>Movie 14</label>
        <caption>
          <p><bold>State-space displays of trajectories of spatial principal components (PC) of VSD(t) of all 6 visual scenes for animal 8</bold>.</p>
        </caption>
        <media xlink:href="Video14.MP4">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SM15">
        <label>Movie 15</label>
        <caption>
          <p><bold>Space-time dynamics of phase relations of the VSD(t) of network of six animals (Methods)</bold>. The VSD(t) in each channel in the time period shown was normalized to the maximal value of 1. Notice the advance of the VSD(t) increase in areas 19/21 initially.</p>
        </caption>
        <media xlink:href="Video15.MPG">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>B.</given-names></name><name><surname>Hanazawa</surname><given-names>A.</given-names></name><name><surname>Undeman</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>D.</given-names></name><name><surname>Valentiniene</surname><given-names>S.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Cortical dynamics subserving visual apparent motion</article-title>. <source>Cereb. Cortex</source>
<volume>18</volume>, <fpage>2796</fpage>–<lpage>2810</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhn038</pub-id><?supplied-pmid 18375528?><pub-id pub-id-type="pmid">18375528</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>J. S.</given-names></name><name><surname>Carandini</surname><given-names>M.</given-names></name><name><surname>Ferster</surname><given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>Orientation tuning of input conductance, excitation, and inhibition in cat primary visual cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>84</volume>, <fpage>909</fpage>–<lpage>926</lpage>. <?supplied-pmid 10938316?><pub-id pub-id-type="pmid">10938316</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arieli</surname><given-names>A.</given-names></name><name><surname>Shoham</surname><given-names>D.</given-names></name><name><surname>Hildesheim</surname><given-names>R.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Coherent spatiotemporal patterns of ongoing activity revealed by real-time optical imaging coupled with single-unit recording in the cat visual cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>73</volume>, <fpage>2072</fpage>–<lpage>2093</lpage>. <?supplied-pmid 7623099?><pub-id pub-id-type="pmid">7623099</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayzenshtat</surname><given-names>I.</given-names></name><name><surname>Meirovithz</surname><given-names>E.</given-names></name><name><surname>Edelman</surname><given-names>H.</given-names></name><name><surname>Werner-Reiss</surname><given-names>U.</given-names></name><name><surname>Bienenstock</surname><given-names>E.</given-names></name><name><surname>Abeles</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Precise spatiotemporal patterns among visual cortical areas and their relation to visual stimulus processing</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>11232</fpage>–<lpage>11245</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5177-09.2010</pub-id><?supplied-pmid 20720131?><pub-id pub-id-type="pmid">20720131</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>H.</given-names></name></person-group> (<year>1961</year>). <article-title>Possible principles underlying the transformations of sensory messages</article-title>, in <source>Sensory communication</source>, ed <person-group person-group-type="editor"><name><surname>Rosenblith</surname><given-names>W. A.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>MIT Press</publisher-name>), <fpage>217</fpage>–<lpage>234</lpage>.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudot</surname><given-names>P.</given-names></name><name><surname>Levy</surname><given-names>M.</given-names></name><name><surname>Marre</surname><given-names>O.</given-names></name><name><surname>Monier</surname><given-names>C.</given-names></name><name><surname>Pananceau</surname><given-names>M.</given-names></name><name><surname>Frégnac</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Animation of natural scene by virtual eye-movements evokes high precision and low noise in V1 neurons</article-title>. <source>Front. Neural Circuits</source>
<volume>7</volume>:<fpage>206</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2013.00206</pub-id><?supplied-pmid 24409121?><pub-id pub-id-type="pmid">24409121</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y.</given-names></name><name><surname>Hochberg</surname><given-names>Y.</given-names></name></person-group> (<year>1995</year>). <article-title>Controlling the false discovery rate- a practical and powerful approach to multiple testing</article-title>. <source>J. R. Stat. Soc. B Methodol.</source>
<volume>57</volume>, <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>T.</given-names></name><name><surname>Borgdorff</surname><given-names>A.</given-names></name><name><surname>Crochet</surname><given-names>S.</given-names></name><name><surname>Neubauer</surname><given-names>F. B.</given-names></name><name><surname>Lefort</surname><given-names>S.</given-names></name><name><surname>Fauvet</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Combined voltage and calcium epiflourescence imaging in vitro and in vivo reveals subthreshold and suprathreshold dynamics of mouse barrel cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>97</volume>, <fpage>3751</fpage>–<lpage>3762</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01178.2006</pub-id><?supplied-pmid 17360827?><pub-id pub-id-type="pmid">17360827</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavane</surname><given-names>F.</given-names></name><name><surname>Sharon</surname><given-names>D.</given-names></name><name><surname>Jancke</surname><given-names>D.</given-names></name><name><surname>Marre</surname><given-names>O.</given-names></name><name><surname>Fregnac</surname><given-names>Y.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Lateral spread of orientation selectivity in V1 is controlled by intracortical cooperativity</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>5</volume>:<fpage>4</fpage>
<pub-id pub-id-type="doi">10.3389/fnsys.2011.00004</pub-id><?supplied-pmid 21629708?><pub-id pub-id-type="pmid">21629708</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chemla</surname><given-names>S.</given-names></name><name><surname>Chavane</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Effects of GABA-A kinetics on cortical population activity: computational studies and physiological confirmations</article-title>. <source>J. Neurophysiol.</source>
<volume>115</volume>, <fpage>2867</fpage>–<lpage>2879</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00352.2015</pub-id><pub-id pub-id-type="pmid">26912588</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-M.</given-names></name><name><surname>Lakatos</surname><given-names>P.</given-names></name><name><surname>Shah</surname><given-names>A. S.</given-names></name><name><surname>Mehta</surname><given-names>A. D.</given-names></name><name><surname>Givre</surname><given-names>S. D.</given-names></name><name><surname>Javitt</surname><given-names>D. C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys</article-title>. <source>Cereb. Cortex</source>
<volume>17</volume>, <fpage>1561</fpage>–<lpage>1569</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhl067</pub-id><?supplied-pmid 16950866?><pub-id pub-id-type="pmid">16950866</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>L. B.</given-names></name><name><surname>Salzberg</surname><given-names>B. M.</given-names></name><name><surname>Davila</surname><given-names>H. V.</given-names></name><name><surname>Ross</surname><given-names>W. N.</given-names></name><name><surname>Landowne</surname><given-names>D.</given-names></name></person-group> (<year>1974</year>). <article-title>Changes in axon fluorescence during activity: molecular probes of membrane potential</article-title>. <source>J. Membr. Biol.</source>
<volume>19</volume>, <fpage>1</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/BF01869968</pub-id><?supplied-pmid 4431037?><pub-id pub-id-type="pmid">4431037</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creutzfeldt</surname><given-names>O. D.</given-names></name><name><surname>Kuhnt</surname><given-names>U.</given-names></name><name><surname>Benevento</surname><given-names>L. A.</given-names></name></person-group> (<year>1974</year>). <article-title>An intracellular analysis of visual cortical neurons to moving stimuli: responses in a co-operative neuronal network</article-title>. <source>Exp. Brain Res.</source>
<volume>21</volume>, <fpage>251</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1007/BF00235746</pub-id><pub-id pub-id-type="pmid">4374364</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deco</surname><given-names>G.</given-names></name><name><surname>Roland</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of multi-area interactions for the computation of apparent motion</article-title>. <source>Neuroimage</source>
<volume>51</volume>, <fpage>1018</fpage>–<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.03.032</pub-id><?supplied-pmid 20303411?><pub-id pub-id-type="pmid">20303411</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehghani</surname><given-names>N.</given-names></name><name><surname>Peyrache</surname><given-names>A.</given-names></name><name><surname>Telenczuk</surname><given-names>B.</given-names></name><name><surname>Le van Quyen</surname><given-names>M.</given-names></name><name><surname>Halgren</surname><given-names>E.</given-names></name><name><surname>Cash</surname><given-names>S. S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Dynamic balance of excitation and inhibition in human and monkey neocortex</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>:<fpage>23176</fpage>. <pub-id pub-id-type="doi">10.1038/srep23176</pub-id><?supplied-pmid 26980663?><pub-id pub-id-type="pmid">26980663</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denéve</surname><given-names>S.</given-names></name><name><surname>Machens</surname><given-names>C. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Efficient codes and balanced networks</article-title>. <source>Nat. Neurosci.</source>
<volume>19</volume>, <fpage>375</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4243</pub-id><?supplied-pmid 26906504?><pub-id pub-id-type="pmid">26906504</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Destexhe</surname><given-names>A.</given-names></name><name><surname>Pare</surname><given-names>D.</given-names></name></person-group> (<year>1999</year>). <article-title>Impact of network activity on the integrative properties of neorcortical pyramidal neurons <italic>in vivo</italic></article-title>. <source>J. Neurophysiol.</source>
<volume>81</volume>, <fpage>1531</fpage>–<lpage>1547</lpage>. <?supplied-pmid 10200189?><pub-id pub-id-type="pmid">10200189</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>D.</given-names></name><name><surname>Tompa</surname><given-names>T.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Non-linear population firing rates and voltage sensitive dye signals in visual areas 17 and 18 to short duration stimuli</article-title>. <source>PLoS ONE</source>
<volume>3</volume>:<fpage>e2673</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0002673</pub-id><?supplied-pmid 18628825?><pub-id pub-id-type="pmid">18628825</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>D.</given-names></name><name><surname>Valentiniene</surname><given-names>S.</given-names></name><name><surname>Papaioannou</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Relating information, encoding and adaptation: decoding the population firing rate in visual areas 17/18 as response to stimulus transition</article-title>. <source>PLoS ONE</source>
<volume>5</volume>:<fpage>e10327</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010327</pub-id><?supplied-pmid 20436907?><pub-id pub-id-type="pmid">20436907</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferezou</surname><given-names>I.</given-names></name><name><surname>Bolea</surname><given-names>S.</given-names></name><name><surname>Petersen</surname><given-names>C. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Visualizing the cortical representation of whisker touch: voltage-sensitive dye imaging in freely moving mice</article-title>. <source>Neuron</source>
<volume>50</volume>, <fpage>617</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.043</pub-id><?supplied-pmid 16701211?><pub-id pub-id-type="pmid">16701211</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fiala</surname><given-names>J. C.</given-names></name><name><surname>Harris</surname><given-names>K. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Dendrite structure</article-title>, in <source>Dendrites</source>, eds <person-group person-group-type="editor"><name><surname>Stuart</surname><given-names>G.</given-names></name><name><surname>Spruston</surname><given-names>N.</given-names></name><name><surname>Häusser</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>1</fpage>–<lpage>34</lpage>.</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsberg</surname><given-names>L. E.</given-names></name><name><surname>Bonde</surname><given-names>L. H.</given-names></name><name><surname>Harvey</surname><given-names>M. A.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2016</year>). <article-title>The second spiking threshold: dynamics of laminar network spiking in the visual cortex</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>10</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2016.00065</pub-id><?supplied-pmid 27582693?><pub-id pub-id-type="pmid">27582693</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinvald</surname><given-names>A.</given-names></name><name><surname>Lieke</surname><given-names>E. E.</given-names></name><name><surname>Frostig</surname><given-names>R. D.</given-names></name><name><surname>Hildesheim</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Cortical point-spread function and long-range lateral interactions revealed by real-time optical imaging of macaque monkey primary visual cortex</article-title>. <source>J. Neurosci.</source>
<volume>14</volume>, <fpage>2545</fpage>–<lpage>2568</lpage>. <?supplied-pmid 8182427?><pub-id pub-id-type="pmid">8182427</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>C. G.</given-names></name><name><surname>Rocha-Miranda</surname><given-names>C. E.</given-names></name><name><surname>Bender</surname><given-names>D. B.</given-names></name></person-group> (<year>1972</year>). <article-title>Visual properties of neurons in inferotemporal cortex of the Macaque</article-title>. <source>J. Neurophysiol.</source>
<volume>35</volume>, <fpage>96</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2010.00028</pub-id><?supplied-pmid 4621506?><pub-id pub-id-type="pmid">4621506</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>B.</given-names></name><name><surname>Duque</surname><given-names>A.</given-names></name><name><surname>Hasenstaub</surname><given-names>A. R.</given-names></name><name><surname>McCormick</surname><given-names>D. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Neocortical network activity <italic>in vivo</italic> is generated through a dynamic balance of excitation and inhibition</article-title>. <source>J. Neurosci.</source>
<volume>26</volume>, <fpage>4535</fpage>–<lpage>4545</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5297-05.2006</pub-id><?supplied-pmid 16641233?><pub-id pub-id-type="pmid">16641233</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>B.</given-names></name><name><surname>Häusser</surname><given-names>M.</given-names></name><name><surname>Carandini</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Inhibition dominates sensory responses in the awake cortex</article-title>. <source>Nature</source>
<volume>493</volume>, <fpage>97</fpage>–<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1038/nature11665</pub-id><?supplied-pmid 23172139?><pub-id pub-id-type="pmid">23172139</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>M. A.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Laminar firing and membrane dynamics in four visual areas exposed to two objects moving to occlusion</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>7</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2013.00023</pub-id><?supplied-pmid 23805082?><pub-id pub-id-type="pmid">23805082</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>M. A.</given-names></name><name><surname>Valentiniene</surname><given-names>S.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Cortical membrane potential dynamics and laminar firing during object motion</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>3</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.3389/neuro.06.007.2009</pub-id><?supplied-pmid 19753323?><pub-id pub-id-type="pmid">19753323</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubel</surname><given-names>D. H.</given-names></name><name><surname>Wiesel</surname><given-names>T. N.</given-names></name></person-group> (<year>1959</year>). <article-title>Receptive fields of single neurons in the cat‘s striate cortex</article-title>. <source>J. Physiol.</source>
<volume>148</volume>, <fpage>574</fpage>–<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1959.sp006308</pub-id><pub-id pub-id-type="pmid">14403679</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huys</surname><given-names>R.</given-names></name><name><surname>Jirsa</surname><given-names>V. K.</given-names></name><name><surname>Darokhan</surname><given-names>Z.</given-names></name><name><surname>Valentiniene</surname><given-names>S.</given-names></name><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Visually evoked spiking evolves while spontaneous ongoing dynamics persist</article-title>. <source>Front. Syst. Neurosci</source>. <volume>9</volume>:<fpage>183</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2015.00183</pub-id><?supplied-pmid 26778982?><pub-id pub-id-type="pmid">26778982</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izhikevich</surname><given-names>E. M.</given-names></name><name><surname>Edelman</surname><given-names>G. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Large-scale model of mammalian thalamocortical systems</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>3593</fpage>–<lpage>3598</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0712231105</pub-id><?supplied-pmid 18292226?><pub-id pub-id-type="pmid">18292226</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jancke</surname><given-names>D.</given-names></name><name><surname>Chavane</surname><given-names>F.</given-names></name><name><surname>Naaman</surname><given-names>S.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Imaging cortical correlates of illusion in early visual cortex</article-title>. <source>Nature</source>
<volume>428</volume>, <fpage>423</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1038/nature02396</pub-id><?supplied-pmid 15042090?><pub-id pub-id-type="pmid">15042090</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisvarday</surname><given-names>Z. F.</given-names></name><name><surname>Toth</surname><given-names>E.</given-names></name><name><surname>Rausch</surname><given-names>M.</given-names></name><name><surname>Eysel</surname><given-names>U. T.</given-names></name></person-group> (<year>1997</year>). <article-title>Orientation-specific relationship between populations of excitatory and inhibitory lateral connections in the visual cortex of the cat</article-title>. <source>Cereb. Cortex</source>
<volume>7</volume>, <fpage>605</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/7.7.605</pub-id><?supplied-pmid 9373017?><pub-id pub-id-type="pmid">9373017</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Schrader</surname><given-names>S.</given-names></name><name><surname>Aertsen</surname><given-names>A.</given-names></name><name><surname>Rotter</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>The high conductance state of cortical networks</article-title>. <source>Neural Comput.</source>
<volume>20</volume>, <fpage>1</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1162/neco.2008.20.1.1</pub-id><?supplied-pmid 18044999?><pub-id pub-id-type="pmid">18044999</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malagarriga</surname><given-names>D.</given-names></name><name><surname>Villa</surname><given-names>A. E. P.</given-names></name><name><surname>Garcia-Ojalvo</surname><given-names>J.</given-names></name><name><surname>Pons</surname><given-names>A. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Mesoscopic segregation of excitation and inhibition in a brain network model</article-title>. <source>PLoS Comput. Biol.</source>
<volume>11</volume>:<fpage>e1004007</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004007</pub-id><?supplied-pmid 25671573?><pub-id pub-id-type="pmid">25671573</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markounikau</surname><given-names>V.</given-names></name><name><surname>Igel</surname><given-names>C.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name><name><surname>Jancke</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>A dynamic neural field model of mesoscopic cortical activity capturted with voltage-sensitive dye imaging (20010)</article-title>. <source>PLoS Comput. Biol.</source>
<volume>6</volume>:<fpage>e1000919</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1000919</pub-id><pub-id pub-id-type="pmid">20838578</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>H.</given-names></name><name><surname>Muller</surname><given-names>E.</given-names></name><name><surname>Ramaswamy</surname><given-names>S.</given-names></name><name><surname>Reimann</surname><given-names>M. W.</given-names></name><name><surname>Abdellah</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>C. A.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Reconstruction and simulation of neocortical microcircuity</article-title>. <source>Cell</source>
<volume>163</volume>, <fpage>456</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.09.029</pub-id><?supplied-pmid 26451489?><pub-id pub-id-type="pmid">26451489</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>L. M.</given-names></name><name><surname>Alonso</surname><given-names>J. M.</given-names></name><name><surname>Reid</surname><given-names>R. C.</given-names></name><name><surname>Hirsch</surname><given-names>J. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Laminar processing of stimulus orientation in cat visual cortex</article-title>. <source>J. Physiol.</source>
<volume>540</volume>, <fpage>321</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2001.012776</pub-id><?supplied-pmid 11927690?><pub-id pub-id-type="pmid">11927690</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mennerick</surname><given-names>S.</given-names></name><name><surname>Chisari</surname><given-names>M.</given-names></name><name><surname>Shu</surname><given-names>H.-J.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Vasek</surname><given-names>M.</given-names></name><name><surname>Eisenmann</surname><given-names>L. N.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Diverse voltage sensitive dyes modulate GABA-A receptor function</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>2871</fpage>–<lpage>2879</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5607-09.2010</pub-id><pub-id pub-id-type="pmid">20181584</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monier</surname><given-names>C.</given-names></name><name><surname>Chavane</surname><given-names>F.</given-names></name><name><surname>Baudot</surname><given-names>P.</given-names></name><name><surname>Graham</surname><given-names>L. J.</given-names></name><name><surname>Frégnac</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Orientation and direction selectivity of synaptic inputs in visual cortical neurons: a diversity of combinations produces spike tuning</article-title>. <source>Neuron</source>
<volume>37</volume>, <fpage>663</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00064-3</pub-id><?supplied-pmid 12597863?><pub-id pub-id-type="pmid">12597863</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monier</surname><given-names>C.</given-names></name><name><surname>Fournier</surname><given-names>J.</given-names></name><name><surname>Frégnac</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> measures of evoked excitatory and inhibitory conductance dynamics in sensory cortices</article-title>. <source>J. Neurosci. Methods</source>
<volume>169</volume>, <fpage>323</fpage>–<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2007.11.008</pub-id><?supplied-pmid 18215425?><pub-id pub-id-type="pmid">18215425</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>L.</given-names></name><name><surname>Reynaud</surname><given-names>A.</given-names></name><name><surname>Chavane</surname><given-names>F.</given-names></name><name><surname>Destexhe</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The stimulus evoked population response in visual cortex of awake monkey is a propagating wave</article-title>. <source>Nat. Commun.</source>
<volume>5</volume>:<fpage>3675</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms4675</pub-id><?supplied-pmid 24770473?><pub-id pub-id-type="pmid">24770473</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>M.</given-names></name><name><surname>Lampl</surname><given-names>I.</given-names></name></person-group> (<year>2008</year>). <article-title>Instantaneous correlation of excitation and inhibition during ongoing and sensory-evoked activities</article-title>. <source>Nat. Neurosci.</source>
<volume>11</volume>, <fpage>535</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2105</pub-id><?supplied-pmid 18376400?><pub-id pub-id-type="pmid">18376400</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onat</surname><given-names>S.</given-names></name><name><surname>König</surname><given-names>P.</given-names></name><name><surname>Jancke</surname><given-names>D.</given-names></name></person-group> (<year>2011a</year>). <article-title>Natural scene evoked population dynamics across cat primary visual cortex captured with voltage-sensitive dye imaging</article-title>. <source>Cereb. Cortex</source>
<volume>21</volume>, <fpage>2542</fpage>–<lpage>2554</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr038</pub-id><?supplied-pmid 21459837?><pub-id pub-id-type="pmid">21459837</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onat</surname><given-names>S.</given-names></name><name><surname>Nortmann</surname><given-names>N.</given-names></name><name><surname>Rekauzke</surname><given-names>S.</given-names></name><name><surname>König</surname><given-names>P.</given-names></name><name><surname>Jancke</surname><given-names>D.</given-names></name></person-group> (<year>2011b</year>). <article-title>Independent encoding of gtrating motion across stationary feature maps in primary visual cortex visualized with voltage-sensitive dye imaging</article-title>. <source>Neuroimage</source>
<volume>55</volume>, <fpage>1763</fpage>–<lpage>1770</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.01.004</pub-id><?supplied-pmid 21232616?><pub-id pub-id-type="pmid">21232616</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>C. C.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name><name><surname>Sakmann</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Spatiotemporal dynamics of sensory responses in layer 2/3 of rat barrel cortex measured <italic>in vivo</italic> by voltage-sensitive dye imaging combined with whole-cell voltage recordings and neuron reconstructions</article-title>. <source>J. Neurosci.</source>
<volume>23</volume>, <fpage>1298</fpage>–<lpage>1309</lpage>. <?supplied-pmid 12598618?><pub-id pub-id-type="pmid">12598618</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priebe</surname><given-names>N.</given-names></name><name><surname>Ferster</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Direction selectivity of excitation and inhibition in simple cells of the cat primary visual cortex</article-title>. <source>Neuron</source>
<volume>45</volume>, <fpage>133</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.024</pub-id><?supplied-pmid 15629708?><pub-id pub-id-type="pmid">15629708</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangan</surname><given-names>A. V.</given-names></name><name><surname>Cai</surname><given-names>D.</given-names></name><name><surname>McLaughlin</surname><given-names>D. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Modeling the spatiotemporal cortical activity associated with the line-motion illusion in primary visual cortex</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>
<volume>102</volume>, <fpage>18793</fpage>–<lpage>18800</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0509481102</pub-id><?supplied-pmid 16380423?><pub-id pub-id-type="pmid">16380423</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rappelsberger</surname><given-names>P.</given-names></name><name><surname>Pockberger</surname><given-names>H.</given-names></name><name><surname>Petsche</surname><given-names>H.</given-names></name></person-group> (<year>1981</year>). <article-title>Current source density analysis: methods and application to simultaneously recorded field potential of the rabbit's visual cortex</article-title>. <source>Phlügers Arch.</source>
<volume>389</volume>, <fpage>159</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1007/BF00582108</pub-id><?supplied-pmid 6259585?><pub-id pub-id-type="pmid">6259585</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>R. C.</given-names></name><name><surname>Victor</surname><given-names>J. D.</given-names></name><name><surname>Shapley</surname><given-names>R. M.</given-names></name></person-group> (<year>1997</year>). <article-title>The use of m-sequences in the analysis of visual neurons: linear receptive field properties</article-title>. <source>Vis. Neurosci.</source>
<volume>14</volume>, <fpage>1015</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1017/S0952523800011743</pub-id><?supplied-pmid 9447685?><pub-id pub-id-type="pmid">9447685</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richmond</surname><given-names>B. J.</given-names></name><name><surname>Optican</surname><given-names>L. M.</given-names></name></person-group> (<year>1990</year>). <article-title>Temporal encoding of two-dimensional patterns by single units in primate primary visual cortex. II. Information transmission</article-title>. <source>J. Neurophysiol.</source>
<volume>64</volume>, <fpage>370</fpage>–<lpage>380</lpage>. <?supplied-pmid 2213123?><pub-id pub-id-type="pmid">2213123</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ries</surname><given-names>C. R.</given-names></name><name><surname>Puil</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Ionic mechanism of isoflurane's action on thalamo-cortical neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>81</volume>, <fpage>1802</fpage>–<lpage>1809</lpage>.<pub-id pub-id-type="pmid">10200214</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Dynamic depolarization fields in the cerebral cortex</article-title>. <source>Trends Neurosci.</source>
<volume>25</volume>, <fpage>183</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-2236(00)02125-1</pub-id><?supplied-pmid 11998686?><pub-id pub-id-type="pmid">11998686</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>P. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Six principles of visual cortical dynamics</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>4</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2010.00028</pub-id><?supplied-pmid 20661451?><pub-id pub-id-type="pmid">20661451</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>P. E.</given-names></name><name><surname>Hanazawa</surname><given-names>A.</given-names></name><name><surname>Undeman</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>D.</given-names></name><name><surname>Tompa</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Cortical feedback depolarization waves: a mechanism of top-down influence on early visual areas</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>103</volume>, <fpage>12586</fpage>–<lpage>12591</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0604925103</pub-id><?supplied-pmid 16891418?><pub-id pub-id-type="pmid">16891418</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>P. E.</given-names></name><name><surname>Hilgetag</surname><given-names>C. C.</given-names></name><name><surname>Deco</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Cortico-cortical communication dynamics</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>8</volume>:<fpage>19</fpage>
<pub-id pub-id-type="doi">10.3389/fnsys.2014.00019</pub-id><pub-id pub-id-type="pmid">24847217</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>M.</given-names></name><name><surname>Pospischil</surname><given-names>M.</given-names></name><name><surname>Timofeev</surname><given-names>I.</given-names></name><name><surname>Destexhe</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Inhibition determines membrane potential dynamics and controls action potential generation in awake and sleeping cat cortex</article-title>. <source>J. Neurosci.</source>
<volume>27</volume>, <fpage>5280</fpage>–<lpage>5290</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4652-06.2007</pub-id><?supplied-pmid 17507551?><pub-id pub-id-type="pmid">17507551</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senseman</surname><given-names>D. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Correspondance between visually evoked voltage-sensitive dye signals and synaptic activity recorded in cortical pyramidal cells with intracellular microelectrodes</article-title>. <source>Vis. Neurosci.</source>
<volume>13</volume>, <fpage>963</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1017/S0952523800009196</pub-id><?supplied-pmid 8903037?><pub-id pub-id-type="pmid">8903037</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slovin</surname><given-names>H.</given-names></name><name><surname>Arieli</surname><given-names>A.</given-names></name><name><surname>Hildesheim</surname><given-names>R.</given-names></name><name><surname>Grinvald</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Long-term voltage-sensitive dye imaging reveals cortical dynamics in behaving monkeys</article-title>. <source>J. Neurophysiol.</source>
<volume>88</volume>, <fpage>3421</fpage>–<lpage>3438</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00194.2002</pub-id><?supplied-pmid 12466458?><pub-id pub-id-type="pmid">12466458</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>A. Y. Y.</given-names></name><name><surname>Brown</surname><given-names>B. D.</given-names></name><name><surname>Scholl</surname><given-names>B.</given-names></name><name><surname>Mohanty</surname><given-names>D.</given-names></name><name><surname>Priebe</surname><given-names>N. J</given-names></name></person-group> (<year>2011</year>). <article-title>Orientation selectivity of synaptic input to neurons in mouse and cat visual cortex</article-title>. <source>J. Neurosci.</source>
<volume>34</volume>, <fpage>12339</fpage>–<lpage>12350</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2039-11.2011</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorpe</surname><given-names>S.</given-names></name><name><surname>Fize</surname><given-names>D.</given-names></name><name><surname>Marlot</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>). <article-title>Speed of processing in the human visual system</article-title>. <source>Nature</source>
<volume>381</volume>, <fpage>520</fpage>–<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1038/381520a0</pub-id><?supplied-pmid 8632824?><pub-id pub-id-type="pmid">8632824</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Vreeswijk</surname><given-names>C.</given-names></name><name><surname>Sompolinsky</surname><given-names>H.</given-names></name></person-group> (<year>1996</year>). <article-title>Chaos in neural networks with balanced excitatory and inhibitory activity</article-title>. <source>Science</source>
<volume>274</volume>, <fpage>1724</fpage>–<lpage>1726</lpage>. <pub-id pub-id-type="doi">10.1126/science.274.5293.1724</pub-id><pub-id pub-id-type="pmid">8939866</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>S. R.</given-names></name><name><surname>Mitchell</surname><given-names>S. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Direct measurement of somatic voltage clamp errors in central neurons</article-title>. <source>Nat. Neurosci.</source>
<volume>11</volume>, <fpage>790</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2137</pub-id><?supplied-pmid 18552844?><pub-id pub-id-type="pmid">18552844</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Atallah</surname><given-names>B. V.</given-names></name><name><surname>Scanziani</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Equalizing excitation-inhibition ratios across visual cortical neurons</article-title>. <source>Nature</source>
<volume>511</volume>, <fpage>596</fpage>–<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1038/nature13321</pub-id><?supplied-pmid 25043046?><pub-id pub-id-type="pmid">25043046</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <glossary>
      <def-list>
        <title>Abbreviations</title>
        <def-item>
          <term>CFOV</term>
          <def>
            <p>center of field of view</p>
          </def>
        </def-item>
        <def-item>
          <term>FDR</term>
          <def>
            <p>false discovery rate</p>
          </def>
        </def-item>
        <def-item>
          <term>FOV</term>
          <def>
            <p>field of view</p>
          </def>
        </def-item>
        <def-item>
          <term>MUA</term>
          <def>
            <p>multi-unit activity</p>
          </def>
        </def-item>
        <def-item>
          <term>NEX</term>
          <def>
            <p>net excitation</p>
          </def>
        </def-item>
        <def-item>
          <term>NINH</term>
          <def>
            <p>net inhibition</p>
          </def>
        </def-item>
        <def-item>
          <term>VSD(t)</term>
          <def>
            <p>averaged voltage sensitive dye signal.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
  </back>
</article>

</metadata></record><resumptionToken>oai%3Apubmedcentral.nih.gov%3A5360109!2017-04-04!2017-04-05!pmc!</resumptionToken></ListRecords></OAI-PMH>